Citrus Sinensis ID: 005001
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 720 | 2.2.26 [Sep-21-2011] | |||||||
| Q6R2J8 | 703 | Protein STRUBBELIG-RECEPT | yes | no | 0.961 | 0.984 | 0.738 | 0.0 | |
| Q9C8M9 | 719 | Protein STRUBBELIG-RECEPT | no | no | 0.934 | 0.936 | 0.518 | 0.0 | |
| Q9LUL4 | 717 | Protein STRUBBELIG-RECEPT | no | no | 0.941 | 0.945 | 0.505 | 1e-180 | |
| Q6R2K1 | 699 | Protein STRUBBELIG-RECEPT | no | no | 0.931 | 0.959 | 0.459 | 1e-175 | |
| Q6R2K2 | 687 | Protein STRUBBELIG-RECEPT | no | no | 0.902 | 0.946 | 0.448 | 1e-155 | |
| Q06BH3 | 775 | Protein STRUBBELIG-RECEPT | no | no | 0.931 | 0.865 | 0.452 | 1e-153 | |
| Q9FG24 | 735 | Protein STRUBBELIG-RECEPT | no | no | 0.909 | 0.891 | 0.410 | 1e-135 | |
| Q6R2K3 | 776 | Protein STRUBBELIG-RECEPT | no | no | 0.430 | 0.399 | 0.625 | 1e-108 | |
| Q8RWZ1 | 768 | Protein STRUBBELIG OS=Ara | no | no | 0.4 | 0.375 | 0.552 | 9e-91 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.437 | 0.760 | 0.451 | 4e-73 |
| >sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1050 bits (2714), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/707 (73%), Positives = 589/707 (83%), Gaps = 15/707 (2%)
Query: 18 LIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKG 77
+ +L ++ S+V+C TD SDVQALQVLYTSLNSPS LTNWK GDPCGESWKG
Sbjct: 8 MFTVLLLFIASISGFSVVRCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWKG 67
Query: 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLA 137
+ CEGSAVV+IDIS LG+SGT+GYLLSDL SLRK D+SGNSIHDT+PYQLPPNLTSLNLA
Sbjct: 68 ITCEGSAVVTIDISDLGVSGTLGYLLSDLKSLRKLDVSGNSIHDTLPYQLPPNLTSLNLA 127
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
NN SGNLPYSI++M SLSY+NVS NSLT SIGDIF + LATLDLS NNFSGDLP+S
Sbjct: 128 RNNLSGNLPYSISAMGSLSYMNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGDLPSSL 187
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
++S +S LY+QNNQ+TGS++V SGLPL TLNVANNHF+G IP+EL SI+T IYDGNSFD
Sbjct: 188 STVSTLSVLYVQNNQLTGSIDVLSGLPLKTLNVANNHFNGSIPKELSSIQTLIYDGNSFD 247
Query: 258 NGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPS-GSQSSSSD--KELPAGAIVGIVLGAVF 314
N PA P P + GS P GS+ SSD K L G + GIV G++F
Sbjct: 248 NVPASPQPERPG--------KKETPSGSKKPKIGSEEKSSDSGKGLSGGVVTGIVFGSLF 299
Query: 315 LVALALLALYFCIRKNRRKVSGA-RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPP 373
+ + L LY C+ K +RKV G+ R+S S P+S E+ EQRVKSVA+V DL P
Sbjct: 300 VAGIIALVLYLCLHKKKRKVRGSTRASQRSLPLSGT---PEVQEQRVKSVASVADLKSSP 356
Query: 374 AEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFAN 433
AEK+ ++RV K+GS+ +I+SPITA+ YTV+SLQ ATNSFSQE +IGEGSLGRVYRAEF N
Sbjct: 357 AEKVTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPN 416
Query: 434 GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493
GKIMA+KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV LAGYC EHGQRLLVYEYVGNG
Sbjct: 417 GKIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNG 476
Query: 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553
NL D LH DD S NLTWNARV+VALGTA+ALEYLHEVCLPS+VHRNFKSANILLD+ELN
Sbjct: 477 NLDDTLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELN 536
Query: 554 PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613
PHLSD GLAALTPNTERQVSTQ+VG+FGYSAPEFALSGIYTVKSDVY+FGVVMLELLTGR
Sbjct: 537 PHLSDSGLAALTPNTERQVSTQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGR 596
Query: 614 KPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEP 673
KPLDSSR R+EQSLVRWATPQLHDIDAL+KMVDP+LNGMYPAKSLSRFADIIALC+QPEP
Sbjct: 597 KPLDSSRTRAEQSLVRWATPQLHDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEP 656
Query: 674 EFRPPMSEVVQALVRLVQRASVVKRRSSDESGFSYRTPDHEAIDTPF 720
EFRPPMSEVVQ LVRLVQRASVVKRRSSD++GFSYRTP+HE +D F
Sbjct: 657 EFRPPMSEVVQQLVRLVQRASVVKRRSSDDTGFSYRTPEHEHVDISF 703
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C8M9|SRF6_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 6 OS=Arabidopsis thaliana GN=SRF6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 647 bits (1669), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/696 (51%), Positives = 464/696 (66%), Gaps = 23/696 (3%)
Query: 21 AFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVAC 80
A + + L + TD+SD AL L++ ++SP+ LT W GDPCG++W+GV C
Sbjct: 9 ALFTLCIVGFELRFIHGATDASDTSALNTLFSGMHSPAQLTQWTAAAGDPCGQNWRGVTC 68
Query: 81 EGSAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN 139
GS V I +SGL LSGT+G Y+L L SL + DLS N++ +PYQ PPNL LNLA+N
Sbjct: 69 SGSRVTQIKLSGLELSGTLGGYMLDKLTSLTELDLSSNNLGGDLPYQFPPNLQRLNLANN 128
Query: 140 NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS 199
F+G YS++ + L YLN+ N I F L L TLD SFN+F+ LP +F S
Sbjct: 129 QFTGAASYSLSQITPLKYLNLGHNQFKGQIAIDFSKLDSLTTLDFSFNSFTNSLPATFSS 188
Query: 200 LSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNG 259
L+++ SLYLQNNQ +G+++V +GLPL TLN+ANN F+GWIP L I T I DGNSF+ G
Sbjct: 189 LTSLKSLYLQNNQFSGTVDVLAGLPLETLNIANNDFTGWIPSSLKGI-TLIKDGNSFNTG 247
Query: 260 PAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGIVLGAVFLVALA 319
PAPPPPP T P G R+ S +++ S K + ++ ++ LV A
Sbjct: 248 PAPPPPPGTPPIRGSPSRKSGGRESRSSDESTRNGDSKKSGIGAGAIAGIIISL-LVVTA 306
Query: 320 LLALYFCIRKNRRKVSG----ARSSAGSFPVSTNNMNTEMHEQRVKSVAAVT-------D 368
LL +F R+ + K S ++ F +++N+ + Q SV +
Sbjct: 307 LLVAFFLFRRKKSKRSSPMDIEKTDNQPFTLASNDFHENNSIQSSSSVETKKLDTSLSIN 366
Query: 369 LTPPPAEKLVI----ERVAKSGSLKK--IKSPITATSYTVASLQTATNSFSQEFLIGEGS 422
L PPP ++ + K ++KK + P Y+VA LQ AT SFS + L+GEG+
Sbjct: 367 LRPPPIDRNKSFDDEDSTRKPIAVKKSTVVVPSNVRLYSVADLQIATGSFSVDNLLGEGT 426
Query: 423 LGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482
GRVYRAEF +GK++AVKKID++AL D+F+E VS ++ L HPN+ L GYCAEHGQ
Sbjct: 427 FGRVYRAEFDDGKVLAVKKIDSSALPHGMTDDFIEMVSKIANLDHPNVTKLVGYCAEHGQ 486
Query: 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFK 542
L+VYE+ NG+LHD LH +++ SK L WN+RV++ALGTARALEYLHEVC PS+V +N K
Sbjct: 487 HLVVYEFHKNGSLHDFLHLSEEESKALVWNSRVKIALGTARALEYLHEVCSPSIVDKNIK 546
Query: 543 SANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSF 602
SANILLD ELNPHLSD GLA+ P T ++ Q GYSAPE ++SG Y++KSD+YSF
Sbjct: 547 SANILLDSELNPHLSDSGLASFLP-TANELLNQT--DEGYSAPEVSMSGQYSLKSDIYSF 603
Query: 603 GVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFA 662
GVVMLELLTGRKP DS+R RSEQSLVRWATPQLHDIDALAKMVDPAL G+YP KSLSRFA
Sbjct: 604 GVVMLELLTGRKPFDSTRSRSEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFA 663
Query: 663 DIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKR 698
D+IALCVQPEPEFRPPMSEVVQALV LVQRA++ KR
Sbjct: 664 DVIALCVQPEPEFRPPMSEVVQALVVLVQRANMSKR 699
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LUL4|SRF7_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 7 OS=Arabidopsis thaliana GN=SRF7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 632 bits (1630), Expect = e-180, Method: Compositional matrix adjust.
Identities = 359/710 (50%), Positives = 474/710 (66%), Gaps = 32/710 (4%)
Query: 13 FSTSRLIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCG 72
+ +R++ A +++ + S + TDSSD AL ++++S+NSP L+ W + GDPCG
Sbjct: 1 MTENRVVLALLILCIVGFEPSFIHGATDSSDTSALNIMFSSMNSPGQLSQWTASGGDPCG 60
Query: 73 ESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLT 132
++WKG+ C GS V I + LGLSG++G++L L S+ +FD+S N++ +PYQLPPNL
Sbjct: 61 QNWKGITCSGSRVTQIKLPSLGLSGSLGFMLDKLTSVTEFDMSNNNLGGDLPYQLPPNLE 120
Query: 133 SLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD 192
LNLA+N F+G+ YSI+ M L YLN++ N L Q D F L L+ LDLS N F G
Sbjct: 121 RLNLANNQFTGSAQYSISMMAPLKYLNLAHNQLKQLAID-FTKLTSLSILDLSSNAFIGS 179
Query: 193 LPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYD 252
LPN+ SL++ S+YLQNNQ +G++++ + LPL LN+ANN F+GWIP L I D
Sbjct: 180 LPNTCSSLTSAKSIYLQNNQFSGTIDILATLPLENLNIANNRFTGWIPDSLKGIN-LQKD 238
Query: 253 GNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKE--LPAGAIVGIVL 310
GN ++GPAPPPPP T P S S +S +G+ S S +S + L AG + GIV+
Sbjct: 239 GNLLNSGPAPPPPPGTPPISKSSPTPKSGNRGNRSNGDSSNSKDSSKSGLGAGGVAGIVI 298
Query: 311 GAVFLVALALLALYFCIRKNRRKVSGARSSAGSF--PV--STNNMNTE--------MHEQ 358
+ + A+ L R R + + + P+ ++N+ + E + E
Sbjct: 299 SLIVVTAVIAFFLIKRKRSKRSSSTDIEKTDNNINQPIILASNDFHQENKSVQNPPLVET 358
Query: 359 RVKSVAAVTDLTPPPAEK----------LVIERVAKSGSLKKIKSPITATSYTVASLQTA 408
+ + +L PPP+E+ + VAK + + P +YTV+ LQ A
Sbjct: 359 KKLDTSLSMNLRPPPSERHKSFDDDDSTMRKPIVAKKAA---VVVPSNVNTYTVSDLQVA 415
Query: 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP 468
TNSFS + L+GEG+ GRVYRA+F +GK++AVKKID++AL D+F E VS ++ L H
Sbjct: 416 TNSFSVDNLLGEGTFGRVYRAQFEDGKVLAVKKIDSSALPTDTADDFTEIVSKIAHLDHE 475
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
N+ L GYC+EHGQ L+VYE+ NG+LHD LH A++ SK L WN RV++ALGTARALEYL
Sbjct: 476 NVTKLDGYCSEHGQHLVVYEFHRNGSLHDFLHLAEEESKPLIWNPRVKIALGTARALEYL 535
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
HEVC PS+VH+N KSANILLD ELNPHLSD GLA+ P T ++ Q GYSAPE +
Sbjct: 536 HEVCSPSIVHKNIKSANILLDSELNPHLSDSGLASFLP-TANELLNQ--NDEGYSAPETS 592
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648
+SG Y++KSDVYSFGVVMLELLTGRKP DS+R RSEQSLVRWATPQLHDIDAL KMVDPA
Sbjct: 593 MSGQYSLKSDVYSFGVVMLELLTGRKPFDSTRSRSEQSLVRWATPQLHDIDALGKMVDPA 652
Query: 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKR 698
L G+YP KSLSRFAD+IALCVQPEPEFRPPMSEVVQALV LVQRA++ KR
Sbjct: 653 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVVLVQRANMSKR 702
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K1|SRF5_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 5 OS=Arabidopsis thaliana GN=SRF5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 617 bits (1590), Expect = e-175, Method: Compositional matrix adjust.
Identities = 325/707 (45%), Positives = 447/707 (63%), Gaps = 36/707 (5%)
Query: 23 VLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEG 82
++I+S+ +T++L+Q TD+ +V AL V++TSLNSPS L WK N GDPC +SW+GV C+G
Sbjct: 8 LVIVSLAITVTLLQAKTDNQEVSALNVMFTSLNSPSKLKGWKANGGDPCEDSWEGVKCKG 67
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS 142
S+V + +SG L G+ GYLLS+L SL FDLS N++ IPYQLPPN+ +L+ + N
Sbjct: 68 SSVTELQLSGFELGGSRGYLLSNLKSLTTFDLSKNNLKGNIPYQLPPNIANLDFSENELD 127
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
GN+PYS++ M +L +N+ +N L + D+F L+ L TLD S N SG LP SF +L++
Sbjct: 128 GNVPYSLSQMKNLQSINLGQNKLNGELPDMFQKLSKLETLDFSLNKLSGKLPQSFANLTS 187
Query: 203 ISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAP 262
+ L+LQ+N+ TG +NV L + LNV +N F GWIP EL I + + GN + AP
Sbjct: 188 LKKLHLQDNRFTGDINVLRNLAIDDLNVEDNQFEGWIPNELKDIDSLLTGGNDWSTETAP 247
Query: 263 PPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGIVLGAVFLVAL---- 318
PPPP + R+ S S G ++ + AGA +G+++ + L+AL
Sbjct: 248 PPPPGV----------KYGRKSSGSKDGGGITAGTGMVIAGACLGVLVLIIVLIALVSKK 297
Query: 319 -ALLALYFCIRKNRRKVSGARS-----SAGSFPVSTNN-----MNTEMHEQRVKSVAA-- 365
+ L+ +F N +S SA V N + + ++ + + +
Sbjct: 298 KSSLSPHFIDEDNSHHTPKFKSLTSHGSAQELRVDFGNDYKDGKSGDSGDENIHRIGSKG 357
Query: 366 VTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGR 425
+ A + K+ S +A + ++ LQ+AT +FS L+GEGS+GR
Sbjct: 358 LKHYVSSRVMSFTDTEFANKLNAKRTTSTRSAVEFELSDLQSATANFSPGNLLGEGSIGR 417
Query: 426 VYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485
VYRA++++G+ +AVKKID+ + + V ++S++RH NI L GYC+E G +L
Sbjct: 418 VYRAKYSDGRTLAVKKIDSTLFDSGKSEGITPIVMSLSKIRHQNIAELVGYCSEQGHNML 477
Query: 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545
VYEY NG+LH+ LH +D SK LTWN RVR+ALGTARA+EYLHE C PSV+H+N KS+N
Sbjct: 478 VYEYFRNGSLHEFLHLSDCFSKPLTWNTRVRIALGTARAVEYLHEACSPSVMHKNIKSSN 537
Query: 546 ILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVV 605
ILLD +LNP LSD GL+ T +Q +G GY+APE YT KSDVYSFGVV
Sbjct: 538 ILLDADLNPRLSDYGLSKFYLRT-----SQNLGE-GYNAPEARDPSAYTPKSDVYSFGVV 591
Query: 606 MLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADII 665
MLELLTGR P D +PR E+SLVRWATPQLHDIDAL+ + DPAL+G+YP KSLSRFADII
Sbjct: 592 MLELLTGRVPFDGEKPRPERSLVRWATPQLHDIDALSNIADPALHGLYPPKSLSRFADII 651
Query: 666 ALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDESGFSYRTPD 712
ALCVQ EPEFRPPMSEVV+ALVR+VQR+S+ + D+ SYR D
Sbjct: 652 ALCVQVEPEFRPPMSEVVEALVRMVQRSSM---KLKDDLSSSYRAHD 695
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K2|SRF4_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 4 OS=Arabidopsis thaliana GN=SRF4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 550 bits (1416), Expect = e-155, Method: Compositional matrix adjust.
Identities = 316/705 (44%), Positives = 424/705 (60%), Gaps = 55/705 (7%)
Query: 17 RLIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWK 76
R++ F+ IF S+V TDS DV AL Y S+NSPS L W + GDPCG+SW
Sbjct: 7 RIVLVFIACFGIFT--SVVLAKTDSQDVSALNDAYKSMNSPSKLKGWSSSGGDPCGDSWD 64
Query: 77 GVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNL 136
G+ C+GS+V I +SG GLSG++GY L +L SL D+S N+++ +PYQLP LT L+
Sbjct: 65 GITCKGSSVTEIKVSGRGLSGSLGYQLGNLKSLTYLDVSKNNLNGNLPYQLPDKLTYLDG 124
Query: 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
+ N+F+GN+PYS++ M LSYLN+ RN+L + D+F L L T+DLS N +G LP S
Sbjct: 125 SENDFNGNVPYSVSLMNDLSYLNLGRNNLNGELSDMFQKLPKLETIDLSSNQLTGKLPQS 184
Query: 197 FISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNS 255
F +L+ + +L+LQ NQ GS+N LP + +NVANN F+GWIP EL +I GN
Sbjct: 185 FANLTGLKTLHLQENQFKGSINALRDLPQIDDVNVANNQFTGWIPNELKNIGNLETGGNK 244
Query: 256 FDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGI-VLGAVF 314
+ +G AP PPP G H +R+ S K L G I+ + +G +
Sbjct: 245 WSSGRAPSPPP------GTRHIDRNSS--------GGGGGSSKALTLGVIIAVSSIGGLI 290
Query: 315 LVALALLALYFCIRKNRRKVS-------GARSSAGSF-PVSTNNMNTEMHEQ--RVKSVA 364
L A L+AL RKN S G S F P S+ + + E+ K+V
Sbjct: 291 LFA-GLIAL-ISRRKNSNDSSHFFDDEKGTNRSKPLFTPQSSQMLQFDNMEEFKNQKTVD 348
Query: 365 AVTDLTPPPAEKLVIERVAKSG-----------------SLKKIKSPIT--ATSYTVASL 405
+ T L P+ K K+ S SP T ++++A L
Sbjct: 349 SNTSLETKPSVKRTSSVSFKNSPTFHLIPSTQVAATPDRSSTSQDSPDTRGVKAFSLADL 408
Query: 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL 465
Q + FS L+GEG++GRVY+A+F +G+ AVK+ID++ L + F VS++S +
Sbjct: 409 QNTASCFSPNRLLGEGTIGRVYKAKFQDGRKFAVKEIDSSLLGKGNPEEFSHIVSSISSI 468
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525
H N+ L GYC+E G+ +LVYEY +G+LH LH +DD SK LTWN R+R+ALGTA+A+
Sbjct: 469 HHKNMAELVGYCSEQGRNMLVYEYFTSGSLHRFLHLSDDFSKPLTWNTRIRIALGTAKAI 528
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
EYLHE C P +VH+N KS+NILLD+ELNP LSD GLA T + + GY+AP
Sbjct: 529 EYLHETCSPPLVHKNIKSSNILLDNELNPRLSDYGLANFHHRTSQNL------GVGYNAP 582
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
E YT KSDVYSFGVVMLELLTGRKP DS RP++EQSLVRWA PQL D+D L +MV
Sbjct: 583 ECTDPSAYTQKSDVYSFGVVMLELLTGRKPYDSGRPKAEQSLVRWAKPQLKDMDTLDEMV 642
Query: 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690
DPAL G+Y +S+S FADI+++CV EP RPP+S VV+AL RLV
Sbjct: 643 DPALCGLYAPESVSSFADIVSICVMTEPGLRPPVSNVVEALKRLV 687
|
Acts as a direct positive regulator of leaf size but not leaf shape. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q06BH3|SRF1_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 1 OS=Arabidopsis thaliana GN=SRF1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 542 bits (1396), Expect = e-153, Method: Compositional matrix adjust.
Identities = 345/763 (45%), Positives = 447/763 (58%), Gaps = 92/763 (12%)
Query: 21 AFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVAC 80
+F LI L+L+L T+ DV A+ L+ +L SP +L W + GDPCGESW+GV C
Sbjct: 19 SFALISLPSLSLAL----TNPDDVAAINSLFLALESP-LLPGWVASGGDPCGESWQGVLC 73
Query: 81 EGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNN 140
S V +I + L G +G L+ SL+ D S N I +IP LP +L +L L+ NN
Sbjct: 74 NASQVETIILISANLGGELGVGLNMFTSLKAMDFSNNHIGGSIPSTLPVSLQNLFLSGNN 133
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
F+G +P S++S+ SLS ++++ N L+ I D+F +L + +DLS NN SG LP S +L
Sbjct: 134 FTGTIPESLSSLKSLSVMSLNNNLLSGKIPDVFQDLGLMINIDLSSNNLSGPLPPSMQNL 193
Query: 201 SNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGP 260
S ++SL LQNN ++G L+V LPL LNV NN F+G IP +L+SI FI GN F+
Sbjct: 194 STLTSLLLQNNHLSGELDVLQDLPLKDLNVENNLFNGPIPEKLLSIPNFIKGGNLFNVTI 253
Query: 261 AP-------------------PPPPSTAPPSGRSHNN---RSHRQGSHSPSGSQSSSSDK 298
AP PP P+ + G++H H +P G + S + K
Sbjct: 254 APSPSPETPPSPTSPKRPFFGPPSPNASAGHGQAHVRSPPSDHHPSRPTPQGKEDSFTSK 313
Query: 299 ELPAGAIVGIVLGAVFLVALALLALYF---CIRKNR---------------RKVSGARSS 340
+ I +LGA V LAL+ L C+RK R G+RS+
Sbjct: 314 RI----IWISILGAFSFVVLALVCLLCGRKCLRKREDSEQLSKPHLTSEYGRAREGSRSN 369
Query: 341 AGSFPVS-TNNMNTE------------MHEQRVKSVAA--------------VTDLTPP- 372
A P S T N + E +H +SV + DL P
Sbjct: 370 ASMLPPSNTFNKDKEARPKERVGGASKLHGGAERSVGSESKQESHEIDMNGNAMDLMHPS 429
Query: 373 --PAEKLVIERVAK--SGSLKKIKS----PITATS-YTVASLQTATNSFSQEFLIGEGSL 423
P K VI + + SLK+ S P+TA +TVASLQ TNSFS E LIG G L
Sbjct: 430 SIPPIKRVIAKATEPAEASLKRTTSKSHGPLTAVKHFTVASLQQHTNSFSHENLIGTGML 489
Query: 424 GRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483
G VYRAE GK+ AV+K+D + + +EE FLE V+N+ R+RH NIV L G+C+EH QR
Sbjct: 490 GSVYRAELPGGKLFAVRKLDKKSPNHEEEGKFLELVNNIDRIRHANIVQLVGFCSEHSQR 549
Query: 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543
LL++EY NG LHD+LH D L+WN RVR+AL A+ALEYLHE+C P +HRNFKS
Sbjct: 550 LLIHEYCRNGTLHDLLHIDDRLKIELSWNVRVRIALEAAKALEYLHEICDPPSIHRNFKS 609
Query: 544 ANILLDDELNPHLSDCGLAAL-TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSF 602
ANILLDD++ H+SDCGLA L + Q+S Q++ A+GY APEF GIYT+K DVYSF
Sbjct: 610 ANILLDDDIRVHVSDCGLAPLISSGAVSQLSGQLLAAYGYGAPEFEY-GIYTMKCDVYSF 668
Query: 603 GVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFA 662
GVVMLELLTGRK D R R EQ LVRWA PQLHDIDALAKMVDP+L G YPAKSLS FA
Sbjct: 669 GVVMLELLTGRKSYDKKRDRGEQFLVRWAIPQLHDIDALAKMVDPSLKGDYPAKSLSHFA 728
Query: 663 DIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDESG 705
D+I+ CVQ EPE+RP MSEVVQ L ++QR + R +D +G
Sbjct: 729 DVISRCVQSEPEYRPLMSEVVQDLSDMIQR----EHRRNDSNG 767
|
Not essential for epidermal patterning and not redundant with STRUBBELIG. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FG24|SRF2_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 2 OS=Arabidopsis thaliana GN=SRF2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 482 bits (1240), Expect = e-135, Method: Compositional matrix adjust.
Identities = 289/704 (41%), Positives = 410/704 (58%), Gaps = 49/704 (6%)
Query: 21 AFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVAC 80
A +L+ +I L+ + TD +V ALQ LY SL +P L W+ GDPCGE+W G++C
Sbjct: 11 ATILLTTILFVLA--KTDTDPLEVLALQDLYKSLRNPEQLRGWRLEGGDPCGEAWLGISC 68
Query: 81 EGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNN 140
GS++V + + L L G++G L L +L+ D+S N++ IP+ LPPN T +N+A NN
Sbjct: 69 SGSSIVDLQLRELKLLGSLGNQLQHLHNLKILDVSFNNLEGEIPFGLPPNATHINMAYNN 128
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
+ ++P+S+ M SL LN+S NSL+ +G++F L + +DLSFNN +GDLP+SF +L
Sbjct: 129 LTQSIPFSLPLMTSLQSLNLSHNSLSGPLGNVFSGLQ-IKEMDLSFNNLTGDLPSSFGTL 187
Query: 201 SNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGP 260
N++SLYLQNN++TGS+ + LPL LN+ +N FSG IP SI GN F P
Sbjct: 188 MNLTSLYLQNNRLTGSVIYLADLPLADLNIEDNQFSGIIPSHFQSIPHLWIWGNKFHVEP 247
Query: 261 APPP---PPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGIVLGAVF--- 314
P P P N + + S + + + GI G+ F
Sbjct: 248 NYKPWKFPLDVRP----LIQNDTGYPTTESSAIMNFPRPETQKVKKKKKGIGAGSTFLLV 303
Query: 315 ---LVALALLALYFCIRKNRRKVSGA-------RSSAGSFPVSTNN---MNTEMHEQRVK 361
+ AL F +R N R+ S A S PVST + TE + Q
Sbjct: 304 GGLALLGTFFAL-FAVRMNHRRAQNLAAIHRSNNSIAYSLPVSTGREYPVATEDNPQ--- 359
Query: 362 SVAAVTDLTPPPAEKL--------VIERVAKSGSLK-KIKSPITATSYTVASLQTATNSF 412
+ PPPA +L I++ A+ S + P A ++ A LQ ATN F
Sbjct: 360 ----IKRFQPPPAPQLRHLPSPPVRIDKSARRKSFSATCQYPSFAKLFSAAELQLATNCF 415
Query: 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
S+E L+GEG LG VYRA+ +G+ V+ I ++LSL EE+ F E + S+LRHPNIVT
Sbjct: 416 SEENLLGEGPLGSVYRAKLPDGQFAVVRNIPMSSLSLHEEEQFTEVLQTASKLRHPNIVT 475
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G+C E+G+ LLVYEYVG+ +L++ +H D+ K L+W R+R+A+G ARAL+YLH
Sbjct: 476 LLGFCIENGEHLLVYEYVGHLSLYNAMH--DEVYKPLSWGLRLRIAIGVARALDYLHSSF 533
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV----STQMVGAFGYSAPEFA 588
P + H + K+ NILLD+EL P ++DCGLA+L P T V S + GY APE
Sbjct: 534 CPPIAHSDLKATNILLDEELTPRIADCGLASLRPLTSNSVKLRASEIAIQNTGYIAPEHG 593
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648
G KSD Y+ GV++LELLTGRK DSSRPR EQ LV+WA+ +LHD +L +M+D
Sbjct: 594 QPGSSGTKSDTYALGVLLLELLTGRKAFDSSRPRGEQLLVKWASTRLHDRRSLEQMIDGG 653
Query: 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
+ G + ++ S++ADII+LC Q E EFRPP+SE+V+AL L+Q+
Sbjct: 654 IAGTFSSRVASQYADIISLCTQAEKEFRPPVSEIVEALTALIQK 697
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K3|SRF3_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 3 OS=Arabidopsis thaliana GN=SRF3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 393 bits (1010), Expect = e-108, Method: Compositional matrix adjust.
Identities = 197/315 (62%), Positives = 234/315 (74%), Gaps = 5/315 (1%)
Query: 380 ERVAKSGSLKKIKSPITATS-YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMA 438
ER K S K++ P+T+ Y++ASLQ T SF+QE LIG G LG VYRA NGK+ A
Sbjct: 454 ERPVKKTSPKRL--PLTSVKHYSIASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFA 511
Query: 439 VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDM 498
VKK+D A Q++ F+E V+N+ +RH NIV L GYCAEH QRLLVYEY NG L D
Sbjct: 512 VKKLDKRASEQQQDHEFIELVNNIDMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDG 571
Query: 499 LHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558
LH D+ K L+WN RV +ALG ARALEYLHEVC P ++HRNFKSAN+LLDD+L+ +SD
Sbjct: 572 LHSDDEFKKKLSWNTRVSMALGAARALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSD 631
Query: 559 CGLAAL-TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
CGLA L + + Q+S Q++ A+GY APEF SGIYT +SDVYSFGVVMLELLTGR D
Sbjct: 632 CGLAPLISSGSVSQLSGQLLAAYGYGAPEFD-SGIYTWQSDVYSFGVVMLELLTGRMSYD 690
Query: 618 SSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRP 677
R R EQ LVRWA PQLHDIDAL KMVDP+LNG YPAKSLS FADII+ CVQ EPEFRP
Sbjct: 691 RDRSRGEQFLVRWAIPQLHDIDALGKMVDPSLNGQYPAKSLSHFADIISRCVQSEPEFRP 750
Query: 678 PMSEVVQALVRLVQR 692
MSEVVQ L+ +++R
Sbjct: 751 LMSEVVQDLLDMIRR 765
|
Not essential for epidermal patterning and not redundant with STRUBBELIG. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q8RWZ1|SUB_ARATH Protein STRUBBELIG OS=Arabidopsis thaliana GN=SUB PE=1 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (858), Expect = 9e-91, Method: Compositional matrix adjust.
Identities = 163/295 (55%), Positives = 214/295 (72%), Gaps = 7/295 (2%)
Query: 396 TATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNF 455
+AT +T+ASLQ TN+FS+E +IGEGS+G VYRAE +GK +AVKK+ N Q + F
Sbjct: 481 SATVFTIASLQQYTNNFSEENIIGEGSIGNVYRAELRHGKFLAVKKLSNTINRTQSDGEF 540
Query: 456 LEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV 515
L VSN+ +L+ +I+ L GYC E GQRLLVYEY NG+L D LH K LTWN R+
Sbjct: 541 LNLVSNVLKLKRGHILELLGYCNEFGQRLLVYEYCPNGSLQDALHLDRKLHKKLTWNVRI 600
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575
+ALG ++AL++LHEVC P VVH+NFKS+ +LLD +L+ ++D GLA + P + ++Q
Sbjct: 601 NIALGASKALQFLHEVCQPPVVHQNFKSSKVLLDGKLSVRVADSGLAYMLPP---RPTSQ 657
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL 635
M GY+APE G YT +SDV+S GVVMLELLTGR+P D +RPR Q+L +WA P+L
Sbjct: 658 MA---GYAAPEVEY-GSYTCQSDVFSLGVVMLELLTGRRPFDRTRPRGHQTLAQWAIPRL 713
Query: 636 HDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690
HDIDAL +MVDP+L+G YP KSLSRFADII+ +Q EP FRPP+SE+VQ L ++
Sbjct: 714 HDIDALTRMVDPSLHGAYPMKSLSRFADIISRSLQMEPGFRPPISEIVQDLQHMI 768
|
Regulates the expression of transcription factors that define the cell fates. Seems to be required for the regulation of cell shape and the orientation of the mitotic division plane. Involved in root hair specification, in the formation of the outer integument and the shape of organs such as carpels and petals and is necessary for the shape and height of the stem. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (706), Expect = 4e-73, Method: Compositional matrix adjust.
Identities = 144/319 (45%), Positives = 204/319 (63%), Gaps = 4/319 (1%)
Query: 370 TPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRA 429
T P K V E+ + K++ + I A +++ L TAT +F QE LIGEG GRVY+
Sbjct: 37 THPENPKTVNEQNKNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKG 96
Query: 430 EFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488
+ G I+AVK++D L +E F+ V +S L H ++V L GYCA+ QRLLVYE
Sbjct: 97 KLEKTGMIVAVKQLDRNGLQGNKE--FIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYE 154
Query: 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548
Y+ G+L D L L W+ R+R+ALG A LEYLH+ P V++R+ K+ANILL
Sbjct: 155 YMSRGSLEDHLLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILL 214
Query: 549 DDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVML 607
D E N LSD GLA L P ++Q VS++++G +GY APE+ +G T KSDVYSFGVV+L
Sbjct: 215 DGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLL 274
Query: 608 ELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIAL 667
EL+TGR+ +D++RP+ EQ+LV WA P + ++ DP+L G++P K+L++ + A+
Sbjct: 275 ELITGRRVIDTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAM 334
Query: 668 CVQPEPEFRPPMSEVVQAL 686
C+Q E RP MS+VV AL
Sbjct: 335 CLQEEATVRPLMSDVVTAL 353
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 720 | ||||||
| 356555690 | 705 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.961 | 0.981 | 0.760 | 0.0 | |
| 359494846 | 729 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.990 | 0.978 | 0.764 | 0.0 | |
| 356532229 | 706 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.952 | 0.971 | 0.763 | 0.0 | |
| 297803912 | 703 | kinase [Arabidopsis lyrata subsp. lyrata | 0.961 | 0.984 | 0.741 | 0.0 | |
| 79481791 | 703 | STRUBBELIG-receptor family 8 protein [Ar | 0.961 | 0.984 | 0.738 | 0.0 | |
| 224117956 | 672 | predicted protein [Populus trichocarpa] | 0.926 | 0.992 | 0.798 | 0.0 | |
| 449455383 | 711 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.956 | 0.969 | 0.75 | 0.0 | |
| 255554777 | 640 | Serine/threonine-protein kinase PBS1, pu | 0.852 | 0.959 | 0.799 | 0.0 | |
| 449513527 | 647 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.890 | 0.990 | 0.720 | 0.0 | |
| 357138966 | 715 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.934 | 0.941 | 0.682 | 0.0 |
| >gi|356555690|ref|XP_003546163.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1094 bits (2829), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 534/702 (76%), Positives = 602/702 (85%), Gaps = 10/702 (1%)
Query: 23 VLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEG 82
+L+ +F+ L L TD SDVQAL+V+Y +LNSP+ LT WK GDPCGESWKGV CEG
Sbjct: 10 ILLSLVFVALPLSLANTDPSDVQALEVMYNALNSPTQLTGWKIGGGDPCGESWKGVTCEG 69
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS 142
SAVVSI +SGLGL GT+GYLLSDL+SLR+ DLS N IHDTIPYQLPPNLTSLN A NN S
Sbjct: 70 SAVVSIKLSGLGLDGTLGYLLSDLMSLRELDLSDNKIHDTIPYQLPPNLTSLNFARNNLS 129
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
GNLPYSI++MVSL+YLN+S N+L+ ++GDIF +L L TLDLSFNNFSGDLP SF++L+N
Sbjct: 130 GNLPYSISAMVSLNYLNLSNNALSMTVGDIFASLQDLGTLDLSFNNFSGDLPPSFVALAN 189
Query: 203 ISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAP 262
+SSL+LQ NQ+TGSL V GLPL TLNVANN+FSGWIP EL SIR FIYDGNSF+N PAP
Sbjct: 190 LSSLFLQKNQLTGSLGVLVGLPLDTLNVANNNFSGWIPHELSSIRNFIYDGNSFENSPAP 249
Query: 263 PPPPSTAPPSGRSHNNRSHRQGSHSP---SGSQSSSSDKELPAGAIVGIVLGAVFLVALA 319
PP T+PP H GSH+ S ++ S K L GA+VGIVLG+V + A+
Sbjct: 250 LPPAFTSPPPNGPHGRHHSGSGSHNKTQVSDNEKSDGHKGLTVGAVVGIVLGSVLVAAIV 309
Query: 320 LLALYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVI 379
LLAL FCIRK + K GAR+ +GS P++ +M EQRVKS A VTDL P PAE + +
Sbjct: 310 LLALVFCIRKQKGK-KGARNFSGSLPLTP-----QMQEQRVKSAAVVTDLKPRPAENVTV 363
Query: 380 ERVA-KSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMA 438
ERVA KSGS+K++KSPIT+T YTVASLQ+ATNSFSQEF+IGEGSLGRVY+A+F NGK+MA
Sbjct: 364 ERVAVKSGSVKQMKSPITSTLYTVASLQSATNSFSQEFIIGEGSLGRVYKADFPNGKVMA 423
Query: 439 VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDM 498
+KKIDN+ALSLQEEDNFLEAVSNMSRLRHP+IVTLAGYCAEHGQRLLVYEY+ NGNLHDM
Sbjct: 424 IKKIDNSALSLQEEDNFLEAVSNMSRLRHPSIVTLAGYCAEHGQRLLVYEYIANGNLHDM 483
Query: 499 LHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558
LHFA+DSSK L+WNARVR+ALGTARALEYLHEVCLPSVVHRNFKSANILLD+ELNPHLSD
Sbjct: 484 LHFAEDSSKALSWNARVRIALGTARALEYLHEVCLPSVVHRNFKSANILLDEELNPHLSD 543
Query: 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDS 618
CGLAALTPNTERQVSTQMVG+FGYSAPEFALSG+YTVKSDVYSFGVVMLELLTGRKPLDS
Sbjct: 544 CGLAALTPNTERQVSTQMVGSFGYSAPEFALSGVYTVKSDVYSFGVVMLELLTGRKPLDS 603
Query: 619 SRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPP 678
R RSEQSLVRWATPQLHDIDALAKMVDP LNGMYPAKSLSRFADIIALCVQPEPEFRPP
Sbjct: 604 LRVRSEQSLVRWATPQLHDIDALAKMVDPTLNGMYPAKSLSRFADIIALCVQPEPEFRPP 663
Query: 679 MSEVVQALVRLVQRASVVKRRSSDESGFSYRTPDHEAIDTPF 720
MSEVVQALVRLVQRASVVKRR S+ESGF ++TPDHEA+D PF
Sbjct: 664 MSEVVQALVRLVQRASVVKRRPSEESGFGHKTPDHEAMDMPF 705
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359494846|ref|XP_002267170.2| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Vitis vinifera] gi|297741762|emb|CBI32991.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1079 bits (2791), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 563/736 (76%), Positives = 618/736 (83%), Gaps = 23/736 (3%)
Query: 1 MAVQYTAVFPLPFSTSRLIDAFVLILS---IFLTLSLVQCTTDSSDVQALQVLYTSLNSP 57
MAV F S SR A +++ S I LS V TD SDVQ LQV+Y SLN P
Sbjct: 1 MAVNGALSFSCSHSHSRFFFALLVLFSFSAILPPLS-VYGATDPSDVQGLQVIYNSLNGP 59
Query: 58 SVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGN 117
S LT W + GDPCGESWKGV CEGSAVVSI ISGLGL+GTMGYLLS+ LSLR D+S N
Sbjct: 60 SQLTGWTNSSGDPCGESWKGVTCEGSAVVSIQISGLGLNGTMGYLLSNFLSLRTLDMSDN 119
Query: 118 SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
+IHDTIPYQLPPNLT+LNLASNN +G+ PYSI++MVSL+YLNVS NS++QSIGDIF LA
Sbjct: 120 NIHDTIPYQLPPNLTNLNLASNNLTGSFPYSISTMVSLNYLNVSHNSISQSIGDIFAKLA 179
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSG 237
GL LDLS NNF+GDLPNSF SLSN+S+LYLQNNQ+TG L+V +GLPLT LNVANN+FSG
Sbjct: 180 GLTILDLSVNNFTGDLPNSFTSLSNLSTLYLQNNQLTGPLSVLTGLPLTDLNVANNNFSG 239
Query: 238 WIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQS---- 293
WIP EL SIR FIYDGNSFDNGPAPPPPP T PP RS +NR+H SP +++
Sbjct: 240 WIPSELRSIRKFIYDGNSFDNGPAPPPPPYTPPPPSRSRSNRTH-----SPPEARTPSSS 294
Query: 294 -------SSSDKELPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKVSGARSSAGSFPV 346
+ +K L G I+GIVLG++ LV +AL+AL FC+RK ++K +GAR S GS PV
Sbjct: 295 DGQSSNSDNGNKGLAIGPIIGIVLGSL-LVLVALIALVFCVRKAKKKGTGARPSVGSVPV 353
Query: 347 STNNMNTE-MHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSGSLKKIKSPITATSYTVAS 404
T +NTE M EQR K A VTDL PPPAE L++ERV K+GS K++KSPITATSYTVAS
Sbjct: 354 VTEKVNTETMQEQRTKFTATVTDLKPPPAENLMVERVQGKNGSGKRVKSPITATSYTVAS 413
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
LQTATNSFSQEFLIGEGSLGRVYRA+F NGK MA+KKIDNAALSLQEEDNFLEAVSNMSR
Sbjct: 414 LQTATNSFSQEFLIGEGSLGRVYRADFPNGKTMAIKKIDNAALSLQEEDNFLEAVSNMSR 473
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
LRH NIVTL GYCAEHGQRLLVYEY+GNG+LHDMLHF DDS K LTWNARVRVALGTARA
Sbjct: 474 LRHQNIVTLVGYCAEHGQRLLVYEYIGNGSLHDMLHFTDDSGKTLTWNARVRVALGTARA 533
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
LEYLHEVCLPS VHRNFKSANILLD+ELNPHLSDCGLAALTPNTERQVSTQMVG+FGYSA
Sbjct: 534 LEYLHEVCLPSTVHRNFKSANILLDEELNPHLSDCGLAALTPNTERQVSTQMVGSFGYSA 593
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644
PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSR RSEQSLVRWATPQLHDIDALAKM
Sbjct: 594 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRVRSEQSLVRWATPQLHDIDALAKM 653
Query: 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDES 704
VDP+LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDES
Sbjct: 654 VDPSLNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDES 713
Query: 705 GFSYRTPDHEAIDTPF 720
GF Y+TP+HEAID F
Sbjct: 714 GFVYKTPEHEAIDMSF 729
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532229|ref|XP_003534676.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1073 bits (2775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 534/699 (76%), Positives = 600/699 (85%), Gaps = 13/699 (1%)
Query: 28 IFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVS 87
IF+ L L TTD SDVQAL+V+Y LNSP+ LT WK GDPCGESWKGV CEGSAVVS
Sbjct: 15 IFVALPLSLATTDPSDVQALEVMYNVLNSPTQLTGWKIGGGDPCGESWKGVTCEGSAVVS 74
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY 147
I +SGLGL GT+GYLLSDL+SLR DLS N IHDTIPYQLPPNLTSLN A NN SGNLPY
Sbjct: 75 IKLSGLGLDGTLGYLLSDLMSLRDLDLSDNKIHDTIPYQLPPNLTSLNFARNNLSGNLPY 134
Query: 148 SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY 207
SI++M SL+YLN+S N+L+ ++GDIF +L L TLDLSFNNFSGDLP S +L+N+SSL+
Sbjct: 135 SISAMGSLNYLNLSNNALSMTVGDIFASLQDLGTLDLSFNNFSGDLPPSVGALANLSSLF 194
Query: 208 LQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPS 267
LQ NQ+TGSL+ GLPL TLNVANN+FSGWIP EL SI FIYDGNSF+N PAP PP
Sbjct: 195 LQKNQLTGSLSALVGLPLDTLNVANNNFSGWIPHELSSIHNFIYDGNSFENRPAPLPPTV 254
Query: 268 TAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKE-----LPAGAIVGIVLGAVFLVALALLA 322
T+PP SH R H GS S + +Q+S ++K L GA++GIVLG+V + A+ LA
Sbjct: 255 TSPPPSGSH--RRHHSGSGSHNKTQASDNEKSNGHKGLTVGAVIGIVLGSVLVAAIVFLA 312
Query: 323 LYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV 382
L FCIRK + K GAR+ +GS P++ +M EQRVKS A VTDL P PAE + +ERV
Sbjct: 313 LVFCIRKQKGKKKGARNFSGSLPLTP-----QMQEQRVKSAAVVTDLKPRPAENVTVERV 367
Query: 383 A-KSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKK 441
A KSGS+K++KSPIT+TSYTVASLQ+ATNSFSQEF+IGEGSLGRVYRA+F NGK+MA+KK
Sbjct: 368 AVKSGSVKQMKSPITSTSYTVASLQSATNSFSQEFIIGEGSLGRVYRADFPNGKVMAIKK 427
Query: 442 IDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHF 501
IDN+ALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY+ NGNLHDMLHF
Sbjct: 428 IDNSALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYIANGNLHDMLHF 487
Query: 502 ADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
A+DSSK+L+WNARVR+ALGTARALEYLHEVCLPSVVHRNFKSANILLD+ELNPHLSDCGL
Sbjct: 488 AEDSSKDLSWNARVRIALGTARALEYLHEVCLPSVVHRNFKSANILLDEELNPHLSDCGL 547
Query: 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP 621
AALTPNTERQVSTQMVG+FGYSAPEFALSG+YTVKSDVYSFGVVMLELLTGRKPLDSSR
Sbjct: 548 AALTPNTERQVSTQMVGSFGYSAPEFALSGVYTVKSDVYSFGVVMLELLTGRKPLDSSRV 607
Query: 622 RSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSE 681
RSEQSLVRWATPQLHDIDALAKMVDP LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSE
Sbjct: 608 RSEQSLVRWATPQLHDIDALAKMVDPTLNGMYPAKSLSRFADIIALCVQPEPEFRPPMSE 667
Query: 682 VVQALVRLVQRASVVKRRSSDESGFSYRTPDHEAIDTPF 720
VVQALVRLVQRASVVKRR S+ESGF ++TPDH+A+D F
Sbjct: 668 VVQALVRLVQRASVVKRRPSEESGFGHKTPDHDAMDMSF 706
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297803912|ref|XP_002869840.1| kinase [Arabidopsis lyrata subsp. lyrata] gi|297315676|gb|EFH46099.1| kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1068 bits (2762), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/707 (74%), Positives = 591/707 (83%), Gaps = 15/707 (2%)
Query: 18 LIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKG 77
+ +L +++ S+V C TD SDVQALQVLYTSLNSPS LTNWK GDPCGESWKG
Sbjct: 8 MFTVLLLFIALISGFSIVSCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWKG 67
Query: 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLA 137
+ CEGSAVVSIDIS LG+SGT+GYLLSDL+SLRK D+SGNSIHDT+PYQLPPNLTSLNLA
Sbjct: 68 ITCEGSAVVSIDISDLGVSGTLGYLLSDLMSLRKLDVSGNSIHDTLPYQLPPNLTSLNLA 127
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
NN SGNLPYSI++M SLSYLNVS NSLT SIGDIF + L+TLDLS NNFSGDLP+S
Sbjct: 128 RNNLSGNLPYSISAMGSLSYLNVSGNSLTMSIGDIFADHKSLSTLDLSHNNFSGDLPSSL 187
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
++S +S LY+QNNQ+TGS++V SGLPLTTLNVANNHF+G IP+EL SI+T IYDGNSFD
Sbjct: 188 STVSALSVLYVQNNQLTGSIDVLSGLPLTTLNVANNHFNGSIPKELSSIQTLIYDGNSFD 247
Query: 258 NGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPS-GSQSSSSD--KELPAGAIVGIVLGAVF 314
N PA P P + GS P GS+ SSD K L G + GIV G++F
Sbjct: 248 NVPATPQPERPG--------KKGEPSGSKKPKIGSEKKSSDSGKGLSGGVVTGIVFGSLF 299
Query: 315 LVALALLALYFCIRKNRRKVSGA-RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPP 373
+ + L LY C+ K +RKV G+ R+S S P+S EM EQRVKSVA+V DL P
Sbjct: 300 VAGIIALVLYLCLHKKKRKVGGSTRASQRSLPLSGT---PEMQEQRVKSVASVADLKSSP 356
Query: 374 AEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFAN 433
AEK+ ++RV K+GS+ +I+SPITA+ YTV+SLQ ATNSFSQE +IGEGSLGRVYRAEF N
Sbjct: 357 AEKVTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPN 416
Query: 434 GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493
GKIMA+KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV LAGYC EHGQRLLVYEYVGNG
Sbjct: 417 GKIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNG 476
Query: 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553
NL DMLH DD S NLTWNARV+VALGTA+ALEYLHEVCLPS+VHRNFKSANILLD+ELN
Sbjct: 477 NLDDMLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELN 536
Query: 554 PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613
PHLSD GLAALTPNTERQVSTQ+VG+FGYSAPEFALSGIYTVKSDVY+FGVVMLELLTGR
Sbjct: 537 PHLSDSGLAALTPNTERQVSTQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGR 596
Query: 614 KPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEP 673
KPLDS+R R EQSLVRWATPQLHDIDAL+KMVDP+LNGMYPAKSLSRFADIIALC+QPEP
Sbjct: 597 KPLDSTRTRVEQSLVRWATPQLHDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEP 656
Query: 674 EFRPPMSEVVQALVRLVQRASVVKRRSSDESGFSYRTPDHEAIDTPF 720
EFRPPMSEVVQ LVRLVQRASV+KRRSSD++GFSYRTP+HE ID +
Sbjct: 657 EFRPPMSEVVQQLVRLVQRASVIKRRSSDDTGFSYRTPEHEHIDISY 703
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79481791|ref|NP_193944.2| STRUBBELIG-receptor family 8 protein [Arabidopsis thaliana] gi|75127758|sp|Q6R2J8.1|SRF8_ARATH RecName: Full=Protein STRUBBELIG-RECEPTOR FAMILY 8; AltName: Full=Leucine-rich repeat receptor kinase-like protein SRF8; Flags: Precursor gi|41323415|gb|AAR99876.1| strubbelig receptor family 8 [Arabidopsis thaliana] gi|224589624|gb|ACN59345.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332659160|gb|AEE84560.1| STRUBBELIG-receptor family 8 protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1050 bits (2714), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/707 (73%), Positives = 589/707 (83%), Gaps = 15/707 (2%)
Query: 18 LIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKG 77
+ +L ++ S+V+C TD SDVQALQVLYTSLNSPS LTNWK GDPCGESWKG
Sbjct: 8 MFTVLLLFIASISGFSVVRCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWKG 67
Query: 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLA 137
+ CEGSAVV+IDIS LG+SGT+GYLLSDL SLRK D+SGNSIHDT+PYQLPPNLTSLNLA
Sbjct: 68 ITCEGSAVVTIDISDLGVSGTLGYLLSDLKSLRKLDVSGNSIHDTLPYQLPPNLTSLNLA 127
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
NN SGNLPYSI++M SLSY+NVS NSLT SIGDIF + LATLDLS NNFSGDLP+S
Sbjct: 128 RNNLSGNLPYSISAMGSLSYMNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGDLPSSL 187
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
++S +S LY+QNNQ+TGS++V SGLPL TLNVANNHF+G IP+EL SI+T IYDGNSFD
Sbjct: 188 STVSTLSVLYVQNNQLTGSIDVLSGLPLKTLNVANNHFNGSIPKELSSIQTLIYDGNSFD 247
Query: 258 NGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPS-GSQSSSSD--KELPAGAIVGIVLGAVF 314
N PA P P + GS P GS+ SSD K L G + GIV G++F
Sbjct: 248 NVPASPQPERPG--------KKETPSGSKKPKIGSEEKSSDSGKGLSGGVVTGIVFGSLF 299
Query: 315 LVALALLALYFCIRKNRRKVSGA-RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPP 373
+ + L LY C+ K +RKV G+ R+S S P+S E+ EQRVKSVA+V DL P
Sbjct: 300 VAGIIALVLYLCLHKKKRKVRGSTRASQRSLPLSGT---PEVQEQRVKSVASVADLKSSP 356
Query: 374 AEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFAN 433
AEK+ ++RV K+GS+ +I+SPITA+ YTV+SLQ ATNSFSQE +IGEGSLGRVYRAEF N
Sbjct: 357 AEKVTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPN 416
Query: 434 GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493
GKIMA+KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV LAGYC EHGQRLLVYEYVGNG
Sbjct: 417 GKIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNG 476
Query: 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553
NL D LH DD S NLTWNARV+VALGTA+ALEYLHEVCLPS+VHRNFKSANILLD+ELN
Sbjct: 477 NLDDTLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELN 536
Query: 554 PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613
PHLSD GLAALTPNTERQVSTQ+VG+FGYSAPEFALSGIYTVKSDVY+FGVVMLELLTGR
Sbjct: 537 PHLSDSGLAALTPNTERQVSTQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGR 596
Query: 614 KPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEP 673
KPLDSSR R+EQSLVRWATPQLHDIDAL+KMVDP+LNGMYPAKSLSRFADIIALC+QPEP
Sbjct: 597 KPLDSSRTRAEQSLVRWATPQLHDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEP 656
Query: 674 EFRPPMSEVVQALVRLVQRASVVKRRSSDESGFSYRTPDHEAIDTPF 720
EFRPPMSEVVQ LVRLVQRASVVKRRSSD++GFSYRTP+HE +D F
Sbjct: 657 EFRPPMSEVVQQLVRLVQRASVVKRRSSDDTGFSYRTPEHEHVDISF 703
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224117956|ref|XP_002331522.1| predicted protein [Populus trichocarpa] gi|222873746|gb|EEF10877.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1046 bits (2706), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 540/676 (79%), Positives = 598/676 (88%), Gaps = 9/676 (1%)
Query: 50 LYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSL 109
+YTSLNSPS LT WK N GDPC ESWKG+ CEGSAVVSI ISGLGL GTMGYLL++L+SL
Sbjct: 1 MYTSLNSPSQLTTWKSNGGDPCAESWKGITCEGSAVVSIQISGLGLDGTMGYLLANLMSL 60
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
R DLS N +HD+ PYQLPPNLTSLNLA NN SGN+PYS++SMVSLSYLN+SRNSL QSI
Sbjct: 61 RTLDLSDNHLHDSFPYQLPPNLTSLNLAKNNLSGNIPYSMSSMVSLSYLNISRNSLAQSI 120
Query: 170 GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLN 229
GD+F NL+ LAT+DLSFN+FSGDLP+SF SLSN+S+L +QNNQ+TGSLNV +GLPLTTLN
Sbjct: 121 GDVFLNLSLLATMDLSFNSFSGDLPSSFNSLSNLSTLNVQNNQLTGSLNVLTGLPLTTLN 180
Query: 230 VANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSP- 288
VANN+FSGWIP+EL SI FIYDGNSFDNGP+PPPPP T PP G+SH NR+H GS +P
Sbjct: 181 VANNNFSGWIPQELSSIPNFIYDGNSFDNGPSPPPPPYTPPPPGKSHRNRTH-PGSGAPV 239
Query: 289 ---SGSQSSSSDKELPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKVSGARSSAGSFP 345
S Q S SDK + GAIVG+ LG++ LV + LLAL FCI+K++ K G ++ GS P
Sbjct: 240 TPSSDGQPSQSDKGISVGAIVGVALGSLVLVLIVLLALVFCIKKHKSKEIGPLATRGSRP 299
Query: 346 VSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSGSLKKIKSPITATSYTVAS 404
T++ M E RVK++AAVTDL PPPAEKLV+ER+ SGS+K++KSPITATSY+VAS
Sbjct: 300 ADTDD---NMQESRVKNMAAVTDLKPPPAEKLVVERLQGNSGSIKRMKSPITATSYSVAS 356
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
LQTATNSFSQEFLIGEGSLGRVYR EF NGK+MAVKKIDNAALSLQEEDNFLEAVSNMS
Sbjct: 357 LQTATNSFSQEFLIGEGSLGRVYRGEFPNGKMMAVKKIDNAALSLQEEDNFLEAVSNMSH 416
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
LRHPNIV+L GYC EHGQRLLVYEY+ NG++HD+LHFADD SK L+WNARVRVALGTARA
Sbjct: 417 LRHPNIVSLVGYCVEHGQRLLVYEYIANGSVHDILHFADDGSKTLSWNARVRVALGTARA 476
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
LEYLHEVCLPSVVHRN KSANILLD+ELNPHLSDCGLAALTPNTERQVSTQMVG+FGYSA
Sbjct: 477 LEYLHEVCLPSVVHRNLKSANILLDEELNPHLSDCGLAALTPNTERQVSTQMVGSFGYSA 536
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644
PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSR RSEQSLVRWATPQLHDIDALAKM
Sbjct: 537 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRVRSEQSLVRWATPQLHDIDALAKM 596
Query: 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDES 704
VDP LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDES
Sbjct: 597 VDPILNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDES 656
Query: 705 GFSYRTPDHEAIDTPF 720
GF+YRTPDHEAID+ F
Sbjct: 657 GFAYRTPDHEAIDSSF 672
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449455383|ref|XP_004145432.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1040 bits (2689), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/696 (75%), Positives = 598/696 (85%), Gaps = 7/696 (1%)
Query: 31 TLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDI 90
++ ++ TD+SDVQALQV+YTSL+SP LT W + GDPC ESWKGV CEGSAVVSI+I
Sbjct: 17 SIPFLRAHTDASDVQALQVMYTSLDSPPQLTGWIVSGGDPCAESWKGVTCEGSAVVSIEI 76
Query: 91 SGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150
SGLGL+GTMGY LS LSL+K D+S NSIHD +PYQLPPNLTSLN+A N+ GNLPYS++
Sbjct: 77 SGLGLNGTMGYALSSFLSLKKLDMSDNSIHDAVPYQLPPNLTSLNMAKNSLIGNLPYSLS 136
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
+M SL+YLN+S N L+Q IGD+F NL L TLDLSFNNF+GDLP S +LSN+SSL+ QN
Sbjct: 137 TMASLNYLNMSHNLLSQVIGDVFTNLTTLETLDLSFNNFTGDLPKSLGTLSNVSSLFFQN 196
Query: 211 NQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAP 270
N++TGSLN+ LPLTTLNVANN+FSGWIP+EL S+ +FIYDGNSFDN PAPPPPP T P
Sbjct: 197 NRLTGSLNILIDLPLTTLNVANNNFSGWIPQELKSVESFIYDGNSFDNSPAPPPPPFTPP 256
Query: 271 PSGRSHNNRSH---RQGSHSP--SGSQSSSSDKELPAGAIVGIVLGAVFLVALALLALYF 325
P GRS N+ H G+H+ S SS S+K LP AIVGIVLGA+ V + L+A
Sbjct: 257 PPGRSRNSPKHPGSSGGTHTAPSSEGSSSHSNKGLPVLAIVGIVLGAIIFVLIVLVAFAV 316
Query: 326 CIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AK 384
C +K +RK G R+S+G + T+ +N E+ E RVKSVAAV D+ P PAEK+ ER+ AK
Sbjct: 317 CFQKRKRKNIGLRASSGRLSIGTS-VNAEVQEHRVKSVAAVADIKPLPAEKMNPERLQAK 375
Query: 385 SGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDN 444
+GS+K+IK+PITATSYTVASLQ ATNSFSQE ++GEGSLGRVY+AEF NGK MA+KKIDN
Sbjct: 376 NGSVKRIKAPITATSYTVASLQAATNSFSQECIVGEGSLGRVYKAEFPNGKTMAIKKIDN 435
Query: 445 AALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD 504
+ALSLQEEDNFLEAVSNMSRLRH NIVTL GYCAEHGQRLLVYE++G+G+LHDMLHFA++
Sbjct: 436 SALSLQEEDNFLEAVSNMSRLRHTNIVTLNGYCAEHGQRLLVYEFIGHGSLHDMLHFAEE 495
Query: 505 SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
SSK LTWNARVRVALGTARALEYLHEVCLPSVVHRN K+ANILLD++LNPHLSDCGLAAL
Sbjct: 496 SSKTLTWNARVRVALGTARALEYLHEVCLPSVVHRNLKTANILLDEDLNPHLSDCGLAAL 555
Query: 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSE 624
TPNTERQ+STQMVG+FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSR RSE
Sbjct: 556 TPNTERQISTQMVGSFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRVRSE 615
Query: 625 QSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
QSLVRWATPQLHDIDALAKMVDP LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ
Sbjct: 616 QSLVRWATPQLHDIDALAKMVDPTLNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 675
Query: 685 ALVRLVQRASVVKRRSSDESGFSYRTPDHEAIDTPF 720
ALVRLVQRASVVKR SSDESGFSY+TP+H+A++ PF
Sbjct: 676 ALVRLVQRASVVKRHSSDESGFSYKTPEHDAVELPF 711
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255554777|ref|XP_002518426.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223542271|gb|EEF43813.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 968 bits (2502), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/627 (79%), Positives = 554/627 (88%), Gaps = 13/627 (2%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166
L + DLS N+IHDTIPYQLPPNLTSLNLA NN SGNLPYSI++MVSL+YLN+S NS++
Sbjct: 14 LRFKGIDLSDNNIHDTIPYQLPPNLTSLNLARNNLSGNLPYSISTMVSLTYLNMSHNSIS 73
Query: 167 QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLT 226
QS+GD+F NLA L TLDLSFNNFSG+LP+SF SLSN+S+ Y+QNNQ+TGSL+V +GLPLT
Sbjct: 74 QSVGDVFANLALLTTLDLSFNNFSGNLPSSFSSLSNLSTFYIQNNQLTGSLDVLAGLPLT 133
Query: 227 TLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHR-QGS 285
TLNVANNH +GWIPREL S+ FIYDGNSFDNGPAPPPPP T PP GRS NN SH G+
Sbjct: 134 TLNVANNHLTGWIPRELNSVPNFIYDGNSFDNGPAPPPPPYTPPPPGRSRNNHSHSGSGT 193
Query: 286 HSP--SGSQSSSSDKELPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKVSGARSSAGS 343
+P S QSS SDK + GAIVGIVLG+V L+ +ALLA+ FC RK ++K GA S GS
Sbjct: 194 RTPPSSDDQSSESDKGMSVGAIVGIVLGSVLLIFIALLAVLFCTRKKKQKDGGAIVSQGS 253
Query: 344 FPVSTNNM---------NTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSGSLKKIKS 393
T + +TEM EQRVKS+AAV DL PPPAEKLV++++ SGS+K++KS
Sbjct: 254 RSAGTTDSAKFSSVIAGDTEMQEQRVKSIAAVADLKPPPAEKLVVDKLQGHSGSVKRMKS 313
Query: 394 PITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED 453
PITATSYTVASLQTATNSFSQEF+IGEGSLGRVYR EF+NGKIMA+KKIDNAALSLQEED
Sbjct: 314 PITATSYTVASLQTATNSFSQEFIIGEGSLGRVYRGEFSNGKIMAIKKIDNAALSLQEED 373
Query: 454 NFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
NFLEAVSNMSRLRHPNIV+LAGYCAEHGQRLLVYE++GNG+LHDMLHFA+D SK L+WNA
Sbjct: 374 NFLEAVSNMSRLRHPNIVSLAGYCAEHGQRLLVYEHIGNGSLHDMLHFAEDGSKTLSWNA 433
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573
RVRVALGTARALEYLHEVCLPS+VHRNFKSANILLD+ELNPHLSDCGLAALTPNTERQVS
Sbjct: 434 RVRVALGTARALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDCGLAALTPNTERQVS 493
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633
TQMVG+FGYSAPEFALSG+YTVKSDVYSFGVVMLELLTGRKPLDSSR RSEQSLVRWATP
Sbjct: 494 TQMVGSFGYSAPEFALSGVYTVKSDVYSFGVVMLELLTGRKPLDSSRVRSEQSLVRWATP 553
Query: 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693
QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA
Sbjct: 554 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 613
Query: 694 SVVKRRSSDESGFSYRTPDHEAIDTPF 720
SVVKRRSSDESGF Y+TPDHEAID F
Sbjct: 614 SVVKRRSSDESGFGYKTPDHEAIDMSF 640
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449513527|ref|XP_004164349.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 947 bits (2449), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/677 (72%), Positives = 555/677 (81%), Gaps = 36/677 (5%)
Query: 50 LYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSL 109
+YTSL+SP LT W + GDPC ESWKGV CEGSAVVSI+ISGLGL+GTMGY LS LSL
Sbjct: 1 MYTSLDSPPQLTGWIVSGGDPCAESWKGVTCEGSAVVSIEISGLGLNGTMGYALSSFLSL 60
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
+K D+S NSIHD +PYQLPPNLTSLN+A N+ GNLPYS+++M SL+YLN+S N L+Q I
Sbjct: 61 KKLDMSDNSIHDAVPYQLPPNLTSLNMAKNSLIGNLPYSLSTMASLNYLNMSHNLLSQVI 120
Query: 170 GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLN 229
GD+F NL L TLDLSFNNF+GDLP S +LSN+SSL+ QNN++TGSLN+ LPLTTLN
Sbjct: 121 GDVFTNLTTLETLDLSFNNFTGDLPKSLGTLSNVSSLFFQNNRLTGSLNILIDLPLTTLN 180
Query: 230 VANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSH---RQGSH 286
VANN+FSGWIP+EL S+ +FIYDGNSFDN PAPPPPP T PP GRS N+ H G+H
Sbjct: 181 VANNNFSGWIPQELKSVESFIYDGNSFDNSPAPPPPPFTPPPPGRSRNSPKHPGSSGGTH 240
Query: 287 SP--SGSQSSSSDKELPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKVSGARSSAGSF 344
+ S SS S+K LP AIVGIVLGA+ V + L+A C +K +RK G R+S+G
Sbjct: 241 TAPSSEGSSSHSNKGLPVLAIVGIVLGAIIFVLIVLVAFAVCFQKRKRKNIGLRASSGRL 300
Query: 345 PVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSGSLKKIKSPITATSYTVA 403
+ T+ +N E+ E RVKSVAAV D+ P PAEK+ ER+ AK+GS+K+IK+PITATSYTVA
Sbjct: 301 SIGTS-VNAEVQEHRVKSVAAVADIKPLPAEKMNPERLQAKNGSVKRIKAPITATSYTVA 359
Query: 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS 463
SLQ ATNSFSQE ++GEGSLGRVY+AEF NGK MA+KKIDN+ALSLQEEDNFLEAVSNMS
Sbjct: 360 SLQAATNSFSQECIVGEGSLGRVYKAEFPNGKTMAIKKIDNSALSLQEEDNFLEAVSNMS 419
Query: 464 RLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
RLRH NIVTL ++SSK LTWNARVRVALGTAR
Sbjct: 420 RLRHTNIVTL-----------------------------NESSKTLTWNARVRVALGTAR 450
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
ALEYLHEVCLPSVVHRN K+ANILLD++LNPHLSDCGLAALTPNTERQ+STQMVG+FGYS
Sbjct: 451 ALEYLHEVCLPSVVHRNLKTANILLDEDLNPHLSDCGLAALTPNTERQISTQMVGSFGYS 510
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643
APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSR RSEQSLVRWATPQLHDIDALAK
Sbjct: 511 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRVRSEQSLVRWATPQLHDIDALAK 570
Query: 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDE 703
MVDP LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKR SSDE
Sbjct: 571 MVDPTLNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRHSSDE 630
Query: 704 SGFSYRTPDHEAIDTPF 720
SGFSY+TP+H+A++ PF
Sbjct: 631 SGFSYKTPEHDAVELPF 647
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357138966|ref|XP_003571057.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2313), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/689 (68%), Positives = 549/689 (79%), Gaps = 16/689 (2%)
Query: 40 DSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTM 99
+SSD AL LYTS NSPS L W + GDPCG W+GV+C GS V I ++G GL+G++
Sbjct: 23 ESSDAAALGNLYTSWNSPSQLAGWSASGGDPCGAGWQGVSCNGSGVTEIKLAGTGLNGSL 82
Query: 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
GY LS+L SL+ DLS N+IH +IPYQLPPNLT LNLA+NNFSGNLPYSI++M S+ YLN
Sbjct: 83 GYELSNLYSLKTLDLSNNNIHGSIPYQLPPNLTYLNLATNNFSGNLPYSISNMASIEYLN 142
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
+S NSL+Q IGD+F NL L+ LD+SFN +GDLPNS SLSNISSLY+QNNQ+TG +NV
Sbjct: 143 ISHNSLSQQIGDLFRNLNSLSELDISFNKLTGDLPNSIGSLSNISSLYMQNNQLTGPVNV 202
Query: 220 FSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNR 279
SGL LTTLN+ANN+FSGWIP+E SI I GNSF NGPAPPPPP PP R N
Sbjct: 203 LSGLGLTTLNIANNNFSGWIPKEFSSIPDVILGGNSFANGPAPPPPPFMPPPPRRPRNRP 262
Query: 280 SHRQGS-HSPSGSQSSSS--DKE--LPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKV 334
++ GS ++P GS+SS+ DK+ L GA+VGI++G++ LL L CIR R++
Sbjct: 263 NNSGGSGNAPKGSESSTGQGDKKQGLQTGALVGIIVGSILAALCVLLVLVLCIRNARKRK 322
Query: 335 SGARSSAGSF--PVSTN-----NMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSG 386
+ S + F P+S N + H SVAA+ L PAEK+ ERV +G
Sbjct: 323 DDSSSESKDFVGPLSVNIQEASDREIAEHGHENTSVAAMKVL---PAEKMTPERVYGING 379
Query: 387 SLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAA 446
S++K K PITAT YTVASLQ ATNSF Q+ L+GEGSLGRVY+A+F NGK++AVKKID+AA
Sbjct: 380 SMRKAKVPITATPYTVASLQVATNSFCQDSLLGEGSLGRVYKADFPNGKVLAVKKIDSAA 439
Query: 447 LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSS 506
LSLQEEDNFLE VS+MSRLRHPNIV L GYC EH QRLLVYEY+GNG LHDMLHF+D+ S
Sbjct: 440 LSLQEEDNFLEVVSSMSRLRHPNIVPLTGYCVEHAQRLLVYEYIGNGTLHDMLHFSDEMS 499
Query: 507 KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
+ LTWN RVR+ALGTARALEYLHEVCLPSVVHRNFKS+NILLD+E N HLSDCGLAALTP
Sbjct: 500 RKLTWNIRVRIALGTARALEYLHEVCLPSVVHRNFKSSNILLDEEHNAHLSDCGLAALTP 559
Query: 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS 626
NTERQVST++VG+FGYSAPE+++SGIYTVKSDVYSFGVVMLELLTGRKPLDSSR RSEQS
Sbjct: 560 NTERQVSTEVVGSFGYSAPEYSMSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRERSEQS 619
Query: 627 LVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
LVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ L
Sbjct: 620 LVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQQL 679
Query: 687 VRLVQRASVVKRRSSDESGFSYRTPDHEA 715
VRL+QRAS+V+R+S +E GFSYR P+ E
Sbjct: 680 VRLMQRASIVRRQSGEELGFSYRAPEREG 708
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 720 | ||||||
| TAIR|locus:2120683 | 703 | SRF8 "STRUBBELIG-receptor fami | 0.965 | 0.988 | 0.701 | 5.8e-256 | |
| TAIR|locus:2091015 | 717 | SRF7 "STRUBBELIG-receptor fami | 0.490 | 0.492 | 0.614 | 7.4e-163 | |
| TAIR|locus:2024837 | 720 | SRF6 "STRUBBELIG-receptor fami | 0.937 | 0.937 | 0.482 | 2.5e-161 | |
| TAIR|locus:2207280 | 699 | SRF5 "STRUBBELIG-receptor fami | 0.437 | 0.450 | 0.583 | 1.2e-149 | |
| TAIR|locus:2125566 | 776 | SRF3 "STRUBBELIG-receptor fami | 0.443 | 0.411 | 0.610 | 2.1e-141 | |
| TAIR|locus:2051404 | 775 | SRF1 "STRUBBELIG-receptor fami | 0.498 | 0.463 | 0.552 | 6.3e-140 | |
| TAIR|locus:2089210 | 687 | SRF4 "STRUBBELIG-receptor fami | 0.468 | 0.490 | 0.508 | 8.2e-138 | |
| TAIR|locus:2202084 | 768 | SUB "STRUBBELIG" [Arabidopsis | 0.406 | 0.381 | 0.553 | 1.7e-122 | |
| TAIR|locus:2170219 | 735 | SRF2 "STRUBBELIG-receptor fami | 0.512 | 0.502 | 0.440 | 1.2e-121 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.395 | 0.450 | 0.357 | 3.7e-72 |
| TAIR|locus:2120683 SRF8 "STRUBBELIG-receptor family 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2464 (872.4 bits), Expect = 5.8e-256, P = 5.8e-256
Identities = 494/704 (70%), Positives = 550/704 (78%)
Query: 18 LIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKG 77
+ +L ++ S+V+C TD SDVQALQVLYTSLNSPS LTNWK GDPCGESWKG
Sbjct: 8 MFTVLLLFIASISGFSVVRCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWKG 67
Query: 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLA 137
+ CEGSAVV+IDIS LG+SGT+GYLLSDL SLRK D+SGNSIHDT+PYQLPPNLTSLNLA
Sbjct: 68 ITCEGSAVVTIDISDLGVSGTLGYLLSDLKSLRKLDVSGNSIHDTLPYQLPPNLTSLNLA 127
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDXXXXX 197
NN SGNLPYSI++M SLSY+NVS NSLT SIGDIF + LATLDLS NNFSGD
Sbjct: 128 RNNLSGNLPYSISAMGSLSYMNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGDLPSSL 187
Query: 198 XXXXXXXXXXXXXXQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
Q+TGS++V SGLPL TLNVANNHF+G IP+EL SI+T IYDGNSFD
Sbjct: 188 STVSTLSVLYVQNNQLTGSIDVLSGLPLKTLNVANNHFNGSIPKELSSIQTLIYDGNSFD 247
Query: 258 NGXXXXXXXXXXXXXGRSHNNXXXXXXXXXXXXXXXXXXDKELPAGAXXXXXXXXXXXXX 317
N G+ K L G
Sbjct: 248 N----VPASPQPERPGKKETPSGSKKPKIGSEEKSSDSG-KGLSGGVVTGIVFGSLFVAG 302
Query: 318 XXXXXXYFCIRKNRRKVSGA-RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEK 376
Y C+ K +RKV G+ R+S S P+S E+ EQRVKSVA+V DL PAEK
Sbjct: 303 IIALVLYLCLHKKKRKVRGSTRASQRSLPLSGT---PEVQEQRVKSVASVADLKSSPAEK 359
Query: 377 LVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKI 436
+ ++RV K+GS+ +I+SPITA+ YTV+SLQ ATNSFSQE +IGEGSLGRVYRAEF NGKI
Sbjct: 360 VTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKI 419
Query: 437 MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLH 496
MA+KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV LAGYC EHGQRLLVYEYVGNGNL
Sbjct: 420 MAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLD 479
Query: 497 DMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556
D LH DD S NLTWNARV+VALGTA+ALEYLHEVCLPS+VHRNFKSANILLD+ELNPHL
Sbjct: 480 DTLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHL 539
Query: 557 SDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
SD GLAALTPNTERQVSTQ+VG+FGYSAPEFALSGIYTVKSDVY+FGVVMLELLTGRKPL
Sbjct: 540 SDSGLAALTPNTERQVSTQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPL 599
Query: 617 DSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFR 676
DSSR R+EQSLVRWATPQLHDIDAL+KMVDP+LNGMYPAKSLSRFADIIALC+QPEPEFR
Sbjct: 600 DSSRTRAEQSLVRWATPQLHDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPEFR 659
Query: 677 PPMSEVVQALVRLVQRASVVKRRSSDESGFSYRTPDHEAIDTPF 720
PPMSEVVQ LVRLVQRASVVKRRSSD++GFSYRTP+HE +D F
Sbjct: 660 PPMSEVVQQLVRLVQRASVVKRRSSDDTGFSYRTPEHEHVDISF 703
|
|
| TAIR|locus:2091015 SRF7 "STRUBBELIG-receptor family 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1092 (389.5 bits), Expect = 7.4e-163, Sum P(2) = 7.4e-163
Identities = 223/363 (61%), Positives = 268/363 (73%)
Query: 352 NTEMHEQRVKSVAAVTDLTPPPAEKLVI-----ERVAKSGSLKK--IKSPITATSYTVAS 404
N + E + + +L PPP+E+ + K KK + P +YTV+
Sbjct: 352 NPPLVETKKLDTSLSMNLRPPPSERHKSFDDDDSTMRKPIVAKKAAVVVPSNVNTYTVSD 411
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
LQ ATNSFS + L+GEG+ GRVYRA+F +GK++AVKKID++AL D+F E VS ++
Sbjct: 412 LQVATNSFSVDNLLGEGTFGRVYRAQFEDGKVLAVKKIDSSALPTDTADDFTEIVSKIAH 471
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
L H N+ L GYC+EHGQ L+VYE+ NG+LHD LH A++ SK L WN RV++ALGTARA
Sbjct: 472 LDHENVTKLDGYCSEHGQHLVVYEFHRNGSLHDFLHLAEEESKPLIWNPRVKIALGTARA 531
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
LEYLHEVC PS+VH+N KSANILLD ELNPHLSD GLA+ P T ++ Q GYSA
Sbjct: 532 LEYLHEVCSPSIVHKNIKSANILLDSELNPHLSDSGLASFLP-TANELLNQ--NDEGYSA 588
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644
PE ++SG Y++KSDVYSFGVVMLELLTGRKP DS+R RSEQSLVRWATPQLHDIDAL KM
Sbjct: 589 PETSMSGQYSLKSDVYSFGVVMLELLTGRKPFDSTRSRSEQSLVRWATPQLHDIDALGKM 648
Query: 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDES 704
VDPAL G+YP KSLSRFAD+IALCVQPEPEFRPPMSEVVQALV LVQRA++ KR S
Sbjct: 649 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVVLVQRANMSKRTVGVGS 708
Query: 705 GFS 707
G S
Sbjct: 709 GSS 711
|
|
| TAIR|locus:2024837 SRF6 "STRUBBELIG-receptor family 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1571 (558.1 bits), Expect = 2.5e-161, P = 2.5e-161
Identities = 338/700 (48%), Positives = 431/700 (61%)
Query: 18 LIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKG 77
++ F L + F L + TD+SD AL L++ ++SP+ LT W GDPCG++W+G
Sbjct: 7 VVALFTLCIVGF-ELRFIHGATDASDTSALNTLFSGMHSPAQLTQWTAAAGDPCGQNWRG 65
Query: 78 VACEGSAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNL 136
V C GS V I +SGL LSGT+G Y+L L SL + DLS N++ +PYQ PPNL LNL
Sbjct: 66 VTCSGSRVTQIKLSGLELSGTLGGYMLDKLTSLTELDLSSNNLGGDLPYQFPPNLQRLNL 125
Query: 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDXXXX 196
A+N F+G YS++ + L YLN+ N I F L L TLD SFN+F+
Sbjct: 126 ANNQFTGAASYSLSQITPLKYLNLGHNQFKGQIAIDFSKLDSLTTLDFSFNSFTNSLPAT 185
Query: 197 XXXXXXXXXXXXXXXQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
Q +G+++V +GLPL TLN+ANN F+GWIP L I T I DGNSF
Sbjct: 186 FSSLTSLKSLYLQNNQFSGTVDVLAGLPLETLNIANNDFTGWIPSSLKGI-TLIKDGNSF 244
Query: 257 DNGXXXXXXXXXXXXXGRSHNNXXXXXXXXXXXXXXXXXXDKELPAGAXXXXXXXXXXXX 316
+ G G S + K+ GA
Sbjct: 245 NTGPAPPPPPGTPPIRG-SPSRKSGGRESRSSDESTRNGDSKKSGIGAGAIAGIIISLLV 303
Query: 317 XXXXXXXYFCIRKNRRKVSGA----RSSAGSFPVSTNNMNTEMHEQRVKSV-------AA 365
+F R+ + K S ++ F +++N+ + Q SV +
Sbjct: 304 VTALLVAFFLFRRKKSKRSSPMDIEKTDNQPFTLASNDFHENNSIQSSSSVETKKLDTSL 363
Query: 366 VTDLTPPPAEKLVI----ERVAKSGSLKK--IKSPITATSYTVASLQTATNSFSQEFLIG 419
+L PPP ++ + K ++KK + P Y+VA LQ AT SFS + L+G
Sbjct: 364 SINLRPPPIDRNKSFDDEDSTRKPIAVKKSTVVVPSNVRLYSVADLQIATGSFSVDNLLG 423
Query: 420 EGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479
EG+ GRVYRAEF +GK++AVKKID++AL D+F+E VS ++ L HPN+ L GYCAE
Sbjct: 424 EGTFGRVYRAEFDDGKVLAVKKIDSSALPHGMTDDFIEMVSKIANLDHPNVTKLVGYCAE 483
Query: 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHR 539
HGQ L+VYE+ NG+LHD LH +++ SK L WN+RV++ALGTARALEYLHEVC PS+V +
Sbjct: 484 HGQHLVVYEFHKNGSLHDFLHLSEEESKALVWNSRVKIALGTARALEYLHEVCSPSIVDK 543
Query: 540 NFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDV 599
N KSANILLD ELNPHLSD GLA+ P T ++ Q GYSAPE ++SG Y++KSD+
Sbjct: 544 NIKSANILLDSELNPHLSDSGLASFLP-TANELLNQTDE--GYSAPEVSMSGQYSLKSDI 600
Query: 600 YSFGVVMLELLTGRKPLDSS-RPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSL 658
YSFGVVMLELLTGRKP DSS R RSEQSLVRWATPQLHDIDALAKMVDPAL G+YP KSL
Sbjct: 601 YSFGVVMLELLTGRKPFDSSTRSRSEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSL 660
Query: 659 SRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKR 698
SRFAD+IALCVQPEPEFRPPMSEVVQALV LVQRA++ KR
Sbjct: 661 SRFADVIALCVQPEPEFRPPMSEVVQALVVLVQRANMSKR 700
|
|
| TAIR|locus:2207280 SRF5 "STRUBBELIG-receptor family 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 948 (338.8 bits), Expect = 1.2e-149, Sum P(2) = 1.2e-149
Identities = 189/324 (58%), Positives = 238/324 (73%)
Query: 389 KKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS 448
K+ S +A + ++ LQ+AT +FS L+GEGS+GRVYRA++++G+ +AVKKID+
Sbjct: 381 KRTTSTRSAVEFELSDLQSATANFSPGNLLGEGSIGRVYRAKYSDGRTLAVKKIDSTLFD 440
Query: 449 LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN 508
+ + V ++S++RH NI L GYC+E G +LVYEY NG+LH+ LH +D SK
Sbjct: 441 SGKSEGITPIVMSLSKIRHQNIAELVGYCSEQGHNMLVYEYFRNGSLHEFLHLSDCFSKP 500
Query: 509 LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568
LTWN RVR+ALGTARA+EYLHE C PSV+H+N KS+NILLD +LNP LSD GL+ T
Sbjct: 501 LTWNTRVRIALGTARAVEYLHEACSPSVMHKNIKSSNILLDADLNPRLSDYGLSKFYLRT 560
Query: 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV 628
+Q +G GY+APE YT KSDVYSFGVVMLELLTGR P D +PR E+SLV
Sbjct: 561 -----SQNLGE-GYNAPEARDPSAYTPKSDVYSFGVVMLELLTGRVPFDGEKPRPERSLV 614
Query: 629 RWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688
RWATPQLHDIDAL+ + DPAL+G+YP KSLSRFADIIALCVQ EPEFRPPMSEVV+ALVR
Sbjct: 615 RWATPQLHDIDALSNIADPALHGLYPPKSLSRFADIIALCVQVEPEFRPPMSEVVEALVR 674
Query: 689 LVQRASVVKRRSSDESGFSYRTPD 712
+VQR+S+ + D+ SYR D
Sbjct: 675 MVQRSSM---KLKDDLSSSYRAHD 695
|
|
| TAIR|locus:2125566 SRF3 "STRUBBELIG-receptor family 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 2.1e-141, Sum P(2) = 2.1e-141
Identities = 202/331 (61%), Positives = 241/331 (72%)
Query: 371 PPPA-EKLVI------ERVAKSGSLKKIKSPITATS-YTVASLQTATNSFSQEFLIGEGS 422
PPP EK+ + ER K S K++ P+T+ Y++ASLQ T SF+QE LIG G
Sbjct: 438 PPPLDEKVTVMPIISPERPVKKTSPKRL--PLTSVKHYSIASLQQYTESFAQENLIGSGM 495
Query: 423 LGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482
LG VYRA NGK+ AVKK+D A Q++ F+E V+N+ +RH NIV L GYCAEH Q
Sbjct: 496 LGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNIDMIRHSNIVELVGYCAEHDQ 555
Query: 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFK 542
RLLVYEY NG L D LH D+ K L+WN RV +ALG ARALEYLHEVC P ++HRNFK
Sbjct: 556 RLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAARALEYLHEVCEPPIIHRNFK 615
Query: 543 SANILLDDELNPHLSDCGLAAL-TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYS 601
SAN+LLDD+L+ +SDCGLA L + + Q+S Q++ A+GY APEF SGIYT +SDVYS
Sbjct: 616 SANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQLLAAYGYGAPEFD-SGIYTWQSDVYS 674
Query: 602 FGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRF 661
FGVVMLELLTGR D R R EQ LVRWA PQLHDIDAL KMVDP+LNG YPAKSLS F
Sbjct: 675 FGVVMLELLTGRMSYDRDRSRGEQFLVRWAIPQLHDIDALGKMVDPSLNGQYPAKSLSHF 734
Query: 662 ADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
ADII+ CVQ EPEFRP MSEVVQ L+ +++R
Sbjct: 735 ADIISRCVQSEPEFRPLMSEVVQDLLDMIRR 765
|
|
| TAIR|locus:2051404 SRF1 "STRUBBELIG-receptor family 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 986 (352.1 bits), Expect = 6.3e-140, Sum P(2) = 6.3e-140
Identities = 206/373 (55%), Positives = 251/373 (67%)
Query: 336 GARSSAGSFPVSTN-NMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSP 394
G+ S S + N N MH + + V PAE + +KS P
Sbjct: 406 GSESKQESHEIDMNGNAMDLMHPSSIPPIKRVIAKATEPAEASLKRTTSKS------HGP 459
Query: 395 ITATS-YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED 453
+TA +TVASLQ TNSFS E LIG G LG VYRAE GK+ AV+K+D + + +EE
Sbjct: 460 LTAVKHFTVASLQQHTNSFSHENLIGTGMLGSVYRAELPGGKLFAVRKLDKKSPNHEEEG 519
Query: 454 NFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
FLE V+N+ R+RH NIV L G+C+EH QRLL++EY NG LHD+LH D L+WN
Sbjct: 520 KFLELVNNIDRIRHANIVQLVGFCSEHSQRLLIHEYCRNGTLHDLLHIDDRLKIELSWNV 579
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL-TPNTERQV 572
RVR+AL A+ALEYLHE+C P +HRNFKSANILLDD++ H+SDCGLA L + Q+
Sbjct: 580 RVRIALEAAKALEYLHEICDPPSIHRNFKSANILLDDDIRVHVSDCGLAPLISSGAVSQL 639
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWAT 632
S Q++ A+GY APEF GIYT+K DVYSFGVVMLELLTGRK D R R EQ LVRWA
Sbjct: 640 SGQLLAAYGYGAPEFEY-GIYTMKCDVYSFGVVMLELLTGRKSYDKKRDRGEQFLVRWAI 698
Query: 633 PQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
PQLHDIDALAKMVDP+L G YPAKSLS FAD+I+ CVQ EPE+RP MSEVVQ L ++QR
Sbjct: 699 PQLHDIDALAKMVDPSLKGDYPAKSLSHFADVISRCVQSEPEYRPLMSEVVQDLSDMIQR 758
Query: 693 ASVVKRRSSDESG 705
+ R +D +G
Sbjct: 759 ----EHRRNDSNG 767
|
|
| TAIR|locus:2089210 SRF4 "STRUBBELIG-receptor family 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 851 (304.6 bits), Expect = 8.2e-138, Sum P(2) = 8.2e-138
Identities = 177/348 (50%), Positives = 235/348 (67%)
Query: 348 TNNMNTEMHEQ-RVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIK--SPIT--ATSYTV 402
T + NT + + VK ++V+ P + +VA + SP T ++++
Sbjct: 346 TVDSNTSLETKPSVKRTSSVSFKNSPTFHLIPSTQVAATPDRSSTSQDSPDTRGVKAFSL 405
Query: 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNM 462
A LQ + FS L+GEG++GRVY+A+F +G+ AVK+ID++ L + F VS++
Sbjct: 406 ADLQNTASCFSPNRLLGEGTIGRVYKAKFQDGRKFAVKEIDSSLLGKGNPEEFSHIVSSI 465
Query: 463 SRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA 522
S + H N+ L GYC+E G+ +LVYEY +G+LH LH +DD SK LTWN R+R+ALGTA
Sbjct: 466 SSIHHKNMAELVGYCSEQGRNMLVYEYFTSGSLHRFLHLSDDFSKPLTWNTRIRIALGTA 525
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY 582
+A+EYLHE C P +VH+N KS+NILLD+ELNP LSD GLA N + S Q +G GY
Sbjct: 526 KAIEYLHETCSPPLVHKNIKSSNILLDNELNPRLSDYGLA----NFHHRTS-QNLGV-GY 579
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642
+APE YT KSDVYSFGVVMLELLTGRKP DS RP++EQSLVRWA PQL D+D L
Sbjct: 580 NAPECTDPSAYTQKSDVYSFGVVMLELLTGRKPYDSGRPKAEQSLVRWAKPQLKDMDTLD 639
Query: 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690
+MVDPAL G+Y +S+S FADI+++CV EP RPP+S VV+AL RLV
Sbjct: 640 EMVDPALCGLYAPESVSSFADIVSICVMTEPGLRPPVSNVVEALKRLV 687
|
|
| TAIR|locus:2202084 SUB "STRUBBELIG" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 833 (298.3 bits), Expect = 1.7e-122, Sum P(2) = 1.7e-122
Identities = 166/300 (55%), Positives = 215/300 (71%)
Query: 391 IKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ 450
+ S +AT +T+ASLQ TN+FS+E +IGEGS+G VYRAE +GK +AVKK+ N Q
Sbjct: 476 LNSSSSATVFTIASLQQYTNNFSEENIIGEGSIGNVYRAELRHGKFLAVKKLSNTINRTQ 535
Query: 451 EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT 510
+ FL VSN+ +L+ +I+ L GYC E GQRLLVYEY NG+L D LH K LT
Sbjct: 536 SDGEFLNLVSNVLKLKRGHILELLGYCNEFGQRLLVYEYCPNGSLQDALHLDRKLHKKLT 595
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
WN R+ +ALG ++AL++LHEVC P VVH+NFKS+ +LLD +L+ ++D GLA + P R
Sbjct: 596 WNVRINIALGASKALQFLHEVCQPPVVHQNFKSSKVLLDGKLSVRVADSGLAYMLP--PR 653
Query: 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW 630
S QM G Y+APE G YT +SDV+S GVVMLELLTGR+P D +RPR Q+L +W
Sbjct: 654 PTS-QMAG---YAAPEVEY-GSYTCQSDVFSLGVVMLELLTGRRPFDRTRPRGHQTLAQW 708
Query: 631 ATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690
A P+LHDIDAL +MVDP+L+G YP KSLSRFADII+ +Q EP FRPP+SE+VQ L ++
Sbjct: 709 AIPRLHDIDALTRMVDPSLHGAYPMKSLSRFADIISRSLQMEPGFRPPISEIVQDLQHMI 768
|
|
| TAIR|locus:2170219 SRF2 "STRUBBELIG-receptor family 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 787 (282.1 bits), Expect = 1.2e-121, Sum P(2) = 1.2e-121
Identities = 175/397 (44%), Positives = 241/397 (60%)
Query: 325 FCIRKNRRKVSGA----RSS---AGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKL 377
F +R N R+ RS+ A S PVST E + + PPPA +L
Sbjct: 316 FAVRMNHRRAQNLAAIHRSNNSIAYSLPVSTGREYPVATEDNPQ----IKRFQPPPAPQL 371
Query: 378 -----VIERVAKSGSLKKIKS----PITATSYTVASLQTATNSFSQEFLIGEGSLGRVYR 428
R+ KS K + P A ++ A LQ ATN FS+E L+GEG LG VYR
Sbjct: 372 RHLPSPPVRIDKSARRKSFSATCQYPSFAKLFSAAELQLATNCFSEENLLGEGPLGSVYR 431
Query: 429 AEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488
A+ +G+ V+ I ++LSL EE+ F E + S+LRHPNIVTL G+C E+G+ LLVYE
Sbjct: 432 AKLPDGQFAVVRNIPMSSLSLHEEEQFTEVLQTASKLRHPNIVTLLGFCIENGEHLLVYE 491
Query: 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548
YVG+ +L++ +H D+ K L+W R+R+A+G ARAL+YLH P + H + K+ NILL
Sbjct: 492 YVGHLSLYNAMH--DEVYKPLSWGLRLRIAIGVARALDYLHSSFCPPIAHSDLKATNILL 549
Query: 549 DDELNPHLSDCGLAALTPNTERQVSTQM----VGAFGYSAPEFALSGIYTVKSDVYSFGV 604
D+EL P ++DCGLA+L P T V + + GY APE G KSD Y+ GV
Sbjct: 550 DEELTPRIADCGLASLRPLTSNSVKLRASEIAIQNTGYIAPEHGQPGSSGTKSDTYALGV 609
Query: 605 VMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADI 664
++LELLTGRK DSSRPR EQ LV+WA+ +LHD +L +M+D + G + ++ S++ADI
Sbjct: 610 LLLELLTGRKAFDSSRPRGEQLLVKWASTRLHDRRSLEQMIDGGIAGTFSSRVASQYADI 669
Query: 665 IALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSS 701
I+LC Q E EFRPP+SE+V+AL L+Q+ + K SS
Sbjct: 670 ISLCTQAEKEFRPPVSEIVEALTALIQKQN--KEASS 704
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 503 (182.1 bits), Expect = 3.7e-72, Sum P(2) = 3.7e-72
Identities = 103/288 (35%), Positives = 167/288 (57%)
Query: 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAV 459
YT L++ATN F+ + ++G G G VY+ +G ++AVK++ + ++ E F V
Sbjct: 289 YTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIA-GGEVQFQTEV 347
Query: 460 SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
+S H N++ L G+C+ + +R+LVY Y+ NG++ L L W+ R ++A+
Sbjct: 348 ETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAV 407
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA 579
GTAR L YLHE C P ++HR+ K+ANILLD++ + D GLA L + + V+T + G
Sbjct: 408 GTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 467
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVRWATPQLHDI 638
G+ APE+ +G + K+DV+ FG+++LEL+TG+K LD R ++ ++ W +LH
Sbjct: 468 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVK-KLHQE 526
Query: 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
L +++D LN + L + LC Q P RP MSEV++ L
Sbjct: 527 GKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKML 574
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6R2J8 | SRF8_ARATH | No assigned EC number | 0.7383 | 0.9611 | 0.9843 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | scaffold_702155.1 | annotation not avaliable (703 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 720 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-12 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-08 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 4e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-48
Identities = 86/271 (31%), Positives = 123/271 (45%), Gaps = 25/271 (9%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G GS G VY+A+ GKI+AVK + + +++ + + RL HPNIV L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ LV EY G+L D L L+ + ++AL R LEYLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN---GI 119
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI-YTV 595
+HR+ K NILLD+ ++D GLA T VG Y APE L G Y
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKK-LLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655
K DV+S GV++ ELLTG+ P + L+R +++ P L P
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIR-------------RILGPPLEFDEPK 225
Query: 656 KSL--SRFADIIALCVQPEPEFRPPMSEVVQ 684
S D+I C+ +P RP E++Q
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 3e-46
Identities = 82/270 (30%), Positives = 119/270 (44%), Gaps = 27/270 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEGS G+VY A + GK++A+K I + E E + + +L+HPNIV L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILRE-IKILKKLKHPNIVRLYD 64
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ + LV EY G+L D+L L+ + ALEYLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEARFYLRQILSALEYLHSKG--- 117
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
+VHR+ K NILLD++ + L+D GLA E+ T VG Y APE L Y
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLGKGYGK 175
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655
D++S GV++ ELLTG+ P ++ K+ P P
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGD---------------DQLLELFKKIGKPKPPFPPPE 220
Query: 656 KSLSR-FADIIALCVQPEPEFRPPMSEVVQ 684
+S D+I + +PE R E +Q
Sbjct: 221 WDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 79/272 (29%), Positives = 114/272 (41%), Gaps = 60/272 (22%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+GEG G VY A GK +A+K I S E+ E + + +L HPNIV L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLRE-IEILKKLNHPNIVKLYGV 59
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ LV EY G+L D+L ++ L+ + +R+ L LEYLH +
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 537 VHRNFKSANILLD-DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE-FALSGIYT 594
+HR+ K NILLD D L+D GL+ L + + + T VG Y APE G Y+
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYS 172
Query: 595 VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP 654
KSD++S GV++ E
Sbjct: 173 EKSDIWSLGVILYE---------------------------------------------- 186
Query: 655 AKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
L D+I +Q +PE RP E+++ L
Sbjct: 187 ---LPELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 4e-45
Identities = 82/284 (28%), Positives = 124/284 (43%), Gaps = 47/284 (16%)
Query: 418 IGEGSLGRVYRA----EFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GEG+ G VY+ + + AVK + A + E+ FLE S M +L HPNIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHPNIVR 65
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G C + +V EY+ G+L D L + LT +++AL A+ +EYL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS-----APEF 587
+ VHR+ + N L+ + L +SD GL+ + G APE
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG----GKLPIKWMAPES 175
Query: 588 ALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646
G +T KSDV+SFGV++ E+ T G +P P + + + L
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLEL--- 216
Query: 647 PALNGMY----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
L Y P +++ C +PE RP SE+V+ L
Sbjct: 217 --LEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 5e-44
Identities = 81/279 (29%), Positives = 122/279 (43%), Gaps = 38/279 (13%)
Query: 418 IGEGSLGRVYRAEFANGKIM------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G VY+ + GK AVK + A Q E+ FL M +L HPN+V
Sbjct: 7 LGEGAFGEVYKGK-LKGKGGKKKVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNVV 64
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C E +V EY+ G+L L + L+ + + AL AR +EYL
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
+HR+ + N L+ + L +SD GL+ + + + APE G
Sbjct: 122 N---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 592 IYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650
+T KSDV+SFGV++ E+ T G +P P + + + L + N
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLEYLK----N 218
Query: 651 GMY---PAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
G P D++ C +PE RP SE+V+ L
Sbjct: 219 GYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 7e-44
Identities = 84/291 (28%), Positives = 123/291 (42%), Gaps = 54/291 (18%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVT 472
+GEG+ G VY+ + AVK + A + +D FL EA M +L HPN+V
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARV-MKKLGHPNVVR 60
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALGTARALEY 527
L G C E LV EY+ G+L D L F L+ + A+ A+ +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ--------MVGA 579
L VHR+ + N L+ ++L +SD GL+ + + M
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDI 638
APE GI+T KSDV+SFGV++ E+ T G P P L +
Sbjct: 175 ----APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY----------------PGLSNE 214
Query: 639 DALAKMVDPALNGMYPAKSL---SRFADIIALCVQPEPEFRPPMSEVVQAL 686
+ L + G K +++ C Q +PE RP SE+V+ L
Sbjct: 215 EVLEYL----RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 5e-43
Identities = 82/279 (29%), Positives = 121/279 (43%), Gaps = 37/279 (13%)
Query: 418 IGEGSLGRVYRAEFANGKIM------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G VY+ GK AVK + A Q E+ FL M +L HPNIV
Sbjct: 7 LGEGAFGEVYKGT-LKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNIV 64
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C E ++V EY+ G+L D L K L+ + + AL AR +EYL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK 122
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
+HR+ + N L+ + L +SD GL+ + + + APE G
Sbjct: 123 N---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 592 IYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650
+T KSDV+SFGV++ E+ T G +P P + + + L +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPY----------------PGMSNAEVLEYLK----K 219
Query: 651 GMY---PAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
G P ++ C +PE RP SE+V+ L
Sbjct: 220 GYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 1e-42
Identities = 161/634 (25%), Positives = 274/634 (43%), Gaps = 97/634 (15%)
Query: 94 GLSGTMGYLLSDLLSLRKFDLSGNSIH---DTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150
SG + + L + D+S N++ ++ + +P +L L+LA N F G LP S
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP-SLQMLSLARNKFFGGLPDSFG 473
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
S L L++SRN + ++ G+L+ L L LS N SG++P+ S + SL L +
Sbjct: 474 SK-RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 211 NQVTGSL-NVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFD--NGPAPPPPP 266
NQ++G + FS +P L+ L+++ N SG IP+ L ++ + + S + +G P
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592
Query: 267 STAPPSGRSHNNRSHRQGSHSPSGSQSSSS-------DKELPAGAIVGIVLGAVFLVALA 319
A N S G+ G ++S K + LGA ++AL
Sbjct: 593 FLAI-------NASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALV 645
Query: 320 LLALYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVI 379
F +N ++ + G++ + +
Sbjct: 646 AFGFVFIRGRNNLELKRVENEDGTWELQFFD----------------------------- 676
Query: 380 ERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAV 439
+V+KS ++ I S S +E +I G G Y+ + + V
Sbjct: 677 SKVSKSITINDILS-----------------SLKEENVISRGKKGASYKGKSIKNGMQFV 719
Query: 440 KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML 499
K N S+ + +++M +L+HPNIV L G C L++EY+ NL ++L
Sbjct: 720 VKEINDVNSIPSSE-----IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774
Query: 500 HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559
+NL+W R ++A+G A+AL +LH C P+VV N I++D + PHL
Sbjct: 775 -------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLS 827
Query: 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSS 619
L +T+ +S+ Y APE + T KSD+Y FG++++ELLTG+ P D+
Sbjct: 828 LPGLLCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881
Query: 620 RPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA--KSLSRFADIIALCVQPEPEFRP 677
S+V WA D L +DP++ G + ++ C +P RP
Sbjct: 882 FGVHG-SIVEWARYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
Query: 678 PMSEVVQALVRLVQRASVVKRRSSDESGFSYRTP 711
++V++ L S + SS +G + +
Sbjct: 940 CANDVLKTL------ESASRSSSSCVTGLKFSSL 967
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 77/274 (28%), Positives = 118/274 (43%), Gaps = 30/274 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLA 474
L+G GS G VY A + G++MAVK ++ + +EE LE + +S L+HPNIV
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVE-LSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 475 GYC--AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G E + EYV G+L +L L + L YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK----KFGKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST-QMVGAFGYSAPEFALSG 591
+VHR+ K ANIL+D + L+D G A + E T + G + APE
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD-IDALAKMVDPALN 650
Y +D++S G ++E+ TG+ P W +L + + AL K+
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP--------------W--SELGNPMAALYKIGSSGEP 222
Query: 651 GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P D + C++ +P+ RP E++Q
Sbjct: 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-32
Identities = 72/270 (26%), Positives = 130/270 (48%), Gaps = 30/270 (11%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
F IG+GS G V++ A+ ++ A+K+ID + ++ +E + ++ +++L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDS--SKNLTWNARVRVALGTARALEYL 528
+ + G+ +V EY NG+LH +L ++ W +++ LG L +L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPEF 587
H ++HR+ KS N+ LD N + D G+A L+ NT + +VG Y +PE
Sbjct: 118 HS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPEL 172
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647
Y KSDV++ GVV+ E TG+ P D++ ++ +L+ + + V P
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALIL----------KIIRGVFP 219
Query: 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRP 677
++ MY + A +I C+ + RP
Sbjct: 220 PVSQMYSQQ----LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 74/269 (27%), Positives = 119/269 (44%), Gaps = 42/269 (15%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLAG 475
IG+G G VY+A GK +A+K I L +E+ + + + + +HPNIV
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHPNIVKY-- 62
Query: 476 YCA--EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
Y + + + +V E+ G+L D+L + + + A V + LEYLH
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTL-TESQIAYV--CKELLKGLEYLHSN-- 117
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGI 592
++HR+ K+ANILL + L D GL+A L+ R MVG + APE
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKP 173
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652
Y K+D++S G+ +EL G+ P ++ + + A NG
Sbjct: 174 YDYKADIWSLGITAIELAEGKPP-------------------YSELPPMKALFKIATNGP 214
Query: 653 YPAKSLSR----FADIIALCVQPEPEFRP 677
++ + F D + C+Q PE RP
Sbjct: 215 PGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 73/278 (26%), Positives = 126/278 (45%), Gaps = 40/278 (14%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG+GS G+VY ++GK+ +K+ID + +S +E ++ L V + +L HPNI+
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 476 YCAEHGQRLL-VYEYVGNGNLHDMLHFADDSSKNLT----WNARVRVALGTARALEYLHE 530
E +L V EY G+L + K + V++ L AL+YLH
Sbjct: 67 -SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLHS 121
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ K NI L L D G++ L+ ++ +VG Y +PE
Sbjct: 122 ---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQ 176
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD--- 646
+ Y KSD++S G V+ EL T + P + + L K++
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFEG---ENLLELAL-------------KILKGQY 220
Query: 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P + Y S ++++ +Q +PE RP +++++Q
Sbjct: 221 PPIPSQYS----SELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G G V ++ K+ AVK + + + + Q FL S M+ LRHPN+V L G
Sbjct: 13 TIGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQA---FLAEASVMTTLRHPNLVQLLGV 68
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ +V EY+ G+L D L + +T ++ AL +EYL E +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGMEYLEE---KNF 123
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFALSGIYT 594
VHR+ + N+L+ ++L +SD GLA + Q G ++APE ++
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEALREKKFS 177
Query: 595 VKSDVYSFGVVMLELLT-GRKP 615
KSDV+SFG+++ E+ + GR P
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 32/265 (12%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
LIG G+ G VY+ G +A+K+I + + + ++ + + L+HPNIV G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
++ EY NG+L ++ ++L +V G L YLHE
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQG----LAYLHE---QG 119
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE-FALSGIYT 594
V+HR+ K+ANIL + L+D G+ A N + +VG + APE +SG +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGV-ATKLNDVSKDDASVVGTPYWMAPEVIEMSGA-S 177
Query: 595 VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP 654
SD++S G ++ELLTG P +D++ +A + + P
Sbjct: 178 TASDIWSLGCTVIELLTGNPP-------------------YYDLNPMAALFRIVQDDHPP 218
Query: 655 -AKSLS-RFADIIALCVQPEPEFRP 677
+ +S D + C Q +P RP
Sbjct: 219 LPEGISPELKDFLMQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
S E +G G G V+ + +AVK + +S + FL+ M +LRH
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA---FLQEAQIMKKLRHDK 62
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+V L C+E +V EY+ G+L D L K L V +A A + YL
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPE 586
+ +HR+ + NIL+ + L ++D GLA L + E T GA ++APE
Sbjct: 121 SR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAPE 174
Query: 587 FALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
A G +T+KSDV+SFG+++ E++T GR P
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 77/264 (29%), Positives = 120/264 (45%), Gaps = 32/264 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEG+ G VY+A + A GK +A+KK+ L Q ++ + + M +HPNIV
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKHPNIVDYYD- 82
Query: 477 CAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
G L +V EY+ G+L D++ + + V + LEYLH +
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQ---NFVRMNEPQIAYVCREVLQGLEYLH---SQN 136
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
V+HR+ KS NILL + + L+D G AA LT ++ S +VG + APE Y
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYG 194
Query: 595 VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP 654
K D++S G++ +E+ G P P ++L T + +
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPYLREPP--LRALFLITTKGIPPLK--------------N 238
Query: 655 AKSLSR-FADIIALCVQPEPEFRP 677
+ S F D + C+ +PE RP
Sbjct: 239 PEKWSPEFKDFLNKCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 79/294 (26%), Positives = 123/294 (41%), Gaps = 68/294 (23%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPNIV 471
IG G+ G+VY A G++MAVK+I +Q+ D + + + L+HPN+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEI-----RIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 472 TLAGYCAE-HGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYL 528
Y E H +++ ++ EY G L ++L +++ +RV L L YL
Sbjct: 63 KY--YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-----IRVYTLQLLEGLAYL 115
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQ--MVGAFGYSAP 585
H +VHR+ K ANI LD L D G A L NT + G Y AP
Sbjct: 116 HS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 586 EFALSGIYTVK---SDVYSFGVVMLELLTGRKP---LDSSRPRSEQSLVRWA-------- 631
E G +D++S G V+LE+ TG++P LD+ +
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----------EFQIMFHVGAG 222
Query: 632 -TPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P + D L+ D + C++ +P+ RP SE++Q
Sbjct: 223 HKPPIPDSLQLSPEG----------------KDFLDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 5e-26
Identities = 84/283 (29%), Positives = 127/283 (44%), Gaps = 30/283 (10%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDN-FLEAVSNMSRLRHP-NIVTLA 474
+GEGS G VY A + K++A+K + S +E FL + ++ L HP NIV L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ + G LV EYV G+L D+L L+ + + + ALEYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLHSKG-- 121
Query: 535 SVVHRNFKSANILLDDELN-PHLSDCGLAALTPNTE-----RQVSTQMVGAFGYSAPEFA 588
++HR+ K NILLD + L D GLA L P+ + + VG GY APE
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 589 LSGI---YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
L + SD++S G+ + ELLTG P + + S AT Q I + ++
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-------ATSQTLKI--ILELP 231
Query: 646 DPALNGMY----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P+L P +D++ + +P+ R S +
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 77/275 (28%), Positives = 120/275 (43%), Gaps = 34/275 (12%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKID----NAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
IG G+ VY A N + +A+K+ID ++ D + V MS+ HPN+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-----DELRKEVQAMSQCNHPNVVK 63
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ LV Y+ G+L D++ + L V + LEYLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQ--VSTQMVGAFGYSAPEFAL 589
+HR+ K+ NILL ++ + ++D G++A L +R V VG + APE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 590 SGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL--VRWATPQLHDIDALAKMVD 646
Y K+D++SFG+ +EL TG P S P + + ++ P L + A K
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPY-SKYPPMKVLMLTLQNDPPSL-ETGADYK--- 234
Query: 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSE 681
K F +I+LC+Q +P RP E
Sbjct: 235 ---------KYSKSFRKMISLCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNA-ALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G+GS G+V + GK+ A+K + + +E ++ L + +SR+ HP IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 476 YCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------AL 525
+ A + LV EY G L L + R + AR AL
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL------------SKEGRFSEERARFYAAEIVLAL 106
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
EYLH + +++R+ K NILLD + + L+D GLA + + +T G Y AP
Sbjct: 107 EYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAP 162
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E L Y D +S GV++ E+LTG+ P
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 71/278 (25%), Positives = 124/278 (44%), Gaps = 31/278 (11%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+F +E +G G G V+ ++ +A+K I A+S ED+F+E M +L HPN+
Sbjct: 7 TFLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNL 61
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L G C + +V EY+ NG L L++ + L + + A+EYL
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCL---LNYLRERKGKLGTEWLLDMCSDVCEAMEYLES 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+HR+ + N L+ ++ +SD GLA + + S ++ PE
Sbjct: 119 NG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY 175
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQ-LHDIDALAKMVDPA 648
++ KSDV+SFGV+M E+ + G+ P + R++ + + + A ++ P
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYE-----------RFSNSEVVESVSAGYRLYRPK 224
Query: 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
L I+ C +PE RP +++ L
Sbjct: 225 LAPT-------EVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 74/275 (26%), Positives = 114/275 (41%), Gaps = 49/275 (17%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G+ G V + GKIMAVK I ++ + L + + + P IV G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV--RVALGTARALEYLHEVCLP 534
+G + EY+ G+L +L R+ ++A+ + L YLHE
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQG-----RIPERILGKIAVAVLKGLTYLHEKH-- 120
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMV--------GAFGYSAPE 586
++HR+ K +NIL++ L D G VS Q+V G Y APE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFG-----------VSGQLVNSLAKTFVGTSSYMAPE 169
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646
Y+VKSD++S G+ ++EL TGR P P + L +V+
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPP-----------ENDPPDGIFELLQYIVN 218
Query: 647 ---PAL-NGMYPAKSLSRFADIIALCVQPEPEFRP 677
P L +G + F D + LC+ +P RP
Sbjct: 219 EPPPRLPSGKFSPD----FQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 76/293 (25%), Positives = 128/293 (43%), Gaps = 40/293 (13%)
Query: 418 IGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GEG G+V + G+ +AVK + N + Q +F + + L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADD--SSKNLTWNARVRVALGTARALEYL 528
G C + G R L+ EY+ +G+L D L D + K L + + + ++YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMDYL 125
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVG---AFGYSAP 585
+HR+ + NIL++ E +SD GLA + P + + G F Y AP
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-AP 181
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644
E + ++ SDV+SFGV + EL T G S P +E + + ++
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDP---SQSPPAEFLRMIGIA---QGQMIVTRL 235
Query: 645 VDPALNGMYPAKSLSRFA-------DIIALCVQPEPEFRPPMSEVVQALVRLV 690
+ + + L R D++ LC + EP+ RP ++++ + RL
Sbjct: 236 L----ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 72/264 (27%), Positives = 120/264 (45%), Gaps = 28/264 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+GS G VY+ GKI A+KKI + + L + + P +V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV--RVALGTARALEYLHEVCLP 534
+ G+ +V EY+ G+L D+L K V +A + L+YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTK--R 119
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
++HR+ K +N+L++ + ++D G++ + NT Q +T VG Y +PE Y+
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPERIQGESYS 178
Query: 595 VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP 654
+D++S G+ +LE G+ P S L + A+ P+L P
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFEL----------MQAICDGPPPSL----P 224
Query: 655 AKSLS-RFADIIALCVQPEPEFRP 677
A+ S F D I+ C+Q +P+ RP
Sbjct: 225 AEEFSPEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 73/279 (26%), Positives = 126/279 (45%), Gaps = 33/279 (11%)
Query: 410 NSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKK--IDNAALSLQEEDNFLEAVSNMSRLR 466
F +GEGS G VY+A G+++A+K ++ + +E +S + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE------ISILKQCD 56
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
P IV G ++ +V EY G G++ D++ ++K LT + T + LE
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLE 113
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
YLH +HR+ K+ NILL++E L+D G++ +T + +T ++G + APE
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPE 169
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP-RSEQSLVRWATPQLHDIDALAKMV 645
Y K+D++S G+ +E+ G+ P P R+ + P L D
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD-------- 221
Query: 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P K F D + C+ +PE RP +++Q
Sbjct: 222 --------PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 82/282 (29%), Positives = 127/282 (45%), Gaps = 48/282 (17%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVK--KIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G GS G VY +G AVK + + + QE LE ++ +S+L+HPNIV
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 473 LAGYCAEHGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
G L ++ E V G+L +L + + ++ LG LEYLH+
Sbjct: 67 YLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHD- 120
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ-----MVGAFGYSAPE 586
+ VHR+ K ANIL+D L+D G+A +QV G+ + APE
Sbjct: 121 --RNTVHRDIKGANILVDTNGVVKLADFGMA-------KQVVEFSFAKSFKGSPYWMAPE 171
Query: 587 FALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
G Y + +D++S G +LE+ TG+ P W+ QL + A+ K+
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP--------------WS--QLEGVAAVFKIG 215
Query: 646 DPALNGMYPA--KSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
+ P LS A D I C+Q +P RP +E+++
Sbjct: 216 R---SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 30/226 (13%)
Query: 412 FSQEFLIGEGSLGRVYRAEFA--NGKIM----AVKKI-DNAALSLQEEDNFLEAVSNMSR 464
F +E +GEG+ G+VY+ E N ++ A+K + +NA +Q+E F + MS
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE--FRQEAELMSD 64
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWN 512
L+HPNIV L G C + +++EY+ +G+LH+ L + +L +
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--R 570
+ +A+ A +EYL VHR+ + N L+ + L +SD GL+ + + R
Sbjct: 125 DFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
S ++ + PE L G +T +SD++SFGVV+ E+ + G +P
Sbjct: 182 VQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-23
Identities = 74/277 (26%), Positives = 124/277 (44%), Gaps = 29/277 (10%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+ QE IG G G V+ + + +A+K I A+S E++F+E M +L HP +
Sbjct: 7 TLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKL 61
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L G C E LV+E++ +G L D L + + + L + YL
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLES 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
V+HR+ + N L+ + +SD G+ + + ST +S+PE
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF 175
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649
Y+ KSDV+SFGV+M E+ + G+ P ++ RS +V I+A ++ P L
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYEN---RSNSEVV-------ETINAGFRLYKPRL 225
Query: 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
+ +++ C + PE RP S ++ L
Sbjct: 226 -------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 75/261 (28%), Positives = 122/261 (46%), Gaps = 27/261 (10%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + +AVK + +S ++FLE M +LRH +V L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+E +V EY+ G+L D L D + L V +A A + Y+ + + +
Sbjct: 71 SEE-PIYIVTEYMSKGSLLDFLK--DGEGRALKLPNLVDMAAQVAAGMAYIERM---NYI 124
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ +SANIL+ D L ++D GLA L + E ++APE AL G +T+KS
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 598 DVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAK 656
DV+SFG+++ EL+T GR P P +++ + L + V+ P
Sbjct: 185 DVWSFGILLTELVTKGRVPY----------------PGMNNREVLEQ-VERGYRMPCPQD 227
Query: 657 SLSRFADIIALCVQPEPEFRP 677
+++ C + +PE RP
Sbjct: 228 CPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 83/284 (29%), Positives = 125/284 (44%), Gaps = 41/284 (14%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAA---LSLQEEDNFLEAVSNMSRLRHPNIVT 472
+IGEG+ G+VY+A G+++A+K +D ++EE N L SN HPNI T
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSN-----HPNIAT 67
Query: 473 LAG------YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
G Q LV E G G++ D++ K L + T R L
Sbjct: 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
YLHE V+HR+ K NILL L D G++A +T + +T +G + APE
Sbjct: 128 YLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT-FIGTPYWMAPE 183
Query: 587 F-----ALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641
Y +SDV+S G+ +EL G+ PL +H + AL
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIELADGKPPL----------------CDMHPMRAL 227
Query: 642 AKMVDPALNGMYPAKSLSR-FADIIALCVQPEPEFRPPMSEVVQ 684
K+ + ++ S+ F D I+ C+ E RP M E+++
Sbjct: 228 FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 418 IGEGSLGRVYRAEFANGK------IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ E + + ++AVK + A + +D F ++ +H NIV
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREAELLTNFQHENIV 71
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML-----HFA-----DDSSKNLTWNARVRVALGT 521
G C E ++V+EY+ +G+L+ L A D LT + +++A+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGA 579
A + YL VHR+ + N L+ +L + D G++ T + R M+
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML-P 187
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ PE + +T +SDV+SFGVV+ E+ T G++P
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 33/279 (11%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA----VSNMSRLRHPNIV 471
+G G+ Y+A + G +MAVK++ + E++ +EA + M+RL HP+I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ G E L E++ G++ +L + + + R L YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSYLHE- 121
Query: 532 CLPSVVHRNFKSANILLDDE-LNPHLSDCGLAA-----LTPNTERQVSTQMVGAFGYSAP 585
++HR+ K AN+L+D ++D G AA T E Q Q++G + AP
Sbjct: 122 --NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ--GQLLGTIAFMAP 177
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
E Y DV+S G V++E+ T + P ++ + + +L + I A A
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-------IFKI-ASATTA 229
Query: 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+ P D+ C++ +PE RPP E+++
Sbjct: 230 PSIPEHLSPG-----LRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 3e-22
Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 28/278 (10%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
S E +G+G G V+ + +A+K + +S + FL+ M +LRH +
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKL 63
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L +E +V EY+ G+L D L + K L V +A A + Y+
Sbjct: 64 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+ + VHR+ ++ANIL+ + L ++D GLA L + E ++APE AL
Sbjct: 121 M---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649
G +T+KSDV+SFG+++ EL T GR P P + + + L + V+
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVPY----------------PGMVNREVLDQ-VERGY 220
Query: 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687
P + D++ C + EPE RP E +QA +
Sbjct: 221 RMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 3e-22
Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 28/278 (10%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
S + +G+G G V+ + +A+K + + + FL+ M +LRH +
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKL 63
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L +E +V E++G G+L D L D K L V +A A + Y+
Sbjct: 64 VPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIER 120
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+ + +HR+ ++ANIL+ D L ++D GLA L + E ++APE AL
Sbjct: 121 M---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649
G +T+KSDV+SFG+++ EL+T GR P P + + + L + V+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPY----------------PGMVNREVLEQ-VERGY 220
Query: 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687
P +++ LC + +P+ RP E +Q+ +
Sbjct: 221 RMPCPQGCPESLHELMKLCWKKDPDERPTF-EYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 55/200 (27%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
F+ E +G G G V+ + N +A+K + + L Q++ F + V + RLRH +++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLI 65
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+L C+ ++ E + G+L L + L + + +A A + YL E
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE- 122
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
+ +HR+ + NIL+ ++L ++D GLA L S + + + ++APE A G
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-PYKWTAPEAASHG 179
Query: 592 IYTVKSDVYSFGVVMLELLT 611
++ KSDV+SFG+++ E+ T
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 71/264 (26%), Positives = 114/264 (43%), Gaps = 36/264 (13%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNA-ALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG+G+ G+V + K+ A+K ++ + N L + L HP +V L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW- 66
Query: 476 YCAEHGQRL-LVYEYVGNGNL--H--DMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
Y + + + LV + + G+L H + F+++ K W + ALEYLH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVK--FWICEI------VLALEYLHS 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ K NILLD++ + H++D +A +TP+T +T G GY APE
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEVLC 172
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLD--SSRPRSEQ----------SLVRWATPQLHD 637
Y+V D +S GV E L G++P S R + W+T +
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDA 232
Query: 638 IDALAKMVDPALNGMYPAKSLSRF 661
I+ L + DP K L
Sbjct: 233 INKLLER-DPQKRLGDNLKDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 70/262 (26%), Positives = 122/262 (46%), Gaps = 29/262 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + +A+K + ++S + FL + M +L+HP +V L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ NG+L D L LT N + +A A + ++ + +
Sbjct: 71 TQE-PIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIER---KNYI 124
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ ++ANIL+ + L ++D GLA L + E ++APE G +T+KS
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 598 DVYSFGVVMLELLT-GRKPLDS-SRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655
DV+SFG+++ E++T GR P + P Q+L R +M P P
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-----------GYRMPRP---DNCPE 230
Query: 656 KSLSRFADIIALCVQPEPEFRP 677
+ +++ LC + +PE RP
Sbjct: 231 E----LYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 72/277 (25%), Positives = 125/277 (45%), Gaps = 29/277 (10%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+F +E +G G G V+ ++ +A+K I+ A+S E++F+E M +L HP +
Sbjct: 7 TFMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKL 61
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L G C + +V E++ NG L L++ L+ + + + +EYL
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
S +HR+ + N L+ +SD G+ + E S+ +S PE
Sbjct: 119 ---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF 175
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649
Y+ KSDV+SFGV+M E+ T G+ P + S +V I ++ P L
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKK---SNYEVVE-------MISRGFRLYRPKL 225
Query: 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
M +++ C +PE RP +E+++A+
Sbjct: 226 ASMT-------VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 83/286 (29%), Positives = 130/286 (45%), Gaps = 47/286 (16%)
Query: 410 NSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALS-----LQEEDNFLEAVSNMS 463
F+ IG+GS G VY+A + +++A+K ID +Q+E FL S
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFL------S 54
Query: 464 RLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA 522
+ R P I G G +L ++ EY G G+ D+L L +
Sbjct: 55 QCRSPYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVL 108
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY 582
LEYLHE +HR+ K+ANILL +E + L+D G++ +T + +T VG +
Sbjct: 109 LGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFW 164
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL- 641
APE Y K+D++S G+ +EL G +P P S+ LH + L
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKG-EP-----PLSD----------LHPMRVLF 208
Query: 642 --AKMVDPALNGMYPAKSLSR-FADIIALCVQPEPEFRPPMSEVVQ 684
K P+L G S+ F D ++LC+ +P+ RP E+++
Sbjct: 209 LIPKNNPPSLEG----NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+GS G V + ++GKI+ K+ID ++ +E+ + V+ + L+HPNIV Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 477 CAE----HGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-- 529
Q L +V EY G+L ++ K + R+ AL H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+V+HR+ K ANI LD N L D GLA + + + VG Y +PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKTYVGTPYYMSPEQLN 183
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
Y KSD++S G ++ EL P
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 26/261 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + N +AVK + ++ +D FL M +LRHP ++ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK--PGTMDPKD-FLAEAQIMKKLRHPKLIQLYAVC 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+V E + G+L + L + + L + +A A + YL + +
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEA---QNYI 125
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ + N+L+ + ++D GLA + + ++APE AL +++KS
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 598 DVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAK 656
DV+SFG+++ E++T GR P P + + + L VD P
Sbjct: 186 DVWSFGILLTEIVTYGRMPY----------------PGMTNAEVLQ-QVDQGYRMPCPPG 228
Query: 657 SLSRFADIIALCVQPEPEFRP 677
DI+ C + +P+ RP
Sbjct: 229 CPKELYDIMLDCWKEDPDDRP 249
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 29/229 (12%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
IGEG+ G+VY+A G+++A+KKI E++ F + + + +LRHPNIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME----NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 473 LAGYCAEH--GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
L G +V+EY+ HD+ D T + L+YLH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL- 589
++HR+ K +NIL++++ L+D GLA T V Y PE L
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638
+ Y + D++S G ++ EL G+ + +E QL I
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIF---QGSTELE-------QLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEG+ G VY+A G+I+A+KKI S L + + L HPNI+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEVCLPS 535
G LV+E++ D+ D + L + ++ L + L + H
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHS---HG 118
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAAL-----TPNTERQVSTQMVGAFGYSAPEFAL- 589
++HR+ K N+L++ E L+D GLA P T V T+ Y APE L
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH-YVVTRW-----YRAPELLLG 172
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y+ D++S G + ELL+ R PL
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR-PL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 418 IGEGSLGRVYRAEFA-NGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG G G V R GK +A+K + + S ++ +FL S M + HPNI+ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + +++ EY+ NG+L L D T V + G A ++YL E+
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG------YSAPEF 587
VHR+ + NIL++ L +SD GL+ ++E +T+ G ++APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWTAPEA 179
Query: 588 ALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+T SDV+SFG+VM E+++ G +P
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 80/274 (29%), Positives = 126/274 (45%), Gaps = 37/274 (13%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEED--NFLEAVSNMSRLRH---PNI 470
LIG G+ G VYR G+++A+K I+ L ++D + V+ +S+LR PNI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQSQPPNI 64
Query: 471 VTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
G G RL ++ EY G++ ++ + K ++ R AL+Y+H
Sbjct: 65 TKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIH 118
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+V V+HR+ K+ANIL+ + N L D G+AAL + ST VG + APE
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVIT 174
Query: 590 SGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648
G Y K+D++S G+ + E+ TG P S+ + + K P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPY------SDV-------DAFRAMMLIPKSKPPR 221
Query: 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEV 682
L +K L F +A C+ EP+ R E+
Sbjct: 222 LEDNGYSKLLREF---VAACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 38/276 (13%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G+GS G VY+ + ++ + A+K++D ++S +E ++ + + ++ + HPNI+
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII---S 63
Query: 476 YCAEH--GQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
Y G +L +V EY G+L + K + R+ + R L+ LHE
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
++HR+ KSANILL + D G++ + + TQ +G Y APE
Sbjct: 123 --KILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQ-IGTPHYMAPEVWKGRP 177
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL-VRWATPQLHDIDALAKMVDPALNG 651
Y+ KSD++S G ++ E+ T P ++ RS Q L + G
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEA---RSMQDLRYK------------------VQRG 216
Query: 652 MYPAKSLSRFAD---IIALCVQPEPEFRPPMSEVVQ 684
YP D I +Q +P+ RP +++
Sbjct: 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLE---AVSNMSRLRHPNIVTL 473
IG G+ G VY+A + A G+++A+K I L+ D+F +S + RHPNIV
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI-----KLEPGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + +V EY G G+L D+ L R L + L YLHE
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHET-- 120
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA---LS 590
+HR+ K ANILL ++ + L+D G++A T + + +G + APE A
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS-FIGTPYWMAPEVAAVERK 178
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y K D+++ G+ +EL + P+
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 82/292 (28%), Positives = 127/292 (43%), Gaps = 44/292 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
IG GS G VY A + +++A+KK+ + E+ + ++ V + +LRHPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 476 -YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y EH LV EY G+ D+L + K L + G + L YLH
Sbjct: 83 CYLREH-TAWLVMEYC-LGSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAAL-TPNTERQVSTQMVGAFGYSAPEFALS--- 590
+HR+ K+ NILL + L+D G A+L +P + VG + APE L+
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDE 188
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650
G Y K DV+S G+ +EL + PL + A L+ I A+ P L+
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMN----------AMSALYHI---AQNDSPTLS 235
Query: 651 GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSD 702
F + + C+Q P+ RP E L++ V++ R
Sbjct: 236 ---SNDWSDYFRNFVDSCLQKIPQDRPSSEE-------LLKHRFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 8e-20
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEED---NFLEA----VSNMSRLRHP 468
LIG GS G VY A +G++MAVK+++ ++S +D + L+A ++ + L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
NIV G + + EYV G++ +L+ + L N VR L + L YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF-VRQIL---KGLNYL 122
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGL-----AALTPNTERQVSTQMVGAFGYS 583
H ++HR+ K ANIL+D++ +SD G+ A + G+ +
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE YT K+D++S G +++E+LTG+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 86/297 (28%), Positives = 126/297 (42%), Gaps = 41/297 (13%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
+G G+ G V + G IMAVK+I A ++ QE+ L + +M + P VT G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
G + E V + +L D + + ++A+ +ALEYLH S
Sbjct: 68 ALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--S 124
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE-----FALS 590
V+HR+ K +N+L++ L D G++ ++ T G Y APE
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKTIDAGCKPYMAPERINPELNQK 182
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP--QLHDIDALAKMVDPA 648
G Y VKSDV+S G+ M+EL TGR P DS W TP QL + + P
Sbjct: 183 G-YDVKSDVWSLGITMIELATGRFPYDS-----------WKTPFQQLKQV---VEEPSPQ 227
Query: 649 LNGMYPAKSLS-RFADIIALCVQPEPEFRPPMSE------VVQALVRLVQRASVVKR 698
L PA+ S F D + C++ + RP E L + AS V
Sbjct: 228 L----PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASFVSL 280
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 38/290 (13%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLR 466
F++ IG+GS G VY+ + +++A+K ID L+E ++ +E + +S+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD 60
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
P I G + + ++ EY+G G+ D+L L + + L+
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLD 115
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
YLH +HR+ K+AN+LL ++ + L+D G+A +T+ + +T VG + APE
Sbjct: 116 YLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPE 171
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646
Y K+D++S G+ +EL G P P L+ +P
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP------------- 218
Query: 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA--LVRLVQRAS 694
P L G Y F + + C+ +P FRP E+++ + R ++ S
Sbjct: 219 PTLEGQYSKP----FKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTS 264
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 77/303 (25%), Positives = 118/303 (38%), Gaps = 61/303 (20%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN------FLEAVSNMSRLRHPN 469
++GEG+ G V + A G+I+A+KK + ED+ L V + +LRH N
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF------KESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH-----FADDSSKNLTWNARVRVALGTARA 524
IV L G+ LV+EYV L ++L D+ ++ W +A
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQ--------LLQA 112
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
+ Y H +++HR+ K NIL+ + L D G A T V Y A
Sbjct: 113 IAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRA 169
Query: 585 PEFALSGI-YTVKSDVYSFGVVMLELLTGRK-------------------PLDSS---RP 621
PE + Y DV++ G +M ELL G PL S
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229
Query: 622 RSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSE 681
S A P+ ++L + YP K S D + C++ +P+ R E
Sbjct: 230 SSNPRFAGVAFPEPSQPESLER--------RYPGKVSSPALDFLKACLRMDPKERLTCDE 281
Query: 682 VVQ 684
++Q
Sbjct: 282 LLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 27/210 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
IGEG+ G VYRA + +G+I+A+KK+ E D L ++ + LRHPNIV
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMD----NERDGIPISSLREITLLLNLRHPNIVE 70
Query: 473 LAGYCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEY 527
L G+ L LV EY D+ D+ + ++V+ + L R L+Y
Sbjct: 71 LKEVVV--GKHLDSIFLVMEYCE----QDLASLLDNMPTPFS-ESQVKCLMLQLLRGLQY 123
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
LHE ++HR+ K +N+LL D+ ++D GLA + ++ ++V + Y APE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW-YRAPEL 179
Query: 588 AL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
L YT D+++ G ++ ELL KPL
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 70/275 (25%), Positives = 125/275 (45%), Gaps = 34/275 (12%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G+ G+VY+A+ + A KI + ED +E + +S +HPNIV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE-IDILSECKHPNIVGLYEAY 71
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ E+ G L ++ + + LT V AL +LH V+
Sbjct: 72 FYENKLWILIEFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFLHS---HKVI 125
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-----SGI 592
HR+ K+ NILL + + L+D G++A +T ++ T +G + APE
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVACETFKDNP 184
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD---PAL 649
Y K+D++S G+ ++EL P +L+ + L K++ P L
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP----------------HHELNPMRVLLKILKSEPPTL 228
Query: 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+ P+K S F D + C+ +P+ RP +E+++
Sbjct: 229 DQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 72/278 (25%), Positives = 116/278 (41%), Gaps = 38/278 (13%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G+ G VY+ +AVK + L + FL+ + + HPNIV L G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C + +V E V G+L L F LT ++++L A +EYL
Sbjct: 61 CVQKQPIYIVMELVPGGSL---LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVG-AFGYSAPEFALSGIYTV 595
+HR+ + N L+ + +SD G++ VS + ++APE G YT
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 596 KSDVYSFGVVMLELLT-GRKP---LDSSRPRSE-QSLVRWATPQL--HDIDALAKMVDPA 648
+SDV+S+G+++ E + G P + + + R +S R PQL +I
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEI---------- 224
Query: 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
++ C +PE RP SE+ L
Sbjct: 225 -------------YRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 71/274 (25%), Positives = 125/274 (45%), Gaps = 37/274 (13%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKI--DNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IGEG G V + E+ G+ +AVK I D A + FLE + M++L H N+V L G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA------FLEETAVMTKLHHKNLVRLLG 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+G + V E + GNL + L + ++ ++ +L A +EYL
Sbjct: 67 VILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLES---KK 120
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
+VHR+ + NIL+ ++ +SD GLA + V + ++APE ++
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKL-PVKWTAPEALKHKKFSS 176
Query: 596 KSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP 654
KSDV+S+GV++ E+ + GR P P+ V+ + + ++ P
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPY----PKMSLKEVKECVEKGYRMEP-------------P 219
Query: 655 AKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688
+ ++ C + EP+ RP ++ + L +
Sbjct: 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 69/297 (23%), Positives = 126/297 (42%), Gaps = 48/297 (16%)
Query: 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLR 466
+F E IG+G VY+A +G+++A+KK+ + + + L+ + + +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-HFADDSS---KNLTWNARVRVALGTA 522
HPN++ E+ + +V E G+L M+ HF + W V++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG- 581
ALE++H ++HR+ K AN+ + L D GL R S++ A
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLG-------RFFSSKTTAAHSL 166
Query: 582 -----YSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLH 636
Y +PE Y KSD++S G ++ E+ + P + +L
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLY-------- 214
Query: 637 DIDALAKMVDPALNGMYPAKSLSRFA----DIIALCVQPEPEFRPPMSEVVQALVRL 689
+L K ++ YP ++ D+++ C+ P+PE RP +S V+Q +
Sbjct: 215 ---SLCKKIE---KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 79/277 (28%), Positives = 119/277 (42%), Gaps = 35/277 (12%)
Query: 417 LIGEGSLGRVYRAEF---ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+IG+G G VY KI K N L+E + FL+ M HPN+++L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 474 AGYC-AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G C G L+V Y+ +G D+ +F + N T + L A+ +EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHG---DLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS-- 116
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFAL 589
VHR+ + N +LD+ ++D GLA + E GA + A E
Sbjct: 117 -KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649
+ +T KSDV+SFGV++ EL+T R A P D+D+ + L
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT-----------------RGAPP-YPDVDSF-DITVYLL 216
Query: 650 NG---MYPAKSLSRFADIIALCVQPEPEFRPPMSEVV 683
G + P +++ C P+PE RP SE+V
Sbjct: 217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 64/274 (23%), Positives = 118/274 (43%), Gaps = 38/274 (13%)
Query: 418 IGEGSLGR--VYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G+G+ G +YR + ++ K+++ LS +E + L + +S L+HPNI+
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVC 532
+ + L+ EY G L+D + + + W A+ Y+H+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHKA- 120
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
++HR+ K+ NI L L D G++ + +E ++ +VG Y +PE
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652
Y KSD+++ G V+ ELLT ++ D++ P +V + G
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNP--------------------LNLVVKIVQGN 217
Query: 653 Y---PAKSLSRFADIIALCVQPEPEFRPPMSEVV 683
Y + S ++ +Q +PE RP EV+
Sbjct: 218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (218), Expect = 6e-19
Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+GEG+ G VY+A + G+I+A+KKI EE+ L +S + L+HPNIV
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD----NEEEGIPSTALREISLLKELKHPNIVK 62
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA--------RA 524
L + LV+EY +L L ++ R
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYLD-----------KRPGPLSPNLIKSIMYQLLRG 110
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYS 583
L Y H ++HR+ K NIL++ + L+D GLA A T V Y
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYR 165
Query: 584 APEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
APE L S Y+ D++S G + E++TG KPL
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITG-KPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 71/269 (26%), Positives = 106/269 (39%), Gaps = 39/269 (14%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQE-------EDNFLEAVSNMSRLRHPN 469
+G+G G V + GK+ A KK+D L ++ E LE VS+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS------RF 54
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEY 527
IV+LA Y E L LV + G+L H + AR A LE+
Sbjct: 55 IVSLA-YAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFP-EARAIFYAAQIICGLEH 110
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
LH+ +V+R+ K N+LLDD N +SD GLA + G GY APE
Sbjct: 111 LHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK--GGKKIKGRAGTPGYMAPEV 165
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647
+Y D ++ G + E++ GR P + + E+ ++ +
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK----------EELKRRTLEMAV 215
Query: 648 ALNGMYPAKSLSRFADIIALCVQPEPEFR 676
YP K D+ +Q +PE R
Sbjct: 216 E----YPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 69/245 (28%), Positives = 112/245 (45%), Gaps = 31/245 (12%)
Query: 418 IGEGSLGRVYRA----EFANGKI-MAVKKI-DNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G G+ G VY+ E KI +A+K + + + +E L+ M+ + HP++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE--ILDEAYVMASVDHPHVV 72
Query: 472 TLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEY 527
L G C ++ L+ + + G L D + D S L W ++ A+ + Y
Sbjct: 73 RLLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSY 124
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ--MVGAFGYSAP 585
L E L VHR+ + N+L+ + ++D GLA L E++ + V + A
Sbjct: 125 LEEKRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV-PIKWMAL 180
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLV----RWATPQLHDIDA 640
E L IYT KSDV+S+GV + EL+T G KP + L+ R P + ID
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240
Query: 641 LAKMV 645
+V
Sbjct: 241 YMVLV 245
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 46/226 (20%)
Query: 417 LIGEGSLGRVYRAEF------ANGKIMAVKKI-DNAALSLQEEDNFLEAVSNMSRL---- 465
+GEG+ G+V +AE +AVK + D+A E + + VS M +
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-----EKDLSDLVSEMEMMKMIG 73
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH----------FADD--SSKNLTWNA 513
+H NI+ L G C + G +V EY +GNL D L D + LT
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV- 572
V A AR +E+L +HR+ + N+L+ ++ ++D GLA R +
Sbjct: 134 LVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLA-------RDIH 183
Query: 573 -------STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+T + APE +YT +SDV+SFGV++ E+ T
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 62/210 (29%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEGS G++Y A+ ++ + +K+ID + ++E++ + V +++++HPNIVT
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLH------FADDSSKNLTWNARVRVALGTARALEYLHE 530
E+G+ +V EY G+L ++ F++D + L+W V+++LG L+++H+
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED--QILSW--FVQISLG----LKHIHD 119
Query: 531 VCLPSVVHRNFKSANILLDDE-LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ KS NI L + L D G+A N +++ VG Y +PE
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDSS 619
+ Y K+D++S G V+ EL T + P + +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V ++ +A+K I ++S ED F+E M +L H +V L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ +V EY+ NG L L++ + K + + + + YL +
Sbjct: 69 TKQRPIYIVTEYMSNGCL---LNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFI 122
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ + N L+DD+ +SD GL+ + E S +S PE L ++ KS
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 598 DVYSFGVVMLELLT-GRKPLD 617
DV++FGV+M E+ + G+ P +
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED-NF--LEAVSNMSRLRHPNIVT 472
+GEG+ VY+A G+I+A+KKI ++ NF L + + L+HPNI+
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 473 L-AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEYLH 529
L + H + LV+E++ D+ D S LT A ++ L T R LEYLH
Sbjct: 67 LLDVFG--HKSNINLVFEFMET----DLEKVIKDKSIVLT-PADIKSYMLMTLRGLEYLH 119
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ K N+L+ + L+D GLA + R+++ Q+V + Y APE
Sbjct: 120 SN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-YRAPELLF 175
Query: 590 -SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ Y V D++S G + ELL R P
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 9/199 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + N +AVK + +S+Q FLE + M L+H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ G+L D L +D+ K + + + A + Y+ + +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLK-SDEGGK-VLLPKLIDFSAQIAEGMAYIER---KNYI 125
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ ++AN+L+ + L ++D GLA + + E ++APE G +T+KS
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV+SFG+++ E++T G+ P
Sbjct: 186 DVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 38/279 (13%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLR 466
F++ IG+GS G V++ + K++A+K ID L+E ++ +E + +S+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD 60
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFAD-DSSKNLTWNARVRVALGTARAL 525
P + G + + ++ EY+G G+ D+L D ++ T + + L
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGL 114
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+YLH +HR+ K+AN+LL + L+D G+A +T+ + VG + AP
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAP 170
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
E Y K+D++S G+ +EL G P P L+ P
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------ 218
Query: 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P L G Y +K L F + C+ EP FRP E+++
Sbjct: 219 -PTLEGNY-SKPLKEF---VEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 27/290 (9%)
Query: 412 FSQEFL-----IGEGSLGRV--YRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSN 461
F + +L +GEG G+V Y + AN G+++AVK + Q + + ++
Sbjct: 1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINI 59
Query: 462 MSRLRHPNIVTLAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
+ L H NIV G C+E G + L+ EYV G+L D L L + A
Sbjct: 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQ 114
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVG- 578
+ YLH +HR+ + N+LLD++ + D GLA P + G
Sbjct: 115 QICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 579 --AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLH 636
F Y A E ++ SDV+SFGV + ELLT S + E+ ++ Q+
Sbjct: 172 SPVFWY-AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMT 229
Query: 637 DIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
+ L ++++ + P ++ C + E +FRP ++ L
Sbjct: 230 VV-RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 76/281 (27%), Positives = 132/281 (46%), Gaps = 39/281 (13%)
Query: 417 LIGEGSLGRVYRAEFANG--KIMAVKKID--NAAL--SLQEED-NFLEAVSNMS----RL 465
+G G+ G VY+ N ++A+K+I+ N A +E D + + VS ++ +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT----WNARVRVALGT 521
RHPNIV E+ + +V + + L + + + + T WN V++ L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG 581
AL YLH+ +VHR+ NI+L ++ ++D GLA T +VG
Sbjct: 125 --ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA--KQKQPESKLTSVVGTIL 178
Query: 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641
YS PE + Y K+DV++FG ++ ++ T + P S+ +++ AT ++A+
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST------NMLSLAT---KIVEAV 229
Query: 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEV 682
+P GMY D+I C+ P+ E RP + +V
Sbjct: 230 ---YEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G VY + +AVK + + ++E FL+ + M ++HPN+V L G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLGV 70
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C ++ E++ GNL D L + + + +A + A+EYL + +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNF 125
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFALSGIY 593
+HR+ + N L+ + ++D GL+ L T GA ++APE +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 594 TVKSDVYSFGVVMLELLT 611
++KSDV++FGV++ E+ T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEA--------VSNMSRLRH 467
LIG+G+ GRVY A G++MAVK+++ A D+ + + + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTAR 523
NIV G+ + EYV G++ L F + + T
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLE 119
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS-TQMVGAFGY 582
L YLH ++HR+ K+ N+L+D + +SD G++ + + M G+ +
Sbjct: 120 GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 583 SAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKP 615
APE S Y+ K D++S G V+LE+ GR+P
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 4e-18
Identities = 77/290 (26%), Positives = 137/290 (47%), Gaps = 37/290 (12%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN---FL 456
T+ S+ +++ IG+G+ G V+ A + A G+ +A+K+I+ LQ++ +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-----LQKQPKKELII 64
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
+ M L++PNIV + +V EY+ G+L D++ + A R
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCR 122
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQ 575
L +ALE+LH V+HR+ KS N+LL + + L+D G A +TP E+ +
Sbjct: 123 ECL---QALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRST 174
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP-RSEQSLVRWATPQ 634
MVG + APE Y K D++S G++ +E++ G P + P R+ + TP+
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234
Query: 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
L + + L+ + F D + C++ + E R E++Q
Sbjct: 235 LQNPEKLSPI----------------FRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV-TLAG 475
IGEG+ G V++A + G+ +A+KK+ L + L + + +HP +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ HG LV EY+ + L ++L D + L + + Y+H
Sbjct: 68 F--PHGSGFVLVMEYMPSD-LSEVLR---DEERPLPEAQVKSYMRMLLKGVAYMHAN--- 118
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-SGIY 593
++HR+ K AN+L+ + ++D GLA L E ++ + V Y APE + Y
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 594 TVKSDVYSFGVVMLELLTGRKPL 616
D+++ G + ELL G PL
Sbjct: 179 DPGVDLWAVGCIFAELLNGS-PL 200
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 69/272 (25%), Positives = 109/272 (40%), Gaps = 34/272 (12%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKI--DNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG G+ G V + G IMAVK+I + L+ V M P IV
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSDCPYIVKF 68
Query: 474 AGYCAEHGQRLLVYEYVGNG--NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
G G + E + + ++ + + ++A+ T +AL YL E
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVY--EVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE----F 587
++HR+ K +NILLD N L D G++ ++ + T+ G Y APE
Sbjct: 127 L--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPS 182
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ--SLVRWATPQLHDIDALAKMV 645
A G Y V+SDV+S G+ + E+ TG+ P +Q +V+ P L
Sbjct: 183 ARDG-YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS--------- 232
Query: 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRP 677
+ + F + I LC+ + RP
Sbjct: 233 -NSEEREFSP----SFVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 67/294 (22%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 417 LIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
++GEG G V + + K+ AVK + + E + FL + M HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 472 TLAGYCAEHGQR------LLVYEYVGNGNLHDMLHFA--DDSSKNLTWNARVRVALGTAR 523
L G C E +++ ++ +G+LH L ++ + L ++ + A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQ--VSTQMVGA 579
+EYL + +HR+ + N +L +++ ++D GL+ + + RQ ++ V
Sbjct: 125 GMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 180
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDI 638
+ A E +YT KSDV++FGV M E+ T G+ P + + H+I
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--------------YPGVENHEI 224
Query: 639 DALAKMVDPALNGM---YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689
D +G P L D++ C + +P+ RP +++ + L +
Sbjct: 225 ------YDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 70/217 (32%), Positives = 106/217 (48%), Gaps = 25/217 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG+G G V ++ G +AVK I N A + FL S M++LRH N+V L G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 478 AE-HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
E G +V EY+ G+L D L S L + ++ +L A+EYL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEA---NNF 123
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFALSGIYT 594
VHR+ + N+L+ ++ +SD GL T+ STQ G ++APE ++
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGL------TKEASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 595 VKSDVYSFGVVMLELLT------GRKPLDSSRPRSEQ 625
KSDV+SFG+++ E+ + R PL PR E+
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 62/229 (27%), Positives = 95/229 (41%), Gaps = 37/229 (16%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRL-RHPNI 470
+IGEGS V A E K A+K +D L +++ + V ++RL HP I
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY---VKIEKEVLTRLNGHPGI 64
Query: 471 VTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+ L Y + + L V EY NG L + S + R A ALEYLH
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKC-TRFYAAE-ILLALEYLH 119
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM------------- 576
++HR+ K NILLD +++ ++D G A + S +
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 577 ------VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSS 619
VG Y +PE SD+++ G ++ ++LTG+ P S
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 83/290 (28%), Positives = 139/290 (47%), Gaps = 37/290 (12%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQ-EEDNFLEA 458
T+ S+ +++ IG+G+ G VY A + A G+ +A+K+++ L Q +++ +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINE 66
Query: 459 VSNMSRLRHPNIVT-LAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
+ M +HPNIV L Y G L +V EY+ G+L D++ + A R
Sbjct: 67 ILVMRENKHPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCR 122
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQ 575
L +ALE+LH V+HR+ KS NILL + + L+D G A +TP E+ +
Sbjct: 123 ECL---QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRST 174
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP-RSEQSLVRWATPQ 634
MVG + APE Y K D++S G++ +E++ G P + P R+ + TP+
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234
Query: 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
L + P K + F D + C++ + E R E++Q
Sbjct: 235 LQN----------------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 46/292 (15%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
IG GS G VY A ++ +++AVKK+ + E+ + ++ V + +L+HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 476 -YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y EH LV EY G+ D+L + + A + G + L YLH +
Sbjct: 89 CYLKEH-TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSHNM- 142
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS---G 591
+HR+ K+ NILL + L+D G A+ + + VG + APE L+ G
Sbjct: 143 --IHRDIKAGNILLTEPGQVKLADFGSASKS-----SPANSFVGTPYWMAPEVILAMDEG 195
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG 651
Y K DV+S G+ +EL + PL + A L+ I A+ P L
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMN----------AMSALYHI---AQNDSPTLQS 242
Query: 652 MYPAKSLSRFADIIALCVQPEPEFRPPMSEVV-----------QALVRLVQR 692
S F D C+Q P+ RP +E++ + L+ L+QR
Sbjct: 243 NEWTDSFRGFVD---YCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQR 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 418 IGEGSLGRV----YRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+G G+ G V Y + +AVK + + FL S M++L HP IV L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-IAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLH 529
G C +LV E G L L K L A A + YL
Sbjct: 62 IGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--------AHQVAMGMAYLE 112
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAF--GYSAPE 586
VHR+ + N+LL + +SD G++ AL ++ +T G + + APE
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT-AGRWPLKWYAPE 168
Query: 587 FALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
G ++ KSDV+S+GV + E + G KP
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 79/289 (27%), Positives = 114/289 (39%), Gaps = 52/289 (17%)
Query: 418 IGEGSLGRVYRAEFANG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG G G+V E G K V K A+ + E+ FL+ V L HPN++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 476 YCAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
C E LLV E+ G+L + L A + K++ R+A A L +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV----LQRMACEVASGLLWLHQ 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST--QMVGAFGYSAPEFA 588
+H + N L +L+ + D GL AL E T + APE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGL-ALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 589 -------LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641
L T KS+++S GV M EL T + +P P L D L
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQP----------YPDLSDEQVL 219
Query: 642 AKMV--------DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEV 682
++V P L+ Y R+ +++ C +PE RP EV
Sbjct: 220 KQVVREQDIKLPKPQLDLKYS----DRWYEVMQFCWL-DPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRL 465
+ +++ +IG G G V+R G+ +A+K + Q +D FL S M +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQF 63
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525
H NI+ L G + +++ EY+ NG L L D + +R G A +
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGM 120
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG--YS 583
+YL ++ + VHR+ + NIL++ L +SD GL+ + + T G ++
Sbjct: 121 KYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
APE +T SDV+SFG+VM E+++ G +P
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 72/270 (26%), Positives = 116/270 (42%), Gaps = 31/270 (11%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
IGEGS G V A + + G+ +AVKK+D L Q+ L V M +HPNIV +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +V E++ G L D++ + + V L +AL +LH
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHA---QG 135
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
V+HR+ KS +ILL + LSD G A ++ R+ S +VG + APE Y
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRLPYG 193
Query: 595 VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP 654
+ D++S G++++E++ G P + P +R P P L
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-------------PKLK--NL 238
Query: 655 AKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
K R + + +P R +E++
Sbjct: 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 73/281 (25%), Positives = 112/281 (39%), Gaps = 52/281 (18%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKI---DNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+GEG+ G V + G I A+K I N L Q L + + P IV
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ----ILRELEINKSCKSPYIVKY 64
Query: 474 AG-YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARV------RVALGTARAL 525
G + E + + EY G+L + K R+ ++A + L
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIY------KKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
YLH ++HR+ K +NILL + L D G++ N+ ++ G Y AP
Sbjct: 119 SYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS---LAGTFTGTSFYMAP 172
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL---------VRWATPQLH 636
E Y++ SDV+S G+ +LE+ R P P E L V P+L
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLGPIELLSYIVNMPNPELK 229
Query: 637 DIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRP 677
D +P NG+ ++ F D I C++ +P RP
Sbjct: 230 D--------EPG-NGIKWSEE---FKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 38/279 (13%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLR 466
F++ IG+GS G V++ + +++A+K ID L+E ++ +E + +S+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD 60
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFAD-DSSKNLTWNARVRVALGTARAL 525
P + G + + ++ EY+G G+ D+L D + T + + L
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEI------LKGL 114
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+YLH +HR+ K+AN+LL ++ + L+D G+A +T+ + +T VG + AP
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAP 170
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
E Y K+D++S G+ +EL G P P V + P K
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLFLIP---------KNN 217
Query: 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P L G + +K F D C+ +P FRP E+++
Sbjct: 218 PPTLTGEF-SKPFKEFIDA---CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 73/296 (24%), Positives = 115/296 (38%), Gaps = 39/296 (13%)
Query: 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED------NFL 456
++LQ T +G G G V+ A+ A G + +LQ+ F
Sbjct: 5 SNLQEIT-------TLGRGEFGEVFLAK-AKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHF---ADDSSK--NLTW 511
+ +L H N+V L G C E ++ EY G+L L D+ K L+
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 512 NARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571
+V + A +++L VHR+ + N L+ + +S L+ N+E
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRW 630
+ + APE ++ KSDV+SFGV+M E+ T G P
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF-------------- 219
Query: 631 ATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
L D + L ++ L P SR ++ C P+ RP SE+V AL
Sbjct: 220 --YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 75/242 (30%), Positives = 113/242 (46%), Gaps = 23/242 (9%)
Query: 417 LIGEGSLGRVYRA----EFANGKI-MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
L+G G G V++ E + KI +A+K I + + Q + + M L H IV
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIV 72
Query: 472 TLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDS-SKNLTWNARVRVALGTARALEYLH 529
L G C G L LV + G+L D + DS N V++A G + YL
Sbjct: 73 RLLGICP--GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG----MYYLE 126
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPEFA 588
E + VHRN + NILL + ++D G+A L P+ ++ ++ + A E
Sbjct: 127 EHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 589 LSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLV----RWATPQLHDIDALAK 643
L G YT +SDV+S+GV + E+++ G +P RP L+ R A PQ+ ID
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMV 243
Query: 644 MV 645
MV
Sbjct: 244 MV 245
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-16
Identities = 80/274 (29%), Positives = 128/274 (46%), Gaps = 40/274 (14%)
Query: 24 LILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPS-VLTNWKGNEGDPCGESWKGVACEG 82
++ + L L + +++ L +S+N P L+NW + D C W+G+ C
Sbjct: 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWN-SSADVC--LWQGITCNN 67
Query: 83 SA-VVSIDISGLGLSGTM---------------------GYLLSDLL----SLRKFDLSG 116
S+ VVSID+SG +SG + G + D+ SLR +LS
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN 127
Query: 117 NSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNL 176
N+ +IP PNL +L+L++N SG +P I S SL L++ N L I + NL
Sbjct: 128 NNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 177 AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLN---VANN 233
L L L+ N G +P + ++ +YL N ++G + G LT+LN + N
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG-GLTSLNHLDLVYN 246
Query: 234 HFSGWIPRELISIRT----FIYDGNSFDNGPAPP 263
+ +G IP L +++ F+Y N +GP PP
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQ-NKL-SGPIPP 278
|
Length = 968 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 417 LIGEGSLGRVYRAEF------ANGKI-MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
+G G+ G VY +G I +AVK + A + QE+ FL+ MS HPN
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPN 60
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTAR 523
IV L G C + + ++ E + G D+L + D+ LT + + L A+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGG---DLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNP-----HLSDCGLAA-LTPNTERQVSTQMV 577
YL ++ +HR+ + N L+ ++ + D GLA + + + + +
Sbjct: 118 GCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 578 GAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ APE L G +T +SDV+SFGV+M E+LT G++P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 3e-16
Identities = 74/290 (25%), Positives = 133/290 (45%), Gaps = 37/290 (12%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN---FL 456
++ S+ +++ IG+G+ G VY A + A G+ +A+++ ++LQ++ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQ-----MNLQQQPKKELII 65
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
+ M ++PNIV + +V EY+ G+L D++ + +
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAA 120
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQ 575
V +ALE+LH V+HR+ KS NILL + + L+D G A +TP E+ +
Sbjct: 121 VCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRST 175
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP-RSEQSLVRWATPQ 634
MVG + APE Y K D++S G++ +E++ G P + P R+ + TP+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE 235
Query: 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
L + P K + F D + C+ + E R E++Q
Sbjct: 236 LQN----------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 69/270 (25%), Positives = 121/270 (44%), Gaps = 27/270 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL-AG 475
+G+GS G V +GK +KK++ S +E + +S+L+HPNIV
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ E G +V + G+L+ L + K L N V + A AL+YLHE
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLK--EQKGKLLPENQVVEWFVQIAMALQYLHE---KH 122
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
++HR+ K+ N+ L + D G+A + N ST ++G Y +PE + Y
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKPYNY 181
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA-KMVDPALNGMYP 654
KSDV++ G + E+ T + ++ D+++L ++++ L M P
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAK-----------------DMNSLVYRIIEGKLPPM-P 223
Query: 655 AKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
++IA + PE RP + +++
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 415 EFLIGEGSLGRVYRAEF-ANGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
E +IG G G V R GK +A+K + + Q D FL S M + HPNI
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+ L G + +++ E++ NG L L D T V + G A ++YL E
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSE 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGA---FGYSAPE 586
+ + VHR+ + NIL++ L +SD GL+ L +T T +G ++APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 587 FALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+T SDV+S+G+VM E+++ G +P
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-16
Identities = 57/163 (34%), Positives = 86/163 (52%), Gaps = 4/163 (2%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNNFSGNL 145
+D+ G L G + L++L SL L+ N + IP +L +L + L NN SG +
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISS 205
PY I + SL++L++ N+LT I GNL L L L N SG +P S SL + S
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288
Query: 206 LYLQNNQVTGSLN--VFSGLPLTTLNVANNHFSGWIPRELISI 246
L L +N ++G + V L L++ +N+F+G IP L S+
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
|
Length = 968 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 418 IGEGSLGR-VYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEGS G+ + +GK +K+I+ + +S +E + + V+ +S ++HPNIV
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP-- 534
E+G +V +Y G+L+ + NA+ V + L++ ++CL
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKI------------NAQRGVLFPEDQILDWFVQICLALK 115
Query: 535 -----SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ KS NI L + L D G+A + +T T +G Y +PE
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICE 174
Query: 590 SGIYTVKSDVYSFGVVMLELLT 611
+ Y KSD+++ G V+ E+ T
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 417 LIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G+G+ G V + G+++AVKK+ ++ + F + + L+H NIV
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD--FEREIEILKSLQHDNIV 68
Query: 472 TLAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
G C G+R LV EY+ G+L D L K+ R L + L Y
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYL------QKH-------RERLDHRKLLLYAS 115
Query: 530 EVC-----LPS--VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA--- 579
++C L S VHR+ + NIL++ E + D GL + P + + G
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI 175
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
F Y APE ++V SDV+SFGVV+ EL T
Sbjct: 176 FWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 55/218 (25%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 418 IGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GE + G++Y+ + +++A+K + + + Q+ F + S M+ L HPNIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVC 71
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSS-------------KNLTWNARVRVAL 519
L G + +++EY+ G+LH+ L S +L + +A+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE-RQVSTQMVG 578
A +EYL VH++ + NIL+ ++L+ +SD GL+ + + +V + +
Sbjct: 132 QIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ PE + G ++ SD++SFGVV+ E+ + G +P
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 417 LIGEGSLGRVYRAEFANG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTL 473
+IGEG+ G+V +A ++ A K S + +F + + +L HPNI+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLH----------FADDSSKNLTWNAR--VRVALGT 521
G C G L EY +GNL D L FA +S T +++ + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG 581
AR ++YL + +HR+ + NIL+ + ++D GL+ + + +G
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRLP 174
Query: 582 --YSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ A E +YT SDV+S+GV++ E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 57/296 (19%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKI--DNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G+G+ GRVY + G+ +AVK++ D + ++E N LE + + L+H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 473 LAGYCAEHGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
G C + L ++ EY+ G++ D L ++ +T ++ G +EYLH
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG----VEYLHS- 122
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG---YSAPEFA 588
+VHR+ K ANIL D N L D G A+ T T M G + +PE
Sbjct: 123 --NMIVHRDIKGANILRDSAGNVKLGDFG-ASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648
Y K+DV+S G ++E+LT + P WA + +A+A
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP--------------WA-----EFEAMAA----- 215
Query: 649 LNGMYPAKSLSRFADIIALCVQP-EPEFRPPMSEVVQALVRLVQRASVVKRRSSDE 703
I + QP P+ +S + +R + KR S++E
Sbjct: 216 ---------------IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEE 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 53/292 (18%)
Query: 417 LIGEGSLGRVYRA-----EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
L+ EG+ GR++ + + + VK + + A S + L+ + L H NI+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNIL 71
Query: 472 TLAGYCAE-HGQRLLVYEYVGNGNLHDMLHFADDSSKN----LTWNARVRVALGTARALE 526
+ C E ++Y Y+ GNL L N L+ V +A+ A +
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA---------ALTPNTERQVSTQMV 577
YLH+ V+H++ + N ++D+EL ++D L+ L N R V
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---- 184
Query: 578 GAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLH 636
+ A E ++ Y+ SDV+SFGV++ EL+T G+ P
Sbjct: 185 ----WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV------------------- 221
Query: 637 DIDA--LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
+ID +A + P ++A C +PE RP S++VQ L
Sbjct: 222 EIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-16
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 415 EFLIGEGSLGRVYRAEFANG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIV 471
E +IGEG+ G+V RA K+ A K+ S + +F + + +L HPNI+
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLH----------FADD--SSKNLTWNARVRVAL 519
L G C G + EY GNL D L FA + ++ LT ++ A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA 579
A ++YL E +HR+ + N+L+ + L ++D GL+ E + +G
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVYVKKTMGR 179
Query: 580 FG--YSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ A E +YT KSDV+SFGV++ E+++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQE-------EDNFLEAVSNMSRLRHPN 469
+G+G G V + N GK+ A KK+D L + E LE V++ P
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS------PF 54
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
IV LA Y E L LV + G+L H + + L + + + +L
Sbjct: 55 IVNLA-YAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHL 111
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H + +V+R+ K N+LLDD+ N LSD GLA + + TQ G GY APE
Sbjct: 112 HSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEIL 166
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y+ D ++ G + E++ GR P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 37/215 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
I EG+ G VYRA + G+I+A+KK+ +E++ F L ++ + +L+HPNIVT
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKME----KEKEGFPITSLREINILLKLQHPNIVT 68
Query: 473 LA----GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
+ G + + +V EYV HD+ + + + + L + +L
Sbjct: 69 VKEVVVG--SNLDKIYMVMEYVE----HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFGY 582
H+ ++HR+ K++N+LL++ + D GLA R+ TQ+V Y
Sbjct: 123 HD---NWILHRDLKTSNLLLNNRGILKICDFGLA-------REYGSPLKPYTQLVVTLWY 172
Query: 583 SAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
APE L Y+ D++S G + ELLT +KPL
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 417 LIGEGSLGRVYRAEF--ANGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G+GS G V R E+ + GK++ AVK + + LS +D FL+ + M L H N++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-FLKEAAIMHSLDHENLIR 60
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G H ++V E G+L D L D+ + + A+ A + YL
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVST-QMVGAFGYSAPEFALS 590
+HR+ + NILL + + D GL AL N + V + F + APE +
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKP 615
++ SDV+ FGV + E+ T G +P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 44/281 (15%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G+G+ G VY A + + +A+K+I + E ++ S L+H NIV G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLH--FADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
+E+G + E V G+L +L + T + L L+YLH+
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL---EGLKYLHDN-- 127
Query: 534 PSVVHRNFKSANILLDDELNP-HLSDCG----LAALTPNTERQVSTQMVGAFGYSAPEFA 588
+VHR+ K N+L++ +SD G LA + P TE G Y APE
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE-----TFTGTLQYMAPEVI 181
Query: 589 LSGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646
G Y +D++S G ++E+ TG+ P + PQ A M
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPP-----------FIELGEPQ-------AAMFK 223
Query: 647 PALNGMYP--AKSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
+ ++P +SLS A + I C +P+P+ R +++Q
Sbjct: 224 VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 68/227 (29%), Positives = 101/227 (44%), Gaps = 54/227 (23%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEED---NFLEAVSNMSRLR---HPN 469
IGEG+ G VY+A + G+ +A+KK+ + L EE + L ++ + +L HPN
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKV---RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 470 IVTLAGYCAEHGQRL-------LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR 516
IV L C HG R LV+E+V + +L L ++ K+L
Sbjct: 63 IVRLLDVC--HGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ---- 115
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-------ALTPNTE 569
R +++LH +VHR+ K NIL+ + ++D GLA ALT
Sbjct: 116 ----LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS--- 165
Query: 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
V T Y APE L Y D++S G + EL R+PL
Sbjct: 166 -VVVTLW-----YRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 38/218 (17%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAAL-------SLQEEDNFLEAVSNMSRLRHPN 469
I +G+ GRV+ A+ + G I A+K I A + + E + L S+ + P
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDIL------SQAQSPY 54
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARA 524
+V L Y + + L LV EY+ G+L +L +D ++ + L A
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYI----AEIVL----A 105
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-------ALTPNTERQVSTQMV 577
LEYLH ++HR+ K NIL+D + L+D GL+ + N + + ++V
Sbjct: 106 LEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 578 GAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
G Y APE L ++ D +S G ++ E L G P
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 418 IGEGSLGRVYRAEFANGKIM---AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+GEG G V + + AVK + A + E ++FL M HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 475 GYCAEHGQR------LLVYEYVGNGNLHDMLHFA--DDSSKNLTWNARVRVALGTARALE 526
G C + + +++ ++ +G+LH L ++ D + L V+ A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQ--VSTQMVGAFGY 582
YL S +HR+ + N +L++ +N ++D GL+ N + RQ ++ V +
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK---W 180
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
A E +YT KSDV+SFGV M E+ T G+ P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 68/256 (26%), Positives = 124/256 (48%), Gaps = 21/256 (8%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN---FL 456
++ S+ +++ IG+G+ G VY A + A G+ +A+K+ ++LQ++ +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQ-----MNLQQQPKKELII 64
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
+ M ++PNIV + +V EY+ G+L D++ + +
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAA 119
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQ 575
V +AL++LH V+HR+ KS NILL + + L+D G A +TP E+ +
Sbjct: 120 VCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRST 174
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP-RSEQSLVRWATPQ 634
MVG + APE Y K D++S G++ +E++ G P + P R+ + TP+
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234
Query: 635 LHDIDALAKMVDPALN 650
L + + L+ + LN
Sbjct: 235 LQNPERLSAVFRDFLN 250
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 40/298 (13%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLR----HPN 469
+GEG G+V AE K A+ + ++D + + VS M ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH--------FADDSSK----NLTWNARVRV 517
I+ L G C + G ++ EY GNL + L ++ D+ K LT+ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQM 576
A AR +EYL +HR+ + N+L+ ++ ++D GLA N + + +T
Sbjct: 140 AYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLH 636
+ APE +YT +SDV+SFGV++ E+ T S P P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---LGGSPYP---------GIP--- 241
Query: 637 DIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694
++ L K++ PA I+ C P RP ++V+ L R++ S
Sbjct: 242 -VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 72/287 (25%), Positives = 116/287 (40%), Gaps = 43/287 (14%)
Query: 418 IGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G G+ G VY + A +AVK + + S Q+E +FL MS+ H NIV
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIV 72
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTARAL 525
L G E R ++ E + G D+ F ++ LT + A A+
Sbjct: 73 RLIGVSFERLPRFILLELMAGG---DLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNP----HLSDCGLAALTPNTE--RQVSTQMVGA 579
+YL E +HR+ + N LL + P ++D G+A R+ M+
Sbjct: 130 KYLEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAML-P 184
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639
+ PE L GI+T K+DV+SFGV++ E+ SL P + +
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF---------------SLGYMPYPGRTNQE 229
Query: 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
+ + V P I+ C Q PE RP + +++ +
Sbjct: 230 VM-EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-15
Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 5/167 (2%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNNFSGNL 145
+D+S L+G + L +L K L NS+ IP L +L + L N+FSG L
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISS 205
P + + +L++S N+L I ++ L L L+ N F G LP+SF S + +
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLEN 479
Query: 206 LYLQNNQVTGSL-NVFSGLP-LTTLNVANNHFSGWIPRELISIRTFI 250
L L NQ +G++ L L L ++ N SG IP EL S + +
Sbjct: 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526
|
Length = 968 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 79/266 (29%), Positives = 121/266 (45%), Gaps = 35/266 (13%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
IG GS G VY A + N +++A+KK+ + E+ + ++ V + +LRHPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 476 -YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y EH LV EY G+ D+L + + A V G + L YLH
Sbjct: 83 CYLREH-TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHS---H 134
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS---G 591
+++HR+ K+ NILL + L D G A++ + VG + APE L+ G
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAMDEG 189
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG 651
Y K DV+S G+ +EL + PL + A L+ I A+ PAL
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMN----------AMSALYHI---AQNESPALQS 236
Query: 652 MYPAKSLSRFADIIALCVQPEPEFRP 677
+ ++ F D C+Q P+ RP
Sbjct: 237 GHWSEYFRNFVDS---CLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 418 IGEGSLGRVYR-AEFANGKIMAVKKID---NAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG+G+ G+VY+ +G + AVK +D + ++ E N L+++ N HPN+V
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN-----HPNVVKF 84
Query: 474 AG--YCAEH---GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
G Y A+ GQ LV E G++ +++ + L + G L++L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF- 587
H ++HR+ K NILL E L D G++A +T + +T VG + APE
Sbjct: 145 HN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEVI 200
Query: 588 ----ALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643
Y + DV+S G+ +EL G PL +H + L K
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPL----------------FDMHPVKTLFK 244
Query: 644 MV-DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+ +P ++P K F I+ C+ + E RP ++ +++
Sbjct: 245 IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 3e-15
Identities = 80/291 (27%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPN 469
F+ IG GS G VY A +++A+KK+ + E+ + ++ V + R++HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 470 IVTLAG-YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
+ G Y EH LV EY G+ D+L + + A + G + L YL
Sbjct: 87 SIEYKGCYLREH-TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYL 141
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H +++HR+ K+ NILL + L+D G A++ + VG + APE
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPEVI 193
Query: 589 LS---GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
L+ G Y K DV+S G+ +EL + PL + A L+ I A+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----------AMSALYHI---AQNE 240
Query: 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696
P L + F D C+Q P+ RP E+++ + L +R V
Sbjct: 241 SPTLQSNEWSDYFRNFVDS---CLQKIPQDRPTSEELLKHMFVLRERPETV 288
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 50/303 (16%)
Query: 418 IGEGSLGRVYRAEF--------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---- 465
+GEG G+V AE +AVK + + A E + + VS M +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIG 78
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML--------HFADD----SSKNLTWNA 513
+H NI+ L G C + G ++ EY GNL + L ++ D + +T+
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-QV 572
V AR +EYL +HR+ + N+L+ + ++D GLA N + +
Sbjct: 139 LVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWA 631
+T + APE +YT +SDV+SFGV+M E+ T G P
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--------------- 240
Query: 632 TPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
P + ++ L K++ PA + ++ C P RP ++V+ L R++
Sbjct: 241 -PGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298
Query: 692 RAS 694
+
Sbjct: 299 LTT 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 58/212 (27%), Positives = 87/212 (41%), Gaps = 27/212 (12%)
Query: 418 IGEGSLGRVYRAEFANGKIM-AVKKIDNAALSL--QEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G GRV + + A+K + + Q+E F E + HP IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK-EILEECNHPFIVKL- 58
Query: 475 GYCA----EHGQRLLVY---EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
Y ++ +Y EY G L +L + + AR +A A EY
Sbjct: 59 -YRTFKDKKY-----IYMLMEYCLGGELWTILRDRGLFDE---YTARFYIA-CVVLAFEY 108
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
LH +++R+ K N+LLD L D G A + ++ + G Y APE
Sbjct: 109 LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPEI 163
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLDSS 619
L+ Y D +S G+++ ELLTGR P
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 35/213 (16%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAG 475
IGEG+ V +A GK A+K + SL E+ N L + + RL HPNI+ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIE 65
Query: 476 --YCAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALGTARALEYL 528
+ + G+ LV+E + + NL++++ + K+ + ++L+++
Sbjct: 66 VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQ--------LLKSLDHM 116
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSD----CGLAALTPNTERQVSTQMVGAFGYSA 584
H + HR+ K NIL+ D++ L+D G+ + P TE +ST+ Y A
Sbjct: 117 HR---NGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTE-YISTRW-----YRA 166
Query: 585 PEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
PE L G Y K D+++ G V E+L+ PL
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS-LFPL 198
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 36/282 (12%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHP 468
+F E IG G VYRA +G +A+KK+ L + + ++ + + +L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-HFADDSS---KNLTWNARVRVALGTARA 524
N++ E + +V E G+L M+ HF + W V++ A
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
LE++H V+HR+ K AN+ + L D GL +++ + +VG Y +
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMS 174
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644
PE Y KSD++S G ++ E+ + P + ++ +L K
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---------------MNLYSLCKK 219
Query: 645 VD----PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEV 682
++ P L + ++ L + + +C+ P+PE RP ++ V
Sbjct: 220 IEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 418 IGEGSLGRVYRAEFANGKI-------MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G+GS G VY A G + +A+K + N S++E FL S M ++
Sbjct: 14 LGQGSFGMVYEG-LAKGVVKGEPETRVAIKTV-NENASMRERIEFLNEASVMKEFNCHHV 71
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML--HFADDSSKNL----TWNARVRVALGTARA 524
V L G + L+V E + G+L L + + T +++A A
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQVSTQMVGAFGY 582
+ YL VHR+ + N ++ ++L + D G+ T+ R+ ++ +
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRW 187
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLT 611
APE G++T KSDV+SFGVV+ E+ T
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 59/277 (21%), Positives = 120/277 (43%), Gaps = 22/277 (7%)
Query: 411 SFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHP 468
+F E IG G VYRA + K +A+KK+ + + + ++ + + +L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
N++ E + +V E G+L M+ + + + + + A+E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H V+HR+ K AN+ + L D GL +++ + +VG Y +PE
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERI 178
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648
Y KSD++S G ++ E+ + P + ++ +L + ++
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---------------MNLFSLCQKIEQC 223
Query: 649 LNGMYPAKSLS-RFADIIALCVQPEPEFRPPMSEVVQ 684
P + S + +++++C+ P+P+ RP + V Q
Sbjct: 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNA--------ALSLQEEDNFLEAVSN 461
+F Q ++G+G G V + A GK+ A KK++ +++L E+ LE V+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEK-QILEKVN- 58
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
SR +V+LA Y E L LV + G+L ++ ++
Sbjct: 59 -SRF----VVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGEA------------GFE 100
Query: 521 TARALEYLHEVCL-------PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573
RA+ Y E+C +V+R+ K NILLDD + +SD GLA P E Q
Sbjct: 101 EGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTI 158
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPR 622
VG GY APE + YT D ++ G ++ E++ G+ P + +
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 73/250 (29%), Positives = 114/250 (45%), Gaps = 41/250 (16%)
Query: 418 IGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQE---------EDNFLEAVSNMSR 464
+G G+ G+V+ GK+ A+K + A + +Q+ E LEAV
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVR---- 62
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TA 522
R P +VTL Y + +L L+ +YV G L L+ ++ T + VRV +
Sbjct: 63 -RCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLY----QREHFT-ESEVRVYIAEIV 115
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTERQVSTQMVGAF 580
AL++LH++ +++R+ K NILLD E + L+D GL+ L ER S G
Sbjct: 116 LALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTI 170
Query: 581 GYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-----LVRWATP 633
Y APE G + D +S GV+ ELLTG P ++ QS +++ P
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP 230
Query: 634 QLHDIDALAK 643
+ A A+
Sbjct: 231 FPKTMSAEAR 240
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 81/310 (26%), Positives = 133/310 (42%), Gaps = 48/310 (15%)
Query: 394 PITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKID---NAALSL 449
P++ + S ++++ IG+G+ G+V++ NG AVK +D + +
Sbjct: 2 PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI 61
Query: 450 QEEDNFLEAVSNMSRLRHPNIVTLAGYC----AEHGQRL-LVYEYVGNGNLHD----MLH 500
+ E N L+A+S+ HPN+V G ++G +L LV E G++ D L
Sbjct: 62 EAEYNILKALSD-----HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK 116
Query: 501 FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560
+ + + +G L++LH +HR+ K NILL E L D G
Sbjct: 117 RGERMEEPIIAYILHEALMG----LQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFG 169
Query: 561 LAALTPNTERQVSTQMVGAFGYSAPEF-----ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
++A +T + +T VG + APE L Y + DV+S G+ +EL G P
Sbjct: 170 VSAQLTSTRLRRNTS-VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
Query: 616 LDSSRP-RSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPE 674
L P R+ + R P LH P + F D I C+ + E
Sbjct: 229 LADLHPMRALFKIPRNPPPTLHQ----------------PELWSNEFNDFIRKCLTKDYE 272
Query: 675 FRPPMSEVVQ 684
RP +S+++Q
Sbjct: 273 KRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 418 IGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ AE N ++AVK + A+ S +++ F ++ L+H +IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTVLQHQHIV 70
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML--HFAD----DSSKN-----LTWNARVRVALG 520
G C E L+V+EY+ +G+L+ L H D ++ LT + +A
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGA 579
A + YL + VHR+ + N L+ L + D G++ +T+ +V + +
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ PE L +T +SD++SFGVV+ E+ T G++P
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 8/204 (3%)
Query: 417 LIGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++GEGS GR + N A+K+I S ED+ EAV +++++HPNIV
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL-LAKMKHPNIVAFKE 65
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
G +V EY G+L M K + ++ + ++++HE
Sbjct: 66 SFEADGHLYIVMEYCDGGDL--MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KR 120
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
V+HR+ KS NI L L D G A L + T VG Y PE + Y
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEIWENMPYNN 179
Query: 596 KSDVYSFGVVMLELLTGRKPLDSS 619
KSD++S G ++ EL T + P ++
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDN------FLEAVSNMSRLRHPN 469
L+GEGS G V + + G+I+A+KK L+ ED+ + + + +LRH N
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF------LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+V L + LV+E+V + L D+ + + L + + R +E+ H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCH 117
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+++HR+ K NIL+ L D G A T +V T V Y APE +
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 590 SGI-YTVKSDVYSFGVVMLELLTGRK--PLDSS--------------RPRSEQSLVR--- 629
Y D+++ G ++ E+LTG P DS PR ++ +
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233
Query: 630 ---WATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P++ +I+ L K P L+G+ D+ C++ +P+ RP S+++
Sbjct: 234 FAGMRLPEVKEIEPLEKRF-PKLSGL--------VLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 67/219 (30%), Positives = 97/219 (44%), Gaps = 46/219 (21%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAV--------SNMSRLRHP 468
IGEG+ G VY+A + G+I+A+KKI L+ ED E V S + L HP
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-----RLETED---EGVPSTAIREISLLKELNHP 58
Query: 469 NIVTLAGYCAEH-GQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
NIV L H +L LV+E++ D+ + D S L
Sbjct: 59 NIVRL--LDVVHSENKLYLVFEFLD----LDLKKYMDSSPL---------TGLDPPLIKS 103
Query: 527 YLHEVCLP-------SVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVG 578
YL+++ V+HR+ K N+L+D E L+D GLA A + T V
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVV 161
Query: 579 AFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L Y+ D++S G + E++ R+PL
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 418 IGEGSLGRVYRAEFANG---------KIMAVKKI-DNAALSLQEEDNFLEAVSNMSRL-- 465
+GEG G+V RAE A G +AVK + DNA + + + +S M +
Sbjct: 20 LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNAT-----DKDLADLISEMELMKL 73
Query: 466 --RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH--------FADDSSK----NLTW 511
+H NI+ L G C + G ++ EY GNL + L + D +K L++
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 512 NARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE-- 569
V A AR +EYL +HR+ + N+L+ ++ ++D GLA + +
Sbjct: 134 KDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
++ S + + APE +YT +SDV+SFG++M E+ T
Sbjct: 191 KKTSNGRL-PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRL-----RHP 468
++G+GS G+V AE ++ AVK K D + LQ++D +E R+ +HP
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKD---VILQDDD--VECTMTEKRVLALAGKHP 56
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+ L C + RL V EYV G+L M H S A L++
Sbjct: 57 FLTQLHS-CFQTKDRLFFVMEYVNGGDL--MFHI--QRSGRFDEPRARFYAAEIVLGLQF 111
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
LHE +++R+ K N+LLD E + ++D G+ ++ G Y APE
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEI 167
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y D ++ GV++ E+L G+ P +
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 74/308 (24%), Positives = 123/308 (39%), Gaps = 75/308 (24%)
Query: 406 QTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNF-----LEAV 459
N IG G+ G+VY+ F G +MAVK++ + +E+N L+ V
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVV 67
Query: 460 SNMSRLRH--PNIVTLAGY----------------CAEHGQRLLVYEYVGNGNLHDMLHF 501
S H P IV GY C + +LL + + D+L
Sbjct: 68 L-KS---HDCPYIVKCYGYFITDSDVFICMELMSTCLD---KLL--KRIQGPIPEDILG- 117
Query: 502 ADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
++ + +AL YL E V+HR+ K +NILLD N L D G+
Sbjct: 118 --------------KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGI 161
Query: 562 AALTPNTERQVSTQMVGAFGYSAPEF----ALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
+ + + T+ G Y APE + Y +++DV+S G+ ++EL TG+ P
Sbjct: 162 SGRL--VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219
Query: 618 SSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSR-FADIIALCVQPEPEFR 676
+ + + + L K++ + P + S F + LC+ + R
Sbjct: 220 NCKT---------------EFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKR 264
Query: 677 PPMSEVVQ 684
P E++Q
Sbjct: 265 PKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 35/225 (15%)
Query: 418 IGEGSLGRVYRAEFANGK----------------IMAVKKIDNAALSLQEEDNFLEAVSN 461
+GEG G V+ E N + ++ KI + ++FL+ V
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 462 MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML--HFADDSSKN----------- 508
+SRL+ PNI+ L G C + ++ EY+ NG+L+ L H DD +N
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 509 --LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LT 565
+++++ + VAL A ++YL + + VHR+ + N L+ + L ++D G++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELL 610
++ + V + A E L G +T SDV++FGV + E+L
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 69/281 (24%), Positives = 114/281 (40%), Gaps = 37/281 (13%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-------HPN 469
+G G+ G+V A + K AV K+ A L+ + E + MS L+ H N
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKV--AVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
IV L G C G L++ EY G+L + L LT + + A+ + +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF---GYSAPE 586
+ +HR+ + N+LL + D GLA N V A + APE
Sbjct: 159 S---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG--NARLPVKWMAPE 213
Query: 587 FALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
+ +YT +SDV+S+G+++ E+ + G P P + K++
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFSLGSNPY----------------PGMPVDSKFYKLI 257
Query: 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
P + + DI+ C +P RP ++VQ +
Sbjct: 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 69/277 (24%), Positives = 113/277 (40%), Gaps = 37/277 (13%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
L+G+G+ G V++ + +AVK L + + FL + + HPNIV L G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C + +V E V G D L F L V+ AL A + YL +
Sbjct: 61 CTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNC 114
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG-------YSAPEFAL 589
+HR+ + N L+ + +SD G++ RQ + + G ++APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS-------RQEDDGIYSSSGLKQIPIKWTAPEALN 167
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649
G Y+ +SDV+S+G+++ E SL P + + A + V+
Sbjct: 168 YGRYSSESDVWSYGILLWETF---------------SLGVCPYPGMTNQQA-REQVEKGY 211
Query: 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
P K ++ C +PE RP SE+ + L
Sbjct: 212 RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
S E +G G G V+ A + +AVK + ++S++ FL + M L+H +
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKL 63
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L + ++ E++ G+L D L + S + L + + A + ++ +
Sbjct: 64 VKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ 120
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+ +HR+ ++ANIL+ L ++D GLA + + E ++APE
Sbjct: 121 ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 177
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKP 615
G +T+KSDV+SFG++++E++T GR P
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 34/232 (14%)
Query: 408 ATNSFSQEFLIGEGSLGRVYRAEF---ANG---KIMAVKKI-DNAALSLQEEDNFLEAVS 460
+T F +E +GE G+VY+ A G + +A+K + D A L+EE F
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE--FKHEAM 60
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFA----------DDSSKNLT 510
SRL+HPNIV L G + +++ Y + +LH+ L DD + T
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 511 WNAR--VRVALGTARALEYL--HEVCLPSVVHRNFKSANILLDDELNPHLSDCGL--AAL 564
V + A +E+L H V H++ + N+L+ D+LN +SD GL
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ + + ++ + +PE + G +++ SD++S+GVV+ E+ + G +P
Sbjct: 176 AADYYKLMGNSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 415 EFLIGEGSLGRVYRAEFA-NGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
E +IG G G V GK +A+K + Q D FL S M + HPNI
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+ L G + ++V EY+ NG+L L D T V + G A ++YL +
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSD 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG--YSAPEFA 588
+ VHR+ + NIL++ L +SD GL+ + + T G ++APE
Sbjct: 125 M---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 589 LSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+T SDV+S+G+VM E+++ G +P
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G GS GRV +GK A+K + A + L++ ++ L + +RHP +V L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
+ L LV EYV G L L F + ++ +V L ALEYLH
Sbjct: 69 -SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYA----AQVVL----ALEYLHS 119
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFAL 589
+ +V+R+ K N+LLD + ++D G A + T T + G Y APE L
Sbjct: 120 L---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT----YT-LCGTPEYLAPEIIL 171
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPR 622
S Y D ++ G+++ E+L G P P
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI 204
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 18/232 (7%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
IGEGS G V A ++GK++AVKK+D L Q+ L V M +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +V E++ G L D++ + + + V L +AL LH
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QG 136
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
V+HR+ KS +ILL + LSD G A + E +VG + APE Y
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP----QLHDIDALAK 643
+ D++S G++++E++ G P + P ++R P LH + K
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLK 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
EFL GEG+ EF ++ K+ A ++ ++FL+ + MSRL++PNI+ L
Sbjct: 30 AEFL-GEGA------PEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSK--------NLTWNARVRVALGTARAL 525
G C ++ EY+ NG+L+ L + S +++ + +A+ A +
Sbjct: 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGM 142
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSA 584
+YL + + VHR+ + N L+ + ++D G++ L ++ + V + A
Sbjct: 143 KYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMA 199
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLT 611
E L G +T SDV++FGV + E+ T
Sbjct: 200 WESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 418 IGEGSLGRVYRAEFAN-----GKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ AE N KI+ AVK + +A+ + +++ F ++ L+H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD--FHREAELLTNLQHEHIV 70
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML--HFAD-------DSSKNLTWNARVRVALGTA 522
G C E ++V+EY+ +G+L+ L H D + LT + + +A A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE-RQVSTQMVGAFG 581
+ YL VHR+ + N L+ + L + D G++ +T+ +V +
Sbjct: 131 AGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ PE + +T +SDV+S GVV+ E+ T G++P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 32/283 (11%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V + + G +MA K + A S++++ L + M R P IV+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ--ILRELQIMHECRSPYIVSFYG 70
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ E++ G+L + + ++A+ L YL+ V
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNV--HR 124
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
++HR+ K +NIL++ L D G++ N+ ++ VG Y +PE G YTV
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKYTV 181
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD---PAL-NG 651
KSDV+S G+ ++EL G+ P S + + +D L ++V P L +
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQD-----DPMGILDLLQQIVQEPPPRLPSS 236
Query: 652 MYPAKSLSRFADIIALCVQPEPEFRP------PMSEVVQALVR 688
+P + L F D C+ +P RP M +QAL
Sbjct: 237 DFP-EDLRDFVDA---CLLKDPTERPTPQQLCAMPPFIQALRA 275
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-14
Identities = 54/164 (32%), Positives = 76/164 (46%), Gaps = 29/164 (17%)
Query: 39 TDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCG---ESWKGVACEGSAVVSI-DISGLG 94
T +V ALQ L +SL P G GDPC W G C+ + I GLG
Sbjct: 369 TLLEEVSALQTLKSSLGLPLRF----GWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLG 424
Query: 95 LS--GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
L G G++ +D+ LR L S+NL+ N+ GN+P S+ S+
Sbjct: 425 LDNQGLRGFIPNDISKLRH-------------------LQSINLSGNSIRGNIPPSLGSI 465
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
SL L++S NS SI + G L L L+L+ N+ SG +P +
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 64/272 (23%), Positives = 121/272 (44%), Gaps = 28/272 (10%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G+ G+VY+A+ ++A K+ + S +E ++++ + ++ HPNIV L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
++ E+ G + ++ + + LT V T AL YLHE ++
Sbjct: 72 YYENNLWILIEFCAGGAVDAVML---ELERPLTEPQIRVVCKQTLEALNYLHE---NKII 125
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI----- 592
HR+ K+ NIL + + L+D G++A T Q +G + APE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652
Y K+DV+S G+ ++E+ P P + + +AK P L
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNP-------------MRVLLKIAKSEPPTL--A 229
Query: 653 YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P++ S F D + C++ + R ++++Q
Sbjct: 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 71/301 (23%), Positives = 132/301 (43%), Gaps = 49/301 (16%)
Query: 418 IGEGSLGRVYRAE------FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG G+V +A A +AVK + A S + D L + + ++ HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD-LLSEFNLLKQVNHPHVI 66
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML---------HFADDSSKN-----------LTW 511
L G C++ G LL+ EY G+L L + D ++N LT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 512 NARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571
+ A +R ++YL E+ +VHR+ + N+L+ + +SD GL+ +
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 572 VS-TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVR 629
V ++ + A E IYT +SDV+SFGV++ E++T G P P +L++
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK 243
Query: 630 WATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689
+ ++ P +++ C + EP+ RP +++ + L ++
Sbjct: 244 TG----YRMER-------------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
Query: 690 V 690
+
Sbjct: 287 M 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 52/235 (22%)
Query: 418 IGEGSLGRVYRAEFANG-------KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
IG+G+ GRV++A A G ++AVK + A S + +F + M+ HPNI
Sbjct: 13 IGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNI 70
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL----TWNARVRVALGTARALE 526
V L G CA L++EY+ G+L++ L S + + R L
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLR--HRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 527 YLHEVCLPS-------------VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573
++C+ VHR+ + N L+ + + ++D GL S
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL-----------S 177
Query: 574 TQMVGAFGYSA------------PEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ A Y A PE YT +SDV+++GVV+ E+ + G +P
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 417 LIGEGSLGRVYRA------EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ GRV+ + K+MA+ ++ + L++E + + + HP I
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEV----IRLKQEQHVHNEKRVLKEVSHPFI 63
Query: 471 VTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR----- 523
+ L + EH QR L + EYV G L L R + T
Sbjct: 64 IRL--FWTEHDQRFLYMLMEYVPGGELFSYLR------------NSGRFSNSTGLFYASE 109
Query: 524 ---ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF 580
ALEYLH +V+R+ K NILLD E + L+D G A R + + G
Sbjct: 110 IVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFA----KKLRDRTWTLCGTP 162
Query: 581 GYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP 621
Y APE S + D ++ G+++ E+L G P P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 8e-14
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+G+ G VY A G+++A+KK+ S +E N E S HPNIV L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 477 CAEHGQRLLVYEYVGNGNLHDML------HFADDSSKNLTWNARVRVALGTARALEYLHE 530
E+ + V+EY+ GNL+ ++ F++ +++ + + L ++H+
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQ--------ILQGLAHIHK 117
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA----ALTPNTERQVSTQMVGAFGYSAPE 586
HR+ K N+L+ ++D GLA + P T+ VST+ Y APE
Sbjct: 118 HGF---FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD-YVSTRW-----YRAPE 168
Query: 587 FAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
L S Y+ D+++ G +M EL T R PL
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR-PL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 48/225 (21%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF-LEAVSNMSRLR---HPNI 470
IGEG+ G+VY+A + G+++A+KK+ DN E++ F + A+ + LR H NI
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDN------EKEGFPITAIREIKILRQLNHRNI 68
Query: 471 VTL----------AGYCAEHGQRLLVYEYVGNGNLHD--------MLHFADDSSKNLTWN 512
V L + + G LV+EY+ HD ++HF++D K+
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLVHFSEDHIKSF--- 121
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
++ L L Y H+ + +HR+ K +NILL+++ L+D GLA L + E +
Sbjct: 122 --MKQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 573 STQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPL 616
T V Y PE L Y DV+S G ++ EL T +KP+
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 42/299 (14%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLR----HPN 469
+GEG G+V AE ++ A+ + + D + + +S M ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHF------------ADDSSKNLTWNARVRV 517
I+ L G C + G ++ EY GNL + L + L++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQM 576
A AR +EYL +HR+ + N+L+ ++ ++D GLA + + + +T
Sbjct: 146 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQL 635
+ APE IYT +SDV+SFGV++ E+ T G P P
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-------------GVP-- 247
Query: 636 HDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694
++ L K++ P+ + ++ C P RP ++V+ L R++ S
Sbjct: 248 --VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 74/284 (26%), Positives = 115/284 (40%), Gaps = 71/284 (25%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED-----NFLEAVSNMSRLRHPNIV 471
IGEG+ G VY+ G+I+A+KKI L+ E+ + +S + L+HPNIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-----RLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L + + L++E++ D+ + D K + YL+++
Sbjct: 63 CLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQY--------MDAELVKSYLYQI 110
Query: 532 CLP-------SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
V+HR+ K N+L+D++ L+D GLA R V T V Y A
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VYTHEVVTLWYRA 169
Query: 585 PEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL---DS---------------------- 618
PE L S Y+ D++S G + E+ T +KPL DS
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228
Query: 619 --SRPRSEQSLVRWATPQLHD---------IDALAKMV--DPAL 649
S P + + +W L +D L KM+ DPA
Sbjct: 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAK 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 29/236 (12%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKID---NAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
L+G G+ G+VY+ G++ A+K +D + +++E N L+ S+ H NI T
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH-----HRNIAT 67
Query: 473 LAGYCAEHG------QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV-RVALGTARAL 525
G + Q LV E+ G G++ D++ ++ W A + R L R L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL---RGL 124
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+LH+ V+HR+ K N+LL + L D G++A T + +T +G + AP
Sbjct: 125 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 180
Query: 586 EFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWATPQL 635
E Y KSD++S G+ +E+ G PL P L+ R P+L
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 68/223 (30%), Positives = 108/223 (48%), Gaps = 21/223 (9%)
Query: 417 LIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH----P 468
++G G+ G+V+ G K+ A+K + AAL +Q+ + + L H P
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSP 65
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALE 526
+VTL Y + +L L+ +YV G + L+ D+ S+ VR G ALE
Sbjct: 66 FLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGEIILALE 119
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
+LH++ +V+R+ K NILLD E + L+D GL+ + E++ + G Y APE
Sbjct: 120 HLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 587 FALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV 628
G + D +S G+++ ELLTG P R+ QS V
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 18/232 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
IGEGS G V A E GK +AVKK+D L Q+ L V M H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +V E++ G L D++ + + + V L RAL YLH
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN---QG 138
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
V+HR+ KS +ILL + LSD G A + E +VG + APE Y
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP----QLHDIDALAK 643
+ D++S G++++E++ G P + P +R P H + ++ +
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLR 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 32/238 (13%)
Query: 418 IGEGSLGRVYRAEFANG---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G+ G VY+A+ +G + A+K+I+ +S+ ++ + L+HPN+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISLQ 64
Query: 475 GYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY----- 527
H R L+++Y HD+ H + V++ G ++L Y
Sbjct: 65 KVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPH-----LSDCGLAALTPNTERQVS--TQMVGAF 580
+H + V+HR+ K ANIL+ E P ++D G A L + + ++ +V F
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 581 GYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637
Y APE L YT D+++ G + ELLT +P+ R Q ++ + P HD
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR----QEDIKTSNPYHHD 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 41/278 (14%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNF---LEAVSNMSRLRHPNIVTL 473
IG G+ G VY+A N G++ A+K I L+ ++F + + M +H NIV
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI-----KLEPGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + + E+ G G+L D+ H S++ V+ T + L YLH
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQI----AYVSRETLQGLYYLHS--- 124
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFAL--- 589
+HR+ K ANILL D + L+D G++A +T ++ S +G + APE A
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVER 182
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV---RWATPQLHDIDALAKMVD 646
G Y D+++ G+ +EL + P+ P L+ + P+L D KM
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD-----KM-- 235
Query: 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
K + F + + + P+ RP +++Q
Sbjct: 236 ---------KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 418 IGEGSLGRVYRAEF---ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G+ G V + + + K +AVK + N +D L + M +L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G C E +LV E G L+ L +K++T + + ++YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEE---T 114
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFALSGI 592
+ VHR+ + N+LL + +SD GL+ E + G + + APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 593 YTVKSDVYSFGVVMLELLT-GRKP 615
++ KSDV+SFGV+M E + G+KP
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 418 IGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ AE N ++AVK + + L+ +++ F ++ L+H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLTNLQHEHIV 70
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML--HFAD----------DSSKNLTWNARVRVAL 519
G C + ++V+EY+ +G+L+ L H D + L + + +A
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE-RQVSTQMVG 578
A + YL VHR+ + N L+ L + D G++ +T+ +V +
Sbjct: 131 QIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ PE + +T +SDV+SFGV++ E+ T G++P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 38/234 (16%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNA--------ALSLQEEDNFLEAVSN 461
+F ++G+G G V + A GK+ A KK++ A++L E+ LE V++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK-QILEKVNS 59
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNL----HDMLHFADDSSKNLTWNARVR 516
+V+LA Y E L LV + G+L ++M + D + + + A +
Sbjct: 60 ------RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI- 111
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM 576
G LE LH +V+R+ K NILLDD + +SD GLA P E
Sbjct: 112 -TCG----LEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGR 161
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW 630
VG GY APE + YT D + G ++ E++ G+ P R R E+ V+
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF---RQRKEK--VKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 72/278 (25%), Positives = 119/278 (42%), Gaps = 43/278 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF---LEAVSNMSRLRHPNIVTL 473
+G G+ G VY+A G++ AVK I L+ D+F + + + +H NIV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII-----KLEPGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSK-NLTWNARVRVALGTARALEYLHEVC 532
G + + EY G G+L D+ H S+ + + R T + L YLH
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHS-- 124
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFAL-- 589
+HR+ K ANILL D + L+D G+AA +T ++ S +G + APE A
Sbjct: 125 -KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVE 181
Query: 590 -SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV---RWATPQLHDIDALAKMV 645
+G Y D+++ G+ +EL + P+ P L+ + P+L D
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKD-------- 233
Query: 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVV 683
K S F + + + + P+ RP ++
Sbjct: 234 --------KTKWSSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 71/285 (24%), Positives = 110/285 (38%), Gaps = 51/285 (17%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V+ A+ +AVK L + FL+ + + HPNIV L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C + +V E V G D L F L +++ A +EYL
Sbjct: 62 CTQKQPIYIVMELVQGG---DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG--------YSAPEFA 588
+HR+ + N L+ ++ +SD G++ R+ + + G ++APE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMS-------REEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 589 LSGIYTVKSDVYSFGVVMLELLT-GRKPL-----DSSRPRSEQSLVRWATPQLHDIDALA 642
G Y+ +SDV+SFG+++ E + G P +R EQ VR P+L
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLPCPELCPDAVYR 227
Query: 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687
M C + +P RP S V Q L
Sbjct: 228 LMER---------------------CWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 42/278 (15%)
Query: 415 EFL--IGEGSLGRVYRA-EFANGKIMAVKKI----DNAALS--LQEEDNFLEAVSNMSRL 465
E L +G+G+ G VY+ G MA+K+I D + + + E D +AVS
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS----- 58
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525
P IV G G + EY+ G+L D L+ +++ + + R+ + L
Sbjct: 59 --PYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
++L E +++HR+ K N+L++ L D G++ N ++ +G Y AP
Sbjct: 116 KFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG---NLVASLAKTNIGCQSYMAP 170
Query: 586 EFALSG------IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639
E SG YTV+SDV+S G+ +LE+ GR P P + ++ +
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANI-------FAQLS 220
Query: 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRP 677
A+ P L P+ D +A C+ P RP
Sbjct: 221 AIVDGDPPTL----PSGYSDDAQDFVAKCLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 23/227 (10%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQE-------EDNFLEAVSNM 462
+F Q ++G+G G V + A GK+ A K+++ + ++ E LE V+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-- 58
Query: 463 SRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGT 521
S+ +V LA Y E L LV + G+L H + + + A
Sbjct: 59 SQF----VVNLA-YAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEERALFYAAEI 111
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG 581
LE LH + V+R+ K NILLDD + +SD GLA P E + VG G
Sbjct: 112 LCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIP--EGESIRGRVGTVG 166
Query: 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV 628
Y APE + YT+ D + G ++ E++ G+ P + + ++ V
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
IGEGS G V A E +G+ +AVK +D L Q+ L V M +H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ ++ E++ G L D++ S L V +AL YLH
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHS---QG 137
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
V+HR+ KS +ILL + LSD G A ++ + ++ S +VG + APE Y
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYG 195
Query: 595 VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633
+ D++S G++++E++ G P S P +R + P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 45/224 (20%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
IG+G+ G V++A +I+A+KK+ L E++ F L + + L+H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 473 LAGYC-----AEHGQR---LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
L C + + LV+E+ HD+ L N V+ L +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCE----HDL--------AGLLSNKNVKFTLSEIKK 123
Query: 525 --------LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA---ALTPNTERQVS 573
L Y+H ++HR+ K+ANIL+ + L+D GLA +L+ N++
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 574 TQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
T V Y PE L Y D++ G +M E+ T R P+
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 77/271 (28%), Positives = 119/271 (43%), Gaps = 32/271 (11%)
Query: 412 FSQEFLIGEGSLGRVYRA----EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH 467
F + ++G G+ G VY+ E KI K A S + L+ M+ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARA 524
P++ L G C +L + + + G L D + D S L W ++ A+
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FG 581
+ YL E L VHR+ + N+L+ + ++D GLA L E++ + G
Sbjct: 122 MNYLEERRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE--GGKVPIK 176
Query: 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLV-----RWATPQL 635
+ A E L IYT +SDV+S+GV + EL+T G KP D P SE S + R P +
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPI 235
Query: 636 HDIDALAKMVDPALNGMYPAKSLSRFADIIA 666
ID MV M A S +F ++I
Sbjct: 236 CTIDVYMIMVK---CWMIDADSRPKFRELII 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-13
Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 4/159 (2%)
Query: 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS 142
++S+D+S LSG + L+ L +L L N+ IP L P L L L SN FS
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS 345
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
G +P ++ +L+ L++S N+LT I + + L L L N+ G++P S + +
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405
Query: 203 ISSLYLQNNQVTGSLNV-FSGLPLTT-LNVANNHFSGWI 239
+ + LQ+N +G L F+ LPL L+++NN+ G I
Sbjct: 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V A + +GK +A+KKI +A L + + +H NI+ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 477 C---AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA-RALEYLHEVC 532
+ + V + +LH ++H S + LT +R L R L+Y+H
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHHIIH----SDQPLT-EEHIRYFLYQLLRGLKYIHSAN 127
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQ-VSTQMVGAFGYSAPEFAL 589
V+HR+ K +N+L++++ + D G+A + TE + T+ V Y APE L
Sbjct: 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 590 S-GIYTVKSDVYSFGVVMLELLTGRKPL 616
S YT D++S G + E+L GR+ L
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVT 472
+IGEG+ G+V +A +G M A+K++ A S + +F + + +L HPNI+
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLH------------FADDSSKNLTWNARVRVALG 520
L G C G L EY +GNL D L A+ ++ L+ + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF 580
AR ++YL + +HR+ + NIL+ + ++D GL+ E V M G
Sbjct: 133 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM-GRL 185
Query: 581 G--YSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ A E +YT SDV+S+GV++ E+++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 62/221 (28%), Positives = 88/221 (39%), Gaps = 44/221 (19%)
Query: 418 IGEGSLGRVYRA---EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIV 471
IG G+ GRVY+A +GK A+KK Q A ++ LR H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFK--GDKEQYTGISQSACREIALLRELKHENVV 65
Query: 472 TLAGYCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL---- 525
+L EH + L+++Y HD+ + RV + ++L
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQ----AKRVSIPPSMVKSLLWQI 117
Query: 526 ----EYLHEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAAL------TPNTERQ 571
YLH V+HR+ K ANIL+ E + D GLA L
Sbjct: 118 LNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 572 VSTQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLT 611
V V Y APE L + YT D+++ G + ELLT
Sbjct: 175 V----VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 71/277 (25%), Positives = 120/277 (43%), Gaps = 34/277 (12%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G+G+ GRVY + G+ +A K++ D + +E + LE + + L+H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 473 LAGYCAEHGQRLLV--YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G + ++ L EY+ G++ D L ++++T ++ G + YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEG----MSYLHS 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG---YSAPEF 587
+VHR+ K ANIL D N L D G A+ T T + G + +PE
Sbjct: 125 ---NMIVHRDIKGANILRDSAGNVKLGDFG-ASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647
Y K+DV+S G ++E+LT + P WA + + A+ K+
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP--------------WA--EYEAMAAIFKIATQ 224
Query: 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
N P+ D + C+ E RP E+++
Sbjct: 225 PTNPQLPSHISEHARDFLG-CIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 68/253 (26%), Positives = 113/253 (44%), Gaps = 35/253 (13%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIV 471
+IG G G VY A+ GK+ A+K +D + +++ + N +S +S P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 472 TLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEY 527
++ Y +L + + + G+LH H + S + + A + LG LE+
Sbjct: 61 CMS-YAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEAEMRFYA-AEIILG----LEH 112
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
+H VV+R+ K ANILLD+ + +SD GLA + S VG GY APE
Sbjct: 113 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEV 166
Query: 588 ALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646
G+ Y +D +S G ++ +LL G P + + + H+ID + +
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----------HEIDRMTLTMA 215
Query: 647 PALNGMYPAKSLS 659
L + + S
Sbjct: 216 VELPDSFSPELRS 228
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLRHP 468
+IG GS +V E +I A+K I ++ +Q E + E SN HP
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN-----HP 56
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+V L C + RL V E+V G+L M H K +AR A + AL +
Sbjct: 57 FLVGLHS-CFQTESRLFFVIEFVSGGDL--MFHM-QRQRKLPEEHARFYSA-EISLALNF 111
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGAFGYSAP 585
LHE +++R+ K N+LLD E + L+D G+ + P ++ G Y AP
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---DTTSTFCGTPNYIAP 165
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLD--SSRPRSEQS 626
E Y D ++ GV+M E++ GR P D +Q+
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-13
Identities = 61/176 (34%), Positives = 88/176 (50%), Gaps = 8/176 (4%)
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASM 152
LSG + Y + L SL DL N++ IP L NL L L N SG +P SI S+
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L L++S NSL+ I ++ L L L L NNF+G +P + SL + L L +N+
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 213 VTGSL--NVFSGLPLTTLNVANNHFSGWIPRELIS---IRTFIYDGNSFDNGPAPP 263
+G + N+ LT L+++ N+ +G IP L S + I NS + G P
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE-GEIPK 398
|
Length = 968 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 63/272 (23%), Positives = 120/272 (44%), Gaps = 28/272 (10%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G+ G+VY+A+ +A K+ S +E ++++ + ++ HP IV L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
G+ ++ E+ G + ++ D R L AL+YLH + ++
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML---EALQYLHSM---KII 132
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI----- 592
HR+ K+ N+LL + + L+D G++A T Q +G + APE +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652
Y K+D++S G+ ++E+ P P + + +AK P L+
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNP-------------MRVLLKIAKSEPPTLSQ- 237
Query: 653 YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P+K F D + + PE RP +++++
Sbjct: 238 -PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 16/216 (7%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKI----DNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
++G+G+ G VY G+++AVK++ N + +E + E V + L+H NIV
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G C + + E+V G++ +L+ + + ++ G A YLH C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNNC 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA-----ALTPNTERQVSTQMVGAFGYSAPEF 587
VVHR+ K N++L L D G A T + M G + APE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRS 623
Y KSD++S G + E+ TG+ PL S +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 22/222 (9%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIV 471
+IG G G VY A+ GK+ A+K +D + +++ + N +S +S P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYL 528
+ + + + + G+LH H + S K + + A + LG LE++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRFYA-TEIILG----LEHM 113
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H VV+R+ K ANILLD+ + +SD GLA + S VG GY APE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVL 167
Query: 589 LSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR 629
G Y +D +S G ++ +LL G P + + + + R
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 61/233 (26%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+GEG+ G VY+A + G+++A+KKI L E+D F L + + +L+HPN+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI----LMHNEKDGFPITALREIKILKKLKHPNVVP 71
Query: 473 LAGYCAEHG-----QRLLVY---EYVGNGNLHD---MLHFADDSSKNLTWNARVRVALGT 521
L E +R VY Y+ HD +L N V++
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMD----HDLSGLLE-----------NPSVKLTESQ 116
Query: 522 AR--------ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA----------- 562
+ + YLHE ++HR+ K+ANIL+D++ ++D GLA
Sbjct: 117 IKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 563 -ALTPNTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGR 613
T + T +V Y PE L YT D++ G V E+ T R
Sbjct: 174 GGGGGGTRKY--TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 79/266 (29%), Positives = 120/266 (45%), Gaps = 32/266 (12%)
Query: 417 LIGEGSLGRVYRA----EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
++G G+ G VY+ E KI KI N + F++ M+ + HP++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLH-FADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C +L V + + +G L D +H D+ L N V++A G + YL E
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG----MMYLEER 128
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP--EFAL 589
L VHR+ + N+L+ + ++D GLA L E++ + A G P AL
Sbjct: 129 RL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN-----ADGGKMPIKWMAL 180
Query: 590 SGI----YTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLV----RWATPQLHDIDA 640
I +T +SDV+S+GV + EL+T G KP D R L+ R P + ID
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV 240
Query: 641 LAKMVDPALNGMYPAKSLSRFADIIA 666
MV M A S +F ++ A
Sbjct: 241 YMVMVK---CWMIDADSRPKFKELAA 263
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 73/273 (26%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNI 470
++G+GS G+V+ AE + A+K + + + D+ +E R+ HP +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFL 58
Query: 471 VTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFAD----DSSKNLTWNARVRVALGTARA 524
L YC + L V EY+ G+L M H D + + A + L
Sbjct: 59 THL--YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGL----- 109
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
++LH +V+R+ K NILLD + + ++D G+ + + T G Y A
Sbjct: 110 -QFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIA 164
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644
PE L Y D +SFGV++ E+L G+ P E+ L I +M
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG---HDEEEL-------FQSI----RM 210
Query: 645 VDPALNGMYPAKSLSRFA-DIIALCVQPEPEFR 676
+P YP + L+R A DI+ EPE R
Sbjct: 211 DNP----CYP-RWLTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 55/155 (35%), Positives = 74/155 (47%), Gaps = 10/155 (6%)
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSIAS 151
LSG + + L L DLS NS+ IP QL NL L+L SNNF+G +P ++ S
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ-NLEILHLFSNNFTGKIPVALTS 330
Query: 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ L L + N + I G L LDLS NN +G++P S N+ L L +N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390
Query: 212 QVTG----SLNVFSGLPLTTLNVANNHFSGWIPRE 242
+ G SL L L +N FSG +P E
Sbjct: 391 SLEGEIPKSLGACRSLRRVRLQ--DNSFSGELPSE 423
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 3/139 (2%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNNFSGNL 145
+D+S SG + L L L + LS N + IP +L L SL+L+ N SG +
Sbjct: 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISS 205
P S + M LS L++S+N L+ I GN+ L +++S N+ G LP++ L+ +S
Sbjct: 540 PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS 599
Query: 206 LYLQNNQVTGSLNVFSGLP 224
N + G + SGLP
Sbjct: 600 AVAGNIDLCGG-DTTSGLP 617
|
Length = 968 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 417 LIGEGSLGRVYRAEF---ANGKI-MAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
IGEG G VY+ + N KI +AVK K + S++E FL+ M + HP+I
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVRE--KFLQEAYIMRQFDHPHI 69
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L G E+ +V E G L + + +L + + + + AL YL
Sbjct: 70 VKLIGVITEN-PVWIVMELAPLGELR---SYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
VHR+ + N+L+ L D GL+ + +++ + APE
Sbjct: 126 K---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKP 615
+T SDV+ FGV M E+L G KP
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEE---DNFLEAVSNMSRLRHPNIVTL 473
IGEG+ G VY+A G+++A+KKI L + E + +S + L HPNIV L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI---RLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV-- 531
+ LV+E++ D+ F D S + + YL ++
Sbjct: 65 LDVIHTENKLYLVFEFLH----QDLKKFMDASPLS---------GIPLPLIKSYLFQLLQ 111
Query: 532 ----CLP-SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
C V+HR+ K N+L++ E L+D GLA R + ++V Y APE
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 170
Query: 587 FAL-SGIYTVKSDVYSFGVVMLELLTGRK--PLDS 618
L Y+ D++S G + E++T R P DS
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTLA 474
IG+GS G+V A+ A+GK AVK + A+ ++E + A N + ++HP +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLH 529
Y + +L V +YV G L L F + ++ + A + ALG YLH
Sbjct: 63 -YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--FYAAEIASALG------YLH 113
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+ ++++R+ K NILLD + + L+D GL + ST G Y APE
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLR 169
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDS 618
Y D + G V+ E+L G P S
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 417 LIGEGSLGRVYRA----EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
++G+G G V A E + + +AVK + S + + FL + M HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 473 LAGYC--AEHGQRL----LVYEYVGNGNLHDMLHFA--DDSSKNLTWNARVRVALGTARA 524
L G + RL ++ ++ +G+LH L + + L VR + A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTERQVSTQMVGAFGY 582
+EYL + +HR+ + N +L++ + ++D GL+ + + RQ + +
Sbjct: 126 MEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-PVKW 181
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
A E +YT SDV++FGV M E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 418 IGEGSLGRVYRAE----------------FANGKIM-AVKKI-DNAALSLQEEDNFLEAV 459
+GEG G V+ E A+ ++ AVK + +A+ + +E+ FL+ V
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED--FLKEV 70
Query: 460 SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML--HFADDS-----SKNLTWN 512
+SRL PNI L G C ++ EY+ NG+L+ L H A+ S SK+L+++
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQ 571
+ +A A + YL + VHR+ + N L+ ++D G++ L + +
Sbjct: 131 TLLYMATQIASGMRYLESLNF---VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT--GRKPLDS 618
V + + A E L G +T KSDV++FGV + E+LT +P +
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 418 IGEGSLGRVYRAEFANG-KIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG+GS G+V + + +I A+K I A + S E + L + ++++ P IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ LV ++ G L H + AR A ALE LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTA-ELLCALENLHKF---N 113
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
V++R+ K NILLD + + L D GL L + + +T G Y APE L YT
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTK 172
Query: 596 KSDVYSFGVVMLELLTGRKP 615
D ++ GV++ E+LTG P
Sbjct: 173 AVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-12
Identities = 50/162 (30%), Positives = 74/162 (45%), Gaps = 19/162 (11%)
Query: 463 SRLRHPNIVTL--AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
+RL HPNIV L +G G V+EYV L ++L A D + L R+ L
Sbjct: 33 ARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVL--AADGA--LPAGETGRLMLQ 87
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQ------ 571
AL H +VHR+ K NI++ + + D G+ L P
Sbjct: 88 VLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613
+T+++G Y APE T SD+Y++G++ LE LTG+
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 28/236 (11%)
Query: 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKID---NAALSLQEEDNFLE 457
+++L+ F ++G G+ G+VY+ G++ A+K +D + ++ E N L+
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 458 AVSNMSRLRHPNIVTLAGYCAEHG------QRLLVYEYVGNGNLHDMLHFADDSSKNLTW 511
S+ H NI T G + Q LV E+ G G++ D++ ++ W
Sbjct: 68 KYSH-----HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122
Query: 512 NARV-RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
A + R L R L +LH V+HR+ K N+LL + L D G++A T
Sbjct: 123 IAYICREIL---RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176
Query: 571 QVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP 621
+ +T +G + APE Y +SD++S G+ +E+ G PL P
Sbjct: 177 RRNT-FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 62/211 (29%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLRHP 468
+IG GS +V +I A+K + ++ +Q E + E SN HP
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-----HP 56
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
+V L + V EYV G+L M H K +AR A + AL YL
Sbjct: 57 FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHM-QRQRKLPEEHARFYSA-EISLALNYL 112
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGAFGYSAPE 586
HE +++R+ K N+LLD E + L+D G+ L P ++ G Y APE
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPE 166
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y D ++ GV+M E++ GR P D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 59/234 (25%), Positives = 94/234 (40%), Gaps = 52/234 (22%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED----------NF--LEAVSNMSR 464
+GEG+ G+V +A GKI+A+KK+ +S +F L + M+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA------ 518
++H NI+ L E LV + + A D K + + ++R+
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-----------ASDLKKVV--DRKIRLTESQVKC 123
Query: 519 --LGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-------------A 563
L L LH+ +HR+ ANI ++ + ++D GLA
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 564 LTPNTERQVSTQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
R+ T V Y APE + + Y D++S G + ELLTG KPL
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+IG+GS G V A + G+ +A+KKI++ + + L + + LRHP+IV +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 476 YCAEHGQR-----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+R +V+E + + +LH ++ DD LT RAL+Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELMES-DLHQVIKANDD----LTPEHHQFFLYQLLRALKYIHT 121
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN-TERQVS-TQMVGAFGYSAPEFA 588
+V HR+ K NIL + + + D GLA + N T + T V Y APE
Sbjct: 122 A---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 589 LS--GIYTVKSDVYSFGVVMLELLTGRKPL 616
S YT D++S G + E+LTG KPL
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 64/234 (27%), Positives = 110/234 (47%), Gaps = 24/234 (10%)
Query: 418 IGEGSLGRVYRAEFANGKI---MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G+ G VY+A+ +GK A+K+I+ +S+ ++ + L+HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIALQ 64
Query: 475 GYCAEHGQR--LLVYEYVGNGNLHDM-LHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
H R L+++Y + H + H A ++K R V + L+ +H +
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 532 CLPSVVHRNFKSANILLDDELNPH-----LSDCGLAALTPNTERQVS--TQMVGAFGYSA 584
V+HR+ K ANIL+ E P ++D G A L + + ++ +V F Y A
Sbjct: 125 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 585 PEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637
PE L YT D+++ G + ELLT +P+ R Q ++ + P HD
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR----QEDIKTSNPFHHD 232
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 35/221 (15%)
Query: 412 FSQEFL-----IGEGSLGRV----YRAEFAN-GKIMAVKKIDNAALSLQEED------NF 455
F + FL +GEG G+V Y E N G+ +AVK SL+ E +
Sbjct: 1 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-------SLKPESGGNHIADL 53
Query: 456 LEAVSNMSRLRHPNIVTLAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKN-LTWN 512
+ + + L H NIV G C E G L+ E++ +G+L + L +KN +
Sbjct: 54 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PRNKNKINLK 109
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTER- 570
+++ A+ + ++YL VHR+ + N+L++ E + D GL A+ + E
Sbjct: 110 QQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 166
Query: 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
V + + APE + + + SDV+SFGV + ELLT
Sbjct: 167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 69/288 (23%), Positives = 125/288 (43%), Gaps = 52/288 (18%)
Query: 418 IGEGSLGRVYRA---------EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP 468
+G+G+ ++++ E +++ +K +D + + E +F EA S MS+L H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVL-LKVLDKSHRNYSE--SFFEAASMMSQLSHK 59
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
++V G C + ++V EYV G+L D + + N++W ++ VA A AL +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISW--KLEVAKQLAWALHFL 116
Query: 529 HEVCLPSVVHRNFKSANILLDDEL-----NP---HLSDCGLAALTPNTERQVSTQMVGAF 580
+ + H N + N+LL E NP LSD G++ E ++
Sbjct: 117 ED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-----ILLERI 168
Query: 581 GYSAPE-FALSGIYTVKSDVYSFGVVMLELLTG-RKPLDSSRPRSEQSLVRWATPQLHDI 638
+ PE ++ +D +SFG + E+ +G KPL + ++ QL
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQFYEDRHQL--- 224
Query: 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
PA + A++I C+ EP+FRP +++ L
Sbjct: 225 ---------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 5e-12
Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 31/214 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQE------EDNFLEAVSNMSRLRHPNI 470
+G+G+ G V++A + +++A+KKI +A + + E FL+ + + HPNI
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD-----HPNI 69
Query: 471 VTL-AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEY 527
V L AE+ + + LV+EY+ +LH ++ N+ + R + +AL+Y
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYM-ETDLHAVIR------ANILEDVHKRYIMYQLLKALKY 122
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA----ALTPNTERQVSTQMVGAFGYS 583
+H +V+HR+ K +NILL+ + L+D GLA L N E V T V Y
Sbjct: 123 IHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 584 APEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
APE L S YT D++S G ++ E+L G KPL
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 36/216 (16%)
Query: 417 LIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEED--------NFLEAVSNMSR 464
++G+G G+V++ GKI A+K + A + ++D N LEAV
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV----- 57
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVAL 519
+HP IV L Y + G +L L+ EY+ G L L F +D++ + + + +AL
Sbjct: 58 -KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTAC--FYLSEISLAL 113
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA 579
E+LH+ +++R+ K NILLD + + L+D GL + + E V+ G
Sbjct: 114 ------EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFCGT 163
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y APE + + D +S G +M ++LTG P
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 28/211 (13%)
Query: 417 LIGEGSLGRVY--RAEFA--NGKIMAVKKIDNAALSLQE------EDNFLEAVSNMSRLR 466
++G+GS G+V+ R G++ A+K + A L +++ E + L V+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN------ 56
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR-VRVALGT-ARA 524
HP IV L G+ L+ +++ G+L L SK + + V+ L A A
Sbjct: 57 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALA 110
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
L++LH + +++R+ K NILLD+E + L+D GL+ + + E++ + G Y A
Sbjct: 111 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMA 166
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE +T +D +SFGV+M E+LTG P
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 410 NSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN-MSRLRH 467
F + L+G G G V E A G I A+K + + L QE +F E + +S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 468 PNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDS-SKNLTWNARVRVALGTARAL 525
P I L Y + L LV EY G+L +L+ +D +++ + L A +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-----AQFYL--AELV 112
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+H V VHR+ K N+L+D + L+D G AA + S VG Y AP
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172
Query: 586 EF--ALSG----IYTVKSDVYSFGVVMLELLTGRKP 615
E ++G Y V+ D +S GV+ E++ GR P
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 71/272 (26%), Positives = 109/272 (40%), Gaps = 43/272 (15%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAAL-SLQEEDNF-LEAVSNMSRLRHPNIVTLA 474
I +G+ G VY A+ + G A+K + + + + + N E M + P + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLH 529
Y + L LV EY+ G+ ++ +D +K V LG +E LH
Sbjct: 64 -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYI----AEVVLG----VEDLH 114
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+ ++HR+ K N+L+D + L+D GL+ + + VG Y APE L
Sbjct: 115 Q---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYLAPETIL 166
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP-----RSEQSLVRW-------ATPQLHD 637
SD +S G V+ E L G P + P + W +P+ D
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVD 226
Query: 638 -IDALAKMVDPAL----NGMYPAKSLSRFADI 664
I+ L M DPA NG KS F I
Sbjct: 227 LINRLLCM-DPAKRLGANGYQEIKSHPFFKSI 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 30/230 (13%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNA--------ALSLQEEDNFLEAVSN 461
+F ++G+G G V + A GK+ A KK++ A++L E+ LE V+
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK-RILEKVN- 58
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
SR +V+LA Y E L LV + G+L H + + + A
Sbjct: 59 -SRF----VVSLA-YAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFDEQRAIFYAAE 110
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF 580
LE L +V+R+ K NILLDD + +SD GLA P E + VG
Sbjct: 111 LCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVRGRVGTV 165
Query: 581 GYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW 630
GY APE + YT D + G ++ E++ G+ P R R E+ V+
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF---RKRKER--VKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKI-DNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G GS GRV A+ G+ A+K + L +++ + + S + L HP IV +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ + + E+V G L L F +D +K ++A + +A EYLH
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK--FYHAELVLAF------EYLHSK 137
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
+++R+ K N+LLD++ + ++D G A P +R + + G Y APE S
Sbjct: 138 ---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT--LCGTPEYLAPEVIQSK 190
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRP 621
+ D ++ GV++ E + G P P
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNI 470
++G+GS G+V A +G++ AVK + + LQ++D +E R+ HP +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDD--VECTMTEKRILSLARNHPFL 58
Query: 471 VTLAGYCAEHGQRLL-VYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYL 528
L C + RL V E+V G+L M H S+ AR R A AL +L
Sbjct: 59 TQLY-CCFQTPDRLFFVMEFVNGGDL--MFHI--QKSRRFD-EARARFYAAEITSALMFL 112
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H+ +++R+ K N+LLD E + L+D G+ + ST G Y APE
Sbjct: 113 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEIL 168
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLDS 618
+Y D ++ GV++ E+L G P ++
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 71/261 (27%), Positives = 102/261 (39%), Gaps = 51/261 (19%)
Query: 423 LGRVYRAEFANGKIMAVKKIDNAALSLQEEDN------------------FLEAVSNMSR 464
LGR R + G + K D+ E F E S M +
Sbjct: 3 LGRGTRTQIYAGILN--YKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
+ H +IV L G C + ++V E+V G L +H S LT + +VA A A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASA 117
Query: 525 LEYLHEVCLPSVVHRNFKSANILL-----DDELNP--HLSDCGLAALTPNT--ERQVSTQ 575
L YL + +VH N + NILL D E P LSD G+ P T RQ +
Sbjct: 118 LSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PITVLSRQ---E 167
Query: 576 MVGAFGYSAPE-FALSGIYTVKSDVYSFGVVMLEL-LTGRKPLD----SSRPRSEQSLVR 629
V + APE S ++ +D +SFG + E+ G PL + + R +
Sbjct: 168 CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCM 227
Query: 630 WATPQLHDIDALAKMVDPALN 650
TP LA ++ +N
Sbjct: 228 LVTP---SCKELADLMTHCMN 245
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 65/209 (31%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 418 IGEGSLGRVYRAEFANGK----IMAVKKID----NAALSLQEEDNFLEAVSNMSRLRHPN 469
+G G G+V AE+ I A+KK D + SL E E + RHP
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN---SERHPF 63
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADD--SSKNLTWNARVRVALGTARALE 526
+V L C + + V EY G+L M+H D S + A V LG L+
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYA-ACVVLG----LQ 115
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
YLHE +V+R+ K N+LLD E ++D GL + ST G + APE
Sbjct: 116 YLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPE 171
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
YT D + GV++ E+L G P
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKI--DNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G+G+ GRVY A+ G+ +AVK++ D + +E N LE + + L H IV
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 473 LAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G + +R L E++ G++ D L S LT N + + YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG---YSAPEF 587
+VHR+ K ANIL D N L D G A+ T T M G + +PE
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFG-ASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y K+D++S G ++E+LT + P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN------FLEAVSNMSRLRHPNI 470
IGEGS G V++ G+I+A+KK ++ ED+ L + + +L+HPN+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF------VESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALE 526
V L + LV+EY + L+++ + K + W T +A+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--------TLQAVN 114
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
+ H+ + +HR+ K NIL+ + L D G A + T V Y APE
Sbjct: 115 FCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY-TDYVATRWYRAPE 170
Query: 587 FALSG--IYTVKSDVYSFGVVMLELLTGRKPL 616
L G Y DV++ G V ELLTG +PL
Sbjct: 171 L-LVGDTQYGPPVDVWAIGCVFAELLTG-QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 418 IGEGSLGRVYRA-EFANG-KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR------HPN 469
IGEG+ G+V++A + NG + +A+K++ + EE L + ++ LR HPN
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 470 IVTLAGYCA-----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTAR 523
+V L C + LV+E+V D+ + D + ++ + R
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
L++LH VVHR+ K NIL+ L+D GLA + + + T +V Y
Sbjct: 122 GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYR 176
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
APE L Y D++S G + E+ RKPL
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 66/272 (24%), Positives = 122/272 (44%), Gaps = 35/272 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G VY+A +I+AVK I + + LQ++ + + + + P I+ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQ--IMSELEILYKCDSPYIIGFYG 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ + E++ G+L D + + + R+A+ + L YL +
Sbjct: 67 AFFVENRISICTEFMDGGSL--------DVYRKIPEHVLGRIAVAVVKGLTYLWSL---K 115
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
++HR+ K +N+L++ L D G++ N+ ++ VG Y APE Y +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGI 172
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD---PALNGM 652
SDV+S G+ +EL GR P + +++ SL+ + L +VD P L
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQ-KNQGSLM--------PLQLLQCIVDEDPPVL--- 220
Query: 653 YPAKSLS-RFADIIALCVQPEPEFRPPMSEVV 683
P S +F I C++ +P+ RP ++
Sbjct: 221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G G+ G V+ A+ K++ +K+I ++ E + L HPNI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY-------L 528
E ++V EY G L + + R L L + L
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYI------------QKRCNSLLDEDTILHFFVQILLAL 114
Query: 529 HEVCLPSVVHRNFKSANILLDDELNP-HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
H V ++HR+ K+ NILLD + D G++ + +++ + T +VG Y +PE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT-VVGTPCYISPEL 172
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLDSS 619
Y KSD+++ G V+ EL + ++ +++
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 417 LIGEGSLGRVYRAEFANGK----IMAVKK----IDNAALSLQEEDNFLEAVSNMSRLRHP 468
++G+GS G+V AE I A+KK D+ E L HP
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-----EHP 56
Query: 469 NIVTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARAL 525
+ L +C + L V EY+ G+L M H + AR R A L
Sbjct: 57 FLTHL--FCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDE---ARARFYAAEIICGL 109
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
++LH+ +++R+ K N+LLD + + ++D G+ N E + ST G Y AP
Sbjct: 110 QFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAP 165
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E Y D +SFGV++ E+L G+ P
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 67/244 (27%), Positives = 100/244 (40%), Gaps = 43/244 (17%)
Query: 455 FLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR 514
F E S MS+L H ++V L G C ++V EYV G L LH ++ +L W +
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHRE-KNNVSLHW--K 103
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNP---HLSDCGLA-ALTP 566
+ VA A AL YL + L VH N NIL+ +E LSD G+ +
Sbjct: 104 LDVAKQLASALHYLEDKKL---VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160
Query: 567 NTERQVSTQMVGAFGYSAPEF--ALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRS 623
ER + APE T+ +D +SFG +LE+ + G +PL S+ S
Sbjct: 161 REERVERIPWI------APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL-STLSSS 213
Query: 624 EQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVV 683
E+ +L P + A++I C +P RP ++
Sbjct: 214 EKERFYQDQHRL------------------PMPDCAELANLINQCWTYDPTKRPSFRAIL 255
Query: 684 QALV 687
+ L
Sbjct: 256 RDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 72/286 (25%), Positives = 125/286 (43%), Gaps = 41/286 (14%)
Query: 418 IGEGSLGRVYRA---EFANGKI---MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G+GS G VY + G+ +AVK ++ +A SL+E FL S M ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 72
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTARAL 525
L G ++ L+V E + +G+L L ++N T +++A A +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQVSTQMVGAFGYS 583
YL+ VHR+ + N ++ + + D G+ T+ R+ ++ +
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWM 188
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643
APE G++T SD++SFGVV+ E+ + +EQ + Q + K
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQPYQGLSNEQ------VLK 232
Query: 644 MVDPALNGMY---PAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
V ++G Y P R D++ +C Q P+ RP E+V L
Sbjct: 233 FV---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 77/292 (26%), Positives = 116/292 (39%), Gaps = 46/292 (15%)
Query: 417 LIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
++G G+ G VY+ + N KI K+ S + L+ M+ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLH 529
L G C +L V + + G L D + D S L W ++ A+ + YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL--TPNTERQVSTQMVGAFGYSAPEF 587
EV L VHR+ + N+L+ + ++D GLA L TE V + A E
Sbjct: 127 EVRL---VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PIKWMALES 182
Query: 588 ALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLV----RWATPQLHDIDALA 642
L +T +SDV+S+GV + EL+T G KP D R L+ R P + ID
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYM 242
Query: 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694
MV C + E RP E+V R+ + S
Sbjct: 243 IMVK---------------------CWMIDSECRPRFRELVDEFSRMARDPS 273
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKI--DNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G G+ G VY A+ G+ +AVK++ D + +E N LE + + LRH IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 473 LAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G + ++ L EY+ G++ D L + LT N R + + YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG---YSAPEF 587
+VHR+ K ANIL D N L D G A+ T T + G + +PE
Sbjct: 125 ---NMIVHRDIKGANILRDSAGNVKLGDFG-ASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y K+DV+S ++E+LT + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-11
Identities = 55/179 (30%), Positives = 81/179 (45%), Gaps = 27/179 (15%)
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNNFSGNLPYSIASM 152
+G + L+ L L+ L N IP L NLT L+L++NN +G +P + S
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+L L + NSL I G L + L N+FSG+LP+ F L + L + NN
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439
Query: 213 VTGSLN------------------VFSGLP-------LTTLNVANNHFSGWIPRELISI 246
+ G +N F GLP L L+++ N FSG +PR+L S+
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSL 498
|
Length = 968 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V A + +A+KKI NA + + L + + L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 477 CAEHGQR-----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHE 530
+ +VYE + + +LH ++ SS+ L+ + + L R L+Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELM-DTDLHQIIR----SSQTLS-DDHCQYFLYQLLRGLKYIHS 126
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+V+HR+ K +N+LL+ + + D GLA T + + T+ V Y APE L+
Sbjct: 127 A---NVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 591 -GIYTVKSDVYSFGVVMLELLTGRKPL 616
YT DV+S G + ELL GRKPL
Sbjct: 183 CSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 418 IGEGSLGRVYRAEFANG------KIMAVKKIDN-----AALSLQEEDN------FLEAVS 460
+GEG G V+ E A G K ++ N A L+E+ N FL+ +
Sbjct: 13 LGEGQFGEVHLCE-AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-------HFADDSSKNLTWNA 513
MSRL+ PNI+ L C ++ EY+ NG+L+ L ++++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQV 572
+ +A A ++YL + + VHR+ + N L+ ++D G++ L ++
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ V + + E L G +T SDV++FGV + E+LT
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 42/235 (17%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEE---DNFLEAVSNMSRLR 466
+F Q +GEG+ VY+ G+I+A+K+I A EE + +S M L+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA----EEGTPSTAIREISLMKELK 56
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFAD----------DSSKNLTWNARVR 516
H NIV L + +LV+EY+ D+ + D ++ K+ T+
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMDK----DLKKYMDTHGVRGALDPNTVKSFTYQ---- 108
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA---ALTPNTERQVS 573
+ + + HE V+HR+ K N+L++ L+D GLA + NT S
Sbjct: 109 ----LLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT---FS 158
Query: 574 TQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL 627
++V + Y AP+ L S Y+ D++S G +M E++TGR PL +Q L
Sbjct: 159 NEVVTLW-YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLL 211
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 69/282 (24%), Positives = 115/282 (40%), Gaps = 29/282 (10%)
Query: 418 IGEGSLGRVYRAEFANGKIMA---VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG G G+V +E +A VK++ A S +E++ FL+ L+HPNI+
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKEL-KANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G C E LLV+EY G+L L +N R+A A + ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH--- 118
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ--MVGAFGYSAPEFA---- 588
+ +H + N L +L + D G+ + E + T+ + APE
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGI-GPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 589 ---LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
++ T S+V++ GV + EL ++++P S S + D K+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFE-----NAAQPYSHLSDREVLNHVIKDQQ--VKLF 230
Query: 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687
P L Y R+ +++ C PE R EV + L
Sbjct: 231 KPQLELPYS----ERWYEVLQFCWLS-PEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEED-----NFLEAVSNMSRLRHPNIV 471
IGEG+ G VY+A + + +A+KKI L++ED + +S + ++H NIV
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-----RLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR-VRVAL-GTARALEYLH 529
L + LV+EY+ +L H DSS + N R ++ L R + Y H
Sbjct: 65 RLQDVVHSEKRLYLVFEYL---DLDLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 530 EVCLPSVVHRNFKSANILLDDELNP-HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
V+HR+ K N+L+D N L+D GLA R + ++V Y APE
Sbjct: 120 S---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEIL 175
Query: 589 L-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
L S Y+ D++S G + E++ +KPL
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNA--ALSLQEE----DNFLEAVSNMSRLRHPNIV 471
+G G+ G V + + M K+ID A L + E D + M +L +P IV
Sbjct: 3 LGSGNFGCVKKGVYK----MRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ G C E +LV E G L+ L D +T + V + + ++YL
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDE---ITVSNVVELMHQVSMGMKYLEG- 113
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFAL 589
+ VHR+ + N+LL ++ +SD GL+ + + G + + APE
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 590 SGIYTVKSDVYSFGVVMLELLT-GRKP 615
++ +SDV+S+G+ M E + G+KP
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 66/246 (26%), Positives = 111/246 (45%), Gaps = 31/246 (12%)
Query: 417 LIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH----P 468
++G G+ G+V+ +G K+ A+K + A + +Q+ + L H P
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSP 65
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALE 526
+VTL Y + +L L+ +Y+ G L L + + V++ G ALE
Sbjct: 66 FLVTLH-YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-----EVQIYSGEIVLALE 119
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTERQVSTQMVGAFGYSA 584
+LH++ +++R+ K NILLD + L+D GL+ ER S G Y A
Sbjct: 120 HLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGTIEYMA 174
Query: 585 PEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-----LVRWATPQLHD 637
P+ G + D +S GV+M ELLTG P ++ Q+ +++ P +
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 234
Query: 638 IDALAK 643
+ ALAK
Sbjct: 235 MSALAK 240
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 69/308 (22%), Positives = 121/308 (39%), Gaps = 58/308 (18%)
Query: 417 LIGEGSLGR----VYRAEFANGKIMAVKKIDNAALSLQEEDNFLE---AVSNMSRLRHPN 469
LIG+ + + + ++AVKKI+ L +++ + +L+HPN
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKIN---LDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDML--HFADDSSKNLTWNARVRVAL---GTARA 524
I+ + +V + G+ D+L HF + + +A A
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA-------IAFILKDVLNA 113
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG--- 581
L+Y+H +HR+ K+++ILL + LS GL + ++V F
Sbjct: 114 LDYIHSK---GFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 582 -----YSAPEF---ALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL--VRWA 631
+ +PE L G Y KSD+YS G+ EL G P P ++ L VR
Sbjct: 169 VKNLPWLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVPF-KDMPATQMLLEKVRGT 226
Query: 632 TPQLHDI-------DALAKMVDPALNGM----YPAKSLSRFAD----IIALCVQPEPEFR 676
P L D D++++ + F++ + LC+Q +PE R
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 677 PPMSEVVQ 684
P S+++
Sbjct: 287 PSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN---MSRLRHPNIVTL 473
+G+G G V + A GK+ A KK++ L++ + A+ ++++ IV+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKK--RLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
A Y + L LV + G+L ++ D+ + LE+LH+
Sbjct: 59 A-YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-- 115
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ-MVGAFGYSAPEFALSG 591
+++R+ K N+LLD++ N +SD GLA + Q T+ G G+ APE
Sbjct: 116 -RRIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ 625
Y D ++ GV + E++ R P R R E+
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPF---RARGEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 8e-11
Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL-- 473
IG G+ G V A G+ +A+KKI N L + L + + LRH NI+ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLD 66
Query: 474 ---AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV----ALGTARALE 526
+ +V E + +LH ++ S + LT + ++ L R L+
Sbjct: 67 ILRPPSPEDFNDVYIVTELMET-DLHKVIK----SPQPLT-DDHIQYFLYQIL---RGLK 117
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGAFGYSA 584
YLH +V+HR+ K +NIL++ + + D GLA E+ T+ V Y A
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174
Query: 585 PEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
PE LS YT D++S G + ELLT RKPL
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLT-RKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTL 473
+IG+GS G+V A+ ++G AVK + + ++E N + A N + L+HP +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYLHEV 531
Y + ++L V +YV G L H + R R A A A+ YLH +
Sbjct: 62 H-YSFQTAEKLYFVLDYVNGGEL--FFHL---QRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
++++R+ K NILLD + + L+D GL E ST G Y APE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKE 171
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDS 618
Y D + G V+ E+L G P S
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 70/233 (30%), Positives = 101/233 (43%), Gaps = 50/233 (21%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI------DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
IG G+ G VY+A + +G +A+K + D LS E L+ + HPNI
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLK---RLEAFDHPNI 64
Query: 471 VTLAGYCA-----EHGQRLLVYEYVGNGNLHDMLHFAD------DSSKNLTWNARVRVAL 519
V L CA + LV+E+V + +L L ++ K+L +R L
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDL-----MRQFL 118
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-------ALTPNTERQV 572
R L++LH C +VHR+ K NIL+ L+D GLA ALTP
Sbjct: 119 ---RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP------ 166
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ 625
+V Y APE L Y D++S G + E+ RKPL ++Q
Sbjct: 167 ---VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIVT 472
+GEG+ V++ ++A+K+I L+ E+ + VS + L+H NIVT
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI-----RLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEV 531
L LV+EY+ + D+ + D+ NL V++ + R L Y H+
Sbjct: 68 LHDIIHTERCLTLVFEYLDS----DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK- 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-S 590
++HR+ K N+L++++ L+D GLA + S ++V Y P+ L S
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 178
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV 628
Y+ D++ G ++ E+ TGR S + E L+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
L+G+G+ G+V E A+GK A+K + + ++E + L + RHP + +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLH 529
Y + RL V EYV G L L F++D ++ + A + AL+YLH
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR--FYGAEI------VSALDYLH 112
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+V+R+ K N++LD + + ++D GL T+ G Y APE
Sbjct: 113 S---GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLE 168
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y D + GVVM E++ GR P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIVT 472
+GEG+ VY+ ++A+K+I L+ E+ + VS + L+H NIVT
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEI-----RLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L LV+EY+ D+ + DD ++ + R L Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR-- 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-SG 591
V+HR+ K N+L+++ L+D GLA + S ++V Y P+ L S
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGST 180
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPL 616
Y+ + D++ G + E+ TGR PL
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR-PL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 418 IGEGSLGRVYRAEFANGKI--MAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
+G GS GRV A + N +A+K+ + + + Q++ D+ ++ + HP V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G + LV E+V G L +K + A EYL +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL--- 150
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
++V+R+ K N+LLD + ++D G A + + + T + G Y APE L+ +
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEILLNVGHG 206
Query: 595 VKSDVYSFGVVMLELLTGRKPLDSSRP 621
+D ++ G+ + E+L G P ++ P
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 66/286 (23%), Positives = 113/286 (39%), Gaps = 31/286 (10%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF---ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH 467
S E ++G G G + R + ++ A S ++ FL + + H
Sbjct: 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH 65
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
NIV L G ++V EY+ NG L L L + + G A ++Y
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKY 122
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVG--AFGYSAP 585
L E+ VH+ + +L++ +L +S G L + + T M G ++AP
Sbjct: 123 LSEM---GYVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644
E ++ SDV+SFG+VM E+++ G +P S Q ++ K
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERPY---WDMSGQDVI--------------KA 220
Query: 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690
V+ P + ++ C Q E RP S++ L ++V
Sbjct: 221 VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEED----NFLEAVSNMSR 464
+S+ + +GEGS VY+ + NGK++A+K I LQEE+ + S +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-----RLQEEEGTPFTAIREASLLKG 59
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
L+H NIV L LV+EYV D+ + D L R
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRG 115
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
L Y+H+ ++HR+ K N+L+ D L+D GLA S ++V Y
Sbjct: 116 LSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRP 171
Query: 585 PEFAL-SGIYTVKSDVYSFGVVMLELLTG 612
P+ L S Y+ D++ G + +E++ G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
L+G+G+ G+V E A G+ A+K + + ++E + + + RHP + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLHE 530
H + V EY G L L F ++ ++ + A + ALEYLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR--FYGAEI------VSALEYLHS 113
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
VV+R+ K N++LD + + ++D GL + + T G Y APE
Sbjct: 114 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLED 169
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPL 616
Y D + GVVM E++ GR P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLRHP 468
+IG GS +V N +I A+K + + +Q E + E S+ +P
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-----NP 56
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+V L C + RL LV EYV G+L M H + L A AL +
Sbjct: 57 FLVGLHS-CFQTTSRLFLVIEYVNGGDL--MFHM--QRQRKLPEEHARFYAAEICIALNF 111
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGAFGYSAP 585
LHE +++R+ K N+LLD + + L+D G+ L P ++ G Y AP
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DTTSTFCGTPNYIAP 165
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
E Y D ++ GV+M E++ GR P D
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED-----NFLEAVSNMSRLRHPNIV 471
IGEG+ G V++A+ +I+A+K++ L ++D + L + + L+H NIV
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 472 TLAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
L Y H + LV+EY D+ + D + ++ + L + H
Sbjct: 63 RL--YDVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+V+HR+ K N+L++ L+D GLA R S ++V Y P+
Sbjct: 117 S---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 172
Query: 590 SG-IYTVKSDVYSFGVVMLELLTGRKPL 616
+Y+ D++S G + EL +PL
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 46/199 (23%), Positives = 92/199 (46%), Gaps = 9/199 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G+ G V + + ++ +K+ + + + + + + P IV G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
G+ + E++ G+L +L +K + +V++ R L YL E ++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIM 126
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ K +NIL++ L D G++ ++ ++ VG Y +PE Y+V+S
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 598 DVYSFGVVMLELLTGRKPL 616
D++S G+ ++EL GR P+
Sbjct: 184 DIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNI 470
++G+GS G+V AE ++ A+K + + LQ++D ++ R+ +HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDD--VDCTMTEKRILALAAKHPFL 58
Query: 471 VTLAGYCAEHGQRLL-VYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEY 527
L C + RL V EYV G+L + + D ++ + A V +AL +
Sbjct: 59 TALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL------MF 111
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGAFGYSAP 585
LH V++R+ K NILLD E + L+D G+ + +T G Y AP
Sbjct: 112 LHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTTFCGTPDYIAP 165
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLDS 618
E Y D ++ GV+M E++ G+ P ++
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 87/368 (23%), Positives = 143/368 (38%), Gaps = 70/368 (19%)
Query: 358 QRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQ-EF 416
QR S+A L PP + S +++S S +A S S+ E
Sbjct: 36 QRDPSLAVPLPLPPPSSS-----------------SSSSSSSSASGSAPSAAKSLSELER 78
Query: 417 L--IGEGSLGRVYRA-EFANGKIMAVKKI-----DNAALSLQEEDNFLEAVSNMSRLRHP 468
+ IG G+ G VY+ G++ A+K I D + E L V+ HP
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN------HP 132
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
N+V +G+ ++ E++ G+L + H AD+ VA + YL
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSL-EGTHIADEQ-------FLADVARQILSGIAYL 184
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H +VHR+ K +N+L++ N ++D G++ + T ++ VG Y +PE
Sbjct: 185 HR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-VGTIAYMSPERI 240
Query: 589 LS----GIYT-VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643
+ G Y D++S GV +LE GR P R SL+
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM-----------CAIC 289
Query: 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDE 703
M P PA + F I+ C+Q EP R + ++L+Q +++ +
Sbjct: 290 MSQPP---EAPATASREFRHFISCCLQREPAKRW-------SAMQLLQHPFILRAQPGQG 339
Query: 704 SGFSYRTP 711
G
Sbjct: 340 QGGPNLHQ 347
|
Length = 353 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 61/246 (24%), Positives = 96/246 (39%), Gaps = 57/246 (23%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRL 465
F + L+G+G +GRV+ GK+ A+K +D + + N ++ V ++ L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM---IKRNKVKRVLTEQEILATL 58
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH------FADDSSKNLTWNARVRVAL 519
HP + TL LV +Y G L +L +++ AR A
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEV-------ARFYAAE 111
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH--LSDCGLAALTPNTERQVSTQM- 576
ALEYLH L +V+R+ K NILL + + H LSD L+ + VS +
Sbjct: 112 VLL-ALEYLH---LLGIVYRDLKPENILLHE--SGHIMLSDFDLSKQSDVEPPPVSKALR 165
Query: 577 ---------------------------VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLEL 609
VG Y APE + D ++ G+++ E+
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
Query: 610 LTGRKP 615
L G P
Sbjct: 226 LYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 17/208 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTL 473
+IG+GS G+V A A K AVK + A+ ++E+ + + N + ++HP +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYLHEVC 532
+ V +Y+ G L F + R R A A AL YLH +
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL-----FYHLQRERCFLEPRARFYAAEIASALGYLHSL- 115
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTERQVSTQMVGAFGYSAPEFALS 590
++V+R+ K NILLD + + L+D GL + N ++ G Y APE
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---TTSTFCGTPEYLAPEVLHK 170
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDS 618
Y D + G V+ E+L G P S
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 64/284 (22%), Positives = 121/284 (42%), Gaps = 37/284 (13%)
Query: 418 IGEGSLGRVYRAEFANGKI-------MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G+GS G VY A G + +A+K ++ AA S++E FL S M ++
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHV 71
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTARA 524
V L G ++ L++ E + G+L L +N + +++A A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQVSTQMVGAFGY 582
+ YL+ VHR+ + N ++ ++ + D G+ T+ R+ ++ +
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRW 187
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642
+PE G++T SDV+SFGVV+ E+ T +EQ + Q+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQPYQGMSNEQVLRFVMEG 237
Query: 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
++D P +++ +C Q P+ RP E++ ++
Sbjct: 238 GLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
L+G+G+ G+V E A GK A+K + + ++E + L + RHP + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLHE 530
H + V EY G L L F++D ++ + A + AL YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--FYGAEI------VSALGYLHS 113
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
VV+R+ K N++LD + + ++D GL + + T G Y APE
Sbjct: 114 C---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLED 169
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKP 615
Y D + GVVM E++ GR P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 42/153 (27%), Positives = 64/153 (41%), Gaps = 22/153 (14%)
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT-ERQVSTQMVGAFGYSAPE 586
+H V ++HR+ KSANILL L D G + + T V G Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI--DALAKM 644
Y+ K+D++S GV++ ELLT ++P D + ++ LA
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------------NMEEVMHKTLAGR 261
Query: 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRP 677
DP P +I+ + +P+ RP
Sbjct: 262 YDP-----LPPSISPEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+GEGS VY+ G+++A+K+I L+ E+ + S + L+H NIVT
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-----RLEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 473 LAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
L H ++ L V+EY+ D+ + DD L+ + VR+ L R L Y H
Sbjct: 68 LHDII--HTKKTLTLVFEYLDT----DLKQYMDDCGGGLSMH-NVRLFLFQLLRGLAYCH 120
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+ V+HR+ K N+L+ + L+D GLA + S ++V + Y P+ L
Sbjct: 121 Q---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW-YRPPDVLL 176
Query: 590 -SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ 625
S Y+ D++ G + E+ TGR S +Q
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 39/193 (20%), Positives = 80/193 (41%), Gaps = 31/193 (16%)
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575
++++ R L YL E ++HR+ K +NIL++ L D G++ ++ ++
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 157
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL 635
VG Y +PE YTV+SD++S G+ ++E+ GR P+ P + L +
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP---PPDAKELEAMFGRPV 214
Query: 636 HDIDALAKMVDPALNGMYPAKSLS-----------------------RFADIIALCVQPE 672
+ +A + + + ++ F D + C++
Sbjct: 215 SEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKN 274
Query: 673 PEFRPPMSEVVQA 685
P+ R + E+ +
Sbjct: 275 PKERADLKELTKH 287
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 19/217 (8%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIVT 472
+GEG+ V++ ++A+K+I L+ E+ + VS + L+H NIVT
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI-----RLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L LV+EY+ D+ + DD ++ + R L Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK----DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR-- 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-SG 591
V+HR+ K N+L+++ L+D GLA + S ++V Y P+ L S
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV 628
Y+ + D++ G + E+ +GR S E L+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVK-----KIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
LI E +Y+ F N K + ++ + L D + N+ R+ NI+
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLI----DITENEIKNLRRIDSNNIL 81
Query: 472 TLAGYCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+ G+ + L L+ EY G L ++L D K+L++ ++ +A+ + L
Sbjct: 82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYN 137
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
L++ + ++N S + L+ + + GL + V Y + +
Sbjct: 138 LYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLE----KILSSPPFKNVNFMVYFSYKM 191
Query: 588 ALSGI---YTVKSDVYSFGVVMLELLTGRKPLD 617
L+ I YT+K D+YS GVV+ E+ TG+ P +
Sbjct: 192 -LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 418 IGEGSLGRVYRAEFANGKIMA---VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG G G+V E +G A VK++ +A S+QE+ FLE L+H N++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV--RVALGTARALEYLHEVC 532
G C E LLV E+ G+L L + ++ +T + R+A A L +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLR-SCRKAELMTPDPTTLQRMACEIALGLLHLHK-- 118
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFA--- 588
+ +H + N LL +L + D GL+ + V Q+ + APE
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 589 ----LSGIYTVKSDVYSFGVVMLELLT-GRKP 615
L T +S+V+S GV + EL G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTL 473
+IG+GS G+V A+ +GK AVK + + ++E + A N + ++HP +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
Y + ++L V ++V G L H + S AR A A AL YLH +
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEP-RARFYAA-EIASALGYLHSI- 115
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
++V+R+ K NILLD + + L+D GL + +T G Y APE
Sbjct: 116 --NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 593 YTVKSDVYSFGVVMLELLTGRKPL 616
Y D + G V+ E+L G P
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
L+G+G+ G+V E A G+ A+K + + ++E + L + RHP + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLHE 530
H + V EY G L L F++D ++ + A + AL+YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--FYGAEI------VSALDYLHS 113
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+VV+R+ K N++LD + + ++D GL + T G Y APE
Sbjct: 114 E--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLED 170
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPL 616
Y D + GVVM E++ GR P
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 409 TNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH 467
TN + +G G+ G V A + G+ +A+KKI + + + LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 468 PNIVTLAG-YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
NI++L+ + + V E +G +LH +L +S+ L R L+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGT-DLHRLL-----TSRPLEKQFIQYFLYQILRGLK 122
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT-PNTERQVSTQMVGAFGYSAP 585
Y+H VVHR+ K +NIL+++ + + D GLA + P VST+ Y AP
Sbjct: 123 YVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAP 174
Query: 586 EFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
E L+ Y V+ D++S G + E+L G KPL
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G+GS G+V AE G+ AVK + + + ++ + L N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 476 YCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR---ALEYLHE 530
YC + L V E++ G+L M H D +L R A L++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDL-----YRATFYAAEIVCGLQFLHS 114
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+++R+ K N++LD + + ++D G+ + + ST G Y APE
Sbjct: 115 ---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQG 170
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPL 616
YT D +SFGV++ E+L G+ P
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 9/208 (4%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANGK-IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP 468
N F ++GEG+ G V + K I+A+KK ++ + + ++ L + + L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
NIV L G+ LV+EYV +ML ++ + +A+ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEK----NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H+ +VHR+ K N+L+ L D G A T+ V Y +PE
Sbjct: 117 HK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPL 616
L Y D++S G ++ EL G +PL
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDG-QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTL 473
++G+GS G+V AE ++ A+K I + +Q++D V ++ P +T
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIK-ILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQ 65
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
C + RL V EYV G+L M H V A + L +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDL--MYHI--QQVGKFKEPQAVFYAAEISVGLFFLHR-- 119
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ-MVGAFGYSAPEFALSG 591
+++R+ K N++LD E + ++D G+ + V+T+ G Y APE
Sbjct: 120 -RGIIYRDLKLDNVMLDSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLD 617
Y D +++GV++ E+L G+ P D
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 31/216 (14%)
Query: 418 IGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR----HPNI 470
+G+G+ G V A A + +A+KKI N ++ A+ + LR H NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNV---FSKKILAKRALRELKLLRHFRGHKNI 64
Query: 471 VTL-----AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARA 524
L + L +YE + +LH ++ S + LT +A + +
Sbjct: 65 TCLYDMDIVFPGNFNE--LYLYEELMEADLHQIIR----SGQPLT-DAHFQSFIYQILCG 117
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVS--TQMVGAFG 581
L+Y+H +V+HR+ K N+L++ + + D GLA + N T+ V
Sbjct: 118 LKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 582 YSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE LS YT DV+S G ++ ELL GRKP+
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 31/209 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + G +AVKK+ S+ + + ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 474 ---AGYCAEHGQRLLVYEYVGN--GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
A E LV +G N+ DD + L + R L+Y+
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 136
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG---YSAP 585
H ++HR+ K +N+ ++++ + D GLA R +M G Y AP
Sbjct: 137 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMTGYVATRWYRAP 186
Query: 586 EFALSGI-YTVKSDVYSFGVVMLELLTGR 613
E L+ + Y D++S G +M ELLTGR
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 32/220 (14%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKI---DNAALSLQEEDNFLEAVSNMSRLRH 467
+ IGEG+ G V A G +A+KKI ++ + L + + R +H
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT----LREIKILRRFKH 62
Query: 468 PNIVTL-----AGYCAEHGQRLLVYEYVGNGNLHDML---HFADDSSKNLTWNARVRVAL 519
NI+ + +V E + +L+ ++ H ++D + +
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQ------- 114
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS--TQMV 577
R L+Y+H +V+HR+ K +N+LL+ + + D GLA + T+ V
Sbjct: 115 -ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 578 GAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L S YT D++S G ++ E+L+ R PL
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 47/137 (34%), Positives = 69/137 (50%), Gaps = 6/137 (4%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L +LL L DL+ N + I L NLTSL+L +NN + P +L L+
Sbjct: 87 ENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELD 146
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
+S N + + NL L LDLSFN+ S DLP +LSN+++L L N+++ L
Sbjct: 147 LSDNKIESLPSPL-RNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP 203
Query: 220 FSGLP--LTTLNVANNH 234
L L L+++NN
Sbjct: 204 EIELLSALEELDLSNNS 220
|
Length = 394 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 39/241 (16%)
Query: 455 FLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR 514
F E S MS++ H ++ + G C + ++V E+V +G L D+ + + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--K 119
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANIL-----LDDELNP--HLSDCGLAALTPN 567
+ VA A AL YL + ++VH N + NIL L + +P LSD G++ +
Sbjct: 120 ITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 568 TERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLEL-LTGRKPLDSSRPRSEQ 625
E +V + APE G + +D +SFG +LE+ G PL P ++
Sbjct: 177 REERVER-----IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231
Query: 626 SLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685
R+ + P S A +I+ C+ EP RP +++
Sbjct: 232 ---RFYEKKHR----------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272
Query: 686 L 686
L
Sbjct: 273 L 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 15/98 (15%)
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG- 581
R L+Y+H ++HR+ K +NI ++++ + D GLA R +M G
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA-------RHTDDEMTGYVAT 178
Query: 582 --YSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L+ + Y D++S G +M ELLTG K L
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-KTL 215
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 418 IGEGSLGRVYR-AEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V+ + +GK +A+KK+ N +L + + +H N+ L+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV--LSAL 65
Query: 477 CAEHGQRLLVYE--YVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEVCL 533
+ +E YV + LH S + L+ + V+V L R L+YLH
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLS-SDHVKVFLYQILRGLKYLHSA-- 122
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-SGI 592
++HR+ K N+L++ + D GLA + E + TQ V Y APE + S
Sbjct: 123 -GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH 181
Query: 593 YTVKSDVYSFGVVMLELLTGR 613
YT D++S G + ELL R
Sbjct: 182 YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 417 LIGEGSLGRVY-------RAEFANGKIMAVKKIDNAALSL--QEEDNFLEAVSNMSRLRH 467
LI G+ G VY R FA +KKI+ L L Q + F+E ++ +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFA------MKKINKQNLILRNQIQQVFVER-DILTFAEN 60
Query: 468 PNIVTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525
P +V++ +C+ +R L V EYV G+ +L ++ AR+ A T AL
Sbjct: 61 PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM---ARMYFA-ETVLAL 114
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-----ALTPN---------TERQ 571
EYLH +VHR+ K N+L+ + L+D GL+ +LT N T
Sbjct: 115 EYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ Q+ G Y APE L Y D ++ G+++ E L G P
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 76/313 (24%), Positives = 121/313 (38%), Gaps = 59/313 (18%)
Query: 418 IGEG--SLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLA 474
IG G +L VY A + +I + +E L+ +S RHPNI+T
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDML--HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
++ ++ G+ + +L +F + S+ L N + G R L YLH+
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLHQ-- 119
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCG-LAALTPNTER--------QVSTQMVGAFGYS 583
+HRN K+++IL+ + LS L +L N ++ Q ST ++
Sbjct: 120 -NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL--- 175
Query: 584 APEFA---LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640
+PE L G Y VKSD+YS G+ EL TGR P R++ L + P +D
Sbjct: 176 SPELLRQDLYG-YNVKSDIYSVGITACELATGRVPF-QDMLRTQMLLQKLKGPPYSPLDI 233
Query: 641 LA------------------------------KMVDPALNGMYPAKSLSRFADIIALCVQ 670
M L F +++ LC+Q
Sbjct: 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQ 293
Query: 671 PEPEFRPPMSEVV 683
+PE RP S ++
Sbjct: 294 QDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 44/199 (22%), Positives = 92/199 (46%), Gaps = 9/199 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G+ G V++ ++ +K+ + + + + + + P IV G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
G+ + E++ G+L +L A + + +V++ + L YL E ++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG----KVSIAVIKGLTYLREK--HKIM 126
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ K +NIL++ L D G++ ++ ++ VG Y +PE Y+V+S
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 598 DVYSFGVVMLELLTGRKPL 616
D++S G+ ++E+ GR P+
Sbjct: 184 DIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-08
Identities = 16/43 (37%), Positives = 21/43 (48%), Gaps = 4/43 (9%)
Query: 40 DSSDVQALQVLYTSLNSPS--VLTNWKGNEGDPCGESWKGVAC 80
+ D AL +SLN L++W + DPC SW GV C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPC--SWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 34/218 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE---DNFLEAVSNMSRLRH-PNIVT 472
IGEG+ G+VY+A + GK++A+KK L + EE L +S + L IV
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK---TRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 473 LAGYCAEH-------GQRLLVYEYVGNGNLHDMLHFADD----SSKNLTWNARVRVALGT 521
L EH LV+EY+ + D+ F D + L
Sbjct: 66 L--LDVEHVEEKNGKPSLYLVFEYLDS----DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNP-HLSDCGLA-ALTPNTERQVSTQMVGA 579
+ + + H+ V+HR+ K N+L+D + ++D GL A + + T +
Sbjct: 120 LKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVT 174
Query: 580 FGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L Y+ D++S G + E+ ++PL
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 43/174 (24%), Positives = 73/174 (41%), Gaps = 25/174 (14%)
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA---LTPNTERQVSTQMVG 578
A+ +E+L +HR+ + NILL + + D GLA P+ R+ ++
Sbjct: 189 AKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHD 637
+ APE +YT++SDV+SFGV++ E+ + G P P +
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----------------PGVKI 287
Query: 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
+ + + P + + C EP RP SE+V+ L L+Q
Sbjct: 288 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 6e-08
Identities = 22/59 (37%), Positives = 29/59 (49%)
Query: 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+L L++S N LT F L L LDLS NN + P +F L ++ SL L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
|
Length = 60 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G+G G+V+ A+ + G+I+A+K++ + L L E + L ++ + +V L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA-RALEYLHEVCL 533
Y + + L L EYV G+ +L ++ + R + A++ LHE+
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLL-----NNLGVLSEDHARFYMAEMFEAVDALHEL-- 120
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
+HR+ K N L+D + L+D GL+ + +VG+ Y APE Y
Sbjct: 121 -GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGY 175
Query: 594 TVKSDVYSFGVVMLELLTGRKPLDSSRP 621
D +S G ++ E L G P S P
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 18/223 (8%)
Query: 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFL-EAV 459
+ LQ + +IG G+ G V ++ K+ A+K + + + + F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 460 SNMSRLRHPNIVTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRV 517
M+ P +V L +CA + L V EY+ G+L +++ D K W A+
Sbjct: 95 DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK---W-AKFYT 148
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMV 577
A AL+ +H + L +HR+ K N+LLD + L+D G T V
Sbjct: 149 A-EVVLALDAIHSMGL---IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204
Query: 578 GAFGYSAPEFALS----GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y +PE S G Y + D +S GV + E+L G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 15/98 (15%)
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF-- 580
+ L+Y+H ++HR+ K N+ ++++ + D GLA RQ ++M G
Sbjct: 129 KGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA-------RQTDSEMTGYVVT 178
Query: 581 -GYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L+ + YT D++S G +M E+LTG KPL
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTLA 474
++G+GS G+V AE + KI + +Q++D V ++ P +T
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFAD----DSSKNLTWNARVRVALGTARALEYLH 529
C + RL V EYV G+L M + + A + + L +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGL------FFLH 118
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ-MVGAFGYSAPEFA 588
+++R+ K N++LD E + ++D G+ N V+T+ G Y APE
Sbjct: 119 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENMWDGVTTKTFCGTPDYIAPEII 173
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y D ++FGV++ E+L G+ P +
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 50/226 (22%), Positives = 87/226 (38%), Gaps = 32/226 (14%)
Query: 421 GSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480
GS GRV+ A V KI Q+ +EA+ + + HP+++ +
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIG------QKGTTLIEAML-LQNVNHPSVIRMKDTLVSG 129
Query: 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA--------RALEYLHEVC 532
+V + H++ D LT +R + + A L YLH
Sbjct: 130 AITCMV-----------LPHYSSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQ- 176
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
++HR+ K+ NI ++D + D G A + + G +APE
Sbjct: 177 --RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVETNAPEVLARDK 232
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638
Y K+D++S G+V+ E+L + P + + V+ L I
Sbjct: 233 YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278
|
Length = 357 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 51/289 (17%)
Query: 433 NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVG 491
G+ + V++I+ A + E FL+ ++S+L HPNIV + +V ++
Sbjct: 24 TGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 492 NGNLHDML--HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549
G+ D++ HF D S+ A + G +AL+Y+H + VHR+ K+++IL+
Sbjct: 83 YGSAKDLICTHFMDGMSEL----AIAYILQGVLKALDYIHHM---GYVHRSVKASHILIS 135
Query: 550 DELNPHLSDCGLAALTPNTERQVSTQMVGAF-GYSA-------PEFALSGI--YTVKSDV 599
+ +LS GL + ++V F YS PE + Y KSD+
Sbjct: 136 VDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 193
Query: 600 YSFGVVMLELLTGRKP---------------------LDSSR-PRSEQSLVRWATPQLHD 637
YS G+ EL G P LD++ P E ++ +
Sbjct: 194 YSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSG 253
Query: 638 I-DALAKMVDPALNGMYPAKSLSR-----FADIIALCVQPEPEFRPPMS 680
+ ++ NG + +R F + C+Q P+ RP S
Sbjct: 254 LGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAS 302
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 68/263 (25%), Positives = 107/263 (40%), Gaps = 48/263 (18%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL----RHPNIVT 472
++G+GS G+V AE + KI + +Q++D +E R+ P +T
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDD--VECTMVEKRVLALPGKPPFLT 64
Query: 473 LAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVRVALGTARAL 525
C + RL V EYV G+L M H F + + V A A L
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHA--------VFYAAEIAIGL 114
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+LH +++R+ K N++LD E + ++D G+ + T G Y AP
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAP 170
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
E Y D ++FGV++ E+L G+ P D E L +
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQSIMEH----------- 216
Query: 646 DPALNGMYPAKSLSRFADIIALC 668
N YP KSLS+ A +++C
Sbjct: 217 ----NVSYP-KSLSKEA--VSIC 232
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNM----SRLRHPNIVT 472
IG+G+ G+VY+ + +I A+K + + ++E N+ P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYL 528
L LV +Y+ G L L F++D A+ +A ALE+L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-------RAKFYIA-ELVLALEHL 112
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN-TERQVSTQMVGAFGYSAPEF 587
H+ +V+R+ K NILLD H++ C N T+ + + G Y APE
Sbjct: 113 HKY---DIVYRDLKPENILLD--ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167
Query: 588 ALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
L YT D +S GV++ E+ G P
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 36/135 (26%), Positives = 58/135 (42%), Gaps = 5/135 (3%)
Query: 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555
D+ + D S L + + AL YLH ++HR+ K+ NI LD+ N
Sbjct: 170 CDLFTYVDRSGP-LPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAV 225
Query: 556 LSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRK 614
L D G A L + + G ++PE Y K+D++S G+V+ E+
Sbjct: 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
Query: 615 PLDSSRPRSEQSLVR 629
L + +S S +R
Sbjct: 286 TLFGKQVKSSSSQLR 300
|
Length = 392 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 54/197 (27%), Positives = 85/197 (43%), Gaps = 34/197 (17%)
Query: 501 FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560
+DD S+ LT + AR +E+L + VHR+ + N+LL + D G
Sbjct: 226 LSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFG 282
Query: 561 LAALTPNTERQVST-QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP--- 615
LA + VS + APE +YT SDV+S+G+++ E+ + G P
Sbjct: 283 LARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
Query: 616 --LDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEP 673
+DS+ +S R A P D A +Y DI+ C EP
Sbjct: 343 MIVDSTFYNKIKSGYRMAKP------------DHATQEVY---------DIMVKCWNSEP 381
Query: 674 EFRPP---MSEVVQALV 687
E RP +S++V++L+
Sbjct: 382 EKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + + +AVKK+ SL + + ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 474 ---AGYCAEHGQRLLVYEYVGNGNLHDMLHF---ADDSSKNLTWNARVRVALGTARALEY 527
A + LV +G +L++++ +D+ + L + R L+Y
Sbjct: 83 FTPATSIENFNEVYLVTNLMG-ADLNNIVKCQKLSDEHVQFLIYQ--------LLRGLKY 133
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG---YSA 584
+H ++HR+ K +N+ ++++ + D GLA RQ +M G Y A
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA-------RQADDEMTGYVATRWYRA 183
Query: 585 PEFALSGI-YTVKSDVYSFGVVMLELLTGR 613
PE L+ + Y D++S G +M ELL G+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 59/264 (22%), Positives = 106/264 (40%), Gaps = 46/264 (17%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN-MSRLRHPNIVTLA 474
+IG G+ G V+ + G++ A+K + + + + + + A + ++ P IV L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 475 GYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
Y + + L V EY+ G+L ++L D + AR +A AL+ +H++
Sbjct: 67 -YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET---ARFYIAELVL-ALDSVHKL- 120
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAA------------------------LTPNT 568
+HR+ K NIL+D + + L+D GL L
Sbjct: 121 --GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 569 ERQVSTQM----VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSE 624
+ + VG Y APE Y ++ D +S GV++ E+L G P S +
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238
Query: 625 QS-LVRWAT----PQLHDIDALAK 643
+ ++ W P + A
Sbjct: 239 YNKIINWKESLRFPPDPPVSPEAI 262
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 63/258 (24%), Positives = 108/258 (41%), Gaps = 44/258 (17%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP 468
+ F +IG G+ G V + + G I A+K + A + +E+ + A ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
V Y + + L L+ E++ G++ +L D S+ T + +A T A++
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEAT---QFYIA-ETVLAIDA 116
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-------------LTPN------- 567
+H++ +HR+ K N+LLD + + LSD GL LT N
Sbjct: 117 IHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 568 --------------TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613
RQ++ VG Y APE + Y D +S GV+M E+L G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 614 KPLDSSRPR-SEQSLVRW 630
P S P+ + + ++ W
Sbjct: 234 PPFCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 71/272 (26%), Positives = 114/272 (41%), Gaps = 36/272 (13%)
Query: 406 QTATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
++ S+ +IG GS G VY A + +A+KK+ LQ+ + M
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKN 115
Query: 465 LRHPNIVTLAGY----CAEHGQRLL----VYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
L H NI+ L Y C + ++ + V E++ +H + ++ L
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKL 174
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH---LSDCGLAALTPNTERQVS 573
+ RAL Y+H + HR+ K N+L+D N H L D G A +R VS
Sbjct: 175 YSYQLCRALAYIHS---KFICHRDLKPQNLLIDP--NTHTLKLCDFGSAKNLLAGQRSVS 229
Query: 574 TQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWAT 632
+ + Y APE L YT D++S G ++ E++ G P+ S + +Q LVR
Sbjct: 230 --YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY-PIFSGQSSVDQ-LVRI-- 283
Query: 633 PQLHDIDALAKMVDPALNGMYPAKSLSRFADI 664
I L + L M P + +F D+
Sbjct: 284 -----IQVLGTPTEDQLKEMNPNYADIKFPDV 310
|
Length = 440 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 9/196 (4%)
Query: 418 IGEGSLGRVY----RAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+G+GS G VY + A ++ +K+I L+ E + +S+L HP IV
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
E ++ EY +L L + K L+ N + + Y+H+
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--- 124
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
++HR+ K+ NI L + L + D G++ L + ++T G Y +PE Y
Sbjct: 125 RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS-CDLATTFTGTPYYMSPEALKHQGY 182
Query: 594 TVKSDVYSFGVVMLEL 609
KSD++S G ++ E+
Sbjct: 183 DSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 25/174 (14%)
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA---LTPNTERQVSTQMVG 578
AR +E+L +HR+ + NILL + + D GLA P+ R+ S ++
Sbjct: 184 ARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-- 238
Query: 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHD 637
+ APE +YT +SDV+SFGV++ E+ + G P P +
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY----------------PGVQI 282
Query: 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
+ + + P + I+ C Q +P+ RP S +V+ L L+Q
Sbjct: 283 NEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 58/251 (23%), Positives = 99/251 (39%), Gaps = 44/251 (17%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+IG G+ G V + + G + A+K + A + +E+ + A ++ V
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y + L L+ E++ G++ +L D LT T A++ +H++
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL--- 120
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGL--------------------------------- 561
+HR+ K N+LLD + + LSD GL
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 562 -AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSR 620
A RQ++ VG Y APE + Y D +S GV+M E+L G P S
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 621 PR-SEQSLVRW 630
P+ + + ++ W
Sbjct: 241 PQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 46/135 (34%), Positives = 67/135 (49%), Gaps = 3/135 (2%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
LLS+L +L DLSGN I D P + SNN L S++++ +LS L +S
Sbjct: 181 LLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELS 240
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
N L + GNL+ L TLDLS NN + S SL+N+ L L N ++ +L + +
Sbjct: 241 NNKLEDLP-ESIGNLSNLETLDLS-NNQISSIS-SLGSLTNLRELDLSGNSLSNALPLIA 297
Query: 222 GLPLTTLNVANNHFS 236
L L + N +
Sbjct: 298 LLLLLLELLLNLLLT 312
|
Length = 394 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 69/262 (26%), Positives = 106/262 (40%), Gaps = 64/262 (24%)
Query: 410 NSFSQEFLIGEGSLGRVYR--AEFANGKIMAVKKIDNAALSLQE-------EDNFLEAVS 460
+ F +IG G+ G V R + G I A+KK+ + + +E E + L
Sbjct: 1 DDFESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD 59
Query: 461 NMSRLRHPNIVTLAGYCA-EHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA 518
N P +V L Y + + L L+ EY+ G++ +L D ++ T R +A
Sbjct: 60 N------PWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET---RFYIA 108
Query: 519 LGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA---------------- 562
T A++ +H++ +HR+ K N+LLD + + LSD GL
Sbjct: 109 -ETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 563 -ALTPNTERQVSTQM--------------------VGAFGYSAPEFALSGIYTVKSDVYS 601
AL N +S M VG Y APE L Y + D +S
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224
Query: 602 FGVVMLELLTGRKPLDSSRPRS 623
GV+M E+L G P S P+
Sbjct: 225 LGVIMYEMLVGYPPFCSDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 53/188 (28%)
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA---LTPNTERQVSTQMVG 578
AR +E+L +HR+ + NILL + + D GLA P+ R+ ++
Sbjct: 183 ARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237
Query: 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPL--------------DSSRPRS 623
+ APE +YT +SDV+SFGV++ E+ + G P + +R R+
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA 297
Query: 624 EQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVV 683
+ +ATP+++ I M+D C PE RP SE+V
Sbjct: 298 PE----YATPEIYSI-----MLD---------------------CWHNNPEDRPTFSELV 327
Query: 684 QALVRLVQ 691
+ L L+Q
Sbjct: 328 EILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-06
Identities = 70/273 (25%), Positives = 103/273 (37%), Gaps = 48/273 (17%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKI-----DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
LIG+G +G VY A + + +A+KKI +N L + FL + L HP I
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLL----KKRFLREAKIAADLIHPGI 64
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFA---DDSSKNLTWNARV----RVALGTAR 523
V + C++ Y+ L +L + SK L V +
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-----------ALTPNTERQV 572
+EY+H V+HR+ K NILL + D G A + +
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 573 STQM------VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT---------GRKPLD 617
+ M VG Y APE L + +D+Y+ GV++ ++LT GRK
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241
Query: 618 SSR--PRSEQSLVRWATPQLHDIDALAKMVDPA 648
E + R P L I A VDPA
Sbjct: 242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPA 274
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 4/100 (4%)
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGY 582
AL+ +H + +HR+ KSANI L L D G + + + V++ G Y
Sbjct: 181 ALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPR 622
APE Y+ K+D++S GV++ ELLT +P R
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277
|
Length = 478 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 30/119 (25%), Positives = 53/119 (44%), Gaps = 22/119 (18%)
Query: 499 LHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558
++D + L + L+Y+H ++HR+ K N+ ++++ + D
Sbjct: 112 HPLSEDKVQYLVYQ--------MLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD 160
Query: 559 CGLAALTPNTERQVSTQMVGAF---GYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGR 613
GLA R +M G Y APE L+ + Y D++S G +M E+LTG+
Sbjct: 161 FGLA-------RHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 44/159 (27%), Positives = 64/159 (40%), Gaps = 22/159 (13%)
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNL----HDMLHFADDSSKNLTWNARVRVALGTAR 523
PN+V L Y LV ++ G L L+ ++ K W A + VAL
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR--WAAEMVVAL---- 98
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD-CGLAALTPNTERQVSTQMVGAFGY 582
+ LH +V R+ NILLDD + L+ + + + + + M Y
Sbjct: 99 --DALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----Y 148
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP 621
APE T D +S G ++ ELLTG K L P
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 19/210 (9%)
Query: 417 LIGEGSLGRVYRAEFANG-KIMAVKKIDN-AALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ G V + N K+ A+K ++ L E F E + + I TL
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDML-HFADDSSKNLT--WNARVRVALGTARALEYLHEV 531
+ LV +Y G+L +L F D +++ + A + +A+ + L Y
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS- 590
VHR+ K NIL+D + L+D G S+ VG Y +PE +
Sbjct: 124 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 591 ----GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y + D +S GV M E+L G P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 71/268 (26%), Positives = 105/268 (39%), Gaps = 71/268 (26%)
Query: 410 NSFSQEFLIGEGSLGRVYRAE-FANGKIMAVK--------KIDNAALSLQEEDNFLEAVS 460
F +IG+G+ G V + GKI A+K K D A E D E+ S
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
P +V+L Y + Q L L+ E++ G+L ML D S+++T R +A
Sbjct: 61 -------PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT---RFYMA- 108
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA---------------- 563
A+E +H++ +HR+ K NIL+D + LSD GL+
Sbjct: 109 ECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 564 --------------------LTPNTERQVST----------QMVGAFGYSAPEFALSGIY 593
LT +++ Q++T VG Y APE L Y
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225
Query: 594 TVKSDVYSFGVVMLELLTGRKPLDSSRP 621
+ D +S G +M E L G P S
Sbjct: 226 GQECDWWSLGAIMFECLIGWPPFCSENS 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-05
Identities = 21/60 (35%), Positives = 33/60 (55%)
Query: 130 NLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189
NL SL+L++N + + + +L L++S N+LT + F L L +LDLS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 3/94 (3%)
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY 582
RA++YLHE ++HR+ K+ NI ++ + L D G A + G
Sbjct: 193 RAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
+APE Y D++S G+V+ E+ T L
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 21/220 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+GEGS VY+ NG+++A+K I S++ E+ + S + L+H NIV
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVI-----SMKTEEGVPFTAIREASLLKGLKHANIVL 67
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL-TWNARVRVALGTARALEYLHEV 531
L V+EY+ D+ + L +N R+ R L Y+H
Sbjct: 68 LHDIIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG- 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
++HR+ K N+L+ L+D GLA + S+++V Y P+ L
Sbjct: 122 --QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGA 178
Query: 592 I-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW 630
Y+ D++ G + +E+L G+ EQ W
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 18/222 (8%)
Query: 402 VASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-EAV 459
+ L+ F +IG G+ G V ++ ++ A+K + + + + F E
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 460 SNMSRLRHPNIVTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRV 517
M+ IV L + A + L V EY+ G+L +++ D K W AR
Sbjct: 95 DIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---W-ARFYT 148
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMV 577
A AL+ +H + +HR+ K N+LLD + L+D G V
Sbjct: 149 A-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204
Query: 578 GAFGYSAPEFALS----GIYTVKSDVYSFGVVMLELLTGRKP 615
G Y +PE S G Y + D +S GV + E+L G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 18/208 (8%)
Query: 417 LIGEGSLGRV--YRAEFANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTL 473
+IG G+ G V R + K+ A+K + + + + F E M+ P +V L
Sbjct: 50 VIGRGAFGEVQLVRHKSTR-KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
+ +V EY+ G+L +++ D K W AR A AL+ +H +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---W-ARFYTA-EVVLALDAIHSM-- 161
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM-VGAFGYSAPEFALS-- 590
+HR+ K N+LLD + L+D G + N E V VG Y +PE S
Sbjct: 162 -GFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 591 --GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y + D +S GV + E+L G P
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
+HR+ + NILL + D GLA + ++ V + APE + +YT
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655
+SDV+S+G+++ E+ + L SS P + KM+ + P
Sbjct: 296 ESDVWSYGILLWEIFS----LGSS-----------PYPGMPVDSKFYKMIKEGYRMLSPE 340
Query: 656 KSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+ S DI+ C +P RP ++VQ
Sbjct: 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 51/197 (25%), Positives = 77/197 (39%), Gaps = 66/197 (33%)
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-------------------- 563
A+E +H++ +HR+ K NIL+D + + L+D GL
Sbjct: 113 AVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD 169
Query: 564 -------------------LTPNTERQVSTQ--------MVGAFGYSAPEFALSGIYTVK 596
L P ER+ + Q +VG Y APE L YT
Sbjct: 170 SMDFSNEWGDPANCRCGDRLKP-LERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228
Query: 597 SDVYSFGVVMLELLTGRKPLDSSRP-RSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655
D +S GV++ E+L G+ P + P ++ ++ W T LH I AK+ P + +
Sbjct: 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT-SLH-IPPQAKL-SPEASDL--- 282
Query: 656 KSLSRFADIIALCVQPE 672
II LC PE
Sbjct: 283 --------IIKLCRGPE 291
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-05
Identities = 19/60 (31%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 108 SLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
+L+ DLS N + PNL L+L+ NN + P + + + SL L++S N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 37/152 (24%), Positives = 58/152 (38%), Gaps = 46/152 (30%)
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL---------------------- 561
A+E +H++ +HR+ K NIL+D + + L+D GL
Sbjct: 113 AIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 562 -------------AALTPNTERQVSTQM-------VGAFGYSAPEFALSGIYTVKSDVYS 601
L P R+ VG Y APE L YT D +S
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229
Query: 602 FGVVMLELLTGRKP-LDSSRPRSEQSLVRWAT 632
GV++ E+L G+ P L + ++ ++ W T
Sbjct: 230 VGVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 5e-05
Identities = 22/60 (36%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHF 235
L +LDLS N + +F L N+ L L N +T S FSGLP L +L+++ N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNA--ALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ G V + + + + KI N L E F E + + I TL
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDML-HFADDSSKNLT--WNARVRVALGTARALEYLHEV 531
+ LV +Y G+L +L F D +++ + A + +A+ + L Y
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY---- 123
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALS 590
VHR+ K N+LLD + L+D G + L N + V S+ VG Y +PE +
Sbjct: 124 -----VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 591 -----GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y + D +S GV M E+L G P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 29/164 (17%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-------SLQEEDNFLEAVSNMSRLRHPN 469
I G+ G+VY N K+ AVK + A + +Q E + L A+S + P
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL-ALS-----KSPF 65
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARAL 525
IV L LV EY+ G++ +LH F ++ + V+ A AL
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA--------VKYISEVALAL 117
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
+YLH ++HR+ K N+L+ +E + L+D GL+ +T N E
Sbjct: 118 DYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 38/145 (26%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLA-ALTPNTERQ--VSTQMVG 578
R L+Y+H +V+HR+ K AN+ ++ ++L + D GLA + P+ + +S +V
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 579 AFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637
+ Y +P LS YT D+++ G + E+LTG+ + + L+ + P + +
Sbjct: 182 KW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240
Query: 638 IDALAKM-VDPAL---NGMYPAKSL 658
D + V P+ +G P + L
Sbjct: 241 EDRNELLNVIPSFVRNDGGEPRRPL 265
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 47/181 (25%), Positives = 60/181 (33%), Gaps = 30/181 (16%)
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM 576
V L AL LH R KS NILL + L D +A TP R
Sbjct: 22 VCLQCLGALRELH---------RQAKSGNILLTWDGLLKL-DGSVAFKTPEQSRP--DPY 69
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLH 636
A PE YT K+D+YS G+ + E L P + R S +
Sbjct: 70 FMA-----PEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD 124
Query: 637 DIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696
D L G+ A+S F D + LC P+ R RA
Sbjct: 125 DPRD-----RSNLEGVSAARS---FEDFMRLCASRLPQRREA-----ANHYLAHCRALFA 171
Query: 697 K 697
+
Sbjct: 172 E 172
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 404 SLQTATNSFS------QEFLIGEGSLGRVYRA-EFANGKIMAVKKI------DNAALSLQ 450
S+Q A ++F+ Q IG G+ G V A + G +AVKK+ A
Sbjct: 9 SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY 68
Query: 451 EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT 510
E L+ V++ + + N+ T E LV E + + NL ++H D
Sbjct: 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELD------ 121
Query: 511 WNARVRVALGTAR-ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
+ R+ L +++LH ++HR+ K +NI++ + + D GLA T T
Sbjct: 122 -HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-TACTN 176
Query: 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG 612
++ +V + Y APE L Y D++S G +M EL+ G
Sbjct: 177 FMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 43/189 (22%), Positives = 77/189 (40%), Gaps = 21/189 (11%)
Query: 504 DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563
+ S L++ V + A +E+L + VHR+ + N+L+ + + D GLA
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 564 LTPNTERQVST-QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRP 621
+S + APE + +YT SDV+SFG+++ E+ T G P
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY----- 342
Query: 622 RSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSE 681
P+L + + PA + +I+ C + + E RP S+
Sbjct: 343 -----------PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQ 391
Query: 682 VVQALVRLV 690
+V + L+
Sbjct: 392 LVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 17/139 (12%)
Query: 485 LVYEYVGNGNLHDML-HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543
LV +Y G+L +L F D +++ AR +A A++ +H++ VHR+ K
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYLA-EMVLAIDSVHQL---GYVHRDIKP 130
Query: 544 ANILLDDELNPHLSDCG--LAALTPNTERQVSTQMVGAFGYSAPEFALS-----GIYTVK 596
N+LLD + L+D G L L T + S VG Y +PE + G Y +
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQ--SNVAVGTPDYISPEILQAMEDGKGRYGPE 188
Query: 597 SDVYSFGVVMLELLTGRKP 615
D +S GV M E+L G P
Sbjct: 189 CDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
+++LH ++HR+ K +NI++ + + D GLA T T ++ +V + Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRY-YR 184
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGR 613
APE L Y D++S G +M E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 32/91 (35%), Positives = 45/91 (49%), Gaps = 10/91 (10%)
Query: 418 IGEGSLGRVYRAEFANG-------KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPN 469
+G G+ GRV A A+G +AVK + + A S E+ + + MS L H N
Sbjct: 45 LGSGAFGRVVEAT-AHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLN 102
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH 500
IV L G C + G ++ EY G+L D LH
Sbjct: 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 18/156 (11%)
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPN-TERQVSTQMVGAFGYSAPEFALSGIYTV 595
+HR+ + N+LL D + D GLA N + V + APE +YTV
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 596 KSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP 654
+SDV+S+G+++ E+ + G+ P P + KMV P
Sbjct: 294 QSDVWSYGILLWEIFSLGKSPY----------------PGILVNSKFYKMVKRGYQMSRP 337
Query: 655 AKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690
+ I+ +C EP RP S++ Q + R +
Sbjct: 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 45/193 (23%), Positives = 78/193 (40%), Gaps = 54/193 (27%)
Query: 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544
V +Y+ G++ +L + + L AR +A T A+E +H++ +HR+ K
Sbjct: 78 FVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAELTL-AIESVHKM---GFIHRDIKPD 130
Query: 545 NILLDDELNPHLSDCGLA---------------------ALTPNT--------------- 568
NIL+D + + L+D GL ++ P+
Sbjct: 131 NILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLK 190
Query: 569 ----------ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDS 618
+R ++ +VG Y APE L YT D +S GV++ E+L G+ P +
Sbjct: 191 TLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLA 250
Query: 619 SRPRSEQ-SLVRW 630
P Q ++ W
Sbjct: 251 PTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 24/223 (10%)
Query: 418 IGEGSLGRVYRAEFANGK-IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT-LAG 475
IG G G V+ + + K I L +E+ + V+ M L+H NIV +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV--- 531
+ + Q+L ++ E+ G+L + + +A V + AL Y H +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 532 -CLPSVVHRNFKSANILLD-------------DELNPH-LSDCGLAALTPNTE-RQVSTQ 575
V+HR+ K NI L + LN ++ G L+ N ++
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHS 200
Query: 576 MVGAFGYSAPEFAL--SGIYTVKSDVYSFGVVMLELLTGRKPL 616
VG Y +PE L + Y KSD+++ G ++ EL +G+ P
Sbjct: 201 CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 27/103 (26%), Positives = 46/103 (44%), Gaps = 4/103 (3%)
Query: 509 LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568
L R + A+EY+H+ L +HR+ K NI L+ + L D G A
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKKL---IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
VG ++PE Y +D++S G+++L++L+
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
+++LH ++HR+ K +NI++ + + D GLA T T ++ +V + Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRY-YR 192
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGR 613
APE L Y D++S G +M E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 11/108 (10%)
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
+++LH ++HR+ K +NI++ + + D GLA T T ++ +V + Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRY-YR 185
Query: 584 APEFALSGIYTVKSDVYSFGVVMLE------LLTGRKPLDSSRPRSEQ 625
APE L Y D++S G +M E L GR +D EQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 720 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.61 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.6 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.54 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.51 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.5 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.43 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.43 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.41 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.26 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.23 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.18 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.07 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.07 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.02 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.98 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.96 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.91 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.89 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.86 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.85 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.83 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.74 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.74 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.6 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.49 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.41 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.35 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.31 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.29 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.26 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.26 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.21 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-61 Score=580.92 Aligned_cols=540 Identities=28% Similarity=0.427 Sum_probs=352.3
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 85 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
++.|+|++|+++|.+|..+.+++.|+.|+|++|.++|.+|..+. ++|+.|+|++|++.|.+|..+ .+++|+.|+|++
T Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~ 484 (968)
T PLN00113 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSR 484 (968)
T ss_pred CCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcC
Confidence 44455555555555555555555555555555555555554332 566666666666666666544 346777788888
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc-CC-CCcCeEEccCccCcccCc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-SG-LPLTTLNVANNHFSGWIP 240 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~-~~L~~l~l~~N~l~g~ip 240 (720)
|++++.+|..+.++++|+.|+|++|++.|.+|..+..+++|++|+|++|+++|.+|.. .. .+|+.|+|++|+++|.+|
T Consensus 485 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 564 (968)
T PLN00113 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP 564 (968)
T ss_pred CccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCC
Confidence 8888888888888888888888888888888888888888888889888888877643 23 358899999999998888
Q ss_pred cccc---ccceeeecCCcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCceehhHHHHHHHH
Q 005001 241 RELI---SIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGS--HSPSGSQSSSSDKELPAGAIVGIVLGAVFL 315 (720)
Q Consensus 241 ~~l~---~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 315 (720)
..+. +|+.+++.+|++.+..+...............+..-+.... ..+.+.. .......+.+++++++++++
T Consensus 565 ~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~---~~~~~~~~~~~~~~~~~~~~ 641 (968)
T PLN00113 565 KNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR---VRKTPSWWFYITCTLGAFLV 641 (968)
T ss_pred hhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc---ccccceeeeehhHHHHHHHH
Confidence 7664 56778888888876444322222111111111111111100 0111111 11111123344444444444
Q ss_pred HHHHHHHHHHHhhcccccccCCCCCCCCCCccCCCcchhhhhcccccccccccCCCCchhHHHHHhhhccCCcccccCCc
Q 005001 316 VALALLALYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPI 395 (720)
Q Consensus 316 i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (720)
+++++++++ +++++++...+ +..... ...+.. .... .
T Consensus 642 ~~~~~~~~~-~~~~~~~~~~~-~~~~~~----------~~~~~~----------------------~~~~---------~ 678 (968)
T PLN00113 642 LALVAFGFV-FIRGRNNLELK-RVENED----------GTWELQ----------------------FFDS---------K 678 (968)
T ss_pred HHHHHHHHH-HHHhhhccccc-cccccc----------cccccc----------------------cccc---------c
Confidence 333333322 22222211110 000000 000000 0000 0
Q ss_pred cccccchhcHHHHhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccc
Q 005001 396 TATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474 (720)
Q Consensus 396 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 474 (720)
..... ........|...++||+|+||.||+|.. .++..||+|++...... ..+|++.+++++||||++++
T Consensus 679 ~~~~~---~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~ 749 (968)
T PLN00113 679 VSKSI---TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLI 749 (968)
T ss_pred cchhh---hHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEE
Confidence 00001 1222334577788999999999999987 57899999998643211 12457788999999999999
Q ss_pred eEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCce
Q 005001 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (720)
Q Consensus 475 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 554 (720)
+++.+.+..++||||+++|+|.++++ .++|.++.+++.|+++||+|||..+.++|+||||||+||+++.++..
T Consensus 750 ~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~ 822 (968)
T PLN00113 750 GLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP 822 (968)
T ss_pred EEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCce
Confidence 99999999999999999999999995 37899999999999999999996655699999999999999999888
Q ss_pred EEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 005001 555 HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 555 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
++. ||....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||+..... ......|....
T Consensus 823 ~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~ 895 (968)
T PLN00113 823 HLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYC 895 (968)
T ss_pred EEE-ecccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHh
Confidence 775 665443221 12236889999999999999999999999999999999999999643322 12233333221
Q ss_pred cccHHHHHhhcccccCC--CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcc
Q 005001 635 LHDIDALAKMVDPALNG--MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 695 (720)
... ......+++.... ..+.....++.+++.+||+.||++||+|.|+++.|+++.+..+.
T Consensus 896 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~ 957 (968)
T PLN00113 896 YSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957 (968)
T ss_pred cCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence 111 1223334444322 23345566788999999999999999999999999998775543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=421.49 Aligned_cols=291 Identities=50% Similarity=0.885 Sum_probs=250.4
Q ss_pred cccccchhcHHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccce
Q 005001 396 TATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475 (720)
Q Consensus 396 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 475 (720)
....|++.++..++++|...+.||+|+||.||+|...+|..||||++....... ..+|..|+.++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 455689999999999999999999999999999999999999999886544321 455999999999999999999999
Q ss_pred EEeecC-eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCce
Q 005001 476 YCAEHG-QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (720)
Q Consensus 476 ~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 554 (720)
||.+.+ +.+||||||++|+|.++++..... .++|.++.+|+.++|+||+|||+.+.|.||||||||+|||+|+++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 999998 599999999999999999843221 88999999999999999999999988889999999999999999999
Q ss_pred EEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 005001 555 HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 555 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
||+|||+|+..+...........||.+|+|||++..+..+.|+|||||||++.||+||+.+.+...+.....+..|..+.
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 99999999766541111111117999999999999999999999999999999999999999876655556678887655
Q ss_pred cccHHHHHhhcccccC-CCCCh-hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 635 LHDIDALAKMVDPALN-GMYPA-KSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
+.+. .+.+++|+.+. ..++. .....+.++..+|++.+|++||+|.||++.|+.+..
T Consensus 297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 5544 78889999976 55664 577789999999999999999999999999866543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=388.10 Aligned_cols=259 Identities=26% Similarity=0.472 Sum_probs=218.3
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC-eEEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-QRLLVYE 488 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e 488 (720)
+.+..+.||+|..|+||++.++ +++.+|+|.+.. .......+++.+|+++++.++||+||.++|.|..++ ...|+||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 3455678999999999999886 688899999943 345667789999999999999999999999999999 5999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
||++|+|++++.. .+.+++....+|+.+|++||.|||+.. +||||||||+|||++..|++||+|||.+....+.
T Consensus 159 YMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999973 478999999999999999999999732 9999999999999999999999999999876544
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
....++||..|||||.+.+..|+.++||||||+.++|+++|+.||....+. ...-.+.+..+++..
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-----------~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-----------YLDIFELLCAIVDEP 298 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-----------CCCHHHHHHHHhcCC
Confidence 456789999999999999999999999999999999999999999865211 111223344444433
Q ss_pred cCCCCCh-hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 649 LNGMYPA-KSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 649 ~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
.. ..|. .++.++..|+..||++||.+||+++|++++ .++.++
T Consensus 299 pP-~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H--pfi~~~ 341 (364)
T KOG0581|consen 299 PP-RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH--PFIKKF 341 (364)
T ss_pred CC-CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC--HHHhhc
Confidence 22 2344 488899999999999999999999999987 344444
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=398.69 Aligned_cols=263 Identities=33% Similarity=0.556 Sum_probs=225.4
Q ss_pred ccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC-eEEEEEEecCC
Q 005001 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-QRLLVYEYVGN 492 (720)
Q Consensus 414 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~~ 492 (720)
..+.||+|+||+||+|.+.....||||++............|.+|+.++.+++|||||+++|++.+.. ..++||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34459999999999999975555999999877666555789999999999999999999999999887 79999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEEecCCCCCEEeCCCC-ceEEcccCCCccCCCCCc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS-VVHRNFKSANILLDDEL-NPHLSDCGLAALTPNTER 570 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~-iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~ 570 (720)
|+|.++++.. ....+++..+++++.|||+|++|||+. + ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999843 367899999999999999999999999 7 99999999999999998 99999999998665432
Q ss_pred cccccccccccccCccccc--cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 571 QVSTQMVGAFGYSAPEFAL--SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....+ ......++...
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----------------~~~~~~v~~~~ 262 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----------------VQVASAVVVGG 262 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHhcC
Confidence 2233468999999999999 66999999999999999999999999986543 12233334445
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccccc
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKR 698 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~ 698 (720)
.+...|..++..+..+|..||+.||++||++.+++..|+.+.........
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~ 312 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGP 312 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCc
Confidence 55566677889999999999999999999999999999998887665433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=384.55 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=209.5
Q ss_pred HhcCCCccceeccCCCcEEEEEE-EcCCcEEEEEEccccccChH-----HHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQ-----EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
..+.|...+.||+|+||.|-+|. .++|+.||||++.+...... ......+|+++|++++|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 44568888999999999999995 45799999999976554321 1233568999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC---CceEEcc
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSD 558 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~D 558 (720)
..|+||||++||+|.+.+- .++.+.+...+.+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999986 467888888899999999999999999 99999999999999766 6799999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCC---cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY---TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL 635 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 635 (720)
||+|+... ....+...+|||.|.|||++.+..+ ..++|+||+||++|-+++|.+||.......
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------------ 388 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------------ 388 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------------
Confidence 99999876 3456677899999999999987653 347899999999999999999998654322
Q ss_pred ccHHHHHhhcccccCC--CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 636 HDIDALAKMVDPALNG--MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 636 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.....+....+.. ..-...+++..+||.+||..||++||++.|++++
T Consensus 389 ---sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 ---SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ---cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1111112222211 1123466788999999999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=396.37 Aligned_cols=260 Identities=27% Similarity=0.452 Sum_probs=228.3
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
....+..++.||+|.||+||.|.+.....||+|.++.... ..+.|.+|+++|++++|+|||++++++..++.++|||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 3344556778999999999999998888999999986543 3567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|||+.|+|.++|+. ..+..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+...+
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999999984 3467889999999999999999999999 999999999999999999999999999996555
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
+........--+..|.|||.+..+.++.|||||||||+||||+| |+.||.+... ..+.+.++
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------------~ev~~~le 418 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------------EEVLELLE 418 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------------HHHHHHHh
Confidence 44444444445678999999999999999999999999999999 9999976543 34445667
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
.+.+-..|..|+..++++|..||+.+|++|||++.+...|+++...
T Consensus 419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 7888888999999999999999999999999999999999887553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=366.06 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=220.7
Q ss_pred cCCCccceeccCCCcEEEEEE-EcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccce-EEeec-CeEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG-YCAEH-GQRLLV 486 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~-~~~~lV 486 (720)
.+|+++++||+|.||+||++. ..+|..+|.|+++-........+....|+.+|++++|||||++++ .+.++ +.++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457888899999999999994 568999999999977778888899999999999999999999998 44444 448999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
||+|++|+|...++..+...+.+++..+++++.|++.||.++|+.. ++ |+||||||.||+++.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999988888999999999999999999999999942 25 89999999999999999999999999998
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
+... .......+|||.||+||.+.+.+|+.++||||+||++|||+.-+.||.+.+-. +...++
T Consensus 178 l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~----------------~L~~KI 240 (375)
T KOG0591|consen 178 LSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL----------------SLCKKI 240 (375)
T ss_pred hcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH----------------HHHHHH
Confidence 7653 34456689999999999999999999999999999999999999999875211 111222
Q ss_pred cccccCCCCC-hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 645 VDPALNGMYP-AKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 645 ~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
...... ..| ...+.++.++|..|+..||+.||+...+++.+..
T Consensus 241 ~qgd~~-~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 241 EQGDYP-PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HcCCCC-CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 222222 233 6688899999999999999999997666666544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=394.34 Aligned_cols=250 Identities=26% Similarity=0.469 Sum_probs=218.7
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.+|...++||+|||+.||.++. ..|+.||+|++.+... +......+.+|+++.+.++|||||+++++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999987 7899999999976544 4445677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|+|..++|..+++ ..+.+++.+++.+++||+.||.|||+. +|+|||||..|++++++.++||+|||+|.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999887 468999999999999999999999999 999999999999999999999999999998765
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
+. ......+|||.|+|||++.+...+..+||||+||+||-|++|++||+...-. +.+.++...
T Consensus 171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk----------------ety~~Ik~~ 233 (592)
T KOG0575|consen 171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK----------------ETYNKIKLN 233 (592)
T ss_pred cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH----------------HHHHHHHhc
Confidence 43 3345589999999999999999999999999999999999999999864322 222222222
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ..|...+.+..+||.++|+.||.+|||+++|+.+
T Consensus 234 ~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 234 EY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred Cc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22 2456777888999999999999999999999976
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=370.88 Aligned_cols=251 Identities=26% Similarity=0.442 Sum_probs=205.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
..+|...+.||+|+||+||+|++. ++..||||.+..........+.+..|+.+++.++|||||.+++++...+..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888888999999999999875 5899999999887767777888999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC------CceEEcccCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE------LNPHLSDCGL 561 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~------~~~kl~Dfg~ 561 (720)
|||+||||.++++ ..+.+++..++.++.|+|.||++||++ +||||||||+|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999998 356899999999999999999999999 99999999999999875 4589999999
Q ss_pred CccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
|+.+... ......+|++-|||||++...+|+.|+|+||+|+++|||++|+.||+...+.+....+.....
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~-------- 231 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE-------- 231 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc--------
Confidence 9988643 344567999999999999999999999999999999999999999987665433222211111
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVV 683 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell 683 (720)
.....+......+.+++...++.+|.+|-++.+-.
T Consensus 232 -------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 232 -------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred -------ccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 11112222333444666666666666665555444
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=397.89 Aligned_cols=264 Identities=27% Similarity=0.460 Sum_probs=225.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
..+.+..+.||+|+||+||+|+.. +...||||.+++.. +.+..++|.+|+++++.++|||||+++|.|.+++.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 344556678999999999999653 34579999998765 55578899999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccC------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADD------S----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~------~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 552 (720)
+++|+|||..|||.++|+.... . ..+++..+.+.||.|||.|++||-++ .+|||||.++|+||+++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 9999999999999999975321 1 23489999999999999999999999 999999999999999999
Q ss_pred ceEEcccCCCccCCCCCccccc-cccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 005001 553 NPHLSDCGLAALTPNTERQVST-QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRW 630 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~ 630 (720)
.|||+|||+++.....+.+... ...-+++|||||.+..++||.+||||||||+|||+++ |+.||.+....
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-------- 712 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-------- 712 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--------
Confidence 9999999999977666655543 3456789999999999999999999999999999999 99999865432
Q ss_pred hccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 631 ATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
+.+..+..... ...|..+|.++++||..||+..|.+||+++||-.+|....+..
T Consensus 713 --------EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 713 --------EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --------HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 33333333344 5678999999999999999999999999999999998876544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=365.52 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=212.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh-HHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|+..++||+|+||+||+++.+ +++.||+|++++..... .+.+....|..++.+++||+||+++..|.+.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357899999999999999999654 68899999998776543 3667888999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
+||+.||.|..+|+ ..+.+++..++-++..|+.||.|||+. +||||||||+|||+|.+|+++|+|||+++...
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999997 468899999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
... .....++||+.|||||++.+..|+.++|+||||+++|||++|.+||...+..... +++..
T Consensus 177 ~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~----------------~~I~~ 239 (357)
T KOG0598|consen 177 KDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY----------------DKILK 239 (357)
T ss_pred cCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH----------------HHHhc
Confidence 332 3345589999999999999999999999999999999999999999876533221 12222
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCC----CHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRP----PMSEVVQ 684 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~ell~ 684 (720)
.. ....|...+.+.++++++.|..||++|. ++.+|-+
T Consensus 240 ~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 240 GK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred Cc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 22 1223444677888999999999999996 4555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=354.36 Aligned_cols=268 Identities=22% Similarity=0.315 Sum_probs=213.0
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
+.|+...++|+|+||.||+++++ +|+.||||++......+...+-.++|++++++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45788889999999999999886 59999999998776666666778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
||+. ++.+-+. .....++...+.+++.|++.|+.|+|++ ++|||||||+|||++.+|.+||+|||+|+.+...
T Consensus 82 ~~dh-TvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9987 4444443 2456788899999999999999999999 9999999999999999999999999999988754
Q ss_pred CccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc--------cHH
Q 005001 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLH--------DID 639 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------~~~ 639 (720)
.+ .-+.++.|.+|+|||.+.+ .+|+.++||||+||++.||++|.+-|.+...-+....+......+. ...
T Consensus 155 gd-~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 GD-NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred cc-hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 33 3355788999999999998 7799999999999999999999999988765444433332111100 001
Q ss_pred HHHhhcccccCCCCC-----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAKMVDPALNGMYP-----AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+..+.-+......| .....-+.++++.||+.||.+|++.++++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111111111111 1234468899999999999999999999865
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=337.08 Aligned_cols=267 Identities=24% Similarity=0.383 Sum_probs=217.2
Q ss_pred cCCCccceeccCCCcEEEEEE-EcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.+|...+++|+|.||.||+|+ .++|+.||||+++............++|+..++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999995 4679999999998776655556778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
||+. +|...++ +....++..+++.++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9986 9999997 4567889999999999999999999999 9999999999999999999999999999988765
Q ss_pred CccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH--hhccc---cccHHH--
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR--WATPQ---LHDIDA-- 640 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~--~~~~~---~~~~~~-- 640 (720)
..... ..+-|..|+|||.+.|. .|+..+|+||.|||+.||+-|.+-|.+...-+....+- ..+|. |.++..
T Consensus 155 ~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 155 NRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred Ccccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 54333 33789999999999985 58999999999999999999888777765544433331 22222 222222
Q ss_pred -HHhh---cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 -LAKM---VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 -~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..++ -.+..+..++ .++.+..+|+.+|+..||.+|++++|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 2221 1222233333 344556999999999999999999999976
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=381.60 Aligned_cols=275 Identities=25% Similarity=0.425 Sum_probs=233.5
Q ss_pred CCCccceeccCCCcEEEEEEEcC----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
...++++||.|.||+||+|+++- ...||||.++... ......+|+.|+.+|.+++||||++|.|........+||
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34567899999999999998752 4579999998654 566788999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
+|||++|+|+.+|+.. .+.+++.+...++++|+.|+.||-+. ++|||||.++|||++.+..+|++|||+++.+.
T Consensus 709 TEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999854 46699999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCccccccccc--cccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 567 NTERQVSTQMVG--AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 567 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
++.....+...| +.+|.|||.+...+++.++|||||||+|||.++ |..||-.+.. .++.+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----------------QdVIk 845 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------------QDVIK 845 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----------------HHHHH
Confidence 544222222222 468999999999999999999999999999888 9999975543 33445
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccccccCCCCCCCccc
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDESGFSYR 709 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~ 709 (720)
.++..++.+.|.+|+..|.+||..||++|-.+||.+.+|+..|.+++.+...-..-.....+-+..
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~ 911 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQP 911 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCccc
Confidence 566778888899999999999999999999999999999999999988766554444444443333
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=363.24 Aligned_cols=270 Identities=26% Similarity=0.392 Sum_probs=219.8
Q ss_pred HhcCCCccceeccCCCcEEEEEE-EcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec--CeEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRL 484 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 484 (720)
..+.|+.++.||+|+||.||+|+ ..+|+.||+|++..+...........+|+.+|++++||||++|.+...+. +.+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34568889999999999999995 46799999999987776666778889999999999999999999998776 7899
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+|+|||+. ||.-++. ...-.+++.+++.+++|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||+|++
T Consensus 195 lVFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence 99999987 8888886 3455899999999999999999999999 999999999999999999999999999998
Q ss_pred CCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hh-hccccccHHHH
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RW-ATPQLHDIDAL 641 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~-~~~~~~~~~~~ 641 (720)
+........+..+-|.+|+|||++.|. .|+.++|+||.|||+.||++|++.|.+..+......+ .. ..|....+. .
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~ 346 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-V 346 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-c
Confidence 877766666778899999999999985 5999999999999999999999999987765444333 22 122222221 1
Q ss_pred Hhhcccc-c--CCCCC-------hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDPA-L--NGMYP-------AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~-~--~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.++-.-. + ...+. ...+....+|+..+|..||.+|.|+.++++.
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1111000 1 11111 1234567799999999999999999998854
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=365.35 Aligned_cols=269 Identities=25% Similarity=0.377 Sum_probs=220.2
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEeecC-eEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG-QRL 484 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~ 484 (720)
.-++|...+.||.|+||.||+|+. ..|+.||||+++....+. ++..-+||+..+++++ ||||+++.+.+.+++ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 346788899999999999999965 468999999999877664 3445578999999998 999999999999988 999
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+|||||+. +|+++++ ..+..+++..++.|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+||.
T Consensus 87 fVfE~Md~-NLYqLmK---~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMK---DRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhhh-hHHHHHh---hcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 99999976 9999997 3478899999999999999999999999 999999999999999888999999999997
Q ss_pred CCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH--hhccccccHH--
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR--WATPQLHDID-- 639 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~--~~~~~~~~~~-- 639 (720)
...... -+.++.|.+|+|||++.+ +-|+.++|+||+|||++|+.+-++.|.+..+.+....+- ..+|....+.
T Consensus 160 v~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 160 VRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 755433 355789999999999865 668999999999999999999999999887765554432 2344433332
Q ss_pred -HHHhhcccccCCCCC-------hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 640 -ALAKMVDPALNGMYP-------AKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 640 -~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.+.+.+.-.+....+ ..++.+..++|.+|+.+||.+||||+|++++-
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 233333222111111 12567889999999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=362.54 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=215.0
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHH-HHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQE-EDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
.++|...+.||+|+|++|++|+. ++++.||||++.+...-.+. .+-...|-..|.++ +||.|++|+..|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 46788899999999999999955 57899999999766543332 34456777888888 89999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|+||+++|+|.++|+. -+.+++..++.++.+|+.||+|||++ |||||||||+|||+|++|++||+|||.|..+
T Consensus 152 vLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999984 48899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcc----------c--cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 005001 566 PNTERQ----------V--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633 (720)
Q Consensus 566 ~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~ 633 (720)
.+.... . ...++||..|.+||++.....++.+|+|+|||++|+|+.|.+||.+.++-
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----------- 293 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----------- 293 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-----------
Confidence 532211 1 14589999999999999999999999999999999999999999876542
Q ss_pred ccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
-.+.++++. .-.+|+..++...+|+++.|..||.+|++.++|.++-
T Consensus 294 -----liFqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 294 -----LIFQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -----HHHHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 222333322 2246677778899999999999999999999998873
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=365.70 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=215.7
Q ss_pred HhcCCCccceeccCCCcEEEEEE-EcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
....|.....||+|+.|.||.|. ..+++.||||++..... ...+-+++|+.+|+..+|+|||++++.|...+.+|+|
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 44567778899999999999994 55789999999975542 2345678999999999999999999999888999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
||||+||+|.|.+. ...+++.++..|+++++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.
T Consensus 349 MEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred EeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999999996 56699999999999999999999999 99999999999999999999999999988765
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.... .....+|||.|||||++....|++++||||||++++||+.|++||...++.....++ +. .
T Consensus 421 ~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-------------a~--n 484 (550)
T KOG0578|consen 421 EEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------AT--N 484 (550)
T ss_pred cccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-------------hh--c
Confidence 5433 445678999999999999999999999999999999999999999875543222111 11 1
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......+...+..+.+|+.+||+.||++|++++|+|++
T Consensus 485 g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 485 GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 223334567788899999999999999999999999987
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=350.04 Aligned_cols=264 Identities=26% Similarity=0.400 Sum_probs=212.6
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..+.|+..++||.|..++||+|+. +.++.||||++.-+..... .+.+.+|++.++.++||||++++..|..+..+|+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 346788899999999999999954 5789999999987765543 78899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|.||.+|++.++++..- ...+++..+..|++++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+..+.
T Consensus 103 mpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999998543 34599999999999999999999999 99999999999999999999999999876554
Q ss_pred CCCccc--c-ccccccccccCcccccc--CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 567 NTERQV--S-TQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 567 ~~~~~~--~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
..+... . ..++||+.|||||++.. ..|+.|+||||||++..||.+|..||....+.......--..+......
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~-- 255 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS-- 255 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc--
Confidence 333211 1 45689999999999654 4599999999999999999999999987766433222111111100000
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.............+.+++..||++||++|||+++++++
T Consensus 256 ------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 ------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00000111234478999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=355.09 Aligned_cols=256 Identities=29% Similarity=0.439 Sum_probs=208.3
Q ss_pred cCCCccceeccCCCcEEEEEEEcC-CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC--eEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLLV 486 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV 486 (720)
.+|...+.||+|+||.||++...+ |...|||.+..... ...+.+.+|+.+|.+++|||||+++|.....+ .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 356777899999999999997764 89999999976522 22667889999999999999999999855544 68999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-CCceEEcccCCCccC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALT 565 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~ 565 (720)
|||+++|+|.+++... ++.+++..+..+.+||++||+|||++ +||||||||+|||++. ++.+||+|||++...
T Consensus 95 mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 9999999999999842 22799999999999999999999999 9999999999999999 799999999999876
Q ss_pred CC--CCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 566 PN--TERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 566 ~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
.. ..........||+.|||||++..+ ....++|||||||++.||+||+.||.... .....+.
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---------------~~~~~~~ 233 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---------------EEAEALL 233 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---------------chHHHHH
Confidence 53 222233457899999999999953 34469999999999999999999997530 0011112
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
++.........|...+.+..+++.+|+..||++||||.+++++..-
T Consensus 234 ~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 234 LIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred HHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2222222235677788899999999999999999999999988643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=332.13 Aligned_cols=238 Identities=26% Similarity=0.405 Sum_probs=210.4
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.+|+..+.||.|+||.|.+++.+ +|..+|+|++.+... ...+.+...+|..+++.+.||+++++++.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56888899999999999999775 588899999976543 4455677788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||++||.|..+++ ..+++++..++-++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999998 467899999999999999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
. ....+|||.|+|||++....|..++|.|||||++|||+.|.+||...++. ....+++..
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----------------~iY~KI~~~ 256 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----------------QIYEKILEG 256 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------------HHHHHHHhC
Confidence 3 34579999999999999999999999999999999999999999876542 334444444
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCC
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFR 676 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~R 676 (720)
.. .+|.....++.+|+...|+.|-.+|
T Consensus 257 ~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 KV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 33 4677888889999999999999999
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.51 Aligned_cols=269 Identities=25% Similarity=0.418 Sum_probs=221.0
Q ss_pred hhcHHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 402 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
..+++...+++.+.+.||+|.||+||+|.+. ..||||++.......+..+.|+.|+.++++-+|.||+-+.||+...+
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3677777888889999999999999999985 45899999988888888999999999999999999999999998887
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
. .||+.+|+|.+|+.++|.. ...+...+.+.|++||++|+.|||.+ +|||||||..||++.++++|||+|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 7 9999999999999999953 47789999999999999999999999 999999999999999999999999999
Q ss_pred CccCCC-CCccccccccccccccCcccccc---CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 005001 562 AALTPN-TERQVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 562 a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
+..-.. .....-....|...|||||+++. .+|++.+||||||+++|||+||..||....... +-|..
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq----IifmV----- 605 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ----IIFMV----- 605 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh----eEEEe-----
Confidence 864321 11122233457889999999975 458999999999999999999999998332211 11111
Q ss_pred HHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
....-+.+ .......++.++.+|+..||..++++||.+.+|+..|+++...
T Consensus 606 -GrG~l~pd---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 606 -GRGYLMPD---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -cccccCcc---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 00000000 1122346788999999999999999999999999999998774
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=351.49 Aligned_cols=265 Identities=24% Similarity=0.370 Sum_probs=218.6
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
+-+.......++||+|-||+|.+++...+..||||+++... ......+|.+|+++|.+++||||++++|+|..++.+++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 33455677888999999999999999888999999998665 34456889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|+|||++|+|.+++..... ....-....+|+.||+.|++||.+. ++|||||.++|+|++.++++||+|||+++.+
T Consensus 613 I~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence 9999999999999975432 2245566778999999999999999 9999999999999999999999999999976
Q ss_pred CCCCcccc-ccccccccccCccccccCCCcccchhhhHHHHHHHHHh--CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 566 PNTERQVS-TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT--GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 566 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
...+.+.. ...+-+.+|||+|.+.-++++.++|||+||+++||+++ ...||......+... ..-
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve-------------n~~ 754 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE-------------NAG 754 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH-------------hhh
Confidence 65554433 34466789999999999999999999999999999887 788987654322111 011
Q ss_pred hhccc---ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 643 KMVDP---ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 643 ~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
.+.+. ......|.-++..++++|..||..|-++||+++++...|.+.
T Consensus 755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11111 112234677899999999999999999999999999888664
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=387.16 Aligned_cols=263 Identities=29% Similarity=0.490 Sum_probs=223.2
Q ss_pred cCCCccceeccCCCcEEEEEEEcC--Cc----EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFAN--GK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
......+.||+|+||.||.|...+ |. .||+|.+.... +.++..+|++|..+|+.++|||||+++|++.+.+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 344567789999999999997653 33 48999997543 677889999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 484 LLVYEYVGNGNLHDMLHFADDS---SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
+|++|||.+|+|..+|+..+.. ...++..+.+.++.|||+|+.||+++ ++|||||.++|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999854321 45689999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccc-cccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccH
Q 005001 561 LAALTPNTERQVSTQM-VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
+|+.....+.+..... .-...|||||.+..+.++.|+|||||||++||++| |..||...+..
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---------------- 911 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---------------- 911 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----------------
Confidence 9995554444433333 34568999999999999999999999999999999 99999765432
Q ss_pred HHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
+.+...+..+ +...|..|++.++++|.+||+.+|++||++..|++++.++.+..
T Consensus 912 ~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 912 EVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 2233233334 67789999999999999999999999999999999998887643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=355.71 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=217.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+......+.+.+.+|+++++.++||||+.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56888889999999999999655 68899999998887788888999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+.| +|+.++. ..+.++++.+..++.|++.||.|||+. +|+|||+||+|||++.+|.+|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9987 9999997 468899999999999999999999999 999999999999999999999999999987754
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
....-+...|||-|||||++.+++|+..+|+||+||++|||++|++||.... +. ..+..+....
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~----------~Lv~~I~~d~ 216 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------IT----------QLVKSILKDP 216 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HH----------HHHHHHhcCC
Confidence 3344456789999999999999999999999999999999999999997422 11 1112222222
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...|...+..+..+++..|.+||.+|.+..+++.+
T Consensus 217 --v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 --VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 12455778889999999999999999999999976
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=361.56 Aligned_cols=265 Identities=25% Similarity=0.435 Sum_probs=210.3
Q ss_pred HhcCCCccceeccCCCcEEEEEEE------cCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeec
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 480 (720)
..++|++.+.||+|+||.||+|.+ .++..||+|++.... .......+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 456799999999999999999964 235689999987543 334456789999999999 899999999988764
Q ss_pred -CeEEEEEEecCCCCHHHHhhhccCC------------------------------------------------------
Q 005001 481 -GQRLLVYEYVGNGNLHDMLHFADDS------------------------------------------------------ 505 (720)
Q Consensus 481 -~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 505 (720)
+..++||||+++|+|.++++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999998743210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc-cccccccc
Q 005001 506 ----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAF 580 (720)
Q Consensus 506 ----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~ 580 (720)
...+++.++..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++......... .....+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 13478889999999999999999999 99999999999999999999999999997653322211 12234678
Q ss_pred cccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHH
Q 005001 581 GYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLS 659 (720)
Q Consensus 581 ~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (720)
.|+|||++.+..++.++|||||||++|||++ |..||........ ....+........+...+.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~ 304 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE----------------FCQRLKDGTRMRAPENATP 304 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH----------------HHHHHhcCCCCCCCCCCCH
Confidence 8999999999999999999999999999997 9999976432111 0011111111223445667
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 660 RFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 660 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
.+.+++.+||+.||++||++.|+++.|++++++
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.81 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=209.1
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
..++|+.+..||+|+||+||+|+- .+|+.+|+|++++... ...+.+..+.|-.+|...++|+||+++..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 457899999999999999999965 4699999999987654 45556778889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||++||++..+|. ..+.+++..+..++.+++-|++.+|+. |+|||||||+|+|||..|++||+|||++.-+
T Consensus 219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999996 468999999999999999999999999 9999999999999999999999999998422
Q ss_pred CC----------------------CCcc-----cc-------------------ccccccccccCccccccCCCcccchh
Q 005001 566 PN----------------------TERQ-----VS-------------------TQMVGAFGYSAPEFALSGIYTVKSDV 599 (720)
Q Consensus 566 ~~----------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~Dv 599 (720)
.. .+.. .. ...+|||.|||||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 0000 00 12579999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCcchhh-HHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCC
Q 005001 600 YSFGVVMLELLTGRKPLDSSRPRSEQS-LVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPP 678 (720)
Q Consensus 600 wSlGv~l~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 678 (720)
||||||+|||+.|.+||.+..+..... ++.|.. .+..+.......+..+||.+|+. ||++|..
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------------TLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh---------------hccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999999887754322 222211 11111122344778899999999 9999975
Q ss_pred ---HHHHHHH
Q 005001 679 ---MSEVVQA 685 (720)
Q Consensus 679 ---~~ell~~ 685 (720)
++||.++
T Consensus 436 ~~G~~EIK~H 445 (550)
T KOG0605|consen 436 SKGAEEIKKH 445 (550)
T ss_pred cccHHHHhcC
Confidence 5555544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=357.69 Aligned_cols=251 Identities=30% Similarity=0.458 Sum_probs=210.7
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC---hHHHHHHHHHHHHhhcCC-CCCccccceEEeecCe
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 482 (720)
....|...+.||+|+||.|+.|.+. +++.||+|.+...... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4567899999999999999999654 6899999977654222 123456668999999998 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC-CceEEcccCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGL 561 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~ 561 (720)
.++||||+.||+|.+++. ..+++.+.++..+++|++.|++|+|++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999997 268899999999999999999999999 99999999999999999 9999999999
Q ss_pred CccCCCCCccccccccccccccCccccccCC-Cc-ccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGI-YT-VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---------------- 230 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---------------- 230 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----------------
Confidence 98774 2334456689999999999999987 86 78999999999999999999998643211
Q ss_pred HHHhhcccccCCCCChhH-HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 005001 640 ALAKMVDPALNGMYPAKS-LSRFADIIALCVQPEPEFRPPMSEVVQ 684 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~ell~ 684 (720)
...++... ...+|... +.++..|+.+|+..||.+|+++.+|++
T Consensus 231 l~~ki~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 231 LYRKIRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HHHHHhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 11111111 12344555 788899999999999999999999993
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=355.38 Aligned_cols=242 Identities=26% Similarity=0.477 Sum_probs=207.1
Q ss_pred CCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
.....+-||.|+.|.||+|+.+ ++.||||+++.-. ..+++-|++++||||+.+.|+|.....+|||||||
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred HhhhhhhhccCcccceeeeecc-CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 3344567999999999999986 7889999985321 23466689999999999999999999999999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
..|-|.+.|+ .+..++......+..+||.|+.|||.+ +|||||||.-||||..+..+||+|||-++...+.
T Consensus 195 a~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-- 265 (904)
T KOG4721|consen 195 AQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-- 265 (904)
T ss_pred ccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence 9999999997 578899999999999999999999999 9999999999999999999999999999876554
Q ss_pred cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccC
Q 005001 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (720)
.....++||..|||||++...+.+.|+|||||||+||||+||..||..-+.. .+.|.. -...+.
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGV------------GsNsL~ 329 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGV------------GSNSLH 329 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEec------------cCCccc
Confidence 3344689999999999999999999999999999999999999999753321 111111 112344
Q ss_pred CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 651 GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 651 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
...|..+++.+.-|+++||+..|..||++.+|+.+|+
T Consensus 330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 5568889999999999999999999999999999983
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=350.83 Aligned_cols=250 Identities=30% Similarity=0.477 Sum_probs=213.0
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
..|...++||+|.||.||+|.+ ..++.||+|.+..+.. ..+...+.+|+.++..++++||.++++.+..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4577778999999999999954 5789999999976653 3456778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
||.||++.+.++ .+..+++..+.-++++++.|+.|||++ +.+|||||+.|||+..+|.+|++|||.+......
T Consensus 92 y~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 999999999997 345558888888999999999999999 9999999999999999999999999999877654
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
... ...++|||.|||||++....|+.|+||||||++.+||.+|.+|+....+.....++. +-..+.
T Consensus 165 ~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-------------k~~PP~ 230 (467)
T KOG0201|consen 165 VKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-------------KSAPPR 230 (467)
T ss_pred hhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-------------CCCCCc
Confidence 433 367899999999999999899999999999999999999999998776643222221 111222
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+. ..++..+.+|+..||.+||+.||+|.+++++
T Consensus 231 L~----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 LD----GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cc----cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22 2456678999999999999999999999976
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=356.38 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=214.3
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEcccc-ccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNA-ALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.-|...+.||+|+.|.|.+|++ .+|+.+|||++.+. .........+.+|+-+|+.+.||||+++++.++++.++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3477888999999999999976 57999999999765 334444667889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|.|++++- ..+++++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+|||+|....+
T Consensus 92 Eyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999996 468999999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
. ..-..-||+|.|.|||++.|.+| +.++||||.|||||.|+||+.||+..+-.. .+.++..
T Consensus 165 g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~----------------LLlKV~~ 226 (786)
T KOG0588|consen 165 G--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV----------------LLLKVQR 226 (786)
T ss_pred C--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH----------------HHHHHHc
Confidence 2 23345689999999999999998 578999999999999999999998543221 1222222
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
..+ ..|...+.+.++|+++|+..||++|.|++||+++-
T Consensus 227 G~f--~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 227 GVF--EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred Ccc--cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 222 24567788899999999999999999999999984
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=356.83 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=210.5
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 483 (720)
...++|...++||+|.||+|++|..+ +++.+|||.+++..+ ...+.+..+.|.+++... +||.+++++..|...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34567999999999999999999876 578999999987665 555667788888887766 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
|+||||+.||++..+.+ .+.+++..+.-++..|+.||.|||++ +|||||||.+|||+|.+|++||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999655443 58899999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
..-..++ ....++|||.|||||++.+..|+.++|+|||||+||||+.|..||.+.++.+ ....
T Consensus 517 e~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee----------------~Fds 579 (694)
T KOG0694|consen 517 EGMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE----------------VFDS 579 (694)
T ss_pred ccCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHH
Confidence 6543333 4566899999999999999999999999999999999999999998765432 2222
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPM 679 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 679 (720)
++.. ...||...+.+...+|+++|..+|++|..+
T Consensus 580 I~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2222 234677888899999999999999999866
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=341.36 Aligned_cols=265 Identities=23% Similarity=0.347 Sum_probs=214.6
Q ss_pred cchhcHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh------------HHHHHHHHHHHHhhcCC
Q 005001 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL------------QEEDNFLEAVSNMSRLR 466 (720)
Q Consensus 400 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~ 466 (720)
+.-.+.....|+|++.+.||+|.||.|-+|+.. +++.||||++.+..... ...+...+|+.+|++++
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 334445566789999999999999999999765 68999999996543211 12357789999999999
Q ss_pred CCCccccceEEee--cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCC
Q 005001 467 HPNIVTLAGYCAE--HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (720)
Q Consensus 467 h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~ 544 (720)
|||||+|+++..+ .+..|||+|||..|.+...- .....+++.+++++++++..||+|||.+ +||||||||+
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPs 239 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPS 239 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchh
Confidence 9999999999876 46889999999998875432 2223399999999999999999999999 9999999999
Q ss_pred CEEeCCCCceEEcccCCCccCCCCC----ccccccccccccccCccccccCC----CcccchhhhHHHHHHHHHhCCCCC
Q 005001 545 NILLDDELNPHLSDCGLAALTPNTE----RQVSTQMVGAFGYSAPEFALSGI----YTVKSDVYSFGVVMLELLTGRKPL 616 (720)
Q Consensus 545 NIll~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~pf 616 (720)
|+|++++|++||+|||.+...+... +..-...+|||.|+|||...++. .+.+.||||+||+||-|+.|+.||
T Consensus 240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 9999999999999999987663321 11123468999999999998743 357899999999999999999999
Q ss_pred CCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 617 DSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
.+... .+...+++...+......+..+.+.+||.++|++||+.|.+..+|..+..
T Consensus 320 ~~~~~----------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 320 FDDFE----------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ccchH----------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 76432 34455666666655544556788999999999999999999999988763
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=355.35 Aligned_cols=263 Identities=28% Similarity=0.474 Sum_probs=221.9
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcC--C--cE-EEEEEccc-cccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFAN--G--KI-MAVKKIDN-AALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~--~--~~-vavK~~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
..++....++||+|+||+||+|.+.. + .. ||+|..+. .........+|++|+++|++++|||||+++|+...+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34445556899999999999997653 2 23 89999985 3356778899999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
.+++|||+|.||+|.++|+. ....++..++..++.+.|.||+|||+. ++|||||.++|+|++.++.+||+|||+
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred ccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccc
Confidence 99999999999999999983 234699999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccc-cccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 562 AALTPNTERQVST-QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 562 a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
++..... .... ..--+..|+|||.+..+.|++++|||||||++||+++ |..||.+.... .
T Consensus 309 s~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----------------~ 370 (474)
T KOG0194|consen 309 SRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----------------E 370 (474)
T ss_pred ccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----------------H
Confidence 8764311 1111 1124578999999999999999999999999999999 88999875532 2
Q ss_pred HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
...++.....+...+...+..+..++.+||..||++||+|.++.+.|+.+.+...
T Consensus 371 v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 371 VKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 2333335566667777889999999999999999999999999999999887755
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=329.04 Aligned_cols=269 Identities=24% Similarity=0.314 Sum_probs=213.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--cCeEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 485 (720)
.++|+..+.|++|+||.||+|+++ +++.||+|+++...-.......-++|+.++.+++|||||.+..+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356888999999999999999765 68999999998655333334567899999999999999999888754 467999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|||||+. +|..+++. ..+++...+++-+..|+++|++|||.. .|+|||||++|+|++..|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999987 99999974 357899999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH--hhccc---cccHH
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR--WATPQ---LHDID 639 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~--~~~~~---~~~~~ 639 (720)
..... ..+..+-|..|+|||++.+.+ |+.++|+||+|||+.||+++++-|.+..+.+....+- ...|. |....
T Consensus 228 gsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 228 GSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred cCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 76543 345567899999999999855 9999999999999999999999998877655443331 11221 11111
Q ss_pred HHH---hhc-----ccccCCCCChh-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALA---KMV-----DPALNGMYPAK-SLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~---~~~-----~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+. ++. ...++..++.. ..+.-++|+..+|..||.+|.|++|.+++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111 110 01122223322 44677899999999999999999999976
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=344.32 Aligned_cols=269 Identities=21% Similarity=0.290 Sum_probs=208.1
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999876 57889999997654444456678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|++++.+..+.+ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999877765543 245789999999999999999999999 9999999999999999999999999999876443
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH--------
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA-------- 640 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 640 (720)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+............
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 332333457899999999999999999999999999999999999999865433222111111101000000
Q ss_pred HHhhcccccC------CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 LAKMVDPALN------GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+... .......+..+.+|+++||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 00111245679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=339.93 Aligned_cols=247 Identities=21% Similarity=0.351 Sum_probs=203.2
Q ss_pred ceeccCCCcEEEEEEEcCCcEEEEEEccccccCh-HHHHHHHHHHHHhhcCCCCCccccceEEee----cCeEEEEEEec
Q 005001 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRLLVYEYV 490 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~ 490 (720)
..||+|++|.||+|.. +|+.||+|++....... ...+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 68999999997654322 224678899999999999999999999876 34689999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
++|+|.++++. .+.+++..+.+++.|++.||.|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999973 457899999999999999999999842 78899999999999999999999999987653321
Q ss_pred cccccccccccccCcccccc--CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 571 QVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||........ ........
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~----------------~~~i~~~~ 238 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI----------------YDLIINKN 238 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHHhcC
Confidence 23468899999999976 6799999999999999999999999976432211 11111122
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
.....+..++..+.+++.+||+.||++||+++|+++.|+.+
T Consensus 239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 22234445778899999999999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=337.59 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=208.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc----CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
.++|+..+.||+|+||.||+|.++ .+..||+|.++... .......+.+|+..+++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 356888899999999999999753 35689999997643 3344567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+..
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 83 IVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999999873 235789999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
.............++..|+|||.+.+..++.++|||||||++||+++ |..||........ . +
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~----------------~-~ 219 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV----------------I-K 219 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----------------H-H
Confidence 32221111122345678999999999999999999999999999875 9999975432111 1 1
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
.+........+..++..+.+++.+||+.+|++||++++|++.|.++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 AVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111112233556777899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.79 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=222.2
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe-EEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ-RLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 487 (720)
++|...+.+|+|+||.++.++++ +++.|++|++........+......|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999999765 57899999998887777777788999999999999999999999999998 99999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
+|++||+|.+.+...+ +..++++.+.+++.|++.|+.|||+. .|+|||||+.||+++.++.+||+|||+|+....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998543 57899999999999999999999988 999999999999999999999999999998876
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. ......+||+.||.||++.+.+|..|+|||||||++|||++-+.+|.+.+.. ....++..
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~----------------~Li~ki~~- 220 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS----------------ELILKINR- 220 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH----------------HHHHHHhh-
Confidence 54 2445678999999999999999999999999999999999999999865432 11222222
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......|.....++..+|..|++.+|+.||++.+++.+
T Consensus 221 ~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22344567788899999999999999999999999987
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=312.26 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=215.6
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
..++|+..+.||+|.||.||.|+.+ ++-.||+|++.+... ......++.+|+++.+.++||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4467889999999999999999654 678899999976654 33446788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
++||..+|+|...++. .....+++..+..++.|+|.||.|+|.. +||||||||+|+|++..+.+||+|||-+...
T Consensus 100 ilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999973 2356788999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
+ .......+||..|.+||...+..++..+|+|++|++.||++.|.+||...... +...++.
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------etYkrI~ 235 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------ETYKRIR 235 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------HHHHHHH
Confidence 4 23445679999999999999999999999999999999999999999864421 2222222
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. .-.+|...+....++|.+|+.++|.+|.+..|++++
T Consensus 236 k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 236 KV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred Hc--cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 22 223566777888999999999999999999999876
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=328.58 Aligned_cols=268 Identities=25% Similarity=0.370 Sum_probs=214.6
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee-----cC
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-----HG 481 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 481 (720)
....|...+.||+|+||.|+.|.. .+|+.||||++..........++-.+|+.+++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345666678999999999999965 478999999998777777778889999999999999999999998755 34
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..|+|+|+|+. +|...++ .++.++...+..++.|+++||.|+|+. +|+||||||.|++++.+..+||+|||+
T Consensus 100 DvYiV~elMet-DL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHHhh-HHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 67999999954 9999997 345699999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCC-CccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 562 AALTPNT-ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 562 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
|+..... .....+..+-|..|+|||++.. ..|+.++||||+|||+.||++|++-|.+.+.-....++....+.- ..+
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~~e 250 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-SEE 250 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-CHH
Confidence 9977542 2234467789999999999865 669999999999999999999999999877554444443222111 111
Q ss_pred HHHhhc--------cc---c----cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAKMV--------DP---A----LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~--------~~---~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+.++. .. . +...+| .......+|+.+||..||.+|+|++|++++
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111 10 0 111122 344567899999999999999999999987
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.18 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=208.4
Q ss_pred HhcCCCccceeccCCCcEEEEEEE------cCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeec
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 480 (720)
..++|+..+.||+|+||.||+|.+ .++..||+|+++... .......+.+|+.+++.+ +||||+++++++...
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 355788899999999999999963 245689999987543 234456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhhccC--------------------------------------------------------
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADD-------------------------------------------------------- 504 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 504 (720)
+..++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999864221
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 505 ---------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 505 ---------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
....+++..+.+++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 112578899999999999999999998 99999999999999999999999999997654332
Q ss_pred ccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 570 RQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 570 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ...+.+..
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----------------~~~~~~~~ 332 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----------------KFYKMIKE 332 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----------------HHHHHHHh
Confidence 211 112345678999999999999999999999999999998 888987543211 11111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
......+...+.++.+++.+||+.||++||++.||++.|++.
T Consensus 333 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 333 GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 112222334566899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=328.96 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=213.3
Q ss_pred HhcCCCccceeccCCCcEEEEEE-EcCCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
...+|++.+.||+|.||.|-+|. +..|+.||||.+++..+. .++.-.+.+|+++|+.++||||+.++.+|+..+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 45678899999999999999995 478999999999877664 4455678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||..+|.|+|++. ..+.+++.+++++++||..|+.|+|++ +++|||||.+|||+|.++++||+|||++-.+
T Consensus 131 vMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999997 468899999999999999999999999 9999999999999999999999999999776
Q ss_pred CCCCccccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
... ..-+.++|+|-|.+||++.+.+| ++.+|-|||||+||-|+.|.+||++.+.. ..++++
T Consensus 204 ~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----------------~lvrQI 265 (668)
T KOG0611|consen 204 ADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----------------RLVRQI 265 (668)
T ss_pred ccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----------------HHHHHh
Confidence 432 34467899999999999999998 57899999999999999999999975432 112222
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
-...++. ...+....-||++||..+|++|-|..+|..+-
T Consensus 266 s~GaYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 266 SRGAYRE---PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred hcccccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 2222222 22334556799999999999999988877653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=326.47 Aligned_cols=255 Identities=27% Similarity=0.353 Sum_probs=213.8
Q ss_pred cCCCccceeccCCCcEEEEEEEcC-CcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
+.|+..+.||+|.-|+||+++..+ +..+|+|++.+.... .....+...|-++|+.++||.++.||+.|+.+...|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456778899999999999998875 588999999876653 334456677889999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|||+||+|..+.+. +.++.+++..++-++..|+-||+|||-. |||+|||||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999998874 4678999999999999999999999999 999999999999999999999999998743210
Q ss_pred ---------------------------------C----------------------CccccccccccccccCccccccCC
Q 005001 568 ---------------------------------T----------------------ERQVSTQMVGAFGYSAPEFALSGI 592 (720)
Q Consensus 568 ---------------------------------~----------------------~~~~~~~~~gt~~y~aPE~~~~~~ 592 (720)
. ....+..++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 001123468999999999999999
Q ss_pred CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCC
Q 005001 593 YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPE 672 (720)
Q Consensus 593 ~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 672 (720)
.+.++|+|+|||++|||+.|..||.+.+.. +.+..++............+..+.+||++.|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 999999999999999999999999986643 3344444444443333466778999999999999
Q ss_pred CCCCCC----HHHHHHH
Q 005001 673 PEFRPP----MSEVVQA 685 (720)
Q Consensus 673 P~~RPs----~~ell~~ 685 (720)
|++|.. +.||-++
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999998 7887765
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.85 Aligned_cols=268 Identities=22% Similarity=0.375 Sum_probs=209.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||++.+. ++..||+|.+.... .......+.+|++++++++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 467999999999999999999776 57889999886542 3344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 83 EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999973 456899999999999999999999862 699999999999999999999999999876533
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc---------------
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWAT--------------- 632 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~--------------- 632 (720)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus 157 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred c---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence 2 2234579999999999999999999999999999999999999997544321111110000
Q ss_pred ---------------cccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 633 ---------------PQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 633 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
+.....+....+.............+.++.+|+.+||+.||++||+++|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000011111111111111123567899999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.35 Aligned_cols=266 Identities=24% Similarity=0.369 Sum_probs=213.7
Q ss_pred HHhcCCCccceeccCCCcEEEEEE-EcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-----
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH----- 480 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 480 (720)
...++|++.+.||+|||+-||+++ ..+++.||+|++.-.. .++.+..++|++..++++||||++++++...+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 345789999999999999999996 4578999999997543 45677889999999999999999999986443
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
...|++++|+..|+|.+.++.....+..+++.+.++|+.+|++||++||+. .|.++||||||.|||+.+++.+++.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 358999999999999999988777777899999999999999999999998 2359999999999999999999999999
Q ss_pred CCccCCCCCcccc--------ccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005001 561 LAALTPNTERQVS--------TQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR 629 (720)
Q Consensus 561 ~a~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~ 629 (720)
.+...+-...... .....|..|+|||.+. +...++++|||||||++|+|+.|..||+..-...
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G------ 248 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG------ 248 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC------
Confidence 9875442211111 1234788999999986 4557899999999999999999999997532211
Q ss_pred hhccccccHHHHHh-hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 005001 630 WATPQLHDIDALAK-MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690 (720)
Q Consensus 630 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 690 (720)
+.+.- +....+..+.....++.+.+++++|++.||.+||++.+++..+.+++
T Consensus 249 ---------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 ---------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 00000 11112222223346788999999999999999999999999987754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=339.24 Aligned_cols=265 Identities=24% Similarity=0.396 Sum_probs=205.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC-----------------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCcc
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN-----------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 471 (720)
.++|+..+.||+|+||.||+|.+.+ +..||+|.+.... .......+.+|+.++.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4578889999999999999997532 3469999987543 344466789999999999999999
Q ss_pred ccceEEeecCeEEEEEEecCCCCHHHHhhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 005001 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD---------------SSKNLTWNARVRVALGTARALEYLHEVCLPSV 536 (720)
Q Consensus 472 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~i 536 (720)
++++++...+..++||||+++|+|.+++..... ....+++..+.+++.|++.||+|||+. +|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 999999999999999999999999999864211 113478889999999999999999999 99
Q ss_pred EEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh--CC
Q 005001 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT--GR 613 (720)
Q Consensus 537 iH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~ 613 (720)
+||||||+||+++.++.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999999765432221 1223356789999999999999999999999999999987 56
Q ss_pred CCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 614 KPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 614 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
.||............ ...............+..++..+.+++.+||+.||++||++.+|.+.|+
T Consensus 240 ~p~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVIENA----------GEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHHHHH----------HHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 777654322111000 0000000001111223456678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.06 Aligned_cols=265 Identities=27% Similarity=0.435 Sum_probs=210.5
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEe
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (720)
....++|+..+.||+|+||.||+|... ++..||+|++.... .......+.+|+++++.+ +|+||+++++++.
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 344567899999999999999998642 34579999997543 233456788999999999 8999999999999
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhccC------------------------------------------------------
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFADD------------------------------------------------------ 504 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------ 504 (720)
..+..++||||+++|+|.++++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999999864211
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc-
Q 005001 505 ------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ- 571 (720)
Q Consensus 505 ------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 571 (720)
....+++.++.+++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 113478899999999999999999999 9999999999999999999999999998765332211
Q ss_pred ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccC
Q 005001 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650 (720)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (720)
......++..|+|||++.+..++.++|||||||++|||++ |+.||....... ...+.......
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----------------~~~~~~~~~~~ 333 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----------------KFYKMVKRGYQ 333 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----------------HHHHHHHcccC
Confidence 1122335678999999999999999999999999999997 999997543211 11111111222
Q ss_pred CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 005001 651 GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690 (720)
Q Consensus 651 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 690 (720)
...+...+.++.+++.+||+.||++||++.++++.|++++
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 2233344678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=321.35 Aligned_cols=272 Identities=26% Similarity=0.376 Sum_probs=206.7
Q ss_pred CccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhc--CCCCCccccceEEeecC----eEEEE
Q 005001 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAEHG----QRLLV 486 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lV 486 (720)
...++||+|.||.||+|.+. ++.||||++. .++.+.|..|-++++. ++|+||++++++-.... .++||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 44568999999999999986 5999999994 5667888888777654 68999999999876554 88999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV------CLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~------~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
++|.+.|+|.+++. ...++|....+|+..+++||+|||+. ++|+|+|||||.+||||..|+++.|+|||
T Consensus 287 t~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999997 67899999999999999999999976 35789999999999999999999999999
Q ss_pred CCccCCCCC-ccccccccccccccCccccccCCC------cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 005001 561 LAALTPNTE-RQVSTQMVGAFGYSAPEFALSGIY------TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633 (720)
Q Consensus 561 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~ 633 (720)
+|..+.... .......+||.+|||||++.+..- -.+.||||+|.++|||++...-++.......+.-.+-...
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 998765322 222334689999999999987542 2368999999999999996665542111111111111111
Q ss_pred ccccHHHHHhhc-ccccCCCCCh-----hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcc
Q 005001 634 QLHDIDALAKMV-DPALNGMYPA-----KSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695 (720)
Q Consensus 634 ~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 695 (720)
.....+.+...+ ..+.+..++. .....+.+.+..||..||+.|.|+.=+.+++.++..-...
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 122222222222 2223333333 3456789999999999999999999999999888665543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.93 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=205.7
Q ss_pred CCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 412 FSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
|+..+.||+|+||.||+|.. .+|+.||+|.+...... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999976 47899999998754332 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999887532 234689999999999999999999999 99999999999999999999999999997654322
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...... ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~-------------~~~~~~-~~ 220 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE-------------VDRRVK-ED 220 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH-------------HHHHhh-cc
Confidence 22345799999999999999999999999999999999999999986543211111 111110 11
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPP-----MSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 685 (720)
...++...+..+.+|+++||+.||++||+ +++++++
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 12234456678899999999999999997 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.53 Aligned_cols=247 Identities=24% Similarity=0.310 Sum_probs=205.3
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999775 688999999864332 2234566888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++ ..+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999986 245789999999999999999999999 999999999999999999999999999876533
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+...
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~----------------~~i~~~ 213 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY----------------EKILAG 213 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------HHHHhC
Confidence 2 12356999999999999999999999999999999999999999764322111 111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPP-----MSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 685 (720)
. ..++...+..+.+++++||+.||.+||+ +++++++
T Consensus 214 ~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 214 K--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred C--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1 1234445667889999999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.50 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=207.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC-----e
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-----Q 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 482 (720)
.-+|...+++|.|+||.||+|... +++.||||++-.+. +.-.+|+++|+.++|||||++..+|.... .
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 345777889999999999999765 47899999986433 22347899999999999999988886532 3
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC-CceEEcccCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGL 561 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~ 561 (720)
..+|||||+. +|.+.++.....+..++...++-+..|+.+||+|||+. +|+||||||+|+|+|.+ |.+||+|||.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence 4689999987 99999987666678899999999999999999999998 99999999999999976 8999999999
Q ss_pred CccCCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH--hhccccccH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR--WATPQLHDI 638 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~--~~~~~~~~~ 638 (720)
|+........ ..+..|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+....+....+- ...|..++.
T Consensus 173 AK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 173 AKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9987654433 456789999999999985 59999999999999999999999999866543332221 223322222
Q ss_pred HHHHhh---------cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKM---------VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..+.-. ........+....+.+..+|+.++|..+|.+|.++.|++++
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 211110 00011111334566789999999999999999999999965
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.23 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=201.6
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
+.||+|+||.||+|... +|+.||+|++..... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999764 689999999975432 2334566788999999999999999999999999999999999999
Q ss_pred CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcccc
Q 005001 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573 (720)
Q Consensus 494 sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 573 (720)
+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 9999886 246789999999999999999999999 99999999999999999999999999987533222 122
Q ss_pred ccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCC
Q 005001 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY 653 (720)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (720)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+... ...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~~--~~~~ 214 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----------------FELILME--EIRF 214 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH----------------HHHHHcC--CCCC
Confidence 345799999999999999999999999999999999999999975432111 1111111 1123
Q ss_pred ChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 654 PAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 654 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
+...+.++.+++.+||+.||++|| ++.+++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 455677889999999999999999 79998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=328.03 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=205.1
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
++|+..+.||+|+||.||+|.++++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 45777889999999999999998888999998864432 245688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 81 MENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 9999999998632 34689999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......... .+... .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~----------------~~i~~-~ 217 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV----------------EMISR-G 217 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH----------------HHHHC-C
Confidence 222223345678999999998899999999999999999999 89999754322111 11111 0
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.....+...+..+.+++.+||+.+|++||+++++++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 218 FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11112333456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=315.33 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=209.0
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.+.|++.+.||+|.|+.||++.+ .+|+.+|+|++..........+.+.+|+.+.+.++||||+++.+.+.+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45678888999999999999954 57999999999877776667788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---CCceEEcccCCCcc
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDCGLAAL 564 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a~~ 564 (720)
|+|.|++|..-+- ....+++..+-..++||+++|.|+|.+ +|||||+||+|+++.. ..-+|++|||+|..
T Consensus 90 e~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999976553 135678899999999999999999999 9999999999999954 34589999999987
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
.. +....-+++|||+|||||++...+|+..+|||+.||++|-|+.|++||.+.+.. ....++
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~----------------rlye~I 224 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----------------RLYEQI 224 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH----------------HHHHHH
Confidence 76 334445678999999999999999999999999999999999999999864321 111222
Q ss_pred cccccC--CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VDPALN--GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+..... ..+=....++..+|+++||..||.+|.|+.|.+++
T Consensus 225 ~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 225 KAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred hccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 222211 11112355677899999999999999999988764
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.45 Aligned_cols=263 Identities=26% Similarity=0.420 Sum_probs=224.2
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc---CCc--EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA---NGK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (720)
.+...+.....++||.|.||.||+|... .|+ .||||..+.+. .....+.|+.|..+|+.++||||++++|+|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 3334445566778999999999999653 233 48889887655 44557889999999999999999999999976
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEccc
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 559 (720)
. ..|||||.++-|.|..+++. ....++......++.||+.||+|||+. ++|||||..+|||+....-+|++||
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred c-ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence 4 68999999999999999974 456788999999999999999999999 9999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccH
Q 005001 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 560 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
|+++.......+......-++.|||||.+.-..++.++|||-|||++||++. |..||.+-...+..
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------------- 602 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------------- 602 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------------
Confidence 9999988776666555556779999999999999999999999999999988 99999875543221
Q ss_pred HHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
..+..+.+.+.|+.|+..++.|+.+||..||.+||.+.|+...|+++.+.
T Consensus 603 ----~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 603 ----GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred ----EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 22334556678899999999999999999999999999999999998873
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=330.18 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=209.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.++|+..++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 45788899999999999999998888899999886432 235678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999998742 345788999999999999999999998 9999999999999999999999999999876543
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.........++..|+|||.+.+..++.++|||||||++|||++ |+.||........... +..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-----------------~~~ 219 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-----------------LQR 219 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH-----------------HHc
Confidence 2222233346778999999999999999999999999999998 9999975432211110 011
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
..........+.++.+++.+||+.+|++||+++++.+.|++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 220 GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11112223456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.14 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=205.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||+|.+. +++.||+|.+..... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999775 588999999865432 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+.+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999873 45788999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ...++...
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~~~~i~~~ 230 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR----------------IYEKILAG 230 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH----------------HHHHHhcC
Confidence 22 23579999999999999999999999999999999999999997543211 11111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPP-----MSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 685 (720)
. ..++...+..+.+|+.+||+.||++||+ +++++++
T Consensus 231 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 231 R--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred C--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 1234445667889999999999999997 6888765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.67 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=207.4
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|++.+.||+|+||.||+|.+. +++.||+|++...... ......+.+|+.++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 5889999999754322 234567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999996 245789999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
......||+.|+|||++.+..++.++|||||||++|||++|..||...........+.. .......
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~----------~~~~~~~ 219 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY----------WKETLQR 219 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh----------ccccccC
Confidence 22345799999999999999999999999999999999999999976543221111100 0000000
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..........+.++.+++.+||..+|.+||++++++++
T Consensus 220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000012346678899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.40 Aligned_cols=268 Identities=23% Similarity=0.411 Sum_probs=230.3
Q ss_pred hcHHHHhcCCCccceeccCCCcEEEEEEEcC-CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 403 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
+.++-...+....++||-|.||+||.|.|+. .-.||||.++.+. .+..+|+.|..+|+.++|||+|+++|+|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 3455555566677899999999999998875 5679999998654 45788999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..|||+|||..|+|.++++.+. ...++....+.++.||..|++||..+ ++|||||.++|+|+.++..+||+|||+
T Consensus 337 PFYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999998643 45677788899999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
++++..+........--.+.|.|||.+....++.|+|||+|||+|||+.| |-.||.+-+. ..
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----------------Sq 474 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQ 474 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----------------HH
Confidence 99987665444433334678999999999999999999999999999999 8888876321 23
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcc
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 695 (720)
+...+...++-..|+.|+..+++||+.||++.|.+||++.|+-+.++.|....+.
T Consensus 475 VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 475 VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 3444556677778999999999999999999999999999999999999877663
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.92 Aligned_cols=258 Identities=26% Similarity=0.466 Sum_probs=210.2
Q ss_pred cCCCccceeccCCCcEEEEEEEcC------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
++|+..+.||+|+||.||+|.... ...|++|.+.... .......+.+|+..+++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 467888999999999999997643 2579999886443 334456789999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC
Q 005001 484 LLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 551 (720)
+++|||+++++|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 999999999999999974321 114688899999999999999999999 99999999999999999
Q ss_pred CceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 005001 552 LNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVR 629 (720)
Q Consensus 552 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~ 629 (720)
+.++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+......
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~----- 235 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV----- 235 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence 9999999999876533222 22233467889999999999999999999999999999998 9999976443211
Q ss_pred hhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 630 WATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
.+.+........+..++.++.+|+.+||+.||.+||+++||+++|++
T Consensus 236 ------------~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 ------------IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111112223355677889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.27 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=209.3
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.++|+..+.||+|+||.||+|...+++.||+|.++.... ....+.+|+.++++++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 456888999999999999999888888999999875432 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999998632 235689999999999999999999999 9999999999999999999999999999876533
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
..........+..|+|||.+.+..++.++||||||+++|||++ |+.||......... ..+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-----------------~~~~~ 219 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-----------------QQVDQ 219 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-----------------HHHHc
Confidence 2221222233457999999999999999999999999999999 99999754321111 11111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
......+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 220 GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11122344566789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=326.15 Aligned_cols=256 Identities=28% Similarity=0.438 Sum_probs=209.1
Q ss_pred cCCCccceeccCCCcEEEEEEEcC----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
++|...+.||+|+||.||+|.+.. ...||+|.+.... .......+.+|+..+++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 568889999999999999998753 4579999886543 34445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++++|.+++.. ....+++..+.+++.|++.||+|||+. +|+||||||+||++++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999873 234789999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 566 PNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 566 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||........ . +
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~----------------~-~ 219 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV----------------I-K 219 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH----------------H-H
Confidence 522221 1222345678999999999999999999999999999998 9999865432111 1 1
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
.+........+...+..+.+++.+||+.+|++||++.|+++.|.++
T Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 220 AVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111111123345667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.98 Aligned_cols=255 Identities=24% Similarity=0.430 Sum_probs=209.2
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.+|+..+.||+|+||.||+|... .++.||+|.+.... .....+.+|++.+++++|+||+++++++...+..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 45777889999999999999765 58899999986432 335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999998632 235689999999999999999999998 9999999999999999999999999998766543
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.........++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..+....
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----------------~~~~~~~ 220 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VYELLEK 220 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----------------HHHHHHC
Confidence 2222222334678999999999999999999999999999998 899987543211 1111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
......+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 222234555678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=325.60 Aligned_cols=262 Identities=23% Similarity=0.393 Sum_probs=212.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccc-cChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|++.+.||+|+||.||+|... +++.||+|.+.... ........+.+|+.+++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999765 68999999876432 23444567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999875544456689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
... ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||........ ... ......
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~-------------~~~~~~ 223 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLC-------------QKIEQC 223 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHH-------------HHHhcC
Confidence 221 12234688899999999998899999999999999999999999865332111 010 111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
......+...+..+.+++.+||+.+|++||++.++++.+.++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111112234557789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=357.16 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=213.0
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC---
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--- 481 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 481 (720)
....++|.+.+.||+|+||.||+|.. .+|+.||+|.+............+.+|+..+..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999965 47899999999766656666778889999999999999999887765432
Q ss_pred -----eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEE
Q 005001 482 -----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (720)
Q Consensus 482 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 556 (720)
..++||||+++|+|.++++........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 36899999999999999975444556799999999999999999999999 9999999999999999999999
Q ss_pred cccCCCccCCCCC-ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 005001 557 SDCGLAALTPNTE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL 635 (720)
Q Consensus 557 ~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 635 (720)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------------ 252 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------------ 252 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------------
Confidence 9999997654322 122334679999999999999999999999999999999999999997543211
Q ss_pred ccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 636 HDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+.+..... ....+...+.++.+++.+||+.||.+||++.+++++
T Consensus 253 ----~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 ----VMHKTLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----HHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111111 122345567789999999999999999999999865
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=342.51 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=205.5
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC--CcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN--GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
.++|...+.||+|+||.||+|.+.+ +..||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568889999999999999997643 36899999864432 23345678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999973 45789999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||....+... ..++.
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----------------~~~i~ 241 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI----------------YQKIL 241 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH----------------HHHHh
Confidence 332 2345799999999999999899999999999999999999999976432111 11111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
... ..+|...+..+.+++++||+.||++|+ ++++++++
T Consensus 242 ~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 242 EGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111 123445566788999999999999995 89988876
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.31 Aligned_cols=266 Identities=26% Similarity=0.423 Sum_probs=210.3
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEee
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (720)
...++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++.++ +|+||+++++++..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 34567999999999999999999532 35789999987543 334456778899999999 89999999998765
Q ss_pred c-CeEEEEEEecCCCCHHHHhhhccCC-----------------------------------------------------
Q 005001 480 H-GQRLLVYEYVGNGNLHDMLHFADDS----------------------------------------------------- 505 (720)
Q Consensus 480 ~-~~~~lV~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 505 (720)
. ...++++||+++++|.+++......
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 5688999999999999998642210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc-cccccccc
Q 005001 506 ----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAF 580 (720)
Q Consensus 506 ----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~ 580 (720)
...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.++|+|||++.......... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 13689999999999999999999999 99999999999999999999999999998654322221 22335677
Q ss_pred cccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHH
Q 005001 581 GYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLS 659 (720)
Q Consensus 581 ~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (720)
.|+|||++.+..++.++|||||||++|||++ |..||....... .+.+.+........+.....
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~ 303 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----------------EFCRRLKEGTRMRAPEYATP 303 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----------------HHHHHHhccCCCCCCccCCH
Confidence 8999999999999999999999999999998 999997533211 11111111112222344567
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 660 RFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 660 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
++.+++.+||+.+|++||++.|++++|+++++.
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.44 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=212.0
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEee
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAE 479 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 479 (720)
...++|++.+.||+|+||.||+|.+. .+..||+|++.... .....+.+.+|+++++++. ||||+++++++.+
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 34568889999999999999999753 23479999996543 3344577899999999995 9999999999999
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccC-------------------------------------------------------
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADD------------------------------------------------------- 504 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------- 504 (720)
.+..++||||+++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999999864321
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEE
Q 005001 505 -------------------------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (720)
Q Consensus 505 -------------------------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIl 547 (720)
....+++..+..++.|++.||+|||+. +|+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 013478888999999999999999998 9999999999999
Q ss_pred eCCCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchh
Q 005001 548 LDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQ 625 (720)
Q Consensus 548 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~ 625 (720)
++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~- 348 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST- 348 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-
Confidence 999999999999998765432221 1223457788999999999999999999999999999997 9999975432110
Q ss_pred hHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 626 SLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
..+.+........+...+..+.+++.+||+.||++||++.+|.+.|+++.+
T Consensus 349 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 ---------------FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---------------HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111111112222344567789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=346.21 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=207.9
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh-HHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|...+.||+|+||.||+|... +++.||+|++....... .....+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999775 68999999997544322 44567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999973 36789999999999999999999998 999999999999999999999999999976544
Q ss_pred CC----------------------------ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCC
Q 005001 568 TE----------------------------RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSS 619 (720)
Q Consensus 568 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~ 619 (720)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223457999999999999999999999999999999999999999865
Q ss_pred CCcchhhHHHhhccccccHHHHHhhcc--cccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 005001 620 RPRSEQSLVRWATPQLHDIDALAKMVD--PALNGMYPAKSLSRFADIIALCVQPEPEFRPP-MSEVVQA 685 (720)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~ 685 (720)
...... .++.. ...........+..+.+++.+|+. ||.+||+ +++++++
T Consensus 234 ~~~~~~----------------~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETY----------------NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHH----------------HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 432111 11111 111111112246788999999998 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=320.32 Aligned_cols=271 Identities=23% Similarity=0.317 Sum_probs=209.0
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCC-ccccceEEeecC------
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN-IVTLAGYCAEHG------ 481 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------ 481 (720)
..|...++||+|+||+||+|+.. +|+.||+|++..............+|+.+++.++|+| |+.+++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34666778999999999999654 6899999999865433233456689999999999999 999999998876
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++|+||++. +|.+++.......+.++...++.++.|++.||+|||++ +|+||||||+|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999976 99999975433225677789999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH--hhccccccH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR--WATPQLHDI 638 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~--~~~~~~~~~ 638 (720)
|+...-+... .+..++|..|+|||++.+. .|+..+||||+|||++||++++.-|.+.........+- ..+|.-..+
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 9865433222 3446789999999999987 68999999999999999999999998876643332221 122322222
Q ss_pred HHHHhhcccc--cCCCC-ChhH-------HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKMVDPA--LNGMY-PAKS-------LSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~~~~~--~~~~~-~~~~-------~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......+-. ..... +... .....+++.+|++.+|.+|.|++.++++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 2222111111 11111 1111 1367899999999999999999999987
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=316.26 Aligned_cols=263 Identities=26% Similarity=0.410 Sum_probs=209.1
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhc--CCCCCccccceEEeec---
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAEH--- 480 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~--- 480 (720)
+....+....+.||+|.||+||+|.+. |+.||||++.. .+++.+.+|.++++. ++|+||+.+++.-..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 344566778899999999999999996 89999999953 346677788777765 4999999999886443
Q ss_pred -CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEecCCCCCEEeCCCCce
Q 005001 481 -GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV-----CLPSVVHRNFKSANILLDDELNP 554 (720)
Q Consensus 481 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----~~~~iiH~Dlkp~NIll~~~~~~ 554 (720)
.++|||++|.+.|+|+|+|. ...++....++++..+|.||+|||-. ++|.|.|||||+.|||+..++.+
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred eEEEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 26799999999999999997 57899999999999999999999954 57899999999999999999999
Q ss_pred EEcccCCCccCCCCCcc---ccccccccccccCccccccCC----C-c-ccchhhhHHHHHHHHHh----------CCCC
Q 005001 555 HLSDCGLAALTPNTERQ---VSTQMVGAFGYSAPEFALSGI----Y-T-VKSDVYSFGVVMLELLT----------GRKP 615 (720)
Q Consensus 555 kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~-~-~~~DvwSlGv~l~ellt----------g~~p 615 (720)
.|+|+|+|-......+. .....+||.+|||||++...- + + ..+||||||.++||+.. -+.|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 99999999877655332 234578999999999997543 2 2 35899999999999985 2345
Q ss_pred CCCCCCcchhhHHHhhccccccHHHHHhhc------ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 616 LDSSRPRSEQSLVRWATPQLHDIDALAKMV------DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 616 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
|....+ .....+++.+++ ....+.+........+.++|+.||..+|..|.|+-.|-+.|.++
T Consensus 436 yyd~Vp------------~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 436 YYDVVP------------SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred cccCCC------------CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 554322 223334444433 22223344456778899999999999999999999999999887
Q ss_pred HH
Q 005001 690 VQ 691 (720)
Q Consensus 690 ~~ 691 (720)
.+
T Consensus 504 ~~ 505 (513)
T KOG2052|consen 504 SN 505 (513)
T ss_pred hc
Confidence 64
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=338.84 Aligned_cols=244 Identities=24% Similarity=0.332 Sum_probs=200.7
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
+.||+|+||.||++... +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999764 689999999975432 2334566788999999999999999999999999999999999999
Q ss_pred CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcccc
Q 005001 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573 (720)
Q Consensus 494 sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 573 (720)
+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 9998886 245789999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred ccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCC
Q 005001 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY 653 (720)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (720)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~----------------~~~~~~~--~~~ 214 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----------------ELILMEE--IRF 214 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH----------------HHHhcCC--CCC
Confidence 3457999999999999999999999999999999999999999754322111 1111111 123
Q ss_pred ChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 654 PAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 654 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
+...+.++.+++.+||+.||++|| ++.+++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 445667889999999999999998 88888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=336.32 Aligned_cols=267 Identities=21% Similarity=0.375 Sum_probs=206.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|.+. ++..+|+|.+.... .......+.+|+++++.++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 467999999999999999999776 57888998876542 3344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++. .+.+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999863 456889999999999999999999852 799999999999999999999999999875533
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh----------------
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA---------------- 631 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~---------------- 631 (720)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 2 123356899999999999989999999999999999999999999754432211111000
Q ss_pred --------cc----ccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 632 --------TP----QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 632 --------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+ ........................+.++.+|+.+||+.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00 0000000000111110000111245678999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=326.56 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=212.8
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
....+|...+.||+|+||.||+|...+++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3456788899999999999999998889999999987543 22355688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 81 TELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred EeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 9999999999999742 345789999999999999999999999 99999999999999999999999999997664
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
..... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||....... .....
T Consensus 156 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~----------------~~~~~- 217 (261)
T cd05148 156 EDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE----------------VYDQI- 217 (261)
T ss_pred Ccccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH----------------HHHHH-
Confidence 33221 223446778999999999899999999999999999998 899997543211 11111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
........+...+..+.+++.+||+.||++||+++++++.|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 218 TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1122223345667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=338.87 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=201.3
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
+.||+|+||.||++... +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999764 689999999975432 2334567888999999999999999999999999999999999999
Q ss_pred CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcccc
Q 005001 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573 (720)
Q Consensus 494 sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 573 (720)
+|.+++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 9998886 245789999999999999999999999 99999999999999999999999999987533221 122
Q ss_pred ccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCC
Q 005001 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY 653 (720)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (720)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... ...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~----------------~~~~~~--~~~~ 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----------------ELILME--DIKF 214 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH----------------HHhccC--CccC
Confidence 3457999999999999999999999999999999999999999754321111 111111 1123
Q ss_pred ChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 654 PAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 654 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
+...+.++.+++.+||+.||++|| ++.+++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 445667889999999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=353.59 Aligned_cols=253 Identities=20% Similarity=0.280 Sum_probs=206.2
Q ss_pred CCCccceeccCCCcEEEEEEEc-C-CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-N-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.|...+.||+|+||.||+|... + ++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 3788899999999999999654 3 677888877533 23344567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++|+|.++++........+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999998865434456789999999999999999999999 9999999999999999999999999999865433
Q ss_pred Cc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 569 ER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 569 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+......
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~----------------~~~~~~~~ 286 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE----------------IMQQVLYG 286 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhC
Confidence 22 12344579999999999999999999999999999999999999997543211 11111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ...+...+..+.++|.+||+.||++||++.+++++
T Consensus 287 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 287 KY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11 12344556789999999999999999999998753
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.35 Aligned_cols=267 Identities=25% Similarity=0.362 Sum_probs=201.0
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-----CeEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQRL 484 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 484 (720)
+|+..+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999765 689999999875443444456788999999999999999999987543 2579
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+. ++|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68998886 245789999999999999999999999 999999999999999999999999999975
Q ss_pred CCCCCc--cccccccccccccCcccccc--CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-hh-ccccccH
Q 005001 565 TPNTER--QVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR-WA-TPQLHDI 638 (720)
Q Consensus 565 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~-~~-~~~~~~~ 638 (720)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+. .. .+.....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432221 11234579999999999876 678999999999999999999999997654322111110 00 0000000
Q ss_pred --------HHHHhhcccccCCCC---ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 --------DALAKMVDPALNGMY---PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 --------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+........ ....+..+.+++.+||+.||++||+++|++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000 01234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=324.08 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=205.1
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
.+|...+.||+|+||.||+|+..++..+|+|.+..... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 35777889999999999999888777899999875432 245688999999999999999999999988899999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+.+|+|.+++... ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++......
T Consensus 81 ~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 81 MSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999998632 34689999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
........++..|+|||.+.+..++.++|||||||++|||++ |..||........ ...... .
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~----------------~~~~~~-~ 217 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET----------------VEKVSQ-G 217 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----------------HHHHhc-C
Confidence 222223346678999999998889999999999999999999 9999875432111 111111 1
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
.....+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 218 LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111123334578899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.62 Aligned_cols=267 Identities=21% Similarity=0.323 Sum_probs=203.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||.||+|... +++.||+|.++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 46888999999999999999765 688999999864432 2234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9975 99988863 234678999999999999999999999 9999999999999999999999999998754332
Q ss_pred CccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh--c------cccccHH
Q 005001 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA--T------PQLHDID 639 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~--~------~~~~~~~ 639 (720)
.. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........+... . +......
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 21 2233568999999999876 56899999999999999999999999865543322211110 0 0111111
Q ss_pred HHHhhcccccCCC----CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAKMVDPALNGM----YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......+..... .....+.+..+|+.+||+.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111111111100 011234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=333.72 Aligned_cols=259 Identities=24% Similarity=0.414 Sum_probs=208.3
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCc----EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
++|+..+.||+|+||.||+|.+. +++ .||+|.+.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46889999999999999999764 333 38999986432 334456788999999999999999999998764 578
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+|+||+++|+|.++++. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999873 235688999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 565 TPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 565 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----------------~~ 221 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------IS 221 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----------------HH
Confidence 65433221 122335678999999999999999999999999999998 999997532211 11
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
...........+..++..+.+++.+||..||++||++.++++.+.++.+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 222 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 111222222334455677899999999999999999999999998886654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.37 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=203.4
Q ss_pred CCCccceeccCCCcEEEEEEEc----CCcEEEEEEcccccc--ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 483 (720)
+|++.+.||+|+||.||+++.. +++.||+|++..... .......+.+|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999999653 578999999865432 122345677899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+++|+|.+++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999986 246789999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+ ..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~------------~~ 221 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV------------SR 221 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH------------HH
Confidence 65443333334467999999999998754 788999999999999999999999754322111110 01
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
++.. .....+...+..+.+++.+||+.||++|| ++++++++
T Consensus 222 ~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 222 RILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111 11223445667788999999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=344.43 Aligned_cols=254 Identities=21% Similarity=0.301 Sum_probs=205.8
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
..++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567899999999999999999775 688999999864332 22334557789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999986 34578899999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCccccccccccccccCccccccC----CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSG----IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------------~~ 256 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----------------TY 256 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----------------HH
Confidence 43332223345799999999998754 37899999999999999999999997643211 11
Q ss_pred HhhcccccCCCCCh--hHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 005001 642 AKMVDPALNGMYPA--KSLSRFADIIALCVQPEPEF--RPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 685 (720)
.++........++. ..+.++.+++.+||+.+|.+ ||++.+++++
T Consensus 257 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 257 SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 12221111111222 35678889999999999998 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.16 Aligned_cols=242 Identities=26% Similarity=0.357 Sum_probs=198.7
Q ss_pred eccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCH
Q 005001 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (720)
Q Consensus 418 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 495 (720)
||+|+||.||+|... +++.||+|++..... .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999775 578999999865432 334456788899999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcccccc
Q 005001 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (720)
Q Consensus 496 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 575 (720)
.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 999862 45789999999999999999999999 99999999999999999999999999987543222 22334
Q ss_pred ccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCCh
Q 005001 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655 (720)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (720)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+..... ..++.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----------------~~~~~~~~~--~~~~~ 214 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----------------MYRKILQEP--LRFPD 214 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----------------HHHHHHcCC--CCCCC
Confidence 579999999999999999999999999999999999999997543211 111111111 12345
Q ss_pred hHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 005001 656 KSLSRFADIIALCVQPEPEFRPP---MSEVVQA 685 (720)
Q Consensus 656 ~~~~~l~~li~~cl~~dP~~RPs---~~ell~~ 685 (720)
..+..+.+++.+||+.||++||+ +.|++++
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 56678899999999999999975 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=327.08 Aligned_cols=259 Identities=22% Similarity=0.377 Sum_probs=206.5
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
..++|+..+.||+|+||.||+|.+. .+..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4677999999999999999999653 35679999986432 3344567889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceE
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDS------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 555 (720)
..++||||+++|+|.++++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998743211 23467888999999999999999998 999999999999999999999
Q ss_pred EcccCCCccCCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhcc
Q 005001 556 LSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATP 633 (720)
Q Consensus 556 l~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~ 633 (720)
|+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~------- 232 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR------- 232 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------
Confidence 99999987554322211 122345788999999999999999999999999999999 788886543221111
Q ss_pred ccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
...... ....+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 233 ---------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 ---------FVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---------HHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111111 11223455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=326.93 Aligned_cols=257 Identities=25% Similarity=0.425 Sum_probs=207.9
Q ss_pred cCCCccceeccCCCcEEEEEEEcC------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
.+|...+.||+|+||.||+|...+ +..||+|.+.... .......+.+|+++++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457778899999999999997643 4789999987543 233457889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhcc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFAD----------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 553 (720)
++||||+++++|.++++... .....+++.++..++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999997532 1234578999999999999999999999 9999999999999999999
Q ss_pred eEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhh
Q 005001 554 PHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWA 631 (720)
Q Consensus 554 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~ 631 (720)
++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~------ 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI------ 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH------
Confidence 99999999875433221 11223456788999999999999999999999999999999 99999754322111
Q ss_pred ccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 632 TPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
.... .......+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 235 ----------~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ----------ECIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----------HHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111 11111223456678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=327.83 Aligned_cols=250 Identities=36% Similarity=0.591 Sum_probs=198.9
Q ss_pred ccceeccCCCcEEEEEEEc-----CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 414 QEFLIGEGSLGRVYRAEFA-----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 414 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
..+.||.|.||.||+|.+. .+..|+||.++.. ........+.+|++.+++++||||++++|++...+..++|+|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 3568999999999999876 3568999999653 344557889999999999999999999999998888999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++|+|.++++.. ....+++.++..++.||++||.|||+. +++|+||+++||+++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999843 246789999999999999999999999 9999999999999999999999999999766322
Q ss_pred Cc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 569 ER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 569 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.. .......+...|+|||.+.+..++.++||||||+++|||++ |+.||...... ....++ .
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~----------------~~~~~~-~ 219 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE----------------EIIEKL-K 219 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH----------------HHHHHH-H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------cccccc-c
Confidence 22 22233457788999999999999999999999999999999 78888654221 111222 2
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
...+...+..++..+.+++.+||+.||++||++.++++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2223334556778899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.50 Aligned_cols=256 Identities=22% Similarity=0.307 Sum_probs=205.7
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
....++|+..+.||+|+||.||+|.+. +++.||+|.+..... .......+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999876 578999999864322 223345678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+++|+|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 119 YMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence 99999999999999986 34578999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccccccccccccccCccccccCC----CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGI----YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
..............||+.|+|||++.+.. ++.++||||+||++|||++|+.||...... .
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~----------------~ 254 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV----------------G 254 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH----------------H
Confidence 66433332334567999999999997643 788999999999999999999999754321 1
Q ss_pred HHHhhcccccCCCCC--hhHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 005001 640 ALAKMVDPALNGMYP--AKSLSRFADIIALCVQPEPEF--RPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 685 (720)
...++........++ ...+..+.+++..|+..++.+ |+++.|++++
T Consensus 255 ~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 255 TYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 112222211111122 234667889999999866654 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=323.05 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=204.7
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
.+|+..+.||+|+||.||+|.++++..+|+|.+..... ....+.+|+++++.++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 35778889999999999999888788899999864432 245678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.++++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 81 MANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred CCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 9999999998632 34789999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......... +.+...
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-----------------~~~~~~ 217 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-----------------ESVSAG 217 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-----------------HHHHcC
Confidence 221222234567999999999999999999999999999999 89999754321111 111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.....+...+.++.+++.+||..+|++||++.|+++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12223445677899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=322.17 Aligned_cols=255 Identities=29% Similarity=0.468 Sum_probs=207.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.++|++.+.||+|+||.||+|.+.++..||+|++..... ....+.+|+++++.++||||+++++++. .+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 456889999999999999999887777899999975432 2356889999999999999999998874 456899999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++|+|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999732 234679999999999999999999999 9999999999999999999999999999766443
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.........++..|+|||+..+..++.++||||||+++|||++ |..||......... ... ..
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~----------------~~~-~~ 218 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL----------------DQV-ER 218 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH----------------HHH-hc
Confidence 3222223456778999999999999999999999999999999 88888654322111 111 11
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
......+...+..+.+++.+||+.||++||++.++++.|++.
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 111122345667889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.68 Aligned_cols=268 Identities=23% Similarity=0.334 Sum_probs=197.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc--CCcEEEEEEccccccChHHHHHHHHHHHHhhcC---CCCCccccceEEe-----e
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA--NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---RHPNIVTLAGYCA-----E 479 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~ 479 (720)
++|+..+.||+|+||.||+|... +++.||+|++............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999763 467899998865443333334455666665554 7999999999875 2
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEccc
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 559 (720)
....++||||++ ++|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 5999988632 234689999999999999999999999 9999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhhc-ccccc
Q 005001 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWAT-PQLHD 637 (720)
Q Consensus 560 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~~~-~~~~~ 637 (720)
|++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+ .... +....
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 999765432 2233457899999999999999999999999999999999999999875543222111 1110 00000
Q ss_pred HHH---HH-hhcccccCC---CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 638 IDA---LA-KMVDPALNG---MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 638 ~~~---~~-~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... .. ......... ......+..+.+++.+||+.||++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 00 000000000 0011245677899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=326.73 Aligned_cols=261 Identities=26% Similarity=0.458 Sum_probs=209.8
Q ss_pred CCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
+|+..+.||+|+||.||+|... ....+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 3677889999999999999753 23568888886543 3344567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCC
Q 005001 485 LVYEYVGNGNLHDMLHFADD--------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~ 544 (720)
+|+||+.+++|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 99999999999999864321 124578999999999999999999998 9999999999
Q ss_pred CEEeCCCCceEEcccCCCccCCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCc
Q 005001 545 NILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPR 622 (720)
Q Consensus 545 NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~ 622 (720)
||++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999987654332211 122345678999999999899999999999999999999 99999754322
Q ss_pred chhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 623 SEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
.. ............+...+.++.+++.+||+.+|++||++.++++.|+++..+
T Consensus 237 ~~-----------------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 RL-----------------FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HH-----------------HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11 111111222233445667899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.67 Aligned_cols=268 Identities=22% Similarity=0.321 Sum_probs=200.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 367899999999999999999875 688999999864432 222345678999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+. ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 83 EYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred ECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 9996 588887753 245688999999999999999999999 999999999999999999999999999875432
Q ss_pred CCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHh--hccccccH---HH
Q 005001 568 TERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ-SLVRW--ATPQLHDI---DA 640 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~-~~~~~--~~~~~~~~---~~ 640 (720)
.. .......||+.|+|||++.+ ..++.++||||+||++|||++|..||......... ..+.. ..+..... ..
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 156 PS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 22 12233568999999999876 45889999999999999999999999865432111 11100 11100000 00
Q ss_pred HHhhcccccCCCCC---------hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 LAKMVDPALNGMYP---------AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.............+ ...+..+.+|+.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000000000001 0123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=340.45 Aligned_cols=253 Identities=25% Similarity=0.314 Sum_probs=206.0
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|...+.||+|+||.||+|... +|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999765 688999999976543 2334566788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999732 35789999999999999999999999 999999999999999999999999999986654
Q ss_pred CCccccccccccccccCccccc------cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 568 TERQVSTQMVGAFGYSAPEFAL------SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
..........||+.|+|||++. +..++.++|||||||++|||++|+.||........ .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------------~ 218 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT----------------Y 218 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH----------------H
Confidence 3333333457999999999987 45678999999999999999999999976433211 1
Q ss_pred Hhhcccc--cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDPA--LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.++.... .........+..+.+|+.+||+ +|.+||++++++++
T Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 219 NNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1111111 1111122356778899999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.85 Aligned_cols=244 Identities=24% Similarity=0.373 Sum_probs=199.9
Q ss_pred ceeccCCCcEEEEEEE----cCCcEEEEEEcccccc--ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 416 FLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+.||+|+||.||+++. .+++.||+|.++.... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 3578999999875432 222345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++|+|.+++.. .+.+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999862 45688899999999999999999999 99999999999999999999999999987543222
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...++....
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----------------~~~~~~~~~- 216 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----------------TIDKILKGK- 216 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcCC-
Confidence 12234579999999999999999999999999999999999999997643211 111111111
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
...+...+..+.+++.+||+.||++|| ++.+++++
T Consensus 217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 123445567889999999999999999 78888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.52 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=198.9
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHH---hhcCCCCCccccceEEeecCeEEEE
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSN---MSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
|++.+.||+|+||.||+|.+. +++.||+|+++.... .......+.+|..+ ++.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999765 689999999975432 22234456666554 4567899999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++|+|..+++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999998885 35789999999999999999999999 99999999999999999999999999986533
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+..
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~----------------~~~i~~ 215 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV----------------FDSIVN 215 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHh
Confidence 222 122346799999999999999999999999999999999999999976432111 111111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
.. ..++...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 216 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 216 DE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 11 123445667889999999999999999 56777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=328.56 Aligned_cols=264 Identities=27% Similarity=0.454 Sum_probs=212.8
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEcC------CcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEe
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (720)
....++|+..+.||+|+||.||++.... ...+|+|.+.... .......+.+|++++.++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3445678889999999999999997642 3678999887543 334456788999999999 8999999999999
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCE
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFAD------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 546 (720)
..+..++||||+++|+|.++++... .....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999996422 2345789999999999999999999998 999999999999
Q ss_pred EeCCCCceEEcccCCCccCCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcch
Q 005001 547 LLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSE 624 (720)
Q Consensus 547 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~ 624 (720)
+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 99999999999999998664432211 122235678999999999999999999999999999998 999986543211
Q ss_pred hhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 005001 625 QSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690 (720)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 690 (720)
..+..........+...+..+.+++.+||..||++|||+.|+++.|++++
T Consensus 243 ----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 ----------------LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111112222234456678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=338.71 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=197.2
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.+|+..+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 44666788999999999999765 68999999986433 33445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++|+|.+. ....+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 153 ~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 153 FMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred cCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999998653 2345677889999999999999999 9999999999999999999999999999765432
Q ss_pred CccccccccccccccCcccccc-----CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 569 ERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
.. ......||..|+|||++.. ...+.++|||||||++|||++|+.||............ .
T Consensus 222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~--------------~ 286 (353)
T PLN00034 222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM--------------C 286 (353)
T ss_pred cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH--------------H
Confidence 21 2234579999999998753 23456899999999999999999999743322111111 1
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..........+...+.++.+||.+||+.||++||++.|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 287 AICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 010111122334566789999999999999999999999976
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=322.77 Aligned_cols=255 Identities=25% Similarity=0.446 Sum_probs=208.6
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
..++|+..++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 3467888999999999999999988899999999875443 2457889999999999999999999864 56789999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+.+++|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999998632 345789999999999999999999998 999999999999999999999999999876653
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
..........++..|+|||++.+..++.++||||||+++|||++ |+.||......... +.+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~~~~ 217 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-----------------QNLE 217 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH-----------------HHHH
Confidence 32222233456778999999999999999999999999999999 99999754322111 1111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
.......+...+.++.+++.+||+.+|++||++++++..|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111122334456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.06 Aligned_cols=261 Identities=25% Similarity=0.421 Sum_probs=213.4
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||+|... +|+.||+|.++.... .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999776 789999998864322 3344678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++.........+++.++..++.|++.||+|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999875544456789999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .. ..+....
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~--------------~~~~~~~ 222 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YS--------------LCKKIEK 222 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-HH--------------HHhhhhc
Confidence 221 1233468899999999999999999999999999999999999996433110 00 0011111
Q ss_pred ccCCCCCh-hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 648 ALNGMYPA-KSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 648 ~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
......+. ..+..+.+++.+||..+|++||++.+|++.|.++
T Consensus 223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11111222 4566889999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=320.05 Aligned_cols=247 Identities=27% Similarity=0.403 Sum_probs=201.7
Q ss_pred eeccCCCcEEEEEEEc---CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCC
Q 005001 417 LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
.||+|+||.||+|.++ +++.+|+|+++.........+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 5788999998765545555678899999999999999999999875 45679999999999
Q ss_pred CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc-
Q 005001 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV- 572 (720)
Q Consensus 494 sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~- 572 (720)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||.||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999862 35689999999999999999999999 99999999999999999999999999997664433211
Q ss_pred -cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccC
Q 005001 573 -STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650 (720)
Q Consensus 573 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (720)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||........ .+.+.....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-----------------~~~i~~~~~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-----------------TQMIESGER 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHHCCCC
Confidence 112234678999999988889999999999999999998 9999975432211 111112222
Q ss_pred CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 651 GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 651 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
...+...+.++.++|.+||+.||++||++.+|.+.|++
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 23455677889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=321.68 Aligned_cols=254 Identities=30% Similarity=0.481 Sum_probs=206.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.++|++.+.||+|+||.||+|...++..+|+|.+...... ...+.+|+.++++++|+|++++++++. .+..++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 4578889999999999999999888889999999754432 356889999999999999999999875 456899999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.++++.. ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999998732 235689999999999999999999999 9999999999999999999999999999765443
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||........ ... +..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~----------------~~~-~~~ 218 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV----------------LEQ-VER 218 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH----------------HHH-HHc
Confidence 3222223345678999999998899999999999999999999 8899965432111 111 111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
......+...+..+.+++.+||..+|++||++.++.+.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11222344566789999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.65 Aligned_cols=262 Identities=23% Similarity=0.384 Sum_probs=212.9
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.+|...+.||+|+||.||+|.. .+++.+++|.+..... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3677888999999999999975 4789999998864332 3344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.++++........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875444456789999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
... ......|+..|+|||.+.+..++.++||||||+++|||++|..||......... ........
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~ 223 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--------------LCKKIEQC 223 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH--------------HhhhhhcC
Confidence 222 122346889999999999999999999999999999999999999653321100 00111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
......+...+..+.+++.+||+.||++|||+.+|++.+.++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111112234667899999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=324.30 Aligned_cols=264 Identities=24% Similarity=0.390 Sum_probs=213.0
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcC-----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee-cC
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HG 481 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 481 (720)
..++|...+.||+|+||.||+|.+.+ +..|++|++.... .......+.+|+.++++++||||+++++++.. +.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 34678888999999999999998765 6889999886432 44556778899999999999999999998765 56
Q ss_pred eEEEEEEecCCCCHHHHhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEc
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDS----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 557 (720)
..++++||+++++|.+++...... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998754322 15689999999999999999999998 99999999999999999999999
Q ss_pred ccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhcccc
Q 005001 558 DCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQL 635 (720)
Q Consensus 558 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 635 (720)
|||+++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||....+....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---------- 229 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA---------- 229 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH----------
Confidence 99999865433222 1122346778999999999999999999999999999999 99999764332111
Q ss_pred ccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 636 HDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
...........+..++..+.+++.+||+.||++||++.++++.|.++.++
T Consensus 230 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 230 -------AYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -------HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11111111122334567889999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.06 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=203.1
Q ss_pred CccceeccCCCcEEEEEEEcCC-c--EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec------CeE
Q 005001 413 SQEFLIGEGSLGRVYRAEFANG-K--IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------GQR 483 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 483 (720)
.+.+.||+|+||.||+|.+.+. . .||+|.++...........+.+|+.+++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999987543 2 589999876555556677889999999999999999999986432 246
Q ss_pred EEEEEecCCCCHHHHhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 484 LLVYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999875322 2234589999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 562 AALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 562 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
+.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----------- 224 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IY----------- 224 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH-----------
Confidence 98664332211 122346778999999999999999999999999999999 888986533211 10
Q ss_pred HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
.... .......+...+..+.+++.+||+.||++||++.++++.|+++
T Consensus 225 --~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 225 --DYLR-QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --HHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 1111123345667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=326.79 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=200.9
Q ss_pred eccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCH
Q 005001 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (720)
Q Consensus 418 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 495 (720)
||+|+||+||++... +++.||+|++...... ......+..|+++++.++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999765 6889999998654332 22335677899999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcccccc
Q 005001 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (720)
Q Consensus 496 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 575 (720)
.+++.........+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988864444456799999999999999999999999 999999999999999999999999999876543222 2234
Q ss_pred ccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCCh
Q 005001 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655 (720)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (720)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ......... ...++.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~------------~~~~~~~~~--~~~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK------------ELKQRILND--SVTYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH------------HHHHhhccc--CCCCcc
Confidence 578999999999999999999999999999999999999997543221110 011111111 112344
Q ss_pred hHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 656 KSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 656 ~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
..+..+.+++.+||+.||++|| ++++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 5667889999999999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.41 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=213.0
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCC-cEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceE-Eee-----
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANG-KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGY-CAE----- 479 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~----- 479 (720)
...++++++.|.+|||+.||+|....+ ..||+|++-.. .......+.+|+++|++++ |+|||.+++. ...
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 345677889999999999999988766 99999999654 4566778899999999995 9999999993 211
Q ss_pred -cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcc
Q 005001 480 -HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (720)
Q Consensus 480 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 558 (720)
.-+.+|.||||.||.|-|++.... ...+++.++++|+.|+++|+++||.. .|+|||||||-|||||+.+|..||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 136789999999999999997433 34599999999999999999999987 56899999999999999999999999
Q ss_pred cCCCccCCCCC-ccc-------cccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH
Q 005001 559 CGLAALTPNTE-RQV-------STQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL 627 (720)
Q Consensus 559 fg~a~~~~~~~-~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~ 627 (720)
||.+.-.-... ... .....-|+-|+|||++. +..+++|+|||+|||+||-|+....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99986322111 111 11245799999999874 67799999999999999999999999986422
Q ss_pred HHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 628 VRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
..++...+........+..+.+||+.||+.||.+||++-+++.++.++.+..-
T Consensus 264 --------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 264 --------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred --------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 12333344333345678899999999999999999999999999998876543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.15 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=203.0
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999775 689999999975432 2234456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999863 45789999999999999999999999 999999999999999999999999999865422
Q ss_pred CCcc-------------------------------------ccccccccccccCccccccCCCcccchhhhHHHHHHHHH
Q 005001 568 TERQ-------------------------------------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELL 610 (720)
Q Consensus 568 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ell 610 (720)
.... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc--cCCCCChhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 005001 611 TGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA--LNGMYPAKSLSRFADIIALCVQPEPEFRPP---MSEVVQA 685 (720)
Q Consensus 611 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~ 685 (720)
+|..||....+.... .++.... .........+..+.+++.+|+. +|.+|++ +.+++++
T Consensus 234 ~G~~Pf~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQETY----------------RKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHHHH----------------HHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999765432111 1111111 1111111345678899999997 9999997 9998875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.48 Aligned_cols=249 Identities=29% Similarity=0.436 Sum_probs=208.6
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
...|...+.||.|+||.||-|++ .+.+.||||++..... +.+.+.+++.|+..+++++|||++.+.|+|-.+...|+|
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 34567778899999999999965 4788999999974432 455678999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
||||-| +-.|++... .+++.+.++..|..+.+.||+|||+. +.||||||+.|||+++.|.|||+|||.|....
T Consensus 105 MEYClG-SAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHhc-cHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 999965 777877643 57888999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 567 NTERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
+ ...++|||.|||||++. .+.|+-++||||||++..||...++|+..++.. ..+..
T Consensus 178 P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM----------------SALYH 236 (948)
T KOG0577|consen 178 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALYH 236 (948)
T ss_pred c-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH----------------HHHHH
Confidence 3 34689999999999986 477999999999999999999999998765432 22222
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+...........+.+..+.+|+..||++-|.+|||..+++++
T Consensus 237 IAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 237 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 222221122245678889999999999999999999998875
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=342.36 Aligned_cols=261 Identities=19% Similarity=0.279 Sum_probs=199.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|.+. +++.||+|+.. ...+.+|++++++++||||+++++++...+..++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 467999999999999999999764 68899999653 234678999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|++. ++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 163 e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9995 688888762 45689999999999999999999999 999999999999999999999999999975433
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcch-----h---hHHHhh-c-c-cc-
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSE-----Q---SLVRWA-T-P-QL- 635 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~-----~---~~~~~~-~-~-~~- 635 (720)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+... . + .+
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 222233346799999999999999999999999999999999999988764332110 0 011000 0 0 00
Q ss_pred -ccHHHHHhh----cccccC--CCCC-----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 636 -HDIDALAKM----VDPALN--GMYP-----AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 636 -~~~~~~~~~----~~~~~~--~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.....+... ...... ...+ ...+.++.+|+.+||+.||++|||++|++++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000011110 000000 0000 1245678999999999999999999999965
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=341.81 Aligned_cols=252 Identities=22% Similarity=0.279 Sum_probs=200.6
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.|+..+.||+|+||+||+|... +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999664 688999999975432 33345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999863 45688999999999999999999999 9999999999999999999999999997532110
Q ss_pred C----------------------------------------------ccccccccccccccCccccccCCCcccchhhhH
Q 005001 569 E----------------------------------------------RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSF 602 (720)
Q Consensus 569 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 602 (720)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 000123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc--cccCCCCChhHHHHHHHHHHHh--cCCCCCCCCC
Q 005001 603 GVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD--PALNGMYPAKSLSRFADIIALC--VQPEPEFRPP 678 (720)
Q Consensus 603 Gv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~c--l~~dP~~RPs 678 (720)
||++|||++|+.||....+..... ++.. ...........+.++.+++.+| +..+|..||+
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~----------------~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQL----------------KVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHH----------------HHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCC
Confidence 999999999999997654321111 1111 0111111223456788899884 4556666999
Q ss_pred HHHHHHH
Q 005001 679 MSEVVQA 685 (720)
Q Consensus 679 ~~ell~~ 685 (720)
+.+++++
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.67 Aligned_cols=262 Identities=25% Similarity=0.422 Sum_probs=209.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
.++|.+.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 356888899999999999999742 3456899988643 23445678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhcc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc
Q 005001 483 RLLVYEYVGNGNLHDMLHFAD---------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 553 (720)
.++||||+++++|.+++.... .....+++.++..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999999997432 1223589999999999999999999999 9999999999999999999
Q ss_pred eEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhh
Q 005001 554 PHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWA 631 (720)
Q Consensus 554 ~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~ 631 (720)
++|+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~------- 231 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------- 231 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 999999998765432211 1222345778999999999999999999999999999999 8999875432211
Q ss_pred ccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 632 TPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
...+..... ...+...+.++.+++.+||+.||.+||++.++++.|+++.+.
T Consensus 232 ---------~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 ---------IECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ---------HHHHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111111111 112233556789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.83 Aligned_cols=258 Identities=23% Similarity=0.423 Sum_probs=206.6
Q ss_pred CCccceeccCCCcEEEEEEEcC----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe-----
Q 005001 412 FSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ----- 482 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 482 (720)
|...+.||+|+||.||+|.... +..||+|+++...........+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999997642 3679999998665555566788999999999999999999998766544
Q ss_pred -EEEEEEecCCCCHHHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEccc
Q 005001 483 -RLLVYEYVGNGNLHDMLHFADD--SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (720)
Q Consensus 483 -~~lV~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 559 (720)
.++|+||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7999999999999998854321 234689999999999999999999999 9999999999999999999999999
Q ss_pred CCCccCCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhcccccc
Q 005001 560 GLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 560 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-------------- 223 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-------------- 223 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--------------
Confidence 9998654332221 112235678999999998899999999999999999999 888886533211
Q ss_pred HHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
....... ......+...+..+.+++.+||+.||++||++.|+++.|.++
T Consensus 224 --~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 224 --IYDYLRH-GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --HHHHHHc-CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111 111223445677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.56 Aligned_cols=244 Identities=23% Similarity=0.337 Sum_probs=199.9
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
+.||+|+||.||++... +|+.||+|.+..... .......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999764 689999999975432 2334566788999999999999999999999999999999999999
Q ss_pred CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 494 sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
+|.+++. ....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 9999886 24578999999999999999999997 6 999999999999999999999999999875432221 2
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~----------------~i~~~--~~~ 214 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----------------LILME--EIR 214 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH----------------HHhcC--CCC
Confidence 233579999999999999999999999999999999999999997543211111 11111 112
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
++...+.++.+++.+||+.||++|+ ++.+++++
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 3445567889999999999999996 89999866
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.72 Aligned_cols=262 Identities=24% Similarity=0.405 Sum_probs=210.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
.+|...+.||+|+||.||+|... ++..+++|.+.... ......+.+|++.+++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 45777889999999999999643 35568889886433 33456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC
Q 005001 484 LLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 551 (720)
++||||+++++|.++++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 999999999999999974321 224589999999999999999999999 99999999999999999
Q ss_pred CceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 005001 552 LNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVR 629 (720)
Q Consensus 552 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~ 629 (720)
+.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||+| |..||.........
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---- 235 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---- 235 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----
Confidence 9999999999876543221 11233456789999999999999999999999999999999 99998764432111
Q ss_pred hhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 630 WATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
..+.. ......+...+..+.+++.+||+.||++||+++++++.|+++.+..
T Consensus 236 ------------~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 236 ------------ECITQ-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred ------------HHHhC-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 11111 1111123345677899999999999999999999999999986653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.34 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=208.4
Q ss_pred cCCCccceeccCCCcEEEEEEEcC-Cc--EEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFAN-GK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
++|+..+.||+|+||.||+|...+ +. .+++|.++... .....+.+.+|+.++.++ +||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 468888999999999999997653 33 46888876322 334456788999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc
Q 005001 486 VYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 553 (720)
|+||+++++|.++++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 9999999999999964321 123588999999999999999999998 9999999999999999999
Q ss_pred eEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 005001 554 PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWAT 632 (720)
Q Consensus 554 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~ 632 (720)
+||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 158 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-------- 227 (297)
T cd05089 158 SKIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-------- 227 (297)
T ss_pred EEECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--------
Confidence 99999999864321111 111223557999999999999999999999999999998 9999975432111
Q ss_pred cccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcc
Q 005001 633 PQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695 (720)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 695 (720)
..+ .........+..++..+.+++.+||+.+|.+||++.++++.|+++.+....
T Consensus 228 --------~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 228 --------YEK-LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred --------HHH-HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111 111122223445667889999999999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=339.33 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=211.4
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEe
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCA 478 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 478 (720)
+...++|.+.+.||+|+||.||+|.+. .++.||+|+++... .......+.+|+.++.++. ||||+++++++.
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 334556888899999999999999764 34689999997543 2333457889999999997 999999999999
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhccC------------------------------------------------------
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFADD------------------------------------------------------ 504 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------ 504 (720)
..+..++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCC
Q 005001 505 ----------------------------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (720)
Q Consensus 505 ----------------------------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~ 544 (720)
....+++..+..++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112467788899999999999999998 9999999999
Q ss_pred CEEeCCCCceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCc
Q 005001 545 NILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPR 622 (720)
Q Consensus 545 NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~ 622 (720)
|||+++++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999976432221 11223457889999999999999999999999999999998 88998653321
Q ss_pred chhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 005001 623 SEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690 (720)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 690 (720)
. ...+.+........+...+..+.+++.+||+.+|++||+++||++.|++++
T Consensus 349 ~----------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 E----------------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 111111222222334456778999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=338.32 Aligned_cols=267 Identities=22% Similarity=0.333 Sum_probs=205.7
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC-----eEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-----QRL 484 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 484 (720)
+|+..+.||+|+||.||+|... +|+.||+|++............+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778889999999999999764 7899999998755434445567889999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+|+||+. ++|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 58888775 356789999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh--hccccccHH--
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW--ATPQLHDID-- 639 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~-- 639 (720)
.............+|+.|+|||++.+. .++.++||||+||++|||++|+.||....+......+.. ..+......
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 544333333445689999999999874 478999999999999999999999987654332222211 011111000
Q ss_pred --HHHhhccc-ccCC-------CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 --ALAKMVDP-ALNG-------MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 --~~~~~~~~-~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.....+.. .... ......+.++.+|+.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 0000 1112335678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=336.55 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=218.3
Q ss_pred CCccceeccCCCcEEEEEEE-cCCc----EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 412 FSQEFLIGEGSLGRVYRAEF-ANGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.+.+++||+|+||+||+|.+ .+|+ +||+|++.... ..+...++++|+..|.+++|||++++++++.... ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34567899999999999954 4454 57888886544 4455678999999999999999999999997665 8899
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
++||+.|+|.|++++ .+..+-.+..+.+..|||+|+.|||++ ++|||||.++|||+.....+||.|||+++...
T Consensus 776 tq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 999999999999986 356788888999999999999999999 99999999999999999999999999999887
Q ss_pred CCCcccccc-ccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 567 NTERQVSTQ-MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 567 ~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
.++...... ..-.+.|||-|.+....|+.++|||||||++||++| |..|+++..- +.+.+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI~dl 912 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEIPDL 912 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHhhHH
Confidence 766554432 234568999999999999999999999999999999 9999986432 334444
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
+....+...|+.++.++..+|.+||..|++.||+++++..++.++...
T Consensus 913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 555556678889999999999999999999999999999999887653
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=338.37 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=199.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||+||+|... +++.||+|++..... .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999765 588999999975432 2233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999862 46789999999999999999999999 999999999999999999999999999875432
Q ss_pred CCc----------------------------------cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCC
Q 005001 568 TER----------------------------------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613 (720)
Q Consensus 568 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~ 613 (720)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCC--hhHHHHHHHHHHHhcC--CCCCCCCCHHHHHHH
Q 005001 614 KPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP--AKSLSRFADIIALCVQ--PEPEFRPPMSEVVQA 685 (720)
Q Consensus 614 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~--~dP~~RPs~~ell~~ 685 (720)
.||....+.... .++........+| ...+.++.+++.+++. .++..||++.||+++
T Consensus 234 ~Pf~~~~~~~~~----------------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQETY----------------KKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHHH----------------HHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 999765432111 1111100001111 1234567788887554 233356899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.47 Aligned_cols=247 Identities=23% Similarity=0.402 Sum_probs=199.9
Q ss_pred eeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCH
Q 005001 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 495 (720)
.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 6999999999999764 68899999886433 344567789999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc-cc
Q 005001 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-ST 574 (720)
Q Consensus 496 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~ 574 (720)
.++++. ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......... ..
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999862 235689999999999999999999999 99999999999999999999999999987543221111 11
Q ss_pred cccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCC
Q 005001 575 QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY 653 (720)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (720)
...++..|+|||.+.++.++.++|||||||++|||++ |..||........ ............
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-----------------~~~~~~~~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-----------------REAIEQGVRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-----------------HHHHHcCCCCCC
Confidence 1123457999999999999999999999999999998 8888865332111 111111122233
Q ss_pred ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 654 PAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 654 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 4456678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.54 Aligned_cols=247 Identities=25% Similarity=0.425 Sum_probs=201.7
Q ss_pred eeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCHH
Q 005001 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLH 496 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 496 (720)
+||+|+||.||+|...++..||+|.+.... .......+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 699999999999998889999999987543 3344557889999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccccccc
Q 005001 497 DMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM 576 (720)
Q Consensus 497 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 576 (720)
+++.. ....+++..+..++.|++.||.|+|+. +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 98863 234678999999999999999999998 999999999999999999999999999875433221111222
Q ss_pred cccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCCh
Q 005001 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655 (720)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (720)
.++..|+|||++.+..++.++||||||+++|||++ |..||.......... .+........+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-----------------QVEKGYRMSCPQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-----------------HHHcCCCCCCCC
Confidence 44678999999999999999999999999999998 999997543211110 111111222344
Q ss_pred hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 656 KSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 656 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
..+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 56678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=333.09 Aligned_cols=244 Identities=22% Similarity=0.370 Sum_probs=197.1
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||.||+|... +++.||+|++..... .......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999775 588999999875432 223445667788887766 799999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999998863 45789999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------------~~~i~~~~--~~ 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL----------------FEAILNDE--VV 214 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----------------HHHHhcCC--CC
Confidence 2345799999999999999999999999999999999999999976432111 11111111 12
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRPPM------SEVVQA 685 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~ 685 (720)
.+...+.++.+++.+||+.||++||++ ++++++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 344456778999999999999999998 556554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.16 Aligned_cols=253 Identities=28% Similarity=0.493 Sum_probs=204.9
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
++|++.+.||+|+||.||+|....+..+|+|.+..... ..+.+.+|++++++++|+|++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 56888899999999999999888777899998865432 2456888999999999999999998875 4568999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+.+++|.++++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999732 234589999999999999999999999 99999999999999999999999999997654332
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
........++..|+|||...+..++.++||||||+++|||++ |+.||........ ...+ ...
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----------------~~~~-~~~ 219 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV----------------LEQV-ERG 219 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHH-HcC
Confidence 222223346778999999999999999999999999999999 8999975432111 0111 111
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
.....+...+..+.+++.+||..||++||+++++++.|++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122344566789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.90 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=200.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|...+.||+|+||.||+|... +++.||+|++..... .......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999664 689999999865432 2334567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999862 46788999999999999999999999 999999999999999999999999999863321
Q ss_pred CCcc----------------------------------------------ccccccccccccCccccccCCCcccchhhh
Q 005001 568 TERQ----------------------------------------------VSTQMVGAFGYSAPEFALSGIYTVKSDVYS 601 (720)
Q Consensus 568 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 601 (720)
.... .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc--cccCCCCChhHHHHHHHHHHHhcCCCCCCC---
Q 005001 602 FGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD--PALNGMYPAKSLSRFADIIALCVQPEPEFR--- 676 (720)
Q Consensus 602 lGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~R--- 676 (720)
|||++|||++|..||......... .++.. ...........+.++.+++.+|+. +|.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~----------------~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETY----------------RKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHH----------------HHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 999999999999999764432111 11111 011111112345678899999998 67665
Q ss_pred CCHHHHHHH
Q 005001 677 PPMSEVVQA 685 (720)
Q Consensus 677 Ps~~ell~~ 685 (720)
+++.|++++
T Consensus 297 ~~~~~~l~h 305 (377)
T cd05629 297 GGAHEIKSH 305 (377)
T ss_pred CCHHHHhcC
Confidence 599999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.45 Aligned_cols=262 Identities=25% Similarity=0.420 Sum_probs=207.9
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCc--EEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
++|+..+.||+|+||.||+|.+. ++. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 56888899999999999999764 444 4577776532 2344566788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc
Q 005001 486 VYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 553 (720)
||||+++++|.++++.... ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999974321 123688999999999999999999999 9999999999999999999
Q ss_pred eEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 005001 554 PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWAT 632 (720)
Q Consensus 554 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~ 632 (720)
+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|||+| |..||........
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------- 232 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------- 232 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--------
Confidence 9999999986432111 1111234668999999988889999999999999999998 9999965432111
Q ss_pred cccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 633 PQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
.+..........+...+..+.+++.+||+.+|++||++.++++.|+++.+...
T Consensus 233 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 233 ---------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ---------HHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 01111111112233456678999999999999999999999999999877664
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.51 Aligned_cols=240 Identities=25% Similarity=0.368 Sum_probs=198.0
Q ss_pred ceeccCCCcEEEEEEE----cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecC
Q 005001 416 FLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 491 (720)
+.||+|+||.||+++. .+|+.||+|++............+.+|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999965 357899999997654444445667789999999999999999999999999999999999
Q ss_pred CCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc
Q 005001 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (720)
Q Consensus 492 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 571 (720)
+|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 999999886 245789999999999999999999999 99999999999999999999999999987653322 1
Q ss_pred ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCC
Q 005001 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG 651 (720)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (720)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.... .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----------------~~~~i~~~~--~ 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE----------------TMTMILKAK--L 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH----------------HHHHHHcCC--C
Confidence 2234579999999999999889999999999999999999999997543211 111111111 1
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCCCCCHHH
Q 005001 652 MYPAKSLSRFADIIALCVQPEPEFRPPMSE 681 (720)
Q Consensus 652 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 681 (720)
..+...+..+.+++++||+.||++||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 234456677899999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.86 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=210.2
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
..++|.+.+.||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++|+||+++++++......++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 4567889999999999999999988888999999875433 3456889999999999999999999999889999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++... ....+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999999732 235789999999999999999999999 999999999999999999999999999876653
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
..........++..|+|||.+.+..++.++||||+|+++|||++ |+.||........ ..++ .
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~----------------~~~~-~ 218 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV----------------LEQV-E 218 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHH-H
Confidence 22222223345678999999999999999999999999999999 9999965432111 1111 1
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
.......+...+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111222334456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.03 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=203.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCc----EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
++|+..+.||+|+||+||+|.+. +++ .+++|.+.... ......++..|+..+++++||||+++++++. ....+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 46778889999999999999764 344 47788875332 2334466778888899999999999999875 45678
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+++||+++|+|.++++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 99999999999999973 245789999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 565 TPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 565 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
....... ......++..|+|||.+.++.++.++|||||||++|||++ |..||....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~---------------- 222 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD---------------- 222 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----------------
Confidence 5433221 2233457788999999999999999999999999999998 999997644321111
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
.+........+..++..+.+++.+||..||++||++.|+++.|..+..
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 223 -LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -HHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111111112233345678899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.01 Aligned_cols=265 Identities=26% Similarity=0.435 Sum_probs=211.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEc--------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEee
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (720)
.++|.+.+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 457889999999999999999753 23569999997543 334456788899999999 79999999999999
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEE
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIl 547 (720)
.+..++||||+++|+|.++++.... ....+++.++.+++.|++.||+|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 9999999999999999999975322 123588999999999999999999998 9999999999999
Q ss_pred eCCCCceEEcccCCCccCCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchh
Q 005001 548 LDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQ 625 (720)
Q Consensus 548 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~ 625 (720)
++.++.+||+|||.+.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--- 249 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 249 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---
Confidence 9999999999999987654322111 111234568999999999999999999999999999998 88888643211
Q ss_pred hHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 626 SLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
.+.+.+........+...+.++.+++.+||..+|++||++.++++.|.++....+
T Consensus 250 --------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 250 --------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred --------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 1111111122223344566789999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=330.95 Aligned_cols=243 Identities=21% Similarity=0.348 Sum_probs=194.2
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhc-CCCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||.||+|... +++.||+|.++.... .......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999765 578899999875432 22233445556666654 4899999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999998862 45789999999999999999999999 99999999999999999999999999987543222 22
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.. ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~----------------~~~i~~--~~~~ 214 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL----------------FDSILN--DRPH 214 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHc--CCCC
Confidence 3345799999999999999999999999999999999999999976432111 111111 1122
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRPPMS-EVVQ 684 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~ 684 (720)
++...+.++.+++.+||+.||++||++. ++++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 3445667788999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.96 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=207.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC---hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
+.|...+.||+|++|.||+|... +++.||+|.+...... ......+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999764 6899999988644322 2234568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999863 35688999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCcccc--ccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 566 PNTERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 566 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
........ ....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~~~~ 218 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA----------------AIFK 218 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH----------------HHHH
Confidence 43221111 23467889999999999999999999999999999999999997543211 1111
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..........+...+..+.+++.+||..+|.+||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 112222233455667788999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.93 Aligned_cols=258 Identities=24% Similarity=0.449 Sum_probs=206.5
Q ss_pred cCCCccceeccCCCcEEEEEEE-----cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
.+|+..+.||+|+||.||+|.. ..+..|++|.+.... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4577788999999999999974 246789999997543 3344567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC
Q 005001 485 LVYEYVGNGNLHDMLHFADD-------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 551 (720)
+||||+++++|.+++..... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 99999999999999853211 123578899999999999999999999 99999999999999999
Q ss_pred CceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 005001 552 LNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVR 629 (720)
Q Consensus 552 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~ 629 (720)
+.+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------ 234 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------ 234 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 9999999999976533221 12233456778999999998889999999999999999999 989986543211
Q ss_pred hhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 630 WATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
..+.+........+..++..+.+++.+||+.||++||++.+|+++|..
T Consensus 235 -----------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 -----------VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -----------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111112344566788999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.75 Aligned_cols=268 Identities=25% Similarity=0.398 Sum_probs=208.3
Q ss_pred CCccceeccCCCcEEEEEEE-----cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec--CeEE
Q 005001 412 FSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRL 484 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 484 (720)
|...+.||+|+||+||++.. .++..||+|.+.... .......+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 37889999999999988643 357889999987543 233456788999999999999999999987653 4679
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++++|.+++. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 85 LIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999999986 34689999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccc--cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 565 TPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 565 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
........ .....++..|+|||.+.+..++.++||||||+++|||+||..||........ ......... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~ 234 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVRLI 234 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhhhh
Confidence 64322211 1223456679999999988999999999999999999999999865432211 111111101 1111222
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 690 (720)
...+.......+...+..+.+++.+||+.||++||+++++++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222223333345566788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=325.75 Aligned_cols=265 Identities=26% Similarity=0.443 Sum_probs=212.1
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc--------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (720)
....+|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 34567888899999999999999642 24579999886542 344557788999999999 899999999999
Q ss_pred eecCeEEEEEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCC
Q 005001 478 AEHGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545 (720)
Q Consensus 478 ~~~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~N 545 (720)
...+..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999975321 124578899999999999999999999 99999999999
Q ss_pred EEeCCCCceEEcccCCCccCCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcc
Q 005001 546 ILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRS 623 (720)
Q Consensus 546 Ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~ 623 (720)
|+++.++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 999999999999999998664432221 222346778999999999999999999999999999998 788886532211
Q ss_pred hhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 624 EQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
+.+.+........+..++..+.+++.+||+.+|++||++.|+++.|.++..-
T Consensus 248 -----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 -----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111112223445677899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=325.31 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=205.4
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.|+..+.||+|+||.||++... +++.||+|++...... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778889999999999999764 6889999998754332 2234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888632 235689999999999999999999999 9999999999999999999999999998765432
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
. ......|++.|+|||++.+..++.++||||+||++|||++|+.||......... +.+...+. .
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-------------~~~~~~~~-~ 219 (285)
T cd05605 156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-------------EEVERRVK-E 219 (285)
T ss_pred C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-------------HHHHHHhh-h
Confidence 2 123357899999999999999999999999999999999999999764332111 01111111 1
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
....++...+..+.+++.+||+.||++|| ++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11223445667789999999999999999 78888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.06 Aligned_cols=252 Identities=25% Similarity=0.432 Sum_probs=209.4
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|...+.||+|+||.||+|... +++.|++|.+............+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3677889999999999999765 689999999876555566677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.++++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999742 246789999999999999999999998 99999999999999999999999999987654432
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
. ......|++.|+|||++.+..++.++|+||||+++|||++|+.||....... ...+... ..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~-~~ 217 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA----------------LILKIIR-GV 217 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHc-CC
Confidence 2 2233568899999999999999999999999999999999999997543211 1111111 11
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 112233556789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=313.40 Aligned_cols=248 Identities=27% Similarity=0.449 Sum_probs=211.4
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
|.++.+||+|+||.||+|.++ .|+.+|||++... .+.+++.+|+.++++++.|+||++||.+..+..+|+|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 666788999999999999665 6999999999643 34678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
..|++.+.++. .+++++++++..+++..++||+|||.. .-||||||+.|||++.+|.+|++|||.+..+.+. -
T Consensus 111 GAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-M 183 (502)
T KOG0574|consen 111 GAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-M 183 (502)
T ss_pred CCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-H
Confidence 99999999973 468999999999999999999999999 8899999999999999999999999999765432 2
Q ss_pred cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccC
Q 005001 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (720)
.......|||.|||||++..-.|+.++||||||++..||..|++||..-.+......+ | ..+...
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----P-----------T~PPPT 248 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----P-----------TKPPPT 248 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----c-----------CCCCCC
Confidence 2345678999999999999999999999999999999999999999754332111000 0 112233
Q ss_pred CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 651 GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 651 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...|+..+.++.+++++||-++|++|-|+.+++++
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 34577788899999999999999999999998876
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=332.33 Aligned_cols=249 Identities=21% Similarity=0.326 Sum_probs=200.6
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCC-CCccccceEEeecCeEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRH-PNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 487 (720)
+|+..+.||+|+||.||+|... +++.||+|++..... .......+..|..++..++| ++|+.+++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999765 578899999875432 23345667888888888876 45888999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999886 245689999999999999999999999 999999999999999999999999999864322
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. .......||+.|+|||++.+..++.++||||+||++|||+||+.||........ ...+...
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~----------------~~~i~~~ 216 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----------------FQSIMEH 216 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHcC
Confidence 11 122345799999999999999999999999999999999999999975432111 1111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPM-----SEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~ 685 (720)
...++...+.++.+++.+||+.||.+|++. .+++++
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 --NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 122344566788899999999999999986 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=321.36 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=217.3
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
..-|..++.||+|.|+.|-+|++- +|++||||++.+.....-....+.+|++.|+.++|||||++|++...+..+|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 345788889999999999999664 7999999999988887777888999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe-CCCCceEEcccCCCccCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL-DDELNPHLSDCGLAALTP 566 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~Dfg~a~~~~ 566 (720)
|.=++|+|+|+|-. ....+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+ ..-|.+||+|||++-.+.
T Consensus 97 ELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999963 356789999999999999999999999 89999999999976 556899999999987654
Q ss_pred CCCccccccccccccccCccccccCCCc-ccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
+.. .-...+|+..|-|||++.+..|+ +++||||||||||-|++|+.||...+. .+.+-.++
T Consensus 171 PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----------------SETLTmIm 232 (864)
T KOG4717|consen 171 PGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----------------SETLTMIM 232 (864)
T ss_pred Ccc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------hhhhhhhh
Confidence 432 23457899999999999999996 679999999999999999999986543 23444556
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 684 (720)
|.++. .|...+.+..+||..||..||.+|-+.+||..
T Consensus 233 DCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 65543 57788999999999999999999999887764
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=325.06 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=209.1
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeec
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 480 (720)
..++|...+.||+|+||.||+|... .+..||+|+++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3457888999999999999999642 34579999887543 233456788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
+..++||||+.+|+|.++++.. ....+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.++++|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999732 123489999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccH
Q 005001 561 LAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 561 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
++......... ......++..|+|||.+.+..++.++||||+||++|||++ |..||.......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------------- 251 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------------- 251 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---------------
Confidence 98765433221 1222346788999999999999999999999999999998 999987543211
Q ss_pred HHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
...+..........+...+..+.+++.+||+.+|++||++.|+++.|.++
T Consensus 252 -~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 -KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111111122222334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=337.75 Aligned_cols=259 Identities=21% Similarity=0.281 Sum_probs=205.9
Q ss_pred cHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 404 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
.+....++|+..+.||+|+||.||+|.+. +++.||+|.+..... .......+.+|..+++.++||||+++++++...+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445678999999999999999999776 578899999864322 2233456778999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+++|+|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999986 34578899999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCccccccCC----CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGI----YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
+...............||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------------- 254 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------------- 254 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH--------------
Confidence 9866543333334567999999999997643 7899999999999999999999997643211
Q ss_pred HHHHHhhcccc--cCCCCChhHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHH
Q 005001 638 IDALAKMVDPA--LNGMYPAKSLSRFADIIALCVQPEPEF--RPPMSEVVQAL 686 (720)
Q Consensus 638 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L 686 (720)
...++.... .........+..+.+++.+|+..++.+ |+++.+++++.
T Consensus 255 --~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 255 --TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred --HHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111111 111112345677889999999844443 78999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=330.35 Aligned_cols=242 Identities=21% Similarity=0.319 Sum_probs=194.0
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhc-CCCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||.||+|.+. +|+.||+|.++..... ......+..|..++.. .+||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999775 5889999999754321 2234455667777765 4899999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++..... ...
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence 999998862 46789999999999999999999999 9999999999999999999999999998643221 122
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~----------------~~~~~~--~~~ 214 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF----------------ESIRVD--TPH 214 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH----------------HHHHhC--CCC
Confidence 33467999999999999999999999999999999999999999754321111 111111 112
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRPPMS-EVV 683 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell 683 (720)
.+...+.++.+++.+||+.||++||++. +++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3334566788999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.33 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=206.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
.++|...+.||+|+||.||+|.+.+ +..|++|.+.... .......+.+|+.+++.++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4678889999999999999997753 5678889886432 33445678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC---ceEE
Q 005001 483 RLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPHL 556 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl 556 (720)
.++||||+++++|.++++.... ....+++..+.+++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999975432 123589999999999999999999999 999999999999998754 5999
Q ss_pred cccCCCccCCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccc
Q 005001 557 SDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 557 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---------- 230 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---------- 230 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----------
Confidence 9999998653322111 112234568999999999999999999999999999997 9999975433211
Q ss_pred cccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
.+.+........+...+..+.+++.+||+.+|++||++.+++++|.
T Consensus 231 -------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 -------MEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111111222334556778999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=344.96 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=199.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-------
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------- 480 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 480 (720)
..+|...+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 457999999999999999999764 68899999885422 2234789999999999999999886432
Q ss_pred -CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC-ceEEcc
Q 005001 481 -GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSD 558 (720)
Q Consensus 481 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~D 558 (720)
...++||||+++ +|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 246799999975 78887765544567899999999999999999999999 999999999999999665 699999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-H-hhcccc
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-R-WATPQL 635 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~-~~~~~~ 635 (720)
||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.........+ . ...+..
T Consensus 215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99998654322 22345789999999998764 6899999999999999999999999865543222111 1 111111
Q ss_pred ccHHHH----Hh-----hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 636 HDIDAL----AK-----MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 636 ~~~~~~----~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...... .. .....+...+|...+.++.+|+.+||+.||.+||++.|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 100000 00 000111112334456788999999999999999999999966
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.33 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=208.5
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
.++|...+.||+|+||.||+|.... +..||+|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4678889999999999999997642 4689999986443 33445678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEE
Q 005001 483 RLLVYEYVGNGNLHDMLHFADD------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 556 (720)
.++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 9999999999999999974322 123478899999999999999999998 9999999999999999999999
Q ss_pred cccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccc
Q 005001 557 SDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 557 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++||+++ |..||.........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--------- 231 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL--------- 231 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---------
Confidence 999998765433221 1223456789999999998889999999999999999998 99998654322111
Q ss_pred cccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
+..........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 232 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 --------KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111122334556788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=331.42 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=198.1
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||.||+|... +++.||+|.+...... ......+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999765 5789999999765332 23445677888887766 899999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|..++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 99998886 246789999999999999999999999 999999999999999999999999999875332221 2
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH-HhhcccccCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL-AKMVDPALNG 651 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 651 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......+ ..+... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~--------~~~~~~~~~~~i~~~--~~ 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVILEK--QI 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc--------ccccHHHHHHHHhcC--CC
Confidence 23457999999999999999999999999999999999999999642211100 00000111 111111 12
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 005001 652 MYPAKSLSRFADIIALCVQPEPEFRPPM------SEVVQA 685 (720)
Q Consensus 652 ~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~ 685 (720)
..|...+..+.+++.+||+.||++||++ .+++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 3455566788999999999999999984 566655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=332.09 Aligned_cols=244 Identities=23% Similarity=0.353 Sum_probs=198.1
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
++||+|+||.||+|... +++.||+|.+..... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999775 578999999875432 233445677788888765 899999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 99999886 245789999999999999999999999 99999999999999999999999999987543222 12
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~----------------~~~i~~~~--~~ 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL----------------FESILHDD--VL 214 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH----------------HHHHHcCC--CC
Confidence 2345799999999999999999999999999999999999999976442211 11111111 12
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRP-------PMSEVVQA 685 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RP-------s~~ell~~ 685 (720)
++...+.++.+++.+||+.||++|| ++++++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 3344567788999999999999999 77888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=340.36 Aligned_cols=251 Identities=24% Similarity=0.301 Sum_probs=199.4
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
+|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999764 688999999875432 23345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999863 35688999999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------ccccccccccccccCccccccCCCcccchhhhH
Q 005001 569 E----------------------------------------------RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSF 602 (720)
Q Consensus 569 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 602 (720)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000123469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc--cccCCCCChhHHHHHHHHHHHhcCCCCCCCCC--
Q 005001 603 GVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD--PALNGMYPAKSLSRFADIIALCVQPEPEFRPP-- 678 (720)
Q Consensus 603 Gv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-- 678 (720)
||++|||++|+.||....+..... ++.. ...........+.++.+++.+|+ .+|++|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~----------------~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~ 297 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQM----------------KVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKN 297 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHH----------------HHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCC
Confidence 999999999999998654321111 1111 11111112234566778888876 59999987
Q ss_pred -HHHHHHH
Q 005001 679 -MSEVVQA 685 (720)
Q Consensus 679 -~~ell~~ 685 (720)
+.+++++
T Consensus 298 ~~~ei~~h 305 (382)
T cd05625 298 GADEIKAH 305 (382)
T ss_pred CHHHHhcC
Confidence 8888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=317.85 Aligned_cols=257 Identities=25% Similarity=0.439 Sum_probs=207.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC-C---cEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN-G---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
.++|+..+.||+|+||.||+|.... + ..+++|++.... .....+.+..|++++++++||||+++.+++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 3467788899999999999997752 3 378999886543 3344567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++++|.++++. ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 83 IITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999999863 235789999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcccc--ccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 565 TPNTERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 565 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
......... .....+..|+|||++.+..++.++|||||||++|||++ |+.||....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-----------------~ 219 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-----------------V 219 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----------------H
Confidence 543222111 11223457999999998899999999999999999998 999996543211 1
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
.+.+........+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 220 ~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 220 MKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111111122223345667889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.19 Aligned_cols=243 Identities=24% Similarity=0.363 Sum_probs=194.2
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhc-CCCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||.||+|.+. +++.||+|.++.... .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 578999999975432 12233455667777765 4999999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 999999862 35788999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i----------------~~~--~~~ 214 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI----------------RMD--NPC 214 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH----------------HhC--CCC
Confidence 23457999999999999999999999999999999999999999764321111100 000 112
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRPPMS-EVVQ 684 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~ 684 (720)
++...+.++.+++.+||+.||++||++. ++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 3334556788999999999999999997 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=322.11 Aligned_cols=263 Identities=25% Similarity=0.391 Sum_probs=208.1
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (720)
...++|++.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+..++.++||||+++++++...
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34578999999999999999999653 24579999886443 233455688899999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCce
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDS------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 554 (720)
+..++||||+++|+|.++++..... ....++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 9999999999999999999753211 23457788899999999999999999 99999999999999999999
Q ss_pred EEcccCCCccCCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 005001 555 HLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWAT 632 (720)
Q Consensus 555 kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~ 632 (720)
+|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... .
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~----- 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---V----- 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H-----
Confidence 999999987554322211 122345678999999999999999999999999999999 788886533211 1
Q ss_pred cccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 005001 633 PQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690 (720)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 690 (720)
.....+. .....+...+..+.+++.+||+.||++||++.++++.|.+.+
T Consensus 231 --------~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 231 --------LKFVMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred --------HHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111111 111223445678999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=317.51 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=206.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc----CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
.+|+..+.||+|+||.||+|.+. .+..+|+|.++... .......+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999764 23479999986543 33445688999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999973 235689999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCcccc--ccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 566 PNTERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 566 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
........ ....++..|+|||.+.+..++.++||||||+++||+++ |..||......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~----------------~ 220 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI----------------K 220 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH----------------H
Confidence 44322211 11233568999999999899999999999999999887 99999754322111 0
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
.+. .......+...+..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 221 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 221 AIE-EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHh-CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111 1111122334567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.94 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=199.0
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||.||+|.+. +++.||+|.++..... ......+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999765 6889999999765432 23345677888988888 799999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 99998886 246799999999999999999999999 99999999999999999999999999986432221 12
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH-HHhhcccccCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA-LAKMVDPALNG 651 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 651 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... ...+.... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~--------~~~~~~~~~~~~~~~~--~ 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP--------DQNTEDYLFQVILEKQ--I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc--------cccchHHHHHHHHcCC--C
Confidence 23467999999999999999999999999999999999999999743221100 0000001 11111111 1
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q 005001 652 MYPAKSLSRFADIIALCVQPEPEFRPP------MSEVVQA 685 (720)
Q Consensus 652 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~ell~~ 685 (720)
..|...+..+.+++.+||+.||.+||+ +.+++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 234456677899999999999999997 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.21 Aligned_cols=257 Identities=23% Similarity=0.385 Sum_probs=205.6
Q ss_pred CCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
+|+..+.||+|+||.||+|... .++.||+|++.... .......+.+|+.++..++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4667788999999999999763 25789999997543 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC
Q 005001 485 LVYEYVGNGNLHDMLHFAD------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 552 (720)
+++||+.+++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985311 1123578889999999999999999999 999999999999999999
Q ss_pred ceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 005001 553 NPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRW 630 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~ 630 (720)
.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 9999999998765432211 1122346789999999998899999999999999999998 888886543211
Q ss_pred hccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 631 ATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
....+... .....+..++..+.+++.+||+.+|++||++++|++.|+.
T Consensus 235 ---------~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 ---------VIEMIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---------HHHHHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111 1223455677889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=309.99 Aligned_cols=269 Identities=25% Similarity=0.380 Sum_probs=228.0
Q ss_pred chhcHHHHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccc
Q 005001 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474 (720)
Q Consensus 401 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 474 (720)
...++.....+++...++.+|.||.||+|.+. +.+.|.+|.++... +.-+...++.|.-++....|||+.++.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 45567777788899999999999999999554 34567778887654 555677889999889999999999999
Q ss_pred eEEee-cCeEEEEEEecCCCCHHHHhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC
Q 005001 475 GYCAE-HGQRLLVYEYVGNGNLHDMLHFADDS----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (720)
Q Consensus 475 ~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~ 549 (720)
+.+.+ .+..++++.++..|+|..++..++.. .+.++..+...++.|++.|++|||++ +|||.||.++|++|+
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 98755 45779999999999999999865432 24578888999999999999999999 999999999999999
Q ss_pred CCCceEEcccCCCccCCCCC-ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 005001 550 DELNPHLSDCGLAALTPNTE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSL 627 (720)
Q Consensus 550 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~ 627 (720)
+..++||+|=.+++.+-+.+ .........+..||+||.+....|+.++|||||||++|||+| |+.||..-+|
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------ 504 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------ 504 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH------
Confidence 99999999999998654433 333445566789999999999999999999999999999999 9999975433
Q ss_pred HHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 005001 628 VRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690 (720)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 690 (720)
..+..++..+.+...|.+|+++++.+|..||..+|++||+++++...|.++-
T Consensus 505 -----------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 505 -----------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred -----------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 4566677778888889999999999999999999999999999999998863
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.71 Aligned_cols=249 Identities=21% Similarity=0.320 Sum_probs=199.9
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 487 (720)
+|...+.||+|+||.||+|... +++.||+|.+..... .......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778889999999999999775 578999999875432 222334566677777766 6899999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998862 45689999999999999999999999 999999999999999999999999999875332
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~----------------~~~i~~~ 216 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----------------FQSIMEH 216 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhC
Confidence 21 122345799999999999999999999999999999999999999976432111 1111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPM-----SEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~ 685 (720)
...+|...+.++.+++.+||+.||++|++. .+++++
T Consensus 217 --~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 217 --NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 122345566788999999999999999985 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=314.79 Aligned_cols=248 Identities=22% Similarity=0.355 Sum_probs=199.8
Q ss_pred eeccCCCcEEEEEEEc---CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCC
Q 005001 417 LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
.||+|+||.||+|.+. .+..||+|.+.... .....+.+.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999764 35579999886543 3344567899999999999999999999875 45789999999999
Q ss_pred CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcccc
Q 005001 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573 (720)
Q Consensus 494 sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 573 (720)
+|.+++.. ....+++..+.+++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 80 ~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 80 PLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 99999862 245789999999999999999999999 999999999999999999999999999876543322211
Q ss_pred --ccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccC
Q 005001 574 --TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650 (720)
Q Consensus 574 --~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (720)
....++..|+|||.+.+..++.++|||||||++|||++ |..||........ ...+.....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----------------~~~~~~~~~ 216 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-----------------MSFIEQGKR 216 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-----------------HHHHHCCCC
Confidence 11234578999999998889999999999999999996 9999975432211 111112222
Q ss_pred CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 651 GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 651 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
...+..++.++.+++.+||..||++||++.+|.+.|+.+
T Consensus 217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 334556678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.17 Aligned_cols=244 Identities=22% Similarity=0.342 Sum_probs=198.0
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||.||+|.+. +++.||+|.++.... .......+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999775 578999999975432 223445667888888777 799999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 999998862 45789999999999999999999999 99999999999999999999999999986432221 12
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+... ...
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~----------------~~~i~~~--~~~ 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL----------------FQSILED--EVR 214 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH----------------HHHHHcC--CCC
Confidence 2335699999999999999999999999999999999999999975432111 1111111 112
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRPPM-----SEVVQA 685 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~ 685 (720)
++...+..+.+++++||+.||++||++ .+++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 344566788999999999999999999 777754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=340.94 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=201.3
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
+.|++.+.||+|+||.||+|+.. +++.||+|.+..... .......+.+|+++++.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999765 588999999865432 2223466788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999963 45688999999999999999999999 999999999999999999999999999743210
Q ss_pred C------------------------------------------CccccccccccccccCccccccCCCcccchhhhHHHH
Q 005001 568 T------------------------------------------ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVV 605 (720)
Q Consensus 568 ~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~ 605 (720)
. .........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 0000123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCC---CHHHH
Q 005001 606 MLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRP---PMSEV 682 (720)
Q Consensus 606 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~el 682 (720)
+|||++|+.||....+......+. . .............+..+.+++.+|+ .+|.+|+ ++.++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~-------------~-~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVI-------------N-WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHh-------------c-cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999998654322111110 0 0001111112234566778898876 5999999 89999
Q ss_pred HHH
Q 005001 683 VQA 685 (720)
Q Consensus 683 l~~ 685 (720)
+++
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=324.08 Aligned_cols=265 Identities=25% Similarity=0.431 Sum_probs=210.7
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc--------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEe
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (720)
...+|.+.+.||+|+||.||+|... ....+|+|.+.... .......+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 3457888899999999999999642 24578999887543 344566788999999999 6999999999999
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCE
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 546 (720)
..+..++||||+++|+|.+++..... ....+++.++.+++.|++.||.|||+. +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 99999999999999999999975321 224589999999999999999999998 999999999999
Q ss_pred EeCCCCceEEcccCCCccCCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcch
Q 005001 547 LLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSE 624 (720)
Q Consensus 547 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~ 624 (720)
+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999997654322111 111234567999999999999999999999999999999 8899865432111
Q ss_pred hhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 625 QSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
.. ..........+..++.++.+++.+||..||++||++.++++.|.++....
T Consensus 246 ~~-----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 246 FK-----------------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HH-----------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11 11111111234456678889999999999999999999999999986654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=301.81 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=204.8
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccCh------HHHHHHHHHHHHhhcC-CCCCccccceEEeec
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL------QEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 480 (720)
-+.|...+.||.|..++|.++.+ ++|+.+|+|++....... .-.+.-.+|+.+++++ .||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35577788999999999999855 468899999985433211 1123345789999987 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
...++|+|.|+.|.|+|++. ..-.+++.+.++|++|+.+|++|||.. +||||||||+|||++++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 99999999999999999997 456799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCcccccc------CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS------GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
+++....... -...+|||+|+|||.+.- ..|+..+|+|++||++|-|+.|.+||.....
T Consensus 169 Fa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------------- 233 (411)
T KOG0599|consen 169 FACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------------- 233 (411)
T ss_pred eeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------------
Confidence 9988765432 345799999999999853 4588899999999999999999999964221
Q ss_pred cccHHHHHhhcccccCCCCC--hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 LHDIDALAKMVDPALNGMYP--AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+--++.++...+....| .+.+....+||.+||+.||++|.|++|++++
T Consensus 234 ---mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 234 ---MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ---HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11222233333332222 2455678899999999999999999999976
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=315.20 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=207.1
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
...+|+..+.||+|+||.||+|...++..+++|.+... ......+.+|++++++++|+||+++++++.. ...+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 34678899999999999999998888888999988643 2345678899999999999999999999877 7789999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999742 245678899999999999999999998 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
..........++..|+|||++.+..++.++|+|||||++|++++ |+.||.......... ...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-----------------~~~ 217 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-----------------ALE 217 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH-----------------HHh
Confidence 32222223346678999999999889999999999999999999 999997543211111 011
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
.......+...+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111112233456678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=318.55 Aligned_cols=271 Identities=24% Similarity=0.362 Sum_probs=206.3
Q ss_pred cCCCccceeccCCCcEEEEEEE-----cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--cCe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQ 482 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 482 (720)
++|+..+.||+|+||.||+|.. .++..||+|++... .......+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4678889999999999999964 25789999998654 23445678899999999999999999998654 346
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++|+||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred eEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 8999999999999999863 234689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcccc--ccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 563 ALTPNTERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 563 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
........... ....++..|+|||++.+..++.++|||||||++|||++|..|+....... ................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-MRMMGNDKQGQMIVYH 234 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-hhhcccccccccchHH
Confidence 87654322111 11234456999999999899999999999999999999887764322110 0000000000011112
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
+.+.+........+...+..+.+++.+||..+|++|||+.|+++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 2222222222233455677899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=317.96 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=204.8
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCc----EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
++|+..+.||+|+||+||+|.+. +++ .||+|.+.... .......+.+|+.++..++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 56788899999999999999753 444 48999886543 33445678899999999999999999998875 4578
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+++||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999863 235689999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 565 TPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 565 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
........ .....+++.|+|||.+.+..++.++|||||||++|||++ |..||........ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-----------------~ 221 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-----------------P 221 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----------------H
Confidence 64332211 122345678999999999999999999999999999998 8999865432111 1
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
..+........+...+..+.+++.+||+.||++||++.++++.|+++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 222 DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111111112233456778999999999999999999999999987744
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=328.48 Aligned_cols=264 Identities=26% Similarity=0.429 Sum_probs=206.3
Q ss_pred hcCCCccceeccCCCcEEEEEEE------cCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeec-
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH- 480 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 480 (720)
.++|+..+.||+|+||.||+|.+ .+++.||||+++... .......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 45799999999999999999963 357889999997543 233456788999999999 689999999987654
Q ss_pred CeEEEEEEecCCCCHHHHhhhccC--------------------------------------------------------
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADD-------------------------------------------------------- 504 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 504 (720)
...++||||+++|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999999864211
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc-cccc
Q 005001 505 -------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-STQM 576 (720)
Q Consensus 505 -------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~ 576 (720)
....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.......... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 012468888999999999999999999 99999999999999999999999999987653322111 1223
Q ss_pred cccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCCh
Q 005001 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655 (720)
Q Consensus 577 ~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (720)
.++..|+|||.+.+..++.++||||||+++|||++ |..||........ ..+.+........+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----------------FCRRLKEGTRMRAPD 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----------------HHHHHhccCCCCCCC
Confidence 45678999999999999999999999999999997 9999865432110 011111111112233
Q ss_pred hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 656 KSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 656 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
..+.++.+++..||+.||++||++.||+++|+++.+.
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3456789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=331.76 Aligned_cols=251 Identities=28% Similarity=0.424 Sum_probs=214.7
Q ss_pred CCccceeccCCCcEEEEEEEc--CCc--EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA--NGK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
....++||+|.||.|++|.|. +|+ .||||.++...... ....|++|+..|-+++|||+++|||...+ ....+|+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 345668999999999999775 354 58999998765443 67899999999999999999999999887 6789999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|.++.|+|.+.|+. .....+-......++.|||.|+.||.++ ++|||||.++|+|+-....+||+|||+.+-+..
T Consensus 190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999985 3456788889999999999999999999 999999999999999999999999999998876
Q ss_pred CCcccc--ccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 568 TERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 568 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
.++... ...--...|+|||.+....++.++|||+|||++|||+| |+.||.+.... .+.+.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----------------qIL~~ 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----------------QILKN 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----------------HHHHh
Confidence 555432 22234568999999999999999999999999999999 88999875542 23344
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
+|.+.+...|..|++++++++..||..+|++||++..|.+.+
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 555566677899999999999999999999999999998554
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=350.46 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=210.1
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..++||+|+||.||+|.+. +|+.||+|++..... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999775 589999999975432 2334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 488 EYVGNGNLHDMLHFADD-------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
||++||+|.++++.... .....++..+.+++.||++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864221 123456778899999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCc-----------------cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcc
Q 005001 561 LAALTPNTER-----------------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRS 623 (720)
Q Consensus 561 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~ 623 (720)
++........ ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976521110 01122469999999999999999999999999999999999999997633211
Q ss_pred hhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHHHhhc
Q 005001 624 EQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRP-PMSEVVQALVRLVQRAS 694 (720)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~~~~~~~ 694 (720)
.... .....+. ........+..+.+++.+||+.||++|| +++++++.|+..++...
T Consensus 239 i~~~--------------~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 239 ISYR--------------DVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred hhhh--------------hhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 1000 0000000 0001123456788999999999999995 67778888988877543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=319.89 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=196.8
Q ss_pred eccCCCcEEEEEEEc-CCcEEEEEEccccccCh-HHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCH
Q 005001 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (720)
Q Consensus 418 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 495 (720)
||+|+||.||++..+ +|+.||+|++....... .....+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999765 58999999986543322 2234556799999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcccccc
Q 005001 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (720)
Q Consensus 496 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 575 (720)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9888632 234588999999999999999999999 99999999999999999999999999987654322 1223
Q ss_pred ccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCCh
Q 005001 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655 (720)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (720)
..|+..|+|||++.+..++.++||||+||++|||++|+.||.......... ............. ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~------------~~~~~~~~~~~~~-~~~ 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE------------ELKRRTLEDEVKF-EHQ 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH------------HHHHHhhcccccc-ccc
Confidence 468999999999999999999999999999999999999997543211110 1111111111111 112
Q ss_pred hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 656 KSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 656 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
..+.++.+++.+||+.||++||+++|+++.+
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 3566789999999999999999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=327.03 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=212.2
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcC-CcEEEEEEccccccC-hHHHHHHHHHHHHhhcCC-CCCccccceEEeecCeEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 484 (720)
....|+..+.||+|.||.||++..+. |+.+|+|.+.+.... ......+.+|+++|+++. ||||+.+++.|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34568888899999999999997765 999999999766543 234567889999999997 999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC----CceEEcccC
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE----LNPHLSDCG 560 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg 560 (720)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999733 399999999999999999999998 99999999999999643 579999999
Q ss_pred CCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+........
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------------- 248 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------------- 248 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------------
Confidence 9988766 344556799999999999999999999999999999999999999998765432221
Q ss_pred HHhhcccc--cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 LAKMVDPA--LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
++.... .....-......+.++++.|+..||.+|+++.+++++
T Consensus 249 --~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 --AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111111 1111223346778899999999999999999999996
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=328.22 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=201.1
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||++... +++.||+|++..... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999765 588999999864322 2334566888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999963 245689999999999999999999999 999999999999999999999999999876544
Q ss_pred CCccccccccccccccCcccccc-----CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 568 TERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||......... .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~----------------~ 218 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----------------G 218 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH----------------H
Confidence 33322333569999999999873 45788999999999999999999999754321111 1
Q ss_pred hhcccccCCC---CChhHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 005001 643 KMVDPALNGM---YPAKSLSRFADIIALCVQPEPEF--RPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 685 (720)
++........ .....+..+.+++++|+..++++ ||++.+++++
T Consensus 219 ~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 219 KIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111110001 11235667889999988664444 7899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=313.42 Aligned_cols=251 Identities=27% Similarity=0.486 Sum_probs=204.0
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
.+|+..+.||+|+||.||+|.+.++..+|+|.+...... ...+.+|++++++++|||++++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 357778899999999999998877889999998754332 45688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.++++. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 81 MEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred CCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 999999999863 235688999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
........++.+|+|||.+.++.++.++||||||+++|||++ |..||....... .. +.....
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~--------------~~~~~~ 217 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VV--------------ETINAG 217 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HH--------------HHHhCC
Confidence 222223345678999999998899999999999999999998 999997533211 11 111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.+...+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 218 FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11112233457789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=327.60 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=201.8
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|...+.||+|+||.||+++.. +++.||+|.+..... .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999775 578899999865322 2233455788899999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999732 35789999999999999999999999 999999999999999999999999999876544
Q ss_pred CCccccccccccccccCcccccc-----CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 568 TERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||....... ...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----------------~~~ 218 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----------------TYG 218 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH----------------HHH
Confidence 33322334579999999999876 567899999999999999999999997543221 111
Q ss_pred hhcccccCCCCC---hhHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 005001 643 KMVDPALNGMYP---AKSLSRFADIIALCVQPEPEF--RPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 685 (720)
++.....+..++ ...+.++.+++.+|+..++++ |+++++++++
T Consensus 219 ~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 219 KIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111111111112 234577889999999876654 4688888866
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.69 Aligned_cols=242 Identities=24% Similarity=0.323 Sum_probs=192.1
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHH-HHhhcCCCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAV-SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||.||+|.+. +++.||+|.+...... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999775 5778999998754321 22233444444 456778999999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 999998862 45688889999999999999999999 99999999999999999999999999987543222 12
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----------------~~~i~~~~--~~ 214 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM----------------YDNILNKP--LQ 214 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH----------------HHHHHhCC--cC
Confidence 2345799999999999999999999999999999999999999975432111 11111111 11
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRPPMSEVV 683 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell 683 (720)
.+...+..+.+++.+||+.||.+||++.+.+
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 2334567788999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.23 Aligned_cols=239 Identities=25% Similarity=0.359 Sum_probs=191.6
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHH-HhhcCCCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVS-NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||+||+|.+. +|+.||+|++...... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999775 6899999998654321 223344455544 56778999999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 99999886 246789999999999999999999999 99999999999999999999999999987532222 22
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----------------~~~~i~~~~~--~ 214 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----------------MYDNILNKPL--R 214 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----------------HHHHHHcCCC--C
Confidence 234579999999999999999999999999999999999999997543211 1111111111 1
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCCCHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRPPMS 680 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ 680 (720)
.+...+..+.+++.+||+.||++||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2334467788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=312.66 Aligned_cols=250 Identities=27% Similarity=0.457 Sum_probs=206.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.++|+..+.||+|+||.||+|... |+.||+|.+..... ...++.+|+.+++.++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 356888899999999999999875 78899999975532 46778899999999999999999999998899999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.++++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 81 YMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999998732 224689999999999999999999999 9999999999999999999999999999766322
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. ...++..|+|||.+.+..++.++||||||+++|||++ |..||....... +...+..
T Consensus 156 ~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~~~~~~ 214 (256)
T cd05039 156 QD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------VVPHVEK 214 (256)
T ss_pred cc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHHhc
Confidence 11 2335668999999998899999999999999999998 999986543211 1111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
......+...+..+.+++.+||..+|++||++.|+++.|..
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 215 GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11222334456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=313.20 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=199.9
Q ss_pred ceeccCCCcEEEEEEEcC----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecC
Q 005001 416 FLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 491 (720)
++||+|+||.||+|.+.. +..+|+|.+...... ...+.+.+|+++++.++||||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 369999999999996532 268999999765533 45677899999999999999999999876 456899999999
Q ss_pred CCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc
Q 005001 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (720)
Q Consensus 492 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 571 (720)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 79 LGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999973 34789999999999999999999999 9999999999999999999999999998866443322
Q ss_pred ccc--cccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 572 VST--QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 572 ~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
... ...++..|+|||.+.+..++.++|||||||++|||++ |..||........ ... +...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~--------------~~~~ 214 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAM--------------LESG 214 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHH--------------HHcC
Confidence 211 1223567999999999999999999999999999998 9999975443211 111 1111
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
.....+...+..+.+++.+||..+|++||++.++++.|+++
T Consensus 215 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11123445667889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=319.75 Aligned_cols=265 Identities=23% Similarity=0.371 Sum_probs=205.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-----------------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCcc
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-----------------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 471 (720)
.++|+..+.||+|+||.||++... ++..||+|.+.... .......+.+|+.+++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 457889999999999999998543 23468999987542 334456789999999999999999
Q ss_pred ccceEEeecCeEEEEEEecCCCCHHHHhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCC
Q 005001 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDS-------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (720)
Q Consensus 472 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~ 544 (720)
++++++...+..++||||+++|+|.+++...... ...+++.++..++.|++.||+|||+. +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 9999999999999999999999999998753211 23478889999999999999999999 9999999999
Q ss_pred CEEeCCCCceEEcccCCCccCCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh--CCCCCCCCCC
Q 005001 545 NILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT--GRKPLDSSRP 621 (720)
Q Consensus 545 NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~pf~~~~~ 621 (720)
||+++.++.++|+|||++.......... .....+++.|+|||...++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999987654322111 122345678999999988899999999999999999998 7788865432
Q ss_pred cchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 622 RSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
....... ....+..........+..++..+.+++.+||+.||++||++.+|++.|.
T Consensus 240 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIENT----------GEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHH----------HHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 2111000 0000000001111123345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=315.62 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=205.7
Q ss_pred cCCCccceeccCCCcEEEEEEEcC-C---cEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFAN-G---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
+.|+..+.||+|+||.||+|.... + ..||+|.+.... .......|..|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 357788899999999999997653 3 369999986542 34456789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++++|.++++. ..+.+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 83 ITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999999863 235689999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCcccc--cccc--ccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 566 PNTERQVS--TQMV--GAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 566 ~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
........ .... .+..|+|||.+.+..++.++|||||||++|||++ |..||........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~------------ 221 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---I------------ 221 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---H------------
Confidence 43222111 1111 2457999999999999999999999999999987 9999975432111 1
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
+.+........+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 222 --~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 222 --NAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --HHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111112223345667789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.79 Aligned_cols=251 Identities=26% Similarity=0.442 Sum_probs=198.4
Q ss_pred eeccCCCcEEEEEEEcC-Cc--EEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEEEecCC
Q 005001 417 LIGEGSLGRVYRAEFAN-GK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
.||+|+||.||+|...+ +. .+++|.++... .......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 68999999999998754 43 46888876432 334456788999999999 899999999999999999999999999
Q ss_pred CCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 493 GNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 493 gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
|+|.++++.... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999974321 123578999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--------------- 220 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------------- 220 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH---------------
Confidence 985322111 1111234567999999998899999999999999999997 9999965332110
Q ss_pred HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 005001 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 690 (720)
. +.+........+...+.++.+++.+||..||.+||++.++++.|.+++
T Consensus 221 -~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 221 -Y-EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -H-HHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1 111111111223345567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=320.21 Aligned_cols=260 Identities=26% Similarity=0.431 Sum_probs=207.4
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
..++|+..+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 3467889999999999999999764 46789999987543 3344567889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADD------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp 543 (720)
..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 99999999999999999974211 123478889999999999999999999 999999999
Q ss_pred CCEEeCCCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCC
Q 005001 544 ANILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRP 621 (720)
Q Consensus 544 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~ 621 (720)
+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999998754332211 1122345678999999999999999999999999999998 8888865432
Q ss_pred cchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 622 RSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
.. ......+... ...+...+.++.+++.+||+.||++||++.|+++.|++
T Consensus 239 ~~----------------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EE----------------VIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH----------------HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 1111111111 12234556789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=332.44 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=204.9
Q ss_pred HHhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-C-----CCccccceEEee
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-H-----PNIVTLAGYCAE 479 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~ 479 (720)
...-+|.+.+.||+|+||.|.+|.+ ++++.||||++++.. ....+-..|+.+|..++ | -|+|+++++|..
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 3344899999999999999999954 579999999998753 33445567788888775 3 479999999999
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC--CceEEc
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE--LNPHLS 557 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~ 557 (720)
.++.|||+|.++. +|+++++... ...++...++.|+.||+.||.+||+. +|||+||||+|||+.+. ..+||+
T Consensus 260 r~HlciVfELL~~-NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVI 333 (586)
T KOG0667|consen 260 RNHLCIVFELLST-NLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVI 333 (586)
T ss_pred ccceeeeehhhhh-hHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEE
Confidence 9999999999965 9999998543 45689999999999999999999999 99999999999999754 369999
Q ss_pred ccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc-----
Q 005001 558 DCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWAT----- 632 (720)
Q Consensus 558 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~----- 632 (720)
|||.|+....... ..+-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.++.+....+.-..
T Consensus 334 DFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 334 DFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred ecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 9999987654332 4677889999999999999999999999999999999988888776544433332100
Q ss_pred --------------c-----ccccHHH---------HHhhcc-cccCCCCC-----------hhHHHHHHHHHHHhcCCC
Q 005001 633 --------------P-----QLHDIDA---------LAKMVD-PALNGMYP-----------AKSLSRFADIIALCVQPE 672 (720)
Q Consensus 633 --------------~-----~~~~~~~---------~~~~~~-~~~~~~~~-----------~~~~~~l~~li~~cl~~d 672 (720)
. ....... ..+... .......| ......+.+++++||.+|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 0 0000000 000000 00000011 123457899999999999
Q ss_pred CCCCCCHHHHHHH
Q 005001 673 PEFRPPMSEVVQA 685 (720)
Q Consensus 673 P~~RPs~~ell~~ 685 (720)
|.+|+|+.+++++
T Consensus 490 P~~R~tp~qal~H 502 (586)
T KOG0667|consen 490 PAERITPAQALNH 502 (586)
T ss_pred chhcCCHHHHhcC
Confidence 9999999999987
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=320.47 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=203.5
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
|+..+.||+|+||.||++... +++.||+|.+...... ......+.+|+.++++++|+||+.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999765 6889999998654332 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.+++... ....+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999988632 234689999999999999999999998 99999999999999999999999999987553322
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||........... ...... ..
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-------------~~~~~~-~~ 220 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-------------VERLVK-EV 220 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-------------HHhhhh-hh
Confidence 1 1234789999999999999999999999999999999999999976432211110 111110 01
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPP-----MSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 685 (720)
...++...+..+.+|+.+||+.||++||+ ++|++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 11233445667889999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=330.99 Aligned_cols=266 Identities=21% Similarity=0.287 Sum_probs=202.1
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC-----
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----- 481 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 481 (720)
..++|+..+.||+|+||.||+|... +|+.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999764 5889999999765444455677889999999999999999999886543
Q ss_pred -eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 482 -QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 482 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
..++||||+++ +|.+.++ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999975 6766664 3578899999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHh-hccccccH
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVRW-ATPQLHDI 638 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~-~~~~-~~~~~~~~ 638 (720)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... .... ..+.....
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 98754322 12234578999999999999999999999999999999999999998654321110 0000 00000000
Q ss_pred H----HHHhhccc--ccC----------------CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 D----ALAKMVDP--ALN----------------GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~----~~~~~~~~--~~~----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ........ ... .......+..+.+|+.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00000000 000 00111234568899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=313.15 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=205.5
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|+..+.||+|+||.||++... +++.||+|.+.... .....+.+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4778899999999999999765 68899999886433 233456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.+++... ....+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 80 CDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999999988632 245688999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
. ......|++.|+|||++.+..++.++|+||||+++|+|++|..||......... ..... ..
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~----------------~~~~~-~~ 216 (255)
T cd08219 155 A-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI----------------LKVCQ-GS 216 (255)
T ss_pred c-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH----------------HHHhc-CC
Confidence 2 223456899999999999989999999999999999999999999754321110 11111 11
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....+...+..+.+++.+||+.||++||++.+++.+
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112334456678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.03 Aligned_cols=271 Identities=21% Similarity=0.372 Sum_probs=206.8
Q ss_pred cCCCccceeccCCCcEEEEEEE-----cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec--Ce
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQ 482 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 482 (720)
+.|...+.||+|+||.||++.. .++..||+|.++... .......+.+|+++++.++||||+++.+++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3467888999999999999974 357889999987543 334456789999999999999999999998775 56
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred eEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 8999999999999999863 234689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc--ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 563 ALTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 563 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
+........ ......++..|+|||.+.+..++.++|||||||++|||++++.|+....... ............ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~-~~~~~~~~~~~~-~~~ 234 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF-LKMIGPTHGQMT-VTR 234 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh-hhhccccccccc-HHH
Confidence 865433221 1123456778999999998889999999999999999999877653321100 000000000000 011
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
..+..........+...+..+.+|+.+||+.||++||+++++++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111222223445677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=319.73 Aligned_cols=265 Identities=22% Similarity=0.348 Sum_probs=204.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC---------------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCcccc
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN---------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 473 (720)
.++|++.+.||+|+||.||++...+ ...||+|+++... .......+.+|++++++++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 4678999999999999999996542 2358999987543 34455678999999999999999999
Q ss_pred ceEEeecCeEEEEEEecCCCCHHHHhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCC
Q 005001 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADD--------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545 (720)
Q Consensus 474 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~N 545 (720)
++++...+..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999999864221 112468899999999999999999999 99999999999
Q ss_pred EEeCCCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh--CCCCCCCCCCc
Q 005001 546 ILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT--GRKPLDSSRPR 622 (720)
Q Consensus 546 Ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~pf~~~~~~ 622 (720)
|+++.++.+||+|||++......... ......++..|+|||.+.++.++.++|||||||++|||++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999998765432211 1122345778999999999999999999999999999998 66777654322
Q ss_pred chhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 623 SEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
....... ..............+...+..+.+++.+||+.||++||++.+|++.|.
T Consensus 240 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTG----------EFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHH----------HhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111000 000000000111123335578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.65 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=207.3
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
.++|...+.||+|+||.||+|.+.+ ...|++|...... .....+.+.+|+.++++++||||+++++++.. +..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 3457788899999999999997643 2468889886443 24455678999999999999999999998875 5678
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 99999999999999963 234689999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||.......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~----------------~ 220 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG----------------R 220 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH----------------H
Confidence 54432222223345568999999988889999999999999999996 999997554321111 1
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
.. .......+..++..+.+++.+||..+|.+||++.++++.|.++.+.
T Consensus 221 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 221 IE-NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 10 1111123445667899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=325.47 Aligned_cols=254 Identities=22% Similarity=0.275 Sum_probs=201.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|...+.||+|+||.||++... +++.||+|.+.+... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999776 477899999864332 2233455788899999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999973 235689999999999999999999999 999999999999999999999999999875533
Q ss_pred CCccccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 568 TERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||........ ..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~----------------~~ 218 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET----------------YG 218 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH----------------HH
Confidence 3322233457999999999986 34688999999999999999999999975432211 11
Q ss_pred hhcccccCCCC---ChhHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 005001 643 KMVDPALNGMY---PAKSLSRFADIIALCVQPEPEF--RPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 685 (720)
++.....+..+ ....+.++.+++++|+..++.+ |+++.|++++
T Consensus 219 ~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 219 KIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111111111 2245677889999999765554 6899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=319.54 Aligned_cols=265 Identities=26% Similarity=0.388 Sum_probs=206.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC-----------------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCcc
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN-----------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 471 (720)
.++|+..+.||+|+||.||+|...+ +..||+|.+.... .....+.+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4578899999999999999997642 2458999887543 334567889999999999999999
Q ss_pred ccceEEeecCeEEEEEEecCCCCHHHHhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCC
Q 005001 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD-------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (720)
Q Consensus 472 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~ 544 (720)
++++++..++..++|+||+++++|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 999999999999999999999999999974331 123689999999999999999999998 9999999999
Q ss_pred CEEeCCCCceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh--CCCCCCCCCC
Q 005001 545 NILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT--GRKPLDSSRP 621 (720)
Q Consensus 545 NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~pf~~~~~ 621 (720)
||+++.++.++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999876543321 12223456788999999999899999999999999999998 6778865432
Q ss_pred cchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 622 RSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
... ..... ...+..........+...+.++.+++.+||+.||++||++.||++.|.
T Consensus 240 ~~~---~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQV---IENAG-------HFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHH---HHHHH-------hccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111 11000 000000011111123345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.59 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=202.3
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35788999999999999999976 468899999986432 223456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.++++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 86 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999998862 45789999999999999999999999 999999999999999999999999999876533
Q ss_pred CCccccccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 568 TERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
.. .......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+....... ... ..
T Consensus 159 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~~---------~~ 226 (267)
T cd06646 159 TI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKS---------NF 226 (267)
T ss_pred cc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ecC---------CC
Confidence 22 1123356889999999885 345788999999999999999999999654322111000 000 00
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
..+ ........+..+.+++++||+.||++||+++++++++
T Consensus 227 ~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPP--KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCC--CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000 0011223456789999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=326.12 Aligned_cols=243 Identities=21% Similarity=0.321 Sum_probs=196.5
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCC-CCCccccceEEeecCeEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 487 (720)
+|+..+.||+|+||.||+|... +|+.||+|++..... .......+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999765 688999999875432 2233456777888888775 577888999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999886 246789999999999999999999999 999999999999999999999999999875432
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...+...
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~----------------~~~i~~~ 216 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL----------------FQSIMEH 216 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhC
Confidence 22 122345699999999999999999999999999999999999999976432111 1111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPM 679 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 679 (720)
...++...+.++.+++.+||+.||.+|++.
T Consensus 217 --~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 --NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 112344556778899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.26 Aligned_cols=266 Identities=27% Similarity=0.441 Sum_probs=210.9
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcC--------CcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEe
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (720)
...+|.+.+.||+|+||.||+|.... +..||+|.+.... .......+.+|+++++++ +||||+++++++.
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 34568889999999999999996531 2368999886432 344567888999999999 8999999999999
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCE
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 546 (720)
..+..++|+||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 99999999999999999999874321 234588899999999999999999999 999999999999
Q ss_pred EeCCCCceEEcccCCCccCCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcch
Q 005001 547 LLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSE 624 (720)
Q Consensus 547 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~ 624 (720)
+++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 244 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 244 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence 99999999999999987654322111 122234567999999999999999999999999999998 888886543211
Q ss_pred hhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 625 QSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
..+.+........+...+..+.+++.+||+.+|++||++.|+++.|.++.....
T Consensus 245 ----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 ----------------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 111111111222344556789999999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=351.44 Aligned_cols=263 Identities=21% Similarity=0.310 Sum_probs=206.9
Q ss_pred cHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--c
Q 005001 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--H 480 (720)
Q Consensus 404 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~ 480 (720)
..+...++|.+.+.||+|+||+||+|.+. +++.||+|.+............+..|+.+++.++||||++++++|.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34455678999999999999999999775 57788999987665555667789999999999999999999998854 4
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCcEEecCCCCCEEeCC------
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL----PSVVHRNFKSANILLDD------ 550 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~----~~iiH~Dlkp~NIll~~------ 550 (720)
+.+|+||||+++|+|.+++.........+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 56899999999999999997544445679999999999999999999998521 25999999999999964
Q ss_pred -----------CCceEEcccCCCccCCCCCccccccccccccccCcccccc--CCCcccchhhhHHHHHHHHHhCCCCCC
Q 005001 551 -----------ELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (720)
Q Consensus 551 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~pf~ 617 (720)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 3358999999997653321 2234579999999999864 458899999999999999999999997
Q ss_pred CCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 618 SSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....... +...+..... ......+..+.+||..||+.+|.+||++.+++++
T Consensus 245 ~~~~~~q----------------li~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 245 KANNFSQ----------------LISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cCCcHHH----------------HHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 5432111 0111111100 0112345678999999999999999999999954
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.19 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=209.6
Q ss_pred CCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|+..+.||+|+||.||.++. .+++.+++|++............+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999965 4688999999876655566677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.+++... ....+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999998732 245689999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
. ......|++.|+|||.+.+..++.++||||||+++|||++|..||....... ...+......
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------------~~~~~~~~~~ 218 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----------------LVVKIVQGNY 218 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHcCCC
Confidence 2 2334568999999999998889999999999999999999999997543221 1111111111
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
. ..+...+.++.+++.+||+.+|++||+++++++++
T Consensus 219 ~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 T-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred C-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1 12234567788999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.69 Aligned_cols=250 Identities=31% Similarity=0.497 Sum_probs=206.7
Q ss_pred ceeccCCCcEEEEEEEcC----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecC
Q 005001 416 FLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 491 (720)
+.||+|+||.||+|.... +..|++|.+....... ....+.+|++.++.++|+||+++++++...+..++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 369999999999997754 7889999997654333 46788999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 492 NGNLHDMLHFADDS-----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 492 ~gsL~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
+++|.++++..... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999743211 47789999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 567 NTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 567 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
.... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||....... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~~~ 219 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-----------------VLEY 219 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHH
Confidence 4331 12233467889999999998899999999999999999999 699997653211 1111
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
+........+...+.++.+++.+||+.+|++||++.++++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111222234555678899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.99 Aligned_cols=253 Identities=30% Similarity=0.524 Sum_probs=204.0
Q ss_pred CCccceeccCCCcEEEEEEEcC-CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 412 FSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
|+..+.||+|+||+||++.... ++.||+|.+..............+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999998764 668999999876554444445566999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
++++|.+++. ....+++.++..++.|+++||++||+. +|+|+||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 9999999997 357789999999999999999999999 999999999999999999999999999875421 22
Q ss_pred cccccccccccccCccccc-cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 571 QVSTQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
.......++..|+|||++. +..++.++||||+|+++|+|++|..||............ .+......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~-------------~~~~~~~~ 219 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII-------------EKILKRPL 219 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH-------------HHHHHTHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh-------------hhcccccc
Confidence 2334567899999999998 888999999999999999999999999865211111111 11110000
Q ss_pred --CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 --NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...........+.+++.+||+.||++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 220 PSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000011123789999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.29 Aligned_cols=266 Identities=23% Similarity=0.379 Sum_probs=206.4
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||.||++.+. ++..||+|.+.... .......+.+|++++.+++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36888999999999999999765 57888998886432 33445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.++++. ...+++..+..++.|+++||.|||+.+ +++||||||+||+++.++.++|+|||++......
T Consensus 80 y~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 80 HMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred ccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 9999999999973 366899999999999999999999742 8999999999999999999999999998754322
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc------------
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLH------------ 636 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------ 636 (720)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||....................
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 12345789999999999888899999999999999999999999975443221111110000000
Q ss_pred --------cHHHHHhhcccccCCCCC-hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 637 --------DIDALAKMVDPALNGMYP-AKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 637 --------~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
..+......... ....+ ...+.++.+++.+||..||++||++.+++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000111111111 11111 12456789999999999999999999999873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.49 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=204.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
.+|+..+.||+|+||.||++... ++..+++|.+... .......+.+|++.++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 46777889999999999999642 3567899988643 334456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC
Q 005001 484 LLVYEYVGNGNLHDMLHFADD-----------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 552 (720)
++||||+++++|.++++.... ....+++..+..++.|++.|++|||+. +++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 999999999999999974321 113588999999999999999999999 999999999999999999
Q ss_pred ceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 005001 553 NPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRW 630 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~ 630 (720)
.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------ 233 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------ 233 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------
Confidence 999999999875433221 11222345788999999999999999999999999999998 8999865432211
Q ss_pred hccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 631 ATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
...... ......+..++..+.+++.+||+.||++||+++||++.|+
T Consensus 234 ----------~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 ----------IECITQ-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----------HHHHHc-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111 1111223445677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=326.50 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=198.2
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||.||+|... +++.||+|++...... ......+.+|..++.++ +||||+.+++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999765 5788999999765432 23445678888888887 699999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T 152 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence 99998886 245799999999999999999999999 999999999999999999999999999875322221 2
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............. .....+.... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~---------~~~~~~~~~~--~~ 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED---------YLFQVILEKP--IR 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHH---------HHHHHHHhCC--CC
Confidence 234679999999999999999999999999999999999999996432211110000 0111111111 12
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRPPM------SEVVQA 685 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~ 685 (720)
.|...+..+.+++.+||+.||++|+++ .+++++
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 344566778899999999999999985 466544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.05 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=202.0
Q ss_pred ceeccCCCcEEEEEEEcC--C--cEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecC
Q 005001 416 FLIGEGSLGRVYRAEFAN--G--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 491 (720)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+.+.+|+..+++++||||+++++++.. ...++|+||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999997643 3 36899999876543 556788999999999999999999999888 88999999999
Q ss_pred CCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc
Q 005001 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (720)
Q Consensus 492 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 571 (720)
+++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 79 LGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 999999997422 15689999999999999999999999 9999999999999999999999999999876443221
Q ss_pred c--cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 572 V--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 572 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
. .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.......... ......
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----------------~~~~~~ 217 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK----------------KIDKEG 217 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------------HHHhcC
Confidence 1 123457789999999999999999999999999999999 999997543221111 011011
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
.....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112233445678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=326.03 Aligned_cols=239 Identities=24% Similarity=0.357 Sum_probs=191.4
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHH-HHhhcCCCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAV-SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
++||+|+||.||+|+.. +++.||+|.+..... .......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999775 588999999865432 222334455554 457888999999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.+.+. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 99998886 246788999999999999999999998 99999999999999999999999999987532222 22
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~i~~~~--~~ 214 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----------------MYDNILHKP--LQ 214 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----------------HHHHHhcCC--CC
Confidence 234579999999999999999999999999999999999999997543211 111111111 12
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCCCHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRPPMS 680 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ 680 (720)
.+...+..+.+++.+||+.||.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3445566788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.19 Aligned_cols=248 Identities=28% Similarity=0.447 Sum_probs=201.1
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEe-ecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA-EHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e 488 (720)
.+|...+.||+|+||.||++... |..|++|.+.... ..+.+.+|+.++++++|+|++++++++. ..+..++|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 46788899999999999999765 7889999886432 3456889999999999999999999754 4567899999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999998632 234588999999999999999999998 9999999999999999999999999998754332
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ....+..
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-----------------~~~~~~~ 214 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------VVPRVEK 214 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHhc
Confidence 2 22345678999999999899999999999999999998 999986432211 1111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
......+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 215 GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11222334566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.33 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=200.3
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999765 688999999964332 2334567788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999986 246789999999999999999999999 999999999999999999999999999864422
Q ss_pred CCc----------------------------------cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCC
Q 005001 568 TER----------------------------------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613 (720)
Q Consensus 568 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~ 613 (720)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 0012347999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCCh--hHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 005001 614 KPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA--KSLSRFADIIALCVQPEPEFRPP---MSEVVQA 685 (720)
Q Consensus 614 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs---~~ell~~ 685 (720)
.||....+.... .++........++. ..+.++.+++.+|+ .||.+|++ +.|++++
T Consensus 234 ~Pf~~~~~~~~~----------------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 234 PPFCSETPQETY----------------RKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCHHHHH----------------HHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 999765432211 11111110111111 24567788998876 49999985 6777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.00 Aligned_cols=252 Identities=28% Similarity=0.463 Sum_probs=195.6
Q ss_pred ceeccCCCcEEEEEEEc----CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEe-ecCeEEEEEEec
Q 005001 416 FLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA-EHGQRLLVYEYV 490 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~ 490 (720)
+.||+|+||.||+|.+. ++..||+|++.... .......+.+|+.+++.++||||+++++++. .++..++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999754 24579999885432 3344667889999999999999999999765 455689999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
.+|+|.++++. .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 80 KHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999999863 234567888899999999999999998 999999999999999999999999999875533211
Q ss_pred c---ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhC-CCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 571 Q---VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG-RKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 571 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
. ......++..|+|||.+.+..++.++|||||||++|||++| ..||....... .. +.+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~--------------~~~~ 216 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---IT--------------VYLL 216 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH--------------HHHh
Confidence 1 11123467789999999998999999999999999999995 55565332111 11 1111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
.......+...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 217 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111112233456678999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.72 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=191.8
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHH-HhhcCCCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVS-NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||.||+|... +|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999764 689999999865432 2223345555554 46778999999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99998886 346789999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+...... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~----------------~~~~~~~~~--~ 214 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM----------------YDNILHKPL--V 214 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH----------------HHHHHcCCc--c
Confidence 2345799999999999999999999999999999999999999975432111 111111111 1
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCCCHHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRPPMSE 681 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 681 (720)
.+...+..+.+++++|++.||++||++.+
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 22335567889999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.23 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=202.2
Q ss_pred ceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCH
Q 005001 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 495 (720)
++||+|+||.||+|...+++.|++|++...... .....+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 369999999999998877999999998765432 4567789999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcccc-c
Q 005001 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS-T 574 (720)
Q Consensus 496 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-~ 574 (720)
.++++. ....+++..+..++.+++.||+|||++ +++||||||+||+++.++.++|+|||++........... .
T Consensus 80 ~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999863 234678999999999999999999999 999999999999999999999999999876542211111 1
Q ss_pred cccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCC
Q 005001 575 QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY 653 (720)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (720)
...++..|+|||.+.+..++.++|||||||++|||++ |..||......... ...........
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-----------------~~~~~~~~~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-----------------ERIESGYRMPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-----------------HHHhcCCCCCC
Confidence 1234667999999998899999999999999999999 88888654332111 11111112223
Q ss_pred ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 654 PAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 654 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
+...+..+.+++.+||+.+|.+||++.|+++.|.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4456678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.12 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=205.9
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
...+|+..+.||+|+||.||+|.. .+++.|++|.+..... .....+.+|+.+++.++|+||+++++.+...+..++|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 345788899999999999999976 4688999998865432 2346688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.++++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 96 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 96 MEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred ecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999999986 34678999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+.... .. ....
T Consensus 168 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~-------------~~~~ 231 (296)
T cd06654 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YL-------------IATN 231 (296)
T ss_pred cccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HH-------------HhcC
Confidence 3221 123346889999999999988999999999999999999999999754431111 00 0011
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......+...+..+.+++.+||..||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 111112234456778899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=328.97 Aligned_cols=266 Identities=21% Similarity=0.264 Sum_probs=202.0
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec------
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 480 (720)
..++|+..+.||+|+||.||+|... .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999764 588999999976544445566788999999999999999999987543
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 7877774 3578899999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hh-hccccccH
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RW-ATPQLHDI 638 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~-~~~~~~~~ 638 (720)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .. ..+.....
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 997653321 223457899999999999999999999999999999999999999765432221111 00 00000000
Q ss_pred HH----HHhhcc--ccc----------------CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DA----LAKMVD--PAL----------------NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~----~~~~~~--~~~----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ...... +.. ...........+.+++.+||+.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 000000 000 000011123568899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.53 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=206.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
++|+..+.||+|+||.||+|..+ +.+.|++|.+.... .......+.+|++++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 56888899999999999999764 24678888886432 223456788999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDS-----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 558 (720)
++||||+++|+|.++++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999743311 12689999999999999999999999 999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhcccccc
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------------- 226 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------------- 226 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--------------
Confidence 99986543332223334467788999999998889999999999999999999 788986432211
Q ss_pred HHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
..............+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 227 --~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 227 --VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --HHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111111111122233456678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=321.49 Aligned_cols=267 Identities=21% Similarity=0.319 Sum_probs=202.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|...+.||+|+||.||+|... +++.||+|.++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 56888999999999999999765 578899999865432 2233457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 85 YLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 9975 88887753 245688999999999999999999999 9999999999999999999999999998754332
Q ss_pred CccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh--cccc------ccHH
Q 005001 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA--TPQL------HDID 639 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~--~~~~------~~~~ 639 (720)
.. ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...........+... .+.. ....
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 158 TK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 21 1223468899999999865 45899999999999999999999999876543322222111 0000 0000
Q ss_pred HHHhhcccccCC----CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAKMVDPALNG----MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......+.... ......+.++.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000000 0011245678899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.20 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=205.1
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee-cCeEEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRLLVYE 488 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e 488 (720)
.|+..+.||+|++|.||++... +++.||+|++..........+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999765 57889999997655455556778899999999999999999988764 446799999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.+++... ....+++.++..++.|++.|+++||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999998732 245689999999999999999999999 9999999999999999999999999998765432
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
.. ......|++.|+|||++.+..++.++||||||+++|||++|+.||........ ...... .
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~----------------~~~~~~-~ 217 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL----------------VYRIIE-G 217 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH----------------HHHHHh-c
Confidence 22 22345689999999999999999999999999999999999999975332110 001111 1
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.....+...+..+.+++.+||+.||++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 218 KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1112334566789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.55 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=203.0
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh-HHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
|+..+.||+|+||+||+|.+. +++.||+|.+....... .....+.+|+++++.++|+||+.+.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999764 68899999986543322 2345578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888632 234699999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
. .....|+..|+|||.+.+..++.++|+|||||++|||++|..||........... ..+.+.. .
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~-------------~~~~~~~-~ 220 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE-------------VDRRVLE-T 220 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHHhhhc-c
Confidence 1 1235789999999999999999999999999999999999999976433211111 1111110 0
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPP-----MSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 685 (720)
...++...+..+.+|+..||+.||++||+ +.+++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11233445667889999999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.00 Aligned_cols=252 Identities=23% Similarity=0.401 Sum_probs=200.3
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||.||+|.+ .+++.||+|.+.... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3577888999999999999976 468899999986442 33445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|..+ ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 80 FMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred cCCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 9999999654 2467888899999999999999999 9999999999999999999999999998765332
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
......||..|+|||++.+..++.++||||||+++|+|++|+.||.......... ..........+..
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~---------~~~~~~~~~~~~~ 216 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL---------MPLQLLQCIVDED 216 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc---------chHHHHHHHhccC
Confidence 2233578999999999999999999999999999999999999997533211110 0001111111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.........+.++.+++.+||+.||++||+++|++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111122345678899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=327.95 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=202.5
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec------
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 480 (720)
..++|+..+.||+|+||.||+|... .++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999764 688999999976554555567788999999999999999999987543
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999975 6777664 3578899999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh-HHH-hhccccccH
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVR-WATPQLHDI 638 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~-~~~-~~~~~~~~~ 638 (720)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+........ .+. ...+.....
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99765332 12234578999999999999999999999999999999999999997654321111 000 000000000
Q ss_pred ----HHHHhhccc---------------cc---CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 ----DALAKMVDP---------------AL---NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ----~~~~~~~~~---------------~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......... .. ....+......+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00 000112234578899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.27 Aligned_cols=254 Identities=25% Similarity=0.432 Sum_probs=201.0
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeec----
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH---- 480 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~---- 480 (720)
.+.+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 45677888999999999999999765 57889999986432 2345678889998888 799999999998653
Q ss_pred --CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcc
Q 005001 481 --GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (720)
Q Consensus 481 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 558 (720)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 4689999999999999998742 235689999999999999999999999 999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~ 633 (720)
||++....... .......|+..|+|||++. +..++.++|||||||++|||++|+.||....+......
T Consensus 155 fg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~------ 227 (272)
T cd06637 155 FGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------ 227 (272)
T ss_pred CCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH------
Confidence 99987653322 1223457899999999986 34578899999999999999999999965432111100
Q ss_pred ccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..........+...+..+.+++.+||..||.+||++.+++++
T Consensus 228 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 ----------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ----------HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000111111223355678999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.88 Aligned_cols=267 Identities=23% Similarity=0.312 Sum_probs=195.4
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhc---CCCCCccccceEEee-----cC
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR---LRHPNIVTLAGYCAE-----HG 481 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~-----~~ 481 (720)
+|+..+.||+|+||.||+|... +++.||+|.+............+.+|+.+++. ++||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999765 68899999987543222223344556665554 479999999998754 34
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+.+ +|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999975 898888632 234589999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHhh-ccccccHH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVRWA-TPQLHDID 639 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~-~~~~~-~~~~~~~~ 639 (720)
+....... ......||..|+|||++.+..++.++||||+||++|||++|+.||.......... ..... .+......
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 97654322 1233568999999999999999999999999999999999999997654322211 11111 00000000
Q ss_pred HHHhhcccccC-------CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAKMVDPALN-------GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........... .......+..+.+++.+||+.||++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 00112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=311.28 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=204.1
Q ss_pred CCCccceeccCCCcEEEEEEEcCCcEEEEEEcccccc----ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL----SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
+|...+.||+|+||.||+|...+++.+|+|.+..... .......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778889999999999999888899999998864322 223345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999963 35678999999999999999999999 99999999999999999999999999987543
Q ss_pred CCC-----ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 567 NTE-----RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 567 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
... ........|+..|+|||++.+..++.++|||||||++|||++|+.||...........+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------------- 220 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------------- 220 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-------------
Confidence 211 11123356899999999999988999999999999999999999999754321111000
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 684 (720)
.. ........+...+..+.+++++||+.+|++||++.++++
T Consensus 221 ~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 221 GA--HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hh--ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 001111233446677899999999999999999999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=311.17 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=206.8
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
..|+..+.||+|+||.||+|.+. +++.||+|.+.... .......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 35777889999999999999765 58899999886443 23456778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.++++ ...+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 83 YLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred cCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999886 35688999999999999999999998 9999999999999999999999999998765432
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
. .......++..|+|||.+.+..++.++|+|||||++|||++|..||....+..... .....
T Consensus 155 ~-~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----------------~~~~~ 216 (277)
T cd06640 155 Q-IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-----------------LIPKN 216 (277)
T ss_pred c-cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-----------------hhhcC
Confidence 2 12233468889999999999889999999999999999999999997544321110 01111
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1223344567789999999999999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=311.66 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=207.4
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCc----EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
.+|+..+.||+|+||.||+|.+. +|+ .+|+|...... .......+.+|+..+++++||||+++++++.. +..+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 46788889999999999999764 233 58899886543 24455678899999999999999999999887 7889
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+|+||+++|+|.++++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999873 234689999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCcccc-ccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 565 TPNTERQVS-TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 565 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
......... ....++..|+|||.+....++.++||||||+++||+++ |+.||....... +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~ 221 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----------------IP 221 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----------------HH
Confidence 653322211 11224568999999988889999999999999999999 999997643211 11
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
..+........+..++..+.+++.+||..||.+||++.++++.|.++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 222 DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111111223344455678899999999999999999999999998855
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.29 Aligned_cols=254 Identities=27% Similarity=0.399 Sum_probs=209.6
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--cCeEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLVY 487 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 487 (720)
+|+..+.||+|+||.||+|... +++.||+|.+..........+.+.+|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778889999999999999654 67899999987665566667788999999999999999999998754 45679999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-----EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-----~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
||+++++|.+++.........+++..+..++.|++.||+||| +. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765445678999999999999999999999 66 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||....... +.
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----------------~~ 219 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-----------------LA 219 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-----------------HH
Confidence 87654332 1233568999999999999889999999999999999999999997643211 11
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+.+........+...+..+.+++.+||+.+|++||++++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 220 SKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111111223344566789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.01 Aligned_cols=265 Identities=25% Similarity=0.361 Sum_probs=207.0
Q ss_pred cchhcHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEE
Q 005001 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (720)
Q Consensus 400 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (720)
..+..+..+.++|+..+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 445667778899999999999999999999764 57899999875422 2235577888888888 799999999987
Q ss_pred e-----ecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC
Q 005001 478 A-----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (720)
Q Consensus 478 ~-----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 552 (720)
. ..+..++||||+++++|.++++........+++..+..++.|++.||.|||+. +++||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 4 34568999999999999998864433456789999999999999999999999 999999999999999999
Q ss_pred ceEEcccCCCccCCCCCccccccccccccccCcccccc-----CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH
Q 005001 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL 627 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~ 627 (720)
.++|+|||++....... .......|++.|+|||++.. ..++.++||||+||++|||++|+.||....+....
T Consensus 162 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-- 238 (286)
T cd06638 162 GVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-- 238 (286)
T ss_pred CEEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--
Confidence 99999999987654322 12233468999999999853 45788999999999999999999999754321111
Q ss_pred HHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 628 VRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.. ..+.. ......+...+..+.+++.+||+.||++||++.|++++.
T Consensus 239 ~~-----------~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FK-----------IPRNP--PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hh-----------ccccC--CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00000 001112233456788999999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.65 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=193.8
Q ss_pred eeccCCCcEEEEEEEcC---CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCC
Q 005001 417 LIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
.||+|+||.||+|...+ +..+|+|+++... .......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999997643 4578999887554 2344567889999999999999999999999989999999999999
Q ss_pred CHHHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 494 NLHDMLHFADD-SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 494 sL~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
+|.++++.... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975332 223567788889999999999999999 99999999999999999999999999986543322111
Q ss_pred -cccccccccccCccccccC-------CCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 573 -STQMVGAFGYSAPEFALSG-------IYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 573 -~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
.....|+..|+|||++.+. .++.++||||||+++|||++ |+.||....+........ . ....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~--~------~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV--R------EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh--h------cccCC
Confidence 2234578899999998642 35789999999999999997 999997543321111000 0 00000
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
... .......+..+.+++..|| .+|++||+++||++.|+
T Consensus 230 ~~~----~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPK----PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCC----CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111 1112234556889999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.39 Aligned_cols=269 Identities=27% Similarity=0.382 Sum_probs=207.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||.||+|.+. +++.||+|+++...........+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999776 58899999987654444456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|++++.+..+.. ....+++.++..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877766554 245689999999999999999999999 9999999999999999999999999998876554
Q ss_pred CccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc--------HH
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD--------ID 639 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------~~ 639 (720)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||..................... ..
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 43233446788999999999888 7899999999999999999999999764432211111100000000 00
Q ss_pred HHHh--hccc----ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAK--MVDP----ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~--~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... .... .....++...+.++.+++++||..+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 0000 00011233346789999999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=325.93 Aligned_cols=251 Identities=25% Similarity=0.443 Sum_probs=209.0
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcE-EEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKI-MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
+-|.++..||.|+||.||+|..++... .|.|.+.. .+.++...|+-|+++|+.++||+||++++.|.-.+.++|+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 346677789999999999998776544 45566643 245677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
||.||-++..+- .-+..+++.++..+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+.....
T Consensus 110 FC~GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~- 182 (1187)
T KOG0579|consen 110 FCGGGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS- 182 (1187)
T ss_pred ecCCchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-
Confidence 999999998875 2467899999999999999999999999 999999999999999999999999999864432
Q ss_pred CccccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 569 ERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
.......+.|||+|||||+.. ..+|+.++||||||++|.||..+.+|-...++. ..+.+
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----------------RVllK 246 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------------RVLLK 246 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----------------HHHHH
Confidence 233456789999999999875 467999999999999999999999998755443 22333
Q ss_pred hccc-ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDP-ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+... ......|......+.+++.+||.+||..||++.+++++
T Consensus 247 iaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 247 IAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 3222 12334577888899999999999999999999999875
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.68 Aligned_cols=245 Identities=27% Similarity=0.410 Sum_probs=204.2
Q ss_pred eeccCCCcEEEEEEEcC-CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCH
Q 005001 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 495 (720)
+||+|.||+||-|++.+ ...+|||.+.... .+..+-+.+|+...++++|.|||+++|.+.+++..-|.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 79999999999997654 5678999986543 34456688999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-CCceEEcccCCCccCCCCCccc
Q 005001 496 HDMLHFADDSSKNL--TWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 496 ~~~l~~~~~~~~~~--~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
.++++. .-+++ .+.+..-+.+||++||.|||++ .|||||||-+|||++. .|.+||+|||-++++..-. ..
T Consensus 660 SsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~ 732 (1226)
T KOG4279|consen 660 SSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PC 732 (1226)
T ss_pred HHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-cc
Confidence 999973 34556 7888888999999999999999 9999999999999975 7899999999998775433 33
Q ss_pred cccccccccccCccccccCC--CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccC
Q 005001 573 STQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (720)
...+.||.-|||||++..++ |+.++|||||||++.||.||++||......... +-++-.-+..
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---------------MFkVGmyKvH 797 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---------------MFKVGMYKVH 797 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---------------hhhhcceecC
Confidence 45678999999999998765 889999999999999999999999754432111 1111111223
Q ss_pred CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 651 GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 651 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...|.+.+.+...+|.+|+.+||.+||+++++++.
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 45678889999999999999999999999999964
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.80 Aligned_cols=269 Identities=22% Similarity=0.299 Sum_probs=202.5
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|+..+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999775 688999999875443333446778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
++ ++|.++++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 58988886432 236789999999999999999999999 99999999999999999999999999987553322
Q ss_pred ccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH-HH-hhcc------ccccHHH
Q 005001 570 RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL-VR-WATP------QLHDIDA 640 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~-~~-~~~~------~~~~~~~ 640 (720)
.......+++.|+|||.+.+. .++.++|||||||++|||+||+.||........... .. +..+ .......
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112234578899999988764 478999999999999999999999976543221110 00 0000 0000011
Q ss_pred HHhhcccccC---CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 LAKMVDPALN---GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......... .......+.++.++|++||+.||++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 1111100000 00112245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.01 Aligned_cols=251 Identities=27% Similarity=0.469 Sum_probs=206.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC-CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|...+ ++.|++|.+.... ....+.+|++++++++||||+++++++...+..++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 3678889999999999999998764 7899999986432 2677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999999863 246789999999999999999999999 999999999999999999999999999876644
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+......+ .. ..
T Consensus 152 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------------~~--~~ 215 (256)
T cd06612 152 TMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------------PN--KP 215 (256)
T ss_pred Ccc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------------cc--CC
Confidence 321 223345888999999999999999999999999999999999999754332111000 00 00
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+...+..+.+++.+||+.||++||+++|++++
T Consensus 216 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 216 PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11111233455678999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.10 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=200.8
Q ss_pred HHhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-----
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH----- 480 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 480 (720)
...++|...+.||+|+||.||+|.. .+++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999976 4688999999976544444456678899999999999999999987543
Q ss_pred -CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEccc
Q 005001 481 -GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (720)
Q Consensus 481 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 559 (720)
...++++|++ +++|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3568999988 679988875 45799999999999999999999999 9999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhh-ccccc
Q 005001 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWA-TPQLH 636 (720)
Q Consensus 560 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~~-~~~~~ 636 (720)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+ ... .+...
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999765432 234578999999999977 56899999999999999999999999765432211111 000 00000
Q ss_pred c-----HHHHHhhcccccCCCCC-------hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 637 D-----IDALAKMVDPALNGMYP-------AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 637 ~-----~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. .....+... ....... ......+.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000000 0000000 1123457899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.19 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=211.4
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeE
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 483 (720)
+......|++.+.||+||.+.||++...+.+.||+|++.......+....|..|+..|.++ +|.+|+++++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3344567999999999999999999998899999999988888888889999999999999 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
|+||||= .-+|..+|+.. ........++.+..|++.++.++|.+ ||||.||||.|+|+-. |.+||+|||+|.
T Consensus 436 YmvmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~ 507 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIAN 507 (677)
T ss_pred EEEeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhc
Confidence 9999975 45999999742 23333337888999999999999999 9999999999999965 589999999998
Q ss_pred cCCCCCcc-ccccccccccccCccccccCC-----------CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 005001 564 LTPNTERQ-VSTQMVGAFGYSAPEFALSGI-----------YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA 631 (720)
Q Consensus 564 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~ 631 (720)
....+... .....+||+.||+||.+.... .++++||||+|||||+|+.|++||....
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----------- 576 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----------- 576 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----------
Confidence 77654433 345568999999999986432 5688999999999999999999996321
Q ss_pred ccccccHHHHHhhcccccCCCCChhHH-HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 632 TPQLHDIDALAKMVDPALNGMYPAKSL-SRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..+..+..+.++.-.-.||.... .++.++|+.||..||.+||+..|+|++
T Consensus 577 ----n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 ----NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12234445556544444443322 338999999999999999999999986
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=313.26 Aligned_cols=268 Identities=24% Similarity=0.353 Sum_probs=204.3
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999876 58999999986543333334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|..++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988888765 245689999999999999999999998 9999999999999999999999999999866443
Q ss_pred CccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-ccccccHHHH-----
Q 005001 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA-TPQLHDIDAL----- 641 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~----- 641 (720)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.........+.-. ..........
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 22 1223467889999999876 45789999999999999999999999865543222111100 0000000000
Q ss_pred --HhhcccccCCCCC-----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 --AKMVDPALNGMYP-----AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 --~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.....+......+ ...+..+.+++.+||+.||++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000000000 1235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=334.53 Aligned_cols=266 Identities=20% Similarity=0.267 Sum_probs=192.8
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC------CCCCccccceEE
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL------RHPNIVTLAGYC 477 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~ 477 (720)
+....++|++.+.||+|+||.||+|.+. .++.||||+++... .....+..|+++++.+ +|.+++.+++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3445688999999999999999999764 57889999986432 1222334455555444 455688888888
Q ss_pred eec-CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEecCCCCCEEeCCCC---
Q 005001 478 AEH-GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDEL--- 552 (720)
Q Consensus 478 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~--- 552 (720)
... ++.++|||++ +++|.+++.. .+.+++..+..++.||+.||+|||+ . +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 664 5789999988 6688888862 4678999999999999999999997 5 999999999999998765
Q ss_pred -------------ceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCC
Q 005001 553 -------------NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSS 619 (720)
Q Consensus 553 -------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~ 619 (720)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998754321 223467999999999999999999999999999999999999999876
Q ss_pred CCcchhhHHHhhccccccH-------HHHHhhcccc--cCCCC---------------ChhHHHHHHHHHHHhcCCCCCC
Q 005001 620 RPRSEQSLVRWATPQLHDI-------DALAKMVDPA--LNGMY---------------PAKSLSRFADIIALCVQPEPEF 675 (720)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~--~~~~~---------------~~~~~~~l~~li~~cl~~dP~~ 675 (720)
........+.......... .......... +.... .......+.+||.+||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 5432222221111000000 0000000000 00000 0012346789999999999999
Q ss_pred CCCHHHHHHH
Q 005001 676 RPPMSEVVQA 685 (720)
Q Consensus 676 RPs~~ell~~ 685 (720)
|||++|++++
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999976
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.79 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=209.9
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccCh-HHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
..+.|+.-++||+|+||+||-++. .+|+.||.|++.+..... ..+...+.|-+++.+++.+.||.+--+|+..+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 346788889999999999999965 479999999997665533 334566889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|+..|.||+|.-+|... .+..++++.++-++.+|+.||++||.. +||+||+||+|||+|+.|+++|+|+|+|..+
T Consensus 263 VLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999888633 346899999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
+.... ..+.+||.+|||||++.++.|+...|+|||||++|||+.|+.||......... +.+.+++
T Consensus 338 ~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------------eEvdrr~ 402 (591)
T KOG0986|consen 338 PEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------------EEVDRRT 402 (591)
T ss_pred CCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------HHHHHHH
Confidence 65433 34458999999999999999999999999999999999999999865543322 1222222
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPM 679 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 679 (720)
.. -...++...+++..++.+..|++||++|...
T Consensus 403 ~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 403 LE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hc-chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 11 1224566777888999999999999999743
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=313.25 Aligned_cols=255 Identities=29% Similarity=0.412 Sum_probs=198.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHH-hhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSN-MSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||+|.+. +|+.||+|++....... ....+..|+.. ++..+||||+++++++..++..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 46888899999999999999775 68999999987554333 23445556554 56679999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||++ |+|.++++........+++..+..++.|++.||+|||++. +++||||||+||+++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9997 5898888754444567999999999999999999999853 899999999999999999999999999876533
Q ss_pred CCccccccccccccccCcccccc----CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 568 TERQVSTQMVGAFGYSAPEFALS----GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
.. ......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||....... +.+..
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------~~~~~ 219 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF---------------QQLKQ 219 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH---------------HHHHH
Confidence 21 1223468899999998865 446889999999999999999999996432211 11111
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..............+.++.+++.+||..+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 220 VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111112345778999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=321.14 Aligned_cols=267 Identities=22% Similarity=0.321 Sum_probs=197.6
Q ss_pred ccceeccC--CCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 414 QEFLIGEG--SLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 414 ~~~~lG~G--~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
..++||+| +|++||++.. .+|+.||+|++............+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 7889999966 47899999999765544445567788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998632 234589999999999999999999999 999999999999999999999999986543221111
Q ss_pred c------ccccccccccccCcccccc--CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHhhcccccc----
Q 005001 571 Q------VSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVRWATPQLHD---- 637 (720)
Q Consensus 571 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~---- 637 (720)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... ......+...+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0 1122356778999999976 458999999999999999999999997543211100 00000000000
Q ss_pred -HHHHH-----hhccc-----------------ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 638 -IDALA-----KMVDP-----------------ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 638 -~~~~~-----~~~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+... ...+. ..........+..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000 00000 00001122345678999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=310.01 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=205.0
Q ss_pred CCCccceeccCCCcEEEEEEEcC--CcEEEEEEccccc--------cChHHHHHHHHHHHHhhc-CCCCCccccceEEee
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFAN--GKIMAVKKIDNAA--------LSLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAE 479 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 479 (720)
.|+..+.||+|+||.||+|.... ++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37778899999999999998765 6889999875332 122334567788887765 799999999999999
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEccc
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 559 (720)
.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+.. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999998654445567999999999999999999999631 8999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 560 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
|.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~--------------- 221 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--------------- 221 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---------------
Confidence 9997654432 22345689999999999998899999999999999999999999965432111
Q ss_pred HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
.................+..+.+++.+||+.||++||++.|+..+++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 222 -ATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -HHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111111111111234567899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=308.97 Aligned_cols=251 Identities=26% Similarity=0.418 Sum_probs=203.4
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh-------HHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-------QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
+|.....||+|+||.||+|... +++.||+|.+....... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677789999999999999764 57899999886543221 123567889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999963 35688999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCc-----cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 005001 563 ALTPNTER-----QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 563 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
+....... .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------------- 219 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-------------- 219 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--------------
Confidence 76642211 11123458899999999999899999999999999999999999997543211
Q ss_pred HHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+... ......+...+..+.+++++||+.||.+||++.+++++
T Consensus 220 --~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 220 --AIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --HHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1111111 11122344566788999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=300.18 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=211.6
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
-++|...++||+|.||.|-+++- .+++.||+|++++..+ ...+.+.-+.|-++++..+||.+..+.-.|..++++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46788899999999999999965 4799999999987765 455567778899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||..||.|.-++. ....+++..++-+...|+.||.|||++ +||+||||.+|.|+|.+|++||+|||+++.-.
T Consensus 247 MeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999886 357889999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
..+ .....++|||.|+|||++....|+.++|+|.+||++|||++|+.||...+....-.++ +.
T Consensus 320 ~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI----------------l~ 382 (516)
T KOG0690|consen 320 KYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI----------------LM 382 (516)
T ss_pred ccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH----------------Hh
Confidence 332 3445689999999999999999999999999999999999999999865432211111 11
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
.. ..+|.....+...|+...|.+||.+|. +++||.++
T Consensus 383 ed--~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 383 ED--LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hh--ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 11 235666777888999999999999995 46666654
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=314.62 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=203.8
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCc----EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
++|+..+.||+|+||.||+|.+. +|+ .||+|.+.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 56778889999999999999764 444 47888886443 233445688999999999999999999988654 567
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+++||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999863 234688999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCccc-cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 565 TPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 565 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~---------------- 222 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD---------------- 222 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------------
Confidence 64332221 122345778999999999999999999999999999998 999997543211111
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
.+........+..++..+.+++.+||..+|++||++.++++.|.++.+.
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 223 -LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -HHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111122333556788999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=308.28 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=199.9
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc---ChHHHHHHHHHHHHhhcCCCCCccccceEEee--cCeE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQR 483 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 483 (720)
.+|...+.||+|+||.||+|... ++..|++|++..... .......+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999764 588999998864432 22344568889999999999999999998865 3577
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999862 35688999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc--cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 564 LTPNTER--QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 564 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----------------~~ 218 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----------------AI 218 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----------------HH
Confidence 5532111 11123458899999999999889999999999999999999999997542211 11
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+..........+......+.+++ .||..+|++||+++|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 219 FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 111111112233445566677888 6888899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=322.49 Aligned_cols=260 Identities=18% Similarity=0.280 Sum_probs=193.5
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
...|+..+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++...+..++|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 357999999999999999999775 4678999875432 2346888999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|++. ++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 588888753 346789999999999999999999999 999999999999999999999999999875332
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh--------HHHhhc-----c-
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS--------LVRWAT-----P- 633 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~--------~~~~~~-----~- 633 (720)
. .......||+.|+|||++.+..++.++|||||||++|||+++..|+....+..... +..... +
T Consensus 210 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 210 A--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred C--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 2 12234579999999999999999999999999999999999665553322211000 000000 0
Q ss_pred cc---ccHHHHHhhcccc--cCCCC-------ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 QL---HDIDALAKMVDPA--LNGMY-------PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 ~~---~~~~~~~~~~~~~--~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+ ..........+.. .+..+ ....+..+.++|.+||+.||++|||+.|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00 0000001111000 00000 01233456779999999999999999999875
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=327.11 Aligned_cols=261 Identities=21% Similarity=0.291 Sum_probs=200.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc---CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
..+|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++...+..++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 457999999999999999999653 3578999988542 234579999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|||++. ++|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++...
T Consensus 164 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999996 58888884 346789999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH----Hhhc--c-cccc
Q 005001 566 PNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV----RWAT--P-QLHD 637 (720)
Q Consensus 566 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~----~~~~--~-~~~~ 637 (720)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......... .... + ....
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 433222 223457999999999999999999999999999999999999999765543211111 1000 0 0000
Q ss_pred ---H---HHHHhhcccccCCCC--C-----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 638 ---I---DALAKMVDPALNGMY--P-----AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 638 ---~---~~~~~~~~~~~~~~~--~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ..+.+. ....+..+ + ...+.++.++|.+||+.||++||++.|++.+
T Consensus 316 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000010 00011111 1 1234568899999999999999999999976
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=307.64 Aligned_cols=252 Identities=22% Similarity=0.385 Sum_probs=207.3
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|+..+.||+|+||.||++... +|+.||+|++............+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999664 688999999875544455567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+.+++|.+++... ....+++.++..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988632 234678999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
. ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||....... ...+.....
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------------~~~~~~~~~- 217 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----------------LVLKIIRGS- 217 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----------------HHHHHhcCC-
Confidence 1 2223468899999999999899999999999999999999999997533211 111111111
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 112344556788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.96 Aligned_cols=250 Identities=27% Similarity=0.448 Sum_probs=199.3
Q ss_pred eeccCCCcEEEEEEEcC-------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 417 LIGEGSLGRVYRAEFAN-------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
.||+|+||.||+|...+ ++.+++|.+.... .......+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 69999999999997642 2578999886432 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC-----ceEEcccCC
Q 005001 490 VGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-----NPHLSDCGL 561 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~Dfg~ 561 (720)
+++++|.++++.... ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999974322 224578999999999999999999998 999999999999999887 899999999
Q ss_pred CccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 562 AALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 562 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
+......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~----------- 223 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---L----------- 223 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---H-----------
Confidence 8755332211 1122345778999999999999999999999999999998 9999975432111 1
Q ss_pred HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
..+........+...+..+.+++.+||+.+|.+||+++++++.|.
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 224 ---QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---HHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111111112234456778899999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.42 Aligned_cols=268 Identities=24% Similarity=0.343 Sum_probs=204.4
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||.||+|.+. +++.||+|++..........+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999875 58999999987554443345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.++.+ ....+++.++..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999988765 234589999999999999999999999 9999999999999999999999999998765443
Q ss_pred CccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH--------H
Q 005001 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI--------D 639 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~ 639 (720)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...........+.......... .
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 22 2233568899999999876 447889999999999999999999997544321111111100000000 0
Q ss_pred HHHhhcccccCC-----CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAKMVDPALNG-----MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....+..+.... ......+..+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000000 0012345778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.46 Aligned_cols=264 Identities=26% Similarity=0.413 Sum_probs=207.7
Q ss_pred cchhcHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEE
Q 005001 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (720)
Q Consensus 400 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (720)
+++.++..+.++|...+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 455667778899999999999999999999774 68899999886432 2235567888888888 899999999998
Q ss_pred eec-----CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC
Q 005001 478 AEH-----GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (720)
Q Consensus 478 ~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 552 (720)
... +..++||||+++++|.++++........+++..+..++.|++.||+|||+. +++||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 654 358999999999999999875444456789999999999999999999998 999999999999999999
Q ss_pred ceEEcccCCCccCCCCCccccccccccccccCccccccCC-----CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH
Q 005001 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI-----YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL 627 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~ 627 (720)
.+||+|||++........ ......|+..|+|||.+.... ++.++|||||||++|||++|+.||....+....
T Consensus 166 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-- 242 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-- 242 (291)
T ss_pred CEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--
Confidence 999999999876543221 122346889999999986543 688999999999999999999999754321111
Q ss_pred HHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 628 VRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ..+ ........+......+.+++.+||+.||++||++.|++++
T Consensus 243 ~~-----------~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FK-----------IPR--NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HH-----------Hhc--CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 000 0001111233445678999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=307.27 Aligned_cols=255 Identities=28% Similarity=0.422 Sum_probs=205.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|... +++.+++|.+..... .....+.+|++++++++||||+++++++...+..+++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 357888999999999999999765 578899999865432 24577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.++++. ....+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 80 EYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred eCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999998863 235789999999999999999999998 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCccccccC---CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSG---IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
.. .......++..|+|||.+.+. .++.++||||||+++|||++|+.||....+....... .+.
T Consensus 154 ~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~-------------~~~ 219 (262)
T cd06613 154 TI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI-------------SKS 219 (262)
T ss_pred hh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------Hhc
Confidence 22 122335688899999999877 8899999999999999999999999764432111110 000
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.........+...+.++.+++++||..+|.+||++.+++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 220 NFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00001111233456779999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=306.15 Aligned_cols=251 Identities=21% Similarity=0.353 Sum_probs=206.5
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|+..+.||+|+||.||+|... +++.+|+|.+............+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999764 688899999876655556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC-CceEEcccCCCccCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGLAALTPNT 568 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~ 568 (720)
+++++|.+++... ....+++..+..++.|++.||+|||++ +++|+||+|+||+++.+ +.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999732 234589999999999999999999999 99999999999999865 46899999998765433
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......... .+... .
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~----------------~~~~~-~ 216 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV----------------LKIMS-G 216 (256)
T ss_pred c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH----------------HHHHh-c
Confidence 2 122356889999999999988999999999999999999999999764432111 11111 1
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.....+...+..+.+++.+||+.||++||++.|++++
T Consensus 217 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 217 TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1112334456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=306.38 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=204.4
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc---ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
+|+..+.||+|+||.||+|... +++.|++|.+..... ..+....+.+|+++++.++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999776 789999998864332 233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
+||+++++|.++++. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999863 35688999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||......... .+..
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~----------------~~~~ 215 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV----------------FKIG 215 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH----------------HHHH
Confidence 332 223456889999999998776 899999999999999999999999754321110 1111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........+...+..+.+++.+||+.+|++||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 216 RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1011122344556788999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=310.99 Aligned_cols=249 Identities=29% Similarity=0.441 Sum_probs=205.1
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||.|+||.||+|... +++.||+|.+.... .......+.+|+++++.++|+||+++++++.+....++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 36888899999999999999765 68899999986543 23445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.++++ ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||+++.....
T Consensus 80 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 80 YCGGGSCLDLLK-----PGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eeCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999987 23789999999999999999999999 9999999999999999999999999999776543
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
. .......|++.|+|||.+.+..++.++||||||+++|||+||+.||....+...... ... .
T Consensus 152 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-------------~~~----~ 213 (274)
T cd06609 152 M-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-------------IPK----N 213 (274)
T ss_pred c-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-------------hhh----c
Confidence 2 122345688899999999998899999999999999999999999975442111100 000 0
Q ss_pred cCCCCChh-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 649 LNGMYPAK-SLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 649 ~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.....+.. .+..+.+++.+||..||++||++++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 214 NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111112 55678899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.93 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=190.1
Q ss_pred eeccCCCcEEEEEEEcCCc---EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCC
Q 005001 417 LIGEGSLGRVYRAEFANGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
.||+|+||.||+|...++. .+++|.+.... .......+.+|+..++.++||||+++++.+......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999755433 45666665432 2345678899999999999999999999999999999999999999
Q ss_pred CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC-ccc
Q 005001 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE-RQV 572 (720)
Q Consensus 494 sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~ 572 (720)
+|.++++.........++..+..++.||+.||+|||+. +++||||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999975433344567778889999999999999998 99999999999999999999999999986432211 112
Q ss_pred cccccccccccCcccccc-------CCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 573 STQMVGAFGYSAPEFALS-------GIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....+......+ ..+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------------~~~~ 225 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV------------IKDQ 225 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------------Hhhc
Confidence 234568899999998853 245789999999999999997 56687643321111000 0000
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.........+......+.+++..|| .+|++||++++|++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 226 QVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred ccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 0000111222335567889999999 6799999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=306.31 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=205.4
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|...+.||+|+||.||+|... +++.|++|.++...........+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5778899999999999999764 688999999876654445678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.++++ ....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999987 235588999999999999999999999 99999999999999999999999999988765433
Q ss_pred ccccc---cccccccccCccccccCC---CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 570 RQVST---QMVGAFGYSAPEFALSGI---YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 570 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
..... ...+++.|+|||++.+.. ++.++||||||+++|||++|+.||.......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~---------------~~ 218 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM---------------FH 218 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH---------------HH
Confidence 32221 346788999999998766 8899999999999999999999997543211110 00
Q ss_pred hcccccCCCCCh--hHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 005001 644 MVDPALNGMYPA--KSLSRFADIIALCVQPEPEFRPPMSEVVQ 684 (720)
Q Consensus 644 ~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~ell~ 684 (720)
... ......+. ..+..+.+++.+||+.+|++||++.+++.
T Consensus 219 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 219 VGA-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred Hhc-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 11111222 23667889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=311.99 Aligned_cols=248 Identities=25% Similarity=0.437 Sum_probs=203.2
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... .......+.+|+.++++++||||+++++++..+...++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 4666778999999999999764 57889999886443 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.+++. ...+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999885 35689999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||....+..... ......
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----------------~~~~~~ 217 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----------------LIPKNS 217 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----------------hhhcCC
Confidence 12223468889999999999999999999999999999999999986543211100 011111
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 112233456678899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=316.17 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=205.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh-HHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||+|... +++.||+|.+....... .....+.+|+++++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999775 48999999997654332 34567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+.+++|.++++. .....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999863 2346789999999999999999999999 999999999999999999999999999865432
Q ss_pred CCcc----------------------------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCC
Q 005001 568 TERQ----------------------------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSS 619 (720)
Q Consensus 568 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~ 619 (720)
.... ......||..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 112346889999999999999999999999999999999999999765
Q ss_pred CCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCC----HHHHHHH
Q 005001 620 RPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPP----MSEVVQA 685 (720)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ell~~ 685 (720)
.... ...++.............+..+.+++.+||+.||++||+ +.|++++
T Consensus 236 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NRDE----------------TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred chHH----------------HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 4321 111112111111111225678999999999999999999 6666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.84 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=206.6
Q ss_pred HHhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
....+|...+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 3456789999999999999999976 4789999999865432 234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++++|.+++. ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 94 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 94 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred eecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 999999999999986 35688999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
..... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+....... ..
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---------------~~ 229 (297)
T cd06656 166 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---------------AT 229 (297)
T ss_pred cCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee---------------cc
Confidence 43221 123346889999999999998999999999999999999999999754332110000 00
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........+...+..+.+++.+||+.||++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111234456678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.16 Aligned_cols=267 Identities=22% Similarity=0.303 Sum_probs=200.3
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|+..+.||+|+||.||+|... +|+.||+|++............+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999775 688999999875443333345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++ +|.+++.. ....+++..+..++.||++||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 974 88887752 245689999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchh-hHH-Hhh-ccccccHHHHHhhc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ-SLV-RWA-TPQLHDIDALAKMV 645 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~-~~~-~~~-~~~~~~~~~~~~~~ 645 (720)
.. .....+++.|+|||.+.+.. ++.++|||||||++|||+||+.|+......... ..+ ... .+............
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 21 22346788999999987754 789999999999999999999987543322111 100 000 00000000011111
Q ss_pred ccccCC---------CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNG---------MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+..... ......+.++.+++.+||+.||.+|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 100000 0112245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=311.82 Aligned_cols=271 Identities=24% Similarity=0.395 Sum_probs=210.0
Q ss_pred cCCCccceeccCCCcEEEEEEEc-----CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--cCe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQ 482 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 482 (720)
..|...+.||+|+||.||+|.+. +++.||+|.+...... .....+.+|++.++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 35677789999999999999753 3688999999755433 356788999999999999999999999877 557
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred eEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 89999999999999999732 23689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCccc--cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 563 ALTPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 563 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
.......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+.......... ... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~-~~~~~~~~~ 234 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM-IGI-AQGQMIVTR 234 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccc-ccc-ccccccHHH
Confidence 8765322211 112245567999999998899999999999999999999999986532211000 000 000011122
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
..+.+........+..++.++.+++.+||+.+|++||++.|+++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2222222333333445667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=318.20 Aligned_cols=262 Identities=22% Similarity=0.372 Sum_probs=189.5
Q ss_pred ceeccCCCcEEEEEEEc---CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--cCeEEEEEEec
Q 005001 416 FLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLVYEYV 490 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~ 490 (720)
.+||+|+||+||+|... +++.||+|.+..... ...+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 47999999999999764 467899999865432 2346789999999999999999998854 45689999998
Q ss_pred CCCCHHHHhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe----CCCCceEEcccCC
Q 005001 491 GNGNLHDMLHFADD-----SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCGL 561 (720)
Q Consensus 491 ~~gsL~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~ 561 (720)
.+ +|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 65 88888764321 123589999999999999999999999 99999999999999 4567899999999
Q ss_pred CccCCCCCcc--ccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcch-------hh---HH
Q 005001 562 AALTPNTERQ--VSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSE-------QS---LV 628 (720)
Q Consensus 562 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~-------~~---~~ 628 (720)
++........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||........ .. ..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 9865432211 12345789999999999874 589999999999999999999999975432110 00 00
Q ss_pred H-hhccccccHHHHHhh---------cccc-cCC--------CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 629 R-WATPQLHDIDALAKM---------VDPA-LNG--------MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 629 ~-~~~~~~~~~~~~~~~---------~~~~-~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ...+....+....++ .... ... .........+.+|+++||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000011111000 0000 000 0001123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=314.45 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=205.9
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
..+|+..+.||.|+||.||+|.. .+++.|++|.+.... ......+.+|+..++.++||||+++++++...+..++|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 35688899999999999999965 578999999986443 223566788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++. ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 96 e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 96 EYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999886 34689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....+......+ .. ..
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~-------------~~--~~ 231 (296)
T cd06655 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------AT--NG 231 (296)
T ss_pred ccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------Hh--cC
Confidence 222 223346889999999999988999999999999999999999999765432111100 00 01
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+...+..+.++|.+||..||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 232 TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11112234456778899999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=311.06 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=200.2
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
|+..+.||+|+||.||+|... ++..+++|.+.... ......+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 567788999999999999776 47788888885432 344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
++++|..++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~- 157 (282)
T cd06643 85 AGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 157 (282)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-
Confidence 99999988763 235789999999999999999999999 99999999999999999999999999987553322
Q ss_pred cccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 571 QVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.......|+..|+|||++. +..++.++|||||||++|||++|+.||....+.... .. .....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~-----------~~~~~ 224 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LK-----------IAKSE 224 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HH-----------HhhcC
Confidence 1223356899999999984 445788999999999999999999999754321110 00 00000
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+...+..+.+++.+||+.||.+||++.+++++
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 225 --PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111233456788999999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=308.05 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=191.9
Q ss_pred eeccCCCcEEEEEEEcC---CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCC
Q 005001 417 LIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
.||+|+||.||+|...+ ...+++|.+.... .......+.+|+..++.++||||+++++.+...+..++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999996543 3468888776432 3444567889999999999999999999999999999999999999
Q ss_pred CHHHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc-
Q 005001 494 NLHDMLHFADDS-SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ- 571 (720)
Q Consensus 494 sL~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 571 (720)
+|.+++...... ....++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999754321 23456788899999999999999999 9999999999999999999999999998654322211
Q ss_pred ccccccccccccCcccccc-------CCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 572 VSTQMVGAFGYSAPEFALS-------GIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
......++..|+|||++.. ..++.++|||||||++|||++ |..||....+....... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------------~~~ 225 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV------------VRE 225 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH------------hhc
Confidence 1123346778999998753 356889999999999999999 78888654322111000 000
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
..........+...+..+.+++..|| .||++||++++|++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 226 QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00001111223345667788999999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.63 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=201.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 346788889999999999999764 68899999886442 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.++++ ..+.+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 86 EFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred eccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 9999999999986 245789999999999999999999999 999999999999999999999999999875533
Q ss_pred CCccccccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 568 TERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
.. .......|+..|+|||++. ...++.++|||||||++|||++|..||....+.......... ..
T Consensus 159 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-----------~~ 226 (267)
T cd06645 159 TI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-----------NF 226 (267)
T ss_pred cc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-----------CC
Confidence 21 1223457899999999975 456889999999999999999999998654432111100000 00
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..+.. ......+..+.+++.+||+.+|++||++++++++
T Consensus 227 ~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 227 QPPKL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCcc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00000 0111244568899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=324.82 Aligned_cols=243 Identities=23% Similarity=0.309 Sum_probs=189.1
Q ss_pred eccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcC---CCCCccccceEEeecCeEEEEEEecCC
Q 005001 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL---RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 418 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
||+|+||+||+|... +++.||+|++..... .......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999765 589999999864332 122334445566665554 799999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.++|+|||++....... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99999886 346789999999999999999999999 99999999999999999999999999987543222 22
Q ss_pred cccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCC
Q 005001 573 STQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG 651 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (720)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+.......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~ 216 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM----------------YRNIAFGKVRF 216 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH----------------HHHHHcCCCCC
Confidence 3346799999999998765 479999999999999999999999976432111 11111111110
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCCCC----CHHHHHHH
Q 005001 652 MYPAKSLSRFADIIALCVQPEPEFRP----PMSEVVQA 685 (720)
Q Consensus 652 ~~~~~~~~~l~~li~~cl~~dP~~RP----s~~ell~~ 685 (720)
.....+..+.+++++||+.||.+|| ++.+++++
T Consensus 217 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 217 -PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred -CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 1112456788999999999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=311.36 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=204.3
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 35788889999999999999776 78999999886432 33445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|..+++... ....+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999886321 1347899999999999999999999742 8999999999999999999999999998765322
Q ss_pred CccccccccccccccCccccccCC------CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGI------YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
. .....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||......... ..+.
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------------~~~~ 220 (286)
T cd06622 157 L---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-------------AQLS 220 (286)
T ss_pred c---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-------------HHHH
Confidence 1 22346888999999986543 588999999999999999999999653221111 1111
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..... .....+...+.++.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 221 AIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111 1122344567788999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=306.82 Aligned_cols=238 Identities=26% Similarity=0.395 Sum_probs=188.2
Q ss_pred eeccCCCcEEEEEEEcC-------------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 417 LIGEGSLGRVYRAEFAN-------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
.||+|+||.||+|.... ...|++|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 68999999999997532 2358888876432 23345788889999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc-------eEE
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-------PHL 556 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~-------~kl 556 (720)
++||||+++|+|..+++. ....+++..+..++.||++||+|||+. +|+||||||+|||++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 999999999999988863 235689999999999999999999999 9999999999999987664 899
Q ss_pred cccCCCccCCCCCccccccccccccccCccccc-cCCCcccchhhhHHHHHHHHH-hCCCCCCCCCCcchhhHHHhhccc
Q 005001 557 SDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELL-TGRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 557 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~ell-tg~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||.........
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--------- 219 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE--------- 219 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH---------
Confidence 999998654322 2345788999999887 466899999999999999998 588887643221110
Q ss_pred cccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
+....... .......++.++|.+||+.||++||++.+|++.|
T Consensus 220 --------~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 --------RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --------HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00011111 1122346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.11 Aligned_cols=258 Identities=23% Similarity=0.432 Sum_probs=203.0
Q ss_pred CCccceeccCCCcEEEEEEEc----CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC------
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 481 (720)
|...+.||+|+||.||+|.+. +++.||+|.+..........+++.+|+++++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556778999999999999753 3688999999766555556778899999999999999999999875432
Q ss_pred eEEEEEEecCCCCHHHHhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEccc
Q 005001 482 QRLLVYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 559 (720)
..++++||+.+|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875322 1223578999999999999999999998 9999999999999999999999999
Q ss_pred CCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhcccccc
Q 005001 560 GLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 560 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
|+++........ ......+++.|++||.+.+..++.++|||||||++|||++ |+.||..........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~----------- 226 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN----------- 226 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH-----------
Confidence 998865432211 1222345678999999999999999999999999999999 888886543211110
Q ss_pred HHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
.+... .....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 227 -----~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 -----YLIKG-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -----HHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11110 01112234557899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=314.38 Aligned_cols=267 Identities=22% Similarity=0.321 Sum_probs=201.1
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 46888999999999999999765 578999999864432 2233457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 997 589888863 245688999999999999999999999 9999999999999999999999999998754332
Q ss_pred CccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh--ccccccHHHHH---
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA--TPQLHDIDALA--- 642 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~--- 642 (720)
.. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+... .+....+....
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 21 12234578899999998764 4788999999999999999999999865432221111100 00000000000
Q ss_pred hhc---ccccCC----CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMV---DPALNG----MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~---~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... .+.... ......+..+.+||.+||+.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 000000 0112345678899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=328.98 Aligned_cols=262 Identities=20% Similarity=0.235 Sum_probs=197.3
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
...|.+.+.||+|+||.||+|.+. .++.||+|... ...+.+|++++++++|+||+++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 457999999999999999999776 47889999642 223568999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|++. ++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 240 e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 240 PKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 9995 688888752 234799999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCc-----c---hhhHHHhhc---ccc
Q 005001 568 TERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPR-----S---EQSLVRWAT---PQL 635 (720)
Q Consensus 568 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~-----~---~~~~~~~~~---~~~ 635 (720)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..|+...... . ....+.... ..+
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 2211 223457999999999999999999999999999999999988765432211 0 011111111 000
Q ss_pred c---cHH---HHHhhcccccCCCCC-------hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 636 H---DID---ALAKMVDPALNGMYP-------AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 636 ~---~~~---~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ... ............... ......+.+|+.+||+.||.+|||+.|++++
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 000 000000000000000 0223468899999999999999999999976
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=312.17 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=205.9
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||+||+|... +|+.||+|++.... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 56788889999999999999765 58889999876443 23345778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.++++. .+.+++..+..++.+++.||.|||+.+ +++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999998863 357899999999999999999999742 8999999999999999999999999998654222
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||............ .....+....+....
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 229 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD-----PMGILDLLQQIVQEP 229 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh-----hhHHHHHHHHHhhcc
Confidence 1 22356899999999998889999999999999999999999999864432110000 000001111121111
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.........+..+.+++.+||+.||++||++.|++++.
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111122556789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.99 Aligned_cols=251 Identities=30% Similarity=0.482 Sum_probs=202.3
Q ss_pred CccceeccCCCcEEEEEEEcC-----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 413 SQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
+..+.||+|+||.||++...+ +..||+|++.... .......+.+|+..+..++|+||+++++++...+..+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456789999999999997754 4889999996543 2235678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++.... ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999987321 12289999999999999999999999 999999999999999999999999999976654
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
..........+++.|+|||.+.+..++.++||||+|+++|||++ |..||......... +...
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~-----------------~~~~ 218 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL-----------------EYLK 218 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------------HHHh
Confidence 32222212347789999999988889999999999999999999 78888653221111 1111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.......+...+.++.+++.+||..||++|||+.++++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 219 KGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111223344677899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.84 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=202.5
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.+.|+..+.||+|+||.||+|... +++.|++|.+... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 356888999999999999999775 4889999998643 3445677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|..++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 89 EFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred ecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999999888753 235689999999999999999999998 999999999999999999999999999865432
Q ss_pred CCccccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 568 TERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
.. .......+++.|+|||++. ...++.++|||||||++|||++|..||....+... ..
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----------------~~ 225 (292)
T cd06644 163 TL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV----------------LL 225 (292)
T ss_pred cc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH----------------HH
Confidence 21 1223456889999999985 34578899999999999999999999965432111 11
Q ss_pred hhcccc-cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPA-LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+..... .....+...+.++.+++.+||+.||++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 226 KIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111110 0111233455678899999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.13 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=200.8
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
.+++.+.....||+|+||.||+|.+. ++..|++|.+.... ......+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 34455556678999999999999754 57789999886543 3345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-CCceEEcccCCC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNL--TWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLA 562 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~--~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a 562 (720)
|+||+++++|.++++.. ...+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||.+
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999999732 2334 7888899999999999999998 9999999999999976 679999999998
Q ss_pred ccCCCCCccccccccccccccCccccccCC--CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
........ ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.......... +
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~---------- 222 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---F---------- 222 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---h----------
Confidence 76533221 122345889999999987654 7889999999999999999999996532211100 0
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+..........+.....++.+++.+||+.+|++||++.|++++
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 223 --KVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --hhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0000011122344566788999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.66 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=200.8
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc---ChHHHHHHHHHHHHhhcCCCCCccccceEEeec--CeE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQR 483 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 483 (720)
++|...+.||+|+||.||+|... ++..||+|.+..... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999764 588999998853321 223456788899999999999999999988663 467
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999862 34578899999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcc--ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 564 LTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 564 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
........ ......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----------------~~ 218 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA----------------AI 218 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----------------HH
Confidence 55322111 1223468899999999998889999999999999999999999996532211 11
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+..........+......+.+++.+||. +|++||+++|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 219 FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11111111223455566778899999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=286.83 Aligned_cols=253 Identities=24% Similarity=0.398 Sum_probs=203.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 486 (720)
.|+.+....||.|+-|.|++++.. +|..+|||.+.... ..++.++++..++++... ++|+||+.+|||..+...++.
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 345566778999999999999765 58999999997655 445566777777776554 589999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
||.|.. .++.+++. ..+++++..+-++...+.+||.||.+++ +|+|||+||+|||+|+.|.+|++|||++.++-
T Consensus 170 MelMs~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 170 MELMST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence 999854 56666653 3467999999999999999999999986 99999999999999999999999999997765
Q ss_pred CCCccccccccccccccCcccccc---CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
+.. ..+.-+|.+.|||||.+.- ..|+.++||||||++++||.||+.||.+.+-. .+.+-+
T Consensus 244 dSk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---------------Fe~ltk 306 (391)
T KOG0983|consen 244 DSK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---------------FEVLTK 306 (391)
T ss_pred ccc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---------------HHHHHH
Confidence 432 2344579999999999974 46899999999999999999999999874322 233333
Q ss_pred hccccc-CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPAL-NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+.+... ........+..+.+++..||++|+.+||...+++++
T Consensus 307 vln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 307 VLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 333221 111222367789999999999999999999999987
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=324.59 Aligned_cols=247 Identities=22% Similarity=0.345 Sum_probs=197.0
Q ss_pred ccceeccCCCcEEEEEEEc-CCcEEEEEEccccc--cChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe--EEEEEE
Q 005001 414 QEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA--LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ--RLLVYE 488 (720)
Q Consensus 414 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lV~e 488 (720)
...+||+|+|-+||+|.+. +|..||.-.++... .+....++|..|+.+|+.++||||++++++|.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3558999999999999654 57777764443322 245556899999999999999999999999987654 789999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-CCceEEcccCCCccCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALTPN 567 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~ 567 (720)
.+..|+|+.++++ .+.++....+.+++||++||.|||++ .|+|||||||-+||+|+. -|.|||+|+|+|.....
T Consensus 124 L~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999974 46788889999999999999999997 579999999999999976 48999999999987644
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
. .....+|||.|||||++. ..|+..+||||||++++||+|+..||..-..... .+.++...
T Consensus 199 s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ---------------IYKKV~SG 259 (632)
T KOG0584|consen 199 S---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ---------------IYKKVTSG 259 (632)
T ss_pred c---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH---------------HHHHHHcC
Confidence 3 223478999999999887 8899999999999999999999999975433211 11122111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.....+..-...++.+||.+|+.. .++||++.|+|+.
T Consensus 260 iKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 260 IKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred CCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 111111112235688999999999 9999999999965
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.46 Aligned_cols=268 Identities=22% Similarity=0.327 Sum_probs=205.4
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|+..+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999764 689999999876554444567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+ +++|.+++.. ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 9999999863 236789999999999999999999999 99999999999999999999999999988765433
Q ss_pred ccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHh-hcc------ccccHHH
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL-VRW-ATP------QLHDIDA 640 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~-~~~-~~~------~~~~~~~ 640 (720)
........|+..|+|||.+.+.. ++.++||||+|+++|||++|..||........... ... ..+ .......
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 22223456899999999987644 68999999999999999999888865443211111 110 000 0000000
Q ss_pred HHhhcccccCC----CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 LAKMVDPALNG----MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........... ......+..+.+++++||+.||++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0011335788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.23 Aligned_cols=247 Identities=27% Similarity=0.444 Sum_probs=199.7
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
++|...+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++++++||||+++++++..+ ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4578889999999999999975 67889999986432 345788999999999999999999988654 47999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 80 MSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 9999999999742 234688999999999999999999998 99999999999999999999999999987543221
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
.....+..|+|||.+.+..++.++|+|||||++|||++ |+.||......... ......
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~~~~~~ 213 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-----------------ECVEKG 213 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-----------------HHHhCC
Confidence 12234568999999998899999999999999999998 99999754322111 111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
.....+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 214 YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112234456788999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.48 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=205.4
Q ss_pred CCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccC----hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS----LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ......+.+|+..+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999975 56899999998643321 1235678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC-ceEEcccCCCcc
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAAL 564 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 564 (720)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999863 35688999999999999999999999 999999999999998776 599999999876
Q ss_pred CCCCCc---cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 565 TPNTER---QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 565 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
...... .......|+..|+|||.+.+..++.++||||+|+++|+|++|..||........... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-------------~ 220 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-------------I 220 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-------------H
Confidence 644321 112234688999999999988899999999999999999999999965432211111 1
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+..........+...+.++.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 221 FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11111122233455567789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=307.14 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=205.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||.||+|.+. +++.|++|.+..... ......+.+|++++++++||||+++++++...+..++|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 35777889999999999999776 688999998875532 3456778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|+++++|.+++... ...+++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 80 YMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred ecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999999742 2678999999999999999999999 7 999999999999999999999999999865532
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ...........
T Consensus 154 ~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~~~~ 219 (265)
T cd06605 154 SLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-----------IFELLQYIVNE 219 (265)
T ss_pred HHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-----------HHHHHHHHhcC
Confidence 211 1256889999999999999999999999999999999999999754321110 00111111111
Q ss_pred ccCCCCChh-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAK-SLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ...+.. .+..+.++|.+||..||++||++.+++++
T Consensus 220 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 PP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11 112222 56778999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=309.35 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=204.5
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.++++++||||+++++++..++..++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 456888999999999999999775 6889999998643 3344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 82 EFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999999863 235689999999999999999999999 999999999999999999999999998865433
Q ss_pred CCccccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 568 TERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
.. .......|++.|+|||.+. +..++.++||||||+++|||++|+.||......... .
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~----------------~ 218 (280)
T cd06611 156 TL-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL----------------L 218 (280)
T ss_pred cc-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH----------------H
Confidence 22 1223456899999999985 345778999999999999999999999764322111 1
Q ss_pred hhcccc-cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPA-LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
++.... .....+...+..+.+++.+||+.||.+||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 219 KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111100 0111233456678899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=307.96 Aligned_cols=238 Identities=26% Similarity=0.404 Sum_probs=187.6
Q ss_pred eeccCCCcEEEEEEEcC-------------------------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCcc
Q 005001 417 LIGEGSLGRVYRAEFAN-------------------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 471 (720)
.||+|+||.||+|.... ...|++|.+.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999996421 1357888886432 23345688899999999999999
Q ss_pred ccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC
Q 005001 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (720)
Q Consensus 472 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 551 (720)
++++++.+....++||||+++|+|..++.. ..+.+++..+..++.|+++||+|||+. +|+||||||+||+++..
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 999999999999999999999999998863 245789999999999999999999998 99999999999999764
Q ss_pred C-------ceEEcccCCCccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHH-hCCCCCCCCCCc
Q 005001 552 L-------NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELL-TGRKPLDSSRPR 622 (720)
Q Consensus 552 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~ell-tg~~pf~~~~~~ 622 (720)
+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred CcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 4 3799999987543221 12357788999998876 56899999999999999995 699999754332
Q ss_pred chhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 623 SEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
..... ..... ..+......+.++|.+||+.+|++||++.++++.|
T Consensus 229 ~~~~~-----------------~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 229 EKERF-----------------YEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHH-----------------HHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11110 00010 11222335688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=350.27 Aligned_cols=259 Identities=27% Similarity=0.373 Sum_probs=214.3
Q ss_pred cHHHHhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 404 SLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 404 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
.+...+-+|+....||.|.||.||.|.. .+|+..|+|.++-..........+.+|+.++..++|||+|+++|+-...+.
T Consensus 1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred HhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 3555567788899999999999999954 579999999886544344445667899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.+|.||||++|+|.++++ .++..++.....+..|++.|++|||+. |||||||||.||+++.+|.+|++|||.|
T Consensus 1309 v~IFMEyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccce
Confidence 999999999999999997 345567777778899999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCccc---cccccccccccCccccccCC---CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc
Q 005001 563 ALTPNTERQV---STQMVGAFGYSAPEFALSGI---YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLH 636 (720)
Q Consensus 563 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 636 (720)
....+..... -....||+.|||||++.+.. ...+.||||+||+..||+||+.||...+.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--------------- 1446 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--------------- 1446 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------------
Confidence 8765543221 23468999999999998754 46789999999999999999999975432
Q ss_pred cHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 637 DIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+.++.-+-.+-..+.|...+.+-.+++..||+.||++|.++.|++++
T Consensus 1447 -e~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1447 -EWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -hhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 223333333344456677788889999999999999999999887765
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.24 Aligned_cols=256 Identities=31% Similarity=0.465 Sum_probs=204.3
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecC---
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG--- 481 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~--- 481 (720)
.++++|+..+.||+|+||.||+|... +++.+++|.+.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 35688999999999999999999875 57889999886443 2346788999999998 7999999999987644
Q ss_pred ---eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcc
Q 005001 482 ---QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (720)
Q Consensus 482 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 558 (720)
..++||||+++++|.++++........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 48999999999999999875444457889999999999999999999999 999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccccccCcccccc-----CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~ 633 (720)
||++....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||.........
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------- 227 (275)
T cd06608 157 FGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-------- 227 (275)
T ss_pred Cccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--------
Confidence 99987654322 22234568999999998854 34678999999999999999999999753321111
Q ss_pred ccccHHHHHhhccc-ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 QLHDIDALAKMVDP-ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.++... ......+...+..+.+++.+||..||++|||+.+++++
T Consensus 228 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 228 --------FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred --------HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111111 11111223356688999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.50 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=205.3
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|...+.||+|+||.||++.+. +++.||+|.+..... .......+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999765 589999999865432 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.++++. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999873 46789999999999999999999998 999999999999999999999999999876644
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ...+....
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~ 213 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----------------IYEKILEG 213 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhcC
Confidence 3 233468999999999998889999999999999999999999997543211 11111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
....+...+..+.+++.+||+.||.+|+ +++|++++
T Consensus 214 --~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 --KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1123444567889999999999999999 77777755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.18 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=207.0
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||.|+||+||+|... ++..+++|++....... ....+.+|+..++.++|+||+++++.+...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 46888999999999999999764 67889999986544333 56778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
++++++|.++++... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 80 YLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred ccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999997422 135689999999999999999999999 9999999999999999999999999998765543
Q ss_pred Ccc---ccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 569 ERQ---VSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 569 ~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
... ......|+..|+|||++... .++.++|+|||||++|||++|+.||......... ..... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~~~~-----------~ 222 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLTLQ-----------N 222 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HHHhc-----------C
Confidence 322 22334689999999999877 7899999999999999999999999765432111 00000 0
Q ss_pred cccccCCC-CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VDPALNGM-YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........ .....+..+.+++.+||+.||++||++.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00111111 112456778999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.24 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=202.2
Q ss_pred hhcHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEee
Q 005001 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (720)
Q Consensus 402 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (720)
+..+..+.+.|+..+.||+|+||.||+|.+. +++.+|+|.+... ......+..|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 3344456678999999999999999999774 6888999987543 23345677888888888 79999999998853
Q ss_pred ------cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc
Q 005001 480 ------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (720)
Q Consensus 480 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 553 (720)
.+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 457899999999999999987432 35678888999999999999999999 9999999999999999999
Q ss_pred eEEcccCCCccCCCCCccccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 005001 554 PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV 628 (720)
Q Consensus 554 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~ 628 (720)
++|+|||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|..||....+.....
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-- 236 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-- 236 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--
Confidence 99999999875432221 123356899999999986 3467889999999999999999999996543211110
Q ss_pred HhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 629 RWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...............+..+.++|.+||+.||.+||++.|++++
T Consensus 237 --------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 --------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0001111111123456789999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.40 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=210.6
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|++.+.||+|+||.||++... +++.+++|.+............+.+|+++++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999654 688999999976655555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999875444456789999999999999999999999 9999999999999999999999999999776543
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
......+++.|+|||.+.+..++.++|+||||+++|||++|+.||........ ........
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-----------------~~~~~~~~ 217 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL-----------------RYKVQRGK 217 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHhcCC
Confidence 22234688899999999999999999999999999999999999975432111 11111111
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....+...+.++.+++.+||+.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 122334566789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.84 Aligned_cols=259 Identities=24% Similarity=0.383 Sum_probs=204.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec--CeEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLV 486 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV 486 (720)
++|+..+.||.|++|.||+|... +++.+|+|.+.... .......+.+|++++++++||||+++++++... +..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 36788899999999999999875 57889999886443 224567788999999999999999999988653 468999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999998875444456789999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCc--chhhHHHhhccccccHHHHHhh
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPR--SEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
... .....++..|+|||.+.+..++.++|||||||++|||++|..||...... .......+.. ..
T Consensus 157 ~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~ 223 (287)
T cd06621 157 NSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----------NM 223 (287)
T ss_pred ccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----------cC
Confidence 221 12345788999999999999999999999999999999999999765321 1111111100 00
Q ss_pred cccccCCCCC--hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VDPALNGMYP--AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..+......+ ...+..+.+++.+||+.+|++||++.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 224 PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0011111111 2345678999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.07 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=206.5
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
+|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999775 589999999975433 22456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+.+++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999863 35789999999999999999999999 9999999999999999999999999998765443
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........... ......
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------------~~~~~~- 216 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI--------------RAKQET- 216 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH--------------HHHhcc-
Confidence 2 22335688899999999998899999999999999999999999986553211111 111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPM--SEVV 683 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~ell 683 (720)
.....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 2233455566889999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.03 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=200.1
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC--------hHHHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS--------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
+|...+.||+|+||.||+|... +|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999654 6889999988532211 112346778999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+++++|.++++. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999873 35789999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCcc-ccccccccccccCccccccCC--CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH
Q 005001 562 AALTPNTERQ-VSTQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 562 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
+......... ......|+..|+|||.+.... ++.++|+||||+++||+++|..||........ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~-------- 224 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKL-------- 224 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHh--------
Confidence 8765432211 123346889999999988755 78999999999999999999999964322110 0000
Q ss_pred HHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.................+..+.+++.+||..||++||++.+++++
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 --GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --hccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000000011111122346788999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=306.74 Aligned_cols=238 Identities=25% Similarity=0.444 Sum_probs=188.7
Q ss_pred eeccCCCcEEEEEEEcC--------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 417 LIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.||+|+||.||+|.... ...|++|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 69999999999997642 2347778775432 2344677889999999999999999999999899999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc--------eEEcccC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN--------PHLSDCG 560 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~Dfg 560 (720)
|+++|+|.++++. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999973 234689999999999999999999999 9999999999999987765 6999999
Q ss_pred CCccCCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCC-CCCCCCCCcchhhHHHhhccccccH
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGR-KPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
++...... ....+++.|+|||++.+. .++.++|||||||++|||++|. .||....+.....
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~------------ 216 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ------------ 216 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH------------
Confidence 88654321 234678899999999874 5799999999999999999985 5554332211100
Q ss_pred HHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.... ....+.....++.+++.+||+.||++||+++++++.|
T Consensus 217 -----~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 217 -----FYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----HHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 1123334456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.57 Aligned_cols=237 Identities=27% Similarity=0.451 Sum_probs=189.2
Q ss_pred ceeccCCCcEEEEEEEcCCc-----------EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 416 FLIGEGSLGRVYRAEFANGK-----------IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
+.||+|+||.||+|.+.+.. .+++|.+..... ....+.+|+.++++++||||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 36999999999999876433 477777654321 15778899999999999999999999887 7789
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC-------ceEEc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-------NPHLS 557 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-------~~kl~ 557 (720)
+||||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 77 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999998732 23789999999999999999999998 999999999999999887 79999
Q ss_pred ccCCCccCCCCCccccccccccccccCccccccC--CCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccc
Q 005001 558 DCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG--IYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 558 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
|||++..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||.............
T Consensus 151 Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~----- 220 (259)
T cd05037 151 DPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ----- 220 (259)
T ss_pred CCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-----
Confidence 9999876543 1234567789999999877 78999999999999999999 577776543211111000
Q ss_pred cccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.. ...+......+.+++.+||..+|.+||++.++++.|
T Consensus 221 -----------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 -----------DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -----------cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 001111226788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=301.64 Aligned_cols=253 Identities=27% Similarity=0.463 Sum_probs=209.2
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|++|.||+|... +++.|++|++...... .....+.+|+..+.+++|+||+++++++...+..++|+|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36788899999999999999776 4899999998765432 456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|+++++|.+++.. ...+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 80 YMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred ecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999963 3678999999999999999999999 8 999999999999999999999999999876643
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||........... ...+..
T Consensus 153 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~-------------~~~~~~- 217 (264)
T cd06623 153 TLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL-------------MQAICD- 217 (264)
T ss_pred CCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH-------------HHHHhc-
Confidence 3322 2235688999999999999999999999999999999999999976543111111 111111
Q ss_pred ccCCCCChh-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAK-SLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+.. .+..+.+++.+||+.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 218 GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111122333 66789999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.28 Aligned_cols=252 Identities=23% Similarity=0.400 Sum_probs=204.5
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|...+.||+|+||.||+|... +|..||+|.+............+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778889999999999999765 588899999876544445566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc-eEEcccCCCccCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-PHLSDCGLAALTPNT 568 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~ 568 (720)
+++++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998632 234679999999999999999999999 9999999999999998864 699999998766433
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
.. ......|++.|+|||.+.+..++.++|+||||+++|||++|..||........ ..+.....
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~~ 218 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL----------------VLKICQGY 218 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHhccc
Confidence 22 22234688999999999988899999999999999999999999975432111 11111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ...+...+..+.+++.+||+.+|++||++.+++++
T Consensus 219 ~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 219 F-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred C-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1 11223445678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.19 Aligned_cols=248 Identities=28% Similarity=0.401 Sum_probs=200.3
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
|.....||+|+||.||++... ++..||+|++.... ......+.+|+..++.++|+||+++++.+...+..++||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 444567999999999999764 68899999886432 334566889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
++++|.+++. .+.+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 102 ~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 102 EGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 9999999885 35688999999999999999999999 999999999999999999999999999875533221
Q ss_pred cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccC
Q 005001 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (720)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... ...........
T Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------------~~~~~~~~~~~ 239 (292)
T cd06658 174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-------------RIRDNLPPRVK 239 (292)
T ss_pred -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHhcCCCccc
Confidence 1233568999999999998889999999999999999999999997543321111 11111111111
Q ss_pred CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 651 GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 651 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.....+..+.+++.+||..||++||++++++++
T Consensus 240 --~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 --DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112345578899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=299.40 Aligned_cols=254 Identities=27% Similarity=0.458 Sum_probs=211.9
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|...+.||+|+||.||++.+. +++.|++|++............+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999775 688999999976655556677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.++++........+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999975433357899999999999999999999999 99999999999999999999999999987664432
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
.......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||....... ....... ..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------------~~~~~~~-~~ 219 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----------------LALKILK-GQ 219 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH----------------HHHHHhc-CC
Confidence 22334578999999999999899999999999999999999999997543211 1111111 11
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....+...+..+.+++.+||..+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 122344566788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.98 Aligned_cols=268 Identities=22% Similarity=0.309 Sum_probs=201.4
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|+..+.||+|+||.||+|... +++.||+|++............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778889999999999999765 688999999875544444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+. ++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 5899888632 246789999999999999999999999 99999999999999999999999999987553322
Q ss_pred ccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHhhccccccH----HHHH-
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ-SLVRWATPQLHDI----DALA- 642 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~----~~~~- 642 (720)
. ......+++.|+|||.+.+.. ++.++||||||+++|||+||+.||......... ............. ....
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1 122335788999999887654 588999999999999999999999754432111 1111111000000 0000
Q ss_pred --hhcccccCC---CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 --KMVDPALNG---MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 --~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......... ......+..+.+++.+||+.||++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000 0011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=306.89 Aligned_cols=267 Identities=25% Similarity=0.312 Sum_probs=201.9
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC---hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
+|...+.||+|+||.||+|... +++.||+|++...... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999765 6899999999765433 22345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+ +++|.++++.. ...+++..+..++.||++||+|||+. +|+|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 88999999631 23789999999999999999999999 99999999999999999999999999997665
Q ss_pred CCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhh-ccccccHHH---
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWA-TPQLHDIDA--- 640 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~~-~~~~~~~~~--- 640 (720)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||....+......+ ... .+.......
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 43222 122356788999998865 45789999999999999999998888755432211111 100 000000000
Q ss_pred HHhhcccccCCC-----CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 LAKMVDPALNGM-----YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
............ .....+..+.+++.+||+.||++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 112345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=307.27 Aligned_cols=267 Identities=22% Similarity=0.311 Sum_probs=198.0
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|++++++++|+||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999775 6889999998654321 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+.+ +|.+++.. ....+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9985 99998863 234789999999999999999999999 9999999999999999999999999998754322
Q ss_pred CccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh---
Q 005001 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM--- 644 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 644 (720)
.. ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.............+..............
T Consensus 157 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 157 SK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred Cc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11 1122356889999999876 458899999999999999999999997554221111000000000000000000
Q ss_pred ---cc--------cccCCCC-ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 ---VD--------PALNGMY-PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ---~~--------~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ....... .......+.+++.+||+.||++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 0000000 01112567899999999999999999998853
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.64 Aligned_cols=268 Identities=24% Similarity=0.332 Sum_probs=203.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec--CeEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLV 486 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV 486 (720)
++|+..+.||+|+||.||+|... +++.+++|.++...........+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999876 588999999975543333344667899999999999999999998877 889999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
+||+++ +|.+++... ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 999988632 34689999999999999999999999 99999999999999999999999999988665
Q ss_pred CCCccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hh-hccccccHHHHHh
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RW-ATPQLHDIDALAK 643 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~-~~~~~~~~~~~~~ 643 (720)
..... .....+++.|+|||.+.+.. ++.++|+||||+++|||++|+.||...........+ .. ..+....+.....
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 43221 22345788999999987654 689999999999999999999999865443222111 10 0000000000000
Q ss_pred -----------hcccccCCCCChh-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 -----------MVDPALNGMYPAK-SLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 -----------~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.........++.. .+..+.+++++||+.||++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000111122222 46678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=308.74 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=200.3
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||++... .++.|++|.+...... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999775 5788999988754322 233567788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.++++. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999963 35689999999999999999999999 999999999999999999999999998863211
Q ss_pred CC--------------ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 005001 568 TE--------------RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633 (720)
Q Consensus 568 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~ 633 (720)
.. ........|+..|+|||.+.+..++.++|+|||||++|||++|..||.+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~--------- 224 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--------- 224 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---------
Confidence 00 0011124578899999999988899999999999999999999999975432111
Q ss_pred ccccHHHHHhhcccccCC-CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 634 QLHDIDALAKMVDPALNG-MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
..+........ ..+...+..+.+++.+||+.||++||++.++.+.|
T Consensus 225 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 225 -------FGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred -------HHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 11111111110 11123566789999999999999999965555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.37 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=188.8
Q ss_pred ceeccCCCcEEEEEEEc---CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--cCeEEEEEEec
Q 005001 416 FLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLVYEYV 490 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~ 490 (720)
.+||+|+||.||+|... ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++|+||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 47999999999999865 357899998865432 2456789999999999999999998854 45789999998
Q ss_pred CCCCHHHHhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe----CCCCceEEcccCC
Q 005001 491 GNGNLHDMLHFADD-----SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCGL 561 (720)
Q Consensus 491 ~~gsL~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~ 561 (720)
.+ +|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 88887753221 223588999999999999999999999 99999999999999 5667899999999
Q ss_pred CccCCCCCcc--ccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcch-------hhHH---
Q 005001 562 AALTPNTERQ--VSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSE-------QSLV--- 628 (720)
Q Consensus 562 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~-------~~~~--- 628 (720)
++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 9866433221 12345789999999999774 579999999999999999999999975432110 0000
Q ss_pred H-hhccccccHHHHHh---------hcccc-c--------CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 629 R-WATPQLHDIDALAK---------MVDPA-L--------NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 629 ~-~~~~~~~~~~~~~~---------~~~~~-~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ...+....+....+ ..... . ...........+.+|+.+||+.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 00000000000000 00000 0 000011123457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=303.28 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=203.7
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
-|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|+..+++++||||+++++++..++..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4677889999999999999764 688999998864432 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.+++. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999999986 35689999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
.......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.......... . +....
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----------------~-~~~~~ 217 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF----------------L-IPKNN 217 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH----------------H-HhcCC
Confidence 11223468889999999998889999999999999999999999997543211110 0 01111
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112233456778899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=328.76 Aligned_cols=277 Identities=16% Similarity=0.202 Sum_probs=195.0
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEcC--CcEEEEEEc--------------cc-cccChHHHHHHHHHHHHhhcCCC
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFAN--GKIMAVKKI--------------DN-AALSLQEEDNFLEAVSNMSRLRH 467 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~--------------~~-~~~~~~~~~~~~~e~~~l~~l~h 467 (720)
.....++|++.+.||+|+||+||++..+. +..++.|.+ .+ ..........+.+|+.++++++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 34456789999999999999999986542 222222211 00 01122234567899999999999
Q ss_pred CCccccceEEeecCeEEEEEEecCCCCHHHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCE
Q 005001 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD-SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (720)
Q Consensus 468 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 546 (720)
|||+++++++...+..|+|+|++.+ +|.+++..... ........++..++.|++.||+|||+. +||||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 9999999999999999999999864 77777642211 122344667888999999999999999 999999999999
Q ss_pred EeCCCCceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCC-CCCCCCcchh
Q 005001 547 LLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP-LDSSRPRSEQ 625 (720)
Q Consensus 547 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p-f~~~~~~~~~ 625 (720)
|++.++.+||+|||++...............||+.|+|||++.+..++.++|||||||++|||++|..+ +.........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999999999999987654433334456799999999999999999999999999999999998764 4333222111
Q ss_pred hHHHhhc------ccccc-HHHHHhhcccccC----CCC-----ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 626 SLVRWAT------PQLHD-IDALAKMVDPALN----GMY-----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 626 ~~~~~~~------~~~~~-~~~~~~~~~~~~~----~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+..... ..+.. ...+...++.... ... ....+..+.+++.+||+.||++||++.|++++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111100 00000 0011111110000 000 01133467788999999999999999999975
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=332.51 Aligned_cols=268 Identities=28% Similarity=0.473 Sum_probs=223.3
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc----C----CcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccce
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA----N----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAG 475 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 475 (720)
++...++..+.+.||+|.||.|++|... . ...||||..+..... .+.+.+..|+++|..+ +|+||+.++|
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 3334444455669999999999999643 1 457999999877655 7788899999999998 6999999999
Q ss_pred EEeecCeEEEEEEecCCCCHHHHhhhcc---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCC
Q 005001 476 YCAEHGQRLLVYEYVGNGNLHDMLHFAD---D-------SS--KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543 (720)
Q Consensus 476 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~-------~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp 543 (720)
++...+..++|+||+..|+|.++++..+ . .. ..++..+...++.|||.|++||++. ++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998655 0 01 2389999999999999999999999 999999999
Q ss_pred CCEEeCCCCceEEcccCCCccCCCCCccccccccc--cccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCC
Q 005001 544 ANILLDDELNPHLSDCGLAALTPNTERQVSTQMVG--AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSR 620 (720)
Q Consensus 544 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~ 620 (720)
+|||+.++..+||+|||+++..............| +..|||||.+....|+.++|||||||++||++| |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999766555444333333 456999999999999999999999999999999 999997522
Q ss_pred CcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 621 PRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
. ...+.+.+..+.+...|..+..+++++|+.||+.+|++||++.++.+.++.++..
T Consensus 527 ~----------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 527 P----------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred c----------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1 1222334556667778889999999999999999999999999999999997653
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=306.99 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=200.8
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
..+.|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++.++||||+++.+++...+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3456888899999999999999765 689999998864332 33445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|+||+. |++.+++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++...
T Consensus 93 v~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 93 VMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence 999997 577777653 235689999999999999999999999 9999999999999999999999999998755
Q ss_pred CCCCccccccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
... ....|++.|+|||++. ...++.++||||||+++|||++|+.||..........
T Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~---------------- 224 (307)
T cd06607 166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---------------- 224 (307)
T ss_pred CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH----------------
Confidence 332 2346888999999885 4568899999999999999999999997543211110
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...........+...+..+.+++.+||+.||++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 225 HIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000011111123356678999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=302.90 Aligned_cols=249 Identities=27% Similarity=0.465 Sum_probs=200.2
Q ss_pred CCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC---CCCccccceEEeecCeEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV 486 (720)
.|+..+.||+|+||.||+|.+ .+++.||+|.+.... .......+.+|+.++++++ |||++++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477788999999999999976 468999999886543 2334566788888888886 99999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.++++ ...+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 81 MEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999886 24789999999999999999999999 99999999999999999999999999987765
Q ss_pred CCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... ......|+..|+|||.+.++ .++.++|||||||++|+|++|..||........... .....
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------------~~~~~ 218 (277)
T cd06917 153 QNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-------------IPKSK 218 (277)
T ss_pred CCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-------------cccCC
Confidence 4332 22335689999999998754 468999999999999999999999975432111100 00000
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+... ....+.++.+++.+||+.||++||++.+++++
T Consensus 219 ~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 01111 11245678899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=300.16 Aligned_cols=244 Identities=23% Similarity=0.344 Sum_probs=201.4
Q ss_pred eccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCH
Q 005001 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (720)
Q Consensus 418 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 495 (720)
||.|+||.||+|... +++.||+|.+...... ......+.+|+.+++.++||||+++++++.+....++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999775 4889999998754432 33456788999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcccccc
Q 005001 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (720)
Q Consensus 496 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 575 (720)
.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999973 34689999999999999999999998 99999999999999999999999999988665432 2233
Q ss_pred ccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCCh
Q 005001 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655 (720)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (720)
..|++.|++||.+.+..++.++|+||+|+++|+|++|..||....... .....++........++.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--------------MEIYNDILKGNGKLEFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--------------HHHHHHHhccCCCCCCCc
Confidence 468899999999998889999999999999999999999997654211 111222222222334455
Q ss_pred hHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 005001 656 KSLSRFADIIALCVQPEPEFRPP-----MSEVVQ 684 (720)
Q Consensus 656 ~~~~~l~~li~~cl~~dP~~RPs-----~~ell~ 684 (720)
..+..+.+++.+||+.||++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 55778999999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=306.02 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=204.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
..+|...+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 467888999999999999999754 67889999985432 223466888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++. ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 96 e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 96 EYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred ecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999986 34678999999999999999999999 999999999999999999999999998875543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
... ......|++.|+|||.+.+..++.++||||||+++||+++|+.||............ ...+
T Consensus 168 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---------------~~~~ 231 (293)
T cd06647 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---------------ATNG 231 (293)
T ss_pred ccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---------------hcCC
Confidence 322 223346889999999999888999999999999999999999999764432111000 0001
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+...+..+.+++.+||..+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111233345678899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=307.77 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=199.5
Q ss_pred CccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecC
Q 005001 413 SQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 491 (720)
+....||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 33447999999999999764 68899999986433 2234567889999999999999999999999999999999999
Q ss_pred CCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc
Q 005001 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (720)
Q Consensus 492 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 571 (720)
+++|.+++. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... .
T Consensus 102 ~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~ 172 (297)
T cd06659 102 GGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-P 172 (297)
T ss_pred CCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-c
Confidence 999999875 35689999999999999999999999 99999999999999999999999999987554322 1
Q ss_pred ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCC
Q 005001 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG 651 (720)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (720)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....+......+ .... ....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-------------~~~~--~~~~ 237 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-------------RDSP--PPKL 237 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------hccC--CCCc
Confidence 223456899999999999989999999999999999999999999754322111100 0000 0011
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 652 MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 652 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+..+.+++.+||+.+|++||++++++++
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1122345678899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.05 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=216.7
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
+.....|.+...||+|.|++|.+|.+. ++..||||.+.+..........+.+|+++|..++|||||+++.+...+..+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 334567899999999999999999764 6899999999988877777677899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+.+|.+++++. ..+...+..+..++.|+.+|++|||++ .|||||||++|||++.+..+||+|||++..
T Consensus 132 lV~eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EEEEeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecccccee
Confidence 9999999999999997 356777799999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
+.. ......++|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++..-.... .+
T Consensus 205 ~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr----------------~r 266 (596)
T KOG0586|consen 205 FDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR----------------PR 266 (596)
T ss_pred ecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc----------------ch
Confidence 753 334566899999999999999887 58899999999999999999999975432211 12
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+...++- |.....+..++|++++-.+|.+|++.+++.+.
T Consensus 267 vl~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 267 VLRGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred heeeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 22223332 33344566799999999999999999999876
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=313.50 Aligned_cols=266 Identities=20% Similarity=0.282 Sum_probs=202.6
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec------
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 480 (720)
..++|+..+.||+|+||.||+|... +++.||+|.+............+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999765 689999999875544444556778899999999999999999987543
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
...++||||+.+ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999965 8888775 2288999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHh-hccccccH
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVRW-ATPQLHDI 638 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~-~~~~-~~~~~~~~ 638 (720)
+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... .... ..+...-.
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 997654322 1233468899999999999999999999999999999999999997654321111 1100 00000000
Q ss_pred HH-------------------HHhhcccc----cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DA-------------------LAKMVDPA----LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~-------------------~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ..+..... .....+...+..+.+++.+||+.||++||++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00000000 0000112345678899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=304.88 Aligned_cols=268 Identities=21% Similarity=0.274 Sum_probs=198.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
+++|...+.||+|+||.||+|... +++.||+|.+..... ......+.+|+++++.++|+||+++++++...+..++|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467889999999999999999764 688999999865432 222345678999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+. ++|.+++.. ....+.+..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 677776642 234578888999999999999999999 999999999999999999999999999875433
Q ss_pred CCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH---HHH-
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID---ALA- 642 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~- 642 (720)
... ......+++.|+|||.+.+. .++.++|||||||++|||++|..||.............+......... ...
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 156 PSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 221 12234578999999998764 478899999999999999999999976543211111111100000000 000
Q ss_pred --hhcccccCCCCC---------hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 --KMVDPALNGMYP---------AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 --~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+..........+ ...+..+.+++.+|+..||++|||++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000000 0124567899999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=292.21 Aligned_cols=274 Identities=24% Similarity=0.326 Sum_probs=207.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC-----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee-cCe
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 482 (720)
...|+....||+|.||.||+|.-++ .+.+|+|+++.............+|+.+++.++||||+.+..++-+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3468889999999999999994432 3368999998664433344567799999999999999999999877 778
Q ss_pred EEEEEEecCCCCHHHHhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC----CceEEc
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSS-KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE----LNPHLS 557 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~ 557 (720)
.++++||.+. +|...|++.+... ..++...++.|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999987 9999998766533 4688899999999999999999999 79999999999999887 899999
Q ss_pred ccCCCccCCCCCccc--cccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcch-------h--
Q 005001 558 DCGLAALTPNTERQV--STQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSE-------Q-- 625 (720)
Q Consensus 558 Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~-------~-- 625 (720)
|||+++.+.+..... ....+-|..|+|||++.+.+ ||.++||||.|||+.||+|-.+-|.+...... .
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999886654332 34567899999999999854 89999999999999999999988875432211 1
Q ss_pred hHH--HhhccccccHHHHHhhccc-----ccC-CC-CCh----------hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 626 SLV--RWATPQLHDIDALAKMVDP-----ALN-GM-YPA----------KSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 626 ~~~--~~~~~~~~~~~~~~~~~~~-----~~~-~~-~~~----------~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
..+ ....|...++..+.++-+- .++ .. .+. .-+....+|+.++|+.||.+|.|+++.+++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 111 1122333333332222110 000 00 000 0112367999999999999999999999774
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=310.41 Aligned_cols=269 Identities=25% Similarity=0.359 Sum_probs=202.3
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeec--CeE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH--GQR 483 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 483 (720)
..++|+..+.||+|+||.||+|.+. +++.+|+|++............+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999765 588999999865433334455677899999999 999999999988654 368
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||++ ++|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIR-----ANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 49998886 23788999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcc----ccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc--c
Q 005001 564 LTPNTERQ----VSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL--H 636 (720)
Q Consensus 564 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~--~ 636 (720)
........ ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65443221 2233568999999998865 457899999999999999999999997654332211111110000 0
Q ss_pred cHHH-----HHhhcc----cccC--CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 637 DIDA-----LAKMVD----PALN--GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 637 ~~~~-----~~~~~~----~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... ...+.+ .... .......+.++.+++.+||+.||++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 000010 0000 00011246678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=295.77 Aligned_cols=253 Identities=28% Similarity=0.403 Sum_probs=210.5
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec--CeEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLVY 487 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 487 (720)
+|...+.||+|++|.||+|... +++.|++|++..........+.+.+|+..+++++||||+++++.+... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999876 688999999876654455678889999999999999999999999888 8899999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999873 33889999999999999999999998 999999999999999999999999999887654
Q ss_pred CCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.... ......++..|+|||.+.+...+.++||||||+++|+|++|..||....... ....+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------------~~~~~~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---------------AALYKIGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---------------HHHHhccc
Confidence 4321 1233568899999999999889999999999999999999999997654110 11111111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......+...+..+.+++.+|++.||++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 122233455567889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=302.38 Aligned_cols=267 Identities=23% Similarity=0.294 Sum_probs=200.5
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
|+..+.||+|++|.||+|... +|..||+|++............+.+|+++++.++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999764 7999999998755433334466788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
+ ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68999886321 24689999999999999999999998 999999999999999999999999999876533221
Q ss_pred cccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHhhccccccH-------HHH
Q 005001 571 QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVRWATPQLHDI-------DAL 641 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~-------~~~ 641 (720)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||.......... ............ ...
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1 1223568899999988764 47899999999999999999999997654321111 111100000000 000
Q ss_pred Hhhccc---ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDP---ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...... ..........+..+.+++.+||+.||++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00001122344678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.91 Aligned_cols=275 Identities=24% Similarity=0.361 Sum_probs=210.7
Q ss_pred CCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC------eEE
Q 005001 412 FSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------QRL 484 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~ 484 (720)
|...+.||+|+||.||+|++ .+|+.||||.+.... .....+...+|++++++++|+|||+++++-++.. ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 55677899999999999985 579999999998655 4556788899999999999999999999865543 568
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC--CCCc--eEEcccC
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELN--PHLSDCG 560 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~--~~~~--~kl~Dfg 560 (720)
+|||||.+|||+..++..+ ....+++.+.+.++.++..||.|||++ +||||||||.||++- ++|+ .||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 9999999999999998543 346799999999999999999999998 999999999999983 3343 6999999
Q ss_pred CCccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
.|+...+.. .....+||+.|++||++.. +.|+..+|.|||||++|+.+||..||...........+.|..-... ..
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk-p~ 246 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK-PS 246 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC-CC
Confidence 999876543 5677899999999999995 8889999999999999999999999975443311111111100000 00
Q ss_pred HHHhhccccc--------CCCCC----hhHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHHHHHhhc
Q 005001 640 ALAKMVDPAL--------NGMYP----AKSLSRFADIIALCVQPEPEFRP--PMSEVVQALVRLVQRAS 694 (720)
Q Consensus 640 ~~~~~~~~~~--------~~~~~----~~~~~~l~~li~~cl~~dP~~RP--s~~ell~~L~~~~~~~~ 694 (720)
...-...+.. ..++| ......+-.++..+|..+|++|. .+.+....+.+|+...-
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 0000001111 11112 22334567899999999999999 88888888888877553
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.31 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=206.7
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
...+.|+..+.||+|+||.||+|.+. ++..|++|.+..... ....+.+|++.++.++|+||+++++++...+..++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45567888889999999999999876 688999999865432 45678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|+||+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 93 VMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 99999999999999732 13799999999999999999999998 9999999999999999999999999988655
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
..... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||....+..... ...
T Consensus 167 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~----------------~~~ 229 (286)
T cd06614 167 TKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF----------------LIT 229 (286)
T ss_pred ccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------HHH
Confidence 43221 2223457889999999998889999999999999999999999997543321111 111
Q ss_pred cccc-CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPAL-NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... ....+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 230 TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111 111122356778999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.60 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=198.0
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEeecCeEEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 488 (720)
+|...+.||+|+||.||++... +++.||+|++...... .....+.+|+..+.++. |+||+++++++...+..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4555678999999999999765 5899999998754432 44567888999999985 9999999999998899999999
Q ss_pred ecCCCCHHHHhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 489 YVGNGNLHDMLHFA-DDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 489 ~~~~gsL~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|+.. ++.++.... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 666654321 123467999999999999999999999742 899999999999999999999999999875543
Q ss_pred CCccccccccccccccCccccccC---CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSG---IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
... .....|++.|+|||++.+. .++.++|||||||++|||++|+.||....... ..+.+.
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------------~~~~~~ 223 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF---------------DQLTQV 223 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH---------------HHHhhh
Confidence 221 1234688999999999876 68999999999999999999999997543100 111111
Q ss_pred c---ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 V---DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. .+......+...+.++.+|+.+||+.||++||++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 224 VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1111112223466789999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.78 Aligned_cols=249 Identities=26% Similarity=0.384 Sum_probs=200.9
Q ss_pred CCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
.|...+.||+|++|.||+|.. .+++.+++|++.... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 355567899999999999976 468899999885332 23355688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.+++. ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 98 ~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 98 LEGGALTDIVT-----HTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred cCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 99999999986 25689999999999999999999999 99999999999999999999999999886544322
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+...... ......+.
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~-------------~~~~~~~~- 234 (285)
T cd06648 170 P-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR-------------IRDNLPPK- 234 (285)
T ss_pred c-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH-------------HHhcCCCC-
Confidence 1 12235689999999999998899999999999999999999999975433211111 01100001
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+...+..+.+++.+||+.+|++||++.+++++
T Consensus 235 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 235 -LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -CcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11122355678999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.91 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=203.0
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccc---cChHHHHHHHHHHHHhhcCCCCCccccceEEeec--CeE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA---LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQR 483 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 483 (720)
++|+..+.||+|+||.||+|... +++.||+|.+.... ........+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999764 68999999875321 1234456788999999999999999999998664 468
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999998862 35688999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCC--ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 564 LTPNTE--RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 564 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
...... ........|+..|+|||.+.+..++.++|+|||||++|||++|+.||...... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~ 218 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----------------AAI 218 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----------------HHH
Confidence 653211 11112356899999999999988999999999999999999999999643211 111
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+..........|....+.+.+++.+||. +|.+||++.+++.+
T Consensus 219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 12222222334566677889999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=308.45 Aligned_cols=271 Identities=25% Similarity=0.360 Sum_probs=199.8
Q ss_pred CCCccceeccCCCcEEEEEEEc---CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeec--CeEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRL 484 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 484 (720)
+|+..+.||+|+||.||+|... +++.||+|.+..... .......+.+|+.+++.++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999775 478999999976431 122235567899999999999999999999888 7899
Q ss_pred EEEEecCCCCHHHHhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC----CCceEEccc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSS-KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD----ELNPHLSDC 559 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Df 559 (720)
+||||+++ +|.+++....... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 7877776443333 3789999999999999999999999 9999999999999999 999999999
Q ss_pred CCCccCCCCCc--cccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcch-------hhH--
Q 005001 560 GLAALTPNTER--QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSE-------QSL-- 627 (720)
Q Consensus 560 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~-------~~~-- 627 (720)
|++........ .......++..|+|||++.+. .++.++|||||||++|||++|+.||........ ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543322 112345688999999988764 578999999999999999999999976543320 000
Q ss_pred -HHhh-ccccccHH------HHHhhcccccCCCCC---------h--hHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 628 -VRWA-TPQLHDID------ALAKMVDPALNGMYP---------A--KSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 628 -~~~~-~~~~~~~~------~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... .+...... ...+..+......++ . .....+.+++.+||+.||++||++.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 00000000 000000000011111 0 234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=302.59 Aligned_cols=244 Identities=26% Similarity=0.365 Sum_probs=190.7
Q ss_pred eeccCCCcEEEEEEEc-CCcEEEEEEccccccChH-HHHHHHHHHH---HhhcCCCCCccccceEEeecCeEEEEEEecC
Q 005001 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ-EEDNFLEAVS---NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 491 (720)
+||+|+||.||++... +++.+|+|.+........ ....+.+|.. .+...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 588999998865443222 2233344433 3334479999999999999999999999999
Q ss_pred CCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc
Q 005001 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (720)
Q Consensus 492 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 571 (720)
+|+|.+++.. .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998862 45799999999999999999999999 99999999999999999999999999987543322
Q ss_pred ccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccC
Q 005001 572 VSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650 (720)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (720)
.....||..|+|||.+.+ ..++.++||||+||++|||++|..||.......... ..+.. ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--------------~~~~~-~~~~ 215 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------IDRMT-LTVN 215 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--------------HHHHh-hcCC
Confidence 123468999999999874 558999999999999999999999997543321111 11110 1112
Q ss_pred CCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 651 GMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 651 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
...+...+.++.+++.+||+.||++|| +++|++++
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 223445667889999999999999999 58888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=304.24 Aligned_cols=271 Identities=20% Similarity=0.273 Sum_probs=199.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCe-----
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQ----- 482 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~----- 482 (720)
++|+..+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999765 689999998865443333345678899999999 46999999999877665
Q ss_pred EEEEEEecCCCCHHHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-CCceEEcccC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDS-SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCG 560 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg 560 (720)
.++||||+++ +|.+++...... ...+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 898888643322 35689999999999999999999999 9999999999999998 8899999999
Q ss_pred CCccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHhh-cccccc
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVRWA-TPQLHD 637 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~-~~~~~-~~~~~~ 637 (720)
++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||.......... ..... .+....
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 9875533211 1122357889999998865 457899999999999999999999997654322211 11100 000000
Q ss_pred ---HHHHHhhcc-cccCC----CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 638 ---IDALAKMVD-PALNG----MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 638 ---~~~~~~~~~-~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......... +.... ......+.++.++|.+||..||.+||++.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000 00000 0012345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.06 Aligned_cols=267 Identities=24% Similarity=0.374 Sum_probs=202.3
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec--CeEEEEEE
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLVYE 488 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 488 (720)
|+..+.||+|+||.||+|... +++.+|+|++............+.+|+++++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999776 588999999976543334456788999999999999999999999888 89999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++ +|.+++.. ....+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 89888862 235789999999999999999999999 9999999999999999999999999999866544
Q ss_pred CccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhhc-cccccHHHHHhh-
Q 005001 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWAT-PQLHDIDALAKM- 644 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~- 644 (720)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+ .... +....+....+.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 3222333467889999998775 45789999999999999999999999865543222111 1100 000000000000
Q ss_pred ----cc------cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 ----VD------PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ----~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ......+....+..+.+++++||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 000000111125678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.89 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=195.1
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeec--CeEEEEE
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH--GQRLLVY 487 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~lV~ 487 (720)
|+..+.||+|+||.||+|... +++.||+|+++....... .....+|+..+.++ +|+||+++++++.+. +..++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 566788999999999999764 688999999875433322 23445788888888 499999999999887 8899999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++ +|.+++.. ....+++.++..++.|++.||+|||+. +++||||||+||+++. +.+||+|||++.....
T Consensus 80 e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 80 ELMDM-NLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred ecCCc-cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 99974 88887763 235789999999999999999999999 9999999999999999 9999999999976543
Q ss_pred CCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|..||.............-...... ....+...
T Consensus 152 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 227 (282)
T cd07831 152 KPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD--AEVLKKFR 227 (282)
T ss_pred CCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCC--HHHHHhhc
Confidence 222 123467899999997754 5578899999999999999999999976544221111110000000 00001100
Q ss_pred cc--cCCCC-----------ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PA--LNGMY-----------PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~--~~~~~-----------~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ....+ ....+..+.+++.+||+.+|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 00001 12346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=306.41 Aligned_cols=269 Identities=26% Similarity=0.348 Sum_probs=200.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec--CeEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 485 (720)
.++|+..+.||+|+||.||+|... +|+.||+|++............+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457889999999999999999775 689999999865433322334566899999999999999999998654 56899
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+.+ +|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 898888632 36789999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-hhccccccH-HHHH
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR-WATPQLHDI-DALA 642 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~-~~~~~~~~~-~~~~ 642 (720)
..... ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||....+......+. ......... ....
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 54321 1222346788999999876 457899999999999999999999998655432222111 100000000 0000
Q ss_pred hhc---ccccCCC-C------ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMV---DPALNGM-Y------PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~---~~~~~~~-~------~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... .-..... . ....+..+.++|.+||+.||++||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000000 0 01135667899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=293.79 Aligned_cols=249 Identities=26% Similarity=0.450 Sum_probs=208.0
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|+..+.||+|++|.||+|... +++.|++|.+............+.+|++++++++|+|++++++++...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777889999999999999765 578999999987665555677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999863 36789999999999999999999999 99999999999999999999999999998765433
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||........ ..+... ..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----------------~~~~~~-~~ 215 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----------------LFRIVQ-DD 215 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHhc-cC
Confidence 22 2335688999999999888889999999999999999999999975432110 001110 11
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 684 (720)
....+...+..+.+++.+||..+|++||++.+++.
T Consensus 216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12234455678899999999999999999999885
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.84 Aligned_cols=265 Identities=23% Similarity=0.329 Sum_probs=196.7
Q ss_pred ceeccC--CCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEG--SLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
..||+| +||+||+|.+. +|+.||+|.+..........+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356776 99999999774 799999999876554555567888999999999999999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987432 34589999999999999999999998 99999999999999999999999998654322111100
Q ss_pred ------cccccccccccCccccccC--CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccc-------ccc
Q 005001 573 ------STQMVGAFGYSAPEFALSG--IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ-------LHD 637 (720)
Q Consensus 573 ------~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~-------~~~ 637 (720)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||................+. ...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0112355679999999774 4789999999999999999999999765422111000000000 000
Q ss_pred HHH--------H---------H-----hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 638 IDA--------L---------A-----KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 638 ~~~--------~---------~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... . . .+.........+...+..+.+|+++||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 0 0 0000111112233466789999999999999999999999966
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=329.65 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=194.4
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec----
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH---- 480 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 480 (720)
.+-.++|+....||+||||.||+++.+ ||..||||++.... +......+.+|+..+++++|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 345677889999999999999999887 89999999998776 666678889999999999999999987654110
Q ss_pred --------------------------------------------------------------------------------
Q 005001 481 -------------------------------------------------------------------------------- 480 (720)
Q Consensus 481 -------------------------------------------------------------------------------- 480 (720)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CeEEEEEEecCCCCHHHHhhhccCCCCCC-CHHHHHHHHHHHHHH
Q 005001 481 -----------------------------------GQRLLVYEYVGNGNLHDMLHFADDSSKNL-TWNARVRVALGTARA 524 (720)
Q Consensus 481 -----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~-~~~~~~~i~~qi~~~ 524 (720)
..+||-||||+..+|.++++.. ... .....++++++|++|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHH
Confidence 1137888999887788777631 111 467889999999999
Q ss_pred HHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC-----------------CCCccccccccccccccCccc
Q 005001 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP-----------------NTERQVSTQMVGAFGYSAPEF 587 (720)
Q Consensus 525 L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~ 587 (720)
|.|+|++ |||||||||.||++++++.|||+|||+|.... .......++.+||.-|+|||+
T Consensus 710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 9999999 99999999999999999999999999997621 011113356789999999999
Q ss_pred cccCC---CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC--CChhHHHHHH
Q 005001 588 ALSGI---YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM--YPAKSLSRFA 662 (720)
Q Consensus 588 ~~~~~---~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 662 (720)
+.+.. |+.|+|+||||||++||+. ||....++ ...+....++.+... +.......=.
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER---------------a~iL~~LR~g~iP~~~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER---------------ASILTNLRKGSIPEPADFFDPEHPEEA 848 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchHHH---------------HHHHHhcccCCCCCCcccccccchHHH
Confidence 98754 9999999999999999986 56543221 112222222222222 1122223346
Q ss_pred HHHHHhcCCCCCCCCCHHHHHH
Q 005001 663 DIIALCVQPEPEFRPPMSEVVQ 684 (720)
Q Consensus 663 ~li~~cl~~dP~~RPs~~ell~ 684 (720)
.+|++|++.||.+||||.|+++
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh
Confidence 8999999999999999999985
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.15 Aligned_cols=260 Identities=17% Similarity=0.211 Sum_probs=187.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCC----cEEEEEEccccccChHH---------HHHHHHHHHHhhcCCCCCccccce
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQE---------EDNFLEAVSNMSRLRHPNIVTLAG 475 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~ 475 (720)
.++|.+.+.||+|+||.||+|...++ ..+|+|........... ......+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46799999999999999999987543 45566653322111100 111223444566779999999998
Q ss_pred EEeecC----eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC
Q 005001 476 YCAEHG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (720)
Q Consensus 476 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 551 (720)
++.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 765543 34788887754 67776652 23457888899999999999999999 99999999999999999
Q ss_pred CceEEcccCCCccCCCCCcc------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchh
Q 005001 552 LNPHLSDCGLAALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ 625 (720)
Q Consensus 552 ~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~ 625 (720)
+.++|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999765432211 112346999999999999999999999999999999999999999765322111
Q ss_pred hHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 626 SLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
+.. ...+...+...... ....++..+.+++..||..+|++||++.++++.|
T Consensus 243 --~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 --IHA-----AKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred --HHH-----hHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 000 00011111111111 1233467899999999999999999999999876
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.64 Aligned_cols=247 Identities=26% Similarity=0.373 Sum_probs=196.6
Q ss_pred eccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCH
Q 005001 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (720)
Q Consensus 418 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 495 (720)
||+|+||+||+|... +|+.||+|.+...... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999654 6889999998654322 22345667899999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcccccc
Q 005001 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (720)
Q Consensus 496 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 575 (720)
.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+...... .....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 99987322 24689999999999999999999999 9999999999999999999999999998765432 12233
Q ss_pred ccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCCh
Q 005001 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655 (720)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (720)
..++..|+|||.+.+..++.++|||||||++|+|++|+.||........... +.+.... .....+.
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~~-~~~~~~~ 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-------------LKRRTLE-MAVEYPD 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-------------HHhcccc-ccccCCc
Confidence 4678899999999988899999999999999999999999976543211111 1111110 1112334
Q ss_pred hHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 656 KSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 656 ~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
..+..+.+++.+||+.||++|| ++.+++++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 4567889999999999999999 66666643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=292.33 Aligned_cols=250 Identities=30% Similarity=0.485 Sum_probs=204.9
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
.|+..+.||+|++|.||++... +++.+++|++..... .....+.+|+..+++++|+||+++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 3677889999999999999875 688999999975442 3567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 79 CSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999998632 25789999999999999999999998 99999999999999999999999999987665433
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||............ .. ....
T Consensus 153 ~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~--~~~~ 215 (253)
T cd05122 153 A--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-------------AT--NGPP 215 (253)
T ss_pred c--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-------------Hh--cCCC
Confidence 2 23456889999999999888999999999999999999999999754322111100 00 0000
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....+...+..+.+++.+||+.||++||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 216 GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111112235678999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=302.88 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=200.4
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.|...+.||+|+||.||+|... +++.||+|++..... .......+.+|++++++++|||++++++++......++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677889999999999999764 688999999864422 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+.+ +|.+.+.. ....+++.++..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9975 78777752 245689999999999999999999999 9999999999999999999999999998654322
Q ss_pred CccccccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 569 ERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
....|++.|+|||.+. ++.++.++|||||||++|||++|+.||........ .....
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----------------~~~~~ 237 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LYHIA 237 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHH
Confidence 2346888999999974 45688999999999999999999999875432111 11111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
............+..+.+++.+||+.+|.+||++.++++++..
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 238 QNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred hccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 1111111223455678999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=331.22 Aligned_cols=259 Identities=24% Similarity=0.308 Sum_probs=217.9
Q ss_pred hcHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeec
Q 005001 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (720)
Q Consensus 403 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (720)
..++....+|.+.++||+|+||.|..++++ +++.||+|++.+-.. ...+.+.|.+|-.+|..-+.+-|+.++-.|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 345556778999999999999999999875 588999999976443 244567788999999988999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
.++|+|||||+||+|-.++.. -.++++..++-++..|.-||.-||+. |+|||||||+|||+|..|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999973 23799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCcccccc-----CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL 635 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 635 (720)
.+-.+..++...+...+|||.|++||++.. +.|+..+|+||+||++|||+.|..||....-
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-------------- 286 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-------------- 286 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--------------
Confidence 998887777777777899999999999963 5689999999999999999999999975321
Q ss_pred ccHHHHHhhcccccCCCCC--hhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 005001 636 HDIDALAKMVDPALNGMYP--AKSLSRFADIIALCVQPEPEFRPP---MSEVVQA 685 (720)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~ 685 (720)
.+.+.++++-.-...+| ...+.+..+||++.+.. |+.|.. +.++..+
T Consensus 287 --veTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 287 --VETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNH 338 (1317)
T ss_pred --HHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhC
Confidence 23344444443334455 45778889999998864 777777 7777765
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.39 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=198.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-----Ce
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 482 (720)
.++|++.+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 467999999999999999999754 68999999986432 223445678899999999999999999986543 35
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++|+||+.+ +|.+.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 7999999975 8888775 46799999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcc--ccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-HhhccccccH
Q 005001 563 ALTPNTERQ--VSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWATPQLHDI 638 (720)
Q Consensus 563 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~ 638 (720)
......... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||............ ..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~--~~~ 231 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT--PSQ 231 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC--CCH
Confidence 765432221 1133568999999998765 56899999999999999999999999764322111111 00000 000
Q ss_pred HHHHhhcccc-------c--CCCC-----ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKMVDPA-------L--NGMY-----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~~~~~-------~--~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+....+.... . .... ....+.++.+++.+||+.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111100000 0 0000 01234668899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.41 Aligned_cols=269 Identities=22% Similarity=0.301 Sum_probs=199.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|++|.||+|... +|+.||+|++............+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999775 68899999986544333344667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-CCceEEcccCCCccCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALTPN 567 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~ 567 (720)
|++ ++|.+++... ....+++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 4888877522 233468888899999999999999999 9999999999999985 56799999999976543
Q ss_pred CCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hh-hccc---cccHHHH
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RW-ATPQ---LHDIDAL 641 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~-~~~~---~~~~~~~ 641 (720)
... ......+++.|+|||.+.+. .++.++||||+||++|+|+||+.||....+....... .. ..+. +.....+
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 221 12234678899999998764 5789999999999999999999999765432221111 00 0000 0000000
Q ss_pred Hhhc--ccccCC----CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMV--DPALNG----MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... .+.... ......+.++.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 000000 0112345668899999999999999999999964
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.07 Aligned_cols=272 Identities=24% Similarity=0.317 Sum_probs=202.3
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC----
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG---- 481 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 481 (720)
...++|+..+.||+|+||.||+|... +|+.||+|.++...........+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999875 5889999998754433334456778999999999999999999887654
Q ss_pred ------eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceE
Q 005001 482 ------QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (720)
Q Consensus 482 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 555 (720)
..++|+||+++ ++.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 77777652 235789999999999999999999999 999999999999999999999
Q ss_pred EcccCCCccCCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-cc
Q 005001 556 LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA-TP 633 (720)
Q Consensus 556 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~-~~ 633 (720)
|+|||++...............++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+... ..
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999976654332222233567889999988654 5789999999999999999999999764432222111110 00
Q ss_pred c----cccHHHHHhh--ccccc-----CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 Q----LHDIDALAKM--VDPAL-----NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 ~----~~~~~~~~~~--~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. +......... .+... ........+..+.+++.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0000000000 00000 000111245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.96 Aligned_cols=272 Identities=23% Similarity=0.332 Sum_probs=204.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-----Ce
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 482 (720)
.++|...+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457889999999999999999764 689999999875443344456677899999999999999999987654 35
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++|+||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 68988886 346799999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-hhccccc----
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR-WATPQLH---- 636 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~-~~~~~~~---- 636 (720)
....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...........+. .......
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 7664332 22334568889999998875 468999999999999999999999997653221111111 0000000
Q ss_pred --cHHHHHhhccc---ccCC---CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHH
Q 005001 637 --DIDALAKMVDP---ALNG---MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA--LVRL 689 (720)
Q Consensus 637 --~~~~~~~~~~~---~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~~ 689 (720)
......+.... .... ......+..+.+++++||+.||++||++++++++ +..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00001111100 0000 0112355678999999999999999999999988 5554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=297.88 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=201.8
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+|+..+.||+|++|.||+|... +|+.||+|++..... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4788899999999999999875 688999999875432 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++ +|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 80 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 80 MDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred CCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 985 8988886322 235689999999999999999999998 99999999999999999999999999987553322
Q ss_pred ccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHhh-ccccccHHHHHhhcc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVRWA-TPQLHDIDALAKMVD 646 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~ 646 (720)
. ......++..|++||.+.+. .++.++|||||||++|||++|+.||.......... ..... .+.-..+..+...
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 231 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL-- 231 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC--
Confidence 1 12234578899999998764 47889999999999999999999997654332211 11111 1111111111100
Q ss_pred cccCCC-----------CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGM-----------YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~-----------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+..... .....+..+.+++.+||+.||.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000001 112335678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.49 Aligned_cols=269 Identities=24% Similarity=0.337 Sum_probs=203.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee----cCeE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQR 483 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 483 (720)
..+|+..+.||+|+||.||+|... +|+.||+|++............+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999765 68999999987654334445677889999999999999999998753 3468
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+. ++|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 58988886 245689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc---cccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh--ccccc-
Q 005001 564 LTPNTER---QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA--TPQLH- 636 (720)
Q Consensus 564 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~--~~~~~- 636 (720)
....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+... .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 5533221 11233578999999999866 45889999999999999999999999765433221111110 00000
Q ss_pred ----cHHHHHhhccc-ccCCCC-----ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 637 ----DIDALAKMVDP-ALNGMY-----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 637 ----~~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+.... ...... ....+.++.+++++||+.||++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00011111110 000011 12346779999999999999999999999976
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.96 Aligned_cols=270 Identities=22% Similarity=0.318 Sum_probs=198.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC------
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 481 (720)
.++|+..+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356889999999999999999765 6889999998654333333445678999999999999999999886644
Q ss_pred --eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEccc
Q 005001 482 --QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (720)
Q Consensus 482 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 559 (720)
..++||||+.+ +|.+.+.. ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999965 88887752 234689999999999999999999999 9999999999999999999999999
Q ss_pred CCCccCCCCCcc---ccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc--
Q 005001 560 GLAALTPNTERQ---VSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP-- 633 (720)
Q Consensus 560 g~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~-- 633 (720)
|++......... ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||....+......+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999765432221 112345788999999887654 78899999999999999999999976554322222211110
Q ss_pred ------ccccHHHHHhhcccc-cCCC-----CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 ------QLHDIDALAKMVDPA-LNGM-----YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 ------~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.............+. .... .+......+.++|.+||+.||++||+++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000000000000 0000 001123456799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=298.56 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=206.2
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCC-CCCccccceEEeecCeEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV 486 (720)
++|...+.||+|+||.||+|... +++.||+|.+..... .......+.+|..++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999765 689999999875433 2334567888999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999973 34799999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCc-------------------cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH
Q 005001 567 NTER-------------------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL 627 (720)
Q Consensus 567 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~ 627 (720)
.... .......|+..|+|||.+.+..++.++||||||++++++++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----- 228 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----- 228 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence 3321 1122346789999999999888999999999999999999999999754321
Q ss_pred HHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Q 005001 628 VRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPM----SEVVQA 685 (720)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~ell~~ 685 (720)
....+.. ......+...+..+.+++.+||+.||.+||++ .+++++
T Consensus 229 -----------~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 229 -----------LTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -----------HHHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1111111 11223445557788999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=261.70 Aligned_cols=267 Identities=23% Similarity=0.328 Sum_probs=210.2
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
.|...++||+|.||+||+|+.. +++.||+|+++............++|+.+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4667789999999999999765 588999999987665555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
|.. +|..+.. .-++.++.+.++.++.|+++||.++|++ ++.|||+||+|.+++.+|++|++|||+++.+.-+.
T Consensus 83 cdq-dlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 976 7777664 4578899999999999999999999999 99999999999999999999999999999876655
Q ss_pred ccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHh--hccccccHHHHHhhc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRW--ATPQLHDIDALAKMV 645 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 645 (720)
...+. .+-|..|++|.++.+.+ |+.+.|+||.||++.|+.. |++.|.+.+-.+....+-+ ..+.-..+..+.+.-
T Consensus 156 rcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 RCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred Eeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 44433 45689999999999876 8999999999999999997 6666766654443333322 233222232232222
Q ss_pred ccccCCCCChh---------HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAK---------SLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~---------~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+-.....+|.. ....-++++++.+.-+|..|.++++.+++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 22222222221 11234689999999999999999998865
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=296.13 Aligned_cols=244 Identities=27% Similarity=0.386 Sum_probs=190.6
Q ss_pred eeccCCCcEEEEEEEc-CCcEEEEEEccccccCh-HHHHHHHHH---HHHhhcCCCCCccccceEEeecCeEEEEEEecC
Q 005001 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEA---VSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 491 (720)
+||+|+||.||+|... +++.||+|.+....... .....+..| +..++...||||+.+.+++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 58899999986543321 112223333 334555689999999999999999999999999
Q ss_pred CCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc
Q 005001 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (720)
Q Consensus 492 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 571 (720)
+|+|.+++. ..+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999999886 245799999999999999999999998 99999999999999999999999999987553322
Q ss_pred ccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccC
Q 005001 572 VSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650 (720)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (720)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||........... .+.. ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--------------~~~~-~~~~ 215 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--------------DRMT-LTMA 215 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--------------HHHh-hccC
Confidence 1234689999999999754 589999999999999999999999976533211110 0100 0111
Q ss_pred CCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 651 GMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 651 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
...+...+..+.+++.+||..+|.+|| ++.+++++
T Consensus 216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 223334567889999999999999999 89898864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=298.24 Aligned_cols=246 Identities=26% Similarity=0.395 Sum_probs=198.8
Q ss_pred ccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCC
Q 005001 414 QEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 414 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
....||+|+||.||++... +++.||+|++... .......+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 3457999999999999774 6899999988543 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
++|.+++. ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++........ .
T Consensus 102 ~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~ 172 (292)
T cd06657 102 GALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 172 (292)
T ss_pred CcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-c
Confidence 99999875 34689999999999999999999999 999999999999999999999999998875543221 1
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....|++.|+|||.+.+..++.++|+||+|+++|||++|..||........... ..........
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-------------~~~~~~~~~~-- 237 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-------------IRDNLPPKLK-- 237 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhhCCcccC--
Confidence 2335688999999999888899999999999999999999999975432111111 1111111111
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.....+..+.+++.+||+.||.+||++.+++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 112345568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=294.33 Aligned_cols=244 Identities=27% Similarity=0.417 Sum_probs=196.6
Q ss_pred eccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCH
Q 005001 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (720)
Q Consensus 418 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 495 (720)
||+|+||.||++... +|+.|++|.+..... .......+.+|++++++++||||+++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 489999999865433 223456788899999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc-----
Q 005001 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER----- 570 (720)
Q Consensus 496 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----- 570 (720)
.++++. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999973 24789999999999999999999999 999999999999999999999999999875433211
Q ss_pred --cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 571 --QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 571 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
.......++..|+|||...+..++.++||||||+++|||++|..||........ ........
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----------------~~~~~~~~ 217 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI----------------FQNILNGK 217 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHhcCC
Confidence 122334688899999999988899999999999999999999999975442211 11111111
Q ss_pred cCCCCChh--HHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 649 LNGMYPAK--SLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 649 ~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
. ..+.. .+..+.+++.+||+.+|++||++.++.+.|
T Consensus 218 ~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 218 I--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred c--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 1 11222 267889999999999999999995555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=297.73 Aligned_cols=256 Identities=24% Similarity=0.345 Sum_probs=201.5
Q ss_pred CCCccceeccCCCcEEEEEEE----cCCcEEEEEEccccccC--hHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAALS--LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 483 (720)
+|+..+.||+|+||.||++.. .+++.||+|.++..... ......+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999964 35788999998654321 22345678899999999 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998862 35688999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccCccccccCC--CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||.......... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------------~~~ 221 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS------------EIS 221 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH------------HHH
Confidence 65443332233456899999999987765 7889999999999999999999996432211110 000
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
...... ....+...+..+.+++.+||+.||++|||+.++.+.|+
T Consensus 222 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 222 RRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 111111 11233445667889999999999999999887776553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=297.33 Aligned_cols=266 Identities=23% Similarity=0.317 Sum_probs=203.3
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
|+..+.||+|++|.||+|... +++.+++|++............+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999765 6889999998765544445667888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
++ +|.+++.. ....+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 88888763 235789999999999999999999999 99999999999999999999999999987665433
Q ss_pred cccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH--hhccccccHHHHHh---h
Q 005001 571 QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR--WATPQLHDIDALAK---M 644 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~---~ 644 (720)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+. ...+.......... .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 112234578899999999877 78999999999999999999999997654322111110 00000000000000 0
Q ss_pred c---ccccC----CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 V---DPALN----GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~---~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. .+... .......+.++.++|.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 00000 00112356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=293.14 Aligned_cols=253 Identities=21% Similarity=0.335 Sum_probs=200.1
Q ss_pred CCCccceeccCCCcEEEEEEEcC-CcEEEEEEccc---cccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDN---AALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
+|.+.+.||+|+||.||++.... +..+++|.++. ..........+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788899999999999997653 34455555432 222333445667889999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
+||+++++|.+++.........+++.++..++.|++.||.|||+. +++|+||||+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999876555567899999999999999999999999 9999999999999975 579999999987654
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ....+...
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----------------~~~~~~~~ 219 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL----------------SVVLRIVE 219 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHHc
Confidence 3322 223356888999999998888999999999999999999999999643211 11111111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+...+.++.++|.+||+.||++||++.+++++
T Consensus 220 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 -GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11112344566788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=305.84 Aligned_cols=267 Identities=25% Similarity=0.335 Sum_probs=204.9
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC-----eEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-----QRL 484 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 484 (720)
+|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+.+++.++|+||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999875 4899999999765433445677889999999999999999999987765 789
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++ +|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999974 8988886 234899999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCc--cccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-hh-ccccc---
Q 005001 565 TPNTER--QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR-WA-TPQLH--- 636 (720)
Q Consensus 565 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~-~~-~~~~~--- 636 (720)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+. .. .+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 654321 112334688899999999988 78999999999999999999999997655322211111 00 00000
Q ss_pred --cHHHHHhhcc---cccC---CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 637 --DIDALAKMVD---PALN---GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 637 --~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........+. .... .......+..+.+++.+||+.||++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000 0000 00112245678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=297.13 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=199.6
Q ss_pred CCCccceeccCCCcEEEEEEE----cCCcEEEEEEcccccc--ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 483 (720)
+|+..+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999999999976 3688999999865432 122345678899999999 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999863 45688999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccCccccccC--CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSG--IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
..............|+..|+|||.+.+. .++.++||||||+++|+|++|..||......... ..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------------~~~ 220 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ-------------AEI 220 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH-------------HHH
Confidence 6543322222345689999999998763 4678999999999999999999999643221111 011
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
.+.+... ...++...+..+.+++.+||+.||++|| ++.+++++
T Consensus 221 ~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 221 SRRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1111111 1123445667788999999999999997 66777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=297.27 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=196.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC-CcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|+..+.||+|+||.||+|.+.+ ++.||+|.++..... .....+.+|+..+.+. +||||+++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3568888999999999999998864 889999998754322 2345566677666555 599999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+. ++|.+++.. ....+++..+..++.|++.||+|||+.. +|+||||+|+||+++.++.+||+|||++....
T Consensus 93 ~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99985 478777653 2347899999999999999999999742 89999999999999999999999999987654
Q ss_pred CCCccccccccccccccCccccccCC----CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGI----YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
.... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... +.+.
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------------~~~~ 229 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---------------EVLT 229 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---------------HHHH
Confidence 3221 12335788999999987654 7899999999999999999999996532210 1111
Q ss_pred hhccccc-CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 643 KMVDPAL-NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 643 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
+...... ........+.++.+++.+||+.||++||++.+++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 230 KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1111111 1111123567789999999999999999999999773
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=292.13 Aligned_cols=243 Identities=22% Similarity=0.275 Sum_probs=189.0
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHH-hhcCCCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSN-MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||.||+|... +++.||+|.+...... ......+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999764 5889999998654322 1222334444443 4455899999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
++|.++++. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999963 35689999999999999999999999 999999999999999999999999999875432
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (720)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||............. .. .......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------~~--~~~~~~~ 215 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL------------SR--RINWPEE 215 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------------hc--ccCCCCc
Confidence 223468889999999998889999999999999999999999997543321110000 00 0001111
Q ss_pred CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 005001 653 YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684 (720)
Q Consensus 653 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 684 (720)
.....+..+.+++.+||+.||++||++.++.+
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 22245678899999999999999997765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=300.00 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=193.4
Q ss_pred eeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCHH
Q 005001 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLH 496 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 496 (720)
.+|.|+++.||++.. +++.||+|++............+.+|++.++.++|+||+++++++...+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344444544444444 6899999999765445556778999999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc------
Q 005001 497 DMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER------ 570 (720)
Q Consensus 497 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~------ 570 (720)
++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 88 ~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 88 DLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999743 234688999999999999999999999 999999999999999999999999998865432211
Q ss_pred cccccccccccccCccccccC--CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHhhccc-cccHH--H----
Q 005001 571 QVSTQMVGAFGYSAPEFALSG--IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ-SLVRWATPQ-LHDID--A---- 640 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~-~~~~~~~~~-~~~~~--~---- 640 (720)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||......... ....-..+. +.... .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 111234577889999998763 5889999999999999999999999754322111 000000000 00000 0
Q ss_pred HHh----hccc----ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 LAK----MVDP----ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 ~~~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... .... ............++.+++.+||+.||++||++++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 0000 01111223345678899999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=292.46 Aligned_cols=247 Identities=20% Similarity=0.293 Sum_probs=191.2
Q ss_pred HHHhcCCCcccee--ccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhc-CCCCCccccceEEeecC
Q 005001 406 QTATNSFSQEFLI--GEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 406 ~~~~~~y~~~~~l--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~ 481 (720)
....+.|+..+.+ |+|+||.||++..+ ++..+|+|.+........ |+..... .+||||+++++++...+
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 3344566666665 99999999999764 678899998865432211 1111111 27999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC-ceEEcccC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCG 560 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg 560 (720)
..++||||+++++|.++++. ...+++.++..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 99999999999999999972 34889999999999999999999999 999999999999999998 99999999
Q ss_pred CCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
++...... ....|+..|+|||++.+..++.++||||||+++|||++|+.||........ .. ..
T Consensus 156 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~-----------~~ 218 (267)
T PHA03390 156 LCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DL-----------ES 218 (267)
T ss_pred cceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hH-----------HH
Confidence 98765332 224688999999999999999999999999999999999999975432210 00 11
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPP-MSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~ 685 (720)
+...... ....+...+..+.+++.+||+.||.+||+ +++++++
T Consensus 219 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 219 LLKRQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHhhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 1111111 11223356678899999999999999996 5888753
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.58 Aligned_cols=246 Identities=28% Similarity=0.444 Sum_probs=196.4
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
|...+.||+|+||.||+|... +++.|++|++..... .......+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566678999999999999764 688999999864432 233446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+. |++.+++.. ....+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 578777752 245689999999999999999999999 999999999999999999999999999864322
Q ss_pred ccccccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 570 RQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.....|+..|+|||++. +..++.++|||||||++|||++|..||........... ...
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~----------------~~~ 234 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----------------IAQ 234 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----------------HHh
Confidence 12356889999999985 45688999999999999999999999976543211111 100
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...........+..+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 235 NDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111122344568899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=298.65 Aligned_cols=249 Identities=29% Similarity=0.431 Sum_probs=198.1
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
+.|...+.||+|+||.||+|... +++.+|+|.+..... .......+.+|+++++.++|+|++++.+++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34667788999999999999765 578899998864322 3334567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+. |+|.+++.. ....+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 588877752 235689999999999999999999999 999999999999999999999999999875433
Q ss_pred CCccccccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 568 TERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
. ....|++.|+|||.+. ...++.++|||||||++|||++|..||......... ...
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----------------~~~ 226 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------------YHI 226 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH----------------HHH
Confidence 2 2346888999999975 356788999999999999999999998653321111 011
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.........+...+..+.++|.+||+.+|++||++.+++++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred hhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 111111111234566788999999999999999999999774
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=305.04 Aligned_cols=267 Identities=19% Similarity=0.305 Sum_probs=199.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec------C
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------G 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 481 (720)
.++|...+.||+|+||.||+|... +|+.||+|++............+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468889999999999999999764 689999999875443333345678999999999999999999998654 3
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999964 776654 24688999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.........+....+ ......
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 238 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG-VPGPEF 238 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCCHHH
Confidence 8764322 223567889999999876 4688999999999999999999999986543221111111000 000000
Q ss_pred HH--------hhcc--ccc-CCCC---ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHHH
Q 005001 641 LA--------KMVD--PAL-NGMY---PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA--LVRLV 690 (720)
Q Consensus 641 ~~--------~~~~--~~~-~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~~~ 690 (720)
.. .... +.. +... ....+..+.+++.+||+.||++||++.+++++ ++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00 0000 000 0000 01234568899999999999999999999966 66653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=300.83 Aligned_cols=267 Identities=24% Similarity=0.346 Sum_probs=202.3
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee-cCeE
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQR 483 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 483 (720)
...+++|+..+.||+|+||.||+|... +++.||+|++............+.+|+++++.++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345788999999999999999999755 78999999986544334445677889999999999999999998865 4578
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++|+||+ +++|.++++ ...+++..+..++.|+++||+|||+. +|+||||+|+||+++.++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 568988885 35678888999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhh-ccc------
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWA-TPQ------ 634 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~~-~~~------ 634 (720)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+ ... .+.
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 123467889999998866 56899999999999999999999999765432111111 000 000
Q ss_pred cccHHHHHhhcccccCCCCC-----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 LHDIDALAKMVDPALNGMYP-----AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...................+ ...+..+.++|++||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000001111111 1245678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.24 Aligned_cols=266 Identities=22% Similarity=0.278 Sum_probs=195.8
Q ss_pred CCCccceeccCCCcEEEEEEEc-C--CcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEee----cCe
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-N--GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE----HGQ 482 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 482 (720)
+|...+.||+|+||.||++... . +..||+|++............+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999765 3 77899999875433333456678899999988 59999999987533 245
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++++||+. ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999886 58998885 346789999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc---ccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH
Q 005001 563 ALTPNTERQ---VSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 563 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
......... ......||..|+|||.+.+ ..++.++||||+||++|+|++|..||................. ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~ 231 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG-TPDE 231 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC-CCCH
Confidence 765432211 1233578999999998766 4689999999999999999999999976543211111000000 0000
Q ss_pred HHHHhh-----------cccccCCC---CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKM-----------VDPALNGM---YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~-----------~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+...+. ........ .....+..+.+++.+||+.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 00000000 011234678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=299.62 Aligned_cols=270 Identities=26% Similarity=0.351 Sum_probs=198.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-------
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------- 480 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 480 (720)
.++|+..+.||+|+||.||+|... +++.+|+|++............+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999765 688999999865443333344567899999999999999999987543
Q ss_pred -CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEccc
Q 005001 481 -GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (720)
Q Consensus 481 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 559 (720)
...++|+||+.+ +|.+.+.. ....+++.++..++.|+++||+|||+. +|+|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999975 77776652 345799999999999999999999999 9999999999999999999999999
Q ss_pred CCCccCCCCCcc----------ccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 005001 560 GLAALTPNTERQ----------VSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV 628 (720)
Q Consensus 560 g~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~ 628 (720)
|+++........ ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 998765432211 11234578889999988754 5789999999999999999999999765543222211
Q ss_pred H-hhc-c---ccccHHHHHhhcccccCCCCC-------hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 629 R-WAT-P---QLHDIDALAKMVDPALNGMYP-------AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 629 ~-~~~-~---~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ... + .+..................+ ......+.+++.+||+.||++||++.|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1 100 0 000000001000000000001 1123568899999999999999999998853
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.97 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=196.3
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC---CCCCccccceEEeecCe-----
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---RHPNIVTLAGYCAEHGQ----- 482 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 482 (720)
|+..+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999876 489999999975433332334555676665544 69999999999988776
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.+++|||+.+ +|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 8998886422 24689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhhccccc-----
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWATPQLH----- 636 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~~~~~~~----- 636 (720)
........ .....++..|+|||.+.+..++.++|||||||++|||++|..||...........+ ........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 76543221 12345788999999999999999999999999999999999999765432211111 10000000
Q ss_pred ----cHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 637 ----DIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 637 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
............. .......+..+.+++.+||+.||.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred Ccccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000000000 00112345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=303.26 Aligned_cols=271 Identities=20% Similarity=0.296 Sum_probs=203.7
Q ss_pred hhcHHHHhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec
Q 005001 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (720)
Q Consensus 402 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (720)
..++....++|...+.||+|+||.||+|.. .+++.||+|++............+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 445666778999999999999999999965 4789999999976543444456788899999999999999999987543
Q ss_pred ------CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCce
Q 005001 481 ------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (720)
Q Consensus 481 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 554 (720)
...+++++++ +++|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3467888877 679988875 34689999999999999999999999 99999999999999999999
Q ss_pred EEcccCCCccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHhhc
Q 005001 555 HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL-VRWAT 632 (720)
Q Consensus 555 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~-~~~~~ 632 (720)
||+|||++...... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........... .....
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998764322 233568899999999876 5688999999999999999999999975443221111 11000
Q ss_pred -------cccccH--HHHHhhcccccCC---CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 633 -------PQLHDI--DALAKMVDPALNG---MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 633 -------~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+..... ............. ......+..+.++|.+|++.||++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000 0000000000000 0011235568899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=280.21 Aligned_cols=250 Identities=25% Similarity=0.361 Sum_probs=196.6
Q ss_pred cceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHH-hhcCCCCCccccceEEeecCeEEEEEEecCC
Q 005001 415 EFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSN-MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
...||.|+||+|++..++ .|+.+|||+++.... ..+..+++.|.+. ++.-+.||||+++|+...++..|+.||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 457999999999999765 699999999987765 3455667777765 4455899999999999999999999999965
Q ss_pred CCHHHHhhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc
Q 005001 493 GNLHDMLHF-ADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (720)
Q Consensus 493 gsL~~~l~~-~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 571 (720)
+|+.+.+. +......+++....+|..-...||.||.+.. .|||||+||+|||++..|.+||+|||++..+.+. .
T Consensus 148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--i 222 (361)
T KOG1006|consen 148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--I 222 (361)
T ss_pred -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--H
Confidence 88776543 2224567889988899999999999999874 9999999999999999999999999998765332 2
Q ss_pred ccccccccccccCcccccc--CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 572 VSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
..+.-+|...|||||.+.. ..|+.++||||||++|||+.||+.||.+++.. .+.+..++....
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv---------------feql~~Vv~gdp 287 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV---------------FEQLCQVVIGDP 287 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH---------------HHHHHHHHcCCC
Confidence 2334578889999999974 34899999999999999999999999875431 122222221111
Q ss_pred -CCCCC---hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 -NGMYP---AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 -~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...++ .+....+.++|..|+.+|-.+||.+.++.+.
T Consensus 288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11112 2356678999999999999999999999876
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=291.29 Aligned_cols=265 Identities=25% Similarity=0.344 Sum_probs=198.4
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEeecCeEEEEEEe
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
|...+.||+|+||+||+|... +++.|++|++...... .......+|+..+++++ |+||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 566789999999999999875 5788999998654332 23344567888999998 99999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+ +|+|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 80 M-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred C-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 9 779999886322 35789999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHhhccccc----cHHHHHh
Q 005001 570 RQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL-VRWATPQLH----DIDALAK 643 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~-~~~~~~~~~----~~~~~~~ 643 (720)
. .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||........... ......... +......
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 P--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred C--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 2 223468889999998854 4578999999999999999999999976543222111 111000000 0000000
Q ss_pred hcccccCC-------CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPALNG-------MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........ ......+..+.+++++||+.||++||+++|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 0011124678899999999999999999999754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.93 Aligned_cols=265 Identities=20% Similarity=0.317 Sum_probs=201.7
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe----
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ---- 482 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 482 (720)
..++|+..+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999875 57899999987544344445667889999999999999999998766554
Q ss_pred --EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 483 --RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 483 --~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
.++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 569999886 35799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhhccc----
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWATPQ---- 634 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~~~~~---- 634 (720)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+ ......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 98765432 233467889999999865 36789999999999999999999999765432211111 100000
Q ss_pred ---cc--cHHHHHhhcccccCCCC---ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 ---LH--DIDALAKMVDPALNGMY---PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 ---~~--~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+. ................+ ....+..+.+++.+||+.||++|||+.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 00000000000000000 01235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.08 Aligned_cols=265 Identities=19% Similarity=0.276 Sum_probs=200.0
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC-----
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----- 481 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 481 (720)
..++|+..+.||+|+||.||+|.. .++..||+|++............+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999965 46899999998654433444566889999999999999999999886543
Q ss_pred -eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 482 -QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 482 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
..++||||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999998 679998885 35789999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHhhcccc---
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL-VRWATPQL--- 635 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~-~~~~~~~~--- 635 (720)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||........... ........
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 98765332 123467889999999876 4578999999999999999999999976543211111 11000000
Q ss_pred ----c--cHHHHHhhcccccCC---CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 636 ----H--DIDALAKMVDPALNG---MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 636 ----~--~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ........+...... ......+..+.+++.+|++.||++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000000000000 0112344568899999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=277.08 Aligned_cols=269 Identities=22% Similarity=0.357 Sum_probs=204.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--------c
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--------H 480 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 480 (720)
..|+...+||+|.||+||+|+.. +|+.||+|++--+..........++|+.++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34666778999999999999765 57788988774332223334566899999999999999999988754 2
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
...|+||++|+. +|..++. .....++..++.++++++..||.|+|.. .|+|||+||.|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 357999999987 8988886 3457899999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccc---cccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh------
Q 005001 561 LAALTPNTERQV---STQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW------ 630 (720)
Q Consensus 561 ~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~------ 630 (720)
+++.+....... .+..+-|..|++||.+.+. .|+++.|||..||++.||+||.+-+.+..+......+..
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 997654332222 2345679999999999875 589999999999999999999998887766544444431
Q ss_pred --hccccccHHHHHhhccccc-CCCC--------ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 631 --ATPQLHDIDALAKMVDPAL-NGMY--------PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 631 --~~~~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+.|...+...+..+-.+.+ .+.+ |..-.++..+|+.+++..||.+|+++++++.+
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1233333333333211111 1111 11223467899999999999999999998866
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.72 Aligned_cols=268 Identities=24% Similarity=0.312 Sum_probs=198.1
Q ss_pred hcCCCc-cceeccCCCcEEEEEEEc-CCcEEEEEEccccccChH------------HHHHHHHHHHHhhcCCCCCccccc
Q 005001 409 TNSFSQ-EFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ------------EEDNFLEAVSNMSRLRHPNIVTLA 474 (720)
Q Consensus 409 ~~~y~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~ 474 (720)
.++|.. .+.||+|+||.||+|... +++.||+|++........ ....+.+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345654 467999999999999765 689999999865432210 012467899999999999999999
Q ss_pred eEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCce
Q 005001 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (720)
Q Consensus 475 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 554 (720)
+++...+..++||||+. |+|.+++. ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence 99999999999999997 58999886 345689999999999999999999998 99999999999999999999
Q ss_pred EEcccCCCccCCCCC-------------ccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCC
Q 005001 555 HLSDCGLAALTPNTE-------------RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSR 620 (720)
Q Consensus 555 kl~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~ 620 (720)
+|+|||++....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987654111 1111223568899999998764 46899999999999999999999997655
Q ss_pred CcchhhHH-Hhh-ccc---cccHHHHHhh------cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 621 PRSEQSLV-RWA-TPQ---LHDIDALAKM------VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 621 ~~~~~~~~-~~~-~~~---~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......+ ... .+. +......... ...... ......+.++.+++.+||+.+|++||++.|++.+
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 43221111 110 000 0000000000 000000 0011235678899999999999999999999964
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=277.18 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=199.6
Q ss_pred cceeccCCCcEEEEE-EEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEEEecCC
Q 005001 415 EFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
.+.||+|+|+.|-.+ ...+|..||||++.+. ......+..+|++++..+ .|+||++++++|+++...|+|||.|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 347999999999988 4578999999999765 445678889999999988 799999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc---eEEcccCCCccCCCCC
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSDCGLAALTPNTE 569 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~~ 569 (720)
|+|..+|+ ....+++.++.++.++|+.||.+||.+ ||.|||+||+|||-..... +||+||.+..-.....
T Consensus 161 GplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 161 GPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred chHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 99999998 357899999999999999999999999 9999999999999976554 7999998875332111
Q ss_pred c--cc----cccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc---
Q 005001 570 R--QV----STQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL--- 635 (720)
Q Consensus 570 ~--~~----~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~--- 635 (720)
+ .. -...+|+..|||||+.. ...|+.+.|.||||||+|-|+.|++||.+.-..+- -|...+.
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----GWdrGe~Cr~ 309 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----GWDRGEVCRV 309 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----CccCCCccHH
Confidence 1 11 12357888999999874 24488999999999999999999999986543211 0111111
Q ss_pred ccHHHHHhhcccccCCCCCh----hHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 005001 636 HDIDALAKMVDPALNGMYPA----KSLSRFADIIALCVQPEPEFRPPMSEVVQ 684 (720)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~ell~ 684 (720)
.+...+..+-+..+. +|. ..+.+..+++...+..|+..|.++.++++
T Consensus 310 CQ~~LFesIQEGkYe--FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYE--FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHhccCCc--CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111222222222222 333 35567789999999999999999999887
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=283.73 Aligned_cols=238 Identities=28% Similarity=0.394 Sum_probs=196.5
Q ss_pred eccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCH
Q 005001 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (720)
Q Consensus 418 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 495 (720)
||+|+||.||++... +++.+++|.+...... ......+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999775 5889999998755432 23456788999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcccccc
Q 005001 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (720)
Q Consensus 496 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 575 (720)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 999963 34689999999999999999999998 99999999999999999999999999987654432 12234
Q ss_pred ccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCCh
Q 005001 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655 (720)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (720)
..++..|+|||.+.+...+.++|+||||+++|||++|..||...... ........ .....+.
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~--~~~~~~~ 214 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK----------------EIYEKILK--DPLRFPE 214 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHhc--CCCCCCC
Confidence 56888999999999888999999999999999999999999754321 01111111 1123444
Q ss_pred hHHHHHHHHHHHhcCCCCCCCCCHHH
Q 005001 656 KSLSRFADIIALCVQPEPEFRPPMSE 681 (720)
Q Consensus 656 ~~~~~l~~li~~cl~~dP~~RPs~~e 681 (720)
..+..+.+++++||..||++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 55778899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=291.29 Aligned_cols=265 Identities=25% Similarity=0.350 Sum_probs=201.0
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
|+..+.||+|+||.||+|... +++.||+|.+............+..|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556778999999999999776 5899999999765433334566778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
+ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 5999999732 25789999999999999999999999 999999999999999999999999999876544322
Q ss_pred cccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHhhccccc-cHHHHHhh---
Q 005001 571 QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVRWATPQLH-DIDALAKM--- 644 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~--- 644 (720)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||.......... .......... .+......
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12234567789999998876 78999999999999999999999997654321111 1110000000 00000000
Q ss_pred ---c----ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 ---V----DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ---~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ........ ...+..+.+++.+||+.||++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0 00000001 1125678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.74 Aligned_cols=266 Identities=23% Similarity=0.294 Sum_probs=196.5
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-------
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------- 480 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 480 (720)
..+|...+.||.|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 367889999999999999999764 688999999865432 3456688899999999999999999876543
Q ss_pred -------CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-CC
Q 005001 481 -------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-EL 552 (720)
Q Consensus 481 -------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~ 552 (720)
...++|+||++ ++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 35789999997 58988875 35688999999999999999999999 9999999999999974 56
Q ss_pred ceEEcccCCCccCCCCCccc--cccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005001 553 NPHLSDCGLAALTPNTERQV--STQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR 629 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~ 629 (720)
.++++|||++.......... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....+........
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 78999999987653322111 122357889999998754 557889999999999999999999997665432221111
Q ss_pred hhcccccc--HHH----HHhhcc-cccCCCC-----ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 630 WATPQLHD--IDA----LAKMVD-PALNGMY-----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 630 ~~~~~~~~--~~~----~~~~~~-~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+.... ... ...... ....... ....+.++.+++.+||+.||++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 11110000 000 000000 0000000 11244678899999999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=274.57 Aligned_cols=244 Identities=23% Similarity=0.283 Sum_probs=191.8
Q ss_pred ceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEee----cCeEEEEEEe
Q 005001 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE----HGQRLLVYEY 489 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~~lV~e~ 489 (720)
++||-|-.|.|..+.++ +|+++|+|++.+. ....+|++..=.. .|||||.++++|.. ...+.+|||.
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 47999999999999665 6899999988643 2345677764443 79999999998754 4567899999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---CCceEEcccCCCccCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDCGLAALTP 566 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~ 566 (720)
|+||.|+..++. ...+.+++.++..|++||+.|+.|||+. +|.||||||+|+|... +..+||+|||+|+...
T Consensus 141 meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 141 MEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred ccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccC
Confidence 999999998873 3456799999999999999999999999 9999999999999965 4568999999998765
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
... .....+-||.|.|||++...+|+...|+||+||++|-|++|.+||......... | +--.++..
T Consensus 216 ~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-------p-----gMk~rI~~ 281 (400)
T KOG0604|consen 216 EPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------P-----GMKRRIRT 281 (400)
T ss_pred CCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-------h-----hHHhHhhc
Confidence 422 223457899999999999999999999999999999999999999865432110 0 01111111
Q ss_pred cccCCCCC--hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYP--AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.-+....+ ...+++..++|+.+|..+|++|.|+.+++.+
T Consensus 282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11111111 1356678899999999999999999999876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=283.53 Aligned_cols=243 Identities=22% Similarity=0.333 Sum_probs=200.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 486 (720)
.+|....+||+|+||.|.+|+.+ +.+.||||++++..+- ....+--+.|-++|+.- +-|.+++++.+|..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46777889999999999999766 4677999999876542 22233334566677665 568999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+.||+|--++++ -+.+.+..+.-++..||-||-+||++ +||+||||..|||++.+|++||+|||+++..-
T Consensus 429 MEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999888873 46788888999999999999999999 99999999999999999999999999987432
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
- .......++|||.|+|||++...+|+.++|+||+||+||||+.|+.||++.++.. ....+++
T Consensus 502 ~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----------------lF~aI~e 564 (683)
T KOG0696|consen 502 F-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQAIME 564 (683)
T ss_pred c-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHHHH
Confidence 2 2334456899999999999999999999999999999999999999999865432 1112221
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCC
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPP 678 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 678 (720)
-+..+|...+.+...+.+..+.+.|.+|..
T Consensus 565 --hnvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 --HNVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --ccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 234578888888999999999999999953
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=316.72 Aligned_cols=147 Identities=27% Similarity=0.399 Sum_probs=131.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|.+.+.||+|+||.||+|.+. +++.||+|+++.... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999776 688999999975432 3334567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
||+.+++|.++++. .+.+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999973 35688999999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=286.02 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=205.6
Q ss_pred hcHHHHhcCCCccceeccCCCcEEEEEE-EcCCcEEEEEEccccccChHH-----HHHHHHHHHHhhcCCCCCccccceE
Q 005001 403 ASLQTATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQE-----EDNFLEAVSNMSRLRHPNIVTLAGY 476 (720)
Q Consensus 403 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~ 476 (720)
.+-....++|-..++||+|||++||+|. ..+.+.||+|+-.......++ .+...+|.++.+.++||.||++|++
T Consensus 456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY 535 (775)
T ss_pred ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence 3444556788889999999999999995 456778888876543322222 2345789999999999999999999
Q ss_pred Eee-cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---CC
Q 005001 477 CAE-HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---EL 552 (720)
Q Consensus 477 ~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~ 552 (720)
|.- .+..|-|+|||+|.+|+-+++ ....+++.+++.|+.||+.||.||.+. .|+|||-||||.|||+.. -|
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence 864 567899999999999999987 457899999999999999999999997 569999999999999954 47
Q ss_pred ceEEcccCCCccCCCCCcc------ccccccccccccCccccccC----CCcccchhhhHHHHHHHHHhCCCCCCCCCCc
Q 005001 553 NPHLSDCGLAALTPNTERQ------VSTQMVGAFGYSAPEFALSG----IYTVKSDVYSFGVVMLELLTGRKPLDSSRPR 622 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGv~l~elltg~~pf~~~~~~ 622 (720)
.+||+|||+++.+.++... ......||.+|++||.+.-+ +++.++||||+|||+|+.+.|+.||......
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 8999999999988765433 23456899999999998643 4789999999999999999999999754321
Q ss_pred chhhHHHhhccccccHHHHHhhcccccCCCCC--hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 623 SEQSLVRWATPQLHDIDALAKMVDPALNGMYP--AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+.+.+..+ +-......+| +....+...+|++||++.-++|.+..++...
T Consensus 691 --QdILqeNT------------IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 691 --QDILQENT------------ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred --HHHHhhhc------------hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 22221110 1111122233 2355678899999999999999999888754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=281.72 Aligned_cols=271 Identities=19% Similarity=0.289 Sum_probs=201.4
Q ss_pred hhcHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-C-CC----ccccc
Q 005001 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-H-PN----IVTLA 474 (720)
Q Consensus 402 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~n----iv~l~ 474 (720)
+......+++|.+...+|+|.||.|-.+.+. .+..||+|+++... ...+..+-|+++++++. + |+ ++.+.
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 3444556889999999999999999999554 57899999997532 22344456788888883 2 33 78888
Q ss_pred eEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC----
Q 005001 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---- 550 (720)
Q Consensus 475 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---- 550 (720)
++|.-.++.+||+|.+ |-++++++.. +...+++...+..|+.|+++++++||+. +++|-||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 9999999999999998 5599999973 2345788999999999999999999999 9999999999999932
Q ss_pred ----------------CCceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCC
Q 005001 551 ----------------ELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRK 614 (720)
Q Consensus 551 ----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 614 (720)
+..++|+|||.|+..... ....+.|..|+|||++.+-.++.++||||+||||+|++||..
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 235899999999864432 245678999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhHHHhhcccccc---HHH-HHhhcccc-cC---------------CCC--------ChhHHHHHHHHHH
Q 005001 615 PLDSSRPRSEQSLVRWATPQLHD---IDA-LAKMVDPA-LN---------------GMY--------PAKSLSRFADIIA 666 (720)
Q Consensus 615 pf~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~-~~---------------~~~--------~~~~~~~l~~li~ 666 (720)
.|..-...+....-+........ ... ..+.+... +. ... ......+|.+|++
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 99876543322111111000000 000 01111000 00 001 1123356999999
Q ss_pred HhcCCCCCCCCCHHHHHHH
Q 005001 667 LCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 667 ~cl~~dP~~RPs~~ell~~ 685 (720)
+||..||.+|+|+.|++++
T Consensus 388 ~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHccCccccccHHHHhcC
Confidence 9999999999999999875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=291.10 Aligned_cols=247 Identities=23% Similarity=0.351 Sum_probs=202.9
Q ss_pred cceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCC
Q 005001 415 EFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
+++||+|.||+||-|.+ ++|+.||||.+.+..+....+.++..|+.+++.+.||.||.+--.|+..+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 67899999999999966 4799999999999888888889999999999999999999999999999999999999976
Q ss_pred CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC---CceEEcccCCCccCCCCCc
Q 005001 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 494 sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~ 570 (720)
+..+.+-. ...+++++....-++.||+.||.|||-+ +|+|+||||+|||+... -++||+|||+|+..+..
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 55454432 3468899998899999999999999999 99999999999999653 47999999999998654
Q ss_pred cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccC
Q 005001 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (720)
......+|||.|+|||+++.+.|...-|+||+|||+|.-++|..||....... +.++ + +..+.+...
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQ-------N----AaFMyPp~P 787 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQ-------N----AAFMYPPNP 787 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhh-------c----cccccCCCc
Confidence 34566899999999999999999999999999999999999999997532211 1111 0 011111100
Q ss_pred CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 651 GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 651 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
=.+......+||...|+..-++|-+.+..+.+
T Consensus 788 ---W~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 788 ---WSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ---hhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 02345567899999999999999998776544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=301.41 Aligned_cols=260 Identities=27% Similarity=0.453 Sum_probs=211.7
Q ss_pred hhcHHHHhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEee
Q 005001 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (720)
Q Consensus 402 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (720)
++.+...+.-|++.++||+|.+|.||+++. ++++.+|+|+..... ....++..|.++++.. .|||++.++|+|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 344555667789999999999999999965 468888998886543 2334455677777766 79999999999854
Q ss_pred -----cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCce
Q 005001 480 -----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (720)
Q Consensus 480 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 554 (720)
.+++|||||||.+|+..|+++... +..+.|..+..|++.++.|+.+||.. .++|||||-.|||++.++.+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 578999999999999999998654 78899999999999999999999999 99999999999999999999
Q ss_pred EEcccCCCccCCCCCccccccccccccccCcccccc-----CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005001 555 HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR 629 (720)
Q Consensus 555 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~ 629 (720)
|+.|||.+...... .......+|||.|||||++.- ..|+..+|+||||++..||.-|.+|+..+.+......+
T Consensus 163 KLvDFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I- 240 (953)
T KOG0587|consen 163 KLVDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI- 240 (953)
T ss_pred EEeeeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-
Confidence 99999999766543 334455789999999999964 34788999999999999999999999766543211110
Q ss_pred hhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 630 WATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
-..+......|.....++.++|..||.+|-++||++.+++++
T Consensus 241 --------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 --------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 112333444577788999999999999999999999988764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=295.95 Aligned_cols=242 Identities=26% Similarity=0.302 Sum_probs=195.1
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
.+..|.....+|.|+|+.|-.+.+ .+++..++|++.+.... -.+|+.++... +||||+++.+.+.+..+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 356788888899999999999865 46888999999765222 22445444443 79999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe-CCCCceEEcccCCCcc
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL-DDELNPHLSDCGLAAL 564 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~Dfg~a~~ 564 (720)
|||.+.|+-+.+.+.. .+....++..|+.+|+.|+.|||++ |||||||||+|||+ +..++++|+|||.++.
T Consensus 394 v~e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eehhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 9999999998888862 3333377888999999999999998 99999999999999 6899999999999987
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
.... ....+-|..|.|||++....|++++||||||++||+|++|+.||...... .+...++
T Consensus 466 ~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------------~ei~~~i 526 (612)
T KOG0603|consen 466 LERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------------IEIHTRI 526 (612)
T ss_pred Cchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---------------HHHHHhh
Confidence 6554 22345688899999999999999999999999999999999999764332 0111111
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
. ...+....+....+|+++||+.||.+||++.++..+=
T Consensus 527 ~----~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 527 Q----MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred c----CCccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 1 1223356777889999999999999999999999773
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=288.92 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=210.0
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCc-EEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGK-IMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++..+..||-|+||.|-++..+... .+|+|.+++..+ ...+.+....|-.+|...+.|.||++|..|.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 44566678999999999999776444 488888875443 4555667788899999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|-|-||.|+..++ ..+.++...+.-++..+++|++|||++ +||+|||||+|.+++.+|.+||.|||+|+....
T Consensus 500 EaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999997 578899999999999999999999999 999999999999999999999999999998765
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. ....++|||.|.|||++.....+.++|.||||+++|||++|.+||.+.++.....++- ..
T Consensus 573 g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL----------------kG 634 (732)
T KOG0614|consen 573 GR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL----------------KG 634 (732)
T ss_pred CC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH----------------hh
Confidence 43 3456899999999999999999999999999999999999999999887754443331 11
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPP-----MSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 685 (720)
.-...+|........+||++....+|.+|.. ..+|-++
T Consensus 635 id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 635 IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1112345566667789999999999999976 4555544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=276.39 Aligned_cols=220 Identities=20% Similarity=0.222 Sum_probs=176.6
Q ss_pred CCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCHHHHh
Q 005001 421 GSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML 499 (720)
Q Consensus 421 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l 499 (720)
|.||.||++.+. +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999764 68899999996542 1223344444557999999999999999999999999999999998
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcccccccccc
Q 005001 500 HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA 579 (720)
Q Consensus 500 ~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 579 (720)
.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+...... .....++
T Consensus 77 ~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~ 145 (237)
T cd05576 77 SK----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVE 145 (237)
T ss_pred HH----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcC
Confidence 63 34689999999999999999999998 9999999999999999999999999987654332 1234567
Q ss_pred ccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHH
Q 005001 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLS 659 (720)
Q Consensus 580 ~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (720)
..|+|||.+.+..++.++||||+|+++|||++|+.|+....... ........+...+.
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------------~~~~~~~~~~~~~~ 203 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------------NTHTTLNIPEWVSE 203 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------------ccccccCCcccCCH
Confidence 78999999988889999999999999999999998875321100 00000112334556
Q ss_pred HHHHHHHHhcCCCCCCCCCHH
Q 005001 660 RFADIIALCVQPEPEFRPPMS 680 (720)
Q Consensus 660 ~l~~li~~cl~~dP~~RPs~~ 680 (720)
.+.+++.+||+.||++||++.
T Consensus 204 ~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHccCCHHHhcCCC
Confidence 788999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-34 Score=268.85 Aligned_cols=266 Identities=24% Similarity=0.372 Sum_probs=210.7
Q ss_pred CccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-----CeEEEE
Q 005001 413 SQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQRLLV 486 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV 486 (720)
+-++.||.|+||.||.+.+. +|+.||+|++.+........+.+.+|+.++..++|.||+..+++..-. ++.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34568999999999999664 799999999987766666778899999999999999999998876432 356889
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
+|.|.. +|...+- ..+.++...++-++.||++||.|||+. +|.||||||.|.|++.+..+||+|||+++...
T Consensus 136 TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 999865 8887774 578899999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH--hhccccccHHH---
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR--WATPQLHDIDA--- 640 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~--- 640 (720)
.+....++..+-|..|+|||++++. .|+.++||||+|||+.|++..+..|....+....+++. ..+|....+..
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 6666666777889999999999985 58999999999999999999999998887765544432 22333332221
Q ss_pred --HHhhcccccCCC-----C----ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 641 --LAKMVDPALNGM-----Y----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 641 --~~~~~~~~~~~~-----~----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
-..++....+.. + +.....+...+..+++..||.+|.+..+.++++
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111121111110 0 112223566889999999999999999998875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=250.03 Aligned_cols=210 Identities=27% Similarity=0.390 Sum_probs=177.5
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhc-CCCCCccccceEEeecCe
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~ 482 (720)
++...+.......||+|+||.|-+.++. +|..+|+|++.... ..++.++++.|+.+..+ ..+|.+|.++|.....+.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 4444555666778999999999888664 79999999997654 45667778888887555 489999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++.||.|+. +|..+.+..-..++.+++...-+|+..|.+||.|||++- .+||||+||+|||++.+|++|++|||++
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 9999999976 998888776677889999999999999999999999984 8999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccCcccccc----CCCcccchhhhHHHHHHHHHhCCCCCCCCC
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALS----GIYTVKSDVYSFGVVMLELLTGRKPLDSSR 620 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGv~l~elltg~~pf~~~~ 620 (720)
..+.+... .+.-.|...|||||.+.. ..|+.++||||||++++||.+++.||+.+.
T Consensus 197 G~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 197 GYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred eeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 87644321 122467788999999864 368999999999999999999999998654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=264.83 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=195.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHH-HHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDN-FLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~-~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
.++|+..++||+|+|+.|.+++++ +.+.||+|+++++.....+... ...|-.+..+. +||.+|-+..+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467889999999999999999775 5788999999877654443322 23344455444 79999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|.||++||+|--+++ ....++++.++-+...|.-||.|||++ |||+||||..|||+|.+|++|++|+|+.+.-
T Consensus 329 vieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999987776 346789999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh-
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM- 644 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 644 (720)
..+.+ ....++|||.|+|||++++..|..++|+|++||+++||+.|+.||+--.... +.....+-+-++
T Consensus 402 l~~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n---------~d~ntedylfqvi 471 (593)
T KOG0695|consen 402 LGPGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN---------PDMNTEDYLFQVI 471 (593)
T ss_pred CCCCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC---------cccchhHHHHHHH
Confidence 44433 3456899999999999999999999999999999999999999997422100 000000111111
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCC
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRP 677 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 677 (720)
+...+ ..|...+-....+++.-|.+||.+|.
T Consensus 472 lekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 472 LEKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 11111 23444444556789999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.07 Aligned_cols=237 Identities=33% Similarity=0.484 Sum_probs=193.3
Q ss_pred CCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCHHHHhh
Q 005001 422 SLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH 500 (720)
Q Consensus 422 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~ 500 (720)
+||.||+|... +++.+++|++........ ...+.+|++.+++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999886 489999999976543221 5788899999999999999999999999999999999999999999986
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccccccccccc
Q 005001 501 FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF 580 (720)
Q Consensus 501 ~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~ 580 (720)
. ...+++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 80 ~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 150 (244)
T smart00220 80 K----RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP 150 (244)
T ss_pred h----ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence 3 22389999999999999999999999 99999999999999999999999999998765432 223456888
Q ss_pred cccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChh--HH
Q 005001 581 GYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAK--SL 658 (720)
Q Consensus 581 ~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 658 (720)
.|++||.+.+..++.++||||||+++|+|++|..||....... ...+............. .+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~ 214 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL----------------ELFKKIGKPKPPFPPPEWKIS 214 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH----------------HHHHHHhccCCCCccccccCC
Confidence 9999999998889999999999999999999999997532111 11111111111111111 55
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 005001 659 SRFADIIALCVQPEPEFRPPMSEVVQ 684 (720)
Q Consensus 659 ~~l~~li~~cl~~dP~~RPs~~ell~ 684 (720)
.++.+++.+||..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 78899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=296.60 Aligned_cols=265 Identities=18% Similarity=0.216 Sum_probs=171.8
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-C----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceE------
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-N----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY------ 476 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------ 476 (720)
..++|+..+.||+|+||.||+|.+. + +..||+|++..... ......+ .+....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 3567899999999999999999775 4 68999998754221 1111111 1112222233322221
Q ss_pred EeecCeEEEEEEecCCCCHHHHhhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEec
Q 005001 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDS----------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRN 540 (720)
Q Consensus 477 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~D 540 (720)
....+..++|+||+.+++|.++++..... ........+..++.|++.||+|||+. +|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 23556889999999999999998632110 00112344667999999999999999 999999
Q ss_pred CCCCCEEeCC-CCceEEcccCCCccCCCCCccccccccccccccCccccccCC----------------------Ccccc
Q 005001 541 FKSANILLDD-ELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI----------------------YTVKS 597 (720)
Q Consensus 541 lkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~ 597 (720)
|||+|||++. ++.+||+|||+++..............+|+.|+|||.+.... ++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999986 579999999999866544444445578999999999764322 34567
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC----C--ChhHHHHHHHHHHHhcCC
Q 005001 598 DVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM----Y--PAKSLSRFADIIALCVQP 671 (720)
Q Consensus 598 DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~l~~li~~cl~~ 671 (720)
|||||||++|||+++..+++... ............................ + .........+|+.+||+.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999999776654211 0000000000001111111111110000 0 000122355899999999
Q ss_pred CCCCCCCHHHHHHH
Q 005001 672 EPEFRPPMSEVVQA 685 (720)
Q Consensus 672 dP~~RPs~~ell~~ 685 (720)
||++|||+++++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=286.78 Aligned_cols=271 Identities=15% Similarity=0.183 Sum_probs=183.4
Q ss_pred HHhcCCCccceeccCCCcEEEEEEE-----------------cCCcEEEEEEccccccCh------------HHHHHHHH
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEF-----------------ANGKIMAVKKIDNAALSL------------QEEDNFLE 457 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~ 457 (720)
...++|+..++||+|+||.||+|.. ..++.||||++....... ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3467899999999999999999954 235679999986432110 01122334
Q ss_pred HHHHhhcCCCCCc-----cccceEEee--------cCeEEEEEEecCCCCHHHHhhhccC--------------------
Q 005001 458 AVSNMSRLRHPNI-----VTLAGYCAE--------HGQRLLVYEYVGNGNLHDMLHFADD-------------------- 504 (720)
Q Consensus 458 e~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~-------------------- 504 (720)
|+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666777766544 677777643 3568999999999999999874211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccccccccccccccC
Q 005001 505 SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584 (720)
Q Consensus 505 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~a 584 (720)
....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...............+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 112356788899999999999999999 99999999999999999999999999987543322211122345889999
Q ss_pred ccccccCCC----------------------cccchhhhHHHHHHHHHhCCC-CCCCCCCcchhhHHHhhccccccHHHH
Q 005001 585 PEFALSGIY----------------------TVKSDVYSFGVVMLELLTGRK-PLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 585 PE~~~~~~~----------------------~~~~DvwSlGv~l~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
||.+..... ..+.||||+||++|||++|.. ||......... ... . .......
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~-~---~~~~~~~ 453 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQ-Y---DNDLNRW 453 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhh-c---cchHHHH
Confidence 999864321 124799999999999999875 66532211000 000 0 0000001
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCC---CCCCCHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEP---EFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~ell~~ 685 (720)
+....................+|+.++|..+| .+|+|++|++++
T Consensus 454 r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 454 RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11111111111122345678899999999876 689999999875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=277.13 Aligned_cols=210 Identities=22% Similarity=0.326 Sum_probs=178.1
Q ss_pred hcCCCccceeccCCCcEEEEEE-EcCCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
...|..++.||-|+||+|.++. .++...||.|.+.+..+ ..........|-++|+.-+.+-||+|+-.|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3457888899999999999994 44567899999876543 444566778889999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||++||++-.+|- .-+.+.+..++-++..+..|+++.|+. |+|||||||+|||||.+|++||+|||++.-+.
T Consensus 708 MdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999886 257888999999999999999999999 99999999999999999999999999985221
Q ss_pred --------CCCcccc---------------------------------ccccccccccCccccccCCCcccchhhhHHHH
Q 005001 567 --------NTERQVS---------------------------------TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVV 605 (720)
Q Consensus 567 --------~~~~~~~---------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~ 605 (720)
..+++.. ...+||+.|+|||++....|+..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 0111000 12479999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCcchh
Q 005001 606 MLELLTGRKPLDSSRPRSEQ 625 (720)
Q Consensus 606 l~elltg~~pf~~~~~~~~~ 625 (720)
||||+.|+.||....+...+
T Consensus 861 l~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HHHHhhCCCCccCCCCCcce
Confidence 99999999999887765433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=286.31 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=188.7
Q ss_pred cCCCccceeccCCCcE-EEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGR-VYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.-|...+++|.|+-|+ ||+|... |+.||||++-.. ......+|++.++.- +||||+++++.-.+++..||..
T Consensus 509 ~~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 509 LFFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eeeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 3456677899999886 5899885 789999998532 344567899998877 7999999999988899999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---C--CceEEcccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---E--LNPHLSDCGLA 562 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~--~~~kl~Dfg~a 562 (720)
|.|.. +|.+++...............+.+..|+++||++||+. +||||||||.||||+. + ..++|+|||++
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99976 99999975311111222245677899999999999998 9999999999999976 2 46899999999
Q ss_pred ccCCCCCcccc--ccccccccccCccccccCCCcccchhhhHHHHHHHHHhC-CCCCCCCCCcchhhHHHhhccccccHH
Q 005001 563 ALTPNTERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG-RKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 563 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
+.......... ....||-+|+|||++....-+.++||||+||++|+.++| .+||...-.++.. ++ ....
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-Il-------~~~~ 730 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-IL-------TGNY 730 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-hh-------cCcc
Confidence 98765443332 346799999999999999888999999999999999995 8999753221100 00 0000
Q ss_pred HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+.. ..+... .+..+||.+|+++||..||++.+|+.+
T Consensus 731 ~L~~--------L~~~~d-~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 731 TLVH--------LEPLPD-CEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ceee--------eccCch-HHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0000 011111 167799999999999999999999854
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=256.85 Aligned_cols=136 Identities=20% Similarity=0.371 Sum_probs=112.6
Q ss_pred HHHHh-cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-----C---CCccccc
Q 005001 405 LQTAT-NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-----H---PNIVTLA 474 (720)
Q Consensus 405 ~~~~~-~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~ 474 (720)
..... .+|.+.++||.|.|++||+|.+ .+.+.||+|+++... ...+..+.|+.+|++++ | .+||+|+
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 34444 7899999999999999999954 567789999997543 23455678899888772 3 3699999
Q ss_pred eEEeec----CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe
Q 005001 475 GYCAEH----GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (720)
Q Consensus 475 ~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll 548 (720)
++|... .+.++|+|++ |.+|..+|.+. .-+.++...+++|++||+.||.|||..| +|||.||||+|||+
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 998653 4789999999 55899999854 3567888999999999999999999998 99999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=251.29 Aligned_cols=264 Identities=20% Similarity=0.278 Sum_probs=202.0
Q ss_pred hcCCCccceeccCCCcEEEEEE-EcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec------C
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------G 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 481 (720)
..+|.....+|.|.- .|..|. .-.++.||+|++..........++..+|+..+..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457888888999998 666663 34689999999987766666678888999999999999999999998443 3
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..|+|||+|.. +|...++ -.++-.....+..|++.|++|||+. +|+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 56999999965 9999886 5567788999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-H-hhcccc---c
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-R-WATPQL---H 636 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~-~~~~~~---~ 636 (720)
++..... -..+.++.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+.+..+....+ + ...+.. .
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 9764332 3456678999999999999999999999999999999999999999865432222111 1 011110 0
Q ss_pred cHHHH----------------Hhhc-ccccCC--CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 637 DIDAL----------------AKMV-DPALNG--MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 637 ~~~~~----------------~~~~-~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+.... .+.+ |..... ..+........+++.+||-.||++|.++++++++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00000 0000 000000 0011223457899999999999999999999977
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=234.25 Aligned_cols=260 Identities=18% Similarity=0.300 Sum_probs=195.1
Q ss_pred hcCCCccceeccCCCcEEEEEE-EcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEeecC--eEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG--QRL 484 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~ 484 (720)
.++|++.+++|+|.|++||.|. ..+.++++||.++.. ..+.+.+|+.++..+. ||||+.+++...+.. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4678999999999999999995 457889999999643 3667889999999995 999999999987754 568
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC-CceEEcccCCCc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGLAA 563 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~ 563 (720)
+|+||+++.+...+. +.++...+...+.++++||.|+|++ ||+|||+||.|+|+|.. ..++|+|+|+|.
T Consensus 112 LiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 999999987776655 5677788899999999999999999 99999999999999864 569999999998
Q ss_pred cCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHhhc--c------
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVRWAT--P------ 633 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~-~~~~~~--~------ 633 (720)
++.+.... .-.+.+..|.-||.+.. ..|+.+-|+|||||++..|+..+.||........+. .+.-+. .
T Consensus 182 FYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 182 FYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 77554322 22356778999999876 558999999999999999999999997654432221 111000 0
Q ss_pred ---ccccHHHHHhhccccc--------CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 ---QLHDIDALAKMVDPAL--------NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 ---~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+.-......++.... ......-...+..+|+.+.|..|-.+|||++|.+.+
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0000011111111100 000111123678899999999999999999999976
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=262.80 Aligned_cols=198 Identities=21% Similarity=0.318 Sum_probs=170.4
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHH------HHHHHHHHHhhcCC---CCCccccceEEee
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEE------DNFLEAVSNMSRLR---HPNIVTLAGYCAE 479 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~------~~~~~e~~~l~~l~---h~niv~l~~~~~~ 479 (720)
.+|...+.+|+|+||.|++|.++ +...|+||.+.+...-...+ -..--|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888999999999999999776 46678999987665422221 12345899999886 9999999999999
Q ss_pred cCeEEEEEEec-CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcc
Q 005001 480 HGQRLLVYEYV-GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (720)
Q Consensus 480 ~~~~~lV~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 558 (720)
++.+||+||.. ++-+|++++. ....+++.++..|++||+.|+++||++ +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999975 5669999997 468899999999999999999999999 999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCC
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLD 617 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~ 617 (720)
||.+...... ....++||.+|.|||++.+.+| +..-|||++|+++|-++...-||.
T Consensus 714 fgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998776432 3456789999999999999998 566899999999999999888885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=270.30 Aligned_cols=256 Identities=27% Similarity=0.381 Sum_probs=205.5
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
....+|+...++|.|.||.||+|++. .++..|+|.++... ....+.+.+|+-+++..+||||+.++|.+...+..++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 34567889999999999999999765 68899999997554 2345566788999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
+||||.+|+|.+..+ ..+++++.++..+.+..++|++|||+. +=+|||||-.||++++.|.+|++|||.+..+
T Consensus 90 cMEycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh
Confidence 999999999999876 468899999999999999999999999 8899999999999999999999999998655
Q ss_pred CCCCccccccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
.... ..+..+.||+.|||||+.. .+.|...+|||++|+...|+---+.|.....+.....+ +-
T Consensus 163 tati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-------------mT 228 (829)
T KOG0576|consen 163 TATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-------------MT 228 (829)
T ss_pred hhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-------------hh
Confidence 4322 3345688999999999874 56689999999999999999887777554332211100 00
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+--........+....+.+-+|++.|+.++|++||+++.++++
T Consensus 229 kS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 229 KSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 0000111122334566778999999999999999999887764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=255.94 Aligned_cols=276 Identities=22% Similarity=0.271 Sum_probs=207.9
Q ss_pred ccchhcHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC------CCCcc
Q 005001 399 SYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR------HPNIV 471 (720)
Q Consensus 399 ~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv 471 (720)
.|.+.-.+..-.+|.+....|+|-|++|.+|.+. .|..||||++.+.... .+.=+.|+++|++++ --|++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 3566667777789999999999999999999654 5889999999865432 233467899999884 35799
Q ss_pred ccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC
Q 005001 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (720)
Q Consensus 472 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 551 (720)
+++..|....++|||+|.+.- +|.++++.+. .+-.+....+..++.|+.-||..|... +|+|.||||.|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~Lsl-NLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLSL-NLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHhhhcceeEEEehhhhc-hHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence 999999999999999998854 9999998654 345678889999999999999999998 99999999999999875
Q ss_pred -CceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh
Q 005001 552 -LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW 630 (720)
Q Consensus 552 -~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~ 630 (720)
..+||||||.|....... .+.+.-+..|.|||++.|-+|+...|+||+||+||||.||+..|.+........+..-
T Consensus 573 k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 467999999987654322 2234456679999999999999999999999999999999999998765433322211
Q ss_pred hcccccc---------HHH----------------------HHhhccc------ccCC--CCC---hhHHHHHHHHHHHh
Q 005001 631 ATPQLHD---------IDA----------------------LAKMVDP------ALNG--MYP---AKSLSRFADIIALC 668 (720)
Q Consensus 631 ~~~~~~~---------~~~----------------------~~~~~~~------~~~~--~~~---~~~~~~l~~li~~c 668 (720)
....+.. ... +...+.+ .+.. .++ ......|.+|+.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 0000000 000 0000000 0000 012 22445789999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 005001 669 VQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 669 l~~dP~~RPs~~ell~~ 685 (720)
+..||++|.+..++|++
T Consensus 730 l~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKH 746 (752)
T ss_pred hccChhhcCCHHHHhcC
Confidence 99999999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=234.72 Aligned_cols=212 Identities=36% Similarity=0.594 Sum_probs=183.6
Q ss_pred eccCCCcEEEEEEEcC-CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCHH
Q 005001 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLH 496 (720)
Q Consensus 418 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 496 (720)
||+|.+|.||++...+ ++.+++|++....... ....+.+|++.++.++|++|+++++++......++++|++++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999998764 8999999997654322 3567889999999999999999999999989999999999999999
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-CCceEEcccCCCccCCCCCcccccc
Q 005001 497 DMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALTPNTERQVSTQ 575 (720)
Q Consensus 497 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 575 (720)
+++... ...+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 80 DLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 998732 14689999999999999999999999 9999999999999999 89999999999876654321 1223
Q ss_pred ccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCC
Q 005001 576 MVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP 654 (720)
Q Consensus 576 ~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (720)
..+...|++||.+... .++.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4578889999999887 788999999999999999
Q ss_pred hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 655 AKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 655 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
..+.+++.+|++.||++||++.++++.+
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3467999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=246.48 Aligned_cols=267 Identities=23% Similarity=0.360 Sum_probs=198.0
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc----CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEee
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (720)
+....+.|..+++||+|.|++||+|.+. ..+.||+|.+.... ....+..|++++..+ .+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 4556678999999999999999999554 46789999996433 356688999999988 79999999999999
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-CCceEEcc
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSD 558 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~D 558 (720)
++...+|+||++..+-.+++. .++..++..+++.++.||.++|.. |||||||||.|+|.+. .+.-.|.|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred CCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence 999999999999988888774 456888999999999999999999 9999999999999985 46789999
Q ss_pred cCCCccCCCC------------------C---------------ccc----------cccccccccccCccccccC-CCc
Q 005001 559 CGLAALTPNT------------------E---------------RQV----------STQMVGAFGYSAPEFALSG-IYT 594 (720)
Q Consensus 559 fg~a~~~~~~------------------~---------------~~~----------~~~~~gt~~y~aPE~~~~~-~~~ 594 (720)
||+|...... + ... ....+||+||+|||++.+- ..+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 9999621100 0 000 0124699999999999874 578
Q ss_pred ccchhhhHHHHHHHHHhCCCCCCCCCCcchh--hHHH-hh---------ccc----cc-----cHHHHHhhccc----cc
Q 005001 595 VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ--SLVR-WA---------TPQ----LH-----DIDALAKMVDP----AL 649 (720)
Q Consensus 595 ~~~DvwSlGv~l~elltg~~pf~~~~~~~~~--~~~~-~~---------~~~----~~-----~~~~~~~~~~~----~~ 649 (720)
+++||||.|||+.-+++++.||......... .+.. +. .+. ++ .......-... ..
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 9999999999999999999999765432110 1100 00 000 00 00000000000 00
Q ss_pred -C--------CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 -N--------GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 -~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. .......+..+++++.+|++.||.+|.++++.|++
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 00112234468899999999999999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=230.76 Aligned_cols=199 Identities=32% Similarity=0.491 Sum_probs=172.1
Q ss_pred CCccceeccCCCcEEEEEEEcC-CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 412 FSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
|...+.||+|++|.||++...+ ++.+++|.+...... .....+.+|++.+++++|+|++++++++......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4567789999999999998875 889999999765432 24678889999999999999999999999989999999999
Q ss_pred CCCCHHHHhhhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 491 GNGNLHDMLHFADDSSKN-LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
++++|.+++... .. +++..+..++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 80 EGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 999999999732 22 88999999999999999999999 99999999999999999999999999988765432
Q ss_pred ccccccccccccccCcccc-ccCCCcccchhhhHHHHHHHHHhCCCCCCC
Q 005001 570 RQVSTQMVGAFGYSAPEFA-LSGIYTVKSDVYSFGVVMLELLTGRKPLDS 618 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGv~l~elltg~~pf~~ 618 (720)
........++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1122345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=225.82 Aligned_cols=252 Identities=20% Similarity=0.323 Sum_probs=185.2
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceE-EeecCeEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGY-CAEHGQRL 484 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~ 484 (720)
..+.|.+.+.+|+|.||.+-+++++ ..+.+++|.+.... ...++|.+|+..--.+ .|.||+.-++. |...+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3467888999999999999999886 46678999887654 3467888888753334 68999987664 77788999
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC--CCCceEEcccCCC
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLA 562 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg~a 562 (720)
+++||++.|+|..-+. ...+-+...++++.|+++|+.|+|+. ++||||||.+||||- +..++|++|||..
T Consensus 99 F~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence 9999999999998774 46678888999999999999999999 999999999999983 3458999999998
Q ss_pred ccCCCCCccccccccccccccCccccccC-----CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSG-----IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
+..+.... ...-+..|.+||..... ...+.+|||.||+++|.++||..||......+ .....|.
T Consensus 171 ~k~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~------ 239 (378)
T KOG1345|consen 171 RKVGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWE------ 239 (378)
T ss_pred cccCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHH------
Confidence 76543221 12345679999987543 24688999999999999999999998433221 1122211
Q ss_pred HHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 005001 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 684 (720)
...+...+.....+ ....+.+.++.++-+..+|++|-...++.+
T Consensus 240 --~w~~rk~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 240 --QWLKRKNPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred --HHhcccCccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 11111111111111 123456789999999999999944444433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=225.32 Aligned_cols=250 Identities=20% Similarity=0.379 Sum_probs=207.8
Q ss_pred CccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCC
Q 005001 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
....+|.+...|+.|+|+++ |..+++|++............|.+|.-.++-+.||||+++++.|....+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34457889999999999997 45556688876666666678899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEc--ccCCCccCCCCCc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS--DCGLAALTPNTER 570 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~--Dfg~a~~~~~~~~ 570 (720)
|+|+..++. ..+-..+..++.+++.++++|++|||+.. |-|..--|....|++|++.+++|. |--++...
T Consensus 272 gslynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe----- 343 (448)
T KOG0195|consen 272 GSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE----- 343 (448)
T ss_pred hHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec-----
Confidence 999999983 33456788999999999999999999984 234445689999999999888765 43333221
Q ss_pred cccccccccccccCccccccCCCc---ccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 571 QVSTQMVGAFGYSAPEFALSGIYT---VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.+..-.|.||+||.+...+-+ .++|+|||.+++||+.|...||... ..++...++..+
T Consensus 344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl----------------spmecgmkiale 404 (448)
T KOG0195|consen 344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL----------------SPMECGMKIALE 404 (448)
T ss_pred ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC----------------Cchhhhhhhhhc
Confidence 122346789999999887643 5799999999999999999999754 345666777778
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 690 (720)
+++...|+..+..+.+||.-|+..||.+||.++.|+-.||++.
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 8888899999999999999999999999999999999999874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=278.25 Aligned_cols=218 Identities=30% Similarity=0.536 Sum_probs=145.7
Q ss_pred cCCChHHHHHHHHHHHhcCCCC-CCCCCCCCCCCCCCCCCceeEecC-CCEEEEEcCCCCCcccccccccCCCCCCEEEc
Q 005001 37 CTTDSSDVQALQVLYTSLNSPS-VLTNWKGNEGDPCGESWKGVACEG-SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDL 114 (720)
Q Consensus 37 ~~~~~~d~~al~~~~~~~~~~~-~l~~w~~~~~~~c~~~w~gv~c~~-~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L 114 (720)
+..++.|.+||++||+++.+|. .+.+|+.. .++| .|.||+|+. ++|+.|+|++|+++|.++..+..+++|++|+|
T Consensus 24 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c--~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~L 100 (968)
T PLN00113 24 SMLHAEELELLLSFKSSINDPLKYLSNWNSS-ADVC--LWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINL 100 (968)
T ss_pred cCCCHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCC--cCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEEC
Confidence 4447789999999999998764 67899643 4556 899999974 68999999999999988888888888888888
Q ss_pred cCCCCCCCCCCCCC---CccceeccccccCc----------------------CCCCccccccCCccEEEcccccccccc
Q 005001 115 SGNSIHDTIPYQLP---PNLTSLNLASNNFS----------------------GNLPYSIASMVSLSYLNVSRNSLTQSI 169 (720)
Q Consensus 115 ~~N~l~~~~p~~~~---~~L~~L~L~~N~l~----------------------g~~p~~~~~l~~L~~L~L~~N~l~~~~ 169 (720)
++|+++|.+|..+. ++|++|+|++|+++ +.+|..++++++|++|+|++|.+.+.+
T Consensus 101 s~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 180 (968)
T PLN00113 101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180 (968)
T ss_pred CCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccC
Confidence 88888877775442 45555555555555 445555555555555555555555555
Q ss_pred ccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc--CCCCcCeEEccCccCcccCccccc---
Q 005001 170 GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF--SGLPLTTLNVANNHFSGWIPRELI--- 244 (720)
Q Consensus 170 p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~g~ip~~l~--- 244 (720)
|..++++++|++|+|++|++.+.+|..++++++|++|+|++|++++.+|.. ...+|+.|+|++|+++|.+|..+.
T Consensus 181 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 260 (968)
T PLN00113 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK 260 (968)
T ss_pred ChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCC
Confidence 555555556666666666555555555555566666666666655544421 123466666666666666665443
Q ss_pred ccceeeecCCcCC
Q 005001 245 SIRTFIYDGNSFD 257 (720)
Q Consensus 245 ~l~~l~l~~n~~~ 257 (720)
+|+.|.+.+|.+.
T Consensus 261 ~L~~L~L~~n~l~ 273 (968)
T PLN00113 261 NLQYLFLYQNKLS 273 (968)
T ss_pred CCCEEECcCCeee
Confidence 4455666666554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=271.98 Aligned_cols=195 Identities=18% Similarity=0.248 Sum_probs=140.5
Q ss_pred cCCC-CCccccceEE-------eecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005001 464 RLRH-PNIVTLAGYC-------AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535 (720)
Q Consensus 464 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ 535 (720)
.++| +||+++++++ ...+..+.++|++ +++|.++++. ....+++.+++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3445 5788888877 2334667889987 5599999962 245699999999999999999999999 9
Q ss_pred cEEecCCCCCEEeCC-------------------CCceEEcccCCCccCCCCCc---------------ccccccccccc
Q 005001 536 VVHRNFKSANILLDD-------------------ELNPHLSDCGLAALTPNTER---------------QVSTQMVGAFG 581 (720)
Q Consensus 536 iiH~Dlkp~NIll~~-------------------~~~~kl~Dfg~a~~~~~~~~---------------~~~~~~~gt~~ 581 (720)
|+||||||+|||++. ++.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44566777777654211000 00011358899
Q ss_pred ccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh-hcccccCCCCChhHHHH
Q 005001 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK-MVDPALNGMYPAKSLSR 660 (720)
Q Consensus 582 y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 660 (720)
|||||++.+..++.++|||||||++|||++|..|+...... . ..+.. ...+. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-----~----------~~~~~~~~~~~-----~~~~~~~ 240 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-----M----------SSLRHRVLPPQ-----ILLNWPK 240 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-----H----------HHHHHhhcChh-----hhhcCHH
Confidence 99999999999999999999999999999988886532110 0 00000 01100 0111234
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 661 FADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 661 l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...++.+||+.||.+||++.|++++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhc
Confidence 5688999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=213.96 Aligned_cols=169 Identities=26% Similarity=0.293 Sum_probs=129.2
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.++++. .+..+++.++..++.|++.||+|||+. + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999973 245799999999999999999999998 5 999999999999999 99987654321
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc-c-C
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA-L-N 650 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~ 650 (720)
..||+.|||||++.+..++.++|||||||++|||+||+.||......... . .......... . .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~-----------~~~~~~~~~~~~~~ 128 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-L-----------EILLNGMPADDPRD 128 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-H-----------HHHHHHhccCCccc
Confidence 25899999999999999999999999999999999999999654321110 0 0000000000 0 0
Q ss_pred CCCChhHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 651 GMYPAKSLS--RFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 651 ~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
...+..... .+.+++.+||..||++||++.|+++++..+..+.
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 011222333 6899999999999999999999999997765443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-23 Score=218.59 Aligned_cols=262 Identities=20% Similarity=0.225 Sum_probs=197.6
Q ss_pred CCCccceeccCCCcEEEEEEEcCC--cEEEEEEccccccChHHHHHHHHHHHHhhcCC----CCCccccceEE-eecCeE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFANG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR----HPNIVTLAGYC-AEHGQR 483 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~l~~~~-~~~~~~ 483 (720)
+|.+.+.||+|+||.||.+..... +.+|+|.......... . .+..|..++..+. .+++..+++.+ ...+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-S-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-c-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 789999999999999999987653 4778777654322211 1 4556677766665 36889999988 477789
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC-----CceEEcc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-----LNPHLSD 558 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~D 558 (720)
++||+.+ |.+|.++..... .+.++..++.+|+.|++.+|++||+. |++||||||.|++++.. ..+.|.|
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 9999987 669999876432 57899999999999999999999999 99999999999999865 3689999
Q ss_pred cCCCc--cCCCCCcc----c---cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005001 559 CGLAA--LTPNTERQ----V---STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR 629 (720)
Q Consensus 559 fg~a~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~ 629 (720)
||+++ .+...... . ...+.||..|+++....+...+.+.|+||++.++.|++.|..||............
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~- 249 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF- 249 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH-
Confidence 99998 33222211 1 12356999999999999999999999999999999999999999765432221111
Q ss_pred hhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 630 WATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
.+..............+..+.++...+-..+..++|....+...+.+.....
T Consensus 250 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 250 ------------EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ------------HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111001110022334566778888888899999999999999988876665
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=197.08 Aligned_cols=258 Identities=20% Similarity=0.259 Sum_probs=203.1
Q ss_pred hcCCCccceeccCCCcEEEEEE-EcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCC-CCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV 486 (720)
.+.|..+++||.|+||.+|.|. ..+|+.||||.-...... .++..|..+.+.+++ ..|..+..+..+...-.+|
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 4678999999999999999995 467999999988655433 346677888888765 7788888888899999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC---CceEEcccCCCc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSDCGLAA 563 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a~ 563 (720)
||.+ |.+|.++..++ ...++..+++-++-|++.-++|+|.+ ++|||||||+|+|..-+ ..+.++|||+|+
T Consensus 90 MdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9998 56999999875 47889999999999999999999999 99999999999999754 468999999998
Q ss_pred cCCCCCccc------cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 005001 564 LTPNTERQV------STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 564 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
.+.+..... .....||.+|.+-....+...+.+.|+-|+|.++.++--|..||.+..........
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy--------- 233 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY--------- 233 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH---------
Confidence 765433221 23467999999988888888899999999999999999999999987654333222
Q ss_pred HHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 005001 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALV 687 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 687 (720)
+.+.+..............|.++.-.+..|-..--++.|+..-+-+.+.
T Consensus 234 -EkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 234 -EKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred -HHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 1222211111111223456778889999999999999999877666553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-23 Score=200.53 Aligned_cols=277 Identities=16% Similarity=0.230 Sum_probs=215.2
Q ss_pred cCCCccceeccCCCcEEEEEE-EcCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 487 (720)
-.|++.++||+|.||+++.|+ +-+++.||||.-.... +..++..|.+..+.+ ..++|...+-+..+..+-.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 368889999999999999995 4589999999764332 345567777777777 5799999998888888889999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC-----ceEEcccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-----NPHLSDCGLA 562 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~Dfg~a 562 (720)
|.+ |.+|.|+...+ +..++..++.-+|.|++.-++|+|++ .+|.|||||+|+||...+ .+.|+|||+|
T Consensus 104 dLL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 998 56999998764 57899999999999999999999999 999999999999997543 5899999999
Q ss_pred ccCCCCCccc------cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc
Q 005001 563 ALTPNTERQV------STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLH 636 (720)
Q Consensus 563 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 636 (720)
+.+.+..... .....||.+||+-....+...+.+.|+-|||-++.+++-|..||.+..........
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY-------- 248 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY-------- 248 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH--------
Confidence 8776554322 23457999999999999999999999999999999999999999876543222111
Q ss_pred cHHHHHhhcccccC---CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcc------ccccCCCCCCCc
Q 005001 637 DIDALAKMVDPALN---GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV------VKRRSSDESGFS 707 (720)
Q Consensus 637 ~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~------~~~~~~~~~~~~ 707 (720)
.++-+.+-. .......+.++...++..-..+-.+-|+.+-+...+.+++++... .+....+..+|.
T Consensus 249 -----eKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln~g~gw~ 323 (449)
T KOG1165|consen 249 -----EKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLNNGKGWP 323 (449)
T ss_pred -----HHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccCCCCCCc
Confidence 111111100 011234677888899999999999999999999888888876543 333344445565
Q ss_pred ccC
Q 005001 708 YRT 710 (720)
Q Consensus 708 ~~~ 710 (720)
..+
T Consensus 324 ~~~ 326 (449)
T KOG1165|consen 324 SGS 326 (449)
T ss_pred ccc
Confidence 443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=217.40 Aligned_cols=169 Identities=17% Similarity=0.162 Sum_probs=130.7
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEc--CCcEEEEEEcccccc---ChHHHHHHHHHHHHhhcCCCCCccccceEEeec
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFA--NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (720)
......|...+.||+|+||+||+|.+. +++.||||++..... .......+.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 344567999999999999999999765 577889998753311 23345678999999999999999853322 2
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecC-CCCCEEeCCCCceEEccc
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNF-KSANILLDDELNPHLSDC 559 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~Df 559 (720)
+..++||||++|++|.. +. ... ...++.|+++||+|||+. +|+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 46899999999999963 21 111 146788999999999999 9999999 999999999999999999
Q ss_pred CCCccCCCCCcccc-------ccccccccccCccccccC
Q 005001 560 GLAALTPNTERQVS-------TQMVGAFGYSAPEFALSG 591 (720)
Q Consensus 560 g~a~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~ 591 (720)
|+++.......... ....+++.|+|||.+...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99986654331111 345688899999998653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-24 Score=236.46 Aligned_cols=255 Identities=22% Similarity=0.256 Sum_probs=189.4
Q ss_pred CccceeccCCCcEEEEEEEc-CCcEEEEEEcc----ccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 413 SQEFLIGEGSLGRVYRAEFA-NGKIMAVKKID----NAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
....++|.|++|.|+.+... ..+..+.|.+. ...........+..|+.+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45668999999988877443 34444444433 11111222223667888888999999998888877777666679
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|||++ +|..++. ....+...++-.+++|++.|++|+|+. ||.|||+|++|+++..+|.+||+|||.+..+.-
T Consensus 401 E~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 9999986 235788999999999999999999999 999999999999999999999999999876543
Q ss_pred CCc---cccccccccccccCccccccCCCccc-chhhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHhhccccccHHHHH
Q 005001 568 TER---QVSTQMVGAFGYSAPEFALSGIYTVK-SDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVRWATPQLHDIDALA 642 (720)
Q Consensus 568 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGv~l~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~ 642 (720)
... ......+|+..|+|||++.+..|++. .||||.|+++..|.+|+.||......+... ...+.. .........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~-~~~~~~~~~ 551 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD-QRNIFEGPN 551 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc-ccccccChH
Confidence 332 44566789999999999999999764 899999999999999999998765443221 000000 000000000
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..-...+..-+.+|.+||+.||.+|-++++|++.
T Consensus 552 ---------~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 552 ---------RLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ---------HHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0112345567789999999999999999999864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=232.57 Aligned_cols=247 Identities=25% Similarity=0.288 Sum_probs=187.4
Q ss_pred CCCccceeccCCCcEEEEEEEcCCcEEEEEEccccc--cChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAA--LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
+|..++.||++.|=+|.+|++++|. |+||++-+.. .+.....+-++|++ ...++|||++++.-....+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667788999999999999999888 7788875433 34444455555666 666799999999888888888899999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC--C
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT--P 566 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~--~ 566 (720)
|+.. +|+|.+. .+.-+...+.+.|+.|++.||..+|+. +|+|||||.+|||++.-..+.|+||..-+.. +
T Consensus 102 yvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9976 9999986 456678889999999999999999999 9999999999999999999999999876532 2
Q ss_pred CCCcccccccccc----ccccCccccccCC-----------CcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 005001 567 NTERQVSTQMVGA----FGYSAPEFALSGI-----------YTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRW 630 (720)
Q Consensus 567 ~~~~~~~~~~~gt----~~y~aPE~~~~~~-----------~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~ 630 (720)
.++.....-+..| .+|+|||.+.... .+++.||||+||++.||++ |++||.- .++..|
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aY 247 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAY 247 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhH
Confidence 2222222222222 3699999885421 5678999999999999999 7888853 223333
Q ss_pred hccc-cccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 631 ATPQ-LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 631 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... ......++++-|. .+++++..|++.||++|.++++.++.
T Consensus 248 r~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 3321 1112223333222 46799999999999999999999987
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-21 Score=205.37 Aligned_cols=258 Identities=30% Similarity=0.480 Sum_probs=199.8
Q ss_pred CCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChH-HHHHHHHHHHHhhcCCCC-CccccceEEeecCeEEEEEEe
Q 005001 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ-EEDNFLEAVSNMSRLRHP-NIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~ 489 (720)
|.....||.|+||.||++... ..+++|.+........ ....+.+|...++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999876 8889999976655443 577889999999999988 799999999777778999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC-ceEEcccCCCccCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTPNT 568 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 568 (720)
+.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777521111 3789999999999999999999999 999999999999999998 7999999999755443
Q ss_pred Ccc-----ccccccccccccCcccccc---CCCcccchhhhHHHHHHHHHhCCCCCCCCCCc-chhhHHHhhccccccHH
Q 005001 569 ERQ-----VSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPR-SEQSLVRWATPQLHDID 639 (720)
Q Consensus 569 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 639 (720)
... ......||..|+|||.+.+ ..++...|+||+|++++++++|..||...... .......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~---------- 225 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK---------- 225 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH----------
Confidence 322 2355689999999999988 57889999999999999999999997655431 0000000
Q ss_pred HHHhhcccccCCCCC----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAKMVDPALNGMYP----AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+.....+....... ......+.+++..|+..+|..|.+..+....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 226 IILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000000111 1223567899999999999999999988765
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=213.21 Aligned_cols=139 Identities=35% Similarity=0.547 Sum_probs=85.3
Q ss_pred cCCChHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCceeEecCC------CEEEEEcCCCCCcccccccccCCCCCC
Q 005001 37 CTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGS------AVVSIDISGLGLSGTMGYLLSDLLSLR 110 (720)
Q Consensus 37 ~~~~~~d~~al~~~~~~~~~~~~l~~w~~~~~~~c~~~w~gv~c~~~------~v~~l~l~~~~l~g~~~~~l~~l~~L~ 110 (720)
..+...|.+||+++|+++.++.. .+|.++.+.|+.+.|.||.|+.. .|+.|+|++|++.|.+|..+++|++|+
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~-~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~ 445 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR-FGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ 445 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc-CCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCC
Confidence 45567899999999999976543 48975432222347999999621 255566666666665555555555555
Q ss_pred EEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCccc
Q 005001 111 KFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS 190 (720)
Q Consensus 111 ~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 190 (720)
.|+|++|+|+ |.+|..++++++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+
T Consensus 446 ~L~Ls~N~l~----------------------g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~ 503 (623)
T PLN03150 446 SINLSGNSIR----------------------GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503 (623)
T ss_pred EEECCCCccc----------------------CcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCccc
Confidence 5554444443 344555555556666666666666666666666666666666666666
Q ss_pred CCCCcccc
Q 005001 191 GDLPNSFI 198 (720)
Q Consensus 191 g~~p~~~~ 198 (720)
|.+|..++
T Consensus 504 g~iP~~l~ 511 (623)
T PLN03150 504 GRVPAALG 511 (623)
T ss_pred ccCChHHh
Confidence 66655543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.1e-21 Score=183.71 Aligned_cols=142 Identities=19% Similarity=0.229 Sum_probs=110.2
Q ss_pred cceeccCCCcEEEEEEEcCCcEEEEEEccccccChHH------------------------HHHHHHHHHHhhcCCCCCc
Q 005001 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQE------------------------EDNFLEAVSNMSRLRHPNI 470 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni 470 (720)
...||+|+||.||+|...+|+.||+|+++........ ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4579999999999998888999999999754321111 1122358889999988887
Q ss_pred cccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEEecCCCCCEEeC
Q 005001 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL-HEVCLPSVVHRNFKSANILLD 549 (720)
Q Consensus 471 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~~~~iiH~Dlkp~NIll~ 549 (720)
.....+.. ...++||||++++++..... ....++...+..++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54443322 23489999999887765432 235788999999999999999999 687 999999999999998
Q ss_pred CCCceEEcccCCCccCC
Q 005001 550 DELNPHLSDCGLAALTP 566 (720)
Q Consensus 550 ~~~~~kl~Dfg~a~~~~ 566 (720)
++.++|+|||+|....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.9e-21 Score=185.17 Aligned_cols=174 Identities=13% Similarity=0.166 Sum_probs=135.3
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHH-HHH------HHHHHHHhhcCCCCCccccceEEee
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQE-EDN------FLEAVSNMSRLRHPNIVTLAGYCAE 479 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~-~~~------~~~e~~~l~~l~h~niv~l~~~~~~ 479 (720)
...++|+..+++|.|+||.||++.. ++..+|+|.+.......+. ... +.+|++.+.++.|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468899999999999999999866 5778999999765433222 122 5789999999999999999988654
Q ss_pred c--------CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC
Q 005001 480 H--------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (720)
Q Consensus 480 ~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 551 (720)
. +..++||||++|.+|.++.. ++. ....+++.++..+|+. +++|||++|+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 3 35789999999999988642 222 2456899999999999 99999999999999998
Q ss_pred CceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHH
Q 005001 552 LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELL 610 (720)
Q Consensus 552 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ell 610 (720)
| ++|+|||.......... . ..++....|..++|+|+||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a--~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKA--K-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhh--H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 99999998865532111 0 01344555778999999999987654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.3e-22 Score=209.36 Aligned_cols=227 Identities=24% Similarity=0.357 Sum_probs=182.9
Q ss_pred eeccCCCcEEEEEE----EcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEeecCeEEEEEEecC
Q 005001 417 LIGEGSLGRVYRAE----FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVG 491 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~ 491 (720)
.+|+|+||.|+++. .+.|.-+|.|..++.............|..++...+ ||.++++...+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999873 335777888888765543333334455667777775 9999999999999999999999999
Q ss_pred CCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc
Q 005001 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (720)
Q Consensus 492 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 571 (720)
+|+|...+. ....+.+.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999998876 356677777888888899999999999 999999999999999999999999999976533221
Q ss_pred ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCC
Q 005001 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG 651 (720)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (720)
.+||..|||||++. ....++|.||||++++||+||..||.. +.+..+.. ...
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~--~~~ 204 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILK--AEL 204 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhh--hcc
Confidence 28999999999998 557889999999999999999999975 11112211 123
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCCCCCH
Q 005001 652 MYPAKSLSRFADIIALCVQPEPEFRPPM 679 (720)
Q Consensus 652 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 679 (720)
..|........+++..++..+|..|.-.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 4577788888999999999999999655
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-19 Score=171.28 Aligned_cols=188 Identities=15% Similarity=0.124 Sum_probs=141.0
Q ss_pred ccceeccCCCcEEEEEEEcCCcEEEEEEccccccChH--HHHHHHHHHHHhhcCC-CCCccccceEEeecCeEEEEEEec
Q 005001 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ--EEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 414 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
....|++|+||+||.+.. .+.+++.+.+........ ....+.+|+++++++. |++|++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999998866 677888777764432111 1235789999999995 5889999886 3469999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecC-CCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNF-KSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
.|.+|...+. .. ...++.|++.+|.++|+. ||+|||| ||+|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~-----~~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPP-----RG------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhh-----hh------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999875432 11 134678999999999999 9999999 7999999999999999999998655433
Q ss_pred cc----c--------cccccccccccCccccccC-CCc-ccchhhhHHHHHHHHHhCCCCCCCCC
Q 005001 570 RQ----V--------STQMVGAFGYSAPEFALSG-IYT-VKSDVYSFGVVMLELLTGRKPLDSSR 620 (720)
Q Consensus 570 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGv~l~elltg~~pf~~~~ 620 (720)
.. . ......++.|+.|+...-- ..+ ...+.++-|+-+|.++|++.+.....
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 0 0012367778888755432 223 56799999999999999999876544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=175.74 Aligned_cols=142 Identities=20% Similarity=0.241 Sum_probs=112.1
Q ss_pred cceeccCCCcEEEEEEEcCCcEEEEEEccccccChH------------------------HHHHHHHHHHHhhcCCCCCc
Q 005001 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ------------------------EEDNFLEAVSNMSRLRHPNI 470 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~ni 470 (720)
...||+|+||.||+|.+.+|+.||||++........ ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 457999999999999887899999999875421100 01223578888999999988
Q ss_pred cccceEEeecCeEEEEEEecCCCCHHHH-hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEecCCCCCEEe
Q 005001 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDM-LHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILL 548 (720)
Q Consensus 471 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll 548 (720)
.....+... ..++||||++++++... +. ...++..++..++.|++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 655554433 24899999998865433 32 3467788999999999999999999 8 99999999999999
Q ss_pred CCCCceEEcccCCCccCCC
Q 005001 549 DDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 549 ~~~~~~kl~Dfg~a~~~~~ 567 (720)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999986644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.4e-20 Score=183.35 Aligned_cols=235 Identities=21% Similarity=0.301 Sum_probs=151.9
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCC----------CCccccceEEe-
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRH----------PNIVTLAGYCA- 478 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~- 478 (720)
+...+.||.|+++.||.+.+. +|+.+|+|.+..... .....+.+.+|......+.+ -.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999876 589999999864432 23356677777655554322 12222222221
Q ss_pred --------ec---C-----eEEEEEEecCCCCHHHHhhhccCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEe
Q 005001 479 --------EH---G-----QRLLVYEYVGNGNLHDMLHFADDSS---KNLTWNARVRVALGTARALEYLHEVCLPSVVHR 539 (720)
Q Consensus 479 --------~~---~-----~~~lV~e~~~~gsL~~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~ 539 (720)
.. . ..+++|+-+. +||.+++....... ..+....+..+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11 1 2367888885 59988876422222 2244556677779999999999999 99999
Q ss_pred cCCCCCEEeCCCCceEEcccCCCccCCCCCccccccccccccccCccccccC--------CCcccchhhhHHHHHHHHHh
Q 005001 540 NFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG--------IYTVKSDVYSFGVVMLELLT 611 (720)
Q Consensus 540 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwSlGv~l~ellt 611 (720)
||+|+|++++.+|.++|+||+.....+.... . ...+..|.+||..... .++.+.|.|++|+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999998765433211 1 2345789999977542 47889999999999999999
Q ss_pred CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCC
Q 005001 612 GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFR 676 (720)
Q Consensus 612 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 676 (720)
|..||....+...... .+. .+. +.++.+.+||+.+|+.||++|
T Consensus 246 ~~lPf~~~~~~~~~~~--------------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW--------------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG--------------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc--------------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999986543211110 111 223 778899999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-19 Score=179.22 Aligned_cols=195 Identities=19% Similarity=0.259 Sum_probs=140.9
Q ss_pred CCCCccccceEEee---------------------------cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHH
Q 005001 466 RHPNIVTLAGYCAE---------------------------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA 518 (720)
Q Consensus 466 ~h~niv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~ 518 (720)
+|||||++.++|.+ ...+|+||..++. +|+.++. .+..+...+.-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHH
Confidence 69999999988743 1245899998876 9999996 4566777788899
Q ss_pred HHHHHHHHHHHhcCCCCcEEecCCCCCEEeC--CCC--ceEEcccCCCccCCCCC-----ccccccccccccccCccccc
Q 005001 519 LGTARALEYLHEVCLPSVVHRNFKSANILLD--DEL--NPHLSDCGLAALTPNTE-----RQVSTQMVGAFGYSAPEFAL 589 (720)
Q Consensus 519 ~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~--~~~--~~kl~Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~ 589 (720)
.|+++|+.|||++ ||.|||+|.+|||+. +|+ .+.|+|||++---.... ........|.-..||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999983 333 46899999864322110 01112235777899999987
Q ss_pred cCC------CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHH
Q 005001 590 SGI------YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFAD 663 (720)
Q Consensus 590 ~~~------~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 663 (720)
..+ --.++|.|+.|-+.||+++..-||.......... ..| .+ .-....|..++..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-r~Y-----------qe----~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-RTY-----------QE----SQLPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-hhh-----------hh----hhCCCCcccCChHHHH
Confidence 543 1358999999999999999999998633221110 001 01 1112235667778899
Q ss_pred HHHHhcCCCCCCCCCHHHHHHH
Q 005001 664 IIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 664 li~~cl~~dP~~RPs~~ell~~ 685 (720)
++...|+.||.+|++..-....
T Consensus 489 lV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHHHHhcCCccccCCccHHHhH
Confidence 9999999999999987554443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=186.20 Aligned_cols=216 Identities=24% Similarity=0.407 Sum_probs=163.4
Q ss_pred hhcCCCCCccccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc-EEec
Q 005001 462 MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV-VHRN 540 (720)
Q Consensus 462 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~i-iH~D 540 (720)
|+.+.|.|+.+++|.+.+....++|.+||..|+|.|.+.. ....+++.-...++++++.||+|||.. .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3567899999999999999999999999999999999973 457789999999999999999999988 55 9999
Q ss_pred CCCCCEEeCCCCceEEcccCCCccCCCCCc-cccccccccccccCccccccCC-------CcccchhhhHHHHHHHHHhC
Q 005001 541 FKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGI-------YTVKSDVYSFGVVMLELLTG 612 (720)
Q Consensus 541 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGv~l~elltg 612 (720)
+++.|++++..+.+||+|||+......... .......-..-|.|||.+.... .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999999876643111 1111112334699999998642 36679999999999999999
Q ss_pred CCCCCCCCCcch-hhHHHhhccccccHHHHHhhcccccCCCCC-h-hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 613 RKPLDSSRPRSE-QSLVRWATPQLHDIDALAKMVDPALNGMYP-A-KSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 613 ~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
..||+....... ..++... .+.-....+.... . +...++..++..||..+|++||+++++-..++.+
T Consensus 155 ~~~~~~~~~~~~~~eii~~~----------~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRV----------KKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cCccccccccCChHHHHHHH----------HhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999986443222 1222111 1101111111111 1 3344788999999999999999999999888777
Q ss_pred HHhh
Q 005001 690 VQRA 693 (720)
Q Consensus 690 ~~~~ 693 (720)
....
T Consensus 225 ~~~~ 228 (484)
T KOG1023|consen 225 NKGG 228 (484)
T ss_pred cccc
Confidence 6654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=197.77 Aligned_cols=256 Identities=20% Similarity=0.263 Sum_probs=186.9
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC---CCCccccceEEeecC
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIVTLAGYCAEHG 481 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~ 481 (720)
.+.-...|.+.+.||+|+||.||+|...+|+.||+|.-+......... -.+++.+++ -+.|..+..++.-.+
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHccCC
Confidence 344456688888999999999999998889999999887654321111 012223333 345666666666777
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-------CCce
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-------ELNP 554 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-------~~~~ 554 (720)
.-++|+||.+.|+|.+++. ..+.+++..+..++.|+++.+++||.. +|||+||||+|+||.. ...+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 8899999999999999997 678899999999999999999999999 9999999999999943 3458
Q ss_pred EEcccCCCccCCC-CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 005001 555 HLSDCGLAALTPN-TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633 (720)
Q Consensus 555 kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~ 633 (720)
+|+|||.+..+.- .+.......++|-.+-.+|+..|..++..+|.|.++-+++-|+.|+.--. .+. . .|...
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~-~~g-~-----~~~~~ 913 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV-KNG-S-----SWMVK 913 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh-cCC-c-----ceecc
Confidence 9999999854321 22234456788999999999999999999999999999999999876320 000 0 00000
Q ss_pred ccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcc
Q 005001 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695 (720)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 695 (720)
..+.+.. -.+...+++..+|..|-..=|...++...|+++..+...
T Consensus 914 -----~~~~Ry~-----------~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 914 -----TNFPRYW-----------KRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred -----ccchhhh-----------hHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 0011111 112345777778875555558888999888888776543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7e-18 Score=164.61 Aligned_cols=136 Identities=15% Similarity=0.173 Sum_probs=104.5
Q ss_pred CccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-----CCCCccccceEEeecC---eEE
Q 005001 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNIVTLAGYCAEHG---QRL 484 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~ 484 (720)
...+.||+|+||.||. +.+....+||++..... ...+.+.+|+..++.+ .||||++++|++.++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 4456899999999996 44333347888865322 2356789999999999 6799999999998873 433
Q ss_pred -EEEEe--cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCcEEecCCCCCEEeCC----CCceEE
Q 005001 485 -LVYEY--VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL-EYLHEVCLPSVVHRNFKSANILLDD----ELNPHL 556 (720)
Q Consensus 485 -lV~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L-~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl 556 (720)
+|+|| +.+|+|.+++.. ..+++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.++|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 557999999962 335554 35677888777 999999 9999999999999974 347999
Q ss_pred cccCCC
Q 005001 557 SDCGLA 562 (720)
Q Consensus 557 ~Dfg~a 562 (720)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.5e-17 Score=160.82 Aligned_cols=136 Identities=21% Similarity=0.313 Sum_probs=113.5
Q ss_pred ceeccCCCcEEEEEEEcCCcEEEEEEccccccChH------HHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ------EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
+.||+|++|.||+|.. .|..+++|+......... ....+.+|+.++..+.|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4799999999999987 677888997654332111 234577899999999999998888887777888999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
++|++|.+++... . . .+..++.+++.+|.++|+. +++|||++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~----~---~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN----G---M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc----c---H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988621 1 1 7888999999999999999 999999999999999 78999999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-18 Score=180.11 Aligned_cols=174 Identities=24% Similarity=0.359 Sum_probs=130.2
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
.+.||.|++|.-.+|.+|+... ......++.....++.|++.|++| + +.+|||+||.||+...+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 3578999999999999999632 234567888899999999999999 5 88999999999999999999999999
Q ss_pred CCccCCCCC-----ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccc
Q 005001 561 LAALTPNTE-----RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 561 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
+........ ....+...||..||+||.+.+..|+.++||||||++++|+++ =..+++.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---------------- 465 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---------------- 465 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------------
Confidence 987665544 233456789999999999999999999999999999999997 2222211
Q ss_pred cccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHH
Q 005001 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSE 681 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 681 (720)
...+..+.+..+...+-.+.+ .=+.|+.+++.+.|.+||++.+
T Consensus 466 ---~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 466 ---IATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ---HHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHH
Confidence 111111111111100111112 2247999999999999994443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-18 Score=190.75 Aligned_cols=208 Identities=25% Similarity=0.370 Sum_probs=145.7
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcC-CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
...+|..++.|..|+||.||.++++. .+.+|+ ++.+...- ++- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-------lRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-------LRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccchh-------hhc--cccccCCccee---------------
Confidence 34678899999999999999998864 667777 44332211 110 22222344444
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|+-.+.++ ..+.++.. ++.+++|||+. +|+|||+||+|.+|+.-|++|++|||+++...
T Consensus 136 ------gDc~tllk----~~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 ------GDCATLLK----NIGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ------chhhhhcc----cCCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 45555554 22334332 26789999999 99999999999999999999999999986322
Q ss_pred CC------Ccc--------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 005001 567 NT------ERQ--------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWAT 632 (720)
Q Consensus 567 ~~------~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~ 632 (720)
.. ..+ ...+.+||+.|+|||++....|...+|+|++|+|+||.+-|..||.+..+......+.
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi--- 271 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI--- 271 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh---
Confidence 11 000 1134689999999999999999999999999999999999999999876643221111
Q ss_pred cccccHHHHHhhcccccCC-CCChhHHHHHHHHHHHhcCCCCCCCC
Q 005001 633 PQLHDIDALAKMVDPALNG-MYPAKSLSRFADIIALCVQPEPEFRP 677 (720)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RP 677 (720)
...... ......+.+.++++.+.|+.+|..|-
T Consensus 272 -------------sd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 -------------SDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -------------hhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 000000 00223445788999999999999994
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=164.64 Aligned_cols=144 Identities=18% Similarity=0.162 Sum_probs=110.6
Q ss_pred CCCccceeccCCCcEEEEEE--EcCCcEEEEEEccccccCh--------------------H--HHHHHHHHHHHhhcCC
Q 005001 411 SFSQEFLIGEGSLGRVYRAE--FANGKIMAVKKIDNAALSL--------------------Q--EEDNFLEAVSNMSRLR 466 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~~--------------------~--~~~~~~~e~~~l~~l~ 466 (720)
-|.+.+.||+|+||.||+|. ..+|+.||+|++....... . ....+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37778899999999999998 5689999999987432110 0 1133567999998886
Q ss_pred CCC--ccccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEEecCCC
Q 005001 467 HPN--IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS-VVHRNFKS 543 (720)
Q Consensus 467 h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~-iiH~Dlkp 543 (720)
+.. +.+++++ ...++||||+++++|..... ........++..++.|++.++.+||+. + |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 533 3333332 23589999999988876542 134456667789999999999999999 8 99999999
Q ss_pred CCEEeCCCCceEEcccCCCccCC
Q 005001 544 ANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 544 ~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999987543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.6e-20 Score=162.65 Aligned_cols=171 Identities=25% Similarity=0.378 Sum_probs=146.8
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEE
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 159 (720)
.++++.|.|++|.++ .+|+.+++|.+|+.|++++|+|+ .+|.++. ++|+.|+++.|++. .+|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 357889999999997 67888999999999999999999 7888886 89999999999999 8999999999999999
Q ss_pred cccccccc-ccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCC-CCcCeEEccCccCcc
Q 005001 160 VSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSG 237 (720)
Q Consensus 160 L~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~l~l~~N~l~g 237 (720)
|.+|+|+. .+|..|-.|+.|+.|+|++|.|. .+|..++++++|+.|.+.+|.+-..+..... ..|++|.+.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~- 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT- 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee-
Confidence 99999984 57889999999999999999999 8999999999999999999998765433333 34899999999999
Q ss_pred cCcccccccc------eeeecCCcCC
Q 005001 238 WIPRELISIR------TFIYDGNSFD 257 (720)
Q Consensus 238 ~ip~~l~~l~------~l~l~~n~~~ 257 (720)
.+|++++++. .+.+..|||-
T Consensus 187 vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 187 VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 7888887654 2345566553
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=156.06 Aligned_cols=140 Identities=18% Similarity=0.128 Sum_probs=108.5
Q ss_pred CCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccCh--------------------HHHHHHHHHHHHhhcCCCCC-
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL--------------------QEEDNFLEAVSNMSRLRHPN- 469 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~h~n- 469 (720)
.|...+.||+|+||.||++...+|+.||||++....... .......+|...+..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 377788999999999999988889999999875432110 01123567888888887774
Q ss_pred -ccccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe
Q 005001 470 -IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (720)
Q Consensus 470 -iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll 548 (720)
+...++ ....++||||+++++|.+... ......++.+++.++.++|+. +|+||||||+||++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 333333 345689999999999876542 033567889999999999998 99999999999999
Q ss_pred CCCCceEEcccCCCccCCC
Q 005001 549 DDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 549 ~~~~~~kl~Dfg~a~~~~~ 567 (720)
++++.++|+|||++.....
T Consensus 159 ~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cCCCcEEEEECCccccCCC
Confidence 9999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=155.15 Aligned_cols=133 Identities=21% Similarity=0.337 Sum_probs=107.7
Q ss_pred eeccCCCcEEEEEEEcCCcEEEEEEccccccC------hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALS------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
.||+|+||.||+|.+ +|..|++|........ .....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 5778889986533211 112356778999999999888766666666677789999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
+|++|.+++... .. .++.+++.+|.+||+. +++|+|++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999987521 11 7899999999999999 999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=177.66 Aligned_cols=142 Identities=18% Similarity=0.314 Sum_probs=113.3
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccC-----hHHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS-----LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
....|...+.||+|+||+||+|.+.+...++.+++.+.... ......+.+|++++..++|++++....++.....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34455678899999999999998765444333333221111 1223568899999999999999988877777778
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++||||+++++|.+++. ....++.+++.+|.+||+. +++||||||+||++ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999884 3567899999999999999 99999999999999 6779999999998
Q ss_pred ccC
Q 005001 563 ALT 565 (720)
Q Consensus 563 ~~~ 565 (720)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-17 Score=146.74 Aligned_cols=156 Identities=29% Similarity=0.486 Sum_probs=139.0
Q ss_pred cccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCC
Q 005001 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179 (720)
Q Consensus 102 ~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 179 (720)
.+.++++.+.|-||+|+++ .+|..+. .+|+.|++++|+++ .+|.+++.|++|+.|+++-|+|. ..|..||.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4667888999999999999 7888886 89999999999999 89999999999999999999998 789999999999
Q ss_pred CeeecCCCccc-CCCCccccCCCCCCeeEeccccccccccccCC-CCcCeEEccCccCcccCccccc---ccceeeecCC
Q 005001 180 ATLDLSFNNFS-GDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWIPRELI---SIRTFIYDGN 254 (720)
Q Consensus 180 ~~L~l~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~l~l~~N~l~g~ip~~l~---~l~~l~l~~n 254 (720)
+.|||..|+|. ..+|..|..|..|..|+|++|.+.-.++.... .+|+.|.+.+|.+- .+|.+++ .|+.|.+.||
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 99999999997 47899999999999999999999987766544 56999999999998 6888765 5667889999
Q ss_pred cCCCCCC
Q 005001 255 SFDNGPA 261 (720)
Q Consensus 255 ~~~~~~~ 261 (720)
.+.-.|+
T Consensus 184 rl~vlpp 190 (264)
T KOG0617|consen 184 RLTVLPP 190 (264)
T ss_pred eeeecCh
Confidence 9986654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.5e-17 Score=170.11 Aligned_cols=170 Identities=27% Similarity=0.332 Sum_probs=131.6
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC---CccceeccccccCcCCCCccccccCCccEEEc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~---~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 160 (720)
.++.|||++|+|. ..|..+-.-+++-+|+||+|+|. +||..+. ..|-.||||+|++. .+|+.+..|.+|+.|+|
T Consensus 104 dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L 180 (1255)
T KOG0444|consen 104 DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL 180 (1255)
T ss_pred cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence 5778888888886 56777777888888888888887 7887765 55667888888888 77888888888888888
Q ss_pred cccccc-------------------------cccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccc
Q 005001 161 SRNSLT-------------------------QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (720)
Q Consensus 161 ~~N~l~-------------------------~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (720)
++|.|. ..+|.++-.|.+|..+|||.|+|. .+|+.+.++.+|..|+||+|+|+.
T Consensus 181 s~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 181 SNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred CCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee
Confidence 888543 225677777888999999999998 889999999999999999999985
Q ss_pred ccccc-CCCCcCeEEccCccCcccCccccccc---ceeeecCCcCCC
Q 005001 216 SLNVF-SGLPLTTLNVANNHFSGWIPRELISI---RTFIYDGNSFDN 258 (720)
Q Consensus 216 ~~~~~-~~~~L~~l~l~~N~l~g~ip~~l~~l---~~l~l~~n~~~~ 258 (720)
.--.. .-.+|++|+||.|+|+ .+|+.++.| +.|...+|.++.
T Consensus 260 L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F 305 (1255)
T KOG0444|consen 260 LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF 305 (1255)
T ss_pred eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc
Confidence 32111 1135889999999998 788877654 456677777665
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.1e-17 Score=168.24 Aligned_cols=183 Identities=26% Similarity=0.313 Sum_probs=139.5
Q ss_pred eeEecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCC--CCccceeccccccCcCCCCccccccCC
Q 005001 77 GVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVS 154 (720)
Q Consensus 77 gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~--~~~L~~L~L~~N~l~g~~p~~~~~l~~ 154 (720)
|+.....++..|+|..|+++..-...+.+|+.|+.|+||+|.|...-+.++ .++|++|+|++|+|+..-+.+|..|..
T Consensus 263 G~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~ 342 (873)
T KOG4194|consen 263 GAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQ 342 (873)
T ss_pred cceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHH
Confidence 444444567888888888887777788888888888888888876555443 478888888888888777778888888
Q ss_pred ccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCc---cccCCCCCCeeEeccccccccc-cccCCC-CcCeEE
Q 005001 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN---SFISLSNISSLYLQNNQVTGSL-NVFSGL-PLTTLN 229 (720)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~---~~~~l~~L~~L~l~~N~l~~~~-~~~~~~-~L~~l~ 229 (720)
|+.|+|++|++...-...|..+++|+.|||++|.|++.|-+ .|.+|++|+.|+|.+|+|.... ..+.+. .|+.||
T Consensus 343 Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~Ld 422 (873)
T KOG4194|consen 343 LEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLD 422 (873)
T ss_pred hhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceec
Confidence 88888888888877777888888888888888888876643 3667888888888888887654 345554 488888
Q ss_pred ccCccCcccCccccc--ccceeeecCCcCCCC
Q 005001 230 VANNHFSGWIPRELI--SIRTFIYDGNSFDNG 259 (720)
Q Consensus 230 l~~N~l~g~ip~~l~--~l~~l~l~~n~~~~~ 259 (720)
|.+|.|...-|+.|. .|+.|.+..-+|.|.
T Consensus 423 L~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCD 454 (873)
T KOG4194|consen 423 LGDNAIASIQPNAFEPMELKELVMNSSSFLCD 454 (873)
T ss_pred CCCCcceeecccccccchhhhhhhcccceEEe
Confidence 888888877777664 556666766666653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.2e-16 Score=179.49 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=191.1
Q ss_pred cCCCccceeccCCCcEEEEEEEc--CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEeecCeEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA--NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV 486 (720)
..|...+.||+|+|+.|-..... ....+|+|.+...............|..+-..+. |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45666777999999999888653 3445666766544323333444555777767775 99999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcEEecCCCCCEEeCCCC-ceEEcccCCCcc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-EVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAAL 564 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 564 (720)
++|..++++.+.+. .......+...+-.++.|+..++.|+| .. ++.|||+||+|.+++..+ ..++.|||+|..
T Consensus 100 ~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999998873 112225566677788999999999999 77 999999999999999999 999999999987
Q ss_pred CCC-C-Cccccccccc-cccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 565 TPN-T-ERQVSTQMVG-AFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 565 ~~~-~-~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
+.. . ........+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+.......... ..|....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~------ 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNK------ 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecccc------
Confidence 665 2 2223344578 99999999999854 4678999999999999999999998655433110 1110000
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
................+++.+++..+|..|.+.+++...
T Consensus 248 ------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 248 ------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ------cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 000011122334556789999999999999998887644
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=6e-15 Score=143.17 Aligned_cols=139 Identities=21% Similarity=0.250 Sum_probs=97.4
Q ss_pred cceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHH----------------------HHHHHHhhcCCCCC--c
Q 005001 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNF----------------------LEAVSNMSRLRHPN--I 470 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~n--i 470 (720)
.+.||+|+||.||+|...+++.||||.+............+ ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999988889999999886543221111111 23455555543332 3
Q ss_pred cccceEEeecCeEEEEEEecCCCCHHH-HhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEecCCCCCEEe
Q 005001 471 VTLAGYCAEHGQRLLVYEYVGNGNLHD-MLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILL 548 (720)
Q Consensus 471 v~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll 548 (720)
.+.+++ ...++||||++++++.. .+.. .... .++..++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-----~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD-----VRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh-----hhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333332 24689999999854421 1110 0001 5678899999999999999 7 99999999999999
Q ss_pred CCCCceEEcccCCCccCCC
Q 005001 549 DDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 549 ~~~~~~kl~Dfg~a~~~~~ 567 (720)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999875533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=166.82 Aligned_cols=211 Identities=21% Similarity=0.295 Sum_probs=134.8
Q ss_pred hhhhccCCChHHHHHHHHHHHhcCCCCCCCC----CCCCCCCCCCCCC--------------ceeEecCCCEE-------
Q 005001 32 LSLVQCTTDSSDVQALQVLYTSLNSPSVLTN----WKGNEGDPCGESW--------------KGVACEGSAVV------- 86 (720)
Q Consensus 32 ~~~~~~~~~~~d~~al~~~~~~~~~~~~l~~----w~~~~~~~c~~~w--------------~gv~c~~~~v~------- 86 (720)
+......+..+|.+.++++.+.+..|..+.+ |.+. .++|.-.- ..|.|.+..|+
T Consensus 53 ~~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~-~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~ 131 (754)
T PRK15370 53 LCHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGA-DQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTES 131 (754)
T ss_pred HhCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCC-CcccccCCcchhhheeeecCCceEEecCCCcccccccccc
Confidence 3444566778999999999999999987777 9865 48884322 23888654443
Q ss_pred --------------------------------------------------EEEcCCCCCcccccccccCCCCCCEEEccC
Q 005001 87 --------------------------------------------------SIDISGLGLSGTMGYLLSDLLSLRKFDLSG 116 (720)
Q Consensus 87 --------------------------------------------------~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~ 116 (720)
.|+|++++++. +|..+. +.|+.|+|++
T Consensus 132 ~~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~ 208 (754)
T PRK15370 132 EQASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTT-IPACIP--EQITTLILDN 208 (754)
T ss_pred cccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecC
Confidence 35666666663 444443 4677788888
Q ss_pred CCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCcc
Q 005001 117 NSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196 (720)
Q Consensus 117 N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 196 (720)
|+|+ .+|..+.++|++|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|++|+|+ .+|..
T Consensus 209 N~Lt-sLP~~l~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~ 280 (754)
T PRK15370 209 NELK-SLPENLQGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPEN 280 (754)
T ss_pred CCCC-cCChhhccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccc
Confidence 8777 567666677788888877777 5565443 36777777777776 4555553 46777777777777 46665
Q ss_pred ccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCccc-ccccceeeecCCcCCC
Q 005001 197 FISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRE-LISIRTFIYDGNSFDN 258 (720)
Q Consensus 197 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~-l~~l~~l~l~~n~~~~ 258 (720)
+. ++|+.|+|++|+|++.+.. ...+|+.|+|++|+|++ +|.. ..+|+.|.+.+|.+.+
T Consensus 281 l~--~sL~~L~Ls~N~Lt~LP~~-lp~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 281 LP--EELRYLSVYDNSIRTLPAH-LPSGITHLNVQSNSLTA-LPETLPPGLKTLEAGENALTS 339 (754)
T ss_pred cC--CCCcEEECCCCccccCccc-chhhHHHHHhcCCcccc-CCccccccceeccccCCcccc
Confidence 53 4677777777777753221 11235555555555553 3332 2345555555555544
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-14 Score=134.99 Aligned_cols=136 Identities=19% Similarity=0.199 Sum_probs=112.8
Q ss_pred ccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCC--CCccccceEEeecCeEEEEEEecC
Q 005001 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH--PNIVTLAGYCAEHGQRLLVYEYVG 491 (720)
Q Consensus 414 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~ 491 (720)
..+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..++++||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 34679999999999998864 7889998865432 4567888888888866 588899888888888999999999
Q ss_pred CCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 492 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
++.+..+ +......++.+++++++++|....++++|+|++|+||++++.+.++++|||.+...
T Consensus 77 g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 77 GETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 8766542 45666778999999999999864447999999999999999899999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.9e-14 Score=143.14 Aligned_cols=137 Identities=16% Similarity=0.212 Sum_probs=105.8
Q ss_pred ceec-cCCCcEEEEEEEcCCcEEEEEEcccccc-----------ChHHHHHHHHHHHHhhcCCCCCc--cccceEEeec-
Q 005001 416 FLIG-EGSLGRVYRAEFANGKIMAVKKIDNAAL-----------SLQEEDNFLEAVSNMSRLRHPNI--VTLAGYCAEH- 480 (720)
Q Consensus 416 ~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~- 480 (720)
..|| .|+.|+||.++.. +..+++|.+..... .......+.+|+.++.+++|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 8999999999885 77888888753211 12234567889999999988875 6666664432
Q ss_pred C---eEEEEEEecCC-CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEE
Q 005001 481 G---QRLLVYEYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (720)
Q Consensus 481 ~---~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 556 (720)
+ ..++|||+++| .+|.+++. ...++.. .+.+++.+|.+||+. ||+||||||+|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQ-----EAPLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 69998885 2344543 356899999999999 9999999999999999999999
Q ss_pred cccCCCccC
Q 005001 557 SDCGLAALT 565 (720)
Q Consensus 557 ~Dfg~a~~~ 565 (720)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.7e-15 Score=156.35 Aligned_cols=172 Identities=23% Similarity=0.269 Sum_probs=133.4
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 85 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
+..|||++|.|+.+-+..|-+|++|+.++|.+|.++ .||.... .+|+.|+|.+|.|+..-.+++.-++.|+.||||.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 566999999999999999999999999999999999 7886554 5788888888888876677888888888888888
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccc-ccC-CCCcCeEEccCccCc---c
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFS-GLPLTTLNVANNHFS---G 237 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~-~~~L~~l~l~~N~l~---g 237 (720)
|.|+...-++|..-.++++|+|++|+|+..--..|.++.+|.+|.|+.|+|+..+. .|. ...|+.|+|..|+|. |
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ 238 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG 238 (873)
T ss_pred chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence 88886666677777788888888888887667778888888888888888887554 333 234888888888774 2
Q ss_pred cCcccccccceeeecCCcCC
Q 005001 238 WIPRELISIRTFIYDGNSFD 257 (720)
Q Consensus 238 ~ip~~l~~l~~l~l~~n~~~ 257 (720)
.--..+.+|+.|.+..|.+.
T Consensus 239 ltFqgL~Sl~nlklqrN~I~ 258 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDIS 258 (873)
T ss_pred hhhcCchhhhhhhhhhcCcc
Confidence 22234455566666666543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.9e-16 Score=161.36 Aligned_cols=171 Identities=23% Similarity=0.349 Sum_probs=116.2
Q ss_pred CEEEEEcCCCCCc-ccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEc
Q 005001 84 AVVSIDISGLGLS-GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 84 ~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 160 (720)
-|..+|+++|.++ +..|.....+++++.|-|...++. .+|.+++ .+|+.|.+++|++. .+-..++.|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3666777777777 466777777777777777777776 6676665 67777777777776 55666777777777777
Q ss_pred ccccccc-ccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccc-ccCCC-CcCeEEccCccCcc
Q 005001 161 SRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGL-PLTTLNVANNHFSG 237 (720)
Q Consensus 161 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~-~L~~l~l~~N~l~g 237 (720)
.+|+|.. -||..+-.|..|+.||||+|+|. ..|..+..-+++-.|+||+|+|...+. .+..+ .|-.||||+|+|.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe- 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE- 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-
Confidence 7777753 35666667777777777777777 677777777777777777777766543 23332 3667777777776
Q ss_pred cCccc---ccccceeeecCCcCCC
Q 005001 238 WIPRE---LISIRTFIYDGNSFDN 258 (720)
Q Consensus 238 ~ip~~---l~~l~~l~l~~n~~~~ 258 (720)
.+|+. +..|++|.+++||+..
T Consensus 164 ~LPPQ~RRL~~LqtL~Ls~NPL~h 187 (1255)
T KOG0444|consen 164 MLPPQIRRLSMLQTLKLSNNPLNH 187 (1255)
T ss_pred hcCHHHHHHhhhhhhhcCCChhhH
Confidence 44443 3456677777777543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.3e-14 Score=161.86 Aligned_cols=162 Identities=20% Similarity=0.292 Sum_probs=121.3
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
..++.|+|++|+|+. +|..+. ++|++|+|++|+|+ .+|..+..+|+.|+|++|+++ .+|..+. .+|+.|+|++
T Consensus 199 ~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~ 271 (754)
T PRK15370 199 EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLPDTIQEMELSINRIT-ELPERLP--SALQSLDLFH 271 (754)
T ss_pred cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhhccccEEECcCCccC-cCChhHh--CCCCEEECcC
Confidence 468899999999985 555544 58999999999998 678877788999999999998 7787664 5899999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCccc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRE 242 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~ 242 (720)
|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+|+..+ .....+|+.|++++|.|++ +|..
T Consensus 272 N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP-~~l~~sL~~L~Ls~N~Lt~-LP~~ 343 (754)
T PRK15370 272 NKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALP-ETLPPGLKTLEAGENALTS-LPAS 343 (754)
T ss_pred CccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCC-ccccccceeccccCCcccc-CChh
Confidence 9998 4676654 58999999999998 4665543 46777888888877533 2223457777777777774 5654
Q ss_pred c-cccceeeecCCcCCCC
Q 005001 243 L-ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 243 l-~~l~~l~l~~n~~~~~ 259 (720)
+ .+|+.|++.+|.+...
T Consensus 344 l~~sL~~L~Ls~N~L~~L 361 (754)
T PRK15370 344 LPPELQVLDVSKNQITVL 361 (754)
T ss_pred hcCcccEEECCCCCCCcC
Confidence 4 3677777777776643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3e-15 Score=150.53 Aligned_cols=192 Identities=27% Similarity=0.351 Sum_probs=136.3
Q ss_pred CCCCCCC---ceeEecCC-----------CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccc
Q 005001 69 DPCGESW---KGVACEGS-----------AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLT 132 (720)
Q Consensus 69 ~~c~~~w---~gv~c~~~-----------~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~ 132 (720)
.+|.|+= .-|.|+.. ..+.|+|..|+|+...+.+|+.+++|+.||||+|+|+..-|..|. ++|.
T Consensus 39 ~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~ 118 (498)
T KOG4237|consen 39 APCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLL 118 (498)
T ss_pred CCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhh
Confidence 4565544 34899753 467899999999999999999999999999999999987787664 4554
Q ss_pred eecc-ccccCcCCCCccccccC------------------------CccEEEcccccccccc------------------
Q 005001 133 SLNL-ASNNFSGNLPYSIASMV------------------------SLSYLNVSRNSLTQSI------------------ 169 (720)
Q Consensus 133 ~L~L-~~N~l~g~~p~~~~~l~------------------------~L~~L~L~~N~l~~~~------------------ 169 (720)
+|-| ++|+|+..--..|++|. +|..|.|..|.+...-
T Consensus 119 ~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~n 198 (498)
T KOG4237|consen 119 SLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQN 198 (498)
T ss_pred HHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcC
Confidence 4444 44777732223444443 4433333333222100
Q ss_pred -------------------------------------------------------------------c-cccCCCCCCCe
Q 005001 170 -------------------------------------------------------------------G-DIFGNLAGLAT 181 (720)
Q Consensus 170 -------------------------------------------------------------------p-~~~~~l~~L~~ 181 (720)
| ..|..|++|+.
T Consensus 199 p~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~ 278 (498)
T KOG4237|consen 199 PFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRK 278 (498)
T ss_pred ccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceE
Confidence 0 12445778888
Q ss_pred eecCCCcccCCCCccccCCCCCCeeEecccccccccc-ccCCCC-cCeEEccCccCcccCcccc---cccceeeecCCcC
Q 005001 182 LDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIPREL---ISIRTFIYDGNSF 256 (720)
Q Consensus 182 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~ 256 (720)
|+|++|+|++.-+.+|.++..|++|+|..|+|...-. .|.+.+ |++|+|.+|+|+-.-|-.| .++.++.+.+|||
T Consensus 279 lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 279 LNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred eccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 8888888888778888888888888888888876432 344444 8999999999997777666 4677889999999
Q ss_pred CCCC
Q 005001 257 DNGP 260 (720)
Q Consensus 257 ~~~~ 260 (720)
+|+.
T Consensus 359 ~CnC 362 (498)
T KOG4237|consen 359 NCNC 362 (498)
T ss_pred cCcc
Confidence 9864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.5e-14 Score=138.97 Aligned_cols=207 Identities=23% Similarity=0.342 Sum_probs=147.9
Q ss_pred HHHhhcCCCCCccccceEEeec-----CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005001 459 VSNMSRLRHPNIVTLAGYCAEH-----GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533 (720)
Q Consensus 459 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~ 533 (720)
+..+-.+.|.|||+++.|+.+. ....++.|||..|++..+|++.+.....+......+++.||+.||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3445556799999999998654 356899999999999999998777777888889999999999999999995 6
Q ss_pred CCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc---cccccccccccCccccccCCCcccchhhhHHHHHHHHH
Q 005001 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV---STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELL 610 (720)
Q Consensus 534 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ell 610 (720)
|.|+|+++.-+-|++..+|-+||.--.-....+...... ...-.+-++|.+||.=.....+.++|||+||....||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 799999999999999999999985322111111111000 11124668999999887777888999999999999999
Q ss_pred hCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 611 TGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 611 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.+..--......... .+.....+....++ .-++++.+|++..|..||+|.+++.+.
T Consensus 277 ilEiq~tnseS~~~~------------ee~ia~~i~~len~--------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEV------------EENIANVIIGLENG--------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcceeeh------------hhhhhhheeeccCc--------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 877642211111100 01111111111110 013688999999999999999988663
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-15 Score=151.80 Aligned_cols=167 Identities=23% Similarity=0.346 Sum_probs=120.3
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC-CccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 85 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
+..++..+|+++ ++|+.++++.+|..|++.+|++....|..+. +.|+.||+..|-++ .+|+.++.|.+|.-|+|.+|
T Consensus 139 l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~N 216 (565)
T KOG0472|consen 139 LEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRN 216 (565)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhc
Confidence 445666677776 5677777788888888888888744444443 67888888888777 77888888888888888888
Q ss_pred ccccccccccCCCCCCCeeecCCCcccCCCCcccc-CCCCCCeeEeccccccccccccCC-CCcCeEEccCccCcccCcc
Q 005001 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI-SLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWIPR 241 (720)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~l~l~~N~l~g~ip~ 241 (720)
+|. .+| +|+++..|.+|+++.|+++ .+|.+.+ .+++|.+|||.+|+++..+..... .+|+.||||+|.|+ .+|.
T Consensus 217 ki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~Lp~ 292 (565)
T KOG0472|consen 217 KIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-SLPY 292 (565)
T ss_pred ccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-cCCc
Confidence 887 445 7778888888888888887 6776665 778888888888888765544333 34888888888888 4666
Q ss_pred ccccc--ceeeecCCcCC
Q 005001 242 ELISI--RTFIYDGNSFD 257 (720)
Q Consensus 242 ~l~~l--~~l~l~~n~~~ 257 (720)
+++++ +.|.+.|||+.
T Consensus 293 sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 293 SLGNLHLKFLALEGNPLR 310 (565)
T ss_pred ccccceeeehhhcCCchH
Confidence 66654 45666777764
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=5e-13 Score=152.27 Aligned_cols=157 Identities=25% Similarity=0.358 Sum_probs=83.3
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCcccc-------------
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA------------- 150 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~------------- 150 (720)
+++.|+|.+|+|+. +|. .+++|++|+|++|+|+ .+|. +.++|+.|+|++|.|+ .+|..+.
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~-lp~sL~~L~Ls~N~L~-~Lp~lp~~L~~L~Ls~N~Lt 295 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV-LPPGLLELSIFSNPLT-HLPALPSGLCKLWIFGNQLT 295 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccC-cccccceeeccCCchh-hhhhchhhcCEEECcCCccc
Confidence 56777777777764 343 2467777777777777 4453 2345555555555554 2222110
Q ss_pred ----ccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcC
Q 005001 151 ----SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLT 226 (720)
Q Consensus 151 ----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~ 226 (720)
.+++|++|+|++|+|++ +|.. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++.++. ..+|+
T Consensus 296 ~LP~~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~LP~l--p~~L~ 365 (788)
T PRK15387 296 SLPVLPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLASLPTL--PSELY 365 (788)
T ss_pred cccccccccceeECCCCcccc-CCCC---cccccccccccCccc-ccccc---ccccceEecCCCccCCCCCC--Ccccc
Confidence 12455666666666654 2221 123334444444444 23321 13567777777777753321 12355
Q ss_pred eEEccCccCcccCcccccccceeeecCCcCCC
Q 005001 227 TLNVANNHFSGWIPRELISIRTFIYDGNSFDN 258 (720)
Q Consensus 227 ~l~l~~N~l~g~ip~~l~~l~~l~l~~n~~~~ 258 (720)
.|++++|+|+ .+|....+|+.|++++|.+..
T Consensus 366 ~L~Ls~N~L~-~LP~l~~~L~~LdLs~N~Lt~ 396 (788)
T PRK15387 366 KLWAYNNRLT-SLPALPSGLKELIVSGNRLTS 396 (788)
T ss_pred eehhhccccc-cCcccccccceEEecCCcccC
Confidence 6666666666 355555556666666666554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.8e-13 Score=150.70 Aligned_cols=162 Identities=22% Similarity=0.348 Sum_probs=103.0
Q ss_pred EecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEE
Q 005001 79 ACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158 (720)
Q Consensus 79 ~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 158 (720)
.|-..+-..|+|++++|+ .+|+.+. ++|+.|+|++|+|+ .+|. +.++|++|+|++|+|+ .+|.. .++|+.|
T Consensus 197 ~Cl~~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~-lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L 267 (788)
T PRK15387 197 ACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA-LPPELRTLEVSGNQLT-SLPVL---PPGLLEL 267 (788)
T ss_pred HHhcCCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC-CCCCCcEEEecCCccC-cccCc---cccccee
Confidence 354445567999999998 6787776 48999999999999 5774 4589999999999999 56753 3577778
Q ss_pred EccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc------------------
Q 005001 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF------------------ 220 (720)
Q Consensus 159 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~------------------ 220 (720)
+|++|.|+. +|.. +++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++.....
T Consensus 268 ~Ls~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~ 339 (788)
T PRK15387 268 SIFSNPLTH-LPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPT 339 (788)
T ss_pred eccCCchhh-hhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCccccCCCCcccccccccccCccccccc
Confidence 888777763 3332 234555666666665 34432 245566666666655422110
Q ss_pred CCCCcCeEEccCccCcccCcccccccceeeecCCcCCC
Q 005001 221 SGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDN 258 (720)
Q Consensus 221 ~~~~L~~l~l~~N~l~g~ip~~l~~l~~l~l~~n~~~~ 258 (720)
...+|+.|+|++|+|+ .+|....+++.|.+.+|.+..
T Consensus 340 lp~~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~ 376 (788)
T PRK15387 340 LPSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTS 376 (788)
T ss_pred cccccceEecCCCccC-CCCCCCcccceehhhcccccc
Confidence 0123555666666665 344444455555555555554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.6e-15 Score=149.28 Aligned_cols=168 Identities=25% Similarity=0.340 Sum_probs=111.7
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccc
Q 005001 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (720)
Q Consensus 87 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~ 164 (720)
.++++.|.+. ++++.++.+..|..|+..+|+++ +.|..+. .+|..|++.+|++.. .|+..-+++.|++||..+|.
T Consensus 118 ~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~ 194 (565)
T KOG0472|consen 118 KLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNL 194 (565)
T ss_pred hhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhh
Confidence 3444444443 34555555555666666666655 4444443 456666666666663 33333337777777777777
Q ss_pred cccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc--CCCCcCeEEccCccCcccCccc
Q 005001 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF--SGLPLTTLNVANNHFSGWIPRE 242 (720)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~g~ip~~ 242 (720)
++ .+|+.++.|.+|.-|||..|++. .+| +|.+++.|++|+++.|+|.-..... ...++..|||.+|+++ +.|++
T Consensus 195 L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde 270 (565)
T KOG0472|consen 195 LE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDE 270 (565)
T ss_pred hh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchH
Confidence 75 67777777777777888888777 667 6777777788888887776543222 2234889999999999 88987
Q ss_pred cc---ccceeeecCCcCCCCCC
Q 005001 243 LI---SIRTFIYDGNSFDNGPA 261 (720)
Q Consensus 243 l~---~l~~l~l~~n~~~~~~~ 261 (720)
++ ++..|++++|.+...|.
T Consensus 271 ~clLrsL~rLDlSNN~is~Lp~ 292 (565)
T KOG0472|consen 271 ICLLRSLERLDLSNNDISSLPY 292 (565)
T ss_pred HHHhhhhhhhcccCCccccCCc
Confidence 75 46678899998886654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=2e-12 Score=141.19 Aligned_cols=144 Identities=22% Similarity=0.295 Sum_probs=100.0
Q ss_pred cceeccCCCcEEEEEEEcCCcEEEEEEccccccChH--------------------------------------HHHHHH
Q 005001 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ--------------------------------------EEDNFL 456 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~~~~~ 456 (720)
.+.||.|++|.||+|++++|+.||||+.+......- .+-.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999999999999999865321100 011244
Q ss_pred HHHHHhhcC----C-CCCccccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 005001 457 EAVSNMSRL----R-HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR-ALEYLHE 530 (720)
Q Consensus 457 ~e~~~l~~l----~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~-~L~~LH~ 530 (720)
+|...+.++ + +++|.-..-+.......++||||++|++|.++..... ... ....++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 455544444 2 3443222222223445799999999999988765211 112 23456666655 4788898
Q ss_pred cCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 531 ~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
. |++|+|++|.||+++.++.++++|||++.....
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 999999999999999999999999999876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.5e-13 Score=142.99 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=184.8
Q ss_pred hcCCCccceecc--CCCcEEEEEEE---cCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCe
Q 005001 409 TNSFSQEFLIGE--GSLGRVYRAEF---ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 482 (720)
...|.....+|. |.+|.||.+.. .++..+|+|+-+...........-++|+....++ .|+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345666778999 99999999965 4688899998654444444445556677766666 59999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCcEEecCCCCCEEeCCC-CceEEc
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR----ALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLS 557 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~----~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~ 557 (720)
.++-+|++. .+|.++.+ ....-++...+.....+... ||.++|+. .++|-|+||.||+...+ ...+++
T Consensus 193 lfiqtE~~~-~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred ceeeecccc-chhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 999999986 57777765 22334677777888888888 99999999 99999999999999999 889999
Q ss_pred ccCCCccCCCCCcccc----ccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 005001 558 DCGLAALTPNTERQVS----TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633 (720)
Q Consensus 558 Dfg~a~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~ 633 (720)
|||+...+....-... ....|...|++||...+ -++.+.|+|++|.++.+-.++..+........
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~---------- 334 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS---------- 334 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC----------
Confidence 9999887655432111 12257778999997655 56889999999999999999887765431110
Q ss_pred ccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
| ...+.+. +...+......++...+..|++.+|..|++.+.+...
T Consensus 335 -W---~~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 335 -W---SQLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred -c---ccccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1 1111111 1112222334456669999999999999998887654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.4e-14 Score=149.10 Aligned_cols=169 Identities=30% Similarity=0.430 Sum_probs=145.3
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 85 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+.+||+.|++. ++|.....+-.|+.|.|+.|.|. .||..+. ..|++|||+.|+++ .+|..++.|+ |+.|-+++
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sN 152 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSN 152 (722)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEec
Confidence 456788888886 67888888888999999999988 7777665 78999999999999 7888888886 89999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCccc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRE 242 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~ 242 (720)
|+++ .+|+.++.+..|..||.+.|++. .+|..++++.+|..|.+..|++...++....++|..||+++|+++ .||-+
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~ 229 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVD 229 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchh
Confidence 9998 77888888899999999999998 788889999999999999999998887777888999999999999 89987
Q ss_pred cc---ccceeeecCCcCCCCC
Q 005001 243 LI---SIRTFIYDGNSFDNGP 260 (720)
Q Consensus 243 l~---~l~~l~l~~n~~~~~~ 260 (720)
|. .|+.|.|.+||+...|
T Consensus 230 fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 230 FRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred hhhhhhheeeeeccCCCCCCh
Confidence 75 4667889999987543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.7e-12 Score=140.39 Aligned_cols=149 Identities=15% Similarity=0.181 Sum_probs=94.3
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcC-CcEEEEEEccccccCh--------------------------------HHHH-
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSL--------------------------------QEED- 453 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~--------------------------------~~~~- 453 (720)
.-..|+. +.||+|++|.||+|.+++ |+.||||+.+...... +..+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3445666 789999999999999987 9999999997542100 0111
Q ss_pred -----HHHHHHHHhhcC----CCCCccccceEEee-cCeEEEEEEecCCCCHHHHhhhccC--CCCCCCHHHHHHHHHHH
Q 005001 454 -----NFLEAVSNMSRL----RHPNIVTLAGYCAE-HGQRLLVYEYVGNGNLHDMLHFADD--SSKNLTWNARVRVALGT 521 (720)
Q Consensus 454 -----~~~~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~~i~~qi 521 (720)
++.+|+..+.++ .+.+.+.+=..+.+ ....++||||++|+.+.++-..... ....+....+..++.|
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q- 275 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ- 275 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-
Confidence 233444433333 23333333233322 3456899999999999875321110 0011222233333333
Q ss_pred HHHHHHHHhcCCCCcEEecCCCCCEEeCCCC----ceEEcccCCCccCCC
Q 005001 522 ARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSDCGLAALTPN 567 (720)
Q Consensus 522 ~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 567 (720)
+... |++|+|++|.||+++.++ +++++|||++.....
T Consensus 276 ------if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ------VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3445 999999999999999988 999999999976654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.6e-13 Score=148.17 Aligned_cols=170 Identities=25% Similarity=0.320 Sum_probs=140.2
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCC----------------------------CCccceecc
Q 005001 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL----------------------------PPNLTSLNL 136 (720)
Q Consensus 85 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~----------------------------~~~L~~L~L 136 (720)
++.|++..|.++ .+|+.+..++.|++|||..|+|. ..|..+ .+.|+.|+|
T Consensus 289 L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Lyl 366 (1081)
T KOG0618|consen 289 LVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYL 366 (1081)
T ss_pred HHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHH
Confidence 445566667775 56777777888888888888876 444221 146888999
Q ss_pred ccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccc
Q 005001 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS 216 (720)
Q Consensus 137 ~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~ 216 (720)
.+|.|+...-+.+.+..+|+.|+|++|+|.......+.++..|+.|+||+|+|+ .+|..+.+++.|++|...+|+|...
T Consensus 367 anN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f 445 (1081)
T KOG0618|consen 367 ANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF 445 (1081)
T ss_pred hcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeec
Confidence 999999888888999999999999999998666668899999999999999999 8999999999999999999999987
Q ss_pred ccccCCCCcCeEEccCccCc-ccCcccc--cccceeeecCCcCC
Q 005001 217 LNVFSGLPLTTLNVANNHFS-GWIPREL--ISIRTFIYDGNSFD 257 (720)
Q Consensus 217 ~~~~~~~~L~~l~l~~N~l~-g~ip~~l--~~l~~l~l~~n~~~ 257 (720)
+.......|+.+||+.|+|+ +.+|..+ .+|+.|++.||...
T Consensus 446 Pe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 446 PELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 75555666999999999996 3566554 58999999999953
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.5e-12 Score=144.06 Aligned_cols=107 Identities=26% Similarity=0.329 Sum_probs=83.2
Q ss_pred CccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc-C-CCCcCeEEcc
Q 005001 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-S-GLPLTTLNVA 231 (720)
Q Consensus 154 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~L~~l~l~ 231 (720)
.++.|+|++|.|+|.+|..++.|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|.. . ..+|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 3677888888888888888888888888888888888888888888888888888888888876643 2 2358888888
Q ss_pred CccCcccCcccccc----cceeeecCCcCCCCC
Q 005001 232 NNHFSGWIPRELIS----IRTFIYDGNSFDNGP 260 (720)
Q Consensus 232 ~N~l~g~ip~~l~~----l~~l~l~~n~~~~~~ 260 (720)
+|+|+|.+|..+.. +..+.+.+|+..|+.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCC
Confidence 88888888887653 456888999888864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.6e-12 Score=136.01 Aligned_cols=252 Identities=18% Similarity=0.177 Sum_probs=183.8
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEE--cCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCe
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEF--ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 482 (720)
.....+|..+..||.|.|+.|+.... .++..|++|...+..........-+.|+.+...+ .|.+++..+..+....+
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 33456788899999999999999853 4678899998877665544444445666666655 68999998888888888
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC-CceEEcccCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGL 561 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~ 561 (720)
.|+-.||++++++...+. ....+++...+++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.
T Consensus 341 ~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 889999999999877663 356788888999999999999999998 99999999999999886 7789999998
Q ss_pred CccCCCCCcccccccccccccc--CccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 562 AALTPNTERQVSTQMVGAFGYS--APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
+..+.-.. ....++-++. +++......+..+.|++|||.-+.|..+|..--......
T Consensus 414 ~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----------------- 472 (524)
T KOG0601|consen 414 WTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----------------- 472 (524)
T ss_pred ccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-----------------
Confidence 86421111 1112223344 555556677889999999999999999877533221110
Q ss_pred HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
..+. .......+. ....+..+.+.+...|+..||.+.++....+..
T Consensus 473 --~~i~-~~~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 473 --LTIR-SGDTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred --eeee-cccccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0000 010111122 226778899999999999999999988765443
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.24 E-value=4e-11 Score=146.94 Aligned_cols=80 Identities=19% Similarity=0.119 Sum_probs=41.1
Q ss_pred CCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc-CCCCcCeEEccCccCcccCcccccccceeeecCCcC
Q 005001 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-SGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256 (720)
Q Consensus 178 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~g~ip~~l~~l~~l~l~~n~~ 256 (720)
+|+.|+|++|...+.+|.+++++++|+.|+|++|..-+.+|.. ...+|+.|+|++|..-..+|....+++.|++.+|.+
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n~i 858 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGI 858 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCccccccccccccCEeECCCCCC
Confidence 4555555555555556666666666666666665433333322 222355555555444334444444555555555544
Q ss_pred C
Q 005001 257 D 257 (720)
Q Consensus 257 ~ 257 (720)
.
T Consensus 859 ~ 859 (1153)
T PLN03210 859 E 859 (1153)
T ss_pred c
Confidence 4
|
syringae 6; Provisional |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1e-10 Score=126.64 Aligned_cols=167 Identities=22% Similarity=0.261 Sum_probs=126.3
Q ss_pred EEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCC
Q 005001 430 EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL 509 (720)
Q Consensus 430 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~ 509 (720)
...++.+|.|...+.... .......+.++.++.++||||+++++.++..+..|+|+|-+. .|..+++. +
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------L 101 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------h
Confidence 344677787777764432 334456677888999999999999999999999999999986 56666652 2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccccccccccccccCccccc
Q 005001 510 TWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589 (720)
Q Consensus 510 ~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 589 (720)
........+.||+.||.+||..+ +++|++|....|+++..|+.||++|.++........ ......--..|..|+.+.
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcC
Confidence 25666778899999999999776 999999999999999999999999998754433221 111112223467777655
Q ss_pred cCCCcccchhhhHHHHHHHHHhC
Q 005001 590 SGIYTVKSDVYSFGVVMLELLTG 612 (720)
Q Consensus 590 ~~~~~~~~DvwSlGv~l~elltg 612 (720)
... -..|.|-|||+++|++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 443 457999999999999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.7e-11 Score=115.42 Aligned_cols=131 Identities=21% Similarity=0.129 Sum_probs=94.4
Q ss_pred cceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCcc-ccceEEeecCeEEEEEEecCCC
Q 005001 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV-TLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~g 493 (720)
.+.|+.|.++.||+++.. ++.|++|....... ....+.+|+..++.+.+.+++ +++.+. .+..++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 356889999999999875 77899998765431 123456777777777555544 444433 33458999999998
Q ss_pred CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC--LPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 494 sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
++.+.- .....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 77 ~l~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 775420 111345678999999999982 11259999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.7e-12 Score=137.33 Aligned_cols=178 Identities=26% Similarity=0.418 Sum_probs=133.2
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCC---CCEEEccCCCCCCC----CCC---CCCCccceeccccccCcCC----CCc
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLSDLLS---LRKFDLSGNSIHDT----IPY---QLPPNLTSLNLASNNFSGN----LPY 147 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~~l~~---L~~L~L~~N~l~~~----~p~---~~~~~L~~L~L~~N~l~g~----~p~ 147 (720)
..+++.|+|++|.+.+..+..+..+.. |++|++++|++++. +.. ...++|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 348999999999998877777776666 99999999998831 111 1126899999999999953 344
Q ss_pred cccccCCccEEEccccccccc----cccccCCCCCCCeeecCCCcccCC----CCccccCCCCCCeeEecccccccc-c-
Q 005001 148 SIASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGS-L- 217 (720)
Q Consensus 148 ~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~-~- 217 (720)
.+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. +...+..+++|++|++++|.+++. +
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence 567788999999999999853 345566778999999999998743 334566788999999999999862 1
Q ss_pred cc---c--CCCCcCeEEccCccCc--c--cCcc---cccccceeeecCCcCCCC
Q 005001 218 NV---F--SGLPLTTLNVANNHFS--G--WIPR---ELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 218 ~~---~--~~~~L~~l~l~~N~l~--g--~ip~---~l~~l~~l~l~~n~~~~~ 259 (720)
.. + ....|+.|++++|.++ | .+.. .+.+++.+++++|.+...
T Consensus 240 ~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 11 1 1246999999999997 2 2222 335788899999988643
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=7.7e-11 Score=112.99 Aligned_cols=137 Identities=16% Similarity=0.184 Sum_probs=97.6
Q ss_pred ceeccCCCcEEEEEEEcC-------CcEEEEEEcccccc--------------------ChHHHHHH----HHHHHHhhc
Q 005001 416 FLIGEGSLGRVYRAEFAN-------GKIMAVKKIDNAAL--------------------SLQEEDNF----LEAVSNMSR 464 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~--------------------~~~~~~~~----~~e~~~l~~ 464 (720)
..||.|--+.||.|...+ +..+|+|..+.... .......+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 469999999999996543 47899998742211 00112222 278888888
Q ss_pred CCC--CCccccceEEeecCeEEEEEEecCCCCHHH-HhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEEec
Q 005001 465 LRH--PNIVTLAGYCAEHGQRLLVYEYVGNGNLHD-MLHFADDSSKNLTWNARVRVALGTARALEYL-HEVCLPSVVHRN 540 (720)
Q Consensus 465 l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~~~~iiH~D 540 (720)
+.. -++..++++ ...++||||+.++.+.. .++ ...++..+...+..+++.+|..+ |+. ++||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 843 456666654 45789999997754422 222 12345556777889999999999 787 999999
Q ss_pred CCCCCEEeCCCCceEEcccCCCccC
Q 005001 541 FKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 541 lkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|++.||++++ +.++|+|||.+-..
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 68999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.3e-10 Score=142.53 Aligned_cols=173 Identities=17% Similarity=0.204 Sum_probs=121.6
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC-C---------------------ccceeccccccC
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-P---------------------NLTSLNLASNNF 141 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~---------------------~L~~L~L~~N~l 141 (720)
+++.|+|++|..-..+|..+++|++|+.|+|++|..-+.+|..+. + +|++|+|++|.+
T Consensus 658 ~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i 737 (1153)
T PLN03210 658 NLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAI 737 (1153)
T ss_pred cccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCCcc
Confidence 456666766665566777777778888888877654445664431 3 445555555555
Q ss_pred cCCCCccc------------------------------cccCCccEEEccccccccccccccCCCCCCCeeecCCCcccC
Q 005001 142 SGNLPYSI------------------------------ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG 191 (720)
Q Consensus 142 ~g~~p~~~------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 191 (720)
. .+|..+ ...++|+.|+|++|...+.+|.+++++++|+.|+|++|..-+
T Consensus 738 ~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~ 816 (1153)
T PLN03210 738 E-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLE 816 (1153)
T ss_pred c-cccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcC
Confidence 4 344321 012467888888888888899999999999999999976555
Q ss_pred CCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCcccc---cccceeeecC-CcCCCCC
Q 005001 192 DLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDG-NSFDNGP 260 (720)
Q Consensus 192 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~-n~~~~~~ 260 (720)
.+|..+ ++++|+.|+|++|..-..+|.. ..+|+.|+|++|.|+ .+|.++ .+|+.|++.+ |.+...+
T Consensus 817 ~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~-~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~ 886 (1153)
T PLN03210 817 TLPTGI-NLESLESLDLSGCSRLRTFPDI-STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVS 886 (1153)
T ss_pred eeCCCC-CccccCEEECCCCCcccccccc-ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccC
Confidence 888776 7899999999998655444432 246999999999998 688654 5677888887 4454433
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.18 E-value=4e-12 Score=134.49 Aligned_cols=175 Identities=22% Similarity=0.221 Sum_probs=125.4
Q ss_pred CCEEEEEcCCCCCc------ccccccccCCCCCCEEEccCCCCCCCCCCCCC-----CccceeccccccCcC----CCCc
Q 005001 83 SAVVSIDISGLGLS------GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-----PNLTSLNLASNNFSG----NLPY 147 (720)
Q Consensus 83 ~~v~~l~l~~~~l~------g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-----~~L~~L~L~~N~l~g----~~p~ 147 (720)
..++.|+++++.+. ..++..+.++++|+.|+|++|.+.+..+..+. ++|+.|+|++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 34778888887776 23455677888999999999998765543332 349999999999883 3344
Q ss_pred ccccc-CCccEEEccccccccc----cccccCCCCCCCeeecCCCcccCC----CCccccCCCCCCeeEeccccccccc-
Q 005001 148 SIASM-VSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSL- 217 (720)
Q Consensus 148 ~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~- 217 (720)
.+..+ ++|+.|+|++|.+++. ++..+..+++|+.|+|++|++++. ++..+..+++|++|+|++|.+++..
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 210 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA 210 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH
Confidence 56677 8899999999999843 344667778899999999998852 3344556679999999999987532
Q ss_pred ---c-cc-CCCCcCeEEccCccCcccCcc----c----ccccceeeecCCcCC
Q 005001 218 ---N-VF-SGLPLTTLNVANNHFSGWIPR----E----LISIRTFIYDGNSFD 257 (720)
Q Consensus 218 ---~-~~-~~~~L~~l~l~~N~l~g~ip~----~----l~~l~~l~l~~n~~~ 257 (720)
. .+ ...+|+.|++++|.+++..+. . ...|+.|++.+|.+.
T Consensus 211 ~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 211 SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 1 11 224599999999998863222 2 257888888888764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.4e-10 Score=103.71 Aligned_cols=133 Identities=22% Similarity=0.293 Sum_probs=101.5
Q ss_pred eeccCCCcEEEEEEEcCCcEEEEEEcccc-ccChHH-----HHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNA-ALSLQE-----EDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
.+++|+-+.+|.+.+.+.. +++|.-..+ ...++- ...-.+|+.++.+++--.|....=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775434 555544322 222222 234567899998887767776666777888889999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
+|..|.+.+... ...++..+-.-+.-||.. +|||+||.++||++..++ +.++|||++...
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888621 245667777788899999 999999999999998875 999999998743
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.8e-12 Score=143.52 Aligned_cols=173 Identities=21% Similarity=0.288 Sum_probs=114.1
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
.++.++++.|++++.. ..++.+.+|+.|+..+|+|+ .+|..+. .+|+.|++.+|.++ -+|..++.++.|+.|+|.
T Consensus 242 nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 4666788888888644 88889999999999999996 6776665 67788888888877 677777778888888888
Q ss_pred ccccccccccccC-------------------------CCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccc
Q 005001 162 RNSLTQSIGDIFG-------------------------NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS 216 (720)
Q Consensus 162 ~N~l~~~~p~~~~-------------------------~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~ 216 (720)
.|+|....+..+. .+..|+.|+|.+|+|+...-..+-+.++|+.|+|++|+|...
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 8877633221111 123466777777777766555667777777777777777654
Q ss_pred cccc-CCC-CcCeEEccCccCcccCcccc---cccceeeecCCcCCCCC
Q 005001 217 LNVF-SGL-PLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 217 ~~~~-~~~-~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~~ 260 (720)
+... ... .|+.|+||+|+|+ .+|..+ ..|.+|...+|.+.+.|
T Consensus 399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP 446 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP 446 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech
Confidence 4322 112 2677777777776 555433 23344444444444433
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.3e-10 Score=110.48 Aligned_cols=143 Identities=22% Similarity=0.286 Sum_probs=109.3
Q ss_pred ceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCC--CCccccceEEeec---CeEEEEEEec
Q 005001 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH--PNIVTLAGYCAEH---GQRLLVYEYV 490 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lV~e~~ 490 (720)
+.|+.|.++.||++...+|+.+++|........ .....+.+|+++++.+.+ .++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 468999999999998877789999998654321 234567888888888865 3456677766553 3668999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC-------------------------------------- 532 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------- 532 (720)
+|.++.+.+. ...++..+...++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9988876542 145677778888888888888888531
Q ss_pred ---------------CCCcEEecCCCCCEEeCC--CCceEEcccCCCcc
Q 005001 533 ---------------LPSVVHRNFKSANILLDD--ELNPHLSDCGLAAL 564 (720)
Q Consensus 533 ---------------~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~ 564 (720)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-09 Score=99.18 Aligned_cols=145 Identities=18% Similarity=0.225 Sum_probs=107.0
Q ss_pred ccceeccCCCcEEEEEEEcCCcEEEEEEcc-ccccCh-----HHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKID-NAALSL-----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 414 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~-~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
....+-+|+-+.|+++.+. |+...||.-. +....+ -..++.++|++.+.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567899999999999886 6666666442 222222 22456678999998887667766666777777788999
Q ss_pred EecCC-CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC---ceEEcccCCCc
Q 005001 488 EYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPHLSDCGLAA 563 (720)
Q Consensus 488 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~ 563 (720)
||++| .++.+++.... ...........++..|-+.+.-||.. +|||+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 47888886432 22222333367888899999999999 999999999999997654 35899999985
Q ss_pred c
Q 005001 564 L 564 (720)
Q Consensus 564 ~ 564 (720)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.4e-11 Score=134.73 Aligned_cols=248 Identities=22% Similarity=0.253 Sum_probs=168.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccc-cChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
..+.+.+-+.+|.++.++.+.-. .|...+.|...... +.....+....+-.+.-...+|.++...--+......++|+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 44555667888999999887433 23333333332111 01111222223333333335577776655555677889999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
+|..+++|...++. .+..+.+-+...+..+..+++|||.. .+.|||++|.|++...++..++.|||.......
T Consensus 884 ~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred HHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999999983 34566666677777888999999998 799999999999999999999999984321110
Q ss_pred C---C-------------------------c--cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCC
Q 005001 568 T---E-------------------------R--QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (720)
Q Consensus 568 ~---~-------------------------~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~ 617 (720)
. . + .......||+.|.+||...+......+|+|++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0 0 01123469999999999999999999999999999999999999998
Q ss_pred CCCCcchhhHHHhhccccccHHHHHhhcccccCC-CCChhHHHHHHHHHHHhcCCCCCCCCCHH
Q 005001 618 SSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG-MYPAKSLSRFADIIALCVQPEPEFRPPMS 680 (720)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 680 (720)
...+.... ..+......+ .-+........+++...+..+|.+|-.+.
T Consensus 1037 a~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 76553221 1111111111 12334556677899999999999997766
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.5e-12 Score=133.42 Aligned_cols=153 Identities=26% Similarity=0.367 Sum_probs=130.6
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC-CccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 85 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
+..+.|..|.+. .+|..+++|..|++|||+.|+++ .+|..+. --|+.|-+++|+++ .+|..++.+..|..||.+.|
T Consensus 100 Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~n 176 (722)
T KOG0532|consen 100 LESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKN 176 (722)
T ss_pred HHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEecCccc-cCCcccccchhHHHhhhhhh
Confidence 555677778776 78899999999999999999998 7787776 57999999999999 88999999999999999999
Q ss_pred ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCC-CcCeEEccCccCcccCccc
Q 005001 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL-PLTTLNVANNHFSGWIPRE 242 (720)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~l~l~~N~l~g~ip~~ 242 (720)
.+. .+|..++.+.+|+.|.+..|++. .+|..++.| .|..||+++|+|+-.+-.|..+ .|++|-|.+|.|. ..|..
T Consensus 177 ei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq-SPPAq 252 (722)
T KOG0532|consen 177 EIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ-SPPAQ 252 (722)
T ss_pred hhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCC-CChHH
Confidence 998 67888999999999999999999 788888866 6899999999999765555554 4999999999998 45665
Q ss_pred cc
Q 005001 243 LI 244 (720)
Q Consensus 243 l~ 244 (720)
++
T Consensus 253 IC 254 (722)
T KOG0532|consen 253 IC 254 (722)
T ss_pred HH
Confidence 54
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.4e-10 Score=124.70 Aligned_cols=170 Identities=31% Similarity=0.472 Sum_probs=84.1
Q ss_pred EEEEEcCCCCCcccccccccCCC-CCCEEEccCCCCCCCC--CCCCCCccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 85 VVSIDISGLGLSGTMGYLLSDLL-SLRKFDLSGNSIHDTI--PYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 85 v~~l~l~~~~l~g~~~~~l~~l~-~L~~L~L~~N~l~~~~--p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
++.|++.+|+++ .+++....++ +|+.|++++|.+. .+ |....++|+.|++++|+++ .+|...+.+++|+.|+++
T Consensus 118 l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls 194 (394)
T COG4886 118 LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS 194 (394)
T ss_pred eeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheecc
Confidence 444555555544 2333444442 5555555555554 22 2333355555555555555 444444455555555555
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCC-CCcCeEEccCccCcccCc
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWIP 240 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~l~l~~N~l~g~ip 240 (720)
+|+++ .+|...+.+..|+.|.+++|++. .++..+.+++++..|.+++|++...+..... .+++.|++++|+++ .++
T Consensus 195 ~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~-~i~ 271 (394)
T COG4886 195 GNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SIS 271 (394)
T ss_pred CCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccc-ccc
Confidence 55554 33333333444555555555333 3444455555555555555555443222222 23777777777776 333
Q ss_pred c--cccccceeeecCCcCCCCC
Q 005001 241 R--ELISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 241 ~--~l~~l~~l~l~~n~~~~~~ 260 (720)
. .+.+++.+++++|.+...+
T Consensus 272 ~~~~~~~l~~L~~s~n~~~~~~ 293 (394)
T COG4886 272 SLGSLTNLRELDLSGNSLSNAL 293 (394)
T ss_pred cccccCccCEEeccCccccccc
Confidence 2 3455666777777665443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.4e-11 Score=116.52 Aligned_cols=127 Identities=24% Similarity=0.282 Sum_probs=92.0
Q ss_pred CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEe
Q 005001 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYL 208 (720)
Q Consensus 129 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 208 (720)
+.|++||||+|.|+ .|.++..-+|+++.|++|+|.|.... .+..|++|+.||||+|.|+ .+-.+-..+-|+++|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 57888889988888 78888888888999999999887432 3778888899999999888 55555567788888899
Q ss_pred ccccccccccccCCCCcCeEEccCccCcccC-ccc---ccccceeeecCCcCCCC
Q 005001 209 QNNQVTGSLNVFSGLPLTTLNVANNHFSGWI-PRE---LISIRTFIYDGNSFDNG 259 (720)
Q Consensus 209 ~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~i-p~~---l~~l~~l~l~~n~~~~~ 259 (720)
++|.|...-..-..-+|..||+++|+|...- -.. ++.|..+.+.+||+...
T Consensus 360 a~N~iE~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 360 AQNKIETLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhHhhhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 9888764322222235888899999885311 122 33455677888887654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.1e-10 Score=106.62 Aligned_cols=82 Identities=32% Similarity=0.408 Sum_probs=19.9
Q ss_pred cCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccc-cCCCCCCeeEecccccccc--c-cccCCCCcCe
Q 005001 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF-ISLSNISSLYLQNNQVTGS--L-NVFSGLPLTT 227 (720)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~L~l~~N~l~~~--~-~~~~~~~L~~ 227 (720)
+.+|+.|+|++|.|+... .+..++.|+.|+|++|+|+ .+...+ ..+++|++|+|++|+|... + +.....+|+.
T Consensus 41 l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 41 LDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV 117 (175)
T ss_dssp -TT--EEE-TTS--S--T--T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred hcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence 344444444444444221 2334444444444444444 232222 2344444444444444431 1 1112223555
Q ss_pred EEccCccCc
Q 005001 228 LNVANNHFS 236 (720)
Q Consensus 228 l~l~~N~l~ 236 (720)
|+|.+|.++
T Consensus 118 L~L~~NPv~ 126 (175)
T PF14580_consen 118 LSLEGNPVC 126 (175)
T ss_dssp EE-TT-GGG
T ss_pred eeccCCccc
Confidence 555555554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3e-10 Score=123.96 Aligned_cols=155 Identities=32% Similarity=0.428 Sum_probs=134.3
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCC--CCCccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ--LPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~--~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
+++.|++++|.+. .+|..+++++.|+.|++++|+++ .+|.. ..++|+.|++++|+++ .+|..++.+..|++|.++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 6889999999997 45578999999999999999999 56655 4589999999999999 888888888889999999
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCcc
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR 241 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~ 241 (720)
+|.+. .++..+.++.++..|.+.+|++. .++..++.+++|++|++++|+++.........+++.|++++|.++..+|.
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccccccccccccccCccCEEeccCccccccchh
Confidence 99744 46678889999999999999998 56888999999999999999999876644446799999999999977775
Q ss_pred cc
Q 005001 242 EL 243 (720)
Q Consensus 242 ~l 243 (720)
..
T Consensus 296 ~~ 297 (394)
T COG4886 296 IA 297 (394)
T ss_pred hh
Confidence 44
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.8e-08 Score=101.01 Aligned_cols=262 Identities=16% Similarity=0.187 Sum_probs=159.9
Q ss_pred cceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceE------E-eecCeEEEE
Q 005001 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGY------C-AEHGQRLLV 486 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~-~~~~~~~lV 486 (720)
.+.||+|+.+.+|..-.- +. .+.|++..... ....+...| |... .||-+-.=+.+ . ......-+.
T Consensus 16 gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Ppp--a~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPP--AAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CccccCCccceeeecchh-hc-hhheeecCCCc--hHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 456999999999975321 12 23466654332 122222222 3333 56644331111 1 122236788
Q ss_pred EEecCCC-CHHHHhhh--ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 487 YEYVGNG-NLHDMLHF--ADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 487 ~e~~~~g-sL~~~l~~--~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
|+.+++. ...++++- .+..-....|.-++++++.++.+.+.||.. |.+-+|+.++|+|+++++.+.+.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 8887763 22232221 112234578999999999999999999999 99999999999999999999999866544
Q ss_pred cCCCCCccccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhC-CCCCCCCCC-----cchh-hHHHhh
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTG-RKPLDSSRP-----RSEQ-SLVRWA 631 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg-~~pf~~~~~-----~~~~-~~~~~~ 631 (720)
...+ +......+|...|.+||.-. +..-+...|.|.|||++++++.| ++||.+-.. ...+ .+..
T Consensus 166 i~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~-- 241 (637)
T COG4248 166 INAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH-- 241 (637)
T ss_pred eccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc--
Confidence 3322 22223357899999999765 34456789999999999999986 899975321 1111 1111
Q ss_pred ccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCC--CCCCCCHHHHHHHHHHHHH
Q 005001 632 TPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPE--PEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~ell~~L~~~~~ 691 (720)
..+........-..+......-.-.+..+..+..+|+... +.-||+++..+..|-++.+
T Consensus 242 -g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 242 -GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred -ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 0011111111111111111111234567888999998653 5689999999888866544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=8.2e-10 Score=103.81 Aligned_cols=113 Identities=26% Similarity=0.323 Sum_probs=40.5
Q ss_pred cccCCCCCCEEEccCCCCCCCCCCC-CCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCC
Q 005001 102 LLSDLLSLRKFDLSGNSIHDTIPYQ-LPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA 180 (720)
Q Consensus 102 ~l~~l~~L~~L~L~~N~l~~~~p~~-~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 180 (720)
.+.+...+++|+|++|.|+..-... ...+|+.|+|++|.|+ .++ .+..+++|+.|+|++|+|+...+.....+++|+
T Consensus 14 ~~~n~~~~~~L~L~~n~I~~Ie~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQISTIENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQ 91 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--
T ss_pred ccccccccccccccccccccccchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCC
Confidence 3455667899999999988432222 1268899999999998 343 577889999999999999854332224688999
Q ss_pred eeecCCCcccCCC-CccccCCCCCCeeEecccccccc
Q 005001 181 TLDLSFNNFSGDL-PNSFISLSNISSLYLQNNQVTGS 216 (720)
Q Consensus 181 ~L~l~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~~ 216 (720)
.|+|++|+|...- -..++.+++|+.|+|.+|.++..
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~ 128 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK 128 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch
Confidence 9999999987421 24567888999999999998753
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2e-10 Score=112.04 Aligned_cols=102 Identities=29% Similarity=0.406 Sum_probs=42.7
Q ss_pred CCCCEEEccCCCCCCCCCCCC--CCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeec
Q 005001 107 LSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDL 184 (720)
Q Consensus 107 ~~L~~L~L~~N~l~~~~p~~~--~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 184 (720)
+.|+.||||+|.|+ .+..+. .+.++.|+||+|.|. .+- ++..|++|+.||||+|.|+. +..+=..|-+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHh-hhhhHhhhcCEeeeeh
Confidence 33444444444444 222221 244444455544444 221 24444444445554444442 2222233444444444
Q ss_pred CCCcccCCCCccccCCCCCCeeEecccccc
Q 005001 185 SFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (720)
Q Consensus 185 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (720)
+.|.|.. + ..+..+-+|..||+++|+|.
T Consensus 360 a~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 360 AQNKIET-L-SGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhhhHhh-h-hhhHhhhhheeccccccchh
Confidence 4444431 1 12334444444444444443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.8e-10 Score=116.72 Aligned_cols=173 Identities=23% Similarity=0.240 Sum_probs=117.8
Q ss_pred CCEEEEEcCCCCCcc--cccccccCCCCCCEEEccCCCCCCCCC---CCCCCccceeccccccCcC-CCCccccccCCcc
Q 005001 83 SAVVSIDISGLGLSG--TMGYLLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSG-NLPYSIASMVSLS 156 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g--~~~~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~~L~~L~L~~N~l~g-~~p~~~~~l~~L~ 156 (720)
.+|+.|||+.|=+.. ++-.....|++|+.|+|+.|++.-... ....++|+.|.|+.+.|+- .+-..+..+|+|+
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 478888888886654 223445678888889999988763322 2223788888888888882 2333455678999
Q ss_pred EEEccccccccccccccCCCCCCCeeecCCCcccCCCC--ccccCCCCCCeeEecccccccc--cccc------CCCCcC
Q 005001 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTGS--LNVF------SGLPLT 226 (720)
Q Consensus 157 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~--~~~~------~~~~L~ 226 (720)
.|+|..|..-+.-......+..|+.|||++|++-. .+ ...+.++.|..|+++.+.|+.. ++.. ...+|+
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~ 304 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLE 304 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccce
Confidence 99999886333333344557789999999999873 44 3467888888888888888762 2221 113489
Q ss_pred eEEccCccCcccCc-----ccccccceeeecCCcCC
Q 005001 227 TLNVANNHFSGWIP-----RELISIRTFIYDGNSFD 257 (720)
Q Consensus 227 ~l~l~~N~l~g~ip-----~~l~~l~~l~l~~n~~~ 257 (720)
+|+++.|++.. .+ ..+.+++.|.+..|+++
T Consensus 305 ~L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 305 YLNISENNIRD-WRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred eeecccCcccc-ccccchhhccchhhhhhccccccc
Confidence 99999999863 22 13456666677677665
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.1e-08 Score=99.72 Aligned_cols=142 Identities=15% Similarity=0.104 Sum_probs=100.2
Q ss_pred eeccCCCcEEEEEEEcCCcEEEEEEccccccCh---------HHHHHHHHHHHHhhcCCCCCc--cccceEEee-----c
Q 005001 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL---------QEEDNFLEAVSNMSRLRHPNI--VTLAGYCAE-----H 480 (720)
Q Consensus 417 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~-----~ 480 (720)
.+-.-....|++.+. +|+.|.||......... .....+.+|...+.++...+| +.++++.+. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 444444455777765 57889999774332110 001136788888777744333 445556543 2
Q ss_pred CeEEEEEEecCCC-CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-------CC
Q 005001 481 GQRLLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-------EL 552 (720)
Q Consensus 481 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-------~~ 552 (720)
...++|+|++++. +|.+++.... ....+...+..++.+++..+..||.. ||+|+|+++.|||++. ++
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 3578999999886 8999885221 24456677888999999999999999 9999999999999975 46
Q ss_pred ceEEcccCCCcc
Q 005001 553 NPHLSDCGLAAL 564 (720)
Q Consensus 553 ~~kl~Dfg~a~~ 564 (720)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.2e-08 Score=97.56 Aligned_cols=127 Identities=23% Similarity=0.283 Sum_probs=82.7
Q ss_pred EEEEEEEcCCcEEEEEEcccccc------------------------ChHHHHHHHHHHHHhhcCCCC--CccccceEEe
Q 005001 425 RVYRAEFANGKIMAVKKIDNAAL------------------------SLQEEDNFLEAVSNMSRLRHP--NIVTLAGYCA 478 (720)
Q Consensus 425 ~Vy~~~~~~~~~vavK~~~~~~~------------------------~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 478 (720)
.||.|...+|..+|+|..+.... .........+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999999999999998743210 011123456799999999765 456665442
Q ss_pred ecCeEEEEEEecC--CCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCcEEecCCCCCEEeCCCCceE
Q 005001 479 EHGQRLLVYEYVG--NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY-LHEVCLPSVVHRNFKSANILLDDELNPH 555 (720)
Q Consensus 479 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~-LH~~~~~~iiH~Dlkp~NIll~~~~~~k 555 (720)
..++||||++ |..+..+.. ..++......++.+++..+.. +|.. ||+|+|+.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~------~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD------VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH------CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHh------ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3579999998 655554433 111133456677788885555 4677 99999999999999988 999
Q ss_pred EcccCCCccC
Q 005001 556 LSDCGLAALT 565 (720)
Q Consensus 556 l~Dfg~a~~~ 565 (720)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.1e-09 Score=83.00 Aligned_cols=60 Identities=43% Similarity=0.577 Sum_probs=32.3
Q ss_pred CccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccc
Q 005001 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQV 213 (720)
Q Consensus 154 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 213 (720)
+|++|+|++|+|+...+..|..+++|++|+|++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544444555555555555555555544444555555555555555543
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.3e-09 Score=82.75 Aligned_cols=61 Identities=43% Similarity=0.573 Sum_probs=54.4
Q ss_pred CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcc
Q 005001 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (720)
Q Consensus 129 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 189 (720)
++|++|+|++|+|+...+..|.++++|++|+|++|.++...|..|..+++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4688889999988866567889999999999999999988888999999999999999986
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.5e-07 Score=96.62 Aligned_cols=170 Identities=19% Similarity=0.262 Sum_probs=124.8
Q ss_pred CCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee----cCeEEEEEEecCC-CCH
Q 005001 422 SLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRLLVYEYVGN-GNL 495 (720)
Q Consensus 422 ~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~-gsL 495 (720)
--.+.|++.. .+|..|++|+++.... ........-+++++++.|+|||++.++|.. +..+++||+|+++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3457799954 4899999999943221 111122345778899999999999988763 4578999999875 567
Q ss_pred HHHhhhc-----------cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 496 HDMLHFA-----------DDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 496 ~~~l~~~-----------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
.++.=.. -..+...++...+.++.|+..||.++|+. |..-+-|.+.+|+++.+.+++|...|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 6643110 01233567899999999999999999999 999999999999999999999998888765
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCC
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRK 614 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 614 (720)
...+.. |-+.+ -.+-|.=.||.++..|.||..
T Consensus 443 l~~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 443 LQEDPT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecCCCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 543220 11222 135688899999999999865
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=6.5e-10 Score=120.25 Aligned_cols=127 Identities=25% Similarity=0.328 Sum_probs=95.0
Q ss_pred CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCcc-ccCCCCCCeeE
Q 005001 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLY 207 (720)
Q Consensus 129 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~ 207 (720)
..|.+.+.+.|.+. ....++.-++.|+.|||++|+++... .+..++.|++|||+.|.|. .+|.- ...+ .|+.|.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeee
Confidence 46777888888888 66777888888888888888888654 6777888888888888888 56542 2244 388888
Q ss_pred eccccccccccccCCCCcCeEEccCccCccc---Cc-ccccccceeeecCCcCCCCC
Q 005001 208 LQNNQVTGSLNVFSGLPLTTLNVANNHFSGW---IP-RELISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 208 l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~---ip-~~l~~l~~l~l~~n~~~~~~ 260 (720)
|+||-++.........+|..|||++|-|.+- .| -.+..|..|.|.|||++|.|
T Consensus 239 lrnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 239 LRNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ecccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 8888888765555666788888888888653 22 24567788888888888865
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=5.2e-09 Score=114.15 Aligned_cols=150 Identities=19% Similarity=0.273 Sum_probs=108.2
Q ss_pred HHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccccc--------cccccccccCcccccc
Q 005001 519 LGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST--------QMVGAFGYSAPEFALS 590 (720)
Q Consensus 519 ~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~ 590 (720)
.+++.|+.|+|... ++||+.|.|++|.++.++..||+.|+.+............ -..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999874 9999999999999999999999999987554432221111 1123457999999999
Q ss_pred CCCcccchhhhHHHHHHHHHhCCCC-CCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhc
Q 005001 591 GIYTVKSDVYSFGVVMLELLTGRKP-LDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCV 669 (720)
Q Consensus 591 ~~~~~~~DvwSlGv~l~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 669 (720)
...+.++|+||+||++|.+..|..+ +........ .......+......++...+.++.+=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--------------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--------------YSFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcch--------------hhhhhcccccccccccccCcHHHHHHHHHHh
Confidence 8899999999999999999954444 443322111 1122222223333445677889999999999
Q ss_pred CCCCCCCCCHHHHHH
Q 005001 670 QPEPEFRPPMSEVVQ 684 (720)
Q Consensus 670 ~~dP~~RPs~~ell~ 684 (720)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998777654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.5e-07 Score=90.88 Aligned_cols=137 Identities=18% Similarity=0.138 Sum_probs=99.7
Q ss_pred CCccceeccCCCcEEEEEEEcCCcEEEEEEccccc------------------cC--hHHHHHHHHHHHHhhcCCCC--C
Q 005001 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAA------------------LS--LQEEDNFLEAVSNMSRLRHP--N 469 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------------------~~--~~~~~~~~~e~~~l~~l~h~--n 469 (720)
..+...||-|--+.||.|....|.++|+|.=+... .+ .-......+|++.|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34557899999999999999999999998532110 01 11123456889999888554 6
Q ss_pred ccccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC
Q 005001 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (720)
Q Consensus 470 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~ 549 (720)
|.+.+++ +...+|||+++|-.|... +++......++..|+.-+.-+-.. ||||+|+++-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 7776654 467899999998655432 113444555666666666666666 999999999999999
Q ss_pred CCCceEEcccCCCcc
Q 005001 550 DELNPHLSDCGLAAL 564 (720)
Q Consensus 550 ~~~~~kl~Dfg~a~~ 564 (720)
++|.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999987653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.5e-09 Score=106.01 Aligned_cols=137 Identities=26% Similarity=0.347 Sum_probs=89.4
Q ss_pred CCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCC-CcccCCCCccccCC
Q 005001 122 TIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF-NNFSGDLPNSFISL 200 (720)
Q Consensus 122 ~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l 200 (720)
.+|..++++-..|+|..|+|+...|.+|+.+++|+.|||++|+|+-+-|.+|.++.+|..|-+.+ |+|+..-...|++|
T Consensus 60 eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL 139 (498)
T KOG4237|consen 60 EVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGL 139 (498)
T ss_pred cCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhH
Confidence 56666666777777777777755556777777777777777777777777777777776665544 77774333456777
Q ss_pred CCCCeeEecccccccccc-ccCC-CCcCeEEccCccCcccCcc----cccccceeeecCCcCCCC
Q 005001 201 SNISSLYLQNNQVTGSLN-VFSG-LPLTTLNVANNHFSGWIPR----ELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 201 ~~L~~L~l~~N~l~~~~~-~~~~-~~L~~l~l~~N~l~g~ip~----~l~~l~~l~l~~n~~~~~ 259 (720)
..|+.|.+.-|++.-... .+.. .+|..|.|-+|.+. .|+. .+.+++.+.+..|+|-|.
T Consensus 140 ~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icd 203 (498)
T KOG4237|consen 140 SSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICD 203 (498)
T ss_pred HHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccc
Confidence 777777777777765442 2222 23666677777765 3443 345566777777876554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.1e-08 Score=112.12 Aligned_cols=170 Identities=24% Similarity=0.240 Sum_probs=98.7
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
.+..|++.+|+|.+... .+..+.+|++|+|++|.|+...+..-...|+.|++++|.|+. + ..+..+++|+.++|++|
T Consensus 96 ~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~N~i~~-~-~~~~~l~~L~~l~l~~n 172 (414)
T KOG0531|consen 96 SLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSGNLISD-I-SGLESLKSLKLLDLSYN 172 (414)
T ss_pred ceeeeeccccchhhccc-chhhhhcchheeccccccccccchhhccchhhheeccCcchh-c-cCCccchhhhcccCCcc
Confidence 56666777776664322 255666677777777777665555555567777777777662 2 23444666777777777
Q ss_pred ccccccc-cccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCC--cCeEEccCccCcc--c
Q 005001 164 SLTQSIG-DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP--LTTLNVANNHFSG--W 238 (720)
Q Consensus 164 ~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~--L~~l~l~~N~l~g--~ 238 (720)
++...-+ . ...+.+|+.|++++|.+. ....+..+..+..+++..|.++-.-+...... |+.+++++|.+.- .
T Consensus 173 ~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~~~~ 249 (414)
T KOG0531|consen 173 RIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRISRSPE 249 (414)
T ss_pred hhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccccccc
Confidence 7664433 2 455666666677776665 12233444455555666666654333222222 6777777777762 1
Q ss_pred CcccccccceeeecCCcCCCC
Q 005001 239 IPRELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 239 ip~~l~~l~~l~l~~n~~~~~ 259 (720)
....+..+..+++.+|.+...
T Consensus 250 ~~~~~~~l~~l~~~~n~~~~~ 270 (414)
T KOG0531|consen 250 GLENLKNLPVLDLSSNRISNL 270 (414)
T ss_pred cccccccccccchhhcccccc
Confidence 234455666666666665543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.3e-07 Score=90.07 Aligned_cols=108 Identities=22% Similarity=0.297 Sum_probs=83.4
Q ss_pred HHHHHHHHHHhhcCCCC--CccccceEEeecC----eEEEEEEecCCC-CHHHHhhhccCCCCCCCHHHHHHHHHHHHHH
Q 005001 452 EDNFLEAVSNMSRLRHP--NIVTLAGYCAEHG----QRLLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARA 524 (720)
Q Consensus 452 ~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~ 524 (720)
.....+|...+..+... .+.+.+++..... ..++|+|++++. +|.+++... ...+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHH
Confidence 44567777777666433 3556666665532 458999999874 799988632 226667788899999999
Q ss_pred HHHHHhcCCCCcEEecCCCCCEEeCCCC---ceEEcccCCCccCC
Q 005001 525 LEYLHEVCLPSVVHRNFKSANILLDDEL---NPHLSDCGLAALTP 566 (720)
Q Consensus 525 L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~ 566 (720)
++-||.. ||+|+|+++.|||++.++ .+.++||+-++...
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999 999999999999999887 89999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.9e-08 Score=103.46 Aligned_cols=174 Identities=21% Similarity=0.192 Sum_probs=123.8
Q ss_pred CEEEEEcCCCCCccccc-ccccCCCCCCEEEccCCCCCCCCC----CCCCCccceeccccccCcCCCCccc-cccCCccE
Q 005001 84 AVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~-~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~ 157 (720)
.+..+.|.+....-... .....|++++.||||.|-|....| .+..++|+.|+|+.|++.-...... ..++.|+.
T Consensus 122 kL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~ 201 (505)
T KOG3207|consen 122 KLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ 201 (505)
T ss_pred hhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence 45556666665542211 467789999999999999885444 2234899999999999984444333 35789999
Q ss_pred EEcccccccc-ccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccc--cccCC-CCcCeEEccCc
Q 005001 158 LNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSG-LPLTTLNVANN 233 (720)
Q Consensus 158 L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~-~~L~~l~l~~N 233 (720)
|.|+.+.|+- .+-..+..+++|+.|+|..|...+.--.....+..|++|+|++|++.... +.... ..|+.|+++.+
T Consensus 202 L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~t 281 (505)
T KOG3207|consen 202 LVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSST 281 (505)
T ss_pred EEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhcccc
Confidence 9999999983 23445567899999999999633333344556788999999999987644 22222 34888888888
Q ss_pred cCcc-cCcc--------cccccceeeecCCcCC
Q 005001 234 HFSG-WIPR--------ELISIRTFIYDGNSFD 257 (720)
Q Consensus 234 ~l~g-~ip~--------~l~~l~~l~l~~n~~~ 257 (720)
.+.. .+|+ .|.+++.|.++.|++.
T Consensus 282 gi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 282 GIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred CcchhcCCCccchhhhcccccceeeecccCccc
Confidence 8854 2443 4678899999999873
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.5e-06 Score=83.57 Aligned_cols=143 Identities=17% Similarity=0.132 Sum_probs=104.9
Q ss_pred cceeccCCCcEEEEEEEcCCcEEEEEEcccccc-C---hHHHHHHHHHHHHhhcCCCC--CccccceEEe-e----cCeE
Q 005001 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL-S---LQEEDNFLEAVSNMSRLRHP--NIVTLAGYCA-E----HGQR 483 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~---~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~-~----~~~~ 483 (720)
.---|+||.+-|++.... |+.+-+|+-..... + +.....|.+|+..+.++... .+.++. ++. . .-..
T Consensus 23 ~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA 100 (216)
T PRK09902 23 EPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRA 100 (216)
T ss_pred CCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEE
Confidence 334678999999998775 44688888752221 1 33467899999988887432 255555 332 1 1245
Q ss_pred EEEEEecCC-CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc--eEEcccC
Q 005001 484 LLVYEYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN--PHLSDCG 560 (720)
Q Consensus 484 ~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg 560 (720)
+||+|-+++ -+|.+++... ...+.+...+..++.+++..++-||.. ++.|+|+.+.||+++.++. ++++||.
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 899997753 5888887521 234567778889999999999999999 9999999999999986667 9999998
Q ss_pred CCcc
Q 005001 561 LAAL 564 (720)
Q Consensus 561 ~a~~ 564 (720)
-++.
T Consensus 176 k~r~ 179 (216)
T PRK09902 176 KSRR 179 (216)
T ss_pred ccch
Confidence 7654
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.7e-07 Score=66.31 Aligned_cols=39 Identities=49% Similarity=1.026 Sum_probs=28.9
Q ss_pred hHHHHHHHHHHHhcCC-C-CCCCCCCCCC-CCCCCCCCceeEec
Q 005001 41 SSDVQALQVLYTSLNS-P-SVLTNWKGNE-GDPCGESWKGVACE 81 (720)
Q Consensus 41 ~~d~~al~~~~~~~~~-~-~~l~~w~~~~-~~~c~~~w~gv~c~ 81 (720)
..|++||++||+++.+ + ..+.+|+.+. .+|| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C--~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC--SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC--CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe--eeccEEeC
Confidence 5799999999999985 4 5899998764 6777 79999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.8e-08 Score=108.76 Aligned_cols=170 Identities=24% Similarity=0.270 Sum_probs=121.9
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCC-CCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+..+++..|.+.- +-..+..+++|..|+|.+|+|.+... ....++|++|+|++|.|+... .+..++.|+.|++++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSG 149 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheecccccccccc--chhhccchhhheecc
Confidence 34455566666653 34457888899999999999986665 455689999999999998543 466777799999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCcc-ccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCcc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR 241 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~ 241 (720)
|.|+.. ..+..+++|+.|++++|++.. +... ...+.+|..+++.+|.+.-.-.......+..+++..|.++-.-+.
T Consensus 150 N~i~~~--~~~~~l~~L~~l~l~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~~~~~l 226 (414)
T KOG0531|consen 150 NLISDI--SGLESLKSLKLLDLSYNRIVD-IENDELSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKISKLEGL 226 (414)
T ss_pred Ccchhc--cCCccchhhhcccCCcchhhh-hhhhhhhhccchHHHhccCCchhcccchHHHHHHHHhhcccccceeccCc
Confidence 998843 345568889999999999884 4332 577788899999999887654444444455568888888643332
Q ss_pred -cccc--cceeeecCCcCCCC
Q 005001 242 -ELIS--IRTFIYDGNSFDNG 259 (720)
Q Consensus 242 -~l~~--l~~l~l~~n~~~~~ 259 (720)
.... ++.+.+.+|++...
T Consensus 227 ~~~~~~~L~~l~l~~n~i~~~ 247 (414)
T KOG0531|consen 227 NELVMLHLRELYLSGNRISRS 247 (414)
T ss_pred ccchhHHHHHHhcccCccccc
Confidence 2222 78888888888755
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.6e-08 Score=87.95 Aligned_cols=125 Identities=28% Similarity=0.345 Sum_probs=79.8
Q ss_pred EEEEcCCCCCcccccc---cccCCCCCCEEEccCCCCCCCCCCCCC---CccceeccccccCcCCCCccccccCCccEEE
Q 005001 86 VSIDISGLGLSGTMGY---LLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (720)
Q Consensus 86 ~~l~l~~~~l~g~~~~---~l~~l~~L~~L~L~~N~l~~~~p~~~~---~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 159 (720)
-.++|+++.|- .++. .+.....|+..+|++|.|. ..|..+. +.++.|+|++|.|+ .+|..+..++.|+.|+
T Consensus 30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 34566666653 3333 3445566667788888887 5555443 46788888888888 6777788888888888
Q ss_pred ccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccc
Q 005001 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (720)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (720)
++.|.|. ..|..+..|.+|..|+..+|.+. .+|..+..-+++-...+.+|.+.+
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~ 160 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGD 160 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccc
Confidence 8888777 45566666777777777777776 566554333333333444444443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=9.5e-09 Score=111.46 Aligned_cols=122 Identities=25% Similarity=0.278 Sum_probs=94.7
Q ss_pred CCCEEEccCCCCCCCCCCC--CCCccceeccccccCcCCCCccccccCCccEEEcccccccccccc-ccCCCCCCCeeec
Q 005001 108 SLRKFDLSGNSIHDTIPYQ--LPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGD-IFGNLAGLATLDL 184 (720)
Q Consensus 108 ~L~~L~L~~N~l~~~~p~~--~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l 184 (720)
.|.+.+.+.|.+. ....+ +.+.|+.|||++|+++..- .+..|++|++|||++|.|+- +|. ....+ .|+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRH-VPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhcc-ccccchhhh-hheeeee
Confidence 3666777788776 33323 3489999999999999543 88999999999999999984 343 22233 4999999
Q ss_pred CCCcccCCCCccccCCCCCCeeEeccccccccc---cccCCCCcCeEEccCccCc
Q 005001 185 SFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL---NVFSGLPLTTLNVANNHFS 236 (720)
Q Consensus 185 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~---~~~~~~~L~~l~l~~N~l~ 236 (720)
.+|.++. + ..+.+|.+|..|||++|-|.+.- |.+....|..|+|.+|.+.
T Consensus 240 rnN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 9999983 3 24788999999999999998843 5556667999999999996
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.5e-08 Score=98.26 Aligned_cols=174 Identities=18% Similarity=0.238 Sum_probs=126.9
Q ss_pred CEEEEEcCCCCCcccccc----cccCCCCCCEEEccCCCCC---CCC-CC---------CC--CCccceeccccccCcCC
Q 005001 84 AVVSIDISGLGLSGTMGY----LLSDLLSLRKFDLSGNSIH---DTI-PY---------QL--PPNLTSLNLASNNFSGN 144 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~----~l~~l~~L~~L~L~~N~l~---~~~-p~---------~~--~~~L~~L~L~~N~l~g~ 144 (720)
+++.||||+|-+.-.-+. .|..++.|++|.|.+|.+. |.. -. -. .+.|+++..++|++...
T Consensus 93 ~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 93 KLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENG 172 (382)
T ss_pred ceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccc
Confidence 789999999988654443 4667899999999999886 111 11 11 26899999999998743
Q ss_pred C----CccccccCCccEEEccccccccc----cccccCCCCCCCeeecCCCcccC----CCCccccCCCCCCeeEecccc
Q 005001 145 L----PYSIASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSG----DLPNSFISLSNISSLYLQNNQ 212 (720)
Q Consensus 145 ~----p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~ 212 (720)
- ...|...+.|+.+.+..|.+.-. +...|..++.|++|||.+|-|+- .+-..+..+++|+.|+++++.
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcl 252 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCL 252 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccc
Confidence 2 34566778999999999988732 34567889999999999999873 233556778899999999999
Q ss_pred cccc--c---cccC--CCCcCeEEccCccCccc----Cc---ccccccceeeecCCcCC
Q 005001 213 VTGS--L---NVFS--GLPLTTLNVANNHFSGW----IP---RELISIRTFIYDGNSFD 257 (720)
Q Consensus 213 l~~~--~---~~~~--~~~L~~l~l~~N~l~g~----ip---~~l~~l~~l~l~~n~~~ 257 (720)
+... . ..+. ..+|+.|.|.+|.++-. +- ...+.|..|.+++|.+.
T Consensus 253 l~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 253 LENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 8752 2 2222 23599999999999632 11 13456788999999885
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.2e-06 Score=96.45 Aligned_cols=143 Identities=23% Similarity=0.275 Sum_probs=92.9
Q ss_pred ceeccCCCcEEEEEEEcCCcEEEEEEccccccC---------------------------hH-----------HHHHHHH
Q 005001 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS---------------------------LQ-----------EEDNFLE 457 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~-----------~~~~~~~ 457 (720)
+.|+.++-|.||+|++++|+.||||+.+..... .. .+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 579999999999999999999999997432110 00 0112334
Q ss_pred HHHHhhcC-----CCCCccccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHH-HHHHHhc
Q 005001 458 AVSNMSRL-----RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA-LEYLHEV 531 (720)
Q Consensus 458 e~~~l~~l-----~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~-L~~LH~~ 531 (720)
|...+.++ +.++|.-..=|++-.....++|||++|-.+.+...-. ....+... ++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHH---HHHHHHHHHHHHHHhc
Confidence 44444433 2344332222333456679999999998888874311 23344222 23332222 2333334
Q ss_pred CCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 532 ~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|+.|.|..|.||+++.+|++.+.|||+......
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.7e-05 Score=76.74 Aligned_cols=140 Identities=14% Similarity=0.181 Sum_probs=91.4
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHH-H------HHHHHHHHhhcC---CCCCccccceEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEE-D------NFLEAVSNMSRL---RHPNIVTLAGYC 477 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~-~------~~~~e~~~l~~l---~h~niv~l~~~~ 477 (720)
..++|...+++-......|.+.+. +|+.+++|.........+.. . ...+++..+.++ .......++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456788888888877777777666 47889999887654221111 1 122333333333 333333333333
Q ss_pred ee-----cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC
Q 005001 478 AE-----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (720)
Q Consensus 478 ~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 552 (720)
.. ....++||||++|..|.+... ++. .++..+.+++..+|+. |+.|+|..|.|++++.+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-
Confidence 22 234578999999987766432 222 2445677889999999 99999999999999865
Q ss_pred ceEEcccCCCcc
Q 005001 553 NPHLSDCGLAAL 564 (720)
Q Consensus 553 ~~kl~Dfg~a~~ 564 (720)
.++++||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 599999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-05 Score=80.35 Aligned_cols=140 Identities=14% Similarity=0.183 Sum_probs=83.3
Q ss_pred ceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCC--ccccceEEeecCeEEEEEEecCCC
Q 005001 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 46899999999984 25567788876422 2344678888888875433 466777777777788999999986
Q ss_pred C-HHHHhh--------------h-----ccCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCCCcEEec
Q 005001 494 N-LHDMLH--------------F-----ADDSSKNLTWNARVR-VAL----------GTAR-ALEYLHEV-CLPSVVHRN 540 (720)
Q Consensus 494 s-L~~~l~--------------~-----~~~~~~~~~~~~~~~-i~~----------qi~~-~L~~LH~~-~~~~iiH~D 540 (720)
+ +...+. . ..-............ +.. .+.. ...+|... ..+.++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 211110 0 000000111111000 000 0001 12222211 123678999
Q ss_pred CCCCCEEeCCCCceEEcccCCCc
Q 005001 541 FKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 541 lkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.1e-06 Score=82.46 Aligned_cols=155 Identities=19% Similarity=0.222 Sum_probs=99.1
Q ss_pred chhcHHHHhcCCCccc---eeccCCCcEEEEEEEcCCcEEEEEEccccccChHHH-----------------HH-----H
Q 005001 401 TVASLQTATNSFSQEF---LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEE-----------------DN-----F 455 (720)
Q Consensus 401 ~~~~~~~~~~~y~~~~---~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~-----------------~~-----~ 455 (720)
+...+....++..+.. .|+.|--+.||+|...++..+|+|+++.....-... .+ .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3444444444544444 466788889999998889999999986433211110 00 1
Q ss_pred HHHHHHhhcCC--CCCccccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005001 456 LEAVSNMSRLR--HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533 (720)
Q Consensus 456 ~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~ 533 (720)
.+|+..|.++. +-.+.+.+++. ...|||||+..... ..-.-..-.+...++..+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 34555565552 34444555443 24799999965311 000000112233367778888888888888743
Q ss_pred CCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 534 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
++||+||+.-|||+. ++.+.|+|||-|....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999999 7899999999886443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 720 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 9e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-06 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-06 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-06 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-06 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 374 bits (963), Expect = e-125
Identities = 106/293 (36%), Positives = 165/293 (56%), Gaps = 6/293 (2%)
Query: 397 ATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ-EEDNF 455
+++ LQ A+++FS + ++G G G+VY+ A+G ++AVK++ Q E F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RTQGGELQF 74
Query: 456 LEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV 515
V +S H N++ L G+C +RLLVY Y+ NG++ L +S L W R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575
R+ALG+AR L YLH+ C P ++HR+ K+ANILLD+E + D GLA L + V+T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS--LVRWATP 633
+ G G+ APE+ +G + K+DV+ +GV++LEL+TG++ D +R ++ L+ W
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
L L +VD L G Y + + + + LC Q P RP MSEVV+ L
Sbjct: 255 -LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 368 bits (947), Expect = e-123
Identities = 104/294 (35%), Positives = 163/294 (55%), Gaps = 7/294 (2%)
Query: 394 PITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED 453
P + + L+ ATN+F +FLIG G G+VY+ +G +A+K+ S Q +
Sbjct: 23 PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIE 80
Query: 454 NFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
F + +S RHP++V+L G+C E + +L+Y+Y+ NGNL L+ +D + +++W
Sbjct: 81 EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-QV 572
R+ + +G AR L YLH +++HR+ KS NILLD+ P ++D G++ ++ +
Sbjct: 141 RLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWAT 632
ST + G GY PE+ + G T KSDVYSFGVV+ E+L R + S PR +L WA
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 633 PQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
H+ L ++VDP L +SL +F D C+ E RP M +V+ L
Sbjct: 258 E-SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-116
Identities = 93/301 (30%), Positives = 154/301 (51%), Gaps = 18/301 (5%)
Query: 399 SYTVASLQTATNSFSQEF------LIGEGSLGRVYRAEFANGKIMAVKKIDNAAL--SLQ 450
S++ L+ TN+F + +GEG G VY+ + N +AVKK+ + +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEE 72
Query: 451 EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT 510
+ F + + M++ +H N+V L G+ ++ LVY Y+ NG+L D L D + L+
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLS 131
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
W+ R ++A G A + +LHE +HR+ KSANILLD+ +SD GLA + +
Sbjct: 132 WHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 571 Q-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR 629
+++++VG Y APE AL G T KSD+YSFGVV+LE++TG +D R Q L+
Sbjct: 189 TVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLD 245
Query: 630 WATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689
+ + +D +N + S+ + + C+ + RP + +V Q L +
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
Query: 690 V 690
Sbjct: 305 T 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 3e-75
Identities = 68/315 (21%), Positives = 122/315 (38%), Gaps = 35/315 (11%)
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFL-EA-VSNM 462
L + + G G V++A+ + +AVK +Q++ ++ E V ++
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKI-----FPIQDKQSWQNEYEVYSL 72
Query: 463 SRLRHPNIVTLAGYCAE----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA 518
++H NI+ G L+ + G+L D L + ++WN +A
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIA 127
Query: 519 LGTARALEYLHE-------VCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTER 570
AR L YLHE P++ HR+ KS N+LL + L ++D GLA
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 571 QVSTQMVGAFGYSAPEFALSGI-----YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ 625
+ VG Y APE I ++ D+Y+ G+V+ EL + D
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 626 SL--VRWATPQLHDIDALA--KMVDPALNGMYPAKS-LSRFADIIALCVQPEPEFRPPMS 680
P L D+ + K P L + + ++ + I C + E R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 681 EVVQALVRLVQRASV 695
V + + ++ + ++
Sbjct: 308 CVGERITQMQRLTNI 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 8e-63
Identities = 88/287 (30%), Positives = 130/287 (45%), Gaps = 26/287 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG GS G V+RAE+ +G +AVK + + + FL V+ M RLRHPNIV G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ +V EY+ G+L+ +LH + + L R+ +A A+ + YLH P +V
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HRN KS N+L+D + + D GL+ L +T S G + APE KS
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 598 DVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM---YP 654
DVYSFGV++ EL T ++P W +++ + P
Sbjct: 221 DVYSFGVILWELATLQQP--------------W-----GNLNPAQVVAAVGFKCKRLEIP 261
Query: 655 AKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSS 701
+ A II C EP RP + ++ L L++ A RS
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 7e-59
Identities = 79/282 (28%), Positives = 129/282 (45%), Gaps = 41/282 (14%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEE--DNFLEAVSNMSRLRHPNIVTLAG 475
IG G G+VYRA + G +AVK + + +N + + L+HPNI+ L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
C + LV E+ G L+ +L K + + V A+ AR + YLH+ +
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 536 VVHRNFKSANILLDDELNPH--------LSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
++HR+ KS+NIL+ ++ ++D GLA T + GA+ + APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEV 185
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647
+ +++ SDV+S+GV++ ELLTG P + ID LA
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVP--------------FR-----GIDGLAVAYGV 226
Query: 648 ALNGM---YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
A+N + P+ FA ++ C P+P RP + ++ L
Sbjct: 227 AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-59
Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 34/278 (12%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G+ G V +A++ K +A+K+I++ E F+ + +SR+ HPNIV L G C
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
LV EY G+L+++LH + T + L ++ + YLH + +++
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 538 HRNFKSANILLDDELN-PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVK 596
HR+ K N+LL + D G A T G+ + APE Y+ K
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 597 SDVYSFGVVMLELLTGRKP---LDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY 653
DV+S+G+++ E++T RKP + R ++ P L
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL------------------ 225
Query: 654 PAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
++ C +P RP M E+V+ + L++
Sbjct: 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 6e-58
Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 45/286 (15%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKI-----DNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
IG+G G V++ + ++A+K + + +++ F V MS L HPNIV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G +V E+V G+L+ L D + + W+ ++R+ L A +EY+
Sbjct: 87 KLYGLMHN--PPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQN- 140
Query: 532 CLPSVVHRNFKSANILLD-----DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
P +VHR+ +S NI L + ++D GL+ + ++ + ++G F + APE
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQWMAPE 196
Query: 587 --FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644
A YT K+D YSF +++ +LTG P + I + +
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGP--------------FDEYSYGKIKFINMI 242
Query: 645 VD----PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
+ P + P R ++I LC +P+ RP S +V+ L
Sbjct: 243 REEGLRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-58
Identities = 66/339 (19%), Positives = 109/339 (32%), Gaps = 46/339 (13%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLE--A 458
+ ++ LIG G G VY+ + + +AVK S NF+
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKV-----FSFANRQNFINEKN 57
Query: 459 VSNMSRLRHPNIVTLAGYCAE-----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
+ + + H NI + LLV EY NG+L L W +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 514 RVRVALGTARALEYLHE------VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567
R+A R L YLH P++ HR+ S N+L+ ++ +SD GL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 568 TERQ-------VSTQMVGAFGYSAPEFALSGI-------YTVKSDVYSFGVVMLELLTGR 613
+ VG Y APE + + D+Y+ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 614 KPLDSSRPRSE-QSLVRWATPQLHDIDALAKMVD-----PALNGMYPAKS--LSRFADII 665
L E Q + + + +V P + S + + I
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 666 ALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDES 704
C + E R + + L+ K S
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-57
Identities = 57/278 (20%), Positives = 116/278 (41%), Gaps = 39/278 (14%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+ E G +++ + G + VK + S ++ +F E + HPN++ + G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 478 AE--HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
L+ ++ G+L+++LH + ++ + + V+ AL AR + +LH P
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHT-LEPL 133
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG---- 591
+ S ++++D+++ +S + Q S + A + APE AL
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVK-----FSFQ-SPGRMYAPAWVAPE-ALQKKPED 186
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG 651
+D++SF V++ EL+T P +A D+ + + AL G
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVP--------------FA-----DLSNMEIGMKVALEG 227
Query: 652 M---YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
+ P + ++ +C+ +P RP +V L
Sbjct: 228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 6e-56
Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 37/283 (13%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+G G+ + G++M +K++ + + FL+ V M L HPN++ G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ + + EY+ G L ++ W+ RV A A + YLH + ++
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTE-------------RQVSTQMVGAFGYS 583
+HR+ S N L+ + N ++D GLA L + + R+ +VG +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643
APE Y K DV+SFG+V+ E++ PR+ + ++
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------NVRGFLD 241
Query: 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
P P+ F I C +PE RP ++ L
Sbjct: 242 RYCP--PNCPPS-----FFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-55
Identities = 73/278 (26%), Positives = 126/278 (45%), Gaps = 25/278 (8%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG GS G VY+ ++ +G + AVK ++ A + Q+ F V + + RH NI+ GY
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
Q +V ++ +L+ LH S + +A TAR ++YLH S++
Sbjct: 90 TAP-QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPE---FALSGIY 593
HR+ KS NI L ++ + D GLA Q+ G+ + APE S Y
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 594 TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY 653
+ +SDVY+FG+V+ EL+TG+ P + R + I+ + +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------------IEMVGRGSLSPDLSKV 250
Query: 654 PAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
+ R ++A C++ + + RP ++ + L +
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-53
Identities = 59/307 (19%), Positives = 120/307 (39%), Gaps = 45/307 (14%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG+G G+VY + +G++ A++ ID + + F V + RH N+V G C
Sbjct: 41 IGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
++ L+ ++ D+ L N ++A + + YLH ++
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNT-ERQVSTQMVGAFG---YSAPE------- 586
H++ KS N+ D+ ++D GL +++ + ++ G + APE
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 587 --FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644
++ SDV++ G + EL P + + + W +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----IIW---------QMGTG 258
Query: 645 VDPALNGMYPAKSLSR-FADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSSDE 703
+ P L + + +DI+ C E E RP ++++ L +L + + R
Sbjct: 259 MKPNL----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK-----RNRRLSH 309
Query: 704 SGFSYRT 710
G +++
Sbjct: 310 PGHFWKS 316
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-52
Identities = 63/299 (21%), Positives = 113/299 (37%), Gaps = 35/299 (11%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFL--EAVSNMSRLRHPNIVTLA 474
IG+G G V+ ++ G+ +AVK EE ++ + +RH NI+
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKV-----FFTTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 475 GYC----AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
Q L+ +Y NG+L+D L S L + +++A + L +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 531 -----VCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL---TPNTERQVSTQMVGAFGY 582
P++ HR+ KS NIL+ ++D GLA N VG Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 583 SAPE------FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP-RSEQSLVRWATPQL 635
PE + +D+YSFG+++ E+ + + + P
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 636 HDIDALA--KMVDPALNGMYPAKS-LSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
D+ + K + P+ + + L + ++ C P R V + L ++ +
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-52
Identities = 63/297 (21%), Positives = 113/297 (38%), Gaps = 35/297 (11%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLE--AVSNMSRLRHPNIVTLA 474
+G+G G V+R + G+ +AVK S ++E ++ + N LRH NI+
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 475 GYC----AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
Q L+ Y G+L+D L L + +R+ L A L +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 531 -----VCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL---TPNTERQVSTQMVGAFGY 582
P++ HR+ KS NIL+ ++D GLA + + N + VG Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 583 SAPE------FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSR----PRSEQSLVRWAT 632
APE + D+++FG+V+ E+ P + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 633 PQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689
+ + + + N + +L+ A ++ C P R + + L ++
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-51
Identities = 72/303 (23%), Positives = 124/303 (40%), Gaps = 35/303 (11%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFL-EA-VSNMSRLRHPNIVTLA 474
IG+G G V+R ++ G+ +AVK S +EE ++ EA + LRH NI+
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENILGFI 102
Query: 475 GYCAEHG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+ Q LV +Y +G+L D L+ +T +++AL TA L +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 531 -----VCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL---TPNTERQVSTQMVGAFGY 582
P++ HR+ KS NIL+ ++D GLA +T VG Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 583 SAPEFALSGI------YTVKSDVYSFGVVMLELLTGRKPLDSSRP-RSEQSLVRWATPQL 635
APE I ++D+Y+ G+V E+ + + + P +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 636 HDIDALA--KMVDPAL-NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
++ + + + P + N ++L A I+ C R + + L +L Q+
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
Query: 693 ASV 695
+
Sbjct: 338 EGI 340
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 57/272 (20%), Positives = 104/272 (38%), Gaps = 32/272 (11%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG GS VY+ + +A ++ + L+ E F E + L+HPNIV
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 476 YC---AEHGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ + +++ E + +G L L K + + L++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 532 CLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
P ++HR+ K NI + + + D GLA L + + ++G + APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650
Y DVY+FG+ MLE+ T P ++ + + + + V +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP--------------YS--ECQNAAQIYRRVTSGVK 247
Query: 651 GMYPAKSLSR-FADIIALCVQPEPEFRPPMSE 681
K +II C++ + R + +
Sbjct: 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-41
Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 16/234 (6%)
Query: 42 SDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGY 101
++ L L ++L +W N+ +PC ++ GV C V SID+S L+
Sbjct: 12 REIHQLISFKDVLPDKNLLPDWSSNK-NPC--TFDGVTCRDDKVTSIDLSSKPLNVGFSA 68
Query: 102 L---LSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLP--YSIASMVSL 155
+ L L L LS + I+ ++ ++ +LTSL+L+ N+ SG + S+ S L
Sbjct: 69 VSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128
Query: 156 SYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL---YLQNN 211
+LNVS N+L L L LDLS N+ SG ++ L + N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 212 QVTGSLNVFSGLPLTTLNVANNHFSGWIP--RELISIRTFIYDGNSFDNGPAPP 263
+++G ++V + L L+V++N+FS IP + +++ GN +G
Sbjct: 189 KISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKL-SGDFSR 241
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-32
Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 11/188 (5%)
Query: 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNL 145
+DISG LSG +S L+ ++S N IP +L L+LA N F+G +
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEI 285
Query: 146 PYSIA-SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS-LSNI 203
P ++ + +L+ L++S N ++ FG+ + L +L LS NNFSG+LP + + +
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345
Query: 204 SSLYLQNNQVTGSL-NVFSGLP--LTTLNVANNHFSGWIPRELI-----SIRTFIYDGNS 255
L L N+ +G L + L L TL++++N+FSG I L +++ N
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405
Query: 256 FDNGPAPP 263
F G PP
Sbjct: 406 F-TGKIPP 412
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 14/188 (7%)
Query: 86 VSIDISGLGLSGTMGY-LLSDLLSLRKFDLSGNSIHDTIPYQLP-----PNLTSLNLASN 139
+++S L L SL DLS NSI L L ++ N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 140 NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS 199
SG++ ++ V+L +L+VS N+ + I + G+ + L LD+S N SGD + +
Sbjct: 189 KISGDVD--VSRCVNLEFLDVSSNNFSTGIPFL-GDCSALQHLDISGNKLSGDFSRAIST 245
Query: 200 LSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELI----SIRTFIYDGNS 255
+ + L + +NQ G + L L++A N F+G IP L ++ GN
Sbjct: 246 CTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH 305
Query: 256 FDNGPAPP 263
F G PP
Sbjct: 306 F-YGAVPP 312
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-31
Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 6/164 (3%)
Query: 86 VSIDISGLGLSGTM--GYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNF 141
+++D+S SG + + +L++ L N IP L L SL+L+ N
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 142 SGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLS 201
SG +P S+ S+ L L + N L I + L TL L FN+ +G++P+ + +
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490
Query: 202 NISSLYLQNNQVTGSL-NVFSGLP-LTTLNVANNHFSGWIPREL 243
N++ + L NN++TG + L L L ++NN FSG IP EL
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-30
Identities = 51/212 (24%), Positives = 80/212 (37%), Gaps = 29/212 (13%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137
+ L G L+ L + +++ ++ L+++
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
N SG +P I SM L LN+ N ++ SI D G+L GL LDLS N G +P +
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTF---IYDGN 254
+L+ LT ++++NN+ SG IP TF + N
Sbjct: 701 SALTM----------------------LTEIDLSNNNLSGPIPEMGQ-FETFPPAKFLNN 737
Query: 255 SFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSH 286
G P P + G +H+ RSH H
Sbjct: 738 PGLCGY-PLPRCDPSNADGYAHHQRSHHHHHH 768
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-25
Identities = 36/159 (22%), Positives = 62/159 (38%), Gaps = 2/159 (1%)
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASM 152
L G + L + +L L N + IP L NL ++L++N +G +P I +
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+L+ L +S NS + +I G+ L LDL+ N F+G +P + S + +
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGK 573
Query: 213 VTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIY 251
+ F G +L + T
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 612
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-22
Identities = 32/186 (17%), Positives = 66/186 (35%), Gaps = 13/186 (6%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137
+ ++ + L+G + LS+ +L LS N + IP + NL L L+
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
+N+FSGN+P + SL +L+++ N +I + ++ N +G
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYI 578
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGL----PLTTLNVANNHFSGWIPRELISIRTFIY-- 251
+ + N + L N+ + + G + + ++
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 252 -DGNSF 256
N
Sbjct: 639 MSYNML 644
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 69/276 (25%), Positives = 111/276 (40%), Gaps = 29/276 (10%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL-A 474
IG GS GR + ++GKI+ K++D +++ E+ + V+ + L+HPNIV
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
L +V EY G+L ++ + L +RV AL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 534 PS--VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
V+HR+ K AN+ LD + N L D GLA + + T VG Y +PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMNRM 191
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG 651
Y KSD++S G ++ EL P + LA + G
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAF-----------------SQKELAGKI---REG 231
Query: 652 MYPA--KSLSR-FADIIALCVQPEPEFRPPMSEVVQ 684
+ S +II + + RP + E+++
Sbjct: 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 36/237 (15%)
Query: 39 TDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVAC----EGSAVVSIDISGLG 94
+ D QAL + L +P+ L++W D C +W GV C + V ++D+SGL
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLAS-NNFSGNLPYSIAS 151
L IP L P L L + NN G +P +IA
Sbjct: 62 LPKPY----------------------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99
Query: 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ L YL ++ +++ +I D + L TLD S+N SG LP S SL N+ + N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 212 QVTGSL-NVFSGLP--LTTLNVANNHFSGWIPREL--ISIRTFIYDGNSFDNGPAPP 263
+++G++ + + T++ ++ N +G IP +++ N G A
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML-EGDASV 215
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 35/142 (24%), Positives = 55/142 (38%), Gaps = 4/142 (2%)
Query: 95 LSGTMGYLLSDLLSLRKF-DLSGNSIHDTIPYQL-PPNLTSLNLASNNFSGNLPYSIASM 152
+SG + L +S N + IP NL ++L+ N G+ S
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD 220
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ +++++NSL +G + G L LDL N G LP L + SL + N
Sbjct: 221 KNTQKIHLAKNSLAFDLGKV-GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 213 VTGSLNVFSGLP-LTTLNVANN 233
+ G + L ANN
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 31/106 (29%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGN 144
+D+S L G L + +K L+ NS+ + L NL L+L +N G
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGT 259
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDI--FGNLAGLATLDLSFNN 188
LP + + L LNVS N+L G+I GNL + N
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLC---GEIPQGGNLQRFDVSAYANNK 302
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-37
Identities = 65/284 (22%), Positives = 106/284 (37%), Gaps = 39/284 (13%)
Query: 418 IGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V+ + AVK L + FL+ + + HPNIV L G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C + +V E V G+ L L +++ A +EYL
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY----SAPEFALSGI 592
+HR+ + N L+ ++ +SD G++ + G +APE G
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEALNYGR 291
Query: 593 YTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG 651
Y+ +SDV+SFG+++ E + G P P L + + V+ G
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPY----------------PNLSNQQTR-EFVE---KG 331
Query: 652 --MY-PAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
+ P ++ C EP RP S + Q L + +R
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 58/272 (21%), Positives = 118/272 (43%), Gaps = 30/272 (11%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IGEGS G+ + +G+ +K+I+ + +S +E + V+ ++ ++HPNIV
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
E+G +V +Y G+L ++ + + + AL+++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHVHD---RK 145
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
++HR+ KS NI L + L D G+A + +T +G Y +PE + Y
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENKPYNN 204
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655
KSD+++ G V+ EL T + ++ + L + ++G +P
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAG-----------------SMKNLVLKI---ISGSFPP 244
Query: 656 --KSLSR-FADIIALCVQPEPEFRPPMSEVVQ 684
S +++ + P RP ++ +++
Sbjct: 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 60/283 (21%), Positives = 111/283 (39%), Gaps = 40/283 (14%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLA 474
IG G +V++ +I A+K ++ Q D++ ++ +++L+ + I+ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y +V E GN +L+ L K++ R A+ +H+
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH--- 146
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPE------- 586
+VH + K AN L+ D L D G+A + P+T V VG Y PE
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 587 ----FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642
+ KSDV+S G ++ + G+ P + I L
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------NQISKLH 250
Query: 643 KMVDPALNGMYPAKSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
++DP +P + D++ C++ +P+ R + E++
Sbjct: 251 AIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 63/278 (22%), Positives = 112/278 (40%), Gaps = 36/278 (12%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG G VYRA +G +A+KK+ L + + ++ + + +L HPN++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT----WNARVRVALGTARALEYLHE 530
E + +V E G+L M+ + + W V++ ALE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS----ALEHMHS 154
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
V+HR+ K AN+ + L D GL + + +VG Y +PE
Sbjct: 155 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHE 210
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650
Y KSD++S G ++ E+ + P ++ +L K +
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYG---------------DKMNLYSLCKKI---EQ 252
Query: 651 GMY---PAKSLSR-FADIIALCVQPEPEFRPPMSEVVQ 684
Y P+ S ++ +C+ P+PE RP ++ V
Sbjct: 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 60/283 (21%), Positives = 111/283 (39%), Gaps = 40/283 (14%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLA 474
IG G +V++ +I A+K ++ Q D++ ++ +++L+ + I+ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y +V E GN +L+ L K++ R A+ +H+
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPE------- 586
+VH + K AN L+ D L D G+A + P+T V VG Y PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 587 ----FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642
+ KSDV+S G ++ + G+ P + I L
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------NQISKLH 231
Query: 643 KMVDPALNGMYPAKSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
++DP +P + D++ C++ +P+ R + E++
Sbjct: 232 AIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 62/273 (22%), Positives = 97/273 (35%), Gaps = 47/273 (17%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G GS G V+R + G AVKK+ ++E + + L P IV L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE-------LVACAGLSSPRIVPLYG 117
Query: 476 YCAEHGQRLLVY-EYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
G + ++ E + G+L ++ +D + AL LEYLH
Sbjct: 118 -AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYL-----GQAL---EGLEYLHT 168
Query: 531 VCLPSVVHRNFKSANILLDDELNP-HLSDCGLAALTPNTERQVSTQ----MVGAFGYSAP 585
++H + K+ N+LL + + L D G A S + G + AP
Sbjct: 169 RR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
E + K D++S +ML +L G P W Q K+
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHP--------------WT--QYFRGPLCLKIA 269
Query: 646 -DPALNGMYPAKSLSRFADIIALCVQPEPEFRP 677
+P P A I ++ EP R
Sbjct: 270 SEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-34
Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 33/283 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G VY + + AVK + + ++E FL+ + M ++HPN+V L G
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLGV 284
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C ++ E++ GNL D L + + + ++ + +A + A+EYL + +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVK 596
+HRN + N L+ + ++D GL+ L ++APE +++K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 597 SDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG--MY 653
SDV++FGV++ E+ T G P P + ++++ M
Sbjct: 400 SDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVY-ELLE---KDYRME 439
Query: 654 -PAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695
P + +++ C Q P RP +E+ QA + Q +S+
Sbjct: 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 482
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 62/284 (21%), Positives = 115/284 (40%), Gaps = 42/284 (14%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLA 474
IG G +V++ +I A+K ++ Q D++ ++ +++L+ + I+ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y +V E GN +L+ L K++ R A+ +H+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPEFALSGI- 592
+VH + K AN L+ D L D G+A + P+T V VGA Y PE A+ +
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMS 232
Query: 593 -----------YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641
+ KSDV+S G ++ + G+ P + I L
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------NQISKL 277
Query: 642 AKMVDPALNGMYPAKSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
++DP +P + D++ C++ +P+ R + E++
Sbjct: 278 HAIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 65/286 (22%), Positives = 105/286 (36%), Gaps = 49/286 (17%)
Query: 412 FSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL- 465
F Q F +G GS G V++ +G++ AVK+ + ++ L V + ++
Sbjct: 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALG 520
+HP V L E G L E G +L + +
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRD-------- 165
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGA 579
T AL +LH +VH + K ANI L L D GL L +V G
Sbjct: 166 TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGD 219
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639
Y APE L G Y +DV+S G+ +LE+ + P H +
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL-----P--------------HGGE 259
Query: 640 ALAKMVDPALNGMYPAKSLSR-FADIIALCVQPEPEFRPPMSEVVQ 684
++ L + A LS ++ + ++P+P+ R ++
Sbjct: 260 GWQQLRQGYLPPEFTAG-LSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 58/303 (19%), Positives = 106/303 (34%), Gaps = 60/303 (19%)
Query: 411 SFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL 465
++ EF IG G G V++ + +G I A+K+ +E N L V + L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 466 -RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
+H ++V AE L+ EY G+L D + + L R
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPH-------------------LSDCGLAALT 565
L Y+H S+VH + K +NI + P+ + D G
Sbjct: 128 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 566 PNTERQVSTQMVGAFGYSAPE-FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSE 624
+ + + + A E + + K+D+++ + ++
Sbjct: 185 SSPQVEEGDSR-----FLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR------- 232
Query: 625 QSLVRWATPQLHDIDALAKMVDPALNGMYPA--KSLSR-FADIIALCVQPEPEFRPPMSE 681
Q H+I G P + LS+ F +++ + + P+PE RP
Sbjct: 233 ------NGDQWHEI----------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMA 276
Query: 682 VVQ 684
+V+
Sbjct: 277 LVK 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 59/301 (19%), Positives = 113/301 (37%), Gaps = 58/301 (19%)
Query: 406 QTATNSFSQEF----LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVS 460
T F +F LIG G G+V++A+ +GK +K++ + E V
Sbjct: 3 HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE------VK 56
Query: 461 NMSRLRHPNIV---------------TLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADD 504
+++L H NIV + + L + E+ G L +
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KR 114
Query: 505 SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-A 563
+ L + + + ++Y+H +++R+ K +NI L D + D GL +
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRS 623
L + +R T+ G Y +PE S Y + D+Y+ G+++ ELL
Sbjct: 172 LKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFE 223
Query: 624 EQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVV 683
+ D ++ ++ K ++ + +PE RP SE++
Sbjct: 224 TSKF-------------FTDLRDGIISDIFDKK----EKTLLQKLLSKKPEDRPNTSEIL 266
Query: 684 Q 684
+
Sbjct: 267 R 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 68/277 (24%), Positives = 111/277 (40%), Gaps = 44/277 (15%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G G VY A E + I+A+K + A L E V S LRHPNI+ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
GY + + L+ EY G ++ L F + + A AL Y H
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANALSYCHS 127
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
V+HR+ K N+LL ++D G + P++ R + G Y PE
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEG 181
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650
++ K D++S GV+ E L G+ P ++ + +
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEA--------------------NTYQETYKRISR 221
Query: 651 GMY--PAKSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
+ P ++ A D+I+ ++ P RP + EV++
Sbjct: 222 VEFTFP-DFVTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 69/284 (24%), Positives = 126/284 (44%), Gaps = 35/284 (12%)
Query: 418 IGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G VY + + AVK + + ++E FL+ + M ++HPN+V L G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLGV 77
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C ++ E++ GNL D L + + + ++ + +A + A+EYL + +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY--SAPEFALSGIYT 594
+HR+ + N L+ + ++D GL+ L F +APE ++
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG--AKFPIKWTAPESLAYNKFS 190
Query: 595 VKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL--NG 651
+KSDV++FGV++ E+ T G P P + S V ++ +M P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPY----PGIDLSQV------YELLEKDYRMERPEGCPEK 240
Query: 652 MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695
+Y +++ C Q P RP +E+ QA + Q +S+
Sbjct: 241 VY---------ELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIM---AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G+ G V + + K++ AVK + N A +D L + M +L +P IV +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G C +LV E G L+ L ++++ + + + ++YL E
Sbjct: 85 GICEAE-SWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESNF- 138
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFALSGI 592
VHR+ + N+LL + +SD GL+ E Q G + + APE
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 593 YTVKSDVYSFGVVMLELLT-GRKP 615
++ KSDV+SFGV+M E + G+KP
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-32
Identities = 73/283 (25%), Positives = 119/283 (42%), Gaps = 45/283 (15%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG+G G V ++ G +AVK I N A FL S M++LRH N+V L G
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 478 AEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
E L +V EY+ G+L D L L + ++ +L A+EYL +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA-FGY--SAPEFALSGIY 593
VHR+ + N+L+ ++ +SD GL ++ S+ +APE +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPEALREKKF 363
Query: 594 TVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG- 651
+ KSDV+SFG+++ E+ + GR P P++ D + V+ G
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPY----------------PRIPLKDVV-PRVE---KGY 403
Query: 652 -MY-PAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
M P D++ C + RP ++ + L +
Sbjct: 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 57/290 (19%), Positives = 111/290 (38%), Gaps = 32/290 (11%)
Query: 418 IGEGSLGRVYRAEF----ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GEG G+V + N AVK + + D + + + L H NIV
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENIVK 87
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G C E G L+ E++ +G+L + L + + +++ A+ + ++YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFA 588
VHR+ + N+L++ E + D GL + + + + APE
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 589 LSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLV-RWATPQLHDIDALAK--- 643
+ + + SDV+SFGV + ELLT + ++ L +
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 261
Query: 644 MVDPAL--NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
+ P + +Y ++ C + +P R +++ L++
Sbjct: 262 LPCPPNCPDEVY---------QLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 63/294 (21%), Positives = 118/294 (40%), Gaps = 34/294 (11%)
Query: 418 IGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G+G+ G V + G+++AVKK+ ++ + F + + L+H NIV
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 106
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G C G+R L+ EY+ G+L D L + + ++ + +EYL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFA 588
+HR+ + NIL+++E + D GL + P + + G + APE
Sbjct: 164 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK----- 643
++V SDV+SFGVV+ EL T + S + + Q+ +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280
Query: 644 -MVDPAL--NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694
+ P + +Y I+ C RP ++ + ++ + +
Sbjct: 281 RLPRPDGCPDEIY---------MIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 33/278 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G G V+ + +A+K + +S + FL+ M +LRH +V L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 248
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+E +V EY+ G+L D L ++ K L V +A A + Y+ + + V
Sbjct: 249 SEE-PIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ ++ANIL+ + L ++D GLA L + E ++APE AL G +T+KS
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 598 DVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG--MY- 653
DV+SFG+++ EL T GR P P + + + L V+ G M
Sbjct: 363 DVWSFGILLTELTTKGRVPY----------------PGMVNREVL-DQVE---RGYRMPC 402
Query: 654 PAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
P + D++ C + EPE RP + L
Sbjct: 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG+G G V + G +AVK I N A FL S M++LRH N+V L G
Sbjct: 29 IGKGEFGDVMLGD-YRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 478 AEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
E L +V EY+ G+L D L L + ++ +L A+EYL +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFALSGIY 593
VHR+ + N+L+ ++ +SD GL ++ S+ ++APE +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPEALREKKF 191
Query: 594 TVKSDVYSFGVVMLELLT-GRKP 615
+ KSDV+SFG+++ E+ + GR P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 72/325 (22%), Positives = 125/325 (38%), Gaps = 63/325 (19%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+G G G V + +I A+K + + ++ +FL S M + HPNI+ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + ++V EY+ NG+L L T V + G A ++YL ++
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM-- 166
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY--SAPEFALSG 591
VHR+ + NIL++ L +SD GL + + T G ++PE
Sbjct: 167 -GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 592 IYTVKSDVYSFGVVMLELLT-GRKP------------LDS----SRPRSEQSLVRWATPQ 634
+T SDV+S+G+V+ E+++ G +P +D P
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD-------CPAA 278
Query: 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694
L+ + M+D C Q + RP ++V L +L++
Sbjct: 279 LYQL-----MLD---------------------CWQKDRNNRPKFEQIVSILDKLIRNPG 312
Query: 695 VVKRRSSDESGFSYRTPDHEAIDTP 719
+K +S + S D +D
Sbjct: 313 SLKIITSAAARPSNLLLDQSNVDIT 337
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 31/277 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG G G V+ + N +A+K I A E++F+E M +L HP +V L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
E LV E++ +G L D L + + L + YL E V+
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 126
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ + N L+ + +SD G+ + + ST +++PE Y+ KS
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 598 DVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL--NGMYP 654
DV+SFGV+M E+ + G+ P S V + DI ++ P L +Y
Sbjct: 187 DVWSFGVLMWEVFSEGKIPY----ENRSNSEV------VEDISTGFRLYKPRLASTHVY- 235
Query: 655 AKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
I+ C + PE RP S +++ L + +
Sbjct: 236 --------QIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 63/294 (21%), Positives = 117/294 (39%), Gaps = 34/294 (11%)
Query: 418 IGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G+G+ G V + G+++AVKK+ ++ + F + + L+H NIV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 75
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G C G+R L+ EY+ G+L D L + + ++ + +EYL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFA 588
+HR+ + NIL+++E + D GL + P + + G + APE
Sbjct: 133 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK----- 643
++V SDV+SFGVV+ EL T + S + + Q+ +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249
Query: 644 -MVDPAL--NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694
+ P + +Y I+ C RP ++ + ++ +
Sbjct: 250 RLPRPDGCPDEIY---------MIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 64/284 (22%), Positives = 104/284 (36%), Gaps = 36/284 (12%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEG V E +G A+K+I Q+ + HPNI+ L
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 476 YCAEHGQR----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
YC L+ + G L + + D LT + + + LG R LE +H
Sbjct: 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAA---LTPNTERQVST-----QMVGAFGYS 583
HR+ K NILL DE P L D G + RQ T Y
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 584 APE-FALSG--IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640
APE F++ + ++DV+S G V+ ++ G P D + + S+ A
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----------A 259
Query: 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+ + + + S ++ + +P RP + ++
Sbjct: 260 VQNQLSIPQSPRHS----SALWQLLNSMMTVDPHQRPHIPLLLS 299
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 78/347 (22%), Positives = 127/347 (36%), Gaps = 72/347 (20%)
Query: 387 SLKKIKSPITATSYTVASLQTATNSFSQEF---------LIGEGSLGRVYRAEF---ANG 434
K + A +T A SF++E +IG G G V
Sbjct: 17 QGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 435 KIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493
+ A+K + A + ++ +FL S M + HPNI+ L G ++V EY+ NG
Sbjct: 77 DVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENG 135
Query: 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553
+L L T V + G + YL ++ VHR+ + N+L+D L
Sbjct: 136 SLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLV 189
Query: 554 PHLSDCGLAALTPNTERQVSTQMVGAFGY--SAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+SD GL+ + + T G +APE ++ SDV+SFGVVM E+L
Sbjct: 190 CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
Query: 612 -GRKP------------LDS----SRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP 654
G +P ++ P LH + M+D
Sbjct: 250 YGERPYWNMTNRDVISSVEEGYRLPAPMG-------CPHALHQL-----MLD-------- 289
Query: 655 AKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRSS 701
C + RP S++V L L++ ++ ++
Sbjct: 290 -------------CWHKDRAQRPRFSQIVSVLDALIRSPESLRATAT 323
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 418 IGEGSLGRVYRAEF----ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G G+ G VY+ + KI A+K++ A S + L+ M+ + +P++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G C L+ + + G L D + + N+ + + A+ + YL +
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFAL 589
L VHR+ + N+L+ + ++D GLA L E++ + G + A E L
Sbjct: 138 L---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESIL 192
Query: 590 SGIYTVKSDVYSFGVVMLELLT-GRKP 615
IYT +SDV+S+GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G G VY A E N IMA+K + + L E + S LRHPNI+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
Y + + L+ E+ G L+ L F + S A AL Y HE
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCHE 132
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
V+HR+ K N+L+ + ++D G + P+ R+ T M G Y PE
Sbjct: 133 ---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPEMIEG 186
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDSS 619
+ K D++ GV+ E L G P DS
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ A + +AVK + ++S++ FL + M L+H +V L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKLHAVV 252
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ E++ G+L D L D + + A + ++ + + +
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ ++ANIL+ L ++D GLA + + E ++APE G +T+KS
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV+SFG++++E++T GR P
Sbjct: 367 DVWSFGILLMEIVTYGRIP 385
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 71/319 (22%), Positives = 123/319 (38%), Gaps = 64/319 (20%)
Query: 418 IGEGSLGRVYRAEFANGKIM-----AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
IG G G VY+ A+K + A + ++ +FL M + H NI+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G +++ +++ EY+ NG L L + + V + G A ++YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY--SAPEFALS 590
VHR+ + NIL++ L +SD GL+ + + T G +APE
Sbjct: 168 Y---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKP------------LDS----SRPRSEQSLVRWATP 633
+T SDV+SFG+VM E++T G +P ++ P
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD-------CPS 277
Query: 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693
++ + M+ C Q E RP +++V L +L++
Sbjct: 278 AIYQL-----MMQ---------------------CWQQERARRPKFADIVSILDKLIRAP 311
Query: 694 SVVKRRSSDESGFSYRTPD 712
+K + + S R P
Sbjct: 312 DSLKTLADFDPRVSIRLPS 330
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 65/278 (23%), Positives = 115/278 (41%), Gaps = 31/278 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V ++ +AVK I + ED F + M +L HP +V G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
++ +V EY+ NG L + L K L + + + + +L +
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ + N L+D +L +SD G+ + + S +SAPE Y+ KS
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 598 DVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL--NGMYP 654
DV++FG++M E+ + G+ P S V + + ++ P L + +Y
Sbjct: 187 DVWAFGILMWEVFSLGKMPY----DLYTNSEV------VLKVSQGHRLYRPHLASDTIY- 235
Query: 655 AKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
I+ C PE RP +++ ++ L ++
Sbjct: 236 --------QIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 72/318 (22%), Positives = 127/318 (39%), Gaps = 39/318 (12%)
Query: 418 IGEGSLGRVYRAEF----ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G+G+ G V + N + AVK++ ++ Q + F + + L IV
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD--FQREIQILKALHSDFIVK 88
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G G++ LV EY+ +G L D L L + + + + +EYL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAF--GYSAPEF 587
VHR+ + NIL++ E + ++D GLA L + + V + G + APE
Sbjct: 146 RRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP-GQSPIFWYAPES 201
Query: 588 ALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHD-IDALAK-- 643
I++ +SDV+SFGVV+ EL T K S P L ++ L +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261
Query: 644 -MVDPAL--NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRRS 700
+ P ++ +++ LC P P+ RP S + L L + +
Sbjct: 262 RLPAPPACPAEVH---------ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET-- 310
Query: 701 SDESGFSYRTPDHEAIDT 718
+ ++ H ++
Sbjct: 311 --HAFTAHPEGKHHSLSF 326
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 3e-31
Identities = 36/301 (11%), Positives = 69/301 (22%), Gaps = 50/301 (16%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+ G V+ + + A+K A S E + EA +RL +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 475 GYC--------------------------AEHGQRLLVYEYVGNGNLHDMLHFADDSSKN 508
LL+ +L + D
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187
Query: 509 ---LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565
A + R L +VH +F N+ + + L D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 566 PNTERQVSTQMVGAFGYSAPEFALSG--IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRS 623
Y+ EF + +T + + G+ + + P P
Sbjct: 245 GTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 624 EQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVV 683
+ +L +L +I + + R E +
Sbjct: 301 K---------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351
Query: 684 Q 684
+
Sbjct: 352 E 352
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 64/283 (22%), Positives = 115/283 (40%), Gaps = 37/283 (13%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V ++ +A+K I ++ ED F+E M L H +V L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ NG L + L + + + A+EYL +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFALSGIYT 594
HR+ + N L++D+ +SD GL+ + E S G+ +S PE + ++
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSPPEVLMYSKFS 199
Query: 595 VKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL--NG 651
KSD+++FGV+M E+ + G+ P R S I ++ P L
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPY----ERFTNSET------AEHIAQGLRLYRPHLASEK 249
Query: 652 MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694
+Y I+ C + + RP ++ ++ ++ S
Sbjct: 250 VY---------TIMYSCWHEKADERPTFKILLSNILDVMDEES 283
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 62/295 (21%), Positives = 108/295 (36%), Gaps = 54/295 (18%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV---- 471
+G G G V+ A+ + A+K+I L E E V +++L HP IV
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE-VKALAKLEHPGIVRYFN 70
Query: 472 -----TLAGYCAEHGQRLLVY---EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
++ +Y + NL D ++ + + + + + L A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHIFLQIAE 129
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-----------LTPNTERQV 572
A+E+LH ++HR+ K +NI + + D GL LTP
Sbjct: 130 AVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWAT 632
T VG Y +PE Y+ K D++S G+++ ELL P + E+
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ---MERVRT---- 236
Query: 633 PQLHDIDALAKMVDPALNGMYP---AKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
L D+ N +P + ++ + P P RP +++
Sbjct: 237 --LTDV----------RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + +AVK + ++S FL + M +L+H +V L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 77
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ NG+L D L S LT N + +A A + ++ E + +
Sbjct: 78 TQEP-IYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ ++ANIL+ D L+ ++D GLA L + E ++APE G +T+KS
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV+SFG+++ E++T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 67/320 (20%), Positives = 116/320 (36%), Gaps = 54/320 (16%)
Query: 418 IGEGSLGRVYRAEF----ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G G G V++ + + KI +K I++ + + + + + L H +IV
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAIGSLDHAHIVR 79
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G C LV +Y+ G+L D + L + + A+ + YL E
Sbjct: 80 LLGLCPGS-SLQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFAL 589
+ VHRN + N+LL ++D G+A L P ++Q+ A + A E
Sbjct: 136 M---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALESIH 190
Query: 590 SGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVR---------WATPQLHDID 639
G YT +SDV+S+GV + EL+T G +P R L+ T ++ +
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMV- 249
Query: 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVKRR 699
MV C + RP E+ R+ +
Sbjct: 250 ----MVK---------------------CWMIDENIRPTFKELANEFTRMARDPPRYLVI 284
Query: 700 SSDESGFSYRTPDHEAIDTP 719
+ P+ +
Sbjct: 285 KRESGPGIAPGPEPHGLTNK 304
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-31
Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 33/278 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G G V+ + +A+K + +S + FL+ M +LRH +V L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 331
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+E +V EY+ G+L D L ++ K L V +A A + Y+ + + V
Sbjct: 332 SEE-PIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ ++ANIL+ + L ++D GLA L + E ++APE AL G +T+KS
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 598 DVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG--MY- 653
DV+SFG+++ EL T GR P P + + + L V+ G M
Sbjct: 446 DVWSFGILLTELTTKGRVPY----------------PGMVNREVL-DQVE---RGYRMPC 485
Query: 654 PAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
P + D++ C + EPE RP + L
Sbjct: 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 66/291 (22%), Positives = 111/291 (38%), Gaps = 34/291 (11%)
Query: 418 IGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GEG G+V + G+++AVK + A + + + + L H +I+
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG-WKQEIDILRTLYHEHIIK 97
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G C + G LV EYV G+L D L ++ + A + YLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFA 588
+HR+ + N+LLD++ + D GLA P + G + APE
Sbjct: 153 QHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 589 LSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLV-RWATPQLHDIDALAK--- 643
+ SDV+SFGV + ELLT E + + L + L +
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269
Query: 644 MVDPAL--NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
+ P +Y ++ C + E FRP ++ L + ++
Sbjct: 270 LPRPDKCPAEVY---------HLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 59/306 (19%), Positives = 116/306 (37%), Gaps = 59/306 (19%)
Query: 412 FSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR 466
++ +F ++G+G+ G+V +A + + A+KKI + ++ L V ++ L
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLN 60
Query: 467 HPNIVTL------------AGYCAEHGQRL-LVYEYVGNGNLHDMLHFAD-DSSKNLTWN 512
H +V + L + EY NG L+D++H + + ++ W
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
++ AL Y+H ++HR+ K NI +D+ N + D GLA + +
Sbjct: 121 LFRQILE----ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 573 S-------------TQMVGAFGYSAPE-FALSGIYTVKSDVYSFGVVMLELLTGRKPLDS 618
T +G Y A E +G Y K D+YS G++ E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST--- 230
Query: 619 SRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPP 678
++++ + + V + + II L + +P RP
Sbjct: 231 --GMERVNILK-------KL----RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277
Query: 679 MSEVVQ 684
++
Sbjct: 278 ARTLLN 283
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 415 EFLIGEGSLGRVYRAEF--ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+ +G G+ G V + + +I A+K + E+ + M +L +P IV
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIV 73
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C +LV E G G LH L + + + + + ++YL E
Sbjct: 74 RLIGVCQAE-ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFAL 589
VHR+ + N+LL + +SD GL+ + + + G + + APE
Sbjct: 130 NF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 186
Query: 590 SGIYTVKSDVYSFGVVMLELLT-GRKP 615
++ +SDV+S+GV M E L+ G+KP
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 72/274 (26%), Positives = 111/274 (40%), Gaps = 35/274 (12%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
L+G+GS VYRA G +A+K ID A+ V +L+HP+I+ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT-WNARVRVALGTARALEYLHEVCL 533
Y + LV E NG ++ L + K + AR + YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLK---NRVKPFSENEAR-HFMHQIITGMLYLHSHG- 132
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
++HR+ +N+LL +N ++D GLA + T + G Y +PE A +
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189
Query: 594 TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY 653
++SDV+S G + LL GR P D+ + V + Y
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTD-----------------TVKNTLNKV---VLADY 229
Query: 654 --PAKSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
P LS A D+I ++ P R +S V+
Sbjct: 230 EMP-SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 75/309 (24%), Positives = 133/309 (43%), Gaps = 44/309 (14%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
F +GEGS G VY+A G+I+A+K++ + ++ E +S M + P++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKE-ISIMQQCDSPHV 86
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V G ++ +V EY G G++ D++ +K LT + + T + LEYLH
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+ +HR+ K+ NILL+ E + L+D G+A +T + +T ++G + APE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQE 199
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL---AKMVDP 647
Y +D++S G+ +E+ G+ P +H + A+ P
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYA----------------DIHPMRAIFMIPTNPPP 243
Query: 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ-----------ALVRLVQRASVV 696
P F D + C+ PE R ++++Q L L+ A V
Sbjct: 244 TFRK--PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDV 301
Query: 697 KRRSSDESG 705
K + +
Sbjct: 302 KLKRQESQQ 310
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 78/309 (25%), Positives = 128/309 (41%), Gaps = 57/309 (18%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
IG+GS G V++ + K++A+K ID L+E ++ +E + +S+ P +
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 473 LAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
G +L ++ EY+G G+ D+L L + + L+YLH
Sbjct: 85 YYG-SYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE 138
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
+HR+ K+AN+LL + L+D G+A +T+ + +T VG + APE
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQS 194
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL---AKMVDPA 648
Y K+D++S G+ +EL G P +LH + L K P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHS----------------ELHPMKVLFLIPKNNPPT 238
Query: 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEV------------VQALVRLVQRASVV 696
L G Y + + C+ EP FRP E+ L L+ R
Sbjct: 239 LEGNYSKP----LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRW 294
Query: 697 K-RRSSDES 704
K +S D+S
Sbjct: 295 KAEQSHDDS 303
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 76/299 (25%), Positives = 134/299 (44%), Gaps = 46/299 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
IG+G+ G VY A + A G+ +A+++++ L Q + + + + M ++PNIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G L +V EY+ G+L D++ + V +ALE+LH
Sbjct: 85 -SYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
V+HR+ KS NILL + + L+D G A +TP ++ + MVG + APE Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 193
Query: 594 TVKSDVYSFGVVMLELLTGRKPLDSSRP-RSEQSLVRWATPQLHDIDALAKMVDPALNGM 652
K D++S G++ +E++ G P + P R+ + TP+L + + L+
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA--------- 244
Query: 653 YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ-----------ALVRLVQRASVVKRRS 700
F D + C++ + E R E++Q +L L+ A + +
Sbjct: 245 -------IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNN 296
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 48/227 (21%)
Query: 418 IGEGSLGRVYRAEFANGKIM----AVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG G V AVK K+DN+ S +E + FL + M HPN++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVI 99
Query: 472 TLAGYCAEHGQR-----LLVYEYVGNGNLHDML--HFADDSSKNLTWNARVRVALGTARA 524
L G C E + +++ ++ G+LH L + K++ ++ + A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ--------- 575
+EYL + +HR+ + N +L D++ ++D GL+ +++ +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS-------KKIYSGDYYRQGRIA 209
Query: 576 ------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ A E +YT KSDV++FGV M E+ T G P
Sbjct: 210 KMPVKWI-------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 418 IGEGSLGRVYRAEFA----NGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G G+ G VY+ + KI A+K++ A S + L+ M+ + +P++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G C L+ + + G L D + + N+ + + A+ + YL +
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFAL 589
L VHR+ + N+L+ + ++D GLA L E++ + G + A E L
Sbjct: 138 L---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESIL 192
Query: 590 SGIYTVKSDVYSFGVVMLELLT-GRKP 615
IYT +SDV+S+GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 63/284 (22%), Positives = 116/284 (40%), Gaps = 35/284 (12%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPNI 470
+G G + VY AE +A+K I + +E++ L E + S+L H NI
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIF---IPPREKEETLKRFEREVHN-SSQLSHQNI 73
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V++ E LV EY+ L + + S L+ + + +++ H+
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPEFAL 589
+ +VHR+ K NIL+D + D G+A AL+ + Q + ++G Y +PE A
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAK 185
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLH-DIDALAKMVDPA 648
+D+YS G+V+ E+L G P + V A + + + V
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSVPNVTTDVRKD 239
Query: 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPP-MSEVVQALVRLVQ 691
+ P +++I + + R + E+ L ++
Sbjct: 240 I----PQS----LSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 418 IGEGSLGRVYRAEF--ANGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG G G VY +GK + AVK ++ + E FL M HPN+++L
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 474 AGYCAE-HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G C G L+V Y+ +G+L + + + + N T + L A+ ++YL
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK- 147
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQ--------MVGAFGY 582
VHR+ + N +LD++ ++D GLA + M
Sbjct: 148 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM------ 199
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
A E + +T KSDV+SFGV++ EL+T G P
Sbjct: 200 -ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 58/296 (19%)
Query: 418 IGEGSLGRVYRAEFANGKIM--------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
+G+G+ ++++ +K +D A + E F EA S MS+L H +
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASMMSKLSHKH 73
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+V G C + +LV E+V G+L L + + ++ VA A A+ +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 530 EVCLPSVVHRNFKSANILLDDELNPH--------LSDCGLAALTPNTERQVSTQMVGAF- 580
E L +H N + NILL E + LSD G++ V + +
Sbjct: 131 ENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------ITVLPKDILQER 180
Query: 581 -GYSAPE-FALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHD 637
+ PE + +D +SFG + E+ + G KPL L
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL----------------SALDS 224
Query: 638 IDALAKMVDPALNG--MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
L + + + + PA + A++I C+ EP+ RP +++ L L
Sbjct: 225 QRKL-QFYE---DRHQL-PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 64/277 (23%), Positives = 111/277 (40%), Gaps = 50/277 (18%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL----SLQEEDNFLEAVSNMSRLRHPNIV 471
++G+G+ G VY + +N +A+K+I L EE ++ L+H NIV
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE------IALHKHLKHKNIV 82
Query: 472 TLAGYCAEHGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA---RALEY 527
G + ++ E V G+L +L L N + + T L+Y
Sbjct: 83 QYLG-SFSENGFIKIFMEQVPGGSLSALLR---SKWGPLKDNEQT-IGFYTKQILEGLKY 137
Query: 528 LHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
LH+ +VHR+ K N+L++ +SD G + T G Y APE
Sbjct: 138 LHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPE 193
Query: 587 FALSGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID-ALAK 643
G Y +D++S G ++E+ TG+ P + +++ A
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPP--------------F-----YELGEPQAA 234
Query: 644 MVDPALNGMYPA--KSLSR-FADIIALCVQPEPEFRP 677
M + ++P +S+S I C +P+P+ R
Sbjct: 235 MFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRA 271
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 15/206 (7%)
Query: 418 IGEGSLGRVYRAEF--ANGKIM--AVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVT 472
+G+GS G V R E+ +GK + AVK + LS E D+F+ V+ M L H N++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G +V E G+L D L + R A+ A + YL
Sbjct: 86 LYGVVLTP-PMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY--SAPEFALS 590
+HR+ + N+LL + D GL P + Q + APE +
Sbjct: 142 F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKP 615
++ SD + FGV + E+ T G++P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 51/226 (22%), Positives = 95/226 (42%), Gaps = 45/226 (19%)
Query: 418 IGEGSLGRVYRAEFANGKIM----AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+G+G G V A+ AVK + ++ + + FL + M HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 474 AGYCAEHGQR------LLVYEYVGNGNLHDML--HFADDSSKNLTWNARVRVALGTARAL 525
G + +++ ++ +G+LH L ++ NL VR + A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ---------- 575
EYL + +HR+ + N +L +++ ++D GL+ R++ +
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS-------RKIYSGDYYRQGCASK 200
Query: 576 -----MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ A E +YTV SDV++FGV M E++T G+ P
Sbjct: 201 LPVKWL-------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 68/311 (21%), Positives = 121/311 (38%), Gaps = 76/311 (24%)
Query: 418 IGEGSLGRVYRAEFANGKIM------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ AE N AVK + + +L +F ++ L+H +IV
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIV 80
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNARVRVAL 519
G C + ++V+EY+ +G+L+ L + L + + +A
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ---- 575
A + YL VHR+ + N L+ L + D G++ R V +
Sbjct: 141 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS-------RDVYSTDYYR 190
Query: 576 -----------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRS 623
M PE + +T +SDV+SFGV++ E+ T G++P
Sbjct: 191 VGGHTMLPIRWM-------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW------- 236
Query: 624 EQSLVRWATPQLHDIDALAKMVDPALNGMY---PAKSLSRFADIIALCVQPEPEFRPPMS 680
QL + + + + + G P D++ C Q EP+ R +
Sbjct: 237 ---------FQLSNTEVI-ECIT---QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIK 283
Query: 681 EVVQALVRLVQ 691
E+ + L L +
Sbjct: 284 EIYKILHALGK 294
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG+G G VY E+ A +I A+K + + +Q+ + FL M L HPN++ L
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 474 AGYC-AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G G ++ Y+ +G+L + +N T + L AR +EYL E
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF---GYSAPEFAL 589
VHR+ + N +LD+ ++D GLA + E Q A ++A E
Sbjct: 145 F---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 590 SGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ +T KSDV+SFGV++ ELLT G P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 55/287 (19%), Positives = 105/287 (36%), Gaps = 41/287 (14%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHP 468
SF + ++G G+ G + + + +AVK+I S E V + HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE------VQLLRESDEHP 78
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
N++ + + + E L + + D + L + + T L +L
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAHL 134
Query: 529 HEVCLPSVVHRNFKSANILL-----DDELNPHLSDCGLAALTPNTER--QVSTQMVGAFG 581
H + ++VHR+ K NIL+ ++ +SD GL + + G G
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 582 YSAPE---FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638
+ APE T D++S G V +++ P +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKS----------LQR 236
Query: 639 DALAKMVDPALNGMYPAKSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
A + +L+ ++P K A ++I + +P+ RP V++
Sbjct: 237 QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 56/293 (19%), Positives = 105/293 (35%), Gaps = 74/293 (25%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G + + + ++ A K + + L + + +S L H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALE 526
G+ ++ +V E +L ++ R + AR +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH------------KRRKALTEPEARYYLRQIVLGCQ 129
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL-------------TPNTERQVS 573
YLH V+HR+ K N+ L+++L + D GLA TPN
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN------ 180
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633
Y APE ++ + DV+S G +M LL G+ P ++S
Sbjct: 181 --------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-------------- 218
Query: 634 QLHDIDALAKMVDPALNGMYPA-KSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
+ + Y K ++ A +I +Q +P RP ++E++
Sbjct: 219 ---CLKETYLRI---KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-29
Identities = 67/299 (22%), Positives = 117/299 (39%), Gaps = 17/299 (5%)
Query: 326 CIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKS 385
C+++ S + +S + P + +T H QR TP PA ++
Sbjct: 249 CLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPM 308
Query: 386 GSLKKIKSPITATSYTVASLQTA---TNSFSQEFLIGEGSLGRVYRAEF--ANGKIM-AV 439
+ + + + N + +G G+ G V + + +I A+
Sbjct: 309 PMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 440 KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML 499
K + E+ + M +L +P IV L G C +LV E G G LH L
Sbjct: 369 KVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL 426
Query: 500 HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559
+ + + + + ++YL E VHRN + N+LL + +SD
Sbjct: 427 V---GKREEIPVSNVAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDF 480
Query: 560 GLAALTPNTERQVSTQMVGAFGY--SAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
GL+ + + + G + APE ++ +SDV+S+GV M E L+ G+KP
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 80/342 (23%), Positives = 138/342 (40%), Gaps = 54/342 (15%)
Query: 382 VAKSGSLKKIKSPITATSYTVASLQTATNS------FSQEFLIGEGSLGRVYRA-EFANG 434
V +S + A+L+ + IGEGS G V A E +G
Sbjct: 11 VDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSG 70
Query: 435 KIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGN 492
+ +AVK +D L Q+ L V M +H N+V + G+ L ++ E++
Sbjct: 71 RQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFNVVEMYK-SYLVGEELWVLMEFLQG 126
Query: 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552
G L D++ L V +AL YLH V+HR+ KS +ILL +
Sbjct: 127 GALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDG 178
Query: 553 NPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
LSD G A ++ + ++ S +VG + APE +Y + D++S G++++E++
Sbjct: 179 RVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD 236
Query: 612 GRKPLDSSRP-RSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQ 670
G P S P ++ + L P+L + ++ D + +
Sbjct: 237 GEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSP----------------VLRDFLERMLV 280
Query: 671 PEPEFRPPMSEVVQ-----------ALVRLVQRASVVKRRSS 701
+P+ R E++ LV L+Q K+ S+
Sbjct: 281 RDPQERATAQELLDHPFLLQTGLPECLVPLIQLYR--KQTST 320
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 68/271 (25%), Positives = 109/271 (40%), Gaps = 33/271 (12%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDN---FLEAVSNMSRLRHPNIVTL 473
IG G+ G V + +G+IMAVK+I ++ E++ ++ M P IV
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G G + E + + + ++ L T +AL +L E
Sbjct: 87 YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL- 145
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE----FAL 589
++HR+ K +NILLD N L D G++ ++ + T+ G Y APE A
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSAS 202
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD--- 646
Y V+SDV+S G+ + EL TGR P D L ++V
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNS---------------VFDQLTQVVKGDP 247
Query: 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRP 677
P L+ + F + + LC+ + RP
Sbjct: 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRP 278
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 56/293 (19%), Positives = 105/293 (35%), Gaps = 74/293 (25%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G + + + ++ A K + + L + + +S L H ++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALE 526
G+ ++ +V E +L ++ R + AR +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH------------KRRKALTEPEARYYLRQIVLGCQ 155
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL-------------TPNTERQVS 573
YLH V+HR+ K N+ L+++L + D GLA TPN
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN------ 206
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633
Y APE ++ + DV+S G +M LL G+ P ++S
Sbjct: 207 --------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-------------- 244
Query: 634 QLHDIDALAKMVDPALNGMYPA-KSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
+ + Y K ++ A +I +Q +P RP ++E++
Sbjct: 245 ---CLKETYLRI---KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 72/299 (24%), Positives = 128/299 (42%), Gaps = 44/299 (14%)
Query: 402 VASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVS 460
+++L+ F L+G G+ G+VY+ G++ A+K +D ++ EE+ + ++
Sbjct: 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEIN 72
Query: 461 NMSRL-RHPNIVT-----LAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
+ + H NI T + +L LV E+ G G++ D++ ++ W A
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 514 RV-RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+ R L R L +LH+ V+HR+ K N+LL + L D G++A T +
Sbjct: 133 YICREIL---RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186
Query: 573 STQMVGAFGYSAPE-----FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP-RSEQS 626
+T +G + APE Y KSD++S G+ +E+ G PL P R+
Sbjct: 187 NT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 245
Query: 627 LVRWATPQLHDIDALAKMVDPALNGMYPAKSLSR-FADIIALCVQPEPEFRPPMSEVVQ 684
+ R P+L K S+ F I C+ RP ++++
Sbjct: 246 IPRNPAPRLKS------------------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 66/272 (24%), Positives = 114/272 (41%), Gaps = 39/272 (14%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDN---FLEAVSNMSRLRHPNIVTL 473
+G G+ G V + +G+IMAVK+I ++ ++ ++ +M + P VT
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIR---ATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G G + E + +L D + + + ++A+ +ALE+LH
Sbjct: 72 YGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL- 129
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE----FAL 589
SV+HR+ K +N+L++ + D G++ + + G Y APE
Sbjct: 130 -SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDAGCKPYMAPERINPELN 186
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD--- 646
Y+VKSD++S G+ M+EL R P DS L ++V+
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWG---------------TPFQQLKQVVEEPS 231
Query: 647 PALNGMYPAKSLSR-FADIIALCVQPEPEFRP 677
P L PA S F D + C++ + RP
Sbjct: 232 PQL----PADKFSAEFVDFTSQCLKKNSKERP 259
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 48/227 (21%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G+GS G VY A G + A+K + N A S++E FL S M ++
Sbjct: 33 LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML------HFADDSSKNLTWNARVRVALGTARA 524
V L G ++ L++ E + G+L L + + + +++A A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ--------- 575
+ YL+ VHR+ + N ++ ++ + D G+ R +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT-------RDIYETDYYRKGGKG 200
Query: 576 ------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
M +PE G++T SDV+SFGVV+ E+ T +P
Sbjct: 201 LLPVRWM-------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 56/205 (27%), Positives = 83/205 (40%), Gaps = 17/205 (8%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IGEG G V++ + N + A+K S + FL+ M + HP+IV L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G E+ ++ E G L L +L + + A + AL YL
Sbjct: 82 IGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFALSG 591
VHR+ + N+L+ L D GL+ ++ G + APE
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFR 192
Query: 592 IYTVKSDVYSFGVVMLELLT-GRKP 615
+T SDV+ FGV M E+L G KP
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 65/362 (17%), Positives = 114/362 (31%), Gaps = 70/362 (19%)
Query: 418 IGEG--SLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG+G L V A G+ + V++I+ A S + + HPNIV
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY- 91
Query: 475 GYCA-EHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARV-RVALGTARALEYLHEV 531
L +V ++ G+ D++ N A + + L +AL+Y+H +
Sbjct: 92 -RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHM 147
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTP-----NTERQVSTQMVGAFGYSAP 585
VHR+ K+++IL+ + +LS + V + +P
Sbjct: 148 ---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 586 EFALSGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRP-RSEQSLVRWATPQLHDIDALA 642
E + Y KSD+YS G+ EL G P + + P L D +
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 643 KMVDPALNGMYPA--------------------------KSLSR-FADIIALCVQPEPEF 675
A ++ S F + C+Q P+
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324
Query: 676 RP--------------------PMSEVVQALVRLVQRASVVKRRSSDESGFSYRTPDHEA 715
RP + E+++ + + + S G + E
Sbjct: 325 RPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLEELEV 384
Query: 716 ID 717
D
Sbjct: 385 DD 386
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 46/295 (15%), Positives = 100/295 (33%), Gaps = 39/295 (13%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEA---------------VSNM 462
+ +G ++ E + K A+KK + + L + + + +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 463 SRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA 522
+ +++ +T G + + ++YEY+ N ++ L N + +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE----YFFVLDKNYTCFIPIQVI 153
Query: 523 R--------ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST 574
+ + Y+H ++ HR+ K +NIL+D LSD G + + + +
Sbjct: 154 KCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--G 209
Query: 575 QMVGAFGYSAPEFALSG---IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSE-QSLVRW 630
G + + PEF S K D++S G+ + + P E + +R
Sbjct: 210 -SRGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267
Query: 631 ATPQLHDIDALAKMVDPALNGMYPAKSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
+ LS D + L ++ P R + ++
Sbjct: 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 13/203 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIM----AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+GEG G VY + N K AVK +L ++ F+ M L HP+IV L
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G E ++ E G L L + +L V +L +A+ YL +
Sbjct: 79 IGIIEEE-PTWIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
VHR+ NIL+ L D GL+ + + ++ + +PE +
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 594 TVKSDVYSFGVVMLELLT-GRKP 615
T SDV+ F V M E+L+ G++P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 73/316 (23%), Positives = 119/316 (37%), Gaps = 75/316 (23%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHP 468
+G G+ G+V A A G I AVK + +A L E + + + +S L H
Sbjct: 31 LGAGAFGKVVEAT-AYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHM 87
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDML--------------HFADDSSKNLTWNAR 514
NIV L G C G L++ EY G+L + L +D L
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST 574
+ + A+ + +L + +HR+ + NILL + D GLA R +
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA-------RDIKN 197
Query: 575 QMVGAFGYS------------APEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRP 621
Y APE + +YT +SDV+S+G+ + EL + G P
Sbjct: 198 DSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----- 248
Query: 622 RSEQSLVRWATPQLHDIDALAKMVDPALNGMY---PAKSLSRFADIIALCVQPEPEFRPP 678
P + KM+ G P + + DI+ C +P RP
Sbjct: 249 -----------PGMPVDSKFYKMIK---EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT 294
Query: 679 MSEVVQALVRLVQRAS 694
++VQ + + + ++
Sbjct: 295 FKQIVQLIEKQISEST 310
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 35/222 (15%)
Query: 417 LIGEGSLGRVYRAEFANGKIM---AVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHPNIV 471
+IGEG+ G+V +A + A+K++ + A S + +F + + +L HPNI+
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNII 89
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNARVRVAL 519
L G C G L EY +GNL D L A+ ++ L+ + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA 579
AR ++YL + +HR+ + NIL+ + ++D GL+ R +
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS-------RGQEVYVKKT 199
Query: 580 FG-----YSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
G + A E +YT SDV+S+GV++ E+++ G P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 79/358 (22%), Positives = 129/358 (36%), Gaps = 84/358 (23%)
Query: 383 AKSGSLKKIKSPITATSYTVASLQTATNSFSQEF---------LIGEGSLGRVYRAEFAN 433
+ S + + + Q +++ +GEG+ G+V+ AE N
Sbjct: 5 SGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHN 64
Query: 434 GKIM------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487
AVK + A S +F ++ L+H +IV G C E L+V+
Sbjct: 65 LLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122
Query: 488 EYVGNGNLHDML-----------HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
EY+ +G+L+ L D + L + VA A + YL +
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HF 179
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ---------------MVGAFG 581
VHR+ + N L+ L + D G++ R + + M
Sbjct: 180 VHRDLATRNCLVGQGLVVKIGDFGMS-------RDIYSTDYYRVGGRTMLPIRWM----- 227
Query: 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDA 640
PE L +T +SDV+SFGVV+ E+ T G++P QL + +A
Sbjct: 228 --PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW----------------YQLSNTEA 269
Query: 641 LAKMVDPALNGMY---PAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695
+ + G P I+ C Q EP+ R + +V L L Q V
Sbjct: 270 I-DCIT---QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 44/305 (14%), Positives = 88/305 (28%), Gaps = 41/305 (13%)
Query: 385 SGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMA 438
L IK Q + L+GEG+ +VY A N +
Sbjct: 48 QCKLPAIK--------PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFV 99
Query: 439 VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDM 498
+K A + E + + + + +LV E G L +
Sbjct: 100 LKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNA 157
Query: 499 L-HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH-- 555
+ + + K + + A+ +E +H+ ++H + K N +L +
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214
Query: 556 ---------LSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVV 605
L D G + + + + T G+ E + + + D +
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274
Query: 606 MLELLTGRKP---LDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFA 662
+ +L G + + E R L +D + LN + L
Sbjct: 275 VYCMLFGTYMKVKNEGGECKPEGLFRR-----LPHLDMWNEFFHVMLN-IPDCHHLPSLD 328
Query: 663 DIIAL 667
+
Sbjct: 329 LLRQK 333
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 75/301 (24%), Positives = 120/301 (39%), Gaps = 37/301 (12%)
Query: 345 PVSTNNMNTEMHEQRVKSVAAVTDLTPPPAE--------KLVIERVAKSGSLKKIKSPIT 396
P+ + H +R SVAA + +L K+GS
Sbjct: 3 PIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN 62
Query: 397 ATSYTVASLQTATNSFSQEFL-------------IGEGSLGRVYRAEF--ANGKIM--AV 439
+++L Q + IG G G VY +GK + AV
Sbjct: 63 TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122
Query: 440 KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-GQRLLVYEYVGNGNLHDM 498
K + N + E FL M HPN+++L G C G L+V Y+ +G+L +
Sbjct: 123 KSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 181
Query: 499 LHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558
+ + + N T + L A+ +++L VHR+ + N +LD++ ++D
Sbjct: 182 IR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVAD 235
Query: 559 CGLAALTPNTERQVSTQMVGAF---GYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRK 614
GLA + E GA + A E + +T KSDV+SFGV++ EL+T G
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295
Query: 615 P 615
P
Sbjct: 296 P 296
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 19/206 (9%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPNI 470
L+G G +G VY AE +I+A+K + +L + F EA + RL+ P++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMS---ETLSSDPVFRTRMQREART-AGRLQEPHV 96
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V + + GQ + + +L ML L V + AL+ H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPEFAL 589
HR+ K NIL+ + +L D G+A A T Q+ VG Y APE
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFS 208
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
T ++D+Y+ V+ E LTG P
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPP 234
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 74/310 (23%), Positives = 129/310 (41%), Gaps = 56/310 (18%)
Query: 389 KKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL 447
+ I Y + QE +IG G+ V A + +A+K+I+
Sbjct: 6 SALPWSINRDDYEL-----------QE-VIGSGATAVVQAAYCAPKKEKVAIKRIN---- 49
Query: 448 SLQEEDNFLEAVSN----MSRLRHPNIVTLAGYCA-EHGQRL-LVYEYVGNGNLHDMLHF 501
L++ ++ + MS+ HPNIV+ Y + L LV + + G++ D++
Sbjct: 50 -LEKCQTSMDELLKEIQAMSQCHHPNIVSY--YTSFVVKDELWLVMKLLSGGSVLDIIKH 106
Query: 502 ADDSSKNLTWNAR-------VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554
++ + +R L LEYLH+ +HR+ K+ NILL ++ +
Sbjct: 107 IVAKGEHKSGVLDESTIATILREVL---EGLEYLHKN---GQIHRDVKAGNILLGEDGSV 160
Query: 555 HLSDCGLAA-LTPNTERQVSTQ---MVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLEL 609
++D G++A L + + VG + APE Y K+D++SFG+ +EL
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
Query: 610 LTGRKPLDSSRP-RSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSR-FADIIAL 667
TG P P + ++ P L +M K + F +I+L
Sbjct: 221 ATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEM----------LKKYGKSFRKMISL 270
Query: 668 CVQPEPEFRP 677
C+Q +PE RP
Sbjct: 271 CLQKDPEKRP 280
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 70/305 (22%), Positives = 113/305 (37%), Gaps = 57/305 (18%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ G VY + +G AVK + S Q+E +FL +S+ H NI
Sbjct: 38 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFA---DDSSKNLTWNARVRVALGTARALEY 527
V G + R ++ E + G+L L +L + VA A +Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHL---SDCGLAALTPNTE---RQVSTQ-----M 576
L E +HR+ + N LL + D G+A + M
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQL 635
PE + GI+T K+D +SFGV++ E+ + G P P
Sbjct: 213 -------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY----------------PSK 249
Query: 636 HDIDALAKMVDPALNG--M-YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
+ + L + V +G M P I+ C Q +PE RP + +++ + Q
Sbjct: 250 SNQEVL-EFVT---SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
Query: 693 ASVVK 697
V+
Sbjct: 306 PDVIN 310
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 54/233 (23%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+GE G+VY+ G A+K + + A + F +RL+HPN+
Sbjct: 17 LGEDRFGKVYKGH-LFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNV 74
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNARVRVA 518
V L G + +++ Y +G+LH+ L L V +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 519 LGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ--- 575
A +EYL VVH++ + N+L+ D+LN +SD GL R+V
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF-------REVYAADYY 184
Query: 576 ------------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
M APE + G +++ SD++S+GVV+ E+ + G +P
Sbjct: 185 KLLGNSLLPIRWM-------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 69/290 (23%), Positives = 115/290 (39%), Gaps = 46/290 (15%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPNI 470
++G G + V+ A + + +AVK + L + +F EA + + L HP I
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLR---ADLARDPSFYLRFRREAQN-AAALNHPAI 74
Query: 471 VTLAGYCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
V + +V EYV L D++H + +T + V +AL
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALN 130
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMV-GAFGYSA 584
+ H+ ++HR+ K ANI++ + D G+A A+ + T V G Y +
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD----IDA 640
PE A +SDVYS G V+ E+LTG P P V A + + A
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPSA 241
Query: 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPP-MSEVVQALVRL 689
+ + L+ ++ + PE R +E+ LVR+
Sbjct: 242 RHEGLSADLD------------AVVLKALAKNPENRYQTAAEMRADLVRV 279
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 73/321 (22%), Positives = 117/321 (36%), Gaps = 80/321 (24%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHP 468
+G G+ G+V A A G AVK + + A E + + + M++L H
Sbjct: 53 LGSGAFGKVMNAT-AYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHE 109
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-------------------HFADDSSKNL 509
NIV L G C G L++EY G+L + L ++ L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 510 TWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
T+ + A A+ +E+L S VHR+ + N+L+ + D GLA
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA------- 219
Query: 570 RQVSTQMVGAFGYS------------APEFALSGIYTVKSDVYSFGVVMLELLT-GRKPL 616
R + + Y APE GIYT+KSDV+S+G+++ E+ + G P
Sbjct: 220 RDIMSDSN----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP- 274
Query: 617 DSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY---PAKSLSRFADIIALCVQPEP 673
P + K++ NG P + I+ C +
Sbjct: 275 ---------------YPGIPVDANFYKLIQ---NGFKMDQPFYATEEIYIIMQSCWAFDS 316
Query: 674 EFRPPMSEVVQALVRLVQRAS 694
RP + L + A
Sbjct: 317 RKRPSFPNLTSFLGCQLADAE 337
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-28
Identities = 35/166 (21%), Positives = 63/166 (37%), Gaps = 11/166 (6%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNL-PYSIASMVSLSYL 158
+ L +L D+S +L L +A N+F N P + +L++L
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS-L 217
++S+ L Q F +L+ L L++S NNF + L+++ L N + S
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535
Query: 218 NVFSGLP--LTTLNVANNHFSG-----WIPRELISIRTFIYDGNSF 256
P L LN+ N F+ + + R + +
Sbjct: 536 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERM 581
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 37/165 (22%), Positives = 61/165 (36%), Gaps = 10/165 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L L D +++ + + NL L+++ + + SL L
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 160 VSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL- 217
++ NS ++ DIF L L LDLS P +F SLS++ L + +N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRELI----SIRTFIYDGNSFD 257
+ L L L+ + NH +EL S+ N F
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 38/195 (19%), Positives = 64/195 (32%), Gaps = 32/195 (16%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140
+ ++D+S L Y L+ DLS I +L++L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF-SGDLPNSFIS 199
+ + + SL L +L G+L L L+++ N S LP F +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 200 LSNISSLYLQNNQVTG-----------------------------SLNVFSGLPLTTLNV 230
L+N+ L L +N++ F + L L +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207
Query: 231 ANNHFSGWIPRELIS 245
NN S + + I
Sbjct: 208 RNNFDSLNVMKTCIQ 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 32/129 (24%), Positives = 52/129 (40%), Gaps = 3/129 (2%)
Query: 111 KFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG 170
+ + + IP LP + +L+L+ N YS S L L++SR +
Sbjct: 11 TYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTL 228
+ +L+ L+TL L+ N +F LS++ L + N L L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 229 NVANNHFSG 237
NVA+N
Sbjct: 130 NVAHNLIQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-24
Identities = 34/159 (21%), Positives = 60/159 (37%), Gaps = 9/159 (5%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIH--DTIPYQL--PPNLTSLNLASNNFSGNLPYS 148
G + DL SL DLS N + +L L+L+ N + +
Sbjct: 333 TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSN 391
Query: 149 IASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY 207
+ L +L+ ++L Q +F +L L LD+S + F LS++ L
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 208 LQNNQVTGSL--NVFSGLP-LTTLNVANNHFSGWIPREL 243
+ N + ++F+ L LT L+++ P
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 32/136 (23%), Positives = 51/136 (37%), Gaps = 4/136 (2%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSG 143
+DIS + + L SL ++GNS + + NLT L+L+
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL-SN 202
P + S+ SL LN+S N+ + L L LD S N+ S+
Sbjct: 485 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 544
Query: 203 ISSLYLQNNQVTGSLN 218
++ L L N +
Sbjct: 545 LAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 40/182 (21%), Positives = 66/182 (36%), Gaps = 28/182 (15%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS------------------- 142
L + L ++ F L +I + L L + F
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK 336
Query: 143 GNLPYSIASMVSLSYLNVSRNSLT--QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
G +S + SL +L++SRN L+ L LDLSFN + ++F+ L
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGL 395
Query: 201 SNISSLYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSGWIPRE---LISIRTFIYDGN 254
+ L Q++ + +VF L L L++++ H L S+ GN
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 255 SF 256
SF
Sbjct: 456 SF 457
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-20
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 7/149 (4%)
Query: 88 IDISGLGLSGTM-GYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN 144
+ ++G + ++L +L DLS + P +L LN++ NNF
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAG-LATLDLSFNNFSGDLPNS-FIS-LS 201
+ + SL L+ S N + S + LA L+L+ N+F+ + F+ +
Sbjct: 510 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIK 569
Query: 202 NISSLYLQNNQVTGSL-NVFSGLPLTTLN 229
+ L ++ ++ + + G+P+ +LN
Sbjct: 570 DQRQLLVEVERMECATPSDKQGMPVLSLN 598
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-16
Identities = 35/186 (18%), Positives = 60/186 (32%), Gaps = 15/186 (8%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKF----DLSGNSIHDTIPYQL-PPNLTSLNLASNNFS 142
+D+S + L L + DLS N ++ P L L L +N S
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDS 213
Query: 143 GNLPY-SIASMVSLSYLNVSRNSLTQSI---GDIFGNLAGLATLDLSFNNFS------GD 192
N+ I + L + L GL L + + D
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273
Query: 193 LPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYD 252
+ + F L+N+SS L + + + L + N F + +L S++ +
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT 333
Query: 253 GNSFDN 258
N N
Sbjct: 334 SNKGGN 339
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 67/296 (22%), Positives = 125/296 (42%), Gaps = 47/296 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
+G+G+ G+VY+A G + A K I+ +EE ++++ + ++ HP IV L G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
H +L ++ E+ G + ++ D + LT V AL +LH
Sbjct: 84 -AYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK--- 136
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI-- 592
++HR+ K+ N+L+ E + L+D G++A T ++ + +G + APE +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMK 195
Query: 593 ---YTVKSDVYSFGVVMLELLTGRKPLDSSRP-RSEQSLVRWATPQLHDIDALAKMVDPA 648
Y K+D++S G+ ++E+ P P R + + P L +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV----- 250
Query: 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ-----------ALVRLVQRA 693
F D + + + PE RP +++++ AL LV A
Sbjct: 251 -----------EFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEA 295
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 79/341 (23%), Positives = 131/341 (38%), Gaps = 79/341 (23%)
Query: 418 IGEGSLGRVYRAEFANGKIM---------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-R 466
+GEG+ G+V AE A G AVK + +A + ++ + + + M + +
Sbjct: 77 LGEGAFGQVVLAE-AIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGK 133
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNAR 514
H NI+ L G C + G ++ EY GNL + L + + + + L+
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST 574
V A AR +EYL +HR+ + N+L+ ++ ++D GLA + + T
Sbjct: 194 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 575 Q--------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQ 625
M APE IYT +SDV+SFGV++ E+ T G P
Sbjct: 251 TNGRLPVKWM-------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---------- 293
Query: 626 SLVRWATPQLHDIDALAK------MVDPAL--NGMYPAKSLSRFADIIALCVQPEPEFRP 677
P + + M P+ N +Y ++ C P RP
Sbjct: 294 ------YPGVPVEELFKLLKEGHRMDKPSNCTNELY---------MMMRDCWHAVPSQRP 338
Query: 678 PMSEVVQALVRLVQRASVVKR-RSSDESGFSYRTPDHEAID 717
++V+ L R+V S + Y P E +
Sbjct: 339 TFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENLY 379
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 70/305 (22%), Positives = 113/305 (37%), Gaps = 57/305 (18%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ G VY + +G AVK + S Q+E +FL +S+ H NI
Sbjct: 79 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLH---FADDSSKNLTWNARVRVALGTARALEY 527
V G + R ++ E + G+L L +L + VA A +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHL---SDCGLAALTPNTE---RQVSTQ-----M 576
L E +HR+ + N LL + D G+A + M
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQL 635
PE + GI+T K+D +SFGV++ E+ + G P P
Sbjct: 254 -------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY----------------PSK 290
Query: 636 HDIDALAKMVDPALNG--M-YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
+ + L + V +G M P I+ C Q +PE RP + +++ + Q
Sbjct: 291 SNQEVL-EFVT---SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
Query: 693 ASVVK 697
V+
Sbjct: 347 PDVIN 351
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 45/230 (19%)
Query: 418 IGEGSLGRVYRAEFANGKIM---------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-R 466
+GEG+ G+V AE A G AVK + D+A + ++ + + + M + +
Sbjct: 43 LGEGAFGQVVMAE-AVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGK 99
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNAR 514
H NI+ L G C + G ++ EY GNL + L + +T+
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST 574
V AR +EYL +HR+ + N+L+ + ++D GLA N + T
Sbjct: 160 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 575 Q--------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
M APE +YT +SDV+SFGV+M E+ T G P
Sbjct: 217 TNGRLPVKWM-------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 405 LQTATNSFSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAV 459
+ + S+ + +G G+ G V A+K I ++S LE V
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 460 SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARV 515
+ + L HPNI+ L + + LV E G L D + F + + + +
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----I 142
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQV 572
+ L + YLH+ ++VHR+ K N+LL + + + D GL+A+ N ++
Sbjct: 143 KQVLS---GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM- 195
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ +G Y APE L Y K DV+S GV++ LL G P
Sbjct: 196 -KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 60/272 (22%), Positives = 108/272 (39%), Gaps = 40/272 (14%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDN---FLEAVSNMSRLRHPNIVTL 473
+G G+ G+V++ F G ++AVK++ S +E+N ++ + P IV
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + + E +G + ++ + +AL YL E
Sbjct: 90 FGTFITNTDVFIAMELMGTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEK-- 143
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE-----FA 588
V+HR+ K +NILLD+ L D G++ + + + + G Y APE
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERIDPPDP 201
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD-- 646
Y +++DV+S G+ ++EL TG+ P + + D + L K++
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKT---------------DFEVLTKVLQEE 246
Query: 647 -PALNGMYPAKSLSRFADIIALCVQPEPEFRP 677
P L G F + C+ + RP
Sbjct: 247 PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRP 276
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 67/310 (21%), Positives = 114/310 (36%), Gaps = 67/310 (21%)
Query: 418 IGEGSLGRVYRAEFA-----NGKIM-AVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHPN 469
+G G+ G+V A + + AVK + A E++ + + MS L +H N
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHEN 111
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDML----------HFADDSSKNLTWNARVRVAL 519
IV L G C G L++ EY G+L + L ++ + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA 579
A+ + +L + +HR+ + N+LL + + D GLA R +
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLA-------RDIMNDSN-- 219
Query: 580 FGYS------------APEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQS 626
Y APE +YTV+SDV+S+G+++ E+ + G P S+
Sbjct: 220 --YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-- 275
Query: 627 LVRWATPQLHDIDALAKMVDPAL--NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+ +M PA +Y I+ C EP RP ++
Sbjct: 276 -------FYKLVKDGYQMAQPAFAPKNIY---------SIMQACWALEPTHRPTFQQICS 319
Query: 685 ALVRLVQRAS 694
L Q
Sbjct: 320 FLQEQAQEDR 329
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-27
Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 13/203 (6%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IGEG G V++ + N + A+K S + FL+ M + HP+IV L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G E+ ++ E G L L S L + + A + AL YL
Sbjct: 457 IGVITEN-PVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKRF 512
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
VHR+ + N+L+ L D GL+ ++ +++ + APE +
Sbjct: 513 ---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 594 TVKSDVYSFGVVMLELLT-GRKP 615
T SDV+ FGV M E+L G KP
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKP 592
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 72/315 (22%), Positives = 121/315 (38%), Gaps = 74/315 (23%)
Query: 418 IGEGSLGRVYRAEFANG-------KIMAVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHP 468
+G G+ G+V A+ A G + +AVK + + A + E + + + + H
Sbjct: 35 LGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHL 91
Query: 469 NIVTLAGYCAEHGQ-RLLVYEYVGNGNLHDML------------HFADDSSKNLTWNARV 515
N+V L G C + G +++ E+ GNL L D LT +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575
+ A+ +E+L +HR+ + NILL ++ + D GLA R +
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA-------RDIYKD 201
Query: 576 MVGAFGYS------------APEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPR 622
Y APE +YT++SDV+SFGV++ E+ + G P
Sbjct: 202 PD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP------- 250
Query: 623 SEQSLVRWATPQLHDIDALAKMVDPALNG--M-YPAKSLSRFADIIALCVQPEPEFRPPM 679
P + + + + G M P + + C EP RP
Sbjct: 251 ---------YPGVKIDEEFCRRLK---EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 298
Query: 680 SEVVQALVRLVQRAS 694
SE+V+ L L+Q +
Sbjct: 299 SELVEHLGNLLQANA 313
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 56/238 (23%)
Query: 418 IGEGSLGRVYRAEFA-----NGKIM-AVKKI-DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+GEG G+V +A G AVK + +NA S E + L + + ++ HP++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHV 88
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML--------------------HFADDSSKNLT 510
+ L G C++ G LL+ EY G+L L + LT
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
+ A ++ ++YL E+ +VHR+ + NIL+ + +SD GL+ R
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS-------R 198
Query: 571 QVSTQMVGAFGYS------------APEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
V + Y A E IYT +SDV+SFGV++ E++T G P
Sbjct: 199 DVYEEDS----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 70/323 (21%), Positives = 121/323 (37%), Gaps = 85/323 (26%)
Query: 418 IGEGSLGRVYRAEFANGKIM------AVKKI-DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
IGEG+ GRV++A AVK + + A S + +F + M+ +PNI
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNI 112
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML--------------------HFADDSSKNLT 510
V L G CA L++EY+ G+L++ L + L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
++ +A A + YL E VHR+ + N L+ + + ++D GL+ R
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS-------R 222
Query: 571 QVSTQ---------------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRK 614
+ + M PE YT +SDV+++GVV+ E+ + G +
Sbjct: 223 NIYSADYYKADGNDAIPIRWM-------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 615 PLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY---PAKSLSRFADIIALCVQP 671
P + + + V +G P +++ LC
Sbjct: 276 PY----------------YGMAHEEVI-YYVR---DGNILACPENCPLELYNLMRLCWSK 315
Query: 672 EPEFRPPMSEVVQALVRLVQRAS 694
P RP + + L R+ +RA
Sbjct: 316 LPADRPSFCSIHRILQRMCERAE 338
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 79/308 (25%), Positives = 125/308 (40%), Gaps = 54/308 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLAG 475
IG GS G VY A + N +++A+KK+ + E+ + V + +LRHPN + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
C LV EY G+ D+L K L V G + L YLH
Sbjct: 122 -CYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH--- 173
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAA-LTP-NTERQVSTQMVGAFGYSAPEFALS-- 590
+++HR+ K+ NILL + L D G A+ + P N+ VG + APE L+
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-------FVGTPYWMAPEVILAMD 226
Query: 591 -GIYTVKSDVYSFGVVMLELLTGRKPLDSSRP-RSEQSLVRWATPQLHDIDALAKMVDPA 648
G Y K DV+S G+ +EL + PL + + + + +P L
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS----------- 275
Query: 649 LNGMYPAKSLSR-FADIIALCVQPEPEFRPPMSEVVQ-----------ALVRLVQRASVV 696
S F + + C+Q P+ RP +++ ++ L+QR
Sbjct: 276 -------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDA 328
Query: 697 KRRSSDES 704
R +
Sbjct: 329 VRELDNLQ 336
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 9e-27
Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G G V R G+ +A+K+ LS + + + + M +L HPN+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 474 ---AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
A + LL EY G+L L+ ++ L + + AL YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 531 VCLPSVVHRNFKSANILLDDELNPH---LSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
++HR+ K NI+L + D G A E + T+ VG Y APE
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPEL 194
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLDS 618
YTV D +SFG + E +TG +P
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 51/227 (22%), Positives = 86/227 (37%), Gaps = 23/227 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G+G+ V+R G + A+K +N + + D + + +L H NIV L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 476 YCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
E R L+ E+ G+L+ +L ++ L + + V + +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 534 PSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGAFGYSAPE--- 586
+VHRN K NI+ + L+D G A + E + G Y P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYE 188
Query: 587 -----FALSGIYTVKSDVYSFGVVMLELLTGRKP-LDSSRPRSEQSL 627
Y D++S GV TG P PR + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 57/250 (22%), Positives = 89/250 (35%), Gaps = 44/250 (17%)
Query: 417 LIGEGSLGRVYRAE--FANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPN 469
I G LG +Y A NG+ + +K L + E ++ + HP+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLK-----GLVHSGDAEAQAMAMAERQF-LAEVVHPS 140
Query: 470 IVTLAGYCAEHGQRL------LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
IV + + EH R +V EYVG +L + L + L
Sbjct: 141 IVQIFNF-VEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILP 193
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGY 582
AL YLH + +V+ + K NI+L +E L D G + + G G+
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGF 243
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRS--EQSLVRWATPQLHDI-- 638
APE +G TV +D+Y+ G + L + E V +
Sbjct: 244 QAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLR 302
Query: 639 DALAKMVDPA 648
A+ DP
Sbjct: 303 RAIDP--DPR 310
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 53/234 (22%)
Query: 418 IGEGSLGRVYRAEFANGKIM---------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-R 466
+GEG G+V AE A G AVK + D+A + ++ + + + M + +
Sbjct: 89 LGEGCFGQVVMAE-AVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGK 145
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNAR 514
H NI+ L G C + G ++ EY GNL + L + +T+
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST 574
V AR +EYL +HR+ + N+L+ + ++D GLA R ++
Sbjct: 206 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLA-------RDINN 255
Query: 575 QMVGAFGYS------------APEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
Y APE +YT +SDV+SFGV+M E+ T G P
Sbjct: 256 IDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 55/295 (18%), Positives = 106/295 (35%), Gaps = 45/295 (15%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G+ G V++ +G +MA K I L+ + + + P IV
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIH-----LEIKPAIRNQIIRELQVLHECNSPYIVG 95
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G G+ + E++ G+L +L A + +V++ + L YL E
Sbjct: 96 FYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
++HR+ K +NIL++ L D G++ ++ ++ VG Y +PE
Sbjct: 152 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH 206
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652
Y+V+SD++S G+ ++E+ GR P+ + + +
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 653 YPAKSLSR--------------------------FADIIALCVQPEPEFRPPMSE 681
+ S F D + C+ P R + +
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 68/328 (20%), Positives = 125/328 (38%), Gaps = 62/328 (18%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLA 474
++ EG VY A+ +G+ A+K++ + ++ ++ V M +L HPNIV
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 475 GYCAEHGQR-------LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+ + L+ + G L + L +S L+ + +++ T RA+++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFG----- 581
+H P ++HR+ K N+LL ++ L D G A ++ + S Q
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 582 -----YSAPE-FALSG--IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633
Y PE L K D+++ G ++ L + P + + + +R
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE------DGAKLR---- 260
Query: 634 QLHDIDALAKMVDPALNGMY-----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQ---- 684
I +NG Y + + F +I +Q PE R ++EVV
Sbjct: 261 ----I----------VNGKYSIPPHDTQY-TVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305
Query: 685 -ALVRLVQRASVVKRRSSDESGFSYRTP 711
A R V S + G+ T
Sbjct: 306 IAAARNVNPKSPITELLEQNGGYGSATL 333
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-26
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 27/224 (12%)
Query: 405 LQTATNSFSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEE-DNFLEA 458
+Q +T FS + ++G+GS G V + G+ AVK I + + + ++ L
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 459 VSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNAR 514
V + +L HPNI+ L + + G LV E G L D + F++ + +
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI----- 131
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQ 571
+R L + Y+H+ +VHR+ K N+LL + N + D GL+ +++
Sbjct: 132 IRQVLS---GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+G Y APE L G Y K DV+S GV++ LL+G P
Sbjct: 186 --KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 34/138 (24%), Positives = 58/138 (42%), Gaps = 3/138 (2%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
S D S + +P LP N+T LNL N + L+ L+V N++++
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGLP-L 225
++ L L L+L N S +F +N++ L+L +N + N F L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 226 TTLNVANNHFSGWIPREL 243
TL++++N S
Sbjct: 124 ITLDLSHNGLSSTKLGTQ 141
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-25
Identities = 40/169 (23%), Positives = 69/169 (40%), Gaps = 6/169 (3%)
Query: 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS 142
+ ++++ L + L D+ N+I P P L LNL N S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
+ A +L+ L++ NS+ + + F L TLDLS N S + + L N
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 203 ISSLYLQNNQVTG----SLNVFSGLPLTTLNVANNHFSGWIPRELISIR 247
+ L L NN++ L++F+ L L +++N + P +I
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-25
Identities = 39/167 (23%), Positives = 60/167 (35%), Gaps = 6/167 (3%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNN 140
S + S+D+ +S L L L+ +L N + NLT L+L SN+
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
+L L++S N L+ + L L L LS N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168
Query: 201 SNIS--SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
+N S L L +NQ+ S F + L L + N + +L
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 36/188 (19%), Positives = 66/188 (35%), Gaps = 18/188 (9%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSG 143
I +S + + SL++ L ++ + P NLT L+L++NN +
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQ--------SIGDIFGNLAGLATLDLSFNNFSGDLPN 195
+ + L L++ N+L + L+ L L+L N F
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 196 SFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIP----RELISIRTF 249
F L + + L N + +VF+ L +LN+ N + ++
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 250 IYDGNSFD 257
N FD
Sbjct: 615 DMRFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 42/169 (24%), Positives = 63/169 (37%), Gaps = 15/169 (8%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSG 143
++++ +S S L L DL N I + Q N+ + L+ N +
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 144 NLPYSIASMVSLSYLNVSRNSLT--QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLS 201
S A + SL L + R +L S F L L LDLS NN + + L
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
Query: 202 NISSLYLQNNQVT---------GSLNVFSGLP-LTTLNVANNHFSGWIP 240
+ L LQ+N + G + GL L LN+ +N F
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 33/177 (18%), Positives = 67/177 (37%), Gaps = 19/177 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-----PNLTSLNLASNNF 141
+++S + + L L+ + ++ +L ++ +L+L+++
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234
Query: 142 SGNLPYSIASM--VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS 199
S + + +L+ L++S N+L D F L L L +NN +S
Sbjct: 235 STTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHG 294
Query: 200 LSNISSLYLQNNQVTGSL----------NVFSGLP-LTTLNVANNHFSGWIPRELIS 245
L N+ L L+ + S+ F L L LN+ +N G I + +
Sbjct: 295 LFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFT 350
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 40/149 (26%), Positives = 61/149 (40%), Gaps = 13/149 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS--------GNLPYSIAS 151
L +L DLS N+I + L L L+L NN + G Y +
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534
Query: 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ L LN+ N + ++F +L L +DL NN + + F + ++ SL LQ N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
Query: 212 QVTG-SLNVFSGLP--LTTLNVANNHFSG 237
+T VF LT L++ N F
Sbjct: 595 LITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 34/172 (19%), Positives = 62/172 (36%), Gaps = 15/172 (8%)
Query: 87 SIDISGLGLSGTM-GYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSG 143
+D+ + + G L ++ + LS N P+L L L
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
Query: 144 --NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--------GDL 193
+ P + +L+ L++S N++ D+ L L LDL NN + G
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 194 PNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
LS++ L L++N + VF L L +++ N+ +
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 34/153 (22%), Positives = 58/153 (37%), Gaps = 11/153 (7%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASM--VSLSY 157
+L DLS N + T NL L L++N + SL
Sbjct: 116 PFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF---ISLSNISSLYLQNNQVT 214
L +S N + + F + L L L+ L ++ ++I +L L N+Q++
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235
Query: 215 GSLN-VFSGLP---LTTLNVANNHFSGWIPREL 243
+ N F GL LT L+++ N+ +
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-21
Identities = 38/183 (20%), Positives = 71/183 (38%), Gaps = 17/183 (9%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137
+ + + +D+S L+ + L L F L N+I + L N+ LNL
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304
Query: 138 SNNFSGNL---------PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188
+ ++ +S + L +LN+ N + ++F L L L LS +
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
Query: 189 FSGD--LPNSFISLSNIS--SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRE 242
S +F+SL++ L L N+++ + FS L L L++ N + +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 243 LIS 245
Sbjct: 425 EWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-21
Identities = 39/200 (19%), Positives = 77/200 (38%), Gaps = 21/200 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY-QLP----------PNLTSLN 135
+ + + L L ++R +L + +I LP L LN
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335
Query: 136 LASNNFSGNLPYSIASMVSLSYLNVSRN--SLTQSIGDIFGNLA--GLATLDLSFNNFSG 191
+ N+ G +++L YL++S + SL + F +LA L L+L+ N S
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395
Query: 192 DLPNSFISLSNISSLYLQNNQVTGSLN--VFSGLP-LTTLNVANNHFSGWIP---RELIS 245
++F L ++ L L N++ L + GL + + ++ N + + S
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455
Query: 246 IRTFIYDGNSFDNGPAPPPP 265
++ + + N + P P
Sbjct: 456 LQRLMLRRVALKNVDSSPSP 475
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-12
Identities = 23/95 (24%), Positives = 40/95 (42%), Gaps = 6/95 (6%)
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
VS + S LTQ D+ N + L+L+ N +F S ++SL + N
Sbjct: 4 VSHEVADCSHLKLTQVPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 213 VTG-SLNVFSGLP-LTTLNVANNHFSGWIPRELIS 245
++ + LP L LN+ +N S + + +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFA 94
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 36/198 (18%), Positives = 73/198 (36%), Gaps = 34/198 (17%)
Query: 45 QALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLS 104
+ L++L N+ + L WK KG+ S + +++ G +
Sbjct: 504 EKLEILDLQHNNLARL--WKHANPGGPIYFLKGL----SHLHILNLESNGFDEIPVEVFK 557
Query: 105 DLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164
DL L+ DL N+++ + VSL LN+ +N
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVF----------------------NNQVSLKSLNLQKNL 595
Query: 165 LTQSIGDIFG-NLAGLATLDLSFNNFSGDLPN-----SFISLSNISSLYLQNNQVTGSLN 218
+T +FG L LD+ FN F + ++I+ ++ + L ++ + +
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
Query: 219 VFSGLPLTTLNVANNHFS 236
+ G P+ + ++ S
Sbjct: 656 HYHGFPVRLFDTSSCKDS 673
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 17/119 (14%), Positives = 39/119 (32%), Gaps = 10/119 (8%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP---NLTSLNLASN 139
+ ID+ L+ + ++ +SL+ +L N I P NLT L++ N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 140 NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF----GNLAGLATLDLSFNNFSGDLP 194
F ++++N + ++ + + G ++
Sbjct: 620 PFDCTCESIAW---FVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSSCKDSAH 675
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 63/328 (19%), Positives = 112/328 (34%), Gaps = 33/328 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G+G+ V+R G + A+K +N + + D + + +L H NIV L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 476 YCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
E R L+ E+ G+L+ +L ++ L + + V + +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 534 PSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGAFGYSAPE--- 586
+VHRN K NI+ + L+D G A + E+ VS + G Y P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYE 188
Query: 587 -----FALSGIYTVKSDVYSFGVVMLELLTGRKP-LDSSRPRSEQSL---VRWATPQLHD 637
Y D++S GV TG P PR + + + P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 638 IDALAKMVDPAL--NGMYPAKSLSRFA-----DIIALCVQPEPEFRPPMSEVVQALVRLV 690
P M + SLSR ++A ++ + E + ++
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308
Query: 691 QRASVVKRRSSDESGFSYRTPDHEAIDT 718
R + + +
Sbjct: 309 HRMVIHVFSLQQMTAHKIYIHSYNTATI 336
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-25
Identities = 33/315 (10%), Positives = 80/315 (25%), Gaps = 61/315 (19%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKID--------------------------NAALSL 449
++G+ A G+ V
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 450 QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLLVYEYVG--NGNLHDMLHFADDS 505
+ F+ + + ++ + + R +Y + ++L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 506 SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565
K+L +AR+++ L R L LH +VH + +I+LD L+
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 566 PNTERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLDSSR 620
+ + +A + T D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD- 320
Query: 621 PRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMS 680
+ W +I + ++ ++ E R
Sbjct: 321 --AALGGSEWIFRSCKNIPQPVR-------------------ALLEGFLRYPKEDRLLPL 359
Query: 681 EVVQALVRLVQRASV 695
+ ++ R +
Sbjct: 360 QAMETPEYEQLRTEL 374
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 70/281 (24%), Positives = 116/281 (41%), Gaps = 53/281 (18%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G+ +V A G+ +A+K ID L+ V M L HPNIV L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 477 -CAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALE 526
E + L L+ EY G + D L A R+ AR A++
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLV------------AHGRMKEKEARSKFRQIVSAVQ 128
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
Y H+ +VHR+ K+ N+LLD ++N ++D G + ++ GA Y+APE
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE-FTVGGKLDAF-CGAPPYAAPE 183
Query: 587 FALSGIYT-VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
Y + DV+S GV++ L++G P D ++ L + V
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-----------------NLKELRERV 226
Query: 646 DPALNGMYPA-KSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
L G Y +S +++ + P R + ++++
Sbjct: 227 ---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 62/304 (20%), Positives = 109/304 (35%), Gaps = 66/304 (21%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAG 475
++G GS G V G+ +AVK++ + D L + ++ HPN++
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDDHPNVIRY-- 74
Query: 476 YCAEHGQRL--LVYEYVGNGNLHDML---HFADDSSKNLTWNARVRVALGTARALEYLHE 530
YC+E R + E NL D++ + +D++ K + + A + +LH
Sbjct: 75 YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 531 VCLPSVVHRNFKSANILLDDELNPH-------------LSDCGLAALTPNTERQVSTQM- 576
+ ++HR+ K NIL+ +SD GL + + T +
Sbjct: 134 L---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 577 --VGAFGYSAPE-------FALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQ- 625
G G+ APE T D++S G V +L+ G+ P R
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 626 -----SLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMS 680
SL + A A D+I+ + +P RP
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEAT-------------------DLISQMIDHDPLKRPTAM 291
Query: 681 EVVQ 684
+V++
Sbjct: 292 KVLR 295
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-25
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+GS G V + + + AVK I+ A+ ++ L V + +L HPNI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 477 CAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ +V E G L D + F++ + + ++ + Y+H+
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFS---GITYMHKH- 140
Query: 533 LPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++VHR+ K NILL + + + + D GL+ + +G Y APE L
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VL 195
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
G Y K DV+S GV++ LL+G P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+GS G V + + + AVK I+ A+ ++ L V + +L HPNI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 477 CAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ +V E G L D + F++ + + ++ + Y+H+
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFS---GITYMHKH- 140
Query: 533 LPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++VHR+ K NILL + + + + D GL+ + +G Y APE L
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VL 195
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
G Y K DV+S GV++ LL+G P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-25
Identities = 42/181 (23%), Positives = 70/181 (38%), Gaps = 10/181 (5%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY---QLPPNLTSLNLASNNFSG 143
S+++S + L DL+ + Q L LNL+ +
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSIG---DIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
+ + +L +LN+ N + + L L L LSF + S ++F SL
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
Query: 201 SNISSLYLQNNQVTG-SLNVFSGLPLTTLNVANNHFSGWIP---RELISIRTFIYDGNSF 256
++ + L +N++T S+ S L LN+A+NH S +P L RT N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
Query: 257 D 257
D
Sbjct: 560 D 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-23
Identities = 31/161 (19%), Positives = 49/161 (30%), Gaps = 7/161 (4%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN 144
+ + LGL+ G L + L + S N + NLT L+L
Sbjct: 16 TYNCENLGLNEIPGTLPNSTECL---EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
+ S L L ++ N L L L S + +
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 205 SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
SLYL +N ++ L L L+ NN ++
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 34/156 (21%), Positives = 59/156 (37%), Gaps = 8/156 (5%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSI- 149
+ S L +L L+ +LS N P L L+LA S
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421
Query: 150 ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG---DLPNSFISLSNISSL 206
++ L LN+S + L S +F L L L+L N+F NS +L + L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 207 YLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIP 240
L ++ + F+ L + +++++N +
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 8/168 (4%)
Query: 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS 142
V SI++ L++ DL+ + +P L L L L++N F
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFE 314
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGD-IFGNLAGLATLDLSFNN--FSGDLPNSFIS 199
S ++ SL++L++ N+ +G NL L LDLS ++ S +
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374
Query: 200 LSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRELIS 245
LS++ SL L N+ F P L L++A +
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 22/130 (16%), Positives = 50/130 (38%), Gaps = 3/130 (2%)
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
+ ++ ++ IP LP + L + N + + +++L++L+++R +
Sbjct: 15 KTYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 170 GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTT 227
D F + L TL L+ N + + L+ ++ L +
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 228 LNVANNHFSG 237
L + +NH S
Sbjct: 134 LYLGSNHISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-21
Identities = 28/147 (19%), Positives = 51/147 (34%), Gaps = 9/147 (6%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
+S+ +L + + L L+L + + S LP + + +L L +S N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDL-PNSFISLSNISSLYLQNNQVTGS---LNV 219
N L L + N +L +L N+ L L ++ + S
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 220 FSGLP-LTTLNVANNHFSGWIPRELIS 245
L L +LN++ N + E
Sbjct: 372 LRNLSHLQSLNLSYNEPLS-LKTEAFK 397
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-21
Identities = 28/163 (17%), Positives = 54/163 (33%), Gaps = 10/163 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
S L++L DL+ I+ L +L L +N +++ +L +L
Sbjct: 53 FSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT----GS 216
+ ++ N L +L L N+ S + L QNN +
Sbjct: 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
Query: 217 LNVFSGLPLTTLNVANNHFSGWIPRE---LISIRTFIYDGNSF 256
++ +LN+ N +G I ++ + G
Sbjct: 173 MSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQN 214
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-21
Identities = 31/143 (21%), Positives = 55/143 (38%), Gaps = 8/143 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN---LPYSIASMVSLS 156
+L L+ +LS + + + P L LNL N+F S+ ++ L
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L +S L+ F +L + +DLS N + + L I L L +N ++
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISII 538
Query: 216 SLNVFSGLP-LTTLNVANNHFSG 237
++ L T+N+ N
Sbjct: 539 LPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-20
Identities = 28/160 (17%), Positives = 55/160 (34%), Gaps = 10/160 (6%)
Query: 87 SIDISGLGLSGTM--GYLLSDLLSLRKFDLSGNSIHD----TIPYQLPPNLTSLNLASNN 140
S++ G + G S + SL D ++ S+NL +
Sbjct: 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
F + L L+++ L++ + L+ L L LS N F S +
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNF 324
Query: 201 SNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFSG 237
+++ L ++ N L L L L+++++
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-16
Identities = 25/143 (17%), Positives = 43/143 (30%), Gaps = 9/143 (6%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
LS +L+ I L L SL L SN+ S L L+
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLD 159
Query: 160 VSRNSLTQSIGDIFGNLAGLA--TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
N++ + +L +L+L+ N+ +G + + SL Q +
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVI 218
Query: 218 ---NVFSGLP-LTTLNVANNHFS 236
S + L +
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDE 241
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-15
Identities = 24/164 (14%), Positives = 54/164 (32%), Gaps = 11/164 (6%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN 144
+ G+S L + +L L N I + L L+ +N
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168
Query: 145 LPYSIASMVSLS--YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN--SFISL 200
++S+ + LN++ N + I + A +L+ + ++
Sbjct: 169 SKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI 227
Query: 201 SNISSLYLQNNQVTG-SLNVFSGLP---LTTLNVANNHFSGWIP 240
++ ++ S VF GL + ++N+ ++F
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 58/202 (28%), Positives = 83/202 (41%), Gaps = 11/202 (5%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G+ G V+ E ++G +K I+ + E E + + L HPNI+ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE-IEVLKSLDHPNIIKIFEV 88
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
++ +V E G L + + A K L+ + AL Y H V
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 537 VHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
VH++ K NIL + D GLA L + ST G Y APE
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGTALYMAPE-VFKRDV 202
Query: 594 TVKSDVYSFGVVMLELLTGRKP 615
T K D++S GVVM LLTG P
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLP 224
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 35/310 (11%), Positives = 82/310 (26%), Gaps = 72/310 (23%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKID--------------------------NAALSL 449
++G+ A + G+ V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 450 QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLLVYEYVG--NGNLHDMLHFADDS 505
+ F+ + + ++ + + R +Y + ++L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 506 SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565
K+L +AR+++ L R L LH +VH + +I+LD L+
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL--- 253
Query: 566 PNTERQVSTQMVGAFGYSAPEFALS-----------GIYTVKSDVYSFGVVMLELLTGRK 614
+ G+ PE + T D ++ G+V+ +
Sbjct: 254 --VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 615 PLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPE 674
P+ + W +I + ++ ++ E
Sbjct: 312 PITK---DAALGGSEWIFRSCKNIPQPVR-------------------ALLEGFLRYPKE 349
Query: 675 FRPPMSEVVQ 684
R + ++
Sbjct: 350 DRLLPLQAME 359
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-24
Identities = 35/180 (19%), Positives = 66/180 (36%), Gaps = 10/180 (5%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSG 143
+D+S G M L L+ D +++ + L L+++ N
Sbjct: 380 HLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
+ + SL+ L ++ NS + ++F N L LDLS F +L
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 203 ISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSG---WIPRELISIRTFIYDGNSFD 257
+ L + +N + + ++ L L+TL+ + N + S+ F NS
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 37/167 (22%), Positives = 59/167 (35%), Gaps = 8/167 (4%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGN 144
+D+S + L L L+GN I P +L +L +
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 145 LPYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNI 203
+ I +++L LNV+ N + + F NL L +DLS+N N L
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 204 S----SLYLQNNQVTG-SLNVFSGLPLTTLNVANNHFSGWIPRELIS 245
SL + N + F G+ L L + N S I + +
Sbjct: 180 PQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQ 226
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 27/133 (20%), Positives = 53/133 (39%), Gaps = 3/133 (2%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166
+ + + +P +P + +++L+ N YS ++ L +L++SR +
Sbjct: 11 VPNITYQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE 69
Query: 167 QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP- 224
+ L L+ L L+ N P SF L+++ +L ++ L
Sbjct: 70 TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129
Query: 225 LTTLNVANNHFSG 237
L LNVA+N
Sbjct: 130 LKKLNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-21
Identities = 38/147 (25%), Positives = 57/147 (38%), Gaps = 6/147 (4%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS--GNLPYSIASMVSLSYLNVS 161
DL L+ L+ N + P+L+ L+L+ N S G YS SL +L++S
Sbjct: 325 LDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL-NV 219
N + F L L LD + S F+SL + L + +
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 220 FSGLP-LTTLNVANNHFSGWIPRELIS 245
F GL L TL +A N F + +
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFA 470
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 32/143 (22%), Positives = 53/143 (37%), Gaps = 9/143 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
S+ L+ DLS I +L++L L N P S + + SL L
Sbjct: 52 FSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTG-SLN 218
L G L L L+++ N LP F +L+N+ + L N + ++N
Sbjct: 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171
Query: 219 VFSGLP-----LTTLNVANNHFS 236
L +L+++ N
Sbjct: 172 DLQFLRENPQVNLSLDMSLNPID 194
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-19
Identities = 46/205 (22%), Positives = 75/205 (36%), Gaps = 32/205 (15%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD---------------------TIPY 125
++ L ++ L+G SI P
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPT 324
Query: 126 QLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAG--LATLD 183
P L SL L N S + + ++ SLSYL++SRN+L+ S + +L L LD
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382
Query: 184 LSFNNFSGDLPNSFISLSNISSLYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSGWIP 240
LSFN + +F+ L + L Q++ + + F L L L+++ +
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
Query: 241 RE---LISIRTFIYDGNSFDNGPAP 262
L S+ T GNSF +
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLS 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 25/175 (14%), Positives = 58/175 (33%), Gaps = 19/175 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD-TIPYQLP--PNLTSLNLASNNFSG 143
++ L+ + + L++L+K +++ N IH +P NL ++L+ N
Sbjct: 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
Query: 144 NLPYSIASMVSLS----YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFI 198
+ + L++S N + F + L L L N S ++
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQ 226
Query: 199 SLSNISSLYLQNNQVTG-------SLNVFSGLP---LTTLNVANNHFSGWIPREL 243
+L+ + L + ++ GL + + + +
Sbjct: 227 NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 35/211 (16%), Positives = 62/211 (29%), Gaps = 44/211 (20%)
Query: 90 ISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY------QLPPNLTSLNLASNNFSG 143
I L S+L +L DLS N I + P SL+++ N
Sbjct: 140 IHSCKLPAY----FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID- 194
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLA---------------------- 180
+ + L L + N + +I NLAGL
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 181 ----------TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNV 230
L++ N D F L+N+S++ L + +V +L++
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSI 314
Query: 231 ANNHFSGWIPRELISIRTFIYDGNSFDNGPA 261
+ +L +++ N
Sbjct: 315 IRCQLKQFPTLDLPFLKSLTLTMNKGSISFK 345
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-24
Identities = 34/157 (21%), Positives = 64/157 (40%), Gaps = 17/157 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHD-TIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
++ + N++ + L L L N G LP + S + L+ LN
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI--SLSNISSLYLQNNQVTG-S 216
++ N +T+ + G + L + N +PN F S+S +S++ N++
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVD 418
Query: 217 LNVFSGLP--------LTTLNVANNHFSGWIPRELIS 245
F L ++++N++NN S P+EL S
Sbjct: 419 GKNFDPLDPTPFKGINVSSINLSNNQISK-FPKELFS 454
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-24
Identities = 27/169 (15%), Positives = 70/169 (41%), Gaps = 23/169 (13%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSG-------NLPYSIA 150
+ + N + IP +++++ + N L +
Sbjct: 372 FCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-------DLPNSFISLSNI 203
+++S +N+S N +++ ++F + L++++L N + D +F + +
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 204 SSLYLQNNQVTGSLN--VFSGLP-LTTLNVANNHFSGWIPRELISIRTF 249
+S+ L+ N++T + + LP L ++++ N FS P + ++ T
Sbjct: 491 TSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 35/277 (12%), Positives = 73/277 (26%), Gaps = 43/277 (15%)
Query: 43 DVQALQVLYTSLNSPS---------VLTNWKGNEGDPCGESWKGVAC-EGSAVVSIDISG 92
D AL+ ++ +LN + NW N+ + GV+ V + + G
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEG 90
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSL------NLASNNFSGNLP 146
G SG + + L L L + P +++ ++
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 147 YSIA--SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
L ++ + +SI + NN + + + + L+ +
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLR 209
Query: 205 SLYLQNNQVTGS-------------LNVFSGLP--------LTTLNVANNHFSGWIPRE- 242
Y+ N+ + LT + V N +P
Sbjct: 210 QFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 243 --LISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHN 277
L ++ N +G +
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 23/178 (12%), Positives = 60/178 (33%), Gaps = 15/178 (8%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD--------TIPYQLP--PNLTSLNL 136
+++ + L L ++ +++ N P + + +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 137 ASNNF-SGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN 195
NN + + S+ M L L N L + FG+ LA+L+L++N + N
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPAN 371
Query: 196 SFISLSNISSLYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFI 250
+ +L +N++ ++ + ++ ++ + N + +
Sbjct: 372 FCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-21
Identities = 29/169 (17%), Positives = 52/169 (30%), Gaps = 17/169 (10%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNF---- 141
+ T +L L ++ +P L P + +N+A N
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL-PEMQLINVACNRGISGE 289
Query: 142 ----SGNLPYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
+ + + N+L + + L L+ +N G +
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPA 348
Query: 197 FISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
F S ++SL L NQ+T N + L+ A+N IP
Sbjct: 349 FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIF 396
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 7e-20
Identities = 30/182 (16%), Positives = 59/182 (32%), Gaps = 32/182 (17%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---------PNLTSLNLA 137
SI++S +S L S L +L GN + + L LTS++L
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 138 SNNFSGNLPYSIA--SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL------DLSFNNF 189
N + L ++ L +++S NS + N + L D N
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRT 554
Query: 190 SGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP------LTTLNVANNHFSGWIPREL 243
+ P +++ L + +N + ++ L++ +N +
Sbjct: 555 LREWPEGITLCPSLTQLQIGSND-------IRKVNEKITPNISVLDIKDNPNISIDLSYV 607
Query: 244 IS 245
Sbjct: 608 CP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-19
Identities = 18/149 (12%), Positives = 38/149 (25%), Gaps = 14/149 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+ L LR+F + + + N ++ L+ + V
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENI---CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYN 258
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNF--------SGDLPNSFISLSNISSLYLQNNQ-V 213
+ L + ++++ N I +Y+ N
Sbjct: 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 214 TGSL-NVFSGLP-LTTLNVANNHFSGWIP 240
T + + L L N G +P
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 23/118 (19%), Positives = 35/118 (29%), Gaps = 12/118 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSL------NLASNNFSGNLPYSIASMVS 154
+ L L DLS NS P Q L + N P I S
Sbjct: 509 ATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567
Query: 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L+ L + N + + I N ++ LD+ N + L ++
Sbjct: 568 LTQLQIGSNDIRKVNEKITPN---ISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 10/78 (12%), Positives = 25/78 (32%), Gaps = 1/78 (1%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYS 148
D G ++ SL + + N I + ++ PN++ L++ N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNISIDLSY 606
Query: 149 IASMVSLSYLNVSRNSLT 166
+ + + +
Sbjct: 607 VCPYIEAGMYMLFYDKTQ 624
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 59/255 (23%), Positives = 95/255 (37%), Gaps = 39/255 (15%)
Query: 384 KSGSLKKIKSPITATSYTVASLQTATNSFSQEF----LIGEGSLGRVYRAEF-ANGKIMA 438
SG I ++ + + +G G+ G V + A
Sbjct: 8 SSGRENLYFQGIAINPGMY--VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKA 65
Query: 439 VKKIDNAALS-----------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487
+K I + + + +S + L HPNI+ L + LV
Sbjct: 66 IKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVT 125
Query: 488 EYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543
E+ G L + + F + + N+ ++ L + YLH+ ++VHR+ K
Sbjct: 126 EFYEGGELFEQIINRHKFDECDAANI-----MKQILS---GICYLHKH---NIVHRDIKP 174
Query: 544 ANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVY 600
NILL + LN + D GL++ + +G Y APE L Y K DV+
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPE-VLKKKYNEKCDVW 231
Query: 601 SFGVVMLELLTGRKP 615
S GV+M LL G P
Sbjct: 232 SCGVIMYILLCGYPP 246
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 57/206 (27%), Positives = 83/206 (40%), Gaps = 24/206 (11%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG GS G V A A KKI + + E + M L HPNI+ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQE-IEIMKSLDHPNIIRLYET 74
Query: 477 CAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
++ LV E G L + + F + + + ++ L A+ Y H++
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLS---AVAYCHKL- 125
Query: 533 LPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+V HR+ K N L + L D GLAA + VG Y +P+ L
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQ-VL 180
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
G+Y + D +S GV+M LL G P
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 38/280 (13%), Positives = 81/280 (28%), Gaps = 53/280 (18%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
G + ++A A + +A+ +D L L +SR+ P + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
L+V E++ G+L ++ + + +R A A + H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
V + + + + G ++
Sbjct: 149 GVALSIDHPSRVRVSID--------GDV-------------VLAYPATMPDA-------N 180
Query: 595 VKSDVYSFGVVMLELLTGRKPLDSSRPRSE-QSLVRWATPQLHDIDALAKMVDPALNGMY 653
+ D+ G + LL R PL + RS R Q + + + + +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI---- 236
Query: 654 PAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693
+ + A VQ + R S ++ + + A
Sbjct: 237 --------SAVAARSVQGDGGIRSA-STLLNLMQQATAVA 267
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 27/152 (17%), Positives = 62/152 (40%), Gaps = 5/152 (3%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLP 146
I ++ + ++ G + +++ ++ + P NL L + + + +
Sbjct: 48 YITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKI 105
Query: 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
+++ + SL+ L++S ++ SI L + ++DLS+N D+ +L + SL
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSL 164
Query: 207 YLQNNQVTGSLNVFSGLP-LTTLNVANNHFSG 237
+Q + V P L L + G
Sbjct: 165 NIQFDGVH-DYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-19
Identities = 25/134 (18%), Positives = 52/134 (38%), Gaps = 3/134 (2%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
+ + SL L+ ++ D + N+ L + + + + P I+ + +L L +
Sbjct: 41 AQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK 98
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL 223
+T L L LD+S + + +L ++S+ L N + L
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTL 158
Query: 224 P-LTTLNVANNHFS 236
P L +LN+ +
Sbjct: 159 PELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 21/143 (14%), Positives = 51/143 (35%), Gaps = 25/143 (17%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ----- 167
L + + IP + S + A M SL+Y+ ++ ++T
Sbjct: 7 GLKASQDNVNIP---DSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIE 63
Query: 168 -------------SIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ L+ L L + + + D + L++++ L + ++
Sbjct: 64 YAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA 123
Query: 213 VTGS-LNVFSGLP-LTTLNVANN 233
S L + LP + +++++ N
Sbjct: 124 HDDSILTKINTLPKVNSIDLSYN 146
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 82/357 (22%), Positives = 128/357 (35%), Gaps = 67/357 (18%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-------SLQEEDNFLEAVSN 461
+ F ++G G G V+ + A GK+ A KK++ L E L V
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH- 243
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWN-ARVR--- 516
IV+LA Y E L LV + G++ H + N + R
Sbjct: 244 -----SRFIVSLA-YAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYT 295
Query: 517 --VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST 574
+ LE+LH+ ++++R+ K N+LLDD+ N +SD GLA + +
Sbjct: 296 AQIVS----GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
Query: 575 QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV------ 628
G G+ APE L Y D ++ GV + E++ R P + + E +
Sbjct: 349 -YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE 407
Query: 629 ------RWATPQLHDIDA--LAKMVDPAL------NGMYPAKSLSRFADI--IALCV-QP 671
+P D L K DP ++ F DI L
Sbjct: 408 QAVTYPDKFSPASKDFCEALLQK--DPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGML 465
Query: 672 EPEFRPPMSEVVQALVRLVQRASVVKRRSSDE------SGFSYRTPDH----EAIDT 718
P F P V ++ V S VK + ++ F+ T E I+T
Sbjct: 466 TPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTEFFQEFASGTCPIPWQEEMIET 522
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 409 TNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS 463
+ FS + +G+G+ V R G A K I+ LS ++
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 464 RLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVAL 519
+L+HPNIV L E LV++ V G L + + +++ + + ++ L
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQIL 115
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH---LSDCGLAALTPNTERQVSTQM 576
++ Y H +VHRN K N+LL + L+D GLA + +
Sbjct: 116 E---SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGF 167
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
G GY +PE Y+ D+++ GV++ LL G P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 56/242 (23%), Positives = 95/242 (39%), Gaps = 25/242 (10%)
Query: 386 GSLKKIKSPITATSYTVASLQTATNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVK 440
G + + A+ FS + +G+G+ V R G A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 441 KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML- 499
I+ LS ++ +L+HPNIV L E LV++ V G L + +
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 500 ---HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH- 555
+++ + + ++ L ++ Y H +VHRN K N+LL +
Sbjct: 121 AREFYSEADASHC-----IQQILE---SIAYCHSN---GIVHRNLKPENLLLASKAKGAA 169
Query: 556 --LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613
L+D GLA ++ + G GY +PE Y+ D+++ GV++ LL G
Sbjct: 170 VKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 227
Query: 614 KP 615
P
Sbjct: 228 PP 229
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 65/239 (27%), Positives = 101/239 (42%), Gaps = 42/239 (17%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-------SLQEEDNFLEAVSN 461
N FS +IG G G VY GK+ A+K +D + E L VS
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVR 516
P IV ++ Y +L + + + G+LH L F++ +R
Sbjct: 249 G---DCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---------DMR 295
Query: 517 -----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571
+ L LE++H VV+R+ K ANILLD+ + +SD GLA +++
Sbjct: 296 FYAAEIIL----GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKK 346
Query: 572 VSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR 629
VG GY APE G+ Y +D +S G ++ +LL G P + + + + R
Sbjct: 347 PHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 29/213 (13%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEG+ G V A + +AVK +D E+ E + L H N+V G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKMLNHENVVKFYG 72
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALEY 527
+ E + L EY G L D + + + A+ + Y
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP--NTERQVSTQMVGAFGYSAP 585
LH + + HR+ K N+LLD+ N +SD GLA + N ER ++ M G Y AP
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 586 EFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
E + DV+S G+V+ +L G P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-22
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+G+ V R + G+ A I+ LS ++ L+HPNIV L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 477 CAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+E G L+++ V G L + + ++++ + + ++ L A+ + H++
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILE---AVLHCHQM- 129
Query: 533 LPSVVHRNFKSANILLDDELNPH---LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
VVHRN K N+LL +L L+D GLA E+Q G GY +PE
Sbjct: 130 --GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTPGYLSPEVLR 186
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
Y D+++ GV++ LL G P
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G G+ V+ + GK+ A+K I + + + ++ + +++H NIVTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLED 73
Query: 476 YCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEV 531
LV + V G L D + + + + + ++ L A++YLHE
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLS---AVKYLHEN 125
Query: 532 CLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
+VHR+ K N+L ++ ++D GL+ + N + + G GY APE
Sbjct: 126 ---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACGTPGYVAPEVL 179
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y+ D +S GV+ LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 29/213 (13%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEG+ G V A + +AVK +D E+ E + L H N+V G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKMLNHENVVKFYG 72
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALEY 527
+ E + L EY G L D + + + A+ + Y
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP--NTERQVSTQMVGAFGYSAP 585
LH + + HR+ K N+LLD+ N +SD GLA + N ER ++ M G Y AP
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 586 EFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
E + DV+S G+V+ +L G P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 29/211 (13%), Positives = 68/211 (32%), Gaps = 21/211 (9%)
Query: 90 ISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS----- 142
I G + + ++ LS N I ++++ L++N +
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 143 --GNLPYSIASMVSLSYLNVSRNSLTQSIGDI-FGNLAGLATLDLSFNNFSGDLPNSFIS 199
+ + L+ +++ N LT D L L+ +D+S+N FS P ++
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLN 774
Query: 200 LSNISSLYLQNNQVTGSLNVFSGLP--------LTTLNVANNHFSGWIPRELI-SIRTFI 250
S + + +++ + + P L L + +N + +L +
Sbjct: 775 SSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYILD 833
Query: 251 YDGNSFDNGPAPPPPPSTAPPSGRSHNNRSH 281
N + P +++
Sbjct: 834 IADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 8e-21
Identities = 29/171 (16%), Positives = 50/171 (29%), Gaps = 17/171 (9%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSG- 143
+ S+L L +L +P L P L SLN+A N
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 144 --------NLPYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLP 194
L + + + N+L + + L LD N
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--L 588
Query: 195 NSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
+F + ++ L L NQ+ + + + L ++N IP
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIF 638
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 6e-20
Identities = 25/161 (15%), Positives = 61/161 (37%), Gaps = 21/161 (13%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGN-----LPYSIASM 152
+ + S N + IP + S++ + N
Sbjct: 614 FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS-------GDLPNSFISLSNISS 205
++ S + +S N + + ++F + ++T+ LS N + ++ + +++
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 206 LYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
+ L+ N++T + LP L+ ++V+ N FS P +
Sbjct: 733 IDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQP 772
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 29/180 (16%), Positives = 61/180 (33%), Gaps = 21/180 (11%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY-----QLP------PNLTSLN 135
+++ + L DL L+ +++ N +L P +
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554
Query: 136 LASNNFSGNLP--YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDL 193
+ NN P S+ MV L L+ N + + + FG L L L +N +
Sbjct: 555 MGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HL-EAFGTNVKLTDLKLDYNQIEE-I 610
Query: 194 PNS-FISLSNISSLYLQNNQVTGSLNVFS--GLP-LTTLNVANNHFSGWIPRELISIRTF 249
P + L +N++ N+F+ + + +++ + N S+ +
Sbjct: 611 PEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDY 670
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 32/202 (15%), Positives = 62/202 (30%), Gaps = 37/202 (18%)
Query: 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGN---SIHDTIPYQLP------PNLTSLNL 136
++ +S + L + + LS N SI + LT+++L
Sbjct: 676 STVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735
Query: 137 ASNNFSGNLPYSIA--SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF------NN 188
N + L ++ LS ++VS N + S N + L + N
Sbjct: 736 RFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNR 793
Query: 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP------LTTLNVANNHF-----SG 237
P + ++ L + +N + L L++A+N +
Sbjct: 794 ILRQWPTGITTCPSLIQLQIGSND-------IRKVDEKLTPQLYILDIADNPNISIDVTS 846
Query: 238 WIPRELISIRTFIYDGNSFDNG 259
P + +YD G
Sbjct: 847 VCPYIEAGMYVLLYDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 22/144 (15%), Positives = 48/144 (33%), Gaps = 13/144 (9%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLA------SNNFSGNLPYSIASMVSL 155
L L DL ++I+ + + ++L N + +I + L
Sbjct: 391 FLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKL 450
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
+ + + T + + + + S+ +L +++ + L N
Sbjct: 451 QIIYFANSPFTYDNIAVDWED-----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505
Query: 216 SL-NVFSGLP-LTTLNVANNHFSG 237
L + LP L +LN+A N
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGIS 529
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 3e-14
Identities = 25/189 (13%), Positives = 49/189 (25%), Gaps = 34/189 (17%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPN--LTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
F+ + D L N +T L+LA G +P +I + L L+ +
Sbjct: 298 HSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTH 357
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-----------------------NSFISL 200
S T S + + +
Sbjct: 358 SETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417
Query: 201 SNISSLYLQNNQVTGSLNVFSGLP--------LTTLNVANNHFSGWIPRELISIRTFIYD 252
S + L++ Q+ N + + L + AN+ F+ +
Sbjct: 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDANSDY 476
Query: 253 GNSFDNGPA 261
++N
Sbjct: 477 AKQYENEEL 485
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 13/164 (7%), Positives = 36/164 (21%), Gaps = 23/164 (14%)
Query: 133 SLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD 192
+L+ + + + ++ + N + G N + L L+ G
Sbjct: 280 ALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 193 LPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYD 252
+P++ L+ L L+ + + T
Sbjct: 339 VPDAIGQLTE----------------------LKVLSFGTHSETVSGRLFGDEELTPDMS 376
Query: 253 GNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSS 296
+ ++ + +P
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 60/236 (25%), Positives = 89/236 (37%), Gaps = 24/236 (10%)
Query: 402 VASLQTATNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL 456
V L + F+ + IG GS R A AVK ID + EE
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---- 65
Query: 457 EAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV 515
+ + R +HPNI+TL + +V E + G L D + K +
Sbjct: 66 --IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREAS 119
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQ 571
V + +EYLH VVHR+ K +NIL DE + D G A
Sbjct: 120 AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL 627
+ T + APE Y D++S GV++ +LTG P + + + +
Sbjct: 177 LMT-PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 36/231 (15%)
Query: 408 ATNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNM 462
+T+ F + + ++G G V R K AVK ID + E
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 463 SR----LR----HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLT 510
+ LR HPNI+ L + LV++ + G L D L ++ ++ +
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI- 129
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
+R L + LH++ ++VHR+ K NILLDD++N L+D G +
Sbjct: 130 ----MRALLE---VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PG 177
Query: 571 QVSTQMVGAFGYSAPE------FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ ++ G Y APE Y + D++S GV+M LL G P
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-21
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 9/178 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L DL+ N I + P LT L L +N S P +A + +L+ L ++
Sbjct: 239 LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 296
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N L NL L L L FNN S P SL+ + L+ NN+V+ ++ +
Sbjct: 297 NQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS-DVSSLAN 351
Query: 223 LP-LTTLNVANNHFSGWIP-RELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNN 278
L + L+ +N S P L I + ++ N P + P + ++
Sbjct: 352 LTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTG 409
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-19
Identities = 36/139 (25%), Positives = 64/139 (46%), Gaps = 8/139 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L + N I D P + NL L+L N ++ ++AS+ +L+ L+++
Sbjct: 195 LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLK-DIG-TLASLTNLTDLDLAN 252
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ L L L L N S ++ L+ +++L L NQ+ ++ S
Sbjct: 253 NQISNLAP--LSGLTKLTELKLGANQIS-NISP-LAGLTALTNLELNENQLE-DISPISN 307
Query: 223 LP-LTTLNVANNHFSGWIP 240
L LT L + N+ S P
Sbjct: 308 LKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-17
Identities = 31/136 (22%), Positives = 59/136 (43%), Gaps = 8/136 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+ L K L ++ DT+ +T+L ++ + + +L+ +N S
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 77
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N LT NL L + ++ N + D+ +L+N++ L L NNQ+T ++
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQIT-DIDPLKN 132
Query: 223 LP-LTTLNVANNHFSG 237
L L L +++N S
Sbjct: 133 LTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-17
Identities = 39/136 (28%), Positives = 59/136 (43%), Gaps = 9/136 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L++L +L L N I D P + NL L L+SN S +++ + SL L+
Sbjct: 108 LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG- 164
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N +T NL L LD+S N S + L+N+ SL NNQ++ +
Sbjct: 165 NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQIS-DITPLGI 219
Query: 223 LP-LTTLNVANNHFSG 237
L L L++ N
Sbjct: 220 LTNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 8e-17
Identities = 39/162 (24%), Positives = 61/162 (37%), Gaps = 7/162 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L +L+ N + D P NLT L L NN S P ++S+ L L
Sbjct: 283 LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ NL + L N S DL +L+ I+ L L + T + +
Sbjct: 341 NKVSDV--SSLANLTNINWLSAGHNQIS-DLTP-LANLTRITQLGLNDQAWTNAPVNYKA 396
Query: 223 LPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPP 264
++ N N I IS + + N P+
Sbjct: 397 N-VSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTN 437
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 23/128 (17%), Positives = 45/128 (35%), Gaps = 8/128 (6%)
Query: 114 LSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF 173
I+ L N + + + ++ L R + SI +
Sbjct: 9 TQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGV- 64
Query: 174 GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232
L L ++ S N + D+ +L+ + + + NNQ+ + + L LT L + N
Sbjct: 65 EYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTLFN 121
Query: 233 NHFSGWIP 240
N + P
Sbjct: 122 NQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 10/120 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L++L ++ N I D P +T L L ++ N P + + VS+ +
Sbjct: 349 LANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNV 407
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
+ I + D+++N S + +S + Q + FSG
Sbjct: 408 TGALIAPATI-SDGGSYTEPDITWNLPS--------YTNEVSYTFSQPVTIGKGTTTFSG 458
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 9/90 (10%)
Query: 154 SLSYLNVSRNSLTQSIGDIFG--NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
L ++++ I IF LA L N + + L +++L
Sbjct: 2 PLGSATITQD---TPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL 56
Query: 212 QVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240
+ S++ L LT +N +NN + P
Sbjct: 57 GIK-SIDGVEYLNNLTQINFSNNQLTDITP 85
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-21
Identities = 70/298 (23%), Positives = 118/298 (39%), Gaps = 40/298 (13%)
Query: 345 PVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVAS 404
+ + + R + A + L P++ + AK + + K ++
Sbjct: 20 RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGP 79
Query: 405 -----LQTATNSFSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEED- 453
A F Q++ +IG G V R A G AVK ++ A L E
Sbjct: 80 EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL 139
Query: 454 -NFLEAVSN----MSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFAD 503
EA + ++ HP+I+TL LV++ + G L D L ++
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE 199
Query: 504 DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563
++++ +R L A+ +LH ++VHR+ K NILLDD + LSD G +
Sbjct: 200 KETRSI-----MRSLLE---AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSC 248
Query: 564 LTPNTERQVSTQMVGAFGYSAPE------FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E+ ++ G GY APE Y + D+++ GV++ LL G P
Sbjct: 249 HLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 8e-21
Identities = 64/220 (29%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSN 461
N+F Q ++G+G G V + A GK+ A KK+ E LE V+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN- 242
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR---- 516
+V+LA Y E L LV + G+L H AR
Sbjct: 243 -----SRFVVSLA-YAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFP-EARAVFYAA 293
Query: 517 -VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575
+ LE LH +V+R+ K NILLDD + +SD GLA E Q
Sbjct: 294 EICC----GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKG 344
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
VG GY APE + YT D ++ G ++ E++ G+ P
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 58/227 (25%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLRHPNIV 471
+G G+ G+V E G +AVK ++ + + + + N+ RHP+I+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI---RSLDVVGKIKREIQNLKLFRHPHII 74
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR-------- 523
L + +V EYV G L D + RV AR
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYI------------CKHGRVEEMEARRLFQQILS 122
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL------------TPNTERQ 571
A++Y H VVHR+ K N+LLD +N ++D GL+ + +PN
Sbjct: 123 AVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN---- 175
Query: 572 VSTQMVGAFGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
Y+APE +Y + D++S GV++ LL G P D
Sbjct: 176 ----------YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 56/240 (23%), Positives = 91/240 (37%), Gaps = 25/240 (10%)
Query: 392 KSPITATSYTVASLQTATNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAA 446
I+ + + F + +IG+G V R G+ AVK +D A
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 447 LSLQEEDNFLEAVSN----MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFA 502
+ E + L+HP+IV L + G +V+E++ +L +
Sbjct: 62 FT-SSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 503 DDSSKNLTWNARVRVALGTAR----ALEYLHEVCLPSVVHRNFKSANILLDDELNPH--- 555
D+ + VA R AL Y H+ +++HR+ K +LL + N
Sbjct: 121 ADAGFVYS----EAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVK 173
Query: 556 LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
L G+A V+ VG + APE Y DV+ GV++ LL+G P
Sbjct: 174 LGGFGVAIQLGE-SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 416 FLIGEGSLGRVYRA---EFANGKIMAVKKI--DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ G VY+A + + K A+K+I ++S E L L+HPN+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALL------RELKHPNV 80
Query: 471 VTLAGYCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA------ 522
++L H R L+++Y HD+ H + V++ G
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 523 --RALEYLHEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAAL--TPNTERQVST 574
+ YLH V+HR+ K ANIL+ E ++D G A L +P
Sbjct: 137 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 575 QMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+V F Y APE L + YT D+++ G + ELLT +P+
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 235
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 38/166 (22%), Positives = 57/166 (34%), Gaps = 8/166 (4%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNL 145
+D+S + L L L+GN I +L L N +
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 146 PYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
+ I + +L LNV+ N + + + F NL L LDLS N L +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 205 ----SLYLQNNQVTG-SLNVFSGLPLTTLNVANNHFSGWIPRELIS 245
SL L N + F + L L + NN S + + I
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-20
Identities = 38/145 (26%), Positives = 64/145 (44%), Gaps = 6/145 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN--NFSGNLPYSIASMVSLSYLNVSRN 163
L SL++ + N + P+L L+L+ N +F G S SL YL++S N
Sbjct: 324 LKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLN-VFS 221
+ ++ F L L LD +N + F+SL N+ L + + + N +F+
Sbjct: 384 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 222 GLP-LTTLNVANNHFSGWIPRELIS 245
GL L L +A N F ++ +
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFT 467
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-20
Identities = 37/156 (23%), Positives = 63/156 (40%), Gaps = 7/156 (4%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY---QLPPNLTSLNLASNNFSG 143
+D+S G+ TM L L D +++ + NL L+++ +
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
+ SL L ++ NS ++ DIF L L LDLS P +F SLS+
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 203 ISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
+ L + +NQ+ +F L L + + N +
Sbjct: 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-19
Identities = 31/128 (24%), Positives = 51/128 (39%), Gaps = 3/128 (2%)
Query: 111 KFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG 170
+ + + IP LP + +L+L+ N YS S L L++SR +
Sbjct: 11 TYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTL 228
+ +L+ L+TL L+ N +F LS++ L + L L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 229 NVANNHFS 236
NVA+N
Sbjct: 130 NVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 33/142 (23%), Positives = 59/142 (41%), Gaps = 9/142 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHD----TIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
DL SL DLS N + + +L L+L+ N + + + L +L
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 401
Query: 159 NVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
+ ++L Q S +F +L L LD+S + F LS++ L + N +
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 218 --NVFSGLP-LTTLNVANNHFS 236
++F+ L LT L+++
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 7e-13
Identities = 27/113 (23%), Positives = 44/113 (38%), Gaps = 3/113 (2%)
Query: 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTS---LNLASNNFS 142
+ +DIS + + L SL ++GNS + + L + L+L+
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN 195
P + S+ SL LN++ N L IF L L + L N + P
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 29/178 (16%), Positives = 57/178 (32%), Gaps = 18/178 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD-TIPYQLP--PNLTSLNLASNNFSG 143
+ L+ + + L +L++ +++ N I +P NL L+L+SN
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 144 NLPYSIASMVSLSY----LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFI 198
+ + + L++S N + F + L L L N S ++
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQ 222
Query: 199 SLSNISSLYL-------QNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTF 249
L+ + L + N + G L L + + I F
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEG--LCNLTIEEFRLAYLDYYLDDIIDLF 278
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 37/206 (17%), Positives = 67/206 (32%), Gaps = 41/206 (19%)
Query: 96 SGTMGYLLSDLLSLRKFDLSGNSIHDTIP------YQLPPNLTSLNLASNNFSGNLPYSI 149
S + S+L +L DLS N I +Q+P SL+L+ N + +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGA 196
Query: 150 ASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSF---------------------- 186
+ L L + N + ++ LAGL L
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 187 -----------NNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHF 235
+ + D+ + F L+N+SS L + + + L + N F
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316
Query: 236 SGWIPRELISIRTFIYDGNSFDNGPA 261
+ +L S++ + N N +
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFS 342
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSR 464
++ + +GEG+ VY+ + ++A+K+I L+ E+ + VS +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-----RLEHEEGAPCTAIREVSLLKD 56
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TAR 523
L+H NIVTL LV+EY+ D+ + DD + V++ L R
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIIN-MHNVKLFLFQLLR 111
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMV 577
L Y H V+HR+ K N+L+++ L+D GLA R S V
Sbjct: 112 GLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLA-------RAKSIPTKTYDNEV 161
Query: 578 GAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y P+ L S Y+ + D++ G + E+ T +PL
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT-GRPL 200
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNI 470
IG+G+ G V++A G+ +A+KK+ +N E++ F L + + L+H N+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMEN------EKEGFPITALREIKILQLLKHENV 78
Query: 471 VTLAGYCAEHGQRL--------LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA 522
V L C LV+++ HD+ + T + RV
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA---ALTPNTERQVSTQMVGA 579
L Y+H ++HR+ K+AN+L+ + L+D GLA +L N++ T V
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 580 FGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y PE L Y D++ G +M E+ T R P+
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 48/254 (18%), Positives = 92/254 (36%), Gaps = 42/254 (16%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLRH--PN 469
L+G G G VY ++ +A+K ++ +S E V + ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 470 IVTLAGYCAEHGQRLLVYEYV-GNGNLHDMLHFADDSSKNLTWNARVRVALGTAR----- 523
++ L + +L+ E +L D + R + AR
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT------------ERGALQEELARSFFWQ 157
Query: 524 ---ALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPNTERQVSTQMVGA 579
A+ + H V+HR+ K NIL+D + L D G AL +T G
Sbjct: 158 VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGT 211
Query: 580 FGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLDSSR--PRSEQSLVRWATPQLH 636
YS PE+ Y + V+S G+++ +++ G P + R + + + +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271
Query: 637 DIDALAKM--VDPA 648
+ + + P+
Sbjct: 272 HL--IRWCLALRPS 283
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 48/215 (22%), Positives = 88/215 (40%), Gaps = 31/215 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQE--EDNFLEAVSN----MSRLRHPNI 470
+G G+ G V A E K +A++ I ++ E + V + +L HP I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALE 526
+ + + + +V E + G L D + + + K + A++
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ--------MLLAVQ 253
Query: 527 YLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
YLHE ++HR+ K N+LL +++ ++D G + + E + + G Y
Sbjct: 254 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYL 308
Query: 584 APE---FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE + Y D +S GV++ L+G P
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 47/254 (18%), Positives = 88/254 (34%), Gaps = 46/254 (18%)
Query: 448 SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH---FADD 504
S D + M N V + + + NL D ++ +D
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 505 SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-- 562
+ + + A A+E+LH ++HR+ K +NI + + D GL
Sbjct: 161 REHGVCL----HIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 563 ---------ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613
LTP T VG Y +PE Y+ K D++S G+++ ELL
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273
Query: 614 KPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP---AKSLSRFADIIALCVQ 670
+ E+ + + D+ N +P + + ++ +
Sbjct: 274 S------TQMERVRI------ITDVR----------NLKFPLLFTQKYPQEHMMVQDMLS 311
Query: 671 PEPEFRPPMSEVVQ 684
P P RP +++++
Sbjct: 312 PSPTERPEATDIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 21/102 (20%), Positives = 34/102 (33%), Gaps = 6/102 (5%)
Query: 412 FSQEF----LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR 466
+ +F +G G G V+ A+ + A+K+I L E E V +++L
Sbjct: 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE-VKALAKLE 62
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN 508
HP IV E E + + S
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSP 104
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 32/142 (22%), Positives = 61/142 (42%), Gaps = 8/142 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+++L L L+ N I D P +L N + ++ +A+M L+ L +
Sbjct: 173 IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQIT-DIT-PVANMTRLNSLKIGN 230
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N +T NL+ L L++ N S N+ L+ + L + +NQ++ ++V +
Sbjct: 231 NKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS-DISVLNN 285
Query: 223 LP-LTTLNVANNHFSGWIPREL 243
L L +L + NN +
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVI 307
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 31/135 (22%), Positives = 61/135 (45%), Gaps = 6/135 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++++ L + N I D P LT L + +N S ++ ++ + L LNV
Sbjct: 217 VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGS 274
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ I + NL+ L +L L+ N + L+N+++L+L N +T + +
Sbjct: 275 NQIS-DI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT-DIRPLAS 331
Query: 223 LP-LTTLNVANNHFS 236
L + + + AN
Sbjct: 332 LSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 28/159 (17%), Positives = 63/159 (39%), Gaps = 25/159 (15%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS-----GNLPY---------- 147
+L S+ K ++G + + NL LNL N + NL
Sbjct: 40 QEELESITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNK 99
Query: 148 -----SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
++ ++ +L L ++ ++++ NL + +L+L N+ DL +++
Sbjct: 100 ITDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTG 156
Query: 203 ISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240
++ L + ++V + + L L +L++ N P
Sbjct: 157 LNYLTVTESKVK-DVTPIANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L SL F N I D P L SL + +N + +L +A++ L++L +
Sbjct: 195 LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKIT-DLS-PLANLSQLTWLEIGT 252
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS-LNVFS 221
N ++ I + +L L L++ N S D+ +LS ++SL+L NNQ+ + V
Sbjct: 253 NQIS-DI-NAVKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIG 308
Query: 222 GLP-LTTLNVANNHFSGWIP-RELISIRTFIYDGN 254
GL LTTL ++ NH + P L + + +
Sbjct: 309 GLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 30/139 (21%), Positives = 63/139 (45%), Gaps = 8/139 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+DL + L S+ D + + ++T L +A + ++ I + +L YLN++
Sbjct: 18 DADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNG 75
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N +T NL L L + N + ++ +L+N+ LYL + ++ ++ +
Sbjct: 76 NQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNIS-DISPLAN 130
Query: 223 LP-LTTLNVANNHFSGWIP 240
L + +LN+ NH +
Sbjct: 131 LTKMYSLNLGANHNLSDLS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 24/130 (18%), Positives = 49/130 (37%), Gaps = 8/130 (6%)
Query: 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168
I+ P L + + + + S++ L V+ + S
Sbjct: 2 AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-S 58
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTT 227
I I L L L+L+ N + D+ +L +++LY+ N++T ++ L L
Sbjct: 59 IQGI-EYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKIT-DISALQNLTNLRE 114
Query: 228 LNVANNHFSG 237
L + ++ S
Sbjct: 115 LYLNEDNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 9e-06
Identities = 14/67 (20%), Positives = 31/67 (46%), Gaps = 4/67 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
L++L L L+ N + + + NLT+L L+ N+ + P +AS+ + +
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340
Query: 161 SRNSLTQ 167
+ + +
Sbjct: 341 ANQVIKK 347
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 26/211 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G V + E + G A K I E + + ++ H N++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYL 528
L +L+ E V G L D L +++ + + ++ L + YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGAFGYSA 584
H + H + K NI+L D+ P L D GLA + + G + A
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVA 186
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE +++D++S GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 58/244 (23%), Positives = 96/244 (39%), Gaps = 37/244 (15%)
Query: 385 SGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKID 443
+GSL+ + P F ++GEGS V A E A + A+K ++
Sbjct: 12 AGSLQHAQPPPQPRKKRP-------EDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64
Query: 444 NAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDML-- 499
+ + MSRL HP V L + + ++L Y NG L +
Sbjct: 65 KRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRK 123
Query: 500 --HFADDSSKNLTWNARVR-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552
F + R + ALEYLH ++HR+ K NILL++++
Sbjct: 124 IGSFDET---------CTRFYTAEIVS----ALEYLHGK---GIIHRDLKPENILLNEDM 167
Query: 553 NPHLSDCGLAALTPNTERQVSTQ-MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ ++D G A + +Q VG Y +PE SD+++ G ++ +L+
Sbjct: 168 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
Query: 612 GRKP 615
G P
Sbjct: 228 GLPP 231
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 62/249 (24%), Positives = 106/249 (42%), Gaps = 35/249 (14%)
Query: 383 AKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKI 442
K L I + + + +++ +IG GS G V++A+ +A+KK+
Sbjct: 13 VKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV 72
Query: 443 DNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL------LVYEYVGNGNLH 496
LQ++ + M ++HPN+V L + +G + LV EYV ++
Sbjct: 73 ------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY 125
Query: 497 DMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEVCLPSVVHRNFKSANILLD---DEL 552
+ + +++ + R+L Y+H + + HR+ K N+LLD L
Sbjct: 126 RASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVL 181
Query: 553 NPHLSDCGLA----ALTPNTERQVSTQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVML 607
L D G A A PN + ++ Y APE + YT D++S G VM
Sbjct: 182 K--LIDFGSAKILIAGEPNVS-YICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMA 233
Query: 608 ELLTGRKPL 616
EL+ G +PL
Sbjct: 234 ELMQG-QPL 241
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 34/213 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNI 470
IGEG+ G V++A +I+A+K++ D+ +++ L + + L+H NI
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDD------DDEGVPSSALREICLLKELKHKNI 63
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L + LV+E+ D+ + D + +L + L + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFGYSA 584
V+HR+ K N+L++ L++ GLA R + V Y
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLA-------RAFGIPVRCYSAEVVTLWYRP 169
Query: 585 PEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
P+ + +Y+ D++S G + EL +PL
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 59/246 (23%), Positives = 83/246 (33%), Gaps = 52/246 (21%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG+GS G V A E I A+K ++ + + ++ + V M +L HPNI L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR---------- 523
+ LV E G+L D L+ D S V+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 524 --------------------------ALEYLHEVCLPSVVHRNFKSANILL--DDELNPH 555
AL YLH + HR+ K N L +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 556 LSDCGLAALTPNTERQVSTQMVGAFG---YSAPEFALSGI---YTVKSDVYSFGVVMLEL 609
L D GL+ M G + APE L+ Y K D +S GV++ L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 610 LTGRKP 615
L G P
Sbjct: 270 LMGAVP 275
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 61/274 (22%), Positives = 95/274 (34%), Gaps = 74/274 (27%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQE--EDNFLEAVSNMSRLRHPNIVTL 473
L+GEGS G+V AVK + L E N + + + RLRH N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 474 AGY---CAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR------ 523
E Q++ +V EY G + +ML R + A
Sbjct: 72 --VDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV----------PEKRFPVCQAHGYFCQL 118
Query: 524 --ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL---------------TP 566
LEYLH +VH++ K N+LL +S G+A +P
Sbjct: 119 IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 567 NTERQVSTQMVGAFGYSAPE-FALSGIYT-VKSDVYSFGVVMLELLTGRKPLDSSRP--- 621
+ PE ++ K D++S GV + + TG P +
Sbjct: 176 A--------------FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL 221
Query: 622 -----RSEQSLVRWATPQLHDIDALAKM--VDPA 648
+ ++ P L D+ L M +PA
Sbjct: 222 FENIGKGSYAIPGDCGPPLSDL--LKGMLEYEPA 253
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 46/202 (22%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G+ G V+R E A G++ K I+ ++ +S M++L HP ++ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ + +L+ E++ G L D + ++ + L+++HE S+
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SI 170
Query: 537 VHRNFKSANILLDDELNPHL--SDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
VH + K NI+ + + + D GLA L P+ ++ ++APE
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPV 227
Query: 594 TVKSDVYSFGVVMLELLTGRKP 615
+D+++ GV+ LL+G P
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSP 249
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 53/224 (23%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLE-AVSNMSRLRHPNIVTLA 474
+GEGS G+V A + + +A+K I L + +E +S + LRHP+I+ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALE 526
++V EY G G L D + + R+ R A+E
Sbjct: 76 DVITTPTDIVMVIEYAG-GELFDYI------------VEKKRMTEDEGRRFFQQIICAIE 122
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL------------TPNTERQVST 574
Y H +VHR+ K N+LLDD LN ++D GL+ + +PN
Sbjct: 123 YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN------- 172
Query: 575 QMVGAFGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
Y+APE +Y + DV+S G+V+ +L GR P D
Sbjct: 173 -------YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA-----VSNMSRLRHPNIV 471
IGEGS G V++ G+I+A+KK E+D ++ + + +L+HPN+V
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKF-----LESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L + LV+EY H +LH D + + + + T +A+ + H+
Sbjct: 66 NLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTER---QVSTQMVGAFGYSAPEF 587
+ +HR+ K NIL+ L D G A LT ++ +V+T+ Y +PE
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-----YRSPEL 173
Query: 588 AL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ Y DV++ G V ELL+G PL
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGV-PL 202
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-20
Identities = 50/211 (23%), Positives = 82/211 (38%), Gaps = 26/211 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G V + E + G A K I E + + ++ HPNI+T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYL 528
L +L+ E V G L D L +++ + + ++ L + YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGAFGYSA 584
H + H + K NI+L D+ P L D GLA + + G + A
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVA 186
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE +++D++S GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 8e-20
Identities = 35/164 (21%), Positives = 62/164 (37%), Gaps = 9/164 (5%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
LS L L L +I+ Y L L ++ + + + ++L+ L
Sbjct: 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+++ +LT +L L L+LS+N S + L + + L Q+
Sbjct: 230 SITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEP 289
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSF 256
F GL L LNV+ N + + + ++ T I D N
Sbjct: 290 YAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 27/145 (18%), Positives = 57/145 (39%), Gaps = 7/145 (4%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
+ DL +L+ ++ N + I ++ +L L L N + +++ + L L
Sbjct: 123 MFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVL 181
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ ++ F L L L++S + + + + N++SL + + +T
Sbjct: 182 RLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY 241
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPR 241
L L LN++ N S I
Sbjct: 242 LAVRHLVYLRFLNLSYNPIS-TIEG 265
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 32/146 (21%), Positives = 53/146 (36%), Gaps = 6/146 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
++L +LR L N + IP + NLT L+++ N L Y + +L L
Sbjct: 76 FNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLN 218
V N L F L L L L N + + L + L L++ +
Sbjct: 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 219 VFSGLP-LTTLNVANNHFSGWIPREL 243
F L L L +++ + +
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNC 220
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-17
Identities = 42/185 (22%), Positives = 66/185 (35%), Gaps = 13/185 (7%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137
C ++ + ++ L DL N I + P+L L L
Sbjct: 9 CSAQDR-AVLCHRKRFVAVPEGIPTETRLL---DLGKNRIKTLNQDEFASFPHLEELELN 64
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
N S P + ++ +L L + N L +F L+ L LD+S N L F
Sbjct: 65 ENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMF 124
Query: 198 ISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIY 251
L N+ SL + +N + S FSGL L L + + + IP E L +
Sbjct: 125 QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRL 183
Query: 252 DGNSF 256
+
Sbjct: 184 RHLNI 188
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 28/129 (21%), Positives = 50/129 (38%), Gaps = 4/129 (3%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSG 143
++IS TM L+L ++ ++ +PY L LNL+ N S
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST 262
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNI 203
+ ++ L + + L F L L L++S N + + F S+ N+
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL 322
Query: 204 SSLYLQNNQ 212
+L L +N
Sbjct: 323 ETLILDSNP 331
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 31/115 (26%), Positives = 47/115 (40%), Gaps = 4/115 (3%)
Query: 79 ACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLN 135
G + S+ I+ L+ + L+ LR +LS N I TI + L +
Sbjct: 220 CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQ 278
Query: 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS 190
L + PY+ + L LNVS N LT +F ++ L TL L N +
Sbjct: 279 LVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 33/212 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA-----VSNMSRLRHPNIV 471
+GEGS G V + G+I+A+KK ++D ++ + + +LRH N+V
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKF-----LESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L C + + LV+E+V H +L + L + + + + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFGYSAP 585
+++HR+ K NIL+ L D G A R ++ V Y AP
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFA-------RTLAAPGEVYDDEVATRWYRAP 193
Query: 586 EFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
E + Y DV++ G ++ E+ G PL
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGE-PL 224
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 53/211 (25%), Positives = 82/211 (38%), Gaps = 26/211 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G V + + GK A K I LS E + + +RHPNI+T
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYL 528
L +L+ E V G L D L +D + ++ L + YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYL 124
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGAFGYSA 584
H + H + K NI+L D+ P+ L D G+A + G + A
Sbjct: 125 HSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPEFVA 179
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE +++D++S GV+ LL+G P
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 36/205 (17%), Positives = 72/205 (35%), Gaps = 6/205 (2%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
+S + L+ +++ + D S NSI + + + LT L L NN + + + +
Sbjct: 191 ANVSYNLLSTLAIPIAVEELDASHNSI-NVVRGPVNVELTILKLQHNNLT-DTA-WLLNY 247
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L +++S N L + + F + L L +S N L + + L L +N
Sbjct: 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 213 VTG-SLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPP 271
+ N L L + +N +++ N +D + A P
Sbjct: 307 LLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARP 366
Query: 272 SGRSHNNRSHRQGSHSPSGSQSSSS 296
+ ++ + G S
Sbjct: 367 AV-DDADQHCKIDYQLEHGLCCKES 390
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 23/160 (14%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA----------- 150
SL+ LS N + + L P+L N++ N S L IA
Sbjct: 160 TFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS-TLAIPIAVEELDASHNSI 217
Query: 151 ------SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
V L+ L + N+LT + N GL +DLS+N + + F+ + +
Sbjct: 218 NVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 275
Query: 205 SLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPREL 243
LY+ NN++ +P L L++++NH + R
Sbjct: 276 RLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-17
Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 7/139 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
LL + +L+ I I + + L + N P+ ++ L+ L
Sbjct: 64 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ RN L+ IF N L TL +S NN ++F + +++ +L L +N++T L
Sbjct: 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL 182
Query: 218 NVFSGLPLTTLNVANNHFS 236
++ L NV+ N S
Sbjct: 183 SLIPS--LFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 27/154 (17%), Positives = 56/154 (36%), Gaps = 6/154 (3%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGN 144
+ I G+ L + + +++ +P L + LNL
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQVELLNLNDLQIEEI 84
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
Y+ A ++ L + N++ +F N+ L L L N+ S F + ++
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144
Query: 205 SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
+L + NN + + F L L +++N +
Sbjct: 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 23/140 (16%), Positives = 51/140 (36%), Gaps = 8/140 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L D+ + + + N + ++ + S + L
Sbjct: 17 LQYDCVFY--DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
N++ + + F + L + FN P+ F ++ ++ L L+ N ++
Sbjct: 75 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR 134
Query: 218 NVFSGLP-LTTLNVANNHFS 236
+F P LTTL+++NN+
Sbjct: 135 GIFHNTPKLTTLSMSNNNLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 31/140 (22%), Positives = 60/140 (42%), Gaps = 14/140 (10%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
+ +++K + N+I +P + P LT L L N+ S +LP I + L+
Sbjct: 88 AFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTT 145
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
L++S N+L + D F L L LS N + + S + ++ + N L
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIPSLFHANVSYNL----L 198
Query: 218 NVFSGLP-LTTLNVANNHFS 236
+ + + L+ ++N +
Sbjct: 199 STLAIPIAVEELDASHNSIN 218
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 31/215 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLRHPNI 470
+G G+ G V A E K +A+K I ++ A + + +L HP I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALE 526
+ + + + +V E + G L D + + + K L A++
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQ 128
Query: 527 YLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
YLHE ++HR+ K N+LL +++ ++D G + + E + + G Y
Sbjct: 129 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYL 183
Query: 584 APE---FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE + Y D +S GV++ L+G P
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 53/253 (20%), Positives = 92/253 (36%), Gaps = 42/253 (16%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDN-------FLEAVSNMSRLRHPN 469
+G G+ G V+ A K + VK I + LE ++ +SR+ H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE-IAILSRVEHAN 90
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGN-LHDMLHFADDSSKNLTWNARVRVALGTAR----- 523
I+ + G LV E G+G L + + R+ A
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFI------------DRHPRLDEPLASYIFRQ 138
Query: 524 ---ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF 580
A+ YL ++HR+ K NI++ ++ L D G AA + T G
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYTF-CGTI 193
Query: 581 GYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV--RWATPQLHD 637
Y APE + Y + +++S GV + L+ P E ++ + +L
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMS 253
Query: 638 IDALAKM--VDPA 648
+ ++ + P
Sbjct: 254 L--VSGLLQPVPE 264
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 14/166 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLP-YSIASMVSLSY 157
L LR+ L N I +IP P+L L+L + + + +L Y
Sbjct: 142 AFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKY 200
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
LN+ ++ + + L GL L++S N+F P SF LS++ L++ N+QV+
Sbjct: 201 LNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258
Query: 217 LNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
N F GL L LN+A+N+ S +P + L + N ++
Sbjct: 259 RNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 30/139 (21%), Positives = 46/139 (33%), Gaps = 7/139 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L L L NSI I +L +L L N + + + L L
Sbjct: 95 FRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW 153
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLN 218
+ N + F + L LDL + +F L N+ L L + +
Sbjct: 154 LRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP 212
Query: 219 VFSGLP-LTTLNVANNHFS 236
+ L L L ++ NHF
Sbjct: 213 NLTPLVGLEELEMSGNHFP 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 9/139 (6%)
Query: 101 YLLSDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS 156
Y + + SL + DL I + L NL LNL N ++P ++ +V L
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLF-NLKYLNLGMCNIK-DMP-NLTPLVGLE 221
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L +S N + F L+ L L + + S N+F L+++ L L +N ++
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSL 281
Query: 216 SLNVFSGLP-LTTLNVANN 233
++F+ L L L++ +N
Sbjct: 282 PHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 34/128 (26%), Positives = 53/128 (41%), Gaps = 3/128 (2%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
K + + +P +P N LNL NN + + L L + RNS+ Q
Sbjct: 55 QFSKVVCTRRGL-SEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ 113
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-L 225
F LA L TL+L N + +F LS + L+L+NN + F+ +P L
Sbjct: 114 IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSL 173
Query: 226 TTLNVANN 233
L++
Sbjct: 174 MRLDLGEL 181
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 60/292 (20%), Positives = 116/292 (39%), Gaps = 25/292 (8%)
Query: 335 SGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSP 394
SG + + + + + + A E++ ++ S I +P
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 395 ITATSYTVASLQTATNS----FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSL 449
+ + + + + S+ ++G G G+V++ E A G +A K I +
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GM 127
Query: 450 QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL 509
++++ +S M++L H N++ L +LV EYV G L D + D S NL
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNL 184
Query: 510 T-WNAR--VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL--SDCGLAA- 563
T + ++ + ++H++ ++H + K NIL + + D GLA
Sbjct: 185 TELDTILFMKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR 238
Query: 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
P + G + APE + +D++S GV+ LL+G P
Sbjct: 239 YKPR---EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNIV 471
+GEG+ G VY+A+ + G+I+A+K+I D E++ + +S + L HPNIV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDA------EDEGIPSTAIREISLLKELHHPNIV 82
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+L LV+E++ D+ D++ L + R + + H+
Sbjct: 83 SLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFGYSAP 585
++HR+ K N+L++ + L+D GLA R T V Y AP
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLA-------RAFGIPVRSYTHEVVTLWYRAP 188
Query: 586 EFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ + S Y+ D++S G + E++T KPL
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMIT-GKPL 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 48/211 (22%), Positives = 79/211 (37%), Gaps = 26/211 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G V + E + G A K I E + + ++HPN++T
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYL 528
L +L+ E V G L D L ++ + ++ L + YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILN---GVYYL 130
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGAFGYSA 584
H + + H + K NI+L D P + D GLA + G + A
Sbjct: 131 HSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVA 185
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE +++D++S GV+ LL+G P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 4e-19
Identities = 56/253 (22%), Positives = 99/253 (39%), Gaps = 19/253 (7%)
Query: 371 PPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGE----GSLGRV 426
+ ++ S Y ++ + + I E G+ G V
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173
Query: 427 YRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485
+R E A G A K + +++ + + MS LRHP +V L + + ++
Sbjct: 174 HRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231
Query: 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545
+YE++ G L + + D ++ + V + L ++HE + VH + K N
Sbjct: 232 IYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPEN 285
Query: 546 ILLDDELNPHL--SDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSF 602
I+ + + L D GL A L P Q G ++APE A +D++S
Sbjct: 286 IMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342
Query: 603 GVVMLELLTGRKP 615
GV+ LL+G P
Sbjct: 343 GVLSYILLSGLSP 355
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 60/273 (21%), Positives = 106/273 (38%), Gaps = 36/273 (13%)
Query: 355 MHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQ 414
MH S E L + ++ + + Y + + ++ S
Sbjct: 1 MHHHHHHSSGV-----DLGTENLYFQSMSSVTASAAPGTASLVPDYWI--DGSNRDALSD 53
Query: 415 EF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
F +G G+ VYR + K A+K + ++ + + RL HPN
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPN 109
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARAL 525
I+ L + LV E V G L D + ++++ + + V+ L A+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILE---AV 161
Query: 526 EYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY 582
YLHE +VHR+ K N+L + ++D GL+ + + + + G GY
Sbjct: 162 AYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGY 216
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE Y + D++S G++ LL G +P
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 58/227 (25%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLRHPNIV 471
+G G+ G+V + G +AVK ++ + + + + N+ RHP+I+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKI---RSLDVVGKIRREIQNLKLFRHPHII 79
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR-------- 523
L + +V EYV G L D + R+ +R
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYI------------CKNGRLDEKESRRLFQQILS 127
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL------------TPNTERQ 571
++Y H VVHR+ K N+LLD +N ++D GL+ + +PN
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN---- 180
Query: 572 VSTQMVGAFGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
Y+APE +Y + D++S GV++ LL G P D
Sbjct: 181 ----------YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 43/219 (19%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNI 470
+GEG+ G VY+A + + +A+K+I ++ EE+ + VS + L+H NI
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEH------EEEGVPGTAIREVSLLKELQHRNI 95
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALEYLH 529
+ L + + L++EY +D+ + D + +++ ++ L + + H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAE----NDLKKYM-DKNPDVS-MRVIKSFLYQLINGVNFCH 149
Query: 530 EVCLPSVVHRNFKSANILLDDELNPH-----LSDCGLAALTPNTERQVS------TQMVG 578
+HR+ K N+LL + D GLA R T +
Sbjct: 150 S---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA-------RAFGIPIRQFTHEII 199
Query: 579 AFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y PE L S Y+ D++S + E+L + PL
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPL 237
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 5e-19
Identities = 37/210 (17%), Positives = 73/210 (34%), Gaps = 6/210 (2%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
+S + L+ +++ + D S NSI+ + + LT L L NN + + + +
Sbjct: 197 ANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLT-DTA-WLLNY 253
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L +++S N L + + F + L L +S N L + + L L +N
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312
Query: 213 VTGSLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPP 271
+ L L + +N +++ N +D + A P
Sbjct: 313 LLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARP 372
Query: 272 SGRSHNNRSHRQGSHSPSGSQSSSSDKELP 301
+ ++ + G SDK
Sbjct: 373 AV-DDADQHCKIDYQLEHGLCCKESDKPYL 401
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 3e-17
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 23/160 (14%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA----------- 150
SL+ LS N + + L P+L N++ N S L IA
Sbjct: 166 TFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS-TLAIPIAVEELDASHNSI 223
Query: 151 ------SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
V L+ L + N+LT + N GL +DLS+N + + F+ + +
Sbjct: 224 NVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281
Query: 205 SLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPREL 243
LY+ NN++ +P L L++++NH + R
Sbjct: 282 RLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 320
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 2e-16
Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 7/139 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
LL + +L+ I I + + L + N P+ ++ L+ L
Sbjct: 70 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ RN L+ IF N L TL +S NN ++F + +++ +L L +N++T L
Sbjct: 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL 188
Query: 218 NVFSGLPLTTLNVANNHFS 236
++ L NV+ N S
Sbjct: 189 SLIPS--LFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-15
Identities = 30/181 (16%), Positives = 61/181 (33%), Gaps = 6/181 (3%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGN 144
+ I G+ L + + +++ +P L + LNL
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEI 90
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
Y+ A ++ L + N++ +F N+ L L L N+ S F + ++
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 205 SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAP 262
+L + NN + + F L L +++N + + S+ N P
Sbjct: 151 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIP 210
Query: 263 P 263
Sbjct: 211 I 211
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 3e-14
Identities = 31/139 (22%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSI-ASMVSLSYL 158
+ +++K + N+I +P + P LT L L N+ S +LP I + L+ L
Sbjct: 95 FAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL 152
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN 218
++S N+L + D F L L LS N + + S + ++ + N L+
Sbjct: 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIPSLFHANVSYNL----LS 205
Query: 219 VFSGLP-LTTLNVANNHFS 236
+ + L+ ++N +
Sbjct: 206 TLAIPIAVEELDASHNSIN 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 5e-14
Identities = 22/130 (16%), Positives = 50/130 (38%), Gaps = 6/130 (4%)
Query: 113 DLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168
D+ + + + N + ++ + S + LN++ + +
Sbjct: 31 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI 90
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LT 226
F + L + FN P+ F ++ ++ L L+ N ++ +F P LT
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 227 TLNVANNHFS 236
TL+++NN+
Sbjct: 151 TLSMSNNNLE 160
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 28/197 (14%), Positives = 58/197 (29%), Gaps = 18/197 (9%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ L + +S N + + P L L+L+ N+ ++ + L L
Sbjct: 273 PFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
+ NS+ ++ L L LS N++ + + N++ + + +
Sbjct: 331 LDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA----DQHC 381
Query: 220 FSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNR 279
L ++ R L I S +A + S +
Sbjct: 382 KIDYQLEHGLCCKESDKPYLDRLLQYIAL-----TSVVEKVQRAQGRCSATDTINSVQSL 436
Query: 280 SHRQGSHSPSGSQSSSS 296
SH Q +
Sbjct: 437 SHYITQQGGVPLQGNEQ 453
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 14/110 (12%), Positives = 27/110 (24%), Gaps = 8/110 (7%)
Query: 135 NLASNNFSGNLPYSIASMVSLSYLNVSRN-SLTQSIGDIFG-----NLAGLATLDLSFNN 188
N P +L Y V + + D++ L + +
Sbjct: 3 GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62
Query: 189 FSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
S + L L + Q+ F+ + L + N
Sbjct: 63 MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 112
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 45/282 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEGS + + + AVK I + Q+E L+ HPNIV L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG-----HPNIVKLHE 73
Query: 476 YCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ LV E + G L + + HF++ + + +R + A+ ++H+V
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVS---AVSHMHDV 125
Query: 532 CLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
VVHR+ K N+L +D L + D G A L P + + T Y+APE
Sbjct: 126 ---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELL 181
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648
Y D++S GV++ +L+G+ P + + + +++
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPF-------------QSHDRSLTCTSAVEIMKKI 228
Query: 649 LNGMY-----PAKSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
G + K++S+ A D+I + +P R MS +
Sbjct: 229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 36/182 (19%), Positives = 59/182 (32%), Gaps = 9/182 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSG-NLPYSIASMVSLSYLN 159
S + L+ N I + L+L N N AS +L +LN
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
+ N + G + A L TLDLS N + + F S + ++ + L+NN++
Sbjct: 176 LQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKA 232
Query: 220 FSGLP-LTTLNVANNHFSGWIPRELISIRTFIY--DGNSFDNGPAPPPPPSTAPPSGRSH 276
L ++ N F R+ S + + T P G
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 277 NN 278
Sbjct: 293 AY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 31/143 (21%), Positives = 59/143 (41%), Gaps = 10/143 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L L +LR DL+ N + + + P++ +L+ A+NN S + S + ++
Sbjct: 76 LESLSTLRTLDLNNNYVQ-ELL--VGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLAN 129
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
N +T G + + LDL N + S + L LQ N + +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188
Query: 222 GLP-LTTLNVANNHFSGWIPREL 243
L TL++++N + ++ E
Sbjct: 189 VFAKLKTLDLSSNKLA-FMGPEF 210
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 31/147 (21%), Positives = 58/147 (39%), Gaps = 13/147 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ + + ++ +S+ + N+ L+L+ N S +A L LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLN 218
+S N L D +L+ L TLDL+ N +L +I +L+ NN ++ S +
Sbjct: 65 LSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNISRVSCS 117
Query: 219 VFSGLPLTTLNVANNHFSGWIPRELIS 245
G + +ANN + +
Sbjct: 118 RGQG--KKNIYLANNKITM-LRDLDEG 141
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 31/152 (20%), Positives = 58/152 (38%), Gaps = 14/152 (9%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP 146
++ L + L ++++ DLSGN + L L LNL+SN
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL 74
Query: 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
+ S+ +L L+++ N + + + TL + NN S + S ++
Sbjct: 75 -DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-RVSCS--RGQGKKNI 125
Query: 207 YLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
YL NN++T + L++ N
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 26/127 (20%), Positives = 49/127 (38%), Gaps = 4/127 (3%)
Query: 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L + +L +L N I+D + L +L+L+SN + + S +++++
Sbjct: 162 AELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD-LPNSFISLSNISSLYLQNNQ-VTGSL 217
+ N L I L DL N F L + F + ++ Q + +TG
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 218 NVFSGLP 224
+P
Sbjct: 280 EEECTVP 286
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 29/120 (24%), Positives = 47/120 (39%), Gaps = 9/120 (7%)
Query: 118 SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
+IH+ Q + ++ L S ++ L++S N L+Q
Sbjct: 1 AIHEIK--QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFT 58
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFS 236
L L+LS N + SLS + +L L NN + P + TL+ ANN+ S
Sbjct: 59 KLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNIS 112
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 6e-19
Identities = 28/154 (18%), Positives = 58/154 (37%), Gaps = 6/154 (3%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIH----DTIPYQLPPNLTSLNLASNNFSGN 144
+S + + L + ++I +T ++ L+L+
Sbjct: 222 GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSL 281
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
++ L LN++ N + + + F L L L+LS+N ++F L ++
Sbjct: 282 NSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341
Query: 205 SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
+ LQ N + F L L TL++ +N +
Sbjct: 342 YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 37/155 (23%), Positives = 58/155 (37%), Gaps = 12/155 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L L+ +L TI L PNL L+L S+ P + + L L
Sbjct: 44 FPFLEQLQLLELGSQYTPLTIDKEAFRNL-PNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102
Query: 159 NVSRNSLTQSI--GDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVT- 214
+ L+ ++ F NL L LDLS N L SF L+++ S+ +NQ+
Sbjct: 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162
Query: 215 ---GSLNVFSGLPLTTLNVANNHFSGWIPRELISI 246
L G L+ ++A N + +
Sbjct: 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-18
Identities = 33/157 (21%), Positives = 56/157 (35%), Gaps = 14/157 (8%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNL- 145
L+ + L + + LS N I P L L L S +
Sbjct: 10 FYRFCNLT----QVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDL--PNSFISLSNI 203
+ ++ +L L++ + + D F L L L L F S + F +L +
Sbjct: 66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125
Query: 204 SSLYLQNNQVTGSLN---VFSGLP-LTTLNVANNHFS 236
+ L L NQ+ SL F L L +++ ++N
Sbjct: 126 TRLDLSKNQIR-SLYLHPSFGKLNSLKSIDFSSNQIF 161
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 9e-18
Identities = 47/252 (18%), Positives = 79/252 (31%), Gaps = 22/252 (8%)
Query: 87 SIDISGLGLSG-TMGYLLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFS 142
I +S L + Y L + L+ L+ N P+L L L N
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 143 GNLPYSI-----ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
+ + L L ++ N L +F +L L L L+ N + N
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL 524
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
+N+ L + NQ+ + N + L+ L++ +N F + TFI + +
Sbjct: 525 --PANLEILDISRNQLL-APNPDVFVSLSVLDITHNKFI-----CECELSTFI-NWLNHT 575
Query: 258 NGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGIVLGAVFLVA 317
N PP S + S S S + + IV +
Sbjct: 576 NVTIAGPPADIYCVYPDSFSGVSLF----SLSTEGCDEEEVLKSLKFSLFIVCTVTLTLF 631
Query: 318 LALLALYFCIRK 329
L + R
Sbjct: 632 LMTILTVTKFRG 643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 7e-17
Identities = 31/159 (19%), Positives = 59/159 (37%), Gaps = 17/159 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNL--PYSIASMVSLSY 157
+L +LR DL + I+ + +L L L S + ++ +L+
Sbjct: 69 FRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
Query: 158 LNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS--SLYLQNNQVT 214
L++S+N + + FG L L ++D S N + L + L N +
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187
Query: 215 --------GSLNVFSGLPLTTLNVANNHFSGWIPRELIS 245
+N F + L L+V+ N ++ I +
Sbjct: 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 42/210 (20%), Positives = 73/210 (34%), Gaps = 24/210 (11%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140
S+V +D+S + + L L+ +L+ N I+ NL LNL+ N
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--GDLP---- 194
+ + ++Y+++ +N + F L L TLDL N + +P
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPD 385
Query: 195 -----NSFISLSNIS----SLYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSG----W 238
N ++L I+ ++L N++ L +P L L + N FS
Sbjct: 386 IFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQ 445
Query: 239 IPRELISIRTFIYDGNSFDNGPAPPPPPST 268
P E S+ N
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDV 475
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-13
Identities = 34/179 (18%), Positives = 67/179 (37%), Gaps = 29/179 (16%)
Query: 87 SIDISGLGLSGTM--GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSL---NLASNNF 141
+ + GLS + +L +L + DLS N I + L SL + +SN
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 142 SGNLPYSIAS--MVSLSYLNVSRNSLTQSIGDIFGNLAG------LATLDLSFNNFSGDL 193
+ + +LS+ +++ NSL + +G L LD+S N ++ D+
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220
Query: 194 PNSFIS------------LSNISSLYLQNNQVTG-SLNVFSGLP---LTTLNVANNHFS 236
+F + +I + + N F+GL + L++++
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 28/150 (18%), Positives = 48/150 (32%), Gaps = 18/150 (12%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSG-NLPYSIASMVSLS 156
L L + L + D + LT L+L+ N L S + SL
Sbjct: 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLK 151
Query: 157 YLNVSRNSLTQSIGDIFGNLAG--LATLDLSFNNFSGDLPNSFISLSN------ISSLYL 208
++ S N + L G L+ L+ N+ + + N + L +
Sbjct: 152 SIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV 211
Query: 209 QNNQVTG-----SLNVFSGLPLTTLNVANN 233
N T N S +L +A++
Sbjct: 212 SGNGWTVDITGNFSNAISKSQAFSLILAHH 241
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 19/87 (21%), Positives = 30/87 (34%), Gaps = 7/87 (8%)
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+LTQ + L L LSFN +SF L + L L +
Sbjct: 4 FDGRIAFYRFCNLTQ----VPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQY 59
Query: 213 VTGSL--NVFSGLP-LTTLNVANNHFS 236
++ F LP L L++ ++
Sbjct: 60 TPLTIDKEAFRNLPNLRILDLGSSKIY 86
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 9e-19
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 34/212 (16%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNIV 471
IGEG+ G VY+A+ G+ A+KKI + E++ + +S + L+H NIV
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEK------EDEGIPSTTIREISILKELKHSNIV 63
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L + +LV+E++ D+ D L L + Y H+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFGYSAP 585
V+HR+ K N+L++ E ++D GLA R T + Y AP
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLA-------RAFGIPVRKYTHEIVTLWYRAP 169
Query: 586 EFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ + S Y+ D++S G + E++ PL
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPL 200
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-19
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 36/224 (16%)
Query: 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH 467
S++ +IG GS G VY+A+ +G+++A+KK+ LQ++ + M +L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDH 106
Query: 468 PNIVTLAGYCAEHGQRL------LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-G 520
NIV L + G++ LV +YV ++ + + + L V++ +
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQ 164
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLA-ALT---PNTERQVS 573
R+L Y+H + HR+ K N+LLD L L D G A L PN +
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLK--LCDFGSAKQLVRGEPNVS-YIC 218
Query: 574 TQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
++ Y APE + YT DV+S G V+ ELL G+ P+
Sbjct: 219 SRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 39/207 (18%), Positives = 83/207 (40%), Gaps = 26/207 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G V+R E ++ K K + ++ + +S ++ RH NI+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHES 69
Query: 477 CAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ ++++E++ ++ + + + + V AL++LH
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVCE---ALQFLHSH 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHL--SDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFA 588
++ H + + NI+ + + + G A L P + A Y APE
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVH 175
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ + +D++S G ++ LL+G P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 39/203 (19%), Positives = 79/203 (38%), Gaps = 12/203 (5%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAG 475
+G G V + + G+ A K + L ++ + + P ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +L+ EY G + + + ++ ++ N +R+ + YLH+ +
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC--LPELAEMVSENDVIRLIKQILEGVYYLHQN---N 151
Query: 536 VVHRNFKSANILLDDELNPH---LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
+VH + K NILL + D G++ +++G Y APE
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEILNYDP 209
Query: 593 YTVKSDVYSFGVVMLELLTGRKP 615
T +D+++ G++ LLT P
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSP 232
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 14/165 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLP-YSIASMVSLSYL 158
L L++ L N I +IP P+L L+L + + + +L YL
Sbjct: 132 FVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
N++ +L I + L L LDLS N+ S P SF L ++ L++ +Q+
Sbjct: 191 NLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER 248
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
N F L L +N+A+N+ + +P + L + N ++
Sbjct: 249 NAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 34/145 (23%), Positives = 50/145 (34%), Gaps = 8/145 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L L LS N I TI NL +L L N + + + L L
Sbjct: 84 FKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLN 218
+ N + F + L LDL + +F LSN+ L L + +
Sbjct: 143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201
Query: 219 VFSGLP-LTTLNVANNHFSGWIPRE 242
+ L L L+++ NH S I
Sbjct: 202 NLTPLIKLDELDLSGNHLS-AIRPG 225
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 9/139 (6%)
Query: 101 YLLSDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS 156
Y + + SLR+ DL I + L NL LNLA N +P ++ ++ L
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLS-NLRYLNLAMCNLR-EIP-NLTPLIKLD 210
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L++S N L+ F L L L + + N+F +L ++ + L +N +T
Sbjct: 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL 270
Query: 216 SLNVFSGLP-LTTLNVANN 233
++F+ L L +++ +N
Sbjct: 271 PHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 32/128 (25%), Positives = 51/128 (39%), Gaps = 3/128 (2%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
K ++ +P + N LNL N S + L L +SRN +
Sbjct: 44 QFSKVICVRKNL-REVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT 102
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-L 225
F LA L TL+L N + +F+ LS + L+L+NN + F+ +P L
Sbjct: 103 IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSL 162
Query: 226 TTLNVANN 233
L++
Sbjct: 163 RRLDLGEL 170
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 34/149 (22%), Positives = 55/149 (36%), Gaps = 10/149 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ L +L +L N + TIP L L L +N Y+ + SL L+
Sbjct: 108 FNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD 166
Query: 160 VSR-NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ L+ F L+ L L+L+ N ++P + L + L L N ++
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRP 224
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRELIS 245
F GL L L + + I R
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQ-VIERNAFD 252
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 23/92 (25%), Positives = 42/92 (45%), Gaps = 2/92 (2%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
L+ L+ L + DLSGN + P +L L + + + ++ SL +N+
Sbjct: 203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINL 262
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD 192
+ N+LT D+F L L + L N ++ +
Sbjct: 263 AHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 14/166 (8%)
Query: 103 LSDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
+ L L + DLS N S+ + L L +L+L L + + +L Y
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGL-GRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
L + N+L D F +L L L L N S +F L ++ L L N+V
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 217 LNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
+ F L L TL + N+ S +P E L +++ + N +
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 30/128 (23%), Positives = 48/128 (37%), Gaps = 6/128 (4%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
+ +P +P + L N S S + +L+ L + N L +
Sbjct: 17 SCPQQGL-QAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 173 FGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTL 228
F LA L LDLS N + +F L + +L+L + L +F GL L L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 229 NVANNHFS 236
+ +N
Sbjct: 135 YLQDNALQ 142
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 34/143 (23%), Positives = 56/143 (39%), Gaps = 13/143 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
+L L N + I L L L+L+ N ++ + + L
Sbjct: 52 FRACRNLTILWLHSNVLA-RIDAAAFTGL-ALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109
Query: 158 LNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTG 215
L++ R L + +F LA L L L N LP ++F L N++ L+L N+++
Sbjct: 110 LHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS 167
Query: 216 -SLNVFSGLP-LTTLNVANNHFS 236
F GL L L + N +
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVA 190
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 30/113 (26%), Positives = 44/113 (38%), Gaps = 4/113 (3%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L L +L+ L N++ +P NLT L L N S + + SL L
Sbjct: 124 LFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ +N + F +L L TL L NN S + L + L L +N
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 47/255 (18%), Positives = 92/255 (36%), Gaps = 42/255 (16%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLR----H 467
L+G+G G V+ + +A+K I + + + + ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR---- 523
P ++ L + +LV E D+ + + + G +R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQ--DLFDYIT---------EKGPLGEGPSRCFFG 146
Query: 524 ----ALEYLHEVCLPSVVHRNFKSANILLDDELNP-HLSDCGLAALTPNTERQVSTQMVG 578
A+++ H VVHR+ K NIL+D L D G AL + G
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DG 200
Query: 579 AFGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLDSSR--PRSEQSLVRWATPQL 635
YS PE+ Y + + V+S G+++ +++ G P + + +E +P
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDC 260
Query: 636 HDIDALAKM--VDPA 648
+ + + P+
Sbjct: 261 CAL--IRRCLAPKPS 273
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS--------RLRHP 468
+GEG VY+A + +I+A+KKI L + ++ + L HP
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKI-----KLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALEY 527
NI+ L LV++++ D+ D+S LT + ++ + T + LEY
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFM----ETDLEVIIKDNSLVLT-PSHIKAYMLMTLQGLEY 127
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFG 581
LH+ ++HR+ K N+LLD+ L+D GLA + T V
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLA-------KSFGSPNRAYTHQVVTRW 177
Query: 582 YSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE + +Y V D+++ G ++ ELL R P
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPF 212
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 40/151 (26%), Positives = 60/151 (39%), Gaps = 8/151 (5%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
D S +IP L + SL+L+ N + + + +L L + + + GD
Sbjct: 11 DGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLN 229
F +L L LDLS N+ S + F LS++ L L N G ++F L L TL
Sbjct: 70 FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129
Query: 230 VANNHFSGWIPRE----LISIRTFIYDGNSF 256
+ N I R L S+ S
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSL 160
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-18
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 13/166 (7%)
Query: 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLL-SLRKFDLSGNSIHDTIPYQLP--PNLTSL 134
++C+ S V D + + S L +++ DLS N I L NL L
Sbjct: 2 LSCDASGVC--DGRSRSFT----SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVL 55
Query: 135 NLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DL 193
L S+ + + S+ SL +L++S N L+ FG L+ L L+L N + +
Sbjct: 56 ILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGV 115
Query: 194 PNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
+ F +L+N+ +L + N + + F+GL L L +
Sbjct: 116 TSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 34/196 (17%), Positives = 66/196 (33%), Gaps = 13/196 (6%)
Query: 103 LSDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L +L+ L + +I Y L +L L+L+ N+ S + SL YLN
Sbjct: 46 LRACANLQVLILKSSRINTIEGDAFYSL-GSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104
Query: 160 VSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTG-S 216
+ N + +F NL L TL + ++ F L++++ L ++ +
Sbjct: 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164
Query: 217 LNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFDNGPAPPPPPSTAPP 271
+ + L + + + ++ L S+R + P P
Sbjct: 165 SQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223
Query: 272 SGRSHNNRSHRQGSHS 287
+ R S
Sbjct: 224 PMKKLAFRGSVLTDES 239
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 14/141 (9%)
Query: 99 MGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLS 156
G +L L +L D+S N+ H +P P + LNL+S + I +L
Sbjct: 379 TGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ--TLE 434
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L+VS N+L L L L +S N LP++ + + + + NQ+
Sbjct: 435 VLDVSNNNLD----SFSLFLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSV 488
Query: 216 SLNVFSGLP-LTTLNVANNHF 235
+F L L + + N +
Sbjct: 489 PDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 38/165 (23%), Positives = 62/165 (37%), Gaps = 19/165 (11%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGNLPYSIASMVSLSY 157
SL+ LS N + NLTSL+++ N F +P S + +
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
LN+S + I L LD+S NN + L + LY+ N++ +L
Sbjct: 415 LNLSSTGIRVVKTCIPQT---LEVLDVSNNNLD-SFS---LFLPRLQELYISRNKLK-TL 466
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
S P L + ++ N +P L S++ N +D
Sbjct: 467 PDASLFPVLLVMKISRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-14
Identities = 23/140 (16%), Positives = 46/140 (32%), Gaps = 8/140 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGNLPY-SIASMVSLS 156
L SL+ +L GN T+ NL +L + + + A + SL+
Sbjct: 93 WFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLN 151
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L + SL ++ + L L + + L LS++ L L++ +
Sbjct: 152 ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211
Query: 216 SLNVFSGLP-LTTLNVANNH 234
+ + +
Sbjct: 212 QFSPLPVDEVSSPMKKLAFR 231
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-13
Identities = 23/138 (16%), Positives = 50/138 (36%), Gaps = 7/138 (5%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
L L F+ S + + + + L++ +L + + + + V + +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGDL---PNSFISLSNISSLYLQNNQVT---GSLNV 219
+L L LDLS N + + ++ +L L N + + +
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382
Query: 220 FSGLP-LTTLNVANNHFS 236
L LT+L+++ N F
Sbjct: 383 LLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 19/143 (13%), Positives = 44/143 (30%), Gaps = 7/143 (4%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L +L +L+ + I +L L + + + S+ S+ + +L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT---- 214
+ + + L+ + L+L N + + S + + +
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237
Query: 215 GSLNVFSGLPLTTLNVANNHFSG 237
S N L L ++ F
Sbjct: 238 ESFNELLKLLRYILELSEVEFDD 260
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 30/199 (15%), Positives = 65/199 (32%), Gaps = 28/199 (14%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGN--- 144
+ + + + L S+R +L ++ LP + S + F G+
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 145 ------LPYSIASMVSLSYLNVSRNSLTQ------SIGDIFGNLAGLAT-----LDLSFN 187
L + ++ LS + +L S D+ L + T L +
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 188 NFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRE--- 242
DL + L + + ++N++V + L L L+++ N +
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356
Query: 243 ---LISIRTFIYDGNSFDN 258
S++T + N +
Sbjct: 357 KGAWPSLQTLVLSQNHLRS 375
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 23/87 (26%), Positives = 35/87 (40%), Gaps = 4/87 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
+L D+S N++ D+ LP L L ++ N LP + L + +SRN L
Sbjct: 430 PQTLEVLDVSNNNL-DSFSLFLP-RLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQL 485
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGD 192
IF L L + L N +
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPWDCS 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 26/158 (16%), Positives = 49/158 (31%), Gaps = 8/158 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
+ L SL + ++ S+ + L ++ L L + + L + S+ YL +
Sbjct: 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
+L + + + S SF L + L+ ++V F
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE-----F 258
Query: 221 SGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDN 258
L L N S + EL + T
Sbjct: 259 DDCTLNGLGDFNPSESDVVS-ELGKVETVTIRRLHIPQ 295
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 14/78 (17%), Positives = 26/78 (33%), Gaps = 4/78 (5%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY 147
+D+S L L L++ +S N + L P L + ++ N
Sbjct: 436 LDVSNNNLD----SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDG 491
Query: 148 SIASMVSLSYLNVSRNSL 165
+ SL + + N
Sbjct: 492 IFDRLTSLQKIWLHTNPW 509
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 49/242 (20%), Positives = 91/242 (37%), Gaps = 61/242 (25%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKID--------------------NAALSLQEEDNF 455
IG+GS G V A + A+K + A +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 456 LEAV----SNMSRLRHPNIVTLAGY----CAEHGQRLLVYEYVGNGNLHDMLHFADDSSK 507
+E V + + +L HPN+V L +V+E V G + ++
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVP-------- 129
Query: 508 NLTWNARVRVALGTAR--------ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559
++ AR +EYLH ++HR+ K +N+L+ ++ + ++D
Sbjct: 130 -----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV----KSDVYSFGVVMLELLTGRKP 615
G++ ++ +S VG + APE +LS + DV++ GV + + G+ P
Sbjct: 182 GVSNEFKGSDALLSNT-VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 616 LD 617
Sbjct: 240 FM 241
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 34/235 (14%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRH 467
+ F IG+GS G+V + K+ A+K ++ + E N + + M L H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 468 PNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDML----HFADDSSKNLTWNARVR-----V 517
P +V L Y + + + +V + + G+L L HF ++ V+ +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---------TVKLFICEL 124
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMV 577
+ AL+YL ++HR+ K NILLD+ + H++D +AA+ P + + M
Sbjct: 125 VM----ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MA 175
Query: 578 GAFGYSAPEFALSGI---YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR 629
G Y APE S Y+ D +S GV ELL GR+P S + +V
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 57/222 (25%), Positives = 90/222 (40%), Gaps = 43/222 (19%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVS-----------NMSRL 465
IG G+ G VY+A + +G +A+K + + + +
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV-----RVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 466 RHPNIVTL----AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
HPN+V L A + ++ LV+E+V D+ + D + ++ +
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 521 -TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS-----T 574
R L++LH C +VHR+ K NIL+ L+D GLA R S T
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA-------RIYSYQMALT 177
Query: 575 QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
+V Y APE L Y D++S G + E+ RKPL
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 27/138 (19%), Positives = 55/138 (39%), Gaps = 8/138 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+ L+ L + LS N + +P ++P L L + N + + + + +
Sbjct: 96 FAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154
Query: 163 NSLTQSI--GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNV 219
N L S F + L+ + ++ N + +P +++ L+L N++T
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLDGNKITKVDAAS 211
Query: 220 FSGLP-LTTLNVANNHFS 236
GL L L ++ N S
Sbjct: 212 LKGLNNLAKLGLSFNSIS 229
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 32/165 (19%), Positives = 56/165 (33%), Gaps = 36/165 (21%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNF-------------------SG 143
+ L ++ +I TIP LPP+LT L+L N S
Sbjct: 167 FQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 144 NLPYSI-----ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI 198
N ++ A+ L L+++ N L + + + + L NN S N F
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284
Query: 199 ------SLSNISSLYLQNNQVTGSL---NVFSGLP-LTTLNVANN 233
++ S + L +N V + F + + + N
Sbjct: 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 29/144 (20%), Positives = 59/144 (40%), Gaps = 14/144 (9%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSIASMV 153
+ + L + +L N + + + L+ + +A N + +P +
Sbjct: 139 SVFNGLNQMIVVELGTNPLKSS---GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PP 192
Query: 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQV 213
SL+ L++ N +T+ L LA L LSFN+ S S + ++ L+L NN++
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 214 TGSLNVFSGLP-LTTLNVANNHFS 236
+ + + + NN+ S
Sbjct: 253 VKVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 32/161 (19%), Positives = 59/161 (36%), Gaps = 27/161 (16%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
LR S + +P LPP+ L+L +N + ++ +L L + N +++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 168 SIGDIFGNLAGLATLDLSFNN--------FSG----DL---------PNSFISLSNISSL 206
F L L L LS N + + F L+ + +
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 150
Query: 207 YLQNNQVTGSL---NVFSGLP-LTTLNVANNHFSGWIPREL 243
L N + S F G+ L+ + +A+ + + IP+ L
Sbjct: 151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL 190
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 64/285 (22%), Positives = 99/285 (34%), Gaps = 54/285 (18%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG G+ G +++AVK I+ A ++N + N LRHPNIV
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKE 83
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALEY 527
++ EY G L++ + R + AR + Y
Sbjct: 84 VILTPTHLAIIMEYASGGELYERI------------CNAGRFSEDEARFFFQQLLSGVSY 131
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHL--SDCGLAALTPNTERQVSTQMVGAFGYSAP 585
H + + HR+ K N LLD P L D G + + + ST VG Y AP
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAP 186
Query: 586 EFALSGI-YT-VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643
E L Y +DV+S GV + +L G P + + K
Sbjct: 187 E-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------------EEPRDYRK 229
Query: 644 MVDPALNGMY---PAKSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
+ L+ Y +S +I+ +P R + E+
Sbjct: 230 TIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 37/174 (21%), Positives = 63/174 (36%), Gaps = 27/174 (15%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPP------NLTSLNLASNNFSGNLPYSIASMVSLS 156
L L+ + + +LP L +L LA N LP SIAS+ L
Sbjct: 100 AFRLSHLQHMTIDAAGLM-----ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153
Query: 157 YLNVSR-NSLTQ---SIG-----DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY 207
L++ LT+ + L L +L L + LP S +L N+ SL
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212
Query: 208 LQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRE---LISIRTF-IYDGNSF 256
++N+ ++ LP L L++ P ++ + D ++
Sbjct: 213 IRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 32/160 (20%), Positives = 57/160 (35%), Gaps = 27/160 (16%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP-----YQLPP------NLTSLNLASNNFSGNLPYSIAS 151
++ L LR+ + +P NL SL L +LP SIA+
Sbjct: 146 IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204
Query: 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ +L L + + L+ ++G +L L LDL + P F + + L L++
Sbjct: 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263
Query: 212 QVTGSLNVFSGLP--------LTTLNVANNHFSGWIPREL 243
+ LP L L++ +P +
Sbjct: 264 ------SNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 11/116 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPP------NLTSLNLASNNFSGNLPYSIASMVSLS 156
+++L +L+ + + + L P L L+L N P L
Sbjct: 202 IANLQNLKSLKIRNSPLS-----ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L + S ++ L L LDL LP+ L + + +
Sbjct: 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 28/155 (18%), Positives = 52/155 (33%), Gaps = 26/155 (16%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPP------NLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+L + Q P +L + + + LP ++ L L
Sbjct: 80 QPGRVALELRSVPLP-----QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLT 133
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF---------ISLSNISSLYLQN 210
++RN L ++ +L L L + +LP L N+ SL L+
Sbjct: 134 LARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192
Query: 211 NQVTGSL-NVFSGLP-LTTLNVANNHFSGWIPREL 243
+ SL + L L +L + N+ S + +
Sbjct: 193 TGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAI 225
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 16/104 (15%), Positives = 30/104 (28%), Gaps = 7/104 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPY---QLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ L L + DL G + P L L L + LP I + L L+
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRA-PLKRLILKDCSNLLTLPLDIHRLTQLEKLD 283
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFN---NFSGDLPNSFISL 200
+ + + L + + + P + +
Sbjct: 284 LRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 15/137 (10%), Positives = 33/137 (24%), Gaps = 26/137 (18%)
Query: 130 NLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI----------------- 172
+L + ++ + +R +
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATA 72
Query: 173 ----FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGLP-LT 226
G L+L P+ LS++ + + + L + L
Sbjct: 73 DLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLE 130
Query: 227 TLNVANNHFSGWIPREL 243
TL +A N +P +
Sbjct: 131 TLTLARNPLRA-LPASI 146
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 37/216 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+G G+ VY+ G +A+K++ L E+ + +S M L+H NIV
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV-----KLDSEEGTPSTAIREISLMKELKHENIVR 67
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWN----ARVRVALG-TARALEY 527
L + LV+E++ +D+ + D + T V+ + L +
Sbjct: 68 LYDVIHTENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFG 581
HE ++HR+ K N+L++ L D GLA R + V
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA-------RAFGIPVNTFSSEVVTLW 173
Query: 582 YSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y AP+ + S Y+ D++S G ++ E++T KPL
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPL 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 55/233 (23%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 408 ATNSFSQEF---------LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLE 457
+T+SFS F ++GEG+ RV + AVK I+ F E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFRE 60
Query: 458 AVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
V + + + H N++ L + E + LV+E + G++ +H ++
Sbjct: 61 -VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASV 115
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH---LSDCGLA------ALTPN 567
V A AL++LH + HR+ K NIL + + D L
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 568 TERQVSTQMVGAFGYSAPE-----FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
G+ Y APE + IY + D++S GV++ LL+G P
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 33/142 (23%), Positives = 58/142 (40%), Gaps = 8/142 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
+ L +L D+S + +L L +A N+F N I + +L++
Sbjct: 121 VFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
L++S+ L Q F +L+ L L++S NNF + L+++ L N +
Sbjct: 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 239
Query: 217 LNVFSGLP--LTTLNVANNHFS 236
P L LN+ N F+
Sbjct: 240 KQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 30/134 (22%), Positives = 56/134 (41%), Gaps = 7/134 (5%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT- 166
S + + + ++P +P + T L L SN + L+ L++S N L+
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 167 QSIGD-IFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGL 223
+ L LDLSFN + ++F+ L + L Q++ + +VF L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 224 P-LTTLNVANNHFS 236
L L++++ H
Sbjct: 126 RNLIYLDISHTHTR 139
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 31/142 (21%), Positives = 56/142 (39%), Gaps = 9/142 (6%)
Query: 103 LSDLLSLRKFDLSGNSIH--DTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L L K LS N + +L L+L+ N + + + L +L
Sbjct: 48 FDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106
Query: 159 NVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
+ ++L Q S +F +L L LD+S + F LS++ L + N +
Sbjct: 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166
Query: 218 --NVFSGLP-LTTLNVANNHFS 236
++F+ L LT L+++
Sbjct: 167 LPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 32/129 (24%), Positives = 49/129 (37%), Gaps = 6/129 (4%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNL 145
DIS + + L SL ++GNS + + NLT L+L+ L
Sbjct: 132 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QL 190
Query: 146 PYSI-ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL-SNI 203
+ S+ SL LN+S N+ + L L LD S N+ S++
Sbjct: 191 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 250
Query: 204 SSLYLQNNQ 212
+ L L N
Sbjct: 251 AFLNLTQND 259
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 48/226 (21%), Positives = 86/226 (38%), Gaps = 29/226 (12%)
Query: 404 SLQTATNSFSQEF-----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLE 457
+ + + ++ ++G G G+V G+ A+K + ++ + QE
Sbjct: 18 GPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE------ 71
Query: 458 AVSNMSRL-RHPNIVTLAGYC--AEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWN 512
V + + P+IV + HG+R L++ E + G L + + T
Sbjct: 72 -VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTER 128
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTE 569
+ A+++LH ++ HR+ K N+L + + L+D G A T
Sbjct: 129 EAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-- 183
Query: 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y APE Y D++S GV+M LL G P
Sbjct: 184 -NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 43/221 (19%)
Query: 418 IGEGSLGRVYRA--EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVS---NMSRLR 466
IGEG+ G+V++A G+ +A+K++ E+ + V+ ++
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT------GEEGMPLSTIREVAVLRHLETFE 72
Query: 467 HPNIVTL----AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG- 520
HPN+V L + +L LV+E+V D+ + D + ++ +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS-----TQ 575
R L++LH VVHR+ K NIL+ L+D GLA R S T
Sbjct: 129 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA-------RIYSFQMALTS 178
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
+V Y APE L Y D++S G + E+ RKPL
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 71/289 (24%), Positives = 110/289 (38%), Gaps = 50/289 (17%)
Query: 350 NMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTAT 409
+ E E+R + A+ + ++ E +SGS T
Sbjct: 87 TFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVT 146
Query: 410 -NSFSQEFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEA 458
N F E+L +G+G+ G+V + A G+ A+K + + E+ L+
Sbjct: 147 MNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 459 VSNMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTW 511
RHP + L Y + RL V EY G L H F++D
Sbjct: 205 S------RHPFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSED------- 248
Query: 512 NARVR-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
R R + AL+YLH +VV+R+ K N++LD + + ++D GL
Sbjct: 249 --RARFYGAEIVS----ALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300
Query: 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ T G Y APE Y D + GVVM E++ GR P
Sbjct: 301 KDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 31/143 (21%), Positives = 58/143 (40%), Gaps = 10/143 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L L +LR DL+ N + + P++ +L+ A+NN S + S + ++
Sbjct: 76 LESLSTLRTLDLNNNYVQ-ELLV--GPSIETLHAANNNIS-RVSCSR--GQGKKNIYLAN 129
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
N +T G + + LDL N + S + L LQ N + +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188
Query: 222 GLP-LTTLNVANNHFSGWIPREL 243
L TL++++N + ++ E
Sbjct: 189 VFAKLKTLDLSSNKLA-FMGPEF 210
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 4e-16
Identities = 33/161 (20%), Positives = 60/161 (37%), Gaps = 14/161 (8%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP 146
++ L + L ++++ DLSGN + L L LNL+SN
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL 74
Query: 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
+ S+ +L L+++ N + + + TL + NN S + N +
Sbjct: 75 -DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISRVSCSRGQGKKN---I 125
Query: 207 YLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRELIS 245
YL NN++T + L++ N EL +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 31/147 (21%), Positives = 58/147 (39%), Gaps = 13/147 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ + + ++ +S+ + N+ L+L+ N S +A L LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLN 218
+S N L D +L+ L TLDL+ N +L +I +L+ NN ++ S +
Sbjct: 65 LSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNISRVSCS 117
Query: 219 VFSGLPLTTLNVANNHFSGWIPRELIS 245
G + +ANN + +
Sbjct: 118 RGQG--KKNIYLANNKITM-LRDLDEG 141
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 30/155 (19%), Positives = 51/155 (32%), Gaps = 10/155 (6%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFS 142
+I ++ ++ ++ DL N I T+ L LNL N
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNFIY 182
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
++ L L++S N L +G F + AG+ + L N + + N
Sbjct: 183 -DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238
Query: 203 ISSLYLQNNQ-VTGSLNVFSGLPLTTLNVANNHFS 236
+ L+ N G+L F VA
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 25/138 (18%), Positives = 47/138 (34%), Gaps = 3/138 (2%)
Query: 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L + +L +L N I+D + L +L+L+SN + + S +++++
Sbjct: 162 AELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD-LPNSFISLSNISSLYLQNNQVTGSLN 218
+ N L I L DL N F L + F + ++ Q + N
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 219 VFSGLPLTTLNVANNHFS 236
T +
Sbjct: 280 EEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 29/120 (24%), Positives = 47/120 (39%), Gaps = 9/120 (7%)
Query: 118 SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
+IH+ Q + ++ L S ++ L++S N L+Q
Sbjct: 1 AIHEIK--QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFT 58
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFS 236
L L+LS N + SLS + +L L NN + P + TL+ ANN+ S
Sbjct: 59 KLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 13/156 (8%), Positives = 35/156 (22%), Gaps = 9/156 (5%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN-------NF 141
++ + G + + +P L +L + +
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYGAYCC-EDLPAPFADRLIALKRKEHALLSGQGSE 324
Query: 142 SGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLS 201
+ L + ++ + I + TL+ + N + +
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384
Query: 202 NISSLYLQNNQVTGSLNVFSGL-PLTTLNVANNHFS 236
+ Q + PL L +
Sbjct: 385 ELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 35/163 (21%), Positives = 63/163 (38%), Gaps = 15/163 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L + L+ D+ NS+ +P LPP+L + +N LP + ++ L+ +
Sbjct: 149 LQNSSFLKIIDVDNNSLK-KLP-DLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADN 204
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
NSL + L ++ N +L ++++Y NN + +
Sbjct: 205 NSLK----KLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK---TLPDL 255
Query: 223 LP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPP 264
P L LNV +N+ + +P S+ N F PP
Sbjct: 256 PPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP 297
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-17
Identities = 35/165 (21%), Positives = 67/165 (40%), Gaps = 25/165 (15%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
+ +L+ + ++P +LPP+L SL + N+ + LP S+ SL N + +L
Sbjct: 70 DRQAHELELNNLGLS-SLP-ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126
Query: 166 TQ-------------SIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
+ + + N + L +D+ N+ LP+ ++ + N
Sbjct: 127 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPD---LPPSLEFIAAGN 182
Query: 211 NQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGN 254
NQ+ L LP LT + NN +P +S+ + + N
Sbjct: 183 NQLE-ELPELQNLPFLTAIYADNNSLKK-LPDLPLSLESIVAGNN 225
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 33/170 (19%), Positives = 56/170 (32%), Gaps = 33/170 (19%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L +L L N + T+P LPP+L +LN+ N + +LP S+ L
Sbjct: 233 LQNLPFLTTIYADNNLLK-TLP-DLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIF 289
Query: 163 NSLTQSIG-------------DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQ 209
+ L++ + L L++S N +LP + L
Sbjct: 290 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIAS 345
Query: 210 NNQVTGSLNVFSGLP-----LTTLNVANNHFSGWIPRELISIRTFIYDGN 254
N + +P L L+V N P S+ + +
Sbjct: 346 FNH-------LAEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSH 387
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 37/153 (24%), Positives = 55/153 (35%), Gaps = 19/153 (12%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
LSL N + + Q P LT++ +N LP SL LNV N L
Sbjct: 214 PLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYL 269
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP- 224
T + ++ +L L + F+ S N+ L +N+ + LP
Sbjct: 270 T-DLPELPQSLTFLDVSENIFSGLSE-------LPPNLYYLNASSNE----IRSLCDLPP 317
Query: 225 -LTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
L LNV+NN +P + I N
Sbjct: 318 SLEELNVSNNKLIE-LPALPPRLERLIASFNHL 349
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 26/152 (17%), Positives = 52/152 (34%), Gaps = 27/152 (17%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L SL + ++S N + +P LPP L L + N+ + +P +L L+V
Sbjct: 312 LCDLPPSLEELNVSNNKL-IELP-ALPPRLERLIASFNHLA-EVPELPQ---NLKQLHVE 365
Query: 162 RNSLTQ---------------SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
N L + + ++ L L + N + P+ ++ L
Sbjct: 366 YNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD---IPESVEDL 421
Query: 207 YLQNNQVTGSLNV-FSGLPLTTLNV-ANNHFS 236
+ + +V +V ++H
Sbjct: 422 RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 27/183 (14%), Positives = 53/183 (28%), Gaps = 39/183 (21%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMV---------- 153
L++ +++ +P + + T A + + N P
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 154 ---SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
L ++ L+ + L +L S N+ + +LP SL ++
Sbjct: 69 LDRQAHELELNNLGLS----SLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 211 NQVTG----------SLNVFSGLP-------LTTLNVANNHFSGWIPRELISIRTFIYDG 253
++ S N LP L ++V NN +P S+
Sbjct: 124 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGN 182
Query: 254 NSF 256
N
Sbjct: 183 NQL 185
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 19/131 (14%), Positives = 43/131 (32%), Gaps = 13/131 (9%)
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
+ S L ++LT + N+ +++ + + P ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 205 SLYLQNNQVTG------SLNVFSGLP-----LTTLNVANNHFSGWIPRELISIRTFIYDG 253
L++ + S LP L +L + N + +P S+++ + D
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLTE-LPELPQSLKSLLVDN 120
Query: 254 NSFDNGPAPPP 264
N+ PP
Sbjct: 121 NNLKALSDLPP 131
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 34/132 (25%), Positives = 62/132 (46%), Gaps = 8/132 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++ L S++ DL+ I D P NL L L N + N+ +A + +L YL++
Sbjct: 103 IAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGN 160
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
++ + NL+ L TL N S D+ SL N+ ++L+NNQ++ ++ +
Sbjct: 161 AQVS-DL-TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSPLAN 215
Query: 223 LP-LTTLNVANN 233
L + + N
Sbjct: 216 TSNLFIVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 34/133 (25%), Positives = 59/133 (44%), Gaps = 8/133 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+DL + G + Q NL L L N + +L + ++ ++ L +S
Sbjct: 37 QADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSG 94
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N L ++ L + TLDL+ + D+ LSN+ LYL NQ+T +++ +G
Sbjct: 95 NPLK-NV-SAIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQIT-NISPLAG 149
Query: 223 LP-LTTLNVANNH 234
L L L++ N
Sbjct: 150 LTNLQYLSIGNAQ 162
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 28/134 (20%), Positives = 55/134 (41%), Gaps = 12/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L + K +++ DT+ +T+L+ + + + + +L L +
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N +T D+ NL + L+LS N ++ L +I +L L + Q+T +
Sbjct: 73 NQIT----DLAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQIT-DVTPL 125
Query: 221 SGLP-LTTLNVANN 233
+GL L L + N
Sbjct: 126 AGLSNLQVLYLDLN 139
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 25/128 (19%), Positives = 53/128 (41%), Gaps = 8/128 (6%)
Query: 114 LSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF 173
+I+ P N + +N + + A + ++ L+ +T +I +
Sbjct: 4 TQPTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGV 59
Query: 174 GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232
L L L+L N + DL +L+ I+ L L N + +++ +GL + TL++ +
Sbjct: 60 QYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTS 116
Query: 233 NHFSGWIP 240
+ P
Sbjct: 117 TQITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 25/131 (19%), Positives = 52/131 (39%), Gaps = 15/131 (11%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L+ + + D P LT+L N S ++ +AS+ +L +++
Sbjct: 147 LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKN 204
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ + N + L + L+ ++N Y N V + SG
Sbjct: 205 NQIS-DV-SPLANTSNLFIVTLTNQT-----------ITNQPVFYNNNLVVPNVVKGPSG 251
Query: 223 LPLTTLNVANN 233
P+ +++N
Sbjct: 252 APIAPATISDN 262
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 12/121 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L + L N I D P NL + L + + N P + +L NV +
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTIT-NQPVFYNN--NLVVPNVVK 247
Query: 163 NSLTQSIGDI-FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
I + A+ +L++N S ++N+S + Q+ + FS
Sbjct: 248 GPSGAPIAPATISDNGTYASPNLTWNLTS--------FINNVSYTFNQSVTFKNTTVPFS 299
Query: 222 G 222
G
Sbjct: 300 G 300
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKI-DNAALSLQEEDNFLEAVSNMSRLR 466
+ F E + G+G+ G V + G +A+KK+ + +E L+ + +++ L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQDLAVLH 77
Query: 467 HPNIVTLAGYCAEHGQR-------LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
HPNIV L Y G+R +V EYV + LH ++V L
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-PILIKVFL 135
Query: 520 -GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC--GLA----ALTPNTERQV 572
R++ LH + +V HR+ K N+L+++ + L C G A PN
Sbjct: 136 FQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEA-DGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 573 STQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
S Y APE + YT D++S G + E++ G +P+
Sbjct: 194 SRY------YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 32/214 (14%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ G V + K+ A+K + + + F E M+ P +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------AL 525
Y + + L +V EY+ G+L + + V AR AL
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYTAEVVLAL 181
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+ +H + +HR+ K N+LLD + L+D G VG Y +P
Sbjct: 182 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 586 EFALS----GIYTVKSDVYSFGVVMLELLTGRKP 615
E S G Y + D +S GV + E+L G P
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 83.2 bits (205), Expect = 9e-17
Identities = 36/134 (26%), Positives = 65/134 (48%), Gaps = 12/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++L S+ + + + I Q PN+T L L N + ++ + ++ +L +L +
Sbjct: 39 QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDE 96
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N + D+ +L L +L L N S D+ + L + SLYL NN++T + V
Sbjct: 97 NKIK----DLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITVL 149
Query: 221 SGLP-LTTLNVANN 233
S L L TL++ +N
Sbjct: 150 SRLTKLDTLSLEDN 163
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 78.2 bits (192), Expect = 4e-15
Identities = 31/134 (23%), Positives = 57/134 (42%), Gaps = 12/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
K +L S+ D + ++ + +++ ++ I + +++ L ++
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 74
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N LT DI NL L L L N DL + L + SL L++N ++ +N
Sbjct: 75 NKLT----DIKPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DINGL 127
Query: 221 SGLP-LTTLNVANN 233
LP L +L + NN
Sbjct: 128 VHLPQLESLYLGNN 141
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 3e-12
Identities = 27/156 (17%), Positives = 48/156 (30%), Gaps = 8/156 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L L L L N I D L +L+L N S ++ +A + L L +S+
Sbjct: 127 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSK 184
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N ++ D+ L L L+L N +L +++ + + +
Sbjct: 185 NHIS----DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
Query: 221 SGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
NV + I +
Sbjct: 241 DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 6e-12
Identities = 23/129 (17%), Positives = 49/129 (37%), Gaps = 8/129 (6%)
Query: 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168
+ + I P NL + + + + S+ + + + + S
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-S 57
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTT 227
+ I L + L L+ N + D+ +L N+ L+L N++ L+ L L +
Sbjct: 58 VQGI-QYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSSLKDLKKLKS 113
Query: 228 LNVANNHFS 236
L++ +N S
Sbjct: 114 LSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 4e-09
Identities = 34/196 (17%), Positives = 63/196 (32%), Gaps = 3/196 (1%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
LS L L L N I D +P L +L L+ N+ S +L ++A + +L L +
Sbjct: 149 LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 206
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
+ NL T+ + + S ++ + T ++ F
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVS-FIF 265
Query: 223 LPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHR 282
T+ A F G + + L + T YD + P + +
Sbjct: 266 YQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFK 325
Query: 283 QGSHSPSGSQSSSSDK 298
+G + +
Sbjct: 326 GWYTEKNGGHEWNFNT 341
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 57/287 (19%), Positives = 98/287 (34%), Gaps = 30/287 (10%)
Query: 355 MHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQ 414
+ + +S PP + + + LQ N+
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61
Query: 415 EF-----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RH 467
++ ++G G G+V + + A+K + + + +E V R +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-------VELHWRASQC 114
Query: 468 PNIVTLAGYCAEHGQR----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
P+IV + L+V E + G L D + T +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIGE 172
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGA 579
A++YLH + ++ HR+ K N+L + P+ L+D G A T T T
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNSLTTPCYT 226
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS 626
Y APE Y D++S GV+M LL G P S+ +
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 29/136 (21%), Positives = 52/136 (38%), Gaps = 9/136 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
S L L+K +S N + IP LP +L L + N + + +++ + +
Sbjct: 98 FSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156
Query: 163 NSLTQSI--GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNV 219
N L S F L L L +S +G + ++ L+L +N++ L
Sbjct: 157 NPLENSGFEPGAFDGLK-LNYLRISEAKLTGIPKDLP---ETLNELHLDHNKIQAIELED 212
Query: 220 FSGLP-LTTLNVANNH 234
L L + +N
Sbjct: 213 LLRYSKLYRLGLGHNQ 228
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 34/160 (21%), Positives = 60/160 (37%), Gaps = 26/160 (16%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
LR S + +P ++ P+ T L+L +N+ S + L L + N +++
Sbjct: 34 HLRVVQCSDLGL-KAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 168 SIGDIFGNLAGLATLDLSFNN--------FSG----DL---------PNSFISLSNISSL 206
F L L L +S N+ S + F L N++ +
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 207 YLQNNQVTGSL---NVFSGLPLTTLNVANNHFSGWIPREL 243
+ N + S F GL L L ++ +G IP++L
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL 191
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 30/161 (18%), Positives = 49/161 (30%), Gaps = 36/161 (22%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNF-------------------SGNLPY 147
L L +S + IP LP L L+L N N
Sbjct: 172 LKLNYLRISEAKLT-GIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230
Query: 148 SI-----ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF----- 197
I + + +L L++ N L+ + +L L + L NN + N F
Sbjct: 231 MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF 289
Query: 198 -ISLSNISSLYLQNNQVTGSL---NVFSGLP-LTTLNVANN 233
+ + + + L NN V F + + N
Sbjct: 290 GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 24/143 (16%), Positives = 53/143 (37%), Gaps = 13/143 (9%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLPP------NLTSLNLASNNFSGNLPYSIASMVS 154
+ S L ++ ++ GN + ++ P L L ++ + +P + +
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSG---FEPGAFDGLKLNYLRISEAKLT-GIPKDLPE--T 194
Query: 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214
L+ L++ N + + + L L L N S L + L+L NN+++
Sbjct: 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
Query: 215 GSLNVFSGLP-LTTLNVANNHFS 236
L L + + N+ +
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 22/123 (17%), Positives = 44/123 (35%), Gaps = 13/123 (10%)
Query: 101 YLLSDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSY 157
L L + L N I + LP L L+L +N S +P + + L
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLP-TLRELHLDNNKLS-RVPAGLPDLKLLQV 268
Query: 158 LNVSRNSLTQSIGDIFGNLAG------LATLDLSFNNFSGDL--PNSFISLSNISSLYLQ 209
+ + N++T+ + F + + L N P +F +++ ++
Sbjct: 269 VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328
Query: 210 NNQ 212
N +
Sbjct: 329 NYK 331
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 36/163 (22%), Positives = 56/163 (34%), Gaps = 17/163 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSI-------HDTIPYQLPPNLTSLNLASN 139
+ I+ + +L DLS N P + P L L L +
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP-TLQVLALRNA 211
Query: 140 NF---SGNLPYSIASMVSLSYLNVSRNSLTQSIGDI-FGNLAGLATLDLSFNNFSGDLPN 195
SG A+ V L L++S NSL + G + L +L+LSF
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKG 271
Query: 196 SFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSG 237
+ +S L L N++ LP + L++ N F
Sbjct: 272 LP---AKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 36/193 (18%), Positives = 64/193 (33%), Gaps = 22/193 (11%)
Query: 82 GSAVVSIDISGLGLSGTMGYLLS----DLLSLRKFDLSGNSIHDTIPYQLP---PNLTSL 134
G + +++ + + +L L+ ++ + P L++L
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS-LNFSCEQVRVFPALSTL 178
Query: 135 NLASNNFSGNLPYSIA----SMVSLSYLNVSRNSLTQ---SIGDIFGNLAGLATLDLSFN 187
+L+ N G A +L L + + + L LDLS N
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238
Query: 188 NFSGDLPN-SFISLSNISSLYLQNNQVTGSLNVFSGLP--LTTLNVANNHFSGW-IPREL 243
+ S S ++SL L + V GLP L+ L+++ N P EL
Sbjct: 239 SLRDAAGAPSCDWPSQLNSLNLSFTGLKQ---VPKGLPAKLSVLDLSYNRLDRNPSPDEL 295
Query: 244 ISIRTFIYDGNSF 256
+ GN F
Sbjct: 296 PQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 28/151 (18%), Positives = 49/151 (32%), Gaps = 17/151 (11%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP-----PNLTSLNLASNNFSGNLPYSIASMV--SL 155
+ LSL++ + I I + L L L + +G P + L
Sbjct: 64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123
Query: 156 SYLNVSRNSLT---QSIGDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ LN+ S + ++ L GL L ++ + +S+L L +N
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183
Query: 212 QVTGSLNVFSGLP------LTTLNVANNHFS 236
G + S L L L + N
Sbjct: 184 PELGERGLISALCPLKFPTLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 34/174 (19%), Positives = 62/174 (35%), Gaps = 19/174 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL----PPNLTSLNLASNNFS 142
+ I L G + L + L++ L + T P L P+L LNL + +++
Sbjct: 77 AARIPSRILFGALRVL--GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134
Query: 143 GNLPY----SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD--LPNS 196
+ L L++++ + L+TLDLS N G+ L ++
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 197 FI--SLSNISSLYLQNNQVTGSLNVFSGL-----PLTTLNVANNHFSGWIPREL 243
+ L L+N + V S L L L++++N
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 31/170 (18%), Positives = 49/170 (28%), Gaps = 18/170 (10%)
Query: 3 VQYTAVFPLPFSTSRLIDAF-VLILS--IFLTLSLVQCTTDSSDVQALQVLYTSLNSPSV 59
+ R+ A L LS L + LQVL
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 60 LTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLL-SLRKFDLSGNS 118
+ +A + +D+S L G D L +LS
Sbjct: 216 PSGV-----------CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264
Query: 119 IHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168
+ +P LP L+ L+L+ N P S + + L++ N S
Sbjct: 265 LK-QVPKGLPAKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 22/134 (16%), Positives = 44/134 (32%), Gaps = 12/134 (8%)
Query: 130 NLTSLNLASNNFSGNLPYS-IASMVSLSYLNVSRNSLTQSIGDI---FGNLAGLATLDLS 185
+L L + + ++ I +SL L V + I ++GL L L
Sbjct: 44 SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103
Query: 186 FNNFSGDLPNSFISLS--NISSLYLQNNQVTGSLNVFSGLP------LTTLNVANNHFSG 237
+G P + + +++ L L+N + L L L++A H
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163
Query: 238 WIPRELISIRTFIY 251
+ ++
Sbjct: 164 FSCEQVRVFPALST 177
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 35/131 (26%), Positives = 56/131 (42%), Gaps = 6/131 (4%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
S + + ++ +P LP + T L+L+ N ++ L+ LN+ R LT+
Sbjct: 11 SHLEVNCDKRNL-TALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK 69
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-L 225
+ G L L TLDLS N LP +L ++ L + N++T L GL L
Sbjct: 70 L--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126
Query: 226 TTLNVANNHFS 236
L + N
Sbjct: 127 QELYLKGNELK 137
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 34/149 (22%), Positives = 53/149 (35%), Gaps = 15/149 (10%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNV 160
L L DLS N + ++P P LT L+++ N + +LP + L L +
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNV 219
N L + L L L+ NN + L N+ +L LQ N +
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGF 191
Query: 220 FSGLPLTTLNVANN---------HFSGWI 239
F L + N +F W+
Sbjct: 192 FGSHLLPFAFLHGNPWLCNCEILYFRRWL 220
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-16
Identities = 55/215 (25%), Positives = 83/215 (38%), Gaps = 31/215 (14%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ G V + K+ A+K ++ L E F E + I TL
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------AL 525
Y + L LV +Y G+L + + R+ AR A+
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDL--LTLLS---------KFEDRLPEEMARFYLAEMVIAI 188
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+ +H++ VHR+ K NIL+D + L+D G S+ VG Y +P
Sbjct: 189 DSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 586 E-----FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E G Y + D +S GV M E+L G P
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 73/270 (27%), Positives = 106/270 (39%), Gaps = 50/270 (18%)
Query: 368 DLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFL--IGEGSLGR 425
D P E L + SG +++ K + AS F + L IG GS +
Sbjct: 11 DYDIPTTENLYFQGAMGSG-IEEEKEAMNTRESGKASSSLGLQDF--DLLRVIGRGSYAK 67
Query: 426 VYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
V +I A++ + D +Q E + E SN HP +V L C
Sbjct: 68 VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-----HPFLVGLH-SC 121
Query: 478 AEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR-----VALGTARAL 525
+ RL V EYV G+L M H ++ R ++L AL
Sbjct: 122 FQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEE---------HARFYSAEISL----AL 166
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
YLHE +++R+ K N+LLD E + L+D G+ ST G Y AP
Sbjct: 167 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAP 222
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E Y D ++ GV+M E++ GR P
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 64/223 (28%), Positives = 91/223 (40%), Gaps = 47/223 (21%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
+ L IG GS +V +I A+K + D +Q E + E SN
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN--- 68
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP +V L C + RL V EYV G+L M H ++ R
Sbjct: 69 --HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEE---------HARF 114
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
++L AL YLHE +++R+ K N+LLD E + L+D G+
Sbjct: 115 YSAEISL----ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
ST G Y APE Y D ++ GV+M E++ GR P
Sbjct: 168 ST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 7e-16
Identities = 35/179 (19%), Positives = 65/179 (36%), Gaps = 22/179 (12%)
Query: 79 ACEGSAVVSIDISGLGLSGTMGYLLSDLL-SLRKFDLSGNSIHDTIPYQLPPNLTSLNLA 137
AC + +++ GL+ L L + + N++ ++P LPP L +L ++
Sbjct: 36 ACLNNGNAVLNVGESGLT----TLPDCLPAHITTLVIPDNNL-TSLP-ALPPELRTLEVS 89
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
N + +LP ++ LS + L GL L + N + LP
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPV-- 138
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
+ L + +NQ+ + S L L NN + +P ++ N
Sbjct: 139 -LPPGLQELSVSDNQLASLPALPSE--LCKLWAYNNQLTS-LPMLPSGLQELSVSDNQL 193
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 4e-12
Identities = 44/220 (20%), Positives = 77/220 (35%), Gaps = 46/220 (20%)
Query: 30 LTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSID 89
L + Q T+ LQ L S N + L + +
Sbjct: 126 LWIFGNQLTSLPVLPPGLQELSVSDNQLASLPALPSE------------------LCKLW 167
Query: 90 ISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI 149
L+ L L++ +S N + ++P LP L L +N + +LP
Sbjct: 168 AYNNQLT----SLPMLPSGLQELSVSDNQLA-SLP-TLPSELYKLWAYNNRLT-SLPALP 220
Query: 150 ASMVSLSYLNVSRNSLTQ---SIG-----DIFGN--------LAGLATLDLSFNNFSGDL 193
+ L L VS N LT + GN +GL +L + N + L
Sbjct: 221 SG---LKELIVSGNRLTSLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RL 276
Query: 194 PNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANN 233
P S I LS+ +++ L+ N ++ + + +T+ +
Sbjct: 277 PESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSG 315
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 6e-12
Identities = 39/167 (23%), Positives = 61/167 (36%), Gaps = 30/167 (17%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L + L K N + ++P LP L L+++ N + +LP + + L N
Sbjct: 156 LPALPSELCKLWAYNNQLT-SLP-MLPSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNR 212
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
SL GL L +S N + LP S + L + N++T
Sbjct: 213 LTSLPALPS-------GLKELIVSGNRLT-SLPV---LPSELKELMVSGNRLT------- 254
Query: 222 GLP-----LTTLNVANNHFSGWIPRE---LISIRTFIYDGNSFDNGP 260
LP L +L+V N + +P L S T +GN
Sbjct: 255 SLPMLPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERT 300
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 28/123 (22%), Positives = 53/123 (43%), Gaps = 10/123 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L + L++ +SGN + ++P LP L L ++ N + +LP + L L+V
Sbjct: 216 LPALPSGLKELIVSGNRLT-SLP-VLPSELKELMVSGNRLT-SLPMLPSG---LLSLSVY 269
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
RN LT + + +L+ T++L N S + + I+S + + +
Sbjct: 270 RNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQAL--REITSAPGYSGPIIRFDMAGA 325
Query: 222 GLP 224
P
Sbjct: 326 SAP 328
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 22/108 (20%), Positives = 46/108 (42%), Gaps = 6/108 (5%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
L++ +SGN + ++P LP L SL++ N + LP S+ + S + +N+ N L++
Sbjct: 242 ELKELMVSGNRL-TSLP-MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 298
Query: 168 SIGDIFGNLAGLATLD---LSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ + F+ P +L ++ +L +
Sbjct: 299 RTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR 346
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++L S+ + + + I Q PN+T L L N + ++ +A++ +L +L +
Sbjct: 42 QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDE 99
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N + D+ +L L +L L N S D+ + L + SLYL NN++T + V
Sbjct: 100 NKVK----DLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITVL 152
Query: 221 SGLP-LTTLNVANN 233
S L L TL++ +N
Sbjct: 153 SRLTKLDTLSLEDN 166
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 31/135 (22%), Positives = 57/135 (42%), Gaps = 12/135 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
K +L S+ D + ++ + +++ ++ I + +++ L ++
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 77
Query: 163 NSLTQSIGDIFG--NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N LT DI NL L L L N DL + L + SL L++N ++ +N
Sbjct: 78 NKLT----DIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DINGL 130
Query: 221 SGLP-LTTLNVANNH 234
LP L +L + NN
Sbjct: 131 VHLPQLESLYLGNNK 145
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 37/143 (25%), Positives = 57/143 (39%), Gaps = 7/143 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L DL L+ L N I D P L SL L +N + ++ ++ + L L++
Sbjct: 108 LKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLED 165
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ I L L L LS N+ S DL L N+ L L + + + +
Sbjct: 166 NQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECL-NKPINHQ 220
Query: 223 LPLTTLNVANNHFSGWIPRELIS 245
L N N + E+IS
Sbjct: 221 SNLVVPNTVKNTDGSLVTPEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 23/124 (18%), Positives = 46/124 (37%), Gaps = 8/124 (6%)
Query: 114 LSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF 173
I NL + + + + S+ + + + + S+ I
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGI- 64
Query: 174 GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232
L + L L+ N + D+ +L N+ L+L N+V L+ L L +L++ +
Sbjct: 65 QYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEH 121
Query: 233 NHFS 236
N S
Sbjct: 122 NGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 31/142 (21%), Positives = 49/142 (34%), Gaps = 17/142 (11%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
LS L L L N I D +P L +L L+ N+ S +L ++A + +L L +
Sbjct: 152 LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY-LQNNQVTGSLNVFS 221
+ NL T+ + S ++ IS + V L F+
Sbjct: 210 QECLNKPINHQSNLVVPNTVK--------NTDGSLVTPEIISDDGDYEKPNVKWHLPEFT 261
Query: 222 GLP------LTTLNVANNHFSG 237
T+ A F G
Sbjct: 262 NEVSFIFYQPVTIGKAKARFHG 283
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 60/261 (22%), Positives = 100/261 (38%), Gaps = 70/261 (26%)
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKI-DNAALSLQEEDNFLEAVSNM 462
L+T++ +S +G GS G V + +GK A+KK+ + +E + M
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE-------LDIM 54
Query: 463 SRLRHPNIVTLAGYCAEHGQRL-------------------------------------- 484
L H NI+ L Y G
Sbjct: 55 KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEVCLPSVVHRNFKS 543
++ EYV + LH +L S +++ + + + RA+ ++H + + HR+ K
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL---GICHRDIKP 169
Query: 544 ANILLD---DELNPHLSDCGLA----ALTPNTERQVSTQMVGAFGYSAPEFALSGI-YTV 595
N+L++ + L L D G A P+ + ++ Y APE L YT
Sbjct: 170 QNLLVNSKDNTLK--LCDFGSAKKLIPSEPSVA-YICSRF-----YRAPELMLGATEYTP 221
Query: 596 KSDVYSFGVVMLELLTGRKPL 616
D++S G V EL+ G KPL
Sbjct: 222 SIDLWSIGCVFGELILG-KPL 241
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 39/167 (23%), Positives = 57/167 (34%), Gaps = 15/167 (8%)
Query: 104 SDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
L L L+GN S+ L +L L N + + I + +L LNV
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 161 SRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN----ISSLYLQNNQVTG 215
+ N + + + F NL L LDLS N L SL L N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 216 -SLNVFSGLPLTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
F + L L + N +P L S++ N +D
Sbjct: 192 IQPGAFKEIRLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 29/138 (21%), Positives = 48/138 (34%), Gaps = 19/138 (13%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
S + DLS N + L L L+L+ + S+ LS L
Sbjct: 29 STKNLDLSFNPLR-----HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-- 217
++ N + F L+ L L N + L + L + +N + S
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKL 141
Query: 218 -NVFSGLP-LTTLNVANN 233
FS L L L++++N
Sbjct: 142 PEYFSNLTNLEHLDLSSN 159
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 33/117 (28%), Positives = 50/117 (42%), Gaps = 4/117 (3%)
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL 182
IP LP + +L+L+ N YS S L L++SR + + +L+ L+TL
Sbjct: 22 IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL 81
Query: 183 DLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
L+ N +F LS++ L + SL L L LNVA+N
Sbjct: 82 ILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 35/135 (25%), Positives = 57/135 (42%), Gaps = 13/135 (9%)
Query: 104 SDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
L+ DLS +I D L +L++L L N +L + + SL L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLS-HLSTLILTGNPIQ-SLALGAFSGLSSLQKLV 106
Query: 160 VSRNSLTQSI-GDIFGNLAGLATLDLSFNNF-SGDLPNSFISLSNISSLYLQNNQVTGSL 217
+L S+ G+L L L+++ N S LP F +L+N+ L L +N++ S+
Sbjct: 107 AVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SI 164
Query: 218 --NVFSGLP-LTTLN 229
L + LN
Sbjct: 165 YCTDLRVLHQMPLLN 179
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 22/207 (10%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
IG G+ G V A + + +A+KK+ + + M + H NI+ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 474 --AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
E Q + +V E + NL ++ L + R+ L +++LH
Sbjct: 93 FTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELD-HERMSYLLYQMLCGIKHLH 144
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ K +NI++ + + D GLA + + T V Y APE L
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 199
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y D++S G +M E++ G L
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 51/209 (24%), Positives = 81/209 (38%), Gaps = 17/209 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ V + G++ A+K ++ L E F E + I L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
+ + L LV EY G+L + + + AR +A A++ +H +
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRL-- 181
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE------- 586
VHR+ K NILLD + L+D G S VG Y +PE
Sbjct: 182 -GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+G Y + D ++ GV E+ G+ P
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.5 bits (193), Expect = 3e-15
Identities = 59/303 (19%), Positives = 103/303 (33%), Gaps = 49/303 (16%)
Query: 338 RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITA 397
++ + + E V + + + +K + I+
Sbjct: 269 KAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISK 328
Query: 398 TSYTVASLQTATNSFSQEFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAAL 447
+ F FL +G+GS G+V +E ++ AVK + D+
Sbjct: 329 FDNNGNRDRMKLTDF--NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE 386
Query: 448 SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------ 500
E L + P + L C + RL V EYV G+L M H
Sbjct: 387 CTMVEKRVLALPG-----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGR 438
Query: 501 FADDSSKNLTWNARVR-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555
F + +A+ L +L +++R+ K N++LD E +
Sbjct: 439 FKEP---------HAVFYAAEIAI----GLFFLQSK---GIIYRDLKLDNVMLDSEGHIK 482
Query: 556 LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
++D G+ T G Y APE Y D ++FGV++ E+L G+ P
Sbjct: 483 IADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
Query: 616 LDS 618
+
Sbjct: 542 FEG 544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 59/223 (26%), Positives = 88/223 (39%), Gaps = 48/223 (21%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
++L +G+G+ G+V A G+ A+K + + E L+
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT----- 62
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
RHP + L Y + RL V EY G L H F ++ R R
Sbjct: 63 -RHPFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEE---------RARF 109
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+ ALEYLH VV+R+ K N++LD + + ++D GL + +
Sbjct: 110 YGAEIVS----ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
T G Y APE Y D + GVVM E++ GR P
Sbjct: 163 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 29/134 (21%), Positives = 58/134 (43%), Gaps = 13/134 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L + K +L S+ D + + + + N ++N +L + +L L++S
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSH 72
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N ++ D+ +L L L ++ N +L I + +S L+L NN++ +
Sbjct: 73 NQIS----DLSPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELR-DTDSL 124
Query: 221 SGLP-LTTLNVANN 233
L L L++ NN
Sbjct: 125 IHLKNLEILSIRNN 138
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 35/134 (26%), Positives = 61/134 (45%), Gaps = 11/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+L ++ F+ ++I Q NL L+L+ N S +L + + L L+V+R
Sbjct: 37 QKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNR 94
Query: 163 NSLTQSIGDIFG-NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
N L ++ G A L+ L L N D + I L N+ L ++NN++ S+ +
Sbjct: 95 NRLK----NLNGIPSACLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SIVMLG 147
Query: 222 GLP-LTTLNVANNH 234
L L L++ N
Sbjct: 148 FLSKLEVLDLHGNE 161
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 26/120 (21%), Positives = 45/120 (37%), Gaps = 7/120 (5%)
Query: 114 LSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF 173
I+ P N NL + + +L S + + N +++ S+ +
Sbjct: 4 QRPTPINQVFPDPGLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLAGM- 59
Query: 174 GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANN 233
L L LS N S DL L+ + L + N++ +LN L+ L + NN
Sbjct: 60 QFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNN 116
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 36/135 (26%), Positives = 61/135 (45%), Gaps = 10/135 (7%)
Query: 108 SLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRN 163
++ DLS + ++ ++ +L L LA N + + + + L LN+S+N
Sbjct: 276 GVKTCDLSKSKIFALLKSVFSHFT-DLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN 333
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFS 221
L +F NL L LDLS+N+ SF+ L N+ L L NQ+ S+ +F
Sbjct: 334 FLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392
Query: 222 GLP-LTTLNVANNHF 235
L L + + N +
Sbjct: 393 RLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 28/113 (24%), Positives = 52/113 (46%), Gaps = 5/113 (4%)
Query: 127 LPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG-DIFGNLAGLATLDLS 185
LP ++ ++L+ N+ + S + + L +L V + + I + F L+ L L L
Sbjct: 28 LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87
Query: 186 FNNFSGDLPNSFISLSNISSLYLQNNQVTGSL---NVFSGLP-LTTLNVANNH 234
+N F +F L+N+ L L + G++ N F L L L + +N+
Sbjct: 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 36/165 (21%), Positives = 58/165 (35%), Gaps = 14/165 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
S L L+ + + I L +L L L N F L + +L
Sbjct: 50 FSRLQDLQFLKVEQQTPGLVIRNNTFRGL-SSLIILKLDYNQFL-QLETGAFNGLANLEV 107
Query: 158 LNVSRNSLTQSI--GDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVT 214
L +++ +L ++ G+ F L L L L NN P S F+++ L L N+V
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167
Query: 215 ----GSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNS 255
L F G T L +++ L + N+
Sbjct: 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 31/143 (21%), Positives = 50/143 (34%), Gaps = 20/143 (13%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
+ DLS NSI +L +L L + + + + SL L
Sbjct: 31 HVNYVDLSLNSIA-----ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNF-SGDLP-NSFISLSNISSLYLQNNQVTGSL 217
+ N Q F LA L L L+ N L N F L+++ L L++N + +
Sbjct: 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KI 144
Query: 218 N---VFSGLP-LTTLNVANNHFS 236
F + L++ N
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKVK 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 31/168 (18%), Positives = 62/168 (36%), Gaps = 21/168 (12%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLAS---------- 138
D++ L S+ DLSGN +++ + + + S
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 139 -----NNFSG--NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG 191
NF N + + ++S++ + + +F + L L L+ N +
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK 313
Query: 192 DLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
N+F L+++ L L N + S+ +F L L L+++ NH
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 24/147 (16%), Positives = 48/147 (32%), Gaps = 23/147 (15%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMV 153
+ L +L L+ ++ + L +L L L NN P S +M
Sbjct: 98 AFNGLANLEVLTLTQCNLDGAV---LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMR 154
Query: 154 SLSYLNVSRNSLTQSIGDIFGNLAGLA----------TLDLSFNNFSGDLPNSFISLSNI 203
L+++ N + + N G D++ + + ++I
Sbjct: 155 RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSI 214
Query: 204 SSLYLQNNQVTGSL--NVFSGLPLTTL 228
++L L N S+ F + T +
Sbjct: 215 TTLDLSGNGFKESMAKRFFDAIAGTKI 241
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 32/165 (19%), Positives = 54/165 (32%), Gaps = 30/165 (18%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFS----------GNLPYS 148
L SL L N+I P + L+L N ++
Sbjct: 124 FFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFT 183
Query: 149 IASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF---ISLSNISS 205
+ + S++ +++ L + TLDLS N F + F I+ + I S
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243
Query: 206 LYLQNNQVTGSL-----------NVFSGLP---LTTLNVANNHFS 236
L L N+ GS F GL + T +++ +
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 32/158 (20%), Positives = 48/158 (30%), Gaps = 7/158 (4%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
D S N + +P L T LN++ N S I S+ L L +S N + +
Sbjct: 6 DRSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLN 229
F L LDLS N + N+ L L N F + L L
Sbjct: 65 FKFNQELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121
Query: 230 VANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPS 267
++ H + + + P
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEG 159
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 40/231 (17%), Positives = 89/231 (38%), Gaps = 7/231 (3%)
Query: 11 LPFSTSRLIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDP 70
+ S L LTL+ ++ T +S V +T++ S+ + D
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265
Query: 71 CGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPN 130
+ G + + ++ + G + Y + ++++ F +SG + +
Sbjct: 266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325
Query: 131 LTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT--QSIGDIFGNLAGLATLDLSFNN 188
L+ ++N + + + + L L + N L I ++ + L LD+S N+
Sbjct: 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385
Query: 189 FSGDLP-NSFISLSNISSLYLQNNQVTGSLNVFSGLP--LTTLNVANNHFS 236
S D ++ SL + +N +T + +F LP + L++ +N
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDT--IFRCLPPRIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 31/139 (22%), Positives = 54/139 (38%), Gaps = 14/139 (10%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQ-----LPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
L L L N + + +L L+++ N+ S + + SL LN
Sbjct: 347 LTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-- 217
+S N LT +I + LDL N +P + L + L + +NQ+ S+
Sbjct: 406 MSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPD 461
Query: 218 NVFSGLP-LTTLNVANNHF 235
+F L L + + N +
Sbjct: 462 GIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 31/173 (17%), Positives = 60/173 (34%), Gaps = 17/173 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L L R FD SG S+ L+ + S+ F Y +++ N +
Sbjct: 259 LQGQLDFRDFDYSGTSLK---------ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV 309
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ---VTGSLNV 219
+ ++ LD S N + + + L+ + +L LQ NQ ++ +
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEM 369
Query: 220 FSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFDNGPAPPPPPS 267
+ + L L+++ N S + S+ + N + PP
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR 422
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 26/138 (18%), Positives = 47/138 (34%), Gaps = 10/138 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ L LR +S N I + ++ L L+L+ N + V+L +L+
Sbjct: 41 ILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLD 96
Query: 160 VSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GS 216
+S N+ I FGN++ L L LS + L+ L +
Sbjct: 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED 156
Query: 217 LNVFSGLPLTTLNVANNH 234
+L++
Sbjct: 157 PEGLQDFNTESLHIVFPT 174
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 21/141 (14%), Positives = 48/141 (34%), Gaps = 10/141 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI---ASMVSLSYLN 159
LS++ + + + + Q P L++L L + + N I ++ Y +
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253
Query: 160 VSRNSLT-----QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214
+S L + +L L+ + + F + SN++ +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 215 G-SLNVFSGLP-LTTLNVANN 233
+ S + L+ +NN
Sbjct: 314 MVHMLCPSKISPFLHLDFSNN 334
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 49/222 (22%), Positives = 78/222 (35%), Gaps = 41/222 (18%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSN---------MSRLRHP 468
I GS G V + G +A+K++ N + + ++ ++ HP
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 469 NIVTL-----AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTA 522
NI+ L + LV E + +L ++H + + ++ +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH----DQRIVISPQHIQYFMYHIL 144
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC-------GLAALTPNTERQVSTQ 575
L LHE VVHR+ NILL + LA T
Sbjct: 145 LGLHVLHEA---GVVHRDLHPGNILLA-------DNNDITICDFNLAREDTADAN--KTH 192
Query: 576 MVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
V Y APE + +T D++S G VM E+ RK L
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKAL 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 52/227 (22%)
Query: 415 EFL--IGEGSLGRVYRAEFANGK----IMAVKKIDNAALSLQEED--------NFLEAVS 460
E L +G+G G+V++ G I A+K + A + +D N LE V
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV- 78
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNA 513
+HP IV L Y + G +L L+ EY+ G L + F +D
Sbjct: 79 -----KHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMED--------- 121
Query: 514 RVR-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568
+++ AL +LH+ +++R+ K NI+L+ + + L+D GL + +
Sbjct: 122 TACFYLAEISM----ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174
Query: 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
T G Y APE + + D +S G +M ++LTG P
Sbjct: 175 GTVTHT-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 54/226 (23%), Positives = 86/226 (38%), Gaps = 47/226 (20%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
FL +G+GS G+V +E ++ AVK + D+ E L
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--- 79
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
P + L C + RL V EYV G+L M H F +
Sbjct: 80 --PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEP---------HAVF 125
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+A+ L +L +++R+ K N++LD E + ++D G+
Sbjct: 126 YAAEIAI----GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDS 618
T G Y APE Y D ++FGV++ E+L G+ P +
Sbjct: 179 KT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 60/223 (26%), Positives = 90/223 (40%), Gaps = 47/223 (21%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
EF+ +G+GS G+V A G + AVK + D+ E L N
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--- 82
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP + L C + RL V E+V G+L M H F + R R
Sbjct: 83 --HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEA---------RARF 128
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+ AL +LH+ +++R+ K N+LLD E + L+D G+
Sbjct: 129 YAAEIIS----ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+T G Y APE +Y D ++ GV++ E+L G P
Sbjct: 182 AT-FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 47/226 (20%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
+G+GS G+V+ AEF + A+K + D+ E L
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE--- 76
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP + + + + L V EY+ G+L M H F R
Sbjct: 77 --HPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLS---------RATF 122
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+ L L++LH +V+R+ K NILLD + + ++D G+ + +
Sbjct: 123 YAAEIIL----GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDS 618
+T G Y APE L Y D +SFGV++ E+L G+ P
Sbjct: 176 NT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 37/129 (28%), Positives = 54/129 (41%), Gaps = 8/129 (6%)
Query: 122 TIPYQLPPNLTSLNLASNNFSGNLP--YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
+P LP L+L+ NN S L ++ + +L L +S N L + F + L
Sbjct: 32 NVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNL 90
Query: 180 ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
LDLS N+ F L + L L NN + + N F + L L ++ N S
Sbjct: 91 RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 237 GWIPRELIS 245
P ELI
Sbjct: 150 -RFPVELIK 157
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 34/139 (24%), Positives = 61/139 (43%), Gaps = 12/139 (8%)
Query: 108 SLRKFDLSGNSIH----DTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSR 162
DLS N++ + P +L NL SL L+ N+ + + + +L YL++S
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLT-NLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFS 221
N L +F +L L L L N+ N+F ++ + LYL NQ++ + +
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIK 157
Query: 222 GLP----LTTLNVANNHFS 236
L L++++N
Sbjct: 158 DGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 32/148 (21%), Positives = 56/148 (37%), Gaps = 15/148 (10%)
Query: 100 GYLLSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVS 154
+ + L +L LS N ++ I + PNL L+L+SN+ L + + + +
Sbjct: 57 EWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV-PNLRYLDLSSNHLH-TLDEFLFSDLQA 113
Query: 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL---YLQNN 211
L L + N + + F ++A L L LS N S + + L L +N
Sbjct: 114 LEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSN 173
Query: 212 QVT----GSLNVFSGLPLTTLNVANNHF 235
++ L L + NN
Sbjct: 174 KLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 50/225 (22%)
Query: 415 EFL--IGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQE------EDNFLEAVSNM 462
E L +G+GS G+V+ + + ++ A+K + A L +++ E + L V
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV--- 83
Query: 463 SRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARV 515
HP IV L Y + +L L+ +++ G+L F ++ V
Sbjct: 84 ---NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEE---------DV 128
Query: 516 R-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
+ +AL AL++LH + +++R+ K NILLD+E + L+D GL+ + + E+
Sbjct: 129 KFYLAELAL----ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ + G Y APE +T +D +SFGV+M E+LTG P
Sbjct: 182 KAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 39/172 (22%), Positives = 68/172 (39%), Gaps = 12/172 (6%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS 142
+ + S+D ++ G + L L K + N+I T+ NLT L SN +
Sbjct: 42 ATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNI-TTLDLSQNTNLTYLACDSNKLT 98
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
NL + + L+YLN N LT+ L L+ + N + ++ S +
Sbjct: 99 -NLD--VTPLTKLTYLNCDTNKLTK---LDVSQNPLLTYLNCARNTLT-EIDVS--HNTQ 149
Query: 203 ISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGN 254
++ L N+ L+V LTTL+ + N + + + D N
Sbjct: 150 LTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTN 201
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 30/135 (22%), Positives = 53/135 (39%), Gaps = 12/135 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++ L L + N + + P LT LN A N + + ++ L+ L+
Sbjct: 102 VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHL 157
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N + L TLD SFN + +L S ++ L N +T L+ +
Sbjct: 158 NKKITKLD--VTPQTQLTTLDCSFNKIT-ELDVS--QNKLLNRLNCDTNNIT-KLD-LNQ 210
Query: 223 LP-LTTLNVANNHFS 236
LT L+ ++N +
Sbjct: 211 NIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 34/150 (22%), Positives = 55/150 (36%), Gaps = 10/150 (6%)
Query: 91 SGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150
+ + T L +L D +SI D + LT L SNN + L ++
Sbjct: 26 AAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT-TLD--LS 82
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
+L+YL N LT ++ L L L+ N + L S ++ L
Sbjct: 83 QNTNLTYLACDSNKLT-NL--DVTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTYLNCAR 136
Query: 211 NQVTGSLNVFSGLPLTTLNVANNHFSGWIP 240
N +T ++V LT L+ N +
Sbjct: 137 NTLT-EIDVSHNTQLTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 28/153 (18%), Positives = 54/153 (35%), Gaps = 12/153 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+S L + + N++ I LT L+ N L + L+ L+ S
Sbjct: 123 VSQNPLLTYLNCARNTL-TEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N +T+ L L+ NN + L + ++ L +N++T ++ +
Sbjct: 180 NKITELD---VSQNKLLNRLNCDTNNIT-KLDLN--QNIQLTFLDCSSNKLT-EID-VTP 231
Query: 223 LP-LTTLNVANNHFSGWIPRELISIRTFIYDGN 254
L LT + + N + L + T
Sbjct: 232 LTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQT 264
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 23/134 (17%), Positives = 49/134 (36%), Gaps = 10/134 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+S L + + N+I + LT L+ +SN + + + + L+Y + S
Sbjct: 187 VSQNKLLNRLNCDTNNI-TKLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSV 242
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N LT + L+ L TL + ++ + + + + + L+V
Sbjct: 243 NPLT-EL--DVSTLSKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEGCRKIKELDVTHN 296
Query: 223 LPLTTLNVANNHFS 236
L L+ +
Sbjct: 297 TQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 19/135 (14%), Positives = 41/135 (30%), Gaps = 10/135 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L F G + L L+ + + L ++ L YL ++
Sbjct: 271 LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNN 327
Query: 163 NSLTQSIGDI-FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
LT ++ + L +L + D S + +++ + Q
Sbjct: 328 TELT----ELDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETL 381
Query: 222 GLPLTTLNVANNHFS 236
T+ V+ +
Sbjct: 382 TNNSLTIAVSPDLLD 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 32/140 (22%), Positives = 55/140 (39%), Gaps = 11/140 (7%)
Query: 117 NSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNL 176
S +D P N S A+ S + +L+ L+ +S+T G L
Sbjct: 9 QSFNDWFP---DDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKL 63
Query: 177 AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHF 235
GL L + NN + L S +N++ L +N++T +L+ + L LT LN N
Sbjct: 64 TGLTKLICTSNNIT-TLDLS--QNTNLTYLACDSNKLT-NLD-VTPLTKLTYLNCDTNKL 118
Query: 236 SGWIPRELISIRTFIYDGNS 255
+ + + N+
Sbjct: 119 TKLDVSQNPLLTYLNCARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 15/122 (12%), Positives = 39/122 (31%), Gaps = 8/122 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++ L D I + + P L L L + + L ++ L L+
Sbjct: 293 VTHNTQLYLLDCQAAGITE-LDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVN 348
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
+ G + L + +P ++ +++ ++ + + + N +
Sbjct: 349 AHIQ-DF-SSVGKIPALNNNFEAEGQTI-TMPKETLTNNSL-TIAVSPDLLDQFGNPMNI 404
Query: 223 LP 224
P
Sbjct: 405 EP 406
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 65/276 (23%), Positives = 109/276 (39%), Gaps = 54/276 (19%)
Query: 368 DLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFL--IGEGSLGR 425
+ A + L +K + + T + + +F E L +G G+ G+
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENF--ELLKVLGTGAYGK 69
Query: 426 VYRAEFA----NGKIMAVKKIDNAALSLQEED--------NFLEAVSNMSRLRHPNIVTL 473
V+ GK+ A+K + A + + + LE + P +VTL
Sbjct: 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTL 124
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR-----VALGT 521
Y + +L L+ +Y+ G L H F + V+ + L
Sbjct: 125 H-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEH---------EVQIYVGEIVL-- 170
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG 581
ALE+LH++ +++R+ K NILLD + L+D GL+ E + + G
Sbjct: 171 --ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 582 YSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKP 615
Y AP+ G + D +S GV+M ELLTG P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 34/213 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLRHPNI 470
IG G+ G V A + + +A+KK+ N A + M + H NI
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNI 123
Query: 471 VTL-----AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTAR 523
++L E Q + LV E + NL ++ L + R+ L
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELD-HERMSYLLYQMLC 175
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
+++LH ++HR+ K +NI++ + + D GLA + + T V Y
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYR 230
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
APE L Y D++S G +M E++ K L
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 27/172 (15%), Positives = 59/172 (34%), Gaps = 17/172 (9%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L S L L+ + I + L L + +++ P S+ S+ ++S+L
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHL 203
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLS--------FNNFSGDLPNSFISLSNISSLYLQN 210
+ + + + L+L F+ S NS I ++ + +
Sbjct: 204 ILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 211 NQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
+ + + + + L L + N +P L S++ N +D
Sbjct: 264 ESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 39/132 (29%), Positives = 60/132 (45%), Gaps = 4/132 (3%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
S S+ ++IP L + SL+L++N + + V+L L ++ N + D
Sbjct: 37 KGSSGSL-NSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS 95
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLN 229
F +L L LDLS+N S + F LS+++ L L N G ++FS L L L
Sbjct: 96 FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155
Query: 230 VANNHFSGWIPR 241
V N I R
Sbjct: 156 VGNMDTFTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 21/149 (14%), Positives = 46/149 (30%), Gaps = 14/149 (9%)
Query: 102 LLSDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
L SL +L GN ++ +T + L L + + + + A + L
Sbjct: 119 WFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE 178
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-- 215
L + + L ++ ++ L L L S++ L L++ +
Sbjct: 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH 238
Query: 216 ----SLNVFSGLP----LTTLNVANNHFS 236
S + L + + +
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLF 267
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 63/226 (27%), Positives = 86/226 (38%), Gaps = 47/226 (20%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
FL IG+GS G+V A A AVK + + E N L
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK--- 97
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP +V L + + +L V +Y+ G L H F + R R
Sbjct: 98 --HPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEP---------RARF 143
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+A AL YLH + ++V+R+ K NILLD + + L+D GL
Sbjct: 144 YAAEIAS----ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDS 618
ST G Y APE Y D + G V+ E+L G P S
Sbjct: 197 ST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 33/224 (14%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRH 467
+ F + +G GS GRV + +G A+K +D + L++ ++ L + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 468 PNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDML----HFADDSSKNLTWNARVR-----V 517
P +V L + + L +V EYV G + L F++ R +
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---------HARFYAAQI 150
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMV 577
L EYLH + +++R+ K N+L+D + ++D G A + +
Sbjct: 151 VL----TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLC 199
Query: 578 GAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP 621
G APE LS Y D ++ GV++ E+ G P + +P
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + G +AVKK+ S+ + + ++H N++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 474 --AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
E + LV +G +L++++ + LT + V+ + R L+Y+H
Sbjct: 97 FTPARSLEEFNDVYLVTHLMGA-DLNNIVK-----CQKLT-DDHVQFLIYQILRGLKYIH 149
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM---VGAFGYSAPE 586
++HR+ K +N+ ++++ + D GLA R + +M V Y APE
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTADEMTGYVATRWYRAPE 199
Query: 587 FALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
L+ Y D++S G +M ELLTG + L
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 31/211 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + +G+ +A+KK+ S + + ++H N++ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 474 --AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
+ LV ++ +L ++ + +++ + + L+Y+H
Sbjct: 92 FTPASSLRNFYDFYLVMPFMQT-DLQKIMG------LKFS-EEKIQYLVYQMLKGLKYIH 143
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM---VGAFGYSAPE 586
VVHR+ K N+ ++++ + D GLA R +M V Y APE
Sbjct: 144 SA---GVVHRDLKPGNLAVNEDCELKILDFGLA-------RHADAEMTGYVVTRWYRAPE 193
Query: 587 FALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
LS Y D++S G +M E+LTG K L
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 39/125 (31%), Positives = 53/125 (42%), Gaps = 7/125 (5%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
D S IP +P + L+L SN S + + L L ++ N L I
Sbjct: 22 DCSSKK-LTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI 80
Query: 173 FGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTL 228
F L L TL ++ N LP F L N++ L L NQ+ SL VF L LT L
Sbjct: 81 FKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYL 138
Query: 229 NVANN 233
++ N
Sbjct: 139 SLGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 37/137 (27%), Positives = 58/137 (42%), Gaps = 10/137 (7%)
Query: 104 SDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
+L +L ++ N + +P + NL L L N +LP + S+ L+YL+
Sbjct: 82 KELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLS 139
Query: 160 VSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ N L QS+ +F L L L L N +F L+ + +L L NNQ+
Sbjct: 140 LGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE 198
Query: 218 NVFSGLP-LTTLNVANN 233
F L L L + N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + G +A+KK+ S + + +RH N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 474 --AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
+ LV ++G +L ++ + L R++ + + L Y+H
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGT-DLGKLMK-----HEKLG-EDRIQFLVYQMLKGLRYIH 145
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM---VGAFGYSAPE 586
++HR+ K N+ ++++ + D GLA RQ ++M V Y APE
Sbjct: 146 AA---GIIHRDLKPGNLAVNEDCELKILDFGLA-------RQADSEMTGYVVTRWYRAPE 195
Query: 587 FALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
L+ YT D++S G +M E++TG K L
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 45/210 (21%), Positives = 84/210 (40%), Gaps = 33/210 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAG 475
+G G V+ A N + + VK + ++ + + LR PNI+TLA
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLAD 98
Query: 476 --YCAEHGQRLLVYEYVGNGNLHDMLH-FADDSSKNLTWNARVRVALGTARALEYLHEVC 532
LV+E+V N + + D + + +AL+Y H +
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKALDYCHSM- 149
Query: 533 LPSVVHRNFKSANILLDDEL-NPHLSDCGLA----ALTPNTERQVSTQMVGAFGYSAPEF 587
++HR+ K N+++D E L D GLA R V+++ + PE
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY-----FKGPEL 201
Query: 588 ALSG-IYTVKSDVYSFGVVMLELLTGRKPL 616
+ +Y D++S G ++ ++ ++P
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 11/144 (7%)
Query: 122 TIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181
IP LP +T + L N P + + L +++S N +++ D F L L +
Sbjct: 25 EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS 84
Query: 182 LDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFSG 237
L L N + +LP S F L ++ L L N++ L + F L L L++ +N
Sbjct: 85 LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQT 142
Query: 238 WIPRE----LISIRTFIYDGNSFD 257
I + L +I+T N F
Sbjct: 143 -IAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 33/146 (22%), Positives = 62/146 (42%), Gaps = 25/146 (17%)
Query: 113 DLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNS 164
L N+I +PP L ++L++N S L + SL+ L + N
Sbjct: 38 RLEQNTIK-----VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGL 223
+T+ +F L L L L+ N + ++F L N++ L L +N++ + FS L
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 224 P-LTTLNVANN---------HFSGWI 239
+ T+++A N + ++
Sbjct: 152 RAIQTMHLAQNPFICDCHLKWLADYL 177
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 33/114 (28%), Positives = 47/114 (41%), Gaps = 8/114 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
S LR+ DLS N I + L +L SL L N + LP S+ + SL
Sbjct: 52 FSPYKKLRRIDLSNNQIS-ELAPDAFQGLR-SLNSLVLYGNKIT-ELPKSLFEGLFSLQL 108
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
L ++ N + D F +L L L L N +F L I +++L N
Sbjct: 109 LLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 29/159 (18%), Positives = 43/159 (27%), Gaps = 31/159 (19%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
S R F + + IP LP N L + + L + +S+N + +
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 168 SIG--------------------------DIFGNLAGLATLDLSFNNFSGDLPNSFISLS 201
I + F NL L L +S I
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128
Query: 202 NISSLYLQ-NNQVTG-SLNVFSGLP--LTTLNVANNHFS 236
L +Q N + N F GL L + N
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 31/207 (14%), Positives = 58/207 (28%), Gaps = 14/207 (6%)
Query: 101 YLLSDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS 156
L D+ N +I L L L N + S + L
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLD 180
Query: 157 YLNVSR-NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
LN+S N+L + D+F +G LD+S +L + + N +
Sbjct: 181 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK--- 237
Query: 216 SLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGR 274
L L L ++ + R I + + N +
Sbjct: 238 KLPTLEKLVALMEASLTYP----SHCCAFANWRRQISELHPICNKSILRQEVDYMTQARG 293
Query: 275 SHNNRSHRQGSHSPSGSQSSSSDKELP 301
++ + S G + ++ +
Sbjct: 294 QRSSLAEDNESSYSRGFDMTYTEFDYD 320
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 24/141 (17%), Positives = 44/141 (31%), Gaps = 9/141 (6%)
Query: 104 SDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
S+L L + + I+ LP NL L +++ + L+
Sbjct: 76 SNLPKLHEIRIEKANNLLYINPEAFQNLP-NLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134
Query: 160 VSRNSLTQSIGD-IFGNLAG-LATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
+ N +I F L+ L L+ N ++F NN +
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 217 LNVFSGLP-LTTLNVANNHFS 236
+VF G L+++
Sbjct: 195 NDVFHGASGPVILDISRTRIH 215
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 33/145 (22%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 122 TIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA 180
IP +P L L +N F+ I + L +N S N +T F +G+
Sbjct: 25 KIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN 84
Query: 181 TLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
+ L+ N ++ + F L ++ +L L++N++T + + F GL + L++ +N +
Sbjct: 85 EILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 237 GWIPRE----LISIRTFIYDGNSFD 257
+ L S+ T N F+
Sbjct: 143 T-VAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 34/143 (23%), Positives = 60/143 (41%), Gaps = 18/143 (12%)
Query: 113 DLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQS 168
L+ N ++ P L +N ++N + ++ ++ + ++ N L
Sbjct: 38 RLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENV 96
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-L 225
+F L L TL L N + +SFI LS++ L L +NQ+T ++ F L L
Sbjct: 97 QHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSL 155
Query: 226 TTLNVANNHF---------SGWI 239
+TLN+ N F W+
Sbjct: 156 STLNLLANPFNCNCYLAWLGEWL 178
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 48/234 (20%), Positives = 85/234 (36%), Gaps = 43/234 (18%)
Query: 404 SLQTATNSFSQEF-----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLE 457
LQ N+ ++ ++G G G+V + + A+K + + + +E
Sbjct: 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE------ 60
Query: 458 AVSNMSRL-RHPNIVTLAGYCAEHGQR----LLVYEYVGNGNLHDMLHFADDSSKNLTWN 512
V R + P+IV + L+V E + G L + D + T
Sbjct: 61 -VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTER 117
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+ A++YLH + ++ HR+ K N+L + PN
Sbjct: 118 EASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSK-------------RPN----- 156
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS 626
+ + FG+ A E Y D++S GV+M LL G P S+ +
Sbjct: 157 AILKLTDFGF-AKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 34/215 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHPNI 470
IGEG+ G V A + N +A+KKI +L+E + + R RH NI
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-------IKILLRFRHENI 87
Query: 471 VTL-----AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARA 524
+ + A + +V + + +L+ +L +++L+ N + L R
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK-----TQHLS-NDHICYFLYQILRG 140
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGAFGY 582
L+Y+H +V+HR+ K +N+LL+ + + D GLA A + T+ V Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 583 SAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
APE L+ YT D++S G ++ E+L+ +P+
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 51/223 (22%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQE------EDNFLEAVSNMSR 464
+ L +G GS GRV+ NG+ A+K + + L++ E L V
Sbjct: 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV----- 63
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP I+ + + Q++ ++ +Y+ G L F + +
Sbjct: 64 -THPFIIRMW-GTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNP---------VAKF 110
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
V L ALEYLH +++R+ K NILLD + ++D G A P+
Sbjct: 111 YAAEVCL----ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---T 160
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
T + G Y APE + Y D +SFG+++ E+L G P
Sbjct: 161 YT-LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 27/149 (18%), Positives = 57/149 (38%), Gaps = 12/149 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
S+L ++ + +S + + Y L +T + + + + + L +
Sbjct: 51 FSNLPNISRIYVSIDVTLQQLESHSFYNLS-KVTHIEIRNTRNLTYIDPDALKELPLLKF 109
Query: 158 LNVSRNSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLP-NSFISLSNIS-SLYLQNNQV 213
L + L D+ + L+++ N + +P N+F L N + +L L NN
Sbjct: 110 LGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168
Query: 214 TG-SLNVFSGLPLTTLNVANNHFSGWIPR 241
T F+G L + + N + I +
Sbjct: 169 TSVQGYAFNGTKLDAVYLNKNKYLTVIDK 197
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 26/145 (17%), Positives = 52/145 (35%), Gaps = 15/145 (10%)
Query: 104 SDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLP--YSIASMVSLSY 157
+L + ++ I +LP L L + + P + S
Sbjct: 77 YNLSKVTHIEIRNTRNLTYIDPDALKELP-LLKFLGIFNTGLK-MFPDLTKVYSTDIFFI 134
Query: 158 LNVSRNSLTQSI-GDIFGNL-AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
L ++ N SI + F L TL L N F+ + + + + ++YL N+
Sbjct: 135 LEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT 193
Query: 216 SL--NVFSGLP--LTTLNVANNHFS 236
+ + F G+ + L+V+ +
Sbjct: 194 VIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 26/133 (19%), Positives = 48/133 (36%), Gaps = 30/133 (22%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
F ++ I IP LPP+ +L L + +I S
Sbjct: 12 QEEDFRVTCKDIQ-RIP-SLPPSTQTLKLIETHLR-----TIPS---------------- 48
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSL--NVFSGLP 224
F NL ++ + +S + L +SF +LS ++ + ++N + + + LP
Sbjct: 49 ---HAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP 105
Query: 225 -LTTLNVANNHFS 236
L L + N
Sbjct: 106 LLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 23/115 (20%), Positives = 47/115 (40%), Gaps = 10/115 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQ----LPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
+ +++ N +IP L +L L +N F+ ++ + L +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 159 NVSRNSLTQSI-GDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+++N I D FG + G + LD+S + + LP+ L ++ L +N
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT 236
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 45/225 (20%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALS---LQEEDNFLEAVSNMSRLRHPNIV 471
+G G G V+ A + K +A+KKI + L+E + + RL H NIV
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE-------IKIIRRLDHDNIV 71
Query: 472 TL-------AGYCAEHGQRL-------LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV 517
+ + L +V EY+ +L ++L L R+
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLL-EEHARL 124
Query: 518 AL-GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC--GLA--ALTPNTERQV 572
+ R L+Y+H +V+HR+ K AN+ ++ E + L GLA + +
Sbjct: 125 FMYQLLRGLKYIHSA---NVLHRDLKPANLFINTE-DLVLKIGDFGLARIMDPHYSHKGH 180
Query: 573 STQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
++ + Y +P LS YT D+++ G + E+LTG K L
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 34/158 (21%), Positives = 57/158 (36%), Gaps = 24/158 (15%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
+ N + L + L L N S +LP ++ ++ L ++
Sbjct: 32 AWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEIT 88
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
+N+L S+ ++ + L LD N S LP SL + L + NNQ +
Sbjct: 89 QNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKH---LDVDNNQ-------LT 133
Query: 222 GLP-----LTTLNVANNHFSGWIPRELISIRTFIYDGN 254
LP L +N NN + +P S+ N
Sbjct: 134 MLPELPALLEYINADNNQLTM-LPELPTSLEVLSVRNN 170
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 28/155 (18%), Positives = 51/155 (32%), Gaps = 12/155 (7%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS----Y 157
L SL + N + +P +LP +L +L++++N +LP +
Sbjct: 155 LPELPTSLEVLSVRNNQLT-FLP-ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIF 211
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
N +T I + +L T+ L N S +S Y
Sbjct: 212 FRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRI---YF 266
Query: 218 NVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYD 252
++ G T + + W P S + I+
Sbjct: 267 SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWH 301
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 19/131 (14%), Positives = 44/131 (33%), Gaps = 12/131 (9%)
Query: 103 LSDLL-SLRKFDLSGNSIHDTIP------YQLPPNLTSLNLASNNFSGNLPYSIASMVSL 155
L +L SL D+S N + ++P + N + ++P +I S+
Sbjct: 175 LPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPT 232
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATL---DLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ + N L+ I + + F+ G L++ + + N+
Sbjct: 233 CTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENK 292
Query: 213 VTGSLNVFSGL 223
+ ++
Sbjct: 293 QSDVSQIWHAF 303
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 43/156 (27%), Positives = 64/156 (41%), Gaps = 23/156 (14%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
+ LS NSI +L L L L+ N +L + + L YL+
Sbjct: 53 RTKALSLSQNSIS-----ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLD 106
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS--FISLSNISSLYLQNNQVT-GS 216
VS N L Q+I +A L LDLSFN+F LP F +L+ ++ L L +
Sbjct: 107 VSHNRL-QNIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLD 162
Query: 217 LNVFSGLPLTT--LNVANNHFSGWIPRELISIRTFI 250
L + L L+ L++ + H G L T +
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTV 198
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 30/124 (24%), Positives = 50/124 (40%), Gaps = 7/124 (5%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
D S ++ +P LPP +L+L+ N+ S I+ + L L +S N + +
Sbjct: 37 DYSNRNLT-HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHV 95
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ--VTGSLNVFSGLP-LTTLN 229
F L LD+S N + ++++ L L N V F L LT L
Sbjct: 96 FLFNQDLEYLDVSHNRLQN-IS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152
Query: 230 VANN 233
++
Sbjct: 153 LSAA 156
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 29/167 (17%), Positives = 57/167 (34%), Gaps = 12/167 (7%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGN-----LPYSIASMVSLSYLNVS 161
++L+ + + + P + LN+ + + YS ++ SL +V
Sbjct: 254 VTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK 313
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS-LNVF 220
S ++ A + LS ++ S S+ + L N T S
Sbjct: 314 NQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGC 373
Query: 221 SGLP-LTTLNVANNHFSGW-----IPRELISIRTFIYDGNSFDNGPA 261
S L L TL + N + + + + S+ T NS ++
Sbjct: 374 STLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAY 420
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 1/94 (1%)
Query: 96 SGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSL 155
S + S+ +LS N + ++ LPP + L+L +N ++P + + +L
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQAL 475
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189
LNV+ N L +F L L + L N +
Sbjct: 476 QELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 33/141 (23%), Positives = 54/141 (38%), Gaps = 18/141 (12%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQ--LPPNLTSLNLASNNFSGNLPYSIASMV-----SLSYL 158
L L+ L N + + N++SL + +L S+ L
Sbjct: 376 LKRLQTLILQRNGLK-NFFKVALMTKNMSSLET-LDVSLNSLNSHAYDRTCAWAESILVL 433
Query: 159 NVSRNSLTQSIGDIFGNL-AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
N+S N LT S+ F L + LDL N +P L + L + +NQ+ S+
Sbjct: 434 NLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SV 488
Query: 218 --NVFSGLP-LTTLNVANNHF 235
VF L L + + +N +
Sbjct: 489 PDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 26/167 (15%), Positives = 46/167 (27%), Gaps = 17/167 (10%)
Query: 107 LSLRKFDLSGNSIHD----TIPYQLPPNLTSLNLASNNFSGNLPYSIASMV---SLSYLN 159
L L L+ + P L ++ L + + + YLN
Sbjct: 223 LQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLN 282
Query: 160 VSRNSLTQSIGDIFGN-----LAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214
+ ++T+ I L L + F + + ++ L +
Sbjct: 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP 342
Query: 215 GSLNVFSGLP--LTTLNVANNHFS---GWIPRELISIRTFIYDGNSF 256
V P T LN N F+ L ++T I N
Sbjct: 343 FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 52/251 (20%), Positives = 89/251 (35%), Gaps = 74/251 (29%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLRHPNI 470
IG GS G VY A + K +A+KK++ ++ ++ ++ ++RL+ I
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMF------EDLIDCKRILREITILNRLKSDYI 87
Query: 471 VTLAG-YCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARA 524
+ L + + +V E + +L + + LT ++ L
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK----TPIFLT-EEHIKTILYNLLLG 141
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC-------GLA-ALTPNTERQVSTQM 576
++HE ++HR+ K AN LL+ DC GLA + + + +
Sbjct: 142 ENFIHES---GIIHRDLKPANCLLN-------QDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 577 VGAFG--------------------YSAPEFAL-SGIYTVKSDVYSFGVVMLELLTG--- 612
Y APE L YT D++S G + ELL
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
Query: 613 -------RKPL 616
R PL
Sbjct: 252 HINDPTNRFPL 262
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 55/229 (24%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHPNI 470
+GEG+ G V A G+I+A+KKI+ A +L+E + + +H NI
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE-------IKILKHFKHENI 71
Query: 471 VTLAG-YCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARA 524
+T+ + + ++ E + +LH ++ S++ L+ + ++ + T RA
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-----STQMLS-DDHIQYFIYQTLRA 124
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC-------GLAALTPNTERQVSTQMV 577
++ LH +V+HR+ K +N+L++ S+C GLA + + S
Sbjct: 125 VKVLHGS---NVIHRDLKPSNLLIN-------SNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 578 GAFG---------YSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y APE L+ Y+ DV+S G ++ EL R+P+
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 33/120 (27%), Positives = 52/120 (43%), Gaps = 4/120 (3%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
D++P +P + L+L S + + + L++LN+ N L +F +L L
Sbjct: 26 LDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 180 ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGL-PLTTLNVANNHFS 236
TL L+ N + F L+ + LYL NQ+ SL VF L L L + N
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 54/198 (27%), Positives = 80/198 (40%), Gaps = 33/198 (16%)
Query: 71 CGESWKGVACEGSAVVSI------DISGLGLSGTMGYLLSD-----LLSLRKFDLSGNSI 119
C E K V C+G ++ S+ D L L T LSD L L +L N +
Sbjct: 12 CNEGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL 71
Query: 120 HDTIP---YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQSI-GDIFG 174
T+ + L +L LA+N + +LP + + L L + N L +S+ +F
Sbjct: 72 -QTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFD 128
Query: 175 NLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVA 231
L L L L+ N +P F L+N+ +L L NQ+ F L L T+ +
Sbjct: 129 RLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187
Query: 232 NNHF----------SGWI 239
N F S WI
Sbjct: 188 GNQFDCSRCEILYLSQWI 205
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 25/107 (23%), Positives = 42/107 (39%), Gaps = 6/107 (5%)
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
R L+ + + +T L+L+ N LP ++A++ L L S N+L ++
Sbjct: 444 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501
Query: 170 GDIFGNLAGLATLDLSFNNFSGDLPN--SFISLSNISSLYLQNNQVT 214
+ NL L L L N +S + L LQ N +
Sbjct: 502 DGV-ANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 2e-10
Identities = 28/144 (19%), Positives = 51/144 (35%), Gaps = 10/144 (6%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQL-----PPNLTSLNLASNNFSGNLPYSIASMVSL 155
LL+ +L +R D + P L+ + F +
Sbjct: 384 CLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV 443
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
L+++ LT + + L + LDLS N LP + +L + L +N +
Sbjct: 444 RVLHLAHKDLT-VLCHL-EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499
Query: 216 SLNVFSGLP-LTTLNVANNHFSGW 238
+++ + LP L L + NN
Sbjct: 500 NVDGVANLPRLQELLLCNNRLQQS 523
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.0 bits (160), Expect = 3e-11
Identities = 63/462 (13%), Positives = 133/462 (28%), Gaps = 134/462 (29%)
Query: 349 NNMNTEMHEQRVKSVAAVTDLTPPPAEKL-------VIERVAKSGSLKKI---KSPITAT 398
++M+ E E + + ++ + + + + + I K ++ T
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT 64
Query: 399 SYTVASLQTATNSFSQEFLIGEGSLGRVY-------RAE------------------FAN 433
+L + Q+F+ E L Y + E + +
Sbjct: 65 LRLFWTLLSKQEEMVQKFV--EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 434 GKIMA---------VKKIDNAALSLQEEDNF--------------LEAVSNMSRLRHP-- 468
++ A K+ A L L+ N L+ +
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDF 182
Query: 469 NI--VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL---TWNARVRVALGTAR 523
I + L C L L +L+ D + + + N ++R+ A
Sbjct: 183 KIFWLNL-KNCNSPETVLE--------MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD-----CGLAALTPNTERQVSTQMVG 578
L + +++ ++L + N + C + T +QV+ +
Sbjct: 234 LRRLLK--------SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRF--KQVTDFLSA 283
Query: 579 AFGYSAP-EFALSGIYTVKSDVYSFGVVMLELL---TGRKPLDSSR------PRS----- 623
A + + + LL +P D R PR
Sbjct: 284 ATTTHISLDHHSMTLTPDEV---------KSLLLKYLDCRPQDLPREVLTTNPRRLSIIA 334
Query: 624 ---EQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPM- 679
L W + + D L +++ +LN + PA+ F L V P P +
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR---LSVFPPSAHIPTIL 391
Query: 680 ---------SEVVQALVRLVQRASVVKRRSSDESGFSYRTPD 712
V +V + + S+V+++ + + P
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE---STISIPS 430
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 53/249 (21%), Positives = 90/249 (36%), Gaps = 65/249 (26%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLRHPNI 470
IG GS G V A + +++A+KKI ++ ++ ++ ++RL H ++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVF------EDLIDCKRILREIAILNRLNHDHV 114
Query: 471 VTL----AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARA 524
V + E L +V E + + + + LT ++ L
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR----TPVYLT-ELHIKTLLYNLLVG 168
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG--- 581
++Y+H ++HR+ K AN L++ + + + D GLA E S +
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 582 -----------------------YSAPEFAL-SGIYTVKSDVYSFGVVMLELLT------ 611
Y APE L YT DV+S G + ELL
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 612 ----GRKPL 616
R PL
Sbjct: 286 AYHADRGPL 294
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 51/266 (19%), Positives = 105/266 (39%), Gaps = 46/266 (17%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHP---- 468
+G G V+ A+ N +A+K + + + ++E L+ V++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 469 -NIVTL------AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALG 520
+I+ L G H ++V+E +G NL ++ + L V+ ++
Sbjct: 86 NHILKLLDHFNHKGPNGVH--VVMVFEVLGE-NLLALIKKYEHRGIPLI---YVKQISKQ 139
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPH------LSDCGLAALTPNTERQVST 574
L+Y+H C ++H + K N+L++ +P ++D G A +
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTN 194
Query: 575 QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ 634
+ Y +PE L + +D++S ++ EL+TG L +
Sbjct: 195 SIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYT-------- 244
Query: 635 LHDIDALAKMVDPALNGMYPAKSLSR 660
D D +A++++ L G P+ L
Sbjct: 245 -KDDDHIAQIIE--LLGELPSYLLRN 267
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-11
Identities = 28/126 (22%), Positives = 46/126 (36%), Gaps = 10/126 (7%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFS--GNLPYSIASMVSLSYLNVSRNSLTQSIG 170
L+ I Y L+L NL A++ ++ S N + +
Sbjct: 3 KLTAELIEQAAQYTNAVRDRELDLRGYKIPVIENLG---ATLDQFDAIDFSDNEIR-KLD 58
Query: 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTT 227
F L L TL ++ N +L +++ L L NN + G L+ + L LT
Sbjct: 59 G-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 117
Query: 228 LNVANN 233
L + N
Sbjct: 118 LCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 29/138 (21%), Positives = 54/138 (39%), Gaps = 17/138 (12%)
Query: 103 LSDLLSLRKFDLSGNSIHDT--IPYQLPPNLTSLNLASNNFS--GNLPYSIASMVSLSYL 158
++ + R+ DL G I + L +++ + N P + L L
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGATL-DQFDAIDFSDNEIRKLDGFP----LLRRLKTL 69
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--GDLPNSFISLSNISSLYLQNNQVTGS 216
V+ N + + + L L L L+ N+ GDL + SL +++ L + N VT
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVTNK 128
Query: 217 LN----VFSGLP-LTTLN 229
+ V +P + L+
Sbjct: 129 KHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 21/88 (23%), Positives = 35/88 (39%), Gaps = 3/88 (3%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L + L D S N I + L L +L + +N ++ L+ L ++
Sbjct: 37 LGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96
Query: 162 RNSLTQSIGDI--FGNLAGLATLDLSFN 187
NSL +GD+ +L L L + N
Sbjct: 97 NNSLV-ELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 21/105 (20%), Positives = 38/105 (36%), Gaps = 8/105 (7%)
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
+ ++ + Q+ + N LDL + N +L ++ +N++ L
Sbjct: 2 VKLTAELIEQAAQ--YTNAVRDRELDLR-GYKIPVIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 218 NVFSGLP-LTTLNVANNHFS---GWIPRELISIRTFIYDGNSFDN 258
+ F L L TL V NN + + L + I NS
Sbjct: 58 DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 102
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 47/211 (22%), Positives = 77/211 (36%), Gaps = 41/211 (19%)
Query: 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555
+ D LT + + A+ +E+L +HR+ + NILL ++
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK 233
Query: 556 LSDCGLAALTPNTERQVSTQ--------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVML 607
+ D GLA V M APE +YT++SDV+SFGV++
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWM-------APETIFDRVYTIQSDVWSFGVLLW 286
Query: 608 ELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY---PAKSLSRFAD 663
E+ + G P P + + + + G P +
Sbjct: 287 EIFSLGASPY----------------PGVKIDEEFCRRLK---EGTRMRAPDYTTPEMYQ 327
Query: 664 IIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694
+ C EP RP SE+V+ L L+Q +
Sbjct: 328 TMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 21/90 (23%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 418 IGEGSLGRVYRAE-----FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIV 471
+G G+ G+V A+ K+ + E + + + + H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 472 TLAGYCAEHGQRLLV-YEYVGNGNLHDMLH 500
L G C + G L+V E+ GNL L
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHPN 469
+IG+GS G+V +A + +A+K + N A EE LE + + N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA---EEIRILEHLRKQDKDNTMN 160
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEYL 528
++ + + +E + NL++++ +L VR A + L+ L
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP---LVRKFAHSILQCLDAL 216
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH--LSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
H+ ++H + K NILL + + D G + V T + F Y APE
Sbjct: 217 HK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR---VYTYIQSRF-YRAPE 269
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
L Y + D++S G ++ ELLTG PL
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTG-YPL 298
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 30/119 (25%), Positives = 49/119 (41%), Gaps = 6/119 (5%)
Query: 119 IHDTIPYQLPPNLTSLNL-ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
IH + + P + L L + G + A V+L +L++ L S+ L
Sbjct: 14 IHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLP 71
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLNVANN 233
L L+LS N G L L N++ L L N++ +L L L +L++ N
Sbjct: 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 32/109 (29%), Positives = 43/109 (39%), Gaps = 14/109 (12%)
Query: 129 PNLTSLNLASNNFS--GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF 186
NL L+L + NLP + L L +S N + + + L L L+LS
Sbjct: 49 VNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSG 104
Query: 187 NNFS--GDLPNSFISLSNISSLYLQNNQVTGSLN----VFSGLP-LTTL 228
N L L + SL L N +VT + VF LP LT L
Sbjct: 105 NKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 6e-08
Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L ++ ++L L + P L L L+ N G L + +L++LN+S
Sbjct: 44 LTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103
Query: 162 RNSLTQSIGDI--FGNLAGLATLDLSFN 187
N L + I + L L +LDL
Sbjct: 104 GNKL-KDISTLEPLKKLECLKSLDLFNC 130
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-10
Identities = 30/119 (25%), Positives = 49/119 (41%), Gaps = 6/119 (5%)
Query: 119 IHDTIPYQLPPNLTSLNLASNNFS-GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
IH + + P ++ L L ++ + G L L +L+ LT SI L
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLN 64
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLNVANN 233
L L+LS N SG L N++ L L N++ ++ L L +L++ N
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 31/134 (23%), Positives = 45/134 (33%), Gaps = 32/134 (23%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L + L + TS+ NLP + L L +S
Sbjct: 37 LTDEFEELEFLSTINVGL------------TSI--------ANLP----KLNKLKKLELS 72
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFS--GDLPNSFISLSNISSLYLQNNQVTGSLN- 218
N ++ + + L L+LS N + L N+ SL L N +VT +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNCEVTNLNDY 131
Query: 219 ---VFSGLP-LTTL 228
VF LP LT L
Sbjct: 132 RENVFKLLPQLTYL 145
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 2e-10
Identities = 18/100 (18%), Positives = 36/100 (36%), Gaps = 2/100 (2%)
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNS 196
+ + + + + + +L+ L + Q + L L L + + P++
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 197 FISLSNISSLYLQNNQVTG-SLNVFSGLPLTTLNVANNHF 235
F +S L L N + S GL L L ++ N
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 7/68 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L L LR + + + + + P L+ LNL+ N +L + +SL L
Sbjct: 52 LRGLGELRNLTIVKSGL-RFVAPDAFHFTP-RLSRLNLSFNALE-SLSWKTVQGLSLQEL 108
Query: 159 NVSRNSLT 166
+S N L
Sbjct: 109 VLSGNPLH 116
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 63/238 (26%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLR-HPN 469
+G+G+ G V+++ + G+++AVKKI +A N +A + ++ L H N
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAF------QNSTDAQRTFREIMILTELSGHEN 70
Query: 470 IVTLAG-YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALE 526
IV L A++ + + LV++Y+ +LH ++ + L + + + ++
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMET-DLHAVIR-----ANILE-PVHKQYVVYQLIKVIK 123
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDC-------GLAALTPNTERQVSTQMVGA 579
YLH ++HR+ K +NILL+ ++C GL+ N R + +
Sbjct: 124 YLHSG---GLLHRDMKPSNILLN-------AECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 580 FG--------------------YSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L S YT D++S G ++ E+L KP+
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPI 230
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 29/128 (22%), Positives = 46/128 (35%), Gaps = 6/128 (4%)
Query: 99 MGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
M LS L + + LS N+I NL L+L N + A +L L
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTGS 216
+S N + S+ I L L L +S N + + + +L + L L N +
Sbjct: 99 WISYNQIA-SLSGI-EKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYND 155
Query: 217 LNVFSGLP 224
+
Sbjct: 156 YKENNATS 163
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 2e-09
Identities = 35/238 (14%), Positives = 64/238 (26%), Gaps = 55/238 (23%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKI------------DNAALSLQEEDNFLEAVSNMSRL 465
IGEG G V++ A+ +A+K I + E + +S +S
Sbjct: 28 IGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 466 ---RHPNIVTL------AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDS----------- 505
R + L G + + G+ +D F D
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 506 --------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557
+K + + +L HR+ N+LL L
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLH 204
Query: 558 DCGLAALTPNTERQVSTQMVGAFGYSAP--EFALSGIYTVKSDVYSFGVVMLELLTGR 613
+ + + G ++ LS + V+ + +L TG
Sbjct: 205 YTLNG----------KSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD 252
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHPN 469
LIG+GS G+V +A + +A+K I N A E LE ++
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ---IEVRLLELMNKHDTEMKYY 117
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEYL 528
IV L + LV+E + NL+D+L + +L R A AL +L
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLN---LTRKFAQQMCTALLFL 173
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH--LSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
L S++H + K NILL + + D G + + + F Y +PE
Sbjct: 174 ATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRF-YRSPE 228
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
L Y + D++S G +++E+ TG +PL
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTG-EPL 257
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 36/133 (27%), Positives = 57/133 (42%), Gaps = 20/133 (15%)
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181
IP +P + T L L N + + L L + RN LT + F + +
Sbjct: 23 IPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQE 82
Query: 182 LDLSFNNFSGDLPN-SFISLSNISSLYLQNNQVT----GSLNVFSGLP-LTTLNVANN-- 233
L L N ++ N F+ L + +L L +NQ++ GS F L LT+LN+A+N
Sbjct: 83 LQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGS---FEHLNSLTSLNLASNPF 138
Query: 234 -------HFSGWI 239
F+ W+
Sbjct: 139 NCNCHLAWFAEWL 151
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 33/109 (30%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 157 YLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
L ++ N L + S +FG L L L+L N +G PN+F S+I L L N++
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 216 SL--NVFSGLP-LTTLNVANNHFSGWIPR----ELISIRTFIYDGNSFD 257
+ +F GL L TLN+ +N S + L S+ + N F+
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPFN 139
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 35/118 (29%), Positives = 50/118 (42%), Gaps = 6/118 (5%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
++P +P T L+L +N+ + SL+ L + N L +F L L
Sbjct: 19 RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 180 ATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANN 233
L+LS N LPN F L+ + L L NQ+ SL VF L L L + N
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 41/146 (28%), Positives = 60/146 (41%), Gaps = 18/146 (12%)
Query: 110 RKFDLSGNSIHDTIP--YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLT 166
DL NS+ + +LT L L N +LP + + SL+YLN+S N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 167 QSIGDIFGNLAGLATLDLSFNNFSGDLPN-SFISLSNISSLYLQNNQVTGSLN-VFSGLP 224
+F L L L L+ N LP+ F L+ + L L NQ+ + VF L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT 148
Query: 225 -LTTLNVANN----------HFSGWI 239
L + + +N + S WI
Sbjct: 149 SLQYIWLHDNPWDCTCPGIRYLSEWI 174
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-09
Identities = 32/129 (24%), Positives = 59/129 (45%), Gaps = 14/129 (10%)
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL 182
+P +P ++T L L N F+ +P +++ L+ +++S N ++ F N+ L TL
Sbjct: 25 LPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL 83
Query: 183 DLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANN------ 233
LS+N P +F L ++ L L N ++ + F+ L L+ L + N
Sbjct: 84 ILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDC 142
Query: 234 ---HFSGWI 239
S W+
Sbjct: 143 NMQWLSDWV 151
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 33/129 (25%), Positives = 54/129 (41%), Gaps = 8/129 (6%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
K +L S+ D + ++ + +++ ++ I + ++ YL + N L
Sbjct: 20 ETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKL-H 76
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP- 224
I L L L L+ N F L+N+ L L NQ+ SL VF L
Sbjct: 77 DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTN 134
Query: 225 LTTLNVANN 233
LT LN+A+N
Sbjct: 135 LTYLNLAHN 143
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 36/131 (27%), Positives = 59/131 (45%), Gaps = 6/131 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
L S+ + + + I Q PN+ L L N ++ ++ + +L+YL ++ N L
Sbjct: 40 LNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQL 97
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGL 223
+F L L L L N F L+N++ L L +NQ+ SL VF L
Sbjct: 98 QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKL 156
Query: 224 P-LTTLNVANN 233
LT L+++ N
Sbjct: 157 TNLTELDLSYN 167
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 42/133 (31%), Positives = 59/133 (44%), Gaps = 8/133 (6%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNS 164
L ++R L GN +HD + NLT L L N +LP + + +L L + N
Sbjct: 62 LPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQ 120
Query: 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL--NVFS 221
L +F L L L+L+ N LP F L+N++ L L NQ+ SL VF
Sbjct: 121 LQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFD 178
Query: 222 GLP-LTTLNVANN 233
L L L + N
Sbjct: 179 KLTQLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 22/116 (18%), Positives = 39/116 (33%), Gaps = 8/116 (6%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
P NL + + + + S+ + + + + G L +
Sbjct: 10 KQIFPDDAFAETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSVQG--IQYLPNV 65
Query: 180 ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANN 233
L L N D+ + L+N++ L L NQ+ VF L L L + N
Sbjct: 66 RYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN 119
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 35/112 (31%), Positives = 52/112 (46%), Gaps = 8/112 (7%)
Query: 106 LLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVS 161
L +L L+GN + ++P + NL L L N +LP + + +L+YLN++
Sbjct: 84 LTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA 141
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQ 212
N L +F L L LDLS+N LP F L+ + L L NQ
Sbjct: 142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQ 192
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 30/166 (18%), Positives = 45/166 (27%), Gaps = 34/166 (20%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL------PPNLTSLNLASNNFS-------------G 143
L L LS N+ T L L L L +N
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 144 NLPYSIASMVSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGD-----LP 194
+ + L + RN L + F + L T+ + N + L
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 195 NSFISLSNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANNH 234
+ L LQ+N T GS + L L L + +
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 255
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 36/242 (14%), Positives = 68/242 (28%), Gaps = 49/242 (20%)
Query: 44 VQALQVLYTSLNSPSVLT--NWKGNE-GDPCGESWKGVACEGSA------VVSIDISG-- 92
+A + L ++ S L + G E + + A + ++ +S
Sbjct: 46 TEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105
Query: 93 LGLSG--TMGYLLSDLLSLRKFDLSGNSI---------------HDTIPYQLPPNLTSLN 135
G + + LS L L N + + P L S+
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165
Query: 136 LASNNFSGNLPYSIASMV----SLSYLNVSRNSLT-----QSIGDIFGNLAGLATLDLSF 186
N A L + + +N + + + L LDL
Sbjct: 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225
Query: 187 NNFSGD----LPNSFISLSNISSLYLQNNQVTG--------SLNVFSGLPLTTLNVANNH 234
N F+ L + S N+ L L + ++ + + + L TL + N
Sbjct: 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 285
Query: 235 FS 236
Sbjct: 286 IE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 27/132 (20%), Positives = 45/132 (34%), Gaps = 22/132 (16%)
Query: 103 LSDLLSLRKFDLSGNSIHD-----TIPYQLPPN--LTSLNLASNNFSGNLPYSIASMV-- 153
L + N I + L L L+L N F+ ++A +
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 154 --SLSYLNVSRNSLT----QSIGDIFGNLA--GLATLDLSFNNFSGD----LPNSFIS-L 200
+L L ++ L+ ++ D F L GL TL L +N D L +
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 302
Query: 201 SNISSLYLQNNQ 212
++ L L N+
Sbjct: 303 PDLLFLELNGNR 314
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 25/174 (14%), Positives = 49/174 (28%), Gaps = 41/174 (23%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL------PPNLTSLNLASNNFSGNLP-------YSI 149
L + S+++ LSGN+I L +L S+ F+G + +
Sbjct: 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF-SDIFTGRVKDEIPEALRLL 86
Query: 150 ASMV----SLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFS----------- 190
+ L + +S N+ + + D L L L N
Sbjct: 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146
Query: 191 --GDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANNHFS 236
+ + + S+ N++ L T+ + N
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 22/168 (13%), Positives = 42/168 (25%), Gaps = 39/168 (23%)
Query: 107 LSLRKFDLSGNSIHDT------IPYQLPPNLTSLNLASNNFSGNLPYSIASMV----SLS 156
S+ L ++I ++ + L+ N ++ + L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 157 YLNVSRNSL----------TQSIGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSN 202
S + + L T+ LS N F L + +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 203 ISSLYLQNNQVT--GSLNVFSGLP-------------LTTLNVANNHF 235
+ LYL NN + + L L ++ N
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 24/119 (20%), Positives = 40/119 (33%), Gaps = 17/119 (14%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT----IPYQLP--PNLTSLNLASNNFS 142
I G+ + L+ L+ DL N+ + L PNL L L S
Sbjct: 198 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
Query: 143 GNLPYSIASMV------SLSYLNVSRNSLT----QSIGD-IFGNLAGLATLDLSFNNFS 190
++ L L + N + +++ I + L L+L+ N FS
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 35/183 (19%), Positives = 56/183 (30%), Gaps = 32/183 (17%)
Query: 86 VSIDISGLGLSGT------MGYLLSDLLSLRKFDLSGNSIHDT----IPYQLP--PNLTS 133
+S+DI L + LL L + L + + I L P L
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 134 LNLASNNFSGNLPYSIASMV-----SLSYLNVSRNSLT----QSIGDIFGNLAGLATLDL 184
LNL SN + + + + L++ LT + L L L L
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 185 SFNNFSGD----LPNSFISL-SNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANN 233
S N L + + L L+ ++ + S L L V+NN
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 234 HFS 236
+
Sbjct: 181 DIN 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 29/161 (18%), Positives = 59/161 (36%), Gaps = 27/161 (16%)
Query: 103 LSDLLSLRKFDLSGNSIHDT-----IPYQLPPN--LTSLNLASNNFSGNLPYSIASMV-- 153
++ SLR+ L N + D P L P+ L +L + + + ++
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 154 --SLSYLNVSRNSLT----QSIGD-IFGNLAGLATLDLSFNNFSGD----LPNSFISLSN 202
SL L+++ N L + + + + L +L + +F+ +
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 203 ISSLYLQNNQVT--GSLNVFSGLP-----LTTLNVANNHFS 236
+ L + NN++ G + GL L L +A+ S
Sbjct: 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 29/162 (17%), Positives = 57/162 (35%), Gaps = 27/162 (16%)
Query: 102 LLSDLLSLRKFDLSGNSIHD----TIPYQL---PPNLTSLNLASNNFSGNLPYSIASMV- 153
L +L + +L N + D + L + L+L + +G ++S +
Sbjct: 51 ALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR 110
Query: 154 ---SLSYLNVSRNSLT----QSIGDIFG-NLAGLATLDLSFNNFS----GDLPNSFISLS 201
+L L++S N L Q + + L L L + + S L + +
Sbjct: 111 TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 170
Query: 202 NISSLYLQNNQV--TGSLNVFSGLP-----LTTLNVANNHFS 236
+ L + NN + G + GL L L + + +
Sbjct: 171 DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 30/162 (18%), Positives = 58/162 (35%), Gaps = 27/162 (16%)
Query: 102 LLSDLLSLRKFDLSGNSIHDT----IPYQLPPN---LTSLNLASNNFS----GNLPYSIA 150
+L ++ +S N I++ + L + L +L L S + +L +A
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224
Query: 151 SMVSLSYLNVSRNSLT----QSIGDIFGN-LAGLATLDLSFNNFSGD----LPNSFISLS 201
S SL L + N L + + + L TL + + L +
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284
Query: 202 NISSLYLQNNQVT--GSLNVFSGL-----PLTTLNVANNHFS 236
++ L L N++ G+ + L L +L V + F+
Sbjct: 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-06
Identities = 30/164 (18%), Positives = 48/164 (29%), Gaps = 32/164 (19%)
Query: 102 LLSDLLSLRKFDLSGNSIHDT----IPYQLP--PNLTSLNLASNNFSGNLPYSIASMV-- 153
LL LR + I + L +L L+LA N + +
Sbjct: 251 LLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLE 310
Query: 154 ---SLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGD--------LPNSFI 198
L L V S T + L L +S N L
Sbjct: 311 PGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQP-- 368
Query: 199 SLSNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANNHFS 236
S + L+L + V+ ++ + L L L+++NN
Sbjct: 369 -GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 36/164 (21%), Positives = 70/164 (42%), Gaps = 29/164 (17%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSGNLPYSIASMV- 153
S + DLS N+++ +L P ++TSLNL+ N+ + ++
Sbjct: 17 FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 154 ----SLSYLNVSRNSLT----QSIGDIF-GNLAGLATLDLSFNNFSGD----LPNSFISL 200
+++ LN+S N L+ + + LDL +N+FS +F +L
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 201 -SNISSLYLQNNQVT--GSLNVFSGLP-----LTTLNVANNHFS 236
++I+SL L+ N + S + L + +LN+ N+ +
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 34/185 (18%), Positives = 62/185 (33%), Gaps = 35/185 (18%)
Query: 87 SIDISGLGLSGTMGYLLSDLL-----SLRKFDLSGNSIHDT-------IPYQLPPNLTSL 134
+D+ S S+ +L GN + I +P N+ SL
Sbjct: 113 VLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL 172
Query: 135 NLASNNFSGNLPYSIASMV-----SLSYLNVSRNSLT----QSIGDIF-GNLAGLATLDL 184
NL NN + +A + S++ L++S N L + IF + +L+L
Sbjct: 173 NLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNL 232
Query: 185 SFNNFSGD----LPNSFISLSNISSLYLQNNQVT-----GSLNVFSGLP----LTTLNVA 231
N G L SL ++ ++YL + V + + P + ++
Sbjct: 233 CLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKN 292
Query: 232 NNHFS 236
Sbjct: 293 GKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 24/130 (18%), Positives = 43/130 (33%), Gaps = 23/130 (17%)
Query: 108 SLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSG----NLPYSIASMVSLS 156
S+ DLS N + +L P ++ SLNL N G NL S+ L
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 157 YLNVSRNSLT-------QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL-----SNIS 204
+ + + + +++G F N+ + +D + +L
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKAD 316
Query: 205 SLYLQNNQVT 214
L N +
Sbjct: 317 VPSLLNQCLI 326
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 32/116 (27%), Positives = 52/116 (44%), Gaps = 3/116 (2%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
H ++P +P N L L N + P S+++L L + N L +F +L L
Sbjct: 31 HASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 180 ATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANN 233
LDL N + LP++ F L ++ L++ N++T L LT L + N
Sbjct: 91 TVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQN 145
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 29/115 (25%), Positives = 46/115 (40%), Gaps = 15/115 (13%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
L++L++ L N + LP LT L+L +N + LP ++ +V L
Sbjct: 63 LINLKELYLGSNQLG-----ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKE 116
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L + N L + L L L L N +F LS+++ YL N
Sbjct: 117 LFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 55/305 (18%), Positives = 97/305 (31%), Gaps = 86/305 (28%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQE----EDNFLEAVSNMSRLRHPN---I 470
+G G V+ + GK K+ +A E E L++V N PN +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDP-NDPNREMV 103
Query: 471 VTL------AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
V L +G H +V+E +G+ +L + ++ + L ++ +
Sbjct: 104 VQLLDDFKISGVNGTH--ICMVFEVLGH-HLLKWIIKSNY--QGLPLPCVKKIIQQVLQG 158
Query: 525 LEYLHEVCLPSVVHRNFKSANILL------------------------------------ 548
L+YLH C ++H + K NILL
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 549 -------------DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
++L ++D G A T+ + Y + E + Y
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYNT 272
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655
+D++S + EL TG + D D +A ++ L G P
Sbjct: 273 PADIWSTACMAFELATGDYLFE----------PHSGEEYTRDEDHIALII--ELLGKVPR 320
Query: 656 KSLSR 660
K +
Sbjct: 321 KLIVA 325
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 41/229 (17%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHPN 469
+G+G+ GRV + N K AVK + N +A + E + L+ + N + N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA---KIEADILKKIQNDDINNN-N 97
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEYL 528
IV G + L++E +G +L++++ + + ++ ++ + +AL YL
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIE---DIKLYCIEILKALNYL 153
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA----FG--- 581
++ S+ H + K NILLDD + T+ G FG
Sbjct: 154 RKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 582 --------------YSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L+ + V SD++SFG V+ EL TG L
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG-SLL 258
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 26/211 (12%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG GS G +Y A G+ +A+K + L E + + I T+
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQG-----GVGIPTIR 71
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
AE ++V E +G +L D+ +F S+ + + +A +EY+H
Sbjct: 72 WCGAEGDYNVMVMELLGP-SLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK--- 124
Query: 535 SVVHRNFKSANILLDDELNPH---LSDCGLAA--LTPNTERQV----STQMVGAFGYSAP 585
+ +HR+ K N L+ + + D GLA T + + + + G Y A
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-AS 183
Query: 586 EFALSGI-YTVKSDVYSFGVVMLELLTGRKP 615
GI + + D+ S G V++ G P
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 48/225 (21%), Positives = 80/225 (35%), Gaps = 37/225 (16%)
Query: 417 LIGEGSLGRVYRA--EFANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHP 468
+GEG+ G+V +A+K I N AA + E N L+ + +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA---RLEINVLKKIKEKDKENKF 82
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEY 527
V ++ + HG + +E +G N + L + L VR +A AL +
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLP---HVRHMAYQLCHALRF 138
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER----------------Q 571
LHE + H + K NIL + L + + + +
Sbjct: 139 LHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
+T + Y PE L + DV+S G ++ E G L
Sbjct: 196 HTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRG-FTL 238
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 27/182 (14%), Positives = 60/182 (32%), Gaps = 29/182 (15%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLL-----SLRKFDLSGNSIHDTIPYQLPP---NLTSL 134
S++ ++++G+ ++ +++ +L +L + +L+ + L P L
Sbjct: 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKL 131
Query: 135 NLASNNFSGNLPYSIASM-----VSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLS 185
L N+ + + ++ L +S N LT + + + L L
Sbjct: 132 GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLL 191
Query: 186 FNNFSGD-----LPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANNH 234
GD L + L + N +L + L L++ N
Sbjct: 192 HTGL-GDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE 250
Query: 235 FS 236
S
Sbjct: 251 LS 252
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 31/153 (20%), Positives = 62/153 (40%), Gaps = 20/153 (13%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IGEGS G ++ N + +A+K + A L++E + ++ I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAG-----CTGIPNVY 72
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ E +LV + +G +L D+L + + A ++ +HE
Sbjct: 73 YFGQEGLHNVLVIDLLGP-SLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK--- 125
Query: 535 SVVHRNFKSANILLDDELNP-----HLSDCGLA 562
S+V+R+ K N L+ + ++ D G+
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 6e-06
Identities = 20/109 (18%), Positives = 36/109 (33%), Gaps = 18/109 (16%)
Query: 102 LLSDLLSLRKFDL---SGNSIHDTIPYQLP--------PNLTSLNLASNNFSGNLPYSIA 150
L SDL +L K L + D PNL L + +
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273
Query: 151 S---MVSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGD 192
+ L +++S LT + + D + L +++ +N S +
Sbjct: 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 1e-05
Identities = 24/177 (13%), Positives = 61/177 (34%), Gaps = 23/177 (12%)
Query: 61 TNWKGNEGDPCGESWKGVACEGSAV-VSIDISGLGLSGTMGYLLSDLLS--LRKFDLSGN 117
W + + SW + ++ L + GT + L+ ++
Sbjct: 144 LFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISG 203
Query: 118 SIHDTIPYQL----PPNLTSLNL--ASNNFSGNLP-------YSIASMVSLSYLNVSRNS 164
+ D++ + PNL L L ++ + +S +L +L +
Sbjct: 204 GLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263
Query: 165 LTQSIGDIFGN---LAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVT 214
+ ++F L L T+D+S + + L + + ++ + ++ N ++
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 35/165 (21%), Positives = 55/165 (33%), Gaps = 26/165 (15%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVK--------KIDNAALSLQEEDNFLEAV---------S 460
+ G +Y A + K+D L E NF +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 461 NMSRLRHPNIVTLAGYCAEHGQ-RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
+ I T G+ + R LV +G +L L+ + ++VA
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSA--LDVSPKHVLSERSVLQVAC 166
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILL--DDELNPHLSDCGLA 562
ALE+LHE VH N + NI + +D+ L+ G A
Sbjct: 167 RLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 33/167 (19%), Positives = 69/167 (41%), Gaps = 28/167 (16%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVK-----KIDNA-ALSLQEEDNFL---------EAVSN 461
IG+G G +Y A+ + + + K++ + L E F +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 462 MSRLRHPNIVTLAGYCAEHGQ----RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV 517
+L++ + G R ++ + G+ +L + + ++K + +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIY---EANAKRFSRKTVLQL 157
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLA 562
+L LEY+HE VH + K++N+LL+ + +L D GLA
Sbjct: 158 SLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 23/109 (21%), Positives = 41/109 (37%), Gaps = 9/109 (8%)
Query: 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188
+ +L+L S + V L+ + +L + I + L +L+LS N
Sbjct: 127 GSQQALDL-KGLRSDPDLVAQNIDVVLNRRSCMAATL-RIIEENIPELL---SLNLSNNR 181
Query: 189 FSG--DLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLPLTTLNVANN 233
D+ + N+ L L N++ L+ GL L L + N
Sbjct: 182 LYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 230
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 45/211 (21%), Positives = 81/211 (38%), Gaps = 26/211 (12%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG GS G +Y + +A+K + L E + I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQG-----GTGIPNVR 69
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ E +LV + +G +L D+ + S+ L+ + +A +E++H
Sbjct: 70 WFGVEGDYNVLVMDLLGP-SLEDLF---NFCSRKLSLKTVLMLADQMINRVEFVHSK--- 122
Query: 535 SVVHRNFKSANILLDDELNPH---LSDCGLAAL--TPNTERQV----STQMVGAFGYSAP 585
S +HR+ K N L+ + + D GLA +T + + + + G Y A
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-AS 181
Query: 586 EFALSGI-YTVKSDVYSFGVVMLELLTGRKP 615
GI + + D+ S G V++ L G P
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 29/153 (18%), Positives = 60/153 (39%), Gaps = 20/153 (13%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG G+ G + + + +A+K + + A L E F + + + I +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS-----GDGIPQVY 71
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ +V E +G +L D+ + + + +A+ +EY+H
Sbjct: 72 YFGPCGKYNAMVLELLGP-SLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSK--- 124
Query: 535 SVVHRNFKSANILLDDELNP-----HLSDCGLA 562
++++R+ K N L+ N H+ D LA
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 47/232 (20%), Positives = 81/232 (34%), Gaps = 51/232 (21%)
Query: 417 LIGEGSLGRVYRA--EFANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHP 468
+GEG+ G+V A G+ +AVK + N AA + E LE ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA---RSEIQVLEHLNTTDPNSTF 77
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR----- 523
V + + HG +V+E +G + +D + K N + L R
Sbjct: 78 RCVQMLEWFEHHGHICIVFELLGL-STYDFI-------KE---NGFLPFRLDHIRKMAYQ 126
Query: 524 ---ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER---------- 570
++ +LH + H + K NIL + +
Sbjct: 127 ICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 571 ------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
ST + Y APE L+ ++ DV+S G +++E G +
Sbjct: 184 ATYDDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLG-FTV 233
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 36/165 (21%), Positives = 62/165 (37%), Gaps = 27/165 (16%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVK--KIDNAALS-LQEEDNFLEAVS---------NMS 463
IG G G +Y A + A K++ L E F + V+
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 464 RLRHPNIVTLAGY----CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
+L + I G R +V E +G +L + + + +++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKIS----GQNGTFKKSTVLQLGI 158
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLA 562
LEY+HE VH + K+AN+LL + +L+D GL+
Sbjct: 159 RMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 32/130 (24%), Positives = 51/130 (39%), Gaps = 14/130 (10%)
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL 182
+P +P + T L L SN + L+ L++S+N + +F L L L
Sbjct: 22 VPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTIL 81
Query: 183 DLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANN------ 233
L N LPN F L+ + L L NQ+ + +F L L + + N
Sbjct: 82 YLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140
Query: 234 ----HFSGWI 239
+ S W+
Sbjct: 141 PRIDYLSRWL 150
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 22/103 (21%)
Query: 108 SLRKFDLSGNSIHDTIPYQ----LPPN--LTSLNLASNNFSGNLPYSIASMV----SLSY 157
++KF + G +D + + L N L SLN+ SN SG+ ++ + SL
Sbjct: 66 YVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIE 125
Query: 158 LNVSRNSLTQSIGD---------IFGNLAGLATLDLSFNNFSG 191
L + S Q +G+ + N L F
Sbjct: 126 LRIDNQS--QPLGNNVEMEIANMLEKN-TTLLKFGYHFTQQGP 165
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 720 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.95 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.89 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.89 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.88 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.86 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.86 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.86 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.85 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.85 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.85 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.84 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.84 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.84 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.83 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.83 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.82 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.82 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.82 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.81 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.81 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.81 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.81 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.8 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.8 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.79 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.79 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.79 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.79 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.79 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.79 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.79 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.78 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.78 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.78 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.78 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.77 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.77 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.77 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.77 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.77 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.76 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.76 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.75 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.75 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.75 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.74 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.74 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.74 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.74 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.74 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.74 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.74 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.74 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.74 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.73 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.72 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.72 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.72 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.72 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.71 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.7 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.7 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.7 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.69 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.69 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.69 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.69 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.68 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.67 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.67 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.67 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.67 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.67 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.66 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.65 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.65 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.59 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.59 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.59 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.58 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.58 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.57 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.57 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.56 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.48 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.44 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.42 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.3 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.23 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.09 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.97 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.9 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.84 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.83 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.73 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.73 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.58 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.54 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.5 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.48 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.44 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.43 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.35 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.15 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.12 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.96 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.88 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.61 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.53 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.53 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.49 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.47 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.33 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.21 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.13 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.1 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.01 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.98 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.76 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.73 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.63 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.47 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.46 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.46 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.37 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.26 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.01 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.38 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.32 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.03 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.94 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.84 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.48 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 93.07 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.52 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.11 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.76 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.33 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-54 Score=443.23 Aligned_cols=264 Identities=25% Similarity=0.409 Sum_probs=212.7
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
+...++|...+.||+|+||+||+|++. ..||||+++.........+.|.+|+.++++++|||||+++|++.+ +..+|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 344567888999999999999999875 359999998666666777889999999999999999999998754 57899
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|||||++|+|.++++. ....+++.++..|+.|||.||+|||++ +||||||||+|||+++++.+||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999973 346799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-ccccccccccccccCcccccc---CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 566 PNTE-RQVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 566 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
.... .......+||+.|||||++.+ +.|+.++|||||||++|||+||+.||........... .+
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~------------~~ 250 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF------------MV 250 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH------------HH
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH------------HH
Confidence 4332 223345689999999999964 4589999999999999999999999986544221111 01
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 690 (720)
.+..........+..++..+.+||.+||+.||++|||+.||++.|+.+.
T Consensus 251 ~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 251 GRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp HTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred hcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111111112345567788999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-54 Score=445.69 Aligned_cols=262 Identities=24% Similarity=0.417 Sum_probs=218.4
Q ss_pred cCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
++|...+.||+|+||+||+|++. ++..||||+++.. .....++|.+|++++++++|||||+++|++.+.+..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 56778889999999999999864 4788999999754 455677899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhcc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCce
Q 005001 484 LLVYEYVGNGNLHDMLHFAD---------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 554 (720)
++|||||++|+|.++++... .....+++.++..++.||++||+|||++ +||||||||+|||++.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997532 2345799999999999999999999999 99999999999999999999
Q ss_pred EEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 005001 555 HLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWAT 632 (720)
Q Consensus 555 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~ 632 (720)
||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.......
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--------- 238 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------- 238 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---------
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------
Confidence 99999999865443322 2234579999999999999999999999999999999999 899997643221
Q ss_pred cccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 633 PQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
.+.. +........|..++.++.+||.+||+.||++|||++||.+.|+++.+..
T Consensus 239 -------~~~~-i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 239 -------VIEC-ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp -------HHHH-HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred -------HHHH-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1111 1112223456778889999999999999999999999999999886543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=446.25 Aligned_cols=261 Identities=27% Similarity=0.428 Sum_probs=212.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
++|...+.||+|+||+||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|++.+.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45667789999999999999864 4788999999754 455667899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC
Q 005001 484 LLVYEYVGNGNLHDMLHFADD-----------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 552 (720)
+||||||++|+|.++++.... ....+++.++..|+.||++||+|||+. +||||||||+|||++.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence 999999999999999975332 235699999999999999999999999 999999999999999999
Q ss_pred ceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 005001 553 NPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRW 630 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~ 630 (720)
.+||+|||+++....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.......
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------- 268 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------- 268 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999986644332 22345679999999999999999999999999999999999 899997643221
Q ss_pred hccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 631 ATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
.+.. +....+...|..++.++.+||.+||+.||++|||++||+++|+.+.+.
T Consensus 269 ---------~~~~-i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 269 ---------AIDC-ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---------HHHH-HHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---------HHHH-HHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111 111223345677888999999999999999999999999999998664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=444.30 Aligned_cols=258 Identities=23% Similarity=0.399 Sum_probs=214.6
Q ss_pred CCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
+++..+.||+|+||+||+|.+. +++.||||+++... .....++|.+|+.++++++|||||+++|++.+.+..+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4556778999999999999863 46889999997543 3345678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC
Q 005001 485 LVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 552 (720)
+|||||++|+|.++++.... ....+++.++..++.|||+||+|||++ +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999964321 124689999999999999999999999 999999999999999999
Q ss_pred ceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 005001 553 NPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRW 630 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~ 630 (720)
.+||+|||+++....... .......||+.|||||++.++.|+.++|||||||++|||+| |+.||.+.....
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~------- 255 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 255 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 999999999986543322 22344679999999999999999999999999999999999 899997654211
Q ss_pred hccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 631 ATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
+...+........|..++..+.+||.+||+.||++|||++||+++|+.+
T Consensus 256 ----------~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 ----------VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----------HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111222233345677888999999999999999999999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=447.75 Aligned_cols=253 Identities=22% Similarity=0.388 Sum_probs=210.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|++.+.||+|+||+||+|++. +|+.||||++..........+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999875 69999999998776666777889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
||+||+|.++++.. ....+++.+++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999632 345689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+..... .+.++....
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----------------~~~~i~~~~ 241 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN----------------LVLKIISGS 241 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHHHHHHTC
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----------------HHHHHHcCC
Confidence 122345689999999999999999999999999999999999999998654221 111222111
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ...+...+.++.+||.+||+.||++|||++|++++
T Consensus 242 ~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 242 F-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 12344567789999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=440.95 Aligned_cols=272 Identities=24% Similarity=0.395 Sum_probs=225.8
Q ss_pred hcHHHHhcCCCccceeccCCCcEEEEEEEcC------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCC-CCccccce
Q 005001 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAG 475 (720)
Q Consensus 403 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~ 475 (720)
..++...++|+..+.||+|+||+||+|.+.. ++.||||++.... .....+.|.+|+.++.+++| ||||+++|
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 3455567889999999999999999997653 3689999997544 34456789999999999965 99999999
Q ss_pred EEeec-CeEEEEEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCC
Q 005001 476 YCAEH-GQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFK 542 (720)
Q Consensus 476 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlk 542 (720)
+|.+. +..++|||||++|+|.++|+.... ....+++.++..++.|||+||+|||++ +|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence 98764 568999999999999999975332 134589999999999999999999999 99999999
Q ss_pred CCCEEeCCCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCC
Q 005001 543 SANILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSR 620 (720)
Q Consensus 543 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~ 620 (720)
|+|||+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+..
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544332 3345679999999999999999999999999999999998 999998654
Q ss_pred CcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 621 PRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
... .+.+.+....+...|..++.++.++|.+||+.||++|||+.||+++|+++++..+
T Consensus 293 ~~~----------------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 293 IDE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp CSH----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHH----------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 321 1222222333445567778899999999999999999999999999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=427.79 Aligned_cols=249 Identities=23% Similarity=0.382 Sum_probs=203.6
Q ss_pred CccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee----cCeEEEEE
Q 005001 413 SQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRLLVY 487 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 487 (720)
+..+.||+|+||+||+|.+. ++..||+|++..........+.|.+|++++++++|||||++++++.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999775 68899999998776677777889999999999999999999999865 34689999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-CCceEEcccCCCccCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALTP 566 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~ 566 (720)
|||++|+|.++++. .+.+++..+..++.||+.||+|||++. ++||||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999973 467999999999999999999999981 13999999999999974 7999999999998643
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||......... ...+..
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~---------------~~~i~~ 244 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRVTS 244 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---------------HHHHTT
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH---------------HHHHHc
Confidence 32 3345689999999998865 6999999999999999999999999754332111 111111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......+...+.++.+||.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111233345678999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=435.16 Aligned_cols=256 Identities=23% Similarity=0.257 Sum_probs=211.9
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
+.|+..++||+|+||+||+|++. +|+.||||+++.... ..+|+.+++.++|||||++++++.+.+..|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45778889999999999999875 689999999975432 2468999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC-ceEEcccCCCccCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTPN 567 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 567 (720)
||+||+|.++++. .+.+++.++..++.||+.||+|||++ +||||||||+|||++.+| ++||+|||+|+....
T Consensus 131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999973 46799999999999999999999999 999999999999999987 699999999987654
Q ss_pred CCcc----ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 568 TERQ----VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 568 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
.... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...........+...
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------------ 271 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE------------ 271 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS------------
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC------------
Confidence 3221 123457999999999999999999999999999999999999999865543222111100
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
+......+..++..+.++|.+||+.||++|||+.|++++|.+.+....
T Consensus 272 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 272 ---PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp ---CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 000112355677889999999999999999999999999988876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=437.55 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=211.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
...|+..+.||+|+||+||+|.+. +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++..||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356888999999999999999875 699999999965432 23456789999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|||+||+|.++++ ...+++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+....
T Consensus 151 Ey~~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 151 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp CCCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999999997 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+ .....
T Consensus 223 ~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------------~~~~~- 287 (346)
T 4fih_A 223 EV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLP- 287 (346)
T ss_dssp SS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HHSSC-
T ss_pred CC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------------HcCCC-
Confidence 32 2334578999999999999999999999999999999999999999764332111111 11111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.....+...+.++.+||.+||+.||++|||++|++++
T Consensus 288 -~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 288 -PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112334567789999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=432.57 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=217.8
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|++.+.||+|+||+||+|++. +|+.||+|++.+... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46899999999999999999775 689999999975433 2234577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||++||+|.++++. .+.+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999973 46799999999999999999999999 999999999999999999999999999987654
Q ss_pred CC-ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+... .+.++..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----------------~~~~i~~ 248 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL----------------IFAKIIK 248 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHc
Confidence 32 233456789999999999999999999999999999999999999997643211 1122222
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcc
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 695 (720)
.. ..+|...+.++.+||.+||+.||++|||++|++.+ ..+.++...
T Consensus 249 ~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~-~~i~~Hp~F 294 (311)
T 4aw0_A 249 LE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPLKAHPFF 294 (311)
T ss_dssp TC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH-HHHHTSGGG
T ss_pred CC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC-HHHHCCCCc
Confidence 22 23455667789999999999999999999998654 344454443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=416.93 Aligned_cols=248 Identities=26% Similarity=0.405 Sum_probs=195.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|++.+.||+|+||+||+|.+. +|+.||+|++...... ......+.+|++++++++||||+++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999764 6999999999765433 333567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+ +|+|.+++.. .+.+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6799999863 46799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||....... ...++..
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~----------------~~~~i~~ 226 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV----------------LFKNISN 226 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHH
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHc
Confidence 22 2345689999999999999886 579999999999999999999997643211 1111111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ..+|...+.++.+|+.+||+.||++|||++|++++
T Consensus 227 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 227 GV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp TC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11 12455567789999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=439.62 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=211.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.+.|+..+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 467999999999999999999875 699999999965432 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|||+||+|.++++ ...+++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+....
T Consensus 228 Ey~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 228 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp ECCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred eCCCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999999996 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+......... +.....+
T Consensus 300 ~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~-------------i~~~~~~ 365 (423)
T 4fie_A 300 EV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-------------IRDNLPP 365 (423)
T ss_dssp SC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HHHSCCC
T ss_pred CC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-------------HHcCCCC
Confidence 32 234457899999999999999999999999999999999999999976443211111 1111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....+...+.++.+||.+||+.||++|||+.|++++
T Consensus 366 --~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 366 --RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp --CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112234566789999999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=429.30 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=200.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc----CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
++|++.+.||+|+||+||+|+.. +++.||+|++............+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56899999999999999999763 47899999997665444445568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|||||+||+|.++++. .+.+++.++..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999973 46799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+... .+.++.
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----------------~~~~i~ 239 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----------------TMTMIL 239 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHH
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----------------HHHHHH
Confidence 4322 22345789999999999999999999999999999999999999998643321 111122
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPM 679 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 679 (720)
... ..+|...+.++.+||.+||+.||++|||+
T Consensus 240 ~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 240 KAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred cCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 111 23455677889999999999999999995
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=422.34 Aligned_cols=273 Identities=24% Similarity=0.336 Sum_probs=205.7
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC----eEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----QRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 485 (720)
++|...+.||+|+||+||+|++ +|+.||||++.... .....+..|+..+.+++|||||++++++.+.+ .++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4567788999999999999988 58999999996432 12222344666677889999999999998754 5799
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV-----CLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
|||||++|+|.++++ ...+++..+.+++.|++.||+|||++ +.++||||||||+|||++.++.+||+|||
T Consensus 79 V~Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 999999999999997 35689999999999999999999975 23589999999999999999999999999
Q ss_pred CCccCCCCCccc---cccccccccccCccccccC------CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 005001 561 LAALTPNTERQV---STQMVGAFGYSAPEFALSG------IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA 631 (720)
Q Consensus 561 ~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~ 631 (720)
+|+......... ....+||+.|||||++.+. .++.++|||||||++|||+||..||......... ....
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p-~~~~- 231 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDL- 231 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTT-
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc-chhc-
Confidence 998765433222 2345799999999999764 4788999999999999999998887543321110 0000
Q ss_pred ccccccHHHHHh-hcccccCCCCC-----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 632 TPQLHDIDALAK-MVDPALNGMYP-----AKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 632 ~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
.+.......+.+ ......+...| ..++..+.+||.+||+.||++||||.||++.|+++.++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 011111222222 22233333333 245678999999999999999999999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=407.66 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=190.0
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC-------
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------- 481 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 481 (720)
++|+..+.||+|+||+||+|++. +|+.||||+++... .....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 45889999999999999999875 68999999996543 3445577899999999999999999999987654
Q ss_pred -----eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEE
Q 005001 482 -----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (720)
Q Consensus 482 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 556 (720)
..|+|||||++|+|.++++... ......+..++.++.||+.||+|||++ +||||||||+|||++.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence 3699999999999999997321 123456777899999999999999999 9999999999999999999999
Q ss_pred cccCCCccCCCCCcc-----------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchh
Q 005001 557 SDCGLAALTPNTERQ-----------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ 625 (720)
Q Consensus 557 ~Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~ 625 (720)
+|||+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||..... .
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---~ 233 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---R 233 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---H
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---H
Confidence 999999876543211 1234579999999999999999999999999999999996 7753110 0
Q ss_pred hHHHhhccccccHHHHHhhcccccCCCCCh---hHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 626 SLVRWATPQLHDIDALAKMVDPALNGMYPA---KSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+.... ...+|. .....+.+|+.+||+.||++|||+.|++++
T Consensus 234 ------------~~~~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 ------------VRTLTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp ------------HHHHHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------------HHHHHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01111111 112222 233456789999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=414.00 Aligned_cols=269 Identities=23% Similarity=0.342 Sum_probs=209.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee------cC
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE------HG 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 481 (720)
.++|++.+.||+|+||+||+|.+. +|+.||||+++...........+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999775 79999999998766666667788999999999999999999998754 36
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..|+|||||+ |+|.+++. ..+.+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 68999986 357899999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCC---ccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh--hcccc
Q 005001 562 AALTPNTE---RQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW--ATPQL 635 (720)
Q Consensus 562 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~--~~~~~ 635 (720)
|+...... .......+||+.|||||++.+.. ++.++||||+||++|||++|+.||.+.+.......+.. ..+..
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98664322 22334578999999999988754 69999999999999999999999987654333222211 11111
Q ss_pred ccHH-----HHHhhccc-ccCCCCC-----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 636 HDID-----ALAKMVDP-ALNGMYP-----AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 636 ~~~~-----~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... ........ ......+ ...+.++.+||.+||+.||++|||+.|++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000000 0000011 1235678899999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=400.87 Aligned_cols=267 Identities=22% Similarity=0.302 Sum_probs=202.5
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc----CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEee
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (720)
+....++|++.+.||+|+||+||+|+.+ .++.||+|++.... ....+.+|+++++.+ +||||+++++++.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 3445688999999999999999999764 46889999986532 345678899999988 69999999999999
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC-CceEEcc
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSD 558 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~D 558 (720)
.++.|+||||+++|+|.++++ .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECc
Confidence 999999999999999999884 489999999999999999999999 99999999999999876 7999999
Q ss_pred cCCCccCCCCCc---------------------------cccccccccccccCccccccC-CCcccchhhhHHHHHHHHH
Q 005001 559 CGLAALTPNTER---------------------------QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELL 610 (720)
Q Consensus 559 fg~a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~ell 610 (720)
||+|+....... ......+||+.|||||++.+. .|+.++||||+||++|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999976543211 112335799999999999876 4899999999999999999
Q ss_pred hCCCCCCCCCCcchh-hHHHhh--cc-------------------ccccHHHH-Hhhc--cc------------ccCCCC
Q 005001 611 TGRKPLDSSRPRSEQ-SLVRWA--TP-------------------QLHDIDAL-AKMV--DP------------ALNGMY 653 (720)
Q Consensus 611 tg~~pf~~~~~~~~~-~~~~~~--~~-------------------~~~~~~~~-~~~~--~~------------~~~~~~ 653 (720)
+|+.||......... ..+... .+ ........ .+.. +. ......
T Consensus 242 ~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 321 (361)
T 4f9c_A 242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG 321 (361)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence 999999765432211 111000 00 00000000 0000 00 000011
Q ss_pred ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 654 PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 654 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....++++.+|+.+||+.||++|||++|++++
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 12345678899999999999999999999865
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=415.83 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=206.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh-HHHHHH---HHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNF---LEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
.++|++.++||+|+||+||+|++. +|+.||+|++.+..... ...... .+++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999775 69999999997543321 112223 3446777888999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999973 46799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
..... .....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+........+ ..
T Consensus 341 ~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i-------------~~ 404 (689)
T 3v5w_A 341 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------DR 404 (689)
T ss_dssp ECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH-------------HH
T ss_pred ecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------HH
Confidence 76433 2345689999999999975 5799999999999999999999999975433221111 11
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPP-----MSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 685 (720)
.+... ...+|...+.++.+||.+||+.||++|++ ++||+++
T Consensus 405 ~i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 405 MTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred hhcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11111 12345667788999999999999999998 6888765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=385.11 Aligned_cols=287 Identities=36% Similarity=0.666 Sum_probs=236.3
Q ss_pred cchhcHHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee
Q 005001 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (720)
Q Consensus 400 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (720)
+...++....++|+..+.||+|+||.||+|.+.+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 44556667889999999999999999999998889999999987543 3346778999999999999999999999999
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEccc
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 559 (720)
.+..++||||+++|+|.+++.........+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999975444445799999999999999999999999 9999999999999999999999999
Q ss_pred CCCccCCCCC-ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH
Q 005001 560 GLAALTPNTE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 560 g~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
|++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|.... ...
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~ 262 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNN 262 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-HTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-ccc
Confidence 9997654322 22233456999999999999999999999999999999999999999876654433333332110 001
Q ss_pred HHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
..+...+++......+...+..+.+++.+||+.||++||++.|++++|+.+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 112233344445556778889999999999999999999999999999988754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=385.92 Aligned_cols=290 Identities=36% Similarity=0.668 Sum_probs=238.0
Q ss_pred ccccchhcHHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceE
Q 005001 397 ATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476 (720)
Q Consensus 397 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 476 (720)
...++..++....++|+..+.||+|+||.||+|...+|+.||+|++...... .....+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3456778899999999999999999999999999888999999999754322 223368899999999999999999999
Q ss_pred EeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEE
Q 005001 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (720)
Q Consensus 477 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 556 (720)
+...+..++||||+++|+|.++++........+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999999865555567999999999999999999999986678999999999999999999999
Q ss_pred cccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCC--CcchhhHHHhhccc
Q 005001 557 SDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSR--PRSEQSLVRWATPQ 634 (720)
Q Consensus 557 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~--~~~~~~~~~~~~~~ 634 (720)
+|||++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........|....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999998776555444555679999999999999999999999999999999999999996321 01111122222211
Q ss_pred cccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
. .........+.......+...+..+.+++.+||+.||++|||+.|++++|++
T Consensus 256 ~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 L-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp T-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred h-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 1 1122233444455556677888999999999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=411.42 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=210.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+.+|+.++||||++++++|.+.+.+|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 367999999999999999999775 69999999986543 344667889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC--CceEEcccCCCccC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE--LNPHLSDCGLAALT 565 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~ 565 (720)
|||+||+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 234 E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 234 EFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp ECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred eecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999999999852 346799999999999999999999999 99999999999999854 89999999999877
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+...... +..+.
T Consensus 308 ~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~----------------~~~i~ 369 (573)
T 3uto_A 308 DPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----------------LRNVK 369 (573)
T ss_dssp CTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----------------HHHHH
T ss_pred cCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----------------HHHHH
Confidence 5432 23446899999999999999999999999999999999999999986543211 11111
Q ss_pred cccc--CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPAL--NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... ........+.++.+||.+||+.||++||++.|++++
T Consensus 370 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 370 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 111123456778999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=373.28 Aligned_cols=265 Identities=32% Similarity=0.459 Sum_probs=212.3
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
..++|++.+.||+|+||.||+|++ +|+.||+|++............+.+|+.++++++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 456788899999999999999987 5889999999877666667788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||+++|+|.++++... ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 114 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp ECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred ecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 9999999999997311 112489999999999999999999999 8 999999999999999999999999999754
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~----------------~~~~ 252 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV----------------AAVG 252 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH----------------HHHH
T ss_pred cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------HHHH
Confidence 3322 2233467999999999999999999999999999999999999999764332111 1111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
........+...+..+.+++.+||+.||++||++.++++.|+++++...
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 1122233455677889999999999999999999999999999987653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=379.69 Aligned_cols=266 Identities=26% Similarity=0.431 Sum_probs=220.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEc--------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEee
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (720)
.++|...+.||+|+||.||+|.+. ++..||+|+++... .......+.+|+.+++++ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 467888999999999999999763 35679999997553 445567899999999999 89999999999999
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEE
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIl 547 (720)
.+..++||||+++|+|.++++.... ....+++.++..++.||+.||+|||+. +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999975431 124689999999999999999999999 9999999999999
Q ss_pred eCCCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchh
Q 005001 548 LDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQ 625 (720)
Q Consensus 548 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~ 625 (720)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~- 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 999999999999999865443221 2233467889999999999999999999999999999999 9999976432211
Q ss_pred hHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcc
Q 005001 626 SLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695 (720)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 695 (720)
...+........+..++..+.++|.+||+.||++||++.|+++.|++++.....
T Consensus 315 ----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 315 ----------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp ----------------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ----------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 111111222334566778899999999999999999999999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=362.71 Aligned_cols=258 Identities=26% Similarity=0.453 Sum_probs=218.3
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.++|+..+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3578889999999999999999988999999999765433 4568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999963 345789999999999999999999999 9999999999999999999999999999866543
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-----------------~~~~~~ 222 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----------------VEDIST 222 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----------------HHHHHT
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-----------------HHHHhc
Confidence 3333344567889999999999999999999999999999999 9999976432111 111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
......+...+..+.+++.+||+.||++||++++++++|+++.+.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 223 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 222333455677899999999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=373.69 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=213.8
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|.+ .+|+.||+|++............+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45789999999999999999987 57999999999877666667788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. .+.+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999963 36799999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccccccccccccccCccccccCCCc-ccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.. .....+||+.|+|||++.+..++ .++|||||||++|||++|+.||......... .++..
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------------~~i~~ 228 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR----------------ERVLR 228 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHH
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH----------------HHHHh
Confidence 32 23456899999999999988875 7999999999999999999999764422111 11111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ...|...+.++.+|+++||+.||.+|||++|++++
T Consensus 229 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 229 GK--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CC--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 12344566788999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=371.01 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=216.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEc----CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
.++|++.+.||+|+||.||+|.+. .+..||||++.... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 467888999999999999999874 35569999997543 4455678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++|+|.++++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 127 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999963 346799999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcc--ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 565 TPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 565 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----------------~ 263 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-----------------V 263 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----------------H
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-----------------H
Confidence 6543222 2223456789999999999999999999999999999999 999997543221 1
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
...+........+..++..+.+++.+||+.||++||++.++++.|+++.+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 11111222334455677889999999999999999999999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=364.56 Aligned_cols=261 Identities=23% Similarity=0.395 Sum_probs=217.5
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
...++|+..+.||+|+||.||+|.+.++..||+|++...... .+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 345678899999999999999999998889999999765433 45688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 98 TEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp ECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999732 35699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
...........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... ..+
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~-----------------~~~ 234 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-----------------EHI 234 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----------------HHH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH-----------------HHH
Confidence 433333334567889999999999999999999999999999998 99999764322111 111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
........+...+..+.+++.+||+.||++||++++++++|.++.++.
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 235 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 112223334555678999999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=363.96 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=211.4
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..++|+..+.||+|+||.||+|.+ .+++.||+|++...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 456899999999999999999976 56899999998654322 356688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++|+|.+++. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 96 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 96 MEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999997 24689999999999999999999999 99999999999999999999999999987665
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....+......+ .. .
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------------~~--~ 231 (297)
T 3fxz_A 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------AT--N 231 (297)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HH--H
T ss_pred Cccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------Hh--C
Confidence 4332 234467999999999999999999999999999999999999999764432111110 00 1
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......+...+..+.+++.+||+.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 232 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111222345667789999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=367.97 Aligned_cols=262 Identities=26% Similarity=0.439 Sum_probs=215.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|...+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 356888899999999999999875 6899999988543 4556778999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 87 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 87 EYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp ECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999973 246799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccc-------------cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 005001 568 TERQV-------------STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 568 ~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
..... .....||+.|+|||++.+..++.++||||||+++|||++|..||....+..... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-------~ 233 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-------G 233 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-------S
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-------h
Confidence 32211 114579999999999999999999999999999999999999987654322110 0
Q ss_pred cccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
......... ..+..++..+.+++.+||+.||++||++.++++.|+++....
T Consensus 234 ~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 234 LNVRGFLDR--------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp BCHHHHHHH--------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhhccccc--------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000011111 123445567889999999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=368.62 Aligned_cols=276 Identities=22% Similarity=0.315 Sum_probs=214.1
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC----eE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----QR 483 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 483 (720)
..++|+..+.||+|+||.||+|++. ++.||||++.... .......+|+.++++++||||+++++++.... ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 4567899999999999999999875 7999999996432 33445567899999999999999999998754 46
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCCcEEecCCCCCEEeCCCCceEE
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV-------CLPSVVHRNFKSANILLDDELNPHL 556 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-------~~~~iiH~Dlkp~NIll~~~~~~kl 556 (720)
++||||+++|+|.++++. ..+++..+..++.|++.||+|||+. +.++|+||||||+|||++.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 999999999999999973 4599999999999999999999975 1238999999999999999999999
Q ss_pred cccCCCccCCCCCcc-ccccccccccccCcccccc-----CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh
Q 005001 557 SDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW 630 (720)
Q Consensus 557 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~ 630 (720)
+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999765443222 2234579999999999987 3567789999999999999999999987554322222111
Q ss_pred hccccccHHHHHhh-cccccCCCC-----ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 631 ATPQLHDIDALAKM-VDPALNGMY-----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 631 ~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
.. ........... ......... ....+..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 253 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 253 IG-QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HC-SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hc-cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11 11112222222 222222222 2245677999999999999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=375.38 Aligned_cols=262 Identities=24% Similarity=0.425 Sum_probs=208.0
Q ss_pred hcCCCccceeccCCCcEEEEEEEc----CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
.++|...+.||+|+||.||+|.+. ++..||||+++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 457899999999999999999765 57789999997543 4455678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++|+|.++++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999973 345799999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccc--cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 565 TPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 565 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
........ .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... .
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-----------------~ 259 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-----------------V 259 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----------------H
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------H
Confidence 65432211 122345778999999999999999999999999999998 999997543211 1
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
.+.+........+..++..+.+++.+||+.||++||++.++++.|+++++...
T Consensus 260 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp HHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred HHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 11222223333455677889999999999999999999999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=380.35 Aligned_cols=261 Identities=23% Similarity=0.388 Sum_probs=218.0
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..++|...+.||+|+||.||+|.+. +++.||+|.++... .......+.+|++++++++||||+++++++...+..++|
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 3457888899999999999999886 78999999987542 344556788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 191 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999732 34689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcccc-ccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 567 NTERQVS-TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 567 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
....... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ..+.
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-----------------~~~~ 327 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----------------TREF 327 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-----------------HHHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHH
Confidence 3221111 12246788999999999999999999999999999998 999997643211 1122
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
+........+..++..+.++|.+||+.||++|||+.++++.|+++.++
T Consensus 328 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 328 VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 222233345666778899999999999999999999999999998765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=359.59 Aligned_cols=258 Identities=25% Similarity=0.400 Sum_probs=217.3
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
..++|+..+.||+|+||.||+|.+.++..||+|++...... ...+.+|++++.+++||||+++++++...+..++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 34678899999999999999999998889999999765433 456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.++++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 83 EYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp ECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 999999999999742 34689999999999999999999999 999999999999999999999999999987655
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... .+. .
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----------------~~~-~ 219 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV----------------LKV-S 219 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----------------HHH-H
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH----------------HHH-H
Confidence 44444444567888999999999999999999999999999999 99999754322111 111 1
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
.......+...+..+.+++.+||+.||++||++.+++++|+++.+
T Consensus 220 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 220 QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 111222344456789999999999999999999999999987744
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=363.76 Aligned_cols=265 Identities=22% Similarity=0.331 Sum_probs=210.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|+..+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999765 688999999854432 344567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.+++.. .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999973 35799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~~~~----------- 229 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IKHIQDSV----------- 229 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HHHHSSCC-----------
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhhccC-----------
Confidence 44333344567999999999999999999999999999999999999999764422111 00000000
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHHHhh
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRP-PMSEVVQALVRLVQRA 693 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~~~~~~ 693 (720)
+......+...+..+.+++.+||+.||++|| +++++.+.|+++....
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0000112334567889999999999999998 8899999887765443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=364.23 Aligned_cols=266 Identities=26% Similarity=0.436 Sum_probs=220.1
Q ss_pred HHhcCCCccceeccCCCcEEEEEEE------cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (720)
...++|...+.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 3456788999999999999999976 245789999997543 455567889999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhhccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEec
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADD--------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRN 540 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~D 540 (720)
+..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 999999999999999999975432 123489999999999999999999999 999999
Q ss_pred CCCCCEEeCCCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCC
Q 005001 541 FKSANILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDS 618 (720)
Q Consensus 541 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~ 618 (720)
|||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999866443322 2233467889999999999999999999999999999999 9999976
Q ss_pred CCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 619 SRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
....... ..+........+...+..+.+++.+||+.||++||++.++++.|++++++.
T Consensus 256 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 256 IPPERLF-----------------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp CCGGGHH-----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCHHHHH-----------------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 5432111 111112222345566788999999999999999999999999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=372.10 Aligned_cols=270 Identities=26% Similarity=0.421 Sum_probs=223.1
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc--------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (720)
...++|.+.+.||+|+||.||+|.+. .+..||+|++.... .......+.+|+++++++ +||||+++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 34568899999999999999999763 23579999997553 445567889999999999 999999999999
Q ss_pred eecCeEEEEEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCC
Q 005001 478 AEHGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545 (720)
Q Consensus 478 ~~~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~N 545 (720)
...+..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 999999999999999999999975431 124699999999999999999999999 99999999999
Q ss_pred EEeCCCCceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcc
Q 005001 546 ILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRS 623 (720)
Q Consensus 546 Ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~ 623 (720)
||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~- 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999986654322 22334567899999999999999999999999999999999 99999754321
Q ss_pred hhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcccc
Q 005001 624 EQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVK 697 (720)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 697 (720)
.+.+.+........+..++.++.+++.+||+.||++||+++|+++.|+++....+...
T Consensus 301 ----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 301 ----------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp ----------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred ----------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 1112222222333455677889999999999999999999999999999987665443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=366.03 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=210.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||+|+.. +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999875 689999999975432 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.+|.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999873 46789999999999999999999999 999999999999999999999999999976433
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------------~~~i~~~ 220 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----------------FELILME 220 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHC
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH----------------HHHHHcC
Confidence 22 223456899999999999999999999999999999999999999975432111 1111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
...+|...+.++.++|.+||+.||++|| +++|++++
T Consensus 221 --~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 --EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1224556677899999999999999999 89999876
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=365.41 Aligned_cols=273 Identities=22% Similarity=0.397 Sum_probs=204.8
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEcCC----cEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (720)
+....++|+..+.||+|+||.||+|.+... ..||+|++..........+.+.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 344567899999999999999999976543 2799999987655566678899999999999999999999999876
Q ss_pred CeE------EEEEEecCCCCHHHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC
Q 005001 481 GQR------LLVYEYVGNGNLHDMLHFADD--SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (720)
Q Consensus 481 ~~~------~lV~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 552 (720)
+.. ++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 655 999999999999999965432 223689999999999999999999999 999999999999999999
Q ss_pred ceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 005001 553 NPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRW 630 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~ 630 (720)
.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.........
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~----- 249 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY----- 249 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH-----
Confidence 999999999976543322 12233457889999999999999999999999999999999 99999765432111
Q ss_pred hccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcccc
Q 005001 631 ATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVK 697 (720)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 697 (720)
.... .......+...+..+.+++.+||+.||++||++.++++.|++++++.....
T Consensus 250 -----------~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 250 -----------NYLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp -----------HHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred -----------HHHh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 1111 111223455667789999999999999999999999999999999876554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=357.36 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=204.6
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcC----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
..++|+..+.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|+.++++++||||+++++++. ++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 34678899999999999999997643 4579999987543 4455678899999999999999999999984 5678
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 999999999999999973 245789999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
..............+|+.|+|||++.+..++.++||||||+++|||++ |..||......... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~----------------~ 228 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----------------G 228 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------H
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH----------------H
Confidence 765443333334567889999999999999999999999999999997 99999765432111 1
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
.+.. ......+...+..+.+++.+||+.||++||++.|+++.|+++.++.
T Consensus 229 ~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 229 RIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 1122345567788999999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=373.40 Aligned_cols=272 Identities=24% Similarity=0.403 Sum_probs=220.5
Q ss_pred hhcHHHHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccc
Q 005001 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLA 474 (720)
Q Consensus 402 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~ 474 (720)
...++...++|+..+.||+|+||.||+|.+. +++.||||++.... .....+.+.+|++++.++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3345556788999999999999999999742 46789999997543 344567789999999999 789999999
Q ss_pred eEEeecC-eEEEEEEecCCCCHHHHhhhccCC------------------------------------------------
Q 005001 475 GYCAEHG-QRLLVYEYVGNGNLHDMLHFADDS------------------------------------------------ 505 (720)
Q Consensus 475 ~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------ 505 (720)
+++...+ ..++||||+++|+|.++++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9988765 489999999999999999753221
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc-
Q 005001 506 --------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER- 570 (720)
Q Consensus 506 --------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 570 (720)
...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 12289999999999999999999999 999999999999999999999999999986543322
Q ss_pred cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||........ ..+.+....
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------------~~~~~~~~~ 313 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----------------FCRRLKEGT 313 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----------------HHHHHHHTC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH----------------HHHHHHcCC
Confidence 22344578999999999999999999999999999999998 9999976543211 111111222
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
....+...+.++.+++.+||+.||++||++.|++++|+++++..
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 23345556778999999999999999999999999999988653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=372.10 Aligned_cols=268 Identities=24% Similarity=0.360 Sum_probs=218.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
.++|...+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++...+.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 467888999999999999999843 46789999996433 45556678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC---ceEE
Q 005001 483 RLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPHL 556 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl 556 (720)
.++||||+++|+|.++++.... ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999985432 234689999999999999999999999 999999999999999555 5999
Q ss_pred cccCCCccCCCCC-ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccc
Q 005001 557 SDCGLAALTPNTE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 557 ~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~----------- 294 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----------- 294 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----------
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------
Confidence 9999987432211 112233568999999999999999999999999999999998 999997643211
Q ss_pred cccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcccc
Q 005001 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVK 697 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 697 (720)
+.+.+........+..++..+.+|+.+||+.||++||++.+|+++|+.+.+......
T Consensus 295 ------~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~ 351 (367)
T 3l9p_A 295 ------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351 (367)
T ss_dssp ------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHT
T ss_pred ------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhcc
Confidence 111122222233455667789999999999999999999999999999887665444
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=369.70 Aligned_cols=268 Identities=26% Similarity=0.423 Sum_probs=218.5
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEe
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA 478 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 478 (720)
+....++|+..+.||+|+||.||+|.+. +++.||+|.++... .......+.+|+.++++++||||+++++++.
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4445678999999999999999999875 34789999997543 4455678999999999999999999999999
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEE
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFADDS--------------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVH 538 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~~~--------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH 538 (720)
..+..++||||+++|+|.++++..... ...+++.+++.++.||+.||+|||+. +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 999999999999999999999753211 26789999999999999999999999 9999
Q ss_pred ecCCCCCEEeCCCCceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCC
Q 005001 539 RNFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPL 616 (720)
Q Consensus 539 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf 616 (720)
|||||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999875433221 12233568999999999999999999999999999999999 99999
Q ss_pred CCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 617 DSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
....... ....+.. ......+..++..+.+++.+||+.||++||++.++++.|+++.++.
T Consensus 278 ~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 278 YGMAHEE----------------VIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTSCHHH----------------HHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCChHH----------------HHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 7543211 1111111 1122345566778999999999999999999999999999986654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=353.66 Aligned_cols=255 Identities=19% Similarity=0.351 Sum_probs=214.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec--CeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV 486 (720)
.++|...+.||+|+||.||+|.+. ++.||+|++..........+.+.+|+.++++++||||+++++++... +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357888999999999999999985 88999999987766667778899999999999999999999999877 788999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
|||+++|+|.++++. .....+++.++..++.|++.||+|||+. + |+||||||+||+++.++.++|.|||++..
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999973 2233689999999999999999999998 7 99999999999999999999999888654
Q ss_pred CCCCCccccccccccccccCccccccCCCcc---cchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTV---KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||....... ..
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~~ 220 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----------------IG 220 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH----------------HH
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH----------------HH
Confidence 322 2346899999999998766544 7999999999999999999997543211 11
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
............+...+..+.+++.+||+.||++||+++++++.|+++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 221 MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 22222233334556677889999999999999999999999999998743
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=358.80 Aligned_cols=271 Identities=21% Similarity=0.315 Sum_probs=208.2
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
...++|+..+.||+|+||.||+|.+.+|+.||+|++............+.+|++++++++||||+++++++.+.+..++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 34578999999999999999999998899999999976554444567788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 98 ~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 98 FEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999985 88888762 345699999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhh-cc---ccccHHH
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWA-TP---QLHDIDA 640 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~~-~~---~~~~~~~ 640 (720)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+ ... .+ .+.....
T Consensus 171 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 171 IPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp SCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 3322 2234578999999999987 56899999999999999999999999876554332221 110 11 0111111
Q ss_pred HHhhcccccC--CC-----CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 LAKMVDPALN--GM-----YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~~~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......... .. .....+.++.+|+.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111110000 00 012244678899999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=375.60 Aligned_cols=255 Identities=23% Similarity=0.301 Sum_probs=211.4
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
...++|+..+.||+|+||.||+|... +|+.||+|++............+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34567999999999999999999764 68999999998766556667789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC---CCCceEEcccCCC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLA 562 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~a 562 (720)
||||+++|+|.+.+.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||++
T Consensus 88 v~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999998873 46799999999999999999999999 999999999999998 4678999999999
Q ss_pred ccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
........ ......||+.|+|||++.+..++.++||||+||++|+|++|..||......... .
T Consensus 161 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~----------------~ 223 (444)
T 3soa_A 161 IEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY----------------Q 223 (444)
T ss_dssp BCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----------------H
T ss_pred EEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH----------------H
Confidence 77654322 234467999999999999999999999999999999999999999764322111 1
Q ss_pred hhcccccC--CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPALN--GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+...... .......+.++.+|+.+||+.||++||++.|++++
T Consensus 224 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 224 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111111 11112456788999999999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=360.48 Aligned_cols=273 Identities=22% Similarity=0.352 Sum_probs=214.1
Q ss_pred hcCCCccceeccCCCcEEEEEEE-----cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec--C
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--G 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 481 (720)
.++|+..+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 46788899999999999999974 36889999999754 345567889999999999999999999998553 5
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 689999999999999999742 34589999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCcc--ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc-cc--c
Q 005001 562 AALTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP-QL--H 636 (720)
Q Consensus 562 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~-~~--~ 636 (720)
+......... ......+|..|+|||.+.+..++.++||||||+++|||++|..||...... ....... .. .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQM 236 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccch
Confidence 9876543221 123345788899999999999999999999999999999999998643211 1110000 00 0
Q ss_pred cHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 637 DIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
......+.+........+..++.++.+++.+||+.||++|||+.|+++.|+++.++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 011222223333344456677889999999999999999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=385.34 Aligned_cols=261 Identities=23% Similarity=0.414 Sum_probs=217.3
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
++...++|...+.||+|+||.||+|.+.++..||||+++.... ..+.+.+|+.++++++||||+++++++. .+..+
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 3445677888999999999999999998899999999976432 3677999999999999999999999986 66789
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++|+|.++++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 9999999999999997321 23688999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
.............+|+.|+|||++.+..++.++|||||||++|||+| |+.||........ .+
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~-----------------~~ 396 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-----------------IR 396 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-----------------HH
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH-----------------HH
Confidence 64432222233457889999999999999999999999999999999 9999976432111 11
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
.+....+...+..++..+.++|.+||+.||++||++++|++.|+++..
T Consensus 397 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 397 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 111222334456678889999999999999999999999999988754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=352.49 Aligned_cols=258 Identities=26% Similarity=0.450 Sum_probs=216.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.++|+..+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 3568889999999999999999988999999999765433 4578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999973 245789999999999999999999999 9999999999999999999999999999866443
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.........+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ ... +..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------~~~-i~~ 220 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------------VED-IST 220 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------HHH-HHT
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH----------------HHH-Hhc
Confidence 2222334567889999999999999999999999999999999 8999975432111 111 111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
......+...+..+.+++.+||+.||++||++.++++.|+++.++
T Consensus 221 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 221 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 122233445667899999999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=357.94 Aligned_cols=267 Identities=24% Similarity=0.420 Sum_probs=225.6
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEcC-CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
++...++|...+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 33456778999999999999999998764 8889999997532 3467788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+++++|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999742 346699999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
..............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~----------------- 222 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----------------- 222 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-----------------
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------------
Confidence 776554444455668889999999999999999999999999999999 99999765432111
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccc
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 696 (720)
+.+........+...+..+.+++.+||+.||++||++.++++.|+++.++....
T Consensus 223 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~ 276 (288)
T 3kfa_A 223 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276 (288)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 111122233345566788999999999999999999999999999998876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=365.34 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=208.9
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh----HHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
..++|...+.||+|+||.||+|... +|+.||+|.+....... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567899999999999999999876 68999999997654321 135678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC----ceEEcc
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSD 558 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~D 558 (720)
.++||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 999999999999999996 356799999999999999999999999 999999999999998877 799999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~------------- 227 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------- 227 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------------
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-------------
Confidence 99998765432 223467999999999999999999999999999999999999999764322111
Q ss_pred HHHHhhcccccCCCCC----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKMVDPALNGMYP----AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..+..... .++ ...+..+.+||.+||..||++|||+.|++++
T Consensus 228 ---~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 228 ---ANITAVSY--DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ---HHHHTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HHHHhcCC--CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111111 111 2345678899999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=367.59 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=211.9
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
...++|+..+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 44567999999999999999999775 68999999998766666667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC---ceEEcccCCC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPHLSDCGLA 562 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a 562 (720)
||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 106 v~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 106 VFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 999999999999886 346789999999999999999999999 999999999999998654 5999999999
Q ss_pred ccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 179 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~ 240 (362)
T 2bdw_A 179 IEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY----------------A 240 (362)
T ss_dssp BCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------H
T ss_pred eEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH----------------H
Confidence 8765332 223467999999999999999999999999999999999999999764321111 1
Q ss_pred hhcccccCCC--CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPALNGM--YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+........ .....+.++.+|+.+||+.||++||++.|++++
T Consensus 241 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 241 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111111 112456788999999999999999999998865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=387.36 Aligned_cols=262 Identities=24% Similarity=0.428 Sum_probs=220.9
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEcC-CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
....+|...+.||+|+||.||+|.+.. +..||||.++.... ..+.|.+|+.++++++||||+++++++...+..++
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 345678889999999999999998875 88999999975432 35678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.++++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 294 v~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 294 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999742 245689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
............+|+.|+|||++.+..++.++|||||||++|||++ |..||........ .+.
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-----------------~~~ 431 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----------------YEL 431 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----------------HHH
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHH
Confidence 5443333344557889999999999999999999999999999999 9999976543211 111
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
+....+...+..++..+.+||.+||+.||++||++.+|++.|+++.+..
T Consensus 432 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 432 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 2223333456677888999999999999999999999999998875443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=352.94 Aligned_cols=256 Identities=30% Similarity=0.492 Sum_probs=201.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccC--hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS--LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|+..+.||+|+||.||+|.+. ++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999875 889999998754322 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC--------CCceEEcc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD--------ELNPHLSD 558 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~--------~~~~kl~D 558 (720)
|||+++++|.++++ ...+++..+..++.|++.||+|||+.+..+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999985 467999999999999999999999992222999999999999986 77899999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
||++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------- 220 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---------------- 220 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH----------------
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------
Confidence 99997654322 22457999999999999999999999999999999999999999754321
Q ss_pred HHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
...............+..++..+.+++.+||+.||++||++.|++++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111122222333344566778899999999999999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.98 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=202.0
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhc--CCCCCccccceEEee----cCe
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAE----HGQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~ 482 (720)
.++|+..+.||+|+||.||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++.. ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 56799999999999999999987 6899999998643 34445556666555 799999999998654 346
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEEecCCCCCEEeCCCCce
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH--------EVCLPSVVHRNFKSANILLDDELNP 554 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--------~~~~~~iiH~Dlkp~NIll~~~~~~ 554 (720)
.++||||+++|+|.++++ ...+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 899999999999999996 467999999999999999999999 77 99999999999999999999
Q ss_pred EEcccCCCccCCCCCccc---cccccccccccCccccccC------CCcccchhhhHHHHHHHHHhC----------CCC
Q 005001 555 HLSDCGLAALTPNTERQV---STQMVGAFGYSAPEFALSG------IYTVKSDVYSFGVVMLELLTG----------RKP 615 (720)
Q Consensus 555 kl~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg----------~~p 615 (720)
||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999997654333221 2234799999999999887 566899999999999999999 778
Q ss_pred CCCCCCcchhhHHHhhccccccHHHHHhhcc-cccCCC-----CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 616 LDSSRPRSEQSLVRWATPQLHDIDALAKMVD-PALNGM-----YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 616 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
|....+.... .....+... ...... .+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 233 f~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDPS------------FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSCC------------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCCcc------------hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 7654332111 111111111 111111 1234678899999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=359.67 Aligned_cols=268 Identities=26% Similarity=0.443 Sum_probs=221.0
Q ss_pred HHhcCCCccceeccCCCcEEEEEEE------cCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEee
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (720)
...++|+..+.||+|+||.||+|.+ .+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 3456789999999999999999975 346789999997543 344567889999999999 99999999999999
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCC
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADD--------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~N 545 (720)
.+..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 9999999999999999999975321 123589999999999999999999999 99999999999
Q ss_pred EEeCCCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcc
Q 005001 546 ILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRS 623 (720)
Q Consensus 546 Ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~ 623 (720)
|+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 99999999999999999876544322 2234567889999999999999999999999999999999 999997654321
Q ss_pred hhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 624 EQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
. ..+.+........+...+..+.+++.+||+.||++||++.|+++.|++++.+..
T Consensus 256 ~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 256 K----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp H----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred H----------------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1 111111222223345567789999999999999999999999999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=351.37 Aligned_cols=283 Identities=31% Similarity=0.522 Sum_probs=227.7
Q ss_pred cccchhcHHHHhcCCCcc------ceeccCCCcEEEEEEEcCCcEEEEEEcccccc--ChHHHHHHHHHHHHhhcCCCCC
Q 005001 398 TSYTVASLQTATNSFSQE------FLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRLRHPN 469 (720)
Q Consensus 398 ~~~~~~~~~~~~~~y~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~n 469 (720)
..++..++..++++|... +.||+|+||.||+|.. +++.||+|++..... .......+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 456777888888888777 8999999999999987 588999999865431 2344677899999999999999
Q ss_pred ccccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC
Q 005001 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (720)
Q Consensus 470 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~ 549 (720)
|+++++++...+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 9999999999999999999999999999997432 245799999999999999999999999 999999999999999
Q ss_pred CCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 005001 550 DELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV 628 (720)
Q Consensus 550 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~ 628 (720)
.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|||++|..||...........+
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 9999999999999865443222 2334579999999998865 5889999999999999999999999865443221111
Q ss_pred -HhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 005001 629 -RWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690 (720)
Q Consensus 629 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 690 (720)
..... ....+...++... ...+...+..+.+++.+||+.||++||++.++++.|+++.
T Consensus 247 ~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 247 KEEIED---EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHT---TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHhhh---hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 10000 0111222333332 2346678889999999999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=362.70 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=205.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 467999999999999999999876 789999999864432 223466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++ ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 85 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 9999999999986 345799999999999999999999999 999999999999999999999999999976532
Q ss_pred CCc-cccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 568 TER-QVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 568 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... .. ...
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~--------------~~~ 222 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS--------------DWK 222 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HH--------------HHH
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HH--------------HHh
Confidence 221 22334679999999999988776 78999999999999999999999765432111 11 111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
............+..+.+|+.+||+.||++|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111111123456778899999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=367.03 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=209.1
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCC--CCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH--PNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~l 485 (720)
..++|++.+.||+|+||.||+|...+++.||+|++............+.+|+.++.+++| |||+++++++...+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 346789999999999999999998889999999997666666667889999999999976 999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||| +.+++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++..
T Consensus 87 v~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 567899999973 46789999999999999999999999 999999999999997 578999999999876
Q ss_pred CCCCcc-ccccccccccccCcccccc-----------CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 005001 566 PNTERQ-VSTQMVGAFGYSAPEFALS-----------GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633 (720)
Q Consensus 566 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~ 633 (720)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------------ 225 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------------ 225 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------------
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------------
Confidence 543322 2334679999999999875 6789999999999999999999999975322
Q ss_pred ccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
.........+......++...+..+.+++.+||+.||++|||+.|++++-
T Consensus 226 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 226 ---QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ---HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 11223334444444455556667899999999999999999999999763
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=381.36 Aligned_cols=260 Identities=29% Similarity=0.471 Sum_probs=211.3
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
...++|+..+.||+|+||.||+|.+.++..||||+++.... ..+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 34567888999999999999999998888999999976443 24678999999999999999999999876 678999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++|+|.++++.. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 257 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp ECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 9999999999999732 235689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
...........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... ....+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----------------~~~~i 394 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------------VLDQV 394 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHH
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHH
Confidence 433333334567889999999999999999999999999999999 999997643211 11111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
....+...+..++..+.++|.+||+.||++|||++++++.|+++...
T Consensus 395 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 395 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 22233344567788899999999999999999999999999887543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=377.00 Aligned_cols=258 Identities=21% Similarity=0.293 Sum_probs=212.1
Q ss_pred cHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 404 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
.+....++|+..+.||+|+||.||+|++. +++.||+|++..... .......+.+|..+++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 44455678999999999999999999876 588999999865322 1122345778999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..|+||||+++|+|.++++ ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EEEEEECCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999996 24689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCccccccCC----CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGI----YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------------- 280 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------------- 280 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------------
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--------------
Confidence 9876554443445678999999999998765 8899999999999999999999997643221
Q ss_pred HHHHHhhcccccCCCCC--hhHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 005001 638 IDALAKMVDPALNGMYP--AKSLSRFADIIALCVQPEPEF--RPPMSEVVQA 685 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 685 (720)
...+++.......+| ...+.++.+||++||+.+|.+ ||+++||+++
T Consensus 281 --~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 281 --TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --HHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --HHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111222111111122 245678899999999999998 9999999976
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.94 Aligned_cols=248 Identities=26% Similarity=0.367 Sum_probs=206.6
Q ss_pred CCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEec
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 490 (720)
|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 666778999999999999876 79999999986543 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
++++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 125 ~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 125 QGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp CSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 9999999986 35799999999999999999999999 999999999999999999999999999976644322
Q ss_pred cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccC
Q 005001 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (720)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+.....+.
T Consensus 197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~-------------~~~~~~~~~~-- 260 (321)
T 2c30_A 197 -KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-------------KRLRDSPPPK-- 260 (321)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------------HHHHHSSCCC--
T ss_pred -ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHhcCCCCC--
Confidence 234467999999999999999999999999999999999999999764322111 1111111111
Q ss_pred CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 651 GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 651 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+...+..+.+++.+||+.||++||++.|++++
T Consensus 261 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 261 LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11233456778999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=367.96 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=205.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
.++|+..+.||+|+||.||+|++. +|+.||+|++..... .......+.+|..++..+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467899999999999999999875 589999999975432 233456678899999887 79999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.++++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999973 36799999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...++.
T Consensus 175 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----------------~~~~i~ 237 (353)
T 3txo_A 175 ICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----------------LFEAIL 237 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHH
T ss_pred ccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH----------------HHHHHH
Confidence 3322 23345689999999999999999999999999999999999999997654321 111122
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPM------SEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~ 685 (720)
... ..+|...+..+.+++++||+.||++||++ +|++++
T Consensus 238 ~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 238 NDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred cCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 111 23455567788999999999999999998 777764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.07 Aligned_cols=268 Identities=22% Similarity=0.306 Sum_probs=207.9
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||+||+|.+. +++.||+|++............+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47889999999999999999875 68999999997665555566788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++ +|.+.+.. ..+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 66665542 356799999999999999999999999 9999999999999999999999999999866433
Q ss_pred CccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchh-h-HHHh-hccccccHHHHHhh
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ-S-LVRW-ATPQLHDIDALAKM 644 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~-~-~~~~-~~~~~~~~~~~~~~ 644 (720)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|..||......... . .... ..+....+....+.
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 22 233457899999999998766 799999999999999999998886544332211 1 1110 11111111111110
Q ss_pred ccc---------ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VDP---------ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+. ..........+..+.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 00011123456788999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=356.38 Aligned_cols=267 Identities=23% Similarity=0.356 Sum_probs=205.1
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
++|+..+.||+|+||.||+|...+|+.||+|++............+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999988899999999976544444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++ +|.+++.. ..+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 99998863 346789999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hh-hccc---cccHHHHHh
Q 005001 570 RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RW-ATPQ---LHDIDALAK 643 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~-~~~~---~~~~~~~~~ 643 (720)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+ .. ..+. +.......+
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 1 22345789999999999764 5899999999999999999999999865432221111 10 0000 000000000
Q ss_pred hcccccC-------CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPALN-------GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.++... .......+.++.+|+.+||+.||++|||+.|++++
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 234 -YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp -CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 01122356778999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=377.93 Aligned_cols=261 Identities=22% Similarity=0.282 Sum_probs=212.8
Q ss_pred hcHHHHhcCCCccceeccCCCcEEEEEEEcC-CcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeec
Q 005001 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (720)
Q Consensus 403 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (720)
..+....++|+..++||+|+||+||+|++.. ++.||+|++..... .......+.+|..++..++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3444556789999999999999999998764 78899999965322 111233478899999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
+..++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999973 246799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL 635 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 635 (720)
+++.............+||+.|+|||++. +..++.++|||||||++|||++|+.||........
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~----------- 289 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----------- 289 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-----------
Confidence 99876554444445568999999999997 56789999999999999999999999986443211
Q ss_pred ccHHHHHhhcccccCCCCC---hhHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 005001 636 HDIDALAKMVDPALNGMYP---AKSLSRFADIIALCVQPEPEF--RPPMSEVVQA 685 (720)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 685 (720)
..+++.......+| ...+.++.+||++||+.+|++ ||+++|++++
T Consensus 290 -----~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 290 -----YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -----HHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -----HHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11111111111122 235678899999999999988 9999999876
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=365.29 Aligned_cols=256 Identities=22% Similarity=0.296 Sum_probs=207.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc---ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
.++|+..+.||+|+||.||+|.+. +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 456889999999999999999775 689999999864321 1123567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc---eEEcccCC
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSDCGL 561 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~ 561 (720)
+||||+++|+|.+.+.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988865444456789999999999999999999999 9999999999999987654 99999999
Q ss_pred CccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~-------------~ 241 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RL-------------F 241 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HH-------------H
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HH-------------H
Confidence 98765432 223446799999999999999999999999999999999999999976321 10 1
Q ss_pred HhhcccccCCC--CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDPALNGM--YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..+........ .....+..+.+||.+||+.||++||++.|++++
T Consensus 242 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 242 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111111000 001345678999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=350.83 Aligned_cols=254 Identities=29% Similarity=0.488 Sum_probs=208.0
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHH-----HHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEE-----DNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
.++|+..+.||+|+||.||+|.+. +++.||+|++.......... +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367888999999999999999874 78999999986544322221 67889999999999999999999986654
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEecCCCCCEEeCCCCc-----eE
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELN-----PH 555 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~~~~~-----~k 555 (720)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 799999999999998862 346799999999999999999999999 8 999999999999988776 99
Q ss_pred EcccCCCccCCCCCccccccccccccccCccccc--cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 005001 556 LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL--SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633 (720)
Q Consensus 556 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~ 633 (720)
|+|||+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.........
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------- 237 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-------- 237 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--------
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH--------
Confidence 999999975432 233467999999999984 455789999999999999999999999765432211
Q ss_pred ccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
..............+..++..+.+++.+||+.||++||+++|+++.|++
T Consensus 238 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 238 ------FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ------HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ------HHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111222233334556677889999999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=358.89 Aligned_cols=266 Identities=15% Similarity=0.188 Sum_probs=214.1
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+|+.+++++ +||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 36788999999999999999986 5789999999864432 23577899999999 999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc-----eEEcccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-----PHLSDCGL 561 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfg~ 561 (720)
|||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 9999 89999999742 46899999999999999999999999 9999999999999999887 99999999
Q ss_pred CccCCCCCcc------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 005001 562 AALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL 635 (720)
Q Consensus 562 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 635 (720)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i---- 232 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI---- 232 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH----
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH----
Confidence 9865433221 123567999999999999999999999999999999999999999876543222211100
Q ss_pred ccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccc
Q 005001 636 HDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696 (720)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 696 (720)
.......... ......+ ++.+++..||+.||.+||++++|++.|+++.++....
T Consensus 233 ---~~~~~~~~~~---~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 233 ---GDTKRATPIE---VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp ---HHHHHHSCHH---HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ---HhhhccCCHH---HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 0000000000 0011234 7899999999999999999999999999998876544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=361.77 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=207.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCc----EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
.++|+..+.||+|+||.||+|.+. +++ +||+|.+.... .......+.+|+.++++++||||+++++++... ..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-Ce
Confidence 356888999999999999999864 344 36888876433 334467889999999999999999999999875 47
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++|+||+.+|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 899999999999999974 346799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 564 LTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 564 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------------- 228 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------- 228 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----------------
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-----------------
Confidence 65433322 2233457889999999999999999999999999999999 9999976543221
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
...+........+..++..+.+++.+||+.||++||++.+++++|+++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 112222223334556777899999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.37 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=200.3
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh------------------------HHHHHHHHHHHHhh
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL------------------------QEEDNFLEAVSNMS 463 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~ 463 (720)
.++|+..+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367889999999999999999775 68899999986543211 12356889999999
Q ss_pred cCCCCCccccceEEee--cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecC
Q 005001 464 RLRHPNIVTLAGYCAE--HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNF 541 (720)
Q Consensus 464 ~l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dl 541 (720)
+++||||+++++++.. .+..++||||+++++|.+++. ...+++.++..++.|++.||+|||+. +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 568899999999999988654 46799999999999999999999999 9999999
Q ss_pred CCCCEEeCCCCceEEcccCCCccCCCCCccccccccccccccCccccccCC---CcccchhhhHHHHHHHHHhCCCCCCC
Q 005001 542 KSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI---YTVKSDVYSFGVVMLELLTGRKPLDS 618 (720)
Q Consensus 542 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~l~elltg~~pf~~ 618 (720)
||+||+++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654322 233467999999999998765 47889999999999999999999975
Q ss_pred CCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 619 SRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...... ...+.............+..+.+++.+||+.||++||++.|++++
T Consensus 243 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ERIMCL----------------HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSHHHH----------------HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccHHHH----------------HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 432111 111111111112223456788999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=374.66 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=212.5
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC-eEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-QRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV 486 (720)
..++|+..+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 3467888899999999999999885 7899999997543 3567899999999999999999999987665 78999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++|+|.++++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 9999999999999743 234579999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.. .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......... ..+
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-----------------~~i 399 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-----------------PRV 399 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-----------------HHH
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------------HHH
Confidence 22 122357889999999999999999999999999999998 99999765432211 111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
....+...+..++..+.++|.+||+.||++||++.++++.|+++...
T Consensus 400 ~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 12223345667788999999999999999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=353.75 Aligned_cols=278 Identities=20% Similarity=0.299 Sum_probs=214.3
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC--eEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 485 (720)
.++|.+.+.||+|+||.||+|.+. +++.||+|++..... ......+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 467889999999999999999876 489999999975432 233567789999999999999999999987765 7899
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe----CCCCceEEcccCC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCGL 561 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~ 561 (720)
||||+++++|.++++... ....+++.++..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999997432 233499999999999999999999999 99999999999999 7888899999999
Q ss_pred CccCCCCCccccccccccccccCccccc--------cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchh-hHHH-hh
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFAL--------SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ-SLVR-WA 631 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~-~~~~-~~ 631 (720)
++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......... .... ..
T Consensus 163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred ceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 987654332 23457999999999987 577899999999999999999999999754432211 1110 00
Q ss_pred --ccc--cccHHHHHh-h--c--ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 632 --TPQ--LHDIDALAK-M--V--DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 632 --~~~--~~~~~~~~~-~--~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
.+. +........ . . ........+...+..+.+++++||+.||++||+++|++++..+...+.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~ 311 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence 000 000000000 0 0 001112345677888999999999999999999999999987764443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=352.61 Aligned_cols=264 Identities=26% Similarity=0.441 Sum_probs=217.9
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
++...++|+..+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++. .+..+
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 3445578899999999999999999998888999999975432 3567889999999999999999999886 45689
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++++|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 999999999999999632 123689999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-----------------~~ 221 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----------------IQ 221 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----------------HH
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH-----------------HH
Confidence 65443333344567889999999999999999999999999999999 9999975432111 11
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
.+........+...+..+.+++.+||+.||++||++.++++.|+++.....
T Consensus 222 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 222 NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 111112223445667789999999999999999999999999999887653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=367.31 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=206.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
.++|+..++||+|+||.||+|+.. +++.||+|++++.... ......+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 356888999999999999999876 5788999999765433 22334577888888776 89999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.++++. .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999973 36799999999999999999999999 9999999999999999999999999999753
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH-HHHhh
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID-ALAKM 644 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 644 (720)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... ....+
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~--------~~~~~~~~~~~i 274 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVI 274 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHHHHH
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc--------chhhHHHHHHHH
Confidence 3222 2334578999999999999999999999999999999999999999754321110 000011 11111
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPM------SEVVQA 685 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~ 685 (720)
... ...+|...+.++.+||++||+.||++||++ .|++++
T Consensus 275 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 275 LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred hcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 111 223456677889999999999999999996 566554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=357.81 Aligned_cols=250 Identities=18% Similarity=0.220 Sum_probs=207.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|.+. +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 467899999999999999999875 5889999998643 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC--CCceEEcccCCCccC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD--ELNPHLSDCGLAALT 565 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~ 565 (720)
||+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++...
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 81 EFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 99999999999962 335799999999999999999999999 9999999999999987 789999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||......... ..+.
T Consensus 155 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----------------~~i~ 216 (321)
T 1tki_A 155 KPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII----------------ENIM 216 (321)
T ss_dssp CTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HHHH
T ss_pred CCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH----------------HHHH
Confidence 5432 223467999999999999998999999999999999999999999764322111 1111
Q ss_pred ccccCCC--CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGM--YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....... .....+.++.+++.+||+.||++|||+.|++++
T Consensus 217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111100 001345678999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=358.62 Aligned_cols=267 Identities=26% Similarity=0.439 Sum_probs=218.1
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc--------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEe
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (720)
..++|...+.||+|+||.||+|.+. ++..||+|++.... .......+.+|+.+++++ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 4567889999999999999999863 46789999997543 445567889999999999 8999999999999
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCE
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFADDS------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 546 (720)
..+..++||||+++|+|.+++...... ...+++.++..++.|++.||+|||+. +|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 999999999999999999999753321 23589999999999999999999999 999999999999
Q ss_pred EeCCCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcch
Q 005001 547 LLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSE 624 (720)
Q Consensus 547 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~ 624 (720)
+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-
Confidence 9999999999999999866543322 2233467889999999999999999999999999999999 999997543211
Q ss_pred hhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcc
Q 005001 625 QSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695 (720)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 695 (720)
+.+.+........+..++..+.+++.+||+.||++||++.|+++.|+++......
T Consensus 268 ----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 268 ----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ----------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ----------------HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1111111122234456677899999999999999999999999999999876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.23 Aligned_cols=264 Identities=27% Similarity=0.441 Sum_probs=203.3
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
...++|+..+.||+|+||.||+|.+. ..||+|+++.........+.+.+|+.++++++||||++++++. ..+..++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34567999999999999999999764 3599999987766677778899999999999999999999965 55678999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.++++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999863 346799999999999999999999999 99999999999999999999999999997654
Q ss_pred CCC-ccccccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 567 NTE-RQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 567 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
... ........||+.|+|||++. +..++.++||||||+++|||++|+.||.......... . ...
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~----------~~~ 239 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--E----------MVG 239 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH--H----------HHH
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH--H----------Hhc
Confidence 322 22223457999999999987 6678899999999999999999999997654322111 0 001
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
+.............++..+.+++.+||+.||++||++.++++.|+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1000111112234567789999999999999999999999999988753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=356.90 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=209.2
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||+|... +|+.||+|++..... .......+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999875 689999999975432 1233566788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.+|.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999973 46789999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...++...
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----------------~~~~i~~~ 218 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----------------TYEKILNA 218 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHHC
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhC
Confidence 2 234679999999999999999999999999999999999999997643211 11122222
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
. ..++...+.++.+++.+||+.||++|| +++|++++
T Consensus 219 ~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 219 E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1 224555677899999999999999999 88998865
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=364.40 Aligned_cols=269 Identities=25% Similarity=0.390 Sum_probs=215.0
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEe
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (720)
+...++|...+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 334578899999999999999999862 45689999997543 333456789999999999 8999999999999
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEe
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFADDS-------------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHR 539 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~ 539 (720)
..+..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999743211 13489999999999999999999999 99999
Q ss_pred cCCCCCEEeCCCCceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCC
Q 005001 540 NFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (720)
Q Consensus 540 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~ 617 (720)
||||+||+++.++.+||+|||++........ .......||+.|+|||.+.+..++.++|||||||++|||+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999976543322 22334568889999999999999999999999999999998 999997
Q ss_pred CCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 618 SSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
...... ...+.+........+...+..+.+++.+||+.||++||++.+++++|+.+.....
T Consensus 277 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 277 GIPVDA----------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TCCCSH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cCCcHH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 654321 1112222223333455667889999999999999999999999999999876554
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=355.30 Aligned_cols=269 Identities=24% Similarity=0.405 Sum_probs=210.1
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc----CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (720)
+....++|...+.||+|+||.||+|... ++..||+|++............+.+|+.++++++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3445577889999999999999999764 345899999987665666678899999999999999999999998775
Q ss_pred C-----eEEEEEEecCCCCHHHHhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc
Q 005001 481 G-----QRLLVYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (720)
Q Consensus 481 ~-----~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 553 (720)
+ ..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence 4 3599999999999999985432 2346799999999999999999999999 9999999999999999999
Q ss_pred eEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhh
Q 005001 554 PHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWA 631 (720)
Q Consensus 554 ~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~ 631 (720)
+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----- 260 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD----- 260 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-----
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH-----
Confidence 999999999765433221 1233467889999999999999999999999999999999 889997644321111
Q ss_pred ccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 632 TPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
... .......+...+..+.+++.+||+.||++||++.+++++|+++.+.-
T Consensus 261 -----------~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 261 -----------YLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp -----------HHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----------HHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111 11122344566778999999999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=368.38 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=207.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC--CCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR--HPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV 486 (720)
..+|++.+.||+|+||.||+|...+++.||||++............+.+|+.++++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3468999999999999999999888999999999766556666788999999999996 59999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|| +.+++|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 567899999973 45789999999999999999999999 999999999999995 5799999999998765
Q ss_pred CCCcc-ccccccccccccCcccccc-----------CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 005001 567 NTERQ-VSTQMVGAFGYSAPEFALS-----------GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 567 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------------ 273 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------------ 273 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------------
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------------
Confidence 43222 2344679999999999875 46899999999999999999999999753321
Q ss_pred cccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+..+++......++...+..+.+||.+||+.||++||++.|++++
T Consensus 274 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 ---ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 122333344444444455556788999999999999999999999976
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.80 Aligned_cols=272 Identities=21% Similarity=0.373 Sum_probs=216.2
Q ss_pred hcCCCccceeccCCCcEEEEEEE-----cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec--C
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--G 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 481 (720)
.++|+..+.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 34588899999999999999984 368999999997543 233457789999999999999999999999876 6
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred eEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence 68999999999999999963 245699999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCc--cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc--cccc
Q 005001 562 AALTPNTER--QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP--QLHD 637 (720)
Q Consensus 562 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~ 637 (720)
+........ .......||..|+|||.+.+..++.++||||||+++|||++|..|+.... ........+ ....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM----ALFLKMIGPTHGQMT 248 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH----HHHHHHHCSCCGGGH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh----hHHhhccCCcccccC
Confidence 987654432 22334568889999999999999999999999999999999999864321 111111111 1111
Q ss_pred HHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
.......+........+...+..+.+++.+||+.||++|||+.++++.|+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 222333333334444566778899999999999999999999999999998864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=356.42 Aligned_cols=274 Identities=24% Similarity=0.375 Sum_probs=219.3
Q ss_pred CCccceeccCCCcEEEEEEEc-----CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec--CeEE
Q 005001 412 FSQEFLIGEGSLGRVYRAEFA-----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRL 484 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 484 (720)
|+..+.||+|+||.||++.+. +++.||+|++.... .......+.+|++++++++||||+++++++.+. ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 488899999999999988643 68899999997553 445567899999999999999999999999874 5789
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++|+|.+++. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 9999999999999996 34599999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcc--ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 565 TPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 565 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
....... ......||+.|+|||++.+..++.++||||||+++|||++|..||....... .....+.. .......+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~ 261 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQ-GQMTVLRLT 261 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCC-HHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccc-cchhHHHHH
Confidence 6543322 2234568889999999999999999999999999999999999986422110 00000000 001112233
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccc
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 696 (720)
+.+........+..++..+.+++.+||+.||++||++.|+++.|+++.++....
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 333444444556677889999999999999999999999999999998876543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.43 Aligned_cols=266 Identities=15% Similarity=0.207 Sum_probs=214.1
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|+..+.||+|+||.||+|.+ .+++.||+|++.... ....+.+|+..++.+ +|+|++++++++......++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 46799999999999999999986 578999999986432 234567888999988 899999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc-----eEEcccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-----PHLSDCGL 561 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfg~ 561 (720)
|||+ +++|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 89999999742 45699999999999999999999999 9999999999999987776 99999999
Q ss_pred CccCCCCCcc------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 005001 562 AALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL 635 (720)
Q Consensus 562 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 635 (720)
+......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---- 233 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI---- 233 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH----
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH----
Confidence 9866543221 123457999999999999999999999999999999999999999875543222211100
Q ss_pred ccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcc
Q 005001 636 HDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695 (720)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 695 (720)
................+..+.+++.+||+.||++||++++|++.|+++.++...
T Consensus 234 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 234 ------GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp ------HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ------HhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 000000000001123457889999999999999999999999999999886643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=363.87 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=208.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999999999999775 588999999865432 223456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+.+|+|.++++ ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999997 356799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCccccccccccccccCcccccc---CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. .
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-------------~ 231 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH-------------T 231 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH-------------H
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH-------------H
Confidence 332 2345689999999999974 458999999999999999999999997654332221111 1
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPP-MSEVVQ 684 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~ 684 (720)
+. .....++...+..+.+||.+||+.||++||+ ++++++
T Consensus 232 ~~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 232 FE--TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HH--HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred Hh--hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11 1122345566788999999999999999998 666654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=360.78 Aligned_cols=260 Identities=24% Similarity=0.394 Sum_probs=208.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcE----EEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKI----MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
.++|+..+.||+|+||.||+|.+. +++. ||+|.+.... .......+.+|+.++++++||||+++++++. .+..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 356888999999999999999765 3443 7888775432 2223345678899999999999999999886 5678
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+.+|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence 999999999999999973 235788999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 564 LTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 564 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------------- 229 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-------------- 229 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH--------------
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH--------------
Confidence 76544322 2344568889999999999999999999999999999999 9999986543322111
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
+........+..++..+.+++.+||+.||++||++.+++++|.++....
T Consensus 230 ---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 230 ---LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ---HHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ---HHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1112222334445667889999999999999999999999999986643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=361.30 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=209.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999875 689999999965432 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999973 35689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...++...
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----------------~~~~i~~~ 253 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----------------IYEKIVSG 253 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHC
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH----------------HHHHHHcC
Confidence 2 234679999999999999999999999999999999999999997643211 11122211
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPP-----MSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 685 (720)
. ..+|...+..+.++|.+||+.||++||+ ++|++++
T Consensus 254 ~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 254 K--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1 2345566788999999999999999998 8888865
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=358.23 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=208.2
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh----HHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
..++|...+.||+|+||.||+|... +|+.||+|.+....... .....+.+|+.++++++||||+++++++...+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3456889999999999999999875 68999999987543321 135678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC----ceEEcc
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSD 558 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~D 558 (720)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 999999999999999996 346799999999999999999999999 999999999999999887 799999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
||++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+....
T Consensus 162 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------ 233 (326)
T 2y0a_A 162 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN------ 233 (326)
T ss_dssp CTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC------
T ss_pred CCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC------
Confidence 99998764322 2234579999999999999999999999999999999999999997643221111110000
Q ss_pred HHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...........+..+.+++.+||+.||++|||+.|++++
T Consensus 234 --------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 --------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000012345678899999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.90 Aligned_cols=271 Identities=22% Similarity=0.366 Sum_probs=220.5
Q ss_pred hhcHHHHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccce
Q 005001 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475 (720)
Q Consensus 402 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 475 (720)
..+++...++|...+.||+|+||.||+|.+. +++.||+|.+.... .......+.+|+.+++.++||||+++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 3455566788999999999999999999764 36789999997543 4455667899999999999999999999
Q ss_pred EEeecCeEEEEEEecCCCCHHHHhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC
Q 005001 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADD------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (720)
Q Consensus 476 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~ 549 (720)
++...+..++||||+++|+|.++++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence 99999999999999999999999975321 125679999999999999999999999 999999999999999
Q ss_pred CCCceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 005001 550 DELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSL 627 (720)
Q Consensus 550 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~ 627 (720)
.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 248 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---- 248 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH----
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH----
Confidence 999999999999975533221 12233467899999999999999999999999999999999 889997543211
Q ss_pred HHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 628 VRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
....+.. ......+...+..+.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 249 ------------~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 249 ------------VLRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp ------------HHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ------------HHHHHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 1111111 1112234566778999999999999999999999999998875544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=351.02 Aligned_cols=267 Identities=22% Similarity=0.367 Sum_probs=207.7
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccc-cChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|+..+.||+|+||.||+|.. .+|+.||+|++.... ........+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35688999999999999999976 478999999997533 2445567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.+++.........+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999976555567899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .......
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--------------~~~~~~~ 252 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--------------LCKKIEQ 252 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH--------------HHHHHHT
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH--------------HHHHhhc
Confidence 3322 223457899999999999999999999999999999999999999754321111 1111111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
...........+..+.+++.+||+.||++||++.++++.|+++....
T Consensus 253 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 11111122445678999999999999999999999999999986654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=347.64 Aligned_cols=262 Identities=22% Similarity=0.331 Sum_probs=216.0
Q ss_pred cCCCccc-eeccCCCcEEEEEEEc---CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 410 NSFSQEF-LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 410 ~~y~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
++|.+.+ .||+|+||.||+|.+. ++..||+|++.... .....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4455555 8999999999999753 57889999997643 445567899999999999999999999998 5567899
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999862 346799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccc--cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 566 PNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 566 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
....... .....||+.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----------------- 223 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM----------------- 223 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-----------------
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-----------------
Confidence 5433222 223457899999999999999999999999999999999 99999765432111
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccc
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 696 (720)
..+........+...+..+.+++.+||+.||++||++.+++++|+++.......
T Consensus 224 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 224 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 111112223345667788999999999999999999999999999998766433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=363.38 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=207.7
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 483 (720)
...++|...+.||+|+||.||+|++. +|+.||+|+++.... .......+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999875 688999999975432 122345677888888776 999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+++|+|.++++. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999973 35789999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------------~~~ 229 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----------------FHS 229 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHH
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH----------------HHH
Confidence 543222 223456899999999999999999999999999999999999999976432211 111
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMS-EVVQA 685 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~~ 685 (720)
+... ...++...+.++.+++.+||+.||++||++. +++++
T Consensus 230 i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 230 IRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 1111 1224455677899999999999999999997 66643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=356.12 Aligned_cols=271 Identities=24% Similarity=0.404 Sum_probs=219.5
Q ss_pred cHHHHhcCCCccceeccCCCcEEEEEEE------cCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceE
Q 005001 404 SLQTATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGY 476 (720)
Q Consensus 404 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 476 (720)
.+....++|+..+.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.++.++ +||||++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 3444567899999999999999999975 346889999997543 344567789999999999 79999999999
Q ss_pred EeecC-eEEEEEEecCCCCHHHHhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCC
Q 005001 477 CAEHG-QRLLVYEYVGNGNLHDMLHFADDS------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543 (720)
Q Consensus 477 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp 543 (720)
+...+ ..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCcc
Confidence 87754 589999999999999999743221 12389999999999999999999999 999999999
Q ss_pred CCEEeCCCCceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCC
Q 005001 544 ANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRP 621 (720)
Q Consensus 544 ~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~ 621 (720)
+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999986644332 22334568899999999999999999999999999999998 9999976543
Q ss_pred cchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 622 RSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
.... .+.+........+...+..+.+++.+||+.||++||++.|++++|+++++...
T Consensus 257 ~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 257 DEEF----------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp SHHH----------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHHH----------------HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 2111 11111111223344566789999999999999999999999999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=355.47 Aligned_cols=264 Identities=26% Similarity=0.441 Sum_probs=212.9
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEE--EEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
++|+..+.||+|+||.||+|.+. ++..+ |+|.+.... .......+.+|+.+++++ +||||+++++++...+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 57888999999999999999765 56544 889886432 334456788999999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHhhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc
Q 005001 486 VYEYVGNGNLHDMLHFAD------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 553 (720)
||||+++|+|.+++.... .....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997432 2235799999999999999999999999 9999999999999999999
Q ss_pred eEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 005001 554 PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWAT 632 (720)
Q Consensus 554 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~ 632 (720)
+||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------- 249 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------- 249 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---------
Confidence 999999998743221 11223457889999999999999999999999999999998 999997643211
Q ss_pred cccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccc
Q 005001 633 PQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696 (720)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 696 (720)
....+........+...+..+.+++.+||+.||++||++.++++.|.++.++....
T Consensus 250 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 250 --------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp --------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred --------HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 11111222233345566788999999999999999999999999999998877544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=351.07 Aligned_cols=264 Identities=26% Similarity=0.365 Sum_probs=214.6
Q ss_pred hcCCCccc-eeccCCCcEEEEEEEc---CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 409 TNSFSQEF-LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 409 ~~~y~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
.++|...+ .||+|+||.||+|.+. +++.||+|++..........+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 9999999999999553 468899999986654555577899999999999999999999998 567889
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++++|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999973 45689999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcccc--ccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 565 TPNTERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 565 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
......... ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~ 229 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------V 229 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------H
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------H
Confidence 654433222 22346789999999999999999999999999999999 999997643221 1
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcccc
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVK 697 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 697 (720)
...+........+...+..+.+++.+||+.||++||++.++++.|+++......+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 230 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 11111122233455677889999999999999999999999999999987765443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=357.93 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=208.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 486 (720)
++|+..+.||+|+||.||+|++. +++.||+|++..... .......+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999875 588999999976543 344456788899999887 899999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999973 35799999999999999999999999 99999999999999999999999999997643
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..........+..
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTEDYLFQVILE 233 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHHHHHHHHH
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc-------cccHHHHHHHHHc
Confidence 322 22345689999999999999999999999999999999999999997532211000 0000011111111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPM------SEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~ 685 (720)
. ...+|...+..+.+++.+||+.||++||++ .|++++
T Consensus 234 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 234 K--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred C--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1 123455677889999999999999999996 566654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=361.60 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=207.0
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccCh-HHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++....... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35789999999999999999987 578999999986543221 2235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+ +|+|.+++.. .+.+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 6799998863 46799999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... + +
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~-i 220 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------K-V 220 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------C-C
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------H-H
Confidence 332 2344579999999999998876 689999999999999999999997643221110 0 0
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ......|...+..+.+|+++||+.||.+|||++|++++
T Consensus 221 ~-~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 221 N-SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp C-SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred H-cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 11122345567788999999999999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=355.03 Aligned_cols=264 Identities=25% Similarity=0.421 Sum_probs=211.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC-----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
.++|...+.||+|+||.||+|.+.. +..||+|++.... .......+.+|+.++++++||||+++++++...+..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 3567788999999999999997653 2359999997543 445566789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 122 MIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence 999999999999999973 346799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcc--ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 564 LTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 564 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----------------- 258 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------- 258 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----------------
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-----------------
Confidence 76443221 1222356889999999999999999999999999999999 999997543211
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccc
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 696 (720)
..+.+........+..++..+.+++.+||+.||++||++.++++.|+++.+.....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 259 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred HHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 11111112222345567788999999999999999999999999999998765543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=371.78 Aligned_cols=259 Identities=21% Similarity=0.246 Sum_probs=209.7
Q ss_pred cHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 404 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
+.....++|+..+.||+|+||.||+|+.. +|+.||+|++.+... .......+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 34445678999999999999999999875 689999999965332 2223345788999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..|+||||+++|+|.++++.. +..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999742 35799999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCccccc-------cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFAL-------SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
++.............+||+.|+|||++. +..++.++|||||||++|||++|+.||.........
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--------- 279 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY--------- 279 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH---------
Confidence 9876554443344568999999999997 356899999999999999999999999764432111
Q ss_pred cccHHHHHhhcccccCCC---CChhHHHHHHHHHHHhcCCCCCCC---CCHHHHHHH
Q 005001 635 LHDIDALAKMVDPALNGM---YPAKSLSRFADIIALCVQPEPEFR---PPMSEVVQA 685 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ell~~ 685 (720)
.+++....... .+...+.++.+||++||+ +|++| |+++|++++
T Consensus 280 -------~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 -------GKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -------HHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -------HHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11111100001 123456788999999999 99998 589988865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=348.50 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=210.4
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcC----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
..++|...+.||+|+||.||+|.+.+ +..||+|.+.... .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 34678889999999999999997653 3469999987543 34556789999999999999999999999865 457
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 88 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence 899999999999999974 245689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~--------------- 226 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV--------------- 226 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH---------------
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH---------------
Confidence 765443333344567889999999999999999999999999999998 9999975433221111
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
+........+...+..+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 227 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 227 --LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp --HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 111112223445667899999999999999999999999999988764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=355.05 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=199.1
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
..++|+..++||+|+||+||+|.+. +|+.||||++............+..|+..+.++ +||||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999876 799999999876655555555666666665554 99999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 66999988643 45799999999999999999999999 9999999999999999999999999998766
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ...+.
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-------------------~~~~~ 265 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-------------------WQQLR 265 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------------------HHHHT
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------------------HHHHh
Confidence 4332 2234569999999998876 789999999999999999999776643210 00111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........+...+..+.+++.+||+.||++||++.|++++
T Consensus 266 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 266 QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1111111122345778999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=361.89 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=197.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 467999999999999999999876 789999999965432 2356789999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc--eEEcccCCCccC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN--PHLSDCGLAALT 565 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~ 565 (720)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++..
T Consensus 96 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 96 EYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999863 35799999999999999999999999 9999999999999987765 999999998743
Q ss_pred CCCCccccccccccccccCccccccCCCccc-chhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVK-SDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
... .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.......... ....++
T Consensus 169 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------------~~~~~~ 234 (361)
T 3uc3_A 169 VLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR------------KTIQRI 234 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH------------HHHHHH
T ss_pred ccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH------------HHHHHH
Confidence 222 12234579999999999998887655 899999999999999999997654321111 111222
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.............+..+.+||.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 22222222223456788999999999999999999999976
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=364.30 Aligned_cols=272 Identities=22% Similarity=0.317 Sum_probs=209.7
Q ss_pred hcCCCccceeccC--CCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 409 TNSFSQEFLIGEG--SLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
.++|++.+.||+| +||.||+|.+. +|+.||+|++............+.+|+.+++.++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678999999999 99999999876 69999999998776666667888999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999742 235699999999999999999999999 9999999999999999999999999988643
Q ss_pred CCCC------ccccccccccccccCcccccc--CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHhhccccc
Q 005001 566 PNTE------RQVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL-VRWATPQLH 636 (720)
Q Consensus 566 ~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~-~~~~~~~~~ 636 (720)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... .....+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 2211 111223478999999999988 6799999999999999999999999976543322110 000000000
Q ss_pred cH-----H-------------HHHhhc---------ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 637 DI-----D-------------ALAKMV---------DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 637 ~~-----~-------------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. . ...... ........+...+..+.+||.+||+.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0 000000 0000111233456779999999999999999999999976
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=351.04 Aligned_cols=268 Identities=22% Similarity=0.329 Sum_probs=205.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|+..+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999875 58999999997766555567788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++++|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999886 346789999999999999999999999 9999999999999999999999999999876533
Q ss_pred CccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc-ccHHHHH---h
Q 005001 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL-HDIDALA---K 643 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~---~ 643 (720)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+....... ....... .
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22 2234579999999999986 668999999999999999999999998765433222221110000 0000000 0
Q ss_pred hcc----cccCCCC-----ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVD----PALNGMY-----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~----~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... +...... ....+..+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0000000 02345678899999999999999999999865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=362.81 Aligned_cols=276 Identities=17% Similarity=0.232 Sum_probs=210.9
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcC------CcEEEEEEccccccChHHH---------HHHHHHHHHhhcCCCCCccc
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEE---------DNFLEAVSNMSRLRHPNIVT 472 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~ 472 (720)
..++|++.+.||+|+||.||+|.+.. ++.||+|++.........+ ..+.+|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34679999999999999999998764 4789999986543211111 22345666778889999999
Q ss_pred cceEEeec----CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe
Q 005001 473 LAGYCAEH----GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (720)
Q Consensus 473 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll 548 (720)
+++++... ...++||||+ +++|.++++. ....+++.++..++.||+.||+|||+. +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 4589999999 9999999973 346799999999999999999999999 99999999999999
Q ss_pred C--CCCceEEcccCCCccCCCCCcc------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCC
Q 005001 549 D--DELNPHLSDCGLAALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSR 620 (720)
Q Consensus 549 ~--~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~ 620 (720)
+ .++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999765432211 1133459999999999999999999999999999999999999998543
Q ss_pred CcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcccc
Q 005001 621 PRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVK 697 (720)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 697 (720)
......... .. .....+....+..+. +...+.++.+++..||+.||++||++.+|++.|+++.+......
T Consensus 266 ~~~~~~~~~--~~--~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 266 KDPKYVRDS--KI--RYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp TCHHHHHHH--HH--HHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred cCHHHHHHH--HH--HhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 321111000 00 000111122221111 13446788999999999999999999999999999998765543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=359.98 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=208.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC-CcEEEEEEcccccc-ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
.++|+..+.||+|+||.||+|+... ++.||+|++..... .......+..|..++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4678999999999999999998864 78899999975432 223356678899999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.++++. .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.+|.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999973 35799999999999999999999999 9999999999999999999999999999764
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...++.
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----------------~~~~i~ 234 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----------------LFQSIM 234 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHH
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH----------------HHHHHH
Confidence 3222 22345689999999999999999999999999999999999999997643211 111222
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPP-----MSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 685 (720)
... ..+|...+.++.+|+.+||+.||++||+ +++++++
T Consensus 235 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 235 EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred hCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111 2345567788999999999999999995 5777654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=361.69 Aligned_cols=261 Identities=26% Similarity=0.430 Sum_probs=202.8
Q ss_pred cCCCccceeccCCCcEEEEEEEc--CC--cEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee-cCeEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA--NG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRL 484 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~ 484 (720)
..|...+.||+|+||.||+|.+. ++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++.. ++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 34667789999999999999764 22 368999886533 34556789999999999999999999998654 56789
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++|+|.++++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 168 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence 99999999999999962 345689999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCcc---ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 565 TPNTERQ---VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 565 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...........+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~------------ 309 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------------ 309 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH------------
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH------------
Confidence 5432211 1233467889999999999999999999999999999999 67777654432211111
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
. .......+..++..+.+++.+||+.||++||++.|+++.|+++.....
T Consensus 310 ----~-~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 310 ----L-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ----H-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----H-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1 111223345667789999999999999999999999999999987664
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.31 Aligned_cols=261 Identities=26% Similarity=0.392 Sum_probs=210.5
Q ss_pred CCCccceeccCCCcEEEEEEEcC----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE-EE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR-LL 485 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~l 485 (720)
.|...+.||+|+||.||+|.+.+ +..||+|++.... .....+.+.+|+.++++++||||+++++++...+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 45667899999999999997643 2379999987533 445567889999999999999999999999876655 99
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+.+|+|.++++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999973 356789999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCc---cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 566 PNTER---QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 566 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+........ ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----------------~~ 238 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------------LT 238 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----------------HH
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----------------HH
Confidence 43221 122335688999999999999999999999999999999996665543222111 11
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
..+........+...+..+.+++.+||+.||++|||++++++.|+++.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 239 HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1111122223345567789999999999999999999999999999987653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=350.56 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=211.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--cCeEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 485 (720)
.++|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467888999999999999999875 68999999998666566667889999999999999999999998754 578999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----cEEecCCCCCEEeCCCCceEEcccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS-----VVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~-----iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
||||+++++|.+++.........+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999986555556799999999999999999999999 7 9999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------------- 225 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA--------------- 225 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------------
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH---------------
Confidence 987654332 1223457899999999999999999999999999999999999999764321111
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
..+.. ......+...+..+.+++.+||+.||++||++.|+++++
T Consensus 226 -~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 226 -GKIRE-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp -HHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred -HHHhh-cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 11111 111233455677899999999999999999999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=351.46 Aligned_cols=266 Identities=24% Similarity=0.394 Sum_probs=206.2
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhc--CCCCCccccceEEeec--
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAEH-- 480 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~-- 480 (720)
.....++|+..+.||+|+||.||+|.+. ++.||+|++... ....+.+|.+++.. ++||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 3445678999999999999999999875 899999998533 23344455555544 4999999999998877
Q ss_pred --CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEEecCCCCCEEeCCCCc
Q 005001 481 --GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC-----LPSVVHRNFKSANILLDDELN 553 (720)
Q Consensus 481 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~ 553 (720)
...++||||+++|+|.++++ ...+++..+..++.|++.||+|||+.. .++|+||||||+|||++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 78899999999999999996 346899999999999999999999751 338999999999999999999
Q ss_pred eEEcccCCCccCCCCCccc---cccccccccccCccccccCCCccc------chhhhHHHHHHHHHhC----------CC
Q 005001 554 PHLSDCGLAALTPNTERQV---STQMVGAFGYSAPEFALSGIYTVK------SDVYSFGVVMLELLTG----------RK 614 (720)
Q Consensus 554 ~kl~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGv~l~elltg----------~~ 614 (720)
+||+|||++.......... .....||+.|+|||++.+..++.+ +|||||||++|||++| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999997654433221 124579999999999988776655 9999999999999999 55
Q ss_pred CCCCCCCcchhhHHHhhccccccHHHHHhhc-ccccCCCCC-----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 615 PLDSSRPRSEQSLVRWATPQLHDIDALAKMV-DPALNGMYP-----AKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 615 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
||....+... ......... ........+ ..++..+.+++.+||+.||++||++.+++++|++
T Consensus 261 p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 261 PYHDLVPSDP------------SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp TTTTTSCSSC------------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cHhhhcCCCC------------chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 5544322111 111111111 112222233 2677889999999999999999999999999999
Q ss_pred HHHhh
Q 005001 689 LVQRA 693 (720)
Q Consensus 689 ~~~~~ 693 (720)
+.+..
T Consensus 329 l~~~~ 333 (337)
T 3mdy_A 329 MSESQ 333 (337)
T ss_dssp HHHTT
T ss_pred HHhhc
Confidence 97765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=356.56 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=199.1
Q ss_pred hcCCCccceeccCCCcEEEEEEE----cCCcEEEEEEcccccc--ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
.++|+..+.||+|+||.||+|+. .+++.||+|+++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35688899999999999999987 4789999999976532 22334567889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999973 35689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~ 231 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----------------TID 231 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHH
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----------------HHH
Confidence 7543322 22334679999999999999999999999999999999999999997643211 111
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
++.... ...+...+..+.+++.+||+.||++|| ++.|++++
T Consensus 232 ~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 232 KILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 111111 123455677899999999999999999 77788775
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=355.24 Aligned_cols=260 Identities=23% Similarity=0.401 Sum_probs=206.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCc----EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
.++|+..+.||+|+||.||+|.+. +++ +||+|.+.... .......+.+|+.++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 367899999999999999999864 344 35777775433 3345678899999999999999999999998654 8
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++|+||+.+|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred eEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 899999999999999973 246799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 564 LTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 564 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------------- 228 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------- 228 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----------------
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-----------------
Confidence 76433222 2233457889999999999999999999999999999999 9999976543221
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
...+........+...+..+.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 229 SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 1112222233345567778999999999999999999999999999988643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.96 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=203.9
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
++|+..+.||+|+||.||+|.+. ++.||+|++... ...+.+.+|++++++++||||+++++++. +..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 56788899999999999999875 788999999643 34577899999999999999999999876 457999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc-eEEcccCCCccCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-PHLSDCGLAALTPNT 568 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~ 568 (720)
+++|+|.++++... ....+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999999997321 1235789999999999999999999932229999999999999998886 799999998754322
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........... .. ....
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--------------~~-~~~~ 220 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--------------WA-VHNG 220 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH--------------HH-HHTT
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH--------------HH-HhcC
Confidence 2234699999999999999999999999999999999999999975432211100 00 1111
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccc
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 696 (720)
.....+...+..+.+++.+||+.||++||++.++++.|+++.+.....
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 122233456678899999999999999999999999999987665443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=348.35 Aligned_cols=261 Identities=26% Similarity=0.423 Sum_probs=209.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEe-ecCeE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA-EHGQR 483 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~ 483 (720)
..+|+..+.||+|+||.||+|.+.+ +..||+|.+.... .......+.+|+.++++++||||+++++++. .++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 4568888999999999999997642 2358999887533 4455678899999999999999999999854 45678
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence 999999999999999962 346789999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCc---cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 564 LTPNTER---QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 564 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
....... .......||+.|+|||.+.+..++.++||||||+++|||++ |.+||...........+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----------- 245 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----------- 245 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-----------
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-----------
Confidence 6643321 11234567889999999999999999999999999999999 55566544322111111
Q ss_pred HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
........+...+..+.+++.+||+.||++||++.|+++.|+++....
T Consensus 246 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 246 ------LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ------hcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111122234456678999999999999999999999999999997754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=367.46 Aligned_cols=269 Identities=23% Similarity=0.349 Sum_probs=199.0
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEeecC--e
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG--Q 482 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~ 482 (720)
...++|+..+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45678999999999999999999764 6899999999766556666778889999999996 999999999997544 6
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.|+||||++ ++|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 59999886 35789999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCC--------------------CccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCC
Q 005001 563 ALTPNT--------------------ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRP 621 (720)
Q Consensus 563 ~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~ 621 (720)
+..... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 765321 1112234679999999999987 6789999999999999999999999987654
Q ss_pred cchhhHHHhhccccccHHHHH---------------hhc---ccccCCC------------CChhHHHHHHHHHHHhcCC
Q 005001 622 RSEQSLVRWATPQLHDIDALA---------------KMV---DPALNGM------------YPAKSLSRFADIIALCVQP 671 (720)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~---------------~~~---~~~~~~~------------~~~~~~~~l~~li~~cl~~ 671 (720)
......+.-.. .......+. ... ....... .+...+.++.+|+.+||+.
T Consensus 237 ~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 MNQLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 32222111000 000000000 000 0000000 0113456789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 005001 672 EPEFRPPMSEVVQA 685 (720)
Q Consensus 672 dP~~RPs~~ell~~ 685 (720)
||++|||++|++++
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999977
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=351.18 Aligned_cols=264 Identities=22% Similarity=0.299 Sum_probs=204.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|+..+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999875 688999999975543 333457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.++++. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999973 35789999999999999999999999 99999999999999999999999999997665
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .......
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------------~~~~~~~ 252 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA-------------HINQAIP 252 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH-------------HHHSCCC
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH-------------HhccCCC
Confidence 433333345679999999999999999999999999999999999999997543210000 0000000
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHHHhhc
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRP-PMSEVVQALVRLVQRAS 694 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~~~~~~~ 694 (720)
.....+...+..+.+++.+||+.||++|| +++++++.|++.+....
T Consensus 253 --~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 253 --RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp --CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred --CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 01112344566789999999999999999 99999999988766554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=380.39 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=210.6
Q ss_pred CCccc-eeccCCCcEEEEEEEc---CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 412 FSQEF-LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 412 y~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
+...+ .||+|+||.||+|.+. ++..||||+++... .....+.+.+|++++++++||||+++++++.. +..++||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 33344 7999999999999764 46679999997653 33456789999999999999999999999876 5689999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 415 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp ECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999963 346799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcccc--ccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 568 TERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 568 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
...... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......... ..
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-----------------~~ 551 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-----------------AF 551 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-----------------HH
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----------------HH
Confidence 332221 22346689999999999999999999999999999998 99999865432211 11
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccc
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 696 (720)
+....+...+..++..+.++|.+||+.||++||++.+|++.|+.+.......
T Consensus 552 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 552 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 2222233456677889999999999999999999999999999987766443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.90 Aligned_cols=252 Identities=22% Similarity=0.325 Sum_probs=211.3
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|.+. +++.||+|++............+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999775 5889999999877666667788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc---eEEcccCCCcc
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSDCGLAAL 564 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a~~ 564 (720)
||+++++|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999998863 36789999999999999999999999 9999999999999986655 99999999976
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... .+
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----------------~~ 219 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA----------------QI 219 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------HH
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH----------------HH
Confidence 64332 2234679999999999999999999999999999999999999997643221111 11
Q ss_pred ccccc--CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VDPAL--NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..... ........+..+.+++.+||+.||++||++.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 220 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11111 111123456778999999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=355.52 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=199.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC------
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 481 (720)
.++|+..+.||+|+||.||+|.+. +|+.||||++.... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 467889999999999999999886 79999999997543 3345678899999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEEecCCCCHHHHhhhccCCCCCCC
Q 005001 482 ---------------------------------------------------QRLLVYEYVGNGNLHDMLHFADDSSKNLT 510 (720)
Q Consensus 482 ---------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~ 510 (720)
..++||||+++|+|.++++... ......
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchh
Confidence 3799999999999999997432 234457
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCc-----------ccccccccc
Q 005001 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-----------QVSTQMVGA 579 (720)
Q Consensus 511 ~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~gt 579 (720)
+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 778999999999999999999 999999999999999999999999999987654321 122345799
Q ss_pred ccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCC---hh
Q 005001 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP---AK 656 (720)
Q Consensus 580 ~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 656 (720)
+.|+|||++.+..++.++|||||||++|||++|..|+... . ....... ....+ ..
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~-------------~~~~~~~----~~~~~~~~~~ 297 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----V-------------RIITDVR----NLKFPLLFTQ 297 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----H-------------HHHHHHH----TTCCCHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----H-------------HHHHHhh----ccCCCccccc
Confidence 9999999999999999999999999999999987664210 0 0001111 11112 23
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 657 SLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 657 ~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
....+.+++.+||+.||++||++.|++++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 44567899999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=384.96 Aligned_cols=260 Identities=29% Similarity=0.474 Sum_probs=216.4
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
+...++|+..+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++||||+++++++.+ +..++
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 334567888999999999999999998888999999976443 24678999999999999999999999876 67899
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.++++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 339 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 99999999999999732 235689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
............+|..|+|||++.+..++.++|||||||++|||++ |+.||....... +...
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-----------------~~~~ 476 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------------VLDQ 476 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-----------------HHHH
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHH
Confidence 5322222233457889999999999999999999999999999999 999997643211 1111
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
+....+...+..++..+.+||.+||+.||++||++.+|++.|+++..
T Consensus 477 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 477 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 12222334456677889999999999999999999999999987754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=358.41 Aligned_cols=263 Identities=23% Similarity=0.248 Sum_probs=206.9
Q ss_pred cHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc---ChHHHHHHHHHHHHhhcCCCCCccccceEEee
Q 005001 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (720)
Q Consensus 404 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (720)
++....++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45667788999999999999999999774 688999999865432 33456788999999999999999999999999
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADDS------------------------------------SKNLTWNARVRVALGTAR 523 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------~~~~~~~~~~~i~~qi~~ 523 (720)
.+..++||||+++|+|.++++..... ...+++..+..++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998532111 122467788899999999
Q ss_pred HHHHHHhcCCCCcEEecCCCCCEEeCCCC--ceEEcccCCCccCCCCC---ccccccccccccccCcccccc--CCCccc
Q 005001 524 ALEYLHEVCLPSVVHRNFKSANILLDDEL--NPHLSDCGLAALTPNTE---RQVSTQMVGAFGYSAPEFALS--GIYTVK 596 (720)
Q Consensus 524 ~L~~LH~~~~~~iiH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 596 (720)
||+|||+. +|+||||||+||+++.++ .+||+|||++....... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998776 89999999997543221 112344679999999999976 678999
Q ss_pred chhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCC--CChhHHHHHHHHHHHhcCCCCC
Q 005001 597 SDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM--YPAKSLSRFADIIALCVQPEPE 674 (720)
Q Consensus 597 ~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~ 674 (720)
+|||||||++|||++|+.||....... ...++........ .....+..+.+++.+||+.||+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDAD----------------TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHH----------------HHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999997644221 1111111111111 1123567889999999999999
Q ss_pred CCCCHHHHHHH
Q 005001 675 FRPPMSEVVQA 685 (720)
Q Consensus 675 ~RPs~~ell~~ 685 (720)
+||++.+++++
T Consensus 321 ~Rps~~~~l~h 331 (345)
T 3hko_A 321 ERFDAMRALQH 331 (345)
T ss_dssp TSCCHHHHHHS
T ss_pred HCCCHHHHhcC
Confidence 99999999976
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=358.57 Aligned_cols=268 Identities=25% Similarity=0.403 Sum_probs=218.7
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEcC------CcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEe
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (720)
+...++|...+.||+|+||.||+|.+.. ...||+|.+.... .......+.+|+.+++++ +||||+++++++.
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3345788999999999999999998643 2479999997543 344567789999999999 8999999999999
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFADD----------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll 548 (720)
..+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 99999999999999999999974321 135689999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 005001 549 DDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQS 626 (720)
Q Consensus 549 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~ 626 (720)
+.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-- 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-- 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--
Confidence 9999999999999976543322 12234567889999999999999999999999999999999 9999976443211
Q ss_pred HHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 627 LVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
..+..........+...+..+.+++.+||+.||.+||++.|+++.|+++.+..
T Consensus 276 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 276 --------------FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp --------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 11112222223334556778999999999999999999999999999887654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.56 Aligned_cols=253 Identities=20% Similarity=0.297 Sum_probs=208.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999775 68899999986543 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC--CCceEEcccCCCccC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD--ELNPHLSDCGLAALT 565 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~ 565 (720)
||+++|+|.+++.. ....+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 128 E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 128 EFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp ECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999999862 235789999999999999999999999 9999999999999974 578999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+ .+ .
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i-------------~~-~ 265 (387)
T 1kob_A 202 NPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-------------KR-C 265 (387)
T ss_dssp CTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------------HH-C
T ss_pred CCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH-------------Hh-C
Confidence 5432 223457999999999999999999999999999999999999999764321111100 00 0
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
............+.++.++|.+||+.||++||++.|++++
T Consensus 266 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 266 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0011111223456788999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=356.93 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=193.0
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..++|+..+.||+|+||.||+|.+. +++.||+|++.... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 4567999999999999999999876 57899999987532 345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---CCceEEcccCCCc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDCGLAA 563 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a~ 563 (720)
|||+++|+|.+++. ..+.+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 127 ~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 127 LELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp ECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 99999999999986 346789999999999999999999999 9999999999999975 8899999999998
Q ss_pred cCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+
T Consensus 200 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---------------~~~~ 262 (349)
T 2w4o_A 200 IVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---------------MFRR 262 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH---------------HHHH
T ss_pred ccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH---------------HHHH
Confidence 654322 22346799999999999999999999999999999999999999976443211 1111
Q ss_pred hccccc--CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPAL--NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+..... ........+..+.+|+.+||+.||++||++.|++++
T Consensus 263 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 263 ILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 111223456788999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=355.79 Aligned_cols=265 Identities=24% Similarity=0.335 Sum_probs=210.4
Q ss_pred HHhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee----cC
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HG 481 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~ 481 (720)
...++|+..+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 3457899999999999999999987 57899999988643 34556788999999999999999999999863 34
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+++|+|.+++.........+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 78999999999999999986655667899999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccc--------cccccccccccCccccccCC---CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh
Q 005001 562 AALTPNTERQV--------STQMVGAFGYSAPEFALSGI---YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW 630 (720)
Q Consensus 562 a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~ 630 (720)
+.......... .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||........
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------ 254 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD------ 254 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS------
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc------
Confidence 87543211110 12245799999999997654 68899999999999999999999953110000
Q ss_pred hccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 631 ATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
..............+...+..+.+++.+||+.||++||++.+++++|+++..
T Consensus 255 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 255 ---------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp ---------CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ---------hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0000111111222234556789999999999999999999999999988743
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=352.34 Aligned_cols=271 Identities=21% Similarity=0.339 Sum_probs=194.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 357899999999999999999765 68999999986543 2223466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 488 EYVGNGNLHDMLHFADD--SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||++ |+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 599998864332 234689999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhh-ccccccHHHHH
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWA-TPQLHDIDALA 642 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~~-~~~~~~~~~~~ 642 (720)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+ ... .+....+....
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 43322 22345789999999999874 6899999999999999999999999865533222111 100 00000000000
Q ss_pred hhc--cccc------------CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMV--DPAL------------NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~--~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+.. .+.. ....+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 0000 000112345678999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=352.03 Aligned_cols=267 Identities=26% Similarity=0.398 Sum_probs=213.3
Q ss_pred hhcHHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhc--CCCCCccccceEEee
Q 005001 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAE 479 (720)
Q Consensus 402 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~ 479 (720)
........++|...+.||+|+||.||+|.+ +|+.||+|++... ....+.+|.+++.. ++||||+++++++..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 334455677899999999999999999988 5899999998543 34567788888776 799999999999987
Q ss_pred cC----eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEEecCCCCCEE
Q 005001 480 HG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH--------EVCLPSVVHRNFKSANIL 547 (720)
Q Consensus 480 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--------~~~~~~iiH~Dlkp~NIl 547 (720)
.+ ..++||||+++|+|.++++. ..+++.++..++.|++.||+||| +. +|+||||||+||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 76 78999999999999999972 46899999999999999999999 67 9999999999999
Q ss_pred eCCCCceEEcccCCCccCCCCCcc---ccccccccccccCccccccC------CCcccchhhhHHHHHHHHHhC------
Q 005001 548 LDDELNPHLSDCGLAALTPNTERQ---VSTQMVGAFGYSAPEFALSG------IYTVKSDVYSFGVVMLELLTG------ 612 (720)
Q Consensus 548 l~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg------ 612 (720)
++.++.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999765443322 22345799999999999876 344789999999999999999
Q ss_pred ----CCCCCCCCCcchhhHHHhhccccccHHHHHh-hcccccCCCCC-----hhHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 005001 613 ----RKPLDSSRPRSEQSLVRWATPQLHDIDALAK-MVDPALNGMYP-----AKSLSRFADIIALCVQPEPEFRPPMSEV 682 (720)
Q Consensus 613 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~el 682 (720)
..||........ ....+.+ ..........+ ..++..+.+++.+||+.||++||++.++
T Consensus 260 ~~~~~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDP------------SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp CCCCCCTTTTTSCSSC------------CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccccccCccccCcCcc------------cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 778765432211 0111111 11222222222 3567789999999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 005001 683 VQALVRLVQRAS 694 (720)
Q Consensus 683 l~~L~~~~~~~~ 694 (720)
+++|+++.++..
T Consensus 328 ~~~L~~i~~~~~ 339 (342)
T 1b6c_B 328 KKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHHHHTTC
T ss_pred HHHHHHHHHHhc
Confidence 999999977653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=346.88 Aligned_cols=250 Identities=21% Similarity=0.310 Sum_probs=207.5
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
..++|+..+.||+|+||.||+|.+. +++.||+|++............+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567899999999999999999876 799999999986655566677888999999998 99999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC--------------
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-------------- 551 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-------------- 551 (720)
||||+++++|.+++.........+++.++..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999986544447799999999999999999999999 99999999999999844
Q ss_pred -----CceEEcccCCCccCCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchh
Q 005001 552 -----LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ 625 (720)
Q Consensus 552 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~ 625 (720)
..+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|||++|..|+.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 479999999998664322 23589999999999876 567899999999999999999887643210
Q ss_pred hHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 626 SLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...... ......+...+..+.+++.+||+.||++||++.|++++
T Consensus 237 ---------------~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ---------------WHEIRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---------------HHHHHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---------------HHHHHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 011111 11122344566789999999999999999999999865
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=355.81 Aligned_cols=274 Identities=24% Similarity=0.364 Sum_probs=218.5
Q ss_pred cCCCccceeccCCCcEEEEEEE-----cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEe--ecCe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA--EHGQ 482 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~ 482 (720)
++|+..+.||+|+||.||+|.+ .+++.||+|++... .....+.+.+|++++++++||||+++++++. +...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 5788899999999999999984 36889999999754 3445677899999999999999999999886 4567
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 89999999999999999742 24689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc--ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh-hccccccHH
Q 005001 563 ALTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW-ATPQLHDID 639 (720)
Q Consensus 563 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 639 (720)
......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...+ .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~ 251 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGCERDVPALS 251 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHCC----CCHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh---hhhcccccccccHH
Confidence 876543322 2233568889999999999999999999999999999999999986432110 0000 011122223
Q ss_pred HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
...+.+........+..++..+.+++.+||+.||++||++.|++++|+++.....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 3344444444555667788899999999999999999999999999998866543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=372.27 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=200.5
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|+..+.||+|+||.||+|... +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999765 689999999975432 333456778899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999873 4578999999999999999999998 7 9999999999999999999999999999764
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----------------~~i~ 362 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----------------ELIL 362 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHH
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH----------------HHHH
Confidence 3322 2234568999999999999999999999999999999999999999764322111 1111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
... ..++...+.++.+||.+||+.||++|| +++|++++
T Consensus 363 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 363 MEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111 124555677899999999999999999 99999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=368.01 Aligned_cols=250 Identities=24% Similarity=0.423 Sum_probs=210.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|...+.||+|+||.||+|.+. +|+.||+|++...... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888999999999999999876 7999999999654321 22356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++|+|.+++. ..+.+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999996 356799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCccccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... ...++.
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----------------~~~~i~ 229 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT----------------LFKKIC 229 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----------------HHHHHH
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----------------HHHHHh
Confidence 422 2334579999999999998776 689999999999999999999997643321 111222
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... ...+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 230 ~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 230 DGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp TTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred cCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 211 12344556788999999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=356.43 Aligned_cols=249 Identities=29% Similarity=0.441 Sum_probs=205.3
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.+.|+..+.||+|+||.||+|.. .+++.||||++..... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45588899999999999999986 5789999999865432 233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+. |+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 588888753 246799999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCccccccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 567 NTERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
.. ....||+.|+|||++. +..++.++|||||||++|||++|+.||........ +.+
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------------~~~ 264 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LYH 264 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------HHH
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----------------HHH
Confidence 32 2357999999999985 56789999999999999999999999975432111 111
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+.........+...+..+.+++.+||+.||++||++.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 265 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111112234456778999999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.94 Aligned_cols=273 Identities=23% Similarity=0.332 Sum_probs=210.3
Q ss_pred cchhcHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-----CCCcccc
Q 005001 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-----HPNIVTL 473 (720)
Q Consensus 400 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l 473 (720)
++........++|.+.+.||+|+||.||+|.+. +++.||+|++... ......+..|+.+++.+. ||||+++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 445556667789999999999999999999874 6889999999642 334556777888888886 9999999
Q ss_pred ceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---
Q 005001 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD--- 550 (720)
Q Consensus 474 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~--- 550 (720)
++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 99999999999999999 88999999742 234689999999999999999999999 9999999999999975
Q ss_pred ----------------------CCceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHH
Q 005001 551 ----------------------ELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLE 608 (720)
Q Consensus 551 ----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~e 608 (720)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999864432 234579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh-------cc-cccCCCCC--------------------hhHHHH
Q 005001 609 LLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM-------VD-PALNGMYP--------------------AKSLSR 660 (720)
Q Consensus 609 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~-~~~~~~~~--------------------~~~~~~ 660 (720)
|++|+.||...........+................ .. .......+ ......
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 999999998654332222222111111110000000 00 00000000 011256
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 661 FADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 661 l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+.+|+.+||+.||++|||++|++++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcC
Confidence 7899999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=344.90 Aligned_cols=269 Identities=19% Similarity=0.262 Sum_probs=208.7
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEE-eecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC-AEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l 485 (720)
..++|+..+.||+|+||.||+|.+ .+++.||+|++..... ...+.+|+.+++.++|++++..++++ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 457899999999999999999986 5788999998654322 23477889999999888877766655 66778899
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe---CCCCceEEcccCCC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLA 562 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a 562 (720)
||||+ +++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 83 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 99999 8899999873 245799999999999999999999999 99999999999999 78899999999999
Q ss_pred ccCCCCCcc------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc
Q 005001 563 ALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLH 636 (720)
Q Consensus 563 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 636 (720)
+........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----- 230 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI----- 230 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH-----
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh-----
Confidence 866443221 123457999999999999999999999999999999999999999875543222111100
Q ss_pred cHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcccc
Q 005001 637 DIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVK 697 (720)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 697 (720)
........ ........+..+.+++.+||+.||++||++.++++.|+++.++.....
T Consensus 231 ----~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 231 ----SEKKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp ----HHHHHHSC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred ----hcccccch-hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 00000000 000112345678999999999999999999999999999998876543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=382.00 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=208.8
Q ss_pred ceeccCCCcEEEEEEEc---CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||.||+|.+. .++.||||+++.........+.+.+|++++++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 4678999999876656666788999999999999999999999986 4568999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc-
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ- 571 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 571 (720)
|+|.++++ ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999996 346799999999999999999999999 9999999999999999999999999999876543322
Q ss_pred -ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 572 -VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 572 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +...+....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~~~i~~~~ 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAMLEKGE 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHHTTC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCC
Confidence 2233457889999999999999999999999999999998 999997654321 112222233
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
....+..++.++.++|.+||+.||++||++.+|++.|+++...
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 3445667788999999999999999999999999999988654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=351.10 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=201.7
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe---
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ--- 482 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 482 (720)
..++|+..+.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.++++++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 346799999999999999999986 5789999999976543 33445678999999999999999999999876543
Q ss_pred -EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 483 -RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 483 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
.++||||+++++|.++++. .+.+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 4999999999999999973 35789999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCcc--ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 562 AALTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 562 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
+......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------------- 229 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------------- 229 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------------
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------------
Confidence 9865443222 2234569999999999999999999999999999999999999997644321111
Q ss_pred HHHhhcccccC--CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHHHHHh
Q 005001 640 ALAKMVDPALN--GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVV-QALVRLVQR 692 (720)
Q Consensus 640 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell-~~L~~~~~~ 692 (720)
........ .......+.++.+++.+||+.||++||++.+++ +.+.++...
T Consensus 230 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 230 ---QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ---HHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ---HHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 00000000 001123556789999999999999999777665 455555443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=359.40 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=196.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHH-hhcCCCCCccccceEEeecCeEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSN-MSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
.++|+..+.||+|+||.||+|+.. +++.||+|++...... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357889999999999999999876 5889999999765442 2334556677766 567899999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.++++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.+|.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999973 35789999999999999999999999 9999999999999999999999999999753
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... +...++.
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----------------~~~~~i~ 252 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----------------EMYDNIL 252 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH----------------HHHHHHH
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHH
Confidence 3222 2234568999999999999999999999999999999999999999754321 1111222
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSE 681 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 681 (720)
... ..++...+..+.+++.+||+.||++||++.+
T Consensus 253 ~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 253 NKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred hcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 221 1234556678899999999999999999853
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.04 Aligned_cols=255 Identities=26% Similarity=0.348 Sum_probs=202.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|...+.||+|+||.||+|... ++..||+|++.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 457888999999999999999775 68899999987554 2334577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe---CCCCceEEcccCCCcc
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAAL 564 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 564 (720)
||+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999999875544567899999999999999999999999 99999999999999 4568899999999976
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
..... ......||+.|+|||++. ..++.++||||||+++|||++|+.||...............
T Consensus 177 ~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~------------- 240 (285)
T 3is5_A 177 FKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK------------- 240 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred cCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-------------
Confidence 54322 234457999999999875 56899999999999999999999999764422111111111
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..... ......+..+.+++.+||+.||++||++.|++++
T Consensus 241 -~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 241 -EPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -CCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -Ccccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110 0111245678899999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=365.39 Aligned_cols=265 Identities=21% Similarity=0.272 Sum_probs=201.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec------C
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------G 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 481 (720)
.++|+..+.||+|+||.||+|.+. +++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999765 689999999987665666678899999999999999999999998654 4
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999976 5777664 3589999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hh-hcccc---c
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RW-ATPQL---H 636 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~-~~~~~---~ 636 (720)
++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+ .. ..+.. .
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9865432 2234568999999999999999999999999999999999999999875532221111 10 00000 0
Q ss_pred c-HHHHHhhcccccC-CC------CC-----------hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 637 D-IDALAKMVDPALN-GM------YP-----------AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 637 ~-~~~~~~~~~~~~~-~~------~~-----------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ............. .. ++ ...+.++.+|+.+||+.||++|||++|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0011111110000 00 00 1125678999999999999999999999976
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=347.67 Aligned_cols=258 Identities=25% Similarity=0.376 Sum_probs=197.2
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..++|+..+.||+|+||.||+|.+ .+|+.||+|++............+.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 356789999999999999999987 4789999999976544444445555666668888999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++ +|.++++........+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999975 998888765555678999999999999999999999853 89999999999999999999999999997654
Q ss_pred CCCccccccccccccccCcccc----ccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 567 NTERQVSTQMVGAFGYSAPEFA----LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....... ....
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------~~~~ 224 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF---------------QQLK 224 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH---------------HHHH
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH---------------HHHH
Confidence 332 22334799999999996 56678999999999999999999999997543211 1111
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...........+...+..+.+++.+||+.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 225 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1222222222233456789999999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=370.97 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=213.0
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|...+.||+|+||.||+|++. +|+.||+|++...... ......+.+|+.++++++||||+++++++...+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888999999999999999875 6999999999754322 22356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||++||+|.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999975444456799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....+..
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~------------~~~~~i~~ 407 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK------------ELKQRVLE 407 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH------------HHHHHHHH
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH------------HHHHHHhh
Confidence 4322 2334589999999999999999999999999999999999999998654321111 11111111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPM-----SEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~ 685 (720)
. ...++...+..+.++|.+||+.||++||++ ++++++
T Consensus 408 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 408 Q--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred c--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 1 123455677889999999999999999975 666653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=340.66 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=207.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|.+. +++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 467889999999999999999876 689999999865432 334577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999999886 346789999999999999999999999 999999999999999999999999999976533
Q ss_pred CCc-cccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 568 TER-QVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 568 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
... .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... .. ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~--------------~~~ 222 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS--------------DWK 222 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HH--------------HHH
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HH--------------Hhh
Confidence 221 12334579999999999988775 78999999999999999999999765432111 11 111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
............+..+.+++.+||+.||++||++.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 1111111123456778899999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=343.67 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=205.9
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467889999999999999999775 5778999998654322 2235678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999999873 35689999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
... ......||+.|+|||.+.+..++.++||||||+++|||++|..||.......... .+.
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------------~~~ 220 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK----------------RIS 220 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----------------HHH
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH----------------HHH
Confidence 332 2234579999999999999999999999999999999999999997543221111 111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+...+..+.+++.+||+.||++||+++|++++
T Consensus 221 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 221 --RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11223445566788999999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=350.03 Aligned_cols=269 Identities=24% Similarity=0.361 Sum_probs=213.9
Q ss_pred HhcCCCccceeccCCCcEEEEEEE------cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
..++|...+.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.++++++||||+++++++...+
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 346799999999999999999973 357789999996433 4455678899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---CCceE
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDS---SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPH 555 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~k 555 (720)
..++||||+++++|.+++...... ...+++.++..++.|++.||.|||+. +|+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999754321 24589999999999999999999999 9999999999999984 44699
Q ss_pred EcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhcc
Q 005001 556 LSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATP 633 (720)
Q Consensus 556 l~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~ 633 (720)
|+|||++........ .......||+.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---------- 253 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---------- 253 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----------
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH----------
Confidence 999999874432221 12233568999999999999999999999999999999998 999997543211
Q ss_pred ccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcccc
Q 005001 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVK 697 (720)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 697 (720)
..+.+........+..++..+.+++.+||+.||++||++.+++++|+.+........
T Consensus 254 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 310 (327)
T 2yfx_A 254 -------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 310 (327)
T ss_dssp -------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHT
T ss_pred -------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHhc
Confidence 111111111223345567789999999999999999999999999999877665443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=342.83 Aligned_cols=250 Identities=22% Similarity=0.371 Sum_probs=204.1
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee----cCeEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRL 484 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 484 (720)
..|...+.||+|+||.||+|.+. ++..||+|++............+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34777889999999999999774 67889999998776677778889999999999999999999998865 35689
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEecCCCCCEEeC-CCCceEEcccCC
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLD-DELNPHLSDCGL 561 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~Dfg~ 561 (720)
+||||+++++|.++++. ...+++..+..++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999973 36789999999999999999999998 7 99999999999997 789999999999
Q ss_pred CccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
+...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......... .
T Consensus 179 ~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---------------~ 239 (290)
T 1t4h_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------Y 239 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---------------H
T ss_pred ccccccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH---------------H
Confidence 9765432 2234579999999998764 5899999999999999999999999764332111 1
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
............+...+..+.+++.+||+.||++||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11111111111223344678999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=359.21 Aligned_cols=278 Identities=21% Similarity=0.296 Sum_probs=215.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC--eEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLL 485 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 485 (720)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++..... ......+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 467899999999999999999876 489999999975432 233567789999999999999999999988765 7799
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe----CCCCceEEcccCC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCGL 561 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~ 561 (720)
||||+++|+|.++++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999997432 223499999999999999999999999 99999999999999 7788899999999
Q ss_pred CccCCCCCccccccccccccccCcccccc--------CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcch-hhHH-Hhh
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALS--------GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSE-QSLV-RWA 631 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~-~~~~-~~~ 631 (720)
++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .... ...
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 98764432 2234679999999999875 5678899999999999999999999975433211 1111 100
Q ss_pred ccc-cccHHHHHhh------c--ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 632 TPQ-LHDIDALAKM------V--DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 632 ~~~-~~~~~~~~~~------~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
... ........+. . ........+...+..+.+++.+||+.||++||+++++++.+.+++++.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 000 0000000000 0 001112234667888999999999999999999999999999998864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=343.00 Aligned_cols=267 Identities=19% Similarity=0.267 Sum_probs=211.2
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEE-eecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC-AEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lV 486 (720)
.++|+..+.||+|+||.||+|.+ .+++.||+|++..... ...+.+|+.+++.++|++++..+.++ ...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 46799999999999999999987 5789999999865432 23578899999999988877666655 566788999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe---CCCCceEEcccCCCc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAA 563 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 563 (720)
|||+ +++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.
T Consensus 84 ~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 84 MELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 9999 8899999973 245799999999999999999999999 99999999999999 488899999999998
Q ss_pred cCCCCCcc------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 005001 564 LTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 564 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------ 230 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI------ 230 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH------
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh------
Confidence 66543321 123457999999999999999999999999999999999999999865433221111100
Q ss_pred HHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccc
Q 005001 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 696 (720)
........ ....+...+..+.+++.+||+.||++||++.++++.|+++.++....
T Consensus 231 ---~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 231 ---SEKKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp ---HHHHHHSC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ---cccccCCc-hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 00000000 00011234567899999999999999999999999999998877544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=352.68 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=181.9
Q ss_pred cceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEeecCeEEEEEEecCC
Q 005001 415 EFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
.+.||+|+||.||+|.+. +++.||+|++... ....+.+|+.+++.+. ||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 468999999999999875 6899999998542 3566778999999996 99999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC---ceEEcccCCCccCCCCC
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPHLSDCGLAALTPNTE 569 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~ 569 (720)
|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++......
T Consensus 91 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 91 GELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp CBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999999973 46799999999999999999999999 999999999999997765 89999999998654432
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+...++.....
T Consensus 164 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 164 -QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC---------TSAVEIMKKIKKGDF 233 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C---------CCHHHHHHHHTTTCC
T ss_pred -CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc---------ccHHHHHHHHHcCCC
Confidence 2233457899999999999999999999999999999999999999764432110 001112222222221
Q ss_pred CCCC--ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 NGMY--PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 ~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... ....+.++.+|+.+||+.||++||+++|++++
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1111 12356789999999999999999999998854
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=372.15 Aligned_cols=257 Identities=24% Similarity=0.378 Sum_probs=212.2
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
..++|+..+.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999875 699999999965432 22335668899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.+|.+||+|||++...
T Consensus 262 VmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999998732 234599999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.+.+
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~-------------~i~~~i 401 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-------------EVERLV 401 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH-------------HHHHHH
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH-------------HHHHHh
Confidence 5432 2234589999999999999999999999999999999999999998654321111 111111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
. .....++...+.++.+||.+||+.||++|| +++|++++
T Consensus 402 ~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 402 K-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp H-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred h-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1 112234556677899999999999999999 78888865
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.29 Aligned_cols=267 Identities=21% Similarity=0.374 Sum_probs=210.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 457889999999999999999876 68899999987543 4455678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.++++. ...+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++.....
T Consensus 111 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999973 356899999999999999999999842 899999999999999999999999999864421
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh-----------------
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW----------------- 630 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~----------------- 630 (720)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 122345799999999999999999999999999999999999999976543221111100
Q ss_pred ---------hccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 631 ---------ATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 631 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..+....................+...+.++.+|+.+||+.||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000011111222222222222223456789999999999999999999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=354.30 Aligned_cols=246 Identities=22% Similarity=0.336 Sum_probs=206.1
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh------HHHHHHHHHHHHhhcCCCCCccccceEEee
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL------QEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (720)
...++|+..+.||+|+||.||+|.+. +++.||+|++....... .....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34578999999999999999999764 68899999997554221 123456789999999999999999999999
Q ss_pred cCeEEEEEEecCCC-CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcc
Q 005001 480 HGQRLLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (720)
Q Consensus 480 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 558 (720)
.+..++||||+.+| +|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEee
Confidence 99999999999777 9999987 346799999999999999999999999 999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
||++....... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 174 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 174 FGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp CTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred cccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 99998765432 2234679999999999998887 88999999999999999999999642110
Q ss_pred HHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... ....+...+.++.+|+.+||+.||++||++.+++++
T Consensus 237 -------~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -------VEA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------TTT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------Hhh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 111233356778999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=351.20 Aligned_cols=269 Identities=22% Similarity=0.345 Sum_probs=206.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357889999999999999999876 5899999998766555566677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988765 346799999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-ccccccHHH-HHh-
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA-TPQLHDIDA-LAK- 643 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~-~~~- 643 (720)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+... ......... ..+
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 322 22345799999999999875 6899999999999999999999999875533222111100 000000000 000
Q ss_pred -----hcccccCCCC-----ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 -----MVDPALNGMY-----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 -----~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+...... ....+..+.+|+.+||+.||++||++.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000111111 12346789999999999999999999999976
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.56 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=204.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-CeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-GQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|+.. |+.||+|.+.... ..+.+.+|+.++++++||||+++++++... +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 467889999999999999999875 8899999997542 456788999999999999999999987554 5789999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999997421 23478999999999999999999999 999999999999999999999999999875433
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.. ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+.
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-----------------~~~~~ 228 (278)
T 1byg_A 170 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----------------VPRVE 228 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-----------------HHHHT
T ss_pred cc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHh
Confidence 21 23457889999999999999999999999999999998 9999975432211 11111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
.......+...+..+.+++.+||+.||++||++.++++.|+++....
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 12223345566788999999999999999999999999999986643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=354.71 Aligned_cols=264 Identities=20% Similarity=0.290 Sum_probs=202.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC------
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 481 (720)
.++|+..+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999874 6999999999766555566778899999999999999999999987653
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+ +++|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 7899999872 5789999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh--hccc----
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW--ATPQ---- 634 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~--~~~~---- 634 (720)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.........+.. ..+.
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9875432 234678999999999987 6799999999999999999999999987553322211110 0000
Q ss_pred --ccc--HHHHHhhcccccC---CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 --LHD--IDALAKMVDPALN---GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 --~~~--~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... .....+....... .......+..+.+|+.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 0001111110000 01123456778999999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=345.83 Aligned_cols=271 Identities=24% Similarity=0.310 Sum_probs=199.7
Q ss_pred HHhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccC---hHHHHHHHHHHHHhhcC---CCCCccccceEEee
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRL---RHPNIVTLAGYCAE 479 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~ 479 (720)
...++|+..+.||+|+||.||+|.+ .+++.||+|++...... ......+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999986 46899999998643321 11123455666665555 59999999999977
Q ss_pred cC-----eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCce
Q 005001 480 HG-----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (720)
Q Consensus 480 ~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 554 (720)
.. ..++||||+. ++|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 55 5799999997 5999998732 234499999999999999999999999 99999999999999999999
Q ss_pred EEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhh-c
Q 005001 555 HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWA-T 632 (720)
Q Consensus 555 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~~-~ 632 (720)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ... .
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999998664332 234467999999999999999999999999999999999999999865433222111 100 0
Q ss_pred cc---cccHHHHHh-hcccccC---CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 633 PQ---LHDIDALAK-MVDPALN---GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 633 ~~---~~~~~~~~~-~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+. +.......+ ....... .......+..+.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 000000000 0000000 00012345678999999999999999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=368.59 Aligned_cols=269 Identities=22% Similarity=0.289 Sum_probs=190.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee-----cCe
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-----HGQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 482 (720)
.++|+..+.||+|+||.||+|.+. +++.||||++..........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999765 68999999997665566667889999999999999999999999843 357
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.|+||||+. ++|.++++ ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 69999886 356799999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCc--------------------------cccccccccccccCcccc-ccCCCcccchhhhHHHHHHHHHh----
Q 005001 563 ALTPNTER--------------------------QVSTQMVGAFGYSAPEFA-LSGIYTVKSDVYSFGVVMLELLT---- 611 (720)
Q Consensus 563 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGv~l~ellt---- 611 (720)
+....... ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 87643221 122445789999999986 45679999999999999999999
Q ss_pred -------CCCCCCCCCCcch-----------------hhH---H-H-hhccccc------c--HHHHHhhcccccCC---
Q 005001 612 -------GRKPLDSSRPRSE-----------------QSL---V-R-WATPQLH------D--IDALAKMVDPALNG--- 651 (720)
Q Consensus 612 -------g~~pf~~~~~~~~-----------------~~~---~-~-~~~~~~~------~--~~~~~~~~~~~~~~--- 651 (720)
|+++|.+...... ... + . ...+... . .....+........
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 5666654321000 000 0 0 0000000 0 00000000000000
Q ss_pred CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 652 MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 652 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+.++.+|+.+||+.||++|||++|++++
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0012335678999999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=355.41 Aligned_cols=246 Identities=23% Similarity=0.322 Sum_probs=198.2
Q ss_pred ccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCC
Q 005001 414 QEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 414 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 3568999999999999764 68999999997543 34567889999999999999999999999999999999999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe--CCCCceEEcccCCCccCCCCCc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL--DDELNPHLSDCGLAALTPNTER 570 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~ 570 (720)
++|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 171 ~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 171 GELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp CEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 999998863 235689999999999999999999999 99999999999999 6678999999999987654322
Q ss_pred cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc-
Q 005001 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL- 649 (720)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 649 (720)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .++.....
T Consensus 245 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----------------~~i~~~~~~ 306 (373)
T 2x4f_A 245 --LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL----------------NNILACRWD 306 (373)
T ss_dssp --CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HHHHHTCCC
T ss_pred --cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------HHHHhccCC
Confidence 23357999999999999999999999999999999999999999765422111 11111110
Q ss_pred -CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 650 -NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 650 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........+.++.+|+.+||+.||++||++.|++++
T Consensus 307 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 307 LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001112346788999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=351.16 Aligned_cols=276 Identities=23% Similarity=0.358 Sum_probs=203.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHH--HHHHhhcCCCCCccccceEEee-----cC
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLE--AVSNMSRLRHPNIVTLAGYCAE-----HG 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~l~~~~~~-----~~ 481 (720)
.++|+..+.||+|+||.||+|.. +++.||+|++.... ...+.. |+..+..++||||+++++.+.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 36788899999999999999976 68999999986432 233333 4444556899999999986533 23
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCcEEecCCCCCEEeCCCCceE
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC------LPSVVHRNFKSANILLDDELNPH 555 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~------~~~iiH~Dlkp~NIll~~~~~~k 555 (720)
..++||||+++|+|.++++. ...++..+..++.|++.||+|||+.. .++|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 67899999999999999963 44589999999999999999999862 23899999999999999999999
Q ss_pred EcccCCCccCCCCC-------ccccccccccccccCcccccc-------CCCcccchhhhHHHHHHHHHhCCCCCCCCCC
Q 005001 556 LSDCGLAALTPNTE-------RQVSTQMVGAFGYSAPEFALS-------GIYTVKSDVYSFGVVMLELLTGRKPLDSSRP 621 (720)
Q Consensus 556 l~Dfg~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~elltg~~pf~~~~~ 621 (720)
|+|||++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999997654321 112234579999999999987 4567899999999999999999877754332
Q ss_pred cch-hhHHHhhccccccHHHHHhhc-ccccCCCCC------hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 622 RSE-QSLVRWATPQLHDIDALAKMV-DPALNGMYP------AKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 622 ~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
... ..................... ........+ ...+..+.++|.+||+.||++|||++|+++.|+++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 211 111111111111112222111 111122222 236678999999999999999999999999999998776
Q ss_pred cc
Q 005001 694 SV 695 (720)
Q Consensus 694 ~~ 695 (720)
..
T Consensus 321 ~~ 322 (336)
T 3g2f_A 321 ER 322 (336)
T ss_dssp CC
T ss_pred Hh
Confidence 43
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.12 Aligned_cols=269 Identities=20% Similarity=0.287 Sum_probs=196.0
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..++|+..+.||+|+||.||+|.+. +++.||+|++............+.+|+.++++++||||+++++++...+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3467899999999999999999765 689999999976654555566788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe-----CCCCceEEcccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL-----DDELNPHLSDCGL 561 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll-----~~~~~~kl~Dfg~ 561 (720)
|||+++ +|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999985 99999873 45699999999999999999999999 99999999999999 4555699999999
Q ss_pred CccCCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-h-hccccccH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR-W-ATPQLHDI 638 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~-~-~~~~~~~~ 638 (720)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+. . ..+.....
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 976543222 22345789999999999875 48999999999999999999999997654322211110 0 00000000
Q ss_pred ---HHHHhhcc--cccCC-----CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 ---DALAKMVD--PALNG-----MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ---~~~~~~~~--~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........ +.... ..+...+.++.+|+.+||+.||++|||++|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000000 00000 0011245678899999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.03 Aligned_cols=264 Identities=18% Similarity=0.259 Sum_probs=213.5
Q ss_pred chhcHHHHhcCCCcc-ceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEE
Q 005001 401 TVASLQTATNSFSQE-FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (720)
Q Consensus 401 ~~~~~~~~~~~y~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (720)
.+...+...++|.+. +.||+|+||.||+|... +++.||+|++............+.+|+.++..+ +||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 455667777888887 89999999999999776 689999999987665555577889999999998 569999999999
Q ss_pred eecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---CCce
Q 005001 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNP 554 (720)
Q Consensus 478 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~ 554 (720)
...+..++||||+++|+|.+++.. .....+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 999999999999999999998852 2346799999999999999999999999 9999999999999998 7899
Q ss_pred EEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 005001 555 HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 555 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+
T Consensus 174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------ 245 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI------ 245 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------
T ss_pred EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH------
Confidence 999999998764332 223457999999999999999999999999999999999999999764432111111
Q ss_pred cccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. .............+..+.+++.+||+.||++||++++++++
T Consensus 246 -------~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 246 -------SQ-VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -------HH-TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -------Hh-cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00 11111222234566788999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=343.29 Aligned_cols=253 Identities=22% Similarity=0.376 Sum_probs=207.4
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee------
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE------ 479 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 479 (720)
...++|+..+.||+|+||.||+|.+. +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 34567899999999999999999886 79999999996532 245689999999999999999998854
Q ss_pred ----------cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC
Q 005001 480 ----------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (720)
Q Consensus 480 ----------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~ 549 (720)
....++||||+++++|.++++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 44579999999999999999743 246789999999999999999999999 999999999999999
Q ss_pred CCCceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005001 550 DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR 629 (720)
Q Consensus 550 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~ 629 (720)
.++.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|..|+... .
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~---- 225 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----S---- 225 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----H----
T ss_pred CCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----H----
Confidence 999999999999987654322 23456999999999999999999999999999999999999887421 0
Q ss_pred hhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 630 WATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
........ ...+...+..+.+++.+||+.||++||++.|++++|..+.+...
T Consensus 226 ---------~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 226 ---------KFFTDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ---------HHHHHHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ---------HHHHHhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 00111111 11233455678899999999999999999999999988755443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=347.23 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=208.2
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh----HHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
..++|+..+.||+|+||.||+|.+. +|+.||+|.+....... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467889999999999999999876 68999999987544322 135678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC----ceEEcc
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSD 558 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~D 558 (720)
.++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 999999999999999997 346789999999999999999999999 999999999999999888 799999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
||++....... ......||+.|+|||++.+..++.++||||||+++|||++|..||..........
T Consensus 163 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------------ 228 (321)
T 2a2a_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------ 228 (321)
T ss_dssp CTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------------
T ss_pred CccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH------------
Confidence 99998665432 2234579999999999999999999999999999999999999997643221111
Q ss_pred HHHHhhcccccC--CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKMVDPALN--GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+...... .......+..+.+++.+||+.||++||++.|++++
T Consensus 229 ----~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 229 ----NITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ----HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ----HHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11110000 00012345678899999999999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.43 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=187.6
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|+..+.||+|+||.||+|.. .+|+.||+|.+...... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35688899999999999999987 47899999999644321 12246788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999872 246789999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .+...
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------~~~~~ 226 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------------NKVVL 226 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCS
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------------HHHhh
Confidence 3222 123357999999999999999999999999999999999999999764432111 11111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ...+...+.++.+++.+||+.||++||++.+++++
T Consensus 227 ~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 227 AD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp SC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11 12344556788999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=346.99 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=203.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC-C-------cEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN-G-------KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (720)
.++|...+.||+|+||.||+|.+.. + ..||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4578889999999999999997653 3 479999986543 34467789999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc-------
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN------- 553 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~------- 553 (720)
+..++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 999999999999999999974 234489999999999999999999999 9999999999999998887
Q ss_pred -eEEcccCCCccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 005001 554 -PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA 631 (720)
Q Consensus 554 -~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~ 631 (720)
+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+..........
T Consensus 159 ~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~----- 228 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL----- 228 (289)
T ss_dssp EEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----
T ss_pred eeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-----
Confidence 999999998654321 23468999999999988 778999999999999999999655544322211110
Q ss_pred ccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 632 TPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
..... ....+...+..+.+++.+||+.||++||++.+++++|+++....
T Consensus 229 -----------~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 229 -----------QFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp -----------HHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred -----------HHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 00000 11122333456889999999999999999999999998876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=352.42 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=202.4
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
..++|+..+.||+|+||.||+|.+. +++.||+|++...... ..+|++++.++ +||||+++++++.+.+..++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3567899999999999999999875 6889999999654322 23567777766 79999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC----CceEEcccCC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE----LNPHLSDCGL 561 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~ 561 (720)
||||+++|+|.+++. ..+.+++.++..++.||+.||+|||+. +|+||||||+|||+..+ +.+||+|||+
T Consensus 94 v~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 94 VTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp EECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 999999999999986 346799999999999999999999999 99999999999998543 3599999999
Q ss_pred CccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
+........ .....+||+.|+|||++.+..++.++|||||||++|||++|..||............
T Consensus 167 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~------------- 232 (342)
T 2qr7_A 167 AKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL------------- 232 (342)
T ss_dssp CEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH-------------
T ss_pred cccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH-------------
Confidence 986544322 233467999999999999888999999999999999999999999764322211111
Q ss_pred Hhhcccc--cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDPA--LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..+.... .........+..+.+|+.+||+.||++||++.+++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 233 ARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111 1112234566788999999999999999999999976
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=349.11 Aligned_cols=272 Identities=22% Similarity=0.363 Sum_probs=215.7
Q ss_pred hcCCCccceeccCCCcEEEEEEE-----cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC--
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-- 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 481 (720)
.++|+..+.||+|+||.||+|.+ .+++.||+|++... .......+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 35688899999999999999984 36889999999753 3445678899999999999999999999986644
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 78999999999999999974 235689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccc--cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc---
Q 005001 562 AALTPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLH--- 636 (720)
Q Consensus 562 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~--- 636 (720)
+.......... .....+|..|+|||.+.+..++.++||||||+++|||++|..||..... ...........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQM 267 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhh
Confidence 98765433221 2234578889999999999999999999999999999999999863210 00110000000
Q ss_pred cHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 637 DIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
....+.+.+........+..++..+.++|.+||+.||++||++.|+++.|+++.++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 01112222222333344566778899999999999999999999999999998765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=355.10 Aligned_cols=251 Identities=20% Similarity=0.267 Sum_probs=192.0
Q ss_pred cCCCcc-ceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHh-hcCCCCCccccceEEee----cCe
Q 005001 410 NSFSQE-FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNM-SRLRHPNIVTLAGYCAE----HGQ 482 (720)
Q Consensus 410 ~~y~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~ 482 (720)
++|... ++||+|+||.||+|.+. +++.||||++... ..+.+|+.++ +..+||||+++++++.. .+.
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 455555 68999999999999775 6889999998532 3456777776 44589999999999875 567
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---CCceEEccc
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDC 559 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Df 559 (720)
.|+||||+++|+|.+++... ....+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence 89999999999999999732 234699999999999999999999999 9999999999999998 789999999
Q ss_pred CCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 560 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
|+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .
T Consensus 209 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------------~ 274 (400)
T 1nxk_A 209 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------G 274 (400)
T ss_dssp TTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC------------S
T ss_pred ccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH------------H
Confidence 9998654322 2234679999999999999999999999999999999999999997654321100 0
Q ss_pred HHHhhcccccC--CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 640 ALAKMVDPALN--GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 640 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
...++...... .......+.++.+||++||+.||++|||+.|++++-
T Consensus 275 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 275 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00011111111 111134567889999999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=366.94 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=207.4
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..++|++.+.||+|+||.||+|.+. +++.||+|++............+.+|+.++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999875 789999999975544444567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC---CCCceEEcccCCCc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLAA 563 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~a~ 563 (720)
|||+.+|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999998863 35799999999999999999999999 999999999999995 45679999999998
Q ss_pred cCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......... .+
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----------------~~ 233 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL----------------KR 233 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HH
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------HH
Confidence 664332 2334579999999999876 5899999999999999999999999764322111 11
Q ss_pred hcccccCCC--CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPALNGM--YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+........ .....+..+.+||.+||+.||++|||+.+++++
T Consensus 234 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111111 113456788999999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=338.67 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=205.5
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..++|+..+.||+|+||.||+|.+. ++..||+|++..... .....+.+|++++++++||||+++++++...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 4567899999999999999999876 477899999875432 2356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe---CCCCceEEcccCCCc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAA 563 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 563 (720)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 85 MELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999998863 45689999999999999999999999 99999999999999 788999999999997
Q ss_pred cCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
...... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......... .+
T Consensus 158 ~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----------------~~ 218 (277)
T 3f3z_A 158 RFKPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM----------------LK 218 (277)
T ss_dssp ECCTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HH
T ss_pred eccCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH----------------HH
Confidence 664432 22345799999999988664 899999999999999999999999764322111 11
Q ss_pred hcccccCCCCCh----hHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPALNGMYPA----KSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+..... ..+. ..+..+.+++.+||+.||++||++.+++++
T Consensus 219 ~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 219 IREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHhCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 1121 345678999999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=350.02 Aligned_cols=269 Identities=21% Similarity=0.302 Sum_probs=204.2
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--------c
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--------H 480 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 480 (720)
++|+..+.||+|+||.||+|.+ .+|+.||+|++............+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788999999999999999987 478999999997655444445678899999999999999999999877 4
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
+..++||||+++ +|.+.+.. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999985 77777752 345799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCc---cccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc---
Q 005001 561 LAALTPNTER---QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP--- 633 (720)
Q Consensus 561 ~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~--- 633 (720)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9976543221 22234578999999999986 4589999999999999999999999987554322222211000
Q ss_pred --ccccHHHHHhh--cccccCCCCCh-------hHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 --QLHDIDALAKM--VDPALNGMYPA-------KSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 --~~~~~~~~~~~--~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+......... ........... ..+..+.+|+.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000000 00000000000 013468899999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=342.25 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=210.0
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.+.|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 456888999999999999999764 688999999865432 234677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 100 EYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp ECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999999986 46799999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||........... ..+
T Consensus 172 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~---- 233 (303)
T 3a7i_A 172 TQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-------------IPK---- 233 (303)
T ss_dssp TB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HHH----
T ss_pred cc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-------------hhc----
Confidence 32 122345799999999999999999999999999999999999999975432211110 111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
......+...+..+.+++.+||+.||++||++.+++++.
T Consensus 234 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 234 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 111123345567789999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=357.23 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=207.5
Q ss_pred hcCCCccceeccCCCcEEEEEEE----cCCcEEEEEEcccccc--ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecC
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 481 (720)
.++|+..+.||+|+||.||+|+. .+++.||+|+++.... .......+.+|+++++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35789999999999999999987 3789999999875432 112234566788888888 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999973 35789999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCcccccc--CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~----------- 274 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI----------- 274 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH-----------
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH-----------
Confidence 98665443334445689999999999986 34789999999999999999999999754432211111
Q ss_pred HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH
Q 005001 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQAL 686 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 686 (720)
...... ....++...+..+.+||.+||+.||++|| +++|++++.
T Consensus 275 -~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 275 -SRRILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -HHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -HHHHhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111111 11234556677889999999999999999 999998764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=352.14 Aligned_cols=259 Identities=16% Similarity=0.215 Sum_probs=209.1
Q ss_pred HHHhcCCCccceeccCCCcEEEEEE------EcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC---CCCccccceE
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAE------FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIVTLAGY 476 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~ 476 (720)
+...++|...+.||+|+||.||+|. ..+++.||+|++.... ...+.+|++++..++ |+||+.++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 3445779999999999999999993 4568899999996532 345666777776665 9999999999
Q ss_pred EeecCeEEEEEEecCCCCHHHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-----
Q 005001 477 CAEHGQRLLVYEYVGNGNLHDMLHFADD-SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD----- 550 (720)
Q Consensus 477 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~----- 550 (720)
+...+..++||||+++|+|.++++.... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999975433 356799999999999999999999999 9999999999999998
Q ss_pred ------CCceEEcccCCCccCCC-CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcc
Q 005001 551 ------ELNPHLSDCGLAALTPN-TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRS 623 (720)
Q Consensus 551 ------~~~~kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~ 623 (720)
++.+||+|||+++.... .........+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999965431 22233445679999999999999999999999999999999999999996432210
Q ss_pred hhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHHHHHhhc
Q 005001 624 EQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFR-PPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~ell~~L~~~~~~~~ 694 (720)
.. ...... .. ...+.+.+++..|++.+|.+| |+++++.+.|++++....
T Consensus 293 ~~-------------------~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 293 CK-------------------PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp EE-------------------ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ee-------------------echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 00 000111 01 235567899999999999998 788889999999887753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=340.94 Aligned_cols=251 Identities=22% Similarity=0.358 Sum_probs=210.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|...+.||+|+||.||+|.+. +++.||+|.+..... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467888999999999999999876 578899999865433 344567788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998863 35789999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------------~~~~~~ 229 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----------------YLRIKK 229 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHT
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHhh
Confidence 3222 22345799999999999999999999999999999999999999976432111 111111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ....+...+..+.+++.+||+.||++||++++++++
T Consensus 230 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 230 N--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred c--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 112344566788999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=342.63 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=202.5
Q ss_pred hcCCCccceeccCCCcEEEEEEEc--CCc--EEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA--NGK--IMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
.++|+..+.||+|+||.||+|.+. +++ .||+|+++.... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457888999999999999999764 233 689999875533 2345678899999999999999999999987754 8
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++|+||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999999742 35689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccc--cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 564 LTPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 564 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~ 233 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------QI 233 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HH
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH----------------HH
Confidence 765443221 233467889999999999999999999999999999999 99999764321 11
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
...+.........+...+..+.+++.+||+.||++||++.++++.|+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 234 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 112222222233445667889999999999999999999999999987644
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=356.56 Aligned_cols=201 Identities=26% Similarity=0.359 Sum_probs=170.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-----Ce
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 482 (720)
.++|+..+.||+|+||.||+|.+. +++.||||++..........+.+.+|+.+++.++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467999999999999999999775 588999999987655666678899999999999999999999998766 57
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.|+||||++ |+|.++++ ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 59999997 356799999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc---------------------ccccccccccccCcccc-ccCCCcccchhhhHHHHHHHHHhCCCCCC
Q 005001 563 ALTPNTERQ---------------------VSTQMVGAFGYSAPEFA-LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (720)
Q Consensus 563 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGv~l~elltg~~pf~ 617 (720)
+........ .....+||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876433211 22456899999999986 55669999999999999999998655443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=357.18 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=195.4
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC------hHHHHHHHHHHHHhhcCCCCCccccceEEe
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCA 478 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 478 (720)
....++|...+.||+|+||.||+|.+. +++.||+|++...... ......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345678999999999999999999765 5899999998754321 112235789999999999999999999975
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC---ceE
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPH 555 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~k 555 (720)
.+..++||||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++ .+|
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred -cCceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEE
Confidence 456899999999999999886 356799999999999999999999999 999999999999997544 599
Q ss_pred EcccCCCccCCCCCccccccccccccccCcccccc---CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHhh
Q 005001 556 LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ-SLVRWA 631 (720)
Q Consensus 556 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~-~~~~~~ 631 (720)
|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..+.
T Consensus 283 l~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~-- 358 (419)
T 3i6u_A 283 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-- 358 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH--
T ss_pred EeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh--
Confidence 9999999876432 22344679999999999864 66889999999999999999999999764332111 1110
Q ss_pred ccccccHHHHHhhcccccCC--CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 632 TPQLHDIDALAKMVDPALNG--MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...... ......+..+.+++.+||+.||++||+++|++++
T Consensus 359 --------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 --------------SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --------------TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --------------cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 0011245678999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.56 Aligned_cols=265 Identities=22% Similarity=0.330 Sum_probs=195.5
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEe----
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCA---- 478 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~---- 478 (720)
+.....+|+..+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.++.++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 3344568999999999999999999875 6899999998543 3445677889999999995 999999999983
Q ss_pred ----ecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEecCCCCCEEeCCCC
Q 005001 479 ----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDEL 552 (720)
Q Consensus 479 ----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~~~~ 552 (720)
.....++||||+. |+|.+++.... ....+++.++..++.|++.||+|||+. + |+||||||+|||++.++
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTS
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCC
Confidence 3445799999996 69999886433 245799999999999999999999998 7 99999999999999999
Q ss_pred ceEEcccCCCccCCCCCccc-----------cccccccccccCcccc---ccCCCcccchhhhHHHHHHHHHhCCCCCCC
Q 005001 553 NPHLSDCGLAALTPNTERQV-----------STQMVGAFGYSAPEFA---LSGIYTVKSDVYSFGVVMLELLTGRKPLDS 618 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGv~l~elltg~~pf~~ 618 (720)
.+||+|||++.......... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999998765432211 1134699999999998 567789999999999999999999999965
Q ss_pred CCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccc
Q 005001 619 SRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696 (720)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 696 (720)
..... ..........+...+..+.+++.+||+.||++||++.|++++|.++.......
T Consensus 256 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 256 GAKLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp ------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred hhHHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 32210 01111111122233445789999999999999999999999999998765543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.79 Aligned_cols=265 Identities=18% Similarity=0.183 Sum_probs=199.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc----CCcEEEEEEccccccChHH---------HHHHHHHHHHhhcCCCCCccccce
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQE---------EDNFLEAVSNMSRLRHPNIVTLAG 475 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~ 475 (720)
.++|...+.||+|+||.||+|.+. ++..||+|++......... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467889999999999999999875 5778999998654321111 134667888899999999999999
Q ss_pred EEee----cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC
Q 005001 476 YCAE----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (720)
Q Consensus 476 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 551 (720)
++.. ....++||||+ +++|.+++.. .+.+++.++..++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9887 67899999999 9999999973 23799999999999999999999999 99999999999999888
Q ss_pred C--ceEEcccCCCccCCCCCc------cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcc
Q 005001 552 L--NPHLSDCGLAALTPNTER------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRS 623 (720)
Q Consensus 552 ~--~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~ 623 (720)
+ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999976543211 11234579999999999999999999999999999999999999996432211
Q ss_pred hhhHHHhhccccccHHHHHhhcccccC-CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 624 EQSLVRWATPQLHDIDALAKMVDPALN-GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
....... ............ .......+.++.+++.+||+.||++||++++|++.|+++
T Consensus 268 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAK--------TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHH--------HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHH--------HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1110000 000000000000 000114556899999999999999999999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=367.10 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=202.9
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
...++|+..+.||+|+||.||+|.+. ++..||+|++............+.+|+.+++.++||||+++++++...+..++
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567999999999999999999875 68899999997665444556778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC---CceEEcccCCC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSDCGLA 562 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a 562 (720)
||||+++|+|.+.+.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.. +.+||+|||++
T Consensus 114 v~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 114 VMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999998863 36789999999999999999999999 99999999999999764 55999999999
Q ss_pred ccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
....... ......||+.|+|||++. ..++.++||||+||++|+|++|..||......... .
T Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----------------~ 247 (494)
T 3lij_A 187 AVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL----------------R 247 (494)
T ss_dssp EECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------H
T ss_pred eECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------H
Confidence 8764432 234467999999999886 56999999999999999999999999765432111 1
Q ss_pred hhcccccCCCC--ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPALNGMY--PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+......... ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 248 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 248 KVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11111111111 12345678999999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=346.11 Aligned_cols=263 Identities=23% Similarity=0.347 Sum_probs=210.8
Q ss_pred cchhcHHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC--CCCccccceEE
Q 005001 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR--HPNIVTLAGYC 477 (720)
Q Consensus 400 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~ 477 (720)
+.+..+....++|+..+.||+|+||.||+|.+.+++.||+|++............+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3344555566789999999999999999999888999999999766556667788999999999996 59999999999
Q ss_pred eecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEc
Q 005001 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557 (720)
Q Consensus 478 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 557 (720)
...+..++||| +.+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++ +.+||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEEC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEe
Confidence 99999999999 567899999973 45789999999999999999999999 9999999999999965 899999
Q ss_pred ccCCCccCCCCCcc-ccccccccccccCcccccc-----------CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchh
Q 005001 558 DCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALS-----------GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ 625 (720)
Q Consensus 558 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~ 625 (720)
|||++......... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--- 245 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 245 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---
Confidence 99999866433221 2234579999999999876 46889999999999999999999999754321
Q ss_pred hHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 005001 626 SLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686 (720)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 686 (720)
........+......++...+..+.+++.+||+.||++||++.|++++-
T Consensus 246 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 246 ------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp ------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1222333344444444555567899999999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=347.98 Aligned_cols=252 Identities=21% Similarity=0.356 Sum_probs=211.0
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
..++|...+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3467889999999999999999876 578999999865433 34456778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 119 v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 119 VLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999998863 36789999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+.
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------------~~~~ 254 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY----------------LRIK 254 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HHHH
T ss_pred ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH----------------HHHh
Confidence 43222 223457999999999999999999999999999999999999999754321111 1111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ....+...+..+.+++.+||+.||++||++.|++++
T Consensus 255 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 255 KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 112344556778999999999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=354.24 Aligned_cols=267 Identities=19% Similarity=0.244 Sum_probs=208.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC---------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccc-------
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN---------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT------- 472 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~------- 472 (720)
.++|+..+.||+|+||.||+|.+.. ++.||+|.+... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 3678999999999999999998764 789999998643 35778899999999999887
Q ss_pred --------cceEEee-cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCC
Q 005001 473 --------LAGYCAE-HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543 (720)
Q Consensus 473 --------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp 543 (720)
+++++.. .+..++||||+ +++|.+++... ....+++.++..++.|++.||+|||+. +|+||||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp 187 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence 5677766 67889999999 99999999742 236799999999999999999999999 999999999
Q ss_pred CCEEeCCCC--ceEEcccCCCccCCCCCcc------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCC
Q 005001 544 ANILLDDEL--NPHLSDCGLAALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615 (720)
Q Consensus 544 ~NIll~~~~--~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p 615 (720)
+||+++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 8999999999765432211 12335799999999999999999999999999999999999999
Q ss_pred CCCCCCcchhhHHHhhccccccHHHHHhhcccccC-CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 616 LDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN-GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 616 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
|.......... ... ............. .......+..+.+++.+||+.||++||+++++++.|+++.++..
T Consensus 268 f~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 268 WTNCLPNTEDI-MKQ-------KQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TGGGTTCHHHH-HHH-------HHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cccCCcCHHHH-HHH-------HHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 97654221110 000 0000000000000 00112346789999999999999999999999999999988775
Q ss_pred cc
Q 005001 695 VV 696 (720)
Q Consensus 695 ~~ 696 (720)
..
T Consensus 340 ~~ 341 (352)
T 2jii_A 340 VS 341 (352)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=349.53 Aligned_cols=267 Identities=22% Similarity=0.315 Sum_probs=198.3
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|...+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 47889999999999999999876 689999999864431 1112245578999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|++ |+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 81 YLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred ccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 997 489988863 345789999999999999999999999 9999999999999999999999999999765432
Q ss_pred CccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh-h-cc------ccccHH
Q 005001 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW-A-TP------QLHDID 639 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~-~-~~------~~~~~~ 639 (720)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.. . .+ ......
T Consensus 154 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 T-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred c-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 2 22234578999999999987 5689999999999999999999999987554322221110 0 00 000001
Q ss_pred HHHhhcccccCCC----CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAKMVDPALNGM----YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......+..... .....+.++.+|+.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1111111110000 012345678899999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=339.07 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=207.9
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|+..+.||+|+||.||+|... +++.||+|++...... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999876 5788999998654321 123467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999973 35689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. .....||+.|+|||++.+..++.++||||||+++|||++|..||........ ...+...
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------------~~~~~~~ 227 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET----------------HRRIVNV 227 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHTT
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH----------------HHHHhcc
Confidence 22 2345799999999999999999999999999999999999999975432111 1111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...++...+..+.+++.+||+.||++||++.+++++
T Consensus 228 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 228 --DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 122445566788999999999999999999999976
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.38 Aligned_cols=267 Identities=21% Similarity=0.310 Sum_probs=206.5
Q ss_pred hhcHHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 402 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
........++|+..+.||+|+||.||+|.+.+ .||+|++..........+.+.+|+.++++++||||+++++++...+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 33444556789999999999999999998754 4899998765444444456778999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999963 345789999999999999999999999 999999999999998 67999999999
Q ss_pred CccCCCCC----ccccccccccccccCcccccc---------CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 005001 562 AALTPNTE----RQVSTQMVGAFGYSAPEFALS---------GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV 628 (720)
Q Consensus 562 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~ 628 (720)
+....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--- 252 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII--- 252 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH---
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 87543211 111233469999999999875 45789999999999999999999999754321111
Q ss_pred HhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 629 RWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
..+.........+...+..+.+++.+||+.||++||++.++++.|+++.++.
T Consensus 253 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 253 -------------WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -------------HHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -------------HHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111111111112234567889999999999999999999999998887654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=366.50 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=209.3
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
..++|+..+.||+|+||.||+|... +|+.||+|++...... ......+.+|+.++++++||||+++++++...+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4567899999999999999999876 7899999998654332 3446778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe---CCCCceEEcccCCC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLA 562 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a 562 (720)
||||+.+|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999886 356799999999999999999999999 99999999999999 56789999999999
Q ss_pred ccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
....... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||........ +.
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------------~~ 237 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI----------------LK 237 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HH
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH----------------HH
Confidence 8664432 2234579999999999876 689999999999999999999999986543211 11
Q ss_pred hhcccccCCC--CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPALNGM--YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
++........ .....+..+.+|+.+||+.||++|||+.|++++
T Consensus 238 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 238 KVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 1111111111 113456788999999999999999999999976
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=339.31 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=204.5
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh----HHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
.++|+..+.||+|+||.||+|... +++.||+|.+....... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356889999999999999999876 68999999987543321 1357789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC----ceEEccc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSDC 559 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Df 559 (720)
++||||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999963 35789999999999999999999999 999999999999998877 8999999
Q ss_pred CCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 560 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
|++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+...
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------- 226 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV-------- 226 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc--------
Confidence 9998654322 223456999999999999999999999999999999999999999764322111111000
Q ss_pred HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
............+..+.+++.+||+.||++||++.+++++
T Consensus 227 ------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 227 ------NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ------CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ------ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0000000012345678899999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=355.25 Aligned_cols=271 Identities=24% Similarity=0.330 Sum_probs=205.9
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec----
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH---- 480 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 480 (720)
+...++|+..+.||+|+||.||+|.+ .+|+.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 44567899999999999999999976 5789999999864422 123789999999999999999998443
Q ss_pred ----------------------------------CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 005001 481 ----------------------------------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526 (720)
Q Consensus 481 ----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~ 526 (720)
...++||||++ |+|.+.+.........+++..+..++.|++.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34889999998 4888888765556788999999999999999999
Q ss_pred HHHhcCCCCcEEecCCCCCEEeC-CCCceEEcccCCCccCCCCCccccccccccccccCccccccCC-CcccchhhhHHH
Q 005001 527 YLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGV 604 (720)
Q Consensus 527 ~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv 604 (720)
|||+. +|+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+.. ++.++||||+||
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999 999999999999997 68899999999998664432 223457899999999988754 899999999999
Q ss_pred HHHHHHhCCCCCCCCCCcchhhHH-Hh-hccccccHHHHHhhcc------------cccCCCCChhHHHHHHHHHHHhcC
Q 005001 605 VMLELLTGRKPLDSSRPRSEQSLV-RW-ATPQLHDIDALAKMVD------------PALNGMYPAKSLSRFADIIALCVQ 670 (720)
Q Consensus 605 ~l~elltg~~pf~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~ 670 (720)
++|||++|+.||.+.........+ .. ..+.. +.+..+-. ......++...+..+.+|+.+||+
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTK---EQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH---HHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH---HHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 999999999999875543222111 11 11111 11111100 000111234456779999999999
Q ss_pred CCCCCCCCHHHHHHH--HHHHHH
Q 005001 671 PEPEFRPPMSEVVQA--LVRLVQ 691 (720)
Q Consensus 671 ~dP~~RPs~~ell~~--L~~~~~ 691 (720)
.||++|||+.|++++ +.++..
T Consensus 308 ~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SSGGGSCCHHHHHTSGGGHHHHH
T ss_pred CChhhCCCHHHHhcCHHHHHHHh
Confidence 999999999999965 444433
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=374.32 Aligned_cols=263 Identities=23% Similarity=0.367 Sum_probs=212.8
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEcC----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (720)
....++|+..+.||+|+||.||+|.+.. +..||+|++.... .......+.+|+.++++++||||+++++++. .+
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 3345778999999999999999997742 4679999986533 3445678999999999999999999999985 46
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence 78999999999999999973 245689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---------------- 601 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---------------- 601 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH----------------
Confidence 98765443333344567889999999999999999999999999999997 9999976432211
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
...+. .......+..++..+.+++.+||+.||++||++.++++.|+++++..
T Consensus 602 ~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 602 IGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp HHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHH-cCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 11111 11122345567788999999999999999999999999999987653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=343.93 Aligned_cols=265 Identities=21% Similarity=0.291 Sum_probs=199.5
Q ss_pred hcCCCcc-ceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 409 TNSFSQE-FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 409 ~~~y~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
.+.|++. +.||+|+||.||+|... +++.||+|++.... ......+.+|++++.++ +||||+++++++.+.+..++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3567774 78999999999999764 68999999996543 23456788999999885 79999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc---eEEcccCCC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSDCGLA 562 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a 562 (720)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 89 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999999999973 35789999999999999999999999 9999999999999998776 999999998
Q ss_pred ccCCCCCc------cccccccccccccCcccccc-----CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 005001 563 ALTPNTER------QVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA 631 (720)
Q Consensus 563 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~ 631 (720)
........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 76532211 11123469999999999975 55889999999999999999999999865432211000000
Q ss_pred ccccccHHHHHhhcccccCCCCCh----hHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 632 TPQLHDIDALAKMVDPALNGMYPA----KSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+ .........+..... .++. ..+..+.+|+.+||+.||++||++.|++++
T Consensus 242 ~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 242 CP-ACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CH-HHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ch-hHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 000001111111111 1221 245678999999999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=348.94 Aligned_cols=265 Identities=21% Similarity=0.268 Sum_probs=198.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC------
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 481 (720)
.++|+..+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467999999999999999999765 6889999999765555566778899999999999999999999987654
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999975 7888885 4589999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh--cc------
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA--TP------ 633 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~--~~------ 633 (720)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.-. .+
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9765432 1223467999999999999999999999999999999999999999875432211111000 00
Q ss_pred cccc-HHH------------HHhhcccccCCC---CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 QLHD-IDA------------LAKMVDPALNGM---YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 ~~~~-~~~------------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... ... ..+......... .+...+..+.+|+.+||+.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 000 000000000000 011236789999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.30 Aligned_cols=250 Identities=23% Similarity=0.369 Sum_probs=205.3
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..++|...+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 3467889999999999999999875 68999999997543 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe---CCCCceEEcccCCCc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAA 563 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 563 (720)
|||+++++|.+++.. .+.+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 85 MQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp ECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999999863 35789999999999999999999999 99999999999999 788999999999987
Q ss_pred cCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------------~~~ 218 (304)
T 2jam_A 158 MEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL----------------FEK 218 (304)
T ss_dssp CCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------HHH
T ss_pred ecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH----------------HHH
Confidence 54332 22335699999999999999999999999999999999999999975432111 111
Q ss_pred hcccc--cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPA--LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+.... .........+..+.+++.+||+.||++||++.|++++
T Consensus 219 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 219 IKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 1112234566789999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.73 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=199.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|.+.+.||+|+||.||+|.+. +|+.||+|.+..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467889999999999999999876 789999999865432 122356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999973 35689999999999999999999999 99999999999999999999999999997664
Q ss_pred CCCccccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... ..+.
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----------------~~~~ 224 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF----------------KKIR 224 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHH
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH----------------HHhh
Confidence 322 2234578999999999988775 68999999999999999999999754321111 1111
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ....+...+..+.+++.+||+.||++||++.|++++
T Consensus 225 ~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 225 GG--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cC--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 112344556788999999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=376.75 Aligned_cols=252 Identities=20% Similarity=0.306 Sum_probs=210.0
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 484 (720)
..++|+..+.||+|+||.||+|.+. +++.||||+++.... .......+..|..++..+ +||||+.+++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467999999999999999999875 588999999975432 223345677888988887 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++|+|.++++. .+.+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999973 35799999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... +...++
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----------------~~~~~i 554 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----------------ELFQSI 554 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHH
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH----------------HHHHHH
Confidence 43322 2334578999999999999999999999999999999999999999764321 112222
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPM-----SEVVQA 685 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~ 685 (720)
.... ..+|...+.++.+||++||+.||++||++ +||+++
T Consensus 555 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 555 MEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 2222 23556677889999999999999999998 666654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.15 Aligned_cols=253 Identities=15% Similarity=0.184 Sum_probs=195.9
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEcccccc-ChHHHHHHHHHH---HHhhcCCCCCccccc-------e
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAV---SNMSRLRHPNIVTLA-------G 475 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~ 475 (720)
..++|...+.||+|+||.||+|.+ .+|+.||||++..... .....+.+.+|+ +.+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 456788999999999999999986 4699999999975422 334567788999 556666899999998 6
Q ss_pred EEeecC-----------------eEEEEEEecCCCCHHHHhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005001 476 YCAEHG-----------------QRLLVYEYVGNGNLHDMLHFADDS---SKNLTWNARVRVALGTARALEYLHEVCLPS 535 (720)
Q Consensus 476 ~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ 535 (720)
++...+ ..++||||+ +|+|.++++..... ...+++..+..++.||+.||+|||+. +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 655543 278999999 57999999743211 12344688889999999999999999 9
Q ss_pred cEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccccccccccccccCccccccC-----------CCcccchhhhHHH
Q 005001 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG-----------IYTVKSDVYSFGV 604 (720)
Q Consensus 536 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGv 604 (720)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999985332 2334567 999999999988 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 005001 605 VMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684 (720)
Q Consensus 605 ~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 684 (720)
++|||++|+.||.......... .... .....+..+.++|.+||+.||++||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~----------------~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE----------------WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSG----------------GGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchh----------------hhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999997543221110 0000 11234567889999999999999999999996
Q ss_pred H--HHHHHH
Q 005001 685 A--LVRLVQ 691 (720)
Q Consensus 685 ~--L~~~~~ 691 (720)
+ +.++.+
T Consensus 360 hp~f~~~~~ 368 (377)
T 3byv_A 360 TPEYEQLRT 368 (377)
T ss_dssp SHHHHHHHH
T ss_pred ChHHHHHHH
Confidence 4 444433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.71 Aligned_cols=271 Identities=25% Similarity=0.335 Sum_probs=200.2
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChH---HHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ---EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
...++|+..+.||+|+||.||+|.+. +|+.||+|++........ ....+.+|+.+++.++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 589999999975432211 12467899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++||||+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999986 88888862 345688999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hh-hccc---cc
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RW-ATPQ---LH 636 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~-~~~~---~~ 636 (720)
+....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...........+ .. ..+. +.
T Consensus 160 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 160 KSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp STTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred eeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 87643322 23345799999999999764 4899999999999999999999999765432221111 10 0000 00
Q ss_pred cHHHHHhhcccccCCCCC-----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 637 DIDALAKMVDPALNGMYP-----AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.................+ ...+..+.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000000000011 2345789999999999999999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.04 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=202.5
Q ss_pred cchhcHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEE
Q 005001 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (720)
Q Consensus 400 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (720)
+....+....++|+..+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+++++ +||||+++++++
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 344455667788999999999999999999874 68999999986433 2346788999999988 899999999999
Q ss_pred ee------cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC
Q 005001 478 AE------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (720)
Q Consensus 478 ~~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 551 (720)
.. .+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN 165 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTT
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCC
Confidence 76 46889999999999999999743 235789999999999999999999999 99999999999999999
Q ss_pred CceEEcccCCCccCCCCCccccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh
Q 005001 552 LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS 626 (720)
Q Consensus 552 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~ 626 (720)
+.+||+|||++....... .......||+.|+|||++. +..++.++|||||||++|||++|+.||.........
T Consensus 166 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~- 243 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL- 243 (326)
T ss_dssp CCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-
T ss_pred CCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH-
Confidence 999999999987654322 1223457999999999997 566899999999999999999999999754321111
Q ss_pred HHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 627 LVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
............+...+..+.+++.+||+.||++||++.+++++
T Consensus 244 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 244 ---------------FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ---------------HHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---------------HHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01111111111233456788999999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=346.35 Aligned_cols=271 Identities=17% Similarity=0.264 Sum_probs=207.5
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChH---------------HHHHHHHHHHHhhcCCCCCccc
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ---------------EEDNFLEAVSNMSRLRHPNIVT 472 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~e~~~l~~l~h~niv~ 472 (720)
..++|+..+.||+|+||.||+|.. +++.||+|++........ ....+.+|+.++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 346899999999999999999988 899999999865432211 1177899999999999999999
Q ss_pred cceEEeecCeEEEEEEecCCCCHHHHhhh----ccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEecCCCCCEE
Q 005001 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHF----ADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANIL 547 (720)
Q Consensus 473 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIl 547 (720)
+++++...+..++||||+++|+|.+++.. .......+++..+..++.|++.||+|||+ . +|+||||||+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 99999999999999999999999998321 11225789999999999999999999999 8 9999999999999
Q ss_pred eCCCCceEEcccCCCccCCCCCccccccccccccccCccccccC-CCcc-cchhhhHHHHHHHHHhCCCCCCCCCCcch-
Q 005001 548 LDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTV-KSDVYSFGVVMLELLTGRKPLDSSRPRSE- 624 (720)
Q Consensus 548 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGv~l~elltg~~pf~~~~~~~~- 624 (720)
++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999999999999999865432 23446799999999999887 6766 99999999999999999999986544211
Q ss_pred hhHHHhhccccccHH-HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 625 QSLVRWATPQLHDID-ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 625 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+........... ..................+..+.+++.+||+.||++||++.|++++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111100000000000 0000000000000113456788999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=356.91 Aligned_cols=265 Identities=20% Similarity=0.285 Sum_probs=210.2
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCC-CCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV 486 (720)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+++++.++| ++|..+..++...+..++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 46799999999999999999986 5689999998764432 2347789999999977 5555666667778889999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe---CCCCceEEcccCCCc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAA 563 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 563 (720)
|||+ +++|.++++.. ...+++.+++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 82 me~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 9999 88999999742 46799999999999999999999999 99999999999999 588999999999998
Q ss_pred cCCCCCcc------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 005001 564 LTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 564 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~----- 229 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS----- 229 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH-----
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh-----
Confidence 76543321 1225679999999999999999999999999999999999999998765533322221100
Q ss_pred HHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
........ ...+..++.++.+++.+||+.||++||++.+|++.|+++..+..
T Consensus 230 ----~~~~~~~~-~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 230 ----EKKVATSI-EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp ----HHHHHSCH-HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----hccccccH-HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 00000000 00012345678999999999999999999999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=363.28 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=204.0
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh-----------HHHHHHHHHHHHhhcCCCCCccccc
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-----------QEEDNFLEAVSNMSRLRHPNIVTLA 474 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l~ 474 (720)
...++|...+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45678999999999999999999875 57899999997544321 2356788999999999999999999
Q ss_pred eEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC--
Q 005001 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-- 552 (720)
Q Consensus 475 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-- 552 (720)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999998863 36799999999999999999999999 999999999999998776
Q ss_pred -ceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 005001 553 -NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA 631 (720)
Q Consensus 553 -~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~ 631 (720)
.+||+|||++....... ......||+.|+|||++. +.++.++||||+||++|+|++|..||..........
T Consensus 186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----- 257 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK----- 257 (504)
T ss_dssp SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----
T ss_pred ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----
Confidence 69999999998765432 233457999999999987 468999999999999999999999998654321111
Q ss_pred ccccccHHHHHhhcccccCCCC--ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 632 TPQLHDIDALAKMVDPALNGMY--PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+......... ....+.++.+|+.+||+.||.+|||+.|++++
T Consensus 258 -----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 -----------KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp -----------HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----------HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111111000 02345678999999999999999999999976
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.40 Aligned_cols=263 Identities=21% Similarity=0.330 Sum_probs=190.2
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec------C
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------G 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 481 (720)
.++|+..+.||+|+||.||+|.+ .+|+.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999976 4689999999976655566677889999999999999999999998654 5
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++|+|++ +++|.++++ .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 679999886 36799999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-h-hccc----
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR-W-ATPQ---- 634 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~-~-~~~~---- 634 (720)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+. . ..+.
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9765432 234679999999999987 678999999999999999999999998755332221111 0 0110
Q ss_pred --cccHHHHHhhcccccC-CCC-----ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 --LHDIDALAKMVDPALN-GMY-----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 --~~~~~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... ......+..... ... ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 255 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCC-HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhh-HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 001111100000 000 01235678899999999999999999999976
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.29 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=206.6
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc--C----hHHHHHHHHHHHHhhcC-CCCCccccceE
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL--S----LQEEDNFLEAVSNMSRL-RHPNIVTLAGY 476 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 476 (720)
.....++|...+.||+|+||.||+|.+. +|+.||||++..... . ......+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999885 799999999864431 1 12245678899999998 89999999999
Q ss_pred EeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEE
Q 005001 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (720)
Q Consensus 477 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 556 (720)
+...+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999973 35789999999999999999999999 9999999999999999999999
Q ss_pred cccCCCccCCCCCccccccccccccccCcccccc------CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh
Q 005001 557 SDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS------GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW 630 (720)
Q Consensus 557 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~ 630 (720)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~---- 315 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR---- 315 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH----
Confidence 9999998765432 2234679999999999864 358899999999999999999999997543211111
Q ss_pred hccccccHHHHHhhcccccCCCCC--hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 631 ATPQLHDIDALAKMVDPALNGMYP--AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+.........+ ...+..+.+++.+||+.||++||++.|++++
T Consensus 316 ------------~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 316 ------------MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ------------HHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------------HHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111110000 1234678899999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=334.14 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=202.2
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|....+||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 34556669999999999999864 68899999986543 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-CCceEEcccCCCccCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALTPN 567 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~ 567 (720)
|+++++|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++.....
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 100 QVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred eCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999999997422 234567899999999999999999999 9999999999999987 89999999999976643
Q ss_pred CCccccccccccccccCccccccCC--CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.. .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||......... ..+..
T Consensus 176 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------------~~~~~ 239 (295)
T 2clq_A 176 IN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---------------MFKVG 239 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---------------HHHHH
T ss_pred CC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---------------HHhhc
Confidence 22 1223457999999999998754 789999999999999999999999643221110 00000
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........+...+..+.+++.+||+.||++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 240 MFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111223455667789999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=338.09 Aligned_cols=253 Identities=26% Similarity=0.455 Sum_probs=203.4
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
...++|+..+.||+|+||.||+|.+. +|+.||+|.+.... ....+.+|+.+++.++||||+++++++...+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34567999999999999999999876 58999999986532 24568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 102 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 102 VMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 9999999999999863 246789999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ....
T Consensus 176 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~-- 239 (314)
T 3com_A 176 TDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-------------MIPT-- 239 (314)
T ss_dssp BTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------------HHHH--
T ss_pred hhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-------------HHhc--
Confidence 43221 2234579999999999999999999999999999999999999997543211110 0001
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........+...+..+.+++.+||+.||++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 240 NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111112244456789999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=343.01 Aligned_cols=267 Identities=22% Similarity=0.310 Sum_probs=205.7
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-----Ce
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 482 (720)
.++|+..+.||+|+||.||+|.+. +++.||+|++.... .......+.+|++++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 457999999999999999999765 68889999997433 344557789999999999999999999998654 46
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++||||+++ +|.++++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~iv~e~~~~-~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCSE-EHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccCc-CHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 8999999974 9999886 35699999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCccc--cccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh-h-cccc--
Q 005001 563 ALTPNTERQV--STQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW-A-TPQL-- 635 (720)
Q Consensus 563 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~-~-~~~~-- 635 (720)
.......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.. . .+..
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 8664332211 234579999999998765 4589999999999999999999999987654433222211 0 0000
Q ss_pred ----ccHHHHHhhcccccCCCC-----ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 636 ----HDIDALAKMVDPALNGMY-----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 636 ----~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.................. ....+.++.+|+.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000011 12345678999999999999999999999976
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=350.00 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=200.0
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe------
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ------ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 482 (720)
..+|...+.||+|+||.||+|.+..+..||+|++...... ..+|+++++.++||||+++++++...+.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 4578999999999999999999987778999988643221 2368999999999999999999865443
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC-CCCceEEcccCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGL 561 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~ 561 (720)
.++||||+++ ++.+.+.........+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+
T Consensus 113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 7899999987 45444443333467899999999999999999999999 999999999999999 799999999999
Q ss_pred CccCCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHh-hccccccH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL-VRW-ATPQLHDI 638 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~-~~~-~~~~~~~~ 638 (720)
++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......... +.. ..+.....
T Consensus 189 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 189 AKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 987643322 2346789999999999765 589999999999999999999999987553322211 111 11111111
Q ss_pred HHHHhh-ccccc--------CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKM-VDPAL--------NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~-~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...... ..... ...++...+.++.+|+.+||+.||++|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 110000 00000 001122356789999999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=341.37 Aligned_cols=266 Identities=26% Similarity=0.412 Sum_probs=190.1
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..++|+..+.||+|+||.||+|.+. +++.||+|++..... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 4578999999999999999999764 688999999865432 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 487 YEYVGNGNLHDMLHFADD----SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999864221 245689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCc----cccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 005001 563 ALTPNTER----QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD 637 (720)
Q Consensus 563 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 637 (720)
........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||................+. .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~ 246 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP--S 246 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC--C
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC--c
Confidence 76543221 11234579999999999976 56899999999999999999999999865433221111000000 0
Q ss_pred HHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 638 IDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ............+..+.+++.+||+.||++||++.+++++
T Consensus 247 ~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 LE------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TT------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cc------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 0000011123345678999999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.10 Aligned_cols=276 Identities=22% Similarity=0.296 Sum_probs=205.0
Q ss_pred chhcHHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEcccccc---------ChHHHHHHHHHHHHhhcCCCCCcc
Q 005001 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL---------SLQEEDNFLEAVSNMSRLRHPNIV 471 (720)
Q Consensus 401 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~niv 471 (720)
...++....++|...+.||+|+||.||+|.+.+|+.||+|++..... .....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35567788899999999999999999999988899999999865332 222347789999999999999999
Q ss_pred ccceEEee-----cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCE
Q 005001 472 TLAGYCAE-----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (720)
Q Consensus 472 ~l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 546 (720)
++++++.. ....++||||++ |+|.+++. .....+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 99999854 336899999998 58888886 2345799999999999999999999999 999999999999
Q ss_pred EeCCCCceEEcccCCCccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchh
Q 005001 547 LLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ 625 (720)
Q Consensus 547 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~ 625 (720)
+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999997543322 2334579999999999987 67899999999999999999999999875432222
Q ss_pred hHH-Hhh-cccccc-----HHHHHhhcccccCCC-------CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 626 SLV-RWA-TPQLHD-----IDALAKMVDPALNGM-------YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 626 ~~~-~~~-~~~~~~-----~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..+ ... .+.... ............... .+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111 111 010000 000111111111100 112335678999999999999999999999976
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.06 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=202.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc--ChHHHHHHHHHHHHhhcCCCCCccccceEE--eecCeE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRLRHPNIVTLAGYC--AEHGQR 483 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~~~ 483 (720)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.++++++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999874 688999999975432 123467789999999999999999999998 445688
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||++++ |.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 77777642 346799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCC-ccccccccccccccCccccccCC--CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 564 LTPNTE-RQVSTQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 564 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
...... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------- 221 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL---------------- 221 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------------
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH----------------
Confidence 654322 22233457999999999998754 47899999999999999999999975432111
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+... ....+..++..+.+++.+||+.||++||++.|++++
T Consensus 222 ~~~i~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 222 FENIGKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHhcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111 112344566788999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=352.31 Aligned_cols=260 Identities=24% Similarity=0.337 Sum_probs=199.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec------Ce
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------GQ 482 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 482 (720)
.+|+..+.||+|+||.||+|.+. +|+.||||++.... ..+.+|+++++.++||||+++++++... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 46888999999999999999885 58999999986432 1234689999999999999999988542 23
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC-CceEEcccCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGL 561 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~ 561 (720)
.++||||+++ +|.+.+.........+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 6799999986 77777765444567899999999999999999999999 99999999999999965 5789999999
Q ss_pred CccCCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHh-hccccccH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS-LVRW-ATPQLHDI 638 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~-~~~~-~~~~~~~~ 638 (720)
++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+........ ++.. ..+. .
T Consensus 204 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~---~ 278 (420)
T 1j1b_A 204 AKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT---R 278 (420)
T ss_dssp CEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC---H
T ss_pred hhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC---H
Confidence 98654332 22346799999999999775 78999999999999999999999998754322211 1111 1111 1
Q ss_pred HHHHhhccccc-CCC------------CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKMVDPAL-NGM------------YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~~~~~~-~~~------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+.+..+ .+.. ... ++...+.++.+|+.+||+.||++||++.|++++
T Consensus 279 ~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 279 EQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 111111 1110 000 223446789999999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=340.56 Aligned_cols=259 Identities=19% Similarity=0.301 Sum_probs=201.6
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEee--cCeEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAE--HGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~l 485 (720)
++|+..+.||+|+||.||+|.+ .+++.||+|++... ....+.+|+.++++++ ||||+++++++.. ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 6788999999999999999976 57899999998643 2467889999999996 9999999999987 667899
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC-ceEEcccCCCcc
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAAL 564 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 564 (720)
||||+++++|.++++ .+++.++..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 111 v~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 999999999999884 388999999999999999999999 999999999999999776 899999999986
Q ss_pred CCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH--Hhhc-cc------
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV--RWAT-PQ------ 634 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~--~~~~-~~------ 634 (720)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ .... +.
T Consensus 181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 644322 234578999999999987 67899999999999999999999999654432211100 0000 00
Q ss_pred ---cccHHHHHhhccc--------ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 ---LHDIDALAKMVDP--------ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 ---~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
............. ......+...+.++.+||.+||+.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000000000 01111222356789999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=333.71 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=207.5
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
...++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34567999999999999999999876 68999999997665555567789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC---CceEEcccCCC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSDCGLA 562 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a 562 (720)
||||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999998863 35689999999999999999999999 99999999999999764 46999999999
Q ss_pred ccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
........ .....||+.|+|||.+.+. ++.++||||||+++|+|++|..||......... .
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----------------~ 232 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL----------------K 232 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------H
T ss_pred eeecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH----------------H
Confidence 76543322 2334689999999988764 899999999999999999999999764322111 1
Q ss_pred hhcccccCCCCC--hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 643 KMVDPALNGMYP--AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 643 ~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+.........+ ...+.++.+++.+||+.||++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 233 RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 111111111111 2346778999999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=353.05 Aligned_cols=256 Identities=14% Similarity=0.091 Sum_probs=185.9
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHH---HHHhhcCCCCCccccc-------eE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEA---VSNMSRLRHPNIVTLA-------GY 476 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e---~~~l~~l~h~niv~l~-------~~ 476 (720)
...|...+.||+|+||.||+|.+. +|+.||+|++..... .......+.+| +..++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 345888999999999999999875 789999999987554 23345567777 455555 799987754 44
Q ss_pred Eeec-----------------CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCC
Q 005001 477 CAEH-----------------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR------VRVALGTARALEYLHEVCL 533 (720)
Q Consensus 477 ~~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~------~~i~~qi~~~L~~LH~~~~ 533 (720)
+... ...++||||++ |+|.++++... ..+.+..+ ..++.||+.||+|||++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-- 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK-- 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC--
Confidence 4433 33799999998 79999997532 23344445 67789999999999999
Q ss_pred CCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccccccccccccccCcccccc--CCCcccchhhhHHHHHHHHHh
Q 005001 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLT 611 (720)
Q Consensus 534 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~ellt 611 (720)
+|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 214 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 214 -GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999999865422 113467799999999987 679999999999999999999
Q ss_pred CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 612 GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 612 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
|+.||....+...... ... ..................+..+.+||.+||+.||++||++.+++++
T Consensus 289 g~~Pf~~~~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSW---KRP------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SSCSTTBCCTTCTTCC---CBC------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCCcCcccccch---hhh------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999987643211100 000 0000001111112223567789999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=340.66 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=198.4
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC------hHHHHHHHHHHHHhhcCCCCCccccceEEeec
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (720)
..++|...+.||+|+||.||+|.+. +++.||||.+...... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999999999999775 5889999998754321 12234578999999999999999999998765
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc---eEEc
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLS 557 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~ 557 (720)
+ .++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 899999999999999886 356799999999999999999999999 9999999999999987664 9999
Q ss_pred ccCCCccCCCCCccccccccccccccCccccc---cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHhhcc
Q 005001 558 DCGLAALTPNTERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ-SLVRWATP 633 (720)
Q Consensus 558 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~-~~~~~~~~ 633 (720)
|||++...... .......||+.|+|||++. +..++.++|||||||++|||++|..||......... ..+.
T Consensus 160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---- 233 (322)
T 2ycf_A 160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---- 233 (322)
T ss_dssp CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH----
T ss_pred cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH----
Confidence 99999876432 2223457999999999974 466899999999999999999999999765432111 1110
Q ss_pred ccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... ..........+..+.+++.+||+.||++||++.+++++
T Consensus 234 ---------~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 ---------SGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp ---------HTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---------hCcc-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0000 00000011345678899999999999999999999853
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=346.68 Aligned_cols=264 Identities=20% Similarity=0.311 Sum_probs=203.7
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE---
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR--- 483 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--- 483 (720)
..++|...+.||+|+||.||+|.+. +|+.||+|++............+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3468999999999999999999765 689999999987665666678889999999999999999999999877654
Q ss_pred ---EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 484 ---LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 484 ---~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
++||||+. ++|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 58888774 4599999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhh-cc----
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RWA-TP---- 633 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~~-~~---- 633 (720)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+ ... .+
T Consensus 190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 99765332 234578999999999987 77899999999999999999999999865432221111 100 00
Q ss_pred --cccc--HHHHHhhcccccCCC---CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 --QLHD--IDALAKMVDPALNGM---YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 --~~~~--~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... .....+......... .....+..+.+|+.+||+.||++|||+.|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 000001111000000 012345788999999999999999999999976
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=333.28 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=206.1
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc---C----hHHHHHHHHHHHHhhcCC-CCCccccceEEe
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL---S----LQEEDNFLEAVSNMSRLR-HPNIVTLAGYCA 478 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~----~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 478 (720)
..++|+..+.||+|+||.||+|.+. +|+.||+|++..... . ......+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999875 688999999864421 1 123456789999999995 999999999999
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcc
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 558 (720)
..+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999973 35789999999999999999999999 999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccccccCccccc------cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFAL------SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWAT 632 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~ 632 (720)
||++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------- 237 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-------- 237 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH--------
Confidence 99997664332 223457999999999985 45688999999999999999999999975432111
Q ss_pred cccccHHHHHhhcccccCC--CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 633 PQLHDIDALAKMVDPALNG--MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+....... ......+..+.+++.+||+.||++||++.|++++
T Consensus 238 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 238 --------LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp --------HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --------HHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11111111111 1123456789999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.62 Aligned_cols=265 Identities=19% Similarity=0.265 Sum_probs=201.6
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcC------CCCCccccceEEeec
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL------RHPNIVTLAGYCAEH 480 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~ 480 (720)
...+|++.+.||+|+||.||+|.+. +++.||||++... ......+.+|+.+++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 3567999999999999999999765 5889999999753 23345566666666555 678999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc--eEEcc
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN--PHLSD 558 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~D 558 (720)
+..++||||+. ++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred CeEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence 99999999996 5999988742 235689999999999999999999999 9999999999999999987 99999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-hhcccccc
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR-WATPQLHD 637 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~-~~~~~~~~ 637 (720)
||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ........
T Consensus 246 FG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 246 FGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321 (429)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 9999764432 234579999999999999999999999999999999999999998765432221111 00000000
Q ss_pred ----HHHHHhhccccc---------------------------CC---------CCChhHHHHHHHHHHHhcCCCCCCCC
Q 005001 638 ----IDALAKMVDPAL---------------------------NG---------MYPAKSLSRFADIIALCVQPEPEFRP 677 (720)
Q Consensus 638 ----~~~~~~~~~~~~---------------------------~~---------~~~~~~~~~l~~li~~cl~~dP~~RP 677 (720)
.......++... .. ..+...+..+.+||.+||+.||++||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 000000000000 00 00111246788999999999999999
Q ss_pred CHHHHHHH
Q 005001 678 PMSEVVQA 685 (720)
Q Consensus 678 s~~ell~~ 685 (720)
|+.|++++
T Consensus 402 ta~e~L~H 409 (429)
T 3kvw_A 402 TPGQALRH 409 (429)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhCC
Confidence 99999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=337.61 Aligned_cols=253 Identities=24% Similarity=0.419 Sum_probs=201.5
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4578999999999999999999886 58899999986543 33456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 95 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999988632 46699999999999999999999999 99999999999999999999999999875321
Q ss_pred CCCccccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 567 NTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
.. ........||+.|+|||++. +..++.++||||||+++|||++|+.||.........
T Consensus 169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------- 231 (302)
T 2j7t_A 169 KT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---------------- 231 (302)
T ss_dssp HH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----------------
T ss_pred cc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH----------------
Confidence 11 01122356899999999984 667899999999999999999999999764322111
Q ss_pred Hhhcccc-cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDPA-LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+..... .....+...+..+.+++.+||+.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 232 LKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111111 1112344566789999999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=336.15 Aligned_cols=265 Identities=18% Similarity=0.291 Sum_probs=205.3
Q ss_pred HhcCCCccceeccCCCcEEEEEEE--cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCC------CccccceEEee
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF--ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP------NIVTLAGYCAE 479 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~ 479 (720)
..++|++.+.||+|+||.||+|.+ .+++.||+|++... ......+.+|+.+++.++|+ +++++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 456899999999999999999976 36889999999643 23456677888888777655 59999999999
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---------
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD--------- 550 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~--------- 550 (720)
.+..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred CCcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence 99999999999 78999998742 234689999999999999999999999 9999999999999987
Q ss_pred ----------CCceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCC
Q 005001 551 ----------ELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSR 620 (720)
Q Consensus 551 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~ 620 (720)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999765432 234579999999999999999999999999999999999999998655
Q ss_pred CcchhhHHHhhcccccc---------------------H----HHHHhhcccc-cCCCCChhHHHHHHHHHHHhcCCCCC
Q 005001 621 PRSEQSLVRWATPQLHD---------------------I----DALAKMVDPA-LNGMYPAKSLSRFADIIALCVQPEPE 674 (720)
Q Consensus 621 ~~~~~~~~~~~~~~~~~---------------------~----~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~ 674 (720)
.......+......... . ....+...+. .....+...+..+.+|+.+||+.||+
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 43222211111000000 0 0000111100 01122345678899999999999999
Q ss_pred CCCCHHHHHHH
Q 005001 675 FRPPMSEVVQA 685 (720)
Q Consensus 675 ~RPs~~ell~~ 685 (720)
+|||+.|++++
T Consensus 319 ~Rpt~~ell~h 329 (339)
T 1z57_A 319 KRITLREALKH 329 (339)
T ss_dssp TSCCHHHHTTS
T ss_pred cccCHHHHhcC
Confidence 99999999865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=339.40 Aligned_cols=270 Identities=23% Similarity=0.327 Sum_probs=202.6
Q ss_pred HhcCCCccceeccCCCcEEEEEEE--cCCcEEEEEEccccccChHHHHHHHHHHHHhhcC---CCCCccccceEEe----
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF--ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---RHPNIVTLAGYCA---- 478 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 478 (720)
..++|+..+.||+|+||.||+|.+ .+|+.||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 4688999999875443322223455666655544 8999999999987
Q ss_pred -ecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEc
Q 005001 479 -EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557 (720)
Q Consensus 479 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 557 (720)
.....++||||++ |+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 5999998743 234589999999999999999999999 99999999999999999999999
Q ss_pred ccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hh-hccc-
Q 005001 558 DCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RW-ATPQ- 634 (720)
Q Consensus 558 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~-~~~~- 634 (720)
|||++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .. ..+.
T Consensus 163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99999765432 2233467899999999999999999999999999999999999999865432221111 10 0000
Q ss_pred --cccHHHHH-hhcc---cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 --LHDIDALA-KMVD---PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 --~~~~~~~~-~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+....... .... ...........+..+.+|+.+||+.||++||++.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 0000 000011223456788999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.05 Aligned_cols=263 Identities=20% Similarity=0.312 Sum_probs=203.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe-----
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ----- 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 482 (720)
.++|...+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467889999999999999999875 68999999997665555667788999999999999999999999987654
Q ss_pred -EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 483 -RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 483 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
.++||||+. ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 58888774 4599999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hh-hcc-----
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RW-ATP----- 633 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~-~~~----- 633 (720)
+...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+ .. ..+
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9765332 234578999999999987 67899999999999999999999999865432211111 00 000
Q ss_pred -ccccH--HHHHhhcccccC---CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 -QLHDI--DALAKMVDPALN---GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 -~~~~~--~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..... ....+....... .......+..+.+++.+||+.||++||++.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 000011111111 11223456789999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.04 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=197.6
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEe---------
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA--------- 478 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--------- 478 (720)
.++|+..+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 467899999999999999999876 4899999998643 3455678899999999999999999998873
Q ss_pred -----ecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC-CCC
Q 005001 479 -----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DEL 552 (720)
Q Consensus 479 -----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-~~~ 552 (720)
..+..++||||++ |+|.++++ .+.+++..+..++.|++.||+|||+. +|+||||||+||+++ .++
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred cccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 3467899999998 59999986 46789999999999999999999999 999999999999997 567
Q ss_pred ceEEcccCCCccCCCCCc--cccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005001 553 NPHLSDCGLAALTPNTER--QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR 629 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~ 629 (720)
.+||+|||+++....... .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999986643221 11233467999999998876 678999999999999999999999998765332222111
Q ss_pred hhccccccHHHHHhhcc-------cccC-CC-----CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 630 WATPQLHDIDALAKMVD-------PALN-GM-----YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 630 ~~~~~~~~~~~~~~~~~-------~~~~-~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+.... ....+... .... .. .....+.++.+++.+||+.||++||++.|++++
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHE-EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCH-HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCch-hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 11111110 00000000 0000 00 112356789999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.49 Aligned_cols=272 Identities=22% Similarity=0.289 Sum_probs=194.8
Q ss_pred cHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe
Q 005001 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 404 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (720)
......++|+..+.||+|+||.||+|.+. +|+.||||++...... ...+.++++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 45566789999999999999999999875 6899999988543322 2345667777888899999999999876443
Q ss_pred -------EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCcEEecCCCCCEEeCC-CC
Q 005001 483 -------RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH--EVCLPSVVHRNFKSANILLDD-EL 552 (720)
Q Consensus 483 -------~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~~~~iiH~Dlkp~NIll~~-~~ 552 (720)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 7899999986 666555443345678899999999999999999999 77 9999999999999997 89
Q ss_pred ceEEcccCCCccCCCCCccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 005001 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA 631 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~ 631 (720)
.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 999999999987654332 23457899999999997654 899999999999999999999999875533222111100
Q ss_pred ccccccHHHHHhhccc---------------ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 632 TPQLHDIDALAKMVDP---------------ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 632 ~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. .............. ......+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 248 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 248 L-GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp H-CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred c-CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 00000111111000 00011222356789999999999999999999999976
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=349.26 Aligned_cols=268 Identities=22% Similarity=0.351 Sum_probs=185.1
Q ss_pred cCCCc-cceeccCCCcEEEEEEEc---CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--cCeE
Q 005001 410 NSFSQ-EFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQR 483 (720)
Q Consensus 410 ~~y~~-~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 483 (720)
+.|+. .++||+|+||.||+|.+. +++.||+|++..... ...+.+|+.++++++||||+++++++.. ....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34555 447999999999999875 578999999975432 2457789999999999999999999954 6789
Q ss_pred EEEEEecCCCCHHHHhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe----CCCCce
Q 005001 484 LLVYEYVGNGNLHDMLHFADD-----SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNP 554 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~ 554 (720)
++||||+.+ +|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence 999999975 88888764321 123589999999999999999999999 99999999999999 677899
Q ss_pred EEcccCCCccCCCCCc--cccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcc-------h
Q 005001 555 HLSDCGLAALTPNTER--QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRS-------E 624 (720)
Q Consensus 555 kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~-------~ 624 (720)
||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 9999999987653221 222346799999999999874 58999999999999999999999997654321 0
Q ss_pred h---hHHH-hhccccc---------cHHHHHhhcccccCCCC---------ChhHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 005001 625 Q---SLVR-WATPQLH---------DIDALAKMVDPALNGMY---------PAKSLSRFADIIALCVQPEPEFRPPMSEV 682 (720)
Q Consensus 625 ~---~~~~-~~~~~~~---------~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~el 682 (720)
. .+.. ...+... ................. ....+..+.+||.+||+.||++|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 0 0000 0001000 00011110100000000 00114567899999999999999999999
Q ss_pred HHH
Q 005001 683 VQA 685 (720)
Q Consensus 683 l~~ 685 (720)
+++
T Consensus 332 L~h 334 (405)
T 3rgf_A 332 MQD 334 (405)
T ss_dssp HTS
T ss_pred hcC
Confidence 976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.60 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=195.9
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee-------
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE------- 479 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 479 (720)
..++|+..+.||+|+||.||+|... +++.||+|++... ......+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 3467889999999999999999875 7899999999542 3456778999999999999999999998755
Q ss_pred ------cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc
Q 005001 480 ------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (720)
Q Consensus 480 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 553 (720)
.+..++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 4567999999999999999973 245678899999999999999999999 9999999999999999999
Q ss_pred eEEcccCCCccCCCCC-------------ccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCC
Q 005001 554 PHLSDCGLAALTPNTE-------------RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSS 619 (720)
Q Consensus 554 ~kl~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~ 619 (720)
+||+|||++....... ........||+.|+|||++.+. .++.++|||||||++|||++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 9999999997654321 1122345699999999999865 68999999999999999998 55421
Q ss_pred CCcchhhHHHhhccccccHHHHHhhc--ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 620 RPRSEQSLVRWATPQLHDIDALAKMV--DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. .. .....+. .......++...+..+.+++.+||+.||++||++.+++++
T Consensus 232 ~~--~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 ME--RV-------------NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HH--HH-------------HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hh--HH-------------HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 10 00 0111111 1122223445566778999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.19 Aligned_cols=268 Identities=22% Similarity=0.327 Sum_probs=203.4
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-----C
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----G 481 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 481 (720)
..++|...+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.++++++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3467899999999999999999875 68999999996432 344566788999999999999999999987654 6
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+. ++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CEEEEECCCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEeccC-ccHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 7899999997 59999886 25789999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCcc---------ccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-h
Q 005001 562 AALTPNTERQ---------VSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR-W 630 (720)
Q Consensus 562 a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~-~ 630 (720)
+......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+. .
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 9866432211 1123578999999998765 678999999999999999999999998654322111110 0
Q ss_pred -hcccc------ccHHHHHhhcccccC-CC-----CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 631 -ATPQL------HDIDALAKMVDPALN-GM-----YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 631 -~~~~~------~~~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..+.. ............... .. .....+..+.+++.+||+.||++||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 000001111100000 00 012355678999999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.10 Aligned_cols=266 Identities=17% Similarity=0.241 Sum_probs=202.6
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC--------CCCccccceEEe
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR--------HPNIVTLAGYCA 478 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~ 478 (720)
..++|++.+.||+|+||.||+|.+. +++.||+|++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 3578999999999999999999764 6889999999643 344567888999888875 788999999987
Q ss_pred ----ecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC--
Q 005001 479 ----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-- 552 (720)
Q Consensus 479 ----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-- 552 (720)
.....++||||+ +++|.+.+.. .....+++..+..++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 456789999999 5566666642 22367999999999999999999999964 899999999999999775
Q ss_pred -----------------------------------------------ceEEcccCCCccCCCCCccccccccccccccCc
Q 005001 553 -----------------------------------------------NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585 (720)
Q Consensus 553 -----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP 585 (720)
.+||+|||++...... .....||+.|+||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aP 262 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCC
Confidence 7999999999865432 2345799999999
Q ss_pred cccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchh---hHHHh---hccccccHHHHHh-----hccc-------
Q 005001 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ---SLVRW---ATPQLHDIDALAK-----MVDP------- 647 (720)
Q Consensus 586 E~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~---~~~~~---~~~~~~~~~~~~~-----~~~~------- 647 (720)
|++.+..++.++|||||||++|||++|+.||......... ..... ............. ....
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 9999999999999999999999999999999865543211 00000 0000000000000 0000
Q ss_pred ------------ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ------------ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......+...+..+.+||.+||+.||++|||+.|++++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00112356677889999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.16 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=183.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHH-HhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVS-NMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|+..+.||+|+||.||+|.+. +|+.||+|++.... .......+.+|+. +++.++||||+++++++...+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 467888999999999999999875 68999999997553 2333445555555 67788999999999999999999999
Q ss_pred EEecCCCCHHHHhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 487 YEYVGNGNLHDMLHFAD-DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|||+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999985 8888776322 23567899999999999999999999962 8999999999999999999999999999765
Q ss_pred CCCCccccccccccccccCcccc----ccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFA----LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ .+
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------~~ 239 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------------QL 239 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------------
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------------HH
Confidence 4322 22334799999999999 456789999999999999999999999975432110 00
Q ss_pred Hhhcc---cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVD---PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..... +..........+..+.+++.+||+.||++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 01111 111111223456789999999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=337.78 Aligned_cols=209 Identities=24% Similarity=0.305 Sum_probs=173.6
Q ss_pred hhcHHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CC-----Cccccc
Q 005001 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HP-----NIVTLA 474 (720)
Q Consensus 402 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~ 474 (720)
+.......++|+..+.||+|+||.||+|.+. +++.||||++... ......+.+|+.+++.++ |+ +|++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 3344555688999999999999999999775 6889999999743 233455667777777664 44 499999
Q ss_pred eEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC--CCC
Q 005001 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DEL 552 (720)
Q Consensus 475 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~--~~~ 552 (720)
+++...+..++||||+++ +|.+++... ....+++..+..++.|++.||.|||+. ..+|+||||||+|||++ .++
T Consensus 123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSY-NLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEETTEEEEEEECCCC-BHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred eeeccCCceEEEEecCCC-CHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence 999999999999999964 999998743 235689999999999999999999952 12999999999999995 478
Q ss_pred ceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCC
Q 005001 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRP 621 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~ 621 (720)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 199 ~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8999999999876432 2345799999999999999999999999999999999999999987554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=334.53 Aligned_cols=252 Identities=19% Similarity=0.277 Sum_probs=174.9
Q ss_pred HhcCCCccc-eeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee----cC
Q 005001 408 ATNSFSQEF-LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HG 481 (720)
Q Consensus 408 ~~~~y~~~~-~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~ 481 (720)
..++|.+.+ +||+|+||.||+|.+. +|+.||+|++.... .... +....++.++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 356788754 6999999999999876 68999999986431 1122 22233556799999999999876 45
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---CCceEEcc
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSD 558 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~D 558 (720)
..++||||+++|+|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred eEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 589999999999999999732 235799999999999999999999999 9999999999999976 45599999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
||++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 175 fg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---------- 241 (336)
T 3fhr_A 175 FGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---------- 241 (336)
T ss_dssp CTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred cccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH----------
Confidence 9999765432 223457899999999999999999999999999999999999999764432110000
Q ss_pred HHHHhhccc--ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKMVDP--ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+... ..........+..+.+|+.+||+.||++|||+.|++++
T Consensus 242 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 242 --KRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --HHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000 11111123456789999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=346.73 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=189.4
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 488 (720)
+.|...+.||+|+||+||.+...+|+.||||++... ....+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 445667889999999998877778999999998543 234567899998875 89999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC-------------C
Q 005001 489 YVGNGNLHDMLHFADDSSKN---LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-------------L 552 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-------------~ 552 (720)
|++ |+|.+++......... .++..+..++.||+.||+|||+. +|+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCce
Confidence 996 5999999743221111 13345678999999999999999 99999999999999754 4
Q ss_pred ceEEcccCCCccCCCCCcc---ccccccccccccCcccccc-------CCCcccchhhhHHHHHHHHHh-CCCCCCCCCC
Q 005001 553 NPHLSDCGLAALTPNTERQ---VSTQMVGAFGYSAPEFALS-------GIYTVKSDVYSFGVVMLELLT-GRKPLDSSRP 621 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~ 621 (720)
.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999876543222 1234579999999999976 668999999999999999999 9999975432
Q ss_pred cchhhHHHhhccccccHHHHHhhcc-cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 622 RSEQSLVRWATPQLHDIDALAKMVD-PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. .... ..... +......+...+.++.+++.+||+.||++||++.+++++
T Consensus 246 ~~-~~i~-------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 246 RE-SNII-------------RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HH-HHHH-------------HTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hH-HHHh-------------cCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 21 1111 11111 111122244667889999999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.81 Aligned_cols=265 Identities=18% Similarity=0.279 Sum_probs=202.0
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CC-cEEEEEEccccccChHHHHHHHHHHHHhhcCCCCC------ccccceEEee
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NG-KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN------IVTLAGYCAE 479 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~ 479 (720)
..++|++.+.||+|+||.||+|... ++ +.||+|++... ......+.+|+.+++.++|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 4578999999999999999999875 34 68999999643 334566778888888886655 8899999999
Q ss_pred cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEe-----------
Q 005001 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----------- 548 (720)
Q Consensus 480 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll----------- 548 (720)
.+..++||||+ +++|.+++.. .....+++.++..++.||+.||+|||+. +|+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred CCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence 99999999999 5577777653 2235799999999999999999999999 99999999999999
Q ss_pred --------CCCCceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCC
Q 005001 549 --------DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSR 620 (720)
Q Consensus 549 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~ 620 (720)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999999764332 234579999999999999999999999999999999999999998654
Q ss_pred CcchhhHHHhhccccccH-------------------------HHHHhhccc-ccCCCCChhHHHHHHHHHHHhcCCCCC
Q 005001 621 PRSEQSLVRWATPQLHDI-------------------------DALAKMVDP-ALNGMYPAKSLSRFADIIALCVQPEPE 674 (720)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~ 674 (720)
.......+.......... ........+ ..........+..+.+|+.+||+.||+
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 332211111110000000 000000000 001112234566899999999999999
Q ss_pred CCCCHHHHHHH
Q 005001 675 FRPPMSEVVQA 685 (720)
Q Consensus 675 ~RPs~~ell~~ 685 (720)
+|||+.|++++
T Consensus 324 ~Rpt~~e~l~h 334 (355)
T 2eu9_A 324 QRITLAEALLH 334 (355)
T ss_dssp TSCCHHHHTTS
T ss_pred hCcCHHHHhcC
Confidence 99999999865
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=329.65 Aligned_cols=254 Identities=21% Similarity=0.341 Sum_probs=185.6
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..++|+..+.||+|+||.||+|.+. +|+.||+|++............+.++..+++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3467888999999999999999875 689999999976543333344455566678888999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|||+ ++.+..+... ....+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||++...
T Consensus 103 ~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp ECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred Eecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999 5566555542 24678999999999999999999998 5 8999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
.... ......||+.|+|||++. +..++.++||||||+++|||++|+.||........ .
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------~ 238 (318)
T 2dyl_A 176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---------------V 238 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---------------H
T ss_pred cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH---------------H
Confidence 4322 223457999999999994 55688999999999999999999999975432111 1
Q ss_pred HHhhcccc-cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 641 LAKMVDPA-LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........ .........+..+.+++.+||+.||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 239 LTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111111 0111112356778999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.01 Aligned_cols=247 Identities=21% Similarity=0.347 Sum_probs=201.7
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccCh----HHHHHHHHHHHHhhcCC--CCCccccceEE
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLR--HPNIVTLAGYC 477 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~ 477 (720)
.....++|+..+.||+|+||.||+|.+ .+++.||+|++....... .....+.+|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 334567899999999999999999976 468899999997543321 12244667888888885 69999999999
Q ss_pred eecCeEEEEEEecCC-CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC-CCCceE
Q 005001 478 AEHGQRLLVYEYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPH 555 (720)
Q Consensus 478 ~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~k 555 (720)
...+..++|+|++.+ ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEE
Confidence 999999999999976 899999873 46789999999999999999999999 999999999999999 789999
Q ss_pred EcccCCCccCCCCCccccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 005001 556 LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 556 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
|+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ..
T Consensus 191 L~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~------- 255 (320)
T 3a99_A 191 LIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI------- 255 (320)
T ss_dssp ECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------
T ss_pred EeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh-------
Confidence 99999998764322 234579999999999988776 788999999999999999999996421 00
Q ss_pred cccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... ....+...+.++.+++.+||+.||++||++.|++++
T Consensus 256 ------~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 ------IRG------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ------HHC------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------hcc------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 011233456778999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.14 Aligned_cols=263 Identities=17% Similarity=0.294 Sum_probs=200.1
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-----------CCCccccceE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-----------HPNIVTLAGY 476 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~ 476 (720)
.++|...+.||+|+||.||+|.+ .+++.||+|++... ......+.+|+.++++++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 35789999999999999999987 46899999999743 234566778888887775 8999999999
Q ss_pred EeecC----eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC---
Q 005001 477 CAEHG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--- 549 (720)
Q Consensus 477 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~--- 549 (720)
+...+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ +|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence 87654 789999999 88999999743 2456899999999999999999999953 899999999999994
Q ss_pred ---CCCceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcch--
Q 005001 550 ---DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSE-- 624 (720)
Q Consensus 550 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~-- 624 (720)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4458999999999765432 2335799999999999999999999999999999999999999986542211
Q ss_pred --hhHHHhh--ccccccHH--------------------------HHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCC
Q 005001 625 --QSLVRWA--TPQLHDID--------------------------ALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPE 674 (720)
Q Consensus 625 --~~~~~~~--~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 674 (720)
....... ........ ...... .....++...+.++.+||.+||+.||+
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH--HHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhh--hhcccCCcchHHHHHHHHHHHhccCcc
Confidence 0000000 00000000 000000 011234567788999999999999999
Q ss_pred CCCCHHHHHHH
Q 005001 675 FRPPMSEVVQA 685 (720)
Q Consensus 675 ~RPs~~ell~~ 685 (720)
+|||+.|++++
T Consensus 324 ~Rpt~~ell~h 334 (373)
T 1q8y_A 324 KRADAGGLVNH 334 (373)
T ss_dssp TCBCHHHHHTC
T ss_pred ccCCHHHHhhC
Confidence 99999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=331.54 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=193.8
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh----HHHHHHHHHHHHhhcC----CCCCccccce
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRL----RHPNIVTLAG 475 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~l~~ 475 (720)
.+...++|+..+.||+|+||.||+|.+. +++.||+|++....... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999764 68899999997543321 1233455688888777 8999999999
Q ss_pred EEeecCeEEEEEEe-cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC-CCCc
Q 005001 476 YCAEHGQRLLVYEY-VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELN 553 (720)
Q Consensus 476 ~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-~~~~ 553 (720)
++...+..++|+|+ +.+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 99999999999999 789999999973 35689999999999999999999999 999999999999999 8899
Q ss_pred eEEcccCCCccCCCCCccccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 005001 554 PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWAT 632 (720)
Q Consensus 554 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~ 632 (720)
+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~------ 244 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E------ 244 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H------
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H------
Confidence 9999999998765432 234569999999999987776 458999999999999999999996421 0
Q ss_pred cccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 633 PQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... .....+...+..+.+++.+||+.||++||++.|++++
T Consensus 245 -------~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 -------ILE------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -------HHH------TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------Hhh------hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0112344566788999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.23 Aligned_cols=249 Identities=20% Similarity=0.276 Sum_probs=188.0
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 487 (720)
..+|...+.||+|+||+||.....+++.||||++..... ..+.+|+++++.+ +||||+++++++.+.+..++||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 456888899999999997766667899999999965432 2245788999988 8999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-----CCceEEcccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-----ELNPHLSDCGLA 562 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfg~a 562 (720)
||+. |+|.+++... .....+..+..++.||+.||+|||+. +|+||||||+|||++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9996 5999999732 23445556778999999999999999 9999999999999953 335889999999
Q ss_pred ccCCCCCc--cccccccccccccCccccc---cCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccc
Q 005001 563 ALTPNTER--QVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLH 636 (720)
Q Consensus 563 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 636 (720)
+....... .......||+.|+|||++. +..++.++|||||||++|||++ |..||..........
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~---------- 240 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---------- 240 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH----------
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH----------
Confidence 87653321 2234467999999999998 4567889999999999999999 899996432211100
Q ss_pred cHHHHHhhcccccC-CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 637 DIDALAKMVDPALN-GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 637 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.. ...... ...+...+..+.+||.+||+.||++||++.|++++
T Consensus 241 ----~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 241 ----LL--GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ----HT--TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----Hh--ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 00 000011 11123455668899999999999999999999953
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=348.84 Aligned_cols=273 Identities=23% Similarity=0.336 Sum_probs=209.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee------cC
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE------HG 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 481 (720)
.++|++.+.||+|+||.||+|.+. +|+.||+|++.... .......+.+|+.++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 367999999999999999999764 68999999987543 45567789999999999999999999998755 66
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc---eEEcc
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSD 558 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~D 558 (720)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred eEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence 7899999999999999997432 234689999999999999999999999 9999999999999997765 99999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
||++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... ..|...... .
T Consensus 168 FG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~-~ 239 (676)
T 3qa8_A 168 LGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVRE-K 239 (676)
T ss_dssp CCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC---
T ss_pred ccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhc-c
Confidence 99998764432 224467999999999999999999999999999999999999999754211 111000000 0
Q ss_pred HHHHhhc----------cc--ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHHHHHhhc
Q 005001 639 DALAKMV----------DP--ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSE-----VVQALVRLVQRAS 694 (720)
Q Consensus 639 ~~~~~~~----------~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----ll~~L~~~~~~~~ 694 (720)
....... .. ..........+..+.+++.+||+.||++||++.+ ..+.+.++++...
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ki 312 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCE
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccc
Confidence 0000000 00 0112234567889999999999999999999998 5677788777664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.24 Aligned_cols=235 Identities=15% Similarity=0.135 Sum_probs=187.8
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... ......+.+|+..+.+++||||+++++++...+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999876 4899999999865443 44557889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.++++. + ....++.+++.|++.||+|||+. +|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999851 2 35667899999999999999999 99999999999999999999998543
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHhhccccccHHHHHhhc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL-VRWATPQLHDIDALAKMV 645 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 645 (720)
|++| ++.++|||||||++|||+||+.||........... ...........
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~------- 225 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP------- 225 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH-------
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh-------
Confidence 3333 68899999999999999999999987543221100 00000000000
Q ss_pred ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 646 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
.......+..+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 226 -----~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 226 -----ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp -----HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred -----hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00123455678999999999999999 9999999998876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=352.23 Aligned_cols=243 Identities=22% Similarity=0.367 Sum_probs=197.0
Q ss_pred hcCCCccceeccCCCcEEEEEEEc--CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCe----
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA--NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ---- 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 482 (720)
.++|++.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 478999999999999999999875 58999999986532 34456678999999999999999999999987665
Q ss_pred -EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 483 -RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 483 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
.|+||||+++++|.+++. ..+++.++..++.||+.||.|||+. +|+||||||+|||++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 799999999999998775 3799999999999999999999999 99999999999999986 999999999
Q ss_pred CccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
++..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||....... ..
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~----- 285 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LP----- 285 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------CC-----
T ss_pred chhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------cc-----
Confidence 9866433 3457999999999987764 889999999999999999998886421100 00
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHHHHHh
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPP-MSEVVQALVRLVQR 692 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~L~~~~~~ 692 (720)
........+..+.++|.+||+.||++||+ ++++.+.|..+...
T Consensus 286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 00001123357889999999999999995 56666777766543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=327.94 Aligned_cols=247 Identities=15% Similarity=0.179 Sum_probs=183.7
Q ss_pred HhcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccc-cChHHHHHHHHHHHHhhcCCC-CCccccc----------
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRH-PNIVTLA---------- 474 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~niv~l~---------- 474 (720)
....|...++||+|+||.||+|.+ .+|+.||||++.... ......+.+.+|+.+++.++| +|.....
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 344577788999999999999985 469999999987332 223345778899999999977 3321111
Q ss_pred -----------eEEee-----cCeEEEEEEecCCCCHHHHhhhc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005001 475 -----------GYCAE-----HGQRLLVYEYVGNGNLHDMLHFA---DDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535 (720)
Q Consensus 475 -----------~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ 535 (720)
.++.. ....+++|+++ +++|.++++.. ......+++..+..++.|++.||+|||+. +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 11111 12356777765 57999998533 22345678889999999999999999999 9
Q ss_pred cEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccccccccccccccCcccc----------ccCCCcccchhhhHHHH
Q 005001 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA----------LSGIYTVKSDVYSFGVV 605 (720)
Q Consensus 536 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGv~ 605 (720)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999998764332 344567 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 606 MLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 606 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+|||++|+.||......... ...+. .....+..+.+||.+||+.||++||++.+++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~----------------~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGS----------------EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCS----------------GGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhhH----------------HHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999999754321110 00111 011334678999999999999999998888654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.74 Aligned_cols=227 Identities=21% Similarity=0.321 Sum_probs=178.0
Q ss_pred cCCCcc-ceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHh-hcCCCCCccccceEEee----cCe
Q 005001 410 NSFSQE-FLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNM-SRLRHPNIVTLAGYCAE----HGQ 482 (720)
Q Consensus 410 ~~y~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~ 482 (720)
++|... +.||+|+||.||+|.+ .+++.||+|++... ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 456665 7899999999999977 46899999998532 3456777776 55699999999999877 677
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---CCceEEccc
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDC 559 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Df 559 (720)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 89999999999999999742 235799999999999999999999999 9999999999999998 789999999
Q ss_pred CCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 560 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
|++.... +..++.++|||||||++|||++|+.||.......... ...
T Consensus 165 g~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------~~~--- 211 (299)
T 3m2w_A 165 GFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMK--- 211 (299)
T ss_dssp TTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------CSC---
T ss_pred ccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------HHH---
Confidence 9986432 2346789999999999999999999997543211000 000
Q ss_pred HHHhhcccccCCCCC----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAKMVDPALNGMYP----AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... ......+ ...+.++.+++.+||+.||++||++.|++++
T Consensus 212 ---~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 212 ---TRIR-MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ---CSSC-TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHh-hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 0001112 2346789999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.03 Aligned_cols=244 Identities=15% Similarity=0.142 Sum_probs=182.3
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEcccccc------ChHHHHHHHHHHHHhhcCC---------CCCcccc
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL------SLQEEDNFLEAVSNMSRLR---------HPNIVTL 473 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~niv~l 473 (720)
.++|+..+.||+|+||.||+|.+ +|+.||||++..... .......+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999988 689999999975432 1223366777877777665 5555555
Q ss_pred ce-----------------EEee-------------cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHH
Q 005001 474 AG-----------------YCAE-------------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523 (720)
Q Consensus 474 ~~-----------------~~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~ 523 (720)
.+ ++.+ .+..++||||+++|++.+.+. ...+++.++..++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 44 4433 678999999999997766664 367899999999999999
Q ss_pred HHHHHH-hcCCCCcEEecCCCCCEEeCCCC--------------------ceEEcccCCCccCCCCCccccccccccccc
Q 005001 524 ALEYLH-EVCLPSVVHRNFKSANILLDDEL--------------------NPHLSDCGLAALTPNTERQVSTQMVGAFGY 582 (720)
Q Consensus 524 ~L~~LH-~~~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y 582 (720)
||+||| +. +|+||||||+|||++.++ .+||+|||+++.... ....||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecc
Confidence 999999 88 999999999999999887 899999999986543 234799999
Q ss_pred cCccccccCCCcccchhhhHHHH-HHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc--cccCCCCChhHHH
Q 005001 583 SAPEFALSGIYTVKSDVYSFGVV-MLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD--PALNGMYPAKSLS 659 (720)
Q Consensus 583 ~aPE~~~~~~~~~~~DvwSlGv~-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 659 (720)
+|||++.+.. +.++||||+|++ .+++++|..||.... |.. .....+.+... .......+...+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~~---~~~~~~~~~~~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WLH---YLTDKMLKQMTFKTKCNTPAMKQIKR 310 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HHH---HHHHHHHHTCCCSSCCCSHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------hhh---HHHHhhhhhhccCcccchhhhhhcCH
Confidence 9999998776 899999998777 778888999884210 000 00001110000 0011111235778
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHH-HH
Q 005001 660 RFADIIALCVQPEPEFRPPMSEVV-QA 685 (720)
Q Consensus 660 ~l~~li~~cl~~dP~~RPs~~ell-~~ 685 (720)
++.+||++||+.| |++|++ ++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHhccC-----CHHHHHhcC
Confidence 8999999999976 898888 53
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=285.79 Aligned_cols=221 Identities=26% Similarity=0.442 Sum_probs=201.3
Q ss_pred CCChHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCceeEecC----CCEEEEEcCCCCCcc--cccccccCCCCCCE
Q 005001 38 TTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEG----SAVVSIDISGLGLSG--TMGYLLSDLLSLRK 111 (720)
Q Consensus 38 ~~~~~d~~al~~~~~~~~~~~~l~~w~~~~~~~c~~~w~gv~c~~----~~v~~l~l~~~~l~g--~~~~~l~~l~~L~~ 111 (720)
.|.+.|.+||++||+++.+|..+.+|.. +.+||.+.|.||+|+. ++|+.|+|++|+++| .+|..|+++++|++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~ 80 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence 4688999999999999998888899975 3577755699999985 689999999999999 99999999999999
Q ss_pred EEccC-CCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCc
Q 005001 112 FDLSG-NSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (720)
Q Consensus 112 L~L~~-N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 188 (720)
|+|++ |.+++.+|..+. ++|++|+|++|++++.+|..+.++++|++|+|++|.+++.+|..|+.+++|++|+|++|+
T Consensus 81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 99995 999999998876 899999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCccccCCC-CCCeeEeccccccccccc-cCCCCcCeEEccCccCcccCcccc---cccceeeecCCcCCCC
Q 005001 189 FSGDLPNSFISLS-NISSLYLQNNQVTGSLNV-FSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 189 l~g~~p~~~~~l~-~L~~L~l~~N~l~~~~~~-~~~~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~ 259 (720)
++|.+|..++.++ +|++|+|++|++++.++. +...+|+.|+|++|++++.+|..+ .+|+.|++.+|.+...
T Consensus 161 l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 236 (313)
T 1ogq_A 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeee
Confidence 9999999999998 999999999999987653 444569999999999999998765 5678899999998643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=286.13 Aligned_cols=187 Identities=16% Similarity=0.101 Sum_probs=131.8
Q ss_pred eccCCCcEEEEEE-EcCCcEEEEEEcccccc--------ChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEEE
Q 005001 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAAL--------SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 418 lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.+.|++|.+..++ .--|+.|++|.+..... .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5667777666653 33588999999865421 123346799999999999 7999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||++|++|.+++. ..++++.. +|+.||+.||+|+|++ |||||||||+|||++.+|.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999997 34566654 5889999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCC
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf 616 (720)
.. ......+||++|||||++.+. +..++|+||+|++++++.++..++
T Consensus 392 ~~-~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DC-SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CC-ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 33 223456899999999998764 577899999999988876655443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=288.16 Aligned_cols=80 Identities=19% Similarity=0.416 Sum_probs=69.6
Q ss_pred CChHHHHHHHHHHHhcCCCCCCCCCCCCC----CCCCCCCC------------ceeEecC-CCEEEEEcCCCCCcccccc
Q 005001 39 TDSSDVQALQVLYTSLNSPSVLTNWKGNE----GDPCGESW------------KGVACEG-SAVVSIDISGLGLSGTMGY 101 (720)
Q Consensus 39 ~~~~d~~al~~~~~~~~~~~~l~~w~~~~----~~~c~~~w------------~gv~c~~-~~v~~l~l~~~~l~g~~~~ 101 (720)
+...|.+||++||+++++| +|+.+. .+||+|+| .||+|+. ++|+.|+|++++|.|.+|+
T Consensus 266 ~~~~d~~ALl~~k~~l~~~----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred cchHHHHHHHHHHHHcCCC----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 3467999999999999887 786553 46755699 9999984 7999999999999999999
Q ss_pred cccCCCCCCEEEc-cCCCCCCC
Q 005001 102 LLSDLLSLRKFDL-SGNSIHDT 122 (720)
Q Consensus 102 ~l~~l~~L~~L~L-~~N~l~~~ 122 (720)
.|++|++|++|+| ++|.++|.
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~ 363 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSG 363 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHT
T ss_pred HHhccccceEeeeccccccccc
Confidence 9999999999999 88877665
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=282.33 Aligned_cols=219 Identities=25% Similarity=0.330 Sum_probs=141.4
Q ss_pred hccCCChHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCceeEecCCCEEEEEcCCCCCccc---ccccc--------
Q 005001 35 VQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGT---MGYLL-------- 103 (720)
Q Consensus 35 ~~~~~~~~d~~al~~~~~~~~~~~~l~~w~~~~~~~c~~~w~gv~c~~~~v~~l~l~~~~l~g~---~~~~l-------- 103 (720)
+++.+.+.|++||++||+++.||..+++|.. +.+|| .|+||+|+.++|+.|+|+++++.|. +++.+
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~~l~~W~~-~~~~C--~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKNLLPDWSS-NKNPC--TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTTSSTTCCT-TSCGG--GSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred ccccCCHHHHHHHHHHHhhCCCcccccCCCC-CCCCc--CCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 3444567899999999999998878899973 34666 8999999988999999999999998 66544
Q ss_pred ---------------cCCCCCCEEEccCCCCCCCCCC--CCC--CccceeccccccCcCCCCccc-cccCCccEEEcccc
Q 005001 104 ---------------SDLLSLRKFDLSGNSIHDTIPY--QLP--PNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRN 163 (720)
Q Consensus 104 ---------------~~l~~L~~L~L~~N~l~~~~p~--~~~--~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~L~~N 163 (720)
+++++|++|||++|.++|.+|. .+. ++|++|+|++|.+++.+|..+ .++++|++|+|++|
T Consensus 82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 4555555555555555555554 333 455555555555555555444 45555555555555
Q ss_pred ccccccccc---cCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCC-CCcCeEEccCccCcccC
Q 005001 164 SLTQSIGDI---FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWI 239 (720)
Q Consensus 164 ~l~~~~p~~---~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~l~l~~N~l~g~i 239 (720)
++++..|.. +.++++|++|+|++|++++.+|. ..+++|++|+|++|++++.++.+.. .+|++|+|++|+++|.+
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 239 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDF 239 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCH
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCcCCCcc
Confidence 555555544 55555566666666665554442 5566666666666666665554333 33777777777777666
Q ss_pred cccc---cccceeeecCCcCCC
Q 005001 240 PREL---ISIRTFIYDGNSFDN 258 (720)
Q Consensus 240 p~~l---~~l~~l~l~~n~~~~ 258 (720)
|..+ .+|+.|++.+|.+..
T Consensus 240 ~~~l~~l~~L~~L~Ls~n~l~~ 261 (768)
T 3rgz_A 240 SRAISTCTELKLLNISSNQFVG 261 (768)
T ss_dssp HHHTTTCSSCCEEECCSSCCEE
T ss_pred cHHHhcCCCCCEEECCCCcccC
Confidence 6544 345666677776653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-28 Score=277.99 Aligned_cols=213 Identities=18% Similarity=0.312 Sum_probs=178.9
Q ss_pred ChHHHHHHHHHHHhcCCCCCC---------CCCCCCCCCCCCCCC---ceeEecC-CCEEEEEcCCCCCcccccccccCC
Q 005001 40 DSSDVQALQVLYTSLNSPSVL---------TNWKGNEGDPCGESW---KGVACEG-SAVVSIDISGLGLSGTMGYLLSDL 106 (720)
Q Consensus 40 ~~~d~~al~~~~~~~~~~~~l---------~~w~~~~~~~c~~~w---~gv~c~~-~~v~~l~l~~~~l~g~~~~~l~~l 106 (720)
...|.+||.+++.++++++|- .+|+.+ .++| .| .||+|+. ++|+.|+|++++++|.+|++|++|
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c--~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L 104 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELD--MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQL 104 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGG--GTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGC
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcc--cccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcC
Confidence 357999999999999877542 379754 4666 89 9999975 699999999999999999999999
Q ss_pred CCCCEEEccCCCC-------------------------------------------------------------------
Q 005001 107 LSLRKFDLSGNSI------------------------------------------------------------------- 119 (720)
Q Consensus 107 ~~L~~L~L~~N~l------------------------------------------------------------------- 119 (720)
++|++|+|++|.+
T Consensus 105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~ 184 (636)
T 4eco_A 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184 (636)
T ss_dssp TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCC
T ss_pred ccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchh
Confidence 9999999999944
Q ss_pred -----------CCCCCCCCC--CccceeccccccCcCC-----------------CCcccc--ccCCccEEEcccccccc
Q 005001 120 -----------HDTIPYQLP--PNLTSLNLASNNFSGN-----------------LPYSIA--SMVSLSYLNVSRNSLTQ 167 (720)
Q Consensus 120 -----------~~~~p~~~~--~~L~~L~L~~N~l~g~-----------------~p~~~~--~l~~L~~L~L~~N~l~~ 167 (720)
+| +|..+. ++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.|
T Consensus 185 ~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~ 263 (636)
T 4eco_A 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263 (636)
T ss_dssp TTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS
T ss_pred hhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc
Confidence 34 666664 7899999999999986 899988 99999999999999999
Q ss_pred ccccccCCCCCCCeeecCCCc-ccC-CCCccccCC------CCCCeeEecccccccccc--ccCC-CCcCeEEccCccCc
Q 005001 168 SIGDIFGNLAGLATLDLSFNN-FSG-DLPNSFISL------SNISSLYLQNNQVTGSLN--VFSG-LPLTTLNVANNHFS 236 (720)
Q Consensus 168 ~~p~~~~~l~~L~~L~l~~N~-l~g-~~p~~~~~l------~~L~~L~l~~N~l~~~~~--~~~~-~~L~~l~l~~N~l~ 236 (720)
.+|..|+++++|++|+|++|+ ++| .+|..++.+ ++|++|+|++|+|+..+. .+.. .+|+.|+|++|+++
T Consensus 264 ~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~ 343 (636)
T 4eco_A 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343 (636)
T ss_dssp SCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCE
T ss_pred cChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCc
Confidence 999999999999999999998 888 888888776 889999999999984333 3444 45999999999999
Q ss_pred ccCcccc---cccceeeecCCcCC
Q 005001 237 GWIPREL---ISIRTFIYDGNSFD 257 (720)
Q Consensus 237 g~ip~~l---~~l~~l~l~~n~~~ 257 (720)
|.+| .+ .+|+.|++.+|.+.
T Consensus 344 g~ip-~~~~l~~L~~L~L~~N~l~ 366 (636)
T 4eco_A 344 GKLP-AFGSEIKLASLNLAYNQIT 366 (636)
T ss_dssp EECC-CCEEEEEESEEECCSSEEE
T ss_pred cchh-hhCCCCCCCEEECCCCccc
Confidence 8888 55 46777888888877
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-27 Score=246.89 Aligned_cols=215 Identities=19% Similarity=0.249 Sum_probs=186.1
Q ss_pred CChHHHHHHHHHHHhcC-CC-CCCCCCC---CCCCCCCCCCCceeEecC----------CCEEEEEcCCCCCcccccccc
Q 005001 39 TDSSDVQALQVLYTSLN-SP-SVLTNWK---GNEGDPCGESWKGVACEG----------SAVVSIDISGLGLSGTMGYLL 103 (720)
Q Consensus 39 ~~~~d~~al~~~~~~~~-~~-~~l~~w~---~~~~~~c~~~w~gv~c~~----------~~v~~l~l~~~~l~g~~~~~l 103 (720)
+..+|.+||++||+++. ++ .++.+|. ....++| .|.|+.|+. .+|+.|+|++|+++ .+|..+
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~--~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE--TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC--CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhccccccccccc--ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 44679999999999883 44 3678894 2334555 799999952 68999999999998 788889
Q ss_pred cCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCC------
Q 005001 104 SDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGN------ 175 (720)
Q Consensus 104 ~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------ 175 (720)
+++++|++|+|++|.|+ .+|..+. ++|++|+|++|+|+ .+|..++++++|++|+|++|++.+.+|..++.
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 99999999999999999 8998776 89999999999999 88999999999999999999999999988765
Q ss_pred ---CCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCC-CCcCeEEccCccCcccCcccc---cccce
Q 005001 176 ---LAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWIPREL---ISIRT 248 (720)
Q Consensus 176 ---l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~l~l~~N~l~g~ip~~l---~~l~~ 248 (720)
+++|++|+|++|+|+ .+|..++.+++|++|+|++|+|++.++.+.. .+|+.|+|++|++.+.+|..+ .+|+.
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~ 257 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCE
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCE
Confidence 999999999999999 8999999999999999999999987665544 459999999999999999865 46778
Q ss_pred eeecCCcCCCC
Q 005001 249 FIYDGNSFDNG 259 (720)
Q Consensus 249 l~l~~n~~~~~ 259 (720)
|++.+|++...
T Consensus 258 L~L~~n~~~~~ 268 (328)
T 4fcg_A 258 LILKDCSNLLT 268 (328)
T ss_dssp EECTTCTTCCB
T ss_pred EECCCCCchhh
Confidence 89999877543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=256.60 Aligned_cols=187 Identities=13% Similarity=0.188 Sum_probs=148.3
Q ss_pred CccceeccCCCcEEEEEEEcCCcEEEEEEccccccCh------HHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL------QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
...+.||+|+||.||+|.. .++.+++|+........ ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4466899999999999944 57788888765433221 1235589999999999999999877777788888999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++++|.++++. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999962 568999999999999999 9999999999999999 99999999998875
Q ss_pred CCCccc------cccccccccccCcccccc--CCCcccchhhhHHHHHHHHHhCCCCCC
Q 005001 567 NTERQV------STQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (720)
Q Consensus 567 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~pf~ 617 (720)
...... .....||+.|||||++.. ..|+..+|+|+..+-..+.+.++-+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 432221 235689999999999987 668889999999999888888777663
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-23 Score=248.22 Aligned_cols=176 Identities=26% Similarity=0.393 Sum_probs=109.6
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 160 (720)
..++.|+|++|+++|.+|..++++++|++|+|++|+++|.+|..+. ++|++|+|++|+++|.+|..++++++|++|+|
T Consensus 466 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 545 (768)
T 3rgz_A 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 545 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEEC
T ss_pred CCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEEC
Confidence 4566777777777777777777777777777777777777766554 56666666666666666666666666666666
Q ss_pred ccccccccccccc-------------------------------------------------------------------
Q 005001 161 SRNSLTQSIGDIF------------------------------------------------------------------- 173 (720)
Q Consensus 161 ~~N~l~~~~p~~~------------------------------------------------------------------- 173 (720)
++|.++|.+|..+
T Consensus 546 s~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~ 625 (768)
T 3rgz_A 546 NTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625 (768)
T ss_dssp CSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECC
T ss_pred CCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCc
Confidence 6666665555432
Q ss_pred ---CCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc-C-CCCcCeEEccCccCcccCccccc---c
Q 005001 174 ---GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-S-GLPLTTLNVANNHFSGWIPRELI---S 245 (720)
Q Consensus 174 ---~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~L~~l~l~~N~l~g~ip~~l~---~ 245 (720)
+.+++|+.|||++|+|+|.+|..++.+++|+.|+|++|+|+|.+|.. . ..+|+.|||++|+++|.||..+. +
T Consensus 626 ~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~ 705 (768)
T 3rgz_A 626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM 705 (768)
T ss_dssp CSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCC
T ss_pred hhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCC
Confidence 22345666666666666666666666666666666666666655432 2 23366666666666666665543 3
Q ss_pred cceeeecCCcCCC
Q 005001 246 IRTFIYDGNSFDN 258 (720)
Q Consensus 246 l~~l~l~~n~~~~ 258 (720)
|+.|++++|++.+
T Consensus 706 L~~L~ls~N~l~g 718 (768)
T 3rgz_A 706 LTEIDLSNNNLSG 718 (768)
T ss_dssp CSEEECCSSEEEE
T ss_pred CCEEECcCCcccc
Confidence 4455666666554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-23 Score=203.02 Aligned_cols=175 Identities=21% Similarity=0.251 Sum_probs=152.5
Q ss_pred CCCCCCCceeEecCC-----------CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceec
Q 005001 69 DPCGESWKGVACEGS-----------AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLN 135 (720)
Q Consensus 69 ~~c~~~w~gv~c~~~-----------~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~ 135 (720)
+.|.|.|.+|.|+.. +++.|+|++|++++..+..+..+++|++|+|++|+|++..+..+. ++|++|+
T Consensus 3 ~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN 82 (208)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence 456679999999742 588999999999988888899999999999999999965554443 8999999
Q ss_pred cccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccc
Q 005001 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (720)
Q Consensus 136 L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (720)
|++|+|++..+..+.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|.+.+
T Consensus 83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 99999997777778999999999999999998888889999999999999999997666678999999999999999887
Q ss_pred cccccCCCCcCeEEccCccCcccCcccccccce
Q 005001 216 SLNVFSGLPLTTLNVANNHFSGWIPRELISIRT 248 (720)
Q Consensus 216 ~~~~~~~~~L~~l~l~~N~l~g~ip~~l~~l~~ 248 (720)
..+ .|+.|+++.|+++|.+|+.++++..
T Consensus 163 ~~~-----~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 TCP-----GIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp CTT-----TTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred CCC-----CHHHHHHHHHhCCceeeccCccccC
Confidence 654 4889999999999999998887654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-22 Score=204.30 Aligned_cols=177 Identities=22% Similarity=0.253 Sum_probs=136.2
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCC--CCccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~--~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
.++.|+|++|++++..+..|.++++|++|+|++|.|++..+..+ .++|++|+|++|++++..+..+.++++|++|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 46778888888887777788888888888888888884333332 2788888888888887666777888888888888
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcccC
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWI 239 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g~i 239 (720)
+|++++..+..|+.+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+. +.. .+|+.|+|++|+|++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence 8888888778888888888888888888865555678888888888888888876653 332 45888888888888654
Q ss_pred cccc---cccceeeecCCcCCCCC
Q 005001 240 PREL---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 240 p~~l---~~l~~l~l~~n~~~~~~ 260 (720)
+..+ .+|+.|++.+|+|.|..
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 198 EGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCSS
T ss_pred HHHhccccCCCEEEecCCCeeCCC
Confidence 4433 56778888888887653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-23 Score=216.67 Aligned_cols=175 Identities=24% Similarity=0.388 Sum_probs=126.7
Q ss_pred CCEEEEEcCC-CCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEE
Q 005001 83 SAVVSIDISG-LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (720)
Q Consensus 83 ~~v~~l~l~~-~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 159 (720)
.+++.|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..+. ++|++|+|++|++++.+|..+.++++|++|+
T Consensus 76 ~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 155 (313)
T 1ogq_A 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred CCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEE
Confidence 4688889984 888888888888888999999998888888887665 7888888888888888888888888888888
Q ss_pred ccccccccccccccCCCC-CCCeeecCCCcccCCCCccccCCCCCCeeEeccccccc-----------------------
Q 005001 160 VSRNSLTQSIGDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG----------------------- 215 (720)
Q Consensus 160 L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~----------------------- 215 (720)
|++|++++.+|..++.++ +|++|+|++|+++|.+|..+..++ |++|+|++|+|++
T Consensus 156 L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 234 (313)
T 1ogq_A 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC
T ss_pred CcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCcee
Confidence 888888888888888777 777777777777766666555554 5555555555544
Q ss_pred -cccccCC-CCcCeEEccCccCcccCcccc---cccceeeecCCcCCC
Q 005001 216 -SLNVFSG-LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDN 258 (720)
Q Consensus 216 -~~~~~~~-~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~ 258 (720)
.++.+.. .+|+.|+|++|+|+|.+|..+ .+|+.|++.+|++..
T Consensus 235 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp CBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred eecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 3333222 236666666666666666544 345556666666653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.1e-23 Score=209.88 Aligned_cols=163 Identities=14% Similarity=0.080 Sum_probs=127.1
Q ss_pred HHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccCh----------------HHHHHHHHHHHHhhcCCCCC
Q 005001 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL----------------QEEDNFLEAVSNMSRLRHPN 469 (720)
Q Consensus 406 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~n 469 (720)
......|...+.||+|+||.||+|.+.+|+.||+|.++...... .....+.+|+.++++++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 33345567779999999999999988779999999996432211 23567889999999998 5
Q ss_pred ccccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC
Q 005001 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (720)
Q Consensus 470 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~ 549 (720)
+++.+++.. +..++||||+++++|.+ +.. .....++.|++.||+|||+. +|+||||||+|||++
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS 227 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence 777776544 56699999999999988 431 22457999999999999999 999999999999999
Q ss_pred CCCceEEcccCCCccCCCCCccccccccccccccCcccccc----------CCCcccchhhh
Q 005001 550 DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS----------GIYTVKSDVYS 601 (720)
Q Consensus 550 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DvwS 601 (720)
++.+||+|||+++. +..|+|||++.+ ..|...+|+|.
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999999999863 344788998754 33455556654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.7e-22 Score=201.45 Aligned_cols=182 Identities=22% Similarity=0.266 Sum_probs=155.6
Q ss_pred CCceeEecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccc
Q 005001 74 SWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIAS 151 (720)
Q Consensus 74 ~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~ 151 (720)
.|.|.+|.. ..+.+++++++++. +|..+. +.|+.|+|++|++++..|..+. ++|++|+|++|+|++..|..+.+
T Consensus 6 ~~~gC~C~~-~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 81 (251)
T 3m19_A 6 TVTGCTCNE-GKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD 81 (251)
T ss_dssp HHHSSEEEG-GGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred CCCceEcCC-CCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhcc
Confidence 799999953 24468999999984 555554 5899999999999987776665 89999999999999888888999
Q ss_pred cCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEE
Q 005001 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLN 229 (720)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~ 229 (720)
+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+. +.. .+|+.|+
T Consensus 82 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 161 (251)
T 3m19_A 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLS 161 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEE
Confidence 99999999999999988888999999999999999999976666788999999999999999987763 433 4699999
Q ss_pred ccCccCcccCcccc---cccceeeecCCcCCCC
Q 005001 230 VANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 230 l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~ 259 (720)
|++|+|++..|..+ .+|+.|++.+|++.|.
T Consensus 162 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 162 LSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999997766554 5788899999999876
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.5e-21 Score=199.00 Aligned_cols=176 Identities=20% Similarity=0.234 Sum_probs=144.5
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
.++.|+|++|++++..+..|.++++|++|+|++|.+++..+..+. ++|++|+|++|++++..+..+.++++|++|+|+
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 588999999999988888999999999999999999966665554 899999999999998888899999999999999
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccC-CCCccccCCCCCCeeEeccccccccccc-cCC-CCcC----eEEccCcc
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLT----TLNVANNH 234 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~----~l~l~~N~ 234 (720)
+|++++..+..++.+++|++|+|++|++++ .+|..++.+++|++|+|++|+|++..+. +.. .+|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 999998888889999999999999999986 3689999999999999999999885432 111 1233 67777777
Q ss_pred CcccCccccc--ccceeeecCCcCCCC
Q 005001 235 FSGWIPRELI--SIRTFIYDGNSFDNG 259 (720)
Q Consensus 235 l~g~ip~~l~--~l~~l~l~~n~~~~~ 259 (720)
+++..+..+. +++.|++.+|.+...
T Consensus 189 l~~~~~~~~~~~~L~~L~L~~n~l~~~ 215 (276)
T 2z62_A 189 MNFIQPGAFKEIRLKELALDTNQLKSV 215 (276)
T ss_dssp CCEECTTSSCSCCEEEEECCSSCCSCC
T ss_pred ccccCccccCCCcccEEECCCCceeec
Confidence 7755444332 566677777776644
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.1e-21 Score=198.41 Aligned_cols=177 Identities=21% Similarity=0.241 Sum_probs=156.9
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceecccccc-CcCCCCccccccCCccEEEc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN-FSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~L 160 (720)
.++.|+|++|++++..+..|.++++|++|+|++|.+++..|..+. ++|++|+|++|. +++..|..+.++++|++|+|
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 588999999999998888999999999999999999987777765 899999999997 88666889999999999999
Q ss_pred cccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCccc
Q 005001 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGW 238 (720)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g~ 238 (720)
++|++++..|..|..+++|++|+|++|++++..+..|+.+++|++|+|++|+|++..+. +.. .+|+.|+|++|++++.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 99999998899999999999999999999977777799999999999999999987653 333 4699999999999988
Q ss_pred Ccccc---cccceeeecCCcCCCCC
Q 005001 239 IPREL---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 239 ip~~l---~~l~~l~l~~n~~~~~~ 260 (720)
.|..+ .+|+.|++.+|.+...+
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~~ 217 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSALP 217 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CHhHccCcccccEeeCCCCcCCcCC
Confidence 88766 47888999999887543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.8e-21 Score=198.89 Aligned_cols=175 Identities=22% Similarity=0.188 Sum_probs=156.0
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
..++.|+|++|++++..+..|.++++|++|+|++|.|++..+....++|++|+|++|+|+ .+|..+.++++|++|+|++
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~ 109 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF 109 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCCCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCC
Confidence 368899999999999999999999999999999999996555555589999999999999 7899999999999999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc-C-CCCcCeEEccCccCcccCc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-S-GLPLTTLNVANNHFSGWIP 240 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~L~~l~l~~N~l~g~ip 240 (720)
|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+.. . ..+|+.|+|++|+|+ .+|
T Consensus 110 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip 188 (290)
T 1p9a_G 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (290)
T ss_dssp SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred CcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccC
Confidence 9999988899999999999999999999777777889999999999999999866543 3 356999999999999 677
Q ss_pred cccc---ccceeeecCCcCCCC
Q 005001 241 RELI---SIRTFIYDGNSFDNG 259 (720)
Q Consensus 241 ~~l~---~l~~l~l~~n~~~~~ 259 (720)
..+. +++.+.+.+|+|.|.
T Consensus 189 ~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 189 KGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp TTTTTTCCCSEEECCSCCBCCS
T ss_pred hhhcccccCCeEEeCCCCccCc
Confidence 7553 578899999999875
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.85 E-value=3.5e-21 Score=212.63 Aligned_cols=186 Identities=18% Similarity=0.176 Sum_probs=148.5
Q ss_pred CCceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceecccccc
Q 005001 74 SWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140 (720)
Q Consensus 74 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~ 140 (720)
.|..|.|.. .+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..+. ++|++|+|++|+
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 468899974 3588999999999999999999999999999999999987776665 899999999999
Q ss_pred CcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCC-ccccCCCCCCeeEeccccccccccc
Q 005001 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLNV 219 (720)
Q Consensus 141 l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~~ 219 (720)
|++..+..+.++++|++|+|++|+|++..+..|.++++|+.|+|++|+..+.++ ..|..+++|++|+|++|+|++....
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 214 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNL 214 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCC
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccccc
Confidence 997777789999999999999999998777788888888888888844333444 4577888888888888888765443
Q ss_pred cCCCCcCeEEccCccCcccCcccc---cccceeeecCCcCCCC
Q 005001 220 FSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 220 ~~~~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~ 259 (720)
....+|+.|+|++|+|++..|..| .+|+.|++.+|.+...
T Consensus 215 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 257 (452)
T 3zyi_A 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257 (452)
T ss_dssp TTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEE
T ss_pred cccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceE
Confidence 334457777888777777666654 3556677777766543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.85 E-value=8e-21 Score=192.36 Aligned_cols=167 Identities=23% Similarity=0.279 Sum_probs=148.9
Q ss_pred CCceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceecccccc
Q 005001 74 SWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140 (720)
Q Consensus 74 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~ 140 (720)
+|..|.|+. ..++.|+|++|++++..+..|.++++|++|+|++|.|++..|..+. ++|++|+|++|+
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 94 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CCeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence 678888864 3588999999999999999999999999999999999987776554 899999999999
Q ss_pred CcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-
Q 005001 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV- 219 (720)
Q Consensus 141 l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~- 219 (720)
|++..+..+.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+.
T Consensus 95 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 174 (251)
T 3m19_A 95 LASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGA 174 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred ccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHH
Confidence 9988888899999999999999999988888899999999999999999977777899999999999999999987763
Q ss_pred cCC-CCcCeEEccCccCcccCc
Q 005001 220 FSG-LPLTTLNVANNHFSGWIP 240 (720)
Q Consensus 220 ~~~-~~L~~l~l~~N~l~g~ip 240 (720)
+.. .+|+.|+|++|.|++..+
T Consensus 175 ~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 175 FDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp TTTCTTCCEEECCSCCBCTTST
T ss_pred HhCCCCCCEEEeeCCceeCCcc
Confidence 333 459999999999987633
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.9e-21 Score=203.16 Aligned_cols=191 Identities=20% Similarity=0.273 Sum_probs=147.4
Q ss_pred CCCCCCCceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCC--CCCCC--CCccce
Q 005001 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT--IPYQL--PPNLTS 133 (720)
Q Consensus 69 ~~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~--~p~~~--~~~L~~ 133 (720)
+.|.|.|++|.|+. .+++.|+|++|+++...+..|.++++|++|+|++|.++.. +|..+ .++|++
T Consensus 3 ~~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 82 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82 (306)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCE
T ss_pred CCCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCE
Confidence 45767999999975 3588999999999976666789999999999999999832 23222 278888
Q ss_pred eccccccCcCCCCccccccCCccEEEccccccccccc-cccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccc
Q 005001 134 LNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG-DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212 (720)
Q Consensus 134 L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 212 (720)
|+|++|.++ .+|..+.++++|++|+|++|++++..+ ..+..+++|++|+|++|++++..|..+..+++|++|+|++|+
T Consensus 83 L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 161 (306)
T 2z66_A 83 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 161 (306)
T ss_dssp EECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE
T ss_pred EECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc
Confidence 888888888 567778888888888888888887655 577888888888888888887777778888888888888888
Q ss_pred ccc-ccc-ccCC-CCcCeEEccCccCcccCcccc---cccceeeecCCcCCCCC
Q 005001 213 VTG-SLN-VFSG-LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 213 l~~-~~~-~~~~-~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~~ 260 (720)
+++ .++ .+.. .+|+.|+|++|++++..|..+ .+|+.|++.+|.+...+
T Consensus 162 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 215 (306)
T 2z66_A 162 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 215 (306)
T ss_dssp EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred cccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccC
Confidence 876 333 2333 358888888888887767655 46677888888776543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.8e-21 Score=225.54 Aligned_cols=89 Identities=22% Similarity=0.248 Sum_probs=76.9
Q ss_pred ccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCcccccccceeee
Q 005001 172 IFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIY 251 (720)
Q Consensus 172 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~l~~l~~l~l 251 (720)
.|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++.....+|+.|+|++|+|+|.+|..+.+++.+++
T Consensus 475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l 554 (844)
T 3j0a_A 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDI 554 (844)
T ss_dssp CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEE
T ss_pred hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEe
Confidence 35667788888888888887778888899999999999999998776665577999999999999999999999999999
Q ss_pred cCCcCCCCC
Q 005001 252 DGNSFDNGP 260 (720)
Q Consensus 252 ~~n~~~~~~ 260 (720)
.+|++.|..
T Consensus 555 ~~Np~~C~c 563 (844)
T 3j0a_A 555 THNKFICEC 563 (844)
T ss_dssp EEECCCCSS
T ss_pred cCCCccccc
Confidence 999999854
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.84 E-value=8e-21 Score=200.20 Aligned_cols=173 Identities=19% Similarity=0.273 Sum_probs=150.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccc---------
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIAS--------- 151 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~--------- 151 (720)
.+++.|+|++|+++ .+|..++++++|++|+|++|.|+ .+|..+. ++|++|+|++|++.+.+|..+..
T Consensus 104 ~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 47889999999999 88999999999999999999999 7887765 79999999999999999988765
Q ss_pred cCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc-CC-CCcCeEE
Q 005001 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-SG-LPLTTLN 229 (720)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~-~~L~~l~ 229 (720)
+++|++|+|++|+|+ .+|..++.+++|++|+|++|++++ +|..++.+++|++|+|++|++.+.+|.. .. .+|+.|+
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 259 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEE
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEE
Confidence 999999999999999 788889999999999999999994 7778999999999999999999887653 33 4599999
Q ss_pred ccCccCcccCcccc---cccceeeecCCcCCCC
Q 005001 230 VANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 230 l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~ 259 (720)
|++|++.+.+|..+ .+|+.|++.+|++...
T Consensus 260 L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~ 292 (328)
T 4fcg_A 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292 (328)
T ss_dssp CTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC
T ss_pred CCCCCchhhcchhhhcCCCCCEEeCCCCCchhh
Confidence 99999999999765 4677889999887654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-20 Score=194.18 Aligned_cols=178 Identities=22% Similarity=0.243 Sum_probs=157.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCC-CCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEE
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-IHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 159 (720)
.+++.|+|++|.+++..+..|.++++|++|+|++|. +++..|..+. ++|++|+|++|++++..|..+.++++|++|+
T Consensus 56 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 135 (285)
T 1ozn_A 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (285)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence 479999999999999989999999999999999998 7765566665 8999999999999988899999999999999
Q ss_pred ccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcc
Q 005001 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSG 237 (720)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g 237 (720)
|++|++++..+..|+.+++|++|+|++|++++..+..+..+++|++|+|++|+|++..+. +.. .+|+.|+|++|+|++
T Consensus 136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 215 (285)
T 1ozn_A 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215 (285)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCc
Confidence 999999988888899999999999999999976666799999999999999999997653 333 469999999999998
Q ss_pred cCcccc---cccceeeecCCcCCCCC
Q 005001 238 WIPREL---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 238 ~ip~~l---~~l~~l~l~~n~~~~~~ 260 (720)
..|..+ .+|+.|++.+|++.|..
T Consensus 216 ~~~~~~~~l~~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 216 LPTEALAPLRALQYLRLNDNPWVCDC 241 (285)
T ss_dssp CCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred CCHHHcccCcccCEEeccCCCccCCC
Confidence 666544 57888999999998753
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4.9e-20 Score=188.90 Aligned_cols=175 Identities=21% Similarity=0.236 Sum_probs=136.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|++++|++... +.+..+++|++|+|++|.+++.-...-.++|++|+|++|++++..+..+.++++|++|+|++
T Consensus 41 ~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 118 (272)
T 3rfs_A 41 NSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118 (272)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCCGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred cceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCchhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCC
Confidence 4678888888887642 35788888888888888888632222237888888888888877777788888888888888
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc-C-CCCcCeEEccCccCcccCc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-S-GLPLTTLNVANNHFSGWIP 240 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~L~~l~l~~N~l~g~ip 240 (720)
|++++..+..|+.+++|++|+|++|++++..+..++.+++|++|+|++|+|++..+.. . ..+|+.|+|++|+|++..|
T Consensus 119 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (272)
T 3rfs_A 119 NQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPD 198 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCH
Confidence 8888877777888888888888888888766666788888888888888888766543 2 3458888888888887766
Q ss_pred ccc---cccceeeecCCcCCCC
Q 005001 241 REL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 241 ~~l---~~l~~l~l~~n~~~~~ 259 (720)
..+ .+|+.|++.+|++.|.
T Consensus 199 ~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 199 GVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp TTTTTCTTCCEEECCSSCBCCC
T ss_pred HHHhCCcCCCEEEccCCCcccc
Confidence 543 5677888888888754
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.5e-20 Score=204.99 Aligned_cols=186 Identities=18% Similarity=0.185 Sum_probs=145.1
Q ss_pred CCceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceecccccc
Q 005001 74 SWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140 (720)
Q Consensus 74 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~ 140 (720)
.|..|.|.. ..++.|+|++|++++..+..|.++++|++|+|++|.|++..+..+. ++|++|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 477899974 3578899999999999899999999999999999999976665554 899999999999
Q ss_pred CcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCC-ccccCCCCCCeeEeccccccccccc
Q 005001 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLNV 219 (720)
Q Consensus 141 l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~~ 219 (720)
|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+..+.++ ..|.++++|++|+|++|+|+.....
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 203 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNL 203 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCC
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccccc
Confidence 997666789999999999999999998777788888888888888844433444 4677788888888888888755433
Q ss_pred cCCCCcCeEEccCccCcccCcccc---cccceeeecCCcCCCC
Q 005001 220 FSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 220 ~~~~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~ 259 (720)
....+|+.|+|++|+|++..|..| .+|+.|++.+|.+...
T Consensus 204 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 246 (440)
T 3zyj_A 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVI 246 (440)
T ss_dssp TTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred CCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEE
Confidence 333457777777777776666554 3556667777766543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2e-20 Score=206.78 Aligned_cols=150 Identities=21% Similarity=0.210 Sum_probs=131.8
Q ss_pred CCCCCCCceeEecC----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCC-CC--Cccceec
Q 005001 69 DPCGESWKGVACEG----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ-LP--PNLTSLN 135 (720)
Q Consensus 69 ~~c~~~w~gv~c~~----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~~--~~L~~L~ 135 (720)
+.|.|.+..|.|+. .+++.|+|++|++++..|..|+++++|++|+|++|.+.+.++.. +. ++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 34533444599975 35899999999999999999999999999999999998777643 43 8999999
Q ss_pred cccccCcCCCCccccccCCccEEEccccccccccccc--cCCCCCCCeeecCCCcccCCCCcc-ccCCCCCCeeEecccc
Q 005001 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQ 212 (720)
Q Consensus 136 L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~l~~N~ 212 (720)
|++|++++..|..++++++|++|+|++|++++.+|.. |+.+++|++|+|++|++++..|.. +..+++|++|+|++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999989999999999999999999999877665 999999999999999999887877 8899999999999999
Q ss_pred cccccc
Q 005001 213 VTGSLN 218 (720)
Q Consensus 213 l~~~~~ 218 (720)
+++..+
T Consensus 166 l~~~~~ 171 (455)
T 3v47_A 166 VKSICE 171 (455)
T ss_dssp BSCCCT
T ss_pred ccccCh
Confidence 998654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-19 Score=192.09 Aligned_cols=196 Identities=18% Similarity=0.220 Sum_probs=153.6
Q ss_pred CCCCCCCCCCCCCCCCceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC
Q 005001 60 LTNWKGNEGDPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP 128 (720)
Q Consensus 60 l~~w~~~~~~~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 128 (720)
+..|.......|.|.|+.+.|+. ..++.|+|++|++++..+..|+++++|++|+|++|.+++..|..+.
T Consensus 18 i~~~~~~cp~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (330)
T 1xku_A 18 IEPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 97 (330)
T ss_dssp ----CCCCCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTT
T ss_pred cccccCCCCCCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhc
Confidence 34454333345667899999974 3578899999999998888999999999999999999988787776
Q ss_pred --CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCccc--CCCCccccCCCCCC
Q 005001 129 --PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--GDLPNSFISLSNIS 204 (720)
Q Consensus 129 --~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--g~~p~~~~~l~~L~ 204 (720)
++|++|+|++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|+.|+|++|++. +..+..+..+++|+
T Consensus 98 ~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~ 174 (330)
T 1xku_A 98 PLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 174 (330)
T ss_dssp TCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCC
T ss_pred CCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcC
Confidence 79999999999998 6776654 78999999999998888888888999999999999885 36677888888888
Q ss_pred eeEeccccccccccccCCCCcCeEEccCccCcccCcccc---cccceeeecCCcCCCC
Q 005001 205 SLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 205 ~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~ 259 (720)
+|++++|+++..... ...+|+.|+|++|++++..|..+ .+|+.|++.+|.+...
T Consensus 175 ~L~l~~n~l~~l~~~-~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 231 (330)
T 1xku_A 175 YIRIADTNITTIPQG-LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 231 (330)
T ss_dssp EEECCSSCCCSCCSS-CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred EEECCCCccccCCcc-ccccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCcee
Confidence 888888888764332 22568888888888887766655 4567777888776643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.5e-20 Score=192.64 Aligned_cols=176 Identities=23% Similarity=0.252 Sum_probs=123.2
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCC-CCCC--CccceeccccccCcCCCCccccccCCccEEE
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 159 (720)
.+++.|+|++|++++ ++..+..+++|++|+|++|++++..+ ..+. ++|++|+|++|.+++..|..+.++++|++|+
T Consensus 78 ~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 156 (306)
T 2z66_A 78 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 156 (306)
T ss_dssp SCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEE
T ss_pred cccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEE
Confidence 456667777777663 55567777777777777777775443 2222 6777777777777777777777777777777
Q ss_pred cccccccc-ccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cC-CCCcCeEEccCccCc
Q 005001 160 VSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FS-GLPLTTLNVANNHFS 236 (720)
Q Consensus 160 L~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~-~~~L~~l~l~~N~l~ 236 (720)
|++|.+++ .+|..+..+++|++|+|++|++++..|..+..+++|++|+|++|+|++..+. +. ..+|+.|+|++|+++
T Consensus 157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 236 (306)
T 2z66_A 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236 (306)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence 77777776 5677777777777777777777766677777777777777777777765442 22 245777777777777
Q ss_pred ccCccccc----ccceeeecCCcCCCC
Q 005001 237 GWIPRELI----SIRTFIYDGNSFDNG 259 (720)
Q Consensus 237 g~ip~~l~----~l~~l~l~~n~~~~~ 259 (720)
+.+|..+. +++.|++.+|++.|.
T Consensus 237 ~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 237 TSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp BCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred ccCHHHHHhhhccCCEEEccCCCeecc
Confidence 77766542 556777777777655
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.1e-20 Score=195.72 Aligned_cols=175 Identities=18% Similarity=0.172 Sum_probs=120.7
Q ss_pred CCEEEEEcCCCCCcccccccc--cCCCCCCEEEccCCCCCCCCCCCCC-------CccceeccccccCcCCCCccccccC
Q 005001 83 SAVVSIDISGLGLSGTMGYLL--SDLLSLRKFDLSGNSIHDTIPYQLP-------PNLTSLNLASNNFSGNLPYSIASMV 153 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l--~~l~~L~~L~L~~N~l~~~~p~~~~-------~~L~~L~L~~N~l~g~~p~~~~~l~ 153 (720)
.+++.|+|++|++++.+|..+ +.+++|++|+|++|++++. |..+. ++|++|+|++|++++..|..+++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 357777777777777777765 7777777777777777765 54332 6777777777777776667777777
Q ss_pred CccEEEccccccccc--ccccc--CCCCCCCeeecCCCcccC--CCC-ccccCCCCCCeeEecccccccccc--ccC-CC
Q 005001 154 SLSYLNVSRNSLTQS--IGDIF--GNLAGLATLDLSFNNFSG--DLP-NSFISLSNISSLYLQNNQVTGSLN--VFS-GL 223 (720)
Q Consensus 154 ~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~g--~~p-~~~~~l~~L~~L~l~~N~l~~~~~--~~~-~~ 223 (720)
+|++|+|++|++.+. +|..+ +.+++|++|+|++|+|++ .++ ..+..+++|++|+|++|+|++.++ .+. ..
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 777777777777765 23344 677777777777777773 222 223466777777777777777553 222 24
Q ss_pred CcCeEEccCccCcccCccccc-ccceeeecCCcCCCC
Q 005001 224 PLTTLNVANNHFSGWIPRELI-SIRTFIYDGNSFDNG 259 (720)
Q Consensus 224 ~L~~l~l~~N~l~g~ip~~l~-~l~~l~l~~n~~~~~ 259 (720)
+|+.|+|++|+|+ .+|..+. +|+.|++++|.+...
T Consensus 254 ~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N~l~~~ 289 (312)
T 1wwl_A 254 QLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNRLDRN 289 (312)
T ss_dssp TCCEEECTTSCCS-SCCSSCCSEEEEEECCSSCCCSC
T ss_pred CCCEEECCCCccC-hhhhhccCCceEEECCCCCCCCC
Confidence 5777778777777 6676554 677777777777654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.81 E-value=4.5e-20 Score=185.34 Aligned_cols=190 Identities=17% Similarity=0.230 Sum_probs=156.8
Q ss_pred CCCCCCC-ce--eEecC--------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCC-CCCCCCCCCC--Ccccee
Q 005001 69 DPCGESW-KG--VACEG--------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-IHDTIPYQLP--PNLTSL 134 (720)
Q Consensus 69 ~~c~~~w-~g--v~c~~--------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~--~~L~~L 134 (720)
..|.|.+ .+ |.|.. ..++.|+|++|++++..+..|.++++|++|+|++|+ +++..+..+. ++|++|
T Consensus 6 ~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L 85 (239)
T 2xwt_C 6 PPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHI 85 (239)
T ss_dssp SSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEE
T ss_pred CCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEE
Confidence 3444433 44 55953 479999999999999888899999999999999997 8754444543 899999
Q ss_pred cccc-ccCcCCCCccccccCCccEEEccccccccccccccCCCCCCC---eeecCCC-cccCCCCccccCCCCCC-eeEe
Q 005001 135 NLAS-NNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA---TLDLSFN-NFSGDLPNSFISLSNIS-SLYL 208 (720)
Q Consensus 135 ~L~~-N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~g~~p~~~~~l~~L~-~L~l 208 (720)
+|++ |++++..+..|.++++|++|+|++|++++ +|. |+.+++|+ +|+|++| ++++..+..|..+++|+ +|+|
T Consensus 86 ~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l 163 (239)
T 2xwt_C 86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163 (239)
T ss_dssp EEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEEC
T ss_pred ECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEc
Confidence 9999 99997777899999999999999999997 666 88999998 9999999 99976667799999999 9999
Q ss_pred cccccccccc-ccCCCCcCeEEccCcc-CcccCcccc----cccceeeecCCcCCCCC
Q 005001 209 QNNQVTGSLN-VFSGLPLTTLNVANNH-FSGWIPREL----ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 209 ~~N~l~~~~~-~~~~~~L~~l~l~~N~-l~g~ip~~l----~~l~~l~l~~n~~~~~~ 260 (720)
++|+|+...+ .+...+|+.|+|++|+ +++..+..| .+|+.|++.+|++...|
T Consensus 164 ~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~ 221 (239)
T 2xwt_C 164 YNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALP 221 (239)
T ss_dssp CSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCC
T ss_pred CCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCC
Confidence 9999995443 2344569999999995 986555544 57788999999997654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.81 E-value=8e-20 Score=187.32 Aligned_cols=172 Identities=23% Similarity=0.262 Sum_probs=149.0
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEE
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 159 (720)
..+++.|+|++|++++. +.++++++|++|+|++|.+++..+..+. ++|++|+|++|++++..+..+.++++|++|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 35799999999999874 4899999999999999999976665443 8999999999999988888899999999999
Q ss_pred ccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc-C-CCCcCeEEccCccCcc
Q 005001 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-S-GLPLTTLNVANNHFSG 237 (720)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~L~~l~l~~N~l~g 237 (720)
|++|+|++..+..|+.+++|+.|+|++|++++..+..++.+++|++|+|++|+|++.++.. . ..+|+.|+|++|.+.+
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 9999999888888999999999999999999877777899999999999999999977643 3 3569999999999998
Q ss_pred cCcccccccceeeecCCcCCCC
Q 005001 238 WIPRELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 238 ~ip~~l~~l~~l~l~~n~~~~~ 259 (720)
..| +++.+.+..|.+...
T Consensus 220 ~~~----~l~~l~~~~n~~~g~ 237 (272)
T 3rfs_A 220 TCP----GIRYLSEWINKHSGV 237 (272)
T ss_dssp CTT----TTHHHHHHHHHTGGG
T ss_pred cCc----HHHHHHHHHHhCCCc
Confidence 765 466677777777643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.6e-20 Score=184.42 Aligned_cols=151 Identities=23% Similarity=0.250 Sum_probs=111.6
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCC---CCccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 87 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~---~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
.|++++|+++. +|..+. ..+++|+|++|+|++..|... .++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 34555566654 455443 345788888888886655432 277888888888888777778888888888888888
Q ss_pred ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcccCc
Q 005001 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIP 240 (720)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g~ip 240 (720)
+|++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+. +.. .+|+.|+|++|.|++..+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 88887777788888888888888888877788888888888888888888886543 333 348888888888876544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=201.99 Aligned_cols=188 Identities=16% Similarity=0.202 Sum_probs=163.7
Q ss_pred CCCCCceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceeccc
Q 005001 71 CGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137 (720)
Q Consensus 71 c~~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~ 137 (720)
|...|..|.|+. ..++.|+|++|++++..+..|.++++|++|+|++|.+++..|..+. ++|++|+|+
T Consensus 9 C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 88 (477)
T 2id5_A 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR 88 (477)
T ss_dssp EETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred ECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence 433578999974 2578899999999999999999999999999999999988787775 899999999
Q ss_pred cccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccc
Q 005001 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217 (720)
Q Consensus 138 ~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (720)
+|++++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..
T Consensus 89 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 168 (477)
T 2id5_A 89 SNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP 168 (477)
T ss_dssp SSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC
T ss_pred CCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC
Confidence 99999766677899999999999999999999999999999999999999999888999999999999999999999866
Q ss_pred cc-c-CCCCcCeEEccCccCcccCcccc---cccceeeecCCcCCC
Q 005001 218 NV-F-SGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDN 258 (720)
Q Consensus 218 ~~-~-~~~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~ 258 (720)
+. + ...+|+.|+|++|.+++..+..+ .+|+.|++.+|++..
T Consensus 169 ~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~ 214 (477)
T 2id5_A 169 TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214 (477)
T ss_dssp HHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCC
T ss_pred hhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcccc
Confidence 43 3 33569999999999998766555 467788888877543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.81 E-value=4.1e-20 Score=178.90 Aligned_cols=171 Identities=20% Similarity=0.247 Sum_probs=134.4
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCC-C--CCccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ-L--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 87 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~--~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
.|++++++|+ .+|..+.. +|++|+|++|+|++..+.. + .++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 3455566663 56665544 8999999999999766643 3 389999999999999988999999999999999999
Q ss_pred ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCC-cCeEEccCccCcccCccc
Q 005001 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRE 242 (720)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~~N~l~g~ip~~ 242 (720)
+|++..+..|..+++|++|+|++|+|++.+|..|..+++|++|+|++|.+++..+...... ++...+..+......|..
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~ 168 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK 168 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChH
Confidence 9999999899999999999999999999889999999999999999999998654321111 333344555666667777
Q ss_pred ccccceeeecCCcCCCCC
Q 005001 243 LISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 243 l~~l~~l~l~~n~~~~~~ 260 (720)
+.......+..+.+.|..
T Consensus 169 l~~~~l~~l~~~~~~C~~ 186 (192)
T 1w8a_A 169 VRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp TTTSBGGGSCTTTCCCCC
T ss_pred HcCCChhhCcHhhcCcCC
Confidence 777777777777777653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.9e-19 Score=190.28 Aligned_cols=186 Identities=18% Similarity=0.231 Sum_probs=150.4
Q ss_pred CCCCCCCceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceec
Q 005001 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLN 135 (720)
Q Consensus 69 ~~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~ 135 (720)
..|.|.|+.+.|+. .+++.|+|++|++++..+..|.++++|++|+|++|++++..|..+. ++|++|+
T Consensus 29 ~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 29 FGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp SSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred CCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 44556899999974 2588999999999988888999999999999999999987776665 7899999
Q ss_pred cccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCccc--CCCCccccCCCCCCeeEeccccc
Q 005001 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--GDLPNSFISLSNISSLYLQNNQV 213 (720)
Q Consensus 136 L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--g~~p~~~~~l~~L~~L~l~~N~l 213 (720)
|++|+++ .+|..+. ++|++|+|++|++++..+..|..+++|+.|+|++|+++ +..|..+..+ +|++|++++|++
T Consensus 109 L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 109 ISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp CCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred CCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 9999998 6776665 88999999999999877778899999999999999996 4677778877 888888888888
Q ss_pred cccccccCCCCcCeEEccCccCcccCcccc---cccceeeecCCcCCCC
Q 005001 214 TGSLNVFSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 214 ~~~~~~~~~~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~ 259 (720)
++... ....+|+.|+|++|.+++..|..+ .+|+.|++.+|.+...
T Consensus 185 ~~l~~-~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~ 232 (332)
T 2ft3_A 185 TGIPK-DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI 232 (332)
T ss_dssp SSCCS-SSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCC
T ss_pred CccCc-cccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcC
Confidence 87433 223568888888888887666554 4566777888877654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.9e-20 Score=208.11 Aligned_cols=132 Identities=20% Similarity=0.251 Sum_probs=97.2
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
++..|++++|.+.+..+..+.++++|++|+|++|.|++..|..+. ++|++|+|++|.|++..|..|+++++|++|+|+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 356677777777766666677777777777777777766655554 677777777777777667777777777777777
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccc
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (720)
+|.|++..+..|+++++|++|+|++|+|++..|..|+.+++|++|+|++|+|++
T Consensus 132 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred CCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 777776656666777777777777777777777777777777777777777765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=178.62 Aligned_cols=156 Identities=26% Similarity=0.324 Sum_probs=115.3
Q ss_pred CCCCCCCceeEecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCC
Q 005001 69 DPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP 146 (720)
Q Consensus 69 ~~c~~~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p 146 (720)
..|.|.|..|.|++ ++++ .+|..+. ++|+.|+|++|+|++..+..+. ++|++|+|++|+|++..|
T Consensus 7 ~~C~C~~~~v~c~~----------~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~ 73 (220)
T 2v9t_B 7 AACTCSNNIVDCRG----------KGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAP 73 (220)
T ss_dssp TTSEEETTEEECTT----------SCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECT
T ss_pred CCCEECCCEEEcCC----------CCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCH
Confidence 45666787777764 3343 3444443 5788888888888855554444 678888888888887778
Q ss_pred ccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CC
Q 005001 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LP 224 (720)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~ 224 (720)
..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+. +.. .+
T Consensus 74 ~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 153 (220)
T 2v9t_B 74 DAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153 (220)
T ss_dssp TTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred HHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCC
Confidence 8888888888888888888866666778888888888888888877777888888888888888888876653 332 35
Q ss_pred cCeEEccCccCcc
Q 005001 225 LTTLNVANNHFSG 237 (720)
Q Consensus 225 L~~l~l~~N~l~g 237 (720)
|+.|+|++|.+..
T Consensus 154 L~~L~L~~N~~~c 166 (220)
T 2v9t_B 154 IQTMHLAQNPFIC 166 (220)
T ss_dssp CCEEECCSSCEEC
T ss_pred CCEEEeCCCCcCC
Confidence 8888888888863
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.4e-20 Score=205.81 Aligned_cols=178 Identities=24% Similarity=0.349 Sum_probs=147.0
Q ss_pred CCCCCCCCCCCCC---CCcee-EecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceecc
Q 005001 61 TNWKGNEGDPCGE---SWKGV-ACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNL 136 (720)
Q Consensus 61 ~~w~~~~~~~c~~---~w~gv-~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L 136 (720)
.+|.. ..++|.. .|.|+ .|..++++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| .+.++|++|+|
T Consensus 34 ~~W~~-~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip-~~l~~L~~L~L 107 (571)
T 3cvr_A 34 DKWEK-QALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP-ELPASLEYLDA 107 (571)
T ss_dssp HHHHT-TCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC-CCCTTCCEEEC
T ss_pred HHHhc-cCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc-cccCCCCEEEc
Confidence 45643 3466744 59999 8988899999999999998 776663 78999999999999 788 77799999999
Q ss_pred ccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccc
Q 005001 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS 216 (720)
Q Consensus 137 ~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~ 216 (720)
++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++.
T Consensus 108 s~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~l 175 (571)
T 3cvr_A 108 CDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFL 175 (571)
T ss_dssp CSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC
T ss_pred cCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCc
Confidence 9999997 887 666 99999999999998 666 68999999999999996 776 578999999999999984
Q ss_pred ccccCCCCcCeEEccCccCcccCccccc-cc-------ceeeecCCcCCCCC
Q 005001 217 LNVFSGLPLTTLNVANNHFSGWIPRELI-SI-------RTFIYDGNSFDNGP 260 (720)
Q Consensus 217 ~~~~~~~~L~~l~l~~N~l~g~ip~~l~-~l-------~~l~l~~n~~~~~~ 260 (720)
.. +. .+|+.|+|++|+|+ .+|. +. +| +.|++.+|.+...|
T Consensus 176 p~-l~-~~L~~L~Ls~N~L~-~lp~-~~~~L~~~~~~L~~L~Ls~N~l~~lp 223 (571)
T 3cvr_A 176 PE-LP-ESLEALDVSTNLLE-SLPA-VPVRNHHSEETEIFFRCRENRITHIP 223 (571)
T ss_dssp CC-CC-TTCCEEECCSSCCS-SCCC-CC--------CCEEEECCSSCCCCCC
T ss_pred ch-hh-CCCCEEECcCCCCC-chhh-HHHhhhcccccceEEecCCCcceecC
Confidence 44 43 77999999999999 6777 43 67 88999999887543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=189.42 Aligned_cols=176 Identities=19% Similarity=0.219 Sum_probs=145.7
Q ss_pred CEEEEEcCCCCCcccccccc--cCCCCCCEEEccCCCCCCCCCC------CCCCccceeccccccCcCCCCccccccCCc
Q 005001 84 AVVSIDISGLGLSGTMGYLL--SDLLSLRKFDLSGNSIHDTIPY------QLPPNLTSLNLASNNFSGNLPYSIASMVSL 155 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l--~~l~~L~~L~L~~N~l~~~~p~------~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L 155 (720)
+++.|+|++|++++..|..+ +++++|++|+|++|.+++..|. ...++|++|+|++|++++..|..++++++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 48899999999999999988 9999999999999999976552 224799999999999998888999999999
Q ss_pred cEEEccccccccc--cc--cccCCCCCCCeeecCCCcccCCCCc----cccCCCCCCeeEecccccccccc-ccCC----
Q 005001 156 SYLNVSRNSLTQS--IG--DIFGNLAGLATLDLSFNNFSGDLPN----SFISLSNISSLYLQNNQVTGSLN-VFSG---- 222 (720)
Q Consensus 156 ~~L~L~~N~l~~~--~p--~~~~~l~~L~~L~l~~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~~~~~-~~~~---- 222 (720)
++|+|++|++.+. ++ ..++.+++|++|+|++|+++ .+|. .++.+++|++|+|++|+|++..| .+..
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 9999999998764 22 33478999999999999997 3443 24678999999999999998743 2222
Q ss_pred CCcCeEEccCccCcccCcccc-cccceeeecCCcCCCCCC
Q 005001 223 LPLTTLNVANNHFSGWIPREL-ISIRTFIYDGNSFDNGPA 261 (720)
Q Consensus 223 ~~L~~l~l~~N~l~g~ip~~l-~~l~~l~l~~n~~~~~~~ 261 (720)
.+|+.|+|++|+|+ .+|..+ .+|+.|++++|.+...|.
T Consensus 251 ~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~~~~ 289 (310)
T 4glp_A 251 SALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNRAPQ 289 (310)
T ss_dssp TTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCSCCC
T ss_pred CcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCCCch
Confidence 36999999999999 677755 589999999999986543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.3e-19 Score=178.76 Aligned_cols=154 Identities=23% Similarity=0.250 Sum_probs=127.1
Q ss_pred CCCceeEecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCcccc
Q 005001 73 ESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIA 150 (720)
Q Consensus 73 ~~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~ 150 (720)
|+|++|.|+..++ + .+|..+. ++|++|+|++|+|++..|..+. ++|++|+|++|+|++..+..|.
T Consensus 19 Cs~~~v~c~~~~l----------~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~ 85 (229)
T 3e6j_A 19 CSGTTVDCRSKRH----------A-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD 85 (229)
T ss_dssp EETTEEECTTSCC----------S-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred EeCCEeEccCCCc----------C-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcc
Confidence 3899999986443 2 4454443 7899999999999987776664 7899999999999866566789
Q ss_pred ccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeE
Q 005001 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTL 228 (720)
Q Consensus 151 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l 228 (720)
++++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+. +.. .+|+.|
T Consensus 86 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 164 (229)
T 3e6j_A 86 SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 9999999999999999888888899999999999999999 7898999999999999999999986653 333 459999
Q ss_pred EccCccCcccCc
Q 005001 229 NVANNHFSGWIP 240 (720)
Q Consensus 229 ~l~~N~l~g~ip 240 (720)
+|++|.+.+..+
T Consensus 165 ~l~~N~~~c~c~ 176 (229)
T 3e6j_A 165 YLFGNPWDCECR 176 (229)
T ss_dssp ECTTSCBCTTBG
T ss_pred EeeCCCccCCcc
Confidence 999999986654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=193.92 Aligned_cols=170 Identities=22% Similarity=0.206 Sum_probs=141.7
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCC---CCccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 87 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~---~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
.+++++++|+. +|..+. ..|+.|+|++|+|++..+..+ .++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 45666677764 555544 358999999999997666554 279999999999999888888999999999999999
Q ss_pred ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccC-----CCCcCeEEccCccCccc
Q 005001 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS-----GLPLTTLNVANNHFSGW 238 (720)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-----~~~L~~l~l~~N~l~g~ 238 (720)
+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+... ..+|+.|+|++|+|++.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 9998888899999999999999999998888999999999999999999998665432 34699999999999965
Q ss_pred Cccccccc-----ceeeecCCcCCCC
Q 005001 239 IPRELISI-----RTFIYDGNSFDNG 259 (720)
Q Consensus 239 ip~~l~~l-----~~l~l~~n~~~~~ 259 (720)
.+..+..+ +.|++.+|+|.|.
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred CHHHhhhccHhhcceEEecCCCccCC
Confidence 55555544 5689999999875
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=193.77 Aligned_cols=187 Identities=18% Similarity=0.221 Sum_probs=157.7
Q ss_pred CCCCceeEecC-------------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceecc
Q 005001 72 GESWKGVACEG-------------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNL 136 (720)
Q Consensus 72 ~~~w~gv~c~~-------------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L 136 (720)
.|.|.|+ |+. .+++.|+|++|++++..+..+.++++|++|+|++|++++..|..+. ++|++|+|
T Consensus 29 ~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 29 SCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp EECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 3378887 642 3689999999999988777999999999999999999987776665 89999999
Q ss_pred ccccCcCCCCccccccCCccEEEccccccccccc-cccCCCCCCCeeecCCC-cccCCCCccccCCCCCCeeEecccccc
Q 005001 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG-DIFGNLAGLATLDLSFN-NFSGDLPNSFISLSNISSLYLQNNQVT 214 (720)
Q Consensus 137 ~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (720)
++|++++..+..+.++++|++|+|++|++++..+ ..+..+++|++|+|++| .+++..|..+..+++|++|++++|+++
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 187 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence 9999996555559999999999999999996554 58999999999999999 477666788999999999999999999
Q ss_pred ccccc-cCC-CCcCeEEccCccCcccCccc----ccccceeeecCCcCCCCC
Q 005001 215 GSLNV-FSG-LPLTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 215 ~~~~~-~~~-~~L~~l~l~~N~l~g~ip~~----l~~l~~l~l~~n~~~~~~ 260 (720)
+..+. +.. .+|+.|++++|+++ .+|.. +.+++.|++.+|.+...+
T Consensus 188 ~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~ 238 (353)
T 2z80_A 188 SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFH 238 (353)
T ss_dssp EECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCC
T ss_pred ccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCcccccc
Confidence 97554 333 35999999999996 55543 468999999999987654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.9e-19 Score=196.31 Aligned_cols=108 Identities=19% Similarity=0.279 Sum_probs=78.9
Q ss_pred CCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cC-CCCcCeEEc
Q 005001 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FS-GLPLTTLNV 230 (720)
Q Consensus 153 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~-~~~L~~l~l 230 (720)
++|+.|+|++|++++.+|..|+.+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+. +. ..+|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 3566666666666666777888888888888888888877777788888888888888888776543 23 245888888
Q ss_pred cCccCcccCcccc---cccceeeecCCcCCCCC
Q 005001 231 ANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 231 ~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~~ 260 (720)
++|++++..|..+ .+|+.|++.+|.+...+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 387 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVP 387 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCCcccccChhhccccccccEEECCCCccccCC
Confidence 8888887777654 45677788888777544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.9e-20 Score=203.66 Aligned_cols=173 Identities=20% Similarity=0.140 Sum_probs=124.1
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCC-------------------ccceeccccccCcCC
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP-------------------NLTSLNLASNNFSGN 144 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-------------------~L~~L~L~~N~l~g~ 144 (720)
+++.|+|++|++++..|..|+.+++|++|+|++|.|++..|....+ +|++|+|++|.|++.
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~ 114 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRV 114 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEECTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCE
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcccccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCC
Confidence 4555555555555555555555555555555555555444432224 455555555555543
Q ss_pred CCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCcccc-CCCCCCeeEeccccccccccccCCC
Q 005001 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI-SLSNISSLYLQNNQVTGSLNVFSGL 223 (720)
Q Consensus 145 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~ 223 (720)
.+. .+++|+.|+|++|.|++..|..++.+++|++|+|++|+|++.+|..+. .+++|++|+|++|.|++..+.....
T Consensus 115 ~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~ 191 (487)
T 3oja_A 115 SCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFA 191 (487)
T ss_dssp EEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCT
T ss_pred Ccc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCC
Confidence 332 467889999999999988888899999999999999999988888876 7899999999999999876665666
Q ss_pred CcCeEEccCccCcccCcc--cccccceeeecCCcCCCC
Q 005001 224 PLTTLNVANNHFSGWIPR--ELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 224 ~L~~l~l~~N~l~g~ip~--~l~~l~~l~l~~n~~~~~ 259 (720)
+|+.|+|++|.|++..|. .+.+|+.|++++|.+...
T Consensus 192 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~l 229 (487)
T 3oja_A 192 KLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLI 229 (487)
T ss_dssp TCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEE
T ss_pred CCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCccc
Confidence 799999999999975554 345788899999988753
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=7.2e-20 Score=191.64 Aligned_cols=174 Identities=20% Similarity=0.248 Sum_probs=146.5
Q ss_pred CCCEEEEEcCCCCCcccccccccCC-----CCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCC--CCccc--c
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLSDL-----LSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN--LPYSI--A 150 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~--~p~~~--~ 150 (720)
..+++.|+|++|++++. |..++.+ ++|++|+|++|+|++..|..+. ++|++|+|++|++.|. +|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 35799999999999998 8888887 9999999999999988777775 8999999999999876 34455 8
Q ss_pred ccCCccEEEcccccccc--ccc-cccCCCCCCCeeecCCCcccCCCC-ccccCCCCCCeeEeccccccccccccCCCCcC
Q 005001 151 SMVSLSYLNVSRNSLTQ--SIG-DIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLNVFSGLPLT 226 (720)
Q Consensus 151 ~l~~L~~L~L~~N~l~~--~~p-~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~ 226 (720)
++++|++|+|++|+|++ .++ ..+..+++|++|+|++|++++.+| ..+..+++|++|+|++|+|+. +|.....+|+
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~~L~ 277 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPAKLS 277 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSS-CCSSCCSEEE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccCh-hhhhccCCce
Confidence 99999999999999994 233 455788999999999999998776 456778999999999999994 4433336799
Q ss_pred eEEccCccCcccCcc--cccccceeeecCCcCCC
Q 005001 227 TLNVANNHFSGWIPR--ELISIRTFIYDGNSFDN 258 (720)
Q Consensus 227 ~l~l~~N~l~g~ip~--~l~~l~~l~l~~n~~~~ 258 (720)
.|+|++|+|++. |. .+.+|+.|++.+|++..
T Consensus 278 ~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 278 VLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp EEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTC
T ss_pred EEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCC
Confidence 999999999976 64 44577889999999864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=204.06 Aligned_cols=185 Identities=19% Similarity=0.226 Sum_probs=160.0
Q ss_pred CCceeEecC-------------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceecccc
Q 005001 74 SWKGVACEG-------------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLAS 138 (720)
Q Consensus 74 ~w~gv~c~~-------------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~ 138 (720)
.|.|| |+. .+++.|+|++|++++..|..|+++++|++|+|++|++++..|..+. ++|++|+|++
T Consensus 5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~ 83 (549)
T 2z81_A 5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83 (549)
T ss_dssp CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred CCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC
Confidence 78888 863 2689999999999999999999999999999999999987776665 7999999999
Q ss_pred ccCcCCCCccccccCCccEEEcccccccc-ccccccCCCCCCCeeecCCCcccCCCC-ccccCCCCCCeeEecccccccc
Q 005001 139 NNFSGNLPYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGS 216 (720)
Q Consensus 139 N~l~g~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~ 216 (720)
|++++..|..++++++|++|+|++|.+++ .+|..++++++|++|+|++|++.+.+| ..+..+++|++|++++|++++.
T Consensus 84 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 163 (549)
T 2z81_A 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163 (549)
T ss_dssp SCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred CccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccccc
Confidence 99998888889999999999999999997 467899999999999999999655665 6799999999999999999997
Q ss_pred cccc-CC-CCcCeEEccCccCcccCccc----ccccceeeecCCcCCCCC
Q 005001 217 LNVF-SG-LPLTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 217 ~~~~-~~-~~L~~l~l~~N~l~g~ip~~----l~~l~~l~l~~n~~~~~~ 260 (720)
++.. .. .+|+.|++++|.+. .+|.. +.+++.|++.+|.+...+
T Consensus 164 ~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~ 212 (549)
T 2z81_A 164 QSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQ 212 (549)
T ss_dssp CTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCC
T ss_pred ChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCcccccc
Confidence 6543 33 35999999999986 45543 578999999999987654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-19 Score=206.64 Aligned_cols=173 Identities=24% Similarity=0.313 Sum_probs=150.2
Q ss_pred CCCCCceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceeccc
Q 005001 71 CGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137 (720)
Q Consensus 71 c~~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~ 137 (720)
|.|.++.|.|+. .+++.|+|++|++++..+..|+++++|++|+|++|.+++..|..+. ++|++|+|+
T Consensus 2 C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 81 (680)
T 1ziw_A 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ 81 (680)
T ss_dssp --CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECC
T ss_pred ceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECC
Confidence 545677788863 3689999999999998888999999999999999999988887664 899999999
Q ss_pred cccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccc
Q 005001 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217 (720)
Q Consensus 138 ~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (720)
+|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++.+++|++|+|++|++++..
T Consensus 82 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred CCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence 99999655567999999999999999999888899999999999999999999988999999999999999999999876
Q ss_pred cc----cCCCCcCeEEccCccCcccCcccc
Q 005001 218 NV----FSGLPLTTLNVANNHFSGWIPREL 243 (720)
Q Consensus 218 ~~----~~~~~L~~l~l~~N~l~g~ip~~l 243 (720)
+. ....+|+.|+|++|++++..|..+
T Consensus 162 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~ 191 (680)
T 1ziw_A 162 SEELDIFANSSLKKLELSSNQIKEFSPGCF 191 (680)
T ss_dssp HHHHGGGTTCEESEEECTTCCCCCBCTTGG
T ss_pred HHHhhccccccccEEECCCCcccccChhhh
Confidence 53 233569999999999988777644
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.7e-20 Score=212.11 Aligned_cols=175 Identities=16% Similarity=0.304 Sum_probs=156.7
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCC-CCC-CCCCCCC--------CccceeccccccCcCCCCc--cc
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-IHD-TIPYQLP--------PNLTSLNLASNNFSGNLPY--SI 149 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~-l~~-~~p~~~~--------~~L~~L~L~~N~l~g~~p~--~~ 149 (720)
..+++.|+|++|++.|.+|..|+++++|++|+|++|+ ++| .+|..+. ++|++|+|++|+++ .+|. .+
T Consensus 248 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l 326 (636)
T 4eco_A 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSL 326 (636)
T ss_dssp CTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHH
T ss_pred cCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhh
Confidence 3579999999999999999999999999999999998 998 8887653 79999999999999 8998 99
Q ss_pred cccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCC-CCeeEeccccccccccccCCC---Cc
Q 005001 150 ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN-ISSLYLQNNQVTGSLNVFSGL---PL 225 (720)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~---~L 225 (720)
+++++|++|+|++|+++|.+| .|+.+++|++|+|++|+++ .+|..++.+++ |++|+|++|+|+..+..+... +|
T Consensus 327 ~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~L 404 (636)
T 4eco_A 327 QKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVM 404 (636)
T ss_dssp TTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSCCCTTCSSCE
T ss_pred ccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccchhhhhcccCcc
Confidence 999999999999999999999 9999999999999999999 89999999999 999999999999443333332 59
Q ss_pred CeEEccCccCcccCccccc----------ccceeeecCCcCCCC
Q 005001 226 TTLNVANNHFSGWIPRELI----------SIRTFIYDGNSFDNG 259 (720)
Q Consensus 226 ~~l~l~~N~l~g~ip~~l~----------~l~~l~l~~n~~~~~ 259 (720)
+.|+|++|+++|.+|..+. +++.|++.+|.+...
T Consensus 405 ~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~l 448 (636)
T 4eco_A 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF 448 (636)
T ss_dssp EEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSC
T ss_pred CEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcC
Confidence 9999999999999998776 788899999998743
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-18 Score=182.89 Aligned_cols=174 Identities=21% Similarity=0.226 Sum_probs=124.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|+|++|++++..|..|+++++|++|+|++|+++ .+|..+.++|++|+|++|++++..+..+.++++|+.|+|++
T Consensus 78 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 156 (332)
T 2ft3_A 78 QHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156 (332)
T ss_dssp TTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCS
T ss_pred CCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCC
Confidence 57999999999999999999999999999999999999 78888889999999999999977677899999999999999
Q ss_pred cccc--cccccccCCCCCCCeeecCCC---------------------cccCCCCccccCCCCCCeeEeccccccccccc
Q 005001 163 NSLT--QSIGDIFGNLAGLATLDLSFN---------------------NFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219 (720)
Q Consensus 163 N~l~--~~~p~~~~~l~~L~~L~l~~N---------------------~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 219 (720)
|.++ +..|..+..+ +|++|++++| ++++..|..+..+++|+.|+|++|+|++..+.
T Consensus 157 n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 235 (332)
T 2ft3_A 157 NPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENG 235 (332)
T ss_dssp CCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTT
T ss_pred CccccCCCCcccccCC-ccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChh
Confidence 9996 3667777766 5555555555 44444444555555555555555555554431
Q ss_pred -cC-CCCcCeEEccCccCcccCcccc---cccceeeecCCcCCCC
Q 005001 220 -FS-GLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 220 -~~-~~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~ 259 (720)
+. ..+|+.|+|++|+|+ .+|..+ .+|+.|++.+|++...
T Consensus 236 ~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~ 279 (332)
T 2ft3_A 236 SLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV 279 (332)
T ss_dssp GGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBC
T ss_pred HhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCcc
Confidence 21 223555555555555 455433 2344555555555443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.5e-19 Score=203.28 Aligned_cols=182 Identities=22% Similarity=0.192 Sum_probs=158.8
Q ss_pred ceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCc
Q 005001 76 KGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS 142 (720)
Q Consensus 76 ~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~ 142 (720)
..|.|++ .+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..+. ++|++|+|++|+++
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~ 93 (606)
T 3vq2_A 14 ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93 (606)
T ss_dssp TEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccc
Confidence 4588854 4689999999999999999999999999999999999987787665 89999999999999
Q ss_pred CCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccC-CCCccccCCCCCCeeEeccccccccccccC
Q 005001 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNVFS 221 (720)
Q Consensus 143 g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~ 221 (720)
+..|..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++ .+|..++++++|++|+|++|++++..+...
T Consensus 94 ~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 173 (606)
T 3vq2_A 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL 173 (606)
T ss_dssp CCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTT
T ss_pred ccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhh
Confidence 8889999999999999999999999888999999999999999999986 679999999999999999999998654322
Q ss_pred -CC-C----cCeEEccCccCcccCccccc--ccceeeecCCcCC
Q 005001 222 -GL-P----LTTLNVANNHFSGWIPRELI--SIRTFIYDGNSFD 257 (720)
Q Consensus 222 -~~-~----L~~l~l~~N~l~g~ip~~l~--~l~~l~l~~n~~~ 257 (720)
.. + +..|++++|.+++..+..+. +++.|++.+|.+.
T Consensus 174 ~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~ 217 (606)
T 3vq2_A 174 QFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNS 217 (606)
T ss_dssp HHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSC
T ss_pred hhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccc
Confidence 11 1 55899999999966655443 6888999998764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=5e-19 Score=210.47 Aligned_cols=187 Identities=20% Similarity=0.156 Sum_probs=162.2
Q ss_pred CCCceeEecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCC-CCCCC--CccceeccccccCcCCCCccc
Q 005001 73 ESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTI-PYQLP--PNLTSLNLASNNFSGNLPYSI 149 (720)
Q Consensus 73 ~~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~--~~L~~L~L~~N~l~g~~p~~~ 149 (720)
++|..|.+-..+++.|+|++|.+++..+..|.++++|++|+|++|.+.+.+ |..+. ++|++|+|++|+|++..|..|
T Consensus 14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 14 CNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CCSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 367777775578999999999999999999999999999999999887777 55554 899999999999999999999
Q ss_pred cccCCccEEEccccccccccccc--cCCCCCCCeeecCCCcccCCCC-ccccCCCCCCeeEeccccccccccccC----C
Q 005001 150 ASMVSLSYLNVSRNSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLNVFS----G 222 (720)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~----~ 222 (720)
+++++|++|+|++|.+++.+|.. |+++++|++|+|++|++++..| ..|+++++|++|+|++|+|++..+... .
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~ 173 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHH
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccC
Confidence 99999999999999999977765 9999999999999999997665 579999999999999999998654322 1
Q ss_pred CCcCeEEccCccCcccCcccccc---------cceeeecCCcCCCC
Q 005001 223 LPLTTLNVANNHFSGWIPRELIS---------IRTFIYDGNSFDNG 259 (720)
Q Consensus 223 ~~L~~l~l~~N~l~g~ip~~l~~---------l~~l~l~~n~~~~~ 259 (720)
.+|+.|+|++|.+++.+|..+.. ++.|++.+|.+...
T Consensus 174 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~ 219 (844)
T 3j0a_A 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVD 219 (844)
T ss_dssp CSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTT
T ss_pred CccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchh
Confidence 56999999999999988876543 78899999977643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-18 Score=172.82 Aligned_cols=149 Identities=23% Similarity=0.313 Sum_probs=133.7
Q ss_pred CEEEccCCCCCCCCCCCCCCccceeccccccCcCCCC-ccccccCCccEEEccccccccccccccCCCCCCCeeecCCCc
Q 005001 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLP-YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (720)
Q Consensus 110 ~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 188 (720)
+.|++++|.++ .+|..+.+.+++|+|++|+|++..| ..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 14 ~~l~~s~n~l~-~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~ 92 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92 (220)
T ss_dssp TEEECCSSCCS-SCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CEeEeCCCCcc-cCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCc
Confidence 58999999998 6899898999999999999997755 468999999999999999999888899999999999999999
Q ss_pred ccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcccCccccc---ccceeeecCCcCCCC
Q 005001 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPRELI---SIRTFIYDGNSFDNG 259 (720)
Q Consensus 189 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g~ip~~l~---~l~~l~l~~n~~~~~ 259 (720)
|++..|..|..+++|++|+|++|+|++..+. +.. .+|+.|+|++|+|++..|..|. +|+.|++.+|+|.|.
T Consensus 93 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 93 LENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred cCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 9988888899999999999999999997654 333 4599999999999988887664 678899999999875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.3e-19 Score=210.59 Aligned_cols=158 Identities=19% Similarity=0.286 Sum_probs=142.2
Q ss_pred ccccccCCCCCCEEEccCCCCCC-----------------CCCCCCC----CccceeccccccCcCCCCccccccCCccE
Q 005001 99 MGYLLSDLLSLRKFDLSGNSIHD-----------------TIPYQLP----PNLTSLNLASNNFSGNLPYSIASMVSLSY 157 (720)
Q Consensus 99 ~~~~l~~l~~L~~L~L~~N~l~~-----------------~~p~~~~----~~L~~L~L~~N~l~g~~p~~~~~l~~L~~ 157 (720)
+|..|++|++|++|+|++|+|+| .+|..+. ++|++|+|++|++.|.+|..+++|++|+.
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 88899999999999999999998 3888874 89999999999999999999999999999
Q ss_pred EEccccc-ccc-ccccccCCCC-------CCCeeecCCCcccCCCCc--cccCCCCCCeeEeccccccccccccCCC-Cc
Q 005001 158 LNVSRNS-LTQ-SIGDIFGNLA-------GLATLDLSFNNFSGDLPN--SFISLSNISSLYLQNNQVTGSLNVFSGL-PL 225 (720)
Q Consensus 158 L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L 225 (720)
|+|++|+ |+| .+|..++.++ +|+.|+|++|+|+ .+|. .++++++|++|+|++|+|+ .+|.+... +|
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L 597 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKL 597 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEE
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcc
Confidence 9999998 999 8998777665 9999999999999 8999 9999999999999999999 66655444 49
Q ss_pred CeEEccCccCcccCcccc---cc-cceeeecCCcCCCC
Q 005001 226 TTLNVANNHFSGWIPREL---IS-IRTFIYDGNSFDNG 259 (720)
Q Consensus 226 ~~l~l~~N~l~g~ip~~l---~~-l~~l~l~~n~~~~~ 259 (720)
+.|+|++|+|+ .+|..+ .+ |+.|++.+|.+...
T Consensus 598 ~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~l 634 (876)
T 4ecn_A 598 TDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYI 634 (876)
T ss_dssp SEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSC
T ss_pred eEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcC
Confidence 99999999999 899766 45 88899999998743
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.3e-19 Score=190.09 Aligned_cols=173 Identities=20% Similarity=0.209 Sum_probs=138.2
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 160 (720)
.+++.|+++++.++...+..+..+++|++|+|++|.+++..|..+. ++|++|+|++|++++..|..++++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 3577899999999876666789999999999999999976665654 89999999999999888888999999999999
Q ss_pred cccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCc
Q 005001 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP 240 (720)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip 240 (720)
++|+++...+..|+.+++|++|+|++|++++..|..+..+++|++|++++|++++. +.....+|+.|++++|.+++.-
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~l~~L~~L~l~~n~l~~~~- 202 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-DLSLIPSLFHANVSYNLLSTLA- 202 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-CGGGCTTCSEEECCSSCCSEEE-
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc-ccccccccceeecccccccccC-
Confidence 99999966666689999999999999999988888899999999999999999874 2222334666666666665421
Q ss_pred ccccccceeeecCCcCCC
Q 005001 241 RELISIRTFIYDGNSFDN 258 (720)
Q Consensus 241 ~~l~~l~~l~l~~n~~~~ 258 (720)
...+++.|++.+|.+..
T Consensus 203 -~~~~L~~L~l~~n~l~~ 219 (390)
T 3o6n_A 203 -IPIAVEELDASHNSINV 219 (390)
T ss_dssp -CCSSCSEEECCSSCCCE
T ss_pred -CCCcceEEECCCCeeee
Confidence 11245555555555543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.6e-18 Score=174.80 Aligned_cols=187 Identities=23% Similarity=0.272 Sum_probs=159.5
Q ss_pred CCCCCCCceeEecC-CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCC
Q 005001 69 DPCGESWKGVACEG-SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNL 145 (720)
Q Consensus 69 ~~c~~~w~gv~c~~-~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~ 145 (720)
+.| .|.|+.|+. ..++.+++++++++. +|..+. ++|++|+|++|++++..+..+. ++|++|+|++|+++...
T Consensus 3 ~~C--~~~~~~C~c~~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 3 ALC--KKDGGVCSCNNNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCB--GGGTCSBEEETTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred ccC--CCCCCCCEeCCCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 556 799999974 457789999999985 565554 6899999999999976665564 89999999999999666
Q ss_pred CccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cC-CC
Q 005001 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FS-GL 223 (720)
Q Consensus 146 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~-~~ 223 (720)
+..+.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+. +. ..
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 66779999999999999999988888899999999999999999988888899999999999999999987654 33 35
Q ss_pred CcCeEEccCccCcccCcccc---cccceeeecCCcCCCCC
Q 005001 224 PLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 224 ~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~~ 260 (720)
+|+.|+|++|+|++..+..| .+|+.|++.+|.+...+
T Consensus 158 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred ccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence 69999999999997666544 57889999999987544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=9.8e-19 Score=200.49 Aligned_cols=180 Identities=19% Similarity=0.135 Sum_probs=153.8
Q ss_pred CceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccC
Q 005001 75 WKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNF 141 (720)
Q Consensus 75 w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l 141 (720)
+..|.|.. ..++.|+|++|++++..|..|+++++|++|+|++|++++..|..+. ++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 56788964 3689999999999999999999999999999999999988887775 8999999999999
Q ss_pred cCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-c
Q 005001 142 SGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-F 220 (720)
Q Consensus 142 ~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~ 220 (720)
++..|..|+++++|++|+|++|++++..|..++++++|++|+|++|++++..+..+..+++|++|+|++|+|++..+. +
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 999999999999999999999999998889999999999999999999974444556699999999999999987543 3
Q ss_pred -CCCCcC--eEEccCccCcccCccccc--ccceeeecCC
Q 005001 221 -SGLPLT--TLNVANNHFSGWIPRELI--SIRTFIYDGN 254 (720)
Q Consensus 221 -~~~~L~--~l~l~~N~l~g~ip~~l~--~l~~l~l~~n 254 (720)
...+|+ .|++++|.+++..|..+. +++.+++.+|
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~ 212 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTC
T ss_pred hhhcccceeEEecCCCccCccChhHhhhccccccccCCc
Confidence 334577 899999999988876653 3444444444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=190.69 Aligned_cols=174 Identities=18% Similarity=0.217 Sum_probs=112.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 160 (720)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..+. ++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 88 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l 167 (440)
T 3zyj_A 88 RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL 167 (440)
T ss_dssp SSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCC
Confidence 4788999999999988888999999999999999999855554443 78999999999888666667777777777777
Q ss_pred cccc-cccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcc
Q 005001 161 SRNS-LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSG 237 (720)
Q Consensus 161 ~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g 237 (720)
++|+ ++...+..|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|+|++..+. +.. .+|+.|+|++|+|++
T Consensus 168 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 245 (440)
T 3zyj_A 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV 245 (440)
T ss_dssp CCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred CCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE
Confidence 7643 33333345666666666666666666 344 255556666666666666554332 222 235555555555554
Q ss_pred cCcccc---cccceeeecCCcCCC
Q 005001 238 WIPREL---ISIRTFIYDGNSFDN 258 (720)
Q Consensus 238 ~ip~~l---~~l~~l~l~~n~~~~ 258 (720)
..|..| .+|+.|++.+|.+..
T Consensus 246 ~~~~~~~~l~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 246 IERNAFDNLQSLVEINLAHNNLTL 269 (440)
T ss_dssp ECTTSSTTCTTCCEEECTTSCCCC
T ss_pred EChhhhcCCCCCCEEECCCCCCCc
Confidence 444333 344445555555443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.9e-19 Score=201.26 Aligned_cols=157 Identities=20% Similarity=0.216 Sum_probs=73.5
Q ss_pred ccccCCCCCCEEEccCCCCCCCCC-CCCC--CccceeccccccCcCCCCccccccCCccEEEcccccccc-ccccccCCC
Q 005001 101 YLLSDLLSLRKFDLSGNSIHDTIP-YQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNL 176 (720)
Q Consensus 101 ~~l~~l~~L~~L~L~~N~l~~~~p-~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l 176 (720)
..+..+++|++|+|++|++++..| ..+. ++|++|+|++|++++.+|..+.++++|++|+|++|.+++ .+|..|+.+
T Consensus 393 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l 472 (606)
T 3vq2_A 393 ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT 472 (606)
T ss_dssp CCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTC
T ss_pred hhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccC
Confidence 344444444444444444444433 1221 445555555555554444455555555555555555554 244445555
Q ss_pred CCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcccCccccc----ccceee
Q 005001 177 AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPRELI----SIRTFI 250 (720)
Q Consensus 177 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g~ip~~l~----~l~~l~ 250 (720)
++|+.|+|++|++++..|..+..+++|++|+|++|++++.+|. +.. .+|+.|+|++|+|+ .+|..+. +++.++
T Consensus 473 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~ 551 (606)
T 3vq2_A 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFN 551 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEE
T ss_pred CCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEE
Confidence 5555555555555544444455555555555555555544332 221 23555555555554 3443321 244455
Q ss_pred ecCCcCCC
Q 005001 251 YDGNSFDN 258 (720)
Q Consensus 251 l~~n~~~~ 258 (720)
+.+|++.|
T Consensus 552 l~~N~~~c 559 (606)
T 3vq2_A 552 LTNNSVAC 559 (606)
T ss_dssp CCSCCCCC
T ss_pred ccCCCccc
Confidence 55555544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.9e-20 Score=215.12 Aligned_cols=193 Identities=23% Similarity=0.204 Sum_probs=66.5
Q ss_pred ChHHHHHHHHHHHhcCCCC--CCCCCCCCCCCCCCCCCceeEecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCC
Q 005001 40 DSSDVQALQVLYTSLNSPS--VLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGN 117 (720)
Q Consensus 40 ~~~d~~al~~~~~~~~~~~--~l~~w~~~~~~~c~~~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N 117 (720)
...+.++|+++..++.... .-..|.......+ +|.++.++..+++.|+|.+|++... +..+ |+.++|+.|
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~~l~L~~n~~~~~-~~~~-----l~~l~Ls~~ 201 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSG--TATNSAVSTPLTPKIELFANGKDEA-NQAL-----LQHKKLSQY 201 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccc--cCCCceecCCccceEEeeCCCCCcc-hhhH-----hhcCccCcc
Confidence 3457789999987764432 2345654433333 7999999988888888877766542 2111 122222222
Q ss_pred CCCC---------CCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCC
Q 005001 118 SIHD---------TIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF 186 (720)
Q Consensus 118 ~l~~---------~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 186 (720)
.|.+ ..|..+. ++|+.|+|++|.|. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++
T Consensus 202 ~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~ 279 (727)
T 4b8c_D 202 SIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSH 279 (727)
T ss_dssp --------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTT
T ss_pred cccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcC
Confidence 2221 1122221 44555555555554 44444445555555555555555 4444455555555555555
Q ss_pred CcccCCCCccccCCCCCCeeEeccccccccccccCC-CCcCeEEccCccCcccCcccc
Q 005001 187 NNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWIPREL 243 (720)
Q Consensus 187 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~l~l~~N~l~g~ip~~l 243 (720)
|+|+ .+|..|+.|++|++|+|++|.|+..+..+.. .+|+.|+|++|.|+|.+|..+
T Consensus 280 N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 280 NRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKIL 336 (727)
T ss_dssp SCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred CcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence 5555 4455555555555555555555432222222 235555555555555544444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.8e-19 Score=198.79 Aligned_cols=171 Identities=20% Similarity=0.246 Sum_probs=139.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCC-------------------CCCCCCCCccceeccccccCcC
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD-------------------TIPYQLPPNLTSLNLASNNFSG 143 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~-------------------~~p~~~~~~L~~L~L~~N~l~g 143 (720)
.+++.|+|++|.+++.+| ++.+++|++|+|++|.|++ ..+. ..++|+.|+|++|.|++
T Consensus 58 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~-~l~~L~~L~L~~N~l~~ 134 (487)
T 3oja_A 58 TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCS-RGQGKKNIYLANNKITM 134 (487)
T ss_dssp TTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEEC-CCSSCEEEECCSSCCCS
T ss_pred CCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCcc-ccCCCCEEECCCCCCCC
Confidence 467777777777776555 6666666666666665543 2222 23789999999999999
Q ss_pred CCCccccccCCccEEEccccccccccccccC-CCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCC
Q 005001 144 NLPYSIASMVSLSYLNVSRNSLTQSIGDIFG-NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222 (720)
Q Consensus 144 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 222 (720)
..|..++++++|++|+|++|.|++.+|..+. .+++|+.|+|++|+|++. |. +..+++|++|+|++|+|++.++.+..
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~ 212 (487)
T 3oja_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQS 212 (487)
T ss_dssp GGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGG
T ss_pred CCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcC
Confidence 9999999999999999999999999998886 799999999999999965 33 44699999999999999998776544
Q ss_pred -CCcCeEEccCccCcccCcccc---cccceeeecCCcCCCC
Q 005001 223 -LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 223 -~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~ 259 (720)
.+|+.|+|++|.|++ +|..+ .+++.|++.+|++.|+
T Consensus 213 l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 213 AAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp GTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred CCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 459999999999996 67655 5788899999999865
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-18 Score=191.29 Aligned_cols=174 Identities=19% Similarity=0.200 Sum_probs=115.3
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 160 (720)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..+. ++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 99 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 178 (452)
T 3zyi_A 99 HHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDL 178 (452)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeC
Confidence 5789999999999998889999999999999999999955554443 78999999999998666667777777777777
Q ss_pred ccc-ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcc
Q 005001 161 SRN-SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSG 237 (720)
Q Consensus 161 ~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g 237 (720)
++| .+....+..|..+++|++|+|++|+|++ +| .+..+++|+.|+|++|+|++..+. +.. .+|+.|+|++|+|++
T Consensus 179 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 256 (452)
T 3zyi_A 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256 (452)
T ss_dssp CCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCE
T ss_pred CCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCce
Confidence 763 3333333456666666666666666663 33 355566666666666666554332 222 235555555555555
Q ss_pred cCcccc---cccceeeecCCcCCC
Q 005001 238 WIPREL---ISIRTFIYDGNSFDN 258 (720)
Q Consensus 238 ~ip~~l---~~l~~l~l~~n~~~~ 258 (720)
..|..| .+|+.|++.+|.+..
T Consensus 257 ~~~~~~~~l~~L~~L~L~~N~l~~ 280 (452)
T 3zyi_A 257 IERNAFDGLASLVELNLAHNNLSS 280 (452)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSC
T ss_pred ECHHHhcCCCCCCEEECCCCcCCc
Confidence 444433 344455555555543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-18 Score=171.12 Aligned_cols=151 Identities=22% Similarity=0.235 Sum_probs=132.1
Q ss_pred CCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCc
Q 005001 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (720)
Q Consensus 109 L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 188 (720)
.+.+++++|+++ .+|..+.++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCEeEccCCCcC-ccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 356888899988 8999899999999999999999889999999999999999999988777889999999999999999
Q ss_pred ccCCCCccccCCCCCCeeEeccccccccccccC-CCCcCeEEccCccCcccCcccc---cccceeeecCCcCCCCC
Q 005001 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS-GLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 189 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~~ 260 (720)
|++..+..|..+++|++|+|++|+|+.....+. ..+|+.|+|++|+|++..+..+ .+|+.|++.+|++.|..
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 997777778999999999999999996544443 3469999999999997655544 57889999999998753
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.3e-18 Score=170.42 Aligned_cols=149 Identities=22% Similarity=0.276 Sum_probs=132.5
Q ss_pred CEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcc
Q 005001 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (720)
Q Consensus 110 ~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 189 (720)
+.+++++|.++ .+|..+.++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp TEEECTTSCCS-SCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred CEEEcCCCCcC-cCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 57899999999 78988889999999999999987778999999999999999999999999999999999999999999
Q ss_pred cCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcccCcccc---cccceeeecCCcCCCC
Q 005001 190 SGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 190 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~ 259 (720)
++..+..|..+++|++|+|++|+|++..+. +.. .+|+.|+|++|+|++..+..| .+++.|++.+|+|.|.
T Consensus 93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 965555678999999999999999997654 333 469999999999998776655 5678899999999874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-18 Score=180.39 Aligned_cols=171 Identities=18% Similarity=0.293 Sum_probs=137.1
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
..+++.|+|++|++++..+ +..+++|++|+|++|.+++.....-.++|++|+|++|++++ ++. +..+++|++|+|+
T Consensus 62 l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~ 137 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLD 137 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECC
T ss_pred cCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCchhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECC
Confidence 3578899999999987655 88999999999999998864322223789999999999985 443 8899999999999
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCc-
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP- 240 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip- 240 (720)
+|++++..+ ++.+++|++|+|++|++++ ++. +..+++|+.|+|++|+|++..+.....+|+.|+|++|++++..|
T Consensus 138 ~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~l 213 (308)
T 1h6u_A 138 LNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSPL 213 (308)
T ss_dssp SSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCGGG
T ss_pred CCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCccccc
Confidence 999987654 8889999999999999985 444 88899999999999999887665555669999999999986554
Q ss_pred ccccccceeeecCCcCCCCC
Q 005001 241 RELISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 241 ~~l~~l~~l~l~~n~~~~~~ 260 (720)
..+.+|+.|++.+|++.+.+
T Consensus 214 ~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 214 ANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp TTCTTCCEEEEEEEEEECCC
T ss_pred cCCCCCCEEEccCCeeecCC
Confidence 24467888899999887644
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.6e-18 Score=198.61 Aligned_cols=175 Identities=23% Similarity=0.204 Sum_probs=111.1
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCC-CC--CccceeccccccCcCCCCccccccCCccEEEc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ-LP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 160 (720)
+++.|+|++|.+.+..+..+..+++|++|+|++|.+++..|.. +. ++|++|+|++|.+++..|..+.++++|++|+|
T Consensus 377 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 456 (606)
T 3t6q_A 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456 (606)
T ss_dssp TCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEEC
Confidence 5666666666666666666666666666666666666555433 22 56667777777766666666666777777777
Q ss_pred cccccccc---cccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccC
Q 005001 161 SRNSLTQS---IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHF 235 (720)
Q Consensus 161 ~~N~l~~~---~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l 235 (720)
++|.+++. .+..+..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+. +.. ..| .|+|++|++
T Consensus 457 ~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l 535 (606)
T 3t6q_A 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535 (606)
T ss_dssp TTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCC
T ss_pred CCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcc
Confidence 77766652 224566667777777777777666666666777777777777777665442 222 236 677777777
Q ss_pred cccCcccc---cccceeeecCCcCCCC
Q 005001 236 SGWIPREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 236 ~g~ip~~l---~~l~~l~l~~n~~~~~ 259 (720)
++.+|..+ .+++.+++.+|++.|.
T Consensus 536 ~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 536 SIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp CCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred cccCHhhcccCCCCCEEeCCCCCcccc
Confidence 76665543 4566677777776654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=4.7e-18 Score=179.32 Aligned_cols=174 Identities=17% Similarity=0.262 Sum_probs=148.1
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|+|++|++++..|..|+++++|++|+|++|+++ .+|..+.++|++|+|++|++++..+..+.++++|+.|+|++
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 154 (330)
T 1xku_A 76 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCS
T ss_pred CCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhcccccEEECCCCcccccCHhHhcCCccccEEECCC
Confidence 57999999999999998999999999999999999999 78888889999999999999988788899999999999999
Q ss_pred ccccc--ccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccc-ccCC-CCcCeEEccCccCccc
Q 005001 163 NSLTQ--SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSG-LPLTTLNVANNHFSGW 238 (720)
Q Consensus 163 N~l~~--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~-~~L~~l~l~~N~l~g~ 238 (720)
|.++. ..+..+..+++|++|++++|+++ .+|..+. ++|++|+|++|+|++..+ .+.. .+|+.|+|++|++++.
T Consensus 155 n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 231 (330)
T 1xku_A 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 231 (330)
T ss_dssp SCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred CcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCcee
Confidence 99964 77888999999999999999998 5776554 788999999999888654 3333 4588899999988877
Q ss_pred Ccccc---cccceeeecCCcCCCCC
Q 005001 239 IPREL---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 239 ip~~l---~~l~~l~l~~n~~~~~~ 260 (720)
.|..+ .+|+.|++.+|.+...|
T Consensus 232 ~~~~~~~l~~L~~L~L~~N~l~~lp 256 (330)
T 1xku_A 232 DNGSLANTPHLRELHLNNNKLVKVP 256 (330)
T ss_dssp CTTTGGGSTTCCEEECCSSCCSSCC
T ss_pred ChhhccCCCCCCEEECCCCcCccCC
Confidence 66544 46778888888887443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.76 E-value=6.7e-18 Score=192.92 Aligned_cols=176 Identities=19% Similarity=0.217 Sum_probs=135.6
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 160 (720)
.+++.|+|++|.+++..+..|+.+++|++|+|++|.|++..|..+. ++|++|+|++|.|++..+..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 4688899999999988888999999999999999999977766554 78999999999988655556788899999999
Q ss_pred cccccccccccccCCCCCCCeeecCCCcccCCC-----------------------------------------------
Q 005001 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDL----------------------------------------------- 193 (720)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~----------------------------------------------- 193 (720)
++|.|++..|..|+.+++|++|+|++|+|++..
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L 234 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVEL 234 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCC
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCC
Confidence 999988888888888888888888888776421
Q ss_pred ------------CccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcccCccc---ccccceeeecCCcC
Q 005001 194 ------------PNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPRE---LISIRTFIYDGNSF 256 (720)
Q Consensus 194 ------------p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g~ip~~---l~~l~~l~l~~n~~ 256 (720)
+..++.+++|+.|+|++|.|++.++. +.. .+|+.|+|++|.|++ +|.. +.+|+.|++.+|.+
T Consensus 235 ~~L~L~~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l 313 (597)
T 3oja_B 235 TILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 313 (597)
T ss_dssp CEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCC
T ss_pred CEEECCCCCCCCChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCC
Confidence 12355667788888888888876543 332 458888888888876 3433 45777788888877
Q ss_pred CCC
Q 005001 257 DNG 259 (720)
Q Consensus 257 ~~~ 259 (720)
...
T Consensus 314 ~~i 316 (597)
T 3oja_B 314 LHV 316 (597)
T ss_dssp CCC
T ss_pred Ccc
Confidence 643
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.5e-18 Score=167.14 Aligned_cols=152 Identities=16% Similarity=0.254 Sum_probs=118.6
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|++++|+++ .++ .+..+++|++|+|++|.++..-+..-.++|++|+|++|++++..|..++++++|++|+|++
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~ 121 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCS
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecC
Confidence 36888999999888 445 6888999999999999776432333347899999999999887888888999999999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSG 237 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g 237 (720)
|++++..|..++.+++|++|+|++|++.+.+| .+..+++|++|++++|+|++..+.....+|+.|++++|+|.+
T Consensus 122 n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 122 SAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp SBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred CccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 99988888888899999999999998333566 688888999999999988875544444568888888888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-18 Score=176.30 Aligned_cols=140 Identities=20% Similarity=0.175 Sum_probs=106.3
Q ss_pred CCccceeccCCCcEEEEEEE-cCCcE--EEEEEccccccC----------------------hHHHHHHHHHHHHhhcCC
Q 005001 412 FSQEFLIGEGSLGRVYRAEF-ANGKI--MAVKKIDNAALS----------------------LQEEDNFLEAVSNMSRLR 466 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~ 466 (720)
|...+.||+|+||.||+|.+ .+|+. ||||+++..... ......+.+|+..+.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999987 68989 999987543211 011246788999999998
Q ss_pred CCCccccceEEeecCeEEEEEEecCC-C----CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcEEec
Q 005001 467 HPNIVTLAGYCAEHGQRLLVYEYVGN-G----NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-EVCLPSVVHRN 540 (720)
Q Consensus 467 h~niv~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~~~~iiH~D 540 (720)
|+++.-..-+.. +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+|||
T Consensus 129 ~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred hCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 886532222222 356899999942 3 67766531 124457789999999999999 87 999999
Q ss_pred CCCCCEEeCCCCceEEcccCCCccC
Q 005001 541 FKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 541 lkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-17 Score=180.82 Aligned_cols=127 Identities=21% Similarity=0.216 Sum_probs=103.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 160 (720)
.+++.|+|++|++++..+..|..+++|++|+|++|.+++..|..+. ++|++|+|++|+++...+..+.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 4688999999999988888999999999999999999987776654 89999999999999544445789999999999
Q ss_pred cccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccc
Q 005001 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212 (720)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 212 (720)
++|++++..|..|+.+++|++|+|++|++++.. +..+++|+.|++++|.
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~ 197 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNL 197 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSC
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeeccccc
Confidence 999999988889999999999999999998642 3334444443333333
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.9e-18 Score=192.79 Aligned_cols=177 Identities=21% Similarity=0.298 Sum_probs=136.5
Q ss_pred CEEEEEcCCCCCcccccccc-----cCCC--------------------------CCCEEEccCCCCCCCCCCCCCCccc
Q 005001 84 AVVSIDISGLGLSGTMGYLL-----SDLL--------------------------SLRKFDLSGNSIHDTIPYQLPPNLT 132 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l-----~~l~--------------------------~L~~L~L~~N~l~~~~p~~~~~~L~ 132 (720)
+++.|++++|.++|.+|..+ .+++ +|++|++++|.+.........++|+
T Consensus 277 ~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~ 356 (562)
T 3a79_B 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356 (562)
T ss_dssp SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCC
T ss_pred cccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCce
Confidence 78999999999998888776 3433 3666666666665322113447889
Q ss_pred eeccccccCcCCCCccccccCCccEEEcccccccc--ccccccCCCCCCCeeecCCCcccCCCCcc-ccCCCCCCeeEec
Q 005001 133 SLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ--SIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQ 209 (720)
Q Consensus 133 ~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~l~ 209 (720)
+|+|++|++++.+|..++++++|++|+|++|++++ .+|..++.+++|++|+|++|++++.+|.. +..+++|++|+|+
T Consensus 357 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~ 436 (562)
T 3a79_B 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436 (562)
T ss_dssp EEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECC
T ss_pred EEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECC
Confidence 99999999998888888899999999999999887 44677888899999999999998756654 7788889999999
Q ss_pred cccccccccccCCCCcCeEEccCccCcccCcccc---cccceeeecCCcCCCCCC
Q 005001 210 NNQVTGSLNVFSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGPA 261 (720)
Q Consensus 210 ~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~~~ 261 (720)
+|+|++.++.....+|+.|+|++|+|+ .+|..+ .+|+.|++.+|.+...|.
T Consensus 437 ~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~ 490 (562)
T 3a79_B 437 SNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPD 490 (562)
T ss_dssp SSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCT
T ss_pred CCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCH
Confidence 999888766544456888999999888 677654 467788888888875443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-18 Score=182.82 Aligned_cols=169 Identities=20% Similarity=0.169 Sum_probs=125.6
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|+|++|.+++..+ +..+++|++|+|++|+|++..+ .++|++|+|++|++++..+. .+++|++|+|++
T Consensus 58 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~---~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~ 129 (317)
T 3o53_A 58 TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV---GPSIETLHAANNNISRVSCS---RGQGKKNIYLAN 129 (317)
T ss_dssp TTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEE---CTTCCEEECCSSCCSEEEEC---CCSSCEEEECCS
T ss_pred CcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccC---CCCcCEEECCCCccCCcCcc---ccCCCCEEECCC
Confidence 467777777777766554 6677777777777777664322 16677777777777754433 367888999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCcccc-CCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCcc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI-SLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR 241 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~ 241 (720)
|++++..+..++.+++|++|+|++|++++..|..+. .+++|++|+|++|+|++........+|+.|+|++|+|++..|.
T Consensus 130 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~l~~~ 209 (317)
T 3o53_A 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPE 209 (317)
T ss_dssp SCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECGG
T ss_pred CCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCcchhh
Confidence 999888888888889999999999999877777664 7889999999999988875555556699999999999864443
Q ss_pred --cccccceeeecCCcCCCC
Q 005001 242 --ELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 242 --~l~~l~~l~l~~n~~~~~ 259 (720)
.+.+|+.|++.+|.+...
T Consensus 210 ~~~l~~L~~L~L~~N~l~~l 229 (317)
T 3o53_A 210 FQSAAGVTWISLRNNKLVLI 229 (317)
T ss_dssp GGGGTTCSEEECTTSCCCEE
T ss_pred hcccCcccEEECcCCcccch
Confidence 235788889999988743
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=8.7e-18 Score=164.74 Aligned_cols=174 Identities=22% Similarity=0.247 Sum_probs=142.8
Q ss_pred eeEecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCC
Q 005001 77 GVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVS 154 (720)
Q Consensus 77 gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~ 154 (720)
+-.|.. +.+++++++++.. |..+ .++|++|+|++|++++..+..+. ++|++|+|++|+|++..+..+.++++
T Consensus 4 ~C~C~~---~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 77 (208)
T 2o6s_A 4 RCSCSG---TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTS 77 (208)
T ss_dssp TCEEET---TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTT
T ss_pred CCEECC---CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCC
Confidence 345653 4678889888754 4333 46899999999999965554443 89999999999999776677899999
Q ss_pred ccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cC-CCCcCeEEccC
Q 005001 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FS-GLPLTTLNVAN 232 (720)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~-~~~L~~l~l~~ 232 (720)
|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+. +. ..+|+.|+|++
T Consensus 78 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 157 (208)
T 2o6s_A 78 LTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHD 157 (208)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred cCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecC
Confidence 99999999999988888899999999999999999977777789999999999999999987664 33 34699999999
Q ss_pred ccCcccCcccccccceeeecCCcCCCCC
Q 005001 233 NHFSGWIPRELISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 233 N~l~g~ip~~l~~l~~l~l~~n~~~~~~ 260 (720)
|.+.+..| +++.|.+..|.+....
T Consensus 158 N~~~~~~~----~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 158 NPWDCTCP----GIRYLSEWINKHSGVV 181 (208)
T ss_dssp CCBCCCTT----TTHHHHHHHHHCTTTB
T ss_pred CCeecCCC----CHHHHHHHHHhCCcee
Confidence 99987654 5777778888877543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.6e-18 Score=171.35 Aligned_cols=170 Identities=18% Similarity=0.229 Sum_probs=144.8
Q ss_pred CCEEEEEcCCCC-CcccccccccCCCCCCEEEccC-CCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCcc--
Q 005001 83 SAVVSIDISGLG-LSGTMGYLLSDLLSLRKFDLSG-NSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLS-- 156 (720)
Q Consensus 83 ~~v~~l~l~~~~-l~g~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~-- 156 (720)
.+++.|+|++|+ +++..+..|.++++|++|+|++ |++++..+..+. ++|++|+|++|++++ +|. +.++++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 579999999997 8877777999999999999999 999965555543 799999999999996 776 88899988
Q ss_pred -EEEcccc-ccccccccccCCCCCCC-eeecCCCcccCCCCccccCCCCCCeeEecccc-ccccccc-cCC--CCcCeEE
Q 005001 157 -YLNVSRN-SLTQSIGDIFGNLAGLA-TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ-VTGSLNV-FSG--LPLTTLN 229 (720)
Q Consensus 157 -~L~L~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~~~-~~~--~~L~~l~ 229 (720)
+|+|++| ++++..+..|..+++|+ .|+|++|+++ .+|......++|+.|+|++|+ |++..+. +.. .+|+.|+
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~ 211 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEE
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEE
Confidence 9999999 99988888899999999 9999999999 677665555899999999995 9876543 444 4699999
Q ss_pred ccCccCcccCcccccccceeeecCCc
Q 005001 230 VANNHFSGWIPRELISIRTFIYDGNS 255 (720)
Q Consensus 230 l~~N~l~g~ip~~l~~l~~l~l~~n~ 255 (720)
|++|+|++..+..+.+++.|.+.++.
T Consensus 212 l~~N~l~~l~~~~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 212 VSQTSVTALPSKGLEHLKELIARNTW 237 (239)
T ss_dssp CTTCCCCCCCCTTCTTCSEEECTTC-
T ss_pred CCCCccccCChhHhccCceeeccCcc
Confidence 99999996555678899999987763
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.9e-18 Score=188.12 Aligned_cols=175 Identities=17% Similarity=0.226 Sum_probs=136.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 160 (720)
.+++.|+|++|.+++..|..|.++++|++|+|++|++++..+..+. ++|++|+|++|++++..|..+.++++|++|+|
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 135 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence 5789999999999998899999999999999999999854443343 79999999999999888889999999999999
Q ss_pred cccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCccc
Q 005001 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGW 238 (720)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g~ 238 (720)
++|.+++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..+. +.. .+|+.|+|++|.+.+.
T Consensus 136 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~ 215 (477)
T 2id5_A 136 GDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215 (477)
T ss_dssp CCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCE
T ss_pred CCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccc
Confidence 99999988888999999999999999999876666688888888888888888775542 222 2366666666555555
Q ss_pred Ccccc---cccceeeecCCcCC
Q 005001 239 IPREL---ISIRTFIYDGNSFD 257 (720)
Q Consensus 239 ip~~l---~~l~~l~l~~n~~~ 257 (720)
+|..+ .+|+.|++.+|.+.
T Consensus 216 ~~~~~~~~~~L~~L~l~~n~l~ 237 (477)
T 2id5_A 216 MTPNCLYGLNLTSLSITHCNLT 237 (477)
T ss_dssp ECTTTTTTCCCSEEEEESSCCC
T ss_pred cCcccccCccccEEECcCCccc
Confidence 44432 14455555555444
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=5.9e-18 Score=194.81 Aligned_cols=172 Identities=20% Similarity=0.205 Sum_probs=128.6
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
.++.|||++|+|++..+..|.++++|++|||++|+|++..|..+. ++|++|+|++|+|++..+..|.+|++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 578888888888887777888888888888888888865555554 788888888888886666778888888888888
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccC-CCCccccCCCCCCeeEeccccccccccccC----C--CCcCeEEccCcc
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNVFS----G--LPLTTLNVANNH 234 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~----~--~~L~~l~l~~N~ 234 (720)
+|+|++..+..|+++++|++|+|++|++++ .+|..++.+++|++|+|++|+|++..+... . ..+..++++.|.
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~ 212 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 212 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCc
Confidence 888888777788888888888888888875 457777888888888888888887543211 1 124567888888
Q ss_pred CcccCcccccc--cceeeecCCc
Q 005001 235 FSGWIPRELIS--IRTFIYDGNS 255 (720)
Q Consensus 235 l~g~ip~~l~~--l~~l~l~~n~ 255 (720)
++...|..+.. +..+.+.+|.
T Consensus 213 l~~i~~~~~~~~~~~~l~l~~n~ 235 (635)
T 4g8a_A 213 MNFIQPGAFKEIRLHKLTLRNNF 235 (635)
T ss_dssp CCEECTTTTTTCEEEEEEEESCC
T ss_pred ccccCcccccchhhhhhhhhccc
Confidence 87555544433 2344555553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-17 Score=194.25 Aligned_cols=178 Identities=19% Similarity=0.198 Sum_probs=127.9
Q ss_pred CCEEEEEcCCCCCccccc-ccccCCCCCCEEEccCCCCCC--------------------------CCCCCCC--Cccce
Q 005001 83 SAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHD--------------------------TIPYQLP--PNLTS 133 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~-~~l~~l~~L~~L~L~~N~l~~--------------------------~~p~~~~--~~L~~ 133 (720)
.+++.|+|++|.+++.++ ..+..+++|++|+|++|++++ .+|..+. ++|++
T Consensus 405 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~ 484 (680)
T 1ziw_A 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484 (680)
T ss_dssp TTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCE
T ss_pred CCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCE
Confidence 457777888887777665 467777777777777776543 3444443 67788
Q ss_pred eccccccCcCCCCccccccCCccEEEccccccccccc--------cccCCCCCCCeeecCCCcccCCCCccccCCCCCCe
Q 005001 134 LNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG--------DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISS 205 (720)
Q Consensus 134 L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 205 (720)
|+|++|+|++..|..+.++++|++|+|++|++++..+ ..|..+++|++|+|++|+++...+..|.++++|+.
T Consensus 485 L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~ 564 (680)
T 1ziw_A 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcce
Confidence 8888888886666677788888888888888776422 23677788888888888888433345788888888
Q ss_pred eEecccccccccccc-CC-CCcCeEEccCccCcccCcc----cccccceeeecCCcCCCCC
Q 005001 206 LYLQNNQVTGSLNVF-SG-LPLTTLNVANNHFSGWIPR----ELISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 206 L~l~~N~l~~~~~~~-~~-~~L~~l~l~~N~l~g~ip~----~l~~l~~l~l~~n~~~~~~ 260 (720)
|+|++|+|++.++.. .. .+|+.|+|++|+|++..|. .+.+++.+++.+|+|.|..
T Consensus 565 L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred eECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence 888888888765543 22 4588888888888877765 3567888888888888764
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-17 Score=173.14 Aligned_cols=169 Identities=21% Similarity=0.266 Sum_probs=143.0
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|++++|++... +.+..+++|++|+|++|++++..+..-.++|++|+|++|++++ +| .+.++++|++|+|++
T Consensus 46 ~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~ 121 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEH 121 (291)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTT
T ss_pred CcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcccccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCC
Confidence 4688999999999865 3588999999999999999976664444899999999999995 34 499999999999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCcc-
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR- 241 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~- 241 (720)
|++++. +.+..+++|+.|+|++|++++. ..+..+++|++|+|++|+|++..+.....+|+.|+|++|+|++ +|.
T Consensus 122 n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~-l~~l 196 (291)
T 1h6t_A 122 NGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRAL 196 (291)
T ss_dssp SCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CGGG
T ss_pred CcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC-Chhh
Confidence 999975 5688999999999999999964 5789999999999999999997774455669999999999986 453
Q ss_pred -cccccceeeecCCcCCCCC
Q 005001 242 -ELISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 242 -~l~~l~~l~l~~n~~~~~~ 260 (720)
.+.+|+.|++.+|++...+
T Consensus 197 ~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 197 AGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp TTCTTCSEEEEEEEEEECCC
T ss_pred ccCCCCCEEECcCCcccCCc
Confidence 4567889999999987644
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.9e-18 Score=181.23 Aligned_cols=169 Identities=17% Similarity=0.198 Sum_probs=144.3
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
..+++.|+|++|++++.. .+++|++|+|++|++++..+.. .++|++|+|++|++++..|..++.+++|++|+|+
T Consensus 79 l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~-~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 152 (317)
T 3o53_A 79 LSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR-GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152 (317)
T ss_dssp CTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC-CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECT
T ss_pred cCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc-cCCCCEEECCCCCCCCccchhhhccCCCCEEECC
Confidence 357999999999998643 3489999999999999655544 5889999999999998888899999999999999
Q ss_pred ccccccccccccC-CCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCC-CCcCeEEccCccCcccC
Q 005001 162 RNSLTQSIGDIFG-NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWI 239 (720)
Q Consensus 162 ~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~l~l~~N~l~g~i 239 (720)
+|.+++..+..+. .+++|++|+|++|++++. |. ...+++|++|+|++|+|++.++.+.. .+|+.|+|++|+|+ .+
T Consensus 153 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l 229 (317)
T 3o53_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LI 229 (317)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EE
T ss_pred CCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-ch
Confidence 9999998888774 799999999999999954 43 44589999999999999987665544 45999999999999 46
Q ss_pred cccc---cccceeeecCCcCCCC
Q 005001 240 PREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 240 p~~l---~~l~~l~l~~n~~~~~ 259 (720)
|..+ .+|+.|++.+|++.|.
T Consensus 230 ~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 230 EKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CTTCCCCTTCCEEECTTCCCBHH
T ss_pred hhHhhcCCCCCEEEccCCCccCc
Confidence 7655 5788999999999864
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.2e-18 Score=183.62 Aligned_cols=176 Identities=20% Similarity=0.262 Sum_probs=148.3
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCC--CCccceeccccccCcCCCCc--cccccCCccEE
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPY--SIASMVSLSYL 158 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~--~~~L~~L~L~~N~l~g~~p~--~~~~l~~L~~L 158 (720)
.+++.|+|++|++++..+..|+++++|++|+|++|++++..+..+ .++|++|+|++|++++ +|. .+.++++|++|
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L 154 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQIL 154 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEE
Confidence 579999999999999888999999999999999999995443323 3899999999999995 554 89999999999
Q ss_pred Ecccc-ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccC--CCCcCeEEccCccC
Q 005001 159 NVSRN-SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS--GLPLTTLNVANNHF 235 (720)
Q Consensus 159 ~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~L~~l~l~~N~l 235 (720)
+|++| .+++..+..|+.+++|++|+|++|++++..|..+..+++|++|++++|+++.....+. ..+|+.|+|++|.+
T Consensus 155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l 234 (353)
T 2z80_A 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDL 234 (353)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBC
T ss_pred ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcc
Confidence 99999 5777778899999999999999999999889999999999999999999976544332 35699999999999
Q ss_pred cccC-------------------------------cc---cccccceeeecCCcCCCC
Q 005001 236 SGWI-------------------------------PR---ELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 236 ~g~i-------------------------------p~---~l~~l~~l~l~~n~~~~~ 259 (720)
++.. |. .+.+|+.|++.+|.+...
T Consensus 235 ~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i 292 (353)
T 2z80_A 235 DTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSV 292 (353)
T ss_dssp TTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCC
T ss_pred ccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCcc
Confidence 8743 32 234778889999988744
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.1e-18 Score=190.11 Aligned_cols=174 Identities=18% Similarity=0.258 Sum_probs=143.2
Q ss_pred CEEEEEcCCCCCcccccccc-----cCCCCCCEEEccCCCCCCCCC----------------------------CCCCCc
Q 005001 84 AVVSIDISGLGLSGTMGYLL-----SDLLSLRKFDLSGNSIHDTIP----------------------------YQLPPN 130 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l-----~~l~~L~~L~L~~N~l~~~~p----------------------------~~~~~~ 130 (720)
+++.|++++|+++|.+|..+ +++++|+.|++++|.+ .+| ....++
T Consensus 248 ~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~ 325 (520)
T 2z7x_B 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325 (520)
T ss_dssp SCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCC
T ss_pred cccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCc
Confidence 67788888888888888877 6676666666666655 333 133478
Q ss_pred cceeccccccCcCCCCccccccCCccEEEcccccccc--ccccccCCCCCCCeeecCCCcccCCCCcc-ccCCCCCCeeE
Q 005001 131 LTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ--SIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLY 207 (720)
Q Consensus 131 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~ 207 (720)
|++|+|++|++++.+|..++++++|++|+|++|++++ .+|..++.+++|++|+|++|++++.+|.. +..+++|++|+
T Consensus 326 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~ 405 (520)
T 2z7x_B 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405 (520)
T ss_dssp CCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEE
T ss_pred ccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEE
Confidence 9999999999999899999999999999999999997 66788999999999999999999867764 78889999999
Q ss_pred eccccccccccccCCCCcCeEEccCccCcccCcccc---cccceeeecCCcCCCCC
Q 005001 208 LQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 208 l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~~ 260 (720)
|++|+|++.++.....+|+.|+|++|+|+ .+|..+ .+|+.|++.+|.+...|
T Consensus 406 Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~ 460 (520)
T 2z7x_B 406 MSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVP 460 (520)
T ss_dssp CCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCC
T ss_pred CcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccC
Confidence 99999998776655567999999999999 788754 57788999999988544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2.1e-17 Score=170.70 Aligned_cols=153 Identities=20% Similarity=0.200 Sum_probs=134.3
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEE
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 159 (720)
..+++.|+|++|+|++..+. +.+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+
T Consensus 54 l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~ 130 (290)
T 1p9a_G 54 YTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (290)
T ss_dssp CTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence 35799999999999875443 89999999999999998 6776654 8999999999999987778999999999999
Q ss_pred ccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccC-CCCcCeEEccCccCcc
Q 005001 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS-GLPLTTLNVANNHFSG 237 (720)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~~L~~l~l~~N~l~g 237 (720)
|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+..+..+. ..+|+.|+|++|.+..
T Consensus 131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccC
Confidence 99999998888889999999999999999996555667889999999999999997655443 3469999999999963
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.72 E-value=3.8e-17 Score=170.48 Aligned_cols=170 Identities=23% Similarity=0.332 Sum_probs=144.8
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|++++++++. ++ .+..+++|++|+|++|.+++..+..-.++|++|+|++|++++ ++ .+.++++|++|+|++
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~ 116 (308)
T 1h6u_A 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTS 116 (308)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTT
T ss_pred CCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChhHccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCC
Confidence 478999999999986 34 689999999999999999976663334899999999999995 44 799999999999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCc-c
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-R 241 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip-~ 241 (720)
|++++.. .+..+++|++|+|++|++++..+ +..+++|+.|+|++|+|++..+.....+|+.|+|++|++++..+ .
T Consensus 117 n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~l~ 192 (308)
T 1h6u_A 117 TQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192 (308)
T ss_dssp SCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGG
T ss_pred CCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChhhc
Confidence 9999753 39999999999999999996443 89999999999999999987664444569999999999996544 3
Q ss_pred cccccceeeecCCcCCCCC
Q 005001 242 ELISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 242 ~l~~l~~l~l~~n~~~~~~ 260 (720)
.+.+|+.|++.+|.+...+
T Consensus 193 ~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 193 SLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp GCTTCCEEECTTSCCCBCG
T ss_pred CCCCCCEEEccCCccCccc
Confidence 5578899999999987654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.5e-17 Score=184.78 Aligned_cols=155 Identities=21% Similarity=0.322 Sum_probs=133.2
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +..+|++|+|++|+|++ +|. .+++|+.|+|++
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 149 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPASLKHLDVDNNQLTM-LPE---LPALLEYINADN 149 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhcCCCEEECCCCcCCC-CCC---cCccccEEeCCC
Confidence 46999999999999 566 568999999999999997 888 77899999999999997 777 789999999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCc-------CeEEccCccC
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPL-------TTLNVANNHF 235 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L-------~~l~l~~N~l 235 (720)
|+|++ +|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+..+. +.. +| +.|+|++|+|
T Consensus 150 N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~-~L~~~~~~L~~L~Ls~N~l 219 (571)
T 3cvr_A 150 NQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV-RNHHSEETEIFFRCRENRI 219 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC---------CCEEEECCSSCC
T ss_pred CccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH-hhhcccccceEEecCCCcc
Confidence 99997 665 67899999999999996 887 66 899999999999995444 333 67 9999999999
Q ss_pred cccCcccc---cccceeeecCCcCCC
Q 005001 236 SGWIPREL---ISIRTFIYDGNSFDN 258 (720)
Q Consensus 236 ~g~ip~~l---~~l~~l~l~~n~~~~ 258 (720)
+ .||..+ .+|+.|++.+|++.+
T Consensus 220 ~-~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 220 T-HIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp C-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred e-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence 9 688755 467789999999876
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=7.4e-18 Score=191.63 Aligned_cols=177 Identities=24% Similarity=0.281 Sum_probs=128.7
Q ss_pred CCEEEEEcCCCCCcccc--cccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCC-ccccccCCccE
Q 005001 83 SAVVSIDISGLGLSGTM--GYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP-YSIASMVSLSY 157 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~ 157 (720)
.+++.|+|++|++++.. +..+..+++|++|+|++|.+++..+. +. ++|+.|+|++|.+++..| ..+.++++|++
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 425 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCE
Confidence 45667777777776554 56677777777777777777743332 32 678888888888876655 46778888888
Q ss_pred EEccccccccccccccCCCCCCCeeecCCCccc-CCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCcc
Q 005001 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS-GDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNH 234 (720)
Q Consensus 158 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~ 234 (720)
|+|++|.+++.+|..|..+++|++|+|++|+++ +.+|..+..+++|++|+|++|++++..+. +.. .+|+.|+|++|+
T Consensus 426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 505 (570)
T 2z63_A 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505 (570)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCc
Confidence 888888888777878888888888888888886 56777788888888888888888876543 322 458888888888
Q ss_pred CcccCcccc---cccceeeecCCcCCCCC
Q 005001 235 FSGWIPREL---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 235 l~g~ip~~l---~~l~~l~l~~n~~~~~~ 260 (720)
|++..|..+ .+|+.+++.+|++.|..
T Consensus 506 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 506 LKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 887666544 45677788888877653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-17 Score=186.35 Aligned_cols=172 Identities=22% Similarity=0.264 Sum_probs=144.2
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcC--CCCccccccCCccEEE
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSG--NLPYSIASMVSLSYLN 159 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~ 159 (720)
+++.|++++|++.+.. .+..+++|++|+|++|++++.+|..+. ++|++|+|++|++++ .+|..++++++|++|+
T Consensus 303 ~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~ 380 (520)
T 2z7x_B 303 NIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380 (520)
T ss_dssp CCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEE
T ss_pred ceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEE
Confidence 4666777777665432 127899999999999999998887775 899999999999997 6778899999999999
Q ss_pred cccccccccccc-ccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCCCCcCeEEccCccCcc
Q 005001 160 VSRNSLTQSIGD-IFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLPLTTLNVANNHFSG 237 (720)
Q Consensus 160 L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~L~~l~l~~N~l~g 237 (720)
|++|.+++.+|. .+..+++|++|+|++|++++.+|..+. ++|+.|+|++|+|+..++. +...+|+.|+|++|+|+
T Consensus 381 Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~- 457 (520)
T 2z7x_B 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLK- 457 (520)
T ss_dssp CCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-
T ss_pred CCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCC-
Confidence 999999996665 488999999999999999988887775 7999999999999954443 34456999999999999
Q ss_pred cCccc-c---cccceeeecCCcCCCCC
Q 005001 238 WIPRE-L---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 238 ~ip~~-l---~~l~~l~l~~n~~~~~~ 260 (720)
.+|.. + .+++.+++.+|++.|..
T Consensus 458 ~l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 458 SVPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ccCHHHhccCCcccEEECcCCCCcccC
Confidence 57764 4 57889999999998753
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-17 Score=160.31 Aligned_cols=131 Identities=25% Similarity=0.322 Sum_probs=118.9
Q ss_pred CEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCc-cccccCCccEEEccccccccccccccCCCCCCCeeecCCCc
Q 005001 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY-SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (720)
Q Consensus 110 ~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 188 (720)
++|++++|+++ .+|..+..+|++|+|++|+|++..+. .++++++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 89 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred CEEEcCCCCcC-cCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCc
Confidence 78999999996 89998889999999999999977664 48999999999999999999999999999999999999999
Q ss_pred ccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcccCcc
Q 005001 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPR 241 (720)
Q Consensus 189 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g~ip~ 241 (720)
|++..|..|..+++|++|+|++|+|++.++. +.. .+|+.|+|++|.|++..+-
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 9988888899999999999999999998664 333 4599999999999987663
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.8e-17 Score=186.48 Aligned_cols=112 Identities=21% Similarity=0.233 Sum_probs=99.0
Q ss_pred cccCCccEEEccccccccccccccCCCCCCCeeecCCCcccC--CCCccccCCCCCCeeEeccccccccccc--cCC-CC
Q 005001 150 ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG--DLPNSFISLSNISSLYLQNNQVTGSLNV--FSG-LP 224 (720)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~~~~~~--~~~-~~ 224 (720)
..+++|++|+|++|++++.+|..++.+++|++|+|++|++++ .+|..+..+++|++|+|++|++++.++. +.. .+
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 678999999999999999999999999999999999999996 3457799999999999999999985543 333 45
Q ss_pred cCeEEccCccCcccCcccc-cccceeeecCCcCCCCCC
Q 005001 225 LTTLNVANNHFSGWIPREL-ISIRTFIYDGNSFDNGPA 261 (720)
Q Consensus 225 L~~l~l~~N~l~g~ip~~l-~~l~~l~l~~n~~~~~~~ 261 (720)
|+.|+|++|+|++.+|..+ .+|+.|++++|.+...|.
T Consensus 430 L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~ 467 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPK 467 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCT
T ss_pred CCEEECCCCCCCcchhhhhcCcCCEEECCCCcCcccCh
Confidence 9999999999999999988 599999999999985543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.7e-17 Score=167.75 Aligned_cols=161 Identities=20% Similarity=0.199 Sum_probs=136.5
Q ss_pred cccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCC
Q 005001 98 TMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGN 175 (720)
Q Consensus 98 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 175 (720)
.+|..+. ++|++|+|++|++++..+..+. ++|++|+|++|++++..+..+.++++|++|+|++|++++..+..|..
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence 3454443 5799999999999976665554 89999999999999877889999999999999999999998999999
Q ss_pred CCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccc-ccc-ccCC-CCcCeEEccCccCcccCccccc---ccc--
Q 005001 176 LAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLN-VFSG-LPLTTLNVANNHFSGWIPRELI---SIR-- 247 (720)
Q Consensus 176 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~-~~~~-~~L~~l~l~~N~l~g~ip~~l~---~l~-- 247 (720)
+++|++|+|++|++++..+..++.+++|++|+|++|+|++ .++ .+.. .+|+.|+|++|++++..+..+. +++
T Consensus 99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l 178 (276)
T 2z62_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178 (276)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred CccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcccc
Confidence 9999999999999998777789999999999999999987 334 3333 5699999999999987776664 444
Q ss_pred --eeeecCCcCCCCC
Q 005001 248 --TFIYDGNSFDNGP 260 (720)
Q Consensus 248 --~l~l~~n~~~~~~ 260 (720)
.+++.+|.+...+
T Consensus 179 ~l~L~ls~n~l~~~~ 193 (276)
T 2z62_A 179 NLSLDLSLNPMNFIQ 193 (276)
T ss_dssp CEEEECCSSCCCEEC
T ss_pred ceeeecCCCcccccC
Confidence 7889999987554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.8e-17 Score=156.73 Aligned_cols=136 Identities=20% Similarity=0.272 Sum_probs=86.2
Q ss_pred CCCCCCCceeEecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCC
Q 005001 69 DPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP 146 (720)
Q Consensus 69 ~~c~~~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p 146 (720)
+.|.|+|++|.|+..+ ++. +|..+ .++|++|+|++|++++..+..+. ++|++|+|++|+|++..+
T Consensus 3 ~~C~C~~~~l~~~~~~----------l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSKG----------LTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD 69 (177)
T ss_dssp TTCEEETTEEECCSSC----------CSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CCCEeCCCEEEecCCC----------Ccc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh
Confidence 4566688888887543 332 33222 25677777777777754443332 567777777777775555
Q ss_pred ccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccc
Q 005001 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217 (720)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (720)
..+.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..+..+++|++|+|++|.+++..
T Consensus 70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 55667777777777777777666666667777777777777776544444566666666666666666543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-17 Score=187.85 Aligned_cols=173 Identities=20% Similarity=0.201 Sum_probs=151.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 160 (720)
.+++.|+|++|++++..+..|.++++|++|+|++|++++..|..+. ++|++|+|++|++++..|..|+++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 3688999999999999899999999999999999999976666664 89999999999999888899999999999999
Q ss_pred cccccccccccccCCCCCCCeeecCCCcccC-CCCccccCCCCCCeeEecccccccccccc-CC-CCc----CeEEccCc
Q 005001 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNVF-SG-LPL----TTLNVANN 233 (720)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~-~~L----~~l~l~~N 233 (720)
++|++++..+..++++++|++|+|++|++++ .+|..|+++++|++|++++|++++..+.. .. .+| ..|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 9999998777789999999999999999997 57999999999999999999999865432 11 234 78999999
Q ss_pred cCcccCccccc--ccceeeecCCc
Q 005001 234 HFSGWIPRELI--SIRTFIYDGNS 255 (720)
Q Consensus 234 ~l~g~ip~~l~--~l~~l~l~~n~ 255 (720)
.+++..|..+. +++.+++.+|.
T Consensus 188 ~l~~~~~~~~~~~~L~~L~l~~n~ 211 (570)
T 2z63_A 188 PMNFIQPGAFKEIRLHKLTLRNNF 211 (570)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCC
T ss_pred CceecCHHHhccCcceeEeccccc
Confidence 99988887664 57788888874
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.7e-17 Score=173.92 Aligned_cols=192 Identities=20% Similarity=0.191 Sum_probs=154.2
Q ss_pred CCCCCCceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC---Cccc-ee
Q 005001 70 PCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLT-SL 134 (720)
Q Consensus 70 ~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~---~~L~-~L 134 (720)
.|.|+|..|.|++ ..++.|+|++|+|+...+..|.+|++|++|+|++|++.+.+|.... ++|. .+
T Consensus 6 ~C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l 85 (350)
T 4ay9_X 6 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85 (350)
T ss_dssp SSEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred ccEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence 3777899999974 2578899999999977777899999999999999999888886543 4444 57
Q ss_pred ccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCC-CcccCCCCccccCCC-CCCeeEecccc
Q 005001 135 NLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF-NNFSGDLPNSFISLS-NISSLYLQNNQ 212 (720)
Q Consensus 135 ~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~-~L~~L~l~~N~ 212 (720)
.+++|+|++..|..|.++++|++|++++|+|++..+..+....++..|++.+ |++....+..|..+. .|+.|+|++|+
T Consensus 86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~ 165 (350)
T 4ay9_X 86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165 (350)
T ss_dssp EEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred cccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccc
Confidence 7888999988889999999999999999999988877888888888999865 567754455666664 68899999999
Q ss_pred ccccccc-cCCCCcCeEEccCccCcccCcc----cccccceeeecCCcCCCCCC
Q 005001 213 VTGSLNV-FSGLPLTTLNVANNHFSGWIPR----ELISIRTFIYDGNSFDNGPA 261 (720)
Q Consensus 213 l~~~~~~-~~~~~L~~l~l~~N~l~g~ip~----~l~~l~~l~l~~n~~~~~~~ 261 (720)
|+...+. +...+|+.|++++|+.-+.||. .+.+|+.|++++|.+...|.
T Consensus 166 i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~ 219 (350)
T 4ay9_X 166 IQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 219 (350)
T ss_dssp CCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCS
T ss_pred ccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccCh
Confidence 9976543 4556699999986544446775 34678899999999886653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=4.1e-17 Score=187.73 Aligned_cols=168 Identities=20% Similarity=0.179 Sum_probs=138.2
Q ss_pred EcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccccc
Q 005001 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166 (720)
Q Consensus 89 ~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~ 166 (720)
+-++.+|+ .+|..+. +++++|||++|+|++..|..+. ++|++|+|++|+|++..|..|.+|++|++|+|++|+|+
T Consensus 37 ~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~ 113 (635)
T 4g8a_A 37 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 113 (635)
T ss_dssp ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence 44455565 4555443 4799999999999966666665 89999999999999877889999999999999999999
Q ss_pred cccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccc-ccc-cC-CCCcCeEEccCccCcccCcccc
Q 005001 167 QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS-LNV-FS-GLPLTTLNVANNHFSGWIPREL 243 (720)
Q Consensus 167 ~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-~~~-~~-~~~L~~l~l~~N~l~g~ip~~l 243 (720)
+..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|+|++. ++. +. ...|+.|+|++|+|++..|..+
T Consensus 114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 193 (635)
T 4g8a_A 114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 193 (635)
T ss_dssp EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence 88888999999999999999999977777899999999999999999873 443 33 3569999999999999888877
Q ss_pred cccc-------eeeecCCcCCCC
Q 005001 244 ISIR-------TFIYDGNSFDNG 259 (720)
Q Consensus 244 ~~l~-------~l~l~~n~~~~~ 259 (720)
..+. .+.+..|.+...
T Consensus 194 ~~L~~l~~~~~~~~ls~n~l~~i 216 (635)
T 4g8a_A 194 RVLHQMPLLNLSLDLSLNPMNFI 216 (635)
T ss_dssp HHHHTCTTCCCEEECTTCCCCEE
T ss_pred cchhhhhhhhhhhhcccCccccc
Confidence 5443 356667766543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.70 E-value=6.6e-17 Score=179.01 Aligned_cols=166 Identities=25% Similarity=0.291 Sum_probs=80.8
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|++++|.+.+..+ ++.+++|++|+|++|.+++.-.....++|+.|+|++|.+++..| +..+++|++|+|++
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~ 274 (466)
T 1o6v_A 199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 274 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred CCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccchhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCC
Confidence 355666666666655444 45555555555555555532111112455555555555554332 45555555555555
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCcc-
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR- 241 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~- 241 (720)
|.+++..+ +..+++|+.|+|++|++++..| +..+++|+.|+|++|++++..+.....+|+.|++++|++++. +.
T Consensus 275 n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~~l 349 (466)
T 1o6v_A 275 NQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV-SSL 349 (466)
T ss_dssp SCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC-GGG
T ss_pred CccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc-hhh
Confidence 55554333 4455555555555555553322 445555555555555555544433333355555555554432 11
Q ss_pred -cccccceeeecCCcCC
Q 005001 242 -ELISIRTFIYDGNSFD 257 (720)
Q Consensus 242 -~l~~l~~l~l~~n~~~ 257 (720)
.+.+|+.|++.+|++.
T Consensus 350 ~~l~~L~~L~l~~n~l~ 366 (466)
T 1o6v_A 350 ANLTNINWLSAGHNQIS 366 (466)
T ss_dssp TTCTTCCEEECCSSCCC
T ss_pred ccCCCCCEEeCCCCccC
Confidence 2233444444444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.70 E-value=5.3e-17 Score=184.14 Aligned_cols=167 Identities=21% Similarity=0.249 Sum_probs=90.9
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
+++.|+|++|++... + .|..|++|+.|+|++|.|++..|..-.++|+.|+|++|+|++ +| .+..|++|+.|+|++|
T Consensus 44 ~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N 119 (605)
T 1m9s_A 44 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHN 119 (605)
T ss_dssp TCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTS
T ss_pred CCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChhhccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCC
Confidence 455555555555432 2 355566666666666666554443333556666666666653 22 4556666666666666
Q ss_pred ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCcc--
Q 005001 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR-- 241 (720)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~-- 241 (720)
+|++. +.+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+|++.++.....+|+.|+|++|+|++. |.
T Consensus 120 ~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l-~~l~ 194 (605)
T 1m9s_A 120 GISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-RALA 194 (605)
T ss_dssp CCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-GGGT
T ss_pred CCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCC-hHHc
Confidence 66542 2355566666666666666543 34555666666666666666555533333466666666666542 32
Q ss_pred cccccceeeecCCcCCCC
Q 005001 242 ELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 242 ~l~~l~~l~l~~n~~~~~ 259 (720)
.+.+|+.|++.+|++...
T Consensus 195 ~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 195 GLKNLDVLELFSQECLNK 212 (605)
T ss_dssp TCTTCSEEECCSEEEECC
T ss_pred cCCCCCEEEccCCcCcCC
Confidence 234555556666655543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.7e-17 Score=157.43 Aligned_cols=153 Identities=14% Similarity=0.202 Sum_probs=127.3
Q ss_pred ccCCCCCCEEEccCCCCCCCCC-CCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCe
Q 005001 103 LSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181 (720)
Q Consensus 103 l~~l~~L~~L~L~~N~l~~~~p-~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 181 (720)
.+.+++|++|+|++|.|+ .+| ....++|++|+|++|.++ .+..+.++++|++|+|++|++++..+..++.+++|++
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCTTGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhhcCCccEEeccCCCcc-ChHHHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 467889999999999999 555 222389999999999776 3458999999999999999999989999999999999
Q ss_pred eecCCCcccCCCCccccCCCCCCeeEecccc-ccccccccCCCCcCeEEccCccCcccCc-ccccccceeeecCCcCCC
Q 005001 182 LDLSFNNFSGDLPNSFISLSNISSLYLQNNQ-VTGSLNVFSGLPLTTLNVANNHFSGWIP-RELISIRTFIYDGNSFDN 258 (720)
Q Consensus 182 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~L~~l~l~~N~l~g~ip-~~l~~l~~l~l~~n~~~~ 258 (720)
|+|++|++++..|..++.+++|++|+|++|+ ++...+.....+|+.|++++|++++..+ ..+.+|+.|++.+|++..
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 9999999998889999999999999999998 5554333344569999999999997422 356789999999998753
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.8e-17 Score=171.71 Aligned_cols=176 Identities=20% Similarity=0.189 Sum_probs=147.7
Q ss_pred CCCEEEEEcCCCCCccccc----ccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCC--C--Cccccc
Q 005001 82 GSAVVSIDISGLGLSGTMG----YLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN--L--PYSIAS 151 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~----~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~--~--p~~~~~ 151 (720)
..+++.|+|++|.+++..+ ..+..+++|++|+|++|++++..|..+. ++|++|+|++|++.+. + +..+.+
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 4578999999999998665 4566899999999999999987777764 8999999999998753 2 233478
Q ss_pred cCCccEEEcccccccccc--cc-ccCCCCCCCeeecCCCcccCCCCccccCC---CCCCeeEeccccccccccccCCCCc
Q 005001 152 MVSLSYLNVSRNSLTQSI--GD-IFGNLAGLATLDLSFNNFSGDLPNSFISL---SNISSLYLQNNQVTGSLNVFSGLPL 225 (720)
Q Consensus 152 l~~L~~L~L~~N~l~~~~--p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~~L 225 (720)
+++|++|+|++|+|+... +. .++.+++|++|+|++|+|++.+|..++.+ ++|++|+|++|+|+. +|.....+|
T Consensus 196 l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~~~L 274 (310)
T 4glp_A 196 FPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGLPAKL 274 (310)
T ss_dssp SCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCCCSCC
T ss_pred CCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhhcCCC
Confidence 999999999999997322 22 35788999999999999998889888877 699999999999995 444444679
Q ss_pred CeEEccCccCcc-cCcccccccceeeecCCcCCC
Q 005001 226 TTLNVANNHFSG-WIPRELISIRTFIYDGNSFDN 258 (720)
Q Consensus 226 ~~l~l~~N~l~g-~ip~~l~~l~~l~l~~n~~~~ 258 (720)
+.|+|++|+|++ .++..+.+|+.|++++|++..
T Consensus 275 ~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 275 RVLDLSSNRLNRAPQPDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp SCEECCSCCCCSCCCTTSCCCCSCEECSSTTTSC
T ss_pred CEEECCCCcCCCCchhhhCCCccEEECcCCCCCC
Confidence 999999999998 567788999999999999863
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=6.7e-17 Score=182.89 Aligned_cols=175 Identities=23% Similarity=0.288 Sum_probs=150.4
Q ss_pred eEecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCc
Q 005001 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSL 155 (720)
Q Consensus 78 v~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L 155 (720)
..|....+ .++++++++. +|..+. ++|++|+|++|++++..|..+. ++|++|+|++|++++..|..|+++++|
T Consensus 2 ~~C~~~~~--c~~~~~~l~~-ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L 76 (549)
T 2z81_A 2 LSCDASGV--CDGRSRSFTS-IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76 (549)
T ss_dssp CEECTTSE--EECTTSCCSS-CCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred ccCCCCce--EECCCCcccc-ccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccC
Confidence 36877776 7999999984 555554 7999999999999988787665 899999999999999888999999999
Q ss_pred cEEEccccccccccccccCCCCCCCeeecCCCcccC-CCCccccCCCCCCeeEecccccccccc--ccCC-CCcCeEEcc
Q 005001 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLN--VFSG-LPLTTLNVA 231 (720)
Q Consensus 156 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~-~~L~~l~l~ 231 (720)
++|+|++|++++..|..|+++++|++|+|++|++++ .+|..++++++|++|++++|++.+.++ .+.. .+|+.|+|+
T Consensus 77 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~ 156 (549)
T 2z81_A 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156 (549)
T ss_dssp CEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred CEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeecc
Confidence 999999999999988889999999999999999996 467889999999999999999666554 3333 359999999
Q ss_pred CccCcccCccccc---ccceeeecCCcCC
Q 005001 232 NNHFSGWIPRELI---SIRTFIYDGNSFD 257 (720)
Q Consensus 232 ~N~l~g~ip~~l~---~l~~l~l~~n~~~ 257 (720)
+|++++.+|..+. +++.|++.+|.+.
T Consensus 157 ~n~l~~~~~~~l~~l~~L~~L~l~~n~~~ 185 (549)
T 2z81_A 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESA 185 (549)
T ss_dssp ETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred CCcccccChhhhhccccCceEecccCccc
Confidence 9999999998775 4667788888764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.6e-16 Score=174.76 Aligned_cols=162 Identities=22% Similarity=0.320 Sum_probs=123.5
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|+|++|++++ +| .++++++|++|+|++|++++ +|... .+|++|+|++|++++ +| .++++++|++|++++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~-~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~ 204 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP-PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADN 204 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC-TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc-ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCC
Confidence 467778888888876 55 58888888888888888885 56443 588888888888886 56 588888888888888
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCccc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRE 242 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~ 242 (720)
|++++ +|... ++|++|+|++|+++ .+|. ++.+++|++|++++|++++.... ..+|+.|++++|++++ +|..
T Consensus 205 N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~l~~~--~~~L~~L~l~~N~l~~-l~~~ 275 (454)
T 1jl5_A 205 NSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKTLPDL--PPSLEALNVRDNYLTD-LPEL 275 (454)
T ss_dssp SCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSSCCSC--CTTCCEEECCSSCCSC-CCCC
T ss_pred CcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCccccc--ccccCEEECCCCcccc-cCcc
Confidence 88886 44332 57888888888888 6774 88888888888888888874332 2468888888888885 7777
Q ss_pred ccccceeeecCCcCCCC
Q 005001 243 LISIRTFIYDGNSFDNG 259 (720)
Q Consensus 243 l~~l~~l~l~~n~~~~~ 259 (720)
+.+++.|++++|.+...
T Consensus 276 ~~~L~~L~ls~N~l~~l 292 (454)
T 1jl5_A 276 PQSLTFLDVSENIFSGL 292 (454)
T ss_dssp CTTCCEEECCSSCCSEE
T ss_pred cCcCCEEECcCCccCcc
Confidence 77888888888887753
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.3e-16 Score=164.99 Aligned_cols=149 Identities=23% Similarity=0.278 Sum_probs=129.3
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
..+++.|+|++|++++..+ +.++++|++|+|++|.+++.-+..-.++|++|+|++|++++. +.+..+++|++|+|+
T Consensus 67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~ 142 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLG 142 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGGGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECC
T ss_pred CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCChhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEcc
Confidence 4589999999999998665 999999999999999999643333338999999999999963 578999999999999
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCccc
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGW 238 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ 238 (720)
+|++++. ..++.+++|+.|+|++|++++..| +..+++|+.|+|++|+|++........+|+.|+|++|+++..
T Consensus 143 ~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 143 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp SSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCGGGTTCTTCSEEEEEEEEEECC
T ss_pred CCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCChhhccCCCCCEEECcCCcccCC
Confidence 9999976 679999999999999999997555 999999999999999999865544445699999999999863
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.67 E-value=4.1e-16 Score=171.63 Aligned_cols=163 Identities=21% Similarity=0.244 Sum_probs=85.2
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|+|++|++++. | .++.+++|++|+|++|+|++ +|..-.++|++|+|++|+|++. | ++++++|++|+|++
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~ 115 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LDLSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDT 115 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CCCTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCS
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-EccccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCC
Confidence 3455666666666553 2 45566666666666666654 3433335566666666666642 2 55566666666666
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCccc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRE 242 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~ 242 (720)
|++++. | ++.+++|++|+|++|+|++ ++ ++.+++|++|++++|+..+.++.....+|+.|++++|+|++.-...
T Consensus 116 N~l~~l-~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~l~l~~ 189 (457)
T 3bz5_A 116 NKLTKL-D--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQ 189 (457)
T ss_dssp SCCSCC-C--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCCCCCTT
T ss_pred CcCCee-c--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccceecccc
Confidence 666552 2 5555666666666666654 22 4555555555555554444443333334555555555555421122
Q ss_pred ccccceeeecCCcCC
Q 005001 243 LISIRTFIYDGNSFD 257 (720)
Q Consensus 243 l~~l~~l~l~~n~~~ 257 (720)
+.+++.|.+.+|.+.
T Consensus 190 l~~L~~L~l~~N~l~ 204 (457)
T 3bz5_A 190 NKLLNRLNCDTNNIT 204 (457)
T ss_dssp CTTCCEEECCSSCCS
T ss_pred CCCCCEEECcCCcCC
Confidence 334444445444444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.67 E-value=1e-16 Score=163.09 Aligned_cols=146 Identities=20% Similarity=0.237 Sum_probs=80.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|++++|+++. ++ .+..+++|++|+|++|+|++..|..-.++|++|+|++|++++ +|.... ++|+.|+|++
T Consensus 41 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~ 115 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDN 115 (263)
T ss_dssp TTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCS
T ss_pred CcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChhhccCCCCCEEECCCCccCC-cCcccc--CcccEEEccC
Confidence 355566666666653 22 456666666666666666654442222566666666666663 333222 6666666666
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSG 237 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g 237 (720)
|+|++. +.+..+++|+.|+|++|+|++ ++ .+..+++|++|+|++|+|++........+|+.|+|++|.+++
T Consensus 116 N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 116 NELRDT--DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp SCCSBS--GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBCTTSTTCCCCCEEEEEEEEEEC
T ss_pred CccCCC--hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcchHHhccCCCCCEEeCCCCcccC
Confidence 666643 245566666666666666663 23 455666666666666666655222222336666666666654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.67 E-value=5.4e-16 Score=170.70 Aligned_cols=164 Identities=20% Similarity=0.249 Sum_probs=138.1
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|+|++|++++. + ++++++|++|+|++|++++ +|..-.++|++|+|++|+|++ ++ ++++++|++|+|++
T Consensus 85 ~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~ 157 (457)
T 3bz5_A 85 TNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LDVSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHL 157 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CCCTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTT
T ss_pred CCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ecCCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCC
Confidence 5789999999999985 3 8999999999999999997 565555899999999999997 43 88999999999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCc-c
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-R 241 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip-~ 241 (720)
|+..+.+ .++.+++|+.|+|++|++++ +| ++.+++|+.|++++|+|++. +.....+|+.|+|++|+|++ +| .
T Consensus 158 n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~N~l~~-ip~~ 230 (457)
T 3bz5_A 158 NKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCSSNKLTE-IDVT 230 (457)
T ss_dssp CSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSC-CCCT
T ss_pred CCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECcCCcccc-cCcc
Confidence 9777666 48889999999999999996 55 88889999999999999885 43344569999999999997 55 3
Q ss_pred cccccceeeecCCcCCCCC
Q 005001 242 ELISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 242 ~l~~l~~l~l~~n~~~~~~ 260 (720)
.+.+|+.|++.+|.+...+
T Consensus 231 ~l~~L~~L~l~~N~l~~~~ 249 (457)
T 3bz5_A 231 PLTQLTYFDCSVNPLTELD 249 (457)
T ss_dssp TCTTCSEEECCSSCCSCCC
T ss_pred ccCCCCEEEeeCCcCCCcC
Confidence 4567888999999888754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.1e-16 Score=167.44 Aligned_cols=150 Identities=23% Similarity=0.241 Sum_probs=132.1
Q ss_pred CEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCcccc-ccCCccEEEccccccccccccccCCCCCCCeeecCCCc
Q 005001 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA-SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (720)
Q Consensus 110 ~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 188 (720)
+.+++++|+++ .+|..+.+.++.|+|++|+|++..+..+. ++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~ 99 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99 (361)
T ss_dssp TEEECCSSCCS-SCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CEEEeCCCCcC-ccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCc
Confidence 58999999999 68999989999999999999988888887 99999999999999999888999999999999999999
Q ss_pred ccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcccCccc------ccccceeeecCCcCCCCC
Q 005001 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPRE------LISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 189 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g~ip~~------l~~l~~l~l~~n~~~~~~ 260 (720)
|++..+..|..+++|++|+|++|+|++..+. +.. .+|+.|+|++|+|++..+.. +.+|+.|++.+|.+...+
T Consensus 100 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 179 (361)
T 2xot_A 100 LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLP 179 (361)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCC
T ss_pred CCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccC
Confidence 9977777899999999999999999987653 433 45999999999999643333 468889999999987544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.67 E-value=4.6e-16 Score=172.24 Aligned_cols=169 Identities=24% Similarity=0.348 Sum_probs=141.6
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|++++|.+++. +.+..+++|++|+|++|.+++..|....++|+.|+|++|++++ + ..+..+++|+.|+|++
T Consensus 177 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~ 252 (466)
T 1o6v_A 177 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLAN 252 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCS
T ss_pred CCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccccccccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCC
Confidence 4688899999988764 3488899999999999999987776666899999999999985 3 4688899999999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCc-c
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-R 241 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip-~ 241 (720)
|.+++..+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..+.....+|+.|+|++|++++..| .
T Consensus 253 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 328 (466)
T 1o6v_A 253 NQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS 328 (466)
T ss_dssp SCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGGGG
T ss_pred Cccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchhhc
Confidence 99998765 8889999999999999996444 88899999999999999987775555679999999999998766 3
Q ss_pred cccccceeeecCCcCCCC
Q 005001 242 ELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 242 ~l~~l~~l~l~~n~~~~~ 259 (720)
.+.+|+.|++.+|++...
T Consensus 329 ~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 329 SLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp GCTTCCEEECCSSCCCCC
T ss_pred cCccCCEeECCCCccCCc
Confidence 557888999999988764
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.67 E-value=4.6e-16 Score=176.43 Aligned_cols=157 Identities=22% Similarity=0.270 Sum_probs=133.3
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
..+++.|+|++|+|++..+ +..|++|+.|+|++|.|++.-...-.++|+.|+|++|+|++ + +.+..|++|+.|+|+
T Consensus 64 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls 139 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG 139 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCTTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECC
T ss_pred CCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCChhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECC
Confidence 4589999999999998766 99999999999999999964323333899999999999996 3 569999999999999
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCcc
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR 241 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~ 241 (720)
+|+|++. ..++.+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++........+|+.|+|++|++++....
T Consensus 140 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l~~l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 140 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp SSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCSEEEECCCCC
T ss_pred CCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCChHHccCCCCCEEEccCCcCcCCccc
Confidence 9999986 689999999999999999997666 999999999999999999864444445699999999999875333
Q ss_pred ccccc
Q 005001 242 ELISI 246 (720)
Q Consensus 242 ~l~~l 246 (720)
.+.++
T Consensus 216 ~~~~l 220 (605)
T 1m9s_A 216 HQSNL 220 (605)
T ss_dssp CCSSC
T ss_pred ccccE
Confidence 33333
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-16 Score=153.37 Aligned_cols=113 Identities=26% Similarity=0.428 Sum_probs=57.4
Q ss_pred CCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCC
Q 005001 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202 (720)
Q Consensus 123 ~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 202 (720)
+|..+.++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++
T Consensus 25 ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~ 103 (193)
T 2wfh_A 25 LPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKS 103 (193)
T ss_dssp CCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTT
T ss_pred CCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCC
Confidence 34333344445555555554 44455555555555555555555555555555555555555555555444445555555
Q ss_pred CCeeEeccccccccccc-cCC-CCcCeEEccCccCc
Q 005001 203 ISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFS 236 (720)
Q Consensus 203 L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~ 236 (720)
|++|+|++|+|++..+. +.. .+|+.|+|++|.+.
T Consensus 104 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 104 LRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 55555555555543332 221 23555555555554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.3e-16 Score=151.35 Aligned_cols=125 Identities=26% Similarity=0.282 Sum_probs=109.0
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEcccccc
Q 005001 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165 (720)
Q Consensus 88 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l 165 (720)
+++++++|+ .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 455566666 4555443 58999999999998 7776665 8999999999999988888999999999999999999
Q ss_pred ccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccc
Q 005001 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS 216 (720)
Q Consensus 166 ~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~ 216 (720)
++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 999999999999999999999999966666789999999999999999763
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.66 E-value=5e-17 Score=178.85 Aligned_cols=161 Identities=22% Similarity=0.245 Sum_probs=101.7
Q ss_pred CEEEEEcCCCCCcccccccccCCCCC-------------CEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCcccc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSL-------------RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L-------------~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~ 150 (720)
+++.|++++|++.|.+|..++++++| ++|++++|.+++ +|. +.++|++|+|++|++++ +|..
T Consensus 35 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~-~~~~L~~L~l~~n~l~~-lp~~-- 109 (454)
T 1jl5_A 35 SKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE-LPPHLESLVASCNSLTE-LPEL-- 109 (454)
T ss_dssp CHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS-CCTTCSEEECCSSCCSS-CCCC--
T ss_pred chhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC-CcCCCCEEEccCCcCCc-cccc--
Confidence 44555555566666666666655543 666666666653 332 33567777777777775 5543
Q ss_pred ccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEc
Q 005001 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNV 230 (720)
Q Consensus 151 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l 230 (720)
+++|++|+|++|++++. |.. .++|++|+|++|++++ +| .++.+++|++|++++|+|++..... .+|+.|++
T Consensus 110 -~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~--~~L~~L~L 180 (454)
T 1jl5_A 110 -PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLP--PSLEFIAA 180 (454)
T ss_dssp -CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCC--TTCCEEEC
T ss_pred -cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCc--ccccEEEC
Confidence 35667777777766642 211 1578888888888875 66 5788888888888888887632221 36778888
Q ss_pred cCccCcccCcc--cccccceeeecCCcCCCC
Q 005001 231 ANNHFSGWIPR--ELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 231 ~~N~l~g~ip~--~l~~l~~l~l~~n~~~~~ 259 (720)
++|++++ +|. .+.+|+.|++.+|.+...
T Consensus 181 ~~n~l~~-l~~~~~l~~L~~L~l~~N~l~~l 210 (454)
T 1jl5_A 181 GNNQLEE-LPELQNLPFLTAIYADNNSLKKL 210 (454)
T ss_dssp CSSCCSS-CCCCTTCTTCCEEECCSSCCSSC
T ss_pred cCCcCCc-CccccCCCCCCEEECCCCcCCcC
Confidence 8887776 553 234566777777777653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.3e-16 Score=164.69 Aligned_cols=169 Identities=20% Similarity=0.261 Sum_probs=113.2
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
+++.|++++|.+.+..+ +..+++|++|++++|.+++..+....++|+.|++++|.+++..+ +..+++|++|+|++|
T Consensus 156 ~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n 231 (347)
T 4fmz_A 156 GLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN 231 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred CCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccccccccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCC
Confidence 45555555555544333 55666666666666666644332333566666666666664333 677778888888888
Q ss_pred ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCcccc
Q 005001 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPREL 243 (720)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~l 243 (720)
++++..+ +..+++|++|+|++|++++ + ..+..+++|++|++++|+|++........+|+.|+|++|++++..|..+
T Consensus 232 ~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l 307 (347)
T 4fmz_A 232 KITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVI 307 (347)
T ss_dssp CCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred ccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCChhhcCCCCCCEEECcCCcCCCcChhHh
Confidence 8876544 7778888888888888874 3 3577788888888888888775333333458888888888887777644
Q ss_pred ---cccceeeecCCcCCCCC
Q 005001 244 ---ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 244 ---~~l~~l~l~~n~~~~~~ 260 (720)
.+|+.|++.+|++...+
T Consensus 308 ~~l~~L~~L~L~~n~l~~~~ 327 (347)
T 4fmz_A 308 GGLTNLTTLFLSQNHITDIR 327 (347)
T ss_dssp HTCTTCSEEECCSSSCCCCG
T ss_pred hccccCCEEEccCCcccccc
Confidence 56777888888877553
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.8e-16 Score=149.57 Aligned_cols=131 Identities=21% Similarity=0.233 Sum_probs=87.5
Q ss_pred CCEEEEEcCCCCCc-ccccccccCCCCCCEEEccCCCCCCCCCCCC--CCccceeccccccCcCCCCccccccCCccEEE
Q 005001 83 SAVVSIDISGLGLS-GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (720)
Q Consensus 83 ~~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~--~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 159 (720)
.+++.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..+ .++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 35677777777776 66777777777777777777777754 222 26677777777777766666666677777777
Q ss_pred cccccccccc-ccccCCCCCCCeeecCCCcccCCCC---ccccCCCCCCeeEeccccccc
Q 005001 160 VSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLP---NSFISLSNISSLYLQNNQVTG 215 (720)
Q Consensus 160 L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~g~~p---~~~~~l~~L~~L~l~~N~l~~ 215 (720)
|++|+|++.. +..+..+++|++|+|++|.+++..+ ..+..+++|++|++++|.+..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 7777776542 2566677777777777777764333 256666777777766666654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.5e-16 Score=147.66 Aligned_cols=131 Identities=20% Similarity=0.261 Sum_probs=117.3
Q ss_pred CCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCc
Q 005001 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (720)
Q Consensus 109 L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 188 (720)
.+.+++++|+++ .+|..+.++|+.|+|++|++++..+..+.++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCEEEecCCCCc-cCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 578999999998 6888888999999999999997777788999999999999999998888889999999999999999
Q ss_pred ccCCCCccccCCCCCCeeEecccccccccccc-C-CCCcCeEEccCccCcccCc
Q 005001 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-S-GLPLTTLNVANNHFSGWIP 240 (720)
Q Consensus 189 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~L~~l~l~~N~l~g~ip 240 (720)
|++..+..+..+++|++|+|++|+|++.++.. . ..+|+.|+|++|.+++..|
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99777777899999999999999999876643 3 3469999999999998766
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.1e-16 Score=164.81 Aligned_cols=168 Identities=23% Similarity=0.319 Sum_probs=142.9
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
..+++.|++++|.+.+..+ +..+++|++|++++|.+++..+....++|++|+|++|++++. +. +..+++|++|+|+
T Consensus 176 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~ 251 (347)
T 4fmz_A 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIG 251 (347)
T ss_dssp CTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECC
T ss_pred CCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCchhhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECC
Confidence 3579999999999987554 899999999999999999776655558999999999999954 44 9999999999999
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-c-CCCCcCeEEccCccCcccC
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-F-SGLPLTTLNVANNHFSGWI 239 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~-~~~~L~~l~l~~N~l~g~i 239 (720)
+|.+++. +.+..+++|++|+|++|++++ + ..+..+++|+.|+|++|++++..+. + ...+|+.|+|++|++++..
T Consensus 252 ~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 327 (347)
T 4fmz_A 252 TNQISDI--NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR 327 (347)
T ss_dssp SSCCCCC--GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCG
T ss_pred CCccCCC--hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccccc
Confidence 9999975 578999999999999999996 4 4588999999999999999986643 3 3456999999999999877
Q ss_pred c-ccccccceeeecCCcCC
Q 005001 240 P-RELISIRTFIYDGNSFD 257 (720)
Q Consensus 240 p-~~l~~l~~l~l~~n~~~ 257 (720)
| ..+.+|+.|++.+|++.
T Consensus 328 ~~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 328 PLASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGGGCTTCSEESSSCC---
T ss_pred Chhhhhccceeehhhhccc
Confidence 7 46678999999999874
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=6.3e-18 Score=182.44 Aligned_cols=177 Identities=19% Similarity=0.240 Sum_probs=142.1
Q ss_pred CCCEEEEEcCCCCCcc----cccccccCCCCCCEEEccCCCCCCCCCCCCC---------------CccceeccccccCc
Q 005001 82 GSAVVSIDISGLGLSG----TMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---------------PNLTSLNLASNNFS 142 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~---------------~~L~~L~L~~N~l~ 142 (720)
..+++.|+|++|.+++ .++..+..+++|++|+|++|.|++..+..+. ++|++|+|++|+++
T Consensus 93 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~ 172 (386)
T 2ca6_A 93 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172 (386)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred CCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence 3578899999999988 5777888999999999999988744333332 58999999999997
Q ss_pred -CCCC---ccccccCCccEEEccccccc--c---ccccccCCCCCCCeeecCCCccc----CCCCccccCCCCCCeeEec
Q 005001 143 -GNLP---YSIASMVSLSYLNVSRNSLT--Q---SIGDIFGNLAGLATLDLSFNNFS----GDLPNSFISLSNISSLYLQ 209 (720)
Q Consensus 143 -g~~p---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~L~l~ 209 (720)
+.+| ..+..+++|+.|+|++|+|+ | .+|..+..+++|+.|+|++|+++ +.+|..+..+++|++|+|+
T Consensus 173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~ 252 (386)
T 2ca6_A 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 252 (386)
T ss_dssp GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence 4555 46778899999999999998 3 45558888999999999999996 5788888899999999999
Q ss_pred ccccccc----ccc-c---CCCCcCeEEccCccCcc----cCcccc----cccceeeecCCcCCC
Q 005001 210 NNQVTGS----LNV-F---SGLPLTTLNVANNHFSG----WIPREL----ISIRTFIYDGNSFDN 258 (720)
Q Consensus 210 ~N~l~~~----~~~-~---~~~~L~~l~l~~N~l~g----~ip~~l----~~l~~l~l~~n~~~~ 258 (720)
+|+|++. ++. + ...+|+.|+|++|.|++ .+|..+ .+|+.|++.+|++..
T Consensus 253 ~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 253 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred CCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 9999875 222 2 24569999999999998 477654 678899999998863
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.1e-16 Score=178.11 Aligned_cols=176 Identities=22% Similarity=0.347 Sum_probs=120.1
Q ss_pred CCCCCCCCCCCCCCCCcee--------EecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCcc
Q 005001 60 LTNWKGNEGDPCGESWKGV--------ACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNL 131 (720)
Q Consensus 60 l~~w~~~~~~~c~~~w~gv--------~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L 131 (720)
+..|... .++| .|+|. .|...+++.|++++|+|+ .+|..+. ++|++|+|++|+|+ .+|. ..++|
T Consensus 12 w~~W~~~-~~~~--~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~-~l~~L 83 (622)
T 3g06_A 12 WSAWRRA-APAE--ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA-LPPEL 83 (622)
T ss_dssp HHHHHHT-CCGG--GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC-CCTTC
T ss_pred HHHHHhc-CCcc--hhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC-cCCCC
Confidence 3456432 2344 68664 334457889999999998 6677665 78999999999998 5666 55889
Q ss_pred ceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccc
Q 005001 132 TSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211 (720)
Q Consensus 132 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 211 (720)
++|+|++|+|+ .+|. .+++|++|+|++|+|++. |. .+++|+.|+|++|+|++ +|.. +++|++|+|++|
T Consensus 84 ~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N 151 (622)
T 3g06_A 84 RTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDN 151 (622)
T ss_dssp CEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSS
T ss_pred CEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCC
Confidence 99999999988 5666 678899999999988864 33 56778888888888874 6653 377888888888
Q ss_pred cccccccccCCCCcCeEEccCccCcccCcccccccceeeecCCcCCC
Q 005001 212 QVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDN 258 (720)
Q Consensus 212 ~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~l~~l~~l~l~~n~~~~ 258 (720)
+|++.... ..+|+.|++++|+|++ +|..+.+|+.|++++|.+..
T Consensus 152 ~l~~l~~~--~~~L~~L~L~~N~l~~-l~~~~~~L~~L~Ls~N~l~~ 195 (622)
T 3g06_A 152 QLASLPAL--PSELCKLWAYNNQLTS-LPMLPSGLQELSVSDNQLAS 195 (622)
T ss_dssp CCSCCCCC--CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSC
T ss_pred cCCCcCCc--cCCCCEEECCCCCCCC-CcccCCCCcEEECCCCCCCC
Confidence 87764321 1235555555555553 44444455555555555443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3e-16 Score=148.12 Aligned_cols=134 Identities=22% Similarity=0.187 Sum_probs=107.5
Q ss_pred CCCCCCEEEccCCCCC-CCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCe
Q 005001 105 DLLSLRKFDLSGNSIH-DTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181 (720)
Q Consensus 105 ~l~~L~~L~L~~N~l~-~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 181 (720)
..++|++|+|++|.++ +.+|..+. ++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3478899999999987 77887654 7899999999998865 78888999999999999998888888888899999
Q ss_pred eecCCCcccCCC-CccccCCCCCCeeEecccccccccc----ccCC-CCcCeEEccCccCcccCcc
Q 005001 182 LDLSFNNFSGDL-PNSFISLSNISSLYLQNNQVTGSLN----VFSG-LPLTTLNVANNHFSGWIPR 241 (720)
Q Consensus 182 L~l~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~-~~L~~l~l~~N~l~g~ip~ 241 (720)
|+|++|++++.. +..+..+++|++|+|++|+|++..+ .+.. .+|+.|++++|.+. .+|.
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 999999988532 2678888899999999999888665 3433 45888888888887 4443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.5e-17 Score=171.61 Aligned_cols=140 Identities=14% Similarity=0.131 Sum_probs=100.1
Q ss_pred CCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccC------------hHHHHH--------HHHHHHHhhcCCCCCc
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS------------LQEEDN--------FLEAVSNMSRLRHPNI 470 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~--------~~~e~~~l~~l~h~ni 470 (720)
-|++...||+|+||.||+|...+|+.||||+++..... ...... ..+|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38999999999999999999999999999987532111 000111 1345555655544443
Q ss_pred cccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC
Q 005001 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD 550 (720)
Q Consensus 471 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~ 550 (720)
.-..-+.. ...++||||++|++|.++.. ......++.|++.+|.+||+. +||||||||.|||+++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 22221211 22479999999988876542 113456889999999999998 9999999999999988
Q ss_pred CC----------ceEEcccCCCccC
Q 005001 551 EL----------NPHLSDCGLAALT 565 (720)
Q Consensus 551 ~~----------~~kl~Dfg~a~~~ 565 (720)
++ .+.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 76 3899999977543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.64 E-value=8.4e-16 Score=156.31 Aligned_cols=165 Identities=22% Similarity=0.284 Sum_probs=134.7
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCC-CCCCCccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 85 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
++.++++++++++.. .+..+++|++|+|++|.|+. +| ....++|++|+|++|+|++. |. +.++++|++|+|++|
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N 95 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LAGMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRN 95 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-chHHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCC
Confidence 445667778887544 68899999999999999984 55 22238999999999999965 44 999999999999999
Q ss_pred ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCc--c
Q 005001 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP--R 241 (720)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip--~ 241 (720)
++++. |.. .. ++|+.|+|++|++++ ++ .+..+++|+.|+|++|+|++........+|+.|+|++|+|++. + .
T Consensus 96 ~l~~l-~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~-~~l~ 169 (263)
T 1xeu_A 96 RLKNL-NGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT-GGLT 169 (263)
T ss_dssp CCSCC-TTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC-TTST
T ss_pred ccCCc-Ccc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch-HHhc
Confidence 99974 332 33 999999999999996 44 5999999999999999999875444556699999999999976 2 2
Q ss_pred cccccceeeecCCcCCCCC
Q 005001 242 ELISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 242 ~l~~l~~l~l~~n~~~~~~ 260 (720)
.+.+|+.|++.+|++.+.+
T Consensus 170 ~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 170 RLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp TCCCCCEEEEEEEEEECCC
T ss_pred cCCCCCEEeCCCCcccCCc
Confidence 4567889999999998764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.9e-16 Score=146.18 Aligned_cols=128 Identities=20% Similarity=0.186 Sum_probs=96.2
Q ss_pred CCEEEEEcCCCCCc-ccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 83 SAVVSIDISGLGLS-GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 83 ~~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
.+++.|++++|+++ +.+|..+..+++|++|+|++|.+++.....-.++|++|+|++|++++.+|..+.++++|++|+|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls 96 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCCTTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECT
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCchhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECC
Confidence 35778888888887 77888888888888888888888865111222678888888888887777777778888888888
Q ss_pred ccccccc-cccccCCCCCCCeeecCCCcccCCCC---ccccCCCCCCeeEecc
Q 005001 162 RNSLTQS-IGDIFGNLAGLATLDLSFNNFSGDLP---NSFISLSNISSLYLQN 210 (720)
Q Consensus 162 ~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~g~~p---~~~~~l~~L~~L~l~~ 210 (720)
+|++++. .+..++.+++|++|+|++|++++..+ ..+..+++|+.|++++
T Consensus 97 ~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8888764 45777888888888888888875544 3677778888877653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.7e-17 Score=186.96 Aligned_cols=169 Identities=17% Similarity=0.203 Sum_probs=92.0
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEccCCC-------------CCCCCCCCCC--Cccceec-cccccCcCCCCc-
Q 005001 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-------------IHDTIPYQLP--PNLTSLN-LASNNFSGNLPY- 147 (720)
Q Consensus 85 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~-------------l~~~~p~~~~--~~L~~L~-L~~N~l~g~~p~- 147 (720)
+..|+|++|+|+ .+|..+++|++|+.|++++|. +.+.+|..+. ++|+.|+ ++.|.+. .++.
T Consensus 351 L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-~L~~l 428 (567)
T 1dce_A 351 LFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-DLRSK 428 (567)
T ss_dssp SSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-HHHHH
T ss_pred ceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-hhhhh
Confidence 445677777775 678888888888888887664 4444443322 3333333 2222221 0000
Q ss_pred -----cccc--cCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc
Q 005001 148 -----SIAS--MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220 (720)
Q Consensus 148 -----~~~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 220 (720)
.+.. ...|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++. |.+
T Consensus 429 ~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~l-p~l 504 (567)
T 1dce_A 429 FLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGV 504 (567)
T ss_dssp HHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGG
T ss_pred hhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCC-ccc
Confidence 0000 0135556666666664 344 666666666666666666 5566666666666666666666653 232
Q ss_pred CC-CCcCeEEccCccCcccC-cccc---cccceeeecCCcCCCC
Q 005001 221 SG-LPLTTLNVANNHFSGWI-PREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 221 ~~-~~L~~l~l~~N~l~g~i-p~~l---~~l~~l~l~~n~~~~~ 259 (720)
.. .+|+.|+|++|+|++.+ |..+ .+|+.|++.+|++...
T Consensus 505 ~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp TTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 22 33666666666666554 5443 3445566666665544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=7.9e-16 Score=142.07 Aligned_cols=111 Identities=18% Similarity=0.173 Sum_probs=69.9
Q ss_pred CCCCCEEEccCCCCC-CCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCee
Q 005001 106 LLSLRKFDLSGNSIH-DTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL 182 (720)
Q Consensus 106 l~~L~~L~L~~N~l~-~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 182 (720)
.++|+.|+|++|.++ +.+|..+. ++|++|+|++|++++. ..++++++|++|+|++|++++.+|..++.+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 356667777777766 56665443 5666666666666644 556666666666666666666666666666666666
Q ss_pred ecCCCcccCC-CCccccCCCCCCeeEecccccccccc
Q 005001 183 DLSFNNFSGD-LPNSFISLSNISSLYLQNNQVTGSLN 218 (720)
Q Consensus 183 ~l~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~~~~~ 218 (720)
+|++|++++. .|..+..+++|++|++++|+|++..+
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 6666666642 23556666666666666666665443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.59 E-value=7.8e-15 Score=166.57 Aligned_cols=38 Identities=21% Similarity=0.364 Sum_probs=29.2
Q ss_pred CCcCeEEccCccCcccCcccccccceeeecCCcCCCCCC
Q 005001 223 LPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPA 261 (720)
Q Consensus 223 ~~L~~l~l~~N~l~g~ip~~l~~l~~l~l~~n~~~~~~~ 261 (720)
.+|+.|+|++|+|++ +|..+.+|+.|++++|.+...|.
T Consensus 221 ~~L~~L~Ls~N~L~~-lp~~l~~L~~L~Ls~N~L~~lp~ 258 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LPVLPSELKELMVSGNRLTSLPM 258 (622)
T ss_dssp TTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCC
T ss_pred CCCCEEEccCCccCc-CCCCCCcCcEEECCCCCCCcCCc
Confidence 348888888888885 77777888888888888875443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.59 E-value=4.5e-15 Score=140.27 Aligned_cols=107 Identities=24% Similarity=0.356 Sum_probs=88.9
Q ss_pred CEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcc
Q 005001 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (720)
Q Consensus 110 ~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 189 (720)
+.|++++|.++ .+|..+.++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 90 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90 (170)
T ss_dssp TEEECTTSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CEEEeCCCCcC-ccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence 35556666666 46766777888888888888888888899999999999999999988888889999999999999999
Q ss_pred cCCCCccccCCCCCCeeEeccccccccc
Q 005001 190 SGDLPNSFISLSNISSLYLQNNQVTGSL 217 (720)
Q Consensus 190 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (720)
++..+..|..+++|++|+|++|.++...
T Consensus 91 ~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 91 KSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 9766667889999999999998887643
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.59 E-value=2e-16 Score=183.88 Aligned_cols=154 Identities=23% Similarity=0.168 Sum_probs=121.7
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEcccccc
Q 005001 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165 (720)
Q Consensus 88 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l 165 (720)
+++..|.+. ..+..+..++.|+.|+|++|.|. .+|..+. ++|++|+|++|.|+ .+|..|++|++|++|+|++|+|
T Consensus 206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l 282 (727)
T 4b8c_D 206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL 282 (727)
T ss_dssp -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence 333334443 45778999999999999999999 7776665 89999999999999 8999999999999999999999
Q ss_pred ccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCC-C--CcCeEEccCccCcccCccc
Q 005001 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-L--PLTTLNVANNHFSGWIPRE 242 (720)
Q Consensus 166 ~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~--~L~~l~l~~N~l~g~ip~~ 242 (720)
+ .+|..|+.|++|++|+|++|+|+ .+|..|+.|++|++|+|++|+|++.+|.... . .+..|+|++|.++|.+|..
T Consensus 283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence 9 78999999999999999999998 8899999999999999999999997765432 2 2345789999999999987
Q ss_pred cccc
Q 005001 243 LISI 246 (720)
Q Consensus 243 l~~l 246 (720)
+..+
T Consensus 361 l~~l 364 (727)
T 4b8c_D 361 RRFI 364 (727)
T ss_dssp ----
T ss_pred ccee
Confidence 7654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.7e-16 Score=169.51 Aligned_cols=176 Identities=21% Similarity=0.258 Sum_probs=119.8
Q ss_pred CCEEEEEcCCCCCccccc----ccccCCC-CCCEEEccCCCCCCCCCCCCC-------CccceeccccccCcCCCCcccc
Q 005001 83 SAVVSIDISGLGLSGTMG----YLLSDLL-SLRKFDLSGNSIHDTIPYQLP-------PNLTSLNLASNNFSGNLPYSIA 150 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~----~~l~~l~-~L~~L~L~~N~l~~~~p~~~~-------~~L~~L~L~~N~l~g~~p~~~~ 150 (720)
.+++.|+|++|++++..+ ..+..++ +|++|+|++|.|++..+..+. ++|++|+|++|++++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 357888888888877666 6677777 788888888888765553331 5788888888888876666544
Q ss_pred cc-----CCccEEEcccccccccccccc----CC-CCCCCeeecCCCcccCCCCc----cccCCC-CCCeeEeccccccc
Q 005001 151 SM-----VSLSYLNVSRNSLTQSIGDIF----GN-LAGLATLDLSFNNFSGDLPN----SFISLS-NISSLYLQNNQVTG 215 (720)
Q Consensus 151 ~l-----~~L~~L~L~~N~l~~~~p~~~----~~-l~~L~~L~l~~N~l~g~~p~----~~~~l~-~L~~L~l~~N~l~~ 215 (720)
.. ++|++|+|++|+|++..+..+ .. .++|++|+|++|++++..+. .+..++ +|++|+|++|+|++
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 43 788888888888877665543 33 25788888888888753333 334444 78888888888876
Q ss_pred ccc-----ccCC--CCcCeEEccCccCccc----Ccccc----cccceeeecCCcCCC
Q 005001 216 SLN-----VFSG--LPLTTLNVANNHFSGW----IPREL----ISIRTFIYDGNSFDN 258 (720)
Q Consensus 216 ~~~-----~~~~--~~L~~l~l~~N~l~g~----ip~~l----~~l~~l~l~~n~~~~ 258 (720)
..+ .+.. .+|+.|+|++|.|++. ++..+ .+|+.|++++|.+..
T Consensus 182 ~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 239 (362)
T 3goz_A 182 KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG 239 (362)
T ss_dssp SCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCC
T ss_pred hhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCc
Confidence 543 1111 3588888888888763 44433 367788888887654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.58 E-value=7.3e-17 Score=170.52 Aligned_cols=139 Identities=19% Similarity=0.237 Sum_probs=63.0
Q ss_pred CCceeEecCCCEEEEEcCCCCCcccccccccCC--CCCCEEEccCCCCCCCCCCCCC-CccceeccccccCcCC-CCccc
Q 005001 74 SWKGVACEGSAVVSIDISGLGLSGTMGYLLSDL--LSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGN-LPYSI 149 (720)
Q Consensus 74 ~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l--~~L~~L~L~~N~l~~~~p~~~~-~~L~~L~L~~N~l~g~-~p~~~ 149 (720)
.|.++.|+...++.|+++++++. +..+..+ ++|+.|++++|.+++..+..+. ++|++|+|++|.+++. +|..+
T Consensus 38 ~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~ 114 (336)
T 2ast_B 38 RWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGIL 114 (336)
T ss_dssp HHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHH
T ss_pred HHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHH
Confidence 35555444434444555544443 2333333 4444455555444443333221 4444455554444433 44444
Q ss_pred cccCCccEEEccccccccccccccCCCCCCCeeecCCC-cccC-CCCccccCCCCCCeeEeccc-cccc
Q 005001 150 ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFN-NFSG-DLPNSFISLSNISSLYLQNN-QVTG 215 (720)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~g-~~p~~~~~l~~L~~L~l~~N-~l~~ 215 (720)
.++++|++|+|++|.+++..+..++.+++|++|+|++| .+++ .++..+..+++|++|+|++| ++++
T Consensus 115 ~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~ 183 (336)
T 2ast_B 115 SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE 183 (336)
T ss_dssp TTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred hhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh
Confidence 44445555555544444444444444444555555444 3443 13333444444444444444 4443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.3e-16 Score=170.12 Aligned_cols=174 Identities=20% Similarity=0.218 Sum_probs=92.3
Q ss_pred CEEEEEcCCC---CCcccccccc-------cCCCCCCEEEccCCCCCC----CCCCCCC--CccceeccccccCcCCCCc
Q 005001 84 AVVSIDISGL---GLSGTMGYLL-------SDLLSLRKFDLSGNSIHD----TIPYQLP--PNLTSLNLASNNFSGNLPY 147 (720)
Q Consensus 84 ~v~~l~l~~~---~l~g~~~~~l-------~~l~~L~~L~L~~N~l~~----~~p~~~~--~~L~~L~L~~N~l~g~~p~ 147 (720)
+++.|+|++| ++.+.+|..+ ..+++|++|+|++|.|++ .+|..+. ++|++|+|++|.|++..+.
T Consensus 61 ~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~ 140 (386)
T 2ca6_A 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA 140 (386)
T ss_dssp TCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHH
T ss_pred CccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHH
Confidence 4556666653 3444444433 456666666666666654 2332222 5666666666666533222
Q ss_pred c----cccc---------CCccEEEccccccc-cccc---cccCCCCCCCeeecCCCccc--C---CCCccccCCCCCCe
Q 005001 148 S----IASM---------VSLSYLNVSRNSLT-QSIG---DIFGNLAGLATLDLSFNNFS--G---DLPNSFISLSNISS 205 (720)
Q Consensus 148 ~----~~~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~--g---~~p~~~~~l~~L~~ 205 (720)
. +..+ ++|++|+|++|+|+ +.++ ..+..+++|+.|+|++|+++ | .+|..+..+++|+.
T Consensus 141 ~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~ 220 (386)
T 2ca6_A 141 KIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKV 220 (386)
T ss_dssp HHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCE
T ss_pred HHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccE
Confidence 2 2223 56666666666665 3333 34555666666666666665 2 23335556666666
Q ss_pred eEecccccc----ccccc-c-CCCCcCeEEccCccCccc----Cccc-----ccccceeeecCCcCC
Q 005001 206 LYLQNNQVT----GSLNV-F-SGLPLTTLNVANNHFSGW----IPRE-----LISIRTFIYDGNSFD 257 (720)
Q Consensus 206 L~l~~N~l~----~~~~~-~-~~~~L~~l~l~~N~l~g~----ip~~-----l~~l~~l~l~~n~~~ 257 (720)
|+|++|+|+ +.++. + ...+|+.|+|++|.|++. +|.. +.+|+.|++.+|.+.
T Consensus 221 L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~ 287 (386)
T 2ca6_A 221 LDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287 (386)
T ss_dssp EECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred EECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCC
Confidence 666666664 22221 1 223466666666666554 3433 345666666666554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.57 E-value=9.3e-15 Score=138.56 Aligned_cols=107 Identities=23% Similarity=0.317 Sum_probs=88.7
Q ss_pred CEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcc
Q 005001 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (720)
Q Consensus 110 ~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 189 (720)
+.+++++|+++ .+|..+.++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l 93 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL 93 (174)
T ss_dssp SEEECCSSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred cEEEeCCCCCC-ccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCcc
Confidence 45667777775 67777778888888888888888888899999999999999999987777788999999999999999
Q ss_pred cCCCCccccCCCCCCeeEeccccccccc
Q 005001 190 SGDLPNSFISLSNISSLYLQNNQVTGSL 217 (720)
Q Consensus 190 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (720)
++..+..|..+++|++|+|++|.|....
T Consensus 94 ~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 94 KSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ceeCHHHhccccCCCEEEeCCCCccccc
Confidence 9655556888999999999999887643
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.56 E-value=6.2e-16 Score=165.23 Aligned_cols=172 Identities=22% Similarity=0.254 Sum_probs=140.6
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCC----CCCC--C-ccceeccccccCcCCCCcccccc-----CC
Q 005001 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP----YQLP--P-NLTSLNLASNNFSGNLPYSIASM-----VS 154 (720)
Q Consensus 87 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p----~~~~--~-~L~~L~L~~N~l~g~~p~~~~~l-----~~ 154 (720)
..+|+.|+++|.+|..+...++|++|||++|.|++..+ ..+. + +|++|+|++|+|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46789999999999999988899999999999996655 2222 4 89999999999998888888876 99
Q ss_pred ccEEEccccccccccccccCC----C-CCCCeeecCCCcccCCCCcccc----C-CCCCCeeEeccccccccc----c-c
Q 005001 155 LSYLNVSRNSLTQSIGDIFGN----L-AGLATLDLSFNNFSGDLPNSFI----S-LSNISSLYLQNNQVTGSL----N-V 219 (720)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~l~~N~l~g~~p~~~~----~-l~~L~~L~l~~N~l~~~~----~-~ 219 (720)
|++|+|++|++++..+..++. + ++|++|+|++|+|++..+..++ . .++|++|+|++|+|++.. + .
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999887775444 4 8999999999999976665544 3 369999999999999632 1 1
Q ss_pred cC-C-CCcCeEEccCccCcccCcccc--------cccceeeecCCcCCC
Q 005001 220 FS-G-LPLTTLNVANNHFSGWIPREL--------ISIRTFIYDGNSFDN 258 (720)
Q Consensus 220 ~~-~-~~L~~l~l~~N~l~g~ip~~l--------~~l~~l~l~~n~~~~ 258 (720)
+. . .+|+.|+|++|+|++..+..+ .+|+.|++++|.+..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~ 210 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGL 210 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence 11 2 369999999999998777533 378999999998763
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1e-15 Score=161.63 Aligned_cols=172 Identities=23% Similarity=0.249 Sum_probs=130.6
Q ss_pred CCEEEEEcCCCCCccc-ccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceeccccc-cCcC-CCCccccccCCccE
Q 005001 83 SAVVSIDISGLGLSGT-MGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASN-NFSG-NLPYSIASMVSLSY 157 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N-~l~g-~~p~~~~~l~~L~~ 157 (720)
.+++.|+|++|.+++. ++..+..+++|++|+|++|.+++..|..+. ++|++|+|++| .+++ .++..+.++++|++
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 4788899999998876 788888999999999999988876665544 78999999998 6775 36777888899999
Q ss_pred EEcccc-ccccc-cccccCCCC-CCCeeecCCC--ccc-CCCCccccCCCCCCeeEecccc-ccccc-ccc-CCCCcCeE
Q 005001 158 LNVSRN-SLTQS-IGDIFGNLA-GLATLDLSFN--NFS-GDLPNSFISLSNISSLYLQNNQ-VTGSL-NVF-SGLPLTTL 228 (720)
Q Consensus 158 L~L~~N-~l~~~-~p~~~~~l~-~L~~L~l~~N--~l~-g~~p~~~~~l~~L~~L~l~~N~-l~~~~-~~~-~~~~L~~l 228 (720)
|+|++| .+++. ++..+..++ +|++|+|++| .++ +.+|..+..+++|++|+|++|. +++.. +.+ ...+|+.|
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L 252 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 252 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEe
Confidence 999999 88865 577788888 8999999888 455 4567777788889999999888 66533 333 23458888
Q ss_pred EccCcc-CcccCc---ccccccceeeecCC
Q 005001 229 NVANNH-FSGWIP---RELISIRTFIYDGN 254 (720)
Q Consensus 229 ~l~~N~-l~g~ip---~~l~~l~~l~l~~n 254 (720)
+|++|. +..... ..+.+|+.|++.+|
T Consensus 253 ~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 253 SLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred eCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 888885 332211 13456778888877
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=6.4e-15 Score=140.11 Aligned_cols=130 Identities=18% Similarity=0.218 Sum_probs=74.5
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCCC--CCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCC
Q 005001 103 LSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA 180 (720)
Q Consensus 103 l~~l~~L~~L~L~~N~l~~~~p~~~--~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 180 (720)
+.++++|++|+|++|+++. +|.-. .++|++|+|++|+|++. ..+.++++|++|+|++|+|++..+..+..+++|+
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred cCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 4455666666666666662 33211 13666666666666643 4566666666666666666654444446666666
Q ss_pred eeecCCCcccCCCCc--cccCCCCCCeeEeccccccccccc----c-CCCCcCeEEccCccCc
Q 005001 181 TLDLSFNNFSGDLPN--SFISLSNISSLYLQNNQVTGSLNV----F-SGLPLTTLNVANNHFS 236 (720)
Q Consensus 181 ~L~l~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~~~~~~----~-~~~~L~~l~l~~N~l~ 236 (720)
+|+|++|+|+ .+|. .+..+++|+.|+|++|.|+...+. + ...+|+.|++++|.+.
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 6666666664 4554 566666666666666666543331 2 2234666666666554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=9.4e-17 Score=156.05 Aligned_cols=130 Identities=25% Similarity=0.290 Sum_probs=91.8
Q ss_pred CEEEEEcCCCCCcccccc------cccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCc
Q 005001 84 AVVSIDISGLGLSGTMGY------LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSL 155 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~------~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L 155 (720)
.++.++++.+++.|.+|. .++.+++|++|+|++|.|++ +| .+. ++|++|+|++|+|+ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 345555666666666665 77888888888888888875 55 443 67888888888877 577777777788
Q ss_pred cEEEccccccccccccccCCCCCCCeeecCCCcccCCCC-ccccCCCCCCeeEecccccccccc
Q 005001 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLN 218 (720)
Q Consensus 156 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~ 218 (720)
++|+|++|+|++ +| .++.+++|++|+|++|++++..+ ..+..+++|++|++++|.+++.++
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 888888888776 34 57777777888888877774222 356777777777777777776543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=1.9e-14 Score=136.85 Aligned_cols=129 Identities=19% Similarity=0.220 Sum_probs=108.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCC-CCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLL-SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
.+++.|+|++|+++.. +. +..+. +|++|+|++|.|++.-...-.++|++|+|++|+|++..+..+..+++|++|+|+
T Consensus 19 ~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 96 (176)
T 1a9n_A 19 VRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96 (176)
T ss_dssp TSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcccccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECC
Confidence 4789999999999954 44 55555 999999999999975222223899999999999996555556999999999999
Q ss_pred cccccccccc--ccCCCCCCCeeecCCCcccCCCCcc----ccCCCCCCeeEeccccccc
Q 005001 162 RNSLTQSIGD--IFGNLAGLATLDLSFNNFSGDLPNS----FISLSNISSLYLQNNQVTG 215 (720)
Q Consensus 162 ~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~----~~~l~~L~~L~l~~N~l~~ 215 (720)
+|+|+ .+|. .+..+++|+.|+|++|.++ .+|.. +..+++|+.|++++|.+..
T Consensus 97 ~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 97 NNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp SCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 99996 4565 8999999999999999998 67774 8899999999999999865
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1e-13 Score=156.27 Aligned_cols=161 Identities=17% Similarity=0.207 Sum_probs=129.5
Q ss_pred CEEEEEcCCCC-------------CcccccccccCCCCCCEEE-ccCCCCCCCCCC---------CC-CCccceeccccc
Q 005001 84 AVVSIDISGLG-------------LSGTMGYLLSDLLSLRKFD-LSGNSIHDTIPY---------QL-PPNLTSLNLASN 139 (720)
Q Consensus 84 ~v~~l~l~~~~-------------l~g~~~~~l~~l~~L~~L~-L~~N~l~~~~p~---------~~-~~~L~~L~L~~N 139 (720)
+++.|++++|. +.+.+|..+++|++|+.|+ ++.|.+. .++. .+ ...|+.|+|++|
T Consensus 373 ~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-~L~~l~l~~n~i~~l~~~~L~~L~Ls~n 451 (567)
T 1dce_A 373 ELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-DLRSKFLLENSVLKMEYADVRVLHLAHK 451 (567)
T ss_dssp HHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-HHHHHHHHHHHHHHHHHTTCSEEECTTS
T ss_pred HHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-hhhhhhhhcccccccCccCceEEEecCC
Confidence 35667776664 6788888999999999998 6666433 1110 00 136999999999
Q ss_pred cCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccc--
Q 005001 140 NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-- 217 (720)
Q Consensus 140 ~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-- 217 (720)
+|++ +|. ++++++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .++.+++|++|+|++|+|++.+
T Consensus 452 ~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p 526 (567)
T 1dce_A 452 DLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAI 526 (567)
T ss_dssp CCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTT
T ss_pred CCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCc
Confidence 9996 776 999999999999999999 789999999999999999999996 77 8999999999999999999974
Q ss_pred cccCC-CCcCeEEccCccCcccCccc------ccccceee
Q 005001 218 NVFSG-LPLTTLNVANNHFSGWIPRE------LISIRTFI 250 (720)
Q Consensus 218 ~~~~~-~~L~~l~l~~N~l~g~ip~~------l~~l~~l~ 250 (720)
..+.. .+|+.|+|++|+|++.+|.. +.+|+.|+
T Consensus 527 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 527 QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp GGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred HHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 44443 45999999999999876632 45666654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=3.6e-16 Score=151.85 Aligned_cols=134 Identities=24% Similarity=0.302 Sum_probs=115.8
Q ss_pred ccCCCCCCEEEccCCCCCCCCCC------CCC--CccceeccccccCcCCCCccccccCCccEEEccccccccccccccC
Q 005001 103 LSDLLSLRKFDLSGNSIHDTIPY------QLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFG 174 (720)
Q Consensus 103 l~~l~~L~~L~L~~N~l~~~~p~------~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 174 (720)
+.....++.++|+.|.++|.+|. .+. ++|++|+|++|++++ +| .+.++++|++|+|++|.|+ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 56677889999999999998886 443 799999999999996 77 9999999999999999999 6788888
Q ss_pred CCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccc--ccC-CCCcCeEEccCccCcccCcc
Q 005001 175 NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN--VFS-GLPLTTLNVANNHFSGWIPR 241 (720)
Q Consensus 175 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~-~~~L~~l~l~~N~l~g~ip~ 241 (720)
.+++|++|+|++|++++ +| .+..+++|++|+|++|+|++..+ .+. ..+|+.|++++|.+++.+|.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 88999999999999996 56 68899999999999999997433 333 35699999999999988765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=9.5e-14 Score=131.08 Aligned_cols=103 Identities=22% Similarity=0.246 Sum_probs=89.3
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccc
Q 005001 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (720)
Q Consensus 87 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~ 164 (720)
.|++++|+|+. +|..+. ++|++|+|++|+|++..|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 45566677765 555553 8899999999999988887665 899999999999997777788999999999999999
Q ss_pred cccccccccCCCCCCCeeecCCCcccCC
Q 005001 165 LTQSIGDIFGNLAGLATLDLSFNNFSGD 192 (720)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 192 (720)
|++..+..|..+++|++|+|++|.++..
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 9988888899999999999999999853
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.44 E-value=3.1e-15 Score=165.23 Aligned_cols=174 Identities=17% Similarity=0.196 Sum_probs=115.0
Q ss_pred CEEEEEcCCCCCccc----ccccccCCCCCCEEEccCCCCCCCCC----CC---CCCccceeccccccCcCC----CCcc
Q 005001 84 AVVSIDISGLGLSGT----MGYLLSDLLSLRKFDLSGNSIHDTIP----YQ---LPPNLTSLNLASNNFSGN----LPYS 148 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~----~~~~l~~l~~L~~L~L~~N~l~~~~p----~~---~~~~L~~L~L~~N~l~g~----~p~~ 148 (720)
+++.|+|++|++++. ++..+..+++|++|+|++|.+++... .. -.++|++|+|++|++++. ++..
T Consensus 200 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 279 (461)
T 1z7x_W 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279 (461)
T ss_dssp CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred CceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHH
Confidence 566666666666653 45566667777777777777653211 11 125777777777777743 5666
Q ss_pred ccccCCccEEEccccccccccccccCC-----CCCCCeeecCCCcccCC----CCccccCCCCCCeeEecccccccccc-
Q 005001 149 IASMVSLSYLNVSRNSLTQSIGDIFGN-----LAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSLN- 218 (720)
Q Consensus 149 ~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~~- 218 (720)
+.++++|++|+|++|.+++..+..+.. .++|+.|+|++|++++. ++..+..+++|++|+|++|+|++...
T Consensus 280 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 359 (461)
T 1z7x_W 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359 (461)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred HhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence 777778888888888777554443332 25788888888887754 45556677888888888888876421
Q ss_pred c----cC--CCCcCeEEccCccCcc----cCcccc---cccceeeecCCcCC
Q 005001 219 V----FS--GLPLTTLNVANNHFSG----WIPREL---ISIRTFIYDGNSFD 257 (720)
Q Consensus 219 ~----~~--~~~L~~l~l~~N~l~g----~ip~~l---~~l~~l~l~~n~~~ 257 (720)
. +. ..+|+.|+|++|.+++ .+|..+ .+|+.|++.+|++.
T Consensus 360 ~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 1 11 3468888888888876 666553 56777888888765
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.42 E-value=6.4e-15 Score=162.67 Aligned_cols=174 Identities=20% Similarity=0.214 Sum_probs=141.4
Q ss_pred CEEEEEcCCCCCcc----cccccccCCCCCCEEEccCCCCCCCCCCCC-------CCccceeccccccCcCC----CCcc
Q 005001 84 AVVSIDISGLGLSG----TMGYLLSDLLSLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSGN----LPYS 148 (720)
Q Consensus 84 ~v~~l~l~~~~l~g----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~-------~~~L~~L~L~~N~l~g~----~p~~ 148 (720)
+++.|+|++|+++. .++..+..+++|++|+|++|.+++..+..+ .++|++|+|++|++++. ++..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 69999999999984 678899999999999999999975433322 24799999999999974 4667
Q ss_pred ccccCCccEEEccccccccccccccC-----CCCCCCeeecCCCcccCC----CCccccCCCCCCeeEeccccccccc--
Q 005001 149 IASMVSLSYLNVSRNSLTQSIGDIFG-----NLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSL-- 217 (720)
Q Consensus 149 ~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~-- 217 (720)
+..+++|++|+|++|.+++..+..+. .+++|+.|+|++|++++. ++..+..+++|++|+|++|+|++..
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 245 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 245 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence 77889999999999999876655554 367999999999999964 5777888999999999999998732
Q ss_pred ---ccc--CCCCcCeEEccCccCccc----Cccc---ccccceeeecCCcCC
Q 005001 218 ---NVF--SGLPLTTLNVANNHFSGW----IPRE---LISIRTFIYDGNSFD 257 (720)
Q Consensus 218 ---~~~--~~~~L~~l~l~~N~l~g~----ip~~---l~~l~~l~l~~n~~~ 257 (720)
+.+ ...+|+.|+|++|.+++. +|.. +.+|+.|++.+|.+.
T Consensus 246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 297 (461)
T 1z7x_W 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence 222 235699999999999864 5654 467889999999874
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=4.5e-13 Score=126.88 Aligned_cols=108 Identities=19% Similarity=0.205 Sum_probs=93.2
Q ss_pred EEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 86 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 46888899985 5666664 8999999999999988887765 89999999999999766667899999999999999
Q ss_pred ccccccccccCCCCCCCeeecCCCcccCCCCccc
Q 005001 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197 (720)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 197 (720)
+|++..+..|..+++|++|+|++|.+. ..+..+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~-c~~~~~ 124 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD-CECRDI 124 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC-TTBGGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc-cccccH
Confidence 999877778999999999999999998 444433
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.42 E-value=5.6e-13 Score=141.52 Aligned_cols=172 Identities=16% Similarity=0.164 Sum_probs=137.9
Q ss_pred CCEEEEEcCCCCCcccccc-cccCCCCCCE-EEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEE
Q 005001 83 SAVVSIDISGLGLSGTMGY-LLSDLLSLRK-FDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~-~l~~l~~L~~-L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 158 (720)
.+++.|+|++|.+.+.++. .|.+|++|.+ +++++|+|+...|..+. ++|++|++++|+|++..+..+....++..|
T Consensus 54 ~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l 133 (350)
T 4ay9_X 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 133 (350)
T ss_dssp TTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEE
T ss_pred CCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhh
Confidence 5799999999999887765 7899999876 67778999966666554 899999999999997777778888899999
Q ss_pred Eccc-cccccccccccCCCC-CCCeeecCCCcccCCCCccccCCCCCCeeEecc-ccccccccc-cCC-CCcCeEEccCc
Q 005001 159 NVSR-NSLTQSIGDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSLYLQN-NQVTGSLNV-FSG-LPLTTLNVANN 233 (720)
Q Consensus 159 ~L~~-N~l~~~~p~~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~~~~~~-~~~-~~L~~l~l~~N 233 (720)
++.+ |++....+..|..+. .|+.|+|++|+|+ .+|.......+|+.|++++ |.++...+. +.. .+|+.|+|++|
T Consensus 134 ~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N 212 (350)
T 4ay9_X 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 212 (350)
T ss_dssp EEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTS
T ss_pred hhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCC
Confidence 9976 677766667777775 6899999999999 5777777778999999986 566654433 333 45999999999
Q ss_pred cCcccCcccccccceeeecCCc
Q 005001 234 HFSGWIPRELISIRTFIYDGNS 255 (720)
Q Consensus 234 ~l~g~ip~~l~~l~~l~l~~n~ 255 (720)
+|+...+..+.+++.|...++.
T Consensus 213 ~l~~lp~~~~~~L~~L~~l~~~ 234 (350)
T 4ay9_X 213 RIHSLPSYGLENLKKLRARSTY 234 (350)
T ss_dssp CCCCCCSSSCTTCCEEECTTCT
T ss_pred CcCccChhhhccchHhhhccCC
Confidence 9995444568899999877664
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-12 Score=138.22 Aligned_cols=110 Identities=19% Similarity=0.230 Sum_probs=77.0
Q ss_pred CCCCceeEecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccC-CCCCCCCCCCCCCccceeccccccCcCCCCcccc
Q 005001 72 GESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSG-NSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150 (720)
Q Consensus 72 ~~~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~ 150 (720)
.|.|.+|.|++. |+|++ +|. |..+++|++|+|++ |+|+ +..|..|.
T Consensus 7 ~C~~~~v~~~~~---------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~----------------------~~~~~~~~ 53 (347)
T 2ifg_A 7 PHGSSGLRCTRD---------GALDS-LHH-LPGAENLTELYIENQQHLQ----------------------HLELRDLR 53 (347)
T ss_dssp CSSSSCEECCSS---------CCCTT-TTT-SCSCSCCSEEECCSCSSCC----------------------EECGGGSC
T ss_pred cccCCEEEcCCC---------CCCCc-cCC-CCCCCCeeEEEccCCCCCC----------------------CcChhHhc
Confidence 457877777532 15554 565 77777777777764 6555 34456677
Q ss_pred ccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccc
Q 005001 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (720)
Q Consensus 151 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (720)
+|++|++|+|++|+|++..|..|.+|++|+.|+|++|+|++..+..|..++ |+.|+|++|.|..
T Consensus 54 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 54 GLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred cccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 788888888888888887777888888888888888888854444455554 8888888888775
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.30 E-value=3.4e-12 Score=135.21 Aligned_cols=103 Identities=18% Similarity=0.189 Sum_probs=92.1
Q ss_pred eeccccc-cCcCCCCccccccCCccEEEccc-cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecc
Q 005001 133 SLNLASN-NFSGNLPYSIASMVSLSYLNVSR-NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210 (720)
Q Consensus 133 ~L~L~~N-~l~g~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 210 (720)
.++++++ +|+ .+|. +..+++|+.|+|++ |+|++..+..|++|++|+.|+|++|+|++..|..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4577777 777 5888 99999999999996 999999999999999999999999999998899999999999999999
Q ss_pred ccccccccc-cCCCCcCeEEccCccCcc
Q 005001 211 NQVTGSLNV-FSGLPLTTLNVANNHFSG 237 (720)
Q Consensus 211 N~l~~~~~~-~~~~~L~~l~l~~N~l~g 237 (720)
|+|++.++. +...+|+.|+|++|.|..
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCccC
Confidence 999987654 444569999999999974
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.5e-13 Score=146.59 Aligned_cols=162 Identities=14% Similarity=0.161 Sum_probs=118.4
Q ss_pred CCEEEEEcCCCCCcccccccccCC-----CCCCEEEccCCCCCCCCCCCCC---CccceeccccccCcCCCCccc-----
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDL-----LSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSI----- 149 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~---~~L~~L~L~~N~l~g~~p~~~----- 149 (720)
..++.|+|++|.|+......|..+ ++|++|+|++|.|+......+. ++|+.|+|++|+|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 468899999999987554444433 7899999999998743333332 689999999999985544444
Q ss_pred cccCCccEEEccccccccc----cccccCCCCCCCeeecCCCcccCC----CCccccCCCCCCeeEeccccccccc----
Q 005001 150 ASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSL---- 217 (720)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~---- 217 (720)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|+|++. ++..+...++|++|+|++|.|+...
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 2467899999999999753 455567788999999999998753 3555677789999999999997632
Q ss_pred c-cc-CCCCcCeEEccCccCcccCccccc
Q 005001 218 N-VF-SGLPLTTLNVANNHFSGWIPRELI 244 (720)
Q Consensus 218 ~-~~-~~~~L~~l~l~~N~l~g~ip~~l~ 244 (720)
. .+ ...+|+.|+|++|.|++.-...+.
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 1 11 234599999999998765444443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=4.5e-11 Score=121.20 Aligned_cols=144 Identities=12% Similarity=0.050 Sum_probs=110.5
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 486 (720)
....|.....++.|+.+.||++... ++.+++|....... .....+.+|+.+++.+ ++..+.++++++...+..|+|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 3456777788898999999999764 68899999864321 1123577888888877 367788999999888899999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC---------------------------------- 532 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---------------------------------- 532 (720)
|||++|.+|.+.+. +......++.+++++|+.||+..
T Consensus 89 ~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 99999999987531 11223467889999999999810
Q ss_pred ----------------------CCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 533 ----------------------LPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 533 ----------------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
.+.++|+|++|.||++++++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0358999999999999876566799999764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.09 E-value=4e-12 Score=135.58 Aligned_cols=153 Identities=21% Similarity=0.175 Sum_probs=115.3
Q ss_pred CCCCCEEEccCCCCCCCCCCCC-------CCccceeccccccCcCCCCccc-cccCCccEEEcccccccccccccc----
Q 005001 106 LLSLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQSIGDIF---- 173 (720)
Q Consensus 106 l~~L~~L~L~~N~l~~~~p~~~-------~~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~---- 173 (720)
++.|+.|+|++|.|+......+ .++|++|+|++|.|+......+ ..+++|+.|+|++|.|+......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4679999999999984322221 2589999999999985433333 357899999999999986655544
Q ss_pred -CCCCCCCeeecCCCcccC----CCCccccCCCCCCeeEeccccccccc-----cc-cCCCCcCeEEccCccCccc----
Q 005001 174 -GNLAGLATLDLSFNNFSG----DLPNSFISLSNISSLYLQNNQVTGSL-----NV-FSGLPLTTLNVANNHFSGW---- 238 (720)
Q Consensus 174 -~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~~~~-----~~-~~~~~L~~l~l~~N~l~g~---- 238 (720)
...++|+.|+|++|+|+. .++..+..+++|++|+|++|+|++.- .. ....+|+.|+|++|.|++.
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 356899999999999974 24445577899999999999998632 11 2234699999999999753
Q ss_pred Ccccc---cccceeeecCCcCCC
Q 005001 239 IPREL---ISIRTFIYDGNSFDN 258 (720)
Q Consensus 239 ip~~l---~~l~~l~l~~n~~~~ 258 (720)
++..+ .+|+.|++++|++..
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHHhCCCCCEEeccCCCCCH
Confidence 33333 679999999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.06 E-value=1.1e-10 Score=117.99 Aligned_cols=135 Identities=19% Similarity=0.171 Sum_probs=97.1
Q ss_pred CCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCC--ccccceEEeecCeEEEEEEe
Q 005001 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 412 y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~ 489 (720)
|....+.+.|..+.||++...+|..+++|...... ...+.+|+.+++.+.+.+ +.+++++....+..++||||
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 33333334566799999987778889999876431 234567777777774434 55688888877889999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC------------------------------------- 532 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~------------------------------------- 532 (720)
++|.+|. .. ..+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SS-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TS-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cC-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998884 21 011 2356777888888888752
Q ss_pred ------------------CCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 533 ------------------LPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 533 ------------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
.+.++|+|++|.||++++++.+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877667799999874
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.97 E-value=8.7e-10 Score=115.69 Aligned_cols=94 Identities=18% Similarity=0.126 Sum_probs=62.5
Q ss_pred cCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCC-eeEeccccccccc-cccCC-CCcCeE
Q 005001 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS-SLYLQNNQVTGSL-NVFSG-LPLTTL 228 (720)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~-~L~l~~N~l~~~~-~~~~~-~~L~~l 228 (720)
+++|+.|+|++|+++...+..|.++++|+.|+|.+| ++...+..|.++++|+ .|++.+ +++... ..|.+ .+|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 677777777777777666667777777888877777 6644555677777777 777777 555433 23333 347777
Q ss_pred EccCccCcccCcccccccc
Q 005001 229 NVANNHFSGWIPRELISIR 247 (720)
Q Consensus 229 ~l~~N~l~g~ip~~l~~l~ 247 (720)
++++|+++..-+..|.++.
T Consensus 303 ~l~~n~i~~I~~~aF~~~~ 321 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGV 321 (329)
T ss_dssp EECSSCCCEECTTTTCTTC
T ss_pred EeCCCccCccchhhhcCCc
Confidence 7777777744444554443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.4e-09 Score=115.70 Aligned_cols=143 Identities=16% Similarity=0.256 Sum_probs=105.5
Q ss_pred ccceeccCCCcEEEEEEEcCCcEEEEEEcc--ccccChHHHHHHHHHHHHhhcCC--CCCccccceEEeec---CeEEEE
Q 005001 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKID--NAALSLQEEDNFLEAVSNMSRLR--HPNIVTLAGYCAEH---GQRLLV 486 (720)
Q Consensus 414 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lV 486 (720)
..+.|+.|.++.||+....+ ..+++|+.. .... ......+.+|+.+++.+. +..+.+++.++.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 35578999999999998764 678888775 3221 122346778888888876 45577888887766 458999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC---------------------------------- 532 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---------------------------------- 532 (720)
|||++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999997775421 234678888999999999999999831
Q ss_pred ---------------------CCCcEEecCCCCCEEeCCCCc--eEEcccCCCcc
Q 005001 533 ---------------------LPSVVHRNFKSANILLDDELN--PHLSDCGLAAL 564 (720)
Q Consensus 533 ---------------------~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 564 (720)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247899999999999997753 68999998864
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.95 E-value=6.4e-11 Score=134.90 Aligned_cols=177 Identities=11% Similarity=0.068 Sum_probs=118.8
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEcc-----------CCCCCCCCCCCC---CCccceeccccccCcCCCCcc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLS-----------GNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYS 148 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~-----------~N~l~~~~p~~~---~~~L~~L~L~~N~l~g~~p~~ 148 (720)
.+++.|+|+++-..+.++..+..+++|++|+|+ .|.+++.....+ .++|++|+|+.|++++..+..
T Consensus 318 ~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~ 397 (592)
T 3ogk_B 318 PNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLES 397 (592)
T ss_dssp TTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHH
T ss_pred cCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHH
Confidence 467888888333333445555678888888888 356653322111 368888888888888777777
Q ss_pred ccc-cCCccEEEcc----ccccccc-----cccccCCCCCCCeeecCCC--cccCCCCcccc-CCCCCCeeEeccccccc
Q 005001 149 IAS-MVSLSYLNVS----RNSLTQS-----IGDIFGNLAGLATLDLSFN--NFSGDLPNSFI-SLSNISSLYLQNNQVTG 215 (720)
Q Consensus 149 ~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~l~~N--~l~g~~p~~~~-~l~~L~~L~l~~N~l~~ 215 (720)
++. +++|+.|+|+ .|.+++. ++..+.++++|+.|+|+++ .+++..+..++ .+++|++|+|++|++++
T Consensus 398 l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~ 477 (592)
T 3ogk_B 398 IGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESD 477 (592)
T ss_dssp HHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSH
T ss_pred HHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCH
Confidence 765 8888888886 6777763 4445667888888888743 36655555554 37788888888888876
Q ss_pred -cccc-c-CCCCcCeEEccCccCcccCcc----cccccceeeecCCcCCCC
Q 005001 216 -SLNV-F-SGLPLTTLNVANNHFSGWIPR----ELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 216 -~~~~-~-~~~~L~~l~l~~N~l~g~ip~----~l~~l~~l~l~~n~~~~~ 259 (720)
.++. . ...+|+.|+|++|.|++.... .+.+|+.|++.+|++...
T Consensus 478 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 478 EGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 2332 2 234588888888888654332 346788888888886543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=6.1e-10 Score=115.48 Aligned_cols=187 Identities=19% Similarity=0.230 Sum_probs=122.3
Q ss_pred cceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCC--ccccceEEeecC---eEEEEEE
Q 005001 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPN--IVTLAGYCAEHG---QRLLVYE 488 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lV~e 488 (720)
.+.++.|....||++. ..+++|..... .....+.+|...++.+ .+.. +.+++......+ ..|+||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 3468999999999874 45888876432 3456788899988776 3333 334444333322 3489999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC------------------------------------ 532 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~------------------------------------ 532 (720)
+++|.+|.+... ..++..++..++.++++.++.||+..
T Consensus 97 ~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 97 KIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp CCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred ccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999988865432 34677788888899999999998621
Q ss_pred -------------------CCCcEEecCCCCCEEeCC--CCceEEcccCCCccCCCCCccccc-------------cccc
Q 005001 533 -------------------LPSVVHRNFKSANILLDD--ELNPHLSDCGLAALTPNTERQVST-------------QMVG 578 (720)
Q Consensus 533 -------------------~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~-------------~~~g 578 (720)
.+.++|+|++|.||++++ +..+.|+||+.+.......+-... .+..
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 135799999999999998 556789999988653221110000 0001
Q ss_pred cccccC-ccccccCCCcccchhhhHHHHHHHHHhCCCCCC
Q 005001 579 AFGYSA-PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (720)
Q Consensus 579 t~~y~a-PE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~ 617 (720)
..+... |+..... ....+.|++|.++|.+.+|..+|.
T Consensus 251 ~Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111122 2222111 223689999999999999988763
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.90 E-value=4.5e-10 Score=127.90 Aligned_cols=166 Identities=13% Similarity=0.102 Sum_probs=88.2
Q ss_pred EEEEEcCCCC-Ccc-cccccccCCCCCCEEEccCCCCCCCCCCC------CCCccceeccccccCc----CCCCcccccc
Q 005001 85 VVSIDISGLG-LSG-TMGYLLSDLLSLRKFDLSGNSIHDTIPYQ------LPPNLTSLNLASNNFS----GNLPYSIASM 152 (720)
Q Consensus 85 v~~l~l~~~~-l~g-~~~~~l~~l~~L~~L~L~~N~l~~~~p~~------~~~~L~~L~L~~N~l~----g~~p~~~~~l 152 (720)
++.|+|+++. ++. .++....++++|++|+|++|.+++.-... -.++|++|+|++|.++ +.++..+.++
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 6777776664 111 12223346677777777777665442111 1256777777777765 2334445566
Q ss_pred CCccEEEccccccccccccccCCCCCCCeeecCCCcc--------------------------cCCCCccccCCCCCCee
Q 005001 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF--------------------------SGDLPNSFISLSNISSL 206 (720)
Q Consensus 153 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l--------------------------~g~~p~~~~~l~~L~~L 206 (720)
++|+.|+|++|.+.+ +|..+..+++|+.|+++++.. .+.+|..+..+++|++|
T Consensus 220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L 298 (592)
T 3ogk_B 220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKL 298 (592)
T ss_dssp TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEE
T ss_pred CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEE
Confidence 777777777776664 445555555555555543211 12445555566666666
Q ss_pred Eecccccccccc--c-cCCCCcCeEEccCccCcc-cCcc---cccccceeeec
Q 005001 207 YLQNNQVTGSLN--V-FSGLPLTTLNVANNHFSG-WIPR---ELISIRTFIYD 252 (720)
Q Consensus 207 ~l~~N~l~~~~~--~-~~~~~L~~l~l~~N~l~g-~ip~---~l~~l~~l~l~ 252 (720)
+|++|.+++... . ....+|+.|+|+ |.+.+ .++. .+.+|+.|++.
T Consensus 299 ~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~ 350 (592)
T 3ogk_B 299 DLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIE 350 (592)
T ss_dssp EETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEE
T ss_pred ecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEee
Confidence 666666554321 1 222346666666 33322 2221 23456666665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.84 E-value=5.1e-09 Score=109.80 Aligned_cols=144 Identities=18% Similarity=0.236 Sum_probs=116.6
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCC-------------CCCCC----------------------
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT-------------IPYQL---------------------- 127 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~-------------~p~~~---------------------- 127 (720)
..++.|+|++ +++..-+.+|.++++|+.|+|++|.++.. +|...
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~ 179 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE 179 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence 4788899998 88877778899999999999999976311 11111
Q ss_pred ---------------------------------------------CCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 128 ---------------------------------------------PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 128 ---------------------------------------------~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.++|+.|+|++|+++..-+..|.+|++|+.|+|.+
T Consensus 180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence 35899999999999965567899999999999999
Q ss_pred cccccccccccCCCCCCC-eeecCCCcccCCCCccccCCCCCCeeEecccccccccc-ccCCC-CcCeEE
Q 005001 163 NSLTQSIGDIFGNLAGLA-TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGL-PLTTLN 229 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~-~L~~l~ 229 (720)
| ++...+.+|.++++|+ .|+|.+ +++...+..|.++++|+.|++++|+++...+ .|... +|+.|+
T Consensus 260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 260 N-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp T-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred c-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 8 8877788999999999 999999 7875667889999999999999999987654 44443 577765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.83 E-value=3.3e-11 Score=121.00 Aligned_cols=116 Identities=17% Similarity=0.153 Sum_probs=53.0
Q ss_pred CCceeEecCC--CEEEEEcCC---CCCccccc-ccccCCCCCCEEEccCCCCCCCCCCCCC---Cccce--eccccccCc
Q 005001 74 SWKGVACEGS--AVVSIDISG---LGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTS--LNLASNNFS 142 (720)
Q Consensus 74 ~w~gv~c~~~--~v~~l~l~~---~~l~g~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~~---~~L~~--L~L~~N~l~ 142 (720)
+|.|+.|+.. +|+.+...+ ..+.|.+. ..+..++. .|...+|..++.++.+-. +.|.. ++++.|+..
T Consensus 79 ~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 79 AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 6999999754 565554443 23333332 22222222 233333333333332211 34444 555555322
Q ss_pred ---CCCCccccccCCccEEEcccccccc--ccccccCCCCCCCeeecCCCcccC
Q 005001 143 ---GNLPYSIASMVSLSYLNVSRNSLTQ--SIGDIFGNLAGLATLDLSFNNFSG 191 (720)
Q Consensus 143 ---g~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~g 191 (720)
+.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++
T Consensus 157 ~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~ 210 (267)
T 3rw6_A 157 CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS 210 (267)
T ss_dssp HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCS
T ss_pred HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCC
Confidence 1111122345555555555555555 333444455555555555555553
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.73 E-value=6.4e-10 Score=126.64 Aligned_cols=128 Identities=15% Similarity=0.143 Sum_probs=82.2
Q ss_pred CCCEEEEEcCCCCCccccccccc-CCCCCCEEEccCC-CCCCC-CCCCC--CCccceeccccccCcCCCCcccc----cc
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLS-DLLSLRKFDLSGN-SIHDT-IPYQL--PPNLTSLNLASNNFSGNLPYSIA----SM 152 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~-~l~~L~~L~L~~N-~l~~~-~p~~~--~~~L~~L~L~~N~l~g~~p~~~~----~l 152 (720)
..+++.|+|+++.+++..+..+. .+++|++|+|++| .+++. ++... .++|++|+|++|.+++..+..+. .+
T Consensus 104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 34688888888888777766665 6788888888887 44421 22111 26788888888887765554443 56
Q ss_pred CCccEEEccccc--cccc-cccccCCCCCCCeeecCCC-cccCCCCccccCCCCCCeeEecc
Q 005001 153 VSLSYLNVSRNS--LTQS-IGDIFGNLAGLATLDLSFN-NFSGDLPNSFISLSNISSLYLQN 210 (720)
Q Consensus 153 ~~L~~L~L~~N~--l~~~-~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~ 210 (720)
++|+.|+|++|. ++.. ++..+..+++|+.|+|++| .+.+ +|..+..+++|+.|+++.
T Consensus 184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~ 244 (594)
T 2p1m_B 184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGG 244 (594)
T ss_dssp CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSB
T ss_pred CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEccccc
Confidence 688888888876 3211 2222344678888888877 3443 555566666666666443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.73 E-value=2.2e-10 Score=130.56 Aligned_cols=102 Identities=15% Similarity=0.080 Sum_probs=55.2
Q ss_pred CCEEEEEcCCCCCccccc-ccccCCCCCCEEEccCCCCCCCCCCCC---CCccceecc---------ccccCcCCCCccc
Q 005001 83 SAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNL---------ASNNFSGNLPYSI 149 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~---~~~L~~L~L---------~~N~l~g~~p~~~ 149 (720)
.+++.|+|++|.+++... ..+.++++|++|+|++| +++.....+ .++|+.|+| +.|.+++.....+
T Consensus 289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l 367 (594)
T 2p1m_B 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV 367 (594)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHH
T ss_pred CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHH
Confidence 578899999998775433 33567788888888877 331111111 245666665 2234443222222
Q ss_pred c-ccCCccEEEccccccccccccccC-CCCCCCeeecC
Q 005001 150 A-SMVSLSYLNVSRNSLTQSIGDIFG-NLAGLATLDLS 185 (720)
Q Consensus 150 ~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~ 185 (720)
. ++++|++|+++.|++++.....+. .+++|+.|+|+
T Consensus 368 ~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~ 405 (594)
T 2p1m_B 368 SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC 405 (594)
T ss_dssp HHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred HHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEee
Confidence 2 355555555555555544444333 35555555555
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.58 E-value=1.3e-08 Score=107.46 Aligned_cols=172 Identities=15% Similarity=0.154 Sum_probs=93.3
Q ss_pred CCEEEEEcCCCCC---------cccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCcccc--c
Q 005001 83 SAVVSIDISGLGL---------SGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA--S 151 (720)
Q Consensus 83 ~~v~~l~l~~~~l---------~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~--~ 151 (720)
.++..|.+.++.. .+.+...+..+++|+.|+|++|.-. .++.--.++|+.|+|..|.++......+. .
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~~~~~~L~~L~L~~~~l~~~~l~~l~~~~ 217 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCSCBCTTCSEEEEECSBCCHHHHHHHHHSB
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eeccccCCCCcEEEEecCCCChHHHHHHHHcc
Confidence 3566666655432 1234455666777777777776311 12221136777777777776543333343 5
Q ss_pred cCCccEEEccc--cccccc-----ccccc--CCCCCCCeeecCCCcccCCCCcccc---CCCCCCeeEeccccccccc--
Q 005001 152 MVSLSYLNVSR--NSLTQS-----IGDIF--GNLAGLATLDLSFNNFSGDLPNSFI---SLSNISSLYLQNNQVTGSL-- 217 (720)
Q Consensus 152 l~~L~~L~L~~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~g~~p~~~~---~l~~L~~L~l~~N~l~~~~-- 217 (720)
+++|+.|+|+. |...+. +...+ ..+++|++|+|++|.+.+..+..+. .+++|++|+|+.|.|++.-
T Consensus 218 lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~ 297 (362)
T 2ra8_A 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGAR 297 (362)
T ss_dssp CTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHH
T ss_pred CCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHH
Confidence 77777777753 222111 11122 2467777777777777643333332 4667777777777776521
Q ss_pred --cc--cCCCCcCeEEccCccCcccCcccccc-c-ceeeecCCc
Q 005001 218 --NV--FSGLPLTTLNVANNHFSGWIPRELIS-I-RTFIYDGNS 255 (720)
Q Consensus 218 --~~--~~~~~L~~l~l~~N~l~g~ip~~l~~-l-~~l~l~~n~ 255 (720)
.. -...+|+.|+|++|.|+...-..|.. + ..+++.+|.
T Consensus 298 ~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 298 LLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp HHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHCCSEEECCSBC
T ss_pred HHHhhcccCCcceEEECCCCcCCHHHHHHHHHHcCCEEEecCCc
Confidence 11 11235777777777776443333332 2 345555554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.54 E-value=3.9e-08 Score=103.83 Aligned_cols=172 Identities=15% Similarity=0.154 Sum_probs=117.0
Q ss_pred CCEEEEEcCCCCCcc-c-------ccccccCCCCCCEEEccCCCCCCC----C-CCCC------CCccceeccccccCcC
Q 005001 83 SAVVSIDISGLGLSG-T-------MGYLLSDLLSLRKFDLSGNSIHDT----I-PYQL------PPNLTSLNLASNNFSG 143 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g-~-------~~~~l~~l~~L~~L~L~~N~l~~~----~-p~~~------~~~L~~L~L~~N~l~g 143 (720)
.+|+.|.+...+..| . +..++..+++|+.|.+..+.+... + ...+ .++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 468888888776653 2 234566789999999977644210 1 1112 279999999988311
Q ss_pred CCCccccccCCccEEEccccccccccccccC--CCCCCCeeecCC--CcccCC-----CCccc--cCCCCCCeeEecccc
Q 005001 144 NLPYSIASMVSLSYLNVSRNSLTQSIGDIFG--NLAGLATLDLSF--NNFSGD-----LPNSF--ISLSNISSLYLQNNQ 212 (720)
Q Consensus 144 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~l~~--N~l~g~-----~p~~~--~~l~~L~~L~l~~N~ 212 (720)
.++. + .+++|+.|+|..|.++......++ .+++|+.|+|+. |...|. +...+ ..+++|++|+|.+|.
T Consensus 186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 2343 4 389999999999998765545554 789999999863 332222 11122 357899999999999
Q ss_pred cccccc-----ccCCCCcCeEEccCccCccc----Ccc---cccccceeeecCCcCC
Q 005001 213 VTGSLN-----VFSGLPLTTLNVANNHFSGW----IPR---ELISIRTFIYDGNSFD 257 (720)
Q Consensus 213 l~~~~~-----~~~~~~L~~l~l~~N~l~g~----ip~---~l~~l~~l~l~~n~~~ 257 (720)
+++... .....+|+.|+|+.|.|.+. ++. .+.+|+.|++.+|.+.
T Consensus 264 i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp THHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 986331 11234599999999999864 333 3578999999988764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.50 E-value=3.8e-09 Score=100.74 Aligned_cols=117 Identities=14% Similarity=0.136 Sum_probs=58.3
Q ss_pred ccccccccCCCCCCEEEccCC-CCCCCCC----CCC--CCccceeccccccCcCC----CCccccccCCccEEEcccccc
Q 005001 97 GTMGYLLSDLLSLRKFDLSGN-SIHDTIP----YQL--PPNLTSLNLASNNFSGN----LPYSIASMVSLSYLNVSRNSL 165 (720)
Q Consensus 97 g~~~~~l~~l~~L~~L~L~~N-~l~~~~p----~~~--~~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l 165 (720)
..+...+...+.|++|+|++| .|+..-- ..+ .++|++|+|++|.|+.. +...+...++|++|+|++|.|
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 344556667777777777777 7662111 111 14555555555555421 223333445566666666655
Q ss_pred ccc----cccccCCCCCCCeeec--CCCcccCCC----CccccCCCCCCeeEeccccc
Q 005001 166 TQS----IGDIFGNLAGLATLDL--SFNNFSGDL----PNSFISLSNISSLYLQNNQV 213 (720)
Q Consensus 166 ~~~----~p~~~~~l~~L~~L~l--~~N~l~g~~----p~~~~~l~~L~~L~l~~N~l 213 (720)
+.. +...+...++|++|+| ++|.|+... ...+...++|++|+|++|.|
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 532 2334444455555555 555554321 12223334555555555544
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.48 E-value=1.8e-08 Score=101.05 Aligned_cols=107 Identities=21% Similarity=0.253 Sum_probs=80.5
Q ss_pred eccccccCcCCCCc-cccccCCccE--EEccccccc---cccccccCCCCCCCeeecCCCcccC--CCCccccCCCCCCe
Q 005001 134 LNLASNNFSGNLPY-SIASMVSLSY--LNVSRNSLT---QSIGDIFGNLAGLATLDLSFNNFSG--DLPNSFISLSNISS 205 (720)
Q Consensus 134 L~L~~N~l~g~~p~-~~~~l~~L~~--L~L~~N~l~---~~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~ 205 (720)
|...+|..++.+.- .+...+.|.. ++++.|+.. +.++-...++++|+.|+|++|+|++ .+|..+..+++|+.
T Consensus 121 l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~ 200 (267)
T 3rw6_A 121 MSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 200 (267)
T ss_dssp HHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCE
T ss_pred HHhccchhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCE
Confidence 44555665655542 3666677776 788888433 3333333578999999999999998 55677789999999
Q ss_pred eEecccccccc--ccccCCCCcCeEEccCccCcccCc
Q 005001 206 LYLQNNQVTGS--LNVFSGLPLTTLNVANNHFSGWIP 240 (720)
Q Consensus 206 L~l~~N~l~~~--~~~~~~~~L~~l~l~~N~l~g~ip 240 (720)
|+|++|+|++. +..+...+|++|+|++|.+++.+|
T Consensus 201 L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 201 LNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp EECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred EECCCCccCCchhhhhcccCCcceEEccCCcCccccC
Confidence 99999999984 344444489999999999998877
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.44 E-value=9.6e-07 Score=94.78 Aligned_cols=125 Identities=15% Similarity=0.186 Sum_probs=82.5
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
.++.++|.+ ++...-..+|.++++|+.++|++|+++ .+|.... .+|+.+.|..| ++..-...|.++++|+.++|.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 467777775 666666678888888999999888887 4443322 67888888744 664555677788888888887
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccc
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (720)
+| ++..-..+|.+ .+|+.+.| .|.++..-...|.++++|+.+++.+|.+.
T Consensus 235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 235 EN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp TT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred CC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 64 44444455555 56666666 34455344555666666777766666654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.43 E-value=1.2e-06 Score=93.96 Aligned_cols=166 Identities=12% Similarity=0.118 Sum_probs=94.3
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCC-CCCC--CccceeccccccCcCCCCccccccCCccEEE
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 159 (720)
..++.|+|++|+++......|. .+.|+.+.|..| ++ .|+ ..+. ++|+.|+|..| ++..-...|.+ .+|+.+.
T Consensus 180 ~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~ 254 (401)
T 4fdw_A 180 YNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVK 254 (401)
T ss_dssp TTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEE
T ss_pred ccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEE
Confidence 3677888888877765555665 477777777644 55 233 2222 56777777654 44233344555 5677777
Q ss_pred ccccccccccccccCCCCCCCeeecCCCccc-----CCCCccccCCCCCCeeEeccccccccc-cccCC-CCcCeEEccC
Q 005001 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFS-----GDLPNSFISLSNISSLYLQNNQVTGSL-NVFSG-LPLTTLNVAN 232 (720)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~-~~L~~l~l~~ 232 (720)
| .|.++......|.++++|+.++|.+|.+. ...+..|.++++|+.+.|.+ .++... ..|.+ .+|+.|+|.+
T Consensus 255 l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~ 332 (401)
T 4fdw_A 255 L-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPA 332 (401)
T ss_dssp E-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECT
T ss_pred e-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECc
Confidence 6 44555555666667777777777666554 23345566667777777763 344322 23333 3466666644
Q ss_pred ccCcccCccccc--ccceeeecCCcC
Q 005001 233 NHFSGWIPRELI--SIRTFIYDGNSF 256 (720)
Q Consensus 233 N~l~g~ip~~l~--~l~~l~l~~n~~ 256 (720)
| ++..-+..|. +|+.+.+.+|..
T Consensus 333 ~-l~~I~~~aF~~~~L~~l~l~~n~~ 357 (401)
T 4fdw_A 333 N-VTQINFSAFNNTGIKEVKVEGTTP 357 (401)
T ss_dssp T-CCEECTTSSSSSCCCEEEECCSSC
T ss_pred c-ccEEcHHhCCCCCCCEEEEcCCCC
Confidence 4 4422222232 556666666643
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.35 E-value=3.3e-08 Score=94.15 Aligned_cols=109 Identities=21% Similarity=0.343 Sum_probs=86.8
Q ss_pred CCCEEEEEcCCC-CCccc----ccccccCCCCCCEEEccCCCCCCCCCCCC----C--CccceeccccccCcCC----CC
Q 005001 82 GSAVVSIDISGL-GLSGT----MGYLLSDLLSLRKFDLSGNSIHDTIPYQL----P--PNLTSLNLASNNFSGN----LP 146 (720)
Q Consensus 82 ~~~v~~l~l~~~-~l~g~----~~~~l~~l~~L~~L~L~~N~l~~~~p~~~----~--~~L~~L~L~~N~l~g~----~p 146 (720)
...++.|+|++| +|... +...+...++|++|+|++|.|+..-...+ . +.|++|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 457999999999 88753 45567788999999999999974322122 1 6899999999999853 46
Q ss_pred ccccccCCccEEEc--cccccccc----cccccCCCCCCCeeecCCCccc
Q 005001 147 YSIASMVSLSYLNV--SRNSLTQS----IGDIFGNLAGLATLDLSFNNFS 190 (720)
Q Consensus 147 ~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 190 (720)
..+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 67788899999999 88999865 3455666789999999999986
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.9e-06 Score=86.67 Aligned_cols=136 Identities=19% Similarity=0.153 Sum_probs=94.7
Q ss_pred cceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCC---CccccceEEe-ecCeEEEEEEec
Q 005001 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP---NIVTLAGYCA-EHGQRLLVYEYV 490 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~ 490 (720)
.+.++.|....||+. |..+++|+... ......+.+|..+++.+.+. .|.+++.+.. ..+..++|||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 446888999999988 56678887532 23456788999999888642 2556666653 455678999999
Q ss_pred CCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 005001 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV--------------------------------------- 531 (720)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------------------------------------- 531 (720)
+|.++.+..- ..++..+...++.++++.|+.||+.
T Consensus 96 ~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 96 QGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred CCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9988876321 2234555555666666666666643
Q ss_pred ------------------CCCCcEEecCCCCCEEeCC---CCc-eEEcccCCCcc
Q 005001 532 ------------------CLPSVVHRNFKSANILLDD---ELN-PHLSDCGLAAL 564 (720)
Q Consensus 532 ------------------~~~~iiH~Dlkp~NIll~~---~~~-~kl~Dfg~a~~ 564 (720)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 455 48999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=4e-06 Score=84.82 Aligned_cols=134 Identities=16% Similarity=0.153 Sum_probs=95.7
Q ss_pred eeccCCCc-EEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEeecCeEEEEEEecCCC
Q 005001 417 LIGEGSLG-RVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 417 ~lG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
.+..|..| .||+.... ++..+++|+-.. .....+.+|...++.+. +--|.++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34556555 68988765 456788887643 23456778888877663 334678888888899999999999998
Q ss_pred CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 005001 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC----------------------------------------- 532 (720)
Q Consensus 494 sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----------------------------------------- 532 (720)
++.+..... ......+..+++..|..||...
T Consensus 106 ~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 106 TAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp EHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred cccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 887765311 1223446667777777777531
Q ss_pred --------------CCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 533 --------------LPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 533 --------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
.+.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999988777899999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.96 E-value=7.3e-05 Score=78.17 Aligned_cols=141 Identities=17% Similarity=0.268 Sum_probs=77.7
Q ss_pred ceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhc-----CCCCCccccc-e--EEeecCeEEEEE
Q 005001 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR-----LRHPNIVTLA-G--YCAEHGQRLLVY 487 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-----l~h~niv~l~-~--~~~~~~~~~lV~ 487 (720)
+.|+.|..+.||+....+| .+++|+.... . ..+..|..+++. +..|.++... | +....+..++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 4566678999999987655 5889988652 1 122223333322 2234444321 1 223467789999
Q ss_pred EecCCCCHH--------------HHhhhccCC---C-------CCCCHHHH-----------------------------
Q 005001 488 EYVGNGNLH--------------DMLHFADDS---S-------KNLTWNAR----------------------------- 514 (720)
Q Consensus 488 e~~~~gsL~--------------~~l~~~~~~---~-------~~~~~~~~----------------------------- 514 (720)
+|++|.++. ..+|..... . ....|...
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 112211110 0 01122210
Q ss_pred --HHHHHHHHHHHHHHHh----------cCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 515 --VRVALGTARALEYLHE----------VCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 515 --~~i~~qi~~~L~~LH~----------~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
..+..++..++++|+. ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666663 013489999999999999888899999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=7.4e-05 Score=78.75 Aligned_cols=82 Identities=7% Similarity=-0.028 Sum_probs=52.3
Q ss_pred cee-ccCCCcEEEEEEEc-------CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCC-C--CCccccceEEeec---
Q 005001 416 FLI-GEGSLGRVYRAEFA-------NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLR-H--PNIVTLAGYCAEH--- 480 (720)
Q Consensus 416 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--- 480 (720)
+.| +.|....+|+.... +++.+++|....... .......+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 467 88999999998764 267788888754320 0000123456666666552 2 3466777776554
Q ss_pred CeEEEEEEecCCCCHHH
Q 005001 481 GQRLLVYEYVGNGNLHD 497 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~ 497 (720)
+..++|||+++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 45789999999876643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.61 E-value=7.7e-05 Score=80.59 Aligned_cols=76 Identities=9% Similarity=0.153 Sum_probs=48.4
Q ss_pred CCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccccccccc--cccccCccccccC---CCcccchhhhHHHHHHH
Q 005001 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVG--AFGYSAPEFALSG---IYTVKSDVYSFGVVMLE 608 (720)
Q Consensus 534 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwSlGv~l~e 608 (720)
+.++|+|+++.|||++.++ ++|+||+.+..-+...+ ... ... ...|++|+..... .-....++......+|+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 4899999999999998876 99999998865322111 000 011 1346666655321 12234566688888888
Q ss_pred HHhC
Q 005001 609 LLTG 612 (720)
Q Consensus 609 lltg 612 (720)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00029 Score=72.38 Aligned_cols=139 Identities=15% Similarity=0.189 Sum_probs=89.8
Q ss_pred cceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC---CCCccccceEEeecCeEEEEEEecC
Q 005001 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIVTLAGYCAEHGQRLLVYEYVG 491 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~ 491 (720)
.+.|+.|....+|+... ++..+++|..... ....+..|+..++.+. ...+.+++.+....+..++||||++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 45789999999999976 4677888877532 2456778887777662 3567888888887888999999999
Q ss_pred CCCHH-----------HHhhhccC-C--C---------------CCCCHHHHH---HHH----------------HHHHH
Q 005001 492 NGNLH-----------DMLHFADD-S--S---------------KNLTWNARV---RVA----------------LGTAR 523 (720)
Q Consensus 492 ~gsL~-----------~~l~~~~~-~--~---------------~~~~~~~~~---~i~----------------~qi~~ 523 (720)
+..+. ..+|.... . + ..-+|.... ++. ..++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87652 12232211 0 0 012344321 111 11111
Q ss_pred H-HHHHHh-cCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 524 A-LEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 524 ~-L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
. ...|.. ...|.++|+|+.+.|++++.++ +.|+|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123321 1246899999999999999887 8899974
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.53 E-value=1.4e-05 Score=74.28 Aligned_cols=85 Identities=6% Similarity=0.111 Sum_probs=54.3
Q ss_pred ccceeccccccCcCCCCccccccCCccEEEccccc-cccccccccCCC----CCCCeeecCCCc-ccCCCCccccCCCCC
Q 005001 130 NLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS-LTQSIGDIFGNL----AGLATLDLSFNN-FSGDLPNSFISLSNI 203 (720)
Q Consensus 130 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~g~~p~~~~~l~~L 203 (720)
+|+.|||+++.++..--..+.+|++|+.|+|+++. ++..--..++.+ ++|++|+|+++. ++...-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555554434456678888888888874 665444445554 368888887763 665444456777888
Q ss_pred CeeEecccc-cc
Q 005001 204 SSLYLQNNQ-VT 214 (720)
Q Consensus 204 ~~L~l~~N~-l~ 214 (720)
++|+|+++. |+
T Consensus 142 ~~L~L~~c~~It 153 (176)
T 3e4g_A 142 KYLFLSDLPGVK 153 (176)
T ss_dssp CEEEEESCTTCC
T ss_pred CEEECCCCCCCC
Confidence 888887764 44
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00029 Score=71.79 Aligned_cols=77 Identities=22% Similarity=0.309 Sum_probs=52.9
Q ss_pred CccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCC---CCccccceEEeecCeEEEEEEe
Q 005001 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH---PNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lV~e~ 489 (720)
...+.+|.|..+.||+.+..+|+.|++|+....... ....|..|+..|+.+.- --+.+++++ +..++||||
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 345679999999999999999999999987543321 23346678877776632 123444443 234789999
Q ss_pred cCCCCH
Q 005001 490 VGNGNL 495 (720)
Q Consensus 490 ~~~gsL 495 (720)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00034 Score=74.87 Aligned_cols=77 Identities=17% Similarity=0.110 Sum_probs=46.9
Q ss_pred cceeccCCCcEEEEEEEc-CCcEEEEEEcccccc--Ch---HHHHHHHHHHHHhhcCCC--CC-ccccceEEeecCeEEE
Q 005001 415 EFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL--SL---QEEDNFLEAVSNMSRLRH--PN-IVTLAGYCAEHGQRLL 485 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~---~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 485 (720)
.+.||.|.++.||++... +++.+++|....... .. .....+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999654 467899997653211 00 112345667777766532 33 3344443 3455689
Q ss_pred EEEecCCC
Q 005001 486 VYEYVGNG 493 (720)
Q Consensus 486 V~e~~~~g 493 (720)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.47 E-value=6.5e-06 Score=77.98 Aligned_cols=88 Identities=18% Similarity=0.146 Sum_probs=40.4
Q ss_pred ccccccCCCCCCEEEccCC-CCCCCCC----CCC--CCccceeccccccCcCC----CCccccccCCccEEEcccccccc
Q 005001 99 MGYLLSDLLSLRKFDLSGN-SIHDTIP----YQL--PPNLTSLNLASNNFSGN----LPYSIASMVSLSYLNVSRNSLTQ 167 (720)
Q Consensus 99 ~~~~l~~l~~L~~L~L~~N-~l~~~~p----~~~--~~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~~ 167 (720)
+...+.+-+.|++|+|++| .|...-- ..+ -..|+.|+|++|+|... +...+..-+.|+.|+|++|.|+.
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3344555666777777764 5542110 001 13555555555555522 22223333455555555555553
Q ss_pred c----cccccCCCCCCCeeecCC
Q 005001 168 S----IGDIFGNLAGLATLDLSF 186 (720)
Q Consensus 168 ~----~p~~~~~l~~L~~L~l~~ 186 (720)
. +-+.+..-+.|+.|+|++
T Consensus 113 ~Ga~ala~aL~~N~tL~~L~L~n 135 (197)
T 1pgv_A 113 ELLARLLRSTLVTQSIVEFKADN 135 (197)
T ss_dssp HHHHHHHHHTTTTCCCSEEECCC
T ss_pred HHHHHHHHHHhhCCceeEEECCC
Confidence 2 122333334455555543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00028 Score=62.31 Aligned_cols=56 Identities=20% Similarity=0.310 Sum_probs=40.1
Q ss_pred EEEccCCCCC-CCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccc
Q 005001 111 KFDLSGNSIH-DTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166 (720)
Q Consensus 111 ~L~L~~N~l~-~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~ 166 (720)
.++.+++.++ ..+|..+.++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4566666665 4667677778888888888888555566777788888888777664
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.21 E-value=6.4e-05 Score=69.76 Aligned_cols=37 Identities=16% Similarity=0.098 Sum_probs=27.5
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCC-CC
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-IH 120 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~-l~ 120 (720)
+++.|||+++.++..--..+..+++|++|+|+++. |+
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~It 99 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIE 99 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccC
Confidence 68888888888776555567778888888888774 55
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.13 E-value=6e-05 Score=71.34 Aligned_cols=110 Identities=19% Similarity=0.257 Sum_probs=79.2
Q ss_pred cCCCEEEEEcCCC-CCcc----cccccccCCCCCCEEEccCCCCCCCCCCCCC------CccceeccccccCcCC----C
Q 005001 81 EGSAVVSIDISGL-GLSG----TMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP------PNLTSLNLASNNFSGN----L 145 (720)
Q Consensus 81 ~~~~v~~l~l~~~-~l~g----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~------~~L~~L~L~~N~l~g~----~ 145 (720)
.+..++.|+|++| +|.. .+...|..-+.|+.|+|++|.|+..--..+. +.|+.|+|+.|.|+.. +
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 3567999999986 7754 3456778889999999999999844333332 6899999999999843 3
Q ss_pred CccccccCCccEEEcccc---ccccc----cccccCCCCCCCeeecCCCccc
Q 005001 146 PYSIASMVSLSYLNVSRN---SLTQS----IGDIFGNLAGLATLDLSFNNFS 190 (720)
Q Consensus 146 p~~~~~l~~L~~L~L~~N---~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 190 (720)
-+.+..-+.|++|+|++| .+... +...+..-+.|+.|+|+.|.+.
T Consensus 119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 345555678999999876 34422 3344555577888888777653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0013 Score=70.28 Aligned_cols=132 Identities=13% Similarity=0.193 Sum_probs=66.5
Q ss_pred cccccCCCCCCEEEccCCCCC-CCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCC
Q 005001 100 GYLLSDLLSLRKFDLSGNSIH-DTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAG 178 (720)
Q Consensus 100 ~~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 178 (720)
..+|.+++.|+.+.+..+..+ |.--+.-.++|+.+.+. +.++..-...|.+|.+|+.++|..| ++..-..+|.++++
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~ 335 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ 335 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred cceeeecccccEEecccccceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence 345666777777776554332 11111112566666664 3444333456667777777777643 55444556777777
Q ss_pred CCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccC
Q 005001 179 LATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHF 235 (720)
Q Consensus 179 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l 235 (720)
|+.+.|..+ ++..-...|.++++|+.+++.+|..... ..+....|+.|.+..|.+
T Consensus 336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~~-~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQWN-AISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp CCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHHH-TCBCCCCC----------
T ss_pred CCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeehh-hhhccCCCCEEEeCCCCE
Confidence 777777543 5533345566777777777766654321 112223455555554443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0018 Score=66.29 Aligned_cols=71 Identities=11% Similarity=0.126 Sum_probs=40.9
Q ss_pred cceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCc-cccceEEeecCeEEEEEEec-CC
Q 005001 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI-VTLAGYCAEHGQRLLVYEYV-GN 492 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~~ 492 (720)
.+.|+.|....+|+. +.+++|+........ ....+|+..++.+....+ .+++++ ..+.-++|+||+ +|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 567999999999998 557888776431110 112345555544422222 344443 333457899999 66
Q ss_pred CCH
Q 005001 493 GNL 495 (720)
Q Consensus 493 gsL 495 (720)
.++
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.014 Score=60.11 Aligned_cols=143 Identities=15% Similarity=0.196 Sum_probs=75.6
Q ss_pred ceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-----CCCCccccc-e--EEeecCeEEEEE
Q 005001 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNIVTLA-G--YCAEHGQRLLVY 487 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lV~ 487 (720)
+.|+.|....+|+....+| .+++|...... . ...+..|+.++..+ .-|.++... | +....+..++++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 4577788899999987666 57788876421 1 12233444444433 223333211 1 122346779999
Q ss_pred EecCCCCHHH--------------HhhhccCC--CC---CC---CHHHHHH------------HHHHHHHHHHHHHhc--
Q 005001 488 EYVGNGNLHD--------------MLHFADDS--SK---NL---TWNARVR------------VALGTARALEYLHEV-- 531 (720)
Q Consensus 488 e~~~~gsL~~--------------~l~~~~~~--~~---~~---~~~~~~~------------i~~qi~~~L~~LH~~-- 531 (720)
+|++|..+.. .+|..... .. .. .|..... +...+...++.++..
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9999865321 12211000 00 01 1221100 001134455566532
Q ss_pred --CCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 532 --CLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 532 --~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
..++++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12378999999999999987666899999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.008 Score=62.08 Aligned_cols=143 Identities=17% Similarity=0.203 Sum_probs=79.2
Q ss_pred ceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCC--CCccccceE-----EeecCeEEEEEE
Q 005001 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH--PNIVTLAGY-----CAEHGQRLLVYE 488 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~-----~~~~~~~~lV~e 488 (720)
..++ |....||+....+|+.+++|........ ...+..|..+++.+.. -.+++++.. ....+..++||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 3566 8889999998777878999998643222 2344456555554421 123444432 223566789999
Q ss_pred ecCCCCHH-----HH---------hhhccCC-----CCCCCHHHH----HHH---------------HHHHHHHHHHHHh
Q 005001 489 YVGNGNLH-----DM---------LHFADDS-----SKNLTWNAR----VRV---------------ALGTARALEYLHE 530 (720)
Q Consensus 489 ~~~~gsL~-----~~---------l~~~~~~-----~~~~~~~~~----~~i---------------~~qi~~~L~~LH~ 530 (720)
+++|..+. .. +|..... ....++... ..+ ...+...++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99875432 11 1111100 111222111 001 1111122333332
Q ss_pred c----CCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 531 V----CLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 531 ~----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
. ..+.++|+|+++.||+++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 123679999999999999 4 899999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0038 Score=64.74 Aligned_cols=32 Identities=31% Similarity=0.314 Sum_probs=27.5
Q ss_pred CCcEEecCCCCCEEeCCC----CceEEcccCCCccC
Q 005001 534 PSVVHRNFKSANILLDDE----LNPHLSDCGLAALT 565 (720)
Q Consensus 534 ~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~a~~~ 565 (720)
+.++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 478999999999999875 68999999988643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0068 Score=57.57 Aligned_cols=102 Identities=14% Similarity=0.076 Sum_probs=66.5
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
-+|.+.|+. .+.++++++++.++.|.+.+|.-+-.... . ..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence 378888874 36899999999999999999877632111 1 1233457899999999988764 1110
Q ss_pred cccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCC
Q 005001 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRK 614 (720)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 614 (720)
.....+.|||... ...+.+.-|||||+++|.-+--..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1122467888764 345678899999999998886333
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0019 Score=56.92 Aligned_cols=56 Identities=23% Similarity=0.262 Sum_probs=36.1
Q ss_pred EEEccccccc-cccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccc
Q 005001 157 YLNVSRNSLT-QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (720)
Q Consensus 157 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (720)
.++.+++.|+ ..+|..+. .+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666666665 34454332 35777788888877544455667777777777777664
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0066 Score=64.61 Aligned_cols=157 Identities=13% Similarity=0.152 Sum_probs=102.7
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCC-CCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIH-DTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.++.+.+.+. +...-...+..+..|+.+.+..+..+ +.........|+.+.+..+.+. ...+..+.+|+.+.+.+
T Consensus 231 ~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~ 306 (394)
T 4fs7_A 231 GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLD 306 (394)
T ss_dssp CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECT
T ss_pred CCceEEECCC-ceecccccccccccceeEEcCCCcceeeccccccccccceeccCceeec---ccccccccccccccccc
Confidence 4666666543 33344557888999999999877543 1111222267777776665432 34677889999999876
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccc-cccCC-CCcCeEEccCccCcccCc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSG-LPLTTLNVANNHFSGWIP 240 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~-~~L~~l~l~~N~l~g~ip 240 (720)
+ ++..-..+|.++++|+.++|.++ ++..-...|.++++|+.+.|..| ++..- ..|.+ .+|+.+++..| ++ .+.
T Consensus 307 ~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~ 381 (394)
T 4fs7_A 307 S-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYR 381 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGG
T ss_pred c-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-Ehh
Confidence 5 66555678888999999999754 66444667888999999999876 55422 34444 56899988755 22 234
Q ss_pred cccccccee
Q 005001 241 RELISIRTF 249 (720)
Q Consensus 241 ~~l~~l~~l 249 (720)
..|.+.+.|
T Consensus 382 ~~F~~c~~L 390 (394)
T 4fs7_A 382 YDFEDTTKF 390 (394)
T ss_dssp GGBCTTCEE
T ss_pred heecCCCCC
Confidence 455555444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.008 Score=63.34 Aligned_cols=142 Identities=15% Similarity=0.160 Sum_probs=80.6
Q ss_pred cceeccCCCcEEEEEEEc--------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEeecCeEEE
Q 005001 415 EFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 485 (720)
.+.|..|-...+|++... +++.|++|+..... .....+.+|..+++.+. +.-..++++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 346777889999999875 25789999874321 12345567888877663 2223556665543 29
Q ss_pred EEEecCCCCHHHH-----------------hhhccCC-CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 005001 486 VYEYVGNGNLHDM-----------------LHFADDS-SKNLT--WNARVRVALGTAR-------------------ALE 526 (720)
Q Consensus 486 V~e~~~~gsL~~~-----------------l~~~~~~-~~~~~--~~~~~~i~~qi~~-------------------~L~ 526 (720)
||||++|.+|..- +|..... ..... +.++.++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998655310 1111111 11222 3444545444321 223
Q ss_pred HHHh----c-CCCCcEEecCCCCCEEeCCC----CceEEcccCCCc
Q 005001 527 YLHE----V-CLPSVVHRNFKSANILLDDE----LNPHLSDCGLAA 563 (720)
Q Consensus 527 ~LH~----~-~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~a~ 563 (720)
.|.+ . ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3322 1 12368999999999999876 789999999874
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.46 E-value=0.013 Score=62.31 Aligned_cols=124 Identities=15% Similarity=0.148 Sum_probs=62.8
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCC-C--CCccceeccccccCcCCC--------------
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ-L--PPNLTSLNLASNNFSGNL-------------- 145 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~--~~~L~~L~L~~N~l~g~~-------------- 145 (720)
..++.++|.+ +++..-..+|.++++|+.++|..| ++ .|+.. + ..+|+.+.+..+ +...-
T Consensus 71 ~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~ 146 (394)
T 4fs7_A 71 RKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITI 146 (394)
T ss_dssp TTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEEC
T ss_pred CCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecceeeeccccccccc
Confidence 3678888864 466555667888888888888654 43 22221 1 145555554433 11111
Q ss_pred --------CccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccc
Q 005001 146 --------PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212 (720)
Q Consensus 146 --------p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 212 (720)
...|.++++|+.+.|.++. .......|.++.+|+.+++..| ++......|.++..|+.+.+.++.
T Consensus 147 ~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~ 219 (394)
T 4fs7_A 147 PEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSL 219 (394)
T ss_dssp CTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTC
T ss_pred CccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCc
Confidence 1234455555555554332 2233344555555555555444 332223344455555555554443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0088 Score=63.19 Aligned_cols=128 Identities=15% Similarity=0.188 Sum_probs=72.2
Q ss_pred cccccCCCCCCEEEccCCCCCCCCC-CCC--CCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCC
Q 005001 100 GYLLSDLLSLRKFDLSGNSIHDTIP-YQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNL 176 (720)
Q Consensus 100 ~~~l~~l~~L~~L~L~~N~l~~~~p-~~~--~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 176 (720)
...+...+.|+.+.+..+ ++ .+. ..+ ...|+.+.+..+ ++..-...+.++.+|+.+.+..+ ++......|.++
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~-~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c 285 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VT-TLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGC 285 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CC-EECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTC
T ss_pred ecccccccccceeeeccc-ee-EEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccc
Confidence 345566677777776544 22 122 111 256777776654 44333456667777777777543 444445566777
Q ss_pred CCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccc-cccCC-CCcCeEEccC
Q 005001 177 AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSG-LPLTTLNVAN 232 (720)
Q Consensus 177 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~-~~L~~l~l~~ 232 (720)
++|+.+.+.+|.++..-...|.++.+|+.+.|.+| ++..- ..|.. .+|+.+.+..
T Consensus 286 ~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 286 SNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp TTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred cccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 77777777777666444456677777777777644 33221 22333 3466665543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.45 E-value=0.005 Score=66.35 Aligned_cols=73 Identities=14% Similarity=0.152 Sum_probs=47.6
Q ss_pred cceeccCCCcEEEEEEEcC--------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCc-cccceEEeecCeEEE
Q 005001 415 EFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI-VTLAGYCAEHGQRLL 485 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~l 485 (720)
.+.|+.|....||++...+ ++.+++|+..... . ...+.+|..+++.+...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4568889999999998753 5788899884321 1 1344567777776633333 556665432 38
Q ss_pred EEEecCCCCH
Q 005001 486 VYEYVGNGNL 495 (720)
Q Consensus 486 V~e~~~~gsL 495 (720)
|+||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986444
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.013 Score=60.99 Aligned_cols=31 Identities=19% Similarity=0.285 Sum_probs=27.5
Q ss_pred CCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 534 PSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 534 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3789999999999999888899999987754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.013 Score=63.36 Aligned_cols=74 Identities=11% Similarity=0.007 Sum_probs=45.6
Q ss_pred cceeccCCCcEEEEEEEcC-CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCc-cccceEEeecCeEEEEEEecCC
Q 005001 415 EFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI-VTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~ 492 (720)
.+.|+.|-...+|++...+ +..+++|+........ ....+|..+++.+...++ .++++.+. + .+|+||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4568889999999998865 5788888875322111 111367777776654444 45666653 2 359999987
Q ss_pred CCH
Q 005001 493 GNL 495 (720)
Q Consensus 493 gsL 495 (720)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.15 E-value=0.0085 Score=63.75 Aligned_cols=122 Identities=15% Similarity=0.200 Sum_probs=81.7
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCC-CC--CccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ-LP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 85 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
++.+.+.++- ...-..+|.+++.|+.+.+. +.++ .|+.. +. .+|+.++|..| ++..-...|.+|.+|+.+.|.
T Consensus 267 L~~i~lp~~~-~~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 267 LASVKMPDSV-VSIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp CCEEECCTTC-CEECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred ccEEeccccc-ceecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 4455554432 23345678899999999996 4555 34433 32 78999999865 664446789999999999997
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccc
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (720)
.+ ++..-..+|.++++|+.+++.+|.... ..+....+|+.+.+..|.+.
T Consensus 343 ~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 343 SS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp TT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred cc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 55 776667899999999999999987652 45777889999998877653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.01 E-value=0.019 Score=60.39 Aligned_cols=73 Identities=8% Similarity=0.008 Sum_probs=40.5
Q ss_pred ceeccCCCcEEEEEEEcC---------CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCC-ccccceEEeecCeEEE
Q 005001 416 FLIGEGSLGRVYRAEFAN---------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN-IVTLAGYCAEHGQRLL 485 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~l 485 (720)
+.|+.|....+|+....+ +..+++|+....... ......|..+++.+...+ +.++++.. . -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---eecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 467788899999998754 267888887543211 111235555555553222 34555443 2 368
Q ss_pred EEEecCCCCH
Q 005001 486 VYEYVGNGNL 495 (720)
Q Consensus 486 V~e~~~~gsL 495 (720)
||||++|.++
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.38 E-value=0.076 Score=55.86 Aligned_cols=131 Identities=14% Similarity=0.153 Sum_probs=79.5
Q ss_pred cccCCCCCCEEEccCCCCC-CCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCC
Q 005001 102 LLSDLLSLRKFDLSGNSIH-DTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA 180 (720)
Q Consensus 102 ~l~~l~~L~~L~L~~N~l~-~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 180 (720)
.+.....+..+.+..+.-. +........+|+.+.+..+ +.......+.++.+|+.+.+..+ ++..-...|.++.+|+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~ 266 (379)
T 4h09_A 189 SYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK 266 (379)
T ss_dssp ECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred cccccccccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence 3444555555554433221 1111222266777777554 33244556778888888888765 5555566777888888
Q ss_pred eeecCCCcccCCCCccccCCCCCCeeEecccccccccc-ccCC-CCcCeEEccCccCc
Q 005001 181 TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSG-LPLTTLNVANNHFS 236 (720)
Q Consensus 181 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~-~~L~~l~l~~N~l~ 236 (720)
.+.+..+ +.......|.++++|+.+.+.+|.++.... .|.. .+|+.+.|..| ++
T Consensus 267 ~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~ 322 (379)
T 4h09_A 267 TLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK 322 (379)
T ss_dssp EEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC
T ss_pred ccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc
Confidence 8888654 543444567788888888888887765332 3333 45888887654 44
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.03 E-value=0.033 Score=37.86 Aligned_cols=30 Identities=20% Similarity=0.360 Sum_probs=17.2
Q ss_pred eehhHHHHHHHHHHHHHHHHHHHhhccccc
Q 005001 304 AIVGIVLGAVFLVALALLALYFCIRKNRRK 333 (720)
Q Consensus 304 ~i~~~~~~~~~~i~~~l~~~~~~~~~~~~~ 333 (720)
.|++.++|+++++++++++.++++|||+.+
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 456666665555555555556666655544
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.94 E-value=0.024 Score=37.35 Aligned_cols=30 Identities=37% Similarity=0.551 Sum_probs=20.5
Q ss_pred CCCceehhHHHHHHHHHHHHHHHHHHHhhc
Q 005001 300 LPAGAIVGIVLGAVFLVALALLALYFCIRK 329 (720)
Q Consensus 300 ~~~~~i~~~~~~~~~~i~~~l~~~~~~~~~ 329 (720)
...+.|+|+++|.++.+++++.+.++++||
T Consensus 8 ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 8 LTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 346688888888887776666555555554
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.84 E-value=0.046 Score=37.08 Aligned_cols=32 Identities=22% Similarity=0.384 Sum_probs=18.6
Q ss_pred ceehhHHHHHHHHHHHHHHHHHHHhhcccccc
Q 005001 303 GAIVGIVLGAVFLVALALLALYFCIRKNRRKV 334 (720)
Q Consensus 303 ~~i~~~~~~~~~~i~~~l~~~~~~~~~~~~~~ 334 (720)
..|++.++|++++++++++..++++|||++++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 35666666666665555555566666655443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.48 E-value=0.38 Score=51.20 Aligned_cols=74 Identities=8% Similarity=-0.038 Sum_probs=45.2
Q ss_pred cceeccCCCcEEEEEEEcC--------CcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEeecCeEEE
Q 005001 415 EFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 485 (720)
.+.+..|-...+|+....+ ++.|++|+....... .....+|..+++.+. +.-..++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 3467778899999998763 578899887543211 111235555555552 22234555433 2 278
Q ss_pred EEEecCCCCH
Q 005001 486 VYEYVGNGNL 495 (720)
Q Consensus 486 V~e~~~~gsL 495 (720)
|+||++|.+|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998664
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=93.07 E-value=0.11 Score=35.22 Aligned_cols=29 Identities=21% Similarity=0.454 Sum_probs=14.8
Q ss_pred ceehhHHHHHHHHHHHHHHHHHHHhhcccc
Q 005001 303 GAIVGIVLGAVFLVALALLALYFCIRKNRR 332 (720)
Q Consensus 303 ~~i~~~~~~~~~~i~~~l~~~~~~~~~~~~ 332 (720)
..+++.++| +++++++.+...+++|||+.
T Consensus 12 ~~Ia~~vVG-vll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 12 TSIISAVVG-ILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHHHHCS
T ss_pred cchHHHHHH-HHHHHHHHHHHHhheehhhh
Confidence 356777777 44444444444444444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.52 E-value=1 Score=47.64 Aligned_cols=28 Identities=25% Similarity=0.398 Sum_probs=24.2
Q ss_pred cEEecCCCCCEEe------CCCCceEEcccCCCc
Q 005001 536 VVHRNFKSANILL------DDELNPHLSDCGLAA 563 (720)
Q Consensus 536 iiH~Dlkp~NIll------~~~~~~kl~Dfg~a~ 563 (720)
++|+|+.+.|||+ +++..++++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456779999999875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.11 E-value=1.9 Score=41.00 Aligned_cols=115 Identities=14% Similarity=0.143 Sum_probs=77.8
Q ss_pred CCCCccccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCcEEecCCCC
Q 005001 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE-YLHEVCLPSVVHRNFKSA 544 (720)
Q Consensus 466 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~-~LH~~~~~~iiH~Dlkp~ 544 (720)
.||++ -..+-.+++...+.++.-+++.=...+ ...+..++++++.+|+.... ++++. +|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence 67887 444556677777777765332222222 45678899999999888777 66655 88899999
Q ss_pred CEEeCCCCceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCC
Q 005001 545 NILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (720)
Q Consensus 545 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~ 617 (720)
|++++.++.++|.-.|+-..+ +|.-+ +..-=+-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999887764333 22211 111113356678888888888774
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.76 E-value=0.18 Score=54.50 Aligned_cols=62 Identities=6% Similarity=0.030 Sum_probs=17.0
Q ss_pred cceeccCCCcEEEEEEEcC-CcEEEE------EEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee
Q 005001 415 EFLIGEGSLGRVYRAEFAN-GKIMAV------KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (720)
.+.|| ||+||+|.+.. ..+||+ |..+......+....+.+|..++...+|||+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 34565 99999998754 357888 7776555555556678889998888999999999887643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.33 E-value=1.4 Score=41.60 Aligned_cols=116 Identities=11% Similarity=0.113 Sum_probs=80.0
Q ss_pred CCCCccccceEEeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCC
Q 005001 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545 (720)
Q Consensus 466 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~N 545 (720)
.||++++. .+-.+.+...+.++.-+ +...+-. -...+...+++++.+|+....++++. +|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 68888876 55566666666666433 2222221 24578899999999999988777666 888999999
Q ss_pred EEeCCCCceEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCC
Q 005001 546 ILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (720)
Q Consensus 546 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~ 617 (720)
++++.++.+++.-.|+...+++ . .++...=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDP------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSC------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCCC------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999987776433322 1 11112223456778888999988885
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 720 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (581), Expect = 5e-70
Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 25/279 (8%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG GS G VY+ ++ +AVK ++ A + Q+ F V + + RH NI+ GY
Sbjct: 15 RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
Q +V ++ +L+ LH + +A TA+ ++YLH S+
Sbjct: 73 S-TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTE-RQVSTQMVGAFGYSAPEFAL---SGI 592
+HR+ KS NI L ++L + D GLA + Q+ G+ + APE
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652
Y+ +SDVY+FG+V+ EL+TG+ P + R + + D+ + A+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM--- 242
Query: 653 YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
++A C++ + + RP +++ ++ L +
Sbjct: 243 ---------KRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 6e-67
Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 25/274 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG G G V+ + N +A+K I E++F+E M +L HP +V L G C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
E LV+E++ +G L D L + + L + YL E C V+
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ + N L+ + +SD G+ + + ST +++PE Y+ KS
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 598 DVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKS 657
DV+SFGV+M E+ + K +R SE + DI ++ P L
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAS------ 228
Query: 658 LSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
+ I+ C + PE RP S +++ L + +
Sbjct: 229 -THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 2e-66
Identities = 66/270 (24%), Positives = 115/270 (42%), Gaps = 25/270 (9%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G V+ + +AVK + + D FL + M +L+H +V L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
++ EY+ NG+L D L S LT N + +A A + ++ E +
Sbjct: 77 V-TQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVK 596
+HR+ ++ANIL+ D L+ ++D GLA L + E ++APE G +T+K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 597 SDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAK 656
SDV+SFG+++ E++T + E + + ++ + P
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPE----------------VIQNLERGYRMVRPDN 234
Query: 657 SLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
++ LC + PE RP + L
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 3e-64
Identities = 72/301 (23%), Positives = 120/301 (39%), Gaps = 33/301 (10%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLAGY 476
IG+G G V+R ++ G+ +AVK + +E F EA + LRH NI+
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 477 CAEHG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ Q LV +Y +G+L D L+ +T +++AL TA L +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 533 L-----PSVVHRNFKSANILLDDELNPHLSDCGLAAL---TPNTERQVSTQMVGAFGYSA 584
+ P++ HR+ KS NIL+ ++D GLA +T VG Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 585 PEFALSGI------YTVKSDVYSFGVVMLELLTGRKPL----DSSRPRSEQSLVRWATPQ 634
PE I ++D+Y+ G+V E+ D P + + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694
+ + K+ N ++L A I+ C R + + L +L Q+
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
Query: 695 V 695
+
Sbjct: 301 I 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 3e-63
Identities = 62/280 (22%), Positives = 122/280 (43%), Gaps = 25/280 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G G VY + +AVK + + ++E FL+ + M ++HPN+V L G
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLG 80
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
C ++ E++ GNL D L + + + ++ + +A + A+EYL + +
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEK---KN 135
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
+HR+ + N L+ + ++D GL+ L ++APE +++
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655
KSDV++FGV++ E+ T D+ + ++++ P
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYELLEKDYRMERPE 239
Query: 656 KSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695
+ +++ C Q P RP +E+ QA + Q +S+
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-63
Identities = 60/272 (22%), Positives = 107/272 (39%), Gaps = 25/272 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V ++ +A+K I + ED F+E M L H +V L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ NG L + L + + A+EYL +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ + N L++D+ +SD GL+ + E S +S PE + ++ KS
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 598 DVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKS 657
D+++FGV+M E+ + K SE A+ + L P +
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRLYRPHLA 226
Query: 658 LSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689
+ I+ C + + RP ++ ++ +
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (530), Expect = 3e-62
Identities = 63/315 (20%), Positives = 124/315 (39%), Gaps = 40/315 (12%)
Query: 400 YTVASLQTATNSFSQEF---------LIGEGSLGRVYRAEFA----NGKIMAVKKIDNAA 446
+T A F++E +IG G G V +A+K + +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG- 65
Query: 447 LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSS 506
+ ++ +FL S M + HPN++ L G + +++ E++ NG+L L +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QND 122
Query: 507 KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
T V + G A ++YL ++ VHR+ + NIL++ L +SD GL+
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 567 NTERQV----STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPR 622
+ + ++APE +T SDV+S+G+VM E+++ +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 623 SEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEV 682
+ + ++ P S ++ C Q + RP ++
Sbjct: 240 QD----------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 683 VQALVRLVQRASVVK 697
V L ++++ + +K
Sbjct: 284 VNTLDKMIRNPNSLK 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 4e-62
Identities = 71/277 (25%), Positives = 115/277 (41%), Gaps = 25/277 (9%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
S E +G+G G V+ + +A+K + + FL+ M +LRH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEK 73
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+V L +V EY+ G+L D L ++ K L V +A A + Y+
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+ VHR+ ++ANIL+ + L ++D GLA L + E ++APE AL
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649
G +T+KSDV+SFG+++ EL T + E + V+
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVERGY 231
Query: 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
P + D++ C + EPE RP + L
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-61
Identities = 60/307 (19%), Positives = 123/307 (40%), Gaps = 37/307 (12%)
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS 463
++ + F + +G G+ G V++ +G +MA K I + + + + + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLH 59
Query: 464 RLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
P IV G G+ + E++ G+L +L + + +V++ +
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIK 115
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
L YL E ++HR+ K +NIL++ L D G++ ++ ++ VG Y
Sbjct: 116 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYM 170
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDS----------------------SRP 621
+PE Y+V+SD++S G+ ++E+ GR P+ RP
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 622 RSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSR----FADIIALCVQPEPEFRP 677
R+ + A+ +++D +N P F D + C+ P R
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 678 PMSEVVQ 684
+ +++
Sbjct: 291 DLKQLMV 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-61
Identities = 66/300 (22%), Positives = 117/300 (39%), Gaps = 41/300 (13%)
Query: 417 LIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPN 469
+G G+ G+V A +AVK + +A L E + + + +S L H N
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMN 88
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH--------------FADDSSKNLTWNARV 515
IV L G C G L++ EY G+L + L +D L +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVST 574
+ A+ + +L + +HR+ + NILL + D GLA + ++ V
Sbjct: 149 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 575 QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ 634
+ APE + +YT +SDV+S+G+ + EL + P +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------- 256
Query: 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694
KM+ + P + + DI+ C +P RP ++VQ + + + ++
Sbjct: 257 ------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-60
Identities = 66/295 (22%), Positives = 123/295 (41%), Gaps = 30/295 (10%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANG-----KIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
+ +++ +IG G G VY+ +A+K + A + ++ +FL M +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQ 65
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
H NI+ L G +++ +++ EY+ NG + F + + V + G A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENG---ALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST--QMVGAFGY 582
++YL + VHR+ + NIL++ L +SD GL+ + + T +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642
+APE +T SDV+SFG+VM E++T + E +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VM 223
Query: 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVVK 697
K ++ P S ++ C Q E RP +++V L +L++ +K
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 7e-60
Identities = 65/274 (23%), Positives = 112/274 (40%), Gaps = 31/274 (11%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G G V ++ G +AVK I N FL S M++LRH N+V L G
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 477 CAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
E L +V EY+ G+L D L L + ++ +L A+EYL +
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NN 123
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
VHR+ + N+L+ ++ +SD GL +T+ ++APE ++
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFST 179
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655
KSDV+SFG+++ E+ + + P + + + K P
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDV------------VPRVEKGYKMDA----PD 223
Query: 656 KSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689
+++ C + RP ++ + L +
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 7e-60
Identities = 67/279 (24%), Positives = 114/279 (40%), Gaps = 31/279 (11%)
Query: 414 QEFLIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
++ +G G+ G V + + K +AVK + N A +D L + M +L +P I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V + G C E +LV E G L+ L ++++ + + + ++YL E
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN--TERQVSTQMVGAFGYSAPEFA 588
+ VHR+ + N+LL + +SD GL+ + T + APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 589 LSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647
++ KSDV+SFGV+M E + G+KP + + M++
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEK 225
Query: 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
PA D++ LC + E RP + V L
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 6e-59
Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 23/273 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG GS GR + ++GKI+ K++D +++ E+ + V+ + L+HPNIV
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 476 YCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE--V 531
+ L V EY G+L ++ + L +RV AL+ H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
+V+HR+ K AN+ LD + N L D GLA + N + + VG Y +PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFVGTPYYMSPEQMNRM 189
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG 651
Y KSD++S G ++ EL P + + +R +
Sbjct: 190 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----------------- 232
Query: 652 MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P + +II + + RP + E+++
Sbjct: 233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 7e-59
Identities = 66/297 (22%), Positives = 110/297 (37%), Gaps = 46/297 (15%)
Query: 417 LIGEGSLGRVYRA------EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPN 469
++G G+ G+V A + +AVK + A S E + + + M++L H N
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHEN 102
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH-------------------FADDSSKNLT 510
IV L G C G L++EY G+L + L ++ LT
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
+ + A A+ +E+L S VHR+ + N+L+ + D GLA +
Sbjct: 163 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 571 QVS-TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR 629
V + APE GIYT+KSDV+S+G+++ E+ + P
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN---- 275
Query: 630 WATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
K++ P + I+ C + RP + L
Sbjct: 276 -----------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 7e-59
Identities = 56/288 (19%), Positives = 107/288 (37%), Gaps = 30/288 (10%)
Query: 405 LQTATNSFS-QEFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVS 460
L ++ + +G G+ G V + + +A+K + + + +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQ 61
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
M +L +P IV L G C + +LV E G G LH L + + + +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQ 117
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP--NTERQVSTQMVG 578
+ ++YL E + VHR+ + N+LL + +SD GL+ ++ +
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638
+ APE ++ +SDV+S+GV M E L+ + E
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------------- 220
Query: 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQAL 686
+ ++ P + +++ C + E RP V Q +
Sbjct: 221 --VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-58
Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 31/284 (10%)
Query: 417 LIGEGSLGRVYRAEFANGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+IG G G VY + AVK ++ + E FL M HPN+++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 473 LAGYCAEH-GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C G L+V Y+ +G+L + F + + N T + L A+ + +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRN---FIRNETHNPTVKDLIGFGLQVAKGM---KFL 146
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE---RQVSTQMVGAFGYSAPEFA 588
VHR+ + N +LD++ ++D GLA + E T + A E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648
+ +T KSDV+SFGV++ EL+T P P + + L L
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLL------- 254
Query: 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
P +++ C P+ E RP SE+V + +
Sbjct: 255 ----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (500), Expect = 5e-58
Identities = 66/316 (20%), Positives = 119/316 (37%), Gaps = 47/316 (14%)
Query: 403 ASLQTATNSFSQEFLIGEGSLGRVYRAE------FANGKIMAVKKIDNAALSLQEEDNFL 456
SL+ N+ IGEG+ GRV++A + ++AVK + A S + +F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQ 64
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH---------------- 500
+ M+ +PNIV L G CA L++EY+ G+L++ L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 501 ----FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556
+ L+ ++ +A A + YL E VHR+ + N L+ + + +
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKI 181
Query: 557 SDCGLA-ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+D GL+ + + + PE YT +SDV+++GVV+ E+ +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 616 LDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEF 675
E + + P +++ LC P
Sbjct: 242 PYYGMAHEEV-IYYVRDGNILAC---------------PENCPLELYNLMRLCWSKLPAD 285
Query: 676 RPPMSEVVQALVRLVQ 691
RP + + L R+ +
Sbjct: 286 RPSFCSIHRILQRMCE 301
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-57
Identities = 57/273 (20%), Positives = 102/273 (37%), Gaps = 30/273 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG GS VY+ +A ++ + L+ E F E + L+HPNIV
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 477 CAEHGQR----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ +LV E + +G L L K + + L++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 533 LPSVVHRNFKSANILLDDELN-PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
P ++HR+ K NI + + D GLA L + + ++G + APE
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPE-MYEE 187
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG 651
Y DVY+FG+ MLE+ T P + ++ ++
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---------------IYRRVTSGVKPA 232
Query: 652 MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+ ++ +II C++ + R + +++
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-56
Identities = 73/323 (22%), Positives = 133/323 (41%), Gaps = 41/323 (12%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANG---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL- 465
N + +IGEG+ G+V +A A+K++ A S + +F + + +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLG 68
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH------------FADDSSKNLTWNA 513
HPNI+ L G C G L EY +GNL D L A+ ++ L+
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573
+ A AR ++YL + +HR+ + NIL+ + ++D GL+ +
Sbjct: 129 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--K 183
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633
T + A E +YT SDV+S+GV++ E+++ +E
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------- 234
Query: 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ-R 692
L + + P D++ C + +P RP ++++ +L R+++ R
Sbjct: 235 -------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 693 ASVVKRRSSDESGFSYRTPDHEA 715
+ V ++ F+Y D A
Sbjct: 288 KTYVNTTLYEK--FTYAGIDCSA 308
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 5e-56
Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 30/273 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+G+ G+VY+A+ + A K ID S +E ++++ + ++ HPNIV L
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
++ E+ G + ++ + + LT + V T AL YLH+ +
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-----G 591
+HR+ K+ NIL + + L+D G++A T Q +G + APE +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNG 651
Y K+DV+S G+ ++E+ P P + +AK P L
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-------------LLKIAKSEPPTLA- 236
Query: 652 MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P++ S F D + C++ + R S+++Q
Sbjct: 237 -QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (482), Expect = 3e-55
Identities = 70/278 (25%), Positives = 112/278 (40%), Gaps = 33/278 (11%)
Query: 412 FSQEFLIGEGSLGRVYRAE-FANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPN 469
FS IG GS G VY A N +++A+KK+ + S ++ + ++ V + +LRHPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+ G LV EY + K L V G + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+++HR+ K+ NILL + L D G A++ VG + APE L
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVIL 184
Query: 590 S---GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646
+ G Y K DV+S G+ +EL + PL ++ + AL +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL----------------FNMNAMSALYHIAQ 228
Query: 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+ F + + C+Q P+ RP +++
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 9e-55
Identities = 66/270 (24%), Positives = 105/270 (38%), Gaps = 30/270 (11%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G G VY A + I+A+K + A L E V S LRHPNI+ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
GY + + L+ EY G ++ L A AL Y H
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS---K 125
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
V+HR+ K N+LL ++D G + P++ R + G Y PE ++
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHD 182
Query: 595 VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP 654
K D++S GV+ E L G+ P +++ + + D V
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF------VTEGA----- 231
Query: 655 AKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
D+I+ ++ P RP + EV++
Sbjct: 232 -------RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 9e-55
Identities = 60/279 (21%), Positives = 103/279 (36%), Gaps = 28/279 (10%)
Query: 417 LIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
IGEG G V++ + + +A+K N S + FL+ M + HP+IV
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVK 72
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G E+ ++ E G L F +L + + A + AL YL
Sbjct: 73 LIGVITEN-PVWIIMELCTLGELRS---FLQVRKYSLDLASLILYAYQLSTALAYLES-- 126
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
VHR+ + N+L+ L D GL+ ++ +++ + APE
Sbjct: 127 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652
+T SDV+ FGV M E+L ++ I + +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------------IGRIENGERLPMPPN 233
Query: 653 YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
P ++ C +P RP +E+ L +++
Sbjct: 234 CP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 6e-54
Identities = 63/279 (22%), Positives = 101/279 (36%), Gaps = 29/279 (10%)
Query: 418 IGEGSLGRVYRAEF----ANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVT 472
+G+GS G V R E+ +AVK + LS E D+F+ V+ M L H N++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G +V E G+L D L + R A+ A + YL
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ--VSTQMVGAFGYSAPEFALS 590
+HR+ + N+LL + D GL P + + F + APE +
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALN 650
++ SD + FGV + E+ T + L+ L K+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPW---------------IGLNGSQILHKIDKEGER 233
Query: 651 GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689
P +++ C +PE RP + L+
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 1e-53
Identities = 70/300 (23%), Positives = 122/300 (40%), Gaps = 42/300 (14%)
Query: 417 LIGEGSLGRVYRAEF--------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RH 467
+GEG+ G+V AE +AVK + + A ++ + + + M + +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKH 78
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHF------------ADDSSKNLTWNARV 515
NI+ L G C + G ++ EY GNL + L + + + L+ V
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575
A AR +EYL +HR+ + N+L+ ++ ++D GLA + + T
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 576 -MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ 634
+ APE IYT +SDV+SFGV++ E+ T P
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------------- 242
Query: 635 LHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694
++ L K++ P+ + ++ C P RP ++V+ L R+V S
Sbjct: 243 ---VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-53
Identities = 68/270 (25%), Positives = 120/270 (44%), Gaps = 29/270 (10%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG+G+ G VY A A G+ +A+++++ +++ + + M ++PNIV
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +V EY+ G+L D++ + V +ALE+LH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---Q 136
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
V+HR+ KS NILL + + L+D G A + + ST MVG + APE Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGP 195
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSE-QSLVRWATPQLHDIDALAKMVDPALNGMYP 654
K D++S G++ +E++ G P + P + TP+L + + L+ +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI---------- 245
Query: 655 AKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
F D + C+ + E R E++Q
Sbjct: 246 ------FRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-53
Identities = 64/281 (22%), Positives = 107/281 (38%), Gaps = 32/281 (11%)
Query: 412 FSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR 466
F +++ +GEG+ G V A + +AVK +D ++ +N + + L
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLN 61
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
H N+V G+ E + L EY G L D + + R +
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVV 117
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAP 585
YLH + HR+ K N+LLD+ N +SD GLA N ++ +M G Y AP
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 586 EFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644
E + DV+S G+V+ +L G P D S Q W + +
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-SCQEYSDWKEKKTY-------- 225
Query: 645 VDPALNGMYPAKSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
+ P K + ++ + P R + ++ +
Sbjct: 226 -------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 59/285 (20%), Positives = 116/285 (40%), Gaps = 28/285 (9%)
Query: 412 FSQEFLIGEGSLGRVYRAEF-ANGKIMAVK---KIDNAALSLQEEDNFLEAVSNMSRLRH 467
F + ++G G+ G VY+ + G+ + + K A S + L+ M+ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
P++ L G C L+ + + G L D + + N+ + + A+ + Y
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPE 586
L + +VHR+ + N+L+ + ++D GLA L E++ + + A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646
L IYT +SDV+S+GV + EL+T P SE ++ +++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILE 227
Query: 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
P I+ C + + RP E++ ++ +
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 6e-53
Identities = 67/298 (22%), Positives = 111/298 (37%), Gaps = 38/298 (12%)
Query: 417 LIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ G+V A+ A + +AVK + A + E + H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 471 VTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------------FADDSSKNLTWNARVRV 517
V L G C + G L ++ E+ GNL L D LT +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-STQM 576
+ A+ +E+L +HR+ + NILL ++ + D GLA V
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLH 636
+ APE +YT++SDV+SFGV++ E+ + P +
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---------------PGVK 241
Query: 637 DIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694
+ + + P + + C EP RP SE+V+ L L+Q +
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 8e-52
Identities = 59/287 (20%), Positives = 118/287 (41%), Gaps = 33/287 (11%)
Query: 418 IGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G+GS G VY +A+K ++ AA S++E FL S M ++V
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 86
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTARAL 525
L G ++ L++ E + G+L L + N + + +++A A +
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSA 584
YL+ VHR+ + N ++ ++ + D G+ + + + + + +
Sbjct: 147 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644
PE G++T SDV+SFGVV+ E+ T + L + L +
Sbjct: 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---------------QGLSNEQVLRFV 248
Query: 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691
++ L P +++ +C Q P+ RP E++ ++ ++
Sbjct: 249 MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-50
Identities = 57/272 (20%), Positives = 105/272 (38%), Gaps = 28/272 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
++GEGS V A E A + A+K ++ + + MSRL HP V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ + Y NG L + + ALEYLH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG---K 127
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAAL-TPNTERQVSTQMVGAFGYSAPEFALSGIY 593
++HR+ K NILL+++++ ++D G A + +P +++ + VG Y +PE
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 594 TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY 653
SD+++ G ++ +L+ G P + ++ K++ L +
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAG----------------NEYLIFQKIIK--LEYDF 229
Query: 654 PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685
P K + D++ + + R E+
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (448), Expect = 5e-50
Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 27/271 (9%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V+R A G A K + +++ + + MS LRHP +V L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHD 90
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ + +++YE++ G L + + D ++ + V + L ++HE
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN--- 144
Query: 536 VVHRNFKSANILLDDELNPH--LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
VH + K NI+ + + L D GL A +Q G ++APE A
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 594 TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY 653
+D++S GV+ LL+G P L ++ K D ++
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDE----------TLRNV----KSCDWNMDDSA 248
Query: 654 PAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+ D I + +P R + + ++
Sbjct: 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (434), Expect = 4e-48
Identities = 49/269 (18%), Positives = 100/269 (37%), Gaps = 23/269 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V+R A G++ K I+ ++ +S M++L HP ++ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHD 93
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ + +L+ E++ G L D + ++ + L+++HE S
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE---HS 147
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
+VH + K NI+ + + + T ++ ++APE
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 207
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655
+D+++ GV+ LL+G P L ++ K D + +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLE----------TLQNV----KRCDWEFDEDAFS 253
Query: 656 KSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
D I +Q EP R + + ++
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 166 bits (422), Expect = 3e-47
Identities = 53/278 (19%), Positives = 104/278 (37%), Gaps = 18/278 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IGEG+ G VY+A+ G+ A+KKI + +S + L+H NIV L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ +LV+E++ + L L + Y H+ V+
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ K N+L++ E ++D GLA R+ + ++V + + S Y+
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 598 DVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWAT-----------PQLHDIDALAKMVD 646
D++S G + E++ G + + +L D + +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
P + D+++ ++ +P R + ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (421), Expect = 3e-47
Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 30/282 (10%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
++G G + V+ A + +AVK + + A F N + L HP IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 475 GYCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+V EYV L D++H + +T + V +AL + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV--STQMVGAFGYSAPEFA 588
++HR+ K ANI++ + D G+A ++ V + ++G Y +PE A
Sbjct: 130 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648
+SDVYS G V+ E+LTG P P S + + A
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----------VAYQHVREDPIPPSA 236
Query: 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPP-MSEVVQALVRL 689
+ A ++ + PE R +E+ LVR+
Sbjct: 237 RHEGLSA----DLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (420), Expect = 1e-46
Identities = 65/272 (23%), Positives = 109/272 (40%), Gaps = 28/272 (10%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G G+ V AE K++A+K I AL +E + ++ + +++HPNIV L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
G L+ + V G L D + T R+ A++YLH++
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDLG--- 127
Query: 536 VVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
+VHR+ K N+L D++ +SD GL+ + V + G GY APE
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGM 652
Y+ D +S GV+ LL G P + A + P + +
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD---------SPYWDDI 236
Query: 653 YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+ D I ++ +PE R + +Q
Sbjct: 237 SDS-----AKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (423), Expect = 2e-46
Identities = 63/274 (22%), Positives = 106/274 (38%), Gaps = 31/274 (11%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEED----NFLEAVSNMSR 464
N FS +IG G G VY GK+ A+K +D + +++ + N +S +S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
P IV ++ + + + + G+LH L + A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 119
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
LE++H VV+R+ K ANILLD+ + +SD GLA + VG GY A
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMA 173
Query: 585 PEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643
PE G+ Y +D +S G ++ +LL G P + + + + R ++
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL----- 228
Query: 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRP 677
P ++ +Q + R
Sbjct: 229 ----------PDSFSPELRSLLEGLLQRDVNRRL 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (415), Expect = 3e-46
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 42/292 (14%)
Query: 412 FSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL-------QEEDNFLEAV 459
F + + ++G G V R K AVK ID + + L+ V
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 460 SNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA 518
+ ++ HPNI+ L + LV++ + G L D L L+ ++
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIM 116
Query: 519 LGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVG 578
+ LH++ +VHR+ K NILLDD++N L+D G + E+ ++ G
Sbjct: 117 RALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCG 171
Query: 579 AFGYSAPEFALSGI------YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWAT 632
Y APE + Y + D++S GV+M LL G P + ++
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231
Query: 633 PQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
Q P + D+++ + +P+ R E +
Sbjct: 232 YQFG---------SPEWDDYSDT-----VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 5e-46
Identities = 53/280 (18%), Positives = 101/280 (36%), Gaps = 18/280 (6%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IGEG+ G VY+A G+++A+KKI + + +S + L HPNIV L
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ LV+E++ M + + + L + H
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
V+HR+ K N+L++ E L+D GLA R + ++V + + Y+
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655
D++S G + E++T R + + ++ P +P
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 656 KSLSRFA-----------DIIALCVQPEPEFRPPMSEVVQ 684
+ F+ +++ + +P R +
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-45
Identities = 60/264 (22%), Positives = 99/264 (37%), Gaps = 29/264 (10%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQE--EDNFLEAVSNMSRLRHPNIVTL 473
++G+GS G+V+ AEF + A+K + + + + E +E HP + +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
V EY+ G+L + S + A L++LH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS--- 121
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
+V+R+ K NILLD + + ++D G+ + + +T G Y APE L Y
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKY 180
Query: 594 TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY 653
D +SFGV++ E+L G+ P +R P Y
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF------------------Y 222
Query: 654 PAKSLSRFADIIALCVQPEPEFRP 677
P D++ EPE R
Sbjct: 223 PRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-45
Identities = 47/271 (17%), Positives = 103/271 (38%), Gaps = 28/271 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G G V+R E ++ K K + + ++ + +S ++ RH NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ ++++E++ ++ + ++ S+ L V AL++LH +
Sbjct: 69 SFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---HN 122
Query: 536 VVHRNFKSANILLDDELNPH--LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
+ H + + NI+ + + + G A + + A Y APE +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVV 180
Query: 594 TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMY 653
+ +D++S G ++ LL+G P + +Q + + + K +
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFKEISIEA---- 234
Query: 654 PAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
D + + E + R SE +Q
Sbjct: 235 --------MDFVDRLLVKERKSRMTASEALQ 257
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (404), Expect = 2e-44
Identities = 59/264 (22%), Positives = 104/264 (39%), Gaps = 31/264 (11%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G GS GRV+ NG+ A+K + + L++ ++ + +S + HP I+ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G + Q ++ +Y+ G L +L S+ A ALEYLH
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS---K 123
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
+++R+ K NILLD + ++D G A P+ + G Y APE + Y
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYN 179
Query: 595 VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYP 654
D +SFG+++ E+L G P S + A + +P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR------------------FP 221
Query: 655 AKSLSRFADIIALCVQPEPEFRPP 678
D+++ + + R
Sbjct: 222 PFFNEDVKDLLSRLITRDLSQRLG 245
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-44
Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 23/283 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEED---NFLEAVSNMSRLRHPNIVT 472
+GEG VY+A +I+A+KKI S ++ L + + L HPNI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L LV++++ D+ D+S LT + L T + LEYLH+
Sbjct: 65 LLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-G 591
++HR+ K N+LLD+ L+D GLA + + + T V Y APE
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR--WATPQLHDIDALAKMVDPAL 649
+Y V D+++ G ++ ELL L + + + TP + + D
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 650 NGMYPAKSLSR--------FADIIALCVQPEPEFRPPMSEVVQ 684
+P L D+I P R ++ ++
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-44
Identities = 59/291 (20%), Positives = 101/291 (34%), Gaps = 41/291 (14%)
Query: 412 FSQEFL---------IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN 461
F QE + +G G V + + G A K I E +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 462 ----MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV 517
+ ++HPN++TL +L+ E V G L D L ++LT
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEF 118
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP----HLSDCGLAALTPNTERQVS 573
+ YLH + + H + K NI+L D P + D GLA
Sbjct: 119 LKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--F 173
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP 633
+ G + APE +++D++S GV+ LL+G P +
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---------- 223
Query: 634 QLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
L ++ V+ Y + + + D I + +P+ R + + +Q
Sbjct: 224 TLANV----SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 8e-44
Identities = 55/283 (19%), Positives = 96/283 (33%), Gaps = 21/283 (7%)
Query: 418 IGEGSLGRVYRAEFA--NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---RHPNIVT 472
IGEG+ G+V++A G+ +A+K++ + + V+ + L HPN+V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLH--DMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
L C + ++ + + + R L++LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
VVHR+ K NIL+ L+D GLA + T +V Y APE L
Sbjct: 135 HR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVLLQ 189
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA--TPQLHDIDALAKMVDPA 648
Y D++S G + E+ + S + + P D + A
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 649 LNGM-------YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+ + D++ C+ P R +
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 1e-43
Identities = 50/287 (17%), Positives = 93/287 (32%), Gaps = 32/287 (11%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG GS G +Y A G+ +A+K + ++ +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+C G +V E +G S+ + + +A +EY+H
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---K 122
Query: 535 SVVHRNFKSANIL---LDDELNPHLSDCGLAALTPNTE------RQVSTQMVGAFGYSAP 585
+ +HR+ K N L ++ D GLA + + + + G Y++
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645
L + + D+ S G V++ G P + +++ + +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------ 236
Query: 646 DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
L YP S FA + C + +P S + Q L R
Sbjct: 237 IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 156 bits (395), Expect = 2e-43
Identities = 40/289 (13%), Positives = 87/289 (30%), Gaps = 34/289 (11%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLA 474
IGEGS G ++ N + +A+K + + L I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ E +LV + +G + D + + A ++ +HE
Sbjct: 68 YFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 535 SVVHRNFKSANILLDDELNPH-----LSDCGLAALTPN------TERQVSTQMVGAFGYS 583
S+V+R+ K N L+ + + + D G+ + + + G Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643
+ L + + D+ + G V + L G P + + + + +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT----------NKQKYERIGE 230
Query: 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692
A F + + P + ++++R
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 58/280 (20%), Positives = 104/280 (37%), Gaps = 20/280 (7%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEG+ G V++A+ +I+A+K++ + L + + L+H NIV L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ LV+E+ V + L+ L +V
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNG-------DLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVK 596
+HR+ K N+L++ L++ GLA R S ++V + + +Y+
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 597 SDVYSFGVVMLELLTGRKPLDSSRPRSEQS---LVRWATPQLHDIDALAKMVDPALNGMY 653
D++S G + EL +PL +Q TP ++ K+ D MY
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 654 PAKSLSR---------FADIIALCVQPEPEFRPPMSEVVQ 684
PA + D++ ++ P R E +Q
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 68/294 (23%), Positives = 108/294 (36%), Gaps = 32/294 (10%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
S++ +IG GS G VY+A+ +G+++A+KK+ E + M +L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRKLDHCN 74
Query: 470 IVTLAGYCAEHGQR------LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
IV L + G++ LV +YV H+ + + L R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFR 133
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPH-LSDCGLAALTPNTERQVSTQMVGAFGY 582
+L Y+H + HR+ K N+LLD + L D G A E VS + + Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYY 188
Query: 583 SAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA--TPQLHDID 639
APE YT DV+S G V+ ELL G+ + + TP I
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 640 ALAKMVDPALNGMYPAKSLSR---------FADIIALCVQPEPEFRPPMSEVVQ 684
+ A ++ + + ++ P R E
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-42
Identities = 54/276 (19%), Positives = 99/276 (35%), Gaps = 31/276 (11%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G G G+V + + A+K + + + +E + A + P+IV +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA------SQCPHIVRIVD 72
Query: 476 YC----AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
A L+V E + G L + D + T + A++YLH +
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 532 CLPSVVHRNFKSANILLDDELNP---HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
++ HR+ K N+L + L+D G A T + + Y APE
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648
Y D++S GV+M LL G P S+ + + +M
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------ISPGMKTRIRMGQYE 235
Query: 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
++ +I ++ EP R ++E +
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-41
Identities = 58/289 (20%), Positives = 110/289 (38%), Gaps = 30/289 (10%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IGEG+ G V A N +A+KKI L + + R RH NI+ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 73
Query: 476 YCA----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
E + + + ++ +L+ +L +++L+ + R L+Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA 128
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAAL--TPNTERQVSTQMVGAFGYSAPEFAL 589
V+HR+ K +N+LL+ + + D GLA + + T+ V Y APE L
Sbjct: 129 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 590 SGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648
+ YT D++S G ++ E+L+ R + + + D + A
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 649 LNGMYPAKSLSR-------------FADIIALCVQPEPEFRPPMSEVVQ 684
N + ++ D++ + P R + + +
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-39
Identities = 52/283 (18%), Positives = 95/283 (33%), Gaps = 22/283 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V A G +A+KK+ S + + +RH N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
++ + L + + + L Y+H +
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII- 143
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI-YT 594
HR+ K N+ ++++ + D GLA + T V Y APE L+ + YT
Sbjct: 144 --HRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYT 197
Query: 595 VKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA--TPQLHDIDALAKMVDPALNGM 652
D++S G +M E++TG+ S + + TP + L
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 653 YPAKSLSRFA-----------DIIALCVQPEPEFRPPMSEVVQ 684
P FA +++ + + E R E +
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 8e-39
Identities = 50/277 (18%), Positives = 89/277 (32%), Gaps = 42/277 (15%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS----LQEEDNFLEAVSNMSRLR--HPN 469
L+G G G VY ++ +A+K ++ +S L V + ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
++ L + +L+ E L A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 127
Query: 530 EVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
V+HR+ K NIL+D + L D G AL +T T G YS PE+
Sbjct: 128 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181
Query: 589 LSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647
Y + V+S G+++ +++ G P + +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV-------------------- 221
Query: 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+ + S +I C+ P RP E+
Sbjct: 222 ----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 60/294 (20%), Positives = 110/294 (37%), Gaps = 34/294 (11%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G+ G V++A G+ +A+KK+ L + + L+H N+V L
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 477 CAEH--------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
C G LV+++ + + + T + RV L Y+
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYI 133
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA---ALTPNTERQVSTQMVGAFGYSAP 585
H ++HR+ K+AN+L+ + L+D GLA +L N++ T V Y P
Sbjct: 134 HRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 586 EFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPR-------------SEQSLVRWA 631
E L Y D++ G +M E+ T + + + + +
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 632 TPQLHDIDALAKMVDPALNGMYPAKSLSRFA-DIIALCVQPEPEFRPPMSEVVQ 684
+L++ L K + A +A D+I + +P R + +
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 1e-36
Identities = 53/263 (20%), Positives = 97/263 (36%), Gaps = 31/263 (11%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G GS GRV + +G A+K +D + L++ ++ L + + P +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
++ +V EYV G + L + A EYLH +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD--- 161
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
+++R+ K N+L+D + ++D G A + G APE LS Y
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEIILSKGYNK 217
Query: 596 KSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPA 655
D ++ GV++ E+ G P + +P + + +P+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------------------FPS 259
Query: 656 KSLSRFADIIALCVQPEPEFRPP 678
S D++ +Q + R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKRFG 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-36
Identities = 60/272 (22%), Positives = 98/272 (36%), Gaps = 28/272 (10%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRH 467
N F L+G+G+ G+V A G+ A+K + ++ E + + + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
P + L H + V EY G L L + T ALEY
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEY 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
LH VV+R+ K N++LD + + ++D GL + + G Y APE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPEV 176
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647
Y D + GVVM E++ GR P + L+ +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------------- 223
Query: 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPM 679
+P ++A ++ +P+ R
Sbjct: 224 -----FPRTLSPEAKSLLAGLLKKDPKQRLGG 250
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 61/274 (22%), Positives = 108/274 (39%), Gaps = 30/274 (10%)
Query: 417 LIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEE--DNFLEAVSNMSRLRH-PN 469
++G G+ G+V+ GK+ A+K + A + + + ++ + +R P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+VTL + L+ +Y+ G L L + T + ALE+LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLH 146
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+ +++R+ K NILLD + L+D GL+ E + + G Y AP+
Sbjct: 147 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 590 SGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647
G + D +S GV+M ELLTG P ++ +I +P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----------SQAEISRRILKSEP 253
Query: 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSE 681
YP + + D+I + +P+ R
Sbjct: 254 P----YPQEMSALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (336), Expect = 5e-35
Identities = 60/294 (20%), Positives = 111/294 (37%), Gaps = 43/294 (14%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLA 474
+G G V+ A N + + VK + ++ + + LR PNI+TLA
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLA 96
Query: 475 GYCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ R LV+E+V N + + + LT +AL+Y H +
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 533 LPSVVHRNFKSANILLDDE-LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS- 590
++HR+ K N+++D E L D GLA + V + + PE +
Sbjct: 150 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDY 204
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA---TPQLHD-IDALAKMVD 646
+Y D++S G ++ ++ ++P +Q + T L+D ID +D
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 647 PALNGMYPAKSLSRFA----------------DIIALCVQPEPEFRPPMSEVVQ 684
P N + S R+ D + ++ + + R E ++
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 48/283 (16%), Positives = 103/283 (36%), Gaps = 22/283 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V A G +AVKK+ S+ + + ++H N++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +L + LT + + R L+Y+H +
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADII- 143
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
HR+ K +N+ ++++ + D GLA +T+ +++ + + + Y
Sbjct: 144 --HRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 596 KSDVYSFGVVMLELLTGRKPLDSS--------------RPRSEQSLVRWATPQLHDIDAL 641
D++S G +M ELLTGR + P +E + + I +L
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258
Query: 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQ 684
+M ++ + D++ + + + R ++ +
Sbjct: 259 TQMPKMNFANVFIGAN-PLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 57/299 (19%), Positives = 105/299 (35%), Gaps = 43/299 (14%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG G+ G V A + +A+KK+ + + M + H NI++L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 476 YCA------EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
E LV E + + D + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ K +NI++ + + D GLA + T V Y APE L
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVIL 191
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP----------------LDSSRPRSEQSLVRWATP 633
Y D++S G +M E++ + L + P + L
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 634 QLHDIDALAKMVDPAL--NGMYPAKSL------SRFADIIALCVQPEPEFRPPMSEVVQ 684
+ + A + P L + ++PA S S+ D+++ + +P R + + +Q
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (284), Expect = 5e-28
Identities = 43/313 (13%), Positives = 102/313 (32%), Gaps = 50/313 (15%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G V+ A+ N +A+K + + + + + + R+ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDS 76
Query: 476 YCAEHGQRLLVYEYVGNGNL------------HDMLHFADDSSKNLTWNARVRVALGTAR 523
A H +LL + N + + + + +++
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAAL-TPNTERQVSTQMVGAFG 581
L+Y+H ++H + K N+L++ + +L +A L + T +
Sbjct: 137 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQS--------------- 626
Y +PE L + +D++S ++ EL+TG + S
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254
Query: 627 ---LVRWATPQLHDIDALAKMVDPALNGMYPAKSLSR------------FADIIALCVQP 671
L+R ++ + + + +P + + +D ++ +Q
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314
Query: 672 EPEFRPPMSEVVQ 684
+P R +V
Sbjct: 315 DPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.6 bits (198), Expect = 4e-18
Identities = 28/200 (14%), Positives = 57/200 (28%), Gaps = 23/200 (11%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQE--------EDNFLEAVSNMSRLRHP 468
L+GEG V+ VK S ++ + +F +R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
+ L G + Y GN M + V +
Sbjct: 67 ALQKLQGLA-------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
+ +VH + N+L+ +E + D + + +++ + +
Sbjct: 120 YHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR---EILERDVRNIITY- 171
Query: 589 LSGIYTVKSDVYSFGVVMLE 608
S Y + D+ S +L+
Sbjct: 172 FSRTYRTEKDINSAIDRILQ 191
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 81.7 bits (200), Expect = 2e-17
Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 10/167 (5%)
Query: 40 DSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSA----VVSIDISGLGL 95
+ D QAL + L +P+ L++W D C +W GV C+ V ++D+SGL L
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 96 SGTMG--YLLSDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150
L++L L + G L L + N SG +P ++
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
+ +L L+ S N+L+ ++ +L L + N SG +P+S+
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 23/75 (30%), Positives = 29/75 (38%), Gaps = 1/75 (1%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
D L NL L+L +N G LP + + L LNVS N+L I GNL
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRF 293
Query: 180 ATLDLSFNNFSGDLP 194
+ N P
Sbjct: 294 DVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 3e-09
Identities = 17/70 (24%), Positives = 29/70 (41%), Gaps = 7/70 (10%)
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
+ L++ N + ++ L L +L++SFNN G++P +L NN
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN---- 301
Query: 216 SLNVFSGLPL 225
G PL
Sbjct: 302 --KCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.4 bits (124), Expect = 8e-08
Identities = 16/59 (27%), Positives = 20/59 (33%), Gaps = 1/59 (1%)
Query: 183 DLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240
DL N G LP L + SL + N + G + L ANN P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 41.7 bits (96), Expect = 2e-04
Identities = 16/92 (17%), Positives = 29/92 (31%), Gaps = 3/92 (3%)
Query: 62 NWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD 121
K + G + +D+ + GT+ L+ L L ++S N++
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 122 TIPY--QLPPNLTSLNLASNNFSGNLPYSIAS 151
IP L A+N P +
Sbjct: 283 EIPQGGNL-QRFDVSAYANNKCLCGSPLPACT 313
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 76.6 bits (187), Expect = 2e-15
Identities = 35/152 (23%), Positives = 62/152 (40%), Gaps = 26/152 (17%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLP---------------- 146
L+ L +L DL+ N I + P LT L L +N S P
Sbjct: 237 LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ 296
Query: 147 ----YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
I+++ +L+YL + N+++ +L L L + N S +S +L+N
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352
Query: 203 ISSLYLQNNQVTGSLNVFSGLP-LTTLNVANN 233
I+ L +NQ++ + L +T L + +
Sbjct: 353 INWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.5 bits (166), Expect = 8e-13
Identities = 36/152 (23%), Positives = 62/152 (40%), Gaps = 7/152 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
L +L + N I D P + NL L+L N ++AS+ +L+ L+++ N +
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPL 225
+ L L L L N S P L+ +++L L NQ+ + + L
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 226 TTLNVANNHFSGWIP-RELISIRTFIYDGNSF 256
T L + N+ S P L ++ + N
Sbjct: 310 TYLTLYFNNISDISPVSSLTKLQRLFFANNKV 341
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.2 bits (129), Expect = 3e-08
Identities = 16/104 (15%), Positives = 35/104 (33%), Gaps = 4/104 (3%)
Query: 60 LTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSI 119
LT E + + + + +S +S L L++ + N +
Sbjct: 284 LTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV 341
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
D N+ L+ N S P +A++ ++ L ++
Sbjct: 342 SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 4e-05
Identities = 19/82 (23%), Positives = 33/82 (40%), Gaps = 8/82 (9%)
Query: 164 SLTQ--SIGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
++TQ I IF LA L N + + + L +++L + S++
Sbjct: 5 TITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG 61
Query: 220 FSGLP-LTTLNVANNHFSGWIP 240
L LT +N +NN + P
Sbjct: 62 VEYLNNLTQINFSNNQLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 4e-05
Identities = 17/86 (19%), Positives = 33/86 (38%), Gaps = 4/86 (4%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
+ L K L ++ DT+ +T+L ++ + + +L+ +N S N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNN 76
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNF 189
LT NL L + ++ N
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQI 100
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 2e-04
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 2/61 (3%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+DL + I + NLT +N ++N + P + ++ L + ++
Sbjct: 40 QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97
Query: 163 N 163
N
Sbjct: 98 N 98
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 64.3 bits (155), Expect = 9e-12
Identities = 39/206 (18%), Positives = 70/206 (33%), Gaps = 23/206 (11%)
Query: 70 PCGESWKGVACEGSAVVSI-----------DISGLGLSGTMGYLLSDLLSLRKFDLSGNS 118
C + V C + + D+ ++ +L +L L N
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 66
Query: 119 IHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNL 176
I P L L L+ N LP + + L V N +T+ +F L
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQ--ELRVHENEITKVRKSVFNGL 123
Query: 177 AGLATLDLSF--NNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP--LTTLNVAN 232
+ ++L SG +F + +S + + + +T + GLP LT L++
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDG 180
Query: 233 NHFSGWIPRELISIRTFIYDGNSFDN 258
N + L + G SF++
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNS 206
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.1 bits (152), Expect = 2e-11
Identities = 37/154 (24%), Positives = 60/154 (38%), Gaps = 10/154 (6%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
L SG + L ++ +I TIP LPP+LT L+L N + S+ +
Sbjct: 136 LKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGL 194
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+L+ L +S NS++ N L L L+ N P I +YL NN
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNN 253
Query: 213 VTG-SLNVFSGLP-------LTTLNVANNHFSGW 238
++ N F + +++ +N W
Sbjct: 254 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 35/200 (17%), Positives = 64/200 (32%), Gaps = 34/200 (17%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN------- 139
++ + +S + L+ L + LS N + +P ++P L L + N
Sbjct: 59 TLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRK 117
Query: 140 -------------------NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA 180
SG + M LSY+ ++ ++T + +L
Sbjct: 118 SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT--- 174
Query: 181 TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG----SLNVFSGLPLTTLNVANNHFS 236
L L N + S L+N++ L L N ++ SL L LN
Sbjct: 175 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV 234
Query: 237 GWIPRELISIRTFIYDGNSF 256
+ I+ N+
Sbjct: 235 PGGLADHKYIQVVYLHNNNI 254
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 19/105 (18%), Positives = 39/105 (37%), Gaps = 3/105 (2%)
Query: 110 RKFDLSGNSIH-DTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ- 167
+ DL+G ++H D L + + + L S + ++++S + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
++ I + L L L S + N+ SN+ L L
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 106
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 14/78 (17%), Positives = 30/78 (38%), Gaps = 4/78 (5%)
Query: 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNF 141
V++ + + S ++ DLS + I + + + L +L+L
Sbjct: 25 VIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83
Query: 142 SGNLPYSIASMVSLSYLN 159
S + ++A +L LN
Sbjct: 84 SDPIVNTLAKNSNLVRLN 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (134), Expect = 5e-09
Identities = 13/95 (13%), Positives = 29/95 (30%), Gaps = 12/95 (12%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPP---NLTSLNLASNNFSG----NLPYSIASMVSLSYLN 159
L ++ D+ + D +L P + L + ++ ++ +L+ LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 160 VSRNSLT----QSIGDIFG-NLAGLATLDLSFNNF 189
+ N L + + L L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.8 bits (132), Expect = 1e-08
Identities = 13/86 (15%), Positives = 26/86 (30%), Gaps = 5/86 (5%)
Query: 130 NLTSLNLASNNFSGN-LPYSIASMVSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDL 184
++ SL++ S + + + + LT + I LA L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 185 SFNNFSGDLPNSFISLSNISSLYLQN 210
N + + S +Q
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQK 88
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 3e-08
Identities = 24/116 (20%), Positives = 40/116 (34%), Gaps = 19/116 (16%)
Query: 115 SGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMV----SLSYLNVSRNSLTQSIG 170
+G Q L L LA + S + S+A+ + SL L++S N L +
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414
Query: 171 DIFG-----NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
L L L +S ++ + +L ++ SL V S
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL-------EKDKP---SLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 1e-07
Identities = 11/93 (11%), Positives = 31/93 (33%), Gaps = 7/93 (7%)
Query: 153 VSLSYLNVSRNSLT-QSIGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLY 207
+ + L++ L+ ++ L + L + + ++ ++ L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 208 LQNNQVT--GSLNVFSGLPLTTLNVANNHFSGW 238
L++N++ G V GL + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 18/86 (20%), Positives = 28/86 (32%), Gaps = 7/86 (8%)
Query: 87 SIDISGLGLSGT-MGYLLSDLLSLRKFDLSGNSIHDTIPYQLP------PNLTSLNLASN 139
S+DI LS LL L + L + + + P L LNL SN
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 140 NFSGNLPYSIASMVSLSYLNVSRNSL 165
+ + + + + SL
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 5e-06
Identities = 13/101 (12%), Positives = 28/101 (27%), Gaps = 21/101 (20%)
Query: 151 SMVSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
L L ++ ++ S+ L LDLS N +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES------ 420
Query: 207 YLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIR 247
++ L L + + ++S + L ++
Sbjct: 421 -VRQPGCL----------LEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 1e-05
Identities = 11/74 (14%), Positives = 23/74 (31%), Gaps = 7/74 (9%)
Query: 179 LATLDLSFNNFS-GDLPNSFISLSNISSLYLQNNQVTGS-----LNVFSGLP-LTTLNVA 231
+ +LD+ S L + L + +T + + P L LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 232 NNHFSGWIPRELIS 245
+N ++
Sbjct: 64 SNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 9e-05
Identities = 21/103 (20%), Positives = 38/103 (36%), Gaps = 11/103 (10%)
Query: 61 TNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGT----MGYLLSDLLSLRKFDLSG 116
+ E E +G+ GS + + ++ +S + + L SLR+ DLS
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406
Query: 117 NSIHDTIPYQL-------PPNLTSLNLASNNFSGNLPYSIASM 152
N + D QL L L L +S + + ++
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.3 bits (122), Expect = 2e-08
Identities = 24/125 (19%), Positives = 43/125 (34%), Gaps = 9/125 (7%)
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
R L+ + + +T L+L+ N P ++A++ L L S N+L
Sbjct: 1 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 170 GDIFGNLAGLATLDLSFNNF-SGDLPNSFISLSNISSLYLQNNQVTGS----LNVFSGLP 224
G L L N +S + L LQ N + + LP
Sbjct: 60 GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 225 -LTTL 228
++++
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 3e-05
Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 7/109 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY-SIASMVSLSYLNVS 161
L LL + DLS N + P L L + + + +A++ L L +
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPP--ALAALRCLEVLQASDNALENVDGVANLPRLQELLLC 73
Query: 162 RNSLTQSIG-DIFGNLAGLATLDLSFNNFSG--DLPNSFIS-LSNISSL 206
N L QS + L L+L N+ + L ++SS+
Sbjct: 74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.003
Identities = 13/86 (15%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 181 TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWI 239
L L+ + + L ++ L L +N++ + L L L ++N
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 240 PRELISIRTFIY-DGNSFDNGPAPPP 264
+ + N A P
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQP 85
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (127), Expect = 2e-08
Identities = 30/218 (13%), Positives = 54/218 (24%), Gaps = 27/218 (12%)
Query: 53 SLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKF 112
S + LT + L L L
Sbjct: 51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110
Query: 113 DLSGNSIHDTIP--YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG 170
L + + P ++ L L L N + + +L++L + N ++
Sbjct: 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170
Query: 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLS------------------------NISSL 206
F L L L L N + P++F L + L
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230
Query: 207 YLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPREL 243
L +N L +++ +P+ L
Sbjct: 231 RLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.1 bits (110), Expect = 4e-06
Identities = 35/207 (16%), Positives = 62/207 (29%), Gaps = 34/207 (16%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN 139
C V+ GL + + + L GN I +P +L +
Sbjct: 8 CYNEPKVTTSCPQQGLQAVPVGIPAASQRI---FLHGNRIS-HVPAASFRACRNLTILWL 63
Query: 140 NFSGNL----------------------------PYSIASMVSLSYLNVSRNSLTQSIGD 171
+ + P + + L L++ R L +
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG 123
Query: 172 IFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGLP-LTTLN 229
+F LA L L L N ++F L N++ L+L N+++ F GL L L
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 230 VANNHFSGWIPRELISIRTFIYDGNSF 256
+ N + P + +
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFA 210
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 2e-04
Identities = 27/134 (20%), Positives = 46/134 (34%), Gaps = 5/134 (3%)
Query: 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188
L +L+L P + +L YL + N+L D F +L L L L N
Sbjct: 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164
Query: 189 FSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGLPLTTLNVANNHFSGWI----PREL 243
S +F L ++ L L N+V + F L + + L
Sbjct: 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224
Query: 244 ISIRTFIYDGNSFD 257
+++ + N +
Sbjct: 225 RALQYLRLNDNPWV 238
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 8e-04
Identities = 12/68 (17%), Positives = 20/68 (29%), Gaps = 4/68 (5%)
Query: 124 PYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLD 183
L L L N + + + L S + + + LAG
Sbjct: 220 ALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVP---CSLPQRLAGRDLKR 275
Query: 184 LSFNNFSG 191
L+ N+ G
Sbjct: 276 LAANDLQG 283
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 1e-07
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 10/94 (10%)
Query: 139 NNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI 198
N S + SL LNVS N L + + L L SFN+ + ++P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPEL-- 322
Query: 199 SLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVAN 232
N+ L+++ N + ++ + L + +
Sbjct: 323 -PQNLKQLHVEYNPLREFPDIPES--VEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 2e-05
Identities = 17/97 (17%), Positives = 34/97 (35%), Gaps = 8/97 (8%)
Query: 63 WKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT 122
+ + + ++ +++S L L + L + S N +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI----ELPALPPRLERLIASFNHL-AE 318
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+P +LP NL L++ N P S+ L +N
Sbjct: 319 VP-ELPQNLKQLHVEYNPLRE-FPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 4e-05
Identities = 20/91 (21%), Positives = 31/91 (34%), Gaps = 12/91 (13%)
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N+ + I + L L++S N +LP + L N L
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNH----LAEV 319
Query: 221 SGLP--LTTLNVANNHFSGW--IPRELISIR 247
LP L L+V N + IP + +R
Sbjct: 320 PELPQNLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 2e-04
Identities = 17/60 (28%), Positives = 29/60 (48%), Gaps = 6/60 (10%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
+ +L+ + ++P +LPP+L SL + N+ + LP SL L V N+L
Sbjct: 39 QAHELELNNLGLS-SLP-ELPPHLESLVASCNSLT-ELPELPQ---SLKSLLVDNNNLKA 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 8e-04
Identities = 14/85 (16%), Positives = 33/85 (38%), Gaps = 8/85 (9%)
Query: 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQV 213
L ++ L+ S+ ++ +L +L S N+ + +LP ++ SL + NN +
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPE---LPQSLKSLLVDNNNL 90
Query: 214 TGSLNVFSGLPLTTLNVANNHFSGW 238
++ L ++
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPE 115
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.003
Identities = 14/82 (17%), Positives = 31/82 (37%), Gaps = 5/82 (6%)
Query: 184 LSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRE 242
N S ++ + ++ L + NN++ + + P L L + NH + +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI---ELPALPPRLERLIASFNHLAE-VPEL 322
Query: 243 LISIRTFIYDGNSFDNGPAPPP 264
+++ + N P P
Sbjct: 323 PQNLKQLHVEYNPLREFPDIPE 344
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.003
Identities = 17/65 (26%), Positives = 25/65 (38%), Gaps = 8/65 (12%)
Query: 127 LPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF 186
L L L + S +LP L L S NSLT + ++ + L +L +
Sbjct: 36 LDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQS---LKSLLVDN 87
Query: 187 NNFSG 191
NN
Sbjct: 88 NNLKA 92
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 33/197 (16%), Positives = 57/197 (28%), Gaps = 3/197 (1%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
S + S + + ++ +P LP + T L+L+ N ++ L+ LN+ R
Sbjct: 7 SKVASHLEVNCDKRNL-TALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL 223
+ + G L L TLDLS N + N + L GL
Sbjct: 66 E--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 224 PLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQ 283
+ +P L++ + + +N P
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 284 GSHSPSGSQSSSSDKEL 300
P G S
Sbjct: 184 LYTIPKGFFGSHLLPFA 200
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 17/73 (23%), Positives = 28/73 (38%), Gaps = 1/73 (1%)
Query: 139 NNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI 198
N P + L L+++ N+LT+ + L L TL L N+ +P F
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
Query: 199 SLSNISSLYLQNN 211
+ +L N
Sbjct: 193 GSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 35/237 (14%), Positives = 62/237 (26%), Gaps = 29/237 (12%)
Query: 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN-- 139
+ +S L L L + +L + P L +L+L+ N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQL 89
Query: 140 ---------------------NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAG 178
+ ++ + L L + N L +
Sbjct: 90 QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149
Query: 179 LATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFS- 236
L L L+ NN + L N+ +L LQ N + F G L + N +
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
Query: 237 ----GWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPS 289
+ R L +Y + A ++ G P+
Sbjct: 210 NCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPT 266
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (113), Expect = 6e-07
Identities = 27/134 (20%), Positives = 45/134 (33%), Gaps = 14/134 (10%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166
S + DL G + Q LN ++ + L ++ L LN+S N L
Sbjct: 22 GSQQALDLKGLRSDPDLVAQ--NIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLY 78
Query: 167 --QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN------ 218
+ I L L+LS N + I + L+L N ++ +
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYI 138
Query: 219 --VFSGLP-LTTLN 229
+ P L L+
Sbjct: 139 SAIRERFPKLLRLD 152
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.4 bits (103), Expect = 1e-05
Identities = 29/176 (16%), Positives = 57/176 (32%), Gaps = 27/176 (15%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVS------------- 154
D +G + IP +P + T L L N + +
Sbjct: 9 EGTTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 155 ------------LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
+ L + N + + +F L L TL+L N S +P SF L++
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 203 ISSLYLQNNQVTGSLNVFSGLPL-TTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
++SL L +N + ++ ++ P ++ ++ + F
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFK 183
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 3e-05
Identities = 16/59 (27%), Positives = 27/59 (45%), Gaps = 2/59 (3%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L++L L N I D P PNL ++L +N S P +A+ +L + ++
Sbjct: 169 LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 8/80 (10%)
Query: 164 SLTQ--SIGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
S+TQ +I IF LA + +N + + + L I++L VT ++
Sbjct: 2 SITQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG 58
Query: 220 FSGLP-LTTLNVANNHFSGW 238
L L L + +N +
Sbjct: 59 VQYLNNLIGLELKDNQITDL 78
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 4/62 (6%)
Query: 149 IASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYL 208
+A++ L+ L N ++ +L L + L N S P + SN+ + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 209 QN 210
N
Sbjct: 225 TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 13/56 (23%), Positives = 25/56 (44%), Gaps = 4/56 (7%)
Query: 130 NLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLS 185
LT+L N S P +AS+ +L +++ N ++ N + L + L+
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 4e-05
Identities = 12/108 (11%), Positives = 29/108 (26%), Gaps = 28/108 (25%)
Query: 112 FDLSGNSIHDTIPYQLP--------PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
L+ + + L +L L N + ++ ++
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV----------- 296
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
I + L L+L+ N F + + + + S +
Sbjct: 297 --------IDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 6e-04
Identities = 10/70 (14%), Positives = 23/70 (32%), Gaps = 6/70 (8%)
Query: 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSN 202
+SI SL ++ +S+ + + + LS N + L + S +
Sbjct: 3 FSIEG-KSLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 203 ISSLYLQNNQ 212
+ +
Sbjct: 61 LEIAEFSDIF 70
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 4e-05
Identities = 13/79 (16%), Positives = 23/79 (29%)
Query: 134 LNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDL 193
L L N + N+L + D+F +G LD+S
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 194 PNSFISLSNISSLYLQNNQ 212
+L + + N +
Sbjct: 218 SYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 9/45 (20%), Positives = 13/45 (28%), Gaps = 1/45 (2%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
S R F + + IP LP N L + +
Sbjct: 9 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGF 52
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 11/46 (23%), Positives = 15/46 (32%), Gaps = 1/46 (2%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLP 146
+ D+S IH ++P NL L S LP
Sbjct: 195 DVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLP 239
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 5e-05
Identities = 24/170 (14%), Positives = 47/170 (27%), Gaps = 42/170 (24%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS-----GNLPYSIASMVSLSY 157
++L S+ + + + I Q PN+T L L N + NL + +
Sbjct: 42 QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENK 101
Query: 158 L----------------------------------NVSRNSLTQSIGDIFGNLAGLATLD 183
+ + +
Sbjct: 102 VKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTL 161
Query: 184 LSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232
+N D+ L+ + +LYL N ++ L +GL L L + +
Sbjct: 162 SLEDNQISDIVP-LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 15/81 (18%), Positives = 31/81 (38%), Gaps = 8/81 (9%)
Query: 163 NSLTQ--SIGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN 218
++T I IF A +L + + + + L++I + N+ + S+
Sbjct: 6 ETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQ 62
Query: 219 VFSGLP-LTTLNVANNHFSGW 238
LP +T L + N +
Sbjct: 63 GIQYLPNVTKLFLNGNKLTDI 83
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 8/80 (10%)
Query: 164 SLTQ--SIGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
++TQ I IF LA L N + + + L +++L + S++
Sbjct: 1 TITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG 57
Query: 220 FSGLP-LTTLNVANNHFSGW 238
L LT +N +NN +
Sbjct: 58 VEYLNNLTQINFSNNQLTDI 77
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.5 bits (83), Expect = 0.004
Identities = 24/129 (18%), Positives = 46/129 (35%), Gaps = 3/129 (2%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY 147
+D+ G + + L + L D S N I + L L +L + +N
Sbjct: 23 LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEG 81
Query: 148 SIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
++ L+ L ++ NSL + D +L L L + N + + + +
Sbjct: 82 LDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQV 141
Query: 207 -YLQNNQVT 214
L +V
Sbjct: 142 RVLDFQKVK 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 720 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.85 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.83 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.79 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.78 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.76 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.7 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.64 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.63 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.63 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.57 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.56 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.55 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.53 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.52 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.43 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.21 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.21 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.18 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.11 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.1 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.09 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.98 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.86 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.71 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.63 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.46 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.29 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.28 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.25 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.11 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.83 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.54 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.3 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.92 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.69 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.86 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.63 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=422.21 Aligned_cols=257 Identities=26% Similarity=0.443 Sum_probs=206.0
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
++|+..+.||+|+||+||+|.+.+++.||||++..... ..++|.+|++++++++||||++++|++..++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 46788899999999999999999899999999976433 346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999863 346789999999999999999999999 99999999999999999999999999998765544
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCC-CCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR-KPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
........||+.|+|||++.+..++.++|||||||++|||+|+. +||...... .+.+.+...
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----------------~~~~~i~~~ 218 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVEDISTG 218 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----------------HHHHHHHHT
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----------------HHHHHHHhc
Confidence 44444567999999999999999999999999999999999954 445432211 111111122
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
.....|..++.++.+++.+||+.||++|||++||+++|+++.+.
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 23344566778899999999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=424.66 Aligned_cols=263 Identities=26% Similarity=0.439 Sum_probs=211.9
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
..++|+..+.||+|+||+||+|+++ ..||||+++.........+.|.+|+.++++++||||+++++++. .+..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence 4578999999999999999999864 35999999876666677889999999999999999999999875 45689999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++. ....+++.++..++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999963 346799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCc-cccccccccccccCcccccc---CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 568 TER-QVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 568 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
... .......||+.|||||++.+ ..|+.++|||||||++|||+||+.||............ ..+
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~------------~~~ 224 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------------VGR 224 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------------HHH
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH------------Hhc
Confidence 322 23345679999999999975 35899999999999999999999999865443221111 111
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
..........+..+++++.+||.+||+.||++|||++||++.|+.+.+
T Consensus 225 ~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 225 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111111112344567889999999999999999999999999998865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-52 Score=425.84 Aligned_cols=266 Identities=23% Similarity=0.392 Sum_probs=225.0
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
++...++|+..+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|++++++++||||+++++++.+.+..
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 3344567888999999999999999876 588999999975432 356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
++||||+++|+|.+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999863 2356899999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
..............||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+.+
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----------------~~~~~ 227 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYE 227 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------------HHHHH
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----------------HHHHH
Confidence 77655544455567899999999999999999999999999999999987776543321 11222
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
.+........+..++.++.+|+.+||+.||++|||++||++.|+.+.++.+
T Consensus 228 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~ 278 (287)
T d1opja_ 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278 (287)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSC
T ss_pred HHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCC
Confidence 233334445566778899999999999999999999999999988866544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=421.98 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=204.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--cCeEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLV 486 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV 486 (720)
++|++.+.||+|+||+||+|.+. +|+.||+|++..........+.+.+|++++++++||||+++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56889999999999999999775 68999999998776666677889999999999999999999999864 4568999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL--PSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~--~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
|||+++|+|.+++.........+++..++.++.|++.||+|||+.+. .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999997655556789999999999999999999999721 1399999999999999999999999999987
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
..... .......||+.|||||++.+..|+.++|||||||++|||+||+.||........ ..++
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~----------------~~~i 226 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL----------------AGKI 226 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------------HHHH
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH----------------HHHH
Confidence 65432 233456899999999999999999999999999999999999999976432211 1111
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..... ...+...++++.+|+.+||+.||++|||+.|++++
T Consensus 227 ~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 227 REGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11111 13345667789999999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=419.84 Aligned_cols=260 Identities=25% Similarity=0.425 Sum_probs=216.9
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
...++|+..+.||+|+||+||+|.+++++.||||+++.... ..+.|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 34567888999999999999999998889999999975432 34679999999999999999999998754 567999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++|+|.+++... ....+++.++.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||+|+...
T Consensus 86 ~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence 9999999999987632 234689999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
...........||+.|+|||++.++.++.++|||||||++|||+||..|+....... .+.+.+.
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~----------------~~~~~i~ 224 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----------------EVIQNLE 224 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHH
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHH
Confidence 554444556679999999999999999999999999999999999766554322211 1111122
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
...+...|..++.++.+|+.+||+.||++|||++||++.|+++..
T Consensus 225 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 223334566677889999999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-51 Score=421.62 Aligned_cols=260 Identities=24% Similarity=0.436 Sum_probs=207.4
Q ss_pred cCCCccceeccCCCcEEEEEEEcC-C---cEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFAN-G---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
++|+..++||+|+||+||+|.+.. + ..||||++.... .....+.|.+|++++++++|||||+++|++...+..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 457778899999999999998752 2 358899886543 44556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.+++.. ..+.+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 105 v~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999998863 346799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccc----cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 566 PNTERQV----STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 566 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
....... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||.......
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~----------------- 241 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD----------------- 241 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----------------
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-----------------
Confidence 5432211 123468999999999999999999999999999999998 899997643221
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
+...+....+...+..++..+.+|+.+||+.||++|||+.||++.|+++++.-
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 242 VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 11112223334456677889999999999999999999999999999988753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=417.17 Aligned_cols=253 Identities=24% Similarity=0.336 Sum_probs=206.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|++.+.||+|+||+||+|.+. +|+.||||++..... ....+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 56889999999999999999875 689999999865432 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++|+|.++++ ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999986 356799999999999999999999999 9999999999999999999999999999876433
Q ss_pred Cc-cccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 569 ER-QVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 569 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.. ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.......... .....
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~---------------~~~~~ 221 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---------------SDWKE 221 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH---------------HHHHT
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH---------------HHHhc
Confidence 22 23345689999999999998876 678999999999999999999997654322111 01111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...........+.++.+|+.+||+.||++|||++|++++
T Consensus 222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111223456778899999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-51 Score=410.95 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=218.3
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
++|+..+.||+|+||+||+|++++++.||||+++.... ..++|++|+.++++++||||++++|++.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 57888999999999999999998888999999976443 346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++|+|.+++.. ....+++..+.+++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999998762 346789999999999999999999999 99999999999999999999999999998766554
Q ss_pred ccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||....... +.+.+...
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-----------------~~~~i~~~ 217 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----------------TAEHIAQG 217 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----------------HHHHHHTT
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-----------------HHHHHHhC
Confidence 444455679999999999999999999999999999999998 899997654221 11111222
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
.+...|..++.++.+||.+||+.||++|||++||+++|.+
T Consensus 218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 3344566777889999999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=415.41 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=211.6
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|+..+.||+|+||+||+|.+ .+|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 35799999999999999999976 46999999998754322 3567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 Ey~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp ECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999999886 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc-c
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV-D 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 646 (720)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... .
T Consensus 169 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----------------~~~~~~ 231 (293)
T d1yhwa1 169 EQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----------------YLIATN 231 (293)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----------------HHHHHH
T ss_pred cc-ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH----------------HHHHhC
Confidence 32 2334568999999999999999999999999999999999999999764322111 1111 1
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.......+...+.++.+||.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223445667889999999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-51 Score=412.36 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=211.2
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|++.+.||+|+||+||+|.+. +++.||+|++...... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999875 6889999998654322 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. .+.+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999973 46799999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||........ ..++...
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----------------~~~i~~~ 219 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET----------------YKRISRV 219 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHTT
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH----------------HHHHHcC
Confidence 32 2346799999999999999999999999999999999999999976432211 1111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ..+|...++++.+|+.+||+.||++|||++|++++
T Consensus 220 ~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 220 E--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred C--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1 23455667889999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=409.34 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=206.6
Q ss_pred ceeccCCCcEEEEEEEcC---CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEecCC
Q 005001 416 FLIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (720)
Q Consensus 416 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 492 (720)
+.||+|+||+||+|.+.+ ++.||||+++.........+.|.+|++++++++||||+++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999997653 4689999997665555567789999999999999999999999864 567899999999
Q ss_pred CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCCccc
Q 005001 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (720)
Q Consensus 493 gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 572 (720)
|+|.++++. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999873 56799999999999999999999999 99999999999999999999999999998765443322
Q ss_pred --cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhccccc
Q 005001 573 --STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPAL 649 (720)
Q Consensus 573 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (720)
.....||+.|||||++.+..++.++|||||||++|||+| |+.||.+..... +...+....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-----------------~~~~i~~~~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAMLEKGE 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHHTTC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-----------------HHHHHHcCC
Confidence 234579999999999999999999999999999999998 899997643221 111222223
Q ss_pred CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 650 NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 650 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
+...|..++.++.+||.+||+.||++|||+++|++.|+....
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 344566778899999999999999999999999988877643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=409.13 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=213.9
Q ss_pred cCCCccce-eccCCCcEEEEEEEc---CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEE
Q 005001 410 NSFSQEFL-IGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~-lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (720)
++|...+. ||+|+||+||+|.+. ++..||||+++... .....+.|.+|++++++++|||||+++|++.. +..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 44555664 999999999999764 35579999997543 45567789999999999999999999999865 56899
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 565 (720)
||||+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 86 vmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999998752 346799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccc--cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 566 PNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 566 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||........ .
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~-----------------~ 222 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----------------M 222 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-----------------H
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH-----------------H
Confidence 5443322 234568999999999999999999999999999999998 9999986543211 1
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
..+....+...|..++.++.+||.+||+.||++||++.+|++.|+.....
T Consensus 223 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11122233345667888999999999999999999999999999876543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=409.18 Aligned_cols=261 Identities=24% Similarity=0.395 Sum_probs=210.5
Q ss_pred cCCCccceeccCCCcEEEEEEEcCC-----cEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANG-----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
..|+..++||+|+||+||+|.+++. ..||||++.... .......|++|++++++++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4577888999999999999987642 369999986543 4455667999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+.+|++.+++.. ....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999998763 356799999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcc--ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 565 TPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 565 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
....... ......||+.|||||++.++.++.++|||||||++|||++|..|+...... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----------------~~~~ 223 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------HEVM 223 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHH
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----------------HHHH
Confidence 6443221 223456899999999999999999999999999999999976665433221 1112
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
+.+....+...+..++..+.+||.+||+.||++||++.||++.|+++++..
T Consensus 224 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 222333444566678889999999999999999999999999999988753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-50 Score=406.85 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=202.5
Q ss_pred CccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee----cCeEEEEE
Q 005001 413 SQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRLLVY 487 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 487 (720)
+..+.||+|+||+||+|.+. +++.||+|++..........+.+.+|++++++++||||+++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55668999999999999875 68899999998776666677889999999999999999999999865 34679999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEecCCCCCEEeC-CCCceEEcccCCCcc
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLD-DELNPHLSDCGLAAL 564 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~~ 564 (720)
||+++|+|.++++. ...+++.++..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+++.
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 99999999999973 46799999999999999999999998 6 99999999999996 578999999999986
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
.... .....+||+.|||||++.+ .++.++|||||||++|||++|+.||......... ...+
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~---------------~~~i 225 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRV 225 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---------------HHHH
T ss_pred ccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH---------------HHHH
Confidence 4332 2345689999999998865 5999999999999999999999999754322111 1111
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.........+...+.++.+||.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11111111223345678999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=422.78 Aligned_cols=267 Identities=21% Similarity=0.372 Sum_probs=210.3
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|++.+.||+|+||+||+|.+. +|+.||+|+++... .......+.+|+.++++++|||||+++++|.+.++.++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 567999999999999999999875 68999999997543 3445678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++. .+.+++..+..++.|++.||.|||+++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999973 357999999999999999999999732 899999999999999999999999999986432
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-h----------------
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR-W---------------- 630 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~-~---------------- 630 (720)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||............. .
T Consensus 158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 22345689999999999999999999999999999999999999998654322111000 0
Q ss_pred ---------hccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 631 ---------ATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 631 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..+........................+.++.+|+.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000011111111111111111112245678999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=412.13 Aligned_cols=257 Identities=21% Similarity=0.319 Sum_probs=211.9
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|++.+.||+|+||+||+|.+. +|+.||||++..... .......+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46889999999999999999875 689999999975432 2234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+. +||||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999998873 46799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ...++..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----------------~~~~i~~ 224 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----------------IFQKIIK 224 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHT
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----------------HHHHHHc
Confidence 322 23345689999999999999999999999999999999999999998643221 1112222
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
.. ..+|...+.++.+||.+||+.||++|||++|+++.- .+.++
T Consensus 225 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~-~i~~H 267 (288)
T d1uu3a_ 225 LE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG-PLKAH 267 (288)
T ss_dssp TC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH-HHHTS
T ss_pred CC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH-HHHcC
Confidence 11 234556677899999999999999999999987652 34444
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=409.70 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=208.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
+.|++.+.||+|+||+||+|.+. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 46888999999999999999875 68999999986542 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 y~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 90 FCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred cCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 9999999998763 246799999999999999999999999 9999999999999999999999999999754321
Q ss_pred CccccccccccccccCccccc-----cCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 569 ERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
........||+.|+|||++. +..|+.++|||||||++|||+||+.||....+.... .+
T Consensus 164 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~----------------~~ 226 (288)
T d2jfla1 164 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL----------------LK 226 (288)
T ss_dssp -HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH----------------HH
T ss_pred -cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH----------------HH
Confidence 12233568999999999984 456899999999999999999999999765432211 11
Q ss_pred hccc-ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDP-ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+... ......+...+.++.+||.+||+.||++|||++|++++
T Consensus 227 i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 227 IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 11222345667889999999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=417.62 Aligned_cols=261 Identities=25% Similarity=0.403 Sum_probs=213.0
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcC-C-----cEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeec
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-G-----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 480 (720)
..++|+..+.||+|+||+||+|++.. + ..||+|++.... .......+.+|+.++.++ +|||||++++++.+.
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 44678899999999999999997753 2 368999886543 233456788999999887 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADD-------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNF 541 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dl 541 (720)
+..++||||+++|+|.++++.... ....+++..++.++.||++||+|||++ +||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999974321 124589999999999999999999999 9999999
Q ss_pred CCCCEEeCCCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCC
Q 005001 542 KSANILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSS 619 (720)
Q Consensus 542 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~ 619 (720)
||+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999865443332 2334678999999999999999999999999999999998 89999764
Q ss_pred CCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 005001 620 RPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVR 688 (720)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 688 (720)
.... .+.+++....+...|..+++++.+||.+||+.||++|||++||+++|..
T Consensus 271 ~~~~----------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 PVDA----------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCSH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHH----------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 4321 1222333334445567778899999999999999999999999999853
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=407.96 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=208.3
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
.++|++.+.||+|+||+||+|.+++++.||||++..... ..+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 467899999999999999999999888999999975443 34679999999999999999999999854 56899999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+++|+|.+++... ..+.+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 y~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 92 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999988643 235699999999999999999999999 9999999999999999999999999999876554
Q ss_pred CccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcccc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPA 648 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (720)
.........||+.|+|||++.++.++.++|||||||++|||++|..|+....... .....+...
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~----------------~~~~~i~~~ 230 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----------------EVLDQVERG 230 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHHTT
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHhc
Confidence 4444455679999999999999999999999999999999999776665432211 111112222
Q ss_pred cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 005001 649 LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQ 691 (720)
Q Consensus 649 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 691 (720)
.....+..+++++.++|.+||+.||++||++++|++.|+++..
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 3334566778889999999999999999999999988877543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=405.03 Aligned_cols=260 Identities=23% Similarity=0.364 Sum_probs=206.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEcC----CcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
.++|++.+.||+|+||.||+|.+.. +..||||+++... .......+.+|+.++++++||||+++++++. ++..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 4678899999999999999997643 3568999886443 4455678999999999999999999999985 46789
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++|+|.+++.. ....+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999998763 346789999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
.............||+.|+|||++.+..++.++|||||||++|||+| |..||......... .+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~----------------~~ 221 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----------------GR 221 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------HH
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH----------------HH
Confidence 65544444455678999999999999999999999999999999998 89999765432211 11
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
+. .......+..++..+.+||.+||+.||++|||++||+++|+++++..
T Consensus 222 i~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 222 IE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11 12223456677889999999999999999999999999999987653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-49 Score=410.25 Aligned_cols=248 Identities=28% Similarity=0.412 Sum_probs=206.6
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-hHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
..|+..+.||+|+||+||+|.+. +|+.||||++...... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888999999999999999764 6889999999755433 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
|||.+|+|..++. ....+++.++..++.||+.||.|||++ +||||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999977664 246799999999999999999999999 999999999999999999999999999986533
Q ss_pred CCccccccccccccccCcccccc---CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhh
Q 005001 568 TERQVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKM 644 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (720)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.||....... .+.++
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~----------------~~~~i 226 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------------ALYHI 226 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHHH
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH----------------HHHHH
Confidence 234579999999999864 458999999999999999999999997543211 11122
Q ss_pred cccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.........+...++.+.+||.+||+.||++|||++|++++
T Consensus 227 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 22222222234566789999999999999999999999863
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-49 Score=409.81 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=195.6
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEE
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 486 (720)
..+.|+..+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.++++++||||+++++++.+++..|+|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4567999999999999999999875 6899999999755433 2345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC---CCCceEEcccCCCc
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLAA 563 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~a~ 563 (720)
|||++||+|.+++. ..+.+++.++..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+++
T Consensus 86 mE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 86 MQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp ECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence 99999999999997 356899999999999999999999999 999999999999994 57899999999998
Q ss_pred cCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
...... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....... ....
T Consensus 159 ~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----------------~~~~ 220 (307)
T d1a06a_ 159 MEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----------------LFEQ 220 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHHH
T ss_pred EccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH----------------HHHH
Confidence 654322 2344679999999999999999999999999999999999999997643221 1111
Q ss_pred hcccc--cCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVDPA--LNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+.... .....+...+.++.+|+.+||+.||++|||++|++++
T Consensus 221 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 12111 1222334567789999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.1e-48 Score=407.40 Aligned_cols=251 Identities=21% Similarity=0.313 Sum_probs=210.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357999999999999999999874 68999999997543 345677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC--CCCceEEcccCCCccC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLAALT 565 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~ 565 (720)
||+++|+|.+++.. ..+.+++.++..++.||+.||+|||++ +||||||||+|||++ .++.+||+|||+++..
T Consensus 103 E~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 103 EFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 99999999999852 346799999999999999999999999 999999999999995 4678999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... ......||+.|||||++.+..++.++|||||||++|||++|+.||.+...... +.++.
T Consensus 177 ~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----------------~~~i~ 238 (350)
T d1koaa2 177 DPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----------------LRNVK 238 (350)
T ss_dssp CTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHH
T ss_pred cccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH----------------HHHHH
Confidence 5433 23446899999999999999999999999999999999999999976432211 11111
Q ss_pred cccc--CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPAL--NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.... ........++++.+||.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 111123456788999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-48 Score=404.60 Aligned_cols=267 Identities=25% Similarity=0.400 Sum_probs=218.7
Q ss_pred hcHHHHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceE
Q 005001 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476 (720)
Q Consensus 403 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 476 (720)
.+++.+.++|+..+.||+|+||+||+|++. +++.||||++.... ......+|.+|++++++++||||++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 345556788999999999999999999864 35789999997543 44556789999999999999999999999
Q ss_pred EeecCeEEEEEEecCCCCHHHHhhhccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 005001 477 CAEHGQRLLVYEYVGNGNLHDMLHFADD--------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSV 536 (720)
Q Consensus 477 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~i 536 (720)
+...+..++||||+++|+|.++++.... ....+++..+..++.|++.||+|||+. +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999964221 123589999999999999999999999 99
Q ss_pred EEecCCCCCEEeCCCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCC-C
Q 005001 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR-K 614 (720)
Q Consensus 537 iH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~ 614 (720)
|||||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999999765433222 223457899999999999999999999999999999999986 5
Q ss_pred CCCCCCCcchhhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 005001 615 PLDSSRPRSEQSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLV 690 (720)
Q Consensus 615 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 690 (720)
||....... ....+.+ ......|..++.++.+|+.+||+.||++||||.||++.|++|.
T Consensus 242 p~~~~~~~e----------------~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEE----------------VIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHH----------------HHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHHH----------------HHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 676543221 1112222 2223346667788999999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=405.48 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=212.6
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|++.+.||+|+||.||+|+. .+|+.||+|++.+... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5689999999999999999987 4799999999975533 2334577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++. .+.+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999873 46789999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
.. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+...... ...+...
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~----------------~~~i~~~ 220 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----------------FELILME 220 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHC
T ss_pred CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH----------------HHHHhcC
Confidence 32 233457899999999999999999999999999999999999999986543211 1111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRPP-----MSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 685 (720)
...+|...+.++.+||.+||++||++||+ ++|++++
T Consensus 221 --~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 --EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 12345667778999999999999999995 7888875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=399.71 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=209.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh----HHHHHHHHHHHHhhcCCCCCccccceEEeecCeE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (720)
.++|++.+.||+|+||+||+|.+. +|+.||||++....... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999874 78999999986543322 2357889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC----ceEEccc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSDC 559 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Df 559 (720)
|+||||+++|+|.+++.. .+.+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 999999999999999973 35799999999999999999999999 999999999999998876 4999999
Q ss_pred CCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHH
Q 005001 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDID 639 (720)
Q Consensus 560 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 639 (720)
|++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------------- 225 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------------- 225 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------------
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH--------------
Confidence 9998764332 234467999999999999999999999999999999999999999864432111
Q ss_pred HHHhhcccccC--CCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 640 ALAKMVDPALN--GMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 640 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..+...... ...+...+..+.+||.+||+.||++|||++|++++
T Consensus 226 --~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 226 --ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp --HHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --HHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111111 00112345678899999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.8e-48 Score=406.78 Aligned_cols=250 Identities=20% Similarity=0.306 Sum_probs=210.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57999999999999999999874 79999999987543 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeC--CCCceEEcccCCCccCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLAALTP 566 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~ 566 (720)
|+++|+|.+++. .....+++.+++.++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+|....
T Consensus 107 ~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999998775 2345799999999999999999999999 999999999999998 57899999999998775
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+...... +.++..
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----------------~~~i~~ 242 (352)
T d1koba_ 181 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET----------------LQNVKR 242 (352)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----------------HHHHHH
T ss_pred CCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHh
Confidence 432 23446799999999999999999999999999999999999999976432211 111111
Q ss_pred c--ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 647 P--ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 647 ~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
. ..........+.++.+||.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 11222334567788999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=401.60 Aligned_cols=267 Identities=24% Similarity=0.386 Sum_probs=206.9
Q ss_pred HHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEee
Q 005001 407 TATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (720)
Q Consensus 407 ~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (720)
...++|+..+.||+|+||.||+|.+. +++.||||+++... .......+.+|...+.++ +|+||+.+++++..
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 34567999999999999999999764 34689999997544 344456677777777666 78999999998766
Q ss_pred c-CeEEEEEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCE
Q 005001 480 H-GQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (720)
Q Consensus 480 ~-~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 546 (720)
. +..++||||+++|+|.++++.... ....+++.++..++.||++||+|||++ +||||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence 4 568999999999999999975332 134589999999999999999999999 999999999999
Q ss_pred EeCCCCceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCC-CCCCCCCCcch
Q 005001 547 LLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR-KPLDSSRPRSE 624 (720)
Q Consensus 547 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~pf~~~~~~~~ 624 (720)
|++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||.......
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~- 244 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 244 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999999866543332 334567999999999999999999999999999999999965 5776543221
Q ss_pred hhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 625 QSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
.+.+.+........+..++.++.++|.+||+.||++|||++|++++|+++++..
T Consensus 245 ---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 245 ---------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp ---------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 111222222333455667788999999999999999999999999999998654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=392.67 Aligned_cols=253 Identities=27% Similarity=0.434 Sum_probs=204.2
Q ss_pred hcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee-cCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~ 487 (720)
.++|+..+.||+|+||.||+|.++ |+.||||++++.. ..+.+.+|++++++++||||++++|++.+ ++..++||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 356778889999999999999985 7899999997543 34678999999999999999999999854 56789999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+++|+|.++++.. ....+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999632 124589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
. .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||........ ...+.
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~-----------------~~~i~ 214 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----------------VPRVE 214 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-----------------HHHHT
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH-----------------HHHHH
Confidence 2 233468899999999999999999999999999999998 6777765432211 11122
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
...+...+...+.++.+|+.+||+.||++|||+.++++.|+++..+
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 2334455667778899999999999999999999999999988543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=402.85 Aligned_cols=258 Identities=24% Similarity=0.406 Sum_probs=209.0
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCc----EEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
.+|+..++||+|+||+||+|.+. +|+ +||+|++.... .....+.+.+|+.++++++|||||+++|++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46899999999999999999764 343 58999886443 344567899999999999999999999999764 567
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+++||+.+|+|.+++.. ....+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.
T Consensus 87 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence 88999999999998863 356799999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHHH
Q 005001 565 TPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDALA 642 (720)
Q Consensus 565 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (720)
....... ......||+.|+|||++.++.++.++|||||||++|||+| |..||........ .
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-----------------~ 223 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----------------S 223 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-----------------H
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-----------------H
Confidence 6543332 2234568999999999999999999999999999999999 7888876443211 1
Q ss_pred hhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHh
Q 005001 643 KMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQR 692 (720)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 692 (720)
..+....+...|..++..+.+|+.+||+.||++|||+.||+++|+++.+.
T Consensus 224 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 12222233345667788899999999999999999999999999988653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-47 Score=399.80 Aligned_cols=247 Identities=25% Similarity=0.403 Sum_probs=210.7
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|++.+.||+|+||+||+|++. +|+.||||+++.... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46889999999999999999874 689999999975432 2234577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||++||+|..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999887 356788999999999999999999999 999999999999999999999999999987644
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
. ....+||+.|||||++.+..|+.++|||||||++|||+||+.||....... ...++...
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------------~~~~i~~~ 216 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----------------TYEKILNA 216 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHHC
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH----------------HHHHHHcC
Confidence 3 234689999999999999999999999999999999999999997643221 11222221
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
. ..+|...+.++.+++.+||+.||.+|+ ++++++++
T Consensus 217 ~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 234556677899999999999999996 89999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=397.23 Aligned_cols=263 Identities=25% Similarity=0.421 Sum_probs=212.1
Q ss_pred cCCCccceeccCCCcEEEEEEEcC-Cc--EEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCeEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFAN-GK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (720)
++|+..+.||+|+||+||+|.+.+ |. .||||++.... .....+.+.+|++++.++ +||||+++++++.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 578888999999999999997753 44 47788875433 334456799999999998 79999999999999999999
Q ss_pred EEEecCCCCHHHHhhhc------------cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc
Q 005001 486 VYEYVGNGNLHDMLHFA------------DDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~------------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 553 (720)
||||+++|+|.++++.. ......+++..+.+++.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 99999999999999743 12346799999999999999999999999 9999999999999999999
Q ss_pred eEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCC-CCCCCCCcchhhHHHhhc
Q 005001 554 PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRK-PLDSSRPRSEQSLVRWAT 632 (720)
Q Consensus 554 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~-pf~~~~~~~~~~~~~~~~ 632 (720)
+||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||......
T Consensus 166 ~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---------- 233 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------- 233 (309)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------
T ss_pred eEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH----------
Confidence 9999999997654322 1234568999999999999999999999999999999999765 56543211
Q ss_pred cccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhcc
Q 005001 633 PQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASV 695 (720)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 695 (720)
.+.+.+....+...+..+++++.+||.+||+.||++|||++||+++|+++++....
T Consensus 234 -------~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 234 -------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp -------HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -------HHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 11112222233445667788999999999999999999999999999999876543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=392.41 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=202.8
Q ss_pred cCCCccceeccCCCcEEEEEEEcC--C--cEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFAN--G--KIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
++|+..+.||+|+||+||+|++.. + ..||||++..... .....+.|.+|+.++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568889999999999999997642 2 3689999875543 33445789999999999999999999999965 4678
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++|++.+.+... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999987632 45699999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccc--cccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 565 TPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 565 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
........ .....||..|+|||++.+..++.++|||||||++|||+| |+.||...... +..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----------------~~~ 224 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------QIL 224 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHH
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----------------HHH
Confidence 75543322 234568889999999999999999999999999999998 89999754322 222
Q ss_pred HhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 005001 642 AKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRL 689 (720)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 689 (720)
.++.....+...+...+..+.+|+.+||+.||++|||++||++.|.+.
T Consensus 225 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 333333344445666778899999999999999999999999888653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-47 Score=391.27 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=206.4
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecC----e
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----Q 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 482 (720)
.++|++.+.||+|+||+||+|.+ .+|+.||||+++.... .......+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999986 4799999999976544 3444667999999999999999999999987654 3
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.|+||||++||+|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+|||++.++..+|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 7999999999999998863 46799999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCc--cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 563 ALTPNTER--QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 563 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
........ ......+||+.|+|||++.+..++.++|||||||++|||+||+.||....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--------------- 223 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--------------- 223 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---------------
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH---------------
Confidence 75433222 2334568999999999999999999999999999999999999999764432111
Q ss_pred HHhhcccc--cCCCCChhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHH
Q 005001 641 LAKMVDPA--LNGMYPAKSLSRFADIIALCVQPEPEFRP-PMSEVVQALVRLV 690 (720)
Q Consensus 641 ~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~~~ 690 (720)
.+.+... .........+.++.++|.+||+.||++|| +++++++.|.++.
T Consensus 224 -~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 224 -YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -HHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -HHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111111 11112234567889999999999999999 8999999998874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=391.87 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=209.2
Q ss_pred cceeccCCCcEEEEEEEcCC----cEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee-cCeEEEEEEe
Q 005001 415 EFLIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRLLVYEY 489 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~ 489 (720)
.++||+|+||+||+|.+.++ ..||||+++.. ......++|.+|++++++++||||++++|++.. ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46799999999999987532 35899998643 255667889999999999999999999999876 4688999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+++|+|.++++. ....+++..+++++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999999873 356778899999999999999999999 99999999999999999999999999998765432
Q ss_pred cc---ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 570 RQ---VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 570 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||........ ....+.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---------------~~~~i~- 248 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------------ITVYLL- 248 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------------------CHHHHH-
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---------------HHHHHH-
Confidence 22 22335789999999999999999999999999999999998888764322110 011111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
...+...|..++.++.+||.+||+.||++||++.||+++|+++.+...
T Consensus 249 ~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred cCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 112233456677889999999999999999999999999999976543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=396.15 Aligned_cols=266 Identities=26% Similarity=0.427 Sum_probs=220.4
Q ss_pred HhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeec
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 480 (720)
..++|+..+.||+|+||.||+|++. +++.||||+++... .......+.+|+.+++++ +|||||++++++.+.
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 3467888999999999999999763 46789999997544 445567899999999998 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCE
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADD--------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 546 (720)
+..++||||+++|+|.++++.... ....+++..+..++.||+.||+|||++ +||||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 999999999999999999975432 234689999999999999999999999 999999999999
Q ss_pred EeCCCCceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHhC-CCCCCCCCCcch
Q 005001 547 LLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG-RKPLDSSRPRSE 624 (720)
Q Consensus 547 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg-~~pf~~~~~~~~ 624 (720)
+++.++.+|++|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+|+ .+||......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987655433 233456899999999999999999999999999999999995 4555443321
Q ss_pred hhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 625 QSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
..+.+++....+...+...+..+.+||.+||+.||++|||+.||++.|++++...
T Consensus 255 --------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 255 --------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp --------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 1122233333444455667788999999999999999999999999999887764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=393.30 Aligned_cols=265 Identities=26% Similarity=0.431 Sum_probs=213.9
Q ss_pred HhcCCCccceeccCCCcEEEEEEEcC--------CcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEe
Q 005001 408 ATNSFSQEFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (720)
Q Consensus 408 ~~~~y~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (720)
..++|++.+.||+|+||.||+|+... +..||||+++... .......+.+|...+.++ +||||+++++++.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 34678889999999999999997642 2479999997654 445567788888888777 8999999999999
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCE
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 546 (720)
+++..++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||+. +||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999975431 235689999999999999999999999 999999999999
Q ss_pred EeCCCCceEEcccCCCccCCCCCc-cccccccccccccCccccccCCCcccchhhhHHHHHHHHHh-CCCCCCCCCCcch
Q 005001 547 LLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDSSRPRSE 624 (720)
Q Consensus 547 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~pf~~~~~~~~ 624 (720)
|++.++.+||+|||+++....... .......||+.|+|||.+.++.|+.++|||||||++|||++ |..||......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-- 244 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 244 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence 999999999999999986644322 22344679999999999999999999999999999999998 68888654321
Q ss_pred hhHHHhhccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 625 QSLVRWATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
.+.+.+........|...+..+.+||.+||+.||++|||+.||++.|++++.-.
T Consensus 245 ---------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 245 ---------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp ---------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---------------HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 111222223334456667788999999999999999999999999999987643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-47 Score=400.79 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=210.1
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
++|++.+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57899999999999999999875 699999999865432 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 567 (720)
||+.+|+|.+++.. .+.+++.++..++.||+.||.|||++ +||||||||+|||++.+|.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999873 35799999999999999999999999 999999999999999999999999999987643
Q ss_pred CCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhccc
Q 005001 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVDP 647 (720)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (720)
. .....||+.|||||++.+..++.++|||||||++|||+||+.||.+..... ...++...
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------------~~~~i~~~ 253 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----------------IYEKIVSG 253 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHC
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH----------------HHHHHhcC
Confidence 2 234689999999999999999999999999999999999999997643221 11111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 005001 648 ALNGMYPAKSLSRFADIIALCVQPEPEFRP-----PMSEVVQA 685 (720)
Q Consensus 648 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 685 (720)
. ...+...+.++.+||++||+.||.+|+ ++++++++
T Consensus 254 ~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 254 K--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1 223456677899999999999999994 89999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-46 Score=399.17 Aligned_cols=251 Identities=26% Similarity=0.351 Sum_probs=204.8
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChH-HHHHHH---HHHHHhhcCCCCCccccceEEeecCeEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ-EEDNFL---EAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (720)
++|++.+.||+|+||.||+|++. +|+.||||++........ ....+. +++.+++.++||||+++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999875 699999999864432211 122333 4477788889999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCcc
Q 005001 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (720)
Q Consensus 485 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 564 (720)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999973 46789999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHh
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAK 643 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (720)
.... ......||+.|+|||++.+ ..|+.++|||||||++|||+||+.||............ ..
T Consensus 157 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-------------~~ 220 (364)
T d1omwa3 157 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-------------RM 220 (364)
T ss_dssp CSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-------------HH
T ss_pred cCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------Hh
Confidence 6433 2334579999999999975 56899999999999999999999999865433221111 11
Q ss_pred hcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 005001 644 MVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPP-----MSEVVQA 685 (720)
Q Consensus 644 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 685 (720)
.. ......+...+.++.+||.+||+.||++||+ ++|++++
T Consensus 221 ~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 221 TL--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SS--SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred cc--cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11 1122334556778999999999999999999 6888865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-46 Score=384.33 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=208.3
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccC-------hHHHHHHHHHHHHhhcCC-CCCccccceEEeec
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEH 480 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 480 (720)
++|+..+.||+|+||+||+|++. +|+.||||++...... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57899999999999999999874 7899999998654322 122356889999999996 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
+..|+||||+++|+|.++++. .+.+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999973 46799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccccccccCcccccc------CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 005001 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS------GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQ 634 (720)
Q Consensus 561 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 634 (720)
+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+......
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~---------- 223 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---------- 223 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH----------
Confidence 998765432 2344689999999999864 3468899999999999999999999986543211
Q ss_pred cccHHHHHhhccccc--CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 LHDIDALAKMVDPAL--NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+..... ........++++.+|+.+||+.||++||+++|++++
T Consensus 224 ------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 224 ------LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ------HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ------HHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111111 122234567889999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=394.15 Aligned_cols=249 Identities=23% Similarity=0.373 Sum_probs=206.1
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEcccccc-ChHHHHHHHHHHHHhh-cCCCCCccccceEEeecCeEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMS-RLRHPNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lV 486 (720)
++|++.+.||+|+||+||+|.+. +|+.||||++++... .......+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46889999999999999999875 689999999975432 2223445566666554 68999999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 566 (720)
|||+++|+|.++++. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999973 46789999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhcc
Q 005001 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMVD 646 (720)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (720)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... .++..
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~----------------~~i~~ 217 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF----------------HSIRM 217 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHH
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH----------------HHHHc
Confidence 332 2334468999999999999999999999999999999999999999865432111 11111
Q ss_pred cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 005001 647 PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMS-EVVQ 684 (720)
Q Consensus 647 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~ 684 (720)
. ...+|...+.++.+||++||+.||++||++. |+++
T Consensus 218 ~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 218 D--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 1234556677899999999999999999996 6765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=390.57 Aligned_cols=248 Identities=18% Similarity=0.260 Sum_probs=207.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 487 (720)
.++|++.+.||+|+||+||+|.+. +|+.||+|.++... .....+.+|+++++.++||||+++++++.+++..|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 467899999999999999999875 68899999997543 33456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCC--CceEEcccCCCccC
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE--LNPHLSDCGLAALT 565 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~ 565 (720)
|||+||+|.++++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++..
T Consensus 81 E~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 81 EFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999999962 235799999999999999999999999 99999999999999854 58999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHHHhhc
Q 005001 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDALAKMV 645 (720)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (720)
.... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||........ +.++.
T Consensus 155 ~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~----------------~~~i~ 216 (321)
T d1tkia_ 155 KPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----------------IENIM 216 (321)
T ss_dssp CTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHH
T ss_pred ccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHH
Confidence 4332 23346799999999999999999999999999999999999999986543211 11111
Q ss_pred ccccCCCCCh----hHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 DPALNGMYPA----KSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
..... ++. ..+.++.+|+.+||+.||++|||++|++++
T Consensus 217 ~~~~~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 217 NAEYT--FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTCCC--CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hCCCC--CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 111 345678899999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=390.89 Aligned_cols=268 Identities=22% Similarity=0.362 Sum_probs=219.3
Q ss_pred HHHHhcCCCccceeccCCCcEEEEEEEc------CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEe
Q 005001 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA 478 (720)
Q Consensus 405 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 478 (720)
++...++|...+.||+|+||+||+|.+. +++.||||+++... .......|.+|+.++++++||||+++++++.
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 3444578888999999999999999764 35789999997543 4556678999999999999999999999999
Q ss_pred ecCeEEEEEEecCCCCHHHHhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC
Q 005001 479 EHGQRLLVYEYVGNGNLHDMLHFAD------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (720)
Q Consensus 479 ~~~~~~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 552 (720)
.++..++||||+++|+|.+++.... .....+++..+.+++.|+++||.|||+. +|+||||||+|||++.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 9999999999999999999987432 1234579999999999999999999999 999999999999999999
Q ss_pred ceEEcccCCCccCCCCCcc-ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCC-CCCCCCCCcchhhHHHh
Q 005001 553 NPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR-KPLDSSRPRSEQSLVRW 630 (720)
Q Consensus 553 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~pf~~~~~~~~~~~~~~ 630 (720)
++||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||......
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-------- 242 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------- 242 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--------
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 9999999999866443322 233457999999999999999999999999999999999985 667543321
Q ss_pred hccccccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 631 ATPQLHDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
+....+.+ ......+..++..+.++|.+||+.||++|||+++|++.|++.+++.
T Consensus 243 --------~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 243 --------QVLRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp --------HHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred --------HHHHHHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 11122222 2223345567788999999999999999999999999997765533
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=386.19 Aligned_cols=273 Identities=24% Similarity=0.330 Sum_probs=204.2
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC----eEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----QRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 485 (720)
.+|...+.||+|+||.||+|++ +|+.||||++.... ........|+..+..++||||+++++++.+.+ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567788999999999999986 58999999986432 11222234555566789999999999997654 5799
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC-----LPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
||||+++|+|.++++. ..+++.++.+++.|++.||+|||+.. .++||||||||+|||++.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999973 46899999999999999999999731 2499999999999999999999999999
Q ss_pred CCccCCCCCcc---ccccccccccccCccccccCC------CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 005001 561 LAALTPNTERQ---VSTQMVGAFGYSAPEFALSGI------YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA 631 (720)
Q Consensus 561 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~ 631 (720)
+++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..||.......... ...
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~-~~~- 231 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDL- 231 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTT-
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch-hhc-
Confidence 99876543322 223467999999999987643 6789999999999999999998875433221110 000
Q ss_pred ccccccHHHHH-hhcccccCCCCC-----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 005001 632 TPQLHDIDALA-KMVDPALNGMYP-----AKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRA 693 (720)
Q Consensus 632 ~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 693 (720)
........... .......+...+ ......+.+|+.+||+.||++|||+.||++.|+++.++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 00111111122 222222322222 235567999999999999999999999999999987654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=386.57 Aligned_cols=269 Identities=23% Similarity=0.331 Sum_probs=203.0
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|++.+.||+|+||+||+|.+ .+|+.||||+++...........+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4788999999999999999987 569999999997655444446788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
|+.+ ++.+++.. .....+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9976 44444432 2356799999999999999999999999 9999999999999999999999999999766433
Q ss_pred CccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHH-Hh-hccccccHHHHHhhc
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLV-RW-ATPQLHDIDALAKMV 645 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~ 645 (720)
. .......||+.|+|||++.... ++.++||||+||++|||++|+.||.+.+.......+ .. ..+............
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 2 2334467999999999987766 478999999999999999999999865432221111 10 011000000000000
Q ss_pred c--cccCCCC-------ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 646 D--PALNGMY-------PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 646 ~--~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+ ....... ....+.++.+|+.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0000000 01234678899999999999999999999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=387.21 Aligned_cols=264 Identities=25% Similarity=0.288 Sum_probs=198.3
Q ss_pred ccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChH---HHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 414 QEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ---EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 414 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
..++||+|+||+||+|.+. +|+.||||+++....... ....+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999875 689999999975443221 134688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+.++++..+.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 99887776654 456789999999999999999999999 99999999999999999999999999998665433
Q ss_pred ccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-h-hccccccHHHHHhh--
Q 005001 570 RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR-W-ATPQLHDIDALAKM-- 644 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~-- 644 (720)
. .....+||+.|+|||++.+. .|+.++|||||||++|||+||..||.+....+....+. . ..+...........
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 2 23346799999999998754 57999999999999999999999997654322211111 0 01100000000000
Q ss_pred -cccccCCCC-----ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 -VDPALNGMY-----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 -~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......... ....++++.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000000 11345678999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=388.98 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=198.9
Q ss_pred hcCCCccc-eeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhc-CCCCCccccceEEee----cC
Q 005001 409 TNSFSQEF-LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAE----HG 481 (720)
Q Consensus 409 ~~~y~~~~-~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~ 481 (720)
.++|.+.. .||+|+||.||+|.+ .+++.||||+++.. ..+.+|+.++.+ .+||||++++++|.+ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 35677764 699999999999977 56899999998642 346678887654 589999999999865 46
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---CCceEEcc
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSD 558 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~D 558 (720)
..|+|||||+||+|.+++.. .....+++.+++.++.||+.||+|||+. +|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence 78999999999999999973 2235799999999999999999999999 9999999999999985 56799999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
||+++...... ......||+.|||||++.+..|+.++|||||||++|||+||+.||.+.........+
T Consensus 158 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---------- 225 (335)
T d2ozaa1 158 FGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------- 225 (335)
T ss_dssp CTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------
T ss_pred cceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----------
Confidence 99998765433 234468999999999999999999999999999999999999999765432211100
Q ss_pred HHHHhhcccccCCCCC--hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKMVDPALNGMYP--AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
...+.........+ ...+.++.+||++||+.||++|||+.|++++
T Consensus 226 --~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 --KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01111111111111 2456789999999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.7e-46 Score=384.39 Aligned_cols=268 Identities=21% Similarity=0.292 Sum_probs=207.6
Q ss_pred cCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEEe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 489 (720)
++|+..+.||+|+||+||+|++++|+.||||++............+.+|+.++++++||||+++++++...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57899999999999999999999999999999976654444567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCCC
Q 005001 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (720)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 569 (720)
+.++.+..+.+ ..+.+++..+..++.||+.||+|||+. +||||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98877766654 457899999999999999999999999 99999999999999999999999999997654332
Q ss_pred ccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHh--hccc---cccHHHHHh
Q 005001 570 RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRW--ATPQ---LHDIDALAK 643 (720)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~--~~~~---~~~~~~~~~ 643 (720)
. ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+.. ..+. +.......+
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 2 23345789999999999765 468999999999999999999999986543322111110 1111 111111111
Q ss_pred hcc------cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 644 MVD------PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 644 ~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
... ...........+..+.+|+++||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 100 000011123345678999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=383.77 Aligned_cols=269 Identities=22% Similarity=0.298 Sum_probs=201.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-C-CcEEEEEEccccccChHHHHHHHHHHHHhhc---CCCCCccccceEEee----
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-N-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSR---LRHPNIVTLAGYCAE---- 479 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~---- 479 (720)
.++|++.+.||+|+||+||+|.+. + ++.||||+++...........+.+|+.+++. .+||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999874 4 5679999987554333333345566666554 489999999999853
Q ss_pred -cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcc
Q 005001 480 -HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (720)
Q Consensus 480 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 558 (720)
....+++|||++++++..... .....+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 346899999999877655443 2456789999999999999999999999 999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhh--ccc--
Q 005001 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWA--TPQ-- 634 (720)
Q Consensus 559 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~--~~~-- 634 (720)
||++...... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...........+... .+.
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 9998764332 2334568999999999999999999999999999999999999999876543222211110 000
Q ss_pred -cccHHHHHhhc----ccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 -LHDIDALAKMV----DPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 -~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+.......+.. ............++.+.+|+.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000 0000111223456778899999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=380.18 Aligned_cols=243 Identities=21% Similarity=0.357 Sum_probs=200.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccCh----HHHHHHHHHHHHhhcCC--CCCccccceEEeecC
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLR--HPNIVTLAGYCAEHG 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 481 (720)
.++|++.+.||+|+||+||+|.+. +|+.||||++....... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 467999999999999999999874 68999999987543321 12234668999998885 899999999999999
Q ss_pred eEEEEEEecCC-CCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-CCceEEccc
Q 005001 482 QRLLVYEYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDC 559 (720)
Q Consensus 482 ~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Df 559 (720)
..++||||+.+ +++.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 678888763 46799999999999999999999999 9999999999999985 479999999
Q ss_pred CCCccCCCCCccccccccccccccCccccccCCC-cccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH
Q 005001 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 560 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
|+++..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ...
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~---------- 217 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII---------- 217 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH----------
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh----------
Confidence 999865432 2345689999999999988775 677999999999999999999996421 000
Q ss_pred HHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
+ . ...++...+.++.+||.+||+.||++|||++|++++
T Consensus 218 ----~---~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 ----R---G--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----H---C--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----h---c--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 0 112334456788999999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-44 Score=376.42 Aligned_cols=264 Identities=20% Similarity=0.273 Sum_probs=202.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC------
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 481 (720)
.++|++.+.||+|+||+||+|.+. +|+.||||+++.........+.+.+|+++++.++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 568999999999999999999874 6999999999876666666788999999999999999999999997654
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..++||||+ +.+|..+++ ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 569999999 568888775 36799999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc-------
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP------- 633 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~------- 633 (720)
++..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.................
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 9865432 2446799999999999874 568999999999999999999999987643322111110000
Q ss_pred ---ccccHHHHHhhcccccCC---CCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 ---QLHDIDALAKMVDPALNG---MYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 ---~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.................. ......+..+.+||.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000001111111111110 1123345678899999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=371.66 Aligned_cols=268 Identities=21% Similarity=0.282 Sum_probs=199.6
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee--------c
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--------H 480 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 480 (720)
++|++.+.||+|+||+||+|.+ .+|+.||||++...........++.+|++++++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6789999999999999999987 479999999997665555556778999999999999999999998755 3
Q ss_pred CeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccC
Q 005001 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (720)
Q Consensus 481 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 560 (720)
+..++||||+.++.+..... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 46799999998876655443 456889999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCc---cccccccccccccCccccccC-CCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcc---
Q 005001 561 LAALTPNTER---QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATP--- 633 (720)
Q Consensus 561 ~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~--- 633 (720)
++........ ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.........+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9976553222 122345799999999999865 689999999999999999999999986543322222111000
Q ss_pred -----ccccHHHHHhhcccccCCCCCh-------hHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 634 -----QLHDIDALAKMVDPALNGMYPA-------KSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 634 -----~~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
............. ......+. .....+.+||.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------C-CSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcc-cccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000000000 00000000 113457789999999999999999999965
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-43 Score=363.35 Aligned_cols=267 Identities=15% Similarity=0.192 Sum_probs=211.4
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCC-CCccccceEEeecCeEEEE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAGYCAEHGQRLLV 486 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV 486 (720)
.++|++.+.||+|+||+||+|.+. +|+.||||++..... ...+.+|++.++.++| +|++.+++++......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 367999999999999999999875 689999998754322 2346678888888865 8999999999999999999
Q ss_pred EEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC-----CCceEEcccCC
Q 005001 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-----ELNPHLSDCGL 561 (720)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfg~ 561 (720)
|||+ +++|.++++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 80 me~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 80 IDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 9999 6799998863 346799999999999999999999999 9999999999999974 57899999999
Q ss_pred CccCCCCCcc------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 005001 562 AALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL 635 (720)
Q Consensus 562 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 635 (720)
|+........ ......||+.|||||.+.+..++.++|||||||++|||+||+.||.+..............
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~--- 229 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG--- 229 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH---
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH---
Confidence 9875432211 1234679999999999999999999999999999999999999998665443322211000
Q ss_pred ccHHHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhccc
Q 005001 636 HDIDALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRASVV 696 (720)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 696 (720)
....... ....+..+++++.+++..|+..+|++||+++.+.+.|+++.++....
T Consensus 230 ----~~~~~~~---~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 230 ----EKKQSTP---LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp ----HHHHHSC---HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ----hccCCCC---hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 0000000 00012234567899999999999999999999999999988766444
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=363.08 Aligned_cols=268 Identities=21% Similarity=0.277 Sum_probs=211.4
Q ss_pred cCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecCeEEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 488 (720)
++|++.+.||+|+||+||+|++. +++.||||+++...........+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999874 78899999997665555667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCccCCCC
Q 005001 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (720)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 568 (720)
++.+++|..+++ ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999888776 457889999999999999999999999 9999999999999999999999999999876543
Q ss_pred CccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchh-hHHH--hhccccccHHHHHhh
Q 005001 569 ERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ-SLVR--WATPQLHDIDALAKM 644 (720)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~ 644 (720)
.. ......+++.|+|||++.+.. ++.++||||+||++|||++|+.||......... ..+. ...+.........+.
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 32 233356788999999988765 689999999999999999999998654433221 1111 111110000000000
Q ss_pred cc---------cccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 645 VD---------PALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 645 ~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
.+ ...........+..+.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 001111223455678899999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=373.26 Aligned_cols=268 Identities=21% Similarity=0.298 Sum_probs=200.1
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeecC----eE
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----QR 483 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 483 (720)
..+|++.+.||+|+||+||+|.+ .+|+.||||++.... .....+.+++|+.++++++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 35799999999999999999976 579999999997543 3445677899999999999999999999986643 33
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
+++++|+.+|+|.+++. ...+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||++.
T Consensus 86 ~~l~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 55556677899999996 35799999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCc--cccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc---
Q 005001 564 LTPNTER--QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHD--- 637 (720)
Q Consensus 564 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--- 637 (720)
....... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.....................
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 6543222 12344679999999999855 55789999999999999999999999875533222111110000000
Q ss_pred -----HHHHHhhcccccCCCCC-----hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 638 -----IDALAKMVDPALNGMYP-----AKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 638 -----~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
................+ ...+.++.+|+.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000011111 1234578899999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-43 Score=362.35 Aligned_cols=264 Identities=20% Similarity=0.262 Sum_probs=201.6
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCcccc-ceEEeecCeEEEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL-AGYCAEHGQRLLVY 487 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lV~ 487 (720)
++|++.+.||+|+||+||+|.+ .+|+.||||.+..... ..++.+|+++++.++|+|++.. .+++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 5799999999999999999976 4689999998765432 2346789999999987765554 55567778899999
Q ss_pred EecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCC---CCceEEcccCCCcc
Q 005001 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDCGLAAL 564 (720)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a~~ 564 (720)
||+. ++|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+.
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 83 ELLG-PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp ECCC-CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEcC-Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 9995 567666542 356799999999999999999999999 9999999999999864 45799999999987
Q ss_pred CCCCCcc------ccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccH
Q 005001 565 TPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDI 638 (720)
Q Consensus 565 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 638 (720)
....... ......||+.|||||.+.+..++.++|||||||++|||+||+.||...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~------- 228 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI------- 228 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH-------
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh-------
Confidence 6443221 223457999999999999999999999999999999999999999865543222111100
Q ss_pred HHHHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 005001 639 DALAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQALVRLVQRAS 694 (720)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 694 (720)
...+...+. ......++.++.+++.+||+.||++||+++++.+.|+++..+..
T Consensus 229 -~~~~~~~~~--~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 229 -SEKKMSTPI--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp -HHHHHHSCH--HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -hcccCCCCh--hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 000000000 00122455778999999999999999999999999988866543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=370.41 Aligned_cols=262 Identities=23% Similarity=0.282 Sum_probs=196.7
Q ss_pred CCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec------CeE
Q 005001 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------GQR 483 (720)
Q Consensus 411 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 483 (720)
+|...++||+|+||+||+|++. +|+.||||++..... .+.+|++++++++||||+++++++... .+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 4777889999999999999875 699999999965432 234789999999999999999998543 357
Q ss_pred EEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC-ceEEcccCCC
Q 005001 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLA 562 (720)
Q Consensus 484 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a 562 (720)
++||||++++.+ +.+.........+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 95 ~lv~Ey~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 95 NLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEECCSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEeccCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 899999987544 44433333567899999999999999999999998 999999999999999775 8999999999
Q ss_pred ccCCCCCccccccccccccccCcccccc-CCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHHH
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDAL 641 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (720)
+...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...........+...... ...+..
T Consensus 171 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~-~~~~~~ 247 (350)
T d1q5ka_ 171 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT-PTREQI 247 (350)
T ss_dssp EECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC-CCHHHH
T ss_pred hhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC-ChHHhh
Confidence 8764432 2334689999999998875 56899999999999999999999999765432222111110000 000111
Q ss_pred Hhhccccc------------CCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 642 AKMVDPAL------------NGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 642 ~~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
........ ........+.++.+|+.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110000 001122356678999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=370.65 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=208.5
Q ss_pred cCCCccceeccCCCcEEEEEEEc----CCcEEEEEEcccccc--ChHHHHHHHHHHHHhhcCCC-CCccccceEEeecCe
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRLRH-PNIVTLAGYCAEHGQ 482 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 482 (720)
++|++.+.||+|+||+||+|... +|+.||||+++.... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56899999999999999999752 478999999875432 12234567889999999966 899999999999999
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++||||+.+|+|.+++.. .+.+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999873 45678899999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccCccccccCC--CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccHHH
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQLHDIDA 640 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 640 (720)
+..............|++.|+|||.+.+.. ++.++|||||||++|||++|+.||...........+
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i------------ 244 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI------------ 244 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH------------
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------
Confidence 876555444455678999999999997654 688999999999999999999999876543222111
Q ss_pred HHhhcccccCCCCChhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 005001 641 LAKMVDPALNGMYPAKSLSRFADIIALCVQPEPEFRPP-----MSEVVQA 685 (720)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 685 (720)
...... ....++...+.++.+|+.+||+.||++||+ ++|++++
T Consensus 245 ~~~~~~--~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 245 SRRILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHhccc--CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 111111 122345567788999999999999999994 7888764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=365.86 Aligned_cols=265 Identities=20% Similarity=0.244 Sum_probs=197.1
Q ss_pred hcCCCccceeccCCCcEEEEEEEc-CCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEee------cC
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE------HG 481 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 481 (720)
.++|++.++||+|+||+||+|.+. +|+.||||++............+.+|+.++++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999875 69999999998776666667789999999999999999999999864 36
Q ss_pred eEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCC
Q 005001 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (720)
Q Consensus 482 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 561 (720)
..|+||||+.++ +.+.+. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 789999999765 445443 5689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHH--hhc-------
Q 005001 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVR--WAT------- 632 (720)
Q Consensus 562 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~--~~~------- 632 (720)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+. ...
T Consensus 166 ~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 8765432 23344679999999999999999999999999999999999999997654322111110 000
Q ss_pred cccccHHHH------------HhhcccccCCC---CChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 633 PQLHDIDAL------------AKMVDPALNGM---YPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 633 ~~~~~~~~~------------~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
......... .+......... .....+.++.+|+++||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 00011111100 112346678999999999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-42 Score=362.56 Aligned_cols=259 Identities=19% Similarity=0.295 Sum_probs=198.8
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEee--cCeEEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAE--HGQRLL 485 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~l 485 (720)
++|++.+.||+|+||+||+|++ .+|+.||||+++.. ..+.+.+|+++++.++ ||||+++++++.. ....++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 5799999999999999999987 46899999998643 2456889999999984 9999999999874 356899
Q ss_pred EEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCC-ceEEcccCCCcc
Q 005001 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAAL 564 (720)
Q Consensus 486 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 564 (720)
||||+++++|.++. +.+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.
T Consensus 110 v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence 99999999987654 4689999999999999999999999 999999999999998655 699999999987
Q ss_pred CCCCCccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhH-H-Hhhc-cc------
Q 005001 565 TPNTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSL-V-RWAT-PQ------ 634 (720)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~-~-~~~~-~~------ 634 (720)
..... ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||........... + .... +.
T Consensus 180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 180 YHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp CCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred ccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 65432 234467999999999988754 79999999999999999999999976554322111 0 0000 00
Q ss_pred ---cccHHHHHhhccc--------ccCCCCChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 635 ---LHDIDALAKMVDP--------ALNGMYPAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 635 ---~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
............. ..........+.++.+||++||+.||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000 00111122345678999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-42 Score=362.58 Aligned_cols=265 Identities=19% Similarity=0.285 Sum_probs=202.8
Q ss_pred hcCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCCCCccccceEEeec-----Ce
Q 005001 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (720)
Q Consensus 409 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 482 (720)
.++|++.+.||+|+||+||+|.+ .+|+.||||++............+.+|++++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999976 4799999999987766666777899999999999999999999998643 34
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEEcccCCC
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 562 (720)
.++|++|+.+|+|.++++ .+.+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 567778888999999986 45799999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccCccccccCC-CcccchhhhHHHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc------
Q 005001 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQSLVRWATPQL------ 635 (720)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~~~~~~~~~~~------ 635 (720)
..... ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.........+.......
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 75432 234467999999999877755 6899999999999999999999998654332222111000000
Q ss_pred -ccHHHHHhhcccccC-CCC-----ChhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 005001 636 -HDIDALAKMVDPALN-GMY-----PAKSLSRFADIIALCVQPEPEFRPPMSEVVQA 685 (720)
Q Consensus 636 -~~~~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 685 (720)
............... ... ....+..+.+||.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000111110000 000 11245678899999999999999999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.7e-37 Score=326.08 Aligned_cols=265 Identities=16% Similarity=0.223 Sum_probs=190.2
Q ss_pred cCCCccceeccCCCcEEEEEEE-cCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC-----------CCCccccceEE
Q 005001 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-----------HPNIVTLAGYC 477 (720)
Q Consensus 410 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~ 477 (720)
.+|++.++||+|+||+||+|++ .+|+.||||+++... .....+.+|+++++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3599999999999999999987 479999999997543 23355667777776654 68899999987
Q ss_pred ee--cCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCc--
Q 005001 478 AE--HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-- 553 (720)
Q Consensus 478 ~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~-- 553 (720)
.. ....+++++++..+........ ......+++..+..++.||+.||+|||+.. +|+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred eeccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCccc
Confidence 54 3466777777655544333222 234578899999999999999999999832 9999999999999986653
Q ss_pred ----eEEcccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHHHHHHhCCCCCCCCCCcchh----
Q 005001 554 ----PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDSSRPRSEQ---- 625 (720)
Q Consensus 554 ----~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~pf~~~~~~~~~---- 625 (720)
++++|||.+...... ....+||+.|+|||++.+..++.++||||+||+++||++|+.||.........
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 899999998765332 23467999999999999999999999999999999999999999754322111
Q ss_pred hHHH--hhccccccHHHH------Hhhccc-------------------ccCCCCChhHHHHHHHHHHHhcCCCCCCCCC
Q 005001 626 SLVR--WATPQLHDIDAL------AKMVDP-------------------ALNGMYPAKSLSRFADIIALCVQPEPEFRPP 678 (720)
Q Consensus 626 ~~~~--~~~~~~~~~~~~------~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 678 (720)
.... ........ ... ....+. ..........+.++.+|+.+||+.||++|||
T Consensus 243 ~~~~~~~~lg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 243 HIAQIIELLGELPS-YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHCSCCH-HHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhCCCCH-HHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 0000 00000000 000 000000 0112234566788999999999999999999
Q ss_pred HHHHHHH
Q 005001 679 MSEVVQA 685 (720)
Q Consensus 679 ~~ell~~ 685 (720)
++|++++
T Consensus 322 a~e~L~H 328 (362)
T d1q8ya_ 322 AGGLVNH 328 (362)
T ss_dssp HHHHHTC
T ss_pred HHHHhcC
Confidence 9999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=4.5e-34 Score=297.66 Aligned_cols=219 Identities=27% Similarity=0.468 Sum_probs=176.5
Q ss_pred CChHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCceeEecCC----CEEEEEcCCCCCcc--cccccccCCCCCCEE
Q 005001 39 TDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGS----AVVSIDISGLGLSG--TMGYLLSDLLSLRKF 112 (720)
Q Consensus 39 ~~~~d~~al~~~~~~~~~~~~l~~w~~~~~~~c~~~w~gv~c~~~----~v~~l~l~~~~l~g--~~~~~l~~l~~L~~L 112 (720)
|.++|++||++||+++.+|+.+++|.. +.|||.++|+||+|+.. ||+.|+|++++++| .+|+.|++|++|++|
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 688999999999999999999999974 45888778999999752 79999999999998 578999999999999
Q ss_pred EccC-CCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcc
Q 005001 113 DLSG-NSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (720)
Q Consensus 113 ~L~~-N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 189 (720)
+|++ |+++|.+|.++. ++|++|+|++|+|.+..|..+.++.+|+.+++++|.+.+.+|..+++++.|+.+++++|.+
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence 9997 899999998886 7999999999999988888888888888888888888888888888888888888888887
Q ss_pred cCCCCccccCCCCC-CeeEeccccccc-----------------------------------------------cccccC
Q 005001 190 SGDLPNSFISLSNI-SSLYLQNNQVTG-----------------------------------------------SLNVFS 221 (720)
Q Consensus 190 ~g~~p~~~~~l~~L-~~L~l~~N~l~~-----------------------------------------------~~~~~~ 221 (720)
+|.+|..+..+.++ +.+++++|+++| .++.+.
T Consensus 162 ~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~ 241 (313)
T d1ogqa_ 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241 (313)
T ss_dssp EEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 77777766665554 555555555433 222211
Q ss_pred C-CCcCeEEccCccCcccCccccc---ccceeeecCCcCCC
Q 005001 222 G-LPLTTLNVANNHFSGWIPRELI---SIRTFIYDGNSFDN 258 (720)
Q Consensus 222 ~-~~L~~l~l~~N~l~g~ip~~l~---~l~~l~l~~n~~~~ 258 (720)
. .+|+.|+|++|+|+|.+|+.|. +|+.|++++|.+.+
T Consensus 242 ~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g 282 (313)
T d1ogqa_ 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccc
Confidence 1 2377888888888888888664 56778888888874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.2e-22 Score=194.37 Aligned_cols=171 Identities=13% Similarity=0.078 Sum_probs=119.9
Q ss_pred CccceeccCCCcEEEEEEEcCCcEEEEEEccccccC----------------hHHHHHHHHHHHHhhcCCCCCccccceE
Q 005001 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS----------------LQEEDNFLEAVSNMSRLRHPNIVTLAGY 476 (720)
Q Consensus 413 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~niv~l~~~ 476 (720)
.+.+.||+|+||+||+|.+.+|+.||||+++..... ........+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 346789999999999999989999999987532110 1112344567888999999999887765
Q ss_pred EeecCeEEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEecCCCCCEEeCCCCceEE
Q 005001 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (720)
Q Consensus 477 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 556 (720)
. ..+++|||++++.+.+ ++...+..++.|++.+++|||+. +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2379999998865433 23344567899999999999999 99999999999999965 5899
Q ss_pred cccCCCccCCCCCccccccccccccccCccccccCCCcccchhhhHHHHH
Q 005001 557 SDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVM 606 (720)
Q Consensus 557 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l 606 (720)
+|||.|........... ....... -.| +....|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~~~--l~rd~~~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREI--LERDVRN-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHH--HHHHHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHH--HHHHHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence 99999876543221100 0000000 011 2246688899999976443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=3.8e-21 Score=194.04 Aligned_cols=174 Identities=22% Similarity=0.204 Sum_probs=154.1
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
.++.|+|++|.|++..+..|.++++|++|+|++|+|+..-+....++|++|+|++|+++ .++..+.++++|+.|+|++|
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~ 110 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN 110 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSS
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccc
Confidence 58899999999998888899999999999999999994333445589999999999999 56788999999999999999
Q ss_pred ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcccCcc
Q 005001 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPR 241 (720)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g~ip~ 241 (720)
.+.+..+..+..+.+|+.|++++|.+++..+..+..+++|+.|++++|+|++..+. +.. .+|+.|+|++|+|+ .+|+
T Consensus 111 ~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~ 189 (266)
T d1p9ag_ 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189 (266)
T ss_dssp CCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCT
T ss_pred ccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccCh
Confidence 99998899999999999999999999977777788999999999999999987754 333 45999999999999 7887
Q ss_pred cc---cccceeeecCCcCCCC
Q 005001 242 EL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 242 ~l---~~l~~l~l~~n~~~~~ 259 (720)
.+ .+|+.|.+.+|||.|.
T Consensus 190 ~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 190 GFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp TTTTTCCCSEEECCSCCBCCS
T ss_pred hHCCCCCCCEEEecCCCCCCC
Confidence 65 4678899999999876
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.83 E-value=3.6e-21 Score=184.03 Aligned_cols=179 Identities=21% Similarity=0.253 Sum_probs=149.3
Q ss_pred CCCCCCceeEecCCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCC-C--CccceeccccccCcCCCC
Q 005001 70 PCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL-P--PNLTSLNLASNNFSGNLP 146 (720)
Q Consensus 70 ~c~~~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~-~--~~L~~L~L~~N~l~g~~p 146 (720)
.|.|+|..|.|+ +++|+ .+|..+. +++++|+|++|+|++.++... . ++|+.|+|++|++.+..+
T Consensus 5 ~C~C~~~~v~Cs----------~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~ 71 (192)
T d1w8aa_ 5 MCHCEGTTVDCT----------GRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP 71 (192)
T ss_dssp TSEEETTEEECT----------TSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCT
T ss_pred CCEEcCCEEEEe----------CCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccc
Confidence 455567666665 45565 4566553 689999999999997665544 2 899999999999999999
Q ss_pred ccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCC-CCc
Q 005001 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPL 225 (720)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L 225 (720)
..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+.... ..+
T Consensus 72 ~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l 151 (192)
T d1w8aa_ 72 NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWL 151 (192)
T ss_dssp TTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHH
T ss_pred cccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhh
Confidence 9999999999999999999999999999999999999999999987788899999999999999999875543221 226
Q ss_pred CeEEccCccCcccCcccccccceeeecCCcCCCCCC
Q 005001 226 TTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPA 261 (720)
Q Consensus 226 ~~l~l~~N~l~g~ip~~l~~l~~l~l~~n~~~~~~~ 261 (720)
+.+.+..|.++...|..+.+++.+++..|.|.|.+.
T Consensus 152 ~~~~l~~~~~~c~~p~~l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 152 RKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp HHHCCSGGGCBBCSSTTTTTSBGGGSCTTTCCCCCC
T ss_pred hhhcccCCCeEeCCChhhcCCEeeecCHhhCcCCCC
Confidence 677788899998899999999889999999987653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=3.1e-19 Score=181.72 Aligned_cols=185 Identities=21% Similarity=0.189 Sum_probs=129.8
Q ss_pred CceeEecCC-----------CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCC----------------
Q 005001 75 WKGVACEGS-----------AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---------------- 127 (720)
Q Consensus 75 w~gv~c~~~-----------~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~---------------- 127 (720)
|.-|.|++. .++.|+|++|+|++..+..|.++++|++|++++|+|.+..+..+
T Consensus 13 ~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 13 KVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp SCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred CeEEEcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 556888752 46789999999998777889999999999999999874433221
Q ss_pred ---------C--CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCcc
Q 005001 128 ---------P--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196 (720)
Q Consensus 128 ---------~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 196 (720)
. ++|++|+|++|.+.+..+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+..
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~ 172 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhh
Confidence 1 46777777777776555666666777777777777777666666777777777777777777666666
Q ss_pred ccCCCCCCeeEecccccccccccc-CC-CCcCeEEccCccCcccCcccc---cccceeeecCCcCCCC
Q 005001 197 FISLSNISSLYLQNNQVTGSLNVF-SG-LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 197 ~~~l~~L~~L~l~~N~l~~~~~~~-~~-~~L~~l~l~~N~l~g~ip~~l---~~l~~l~l~~n~~~~~ 259 (720)
|.++++|+.|++++|++++..+.. .. .+|+.|++++|.+++..|..| .+|+.+++++|++.|.
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred hccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 677777777777777777654432 22 347777777777776655544 3466677777777654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.78 E-value=3.3e-20 Score=191.80 Aligned_cols=181 Identities=27% Similarity=0.355 Sum_probs=142.7
Q ss_pred CCEEEEEcCC-CCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEE
Q 005001 83 SAVVSIDISG-LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (720)
Q Consensus 83 ~~v~~l~l~~-~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 159 (720)
..++.|+|++ |+++|.+|+.|++|++|++|+|++|+|.+..|..+. .+|+.+++++|++.+.+|..++++++|+.++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceee
Confidence 4688899987 899999999999999999999999999987775443 6677777777777777777777777777777
Q ss_pred ccccccccccccccCC------------------------------------------------CCCCCeeecCCCcccC
Q 005001 160 VSRNSLTQSIGDIFGN------------------------------------------------LAGLATLDLSFNNFSG 191 (720)
Q Consensus 160 L~~N~l~~~~p~~~~~------------------------------------------------l~~L~~L~l~~N~l~g 191 (720)
+++|.++|.+|..+.. +++|+.|++++|.+++
T Consensus 156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 7777777666654433 3456666666666665
Q ss_pred CCCccccCCCCCCeeEecccccccccccc-CC-CCcCeEEccCccCcccCcc--cccccceeeecCCcCCCCCCCCC
Q 005001 192 DLPNSFISLSNISSLYLQNNQVTGSLNVF-SG-LPLTTLNVANNHFSGWIPR--ELISIRTFIYDGNSFDNGPAPPP 264 (720)
Q Consensus 192 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~-~~L~~l~l~~N~l~g~ip~--~l~~l~~l~l~~n~~~~~~~~~~ 264 (720)
.+| .++.+++|+.|+|++|+|+|.+|.. .. .+|+.|+|++|+|+|.+|. .+.+|+.+.+.+|++.|+.|.|+
T Consensus 236 ~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~ 311 (313)
T d1ogqa_ 236 DLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311 (313)
T ss_dssp BGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSC
T ss_pred ccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCC
Confidence 544 5777889999999999999988753 33 4599999999999999996 35678888999999888765443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.76 E-value=2.4e-18 Score=176.93 Aligned_cols=186 Identities=22% Similarity=0.262 Sum_probs=122.1
Q ss_pred CCCCCCCceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceec
Q 005001 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLN 135 (720)
Q Consensus 69 ~~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~ 135 (720)
-.|.|.|++|.|++ ..++.|+|++|+|+...+..|.++++|++|++++|.+....|..+. ++|+.|+
T Consensus 6 ~~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~ 85 (305)
T d1xkua_ 6 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 85 (305)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEec
Confidence 35667999999975 3577899999999977777899999999999999999976676554 7888888
Q ss_pred cccccCcCCCCcc------------------------------------------------ccccCCccEEEcccccccc
Q 005001 136 LASNNFSGNLPYS------------------------------------------------IASMVSLSYLNVSRNSLTQ 167 (720)
Q Consensus 136 L~~N~l~g~~p~~------------------------------------------------~~~l~~L~~L~L~~N~l~~ 167 (720)
|++|+++ .+|.. +..+++|+++++++|.++.
T Consensus 86 l~~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~ 164 (305)
T d1xkua_ 86 LSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164 (305)
T ss_dssp CCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred ccCCccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence 8888776 23322 2223455555555555542
Q ss_pred ccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccccccccc-C-CCCcCeEEccCccCcccCcccc--
Q 005001 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-S-GLPLTTLNVANNHFSGWIPREL-- 243 (720)
Q Consensus 168 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~L~~l~l~~N~l~g~ip~~l-- 243 (720)
+|.. .+++|+.|++++|.+++..+..+..++.++.|++++|.+++..+.. . ..+|++|+|++|+|+ .+|..|
T Consensus 165 -l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~ 240 (305)
T d1xkua_ 165 -IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240 (305)
T ss_dssp -CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -cCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccc
Confidence 2222 2455666666666666666666666666666666666666644322 1 234666666666666 445433
Q ss_pred -cccceeeecCCcCCCC
Q 005001 244 -ISIRTFIYDGNSFDNG 259 (720)
Q Consensus 244 -~~l~~l~l~~n~~~~~ 259 (720)
.+|+.|++.+|++...
T Consensus 241 l~~L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISAI 257 (305)
T ss_dssp CSSCCEEECCSSCCCCC
T ss_pred ccCCCEEECCCCccCcc
Confidence 3555666666665543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=5.9e-17 Score=162.80 Aligned_cols=172 Identities=23% Similarity=0.260 Sum_probs=142.7
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEcc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~ 161 (720)
+...++.++++|+. +|+.+. ++|++|+|++|+|++..+..+. ++|++|+|++|+|+ .+| .++.+++|++|+|+
T Consensus 11 ~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccc
Confidence 44556788888884 676664 5799999999999965444454 89999999999999 455 46789999999999
Q ss_pred ccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccC-C-CCcCeEEccCccCcccC
Q 005001 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS-G-LPLTTLNVANNHFSGWI 239 (720)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~l~l~~N~l~g~i 239 (720)
+|+|++ ++..+..+++|++|++++|.+.+..+..+..+.+|.+|++++|.+++..+... . ..++.|++++|+|++..
T Consensus 86 ~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~ 164 (266)
T d1p9ag_ 86 HNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164 (266)
T ss_dssp SSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred cccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence 999985 47789999999999999999998788888999999999999999998765433 2 45999999999999877
Q ss_pred cccc---cccceeeecCCcCCCCCC
Q 005001 240 PREL---ISIRTFIYDGNSFDNGPA 261 (720)
Q Consensus 240 p~~l---~~l~~l~l~~n~~~~~~~ 261 (720)
|..| .+|+.|++.+|.+...|.
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~~lp~ 189 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLYTIPK 189 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred ccccccccccceeecccCCCcccCh
Confidence 7654 678899999999986543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=2.8e-17 Score=156.58 Aligned_cols=151 Identities=24% Similarity=0.290 Sum_probs=128.6
Q ss_pred CCEEEccCCCCCCCCCCCCCCccceeccccccCcCCC-CccccccCCccEEEccccccccccccccCCCCCCCeeecCCC
Q 005001 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNL-PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFN 187 (720)
Q Consensus 109 L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 187 (720)
.+.++.++|+++ .+|..+.+++++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CCEEEEeCCCcC-ccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 357899999999 899999999999999999998755 567899999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCeeEeccccccccccc-cCC-CCcCeEEccCccCcccCccc-c-cccceeeecCCcCCCCC
Q 005001 188 NFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPRE-L-ISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 188 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~l~l~~N~l~g~ip~~-l-~~l~~l~l~~n~~~~~~ 260 (720)
+|++..|..|.++++|++|+|++|+|++..+. +.. .+|++|+|++|.+....+.. + ..++.+.+..|.+.|..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCC
Confidence 99987788899999999999999999997764 333 45999999999998644322 2 34556667777777643
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=6.8e-17 Score=164.10 Aligned_cols=175 Identities=18% Similarity=0.181 Sum_probs=143.2
Q ss_pred CEEEEEc-CCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEc
Q 005001 84 AVVSIDI-SGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (720)
Q Consensus 84 ~v~~l~l-~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 160 (720)
.+..++. ..+.++...+..|.++++|++|+|++|.+.+..+..+. .+|+.+++++|+|++..+..|..+++|+.|+|
T Consensus 81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhccc
Confidence 4556655 46677777788999999999999999999865554443 78999999999999777788999999999999
Q ss_pred cccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccc-cC-CCCcCeEEccCccCccc
Q 005001 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FS-GLPLTTLNVANNHFSGW 238 (720)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~-~~~L~~l~l~~N~l~g~ 238 (720)
++|+|++..+..|.++++|+.|++++|++++..|..|..+++|++|++++|+|++..+. +. ..+|+.|+|++|.+.+.
T Consensus 161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 99999999999999999999999999999998899999999999999999999997753 33 34599999999999864
Q ss_pred Cccc-c-cccceeeecCCcCCC
Q 005001 239 IPRE-L-ISIRTFIYDGNSFDN 258 (720)
Q Consensus 239 ip~~-l-~~l~~l~l~~n~~~~ 258 (720)
-+.. + ..++.+....+.+.|
T Consensus 241 C~~~~l~~~l~~~~~~~~~~~C 262 (284)
T d1ozna_ 241 CRARPLWAWLQKFRGSSSEVPC 262 (284)
T ss_dssp GGGHHHHHHHHHCCSEECCCBE
T ss_pred ccchHHHHHHHhCcCCCCceEe
Confidence 4321 1 234444444455554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.63 E-value=1.1e-15 Score=146.06 Aligned_cols=155 Identities=24% Similarity=0.362 Sum_probs=127.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|+++++++... +.+..+++|++|+|++|+|++..|..-.++|+.|++++|.+. .++ .++++++|+.|++++
T Consensus 40 ~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~ 115 (199)
T d2omxa2 40 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFN 115 (199)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCS
T ss_pred cCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCcccccCCcccccccccccccc-ccc-ccccccccccccccc
Confidence 4688999999998753 358899999999999999997666444589999999999988 444 488999999999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCccc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRE 242 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~~ 242 (720)
|.+.... .+..+++|+.|++++|++. .++ .+..+++|+.|++.+|++++..+.....+|+.|+|++|++++ +| .
T Consensus 116 ~~~~~~~--~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~-i~-~ 189 (199)
T d2omxa2 116 NQITDID--PLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-IS-V 189 (199)
T ss_dssp SCCCCCG--GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-G
T ss_pred ccccccc--ccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCCC-Cc-c
Confidence 9998653 4788999999999999998 444 588999999999999999986655555679999999999985 44 3
Q ss_pred ccccc
Q 005001 243 LISIR 247 (720)
Q Consensus 243 l~~l~ 247 (720)
+.+++
T Consensus 190 l~~L~ 194 (199)
T d2omxa2 190 LAKLT 194 (199)
T ss_dssp GGGCT
T ss_pred ccCCC
Confidence 44443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.63 E-value=9.9e-16 Score=147.84 Aligned_cols=161 Identities=21% Similarity=0.268 Sum_probs=133.3
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
.++.|+++++++++.. .+..+++|++|+|++|+|++..|....++|++|+|++|+|++ +| .+.++++|+.|++++|
T Consensus 47 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~ 122 (210)
T d1h6ta2 47 SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHN 122 (210)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTS
T ss_pred CccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCccccccCccccccccccccccc-cc-cccccccccccccccc
Confidence 6889999999998643 488999999999999999986666556899999999999994 55 5899999999999999
Q ss_pred ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCcc--
Q 005001 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR-- 241 (720)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip~-- 241 (720)
.+... ..+..++.|+.+++++|.+++ +..+..+++|+++++++|++++..+.....+|+.|+|++|+|+. +|.
T Consensus 123 ~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~~-l~~l~ 197 (210)
T d1h6ta2 123 GISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRALA 197 (210)
T ss_dssp CCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CGGGT
T ss_pred ccccc--ccccccccccccccccccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCCC-Chhhc
Confidence 98743 468889999999999999984 34578899999999999999986665555679999999999984 663
Q ss_pred cccccceeeecC
Q 005001 242 ELISIRTFIYDG 253 (720)
Q Consensus 242 ~l~~l~~l~l~~ 253 (720)
.+.+|+.|++.+
T Consensus 198 ~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 198 GLKNLDVLELFS 209 (210)
T ss_dssp TCTTCSEEEEEE
T ss_pred CCCCCCEEEccC
Confidence 345677777653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.57 E-value=8.4e-15 Score=139.93 Aligned_cols=164 Identities=18% Similarity=0.242 Sum_probs=131.4
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcccccccc
Q 005001 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167 (720)
Q Consensus 88 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~ 167 (720)
+.++.+++++.++ ...+.+|++|++++|.++..-..+..++|++|+|++|+|++. ++ ++++++|++|++++|.+..
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~~ 98 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIAD 98 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCccccccCCCcCcCccccccccCc-cc-ccCCccccccccccccccc
Confidence 3455666666543 356789999999999998533334458999999999999964 33 8999999999999999985
Q ss_pred ccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCc-cccccc
Q 005001 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-RELISI 246 (720)
Q Consensus 168 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip-~~l~~l 246 (720)
.. .+.+++.|+.|++++|.+... ..+..+++|+.|++++|++..........+|+.|++++|++++..| ..+.+|
T Consensus 99 ~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L 174 (199)
T d2omxa2 99 IT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTL 174 (199)
T ss_dssp CG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGGGTTCTTC
T ss_pred cc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcccccccccccccccccccccccCCccccCCCCC
Confidence 43 488999999999999999853 3488899999999999999875444555679999999999996433 356789
Q ss_pred ceeeecCCcCCCC
Q 005001 247 RTFIYDGNSFDNG 259 (720)
Q Consensus 247 ~~l~l~~n~~~~~ 259 (720)
+.|++.+|++...
T Consensus 175 ~~L~ls~N~i~~i 187 (199)
T d2omxa2 175 ERLDISSNKVSDI 187 (199)
T ss_dssp CEEECCSSCCCCC
T ss_pred CEEECCCCCCCCC
Confidence 9999999988653
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.56 E-value=1e-14 Score=142.40 Aligned_cols=168 Identities=23% Similarity=0.326 Sum_probs=120.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
..++.|++.+++|+. + +.+..+++|++|+|++|++++..|....++|++|++++|.++ .++ .+.++++|+.|++++
T Consensus 41 ~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~ 116 (227)
T d1h6ua2 41 DGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTS 116 (227)
T ss_dssp HTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTT
T ss_pred CCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccccccccccccccccccccc-ccc-ccccccccccccccc
Confidence 468889999999885 3 358899999999999999987777666689999999999887 343 578899999999998
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCc--
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-- 240 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip-- 240 (720)
|...+..+ +...+.+..+.++++.+.... .+..+++|+.|++++|++++..+.....+|+.|+|++|++++ +|
T Consensus 117 ~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~-l~~l 191 (227)
T d1h6ua2 117 TQITDVTP--LAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPL 191 (227)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CGGG
T ss_pred ccccccch--hccccchhhhhchhhhhchhh--hhccccccccccccccccccchhhcccccceecccCCCccCC-Chhh
Confidence 88775433 455667777777777766432 255666777777777777655544444457777777777764 33
Q ss_pred ccccccceeeecCCcCCCC
Q 005001 241 RELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 241 ~~l~~l~~l~l~~n~~~~~ 259 (720)
..+.+|+.|++.+|++...
T Consensus 192 ~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 192 ASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp GGCTTCCEEECTTSCCCBC
T ss_pred cCCCCCCEEECcCCcCCCC
Confidence 2455666777777766543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.55 E-value=1.1e-14 Score=153.83 Aligned_cols=163 Identities=26% Similarity=0.359 Sum_probs=91.1
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcccc
Q 005001 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 163 (720)
+++.|++++|.++.. +.+..+++|+.|++++|.+++..+....++|++|++++|++++.. .+.+++.++.+++++|
T Consensus 220 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n 295 (384)
T d2omza2 220 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNEN 295 (384)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSS
T ss_pred CCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCcccccccCCEeeccCcccCCCC--cccccccccccccccc
Confidence 345555555555432 245555555566666665555444444455666666666555322 2455555566666666
Q ss_pred ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCc-cc
Q 005001 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-RE 242 (720)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip-~~ 242 (720)
.+++. ..+..+++++.|+|++|++++.. .+..+++|+.|+|++|+|++........+|+.|+|++|+|++.+| ..
T Consensus 296 ~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~~l~~l~~ 371 (384)
T d2omza2 296 QLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLTPLAN 371 (384)
T ss_dssp CCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCBCGGGTT
T ss_pred ccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCChhHcCCCCCCEEECCCCcCCCChhhcc
Confidence 55542 23555666667777777766432 256666777777777766653322233446777777777765444 23
Q ss_pred ccccceeeecCC
Q 005001 243 LISIRTFIYDGN 254 (720)
Q Consensus 243 l~~l~~l~l~~n 254 (720)
+.+|+.|++++|
T Consensus 372 l~~L~~L~L~~N 383 (384)
T d2omza2 372 LTRITQLGLNDQ 383 (384)
T ss_dssp CTTCSEEECCCE
T ss_pred CCCCCEeeCCCC
Confidence 445666666655
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.53 E-value=2e-14 Score=138.52 Aligned_cols=163 Identities=23% Similarity=0.388 Sum_probs=132.2
Q ss_pred EcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccc
Q 005001 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168 (720)
Q Consensus 89 ~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~ 168 (720)
++..+.+.+.++. ..|.+|++|++++|.+++..+.+..++|++|+|++|+|++ ++ .++++++|++|++++|+|++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~- 104 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD- 104 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCchhHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-
Confidence 4455555555443 3577899999999999865555556999999999999996 44 47899999999999999986
Q ss_pred cccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCc-ccccccc
Q 005001 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-RELISIR 247 (720)
Q Consensus 169 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip-~~l~~l~ 247 (720)
+| .+..+++|+.|++++|.+. .+ ..+..+++|+.+++++|.+++........+|+.+++++|++++..| ..+.+|+
T Consensus 105 l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~ 181 (210)
T d1h6ta2 105 LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQ 181 (210)
T ss_dssp GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCC
T ss_pred cc-ccccccccccccccccccc-cc-ccccccccccccccccccccccccccccccccccccccccccccccccCCCCCC
Confidence 44 5889999999999999997 34 3588999999999999999986655556679999999999996433 3567889
Q ss_pred eeeecCCcCCCC
Q 005001 248 TFIYDGNSFDNG 259 (720)
Q Consensus 248 ~l~l~~n~~~~~ 259 (720)
.|++++|.+...
T Consensus 182 ~L~Ls~N~i~~l 193 (210)
T d1h6ta2 182 NLYLSKNHISDL 193 (210)
T ss_dssp EEECCSSCCCBC
T ss_pred EEECCCCCCCCC
Confidence 999999988643
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.52 E-value=4.6e-14 Score=144.37 Aligned_cols=114 Identities=26% Similarity=0.392 Sum_probs=70.8
Q ss_pred cccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCC
Q 005001 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179 (720)
Q Consensus 100 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 179 (720)
+..+..+++|+.+++++|.++ .+|..+.++|+.|++++|.+++..+..+.+++.+++|++++|.+++..+..+.++++|
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~-~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L 221 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCC-SCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred ccccccccccCccccccCCcc-ccCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccc
Confidence 334555666666666666665 4555555666666666666666666666666666666666666666656666666666
Q ss_pred CeeecCCCcccCCCCccccCCCCCCeeEeccccccc
Q 005001 180 ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (720)
Q Consensus 180 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (720)
++|+|++|+|+ .+|..|..+++|++|+|++|+|+.
T Consensus 222 ~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 222 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred eeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence 66666666666 456566666666666666666654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=4.5e-14 Score=139.18 Aligned_cols=191 Identities=19% Similarity=0.202 Sum_probs=140.9
Q ss_pred CCCCCCCceeEecC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCC---CCcccee
Q 005001 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSL 134 (720)
Q Consensus 69 ~~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~---~~~L~~L 134 (720)
..|.|....|.|+. ..++.|+|++|.|+...+..|.++++|++|+|++|.+...+|... .+++++|
T Consensus 4 ~~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l 83 (242)
T d1xwdc1 4 RICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 83 (242)
T ss_dssp SSEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEE
T ss_pred CcCCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccc
Confidence 35767889999973 258889999999987767789999999999999999987766543 2678888
Q ss_pred ccc-cccCcCCCCccccccCCccEEEcccccccccccc-ccCCCCCCCeeecCCCcccCCCCccccCCC-CCCeeEeccc
Q 005001 135 NLA-SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGD-IFGNLAGLATLDLSFNNFSGDLPNSFISLS-NISSLYLQNN 211 (720)
Q Consensus 135 ~L~-~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~-~L~~L~l~~N 211 (720)
++. .|++....+..|.++++|+.|++++|.+....+. .+..+..|..+..+++++....+..+..++ .++.|++++|
T Consensus 84 ~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n 163 (242)
T d1xwdc1 84 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 163 (242)
T ss_dssp EEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred cccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccc
Confidence 875 4788877888899999999999999999754332 344566666667778788755556666554 7888888888
Q ss_pred cccccccc-cCCCCcCe-EEccCccCcccCcc-c---ccccceeeecCCcCCCCC
Q 005001 212 QVTGSLNV-FSGLPLTT-LNVANNHFSGWIPR-E---LISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 212 ~l~~~~~~-~~~~~L~~-l~l~~N~l~g~ip~-~---l~~l~~l~l~~n~~~~~~ 260 (720)
+++...+. +...++.. +++++|+|+ .+|. . +.+|+.|++.+|++...|
T Consensus 164 ~l~~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~ 217 (242)
T d1xwdc1 164 GIQEIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLP 217 (242)
T ss_dssp CCCEECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCC
T ss_pred cccccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCccC
Confidence 88875443 33444444 456777887 4553 2 357788888888887543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=6.1e-14 Score=122.43 Aligned_cols=83 Identities=28% Similarity=0.334 Sum_probs=39.0
Q ss_pred CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCC-CccccCCCCCCeeE
Q 005001 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDL-PNSFISLSNISSLY 207 (720)
Q Consensus 129 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~L~ 207 (720)
++|++|+|++|+|+ .+|+.++.+++|+.|++++|.|++. | .++.+++|++|++++|+|+... ...++.+++|++|+
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~ 96 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 96 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEE
Confidence 34444444444444 3444455555555555555555432 2 2455555555555555554211 12344455555555
Q ss_pred ecccccc
Q 005001 208 LQNNQVT 214 (720)
Q Consensus 208 l~~N~l~ 214 (720)
+++|+|+
T Consensus 97 l~~N~i~ 103 (124)
T d1dcea3 97 LQGNSLC 103 (124)
T ss_dssp CTTSGGG
T ss_pred CCCCcCC
Confidence 5555544
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.47 E-value=9.2e-14 Score=146.64 Aligned_cols=143 Identities=24% Similarity=0.321 Sum_probs=125.6
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
..++.|++++|.+++..+ ++.+++|++|++++|.+++..+....+.++.++++.|++++ ...+..+++|+.|+|++
T Consensus 241 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~ 316 (384)
T d2omza2 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYF 316 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCS
T ss_pred cccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccccccccc--ccccchhcccCeEECCC
Confidence 468899999999987654 88999999999999999977766666899999999999996 34689999999999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANN 233 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N 233 (720)
|++++..+ +..+++|+.|+|++|+|++ ++ .++++++|++|+|++|+|++.++.....+|+.|+|++|
T Consensus 317 n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 317 NNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 99998643 8899999999999999994 55 69999999999999999999877555567999999998
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=3.2e-14 Score=130.65 Aligned_cols=110 Identities=22% Similarity=0.276 Sum_probs=67.5
Q ss_pred cccCCCCCCEEEccCCCCCCCCCCCC--CCccceeccccccCcCCCCccccccCCccEEEccccccccccccccCCCCCC
Q 005001 102 LLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179 (720)
Q Consensus 102 ~l~~l~~L~~L~L~~N~l~~~~p~~~--~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 179 (720)
.+.+...|++|||++|+|+ .+|..+ .++|+.|+|++|+|+ .++ .+..+++|++|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 3556667777777777776 334221 256666666666666 332 46666677777777777665555455566677
Q ss_pred CeeecCCCcccCCCC--ccccCCCCCCeeEeccccccc
Q 005001 180 ATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTG 215 (720)
Q Consensus 180 ~~L~l~~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~ 215 (720)
+.|+|++|+|+. ++ ..+..+++|++|++++|.++.
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCcccc
Confidence 777777776662 33 245566666666666666654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=1.4e-13 Score=120.13 Aligned_cols=115 Identities=23% Similarity=0.282 Sum_probs=94.8
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccc
Q 005001 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (720)
Q Consensus 87 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~ 164 (720)
.|+|++|+|+. ++ .+..+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++ +| .++++++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 68999999984 44 5899999999999999998 6776665 899999999999994 55 59999999999999999
Q ss_pred ccccc-ccccCCCCCCCeeecCCCcccCCC--Cc-cccCCCCCCee
Q 005001 165 LTQSI-GDIFGNLAGLATLDLSFNNFSGDL--PN-SFISLSNISSL 206 (720)
Q Consensus 165 l~~~~-p~~~~~l~~L~~L~l~~N~l~g~~--p~-~~~~l~~L~~L 206 (720)
|+... ...+..+++|+.|+|++|.++..- +. .+..+++|+.|
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 99654 367899999999999999998421 22 23456777765
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=9.3e-14 Score=127.44 Aligned_cols=123 Identities=19% Similarity=0.162 Sum_probs=101.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.++..|+|++|+|+.. +..+..+++|++|||++|.|+..-.....++|++|+|++|+++...+..+..+++|+.|+|++
T Consensus 18 ~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~ 96 (162)
T d1a9na_ 18 VRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 96 (162)
T ss_dssp TSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred CcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCccCCcccCcchhhhhcccccccCCCccccccccccccceecc
Confidence 3688999999999865 666788999999999999999432233348999999999999965555677899999999999
Q ss_pred cccccccc-cccCCCCCCCeeecCCCcccCCCCc----cccCCCCCCeeE
Q 005001 163 NSLTQSIG-DIFGNLAGLATLDLSFNNFSGDLPN----SFISLSNISSLY 207 (720)
Q Consensus 163 N~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~----~~~~l~~L~~L~ 207 (720)
|+|+.... ..+..+++|++|+|++|.++ ..|. .+..+++|++||
T Consensus 97 N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 97 NSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred ccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 99986432 56889999999999999998 4553 477889999887
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.40 E-value=4.5e-13 Score=130.51 Aligned_cols=167 Identities=23% Similarity=0.326 Sum_probs=135.1
Q ss_pred EEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEcccccc
Q 005001 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165 (720)
Q Consensus 86 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l 165 (720)
+.++++.+++++.+ .+..|++|+.|++++|+|+..-+.+..++|++|+|++|++++..| +.++++|++|++++|.+
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcchhHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence 34456666666643 467789999999999999854333445999999999999996543 89999999999999999
Q ss_pred ccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEeccccccccccccCCCCcCeEEccCccCcccCc-cccc
Q 005001 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-RELI 244 (720)
Q Consensus 166 ~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~g~ip-~~l~ 244 (720)
+. + +.+..+++|+.|++++|...+.. .+...+.+..++++++.+....+.....+|+.|++++|.+++..+ ..+.
T Consensus 98 ~~-i-~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~l~~l~ 173 (227)
T d1h6ua2 98 KN-V-SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLS 173 (227)
T ss_dssp SC-C-GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGTTCT
T ss_pred cc-c-ccccccccccccccccccccccc--hhccccchhhhhchhhhhchhhhhccccccccccccccccccchhhcccc
Confidence 84 3 35889999999999999988543 367788999999999999887776667779999999999986544 4567
Q ss_pred ccceeeecCCcCCCCC
Q 005001 245 SIRTFIYDGNSFDNGP 260 (720)
Q Consensus 245 ~l~~l~l~~n~~~~~~ 260 (720)
+|+.|++.+|.+...+
T Consensus 174 ~L~~L~Ls~n~l~~l~ 189 (227)
T d1h6ua2 174 KLTTLKADDNKISDIS 189 (227)
T ss_dssp TCCEEECCSSCCCCCG
T ss_pred cceecccCCCccCCCh
Confidence 8999999999987543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=7.6e-12 Score=113.65 Aligned_cols=73 Identities=21% Similarity=0.237 Sum_probs=52.9
Q ss_pred CcCCCCccccccCCccEEEccccccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEecccccc
Q 005001 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (720)
Q Consensus 141 l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (720)
|+..-+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+ .+|.......+|+.|+|++|.|.
T Consensus 44 l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 44 LQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 34333456777888888888888888777778888888888888888888 55555444446777777777764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.21 E-value=1.6e-11 Score=111.41 Aligned_cols=105 Identities=17% Similarity=0.151 Sum_probs=88.5
Q ss_pred cceeccccccCcCCCCccccccCCccEEEcccc-ccccccccccCCCCCCCeeecCCCcccCCCCccccCCCCCCeeEec
Q 005001 131 LTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN-SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQ 209 (720)
Q Consensus 131 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 209 (720)
.+.++++++++. .+|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 445677777776 57788888999999999866 5888778899999999999999999997778889999999999999
Q ss_pred cccccccccc-cCCCCcCeEEccCccCc
Q 005001 210 NNQVTGSLNV-FSGLPLTTLNVANNHFS 236 (720)
Q Consensus 210 ~N~l~~~~~~-~~~~~L~~l~l~~N~l~ 236 (720)
+|+|+...+. +...+|+.|+|++|.|.
T Consensus 89 ~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCcccChhhhccccccccccCCCccc
Confidence 9999975543 44457899999999884
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.21 E-value=9.7e-14 Score=131.93 Aligned_cols=114 Identities=25% Similarity=0.291 Sum_probs=87.4
Q ss_pred cccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEEccccccccccccccCC
Q 005001 98 TMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGN 175 (720)
Q Consensus 98 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 175 (720)
.++..|..|++|++|+|++|+|+. ++ .+. ++|++|+|++|+|+ .+|.....+++|+.|++++|+|+.. +.+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence 345678889999999999999884 43 233 78888889888887 5676666677888888888888853 34677
Q ss_pred CCCCCeeecCCCcccCCCC--ccccCCCCCCeeEeccccccccc
Q 005001 176 LAGLATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTGSL 217 (720)
Q Consensus 176 l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~~ 217 (720)
+++|+.|+|++|+|+. ++ ..+..+++|+.|+|++|+++...
T Consensus 114 l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~ 156 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp HHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred cccccccccccchhcc-ccccccccCCCccceeecCCCccccCc
Confidence 8888888888888874 33 35778888888888888877643
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.18 E-value=2.2e-10 Score=118.44 Aligned_cols=169 Identities=22% Similarity=0.269 Sum_probs=109.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|+|++|+|+ .+|..+ .+|+.|++++|+++ .++ .+.+.|++|+|++|.++ .+|. ++.+++|+.|++++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~-~lp~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~ 129 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALS-DLPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDN 129 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCC-SCCTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCS
T ss_pred CCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhh-hhccccccccccccccc-cccc-hhhhccceeecccc
Confidence 36788888888887 556543 46778888888887 344 34567999999999988 5664 57888999999888
Q ss_pred cccccccc------------------cccCCCCCCCeeecCCCcccCCC------------------CccccCCCCCCee
Q 005001 163 NSLTQSIG------------------DIFGNLAGLATLDLSFNNFSGDL------------------PNSFISLSNISSL 206 (720)
Q Consensus 163 N~l~~~~p------------------~~~~~l~~L~~L~l~~N~l~g~~------------------p~~~~~l~~L~~L 206 (720)
|.++.... ..+..++.++.|++++|.+.... ...+..++.|+.+
T Consensus 130 ~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l 209 (353)
T d1jl5a_ 130 NSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTI 209 (353)
T ss_dssp SCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEE
T ss_pred ccccccccccccccchhhccccccccccccccccceeccccccccccccccccccccccccccccccccccccccccccc
Confidence 87764322 22444556666666666544210 1123345556666
Q ss_pred Eeccccccccc------------------------------------------cc--------------c-C-CCCcCeE
Q 005001 207 YLQNNQVTGSL------------------------------------------NV--------------F-S-GLPLTTL 228 (720)
Q Consensus 207 ~l~~N~l~~~~------------------------------------------~~--------------~-~-~~~L~~l 228 (720)
++++|...... +. . . ..+|++|
T Consensus 210 ~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L 289 (353)
T d1jl5a_ 210 YADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEEL 289 (353)
T ss_dssp ECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhcccccccCccccccccCCCCCEE
Confidence 66555432100 00 0 0 0147888
Q ss_pred EccCccCcccCcccccccceeeecCCcCCCCC
Q 005001 229 NVANNHFSGWIPRELISIRTFIYDGNSFDNGP 260 (720)
Q Consensus 229 ~l~~N~l~g~ip~~l~~l~~l~l~~n~~~~~~ 260 (720)
+|++|+|+ .+|..+.+|+.|++++|.+...|
T Consensus 290 ~Ls~N~l~-~lp~~~~~L~~L~L~~N~L~~l~ 320 (353)
T d1jl5a_ 290 NVSNNKLI-ELPALPPRLERLIASFNHLAEVP 320 (353)
T ss_dssp ECCSSCCS-CCCCCCTTCCEEECCSSCCSCCC
T ss_pred ECCCCccC-ccccccCCCCEEECCCCcCCccc
Confidence 88888888 68888888888888888877554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.11 E-value=8.4e-13 Score=125.32 Aligned_cols=126 Identities=25% Similarity=0.254 Sum_probs=101.2
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCC--CccceeccccccCcCCCCccccccCCccEEE
Q 005001 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (720)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 159 (720)
-.+++.|+|++|+|+. ++ .|..|++|++|+|++|.|+ .+|.... ++|++|+|++|+++. + +.+.++++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEE
T ss_pred ccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccccccc
Confidence 3579999999999985 44 5999999999999999998 5554332 689999999999994 4 4588999999999
Q ss_pred ccccccccccc-cccCCCCCCCeeecCCCcccCCCCcc----------ccCCCCCCeeEecccccc
Q 005001 160 VSRNSLTQSIG-DIFGNLAGLATLDLSFNNFSGDLPNS----------FISLSNISSLYLQNNQVT 214 (720)
Q Consensus 160 L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~----------~~~l~~L~~L~l~~N~l~ 214 (720)
|++|+|+.... ..+..+++|+.|+|++|.+....+.. +..+++|+.|| +..|+
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence 99999986532 57899999999999999997544432 45678888876 44443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.10 E-value=4.7e-10 Score=115.87 Aligned_cols=121 Identities=26% Similarity=0.328 Sum_probs=91.5
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCccEEEccc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 162 (720)
.+++.|||++++|+. +|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .++|++|+|++
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~-~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP-QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC-TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch-hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 467899999999984 6654 468999999999999 778654 79999999999998 44431 14699999999
Q ss_pred cccccccccccCCCCCCCeeecCCCcccCCCC------------------ccccCCCCCCeeEeccccccc
Q 005001 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP------------------NSFISLSNISSLYLQNNQVTG 215 (720)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p------------------~~~~~l~~L~~L~l~~N~l~~ 215 (720)
|.++. +|. ++.+++|+.|++++|.+....+ ..+..++.++.|++++|.+..
T Consensus 108 n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 108 NQLEK-LPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp SCCSS-CCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS
T ss_pred ccccc-ccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccc
Confidence 99984 554 6889999999999998874222 123344555666666665543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.09 E-value=2.2e-10 Score=112.05 Aligned_cols=171 Identities=16% Similarity=0.171 Sum_probs=130.1
Q ss_pred CCEEEEEcCCCCCccccc-ccccCCCCCCEEEccC-CCCCCCCCCCCC--CccceeccccccCcCCCC-ccccccCCccE
Q 005001 83 SAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSG-NSIHDTIPYQLP--PNLTSLNLASNNFSGNLP-YSIASMVSLSY 157 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~-~~l~~l~~L~~L~L~~-N~l~~~~p~~~~--~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~ 157 (720)
.+++.|+|++|.+...++ ..|.+++.+++|++.. |++....+..+. ++|+.|++++|++....+ ..+..+..|..
T Consensus 53 ~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~ 132 (242)
T d1xwdc1 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132 (242)
T ss_dssp TTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEE
T ss_pred chhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccc
Confidence 479999999999987664 4789999999999875 677755555443 899999999999984433 34556788888
Q ss_pred EEccccccccccccccCCCC-CCCeeecCCCcccCCCCccccCCCCCCee-Eeccccccccccc-cCC-CCcCeEEccCc
Q 005001 158 LNVSRNSLTQSIGDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSL-YLQNNQVTGSLNV-FSG-LPLTTLNVANN 233 (720)
Q Consensus 158 L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l~~L~~L-~l~~N~l~~~~~~-~~~-~~L~~l~l~~N 233 (720)
+..+++.+....+..|..++ .++.|++++|+++ .++.......+++.+ ++++|+|+...+. +.. .+|+.|+|++|
T Consensus 133 ~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N 211 (242)
T d1xwdc1 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 211 (242)
T ss_dssp EEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTS
T ss_pred ccccccccccccccccccccccceeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCC
Confidence 88889899877777887765 7899999999999 465555566676655 5788889875443 444 56999999999
Q ss_pred cCcccCcccccccceeeecCC
Q 005001 234 HFSGWIPRELISIRTFIYDGN 254 (720)
Q Consensus 234 ~l~g~ip~~l~~l~~l~l~~n 254 (720)
+|+...+..|.+++.|...++
T Consensus 212 ~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 212 RIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CCCCCCSSSCTTCCEEESSSE
T ss_pred cCCccCHHHHcCCcccccCcC
Confidence 999443446788887765443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.98 E-value=1.8e-11 Score=127.00 Aligned_cols=175 Identities=18% Similarity=0.200 Sum_probs=129.0
Q ss_pred CCEEEEEcCCCCCccc----ccccccCCCCCCEEEccCCCCCCCCCCC---------------CCCccceeccccccCcC
Q 005001 83 SAVVSIDISGLGLSGT----MGYLLSDLLSLRKFDLSGNSIHDTIPYQ---------------LPPNLTSLNLASNNFSG 143 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~----~~~~l~~l~~L~~L~L~~N~l~~~~p~~---------------~~~~L~~L~L~~N~l~g 143 (720)
.+++.|+|++|.++.. +...+...++|++|+|++|.++...... ..+.|+.|++++|+++.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 5788999999988764 3445667889999999999875211100 12578899999998873
Q ss_pred C----CCccccccCCccEEEccccccccc-----cccccCCCCCCCeeecCCCcccCC----CCccccCCCCCCeeEecc
Q 005001 144 N----LPYSIASMVSLSYLNVSRNSLTQS-----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQN 210 (720)
Q Consensus 144 ~----~p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~ 210 (720)
. +...+..+++|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 2 334456788999999999998743 345677889999999999998642 345567889999999999
Q ss_pred ccccccc--------cccCCCCcCeEEccCccCccc----Cccc----ccccceeeecCCcCC
Q 005001 211 NQVTGSL--------NVFSGLPLTTLNVANNHFSGW----IPRE----LISIRTFIYDGNSFD 257 (720)
Q Consensus 211 N~l~~~~--------~~~~~~~L~~l~l~~N~l~g~----ip~~----l~~l~~l~l~~n~~~ 257 (720)
|.|++.- .......|+.|++++|+|+.. +... ..+++.|++++|.+.
T Consensus 253 n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 9998631 112234699999999999753 2222 357889999999885
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.86 E-value=2.1e-10 Score=115.15 Aligned_cols=171 Identities=23% Similarity=0.237 Sum_probs=99.5
Q ss_pred CEEEEEcCCCCCccc-ccccccCCCCCCEEEccCCCCCCCCCCCCC--Cccceeccccc-cCcCC-CCccccccCCccEE
Q 005001 84 AVVSIDISGLGLSGT-MGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASN-NFSGN-LPYSIASMVSLSYL 158 (720)
Q Consensus 84 ~v~~l~l~~~~l~g~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N-~l~g~-~p~~~~~l~~L~~L 158 (720)
++..|||+++.+.+. +...+..+++|++|+|+++.+++..+..+. ++|++|+|+++ .++.. +.....++++|++|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L 126 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence 677888888877654 345577788888888888887765554443 67888888874 55522 22234567888888
Q ss_pred Ecccc-ccccc-cccccCC-CCCCCeeecCCC--cccCC-CCccccCCCCCCeeEeccc-cccccc-ccc-CCCCcCeEE
Q 005001 159 NVSRN-SLTQS-IGDIFGN-LAGLATLDLSFN--NFSGD-LPNSFISLSNISSLYLQNN-QVTGSL-NVF-SGLPLTTLN 229 (720)
Q Consensus 159 ~L~~N-~l~~~-~p~~~~~-l~~L~~L~l~~N--~l~g~-~p~~~~~l~~L~~L~l~~N-~l~~~~-~~~-~~~~L~~l~ 229 (720)
+|+++ .++.. +...+.. .++|+.|++++. .++.. +...+..+++|++|+|++| .+++.. ..+ ...+|+.|+
T Consensus 127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~ 206 (284)
T d2astb2 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS 206 (284)
T ss_dssp ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEE
Confidence 88774 44422 1222222 356777777653 33321 2222345677777777764 355422 222 223477777
Q ss_pred ccC-ccCcccCcccc---cccceeeecCC
Q 005001 230 VAN-NHFSGWIPREL---ISIRTFIYDGN 254 (720)
Q Consensus 230 l~~-N~l~g~ip~~l---~~l~~l~l~~n 254 (720)
|++ +.+++.....+ .+|+.|++.++
T Consensus 207 L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 207 LSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 777 45655444333 45556666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.71 E-value=1.3e-09 Score=112.68 Aligned_cols=175 Identities=19% Similarity=0.151 Sum_probs=99.8
Q ss_pred CCEEEEEcCCCCCccc----------ccccccCCCCCCEEEccCCCCCCCCCCCC------CCccceeccccccCcCCCC
Q 005001 83 SAVVSIDISGLGLSGT----------MGYLLSDLLSLRKFDLSGNSIHDTIPYQL------PPNLTSLNLASNNFSGNLP 146 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~----------~~~~l~~l~~L~~L~L~~N~l~~~~p~~~------~~~L~~L~L~~N~l~g~~p 146 (720)
.++..|+++++.+... +...+...++|++|+|++|.++..-...+ .++|+.|+|++|.++..-.
T Consensus 59 ~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~ 138 (344)
T d2ca6a1 59 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 138 (344)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccc
Confidence 4566677766543211 22335556777777777777764322111 1567777777776642111
Q ss_pred cc-------------ccccCCccEEEccccccccc----cccccCCCCCCCeeecCCCcccCC-----CCccccCCCCCC
Q 005001 147 YS-------------IASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD-----LPNSFISLSNIS 204 (720)
Q Consensus 147 ~~-------------~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~-----~p~~~~~l~~L~ 204 (720)
.. ....+.|+.|++++|+++.. +...+...+.|+.|+|++|+++.. +...+..+++|+
T Consensus 139 ~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~ 218 (344)
T d2ca6a1 139 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 218 (344)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred ccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhc
Confidence 11 12355677777777776632 233345567778888888777531 234456677788
Q ss_pred eeEecccccccc----c-cc-cCCCCcCeEEccCccCcccCcccc---------cccceeeecCCcCC
Q 005001 205 SLYLQNNQVTGS----L-NV-FSGLPLTTLNVANNHFSGWIPREL---------ISIRTFIYDGNSFD 257 (720)
Q Consensus 205 ~L~l~~N~l~~~----~-~~-~~~~~L~~l~l~~N~l~g~ip~~l---------~~l~~l~l~~n~~~ 257 (720)
.|+|++|.|+.. + .. ....+|+.|+|++|.|++.-...+ .+++.|++++|.+.
T Consensus 219 ~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 219 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred ccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 888888877542 1 11 123457788888887765422211 34667777777653
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=1.7e-09 Score=108.46 Aligned_cols=177 Identities=21% Similarity=0.232 Sum_probs=127.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEccCC-CCCCCCCC---CCCCccceeccccc-cCcCC-CCccccc-cCCc
Q 005001 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGN-SIHDTIPY---QLPPNLTSLNLASN-NFSGN-LPYSIAS-MVSL 155 (720)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N-~l~~~~p~---~~~~~L~~L~L~~N-~l~g~-~p~~~~~-l~~L 155 (720)
.+++.|+|+++.+++.....++.+++|++|+|+++ .+++..-. .-.++|++|+|+++ .++.. +...+.. .++|
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccccc
Confidence 47999999999999888889999999999999995 66632111 11379999999985 55522 2333444 4789
Q ss_pred cEEEcccc--ccccc-cccccCCCCCCCeeecCCC-cccCCCCccccCCCCCCeeEecc-ccccccc--cccCCCCcCeE
Q 005001 156 SYLNVSRN--SLTQS-IGDIFGNLAGLATLDLSFN-NFSGDLPNSFISLSNISSLYLQN-NQVTGSL--NVFSGLPLTTL 228 (720)
Q Consensus 156 ~~L~L~~N--~l~~~-~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~~~~--~~~~~~~L~~l 228 (720)
+.|+|++. .++.. +...+.++++|++|+|++| .+++..+..+.++++|++|+|++ +.|++.. ......+|+.|
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L 230 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 230 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred chhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEE
Confidence 99999864 45533 3344567899999999986 58878888899999999999999 5677632 22233569999
Q ss_pred EccCccCcccCcccccccceeeecCCcCCCC
Q 005001 229 NVANNHFSGWIPRELISIRTFIYDGNSFDNG 259 (720)
Q Consensus 229 ~l~~N~l~g~ip~~l~~l~~l~l~~n~~~~~ 259 (720)
+++++.-.+.++.-...++.|.+..+++...
T Consensus 231 ~l~~~~~d~~l~~l~~~lp~L~i~~~~ls~~ 261 (284)
T d2astb2 231 QVFGIVPDGTLQLLKEALPHLQINCSHFTTI 261 (284)
T ss_dssp ECTTSSCTTCHHHHHHHSTTSEESCCCSCCT
T ss_pred eeeCCCCHHHHHHHHHhCccccccCccCCCC
Confidence 9998832333433335677788877776644
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=2.1e-09 Score=114.94 Aligned_cols=132 Identities=20% Similarity=0.142 Sum_probs=55.6
Q ss_pred CEEEEEcCCCCCcc-----cccccccCCCCCCEEEccCCCCCCCCCCC----C--CCccceeccccccCcCCCCccc---
Q 005001 84 AVVSIDISGLGLSG-----TMGYLLSDLLSLRKFDLSGNSIHDTIPYQ----L--PPNLTSLNLASNNFSGNLPYSI--- 149 (720)
Q Consensus 84 ~v~~l~l~~~~l~g-----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~----~--~~~L~~L~L~~N~l~g~~p~~~--- 149 (720)
....+++.+|.+.. ...........|+.|++++|.+....... + .+.++.+++++|.++......+
T Consensus 227 ~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~ 306 (460)
T d1z7xw1 227 SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET 306 (460)
T ss_dssp TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH
T ss_pred cccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcc
Confidence 44555555554422 12223334455555555555554211100 0 1345555555555542211111
Q ss_pred --cccCCccEEEcccccccccccc----ccCCCCCCCeeecCCCcccCC----CCcccc-CCCCCCeeEeccccccc
Q 005001 150 --ASMVSLSYLNVSRNSLTQSIGD----IFGNLAGLATLDLSFNNFSGD----LPNSFI-SLSNISSLYLQNNQVTG 215 (720)
Q Consensus 150 --~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~g~----~p~~~~-~l~~L~~L~l~~N~l~~ 215 (720)
.....|+.+++++|.++..... .+...++|++|+|++|++++. ++..+. ..+.|++|+|++|+|+.
T Consensus 307 l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~ 383 (460)
T d1z7xw1 307 LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 383 (460)
T ss_dssp HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred ccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence 1223455555555555433222 222334555555555555421 122221 23445555555555543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.29 E-value=9.1e-07 Score=86.70 Aligned_cols=148 Identities=12% Similarity=0.074 Sum_probs=97.0
Q ss_pred cHHHHhcCCCccceeccCCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcC-CCCCccccceEEeecCe
Q 005001 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQ 482 (720)
Q Consensus 404 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 482 (720)
++...-..|+..+..+-++.+.||+... +++.+++|+....... ....+.+|...+..+ .+--+.+++.+....+.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 3444455666655544455678999865 4566778877543221 122355666666554 24346777888888889
Q ss_pred EEEEEEecCCCCHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 005001 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC------------------------------ 532 (720)
Q Consensus 483 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~------------------------------ 532 (720)
.++||++++|.++.+... ... ....++.++++.++.||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~------~~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYE------DEQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTT------TCS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEeccccccccccc------ccc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 999999999988865442 111 12334556666666666432
Q ss_pred --------------------------CCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 533 --------------------------LPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 533 --------------------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
.+.++|+|+.|.||++++++..-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987667799999874
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=4e-08 Score=89.10 Aligned_cols=67 Identities=24% Similarity=0.269 Sum_probs=34.3
Q ss_pred cCCCCCCCeeecCCCcccCC--CCccccCCCCCCeeEecccccccccc--ccCCCCcCeEEccCccCcccC
Q 005001 173 FGNLAGLATLDLSFNNFSGD--LPNSFISLSNISSLYLQNNQVTGSLN--VFSGLPLTTLNVANNHFSGWI 239 (720)
Q Consensus 173 ~~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~L~~l~l~~N~l~g~i 239 (720)
+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+ .....+|+.|+|++|.+++..
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence 33455555555555555532 12234455566666666666554322 222334666666666665443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.25 E-value=2.1e-08 Score=106.98 Aligned_cols=68 Identities=19% Similarity=0.247 Sum_probs=31.6
Q ss_pred ccccccCCccEEEccccccccc----cccccC-CCCCCCeeecCCCcccCC----CCccccCCCCCCeeEecccccc
Q 005001 147 YSIASMVSLSYLNVSRNSLTQS----IGDIFG-NLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVT 214 (720)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 214 (720)
..+..+++|++|||++|.|+.. +...+. ...+|+.|+|++|++++. ++..+..+++|++|+|++|+|+
T Consensus 49 ~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 49 SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp HHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred HHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 3344555555555555555421 111221 123455555555555432 2333445555555555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.11 E-value=4.2e-07 Score=82.12 Aligned_cols=67 Identities=24% Similarity=0.278 Sum_probs=33.9
Q ss_pred cccccCCccEEEccccccccc--cccccCCCCCCCeeecCCCcccCCCCc-cccCCCCCCeeEeccccccc
Q 005001 148 SIASMVSLSYLNVSRNSLTQS--IGDIFGNLAGLATLDLSFNNFSGDLPN-SFISLSNISSLYLQNNQVTG 215 (720)
Q Consensus 148 ~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~~ 215 (720)
...++++|++|+|++|+|+.. ++..+..+++|+.|+|++|+++. ++. .+....+|+.|+|++|.++.
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCc
Confidence 334555555555665555543 23344455556666666666552 222 22233345556666665554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.83 E-value=7.8e-06 Score=79.35 Aligned_cols=130 Identities=20% Similarity=0.198 Sum_probs=83.2
Q ss_pred eeccCCC-cEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCC--CCCccccceEEeecCeEEEEEEecCCC
Q 005001 417 LIGEGSL-GRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR--HPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 417 ~lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~g 493 (720)
.+..|.. +.||+....++..+++|....... ..+.+|...++.+. .-.+.+++.+..+.+..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3445553 678999988888889998754432 23445555554442 233667788888888899999999886
Q ss_pred CHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 005001 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC----------------------------------------- 532 (720)
Q Consensus 494 sL~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----------------------------------------- 532 (720)
++.+. .... ...+.++.+.|+-||+..
T Consensus 92 ~~~~~---------~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 92 DLLSS---------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp ETTTS---------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred ccccc---------cccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 55321 1111 111223333344444211
Q ss_pred --------------CCCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 533 --------------LPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 533 --------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1237999999999999987667899999764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.54 E-value=5.7e-06 Score=74.79 Aligned_cols=39 Identities=21% Similarity=0.072 Sum_probs=17.8
Q ss_pred ccCCccEEEccccccccc----cccccCCCCCCCeeecCCCcc
Q 005001 151 SMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNF 189 (720)
Q Consensus 151 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l 189 (720)
..+.|++|+|++|.|+.. +-..+..-++|++|+|++|.+
T Consensus 70 ~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 70 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred hcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence 344555555555555432 122333444455555555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.53 E-value=6.7e-06 Score=74.32 Aligned_cols=107 Identities=19% Similarity=0.229 Sum_probs=76.4
Q ss_pred CCEEEEEcCCC-CCccc----ccccccCCCCCCEEEccCCCCCCCCCCCCC------CccceeccccccCcCC----CCc
Q 005001 83 SAVVSIDISGL-GLSGT----MGYLLSDLLSLRKFDLSGNSIHDTIPYQLP------PNLTSLNLASNNFSGN----LPY 147 (720)
Q Consensus 83 ~~v~~l~l~~~-~l~g~----~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~------~~L~~L~L~~N~l~g~----~p~ 147 (720)
..++.|+|+++ .++.. +...+...+.|++|+|++|.++......+. +.|+.|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 46899999874 46542 445677889999999999998743333332 7899999999999843 234
Q ss_pred cccccCCccEEEccccccccc-------cccccCCCCCCCeeecCCCcc
Q 005001 148 SIASMVSLSYLNVSRNSLTQS-------IGDIFGNLAGLATLDLSFNNF 189 (720)
Q Consensus 148 ~~~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~l 189 (720)
.+...++|++|+|++|.+... +...+..-++|+.|+++.+..
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 566778999999999976532 334445557777777766543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.30 E-value=0.00025 Score=73.04 Aligned_cols=78 Identities=17% Similarity=0.071 Sum_probs=45.6
Q ss_pred cceeccCCCcEEEEEEEcC-CcEEEEEEcccccc-----ChHHHHHHHHHHHHhhcC-CC--CCccccceEEeecCeEEE
Q 005001 415 EFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-----SLQEEDNFLEAVSNMSRL-RH--PNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~~~~e~~~l~~l-~h--~niv~l~~~~~~~~~~~l 485 (720)
.+.||.|....||++...+ ++.|++|.-..... ......+...|...++.+ .+ ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999997654 67888886432110 011122344566666544 22 334455543 4556789
Q ss_pred EEEecCCCC
Q 005001 486 VYEYVGNGN 494 (720)
Q Consensus 486 V~e~~~~gs 494 (720)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.92 E-value=1.6e-05 Score=71.73 Aligned_cols=14 Identities=14% Similarity=0.214 Sum_probs=7.7
Q ss_pred ccCCCCCCEEEccC
Q 005001 103 LSDLLSLRKFDLSG 116 (720)
Q Consensus 103 l~~l~~L~~L~L~~ 116 (720)
..+.+.|++|+|++
T Consensus 13 ~~~~~~L~~L~L~~ 26 (166)
T d1io0a_ 13 QNNDPDLEEVNLNN 26 (166)
T ss_dssp HTTCTTCCEEECTT
T ss_pred HhcCCCCcEEEcCC
Confidence 34455566666654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.69 E-value=7.2e-05 Score=67.17 Aligned_cols=114 Identities=14% Similarity=0.230 Sum_probs=61.5
Q ss_pred CCCEEEEEcCC-CCCcc----cccccccCCCCCCEEEccCCCCCCCCCCCCCCccceeccccccCcCCCCccccccCCcc
Q 005001 82 GSAVVSIDISG-LGLSG----TMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS 156 (720)
Q Consensus 82 ~~~v~~l~l~~-~~l~g----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 156 (720)
...++.|+|++ +.++. .+...+...++|++|+|++|.++...-.. +-..+...++|+
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~------------------L~~~l~~~~~l~ 77 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFA------------------LAEMLKVNNTLK 77 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHH------------------HHHHHHHCSSCC
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHH------------------HHHHHhhcccch
Confidence 35688999987 45653 23456678889999999999887321111 112223334455
Q ss_pred EEEccccccccc----cccccCCCCCCCeeec--CCCcccC----CCCccccCCCCCCeeEeccccc
Q 005001 157 YLNVSRNSLTQS----IGDIFGNLAGLATLDL--SFNNFSG----DLPNSFISLSNISSLYLQNNQV 213 (720)
Q Consensus 157 ~L~L~~N~l~~~----~p~~~~~l~~L~~L~l--~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l 213 (720)
.|++++|.++.. +...+...++|+.++| ++|.+.. .+...+...++|+.|+++.|..
T Consensus 78 ~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 78 SLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp EEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred hhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 555555554422 2234444555554333 3444532 2223344556666666665543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.42 E-value=0.013 Score=57.91 Aligned_cols=70 Identities=20% Similarity=0.214 Sum_probs=44.5
Q ss_pred CCCcEEEEEEEcCCcEEEEEEccccccChHHHHHHHHHHHHhhcCCC-----CCccccc--eEEeecCeEEEEEEecCCC
Q 005001 421 GSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-----PNIVTLA--GYCAEHGQRLLVYEYVGNG 493 (720)
Q Consensus 421 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv~l~--~~~~~~~~~~lV~e~~~~g 493 (720)
+.--.||++..++|+.|++|..+....+ .+++.+|...+..+.. +..+..- ..+...+..+.++++++|.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 4456899999999999999998654322 3445566665554421 2112221 1235567789999999863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.86 E-value=0.0086 Score=61.17 Aligned_cols=73 Identities=14% Similarity=0.092 Sum_probs=47.1
Q ss_pred cceeccCCCcEEEEEEEcCC--------cEEEEEEccccccChHHHHHHHHHHHHhhcCC-CCCccccceEEeecCeEEE
Q 005001 415 EFLIGEGSLGRVYRAEFANG--------KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLL 485 (720)
Q Consensus 415 ~~~lG~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 485 (720)
++.|+.|-.-.+|++...++ +.|.+++..... . .....+|..+++.+. +.-..++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 45688899999999987543 467777665321 2 233456777777663 3334466776643 68
Q ss_pred EEEecCCCCH
Q 005001 486 VYEYVGNGNL 495 (720)
Q Consensus 486 V~e~~~~gsL 495 (720)
|+||++|.+|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.63 E-value=0.035 Score=54.36 Aligned_cols=30 Identities=20% Similarity=0.260 Sum_probs=26.8
Q ss_pred CCcEEecCCCCCEEeCCCCceEEcccCCCc
Q 005001 534 PSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (720)
Q Consensus 534 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 563 (720)
.++||+|+.+.||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999998777899999874
|